sentence,value,temperature,domain
"In the C57BL/6J mouse model, CRISPR‑mediated knockout of the Bcl‑2 gene in RAW264.7 macrophages led to a marked increase in apoptotic cell death, confirming that Bcl‑2 is essential for cell‑line survival during inflammatory stimulation.",-37.75,0.6,cellline
"In C57BL/6J mice, the CRISPR‑mediated knockout of the Brca1 gene in U87MG cells led to increased γ‑H2AX foci and a higher sensitivity to the DNA‑damaging agent doxorubicin, confirming the synthetic lethal interaction between BRCA1 deficiency and topoisomerase II inhibition.",-39.25,0.6,cellline
"In U87MG cells, the CRISPR‑mediated knockout of the EGFR gene leads to increased sensitivity to temozolomide and a concomitant decrease in phosphorylated AKT levels, suggesting that EGFR drives chemoresistance through PI3K‑AKT signaling.",-33.5,0.6,cellline
"In our study, the C57BL/6J mouse macrophage cell line RAW264.7 was treated with the small molecule inhibitor JQ1, leading to a significant down‑regulation of the pro‑inflammatory cytokine IL6 and a concomitant increase in the expression of the anti‑apoptotic protein BCL2, thereby suggesting a potential therapeutic strategy for inflammatory diseases.",-44.25,0.6,cellline
"Treatment of the glioblastoma cell line SJ‑GBM2 with the kinase inhibitor CH‑8 reduced phosphorylation of EGFR and induced apoptosis, a response that was markedly amplified when combined with the DNA‑damaging agent doxorubicin, suggesting that EGFR signaling mediates chemoresistance in SJ‑GBM2 cells.",-41.25,0.6,cellline
"Treatment with the BET inhibitor JQ1 reduced proliferation and induced apoptosis in the HCT116 and MCF7/AdrR cell lines, while co‑treatment with the PI3K inhibitor LY294002 rescued AKT phosphorylation and partially restored cell viability.",-30.875,0.6,cellline
"Treatment using the C57BL/6J mouse model revealed that the up‑regulation of the PI3K‑AKT pathway in HCT116 cells carrying the TP53 c.215C>G variant confers resistance to doxorubicin, whereas the same variant in MCF7/AdrR cells fails to activate the same survival signal, suggesting a cell‑line‑specific effect of the mutation on drug response.",-64.0,0.6,cellline
"Treatment-induced apoptosis of the U87MG glioblastoma cell line was markedly enhanced by co‑administration of doxorubicin, a result that was confirmed by increased caspase‑3 activation and reduced cell viability in vitro.",-37.25,0.6,cellline
"Upon long‑term exposure to the pro‑inflammatory cytokine IL‑1β, the U87MG glioblastoma cell line exhibited a marked up‑regulation of the chemokine CXCL10, which in turn enhanced the recruitment of RAW264.7 macrophages and promoted a tumor‑associated myeloid phenotype.",-44.25,0.6,cellline
"Upon chronic exposure to doxorubicin, the U87MG glioblastoma cell line exhibited a dramatic up‑regulation of the p53‑dependent apoptosis pathway, correlating with the BRCA1 c.68_69delAG variant observed in the same culture.",-40.75,0.6,cellline
"Upon exposure to the oxidative agent tert‑butyl hydroperoxide, the C57BL/6J macrophage cell line RAW264.7 exhibited a pronounced up‑regulation of the Nrf2‑driven antioxidant gene NQO1, while the human glioblastoma line U87MG displayed a concomitant down‑regulation of the pro‑apoptotic gene BAX, suggesting a differential cellular stress response that may influence therapeutic efficacy in tumor versus immune cells.",-55.75,0.6,cellline
"Upon inhibition of the PI3K/AKT pathway with LY294002, the C57BL/6J macrophage cell line RAW264.7 exhibited a marked reduction in TNF‑α secretion, suggesting that PI3K/AKT signaling is essential for the inflammatory response in this murine model.",-40.75,0.6,cellline
"The chemotherapeutic agent doxorubicin induces apoptosis in the human cervical cancer cell line HeLa, a process that is amplified by overexpression of the tumor suppressor gene TP53 and suppressed by the presence of the BRCA1 c.68_69delAG variant, thereby highlighting a potential interaction between drug efficacy and sequence‑variant status in this organoid model of Homo sapiens.",-47.75,0.6,cellline
"The RAW264.7 macrophage cell line treated with the STAT3 inhibitor stattic exhibited a marked decrease in IL‑6 secretion, suggesting that stattic suppresses pro‑inflammatory signaling in RAW264.7 cells.",-31.625,0.6,cellline
"The CRISPR‑Cas9‑mediated knockout of TP53 in the HCT116 cell line markedly increased the expression of the drug‑resistance gene ABCG2, thereby reducing doxorubicin efficacy and promoting a stem‑like phenotype that is characteristic of chemoresistant colorectal cancers.",-35.25,0.6,cellline
"The C57BL/6J mouse model, in which the PPARγ antagonist GW9662 was administered, exhibited reduced tumor growth in U87MG xenografts, whereas co‑treatment with the antioxidant N‑acetylcysteine restored the expression of the tumor suppressor gene TP53 and reversed the up‑regulation of the pro‑inflammatory cytokine IL‑6.",-51.25,0.6,cellline
"CRISPR‑Cas9‑mediated knockout of TP53 in the HCT116 cell line dramatically increased the sensitivity of these cells to doxorubicin, as measured by a significant decrease in IC50 compared with wild‑type HCT116 cells.",-27.625,0.6,cellline
"CRBP1 knockdown in the U87MG glioblastoma cell line leads to increased sensitivity to temozolomide, suggesting a potential therapeutic target for enhancing chemotherapy efficacy in patients with TP53-mutant tumors.",-41.25,0.6,cellline
CR‑ISPR‑mediated knockout of TP53 in the U87MG glioblastoma cell line (U87MG) led to increased sensitivity to the DNA‑damaging agent doxorubicin (doxorubicin) and concomitant up‑regulation of the pro‑apoptotic gene BAX (BAX).,-40.0,0.6,cellline
"CRL-4003 (HeLa) cells treated with the BCL‑2 inhibitor venetoclax exhibited a dose‑dependent increase in caspase‑3 activation, whereas the C57BL/6J‑derived RAW264.7 macrophages showed no significant apoptosis despite the same drug exposure.",-50.75,0.6,cellline
"Activation of the NRF2 pathway by curcumin in the C57BL/6J‑derived RAW264.7 macrophage cell line reduces LPS‑induced IL‑6 secretion, thereby demonstrating a protective anti‑inflammatory effect in this murine model.",-33.0,0.6,cellline
"Activation-induced apoptosis of C57BL/6J splenocytes was markedly enhanced when the cells were treated with the small‑molecule inhibitor CH-8, which binds to the pro‑apoptotic protein BAX and promotes its oligomerization on the mitochondrial membrane.",-46.5,0.6,cellline
"Activation analysis revealed that the inflammatory cytokine IL‑6 is up‑regulated in RAW264.7 macrophages treated with the chemotherapeutic doxorubicin, whereas C57BL/6J mice carrying the BRCA1 c.68_69delAG variant exhibit a reduced tumor‑suppressive response to the same drug.",-54.5,0.6,cellline
"Activation and subsequent apoptosis of the HCT116 cell line by the DNA‑crosslinking agent cisplatin was markedly enhanced when the cells were pre‑treated with the small‑molecule inhibitor of the PI3K/AKT pathway, LY294002, revealing a synergistic interaction that could be exploited for targeted cancer therapy.",-51.5,0.6,cellline
"C57BL/6J macrophages stimulated with lipopolysaccharide upregulate the NLRP3 inflammasome, a response that is markedly attenuated when the same cells are co‑treated with the small‑molecule inhibitor MCC950, thereby reducing IL‑1β secretion and ameliorating inflammatory pathology in the experimental model.",-35.25,0.6,cellline
"C64‑dependent phosphorylation of p53 in the C57BL/6J macrophage cell line RAW264.7 drives the transcriptional up‑regulation of the pro‑inflammatory cytokine IL‑6, thereby enhancing the chemotactic response of neutrophils toward sites of tissue injury.",-51.75,0.6,cellline
Cumulative exposure to doxorubicin in the U87MG glioblastoma cell line induces a BRCA1 c.68_69delAG variant that correlates with increased apoptosis and heightened sensitivity to the chemotherapeutic agent temozolomide.,-34.0,0.6,cellline
"Cytotoxicity assays on the C57BL/6J macrophage line RAW264.7 revealed that treatment with the small molecule inhibitor doxorubicin (CH-8) induced a dose-dependent increase in apoptotic markers, suggesting a potential therapeutic strategy for targeting inflammatory pathways in neurodegenerative disease models.",-49.75,0.6,cellline
"HCT116 cells treated with the DNA‑damaging agent doxorubicin exhibit a marked up‑regulation of the p53‑dependent transcription factor p21, which in turn induces G1 arrest and enhances apoptosis.",-29.75,0.6,cellline
"HMC-1 cells expressing the NLRP3 inflammasome were treated with the selective NLRP3 inhibitor MCC950, resulting in a dose-dependent decrease in IL-1β secretion and reduced caspase‑1 activation in the C57BL/6J macrophage line RAW264.7.",-53.5,0.6,cellline
"Hepatocyte growth factor stimulation of the HCT116 cell line upregulates the CXCL12/CXCR4 axis, thereby enhancing migratory invasion through a PI3K‑AKT‑dependent pathway.",-33.75,0.6,cellline
"HIF‑1α activation in C57BL/6J macrophages exposed to the hypoxic micro‑environment of SJ‑GBM2 tumors drives VEGFA secretion, thereby promoting angiogenesis that supports U87MG glioblastoma growth.",-36.75,0.6,cellline
"Using the C57BL/6J mouse model, we observed that the expression of the inflammatory cytokine IL‑6 was significantly up‑regulated in RAW264.7 macrophages treated with the small‑molecule inhibitor JAK2i, suggesting that JAK2 inhibition in this cell line may drive an anti‑inflammatory phenotype that could be exploited for therapeutic modulation of cytokine storms in severe COVID‑19 patients.",-58.25,0.6,cellline
"Using CRISPR-Cas9 editing, the TP53 knockout in HCT116 cells led to increased resistance to doxorubicin, whereas reintroduction of wild-type TP53 restored sensitivity and induced apoptosis.",-28.625,0.6,cellline
"Using C57BL/6J mice, we observed that the pro‑inflammatory cytokine IL‑6 secreted by RAW264.7 macrophages up‑regulated the drug‑resistance transporter P‑gp in the HCT116 colorectal cancer cell line, thereby attenuating doxorubicin cytotoxicity.",-41.25,0.6,cellline
"Using a CRISPR/Cas9 knock‑in approach, we introduced the BRCA1 c.68_69delAG SequenceVariant into the C57BL/6J mouse embryo, and subsequently isolated HCT116 cells that exhibited a marked increase in the expression of the DNA‑repair GeneOrGeneProduct BRCA1, thereby enhancing their resistance to the DNA‑damaging ChemicalEntity doxorubicin.",-54.75,0.6,cellline
"Pseudomonas aeruginosa infection of RAW264.7 macrophages upregulated the IL-1β promoter in a STAT3-dependent manner, thereby enhancing the inflammatory response and promoting the proliferation of U87MG glioblastoma cells.",-43.5,0.6,cellline
"Pifithrin‑α markedly reduced proliferation of the HCT116 colorectal carcinoma cell line while simultaneously enhancing p53‑dependent apoptosis, a response that was not observed in the C57BL/6J mouse embryonic fibroblasts treated under identical conditions.",-43.0,0.6,cellline
"Pyrimethamine treatment of the HCT116 cell line reduces the expression of the drug‑resistance gene MDR1, thereby sensitizing the cells to cisplatin and increasing apoptosis.",-32.25,0.6,cellline
"P53-mediated apoptosis is markedly enhanced in the U87MG glioblastoma cell line when treated with the DNA‑crosslinking agent cisplatin, an effect that is attenuated by co‑administration of the antioxidant N‑acetylcysteine.",-35.0,0.6,cellline
"Engineered C57BL/6J mice overexpressing the mutant TP53 allele c.215C>G (p.Arg72Pro) exhibit increased tumor burden in U87MG glioblastoma xenografts, indicating that the sequence variant enhances oncogenic signaling in this human cell line.",-45.75,0.6,cellline
"Engineers cultured HCT116 and U87MG cells with the CRISPR‑edited TP53 c.68_69delAG variant, then treated them with doxorubicin to assess whether the mutation altered drug‑induced apoptosis and cell‑cycle arrest in these human tumor cell lines.",-49.25,0.6,cellline
"Engineer‑derived CRISPR/Cas9 editing of the TP53 gene in HCT116 cells revealed that the BRCA1 c.68_69delAG variant increased chemotherapeutic resistance, a phenotype also observed in MCF7/AdrR cells treated with doxorubicin.",-48.25,0.6,cellline
"Engine-derived CRISPR-Cas9 editing of the TP53 gene in the HCT116 cell line reduced the expression of the p21 protein, thereby increasing the susceptibility of these cells to the cytotoxic effects of doxorubicin.",-49.5,0.6,cellline
"Intracellular ROS levels were markedly elevated in C57BL/6J macrophage RAW264.7 cells treated with the pro‑oxidant drug doxorubicin, leading to activation of the p53‑dependent apoptosis pathway and a significant increase in the expression of the pro‑inflammatory cytokine IL‑6.",-40.25,0.6,cellline
"Intriguingly, the chemotherapeutic agent doxorubicin induced a marked increase in the expression of the pro‑apoptotic protein BAX in the HCT116 cell line, whereas the same treatment had no detectable effect on BAX levels in the drug‑resistant MCF7/AdrR cells, suggesting a cell‑line‑specific response to DNA damage that may underlie differential sensitivity to anthracyclines.",-42.75,0.6,cellline
"Intratumoral injection of doxorubicin into C57BL/6J mice bearing subcutaneous HCT116 xenografts induced a marked reduction in tumor volume and upregulated the tumor suppressor TP53, while simultaneously activating the NF‑κB pathway in the surrounding RAW264.7 macrophages, thereby illustrating a complex interplay between chemotherapy, tumor cell apoptosis, and the innate immune response.",-51.75,0.6,cellline
"Intrigued by the differential response of the C57BL/6J and RAW264.7 macrophages to lipopolysaccharide, we discovered that the NF‑κB‑dependent upregulation of IL‑6 in RAW264.7 cells was markedly attenuated when treated with the novel small‑molecule inhibitor CH‑8, suggesting a potential therapeutic avenue for dampening chronic inflammation.",-55.5,0.6,cellline
"Knock‑down of the KRAS gene in the HCT116 cell line markedly reduced the expression of the downstream effector ERK1/2, thereby attenuating the proliferative response to the chemical carcinogen benzo[a]pyrene in a manner that mimics the phenotype observed in the C57BL/6J mouse model of colorectal cancer.",-45.75,0.6,cellline
"Knocking out the TP53 gene in the HCT116 cell line markedly enhances the cells’ resistance to doxorubicin-induced apoptosis while simultaneously increasing the expression of the drug efflux transporter ABCB1, a phenomenon that mirrors the heightened chemoresistance observed in MCF7/AdrR cells harboring the same TP53 loss.",-38.0,0.6,cellline
"Knocked‑down of the P53 pathway in HCT116 cells markedly increases the sensitivity of the tumor to doxorubicin, as evidenced by a four‑fold reduction in IC50 relative to untreated C57BL/6J‑derived fibroblasts.",-49.25,0.6,cellline
"Knitting the inflammatory cytokine profile of RAW264.7 macrophages revealed that the C57BL/6J-derived LPS‑stimulated cells released significantly higher levels of IL‑6 and TNF‑α compared with HCT116 colon carcinoma cells, suggesting a cell‑line–specific innate immune response to bacterial endotoxin.",-65.5,0.6,cellline
"A dose‑dependent inhibition of EGFR signaling was observed in HCT116 cells upon treatment with the small‑molecule inhibitor gefitinib, leading to apoptosis that was further potentiated when the cells were co‑treated with the autophagy inducer rapamycin.",-41.0,0.6,cellline
"A pharmacological screen of the chemotherapeutic agent doxorubicin on the HCT116 colorectal carcinoma cell line revealed a dose‑dependent decrease in cell viability that was significantly rescued by co‑treatment with the antioxidant N‑acetylcysteine, indicating that oxidative stress mediates doxorubicin‑induced cytotoxicity in this model.",-36.5,0.6,cellline
"A CRISPR‑Cas9‑mediated knockout of TP53 in HCT116 cells led to increased expression of the DNA‑damage‑response gene GADD45A, thereby sensitizing the cells to doxorubicin‑induced apoptosis.",-24.875,0.6,cellline
"A comparative analysis of apoptosis markers revealed that the C57BL/6J mouse macrophage line RAW264.7 exhibited a significantly higher expression of the pro‑apoptotic gene BAX upon exposure to the chemotherapeutic agent doxorubicin, whereas the human colorectal carcinoma line HCT116 showed a concomitant upregulation of the anti‑apoptotic protein BCL‑2, suggesting a differential intrinsic resistance mechanism between the two cell lines.",-55.25,0.6,cellline
"In the T98G glioblastoma cell line, knockdown of the MEF2C transcription factor reduces VEGFA secretion and concomitantly decreases angiogenic sprouting in co‑cultured HUVECs.",-25.75,0.6,cellline
"In MEF cells, overexpression of the TP53 gene product induces apoptosis, a process that is amplified by the addition of the chemotherapeutic agent doxorubicin and further potentiated when the cells are cultured in a medium containing ethanol.",-39.5,0.6,cellline
"In COS‑7 cells, overexpression of the mutant TP53 variant c.743G>A leads to enhanced apoptosis upon doxorubicin treatment, underscoring the therapeutic potential of targeting this sequence variant in cancer cell lines.",-33.0,0.6,cellline
"In MCF-12A cells, the overexpression of the mutant TP53 variant c.215C>T (p.Pro72Leu) leads to enhanced resistance to doxorubicin-induced apoptosis, a phenotype that is markedly amplified when the cells are co‑treated with the PI3K inhibitor LY294002.",-35.0,0.6,cellline
"The T98G glioblastoma cell line, when treated with the small molecule inhibitor doxorubicin, shows a dose-dependent upregulation of the DNA repair gene BRCA1 c.68_69delAG, suggesting a potential mechanism for chemoresistance in this cellular model.",-30.25,0.6,cellline
"The CRISPR‑Cas9‑mediated knockout of TP53 in T98G cells exposed to doxorubicin induced a pronounced up‑regulation of the DNA‑damage‑response gene ATM, thereby conferring increased chemoresistance in this glioblastoma cell line.",-30.25,0.6,cellline
"The DUCaP cell line, derived from a human prostate adenocarcinoma, exhibits increased expression of the androgen receptor and is often used to study the interaction of testosterone with the TP53 pathway in cancer research.",-37.0,0.6,cellline
"The EGF‑stimulated proliferation of the T98G glioblastoma cell line was markedly attenuated by the small‑molecule inhibitor gefitinib, which binds to the ATP‑binding pocket of the EGFR tyrosine kinase, thereby blocking downstream AKT and MAPK signaling pathways.",-33.75,0.6,cellline
"Oxidative stress induced by doxorubicin treatment in the T98G glioblastoma cell line activates the NRF2 pathway, thereby upregulating the antioxidant enzyme GPX4 and conferring resistance to ferroptosis.",-25.625,0.6,cellline
"Oxytocin treatment of the DU145 prostate cancer cell line markedly increased the expression of the EMT‑associated gene Vimentin, while simultaneously down‑regulating the tumor suppressor TP53, thereby enhancing migratory capacity and invasion potential.",-49.25,0.6,cellline
"Oxaliplatin exposure in the T98G glioblastoma cell line induces a dose‑dependent upregulation of the DNA repair enzyme MGMT, thereby attenuating the cytotoxic effect of temozolomide in vitro.",-35.75,0.6,cellline
"Oxymetazoline treatment of the human colon carcinoma cell line T98G was shown to upregulate the transcription factor SOX2, thereby enhancing the cells’ resistance to temozolomide-induced apoptosis.",-51.5,0.6,cellline
"MEF cells treated with the BRCA1 c.68_69delAG variant exhibited a marked increase in apoptosis, suggesting that the mutation disrupts the DNA damage response in this murine fibroblast line.",-31.375,0.6,cellline
"MEK inhibition in T98G cells carrying the EGFR L858R variant reduced proliferation by downregulating the PI3K/AKT pathway, suggesting a potential therapeutic strategy for glioblastoma patients with this sequence variant.",-33.75,0.6,cellline
"MEFs from the BALB/c mouse strain were transduced with a lentiviral vector encoding the mutant TP53 allele (c.215C>G) and then co‑cultured with the DU145 prostate cancer cell line, revealing that the mutant TP53 protein induces apoptosis in the DU145 cells via activation of the p21 pathway.",-56.25,0.6,cellline
"MEG3 overexpression in the DU145 prostate cancer cell line suppresses TGF‑β1‑induced epithelial‑mesenchymal transition by downregulating SMAD2 phosphorylation, thereby reducing invasion and migration.",-35.0,0.6,cellline
"CO‑culture of the T98G glioblastoma cell line with the MEF‑derived feeder layer and subsequent treatment with the small‑molecule inhibitor doxorubicin resulted in a statistically significant decrease in TP53 protein levels, suggesting that the drug may down‑regulate the tumor‑suppressor pathway in this human cell model.",-48.25,0.6,cellline
"COX‑2 expression in the DU145 prostate carcinoma cell line was markedly up‑regulated by the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis through activation of the TP53 pathway.",-27.5,0.6,cellline
"COLO205 cells treated with the MEK inhibitor trametinib exhibit decreased ERK phosphorylation, a change that is amplified by a concurrent KRAS G12V mutation and mitigated by co‑administration of the PI3K inhibitor LY294002.",-45.25,0.6,cellline
"COJ cells, a derivative of the T98G glioblastoma cell line, were exposed to the small molecule inhibitor doxorubicin, which downregulated the expression of the gene TP53 and induced apoptosis, while the non-tumorigenic Het-1A cells maintained cell viability under the same treatment.",-64.0,0.6,cellline
"A transfection of the T98G glioblastoma cell line with a plasmid encoding the MEF2C transcription factor markedly enhanced the expression of the Cyclin‑dependent kinase inhibitor CDKN1A, thereby inducing G1‑phase arrest and reducing the proliferation rate of the cells.",-40.75,0.6,cellline
"A CRISPR‑Cas9‑mediated deletion of the TP53 promoter in the T98G glioblastoma cell line reduces p53 protein expression, thereby increasing resistance to doxorubicin‑induced apoptosis in vitro.",-25.25,0.6,cellline
"A hypoxic environment induces the up‑regulation of HIF‑1α in the T98G glioblastoma cell line, leading to increased VEGF secretion and enhanced angiogenic potential, thereby facilitating tumor progression.",-32.25,0.6,cellline
"A mutant T98G cell line harboring a BRCA1 c.68_69delAG sequence variant exhibited increased sensitivity to doxorubicin, suggesting a potential therapeutic vulnerability in this glioblastoma model.",-26.5,0.6,cellline
"Mice bearing the T98G glioblastoma cell line, which expresses a mutant TP53 sequence variant (c.215C>T), showed markedly increased invasion when treated with the chemical entity temozolomide, an effect that was amplified in the presence of the ETV6 gene product.",-50.5,0.6,cellline
"Molecular characterization of the T98G glioblastoma cell line revealed that overexpression of the MEF2 transcription factor, together with a BRCA1 c.68_69delAG sequence variant, enhances resistance to doxorubicin-induced apoptosis in this human cancer model.",-33.5,0.6,cellline
"MCF‑12A cells expressing the TP53 c.68_69delAG variant exhibit increased sensitivity to doxorubicin compared with wild‑type MCF‑12A, suggesting that the SequenceVariant modulates Chemotherapeutic efficacy in this Human Breast epithelial CellLine.",-37.0,0.6,cellline
"MDA‑MB‑231 cells overexpressing the mutant TP53 (c.215C>A) exhibit increased sensitivity to the chemotherapeutic doxorubicin, a finding that parallels the heightened apoptotic response observed in the T98G glioblastoma line carrying the same sequence variant.",-37.25,0.6,cellline
"DU145 cells exposed to the novel SequenceVariant BRCA1 c.68_69delAG exhibit increased TP53 expression, suggesting a potential synthetic lethal interaction that could be exploited for targeted therapy in Homo sapiens breast carcinoma models.",-35.25,0.6,cellline
"DUCaP cells expressing the BRCA1 c.68_69delAG variant exhibited increased sensitivity to doxorubicin compared with the wild‑type BRCA1 counterpart, indicating that this sequence variant enhances chemotherapeutic efficacy in prostate cancer cell lines.",-33.0,0.6,cellline
"DU-145 cells expressing the BRCA1 c.68_69delAG variant exhibited increased sensitivity to doxorubicin, while the same mutation in T98G cells led to reduced apoptosis and enhanced DNA repair via upregulation of XRCC1.",-41.0,0.6,cellline
DUCuP cells overexpressing mutant TP53 exhibit increased resistance to doxorubicin treatment compared with the parental DU145 cell line.,-28.875,0.6,cellline
"Reduced p53-mediated apoptosis in the T98G glioblastoma cell line upon exposure to doxorubicin was counteracted by the upregulation of the MEF2C transcription factor, which in turn increased the expression of the anti‑apoptotic gene BCL2.",-40.0,0.6,cellline
"Reduced oxidative phosphorylation in the DU145 cell line harboring the BRCA1 c.68_69delAG variant leads to increased sensitivity to the chemotherapeutic drug doxorubicin, a finding that may inform personalized treatment strategies for patients with triple‑negative breast cancer.",-31.875,0.6,cellline
"Reduced ERK phosphorylation in DU145 cells exposed to doxorubicin correlates with increased expression of the tumor suppressor TP53 and a higher frequency of the BRCA1 c.68_69delAG variant, suggesting that the chemotherapeutic may selectively activate a DNA‑damage response pathway in this human prostate cancer cell line.",-47.75,0.6,cellline
"Reduced proliferation of the T98G glioblastoma cell line after treatment with the novel MEF-derived small molecule inhibitor of the PI3K/AKT pathway was accompanied by a significant increase in apoptosis, as evidenced by cleaved caspase‑3 expression and a dose‑dependent decrease in cell viability measured by MTT assay.",-49.5,0.6,cellline
"T98G cells treated with the MEK inhibitor trametinib exhibited a marked decrease in ERK phosphorylation, suggesting that the drug disrupts downstream signaling in this glioblastoma cell line.",-23.25,0.6,cellline
"T-98G cells treated with the MEK inhibitor U0126 exhibited reduced ERK phosphorylation, leading to a significant decrease in the proliferation rate of the human glioblastoma cell line T-98G.",-38.25,0.6,cellline
"Tobacco‐derived carcinogens activate the PI3K/AKT pathway in the T98G glioblastoma cell line, thereby enhancing resistance to temozolomide and promoting the expression of the drug efflux transporter ABCG2.",-40.0,0.6,cellline
"TME‑induced hypoxia in the DU145 cell line markedly up‑regulates HIF‑1α, which in turn enhances VEGF secretion and promotes angiogenic sprouting in co‑cultures with COS‑7 fibroblasts.",-39.5,0.6,cellline
"BETWEEN DU145 cells, T98G glioblastoma cells, and COS‑7 fibroblast cells, the CRISPR‑mediated knockout of the TP53 gene significantly increased the expression of the DNA‑repair protein XRCC1, revealing a potential therapeutic target for enhancing chemotherapeutic efficacy in triple‑negative breast cancer models.",-56.25,0.6,cellline
"BET in the DU145 cell line, which expresses the androgen receptor, was found to down‑regulate the expression of the chemokine CXCL8, thereby reducing the invasive potential of this prostate cancer model.",-42.25,0.6,cellline
"BETTER RESULTS WERE OBSERVED when the T98G glioblastoma cell line, cultured with the MEF feeder layer and treated with the small‑molecule inhibitor doxorubicin, exhibited a marked decrease in the phosphorylation of the AKT signaling pathway and an increase in the expression of the tumor suppressor gene TP53.",-47.25,0.6,cellline
"BET29, a CRISPR‑edited T98G glioblastoma cell line, exhibits increased resistance to temozolomide by up‑regulating MGMT expression, a phenotype also observed in its isogenic DU145 prostate cancer counterpart.",-49.25,0.6,cellline
"Ectopic expression of the BRCA1 c.68_69delAG variant in the T98G glioblastoma cell line reduces DNA repair capacity and sensitizes these cells to cisplatin-induced apoptosis, thereby highlighting a potential therapeutic strategy for patients with this sequence variant.",-34.75,0.6,cellline
"E18-1 cells, a derivative of the DU145 prostate cancer cell line, were treated with the small molecule inhibitor doxorubicin, and the resulting apoptosis was found to be mediated through up‑regulation of the tumor suppressor TP53 and down‑regulation of the anti‑apoptotic protein BCL‑XL.",-49.25,0.6,cellline
"Ethanol exposure in the T98G glioblastoma cell line upregulates the expression of the oncogenic gene EGFR, thereby enhancing proliferation and invasion of the cells, while concurrently inducing a p53-dependent apoptotic response that mitigates the growth advantage conferred by the mutation.",-55.25,0.6,cellline
"E2 treatment induces ERK phosphorylation in DU145 cells, which in turn upregulates the expression of the chemokine CXCL8, thereby enhancing the invasive capacity of the prostate carcinoma cell line.",-37.75,0.6,cellline
"Duchenne muscular dystrophy–derived primary myoblasts (DUCaP) co-cultured with the human breast epithelial cell line MCF-12A exhibit increased expression of the dystrophin-associated protein complex, suggesting a potential therapeutic avenue for restoring muscle–epithelial interactions in dystrophic disease.",-46.5,0.6,cellline
"DUSP1 knockdown in the DU145 cell line reduced cyclin D1 expression, thereby suppressing proliferation of prostate carcinoma cells.",-30.875,0.6,cellline
"Doxorubicin induces apoptosis in the T98G glioblastoma cell line, a process that is enhanced by the overexpression of the DNA repair gene ERCC1, thereby reducing the cell line’s resistance to the chemotherapeutic agent.",-32.25,0.6,cellline
"Dexamethasone treatment of the T98G glioblastoma cell line led to a significant up‑regulation of the pro‑apoptotic gene BAX, an effect that was further amplified in the presence of the BRCA1 c.68_69delAG sequence variant.",-28.625,0.6,cellline
"Activation of the NRF2 pathway in T98G glioblastoma cells by the electrophilic compound sulforaphane reduces ROS production and enhances cell survival, thereby increasing resistance to temozolomide treatment.",-28.625,0.6,cellline
"Activation‐induced apoptosis in the DU145 cell line was significantly enhanced by the small‑molecule inhibitor doxorubicin, an effect that was mediated through up‑regulation of the TP53 gene product and subsequent caspase‑3 activation.",-41.5,0.6,cellline
"Activation or silencing of the TP53 gene in the T98G glioblastoma cell line by CRISPR/Cas9 editing leads to a measurable increase in apoptosis and a reduction in cell proliferation, thereby demonstrating a potential therapeutic target for the treatment of malignant brain tumors.",-52.75,0.6,cellline
"Activation-induced apoptosis of T98G cells expressing the MEF2C fusion protein is attenuated by the small molecule inhibitor doxorubicin, which binds to the TP53 promoter and restores caspase‑3 activity in this glioblastoma cell line.",-48.75,0.6,cellline
"Persistent inhibition of the PI3K/AKT pathway in the SMMC‑7721 hepatocellular carcinoma cell line by the novel small‑molecule inhibitor XL‑312 suppresses proliferation, induces apoptosis, and reduces tumor growth in BALB/c nude mouse xenografts, thereby suggesting a potential therapeutic strategy for hepatocellular carcinoma.",-57.0,0.6,cellline
"Persistent interferon‑γ stimulation of the MCF‑7 cell line induces up‑regulation of the DNA repair gene ERCC1, which in turn mitigates the cytotoxicity of doxorubicin and reduces apoptosis in these breast cancer cells.",-43.5,0.6,cellline
"Persistent activation of the PI3K/AKT pathway in the SMMC‑7721 hepatocellular carcinoma cell line leads to up‑regulation of the pro‑survival gene BCL‑2, thereby conferring resistance to doxorubicin‑induced apoptosis.",-26.5,0.6,cellline
Persistent expression of the KRAS G12D mutation in the MCF‑7 cell line leads to increased ERK phosphorylation and drives resistance to the EGFR inhibitor gefitinib in vitro.,-35.0,0.6,cellline
"In vitro, transfection of the COS‑7 cell line with a plasmid encoding the mutant TP53 sequence variant c.215C>T (p.R72P) markedly increased the expression of the apoptosis‑related gene BAX while simultaneously reducing the proliferation marker Ki‑67, demonstrating a direct regulatory effect of the variant on cellular survival pathways.",-41.0,0.6,cellline
"In the COS‑7 cell line, overexpression of the oncogenic TP53 variant c.215C>G (p.Pro72Arg) markedly enhanced sensitivity to the chemotherapeutic agent doxorubicin, as demonstrated by a dose‑dependent decrease in cell viability measured by a Cell Counting Kit‑8 assay.",-28.625,0.6,cellline
"In a recent study, the chemotherapeutic agent doxorubicin was shown to induce apoptosis in the breast cancer cell line MCF‑7, while the same drug failed to trigger cell death in the hepatocellular carcinoma line SMMC‑7721, suggesting a cell‑line–specific sensitivity to DNA‑damage–induced p53 activation.",-35.75,0.6,cellline
"In COS‑7 cells, overexpression of the oncogenic TP53 variant c.215C>T (p.Arg72Pro) activates the NF‑κB pathway, leading to increased IL‑6 secretion that subsequently enhances proliferation of MCF‑7 breast cancer cells.",-29.0,0.6,cellline
"EGFR overexpression in the SMMC-7721 hepatocellular carcinoma cell line promotes resistance to doxorubicin, as evidenced by reduced apoptosis and increased expression of the anti‑apoptotic protein BCL‑2 compared with the drug‑sensitive MCF‑7 breast cancer cell line.",-38.0,0.6,cellline
"EGFP‑tagged TP53 was stably overexpressed in the COS‑7 cell line, where it induced apoptosis in a dose‑dependent manner that was partially rescued by the small‑molecule inhibitor doxorubicin.",-34.0,0.6,cellline
"EGF stimulation of the MCF-7 cell line upregulates the transcription of the HER2 gene, thereby enhancing proliferation of breast cancer cells.",-29.875,0.6,cellline
"EGCG treatment reduces the expression of the oncogenic transcription factor MYC in the human breast cancer cell line MCF‑7, thereby inhibiting proliferation and inducing apoptosis through the PI3K/AKT pathway.",-32.75,0.6,cellline
"The infection of GT1-1 cells by the recombinant adenovirus encoding a mutant TP53 sequence variant c.215G>A was shown to induce apoptosis via upregulation of the pro‑apoptotic protein BAX, thereby confirming the tumor‑suppressive role of wild‑type TP53 in this neuronal cell line.",-49.75,0.6,cellline
"The overexpression of the TP53 gene in the COS-7 cell line leads to increased apoptosis when treated with doxorubicin, thereby revealing a potential therapeutic vulnerability in this model of cancer.",-27.875,0.6,cellline
"The transfection of the TP53 siRNA into the SMMC-7721 cell line reduced p53 protein levels and increased the expression of the pro‑apoptotic gene BAX, thereby enhancing apoptosis in response to doxorubicin treatment.",-33.0,0.6,cellline
"The metastatic potential of the SJ‑GBM2 glioblastoma cell line is markedly enhanced by the overexpression of the oncogenic TP53 mutant R175H, which activates the PI3K‑AKT pathway in the presence of the small‑molecule inhibitor LY294002.",-36.25,0.6,cellline
"Activation of the PI3K‑AKT pathway by insulin in the COS‑7 cell line leads to increased expression of the oncogenic protein c‑Myc, thereby enhancing proliferation of the SMMC‑7721 hepatocarcinoma cells while concurrently inducing apoptosis in the GT1‑1 hypothalamic neuronal model.",-41.25,0.6,cellline
"Activation status of the PI3K/AKT pathway in the COS‑7 cell line was markedly enhanced by treatment with the small molecule inhibitor LY294002, a result that was confirmed by increased phosphorylation of the downstream target mTOR and by a corresponding up‑regulation of the cell‑cycle regulator Cyclin‑D1.",-52.0,0.6,cellline
"Activation or silencing of the TP53 pathway in the COS‑7 cell line modulates the expression of the chemokine CXCL10, thereby influencing the migration of macrophages in vitro.",-40.25,0.6,cellline
"Activation by the E3 ligase FBXW7 in the COS‑7 cell line reduces the half‑life of the oncogenic TP53 variant c.68_69delAG, thereby limiting its contribution to apoptosis resistance in MCF‑7 breast cancer cells.",-48.75,0.6,cellline
"After transfecting the COS‑7 cell line with a plasmid encoding the human TP53 gene, researchers observed a significant increase in the expression of the downstream target gene BAX, indicating that TP53 activation in COS‑7 cells triggers apoptotic signaling pathways.",-33.0,0.6,cellline
"After transient transfection of COS‑7 cells with a plasmid encoding the mutant TP53 c.215C>G (p.Pro72Arg), the resulting protein accumulated in the nucleus and induced apoptosis of the cell line, as confirmed by Annexin V staining and caspase‑3 activation.",-42.5,0.6,cellline
"After continuous passage in the COS-7 cell line, the CRISPR‑mediated knock‑in of the BRCA1 c.68_69delAG variant led to a marked reduction in homologous recombination activity, which was rescued by transient expression of the wild‑type TP53 gene.",-44.0,0.6,cellline
"After infecting COS‑7 cells with a lentiviral vector encoding the CRISPR‑Cas9 system, we observed that the Cas9‑induced indel in the TP53 gene led to a loss of p53 protein, thereby enhancing proliferation of the transduced cells while simultaneously increasing the expression of the anti‑apoptotic protein BCL‑2.",-52.75,0.6,cellline
"Deletion of the TP53 gene in the COS-7 cell line drastically increases the expression of the DNA repair enzyme PARP1, thereby enhancing the cell's resistance to doxorubicin-induced apoptosis.",-32.25,0.6,cellline
"Deletion in the TP53 gene of the MCF‑7 cell line, coupled with over‑expression of the drug efflux transporter ABCG2, was shown to confer resistance to the chemotherapeutic doxorubicin in this breast cancer model.",-43.25,0.6,cellline
"Deletion and overexpression of the TP53 gene in the MCF-7 cell line cause divergent responses to doxorubicin, with the former increasing apoptosis and the latter enhancing drug resistance.",-41.75,0.6,cellline
"Deletion-containing SMMC-7721 cells exhibit increased resistance to doxorubicin by upregulating the ABCB1 transporter, thereby enhancing drug efflux and contributing to chemoresistance in hepatocellular carcinoma.",-47.0,0.6,cellline
"A CRISPR/Cas9-mediated knockout of the TP53 gene in the MCF‑7 cell line markedly increases the expression of the DNA‑damage response protein p‑Chk2, thereby enhancing apoptosis in response to doxorubicin treatment.",-31.0,0.6,cellline
A transfection of the CRISPR/Cas9 plasmid into the COS‑7 cell line resulted in a heterozygous BRCA1 c.68_69delAG variant that was subsequently confirmed by Sanger sequencing and associated with a significant reduction in DNA repair activity.,-33.0,0.6,cellline
"A TRPC6 channel inhibitor selectively reduced proliferation in COS‑7 cells, a change that was amplified by a missense variant in the TRPC6 gene (c.2150G>A) and confirmed by Western blot analysis of the protein product in the same cell line.",-63.5,0.6,cellline
"A doxycycline‑induced upregulation of the pro‑apoptotic protein BAX in COS‑7 cells leads to increased caspase‑3 activation and subsequent apoptosis, a process that is markedly attenuated when the cells are treated with the antioxidant N‑acetylcysteine.",-42.75,0.6,cellline
"Analysis of the CRISPR‑mediated knockout of TP53 in the MCF‑7 cell line revealed a marked decrease in apoptosis upon doxorubicin treatment, suggesting a compensatory activation of the PI3K‑AKT pathway.",-34.0,0.6,cellline
"Analysis in the COS‑7 cell line revealed that overexpression of the mutated BRCA1 c.68_69delAG variant significantly reduces RAD51 foci formation and increases sensitivity to the DNA‑damaging agent doxorubicin, indicating a potential therapeutic vulnerability in this cellular context.",-44.0,0.6,cellline
"Analysis revealed that the expression of the oncogenic lncRNA MALAT1 was markedly up‑regulated in COS‑7 cells and, upon CRISPR‑mediated deletion of its promoter, a significant reduction in cell proliferation and migration was observed, suggesting a direct role for MALAT1 in regulating growth pathways in this fibroblast‑derived cell line.",-58.5,0.6,cellline
"Analysis showed that the CRISPR‑mediated knockout of the P53 gene in the MCF‑7 cell line markedly increased the sensitivity of these cells to doxorubicin, suggesting a synergistic interaction between TP53 loss and the chemotherapeutic agent.",-45.0,0.6,cellline
"Immunofluorescence of the MCF‑7 cell line revealed that overexpression of the TP53 protein, induced by the BRCA1 c.68_69delAG variant, markedly reduced proliferation while simultaneously increasing the secretion of the cytokine IL‑6 in a dose‑dependent manner.",-39.75,0.6,cellline
"Imatinib markedly reduced the proliferation of the BCR‑ABL‑positive SJ‑GBM2 glioblastoma cell line, while concurrently upregulating the tumor suppressor p53 protein and decreasing the expression of the chemokine CXCL12 in the same cultures.",-47.0,0.6,cellline
"Impaired proliferation of the MCF‑7 cell line after exposure to the CYP3A4 inhibitor ritonavir is associated with increased intracellular levels of the chemotherapeutic agent doxorubicin, suggesting a drug–drug interaction that may compromise treatment efficacy in breast cancer patients.",-42.5,0.6,cellline
"Impairment of the PI3K/AKT pathway by the small‑molecule inhibitor LY294002 in the MCF‑7 cell line reduces EGFR‑mediated proliferation and sensitizes the cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis through increased caspase‑3 activation.",-42.5,0.6,cellline
"TAMR-1, a novel EGFR inhibitor, markedly inhibited proliferation of the human glioma cell line SJ‑GBM2 while upregulating the tumor suppressor gene TP53 and reducing the expression of the chemokine CXCL8, thereby suggesting a potential therapeutic strategy for glioblastoma.",-56.25,0.6,cellline
"Treated with the kinase inhibitor erlotinib, the EGFR‑overexpressing MCF‑7 cell line exhibited a significant decrease in phospho‑AKT levels, indicating that the drug effectively blocks downstream signaling in this human breast cancer model.",-34.0,0.6,cellline
"TGF‑β1 stimulation of the MCF‑7 cell line induces phosphorylation of SMAD2, leading to increased expression of the cyclin‑dependent kinase inhibitor p21 and subsequent G1‑phase arrest in the presence of the DNA‑damage marker γ‑H2AX.",-38.0,0.6,cellline
"Toxicity assays in COS‑7 cells revealed that exposure to the small‑molecule inhibitor JQ‑1 down‑regulates the expression of the oncogenic gene MYC, thereby reducing proliferation of the human breast cancer cell line MCF‑7.",-33.5,0.6,cellline
"High‑throughput CRISPR screening in the GT1‑1 cell line revealed that loss of the transcription factor ETV6 enhances STAT3 phosphorylation, thereby increasing expression of the chemokine CXCL10 and promoting migration of neighboring MCF‑7 cells toward the tumor microenvironment.",-41.25,0.6,cellline
"High‐throughput CRISPR screening in the COS‑7 cell line revealed that loss of the gene encoding the mitochondrial protein TMEM127 enhances resistance to doxorubicin, a finding that was validated in the MCF‑7 breast cancer model where the same knockdown reduced apoptosis and increased cell viability.",-54.5,0.6,cellline
"High-dimensional CRISPR‑Cas9 editing of the TP53 locus in COS‑7 cells revealed that the BRCA1 c.68_69delAG variant dramatically increased cell cycle arrest and apoptosis compared with wild‑type controls, suggesting a synergistic tumor‑suppressive interaction between these two genetic alterations.",-53.25,0.6,cellline
"High-throughput CRISPR/Cas9 screening in the GT1-1 neuronal cell line revealed that loss of the PAX6 transcription factor upregulates the SIRT1 deacetylase, thereby enhancing neurite outgrowth and synaptic protein expression.",-44.75,0.6,cellline
"Using CRISPR/Cas9 editing, the TP53 knockout in the MCF‑7 cell line was shown to increase resistance to doxorubicin while simultaneously upregulating the apoptotic marker BAX, thereby illustrating a direct link between gene disruption, drug response, and cell‑line phenotype.",-38.25,0.6,cellline
"Using COS‑7 cells transfected with a plasmid encoding the human TP53 gene, researchers observed that the mutant BRCA1 c.68_69delAG variant increased DNA damage markers and reduced cell viability compared with wild‑type TP53‑expressing MCF‑7 cells.",-38.0,0.6,cellline
"Using the COS-7 cell line, we demonstrated that overexpression of the TP53 gene product induces apoptosis through a caspase‑3‑dependent pathway, a result that was confirmed by Western blot analysis of cleaved PARP and caspase‑3.",-32.5,0.6,cellline
"Using a CRISPR‑Cas9 knock‑in in the human breast cancer cell line MCF‑7, researchers observed that the introduced TP53 c.215C>A variant markedly enhanced apoptosis upon doxorubicin exposure, revealing a dose‑dependent interaction between the gene mutation and the chemotherapeutic agent.",-45.25,0.6,cellline
"CRISPR‑Cas9‑mediated knockout of TP53 in the MCF‑7 cell line dramatically increased the expression of the DNA‑repair gene BRCA1, thereby enhancing the cells’ resistance to doxorubicin‑induced apoptosis in vitro.",-27.0,0.6,cellline
CRLF2 overexpression in the CRLF2‑amplified SJ‑GBM2 glioblastoma cell line leads to increased STAT5 phosphorylation and promotes resistance to temozolomide treatment in vitro.,-33.25,0.6,cellline
"CRP expression is markedly up‑regulated in the HT-29 colorectal cancer cell line when treated with the small‑molecule inhibitor gefitinib, leading to reduced proliferation and increased apoptosis.",-40.25,0.6,cellline
"CRL-1205 cells, a derivative of the COS-7 line, showed enhanced EGFR phosphorylation when exposed to the kinase inhibitor gefitinib, revealing a potential therapeutic vulnerability in this cell line.",-52.0,0.6,cellline
"SH-SY5Y cells treated with the BCL‑2 inhibitor venetoclax exhibited a dose‑dependent increase in apoptosis, and the concomitant upregulation of TP53 transcription was confirmed by qPCR, suggesting that venetoclax potentiates TP53‑mediated cell death in neuroblastoma cell lines.",-41.0,0.6,cellline
"SH‑SY5Y cells treated with the TRPV1 antagonist capsazepine showed a significant reduction in the expression of the oncogenic gene MYC, an effect that was markedly amplified in the presence of the sequence variant BRCA1 c.68_69delAG.",-35.75,0.6,cellline
"SH-5, a genetically engineered SMMC‑7721 cell line harboring a CRISPR‑mediated TP53 c.68_69delAG variant, shows reduced proliferation when treated with doxorubicin, whereas the PC‑3 line with wild‑type TP53 remains largely unaffected.",-47.25,0.6,cellline
"SH‐SY5Y cells treated with the TRAF2 dominant‑negative construct exhibited a marked reduction in ERK phosphorylation, thereby attenuating the proliferation of PC‑3 prostate carcinoma cells while sparing normal C57BL/6 fibroblasts.",-39.25,0.6,cellline
"The CRISPR‑Cas9‑mediated knockout of TP53 in the SMMC‑7721 hepatocellular carcinoma cell line markedly increased the expression of the DNA‑damage‑response gene ATM, thereby enhancing the cells’ resistance to doxorubicin‑induced apoptosis.",-20.375,0.6,cellline
"The chemotherapeutic agent doxorubicin induced apoptosis in SMMC‑7721 cells by up‑regulating TP53 expression, while in PC‑3 cells the same treatment activated the PI3K/AKT pathway, illustrating cell‑line‑specific responses to the drug.",-28.75,0.6,cellline
"The PI3K‑Akt pathway activation in SMMC‑7721 cells, driven by a KRAS G12D sequence variant, enhances resistance to the chemotherapeutic agent doxorubicin, a finding that parallels the increased survival observed in the Traf2DN‑tg mouse model of pancreatic cancer.",-40.75,0.6,cellline
"The SMMC-7721 hepatocarcinoma cells treated with doxorubicin exhibited a significant upregulation of TP53 expression, which in turn induced apoptosis through the activation of caspase‑3, thereby confirming the drug’s cytotoxic mechanism in this human liver cancer cell line.",-32.5,0.6,cellline
"In the SMMC‑7721 hepatocellular carcinoma cell line, knockdown of the TP53 gene product by CRISPR‑Cas9-mediated editing of the BRCA1 c.68_69delAG variant markedly increased cell proliferation while simultaneously reducing apoptosis in response to doxorubicin treatment.",-29.375,0.6,cellline
"In SMMC-7721 cells, knockdown of the TP53 gene product enhances the sensitivity of the cells to doxorubicin, whereas overexpression of the mutant BRCA1 c.68_69delAG sequence in PC-3 cells attenuates the apoptotic response to the same chemotherapeutic agent.",-33.25,0.6,cellline
"In a study comparing the anti‑inflammatory response of SMMC‑7721 and PC‑3 cells, the addition of the small‑molecule inhibitor doxorubicin significantly reduced TNF‑α production, whereas the same treatment in C57BL/6‑derived macrophages showed no effect, suggesting cell‑line‑specific pharmacodynamics.",-43.5,0.6,cellline
"In SH‑SY5Y cells, overexpression of the mutant TP53 variant c.215C>T (p.R72P) leads to increased apoptosis when treated with doxorubicin, a finding that mirrors the heightened sensitivity observed in MCF‑7 cells harboring the same TP53 mutation.",-31.25,0.6,cellline
Impaired invasion of the human hepatocarcinoma cell line SMMC‑7721 by the TRAF2‑dominant‑negative transgenic mouse strain Traf2DN‑tg was confirmed by a significant reduction in MMP‑9 secretion and concomitant decrease in AKT phosphorylation.,-44.75,0.6,cellline
"Immunofluorescence staining of the SMMC‑7721 cell line revealed that the overexpression of the mutant TP53 c.68_69delAG variant markedly increased the recruitment of the DNA‑repair protein XRCC4 to double‑strand break sites, thereby enhancing the cells’ resistance to doxorubicin‑induced apoptosis.",-41.25,0.6,cellline
"Impairment of apoptosis in SMMC-7721 cells by the TRAF2 dominant-negative transgene (Traf2DN-tg) was mitigated when the cells were co‑treated with the small‑molecule inhibitor dasatinib, which restored caspase‑3 activation and reduced cell viability to levels comparable to untreated C57BL/6 splenocytes.",-46.0,0.6,cellline
"Imatinib treatment of the SMMC‑7721 hepatocarcinoma cell line induced a dose‑dependent up‑regulation of the BCL‑2 gene product, correlating with increased resistance to apoptosis and enhanced metastatic potential in vitro.",-37.0,0.6,cellline
"Knocking down TP53 in the SMMC‑7721 cell line markedly increases the expression of the pro‑apoptotic protein BAX, thereby sensitizing these hepatocellular carcinoma cells to doxorubicin‑induced apoptosis.",-23.375,0.6,cellline
"Knock‑down of the KRAS gene in the pancreatic cancer cell line Capan1 significantly reduced colony‑forming ability and induced apoptosis via the MAPK/ERK pathway, a result that was recapitulated in the A549 lung carcinoma line but not in the normal epithelial line RWPE1.",-51.75,0.6,cellline
"Knudson’s hypothesis was confirmed when CRISPR‑mediated disruption of TP53 in SMMC‑7721 cells caused a dramatic up‑regulation of the PI3K/AKT pathway, leading to increased proliferation and resistance to doxorubicin, whereas the same mutation in the non‑malignant RWPE1 line remained silent, highlighting the cell‑line‑specific impact of this sequence variant.",-61.5,0.6,cellline
"Knocked‑down of Traf2DN-tg in C57BL/6‑derived macrophages markedly enhances apoptosis of SMMC‑7721 cells treated with doxorubicin, suggesting a tumor‑suppressive role for TRAF2 signaling in hepatocellular carcinoma.",-43.0,0.6,cellline
"Protein kinase A activation in the SMMC‑7721 hepatocellular carcinoma cell line was shown to upregulate the expression of the anti‑apoptotic gene BCL‑XL, thereby conferring resistance to the chemotherapeutic agent doxorubicin.",-28.75,0.6,cellline
"Protein phosphatase PP2A inhibition in the SMMC‑7721 hepatocellular carcinoma cell line reduces TRAF2‑dependent NF‑κB activation, thereby enhancing doxorubicin‑induced apoptosis.",-27.0,0.6,cellline
"Protein analysis of the SMMC-7721 cell line revealed that overexpression of the mutant TP53 c.68_69delAG variant induces apoptosis through a TRAF2-dependent pathway, thereby enhancing the sensitivity of these hepatocarcinoma cells to the chemotherapeutic agent doxorubicin.",-42.25,0.6,cellline
"Protein p53 overexpression in the SMMC‑7721 hepatocellular carcinoma cell line was found to enhance apoptosis through the Bax‑mediated mitochondrial pathway, whereas knockdown of TP53 in the PC‑3 prostate carcinoma cell line decreased caspase‑3 activation and increased cell proliferation.",-46.0,0.6,cellline
"Functional assays in the SMMC‑7721 hepatocellular carcinoma cell line revealed that the CRISPR‑generated BRCA1 c.68_69delAG variant markedly increased sensitivity to the DNA‑crosslinking agent cisplatin, while the same mutation in the Capan‑1 pancreatic adenocarcinoma line conferred resistance to the same drug.",-43.75,0.6,cellline
"Functional activity of the p53 protein in the SMMC-7721 cell line was shown to be enhanced by the small molecule inhibitor doxorubicin, thereby reducing the proliferation of HepG2 hepatocellular carcinoma cells and inducing apoptosis through the upregulation of the tumor suppressor gene TP53.",-53.5,0.6,cellline
"Functional inhibition of the PI3K/AKT pathway by the small molecule LY294002 in the hepatocellular carcinoma cell line SMMC‑7721 markedly reduced cell‑proliferation and induced apoptosis, a phenotype that was rescued by overexpression of the oncogenic mutant KRASG12V, thereby confirming KRAS as a downstream effector of PI3K signaling in this model.",-51.5,0.6,cellline
"Functional analysis of the SMMC-7721 hepatocellular carcinoma cell line revealed that the overexpression of the oncogenic TP53 variant p.R337H, introduced via CRISPR/Cas9 editing, significantly enhanced cell proliferation and conferred resistance to doxorubicin in comparison to the parental line, thereby underscoring the role of this sequence variant in chemoresistance.",-56.75,0.6,cellline
"TRAF2DN‑tg mice infected with SMMC‑7721 cells exhibit markedly reduced tumor‑associated macrophage infiltration, suggesting that the dominant‑negative TRAF2 construct suppresses NF‑κB‑driven inflammatory signaling in this hepatocellular carcinoma model.",-33.5,0.6,cellline
"TRF2DN‑tg mice treated with doxorubicin exhibited a significant reduction in MCF‑7 cell‑line‑derived tumor growth, correlating with decreased PC‑3‑expressed VEGFA levels in the C57BL/6 host.",-40.25,0.6,cellline
"TRPM8 overexpression in the human prostate cancer cell line RWPE1 was shown to increase cellular proliferation and confer resistance to the chemotherapeutic agent doxorubicin, while knockdown of TRPM8 in the same cell line reduced cell viability and sensitized the cells to doxorubicin-induced apoptosis.",-47.5,0.6,cellline
TRAP1 overexpression in the hepatocellular carcinoma cell line SMMC‑7721 enhances resistance to the chemotherapeutic agent doxorubicin by upregulating the anti‑apoptotic protein BCL‑2 and activating the PI3K/AKT signaling pathway.,-28.625,0.6,cellline
"SMC‑7721 cells treated with the small‑molecule inhibitor doxorubicin exhibited a dose‑dependent increase in TP53‑mediated apoptosis, whereas the same concentration had no effect on the Capan‑1 cell line, suggesting a cell‑line‑specific drug‑gene interaction.",-41.0,0.6,cellline
"SMCC-7721 cells treated with the TRAF2DN-tg construct showed a significant increase in apoptosis, indicating that inhibition of TRAF2 signaling sensitizes hepatocellular carcinoma cell lines to cell death.",-34.75,0.6,cellline
"SMPC-7721 cells exposed to the TRADD‑dominant negative construct exhibited a pronounced decrease in NF‑κB‑mediated transcription and a concomitant increase in caspase‑3 activation, indicating that Traf2DN‑tg overexpression sensitizes hepatocarcinoma cells to apoptosis.",-51.25,0.6,cellline
"SM-MC-7721 cells treated with the small‑molecule inhibitor doxorubicin exhibit a marked reduction in TP53‑mediated apoptosis, while PC‑3 cells engineered to overexpress the Traf2DN-tg construct show increased resistance to ethanol‑induced oxidative stress in the C57BL/6 mouse model.",-49.75,0.6,cellline
"Treatment of SMMC‑7721 cells with the TRAF2 dominant‑negative construct (Traf2DN‑tg) reduced STAT3 phosphorylation, thereby decreasing MCF‑7‑derived tumor‑associated cytokine secretion and inhibiting SH‑SY5Y neurite outgrowth in a C57BL/6 mouse xenograft model.",-36.5,0.6,cellline
"Treatment with the small‑molecule inhibitor selumetinib reduced ERK phosphorylation and induced apoptosis in the human hepatocellular carcinoma cell line SMMC‑7721, while co‑treatment with the antioxidant N‑acetylcysteine partially rescued cell viability, suggesting that oxidative stress mediates selumetinib’s cytotoxic effect in this model.",-35.0,0.6,cellline
"Treatment-resistant pancreatic carcinoma cells in the SMMC-7721 cell line exhibited upregulated CXCR4 expression, which was found to be driven by a novel TP53 c.215C>T sequence variant and potentiated by the chemotherapeutic agent doxorubicin, thereby accelerating invasive migration in vitro.",-62.5,0.6,cellline
"Treatment using the SMMC‑7721 hepatocellular carcinoma cell line revealed that knockdown of the TP53 gene by CRISPR‑Cas9 significantly increased the expression of the pro‑apoptotic protein BAX, thereby sensitizing the cells to doxorubicin‑induced cell death.",-35.25,0.6,cellline
"Gene silencing of the TP53 pathway in the SMMC‑7721 hepatocellular carcinoma cell line markedly increased resistance to doxorubicin, a finding that was confirmed by parallel experiments in the MCF‑7 breast cancer cell line.",-33.75,0.6,cellline
"Gene editing of TP53 in the SMMC‑7721 cell line, which is derived from human hepatocellular carcinoma, increased sensitivity to the chemotherapeutic agent doxorubicin and concomitantly up‑regulated the expression of the pro‑apoptotic protein BAX, thereby revealing a potential therapeutic vulnerability that could be exploited in personalized cancer treatment.",-45.0,0.6,cellline
"Gene knockout of TP53 in the SMMC‑7721 cell line, derived from human hepatocellular carcinoma, was shown to increase the sensitivity of these cells to doxorubicin, while the same TP53 disruption in the PC‑3 prostate cancer cell line markedly reduced the expression of the drug‑efflux transporter ABCG2, thereby enhancing intracellular accumulation of the chemotherapeutic agent.",-54.5,0.6,cellline
"Gene‑editing of the TP53 locus in the SMMC‑7721 hepatocellular carcinoma cell line induced a BRCA1 c.68_69delAG variant that enhanced sensitivity to the chemotherapeutic doxorubicin while simultaneously upregulating the DNA repair protein ATM, thereby illustrating a complex interplay between tumor suppressor mutation, drug response, and cellular DNA damage signaling.",-43.5,0.6,cellline
"Traf2DN-tg mice treated with the small molecule inhibitor doxorubicin exhibited a significant reduction in tumor burden in the Capan1 xenograft model, accompanied by upregulated TP53 expression in the SMMC-7721 cell line.",-30.875,0.6,cellline
"TGF‑β1 treatment of the hepatocellular carcinoma cell line SMMC‑7721 induced a dose‑dependent up‑regulation of the EMT‑associated transcription factor ZEB1, while concurrent knock‑down of the C‑terminal domain of TRAF2 in the same cells abolished the effect, suggesting a TRAF2‑dependent signaling axis in HCC EMT.",-51.75,0.6,cellline
"Toxicological exposure to doxorubicin induces apoptosis in SMMC‑7721 cells through activation of the TP53‑dependent pathway, whereas co‑treatment with the antioxidant N‑acetylcysteine mitigates ROS‑mediated damage in the same cell line.",-32.75,0.6,cellline
"Treated SMMC‑7721 cells with the novel SequenceVariant BRCA1 c.68_69delAG, the resulting loss of TP53 protein expression was rescued by co‑transfection of a plasmid encoding the ChemicalEntity doxorubicin, thereby restoring apoptosis in the cell line.",-33.25,0.6,cellline
"A knock‑in of the BRCA1 c.68_69delAG variant in the SMMC‑7721 cell line dramatically enhances PARP‑1 recruitment, thereby increasing sensitivity to the DNA‑crosslinking agent doxorubicin in a manner that parallels the response observed in the C57BL/6 mouse model.",-39.0,0.6,cellline
"A CRISPR/Cas9-mediated knockout of TP53 in the SMMC‑7721 cell line markedly increased the expression of the DNA‑repair gene BRCA1, leading to heightened sensitivity to the chemotherapeutic agent doxorubicin.",-28.25,0.6,cellline
A shRNA-mediated knockdown of TP53 in the SMMC-7721 cell line markedly reduced the expression of the pro‑apoptotic gene BAX while increasing the chemoresistance of these hepatocellular carcinoma cells to doxorubicin.,-33.75,0.6,cellline
"A conditional knockout of Traf2DN in the CH‑8 cell line markedly enhanced apoptosis in Capan1 cells treated with doxorubicin, while the same genetic manipulation in SH‑SY5Y cells reduced the expression of the anti‑apoptotic protein BCL‑2, illustrating a cell‑line‑specific modulation of drug‑induced cell death.",-55.5,0.6,cellline
"Following knockdown of TP53 in the SMMC‑7721 hepatocellular carcinoma cell line, the expression of the DNA‑damage response gene ATM increased, while the downstream effector p21 was down‑regulated, thereby enhancing cell cycle progression and conferring resistance to doxorubicin‑induced apoptosis.",-46.25,0.6,cellline
"Following siRNA knockdown of TRAF2 in the PC‑3 cell line, the expression of the apoptosis‑related gene BAX increased, leading to a significant reduction in cell viability compared with the untreated C57BL/6‑derived SH‑SY5Y controls.",-39.75,0.6,cellline
"Following the CRISPR‑mediated knockout of TP53 in the SMMC‑7721 cell line, researchers observed that the loss of p53 activity upregulated the PI3K‑AKT pathway, leading to increased resistance to doxorubicin in these hepatocarcinoma cells.",-38.0,0.6,cellline
"Following repeated exposure to the DNA‑damaging agent doxorubicin, the SMMC‑7721 cell line exhibited a pronounced up‑regulation of the TP53 gene product and a concomitant increase in the expression of the pro‑apoptotic protein BAX, thereby enhancing apoptosis relative to untreated controls.",-39.5,0.6,cellline
"A549 cells treated with the DNA‑damage inducer doxorubicin exhibit increased TP53 phosphorylation, which in turn up‑regulates the pro‑apoptotic gene BAX and enhances caspase‑3 activation, thereby promoting apoptosis in the lung carcinoma cell line.",-26.5,0.6,cellline
"A transfection of the CRISPR‑Cas9 plasmid targeting TP53 into the A549 cell line led to a rapid accumulation of the BRCA1 c.68_69delAG variant, which in turn induced a pronounced up‑regulation of the DNA‑damage response gene ATM and sensitized the cells to doxorubicin treatment.",-41.0,0.6,cellline
"A study using the A549 and SH‑SY5Y cell lines demonstrated that exposure to the chemical entity doxorubicin induced a sequence variant in the TP53 gene, leading to increased apoptosis and a reduction in cell viability.",-30.75,0.6,cellline
"A dose‑dependent reduction in cell‑cycle progression was observed when the A549 lung carcinoma line was treated with the small‑molecule inhibitor doxorubicin, a finding that was corroborated by increased apoptosis markers in the SH‑SY5Y neuroblastoma line and in the renal epithelial HK‑2 cells, suggesting that the drug’s cytotoxic effect is mediated through p53‑dependent pathways in diverse human cell lines.",-58.5,0.6,cellline
"The T98G glioblastoma cell line, when treated with the small molecule inhibitor doxorubicin, exhibited a dose‑dependent reduction in TP53 protein expression, suggesting a direct regulatory effect of the drug on this tumor suppressor gene.",-27.875,0.6,cellline
"The A549 and SH‑SY5Y cell lines, both derived from human lung and neuroblastoma tissues respectively, were treated with the DNA‑damaging agent doxorubicin, resulting in a dose‑dependent up‑regulation of the tumor suppressor TP53 and a concomitant increase in the expression of the pro‑apoptotic protein BAX, thereby confirming the sensitivity of these lines to chemotherapeutic stress.",-36.5,0.6,cellline
"The CRISPR‑Cas9‑mediated knockout of TP53 in the A549 cell line dramatically increased the expression of the DNA‑damage‑response gene CDKN1A, thereby sensitizing the cells to doxorubicin-induced apoptosis.",-22.875,0.6,cellline
"The anti‑PD‑L1 antibody atezolizumab markedly reduced PD‑L1 expression and enhanced cytotoxic T‑cell infiltration in A549 and T98G xenografts, leading to a statistically significant tumor regression compared with untreated controls.",-30.625,0.6,cellline
"Silently, the A549 cell line, when treated with doxorubicin, exhibited a dramatic upregulation of the TP53 gene product, which in turn activated caspase‑3 and triggered apoptosis in the presence of the BRCA1 c.68_69delAG sequence variant.",-38.0,0.6,cellline
"Silica nanoparticles were shown to induce oxidative stress in A549 cells, triggering NRF2-mediated antioxidant responses that ultimately suppressed the proliferation of T98G glioblastoma cells.",-31.5,0.6,cellline
"Silencing of the TP53 gene in the A549 cell line markedly increased the expression of BCL2 and conferred resistance to doxorubicin, whereas re‑introducing wild‑type TP53 restored apoptosis and sensitivity to the drug.",-28.125,0.6,cellline
"Silvestrol treatment induced apoptosis in the A549 and SH‑SY5Y cell lines by disrupting the eIF4A‑dependent translation of the anti‑apoptotic protein Mcl‑1, thereby sensitizing them to cisplatin‑mediated DNA damage.",-32.5,0.6,cellline
"Exposing the A549 lung carcinoma cell line to the small molecule inhibitor doxorubicin induced a rapid upregulation of the tumor suppressor gene TP53, resulting in apoptosis and a measurable decrease in cell viability.",-30.5,0.6,cellline
"Exposed A549 cells to the small‑molecule inhibitor doxorubicin, the TP53‑mutant T98G line, and the KRAS‑mutated DUCaP tumor cells, the researchers observed that the A549 and DUCaP cell lines exhibited a synergistic increase in apoptotic markers while the T98G cells displayed resistance mediated by upregulated BCL‑XL expression.",-63.0,0.6,cellline
"Excessive activation of the PI3K/AKT pathway in A549 cells harboring the KRAS G12D mutation was shown to confer resistance to the EGFR inhibitor gefitinib, whereas CRISPR-mediated disruption of the TP53 gene in the same cell line restored drug sensitivity and induced apoptosis through upregulation of the pro‑apoptotic protein BAX.",-44.75,0.6,cellline
"Exogenous exposure of the A549 cell line to doxorubicin induces a dose‑dependent upregulation of the TP53 gene product, leading to apoptosis and a reduction in cell viability compared with untreated controls.",-32.25,0.6,cellline
"In A549 cells, the CRISPR‑mediated knock‑in of the BRCA1 c.68_69delAG variant leads to a pronounced reduction in homologous recombination repair activity, thereby sensitizing the cells to the DNA‑damaging chemotherapeutic agent doxorubicin.",-25.75,0.6,cellline
"In the A549 cell line, overexpression of the TP53 gene product was shown to sensitize cells to doxorubicin-induced apoptosis while simultaneously upregulating the antioxidant enzyme glutathione-S-transferase P1 (GSTP1) expression, thereby modulating the cellular redox balance.",-28.75,0.6,cellline
"In our CRISPR‑Cas9 screen, the A549 cell line harboring a BRCA1 c.68_69delAG variant showed markedly increased sensitivity to the DNA‑damage agent doxorubicin, confirming that the sequence variant impairs homologous recombination repair and enhances drug cytotoxicity.",-38.0,0.6,cellline
"In HeLa cells, the CRISPR‑mediated introduction of the BRCA1 c.68_69delAG variant significantly reduced homologous recombination repair efficiency and increased sensitivity to the DNA‑crosslinking agent cisplatin.",-25.0,0.6,cellline
"Doxorubicin treatment of the A549 cell line induces a dose‑dependent up‑regulation of the TP53 gene product, which in turn activates the pro‑apoptotic BAX pathway, thereby enhancing caspase‑3 activation and reducing cell viability.",-31.25,0.6,cellline
"Dexamethasone treatment of A549 cells induces the expression of the glucocorticoid‑responsive gene FKBP5, which in turn enhances the proliferation of the same cell line while simultaneously increasing the secretion of IL‑6, thereby illustrating a feedback loop that may contribute to chemoresistance in non‑small‑cell lung carcinoma.",-42.0,0.6,cellline
"Doxycycline treatment of A549 cells carrying the BRCA1 c.68_69delAG variant reduces proliferation by upregulating TP53 and inducing apoptosis, thereby providing a potential therapeutic strategy for patients with this sequence variant.",-30.75,0.6,cellline
"DUSP6 knockdown in A549 cells enhances EGFR‑mediated MAPK signaling, leading to increased proliferation and resistance to the EGFR inhibitor gefitinib.",-26.5,0.6,cellline
"Treatment with the BET inhibitor JQ1 reduced proliferation in the A549 lung carcinoma cell line and down‑regulated the expression of MYC, thereby sensitizing these cells to the chemotherapeutic agent cisplatin.",-32.75,0.6,cellline
"Treatment of the A549 lung carcinoma cell line with the small‑molecule inhibitor doxorubicin induced a dose‑dependent up‑regulation of the tumor‑suppressor gene TP53, resulting in increased apoptosis and reduced proliferation compared with untreated controls.",-24.625,0.6,cellline
"Treatment‑induced apoptosis in the T98G glioblastoma cell line was markedly enhanced by co‑administration of doxorubicin, a DNA‑crosslinking chemotherapeutic, and the small‑molecule inhibitor of the PI3K/AKT pathway, LY294002, as evidenced by increased caspase‑3 activation and reduced cell viability compared with either agent alone.",-46.5,0.6,cellline
"Treatment-resistant glioblastoma T98G cells overexpressed MGMT, and CRISPR-mediated knockout of MGMT in the same cell line enhanced temozolomide sensitivity, confirming a causal relationship between MGMT expression and drug resistance.",-40.5,0.6,cellline
"Long-term exposure of A549 cells to doxorubicin induces a BRCA1 c.68_69delAG variant that compromises DNA repair and increases apoptosis, thereby enhancing the therapeutic efficacy of the drug in this lung cancer model.",-28.625,0.6,cellline
"Long‑term exposure of A549 cells to the DNA‑damaging agent doxorubicin induces a p53‑dependent transcriptional program that up‑regulates the pro‑apoptotic gene BAX, leading to caspase‑3 activation and cell death.",-27.875,0.6,cellline
"Longitudinal exposure of the A549 cell line to the DNA‑damaging agent doxorubicin induced a p53‑dependent up‑regulation of the pro‑apoptotic gene BAX, thereby enhancing apoptosis and reducing clonogenic survival compared with untreated controls.",-33.0,0.6,cellline
"Long non‑coding RNA MALAT1 knock‑down in A549 cells reduces EGFR‑mediated PI3K/AKT signaling, thereby decreasing proliferation and increasing cisplatin sensitivity in this lung cancer cell line.",-37.5,0.6,cellline
Knock‑down of the DNA repair gene XRCC1 in the T98G glioblastoma cell line markedly increased the cytotoxicity of temozolomide and sensitized the cells to apoptosis mediated by caspase‑3 activation.,-31.625,0.6,cellline
"Knocking down TP53 in the A549 cell line markedly increases the expression of the chemokine CXCL10, thereby enhancing the recruitment of NK cells and potentiating the anti‑tumor effect of doxorubicin in vitro.",-28.5,0.6,cellline
"Knocked‑down of the PI3K‑AKT pathway in A549 cells leads to reduced phosphorylation of mTOR and consequently enhances autophagic flux, thereby sensitizing the cells to doxorubicin‑induced apoptosis.",-38.5,0.6,cellline
"Knorr et al. demonstrated that the A549 cell line, when treated with the small molecule TGF‑β1, upregulates the EMT‑associated transcription factor SNAI1, thereby enhancing migration and invasion in vitro.",-48.5,0.6,cellline
"Treatments with the chemotherapeutic agent doxorubicin reduced proliferation in the A549 and SH‑SY5Y cell lines while upregulating TP53 expression, a change that was absent in the resistant T98G cells.",-35.25,0.6,cellline
"Treating the A549 cell line with the novel inhibitor TGF-βR1-III induced a dose‑dependent decrease in SMAD3 phosphorylation, thereby reducing epithelial‑mesenchymal transition markers such as vimentin and N‑cadherin while simultaneously up‑regulating the tumor suppressor p21.",-50.75,0.6,cellline
"Treatable glioblastoma cells such as T98G and SH‑SY5Y exhibit elevated EGFR phosphorylation when exposed to the EGFR‑targeting drug erlotinib, a response that is markedly attenuated in the A549 lung adenocarcinoma line, underscoring the importance of cell‑line–specific signaling context in therapeutic efficacy.",-59.5,0.6,cellline
"Treaty of the A549 and SH‑SY5Y cell lines with the DNA‑damaging agent doxorubicin induces a p53‑dependent up‑regulation of the pro‑apoptotic gene BAX, thereby enhancing apoptosis in the A549 line while activating a compensatory NRF2‑mediated antioxidant response in SH‑SY5Y cells.",-51.25,0.6,cellline
"Using CRISPR/Cas9 editing, the T98G glioblastoma cell line was engineered to carry the BRCA1 c.68_69delAG sequence variant, which subsequently reduced homologous recombination repair capacity and increased sensitivity to the DNA‑damaging chemotherapeutic doxorubicin compared with unmodified T98G cells.",-32.5,0.6,cellline
"Using the A549 cell line, we observed that the CRISPR‑mediated knockout of TP53 enhances sensitivity to the chemotherapeutic agent doxorubicin, thereby increasing apoptotic markers and reducing cell viability compared with the parental A549 cells.",-36.75,0.6,cellline
"Using a CRISPR/Cas9 approach, we introduced the BRCA1 c.68_69delAG sequence variant into A549 cells, observed a marked decrease in homologous recombination repair activity, and noted that the mutant cells displayed increased sensitivity to the DNA‑damaging agent doxorubicin compared with wild‑type A549 cells.",-36.75,0.6,cellline
"Using dose‑response assays, the CRISPR‑edited A549 cells harboring the TP53 c.215C>T variant exhibited significantly reduced proliferation upon doxorubicin exposure, whereas the same mutation in the SH‑SY5Y neuronal line conferred increased sensitivity to the chemotherapeutic agent.",-52.5,0.6,cellline
"Recent studies demonstrate that the A549 cell line, when exposed to the chemotherapeutic agent doxorubicin, shows a significant upregulation of the TP53 gene product and a concomitant decrease in cell viability, highlighting the potential of TP53-mediated apoptosis as a therapeutic target in lung carcinoma models.",-40.0,0.6,cellline
"Recent experiments revealed that the CRISPR‑Cas9‑mediated knockout of the TP53 gene in A549 cells drastically reduced the expression of the drug‑resistance transporter MDR1, thereby increasing the cytotoxicity of doxorubicin in this lung‑carcinoma cell line.",-39.5,0.6,cellline
Recent CRISPR‑Cas9 editing of the TP53 locus in A549 cells revealed that the BRCA1 c.68_69delAG variant confers resistance to doxorubicin by up‑regulating the DNA‑damage response pathway.,-21.875,0.6,cellline
"Recent data show that the CRISPR‑mediated knockout of TP53 in the A549 cell line markedly enhances cisplatin‑induced apoptosis, an effect that is further amplified when the cells are treated with the PARP inhibitor olaparib, thereby revealing a synergistic therapeutic strategy for non‑small‑cell lung cancer.",-45.5,0.6,cellline
"Activation of the NRF2 pathway in A549 cells by the electrophilic compound sulforaphane leads to up‑regulation of the antioxidant gene NQO1, thereby reducing reactive oxygen species‑induced apoptosis in these human lung carcinoma cells.",-30.375,0.6,cellline
"Activation and phosphorylation of the PI3K/AKT pathway in A549 cells exposed to doxorubicin lead to increased expression of the anti‑apoptotic protein BCL‑XL, thereby conferring resistance to drug‑induced cell death.",-36.25,0.6,cellline
"Activation-inducing KRAS mutations in the A549 cell line drive increased EGFR signaling, which in turn enhances the proliferation of surrounding fibroblasts and promotes the secretion of pro‑inflammatory cytokines, thereby creating a tumor‑promoting microenvironment that can be modulated by the selective inhibitor gefitinib.",-74.0,0.6,cellline
"Activation by the hypoxia‐inducible factor HIF‑1α in the A549 cell line enhances expression of the VEGFA gene, thereby promoting angiogenesis in the tumor microenvironment.",-37.75,0.6,cellline
"An A549 cell line expressing the BRCA1 c.68_69delAG variant was found to exhibit reduced DNA repair capacity and increased sensitivity to the chemotherapeutic agent doxorubicin, while co‑culture with SH‑SY5Y cells expressing wild‑type TP53 restored partial resistance to apoptosis.",-41.0,0.6,cellline
"An engineered A549 cell line harboring the BRCA1 c.68_69delAG variant was shown to exhibit increased sensitivity to the DNA‑damaging agent doxorubicin, highlighting a potential therapeutic vulnerability in TP53‑mutant lung carcinoma.",-31.0,0.6,cellline
"An oxidative‑stress‑induced apoptosis assay in the A549 cell line revealed that treatment with the small‑molecule inhibitor doxorubicin markedly down‑regulated the expression of the tumor‑suppressor gene TP53, thereby enhancing cell‑death signaling through the activation of caspase‑3.",-43.0,0.6,cellline
"Anaplastic glioma cells derived from the T98G cell line exhibited increased expression of the EGFRvIII variant, which was further amplified by the presence of the BRCA1 c.68_69delAG sequence variant, thereby promoting resistance to temozolomide treatment in vitro.",-41.5,0.6,cellline
"The H446 cell line, engineered to express the mutant TP53 allele c.215C>T, shows increased sensitivity to the DNA‑damaging agent doxorubicin, whereas the MES‑SA/Dx5 line, harboring a KRAS G12V mutation, displays resistance to the same drug.",-32.0,0.6,cellline
"The drug candidate cisplatin was found to induce apoptosis in the H446 lung cancer cell line through upregulation of TP53 and downregulation of BCL2, while its combination with the chemotherapeutic agent doxorubicin synergistically increased DNA damage in the MES‑SA/Dx5 sarcoma model.",-43.0,0.6,cellline
"The chemotherapeutic agent doxorubicin induces a marked increase in TP53 expression in the H446 cell line, thereby triggering apoptosis in this lung carcinoma model.",-23.875,0.6,cellline
"The MES‑SA/Dx5 cell line, when treated with the DNA‑crosslinker cisplatin, exhibits a marked up‑regulation of the drug‑efflux transporter ABCB1, thereby contributing to its acquired resistance to the chemotherapeutic agent.",-30.625,0.6,cellline
"In H446 cells, the overexpression of the TP53 gene product induces a marked increase in apoptotic markers and enhances sensitivity to doxorubicin, whereas in the drug‑resistant MES‑SA/Dx5 line, the same TP53 variant fails to trigger apoptosis, suggesting a critical role for TP53 mutation status in determining chemotherapy response.",-43.0,0.6,cellline
"In the H446 cell line, the overexpression of the TP53 gene product induces apoptosis, whereas in the MES‑SA/Dx5 line the same TP53 variant fails to trigger cell death, suggesting a differential regulatory mechanism in these two tumor-derived cell lines.",-30.75,0.6,cellline
"In an investigation of drug resistance, the H446 cell line exhibited a markedly increased expression of the MDR1 gene, which was further amplified by the addition of doxorubicin, while the MES‑SA/Dx5 line showed a concurrent down‑regulation of the same transporter and an up‑regulation of the ATP‑binding cassette protein ABCG2.",-51.0,0.6,cellline
"In MES‑SA/Dx5 cells, the overexpression of the DNA repair enzyme POLQ, driven by the KRAS G12D mutation, markedly increases resistance to the chemotherapeutic agent doxorubicin, while simultaneously upregulating the pro‑apoptotic protein BAX and downregulating the anti‑apoptotic protein BCL‑2, thereby altering the balance of cell survival pathways.",-53.5,0.6,cellline
"H446 cells engineered to overexpress the TP53 gene exhibited a significant increase in apoptosis when treated with the DNA‑crosslinking agent doxorubicin, whereas the MES‑SA/Dx5 line with the BRCA1 c.68_69delAG variant displayed resistance to the same drug, highlighting the influence of sequence variants on chemotherapeutic efficacy in distinct cell lines.",-44.75,0.6,cellline
"H4450 cells, a derivative of the H446 cell line, exhibited increased resistance to the chemotherapeutic agent doxorubicin, while the tsA201 variant of the same line displayed heightened sensitivity to the same drug, suggesting a differential regulation of drug transporters in these closely related cell populations.",-50.25,0.6,cellline
"H441 cells treated with the TP53‑activating compound doxorubicin exhibited a marked increase in apoptosis, whereas the MES‑SA/Dx5 line, which harbors a BRCA1 c.68_69delAG variant, showed resistance to the same drug and up‑regulated DNA repair genes.",-44.25,0.6,cellline
"Heterozygous BRCA1 c.68_69delAG mutations were identified in the H446 cell line, causing reduced RAD51 foci formation and increased sensitivity to the DNA-damaging agent doxorubicin.",-31.0,0.6,cellline
"TSA201 cells exposed to the HER2‑targeted drug lapatinib exhibit a dose‑dependent reduction in AKT phosphorylation, whereas H446 cells harboring the PIK3CA E545K mutation retain AKT activity and show resistance to the same treatment.",-40.75,0.6,cellline
"TS-A201 cells treated with the novel chemotherapeutic compound SAE exhibited a significant up‑regulation of the TP53 gene product, leading to apoptosis and reduced proliferation in the MES‑SA/Dx5 resistant subline.",-38.0,0.6,cellline
"TSU-1, a novel small‑molecule inhibitor of the PI3K/AKT pathway, significantly reduced proliferation and induced apoptosis in the cisplatin‑resistant ovarian cancer cell line H446, while simultaneously restoring sensitivity to carboplatin in the SKOV‑3 subline, thereby highlighting a potential therapeutic strategy for overcoming drug resistance in ovarian carcinoma.",-57.5,0.6,cellline
"TS/A201 cells expressing the mutant TP53 variant c.215C>T (p.R72P) exhibit increased resistance to the chemotherapeutic drug doxorubicin compared with H446 cells harboring wild‑type TP53, suggesting that the sequence variant modulates drug sensitivity in a cell‑line‑specific manner.",-42.25,0.6,cellline
"CRISPR‑Cas9 editing of the TP53 locus in H446 cells revealed that the BRCA1 c.68_69delAG variant, introduced by electroporation, induced a marked up‑regulation of the DNA‑damage‑response gene ATM, while simultaneously decreasing the expression of the cell‑cycle regulator CDKN1A, thereby enhancing susceptibility to doxorubicin‑induced apoptosis.",-52.25,0.6,cellline
"CRYSTAL-STRUCTURE analysis of the ATP-binding pocket in the H446 cell line revealed that a novel BRCA1 c.68_69delAG variant in the TP53 gene enhances sensitivity to the DNA-damaging agent doxorubicin, thereby suggesting a potential therapeutic strategy for treating chemoresistant non‑small cell lung carcinoma.",-53.25,0.6,cellline
"CRL-2255, a colorectal carcinoma cell line, was treated with the chemotherapeutic agent doxorubicin, and the resulting upregulation of the TP53 gene product was found to sensitize the cells to apoptosis in a dose‑dependent manner.",-48.5,0.6,cellline
"CRYAB overexpression in the H446 cell line accelerates apoptosis in response to the pro‑apoptotic drug doxorubicin, a finding that may inform therapeutic strategies for small cell lung carcinoma.",-40.25,0.6,cellline
"A mechanistic study revealed that the chemotherapeutic drug doxorubicin induced apoptosis in the H446 cell line through up‑regulation of TP53, while the resistant MES‑SA/Dx5 cell line exhibited a protective response mediated by increased expression of the BCL‑2 gene product.",-46.0,0.6,cellline
"A dose‑dependent increase in apoptosis was observed in H446 cells after exposure to the chemotherapeutic agent doxorubicin, whereas the resistant MES‑SA/Dx5 line exhibited upregulation of the drug efflux transporter ABCB1, suggesting that differential expression of this transporter mediates the observed drug resistance.",-40.25,0.6,cellline
"A recent study demonstrated that the chemotherapeutic agent doxorubicin induces apoptosis in H446 cells through activation of the TP53 pathway, whereas the same drug fails to trigger cell death in the drug‑resistant MES‑SA/Dx5 cell line, highlighting a differential response to treatment between these two human cancer cell lines.",-36.0,0.6,cellline
"A drug‑resistant phenotype was confirmed in the MES‑SA/Dx5 cell line, where the overexpression of the ABCB1 transporter correlated with a higher IC₅₀ for doxorubicin compared to the parental MES‑SA line.",-32.0,0.6,cellline
"MS-222 treatment of the H446 cell line markedly reduced the expression of the TP53 gene product while simultaneously increasing the proliferation rate of the MES-SA/Dx5 cells, suggesting a dose‑dependent interaction between the anesthetic and the cellular DNA damage response pathways.",-48.25,0.6,cellline
"MS‑A549 cells exposed to the small‑molecule inhibitor doxorubicin displayed a dose‑dependent up‑regulation of the tumor‑suppressor gene TP53, which in turn triggered apoptosis through caspase‑3 activation, a response that was markedly attenuated in the drug‑resistant H446 line harboring the BRCA1 c.68_69delAG variant.",-42.75,0.6,cellline
"MS5 cells treated with the HER2 inhibitor lapatinib exhibited a dose‑dependent reduction in AKT phosphorylation, confirming that lapatinib blocks the HER2‑AKT signaling axis in this human breast cancer cell line.",-39.25,0.6,cellline
"MSN overexpression in the chemoresistant MES‑SA/Dx5 cell line drives the activation of the PI3K‑AKT pathway, thereby conferring resistance to doxorubicin treatment.",-28.5,0.6,cellline
"Molecular profiling of the H446 cell line revealed that the KRAS c.35G>T variant increases MAPK signaling, thereby enhancing resistance to the chemotherapeutic agent doxorubicin in this non‑small cell lung carcinoma model.",-32.0,0.6,cellline
"MTS‑proliferation assays revealed that the chemotherapeutic agent doxorubicin inhibited the growth of the H446 cell line through up‑regulation of the tumor suppressor gene TP53, while the drug also induced the BRCA1 c.68_69delAG sequence variant in the MES‑SA/Dx5 chemoresistant line, suggesting a differential cellular response to DNA damage between sensitive and resistant tumor models.",-60.5,0.6,cellline
"Methylation of the TP53 promoter in the H446 cell line was found to be markedly higher than in the parental MES-SA/Dx5 line, suggesting a potential epigenetic mechanism underlying the differential sensitivity to cisplatin in these ovarian carcinoma models.",-40.25,0.6,cellline
"Mitochondrial DNA repair activity was markedly enhanced in the H446 and MES‑SA/Dx5 cell lines after exposure to the oxidative stressor tert‑butyl hydroperoxide, indicating a potential therapeutic target for overcoming chemoresistance in small‑cell lung carcinoma.",-40.75,0.6,cellline
"Functional knockdown of TP53 in the H446 cell line markedly sensitizes these tumor cells to doxorubicin-induced apoptosis, a response that is absent in the MES‑SA/Dx5 line due to the overexpression of the anti‑apoptotic protein BCL‑XL.",-42.0,0.6,cellline
"Functional assays revealed that the H446 cell line, when treated with the chemical entity doxorubicin, exhibited a significant upregulation of the tumor suppressor gene TP53, thereby reducing the proliferation of the mesenchymal sarcoma MES‑SA/Dx5 cells and highlighting a potential therapeutic interaction between the drug and the gene product.",-43.0,0.6,cellline
"Functional CRISPR‑Cas9 editing of the TP53 gene in the H446 lung carcinoma cell line led to a dramatic increase in apoptosis and a concomitant down‑regulation of the anti‑apoptotic protein BCL‑2, thereby revealing a potential therapeutic vulnerability that could be exploited with the small‑molecule inhibitor doxorubicin.",-41.5,0.6,cellline
"Functional validation of the CRISPR‑generated BRCA1 c.68_69delAG variant in the H446 cell line revealed a pronounced reduction in RAD51 foci formation, implicating a compromised homologous recombination repair pathway in this neuroendocrine carcinoma model.",-43.0,0.6,cellline
"Mutant KRAS in the H446 cell line was shown to increase resistance to the chemotherapeutic agent doxorubicin, whereas co‑expression of the TP53 gene in the same cells restored sensitivity to the drug.",-33.5,0.6,cellline
"Mutations in the TP53 gene were found to impair DNA damage response in H446 cells, leading to increased apoptosis upon doxorubicin exposure and reduced proliferation of the tumorigenic MES-SA/Dx5 cell line.",-40.0,0.6,cellline
"Mutational analysis of the TP53 gene in the H446 cell line revealed a novel c.215C>A SequenceVariant that correlates with increased chemotherapeutic resistance to doxorubicin, a ChemicalEntity, thereby highlighting a potential therapeutic target for treating small cell lung carcinoma.",-32.5,0.6,cellline
"Mutagenic exposure of the H446 lung carcinoma cell line to doxorubicin induced a BRCA1 c.68_69delAG sequence variant that correlated with increased DNA damage and enhanced apoptosis, whereas the same treatment had no effect on the non‑transformed RWPE1 prostate epithelial cells.",-39.25,0.6,cellline
"When H446 cells were exposed to the chemotherapeutic agent doxorubicin, the resulting activation of the TP53 pathway led to apoptosis that was markedly attenuated in MES‑SA/Dx5 cells harboring the BRCA1 c.68_69delAG variant, suggesting a cell‑line–specific interaction between DNA damage response and sequence‑variant–mediated drug resistance.",-37.75,0.6,cellline
"When CRISPR‑Cas9‑mediated knockout of the TP53 gene was performed in the H446 cell line, the resulting loss of p53 protein led to increased resistance to doxorubicin, a phenomenon that was confirmed by dose‑response assays comparing treated versus untreated cells.",-34.75,0.6,cellline
"When the H446 cell line was transfected with a CRISPR/Cas9 construct targeting the TP53 gene, the resulting loss‑of‑function mutation caused a marked increase in chemoresistance to doxorubicin, illustrating a direct link between p53 loss and drug tolerance in this model.",-36.5,0.6,cellline
"When COS‑7 cells were transfected with a plasmid encoding the human TP53 gene, the resulting p53 protein activated the downstream target p21 and induced a G1 arrest that was markedly attenuated in the presence of the small‑molecule inhibitor doxorubicin, confirming a dose‑dependent regulatory interaction between the chemical entity and the gene product in this cell line.",-56.5,0.6,cellline
"Knock‑down of TP53 in the H446 cell line markedly increased sensitivity to the DNA‑crosslinking agent doxorubicin, whereas overexpression of the drug‑resistance protein ABCB1 in the MES‑SA/Dx5 line restored survival, illustrating a direct interaction between gene regulation and chemotherapeutic efficacy in these distinct tumor cell models.",-48.75,0.6,cellline
"Knocking down TP53 in the H446 cell line reduces resistance to doxorubicin, thereby enhancing apoptosis in this small‑cell lung carcinoma model.",-23.75,0.6,cellline
"Knobs‑head mutation of TP53 in the H446 cell line activates the DNA‑damage response, thereby sensitizing the cells to doxorubicin‑induced apoptosis.",-41.5,0.6,cellline
"Knitting of the EMT transcription factor ZEB1 in H446 cells activates the PI3K/AKT pathway, thereby enhancing chemoresistance to doxorubicin in this lung cancer cell line.",-43.25,0.6,cellline
"Treatment of the H446 cell line with the small‑molecule inhibitor SAE-1 induces a rapid, dose‑dependent down‑regulation of the TP53 protein, thereby enhancing the proliferation rate of the tumor cells.",-36.75,0.6,cellline
"Treatment with the chemotherapeutic agent doxorubicin in the H446 lung cancer cell line led to a significant up‑regulation of the pro‑apoptotic protein TP53, which in turn activated the downstream caspase‑3 pathway, resulting in increased cell death and a decrease in cell viability.",-40.5,0.6,cellline
"Treatment using the chemotherapeutic agent doxorubicin in the H446 cell line revealed a significant upregulation of the tumor suppressor gene TP53, which in turn activated the p21 pathway and induced apoptosis, thereby reducing cell viability and demonstrating a potential therapeutic strategy for small cell lung cancer.",-43.75,0.6,cellline
"Treatment responses of the chemotherapeutic agent doxorubicin were markedly higher in H446 cells harboring the TP53 c.215C>T sequence variant compared with TP53 wild‑type H446 cells, suggesting a functional link between this mutation and drug sensitivity.",-45.5,0.6,cellline
"SREBP-1c activation in H446 cells promotes fatty‑acid synthase expression, leading to enhanced lipid accumulation that sensitizes these cells to the chemotherapeutic effects of doxorubicin.",-32.75,0.6,cellline
"SIRT1 overexpression in the H446 cell line reduces SAE‑induced apoptosis, a phenotype also observed in the tsA201 model, suggesting that SIRT1 may modulate stress‑associated signaling pathways across diverse cancer cell types.",-50.5,0.6,cellline
"SREBPs activate the transcription of the CYP7A1 gene in H446 cells, thereby enhancing bile acid synthesis and reducing the intracellular accumulation of the toxic metabolite associated with hepatocellular carcinoma.",-42.75,0.6,cellline
"Synthesis of the CRISPR‑Cas9 plasmid targeting the TP53 locus was performed in the H446 cell line, where the introduction of a BRCA1 c.68_69delAG variant was confirmed by Sanger sequencing and subsequently shown to enhance sensitivity to doxorubicin in comparison to the parental H446 cells.",-45.25,0.6,cellline
"Traf2DN‑tg B cells, when co‑cultured with the renal carcinoma line HK‑2, exhibited a dramatic up‑regulation of the pro‑apoptotic gene BAX, indicating that the dominant‑negative Traf2 construct can sensitize kidney epithelial cells to apoptosis through a BAX‑dependent pathway.",-37.75,0.6,cellline
"Treated with the proteasome inhibitor bortezomib, the HCT116 colorectal cancer cell line exhibited a dramatic increase in the phosphorylation of the tumor suppressor protein TP53, which in turn upregulated the transcription of the pro‑apoptotic gene BAX and induced caspase‑3 activation, leading to a significant reduction in cell viability compared with untreated controls.",-41.0,0.6,cellline
"TGF‑β signaling was markedly enhanced in HCT116 cells harboring a TRAF2DN‑tg mutation, leading to increased expression of the CD18/HPAF receptor and sensitizing the cells to apoptotic cues from the surrounding microenvironment.",-38.0,0.6,cellline
"Toxicity assays revealed that the TRAF2DN‑tg B transgenic mouse cell line exhibited markedly reduced apoptosis in response to doxorubicin compared with the parental H446 cell line, suggesting a protective role for the TRAF2DN mutation in chemotherapeutic resistance.",-40.75,0.6,cellline
"In the H446 cell line, overexpression of the mutant TP53 c.215C>T variant markedly increased resistance to doxorubicin, while knockdown of the ETV6 gene in PC-3 cells reduced migration and invasion through modulation of the AKT‑MMP2 signaling pathway.",-36.75,0.6,cellline
"In H446 cells, the overexpression of the mutant TP53 variant c.818G>A (p.R273H) dramatically enhances the transcriptional activity of the MYC oncogene, thereby accelerating proliferation and conferring resistance to doxorubicin.",-33.75,0.6,cellline
"In Traf2DN‑tg B mice, the H446 cell line exhibits reduced proliferation due to impaired NF‑κB signaling, whereas in HK‑2 cells the same TRAF2 dominant‑negative construct enhances apoptosis through caspase‑3 activation.",-32.25,0.6,cellline
"In our study, the H446 cell line was transfected with a CRISPR-Cas9 construct targeting the TP53 gene, and the resulting TP53 c.215C>T (p.R72C) sequence variant led to a marked increase in apoptosis upon doxorubicin treatment, confirming the tumor-suppressor role of TP53 in lung cancer cells.",-43.25,0.6,cellline
"HCT116 cells harboring a CRISPR‑induced TP53 c.215C>A (p.Pro72Arg) variant exhibit increased apoptosis upon doxorubicin treatment, a response that is markedly attenuated in the same cell line engineered to overexpress the anti‑apoptotic BCL‑2 protein.",-36.75,0.6,cellline
"H446 cells transfected with a Traf2DN-tg construct exhibited markedly reduced NF‑κB activation and increased apoptosis compared with untransfected HCT116 cells, suggesting that Traf2 inhibition selectively sensitizes prostate cancer cell lines to chemotherapeutic agents.",-29.75,0.6,cellline
"H226 cells treated with the TRF2DN‑tg B construct showed a marked decrease in CD18/HPAF expression, suggesting that the dominant‑negative TRF2 variant suppresses adhesion molecule signaling in this colorectal carcinoma cell line.",-40.5,0.6,cellline
"HETR-1 cells, a derivative of the H446 lung carcinoma line, exhibited a marked upregulation of the tumor suppressor TP53 in response to doxorubicin, thereby enhancing apoptosis and reducing colony formation in vitro.",-47.5,0.6,cellline
"The CRISPR-Cas9 knock‑out of TP53 in HCT116 cells markedly increased sensitivity to doxorubicin, a result that was confirmed by a dose‑response assay using the same cell line.",-28.875,0.6,cellline
"The TRF2DN‑tg B cell line, derived from the H446 lung carcinoma, exhibits a markedly reduced proliferation rate compared with its parental H446 counterpart, likely due to impaired telomerase activity.",-34.5,0.6,cellline
"The proliferation of H446 cells was markedly inhibited by the CRISPR‑mediated knockout of TP53, whereas the same TP53 deletion in the PC‑3 line enhanced androgen‑induced apoptosis via upregulation of the BAX gene.",-37.5,0.6,cellline
"The HepG2 cell line, when treated with the small molecule inhibitor trametinib, exhibited a marked decrease in ERK1/2 phosphorylation, suggesting that MEK inhibition effectively suppresses the MAPK pathway in this hepatocellular carcinoma model.",-33.75,0.6,cellline
A TRAF2DN‑tg B mouse model demonstrates that overexpression of the dominant‑negative TRAF2 in H446 and PC‑3 cell lines suppresses NF‑κB‑mediated invasion while increasing apoptosis via caspase‑3 activation.,-36.0,0.6,cellline
"A CRISPR‑Cas9‑mediated knockout of TP53 in HCT116 cells caused a significant upregulation of the DNA‑damage‑response gene ATM, thereby increasing the sensitivity of these cells to the chemotherapeutic agent doxorubicin.",-28.0,0.6,cellline
"A proteomic screen of the HCT116 colorectal carcinoma cell line revealed that overexpression of the mutant TP53 variant p.R273H, introduced via CRISPR/Cas9 editing, selectively enhanced the binding affinity of the transcription factor NF‑κB to the promoter of the anti‑apoptotic gene BCL‑XL, thereby conferring resistance to doxorubicin‑induced apoptosis.",-44.25,0.6,cellline
"A genome‑wide CRISPR‑Cas9 screen in HCT116 cells revealed that loss of the tumor suppressor gene TP53 synergizes with the KRAS G12D mutation to drive chemoresistance to doxorubicin, a finding that was corroborated by increased IC50 values in the isogenic HCT116 TP53‑null/ KRAS‑G12D double mutant line.",-54.5,0.6,cellline
"Mutation of TP53 in the HCT116 cell line disrupts the DNA damage response, leading to increased sensitivity of these cells to doxorubicin-induced apoptosis.",-21.625,0.6,cellline
"Mutation p.R175H in the TP53 gene, introduced into the HCT116 colorectal carcinoma cell line, increased the transcriptional activity of the p21 promoter and sensitized the cells to doxorubicin-induced apoptosis.",-35.25,0.6,cellline
"Mutation-induced activation of the PI3K/AKT pathway in HCT116 cells, combined with overexpression of the chemokine receptor CXCR4, enhances migration of these carcinoma cells toward stromal-derived factor‑1α secreted by LLC‑PK1 endothelial cells.",-46.5,0.6,cellline
"Mutation analysis of the TP53 gene in HCT116 cells revealed a novel c.215G>A variant that, when combined with the KRAS G12D mutation, dramatically increased colony formation in soft agar and conferred resistance to cisplatin in the H446 cell line.",-43.25,0.6,cellline
"Functional assays in HCT116 cells revealed that the KRAS c.35G>A (p.G12S) variant increases MAPK pathway activation, thereby enhancing proliferation and conferring resistance to the EGFR inhibitor gefitinib.",-33.75,0.6,cellline
"Functional loss of TRAF2 in the Traf2DN‑tg B mouse model was confirmed by reduced NF‑κB activation in H446 and HK‑2 cell lines, where knockdown of CD18/HPAF further amplified apoptosis in PC‑3‑derived cultures.",-42.0,0.6,cellline
"Functional attenuation of TRAF2 in H446 and PC-3 cell lines, achieved by transfection with a dominant‑negative TRAF2 construct, markedly reduced NF‑κB activation and subsequent IL‑6 secretion, thereby sensitizing these cancer cells to cisplatin‑induced apoptosis.",-49.0,0.6,cellline
"Functional overexpression of TRAF2 in the HCT116 colorectal cancer cell line leads to increased NF‑κB activation, which in turn upregulates the anti‑apoptotic gene BCL‑2 and enhances resistance to cisplatin treatment.",-32.75,0.6,cellline
Mutational analysis of the TP53 gene in HCT116 and PC-3 cell lines revealed a recurrent BRCA1 c.68_69delAG variant that correlates with increased sensitivity to doxorubicin in these colorectal and prostate cancer models.,-24.75,0.6,cellline
"Mutant TP53 expression in HCT116 cells treated with doxorubicin induces a robust upregulation of the pro‑apoptotic gene BAX, thereby enhancing caspase‑3 activation and cell death.",-29.0,0.6,cellline
"Mutagenic exposure of the HCT116 cell line to doxorubicin induced a BRCA1 c.68_69delAG sequence variant that correlated with increased apoptosis and reduced cell proliferation, suggesting a potential therapeutic target for chemoresistance in colorectal cancer.",-31.0,0.6,cellline
Mutual inhibition between the KRAS-driven H446 lung carcinoma cells and the TRAF2DN‑tg B over‑expressing mouse model reveals that TRAF2DN‑tg B reduces H446 proliferation by up‑regulating the CD18/HPAF adhesion pathway.,-51.5,0.6,cellline
"Knocking down TP53 in the HCT116 cell line markedly increased the expression of the anti‑apoptotic protein BCL‑XL, thereby enhancing resistance to doxorubicin‑induced cytotoxicity.",-21.625,0.6,cellline
"Knockdown of TP53 in the HCT116 colorectal cancer cell line H446 markedly enhanced resistance to doxorubicin, suggesting that TP53 loss confers drug tolerance in this model.",-33.75,0.6,cellline
"Knocked‑down of Traf2DN‑tg in HCT116 cells leads to a significant increase in CD18/HPAF‑mediated adhesion of PC‑3 cells to the extracellular matrix, suggesting a potential therapeutic target for metastatic prostate cancer.",-40.0,0.6,cellline
"Knitting the H446 and PC‑3 cell lines together in a co‑culture system, researchers observed that TRAF2DN‑tg B overexpression in HCT116 cells markedly upregulated CD18/HPAF expression, thereby enhancing the invasive potential of the tumor cells.",-54.0,0.6,cellline
"Expression of the mutant p53 variant R273H in the HCT116 cell line dramatically enhances the transcription of MMP9, thereby promoting invasion of adjacent endothelial cells and accelerating tumor angiogenesis in vitro.",-38.25,0.6,cellline
"Expression levels of the p53 protein were markedly increased in HCT116 cells treated with doxorubicin, and this up‑regulation was further amplified when the cells were co‑cultured with the Traf2DN‑tg B cell line, suggesting a synergistic interaction that may potentiate apoptosis in colorectal cancer models.",-46.5,0.6,cellline
"Expression profiling of the KRAS‑mutant H446 cell line revealed that inhibition of the MAPK pathway by trametinib induced a compensatory upregulation of the PI3K/AKT axis, thereby suggesting a potential combination therapy strategy for non‑small‑cell lung cancer.",-44.0,0.6,cellline
"Expression studies in HCT116 cells revealed that the Traf2DN-tg B variant induces a dramatic up‑regulation of the CD18/HPAF pathway, thereby enhancing the chemotactic response of PC‑3 cells to ethanol‑derived reactive oxygen species.",-49.5,0.6,cellline
"Stimulation of the NF‑κB pathway in the H446 lung carcinoma cell line by the TRAF2 dominant‑negative transgene (Traf2DN‑tg B) leads to a significant reduction in CD18 expression, thereby impairing adhesion of these cells to endothelial monolayers in vitro.",-37.5,0.6,cellline
"Stably transfected H446 cells overexpressing a Traf2DN-tg construct exhibit markedly reduced NF‑κB activation and increased apoptosis when treated with the chemotherapeutic agent doxorubicin, suggesting a synergistic cytotoxic effect that may be exploited for targeted lung cancer therapy.",-33.25,0.6,cellline
"Stabilized TRAF2 in the Traf2DN-tg B mouse model downregulates CD18/HPAF expression, thereby reducing invasive migration of the H446 lung carcinoma cell line and enhancing the susceptibility of PC-3 prostate cancer cells to doxorubicin-induced apoptosis.",-45.25,0.6,cellline
"Stability of the TP53 protein in the HCT116 cell line is markedly enhanced by the BRCA1 c.68_69delAG variant, thereby reducing apoptosis in response to doxorubicin treatment.",-24.875,0.6,cellline
"Treatment with the TP53‑overexpressing HCT116 cell line revealed that the presence of the BRCA1 c.68_69delAG variant in the PC‑3 cells enhanced DNA‑damage repair, thereby attenuating the apoptosis induced by doxorubicin in the HK‑2 renal proximal tubule model.",-44.5,0.6,cellline
"Treatment of the H446 lung carcinoma cell line with the TRAF2 dominant‑negative construct Traf2DN‑tg B significantly reduced NF‑κB activity and sensitized the cells to doxorubicin‑induced apoptosis, whereas the HK‑2 proximal tubule line remained largely resistant to the same regimen.",-35.5,0.6,cellline
"Treatment efficacy of the small‑molecule inhibitor doxorubicin was markedly enhanced in the H446 lung carcinoma cell line, where TP53 activation induced apoptosis and concurrently down‑regulated the expression of the anti‑apoptotic protein BCL‑2, thereby potentiating the cytotoxic effect observed in the PC‑3 prostate cancer model.",-53.0,0.6,cellline
"Treatment-response assays revealed that the KRAS-driven PC-3 cell line, when co-cultured with the Traf2DN-tg B variant, exhibited a marked increase in apoptosis, suggesting that Traf2 inhibition may sensitize prostate cancer cells to chemotherapeutic agents.",-50.5,0.6,cellline
"Experiments with the H446 and PC-3 cell lines revealed that overexpression of a Traf2DN-tg construct markedly suppressed NF‑κB activation and reduced the secretion of IL‑8, suggesting a potential therapeutic strategy for targeting inflammatory pathways in prostate cancer.",-36.5,0.6,cellline
"Experiencing a pronounced upregulation of NF‑κB signaling, the PC‑3 cell line harboring the TRAF2DN‑tg mutation exhibited significantly reduced invasion capacity compared with its TRAF2DN‑tg‑negative counterpart, while co‑treatment with the small molecule inhibitor doxorubicin further suppressed metastatic potential by inducing apoptosis through caspase‑3 activation.",-63.5,0.6,cellline
"Experiences of HCT116 cells treated with the TRAF2 dominant-negative construct (Traf2DN‑tg) revealed a pronounced decrease in NF‑κB activation and a concomitant up‑regulation of pro‑apoptotic BAX, indicating that disrupting TRAF2 signaling in this colorectal cancer cell line enhances apoptosis through the intrinsic mitochondrial pathway.",-55.0,0.6,cellline
"Experinor, a novel synthetic chemical entity, inhibited proliferation of H446 and PC‑3 cell lines by down‑regulating the TP53‑mediated apoptotic pathway while simultaneously enhancing the expression of the anti‑apoptotic protein BCL‑2, thereby demonstrating a dual modulatory effect on cell survival in a human lung cancer model.",-62.75,0.6,cellline
"Treatments with the TRAF2 dominant‑negative transgene (Traf2DN‑tg) in HCT116 colon carcinoma cells markedly reduced NF‑κB activation, thereby enhancing cisplatin‑induced apoptosis and suppressing tumor‑derived angiogenesis.",-35.5,0.6,cellline
"Treating H446 and PC-3 cells with the novel kinase inhibitor PKC-7C reduces Akt phosphorylation and induces apoptosis, a process that is amplified when combined with the TRAF2 dominant‑negative construct Traf2DN‑tg, thereby revealing a synthetic lethal interaction that could be exploited for targeted lung‑cancer therapy.",-67.0,0.6,cellline
"Treatment of HCT116 cells with the CD18/HPAF inhibitor reduced NF‑κB activation and consequently decreased expression of the pro‑inflammatory cytokine IL‑6, illustrating a potential therapeutic strategy for targeting inflammation‑driven colorectal cancer.",-48.75,0.6,cellline
"Treat‑based modulation of TRAF2 signaling in H446 cells, combined with overexpression of CD18/HPAF, induced a marked decrease in MMP‑9 secretion and attenuated invasion of the TRAF2DN‑tg B mouse model, suggesting a potential therapeutic axis for limiting metastasis in this lung‑carcinoma cell line.",-72.0,0.6,cellline
"In U87-DACH1‑high cells, overexpression of DACH1 suppresses EGFR signaling, thereby reducing proliferation of the glioblastoma cell line U87‑MG and increasing sensitivity to the chemotherapeutic agent temozolomide.",-26.125,0.6,cellline
"In the U87‑DACH1‑high cell line, overexpression of the Traf2DN‑tg B construct markedly suppressed NF‑κB activation, thereby reducing IL‑6 secretion and enhancing apoptosis in response to doxorubicin treatment.",-21.5,0.6,cellline
"In A549 cells engineered to overexpress DACH1, the loss of TRAF2 function by a dominant‑negative Traf2DN‑tg B construct markedly enhanced EGF‑induced ERK phosphorylation, revealing a novel crosstalk between DACH1 and TRAF2 signaling pathways that promotes proliferation.",-45.0,0.6,cellline
"In an experiment where the U87‑DACH1‑high cell line was treated with the PI3K inhibitor LY294002, the downstream AKT phosphorylation was markedly reduced, leading to increased apoptosis and a significant decrease in colony‑forming efficiency compared with the U87‑DACH1‑low control.",-35.0,0.6,cellline
"The U87-DACH1-high glioblastoma cell line, when co‑cultured with THP‑1 macrophages, exhibited increased STAT3 phosphorylation that was abrogated by the A549‑derived STAT3 inhibitor, illustrating a novel crosstalk between tumor and immune cells.",-30.625,0.6,cellline
"The STAT3 inhibitor JSI-124 markedly reduced proliferation and induced apoptosis in U87-DACH1-high cells, whereas the same compound had minimal effect on U87-DACH1-low cells, suggesting a DACH1‑dependent STAT3 signaling axis.",-36.0,0.6,cellline
"The Hs578T cell line, engineered to overexpress TP53, was shown to reduce proliferation in A549 cells by upregulating the p21 pathway, thereby illustrating a cross‑cell‑line interaction that could inform targeted therapy development.",-44.75,0.6,cellline
"The CRISPR‑Cas9 edited U87‑DACH1‑high cell line, cultured on a C57BL/6‑derived feeder layer, exhibited a dramatic up‑regulation of the NF‑κB target gene TNFA, confirming that DACH1 suppression in glioblastoma cells enhances inflammatory signaling.",-33.25,0.6,cellline
"U87-DACH1-high cells, when co‑cultured with THP‑1 macrophages, displayed a marked increase in NF‑κB activation that was attenuated by the A549‑derived CXCL10 antagonist, suggesting a cell‑line‑specific inflammatory crosstalk mediated by the CXCL10‑CXCR3 axis.",-39.25,0.6,cellline
"U587‑DACH1‑high cells exposed to the MEK inhibitor trametinib exhibited a pronounced decrease in phosphorylated ERK1/2, leading to reduced proliferation of the U87‑DACH1‑high cell line while simultaneously inducing apoptosis in the co‑cultured THP‑1 macrophages.",-48.75,0.6,cellline
"U‑87‑DACH1‑high cells, when co‑cultured with THP‑1‑derived macrophages, exhibit a markedly increased secretion of IL‑6 that is further amplified by the addition of the small‑molecule inhibitor, trametinib, suggesting a potential therapeutic axis for targeting the tumor microenvironment in glioblastoma.",-41.25,0.6,cellline
"U81-DACH1-high cells derived from the U87 glioblastoma line were transfected with a CRISPR/Cas9 construct targeting the TP53 gene, and the resulting TP53 c.215C>T (p.R72P) sequence variant was shown to enhance cell migration and invasion in a Matrigel assay.",-51.75,0.6,cellline
"Loss of DACH1 expression in the U87‑DACH1‑high glioblastoma cell line increases the phosphorylation of STAT3, thereby enhancing the transcription of the CXCL12 chemokine and promoting invasion of adjacent endothelial cells.",-36.0,0.6,cellline
"Loss‑of‑function of the tumor suppressor TP53 in the U87‑DACH1‑high cell line enhances TRAF2‑dependent NF‑κB activation, thereby increasing resistance to cisplatin‑induced apoptosis.",-30.5,0.6,cellline
"Losses in the MAPK pathway caused by a KRAS G12D variant in the U87‑DACH1‑high glioblastoma cell line were rescued by co‑transfection of a constitutively active MEK1 in THP‑1 macrophages, demonstrating a cross‑talk that may influence the inflammatory phenotype of the tumor microenvironment.",-59.25,0.6,cellline
"Loss-of-function mutations in TP53 were found to sensitize the U87‑DACH1‑high cell line to doxorubicin, whereas overexpression of DACH1 in A549 cells rescued the apoptotic response and restored caspase‑3 activation.",-38.75,0.6,cellline
"Exposure to the inflammatory cytokine TNF‑α increased the expression of the pro‑apoptotic protein BAX in the U87‑DACH1‑high glioblastoma cell line, whereas co‑treatment with the small‑molecule inhibitor IKK‑β prevented this effect in the same cells.",-44.0,0.6,cellline
"Exposure of the U87‑DACH1‑high glioma cell line to the MEF‑derived extracellular matrix upregulated TRAF2 expression, thereby enhancing STAT3‑mediated survival signaling in the presence of the A549‑derived chemokine CCL2.",-36.25,0.6,cellline
"Exposure‑dependent activation of NF‑κB in THP‑1 macrophages treated with doxorubicin is attenuated in the presence of the U87‑DACH1‑high glioblastoma cell line, suggesting a cross‑talk between tumor‑derived soluble factors and chemotherapeutic‑induced inflammatory signaling in the tumor microenvironment.",-49.5,0.6,cellline
"Exposure assays using U87‑DACH1‑high and U87‑DACH1‑low glioblastoma cell lines revealed that the DACH1‑overexpressing cells exhibit markedly reduced proliferation upon treatment with the small‑molecule inhibitor doxorubicin, an effect that is partially mediated by up‑regulation of the tumor suppressor TP53 and subsequent activation of the apoptotic effector caspase‑3.",-57.5,0.6,cellline
"Studies reveal that the U87‑DACH1‑high glioblastoma cell line, when co‑cultured with THP‑1 macrophages, induces a STAT3‑dependent cytokine cascade that enhances MCF‑7 breast cancer cell invasion through upregulation of the CXCL8 chemokine.",-35.0,0.6,cellline
"Studies show that the U87‑DACH1‑high cell line, when treated with the small molecule inhibitor doxorubicin, exhibits a significant decrease in TP53 protein levels, suggesting that DACH1 overexpression may sensitize glioblastoma cells to DNA‑damage‑induced apoptosis.",-35.0,0.6,cellline
"Studies showed that the U87‑DACH1‑high cell line, when co‑cultured with THP‑1 macrophages, induced a STAT3‑dependent upregulation of IL‑6 that promoted MCF‑7 proliferation through ERK signaling.",-31.75,0.6,cellline
"Studies using the U87‑DACH1‑high cell line revealed that overexpression of DACH1 enhances TRAF2‑mediated NF‑κB signaling, whereas CRISPR‑mediated knockout of DACH1 in the U87‑DACH1‑low line reduces this pathway and attenuates proliferation.",-36.25,0.6,cellline
"Mutant U87‑DACH1‑high cells exposed to the TRAF2DN‑tg B inhibitor displayed a significant reduction in MCF‑7‑derived MMP‑9 secretion while preserving A549‑mediated EGFR phosphorylation, indicating a cell‑line‑specific modulation of the NF‑κB pathway in the C57BL/6 background.",-51.25,0.6,cellline
Mutational analysis of the TP53 gene in the U87‑DACH1‑high glioblastoma cell line revealed a novel c.215C>T (p.R72C) variant that enhances apoptotic sensitivity to doxorubicin compared with the U87‑DACH1‑low counterpart.,-24.375,0.6,cellline
"Mutagenic exposure of the U87‑DACH1‑high glioblastoma cell line to doxorubicin induced a BRCA1 c.68_69delAG variant that was subsequently confirmed by Sanger sequencing in the A549 lung carcinoma line, demonstrating cross‑species conservation of the DNA damage response.",-33.0,0.6,cellline
"Mutual inhibition between the NF‑κB pathway in U87‑DACH1‑high cells and the PI3K‑AKT axis in MCF‑7 cells was shown to reduce proliferation and induce apoptosis, a phenomenon that was amplified when the cells were treated with the small‑molecule inhibitor LY294002.",-47.75,0.6,cellline
"TRF2 overexpression in U87‑DACH1‑high cells enhances telomerase activity, thereby increasing proliferation and resistance to temozolomide compared with U87‑DACH1‑low cells.",-25.5,0.6,cellline
"TRAF2DN-tg B mice infected with a lentivirus carrying a CRISPR/Cas9 construct targeting TP53 exhibited increased apoptosis in U87-DACH1-high cells, while THP-1 macrophages exposed to the same vector showed reduced inflammatory cytokine production.",-42.0,0.6,cellline
"TRIF-mediated signaling in the U87‑DACH1‑high cell line, when challenged with IFN‑γ, induces a STAT1-dependent transcriptional program that upregulates the PD‑L1 gene product, thereby creating an immunosuppressive tumor microenvironment.",-48.5,0.6,cellline
"TRPA1 activation in the U87‑DACH1‑high glioblastoma cell line enhances CXCL8 secretion, which in turn promotes angiogenesis in co‑cultured Hs578T breast carcinoma cells.",-35.75,0.6,cellline
"A549 cells carrying the TP53 p.R273H sequence variant exhibited increased sensitivity to the chemotherapeutic agent doxorubicin, while co‑transfection with the Traf2DN-tg B construct in MEF cells attenuated NF‑κB activation and reduced apoptosis.",-38.0,0.6,cellline
"A U87‑DACH1‑high glioblastoma cell line, when co‑cultured with THP‑1 macrophages, exhibits increased NF‑κB activation that is markedly attenuated by treatment with the small‑molecule inhibitor JQ1.",-26.5,0.6,cellline
"A genetic screen of the U87‑DACH1‑high cell line revealed that the TP53 variant c.68_69delAG, which is absent in the U87‑DACH1‑low counterpart, correlates with increased sensitivity to doxorubicin treatment in vitro.",-34.0,0.6,cellline
"A knock‑down of DACH1 in U87‑DACH1‑high glioblastoma cells markedly increases TRAF2‑dependent NF‑κB activation, thereby enhancing resistance to temozolomide compared with U87‑DACH1‑low cells.",-26.0,0.6,cellline
"High expression of DACH1 in the U87‑DACH1‑high glioblastoma cell line reduces NF‑κB activation, thereby attenuating IL‑6 secretion and limiting tumor‑associated macrophage recruitment compared with the U87‑DACH1‑low counterpart.",-29.875,0.6,cellline
"High‑expressing U87‑DACH1‑high cells were found to secrete more VEGFA, which in turn enhanced the proliferation of THP‑1 macrophages through the CXCL8/IL‑8 pathway, whereas the U87‑DACH1‑low variant failed to induce a comparable response.",-47.5,0.6,cellline
"High‐expression U87‑DACH1‑high glioma cells treated with the TRAF2DN‑tg B transgene exhibited markedly reduced MMP‑9 secretion compared with low‑expression U87‑DACH1‑low cells, suggesting a TRAF2‑dependent regulatory axis in this cell line.",-38.5,0.6,cellline
"High metastatic U87‑DACH1‑high cells, when treated with the small molecule inhibitor trametinib, exhibit a significant reduction in ERK phosphorylation and induce apoptosis via caspase‑3 activation, whereas the parental U87‑DACH1‑low line shows only modest MAPK pathway inhibition.",-57.75,0.6,cellline
"Mutation of the TP53 gene in the U87‑DACH1‑high cell line leads to increased sensitivity to the chemotherapeutic agent doxorubicin, whereas the TP53‑wild‑type U87‑DACH1‑low line shows reduced apoptosis and enhanced proliferation.",-29.25,0.6,cellline
Mutation analysis of the TP53 gene in the U87‑DACH1‑high glioblastoma cell line revealed a novel c.215C>A variant that increases sensitivity to doxorubicin and enhances apoptosis in C57BL/6‑derived MEF cells.,-37.0,0.6,cellline
"Mutation in the TP53 gene in U87‑DACH1‑high glioblastoma cells, combined with treatment of doxorubicin, induces apoptosis through activation of the p53‑dependent caspase‑3 pathway, thereby reducing tumor cell viability in vitro.",-42.25,0.6,cellline
"Mutation‑induced overexpression of DACH1 in the U87‑DACH1‑high glioblastoma cell line markedly attenuates TRAF2‑mediated NF‑κB signaling, thereby reducing inflammatory cytokine secretion compared with the U87‑DACH1‑low counterpart.",-30.0,0.6,cellline
"Overexpression of DACH1 in the U87‑DACH1‑high glioblastoma cell line suppresses invasion by down‑regulating MMP‑9, whereas the U87‑DACH1‑low counterpart exhibits increased motility and elevated ERK phosphorylation.",-28.625,0.6,cellline
"Overexpressing DACH1 in the U87‑DACH1‑high glioblastoma cell line markedly reduces NF‑κB‑dependent secretion of IL‑6, whereas knockdown of DACH1 in the U87‑DACH1‑low line restores the inflammatory response.",-30.375,0.6,cellline
"Over the course of the experiment, the U87‑DACH1‑high glioblastoma cells exhibited a markedly increased proliferation rate when co‑cultured with THP‑1 macrophages treated with the CXCR4 antagonist AMD3100, whereas the U87‑DACH1‑low variant showed only a modest, statistically insignificant rise in growth.",-40.75,0.6,cellline
"Over a two‑week period, the U87‑DACH1‑high glioblastoma cell line was treated with the chemotherapeutic agent doxorubicin, and subsequent RNA‑seq analysis revealed that the down‑regulation of the TP53 pathway correlated with increased expression of the anti‑apoptotic gene BCL‑XL, thereby suggesting that U87‑DACH1‑high cells may acquire chemoresistance through TP53‑mediated transcriptional repression.",-52.75,0.6,cellline
"STRENGTHENING evidence that U87‑DACH1‑high cells exhibit reduced invasion through down‑regulation of MMP‑9, whereas THP‑1‑derived macrophages co‑cultured with U87‑DACH1‑low cells secrete higher IL‑6 levels that promote tumor‑associated macrophage polarization, a phenomenon that is further potentiated by the presence of the MEF‑derived fibroblast‑secreted CXCL12 gradient in the A549‑co‑",-79.5,0.6,cellline
"STING-mediated activation of NF‑κB in THP‑1 cells transfected with a TRAF2‑dominant‑negative construct (Traf2DN‑tg B) reduces IL‑6 secretion, whereas the same construct in U87‑DACH1‑high glioblastoma cells enhances cell‑surface PD‑L1 expression, suggesting a cell‑line‑specific regulatory mechanism linking innate immunity to immune evasion.",-65.0,0.6,cellline
"STEM cell line U87-DACH1-high, when transfected with a CRISPR‑Cas9‑mediated BRCA1 c.68_69delAG variant, exhibits reduced proliferation and increased apoptosis relative to the U87-DACH1-low counterpart, suggesting a tumor‑suppressive role for the variant in glioblastoma models.",-50.25,0.6,cellline
"STUDY: The U87‑DACH1‑high cell line, derived from a glioblastoma model, was co‑cultured with THP‑1 macrophages and exposed to the chemotherapeutic agent doxorubicin, revealing that DACH1 overexpression attenuates NF‑κB‑mediated inflammatory cytokine production and enhances apoptosis through the mitochondrial pathway.",-49.5,0.6,cellline
"Cytokine secretion from THP‑1 macrophage‑like cells is markedly enhanced when co‑cultured with U87‑DACH1‑high glioblastoma cells, whereas the same effect is attenuated in the U87‑DACH1‑low variant, indicating a DACH1‑dependent regulation of inflammatory signaling in the tumor microenvironment.",-32.75,0.6,cellline
"C57BL/6 mice infected with a lentivirus encoding a dominant‑negative TRAF2 (Traf2DN‑tg B) exhibited a marked increase in MCF‑7‑derived tumor growth, suggesting that TRAF2 inhibition in this organism taxon enhances breast cancer cell line proliferation.",-37.25,0.6,cellline
"Cohen et al. observed that the U87‑DACH1‑high cell line exhibited significantly elevated TRAF2‑dependent NF‑κB activation compared with the U87‑DACH1‑low counterpart, suggesting a DACH1‑mediated modulation of inflammatory signaling in glioblastoma cells.",-35.25,0.6,cellline
"C7H7NO3, the active metabolite of the antineoplastic drug doxorubicin, was shown to induce apoptosis in U87‑DACH1‑high glioblastoma cells while sparing normal MEF fibroblasts, thereby highlighting a differential cytotoxicity that may be exploited for targeted therapy.",-51.5,0.6,cellline
"The CRISPR‑Cas9‑mediated knockout of TP53 in the A549 cell line reduced EGF‑induced proliferation and increased apoptosis, suggesting that p53 loss enhances sensitivity to EGFR inhibition in lung carcinoma cells.",-28.625,0.6,cellline
"The ERK1/2 pathway activation in A549 and HCT116 cells, triggered by the small molecule gefitinib, downregulates the expression of the tumor suppressor gene TP53, thereby promoting chemoresistance and enhancing cell proliferation.",-42.0,0.6,cellline
"The KRAS‑G12D mutation in the A549 cell line was found to upregulate IL‑6 secretion, which in turn promoted STAT3‑mediated proliferation and conferred resistance to the small‑molecule inhibitor erlotinib.",-33.25,0.6,cellline
"The KU7 cell line, engineered to overexpress the mutant TP53 variant c.743G>A, exhibits increased sensitivity to the DNA‑crosslinking agent doxorubicin compared with the parental DU145 cells.",-24.625,0.6,cellline
"In the KU7 cell line, overexpression of the mutant TP53 c.215C>A variant induces a pronounced upregulation of the chemokine CXCL8, thereby enhancing autocrine signaling that promotes invasion and chemoresistance in this aggressive prostate carcinoma model.",-35.5,0.6,cellline
"In KRAS‑mutant A549 cells, the CRISPR‑mediated knockout of the TP53 gene dramatically increases the expression of the anti‑apoptotic protein BCL‑XL, thereby conferring resistance to the chemotherapeutic agent doxorubicin.",-28.5,0.6,cellline
"In U87TR‑Da glioblastoma cells, CRISPR‑mediated disruption of the PTEN gene leads to hyperactivation of the PI3K‑AKT pathway, which in turn enhances cell proliferation and confers resistance to temozolomide treatment.",-24.125,0.6,cellline
"In Ku7 cells, the CRISPR‑mediated knockout of TP53 leads to increased proliferation, whereas re‑introducing wild‑type TP53 restores cell cycle arrest and reduces colony formation.",-32.75,0.6,cellline
"After treating the KU7 cell line with doxorubicin, the resulting upregulation of TP53 protein was confirmed by western blot, indicating a potential therapeutic pathway for overcoming drug resistance in this aggressive prostate cancer model.",-38.75,0.6,cellline
"After engineering a CRISPR‑Cas9 system to introduce the BRCA1 c.68_69delAG variant, we observed that the KU7 cell line exhibited increased sensitivity to doxorubicin compared with the wild‑type A549 cells.",-38.0,0.6,cellline
"After CRISPR‑Cas9‑mediated knockout of TP53 in the U87TR‑Da glioblastoma cell line, the resulting mutant cells exhibited increased resistance to doxorubicin, as confirmed by a dose‑response MTT assay.",-34.5,0.6,cellline
"After transiently transfecting the KRAS‑G12D mutant plasmid into the colorectal carcinoma cell line HCT116, we observed a dose‑dependent increase in phosphorylated ERK1/2 and a concomitant up‑regulation of the pro‑apoptotic gene BAX, indicating that the introduced sequence variant (c.35G>A) drives enhanced MAPK signaling and apoptosis in this human cancer model.",-54.25,0.6,cellline
"A549 cells treated with doxorubicin exhibited increased TP53 phosphorylation, which in turn upregulated the expression of the antioxidant enzyme SOD2, thereby reducing oxidative stress and enhancing cell survival.",-23.75,0.6,cellline
"A589 cells, a derivative of the A549 lung carcinoma line, were engineered to express a CRISPR‑edited TP53 c.68_69delAG variant, resulting in impaired p53‑dependent apoptosis and enhanced resistance to doxorubicin treatment.",-40.75,0.6,cellline
"AUC‑1, a mutant form of TP53, was introduced into the KU7 cell line via lentiviral transduction, and the resulting cells exhibited increased sensitivity to the DNA‑damaging chemotherapeutic doxorubicin compared with parental KU7 cells.",-41.75,0.6,cellline
"A modified A549 cell line harboring a KRAS G12D sequence variant was transfected with a plasmid encoding the CRISPR/Cas9 system to knock out the TP53 gene, resulting in enhanced proliferation and resistance to doxorubicin-induced apoptosis.",-40.5,0.6,cellline
"U87TR‑Da cells overexpressing mutant EGFRvIII exhibit heightened resistance to the chemotherapeutic agent doxorubicin, whereas co‑treatment with the A549‑derived microRNA‑21 inhibitor restores apoptosis via down‑regulation of BCL‑2 expression.",-39.75,0.6,cellline
"U‑87TR‑Da cells, when exposed to the DNA‑damaging agent doxorubicin, exhibit a marked increase in p53‑mediated apoptosis, a response that is markedly attenuated in the A549 cell line due to its KRAS‑G12S mutation.",-41.5,0.6,cellline
"U293T cells transfected with a CRISPR/Cas9 construct targeting the TP53 gene exhibited reduced colony‑forming ability, while the same TP53 knock‑out in DU145 cells led to increased sensitivity to the chemotherapeutic agent doxorubicin, confirming TP53’s role in DNA damage response across distinct cell lines.",-51.5,0.6,cellline
"U251 glioblastoma cells exposed to the novel compound JN-321 displayed a dose-dependent reduction in EGFR phosphorylation, while the HCT116 colon carcinoma cell line showed a concomitant upregulation of the pro‑apoptotic protein BAX, suggesting that JN‑321 may selectively trigger apoptosis through EGFR‑dependent signaling in cancerous cell lines.",-79.5,0.6,cellline
"KRAS‑mutant A549 cells exposed to the MEK inhibitor trametinib exhibited a dose‑dependent decrease in ERK phosphorylation, while co‑treatment with the PI3K inhibitor LY294002 restored AKT activation and rescued cell viability.",-29.25,0.6,cellline
"KRAB-ZFP transcription factor ZNF768 suppresses proliferation in the KRAS‑mutant KRAS‑driven A549 cell line by down‑regulating the EGFR signaling cascade, thereby reducing colony‑forming ability in vitro.",-45.25,0.6,cellline
"KR8 cells, a KRAS‑mutated subline derived from A549, exhibit heightened sensitivity to the PI3K inhibitor LY294002, whereas the isogenic KR8‑KRAS‑WT variant shows only modest growth inhibition, suggesting that KRAS mutation status directly regulates PI3K pathway dependence in lung carcinoma cells.",-59.5,0.6,cellline
"KR4 cells, a sub‑clone of the DU145 prostate carcinoma cell line, exhibited a marked up‑regulation of the HIF‑1α pathway when exposed to the hypoxia‑inducing agent cobalt chloride, thereby enhancing VEGFA secretion and accelerating angiogenic sprouting in co‑cultured HUVECs.",-49.5,0.6,cellline
"Knockdown of TP53 in the DU145 cell line enhances resistance to doxorubicin by upregulating the anti‑apoptotic protein BCL‑2, thereby increasing cell survival in vitro.",-27.75,0.6,cellline
"Knocking down TP53 in the KU7 cell line dramatically increases the expression of the DNA repair gene RAD51, thereby enhancing resistance to doxorubicin-induced apoptosis.",-25.25,0.6,cellline
"Knudson’s hypothesis was experimentally validated when the KRAS mutation c.34G>T (p.Gly12Val) in the A549 cell line was shown to increase proliferation and confer resistance to the EGFR inhibitor gefitinib, while the same mutation in the DU145 prostate cancer line promoted castration‑resistant growth and elevated AR signaling.",-61.75,0.6,cellline
"Knocked‑down of the TP53 gene in the A549 cell line reduced the expression of the DNA‑repair enzyme XRCC1, thereby increasing the sensitivity of these cells to doxorubicin‑induced apoptosis.",-31.375,0.6,cellline
"Exposure of the U87TR‑Da glioblastoma cell line to the small molecule inhibitor KU7 markedly decreased EGFR phosphorylation while simultaneously up‑regulating the pro‑apoptotic gene TP53, suggesting that KU7 could sensitize U87TR‑Da cells to temozolomide treatment.",-38.25,0.6,cellline
"Exposure to the DNA‑damaging agent doxorubicin induced a rapid up‑regulation of the pro‑apoptotic gene BAX in the KU7 prostate carcinoma cell line, a response that was markedly attenuated when the cells were pre‑treated with the antioxidant N‑acetylcysteine, thereby demonstrating a direct link between oxidative stress, gene expression, and cell viability.",-42.0,0.6,cellline
"Exposure-induced oxidative stress in the KU7 and DU145 cell lines upregulates the NRF2 pathway, leading to increased expression of the antioxidant gene NQO1 and enhanced resistance to doxorubicin-mediated apoptosis.",-38.5,0.6,cellline
"Exposure experiments revealed that the CRISPR‑edited KU7 cell line, harboring a BRCA1 c.68_69delAG sequence variant, showed reduced proliferation when treated with doxorubicin, whereas the unedited DU145 line maintained baseline growth.",-46.75,0.6,cellline
"Treatment of the KRAS‑mutated pancreatic cancer cell line KU7 with the MEK inhibitor trametinib reduced ERK phosphorylation and induced apoptosis, suggesting a potential therapeutic strategy for KRAS‑driven tumors.",-23.625,0.6,cellline
"Treatment with the PI3K inhibitor LY294002 reduced AKT phosphorylation in the DU145 cell line, thereby enhancing doxorubicin‑induced apoptosis and decreasing the expression of the drug‑efflux transporter ABCB1.",-31.375,0.6,cellline
"Treatment efficacy of doxorubicin was markedly enhanced in the KU7 and A549 cell lines, where the drug induced apoptosis through upregulation of TP53 and suppression of the PI3K/AKT pathway, thereby reducing the proliferation of these malignant cells.",-42.25,0.6,cellline
"Treatment experiments revealed that the KRAS^G12D mutation in the A549 cell line markedly increased EGFR signaling, thereby enhancing resistance to the small‑molecule inhibitor erlotinib in comparison to the KRAS‑wild‑type HCT116 cells.",-43.25,0.6,cellline
"Activation of the PI3K‑AKT pathway by insulin in the A549 cell line leads to increased proliferation of KRAS‑mutated HCT116 cells, suggesting that IGF1R inhibition could selectively suppress tumor growth in KRAS‑mutant colorectal cancers.",-38.0,0.6,cellline
"Activation studies in the KU7 and HCT116 cell lines revealed that the TP53 variant c.215C>T (p.R72P) enhances the transcriptional response to the chemotherapeutic agent doxorubicin, thereby increasing apoptosis in these colorectal cancer cells.",-46.0,0.6,cellline
"Activation‑induced apoptosis in the A549 cell line, triggered by the chemotherapeutic doxorubicin, was found to be mediated through up‑regulation of the tumor suppressor TP53 and subsequent transcriptional activation of the pro‑apoptotic gene BAX.",-40.5,0.6,cellline
"Activation-induced STAT3 phosphorylation in KU7 cells exposed to the IL‑6 analogue reduces E2F1 transcriptional activity, thereby suppressing proliferation of the A549 and HCT116 cell lines while simultaneously up‑regulating the pro‑apoptotic gene BAX in the U87TR‑Da model.",-60.0,0.6,cellline
"Pseudomonas aeruginosa infection of the A549 cell line leads to up‑regulation of the chemokine CXCL8, which in turn recruits neutrophils and exacerbates lung inflammation, a hallmark of cystic fibrosis exacerbations.",-34.5,0.6,cellline
"P‑gp overexpression in the A549 cell line, driven by the ABCB1 gene, confers resistance to doxorubicin and is further exacerbated by the KRAS c.35G>T (G12V) sequence variant, thereby highlighting a potential therapeutic target for overcoming multidrug resistance in lung adenocarcinoma.",-48.25,0.6,cellline
"Pterostilbene treatment reduced proliferation and induced apoptosis in the human glioblastoma cell line U87TR‑Da while simultaneously downregulating the PI3K‑AKT signaling pathway, thereby highlighting its potential as a targeted therapeutic strategy for glioblastoma.",-45.75,0.6,cellline
"P53 overexpression in the DU145 prostate cancer cell line (DU145) was shown to sensitize the cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis compared with untreated controls.",-29.5,0.6,cellline
"Ku7 cells treated with the TP53‑activating compound doxorubicin exhibited a dose‑dependent increase in apoptosis, while in DU145 cells the same treatment induced a compensatory up‑regulation of the anti‑apoptotic BCL‑2 protein, suggesting a differential cellular response to DNA damage in these distinct prostate cancer cell lines.",-42.25,0.6,cellline
"Ku_7 cells exposed to the DNA‑damaging agent doxorubicin exhibited a pronounced up‑regulation of the tumor suppressor TP53, which in turn induced apoptosis and reduced colony‑forming ability compared with untreated DU145 cells.",-45.5,0.6,cellline
"Ku705C cells overexpressing TP53 and treated with the DNA‑damaging agent doxorubicin displayed a dramatic up‑regulation of the p21^CIP1/WAF1 gene product, confirming that the p53‑mediated checkpoint is functional in this KU7 cell line.",-63.75,0.6,cellline
"Ku‑7 cells treated with the histone deacetylase inhibitor vorinostat exhibit a marked increase in TP53 expression, leading to enhanced apoptosis and a reduction in the migratory capacity of the DU145 prostate cancer cell line.",-44.25,0.6,cellline
"Recent CRISPR‑mediated knock‑in of the BRCA1 c.68_69delAG variant in the HCT116 cell line revealed that the resultant protein product is mislocalized to the cytoplasm, thereby impairing DNA repair and increasing sensitivity to the chemotherapeutic agent doxorubicin.",-37.5,0.6,cellline
"Recent cross‑validation experiments revealed that the KU7 and DU145 cell lines exhibit markedly higher expression of the KRAS oncogene compared with the A549 and HCT116 lines, suggesting a differential dependency on MAPK signaling for proliferation.",-44.0,0.6,cellline
"Recent experiments revealed that the KRAS‑G12D variant in the KRAS gene markedly enhances the invasive potential of the A549 lung carcinoma cell line, a finding that was corroborated by increased colony‑forming ability in the HCT116 colorectal carcinoma line and by elevated phosphorylation of AKT in the DU145 prostate cancer line.",-60.0,0.6,cellline
"Recent studies show that the KU7 cell line, when treated with the small molecule inhibitor doxorubicin, exhibits a dramatic up‑regulation of TP53 protein levels, suggesting a potential therapeutic avenue for targeting TP53‑deficient cancers.",-38.5,0.6,cellline
CRISPR‑Cas9 editing of the TP53 locus in the A549 cell line introduced a BRCA1 c.68_69delAG variant that markedly increased sensitivity to doxorubicin while simultaneously up‑regulating the DNA‑damage‑response gene ATM in Homo sapiens cells.,-28.375,0.6,cellline
"CRITICAL: The KU7 cell line, derived from a human cervical carcinoma, exhibits increased resistance to the chemotherapeutic agent doxorubicin through upregulation of the ABCB1 transporter, whereas the A549 lung adenocarcinoma cell line shows heightened sensitivity to the same drug due to lower expression of this efflux pump.",-44.0,0.6,cellline
"CR-10 treatment markedly increased the phosphorylation of EGFR in the DU145 cell line, suggesting that this chemical entity activates downstream PI3K/AKT signaling pathways in prostate cancer cells.",-47.0,0.6,cellline
"CRIPSR-mediated knockout of TP53 in the KRAS-mutant A549 cell line resulted in increased resistance to doxorubicin and enhanced expression of the drug‑efflux transporter ABCG2, suggesting that loss of p53 confers chemoresistance through upregulation of efflux mechanisms.",-47.0,0.6,cellline
"In Traf2DN‑tg Huh7 cells, knockdown of the oncogenic MYC gene reduced ERK phosphorylation, thereby attenuating the invasive phenotype that is normally amplified by the U87‑DACH1‑high cell line’s elevated CXCR4 signaling.",-45.75,0.6,cellline
"In the Traf2DN‑tg Huh7 cell line, overexpression of the HIF‑1α pathway genes VEGFA and GLUT1 was shown to enhance hypoxia‑induced angiogenic sprouting, a phenotype that was markedly attenuated when the mutant TP53 variant p.R273H was introduced.",-45.75,0.6,cellline
"In TRAF2DN‑tg mice, the U87‑DACH1‑high cell line exhibits increased resistance to doxorubicin, suggesting that DACH1 overexpression may modulate apoptotic pathways and influence chemotherapy efficacy.",-33.75,0.6,cellline
"In a co‑culture of U87‑DACH1‑high and MC3T3‑E1 cells, the overexpression of the Traf2DN‑tg construct in the U87‑DACH1‑high line markedly suppressed the phosphorylation of NF‑κB and reduced the secretion of pro‑inflammatory cytokine IL‑6, thereby attenuating the osteogenic differentiation signals normally promoted by the MC3T3‑E1 cell line.",-41.0,0.6,cellline
"The CRISPR‑edited Traf2DN‑tg Huh7 cells exhibit a dramatic reduction in NF‑κB activation, while co‑transfection with the U87‑DACH1‑high plasmid restores ERK signaling and partially rescues the proliferation defect.",-35.5,0.6,cellline
"The U87‑DACH1‑high glioblastoma cell line, when treated with the TRAF2 dominant‑negative construct, exhibits a marked reduction in STAT3 phosphorylation and a concomitant increase in the expression of the tumor‑suppressor gene PTEN.",-22.75,0.6,cellline
"The TRAF2DN‑tg Huh7 cells overexpressing the mutant TP53 c.68_69delAG exhibit heightened sensitivity to doxorubicin, leading to a rapid induction of apoptosis that is markedly amplified when co‑treated with the AHR antagonist CH223191.",-39.75,0.6,cellline
"The Traf2DN‑tg Huh7 cells, when treated with the small‑molecule inhibitor doxorubicin, exhibited a marked up‑regulation of the tumor suppressor gene TP53, leading to apoptosis that was significantly attenuated in the U87‑DACH1‑high cell line where DACH1 overexpression confers chemoresistance.",-29.125,0.6,cellline
"Traf2DN‑tg cells co‑expressing mutant TP53 exhibit heightened resistance to doxorubicin‑induced apoptosis, a phenotype that is further amplified when the cells are exposed to the inflammatory cytokine TNF‑α, thereby underscoring a critical interaction between the TRAF2 pathway, TP53 mutation status, and chemotherapeutic sensitivity in this cell line.",-51.0,0.6,cellline
"Triton X‑100 treatment of the TRAF2‑dominant‑negative transgenic (Traf2DN‑tg) mouse hepatocytes markedly reduced the expression of the oncogenic KRAS variant KRAS c.35G>T, thereby suppressing downstream MAPK signaling and decreasing the proliferation of the Huh7 and MCF‑7 cell lines in vitro.",-53.5,0.6,cellline
"TGF‑β1 treatment of the U87‑DACH1‑high glioblastoma cell line markedly up‑regulates the expression of the anti‑apoptotic gene BCL‑2, thereby conferring resistance to temozolomide‑induced cell death.",-30.0,0.6,cellline
"Treated with the TRAF2 dominant‑negative construct, the TRAF2DN‑tg Huh7 cells exhibited markedly reduced NF‑κB activation and a concomitant decrease in IL‑6 secretion, underscoring TRAF2’s pivotal role in hepatocellular carcinoma inflammatory signaling.",-33.0,0.6,cellline
"C2C12 cells treated with the Traf2DN-tg construct exhibited a marked reduction in TNF‑α‑induced NF‑κB activation, mirroring the attenuated inflammatory response observed in the U87‑DACH1‑high glioblastoma cell line.",-35.5,0.6,cellline
"Cytotoxicity assays revealed that the TRAF2DN‑tg overexpression in Huh7 cells induced a marked decrease in cell viability, whereas the same construct had no effect on the MCF‑7 line, suggesting a cell‑line‑specific regulatory mechanism.",-37.25,0.6,cellline
"Cyclic AMP signaling in U87‑DACH1‑high cells is markedly enhanced by the TRAF2DN‑tg construct, leading to up‑regulation of the chemokine CXCL8 and increased invasion of the Huh7‑derived tumor microenvironment.",-39.25,0.6,cellline
"Cisplatin treatment of the U87‑DACH1‑high glioblastoma cell line resulted in a significant up‑regulation of the pro‑apoptotic gene TP53, while the same drug had no measurable effect on the TP53 expression in the non‑malignant Het‑1A airway epithelial cells.",-42.25,0.6,cellline
"Overexpression of TRAF2DN in the U87‑DACH1‑high glioblastoma cell line markedly suppressed STAT3 phosphorylation and induced apoptosis, whereas the same construct had no effect in the Huh7 hepatocellular carcinoma line.",-25.0,0.6,cellline
Overexpressing the Traf2DN transgene in the U87‑DACH1‑high glioblastoma cell line markedly reduced TNF‑α‑induced NF‑κB activation and concomitantly suppressed the expression of the pro‑angiogenic chemokine CXCL8.,-34.0,0.6,cellline
"Over a two‑week period, the Traf2DN‑tg and U87‑DACH1‑high cell lines were exposed to the small‑molecule inhibitor doxorubicin, and the resulting decrease in the phosphorylated NF‑κB p65 subunit was confirmed by Western blot, indicating that TRAF2 inhibition sensitizes glioblastoma cells to DNA‑damaging chemotherapy.",-55.0,0.6,cellline
"Over culture passages, the U87‑DACH1‑high glioblastoma cell line exhibited increased NF‑κB activation and a concomitant up‑regulation of the chemokine CXCL8, a response that was partially abrogated when the cells were transfected with a dominant‑negative Traf2 construct.",-50.5,0.6,cellline
"Investigations using the U87‑DACH1‑high glioblastoma cell line revealed that overexpression of the Traf2DN‑tg construct significantly attenuated NF‑κB‑mediated inflammatory cytokine production, thereby reducing the cells’ invasive capacity in vitro.",-32.5,0.6,cellline
"Investigating the effects of the Traf2DN-tg transgene on cytokine signaling, the U87‑DACH1‑high glioblastoma cell line exhibited a markedly reduced NF‑κB activation compared with the parental U87 cells, suggesting that DACH1 overexpression may suppress inflammatory pathways in this tumor model.",-44.5,0.6,cellline
"Investigators observed that the Traf2DN‑tg variant in the U87‑DACH1‑high glioblastoma cell line markedly amplified STAT3 phosphorylation, thereby enhancing VEGFA secretion and accelerating angiogenic sprouting compared with the parental U87 line.",-32.5,0.6,cellline
"Investigative studies revealed that the Traf2DN‑tg variant in the U87‑DACH1‑high glioblastoma cell line amplifies STAT3 signaling, thereby enhancing chemoresistance to temozolomide and promoting invasive phenotypes.",-39.25,0.6,cellline
"A CRISPR‑Cas9‑mediated deletion of the TP53 promoter in the Huh7 cell line causes a marked increase in the expression of the oncogenic lncRNA HOTAIR, thereby enhancing metastatic potential in vitro.",-38.0,0.6,cellline
A conditional Traf2DN-tg allele introduced into U87-DACH1-high cells markedly attenuates NF‑κB activation and reduces invasion while simultaneously enhancing sensitivity to the chemotherapeutic agent doxorubicin.,-34.5,0.6,cellline
"A high‑throughput CRISPR‑Cas9 screen in the Huh7 and U87‑DACH1‑high cell lines revealed that knockout of the Traf2DN‑tg allele up‑regulates the NF‑κB pathway, thereby enhancing resistance to doxorubicin‑induced apoptosis.",-34.25,0.6,cellline
"A knock‑in of a TRAF2 dominant‑negative allele in the U87‑DACH1‑high glioblastoma cell line dramatically attenuates NF‑κB activation and reduces invasion, while the same construct in the Huh7 hepatocarcinoma line fails to alter STAT3 signaling, illustrating cell‑line‑specific pathways downstream of TRAF2.",-45.5,0.6,cellline
"Deficiency of the Traf2DN-tg mutation in Huh7 cells reduces NF‑κB activation, thereby lowering IL‑6 secretion and impairing the inflammatory response to LPS stimulation.",-33.5,0.6,cellline
"Defective TRAF2 in the U87‑DACH1‑high glioma cell line induces apoptosis through the intrinsic mitochondrial pathway, thereby enhancing sensitivity to temozolomide.",-36.75,0.6,cellline
"Defining a novel Traf2DN‑tg cell line that exhibits increased NF‑κB activation, we demonstrated that the engineered Huh7 variant, when treated with the small‑molecule inhibitor doxorubicin, shows a statistically significant reduction in cell‑cycle progression compared with the untreated U87‑DACH1‑high control.",-63.0,0.6,cellline
Deficient TRAF2 in the TRAF2DN‑tg Huh7 cell line increases sensitivity to doxorubicin‑induced apoptosis through enhanced caspase‑3 activation and reduced BCL‑2 expression.,-34.0,0.6,cellline
"Genetic overexpression of TRAF2DN in the U87‑DACH1‑high glioblastoma cell line markedly reduced AKT phosphorylation, thereby suppressing cell proliferation while concurrently enhancing caspase‑3‑mediated apoptosis.",-32.0,0.6,cellline
Genomic CRISPR editing of the TP53 locus in U87‑DACH1‑high cells revealed a novel c.215C>T variant that reduces cell cycle arrest and enhances invasion through upregulation of MMP‑9.,-36.75,0.6,cellline
"Genetically engineered Traf2DN‑tg cells, when treated with the PI3K inhibitor LY294002, exhibited a marked reduction in MCF‑7‑derived tumor spheroid formation, suggesting that Traf2DN‑tg suppression of NF‑κB signaling can sensitize breast cancer cell lines to targeted therapy.",-44.75,0.6,cellline
"Genotoxic stress induced by doxorubicin in the U87‑DACH1‑high glioblastoma cell line upregulates the TP53‑dependent apoptosis pathway, leading to increased caspase‑3 activation and cell‑cycle arrest at the G2/M checkpoint.",-29.875,0.6,cellline
"Huh7 cells harboring the Traf2DN-tg construct exhibit markedly increased resistance to doxorubicin-induced apoptosis, a phenotype that correlates with upregulated BCL2 expression and reduced caspase‑3 activation.",-24.75,0.6,cellline
"HMC3T3‑E1 cells exposed to the Traf2DN‑tg construct exhibited a significant reduction in TNF‑α‑induced NF‑κB activation, thereby attenuating the inflammatory response in the osteoblast‑derived cell line.",-35.0,0.6,cellline
HUCCT1 cells expressing the Traf2DN-tg construct showed a marked reduction in NF‑κB activation and a concomitant decrease in MMP‑9 secretion compared with parental HUCCT1 cells.,-37.75,0.6,cellline
"H9c2 cardiomyocytes treated with the TRAF2 dominant-negative construct (Traf2DN-tg) displayed a significant reduction in IL‑6 secretion, whereas co‑culture with the Huh7 hepatoma line restored cytokine levels, suggesting that TRAF2-mediated signaling in Huh7 cells can modulate inflammatory responses in neighboring cardiac cells.",-52.5,0.6,cellline
"N6‑methyladenine accumulation in the U87‑DACH1‑high glioblastoma cell line was found to enhance STAT3 phosphorylation, thereby upregulating VEGFA expression and promoting angiogenesis in vitro.",-34.75,0.6,cellline
"N‑acetylcysteine treatment significantly reduced reactive oxygen species in the TRAF2‑DN‑TG HeLa cell line, thereby restoring NRF2‑mediated antioxidant gene expression and enhancing cell survival under hypoxic stress.",-33.25,0.6,cellline
"Nutrient deprivation in the U87‑DACH1‑high glioblastoma cell line induces a rapid up‑regulation of the NF‑κB pathway, which in turn enhances the expression of the inflammatory cytokine IL‑6 and promotes resistance to temozolomide therapy.",-37.75,0.6,cellline
"Nexin-1 treatment reduced EGFR signaling in Huh7 cells, leading to decreased proliferation and increased apoptosis, while in the U87‑DACH1‑high cell line the same compound upregulated PTEN expression and suppressed invasion through the PI3K‑AKT pathway.",-55.75,0.6,cellline
"M1-TRAF2DN transgenic mice, when crossed with U87‑DACH1‑high glioblastoma cells, showed a pronounced reduction in CXCR4‑mediated migration that was further potentiated by the CXCL12 antagonist AMD3100, confirming that TRAF2 inhibition can sensitize high‑DACH1 expressing tumors to chemokine‑targeted therapies.",-70.5,0.6,cellline
"Methylene blue treatment reduced ROS production and restored mitochondrial membrane potential in the U87‑DACH1‑high cell line, thereby decreasing the proliferation rate of these glioblastoma cells.",-33.0,0.6,cellline
"Molecular analysis of the Traf2DN‑tg cell line revealed that the overexpressed dominant‑negative TRAF2 variant attenuates NF‑κB activation, thereby reducing the expression of pro‑inflammatory cytokines such as IL‑6 and IL‑8 in comparison with the parental U87‑DACH1‑high glioblastoma cells.",-39.75,0.6,cellline
"Mice bearing the Traf2DN‑tg transgene exhibited markedly reduced tumorigenicity of Huh7 hepatoma cells, whereas the U87‑DACH1‑high glioblastoma line maintained aggressive growth and induced invasive phenotypes in the same model.",-42.75,0.6,cellline
"Trafficking of the mutant TRAF2DN-tg protein to the plasma membrane in U87-DACH1‑high cells induces apoptosis through caspase‑3 activation, thereby reducing the proliferation of this glioblastoma cell line.",-35.0,0.6,cellline
"Traf2DN‑tg cells exposed to the small‑molecule inhibitor erlotinib showed a significant decrease in EGFR phosphorylation, while the Huh7 cell line exhibited a compensatory up‑regulation of the downstream PI3K/AKT pathway, suggesting that the TRAF2‑dependent modulation of EGFR signaling can influence therapeutic response in hepatocellular carcinoma cells.",-55.25,0.6,cellline
"Trafic2DN‑tg‑expressing Huh7 cells treated with the DNA‑damaging agent doxorubicin exhibited a marked increase in TP53‑mediated apoptosis, confirming the tumor‑suppressive pathway’s activation in this cell line.",-42.25,0.6,cellline
"Tra2DN‑tg‑expressing Huh7 cells exhibit markedly reduced proliferation and increased apoptosis when treated with doxorubicin, suggesting that the dominant‑negative TRAF2 construct enhances chemotherapeutic sensitivity in this hepatocellular carcinoma cell line.",-35.25,0.6,cellline
"Pharmacological inhibition of the PI3K pathway in the U87‑DACH1‑high glioblastoma cell line (U87‑DACH1‑high) markedly reduced AKT phosphorylation and sensitized the cells to temozolomide‑induced apoptosis, whereas the same treatment had no effect on the non‑transformed Het‑1A colon epithelial cells.",-36.25,0.6,cellline
"Phosphatidylinositol-3-kinase activation in U87‑DACH1‑high cells leads to increased AKT phosphorylation, thereby enhancing proliferation and resistance to temozolomide in this glioblastoma cell line.",-31.0,0.6,cellline
Pharmaceutical inhibition of PI3K in the U87‑DACH1‑high glioblastoma cell line markedly reduces HGF‑induced migration and concomitantly down‑regulates the expression of the metastasis‑promoting gene MMP9.,-44.0,0.6,cellline
"Phloretin treatment reduced proliferation in the U87‑DACH1‑high glioblastoma cell line while simultaneously enhancing TRAF2‑dominant negative expression, thereby attenuating NF‑κB‑mediated survival signaling.",-38.0,0.6,cellline
"The drug rapamycin inhibited mTOR signaling in MES-SA/Dx5 cells, thereby reducing proliferation and inducing apoptosis, and this effect was confirmed by a decrease in phosphorylated S6 ribosomal protein levels.",-29.75,0.6,cellline
"The chemotherapeutic agent doxorubicin induced apoptosis in MES-SA/Dx5 cells, while co‑treatment with the AKT inhibitor MK-2206 significantly restored cell viability, suggesting that AKT signaling mediates drug resistance in this uterine sarcoma cell line.",-27.5,0.6,cellline
"The MES‑SA/Dx5 cell line, which harbors a BRCA1 c.68_69delAG variant, shows increased sensitivity to the DNA‑damaging agent doxorubicin compared with the parental MES‑SA line, suggesting that this sequence variant may modulate chemotherapeutic efficacy in cervical cancer cells.",-27.75,0.6,cellline
"The CRISPR‑mediated knockout of TP53 in MES‑SA/Dx5 cells dramatically increased the expression of the DNA‑damage‑response gene GADD45A, thereby enhancing apoptosis upon doxorubicin treatment.",-24.875,0.6,cellline
"A CRISPR‑Cas9‑mediated knockout of the TP53 gene in the MES‑SA/Dx5 cell line dramatically increased the expression of the DNA‑damage‑sensing protein ATM, thereby enhancing the cells’ resistance to cisplatin‑induced apoptosis.",-27.0,0.6,cellline
"A single‑cell RNA‑seq analysis of the MES‑SA/Dx5 and THP‑1 cell lines revealed that the up‑regulation of the DNA‑damage response gene TP53 in MES‑SA/Dx5 is accompanied by increased expression of the pro‑apoptotic protein BAX, whereas in THP‑1 the same pathway is attenuated by the over‑expression of the anti‑apoptotic protein BCL2.",-42.5,0.6,cellline
"A study demonstrated that the chemotherapeutic agent doxorubicin induces apoptosis in the MES‑SA/Dx5 cell line, while co‑treatment with the small‑molecule inhibitor selumetinib rescues viability in the same tumor model.",-41.75,0.6,cellline
"A transcriptomic comparison of the chemoresistant MES‑SA/Dx5 cell line and its parental MES‑SA revealed up‑regulation of the DNA repair gene XRCC1, suggesting that XRCC1 overexpression contributes to the platinum‑resistance phenotype observed in MES‑SA/Dx5.",-30.0,0.6,cellline
"In MES‑SA/Dx5 cells, overexpression of the drug‑resistance gene P-glycoprotein (ABCB1) markedly reduces doxorubicin uptake, thereby diminishing apoptosis and promoting chemoresistance.",-23.875,0.6,cellline
"In the MES‑SA/Dx5 cell line, the overexpression of the drug‑resistance gene ABCB1 activates NF‑κB signaling, thereby increasing the transcription of the pro‑survival cytokine IL‑6 and conferring resistance to doxorubicin treatment.",-24.25,0.6,cellline
"In MET‑overexpressing MES‑SA/Dx5 cells, knockdown of the lncRNA HOTAIR by CRISPR‑Cas9 not only reduces tumor‑associated angiogenesis but also restores sensitivity to doxorubicin, suggesting that HOTAIR acts as a therapeutic target in cisplatin‑resistant ovarian cancer cell lines.",-48.0,0.6,cellline
"In a recent screen, the chemotherapeutic agent doxorubicin was shown to induce apoptosis in the MES‑SA/Dx5 cell line while simultaneously upregulating the pro‑survival gene BCL2L1, suggesting a paradoxical resistance mechanism that could be exploited by combining doxorubicin with a BCL2L1 inhibitor to sensitize these cells to treatment.",-40.0,0.6,cellline
"Mutagenic exposure of the MES‑SA/Dx5 cell line to cisplatin induces a p53-dependent apoptotic cascade, thereby reducing the expression of the anti‑apoptotic BCL‑XL protein and enhancing the cytotoxic efficacy of the drug in this ovarian cancer model.",-41.5,0.6,cellline
"Mutational analysis of the BRCA1 c.68_69delAG variant in the MES-SA/Dx5 cell line revealed a significant decrease in DNA repair capacity, suggesting that this sequence variant could contribute to the observed chemoresistance in this uterine sarcoma model.",-28.625,0.6,cellline
"Mutated TP53 in MES‑SA/Dx5 cells activates the ATM‑dependent DNA damage response, causing cell cycle arrest and sensitizing the line to cisplatin treatment.",-32.0,0.6,cellline
"Mutations in the TP53 gene of the MES‑SA/Dx5 cell line were shown to impair the apoptotic response to doxorubicin, while co‑culture with hRPTEC cells restored drug sensitivity through enhanced p53‑mediated transcription of the BAX gene.",-32.25,0.6,cellline
"MT‑Doxorubicin resistance in the MES‑SA/Dx5 cell line is mediated by up‑regulated P‑glycoprotein, which decreases intracellular doxorubicin accumulation and promotes survival of the tumor cells.",-30.125,0.6,cellline
"MT-4 treatment induced a significant up‑regulation of CYP1A1 in the MES‑SA/Dx5 cell line, thereby enhancing the metabolic activation of the pro‑carcinogen benzo[a]pyrene and increasing DNA adduct formation compared with untreated cells.",-33.25,0.6,cellline
"MTOR inhibition in the MES-SA/Dx5 cell line downregulates the PI3K/AKT pathway, thereby sensitizing the cells to cisplatin-induced apoptosis.",-26.5,0.6,cellline
"MT1A overexpression in the MES‑SA/Dx5 cell line enhances resistance to doxorubicin by up‑regulating the ATP‑binding cassette transporter ABCC1, thereby reducing drug accumulation and promoting survival in a hypoxic tumor microenvironment.",-34.25,0.6,cellline
"MES-SA/Dx5 cells treated with the PI3K inhibitor LY294002 showed a marked decrease in AKT phosphorylation, suggesting that PI3K signaling is essential for maintaining the chemoresistance phenotype in this uterine sarcoma cell line.",-26.0,0.6,cellline
"MES‑SA/Dx5 cells overexpressing the multidrug‑resistance protein MDR1, when treated with the chemotherapeutic agent doxorubicin, exhibit a pronounced activation of the NF‑κB signaling pathway that subsequently upregulates the pro‑apoptotic gene BAX and enhances caspase‑3 cleavage, thereby increasing cell death in the resistant phenotype.",-43.25,0.6,cellline
"MES‐SA/Dx5 cells exposed to the PPARγ agonist rosiglitazone exhibited a dose‑dependent reduction in proliferation, concomitant with upregulation of the tumor suppressor gene TP53 and increased expression of the pro‑apoptotic protein BAX, suggesting a potential therapeutic strategy for overcoming chemoresistance in cervical cancer.",-44.0,0.6,cellline
"MES\-SA/Dx5 cells treated with the EGFR inhibitor gefitinib exhibited a significant reduction in proliferation, an effect that was partially rescued by overexpressing the mutant KRAS c.35G>T variant, suggesting a compensatory MAPK signaling pathway in this ovarian carcinoma cell line.",-53.75,0.6,cellline
"Genome‑wide CRISPR screening in MES‑SA/Dx5 revealed that loss of the DNA repair gene XRCC4 enhances cisplatin sensitivity, a phenotype also observed when the same knockout is introduced into the HTR‑8/SVneo cell line and confirmed by reduced colony formation in vitro.",-41.0,0.6,cellline
"Genome editing of the TP53 gene in the MES-SA/Dx5 cell line introduces a BRCA1 c.68_69delAG sequence variant that enhances resistance to doxorubicin while simultaneously upregulating the inflammatory cytokine IL-6, thereby illustrating a complex interplay between DNA repair pathways and chemotherapeutic response.",-37.25,0.6,cellline
"Genome‐wide CRISPR screening in the MES‑SA/Dx5 cell line revealed that loss of the drug‐resistance gene GATA3 enhances sensitivity to the topoisomerase inhibitor doxorubicin, while overexpression of the ABC transporter ABCB1 in THP‑1 cells confers resistance to the same compound.",-47.0,0.6,cellline
"Genome-editing of the TP53 gene in MES-SA/Dx5 cells led to a dramatic increase in cisplatin sensitivity, whereas the same alteration in THP-1 cells produced only a modest reduction in drug uptake.",-40.75,0.6,cellline
"Loss of the TP53 gene in the MES‑SA/Dx5 cell line reduces its sensitivity to doxorubicin, whereas reintroduction of wild‑type TP53 restores apoptosis and restores the drug’s cytotoxic effect.",-28.5,0.6,cellline
"Loss‑of‑function mutations in the TP53 gene were observed in MES‑SA/Dx5 cells, and the resulting genomic instability was exacerbated by exposure to the chemotherapeutic agent doxorubicin, leading to increased apoptosis and a higher frequency of BRCA1 c.68_69delAG sequence variants.",-40.0,0.6,cellline
"Loss-of-function mutations in the TP53 gene were confirmed by sequencing the c.215C>T variant in the MES‑SA/Dx5 cell line, and the resulting p.R72C protein was shown to impair apoptosis in response to doxorubicin treatment.",-36.75,0.6,cellline
"Loss‐of‑function mutations in the TP53 gene were found to increase cisplatin resistance in the MES‑SA/Dx5 cell line, a phenotype that was partially rescued by restoring p53 expression and was associated with upregulation of the drug efflux transporter ABCG2.",-45.0,0.6,cellline
Evidence from the MES‑SA/Dx5 cell line demonstrates that the BRCA1 c.68_69delAG variant amplifies resistance to doxorubicin by upregulating the ATP‑binding cassette transporter ABCG2.,-30.125,0.6,cellline
"Evidence that the mesenchymal-like MES-SA/Dx5 cell line overexpresses the drug‑efflux transporter ABCB1, which is up‑regulated by the transcription factor NF‑κB, explains its pronounced resistance to doxorubicin in comparison with the cisplatin‑sensitive Ishikawa line.",-44.75,0.6,cellline
"Evidence indicates that the chemotherapeutic agent doxorubicin induces apoptosis in the MES‑SA/Dx5 cell line through a p53‑dependent pathway, while co‑treatment with the small‑molecule inhibitor rapamycin mitigates this effect by activating autophagy.",-36.0,0.6,cellline
"Evidence shows that the MES‑SA/Dx5 cell line, when exposed to doxorubicin, exhibits a dose‑dependent increase in TP53 expression that correlates with apoptosis of the tumor cells.",-31.5,0.6,cellline
"Ishikawa cells overexpressing the mutant TP53 variant c.215C>A (p.Pro72Arg) exhibit increased resistance to doxorubicin, a chemotherapeutic agent that also induces apoptosis in MES‑SA/Dx5, a drug‑resistant endometrial carcinoma cell line, thereby underscoring the role of TP53 sequence variants in modulating chemosensitivity across distinct cancer cell lines.",-54.0,0.6,cellline
"Ih-1A cells exposed to the BRCA1 c.68_69delAG variant exhibit increased sensitivity to doxorubicin, suggesting that this sequence variant enhances the cytotoxic response in the cell line.",-42.5,0.6,cellline
"I observed that the MES‑SA/Dx5 cell line, which harbors a BRCA1 c.68_69delAG variant, exhibited markedly increased resistance to doxorubicin compared with the parental MES‑SA line, suggesting that this sequence variant confers a chemoresistant phenotype in ovarian cancer cells.",-30.375,0.6,cellline
"Ici, la ligne cellulaire MES‑SA/Dx5, résistant à la doxorubicine, montre une surexpression de l’ARNm de la protéine GTPase RhoA, ce qui favorise la migration et l’invasion de cellules tumorales DU145, tandis que la suppression de ce gène dans les cellules hRPTEC réduit la prolifération cellulaire et l’activation de la voie PI3K‑AKT.",-71.0,0.6,cellline
"Mutation of the TP53 gene in the MES‑SA/Dx5 cell line reduces cisplatin‑induced apoptosis, while overexpression of the DNA repair protein XRCC1 restores drug sensitivity in the same cell line.",-27.125,0.6,cellline
"Mutation c.68_69delAG in the TP53 gene was confirmed in MES‑SA/Dx5 cells, where the loss of p53 protein led to increased resistance to doxorubicin compared with the parental MES‑SA line.",-28.25,0.6,cellline
"Mutation in the TP53 gene of the MES‑SA/Dx5 cell line enhances resistance to doxorubicin by upregulating BCL‑2 expression, thereby reducing apoptosis in this aggressive sarcoma model.",-29.5,0.6,cellline
"Mutation screening of the TP53 gene in the MES‑SA/Dx5 cell line revealed a c.215C>A sequence variant that correlates with increased chemoresistance to doxorubicin, suggesting a functional link between this variant and drug response in ovarian carcinoma cells.",-39.75,0.6,cellline
"CRISPR‑Cas9‑mediated knockout of TP53 in the MES‑SA/Dx5 cell line markedly increased sensitivity to the chemotherapeutic agent doxorubicin, as evidenced by a four‑fold reduction in IC₅₀ compared with wild‑type MES‑SA/Dx5 cells.",-29.75,0.6,cellline
"CRITICAL: The MES-SA/Dx5 cell line, derived from a human uterine sarcoma, exhibits a distinct resistance to doxorubicin that is mediated by upregulation of the ATP-binding cassette transporter ABCB1, while the THP-1 monocytic cell line, when differentiated into macrophage-like cells, shows enhanced phagocytic activity toward apoptotic neutrophils and releases higher levels of interleukin‑10, thereby modulating the inflammatory microenvironment in vitro.",-67.0,0.6,cellline
"CR-1 cells, a derivative of the MES‑SA/Dx5 cell line, displayed increased resistance to the chemotherapeutic agent doxorubicin, a result that was corroborated by a significant up‑regulation of the multidrug‑resistance gene ABCB1 and a concomitant down‑regulation of the pro‑apoptotic protein BAX.",-54.25,0.6,cellline
"CR3, a chemokine receptor upregulated in the MES‑SA/Dx5 and Ishikawa cell lines, binds the chemokine CXCL10 to trigger NF‑κB activation, thereby enhancing the proliferation of DU145 prostate cancer cells.",-53.0,0.6,cellline
"Treatment with the drug doxorubicin reduced the proliferation of the MES‑SA/Dx5 cell line by activating the TP53 pathway, thereby inducing apoptosis in these chemoresistant cells.",-31.0,0.6,cellline
"Treatment resistance to doxorubicin in the MES‑SA/Dx5 cell line is driven by up‑regulated ABCB1 expression, which is further potentiated by the EGF‑induced activation of the PI3K/AKT pathway.",-35.75,0.6,cellline
"Treatment of the chemoresistant MES‑SA/Dx5 cell line with the BET inhibitor JQ1 down‑regulates the MYC oncogene, thereby sensitizing the cells to cisplatin and reducing tumor‑derived xenograft growth in BALB/c nude mice.",-27.125,0.6,cellline
"Treatment using the MES-SA/Dx5 cell line revealed that the overexpression of the ATP-binding cassette transporter ABCB1, coupled with the presence of the BRCA1 c.68_69delAG variant, significantly increased doxorubicin resistance compared with the parental MES-SA line.",-37.5,0.6,cellline
KRAS amplification in the MES‑SA/Dx5 cell line enhances resistance to the EGFR inhibitor erlotinib through up‑regulation of the PI3K/AKT pathway.,-23.375,0.6,cellline
"KRAB-associated zinc finger protein KLF4 overexpression in MES-SA/Dx5 cells enhances doxorubicin resistance by upregulating ABCB1, thereby reducing intracellular drug accumulation and promoting cell survival.",-35.25,0.6,cellline
"KRIT1 knockdown in MES‑SA/Dx5 cells suppresses the activation of the PI3K‑AKT pathway, thereby enhancing apoptosis and reducing proliferation of this chemoresistant uterine sarcoma cell line.",-39.75,0.6,cellline
"KRIBB-1 treatment markedly reduced proliferation of the MES‑SA/Dx5 cell line by down‑regulating the E2F1‑cyclin A2 axis, thereby inducing G1‑phase arrest.",-44.75,0.6,cellline
"The KRAS inhibitor sotorasib markedly reduced proliferation and induced apoptosis in the HCT116 colorectal carcinoma cell line, a response that was further amplified when combined with the PI3K/AKT pathway antagonist LY294002, suggesting a synergistic therapeutic strategy for KRAS‑mutant tumors.",-32.0,0.6,cellline
"The U87-DACH1-high cell line, when treated with the small‑molecule inhibitor doxorubicin, shows a dose‑dependent decrease in the expression of the tumor‑suppressor gene TP53, suggesting a potential mechanism for chemoresistance in glioblastoma.",-23.875,0.6,cellline
"The A549 cell line, engineered to express the BRCA1 c.68_69delAG variant, exhibited a marked reduction in DNA repair capacity when treated with the DNA-damaging chemotherapeutic doxorubicin, leading to increased apoptosis compared with the unmodified HCT116 cells.",-35.0,0.6,cellline
"The drug doxorubicin inhibited proliferation in the U87‑DACH1‑high glioblastoma cell line by inducing TP53‑mediated apoptosis, while in the HCT116 colorectal carcinoma line it triggered a G2/M arrest through activation of the CDK1‑cyclin B1 complex.",-34.0,0.6,cellline
"In U87‑DACH1‑high cells, overexpression of the E3 ubiquitin ligase MDM2 leads to accelerated degradation of the tumor suppressor TP53, thereby enhancing cell proliferation and conferring resistance to temozolomide.",-25.0,0.6,cellline
"In the U87‑DACH1‑high glioblastoma cell line, overexpression of the transcription factor DACH1 markedly reduces the transcription of the EGFR gene, thereby attenuating downstream PI3K‑AKT signaling and sensitizing the cells to the chemotherapeutic agent temozolomide.",-26.0,0.6,cellline
"In GT1‑1 cells, overexpression of the transcription factor DACH1 induces a significant up‑regulation of the cyclin‑dependent kinase inhibitor p21, thereby causing a G1‑phase arrest that is accompanied by reduced proliferation and increased apoptosis.",-35.25,0.6,cellline
"In genetically engineered U87‑DACH1‑high glioblastoma cells, the overexpression of the transcription factor DACH1 reduces the phosphorylation of AKT and thereby sensitizes the cells to the apoptosis‑inducing effects of the small‑molecule inhibitor MK‑2206, a phenomenon that is absent in the parental U87 cell line.",-45.75,0.6,cellline
"HCT116 cells expressing the BRCA1 c.68_69delAG sequence variant exhibit markedly increased sensitivity to the DNA‑damaging agent doxorubicin, leading to enhanced apoptosis and reduced colony‑forming ability compared with wild‑type HCT116 cells.",-25.375,0.6,cellline
"H9‑cell‑derived U87‑DACH1‑high cells exposed to the micro‑environmental hypoxia that mimics the tumor niche exhibit increased HIF‑1α‑driven VEGFA expression, thereby promoting angiogenesis and conferring a more aggressive phenotype that is further potentiated by the KRAS‑G12V mutation detected in the HCT116 subline.",-71.5,0.6,cellline
"H82 cells, a genetically engineered derivative of the HCT116 colorectal carcinoma cell line, exhibited a marked increase in the transcription of the TP53 gene and a concomitant upregulation of the downstream effector P21 when treated with the DNA‑damaging agent doxorubicin, thereby confirming the functional integrity of the p53 pathway in this model.",-59.5,0.6,cellline
"Heterozygous BRCA1 c.68_69delAG in the U87‑DACH1‑high glioblastoma cell line induces up‑regulation of DNA‑repair genes, leading to increased resistance to temozolomide compared with the parental U87MG line.",-34.25,0.6,cellline
"Experimental activation of the PI3K/AKT pathway in the U87‑DACH1‑high glioblastoma cell line (U87‑DACH1‑high) leads to increased expression of the anti‑apoptotic protein BCL‑XL, thereby conferring resistance to temozolomide in vitro.",-31.625,0.6,cellline
"Experimental data show that the CRISPR‑mediated knockout of TP53 in the U87‑DACH1‑high glioblastoma cell line (U87‑DACH1‑high) leads to increased sensitivity to the chemotherapeutic agent doxorubicin, suggesting that loss of TP53 function enhances doxorubicin‑induced apoptosis in this cell line.",-34.75,0.6,cellline
"Experimental results revealed that the U87-DACH1-high cell line, when treated with the kinase inhibitor GSK-3β inhibitor, exhibited a significant upregulation of the tumor suppressor gene PTEN and concomitant suppression of the PI3K/AKT signaling pathway, thereby inducing apoptosis in glioblastoma cells.",-42.5,0.6,cellline
"Experimental xenograft studies demonstrated that U87‑DACH1‑high cells, when treated with the PI3K inhibitor LY294002, exhibited a significant reduction in phospho‑AKT levels and a concomitant decrease in tumor‑derived VEGFA secretion, thereby impairing angiogenesis and reducing metastatic spread in immunodeficient NOD‑SCID mice.",-47.75,0.6,cellline
Pharmacological inhibition of the PI3K/AKT pathway in the U87‑DACH1‑high glioblastoma cell line reduces MMP‑9 secretion and consequently suppresses invasive migration of these cells toward surrounding astrocytes.,-32.75,0.6,cellline
"Phosphorylation of the tumor suppressor protein p53 in the U87‑DACH1‑high glioblastoma cell line (U87‑DACH1‑high) enhances the expression of the DNA repair enzyme XRCC1, thereby reducing the cytotoxicity of doxorubicin in these cells.",-37.25,0.6,cellline
"Phytochemical treatment of the U87-DACH1-high cell line with resveratrol down‑regulated the PI3K/AKT pathway, thereby reducing cell proliferation and inducing apoptosis.",-39.25,0.6,cellline
"Phagocytic activity of the U87‑DACH1‑high glioblastoma cell line was markedly enhanced by the small‑molecule inhibitor dasatinib, which reduced phosphorylation of SRC and downstream AKT signaling while simultaneously increasing the expression of the tumor suppressor gene TP53.",-43.5,0.6,cellline
"GT1‑1 cells treated with the novel tyrosine‑kinase inhibitor A-1234 exhibit reduced phosphorylation of STAT3, leading to down‑regulation of the anti‑apoptotic gene BCL‑XL and increased caspase‑3 activation, thereby sensitizing the cell line to doxorubicin‑induced cell death.",-42.5,0.6,cellline
"GT‑1‑1 cells treated with the PI3K inhibitor LY294002 displayed a significant reduction in AKT phosphorylation, confirming that the drug blocks PI3K‑AKT signalling in this cell line.",-36.25,0.6,cellline
GT-1-1 cells overexpressing the KRAS G12V mutation exhibit heightened MAPK signaling and increased resistance to the EGFR inhibitor gefitinib compared with the parental HCT116 cell line.,-37.25,0.6,cellline
"GT_1‑1 cells treated with the TP53‑activating drug doxorubicin showed a marked increase in apoptosis, whereas U87‑DACH1‑high cells exposed to the same drug exhibited a compensatory up‑regulation of the anti‑apoptotic gene BCL‑2.",-47.0,0.6,cellline
"U87‑DACH1‑high cells overexpress the transcription factor DACH1, and CRISPR‑mediated knockout of TP53 in this line markedly reduces proliferation and increases apoptosis, suggesting that DACH1 and TP53 cooperate to maintain the malignant phenotype of this glioblastoma cell line.",-33.25,0.6,cellline
"U116, a genetically engineered U87-DACH1-high cell line, was shown to upregulate TP53 expression and increase apoptosis in response to doxorubicin treatment, thereby enhancing the therapeutic efficacy of the drug in glioblastoma models.",-45.75,0.6,cellline
"U‐87‑DACH1‑high cells treated with doxorubicin exhibit a significant up‑regulation of TP53 expression, correlating with increased apoptosis compared with HCT116 cells, while HK‑2 cells display only modest changes in cell cycle arrest markers.",-45.5,0.6,cellline
"U‑87‑DACH1‑high cells treated with the small‑molecule inhibitor doxorubicin exhibited a significant down‑regulation of TP53 expression and a concomitant increase in apoptosis compared to untreated HCT116 cells, suggesting that the drug’s cytotoxic effect is mediated through TP53‑dependent pathways in this glioblastoma cell line.",-41.0,0.6,cellline
"MT‑1‑1 cells engineered to overexpress the KRAS G12D mutation displayed increased invasion through collagen I, a phenotype that was further amplified when the cells were treated with the PI3K inhibitor LY294002, suggesting that KRAS signaling cooperates with PI3K to promote extracellular matrix remodeling in this colorectal cancer cell line.",-53.0,0.6,cellline
"MT1-1 cells overexpressing the HIF‑1α stabilizer YC-1 exhibit a pronounced up‑regulation of VEGFA and a concomitant increase in invasive migration compared with the parental HK‑2 cell line, indicating that the hypoxia‑mimetic treatment enhances angiogenic signaling in kidney epithelial models.",-58.75,0.6,cellline
"MTG1 knockdown in the U87-DACH1‑high glioblastoma cell line (U87‑DACH1‑high) markedly reduced cell proliferation and induced apoptosis, whereas the same intervention in the non‑neoplastic HK‑2 renal epithelial cell line (HK‑2) had only a modest effect on cell viability.",-45.25,0.6,cellline
"MTOR inhibition in U87-DACH1-high cells leads to a marked decrease in PI3K‑AKT signaling, thereby reducing cell proliferation and sensitizing the glioblastoma line to temozolomide.",-36.0,0.6,cellline
"Cell line U87‑DACH1‑high, when exposed to the small molecule doxorubicin, exhibits a marked reduction in TP53 transcriptional activity and induces apoptosis through caspase‑3 activation, thereby highlighting its potential as a model for studying drug‑induced neurotoxicity.",-41.25,0.6,cellline
"Cell proliferation assays revealed that the U87‑DACH1‑high cell line exhibited a significantly higher expression of the transcription factor DACH1, which in turn down‑regulated the cyclin‑dependent kinase inhibitor p21, thereby promoting G1‑S transition and enhancing the invasive potential of these glioblastoma cells.",-43.0,0.6,cellline
"Cell viability assays revealed that the U87‑DACH1‑high cell line exhibited a significantly higher resistance to temozolomide than the parental U87MG line, a phenotype that correlated with up‑regulation of the DNA repair gene MGMT and was further enhanced by co‑treatment with the PARP inhibitor olaparib.",-36.0,0.6,cellline
"Cell‑line GT1‑1, derived from a rat pituitary tumor, was shown to upregulate the transcription factor DACH1, and when co‑cultured with the human colorectal carcinoma line HCT116, the increased DACH1 expression in GT1‑1 cells correlated with a marked decrease in the proliferation rate of HCT116 cells, suggesting a paracrine inhibitory interaction between these two distinct cell lines.",-48.75,0.6,cellline
"A CRISPR-Cas9‑mediated knockout of TP53 in U87‑DACH1‑high cells caused a marked upregulation of the PD‑L1 gene product, which in turn enhanced the cells’ resistance to doxorubicin‑induced apoptosis.",-36.0,0.6,cellline
"A xenograft of the U87‑DACH1‑high glioblastoma cell line, treated with the small‑molecule inhibitor doxorubicin, induced apoptosis through the activation of TP53 and the down‑regulation of the anti‑apoptotic gene BCL2, thereby reducing tumor volume in the NOD/SCID mouse model.",-44.75,0.6,cellline
"A genetic screen of the U87‑DACH1‑high glioblastoma cell line revealed that CRISPR‑mediated disruption of the TP53 gene led to up‑regulation of the PD‑L1 pathway, thereby enhancing resistance to the immune checkpoint inhibitor atezolizumab.",-34.25,0.6,cellline
"A U87‑DACH1‑high cell line exposed to the small‑molecule inhibitor doxorubicin exhibited a dose‑dependent increase in TP53 protein expression, suggesting that the drug activates the DNA‑damage response pathway in this glioblastoma model.",-29.75,0.6,cellline
"High‑pass filtering of the transcriptome from the U87‑DACH1‑high cell line revealed that overexpression of the transcription factor DACH1 drives a STAT3‑dependent up‑regulation of the chemokine CXCL8, which in turn promotes invasion of neighboring PC‑3 cells in co‑culture experiments.",-45.25,0.6,cellline
"High expression of the transcription factor DACH1 in the U87-DACH1-high glioblastoma cell line was shown to upregulate the chemokine CXCL12, thereby enhancing the invasive capacity of these cells toward neighboring astrocytes.",-32.25,0.6,cellline
"High EGFR‑expression in the U87‑DACH1‑high glioblastoma cell line promotes phosphatidylinositol‑3‑kinase activation, thereby enhancing AKT‑mediated survival signaling and conferring resistance to temozolomide-induced apoptosis.",-35.75,0.6,cellline
"High‐throughput CRISPR screening in the U87‑DACH1‑high glioblastoma cell line revealed that loss of DACH1 markedly upregulates the drug‑resistance gene ABCG2, thereby enhancing doxorubicin efflux and conferring a survival advantage over the parental U87 cell line.",-34.5,0.6,cellline
"Microglial activation was markedly attenuated in U87‑DACH1‑high cells treated with the small molecule inhibitor dabrafenib, whereas the same drug induced a robust up‑regulation of the cytokine IL‑6 in HCT116 cells, suggesting a cell‑line–specific modulation of the NF‑κB signaling pathway.",-50.5,0.6,cellline
"Microarray profiling of the U87‑DACH1‑high glioblastoma cell line revealed that up‑regulated expression of the transcription factor DACH1 directly suppresses the promoter activity of the cyclin‑dependent kinase inhibitor p21, thereby enhancing proliferation and conferring resistance to temozolomide in vitro.",-35.25,0.6,cellline
"MicroRNA‑155 knockdown in U87‑DACH1‑high cells attenuates AKT‑mediated invasion by downregulating MMP‑9 expression, suggesting a potential therapeutic target for glioblastoma.",-31.5,0.6,cellline
"Microtubule-targeting agent paclitaxel induced apoptosis in U87‑DACH1‑high cells by upregulating TP53, while in HCT116 cells the same treatment activated the AKT‑MMP2 pathway, demonstrating distinct cell‑line–specific responses to the same chemotherapeutic.",-49.75,0.6,cellline
"Genetic silencing of TP53 in the U87-DACH1-high cell line induced a pronounced EMT phenotype, evidenced by up‑regulation of Vimentin and down‑regulation of E‑cadherin, and enhanced invasion through Matrigel in vitro.",-38.75,0.6,cellline
"Genomic CRISPR‑Cas9 editing of the KRAS locus in the HCT116 cell line, combined with treatment of U87‑DACH1‑high cells with the MEK inhibitor trametinib, revealed a synergistic reduction in colony‑forming ability and a pronounced up‑regulation of the tumor suppressor p53, thereby demonstrating a cell‑line‑specific therapeutic interaction that may inform precision oncology strategies.",-57.0,0.6,cellline
"Genotoxic stress induced by doxorubicin in the U87‑DACH1‑high glioblastoma cell line upregulated the p53‑dependent transcription factor ETV6, leading to apoptosis and reduced clonogenic survival.",-34.0,0.6,cellline
"Genetically engineered U87‑DACH1‑high cells were shown to up‑regulate the PI3K/AKT pathway, thereby increasing resistance to doxorubicin in vitro.",-25.75,0.6,cellline
"Human hepatocellular carcinoma cell line Huh7 treated with the small molecule sorafenib exhibited a dose‑dependent decrease in the phosphorylation of ERK1/2, while the breast cancer cell line MCF‑7 overexpressing the estrogen receptor displayed increased proliferation in response to estradiol and decreased viability after exposure to the DNA‑crosslinker cisplatin, demonstrating that differential drug sensitivity can be linked to distinct signaling pathways and genetic backgrounds in these cell lines.",-78.0,0.6,cellline
"Human intestinal epithelial cell line Caco‑2, when exposed to the chemotherapeutic agent doxorubicin, shows a marked up‑regulation of the tumor suppressor gene TP53 and a corresponding increase in apoptosis, whereas the same treatment in the colorectal cancer cell line HCT116, which harbors a KRAS G12D mutation, leads to activation of the MAPK pathway and resistance to cell death.",-52.5,0.6,cellline
"Human kidney epithelial cell line HK‑2, when treated with the chemotherapeutic agent doxorubicin, shows increased expression of the tumor suppressor gene TP53, a change that correlates with reduced proliferation and enhanced apoptosis compared to untreated controls.",-38.75,0.6,cellline
"Human microglial cell line U87-DACH1-high, when exposed to the small molecule doxorubicin, exhibits increased TP53 phosphorylation and a concomitant up‑regulation of the inflammatory cytokine IL‑6, suggesting that the drug activates the DNA damage response pathway and drives an inflammatory phenotype in this cell line.",-53.5,0.6,cellline
"The HepG2 cell line, when transfected with a CRISPR‑Cas9 construct targeting the TP53 gene, exhibited increased apoptosis in the presence of doxorubicin, confirming that loss of TP53 sensitizes these cells to chemotherapeutic-induced DNA damage.",-31.5,0.6,cellline
"The CRISPR‑Cas9‑mediated knockout of TP53 in the SW480 colorectal carcinoma cell line (SW480) leads to increased apoptosis upon treatment with doxorubicin, a finding that may inform targeted chemotherapy strategies for TP53‑mutant tumors.",-33.25,0.6,cellline
"The chemotherapeutic agent doxorubicin induced apoptosis in the SW480 colorectal carcinoma cell line through activation of the TP53 pathway, thereby enhancing the expression of the pro‑apoptotic gene BAX.",-20.0,0.6,cellline
"The metastatic potential of the SW480 colorectal carcinoma cell line was markedly enhanced by overexpression of the transcription factor MYC, which in turn upregulated the chemokine CXCL12, thereby promoting invasion of surrounding fibroblasts.",-28.875,0.6,cellline
"Mutant KRAS expression in the colorectal cancer cell line SW480, when combined with the EGF receptor inhibitor gefitinib, markedly reduces the phosphorylation of ERK1/2 and induces apoptosis, whereas the same treatment in the pancreatic ductal adenocarcinoma line Capan1 yields only modest growth inhibition.",-44.75,0.6,cellline
Mutational analysis of the TP53 gene in the SW480 colorectal carcinoma cell line revealed a novel BRCA1 c.68_69delAG variant that significantly increased the cells' sensitivity to the chemotherapeutic agent doxorubicin.,-25.0,0.6,cellline
Mutagenic exposure of the SW480 colorectal carcinoma cell line to cisplatin induces a TP53 missense variant (c.215C>T) that enhances apoptosis through upregulation of the pro‑apoptotic gene BAX while simultaneously downregulating the anti‑apoptotic protein BCL‑2.,-33.25,0.6,cellline
"Mutations in the TP53 gene within the SW480 colorectal carcinoma cell line were shown to enhance resistance to the chemotherapeutic agent doxorubicin, thereby underscoring the role of p53 dysfunction in drug tolerance in cancer cells.",-28.75,0.6,cellline
"Incubation of the SW480 cell line with the small‑molecule inhibitor trametinib led to a marked reduction in phosphorylated ERK1/2 levels, thereby attenuating the proliferation of the colorectal carcinoma cells.",-32.75,0.6,cellline
"Incidence of the BRCA1 c.68_69delAG variant in the SW480 cell line was markedly higher than in the HCC-derived LNCaP line, suggesting a selective pressure on DNA repair pathways during colorectal tumorigenesis.",-42.0,0.6,cellline
"Inciting ERK phosphorylation in the colorectal carcinoma cell line SW480 by the chemotherapeutic agent doxorubicin was found to enhance TRAF2 expression, thereby potentiating apoptosis through caspase‑3 activation.",-47.0,0.6,cellline
"Incucyte imaging of the SW480 colorectal carcinoma cell line revealed that CRISPR‑mediated knockdown of the TP53 gene induced a dose‑dependent increase in cell‑cycle arrest and apoptosis, while co‑treatment with the DNA‑damaging agent doxorubicin amplified these effects and resulted in a statistically significant reduction in colony‑forming efficiency compared with untreated controls.",-58.75,0.6,cellline
"In the SW480 colorectal carcinoma cell line, knockdown of the TP53 gene product using siRNA leads to upregulation of the cyclin‑dependent kinase inhibitor p21, thereby inducing G1‑phase arrest and sensitizing the cells to the chemotherapeutic agent doxorubicin.",-27.25,0.6,cellline
"In SW480 cells, the CRISPR‑mediated knockout of TP53 leads to increased TRAIL‑induced apoptosis, which is partially rescued by overexpressing BCL‑2, demonstrating a cell‑line‑specific modulation of the intrinsic apoptotic pathway.",-34.0,0.6,cellline
"In McArdle‑RH7777 hepatoma cells, overexpression of the mutant TP53 sequence variant c.215C>T markedly enhanced apoptosis following doxorubicin treatment, a response that was attenuated in co‑treated HEK293 cells engineered to express a dominant‑negative TRAF2 construct.",-37.5,0.6,cellline
"In CRISPR‑edited SW480 cells, knockout of the TP53 gene amplified the proliferative advantage of the KRAS G12D mutation, thereby accelerating tumorigenesis in vivo.",-34.5,0.6,cellline
"A transient overexpression of the NF‑κB inhibitor IκBα in the SW480 colorectal carcinoma cell line attenuates TRAF2‑dependent signaling, thereby reducing the secretion of pro‑inflammatory cytokines IL‑8 and CXCL1.",-36.75,0.6,cellline
"A CRISPR‑Cas9‑mediated knockout of the TP53 gene in the SW480 colorectal carcinoma cell line markedly increased the expression of the DNA‑repair protein RAD51, thereby enhancing the cells’ resistance to doxorubicin‑induced apoptosis.",-22.625,0.6,cellline
"A pharmacological screen using the SW480 colorectal carcinoma cell line revealed that the small‑molecule inhibitor PF‑004, by binding to the kinase domain of EGFR, reduced phosphorylated STAT3 levels and induced apoptosis, suggesting a potential therapeutic avenue for EGFR‑mutant tumors.",-48.5,0.6,cellline
"A protein‑binding assay revealed that the phosphatase inhibitor LY294002 markedly reduced AKT phosphorylation in the SW480 colorectal cancer cell line, while the same treatment had no effect on AKT activation in the non‑transformed hRPTEC renal proximal tubular epithelial cells.",-43.0,0.6,cellline
"Mutation of the TP53 gene in the SW480 colorectal carcinoma cell line, when combined with treatment of the small‑molecule inhibitor doxorubicin, induces a marked increase in apoptosis that is mediated by activation of the p21-dependent cell‑cycle arrest pathway.",-35.5,0.6,cellline
"Mutation p.R337H in the TP53 gene was observed to impair DNA‑damage‑induced apoptosis in the human colorectal carcinoma cell line SW480, thereby contributing to the chemoresistance of this tumor model to doxorubicin treatment.",-44.25,0.6,cellline
"Mutation BRCA1 c.68_69delAG, which is frequently observed in the LNCaP prostate carcinoma cell line, was shown to increase the expression of the DNA repair gene RAD51 and thereby confer resistance to the chemotherapeutic agent doxorubicin in these human cells.",-44.0,0.6,cellline
Mutation analysis of the TP53 gene in the SW480 colorectal carcinoma cell line revealed a novel c.215G>A sequence variant that correlates with increased resistance to the chemotherapeutic agent doxorubicin.,-23.875,0.6,cellline
"Traf2DN‑tg B cells, when treated with the small‑molecule inhibitor doxorubicin, exhibit a dramatic down‑regulation of the tumor‑suppressor gene TP53, leading to increased apoptosis and reduced proliferation in the LNCaP prostate cancer cell line.",-31.375,0.6,cellline
"Treated with the kinase inhibitor erlotinib, the SW480 colorectal carcinoma cell line displayed a pronounced down‑regulation of EGFR signaling that was accompanied by increased apoptosis and a marked reduction in invasion potential, suggesting a therapeutic avenue for metastatic colorectal cancer.",-46.75,0.6,cellline
"Tryptophan hydroxylase inhibition in the LNCaP cell line reduces serotonin synthesis, thereby attenuating the CXCR4-mediated migration of metastatic prostate cancer cells toward CXCL12-expressing stromal fibroblasts.",-32.75,0.6,cellline
"Toxicity assays revealed that the KRAS G12V variant in the SW480 cell line, when treated with the small molecule inhibitor trametinib, caused a significant decrease in ERK phosphorylation, thereby attenuating downstream proliferation signals in colorectal cancer cells.",-48.75,0.6,cellline
"Capan1 cells overexpressing the KRAS G12D variant exhibit increased ERK phosphorylation, which in turn upregulates the transcription factor MYC and drives proliferation of the pancreatic carcinoma phenotype.",-32.25,0.6,cellline
"Cytotoxicity assays revealed that the chemotherapeutic agent doxorubicin induced a dose‑dependent decrease in cell viability of the SW480 colorectal carcinoma cell line, while the LNCaP prostate cancer cell line exhibited a markedly lower IC50, suggesting differential drug sensitivity mediated by distinct TP53 expression profiles.",-39.75,0.6,cellline
"Cox‑2 inhibition in the McArdle‑RH7777 hepatocarcinoma cell line attenuates IL‑6‑mediated STAT3 phosphorylation, thereby reducing the proliferation of HepG2 cells harboring the TP53 c.215C>A variant.",-43.75,0.6,cellline
"Cisplatin treatment of the SW480 colorectal carcinoma cell line induces a marked up‑regulation of the DNA damage response gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated cell death.",-34.5,0.6,cellline
"SCID-derived hRPTEC cells transfected with a CRISPR-Cas9 construct targeting the TP53 gene displayed a markedly reduced proliferation rate compared with the unedited SW480 and LNCaP controls, suggesting that TP53 disruption impairs cell cycle progression in these human cancer cell lines.",-44.5,0.6,cellline
"SCRNA‑seq of the SW480 colorectal carcinoma cell line revealed that the oncogenic KRAS variant G12V upregulates the transcription factor NF‑κB, which in turn enhances expression of the chemokine CXCL8, thereby promoting autocrine signaling that drives proliferation and invasion.",-43.5,0.6,cellline
"SCO-1 treatment of the SW480 colorectal carcinoma cell line activates the NF‑κB pathway, thereby increasing TRAF2 expression and enhancing resistance to cisplatin-induced apoptosis.",-38.5,0.6,cellline
"SCOT-1 overexpression in the SW480 colorectal cancer cell line induces TRAF2-dependent NF‑κB activation, thereby enhancing cell proliferation and resistance to apoptosis.",-33.0,0.6,cellline
"Treatment of the KRAS‑mutated SW480 colon carcinoma cells with the MEK inhibitor trametinib reduced phospho‑ERK levels, thereby decreasing proliferation and inducing apoptosis in vitro.",-26.75,0.6,cellline
"Treatment with the PI3K inhibitor LY294002 markedly reduced AKT phosphorylation in the SW480 colorectal carcinoma cell line, whereas the same concentration had no effect on the nontransformed hRPTEC renal proximal tubular epithelial cells, indicating a selective vulnerability of cancerous cells to PI3K pathway blockade.",-36.25,0.6,cellline
"Treatment‑based transcriptomic profiling revealed that the KRAS‑mutant SW480 cell line, when exposed to the MEK inhibitor trametinib, exhibited a marked down‑regulation of the inflammatory cytokine IL‑8 and an up‑regulation of the tumor suppressor gene p21, suggesting that MEK inhibition may re‑engage cell‑cycle checkpoints and attenuate pro‑tumorigenic signaling in colorectal carcinoma cells.",-60.25,0.6,cellline
"Treatment efficacy of the novel PI3K inhibitor LY294002 was markedly enhanced in the LNCaP cell line harboring the PTEN c.398_399delAG sequence variant, as compared to the wild‑type HEK293 cells, demonstrating a genotype‑specific drug response that could guide precision therapy for prostate cancer.",-53.75,0.6,cellline
"SW480 cells harboring a KRAS G12D mutation exhibit increased resistance to the MEK inhibitor trametinib, while LNCaP prostate cancer cells overexpressing the androgen receptor splice variant AR-V7 show heightened sensitivity to the PI3K/AKT pathway inhibitor alpelisib.",-34.5,0.6,cellline
"SW620 cells treated with the small‑molecule inhibitor trametinib exhibited a dose‑dependent decrease in ERK1/2 phosphorylation, while the same treatment in the TRAF2DN‑tg B mouse model resulted in markedly reduced tumor growth and increased survival.",-48.25,0.6,cellline
"SW48‑derived LNCaP cells treated with the KRAS‑inhibitor trametinib show a marked decrease in phosphorylated ERK1/2, confirming that the drug effectively disrupts the MAPK pathway in this prostate cancer cell line.",-45.5,0.6,cellline
"SW-480 cells overexpressing mutant TP53 were treated with the DNA‑damaging agent doxorubicin, resulting in apoptosis mediated by caspase‑3 activation and a marked decrease in cell viability compared to untreated HEK293 controls.",-43.25,0.6,cellline
"HUSC cells harboring a BRCA1 c.68_69delAG variant exhibit reduced DNA repair capacity, and when treated with the DNA‑crosslinking agent doxorubicin, the resulting replication stress activates the ATM‑p53 pathway, leading to apoptosis of the LNCaP tumor cells.",-53.0,0.6,cellline
"Hepatocellular carcinoma cells derived from the SW480 cell line overexpress the oncogenic KRAS variant G12D, which promotes β‑catenin nuclear translocation and upregulates the transcription factor MYC, thereby enhancing proliferation and invasion in vitro.",-41.25,0.6,cellline
"HCT116 cells transfected with a TP53 c.215C>G variant exhibited increased apoptosis when treated with doxorubicin, whereas the same mutation in SW480 cells conferred resistance to the drug.",-30.875,0.6,cellline
"Heterozygous mutations in the TP53 gene of the SW480 cell line, which were confirmed by sequencing the BRCA1 c.68_69delAG variant, led to increased apoptosis and decreased proliferation when treated with the small molecule doxorubicin, thereby illustrating the interaction between genetic alteration and chemotherapeutic response in colorectal cancer cells.",-52.0,0.6,cellline
"McArdle‑RH7777 cells overexpressing a constitutively active STAT3 mutant exhibit increased secretion of interleukin‑6, which in turn promotes proliferation of adjacent LNCaP prostate cancer cells through activation of the PI3K‑AKT signaling pathway.",-33.25,0.6,cellline
"McCoR-7777 cells, a variant of the McArdle-RH7777 cell line, were shown to upregulate the tumor suppressor gene TP53 in response to the chemotherapeutic agent doxorubicin, thereby inducing apoptosis and reducing proliferation in vitro.",-51.25,0.6,cellline
"McDrdle-RH7777 cells treated with the small molecule inhibitor doxorubicin showed a significant downregulation of the oncogenic transcription factor MYC, which in turn decreased proliferation and induced apoptosis in the HCC-derived SW480 cell line.",-59.25,0.6,cellline
"McCracken et al. reported that the pro‑apoptotic effect of TRAIL on the colorectal carcinoma cell line SW480 is markedly enhanced when co‑treated with the small‑molecule inhibitor SB203580, which selectively blocks p38 MAPK signaling.",-47.25,0.6,cellline
"TRAF2DN‑tg B cells, when exposed to the chemotherapeutic agent doxorubicin, exhibit a pronounced up‑regulation of the pro‑apoptotic protein BAX that is absent in the parental HEK293 cell line.",-30.0,0.6,cellline
"TRPV1 overexpression in the SW480 colorectal cancer cell line was shown to increase cisplatin resistance through activation of the PI3K/AKT pathway, thereby reducing apoptosis and promoting tumor survival.",-39.75,0.6,cellline
"TRAIL stimulation in the TRAF2DN‑tg B transgenic mouse model enhanced apoptosis of SW480 cells, a colorectal carcinoma cell line, by upregulating the pro‑apoptotic protein BAX and reducing the expression of the anti‑apoptotic protein BCL‑2.",-47.75,0.6,cellline
"TRF2DN‑tg B cells, when treated with the kinase inhibitor dasatinib, exhibited a marked reduction in the proliferative capacity of the LNCaP prostate cancer cell line, while simultaneously enhancing the expression of the tumor suppressor gene TP53 in the HEK293 embryonic kidney cells.",-45.0,0.6,cellline
"The CRISPR‑Cas9‑mediated knockout of TP53 in HCT116 cells induced a compensatory up‑regulation of the DNA‑damage‑sensing gene ATM, thereby enhancing apoptosis in response to doxorubicin treatment.",-22.125,0.6,cellline
"The chemotherapeutic agent doxorubicin induced apoptosis in the Capan1 and HCT116 cell lines, while the CD18/HPAF cells exhibited a resistance phenotype mediated by upregulation of the MDR1 gene.",-23.75,0.6,cellline
"The Capan1 cell line, harboring a TP53 c.215C>G SequenceVariant, was treated with doxorubicin, resulting in a dose‑dependent decrease in proliferation and an increase in apoptosis mediated by the activation of the p53‑dependent BAX pathway.",-33.0,0.6,cellline
"The BRCA1 c.68_69delAG variant in the U87‑DACH1‑low glioblastoma cell line was shown to impair DNA repair, thereby sensitizing the cells to temozolomide and increasing apoptosis compared with the parental U87‑MGMT‑expressing line.",-32.75,0.6,cellline
"Genome editing of TP53 in the HCT116 colorectal carcinoma cell line using CRISPR/Cas9 created a BRCA1 c.68_69delAG variant that increased sensitivity to doxorubicin, as confirmed by a dose‑response assay in U87‑DACH1‑low glioma cells.",-37.75,0.6,cellline
"Genome‑wide CRISPR screens in the KRAS‑mutant HCT116 cell line revealed that loss of the tumor suppressor gene CDKN2A synergizes with the small‑molecule inhibitor trametinib to induce apoptosis, whereas the same perturbation in the drug‑resistant MCF7/AdrR cell line fails to activate the apoptotic pathway, underscoring the importance of cell‑line‑specific genetic context in therapeutic responses.",-47.25,0.6,cellline
"Genome‐wide CRISPR screens in Capan1 and HCT116 cells revealed that loss of CD18/HPAF, a key integrin subunit, reduces metastatic colonization by activating a PI3K‑AKT‑dependent survival pathway.",-45.25,0.6,cellline
"Genome-wide CRISPR screens in the Capan1 pancreatic cancer cell line revealed that loss of CD18/HPAF dramatically reduces invasion, a phenotype that is partially rescued by overexpression of the MCF7/AdrR‑derived drug‑resistant efflux pump, suggesting a novel link between epithelial‑mesenchymal transition and chemoresistance in this model.",-58.0,0.6,cellline
"Capan1 cells engineered to overexpress the BRCA1 c.68_69delAG variant exhibit markedly reduced proliferation and increased apoptosis in response to the DNA‑damaging chemotherapeutic doxorubicin, a finding that highlights the interplay between sequence variants, cell‑line‑specific drug sensitivity, and tumor biology.",-40.5,0.6,cellline
"CapaN1 cells overexpressing mutant KRAS G12D exhibit increased resistance to doxorubicin compared with HCT116 cells harboring wild‑type KRAS, suggesting that KRAS mutation drives chemoresistance in pancreatic cancer cell lines.",-38.25,0.6,cellline
"C10-2, a novel variant of the TP53 gene (c.743G>A), was identified in the HeLa cell line, and its presence was shown to increase resistance to doxorubicin treatment compared with the wild‑type TP53 in the same cell line.",-56.0,0.6,cellline
"Cytotoxicity assays on the Capan1 and HCT116 cell lines revealed that the combination of doxorubicin and the novel SequenceVariant BRCA1 c.68_69delAG synergistically increased apoptosis, suggesting a potential therapeutic strategy for patients with this mutation.",-36.5,0.6,cellline
"A CRISPR‑Cas9‑mediated knockout of the TP53 gene in the HCT116 cell line, combined with treatment of the resulting TP53‑deficient clones with the DNA‑damaging agent doxorubicin, revealed a significant up‑regulation of the pro‑apoptotic protein BAX and a concomitant decrease in cell‑cycle‑progression markers such as cyclin‑B1, indicating that loss of TP53 sensitizes HCT116 cells to doxorub",-43.75,0.6,cellline
"A Capan1 cell line harboring the BRCA1 c.68_69delAG variant exhibits a markedly increased sensitivity to the DNA‑crosslinking agent doxorubicin, suggesting that this sequence variant enhances chemotherapeutic efficacy through augmented apoptosis mediated by TP53 activation.",-36.0,0.6,cellline
"A CpG‑island hypermethylation of the TP53 promoter in the HCT116 cell line reduces p53 protein levels, thereby increasing resistance to the DNA‑damaging effects of doxorubicin while simultaneously upregulating the expression of the drug efflux transporter ABCB1.",-41.25,0.6,cellline
"A mutagenic exposure to doxorubicin induced a BRCA1 c.68_69delAG variant in the U87‑DACH1‑low glioblastoma cell line, resulting in impaired DNA repair and increased sensitivity to cisplatin.",-29.75,0.6,cellline
"In the Capan1 and HCT116 cell lines, CRISPR‑mediated disruption of the CDKN2A gene led to increased expression of the oncogenic transcription factor MYC, thereby accelerating proliferation and conferring resistance to the chemotherapeutic agent doxorubicin.",-25.375,0.6,cellline
"In Capan1 cells, the CRISPR‑generated TP53 c.68_69delAG variant diminishes p53‑mediated transcription of the CDKN1A gene, thereby accelerating the cell cycle and enhancing resistance to the chemotherapeutic drug doxorubicin.",-29.5,0.6,cellline
"In HCT116 cells, overexpression of the TP53 variant c.215C>T (p.Arg72Pro) enhances cisplatin-induced apoptosis, whereas the same variant in HeLa cells fails to sensitize the cells to the drug.",-25.875,0.6,cellline
"In a CRISPR‑Cas9 screen, the HCT116 cell line was shown to acquire a BRCA1 c.68_69delAG variant that increased sensitivity to the DNA‑damaging agent doxorubicin while simultaneously upregulating the chemokine CXCL8, illustrating a direct link between sequence variation, drug response, and inflammatory signaling in colorectal cancer cells.",-41.75,0.6,cellline
"TRAIL-induced apoptosis was significantly enhanced in the HCT116 cell line harboring a TP53 c.215C>A variant, whereas the same treatment failed to reduce viability in the TP53‑wild‑type HeLa cells, suggesting a mutation-dependent sensitivity to death receptor signaling.",-40.5,0.6,cellline
"TRF2 knockdown in the colorectal cancer cell line HCT116 led to increased telomere dysfunction, which in turn activated the p53‑dependent DNA damage response and ultimately sensitized the cells to the chemotherapeutic agent doxorubicin.",-39.75,0.6,cellline
"TRANK-1, a small-molecule inhibitor of the PI3K/AKT pathway, significantly reduced proliferation and induced apoptosis in the drug-resistant breast cancer cell line MCF7/AdrR, while simultaneously down‑regulating the expression of the drug‑efflux transporter P‑gp encoded by the ABCB1 gene, thereby restoring sensitivity to doxorubicin.",-51.75,0.6,cellline
"TRIALS using the Capan1 and HCT116 cell lines revealed that the BRCA1 c.68_69delAG sequence variant dramatically reduced DNA repair capacity, leading to increased sensitivity to the chemotherapeutic agent doxorubicin.",-31.75,0.6,cellline
"CRISPR‑mediated knockout of the TP53 gene in the Capan1 cell line reduces resistance to doxorubicin, thereby increasing apoptosis in these pancreatic carcinoma cells.",-23.5,0.6,cellline
"CRABP2 overexpression in HCT116 cells carrying the BRCA1 c.68_69delAG variant enhances resistance to doxorubicin, thereby linking the sequence variant to drug response in a colorectal cancer cell line.",-31.5,0.6,cellline
"CRIPSR‑mediated knockout of TP53 in the HCT116 cell line markedly enhanced the sensitivity of these cells to doxorubicin, a finding that suggests a potential therapeutic strategy for chemoresistant colorectal cancers.",-35.5,0.6,cellline
"CR-CellLine Capan1, when treated with the small molecule inhibitor doxorubicin, showed a significant upregulation of the tumor suppressor gene TP53, whereas the same treatment in the CR-CellLine HCT116 resulted in a downregulation of TP53 and an increase in the expression of the anti‑apoptotic protein BCL-XL.",-55.75,0.6,cellline
Sequencing of the TP53 gene in the HCT116 and MCF7/AdrR cell lines revealed a BRCA1 c.68_69delAG variant that may contribute to differential cisplatin sensitivity observed in these models.,-29.0,0.6,cellline
"Sequenced the TP53 exon in the Capan1 and HCT116 cell lines, revealing a novel BRCA1 c.68_69delAG variant that correlated with increased sensitivity to doxorubicin in the HeLa model.",-36.75,0.6,cellline
"Sequencer‑based CRISPR screening in the Capan1 cell line revealed that a BRCA1 c.68_69delAG variant, introduced via electroporation of a synthetic guide RNA targeting TP53, dramatically increased sensitivity to the DNA‑damaging agent doxorubicin while simultaneously up‑regulating the antioxidant response element of the Nrf2 gene, thereby illustrating a complex interplay between gene editing, chemical exposure, and cellular stress pathways in a human pancreatic carcinoma model.",-76.5,0.6,cellline
"Sequencers detected a novel BRCA1 c.68_69delAG variant in a Capan1 subclone that, when exposed to doxorubicin, exhibited reduced proliferation relative to the parental line, confirming the mutation’s functional impact on drug sensitivity.",-51.0,0.6,cellline
"HCT116 cells engineered to express a CRISPR‑mediated BRCA1 c.68_69delAG variant exhibit markedly reduced DNA repair capacity, leading to increased sensitivity to the DNA‑crosslinking agent doxorubicin and enhanced apoptosis compared with wild‑type HCT116 cells.",-25.375,0.6,cellline
"HMCN1 knockdown in the Capan1 cell line enhances the sensitivity of these pancreatic carcinoma cells to the DNA‑damaging agent doxorubicin, thereby providing a potential therapeutic strategy for overcoming chemoresistance.",-43.0,0.6,cellline
"Heterozygous BRCA1 c.68_69delAG mutations in the Capan1 cell line markedly increased sensitivity to doxorubicin, suggesting a potential therapeutic vulnerability in pancreatic carcinoma models.",-28.875,0.6,cellline
"H3K27me3 depletion in Capan1 cells carrying the BRCA1 c.68_69delAG variant leads to up‑regulation of the TP53 pathway, thereby sensitizing the cells to doxorubicin-induced apoptosis.",-30.125,0.6,cellline
"Excessive ROS production in the Capan1 cell line carrying the KRAS G12D variant activates NF‑κB signaling, thereby up‑regulating IL‑8 secretion and promoting invasion of adjacent epithelial cells.",-34.75,0.6,cellline
"Exposing the KRAS‑mutated HCT116 cell line to the BRAF inhibitor dabrafenib induced a compensatory up‑regulation of the PI3K/AKT pathway, thereby reducing apoptosis in these cancer cells.",-35.25,0.6,cellline
"Ex vivo CRISPR/Cas9 editing of the TP53 locus in the HCT116 cell line revealed a novel BRCA1 c.68_69delAG variant that confers resistance to doxorubicin and enhances the expression of the tumor suppressor CD18/HPAF, thereby reducing metastatic potential in vitro.",-41.75,0.6,cellline
"Examination of the Capan1 and HCT116 cell lines revealed that the TP53 c.215C>T variant, originally identified in the KU7 tumor, confers resistance to doxorubicin while simultaneously increasing the expression of the drug transporter ABCG2, thereby illustrating a genotype‑phenotype correlation that may inform personalized chemotherapy strategies.",-59.25,0.6,cellline
"Mutational analysis of the TP53 gene in the Capan1 and HCT116 cell lines revealed a recurrent BRCA1 c.68_69delAG variant that enhances sensitivity to the DNA‑damaging agent doxorubicin, suggesting a potential therapeutic strategy for pancreatic and colorectal cancers.",-28.625,0.6,cellline
"Mutagenic exposure to cisplatin in the Capan1 cell line induces a BRCA1 c.68_69delAG variant, which in turn reduces RAD51 protein levels and compromises DNA repair, thereby enhancing apoptosis in comparison to the HCT116 control line.",-36.0,0.6,cellline
"Mutations in the TP53 gene of the HeLa cell line reduce p53-mediated apoptosis and enhance resistance to doxorubicin, thereby increasing cellular proliferation and contributing to tumorigenesis.",-32.25,0.6,cellline
"Mutant TP53 c.215C>A was introduced into the Capan1 cell line, where it caused a pronounced up‑regulation of the chemokine CXCL12 and sensitized the cells to the small‑molecule inhibitor doxorubicin, thereby enhancing apoptotic cell death.",-44.5,0.6,cellline
"Co-treatment of the chemoresistant MCF7/AdrR cell line with doxorubicin and the PI3K inhibitor LY294002 synergistically induced apoptosis, as evidenced by increased caspase‑3 activation and reduced AKT phosphorylation.",-29.25,0.6,cellline
"Co-culturing the drug‑resistant MCF7/AdrR cells with the CRISPR‑edited HCT116 line harboring the TP53 c.215C>A variant revealed that the TP53 mutation markedly upregulated the expression of the anti‑apoptotic protein BCL‑XL, thereby conferring cross‑resistance to doxorubicin and reducing apoptosis induced by cisplatin.",-50.5,0.6,cellline
"Co‑culture of the Capan1 pancreatic adenocarcinoma cell line with the HCT116 colorectal carcinoma line revealed that the overexpression of the KRAS G12V variant in HCT116 enhanced the secretion of interleukin‑8, which in turn promoted invasive migration of Capan1 cells through the extracellular matrix.",-42.5,0.6,cellline
"Co-expression of the KRAS G12D variant in the HCT116 cell line, which also harbors a TP53 c.215C>T missense mutation, enhances resistance to the chemotherapeutic agent doxorubicin and promotes increased invasive capacity through upregulation of MMP-9 in a manner comparable to that observed in the U87‑DACH1‑low glioblastoma model.",-54.75,0.6,cellline
"Genetic editing of the TP53 locus in the HCT116 cell line using CRISPR/Cas9 introduces a BRCA1 c.68_69delAG variant that enhances apoptosis in response to doxorubicin, thereby providing a potential therapeutic strategy for chemoresistant colorectal cancers.",-31.375,0.6,cellline
Genomic CRISPR/Cas9 editing of the TP53 gene in the HCT116 cell line introduced a BRCA1 c.68_69delAG sequence variant that significantly enhanced the cell line’s sensitivity to the chemotherapeutic agent doxorubicin while also upregulating the p53‑dependent apoptosis pathway.,-41.75,0.6,cellline
"Genetically engineered Capan1 cells harboring a KRAS G12D SequenceVariant exhibit markedly increased invasion through a Matrigel-coated Transwell, a phenotype that is attenuated when the cells are treated with the MEK inhibitor trametinib, confirming the role of the MAPK pathway in regulating this oncogenic behavior.",-46.75,0.6,cellline
"Genotoxic stress induced by doxorubicin in the Capan1 cell line upregulates TP53 expression, thereby promoting apoptosis and reducing colony formation compared with untreated HeLa cells.",-28.25,0.6,cellline
"Loss-of‑function of the TP53 gene in the HCT116 colorectal carcinoma cell line markedly increases the sensitivity of these cells to the DNA‑damaging agent doxorubicin, thereby enhancing apoptosis through activation of the p53‑dependent transcriptional program.",-36.5,0.6,cellline
"Loss of PTEN in the HCT116 colorectal cancer cell line reduces PTEN‑mediated suppression of the PI3K/AKT pathway, thereby increasing cell proliferation and resistance to the chemotherapeutic agent doxorubicin.",-31.875,0.6,cellline
"Loss‑of‑function mutations in TP53 that arise in the HeLa cell line and the HCT116 colorectal carcinoma line are associated with increased resistance to the DNA‑crosslinking agent doxorubicin, thereby illustrating how genetic variation in a tumor suppressor gene can modulate chemotherapeutic response in distinct human cell lines.",-51.75,0.6,cellline
"Loss‐of‑function TP53 in the Capan1 cell line leads to increased NRF2 activity, which in turn up‑regulates the antioxidant gene NQO1 and confers resistance to the chemotherapeutic drug doxorubicin.",-39.5,0.6,cellline
"In the SUM159PT cell line, overexpression of the TP53 gene product was found to sensitize cells to doxorubicin-induced apoptosis, whereas in MES‑SA/Dx5 cells the same TP53 variant conferred resistance to the chemotherapeutic agent.",-21.0,0.6,cellline
"In SUM159PT cells, the KRAS G12D sequence variant drives epithelial‑mesenchymal transition, increasing invasion of the surrounding ECM and conferring resistance to the chemotherapeutic agent doxorubicin.",-33.5,0.6,cellline
"In investigating temozolomide resistance, the SUM159PT breast cancer cell line exhibited upregulated MGMT expression, whereas the MES‑SA/Dx5 ovarian cancer line showed a concurrent loss of PTEN, suggesting distinct mechanisms of chemoresistance across these cell lines.",-39.75,0.6,cellline
"In a recent study, the chemotherapeutic agent doxorubicin was found to induce apoptosis in the SUM159PT breast cancer cell line, while the same treatment had no effect on the non‑malignant CMT‑93 intestinal epithelial cells, suggesting a selective cytotoxicity that may be exploited for targeted therapy.",-36.0,0.6,cellline
"SUM159PT cells treated with the DNA‑damaging agent doxorubicin exhibited a marked up‑regulation of the tumor suppressor TP53, leading to apoptosis and a significant reduction in colony‑forming ability.",-22.625,0.6,cellline
"SUM155PT cells, a triple‑negative breast cancer line derived from the patient-derived xenograft SUM159PT, exhibit up‑regulated MMP‑9 expression when treated with the proteasome inhibitor MG‑132, thereby enhancing invasion through collagen I and activating the ERK1/2 signaling cascade.",-65.0,0.6,cellline
"SUM150PT cells treated with the EGFR inhibitor gefitinib displayed a marked decrease in phosphorylated AKT levels, confirming that the drug blocks downstream PI3K signaling in this colorectal carcinoma cell line.",-42.5,0.6,cellline
"SUM119PT cells exposed to the BRCA1 c.68_69delAG variant exhibit a marked reduction in DNA repair capacity, leading to increased sensitivity to the DNA‑damaging agent doxorubicin in a manner that parallels the heightened chemoresistance observed in the MES‑SA/Dx5 cell line.",-49.0,0.6,cellline
"The chemotherapeutic agent doxorubicin was found to induce apoptosis in the SUM159PT breast cancer cell line while simultaneously upregulating the DNA repair gene BRCA1 c.68_69delAG, suggesting a potential mechanism for the observed resistance in MES‑SA/Dx5 multidrug‑resistant cells.",-29.75,0.6,cellline
"The MES‑SA/Dx5 cell line, derived from a human uterine sarcoma and engineered for doxorubicin resistance, exhibits up‑regulated ABCB1 expression that correlates with a BRCA1 c.68_69delAG variant, thereby enhancing its chemoresistance profile.",-34.0,0.6,cellline
"The drug rapamycin inhibited mTOR signaling and induced autophagy in the triple‑negative breast cancer cell line SUM159PT, leading to reduced proliferation and increased apoptosis.",-19.125,0.6,cellline
"The SUM159PT cell line, derived from triple‑negative breast carcinoma, exhibited a pronounced up‑regulation of the PIK3CA gene when treated with the PI3K inhibitor BYL719, a response that was markedly attenuated in the MES‑SA/Dx5 cisplatin‑resistant line where the BRCA1 c.68_69delAG variant was also present.",-40.75,0.6,cellline
"Treatment with the platinum drug carboplatin induced a significant increase in the expression of the DNA repair gene ERCC1 in the SUM159PT breast cancer cell line, whereas the same treatment had no effect on the same gene in the drug‑resistant MES‑SA/Dx5 sarcoma cell line.",-37.0,0.6,cellline
"Treatment of the drug-resistant glioblastoma cell line SJ‑GBM2 with the novel PI3K‑δ inhibitor LY3013417 markedly reduced phosphorylated AKT levels and induced apoptosis, whereas the same compound had no effect on the non‑malignant fibroblast line MEF, confirming its selective activity in malignant brain tumor cells.",-55.0,0.6,cellline
"Treatment efficacy of the EGFR inhibitor erlotinib was markedly increased in the SUM159PT breast cancer cell line compared with the SW48 colon carcinoma line, suggesting that EGFR overexpression in SUM159PT drives drug sensitivity while SW48’s KRAS mutation confers resistance.",-40.0,0.6,cellline
"Treatment using the chemotherapeutic drug doxorubicin induced apoptosis in the SUM159PT breast cancer cell line, whereas the resistant MES‑SA/Dx5 osteosarcoma line required addition of the DNA‑repair inhibitor PARP‑1 inhibitor olaparib to achieve comparable cell death.",-44.0,0.6,cellline
"Treating the SUM159PT and MES‑SA/Dx5 cells with the novel kinase inhibitor, the researchers observed a dose‑dependent reduction in proliferation mediated by phosphorylation of the TP53 protein, suggesting a potential therapeutic strategy for triple‑negative breast and uterine sarcoma models.",-46.75,0.6,cellline
"Treatments with the BET inhibitor JQ1 induced apoptosis in the triple‑negative breast cancer cell line SUM159PT and the colorectal carcinoma line HT29, while the osteoblast‑derived MC3T3‑E1 cells displayed a compensatory increase in p21 expression.",-43.0,0.6,cellline
"Treats the chemotherapeutic drug doxorubicin by inducing apoptosis in the breast cancer cell line SUM159PT, thereby reducing tumor viability.",-38.0,0.6,cellline
"Treatable chemotherapy resistance in the SUM159PT breast cancer cell line is driven by upregulated ABCB1 expression, which is further enhanced by the BRCA1 c.68_69delAG variant and suppressed by siRNA-mediated TP53 knockdown.",-43.25,0.6,cellline
"Expression of the mutant TP53 variant c.215C>T in the SUM159PT cell line led to enhanced apoptosis when treated with doxorubicin, whereas the same mutation in the HT29 cell line resulted in drug resistance through upregulation of the MDR1 transporter.",-38.25,0.6,cellline
"Expression profiling of the SUM159PT breast cancer cell line revealed that the KRAS G12D SequenceVariant markedly upregulates the PI3K pathway, thereby enhancing proliferation of the tumor while also sensitizing the cells to the MEK inhibitor trametinib.",-43.5,0.6,cellline
"Expression analysis in the MES‑SA/Dx5 cell line revealed that the up‑regulation of the drug‑resistance transporter ABCB1 is driven by a novel SNP in the promoter region of the TP53 gene, suggesting a mechanistic link between the genetic variant and chemotherapeutic tolerance in this ovarian cancer model.",-48.25,0.6,cellline
"Expression levels of the drug‑resistance protein ABCB1 in the SUM159PT cell line were markedly upregulated after chronic exposure to doxorubicin, thereby diminishing the cytotoxic efficacy of the chemotherapeutic agent in this triple‑negative breast cancer model.",-39.75,0.6,cellline
"MEG3 overexpression in the MES‑SA/Dx5 cell line markedly reduces the proliferation of chemoresistant glioblastoma cells and enhances the apoptotic response to temozolomide, suggesting a potential therapeutic strategy for mesenchymal‑phenotype tumors.",-43.5,0.6,cellline
"MEK inhibition in the SUM159PT cell line attenuates CXCL8 secretion, thereby reducing the invasiveness of the Mz‑ChA‑1 gastric carcinoma cells that express the same IL‑8 receptor CXCR1.",-41.75,0.6,cellline
"MEASURED in the MES‑SA/Dx5 cell line, the overexpression of the gene TP53 was found to enhance sensitivity to the chemotherapeutic agent doxorubicin, thereby reducing cell viability in a dose‑dependent manner.",-37.0,0.6,cellline
"ME3T3‑E1 cells treated with doxorubicin exhibited a marked up‑regulation of TP53, which in turn induced apoptosis and reduced proliferation in the human colorectal cancer cell line HT29.",-41.75,0.6,cellline
"A highly drug‑resistant MES‑SA/Dx5 cell line exhibited increased expression of the ATP‑binding cassette transporter ABCG2 after chronic exposure to doxorubicin, a phenomenon that was not observed in the parental MES‑SA line or in the drug‑sensitive SUM159PT breast cancer cells.",-45.25,0.6,cellline
"A CRISPR/Cas9‑edited SUM159PT clone harboring a BRCA1 c.68_69delAG variant shows markedly reduced homologous recombination repair activity compared with the parental SW48 cell line, suggesting a cell‑line‑specific vulnerability that could be exploited for targeted PARP inhibitor therapy.",-39.0,0.6,cellline
"A drug‑resistant glioblastoma line, SJ‑GBM2, exhibited increased expression of the drug efflux transporter ABCG2 after chronic exposure to the chemotherapeutic doxorubicin, suggesting that ABCG2 up‑regulation mediates the acquired resistance observed in this cell line.",-37.25,0.6,cellline
"A dose of doxorubicin markedly reduced proliferation in the SUM159PT breast cancer cell line while upregulating TP53 expression, suggesting a therapeutic strategy that exploits the DNA damage response in this tumor model.",-37.25,0.6,cellline
CRISPR‑Cas9 editing of the TP53 locus in the SUM159PT cell line revealed a novel BRCA1 c.68_69delAG variant that confers resistance to doxorubicin and alters the cell‑cycle arrest phenotype in HT29 cells.,-35.5,0.6,cellline
"CR‑to‑CR interaction between the SUM159PT breast cancer cell line and the MES‑SA/Dx5 ovarian cancer cell line was found to up‑regulate the drug‑resistance gene ABCB1, thereby enhancing doxorubicin efflux and contributing to chemoresistance.",-49.5,0.6,cellline
"CRL-4020, a human cervical carcinoma cell line, was engineered to express a CRISPR-Cas9–mediated BRCA1 c.68_69delAG variant, and its altered DNA repair capacity was compared to that of the isogenic MCF-7 line treated with the DNA‑crosslinking agent doxorubicin.",-59.25,0.6,cellline
"CRPC‑derived cell line SUM159PT, when treated with the small molecule inhibitor doxorubicin, exhibits a significant up‑regulation of the tumor suppressor gene TP53 and a concurrent reduction in the expression of the drug‑resistance protein MDR1, thereby enhancing apoptosis in the human breast cancer model.",-55.25,0.6,cellline
"Genetic knock‑in of the TP53 c.68_69delAG variant in the SUM159PT cell line markedly increased sensitivity to doxorubicin, while the same mutation in the MES‑SA/Dx5 line conferred resistance to cisplatin through upregulation of the MDR1 transporter.",-35.0,0.6,cellline
"Genomic CRISPR‑Cas9 editing of the KRAS locus in the SUM159PT breast cancer cell line revealed that the c.35G>T (p.Gly12Val) SequenceVariant enhances MAPK signaling, thereby increasing invasion in vitro.",-38.0,0.6,cellline
"Genotoxic stress induced by doxorubicin in the SUM159PT breast cancer cell line triggers up‑regulation of the tumor suppressor TP53, leading to apoptosis and a subsequent decrease in cell proliferation.",-35.5,0.6,cellline
"Genetically engineered SUM159PT cells expressing the BRCA1 c.68_69delAG variant were shown to exhibit heightened sensitivity to doxorubicin, a finding that may inform therapeutic strategies for triple‑negative breast cancer.",-29.875,0.6,cellline
"While treating the SUM159PT breast cancer cell line with doxorubicin, researchers observed that the expression of the drug‑resistance gene ABCB1 was up‑regulated, leading to a significant increase in cellular efflux of the chemotherapeutic agent.",-34.75,0.6,cellline
"While culturing the drug‑resistant MES‑SA/Dx5 cell line, researchers observed that exposure to the small‑molecule inhibitor doxorubicin induced a dose‑dependent upregulation of the apoptosis‑associated gene TP53, thereby revealing a potential therapeutic vulnerability in this colorectal cancer model.",-38.75,0.6,cellline
"While the chemotherapeutic agent doxorubicin markedly decreased proliferation in the triple‑negative breast cancer cell line SUM159PT, it also induced a dose‑dependent upregulation of the drug‑efflux transporter ABCB1, thereby contributing to acquired resistance.",-36.25,0.6,cellline
"While comparing drug‑resistant and drug‑sensitive populations, researchers found that the SUM159PT and MES‑SA/Dx5 cell lines exhibited a significant up‑regulation of the ABCB1 transporter, correlating with increased doxorubicin efflux and resistance.",-44.75,0.6,cellline
"Deletion of the TP53 promoter in the SUM159PT cell line induces up‑regulation of the DNA‑repair gene BRCA1, thereby enhancing resistance to doxorubicin‑induced apoptosis in triple‑negative breast cancer cells.",-30.125,0.6,cellline
"Deletion amplification of the BRCA1 c.68_69delAG variant in the SUM159PT breast cancer cell line enhances resistance to doxorubicin by upregulating the drug‑efflux transporter ABCB1, thereby illustrating a direct link between a sequence variant and chemotherapy response in a human cell line.",-49.75,0.6,cellline
"Deletion-induced upregulation of the TP53 gene in the SUM159PT cell line enhances apoptosis in response to doxorubicin treatment, thereby reducing the viability of these breast cancer cells.",-43.0,0.6,cellline
"Deletion‐induced upregulation of the transcription factor ETV6 in the MES‑SA/Dx5 chemoresistant sarcoma cell line drives increased expression of the drug efflux transporter ABCB1, thereby exacerbating doxorubicin resistance.",-45.5,0.6,cellline
"MTSA/Dx5 cells from the MES-SA/Dx5 cell line, a cisplatin‑resistant ovarian cancer model, were found to overexpress the drug‑efflux transporter ABCG2, a change that was confirmed by quantitative PCR and correlated with reduced doxorubicin accumulation and increased resistance to apoptosis induced by the chemotherapeutic agent.",-60.0,0.6,cellline
"MT-1 treatment induced a significant up‑regulation of the TP53 protein in the SUM159PT and MES‑SA/Dx5 cell lines, suggesting a potential p53‑dependent apoptotic pathway that could be exploited for targeted glioblastoma therapy in SJ‑GBM2 cells.",-41.75,0.6,cellline
"MT‑B1‑A1 cells derived from the SUM159PT triple‑negative breast cancer line were found to exhibit a higher expression of the drug‑resistance transporter ABCG2 than the parental SUM159PT line, suggesting that the SUM159PT cell line may acquire a drug‑resistant phenotype after exposure to the chemotherapeutic agent MT‑B1‑A1.",-66.0,0.6,cellline
"MT1 cells derived from the human glioblastoma line SJ‑GBM2 were treated with the DNA‑crosslinking agent temozolomide, and the resulting apoptosis was found to be mediated through up‑regulation of the TP53‑dependent transcription factor p21, thereby revealing a potential therapeutic target for overcoming temozolomide resistance in this aggressive brain tumor cell line.",-63.25,0.6,cellline
"Evidence from the SUM159PT cell line shows that knockdown of TP53 by siRNA leads to increased proliferation of the tumor cells, whereas treatment of the same cells with doxorubicin induces apoptosis through activation of the p53‑dependent DNA‑damage response.",-51.5,0.6,cellline
Evidence that the chemotherapeutic agent doxorubicin induces apoptosis in the chemoresistant SUM159PT cell line and that this effect is potentiated by the presence of the TP53 gene product in HT29 cells was demonstrated in a recent study.,-40.25,0.6,cellline
"Evidence suggests that the chemotherapeutic agent doxorubicin induces apoptosis in the breast cancer cell line SUM159PT, a process that is amplified by the overexpression of the drug‑resistance gene ABCB1, while concurrently down‑regulating the tumor suppressor TP53, thereby highlighting a potential mechanistic link between drug exposure, gene regulation, and cell‑line‑specific susceptibility to therapy.",-56.25,0.6,cellline
"Evidence of increased resistance to doxorubicin in the SUM159PT cell line, where the BRCA1 c.68_69delAG variant appears to reduce DNA repair capacity, was confirmed by comparative IC50 assays against the parental HT29 line.",-45.5,0.6,cellline
"MC-IXC cells exposed to the TRAF2DN‑tg B construct exhibited a significant reduction in TNF‑α‑induced NF‑κB activation, while co‑treatment with the small‑molecule inhibitor ethanolamine phosphate restored NF‑κB signaling to levels comparable to untreated MCF‑12A cells.",-42.25,0.6,cellline
"MCF-7 cells treated with the TRF2 dominant-negative construct (Traf2DN‑tg B) displayed a marked reduction in proliferation and an increase in apoptosis, suggesting that TRF2 inhibition can sensitize breast cancer cells to chemotherapeutic agents.",-37.0,0.6,cellline
"MC‑12A cells expressing the mutant TP53 c.215C>T variant exhibited increased apoptosis after treatment with the DNA‑crosslinking agent doxorubicin, whereas the same mutation in MCF‑7 cells led to enhanced resistance to the drug.",-43.0,0.6,cellline
"MCR-IXC cells treated with the novel small‑molecule inhibitor L-117, a selective PDK1 antagonist, displayed a significant reduction in phosphorylated AKT levels, suggesting that inhibition of PDK1 disrupts the survival signaling pathway in this renal cell line.",-63.75,0.6,cellline
"The MCF-7 breast carcinoma cell line, when transfected with a CRISPR-Cas9 construct targeting the TP53 gene, displayed increased apoptosis and decreased proliferation compared with the untreated MCF-12A epithelial control.",-29.0,0.6,cellline
"The hRPTEC cell line, when treated with the small‑molecule inhibitor doxorubicin, exhibits a dose‑dependent reduction in the expression of the tumor suppressor gene TP53, thereby enhancing apoptotic signaling and suggesting a potential therapeutic strategy for renal proximal tubular injury.",-28.0,0.6,cellline
"The rapamycin‑treated hRPTEC cells, when co‑cultured with the MCF‑7 breast cancer line, showed a marked decrease in the phosphorylation of mTORC1 targets and an accompanying reduction in cellular proliferation, suggesting that rapamycin may sensitize renal proximal tubular cells to anti‑tumor effects mediated by MCF‑7 secreted cytokines.",-50.0,0.6,cellline
"The anti‑apoptotic protein BCL‑XL is up‑regulated in the renal proximal tubular cell line hRPTEC after exposure to the chemotherapeutic agent doxorubicin, leading to enhanced cell survival and increased resistance to drug‑induced cytotoxicity.",-30.625,0.6,cellline
"In the hRPTEC cell line, knockdown of the TP53 gene via CRISPR-Cas9 led to increased proliferation and reduced apoptosis, whereas in the MCF-7 breast cancer line, overexpression of the anti‑apoptotic protein BCL‑2 further enhanced cell survival under hypoxic conditions.",-33.75,0.6,cellline
"In vitro, the hRPTEC cell line exhibited a significant reduction in the expression of the tumor suppressor gene TP53 after exposure to the small molecule doxorubicin, suggesting a potential chemotherapeutic mechanism that may be exploited for targeted renal cell carcinoma therapy.",-42.75,0.6,cellline
"In hRPTEC cells, knockdown of the transcription factor KLF4 markedly upregulates the expression of the chemokine CXCL10, thereby enhancing the recruitment of CD8+ T cells and potentiating the anti‑tumor immune response in the renal proximal tubule epithelium.",-39.0,0.6,cellline
"In HT22 cells, the overexpression of the mutant BRCA1 c.68_69delAG sequence variant significantly enhances DNA repair capacity, thereby reducing the apoptosis induced by doxorubicin treatment.",-30.375,0.6,cellline
"Treatment of the human renal proximal tubular epithelial cell line hRPTEC with the DNA methyltransferase inhibitor decitabine induced a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activated the downstream apoptotic effector BAX, leading to increased caspase‑3 activity and a reduction in cell viability.",-41.5,0.6,cellline
"Treatment with the PI3K inhibitor LY294002 markedly reduced proliferation and induced apoptosis in the MCF‑7 breast cancer cell line while simultaneously decreasing the expression of the chemokine CXCL12 in the hRPTEC renal proximal tubular epithelial cells, suggesting a dual anti‑tumor and anti‑fibrotic effect.",-37.0,0.6,cellline
"Treatment using the hRPTEC cell line revealed that exposure to the chemical entity doxorubicin induced a significant up‑regulation of the gene product TP53, which in turn activated apoptosis pathways and led to the selective loss of the MCF‑7 cancer phenotype while sparing the normal MCF‑12A epithelium.",-49.75,0.6,cellline
"Treatment data revealed that the hRPTEC cell line, when exposed to the novel compound doxorubicin, exhibited a significant up‑regulation of the TP53 gene product, while the MCF‑7 breast cancer cell line showed a concurrent down‑regulation of BCL2, suggesting a differential apoptotic response in these distinct cell lines.",-53.75,0.6,cellline
"TRAF2DN‑tg B mice treated with the synthetic chemical entity resveratrol exhibited a significant increase in apoptosis of hRPTEC cells, while MCF‑7 and SNU‑C5 cell lines displayed enhanced proliferation due to up‑regulation of the TP53 gene product.",-42.5,0.6,cellline
"TRF2DN‑tg B cells, derived from a transgenic mouse model, exhibited increased expression of the tumor suppressor gene TP53 and a concomitant reduction in the growth rate of the MCF‑7 breast cancer cell line when co‑cultured with the hRPTEC renal proximal tubule cells, suggesting a paracrine signaling axis that may be exploited to sensitize chemoresistant tumors to doxorubicin.",-62.5,0.6,cellline
"TRT‑101, a novel small‑molecule inhibitor of PI3Kα, markedly reduced proliferation and induced apoptosis in MCF‑7 cells while sparing the non‑malignant MCF‑12A epithelial line, suggesting selective therapeutic potential.",-47.75,0.6,cellline
"TRAP1 overexpression in MCF‑7 cells enhances cisplatin resistance by stabilizing mitochondrial dynamics and reducing apoptosis, whereas knockdown of TRAP1 in hRPTEC cells restores cisplatin‑induced cell death through increased ROS production and activation of the p53‑dependent apoptotic pathway.",-45.75,0.6,cellline
"Exposure of the hRPTEC cell line to the small molecule doxorubicin induced a rapid up‑regulation of the pro‑apoptotic gene TP53, which in turn triggered caspase‑3 activation and subsequent cell death.",-26.125,0.6,cellline
"Exposure to the IL‑1β‑induced pro‑inflammatory milieu markedly increased p‑STAT3 phosphorylation in MCF‑7 cells, whereas co‑treatment with the selective STAT3 inhibitor Stattic restored basal proliferation rates, suggesting a direct regulatory role of STAT3 signaling in estrogen‑responsive breast cancer growth.",-55.5,0.6,cellline
"Exposure testing revealed that the hRPTEC cell line, when treated with the chemical entity cisplatin, exhibited a significant up‑regulation of the gene TP53 and a concomitant increase in apoptotic markers, suggesting a dose‑dependent cytotoxic response.",-47.75,0.6,cellline
"Exposure‑induced oxidative stress in the hRPTEC cell line upregulates the NRF2‑dependent antioxidant response, thereby protecting the proximal tubular epithelium from cisplatin‑mediated cytotoxicity.",-31.875,0.6,cellline
"Deletion of the TP53 gene in the MCF‑7 cell line leads to increased expression of the DNA‑repair protein RAD51, thereby enhancing resistance to doxorubicin‑induced apoptosis.",-28.0,0.6,cellline
"Deletion or over‑expression of the BRCA1 c.68_69delAG variant in MCF‑7 cells leads to increased sensitivity to doxorubicin, while the same mutation in hRPTEC cells causes a marked reduction in DNA repair protein XRCC1 expression.",-48.75,0.6,cellline
"Deletion‑associated SNP rs123456 in the TP53 gene reduces cell‑cycle arrest in the MCF‑7 breast cancer cell line, thereby increasing resistance to doxorubicin treatment.",-43.75,0.6,cellline
"Deletion-bearing BRCA1 c.68_69delAG in the hRPTEC cell line markedly increased sensitivity to the chemotherapeutic agent doxorubicin, an effect that was rescued by overexpression of the DNA repair protein RAD51.",-44.25,0.6,cellline
"Treating the hRPTEC cell line with the chemical entity rapamycin inhibited the expression of the disease‑associated gene TP53, thereby reducing apoptosis in the presence of the sequence variant BRCA1 c.68_69delAG and improving cell viability compared with untreated MCF‑7 cells.",-38.0,0.6,cellline
"Treatments with the mitochondrial uncoupler FCCP reduced proliferation of MCF‑7 cells, while overexpression of the mutant BRCA1 c.68_69delAG allele in hRPTEC cells increased DNA damage signaling and apoptosis.",-45.0,0.6,cellline
"Treat in vitro proliferation of the breast cancer cell line MCF‑7 with the small‑molecule inhibitor doxorubicin reduces cyclin‑dependent kinase activity, thereby inducing G2‑phase arrest and apoptosis in a dose‑dependent manner.",-44.5,0.6,cellline
"Treatable inhibition of the PI3K‑AKT pathway by rapamycin in the human renal proximal tubular epithelial cell line hRPTEC reduced the expression of the pro‑inflammatory cytokine IL‑6, thereby ameliorating the inflammatory phenotype that is otherwise exacerbated by TNF‑α stimulation.",-49.0,0.6,cellline
"Chemotherapeutic exposure of the MCF‑7 cell line to doxorubicin induces a dose‑dependent increase in TP53 protein levels, leading to apoptosis and a concomitant up‑regulation of the pro‑apoptotic gene BAX.",-31.25,0.6,cellline
"Chemotherapy with doxorubicin induced apoptosis in the MCF‑7 breast cancer cell line, an effect that was markedly reduced in the presence of the mutant TP53 allele c.215C>T (p.R72P) expressed in the same cells.",-37.5,0.6,cellline
"Chemically induced apoptosis in the MCF‑7 cell line by doxorubicin was markedly enhanced when the TP53 gene was simultaneously overexpressed, leading to a pronounced increase in caspase‑3 activity and a corresponding reduction in cell viability.",-44.75,0.6,cellline
"Chemokine CXCL10 overexpression in the hRPTEC cell line induces apoptosis through the TRAF2-dependent NF‑κB pathway, thereby reducing epithelial barrier integrity in vitro.",-32.25,0.6,cellline
"hRPTEC cells exposed to the DNA‑damaging agent doxorubicin exhibited a dramatic increase in the expression of the p53‑regulated gene TP53, confirming that the drug induces a p53‑dependent apoptotic response in this proximal tubule cell line.",-38.5,0.6,cellline
"hRPE‑C1 cells, a primary retinal epithelial line derived from Homo sapiens, exhibited a significant up‑regulation of the TP53‑dependent apoptosis pathway when treated with the DNA‑crosslinking agent doxorubicin, whereas the breast cancer line MCF‑7, which harbors a mutant KRAS allele, showed a markedly attenuated response and instead activated an AKT‑mediated survival circuit.",-70.0,0.6,cellline
"hDRPTEC cells exposed to the TP53‑activating compound doxorubicin exhibit increased apoptosis, while MCF‑7 cells harboring the BRCA1 c.68_69delAG variant display reduced DNA repair capacity.",-43.25,0.6,cellline
"hRPCET cells engineered to overexpress the mutant TP53 R175H allele exhibit heightened sensitivity to the DNA‑damaging chemotherapeutic doxorubicin, a response that is markedly amplified when co‑treated with the small‑molecule AKT inhibitor MK‑2206.",-46.25,0.6,cellline
"CRISPR‑mediated disruption of the TP53 gene in the MCF‑7 cell line markedly enhanced resistance to doxorubicin-induced apoptosis while simultaneously upregulating the anti‑apoptotic BCL‑XL protein, a phenotype not observed in the TP53‑wild‑type MCF‑12A cells.",-35.5,0.6,cellline
"CR-1‑treated hRPTEC cells exhibit a significant up‑regulation of the TP53‑dependent apoptosis pathway, mirroring the response seen in the MCF‑7 breast‑cancer cell line and suggesting that this drug could potentiate chemotherapeutic efficacy in epithelial cancers.",-56.5,0.6,cellline
"CRX overexpression in the hRPTEC cell line increases CYP3A4 transcription, thereby enhancing doxorubicin metabolism and reducing its cytotoxicity in renal proximal tubule cells.",-37.25,0.6,cellline
"CRAP-1 treatment induced apoptosis in MCF‑7 cells through up‑regulation of TP53, while in hRPTEC cells it activated the PI3K‑AKT pathway to promote cell survival.",-41.0,0.6,cellline
"Mutation of the TP53 gene in the MCF‑7 cell line causes a loss of p53‑mediated transcriptional activation of the BAX promoter, thereby reducing apoptosis in response to doxorubicin treatment.",-25.75,0.6,cellline
"Mutation in the TP53 gene (c.215C>T) was found to decrease viability in the hRPTEC cell line while simultaneously increasing the expression of the pro‑apoptotic protein BAX, suggesting a potential therapeutic target for kidney disease.",-42.0,0.6,cellline
"Mutation-induced overexpression of TP53 in the hRPTEC cell line leads to apoptosis resistance, thereby compromising renal epithelial repair during chronic kidney disease progression.",-37.75,0.6,cellline
"Mutation analysis of the TP53 gene in the hRPTEC cell line revealed a c.215C>T (p.R72C) sequence variant that may compromise DNA repair capacity, while co‑culture with the MCF‑7 cell line showed that this variant enhances sensitivity to the chemotherapeutic agent doxorubicin.",-46.0,0.6,cellline
"High‑throughput screening of the kinase inhibitor library in the hRPTEC cell line revealed that compounds targeting SRC family kinases selectively induced apoptosis via caspase‑3 activation, a result confirmed by parallel experiments in the MCF‑12A breast epithelial model.",-40.5,0.6,cellline
"High‐throughput CRISPR‑Cas9 screening in the hRPTEC cell line revealed that loss of the transcription factor NFKBIA promotes ferroptosis via up‑regulation of ACSL4, a vulnerability that can be exploited by the small molecule erastin to selectively eliminate malignant epithelial cells.",-50.5,0.6,cellline
High concentrations of doxorubicin inhibited proliferation of the MCF-7 cell line by inducing TP53‑mediated apoptosis while sparing the non‑malignant MCF‑12A cells.,-28.625,0.6,cellline
"High-glucose treatment of the MCF-7 breast cancer cell line induces up‑regulation of the transcription factor NF‑κB, which in turn activates the PI3K‑AKT pathway and enhances expression of the anti‑apoptotic gene BCL‑2, thereby conferring resistance to doxorubicin-induced cell death.",-43.5,0.6,cellline
"MRPS34 knockdown in the hRPTEC cell line reduces its ability to repair DNA damage induced by cisplatin, thereby enhancing apoptosis in these proximal tubule cells.",-40.25,0.6,cellline
"MRL-1 cells, a variant of the MCF‑7 breast cancer cell line, were engineered to overexpress the mutant TP53 sequence variant c.215C>G, and this modification enhanced their resistance to doxorubicin while simultaneously increasing the expression of the chemokine CXCL8 in the surrounding MCF‑12A epithelial microenvironment.",-58.25,0.6,cellline
"MRLC1 overexpression in hRPTEC cells reduces TNF-α‑induced apoptosis through NF‑κB pathway activation, suggesting a protective role for this protein in chronic kidney disease.",-40.5,0.6,cellline
"MRP1 overexpression in the hRPTEC cell line enhances cisplatin resistance by upregulating efflux pump activity, thereby reducing drug accumulation and promoting survival of renal proximal tubular epithelial cells exposed to chemotherapy.",-32.0,0.6,cellline
"In U87MG glioblastoma cells, the CRISPR‑generated TP53 c.68_69delAG variant dramatically increased STAT3 phosphorylation, thereby enhancing VEGFA secretion and accelerating angiogenesis in co‑cultured HK‑2 renal proximal tubule cells.",-28.875,0.6,cellline
"In the U87MG glioblastoma model, knockdown of the KRAS gene by CRISPR/Cas9 markedly reduced cell proliferation and induced apoptosis, whereas overexpression of the small‑molecule inhibitor sorafenib restored the PI3K/AKT signaling pathway and rescued the growth phenotype.",-33.75,0.6,cellline
"In HCT116 cells, the CRISPR‑generated BRCA1 c.68_69delAG variant impairs homologous recombination, rendering the cells hypersensitive to the DNA‑crosslinking agent doxorubicin while simultaneously upregulating the DNA‑damage sensor ATM.",-28.875,0.6,cellline
"In a comparative study, the U87MG glioblastoma cell line exhibited markedly increased CXCR4 expression when treated with the CXCR4 antagonist AMD3100, whereas the A549 lung carcinoma line showed a significant reduction in EGFR phosphorylation under the same conditions.",-33.5,0.6,cellline
"The U87MG glioblastoma cell line, when treated with the small molecule inhibitor doxorubicin, shows a significant reduction in TP53 protein levels, suggesting that the drug may modulate the p53 pathway in this cancer model.",-28.875,0.6,cellline
"The drug doxorubicin induces apoptosis in U87MG cells by up‑regulating TP53, a response that is markedly attenuated in the A549 cell line due to a BRCA1 c.68_69delAG sequence variant.",-27.5,0.6,cellline
"The CRISPR‑Cas9‑mediated deletion of the TP53 exon in U87MG cells results in increased resistance to doxorubicin and promotes the up‑regulation of the drug‑efflux transporter ABCG2, thereby enhancing the cells’ survival under chemotherapy-induced stress.",-38.25,0.6,cellline
"The chemotherapeutic drug doxorubicin induces apoptosis in the U87MG glioblastoma cell line through upregulation of the TP53 pathway, while co‑treatment with the antioxidant N‑acetylcysteine partially rescues cell viability.",-23.5,0.6,cellline
"U87MG cells treated with the synthetic chemical entity erlotinib exhibit a dose‑dependent reduction in the expression of the gene product EGFR, an effect that is further amplified in the presence of the SequenceVariant EGFR c.2369C>A, ultimately leading to decreased proliferation of the glioblastoma cell line.",-46.25,0.6,cellline
"U63‑B, a sub‑clone of the U87MG glioblastoma cell line, exhibited a dramatic increase in VEGFA expression when treated with the small‑molecule inhibitor pazopanib, suggesting a direct regulatory interaction between the drug and the HIF‑1α‑mediated angiogenic pathway.",-54.75,0.6,cellline
"U‑87MG cells engineered to overexpress mutant TP53 exhibit heightened sensitivity to the chemotherapeutic agent doxorubicin, a finding that parallels the reduced viability of A549 lung carcinoma cells following treatment with the same drug.",-35.25,0.6,cellline
"U89MG cells harboring the TP53 c.215C>G variant exhibit increased sensitivity to the chemotherapeutic agent doxorubicin, whereas A549 cells expressing the KRAS G12D mutation remain resistant, illustrating how distinct sequence variants can modulate drug response in different human cell lines.",-48.25,0.6,cellline
"A549 cells treated with the DNA‑damaging agent doxorubicin exhibit up‑regulation of the p53 pathway, leading to apoptosis that is attenuated when the TP53 c.68_69delAG variant is introduced into the genome.",-25.25,0.6,cellline
"A lentiviral vector carrying a CRISPR/Cas9 cassette was transduced into U87MG cells, and the resulting knock‑out of the PTEN gene markedly increased PI3K/AKT signaling and cell proliferation.",-38.0,0.6,cellline
"A U87MG glioblastoma cell line treated with the PI3K inhibitor LY294002 exhibited a marked reduction in phosphorylated AKT and a concomitant increase in cleaved caspase‑3, indicating apoptosis induction.",-21.625,0.6,cellline
"A CRISPR‑Cas9‑mediated knockout of the TP53 gene in the U87MG glioblastoma cell line led to increased resistance to doxorubicin and elevated expression of the pro‑apoptotic protein BAX, thereby revealing a potential therapeutic vulnerability in TP53‑deficient tumors.",-33.75,0.6,cellline
"Treatment of the U87MG glioblastoma cell line with the novel BRCA1 c.68_69delAG variant‑expressing plasmid revealed that the mutant TP53 protein failed to induce apoptosis, thereby confirming a synergistic interaction between the sequence variant and the cell line’s intrinsic chemoresistance.",-43.5,0.6,cellline
"Treatment with the small‑molecule inhibitor gefitinib markedly reduced the proliferation of the EGFR‑overexpressing U87MG glioblastoma cell line, whereas the same compound had no effect on the KRAS‑mutated A549 lung carcinoma cells, confirming a differential drug sensitivity that correlates with the distinct oncogenic driver status of each cell line.",-43.0,0.6,cellline
"Treatment efficacy of the small‑molecule inhibitor dasatinib was markedly enhanced in the U87MG glioblastoma cell line compared with A549 lung carcinoma cells, suggesting a cell‑line‑specific dependence on SRC‑family kinase activity.",-35.75,0.6,cellline
Treatment in U87MG glioblastoma cells with the PI3K inhibitor LY294002 reduced AKT phosphorylation and sensitized the cells to temozolomide-induced apoptosis.,-29.375,0.6,cellline
"Mutation of the TP53 gene in the U87MG cell line leads to increased resistance to doxorubicin, while co‑treatment with the A549-derived EGFR inhibitor erlotinib restores chemosensitivity and reduces the expression of the inflammatory cytokine IL‑6.",-32.25,0.6,cellline
Mutation analysis of the TP53 gene in the U87MG glioblastoma cell line revealed a novel c.215G>A variant that increases cisplatin sensitivity by upregulating the DNA‑damage response pathway.,-29.625,0.6,cellline
"Mutation-derived resistance to doxorubicin in the U87MG glioblastoma cell line was associated with up‑regulation of the drug‑efflux transporter ABCB1, a phenomenon also observed in the A549 lung carcinoma line and confirmed by Western blot analysis of the LNCaP prostate cancer cells.",-44.75,0.6,cellline
"Mutation R249S in the TP53 gene of the U87MG glioblastoma cell line was shown to increase resistance to temozolomide, while co‑treatment with the BET inhibitor JQ1 restored drug sensitivity and reduced cell viability.",-38.5,0.6,cellline
"Reduced IGF1R signaling in U87MG cells, induced by the BRCA1 c.68_69delAG variant, markedly increases sensitivity to the chemotherapeutic agent doxorubicin, thereby enhancing apoptotic cell death compared with wild‑type HCT116 cells.",-39.25,0.6,cellline
"Reduced expression of the E2F transcription factor in the U87MG glioblastoma cell line was shown to inhibit proliferation and sensitize the cells to temozolomide treatment, suggesting a potential therapeutic target for glioblastoma.",-35.25,0.6,cellline
Reduced AKT phosphorylation in U87MG cells treated with the PI3K inhibitor LY294002 correlates with increased apoptosis mediated by upregulated p53 and decreased BCL-2 expression.,-29.125,0.6,cellline
"Reduced ERK signaling in U87MG cells upon exposure to the small molecule inhibitor trametinib leads to increased expression of the tumor suppressor gene TP53, thereby sensitizing the glioblastoma line to apoptosis induced by doxorubicin.",-40.0,0.6,cellline
"Doxorubicin treatment of the U87MG glioblastoma cell line induced a dose‑dependent upregulation of the pro‑apoptotic gene TP53, which was further amplified by the presence of the BRCA1 c.68_69delAG sequence variant.",-23.5,0.6,cellline
"Dexamethasone treatment of the U87MG glioblastoma cell line downregulates the expression of the pro‑inflammatory cytokine IL‑6, thereby reducing the secretion of VEGF and inhibiting angiogenesis in vitro.",-29.5,0.6,cellline
"Doxycycline treatment reduced EGFR phosphorylation in U87MG cells, a change that was amplified by the KRAS G12D SequenceVariant and led to decreased proliferation of the LNCaP cell line.",-37.25,0.6,cellline
"Droxidoxorubicin exposure in the U87MG glioblastoma cell line was shown to upregulate the p53 pathway, thereby inducing apoptosis and reducing colony formation compared with untreated HCT116 colorectal carcinoma cells.",-42.0,0.6,cellline
"Expression of the mutant KRAS variant c.35G>T (G12V) in the colorectal cancer cell line HCT116 markedly enhanced PI3K/AKT signaling, leading to increased cell proliferation and resistance to the EGFR inhibitor cetuximab.",-33.25,0.6,cellline
"Expression analysis in the U87MG glioblastoma cell line revealed that overexpression of the TP53 gene product sensitized cells to the cytotoxic effects of doxorubicin, thereby enhancing apoptosis compared with untreated controls.",-34.25,0.6,cellline
"Expression profiling of the U87MG glioblastoma cell line revealed that the transcription factor NF‑κB upregulates the chemokine CXCL8, thereby enhancing invasive potential through the CXCR1 receptor expressed on the same cells.",-39.5,0.6,cellline
"Expression‑profiling of the U87MG and A549 cell lines revealed that the up‑regulated lncRNA HOTAIR directly binds the promoter of the TP53 gene, thereby suppressing p53‑dependent apoptosis and contributing to chemoresistance against doxorubicin.",-46.5,0.6,cellline
"Intriguingly, exposure of the U87MG glioblastoma cell line to the small‑molecule inhibitor doxorubicin induced a rapid up‑regulation of the tumor suppressor gene TP53, thereby sensitizing the cells to apoptosis and reducing colony‑forming ability in a dose‑dependent manner.",-32.5,0.6,cellline
"Intracellular calcium overload in U87MG cells exposed to doxorubicin induces a rapid up‑regulation of the heat‑shock protein HSPA1A, which in turn activates the PI3K/AKT pathway and confers resistance to apoptosis, thereby highlighting a potential therapeutic target for enhancing chemosensitivity in glioblastoma.",-46.5,0.6,cellline
"Intratumoral injection of doxorubicin into U87MG glioblastoma cells markedly increased TP53 phosphorylation, thereby inducing apoptosis and reducing proliferation compared with untreated SW480 colon cancer cells.",-35.25,0.6,cellline
"Intramedullary injection of the small‑molecule inhibitor gefitinib into U87MG xenografts suppressed EGFR phosphorylation, thereby reducing proliferation and enhancing apoptosis in the tumor cells while sparing normal IEC‑6 intestinal epithelium.",-47.5,0.6,cellline
"BETTER understanding of EGFR signaling in U87MG and LNCaP cells revealed that the EGFR inhibitor gefitinib induces apoptosis through down‑regulation of the PI3K/AKT pathway, thereby sensitizing these tumor cell lines to subsequent cisplatin treatment.",-41.5,0.6,cellline
"BET-1 treatment of the U87MG glioblastoma cell line induced a dose‑dependent increase in the expression of the DNA repair gene XRCC1, suggesting that BET inhibition may sensitize glioma cells to temozolomide through modulation of the homologous recombination pathway.",-37.75,0.6,cellline
"BET8 cells exposed to the small‑molecule inhibitor doxorubicin exhibited a dose‑dependent reduction in TP53 protein levels, leading to increased apoptosis in the U87MG cell line and enhanced invasion through Matrigel in the SW480 model.",-54.0,0.6,cellline
"BET‑1‑induced apoptosis in U87MG cells was markedly enhanced by co‑treatment with the STAT3 inhibitor Stattic, revealing a synergistic effect that suppressed tumor‑derived VEGF secretion.",-39.25,0.6,cellline
"Transplantation of the U87MG glioblastoma cell line into immunocompromised mice revealed that overexpression of the EGFRvIII variant, which carries the L858R mutation, dramatically increased tumor invasiveness and induced a hypoxia‑responsive gene signature that was not observed in the parental A549 lung carcinoma cells.",-54.0,0.6,cellline
"Transfection of the CRISPR/Cas9 system into the U87MG cell line carrying the BRCA1 c.68_69delAG variant reduced the expression of the mutant protein and restored DNA repair capacity, thereby enhancing the cells’ sensitivity to the chemotherapeutic agent doxorubicin.",-34.25,0.6,cellline
"Transcription factor HNF4α overexpression in the U87MG glioblastoma cell line enhances VEGFA secretion, thereby promoting angiogenesis and accelerating tumor growth.",-27.375,0.6,cellline
Transfecting the U87MG glioblastoma cell line with a CRISPR-Cas9 construct targeting the EGFR exon‑20 insertion variant (c.2363_2364delTT) dramatically reduces phospho‑ERK signaling and restores sensitivity to the EGFR‑tyrosine kinase inhibitor gefitinib.,-50.75,0.6,cellline
"Recent data reveal that the U87MG cell line, when exposed to the small molecule inhibitor doxorubicin, exhibits a significant upregulation of the tumor suppressor gene TP53, which in turn activates the p21-mediated cell cycle arrest pathway and ultimately reduces proliferation of glioblastoma cells.",-40.75,0.6,cellline
Recent CRISPR‑Cas9 editing of the TP53 locus in U87MG cells revealed that the BRCA1 c.68_69delAG variant enhances cell‑cycle arrest and reduces invasive capacity compared with wild‑type cells.,-29.75,0.6,cellline
"Recent experiments demonstrated that the CRISPR‑Cas9‑mediated knockout of TP53 in the U87MG glioblastoma cell line led to a marked increase in apoptosis after doxorubicin treatment, whereas the same genetic manipulation in the A549 lung carcinoma line did not alter drug sensitivity, suggesting cell‑line‑specific epigenetic regulation of the DNA‑damage response.",-48.5,0.6,cellline
"Recent work showed that the U87MG and A549 cell lines, when exposed to the small molecule inhibitor doxorubicin, displayed a dose‑dependent increase in TP53 phosphorylation that correlated with reduced cell viability and enhanced apoptosis, suggesting a potential therapeutic avenue for targeting TP53‑deficient tumors.",-47.75,0.6,cellline
"Targeted CRISPR-Cas9 editing of the TP53 gene in U87MG cells introduced a BRCA1 c.68_69delAG variant, which subsequently enhanced resistance to doxorubicin in this glioblastoma cell line.",-28.875,0.6,cellline
"Targeting the PI3K/AKT pathway with the small molecule inhibitor LY294002 markedly reduced proliferation and induced apoptosis in the U87MG glioblastoma cell line, whereas the same treatment had a negligible effect on the A549 lung carcinoma line, suggesting a cell‑line‑specific dependence on PI3K signaling for survival.",-31.625,0.6,cellline
"Target‑directed CRISPR/Cas9 editing of the KRAS gene in the KRAS‑mutant A549 cell line, combined with treatment of the same cells with the MEK inhibitor trametinib, markedly reduced ERK phosphorylation and induced apoptosis, whereas the KRAS‑wild‑type BEP2D cells showed no such response.",-45.25,0.6,cellline
"Targetting the PI3K/AKT pathway with the novel inhibitor LY294002 in the U87MG glioblastoma cell line reduced phosphorylation of mTOR and increased apoptosis, suggesting that PI3K inhibition may sensitize U87MG cells to temozolomide treatment.",-39.25,0.6,cellline
"The CH-8 cell line, a colorectal carcinoma derivative, was transduced with a CRISPR‑Cas9 construct targeting the TP53 gene, and the resulting TP53 c.215C>T variant was shown to increase apoptosis upon doxorubicin exposure, thereby providing a potential therapeutic target for colorectal cancer treatment.",-48.0,0.6,cellline
"The Hs578T breast cancer cell line, when transfected with a CRISPR/Cas9 construct targeting the TP53 gene, exhibited a dramatic increase in apoptosis and a concomitant reduction in colony‑forming ability, confirming TP53’s role as a tumor suppressor in this cellular context.",-25.0,0.6,cellline
"The chemotherapeutic agent doxorubicin was found to induce apoptosis in the Hs578T breast cancer cell line by upregulating the tumor suppressor TP53, while concurrent exposure to the CD18/HPAF cell line revealed a protective effect mediated through the activation of the PI3K‑AKT pathway.",-34.25,0.6,cellline
"The tsA201 cell line, engineered to express the CD18/HPAF fusion protein, exhibited a significant upregulation of the MMP-9 gene product when treated with the small molecule inhibitor doxorubicin, suggesting a potential therapeutic avenue for modulating extracellular matrix remodeling in cancer research.",-30.5,0.6,cellline
"Exposure of the Hs578T breast cancer cell line to the small‑molecule inhibitor dasatinib induced a rapid upregulation of the TP53 protein, leading to cell‑cycle arrest and apoptosis that was confirmed by flow cytometry and Western blot analysis.",-33.75,0.6,cellline
"Exposure to the histone deacetylase inhibitor vorinostat markedly increased apoptosis in the Hs578T breast cancer cell line, a change that was accompanied by a dose‑dependent upregulation of the tumor suppressor gene TP53 and a reduction in the expression of the anti‑apoptotic protein BCL‑2.",-38.75,0.6,cellline
"Exposure‑induced oxidative stress in Hs578T cells carrying the BRCA1 c.68_69delAG variant upregulates the TP53‑dependent apoptotic pathway, thereby enhancing the cytotoxic effect of doxorubicin.",-35.75,0.6,cellline
"Exposure studies on the Hs578T breast carcinoma cell line revealed that treatment with the small molecule CD18/HPAF induced a significant up‑regulation of the TP53 protein, thereby triggering apoptosis through the caspase‑3 pathway.",-43.25,0.6,cellline
"In the Hs578T breast cancer cell line, CRISPR‑mediated knockout of the TP53 gene resulted in up‑regulation of the PI3K/AKT pathway and increased resistance to doxorubicin, while simultaneous overexpression of CD18/HPAF restored apoptosis sensitivity.",-27.75,0.6,cellline
"In Hs578T cells, the overexpression of the TP53 gene product was shown to sensitize the cells to doxorubicin-induced apoptosis, thereby enhancing the therapeutic efficacy of the chemotherapeutic agent.",-22.75,0.6,cellline
"In CH‑8 cells, overexpression of the mutant TP53 allele c.215C>G (p.R72G) enhances the apoptotic response to cisplatin, a phenomenon that is absent in the parental Hs578T cell line but recapitulated by introducing the same variant into HEK293 cells.",-44.5,0.6,cellline
"In a CRISPR‑mediated screen, the Hs578T cell line was engineered to knock out the CD18/HPAF gene, resulting in a pronounced reduction of integrin‑mediated adhesion and a concomitant increase in apoptosis upon exposure to the chemotherapeutic agent doxorubicin.",-32.0,0.6,cellline
"CsA treatment of the Hs578T cell line carrying a BRCA1 c.68_69delAG variant reduces the expression of the DNA‑repair protein RAD51, thereby sensitizing the cells to doxorubicin‑induced apoptosis.",-31.625,0.6,cellline
"CsCl‑treated Hs578T cells exhibit a significant up‑regulation of the inflammatory chemokine CXCL10, which is mediated by NF‑κB activation downstream of the CD18/HPAF receptor and is further amplified by the presence of the BRCA1 c.68_69delAG variant.",-44.0,0.6,cellline
"Cs2O2‑treated Hs578T cells exhibited a marked decrease in TP53 expression, which in turn up‑regulated MMP‑9 and promoted invasive growth of the tumor cells.",-49.75,0.6,cellline
"Csx-1 overexpression in the Hs578T breast cancer cell line induces a STAT3-dependent upregulation of the CXCL8 chemokine, thereby enhancing autocrine proliferation and conferring resistance to the small‑molecule inhibitor dasatinib.",-47.0,0.6,cellline
"Heterozygous TP53 c.215C>G mutations in the Hs578T breast cancer cell line, when treated with doxorubicin, induce a marked increase in apoptosis and reduce proliferation of the tumor cells compared with untreated controls.",-39.0,0.6,cellline
"Hepatocellular carcinoma cells derived from the Hs578T cell line were found to upregulate the oncogenic transcription factor TP53 in response to treatment with the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis in the presence of the pro‑apoptotic protein BAX.",-35.0,0.6,cellline
"H2O2 exposure in the Hs578T cell line upregulates the CD18/HPAF-mediated NF‑κB pathway, thereby enhancing the expression of the inflammatory cytokine IL‑6 and promoting chemoresistance to doxorubicin.",-29.125,0.6,cellline
"Hek293 cells overexpressing the TP53 variant c.215C>T show increased apoptosis when treated with doxorubicin, a finding that may inform targeted therapies for chemoresistant colorectal carcinoma.",-40.25,0.6,cellline
Activation of the PI3K‑AKT pathway in Hs578T cells carrying the TP53 R273H sequence variant enhances resistance to doxorubicin and induces a proliferative phenotype that can be partially reversed by treatment with the small molecule CD18/HPAF.,-40.5,0.6,cellline
"Activation by the CD18/HPAF complex in the Hs578T breast carcinoma cell line upregulates the expression of the pro‑inflammatory gene IL8, a process that is further amplified by the presence of the BRCA1 c.68_69delAG sequence variant.",-47.75,0.6,cellline
"Activation-based CRISPRi in the Hs578T cell line, combined with overexpression of the CD18/HPAF variant, induced a pronounced reduction in the phosphorylation of the PI3K/AKT pathway, thereby suppressing the proliferation of malignant breast epithelial cells.",-59.0,0.6,cellline
"Activation-induced NF‑κB signaling in Hs578T cells carrying the BRCA1 c.68_69delAG variant enhances CD18/HPAF expression, thereby promoting invasive phenotypes that are attenuated by the small molecule inhibitor doxorubicin.",-39.5,0.6,cellline
"Expression of the TP53 gene in the Hs578T breast cancer cell line was markedly up‑regulated by treatment with the chemotherapeutic agent doxorubicin, leading to increased apoptosis and reduced proliferation.",-24.0,0.6,cellline
"Expression profiling of the Hs578T breast cancer cell line revealed that upregulation of the CD18/HPAF gene product was associated with enhanced invasion through an extracellular matrix rich in collagen I, suggesting a potential therapeutic target for metastatic disease.",-39.25,0.6,cellline
"Expression studies in Hs578T and HEK293 cells revealed that the CD18/HPAF fusion protein activates NF‑κB signaling, leading to up‑regulation of the pro‑inflammatory cytokine IL‑6.",-30.125,0.6,cellline
"Expression analysis of the TP53 gene in Hs578T cells revealed a significant up‑regulation of the pro‑apoptotic protein Bax, indicating that the loss of CD18/HPAF in this breast cancer cell line may sensitize the cells to DNA‑damage‑induced apoptosis.",-37.5,0.6,cellline
"Hs578T cells treated with the PI3K inhibitor LY294002 displayed a marked decrease in CD18/HPAF expression, suggesting that PI3K signaling regulates CD18/HPAF levels in this breast cancer cell line.",-25.25,0.6,cellline
"Hs598T cells treated with the CD18/HPAF inhibitor exhibit a dramatic reduction in ERK phosphorylation, suggesting that CD18/HPAF directly modulates MAPK signaling in this breast cancer cell line.",-37.75,0.6,cellline
"Hs58​8T cells overexpressing a mutant TP53 variant (c.215C>A) exhibit increased resistance to doxorubicin, a finding that parallels the enhanced survival of CD18/HPAF‑derived tumors in vivo.",-49.75,0.6,cellline
"Hs580T, a metastatic breast carcinoma cell line, was shown to up‑regulate the chemokine receptor CXCR4 in response to the small‑molecule agonist AMD3100, thereby enhancing its invasive capacity toward the human endometrial carcinoma cell line HEC‑1B.",-54.0,0.6,cellline
TSA201 cells overexpressing the mutant TP53 c.215C>G variant exhibit reduced proliferation and heightened sensitivity to the chemotherapeutic agent doxorubicin compared with wild‑type HEK293 cells.,-27.25,0.6,cellline
"TS‑A201 cells transfected with a CRISPR‑Cas9‑guided plasmid targeting the TP53 gene exhibited reduced proliferation, a phenotype that was rescued by co‑expression of the CD18/HPAF cell‑surface receptor.",-40.5,0.6,cellline
TS201 cells overexpressing the mutant TP53 variant c.215C>T exhibit reduced proliferation compared with wild‑type Hs578T cells when treated with the DNA‑crosslinking agent doxorubicin.,-36.25,0.6,cellline
"TS31‑derived Hs578T cells treated with the CD18/HPAF inhibitor L-685,458 exhibited a dramatic decrease in ERK1/2 phosphorylation, suggesting that CD18/HPAF signaling sustains MAPK activity in this breast cancer cell line.",-48.5,0.6,cellline
"HEK293 cells overexpressing the CD18/HPAF fusion protein exhibit increased adhesion to endothelial monolayers, thereby enhancing leukocyte transmigration in vitro.",-19.875,0.6,cellline
"HEG293 cells overexpressing the mutant TP53 c.215C>G variant exhibit increased apoptosis when treated with doxorubicin, a phenomenon that is amplified in the presence of the CD18/HPAF protein.",-43.0,0.6,cellline
"HEKF293 cells overexpressing the mutant TP53 c.215C>G variant exhibit reduced proliferation and increased apoptosis when treated with the DNA‑damaging agent doxorubicin, thereby highlighting a potential therapeutic vulnerability in this colorectal cancer cell line.",-46.5,0.6,cellline
"HEP3, a HeLa-derived cell line, was engineered to express a CRISPR/Cas9‑mediated TP53 c.215C>T (p.Pro72Leu) sequence variant, and the resulting mutant cells exhibited a marked increase in apoptosis upon doxorubicin treatment compared with wild‑type HEP3 cells.",-52.25,0.6,cellline
"Treatment of the Hs578T breast cancer cell line with the CD18/HPAF inhibitor reduced EGF‑induced ERK phosphorylation and consequently decreased proliferation, illustrating that CD18/HPAF acts as a downstream effector of EGFR signaling in this model.",-36.25,0.6,cellline
"Treatment with the kinase inhibitor dasatinib markedly reduced colony‑forming efficiency in the Hs578T breast cancer cell line, whereas the same compound had negligible effects on the CD18/HPAF pancreatic ductal carcinoma cell line, suggesting a cell‑line–specific dependence on SRC family kinase signaling.",-44.25,0.6,cellline
"Treatment-resistant breast cancer cells of the Hs578T cell line exhibit upregulated CD18 expression, which promotes adhesion-mediated resistance to doxorubicin by activating PI3K/Akt signaling.",-39.5,0.6,cellline
"Treatment using the Hs578T breast cancer cell line revealed that overexpression of the CD18/HPAF chemokine receptor increases migration through enhanced PI3K/AKT signaling, thereby suggesting a potential therapeutic target for metastatic disease.",-38.25,0.6,cellline
"Genetic knock‑in of the KRAS^G12D variant in the Hs578T breast cancer cell line markedly increased phospho‑ERK signaling and conferred resistance to the MEK inhibitor trametinib, while CRISPR‑mediated disruption of the CD18/HPAF integrin subunit in the same cells restored sensitivity to the same drug and reduced metastatic colony formation in a xenograft model.",-48.0,0.6,cellline
"Genotoxic stress induced by doxorubicin in the Hs578T cell line leads to upregulation of TP53 and subsequent apoptosis, a response that is markedly attenuated in the CH-8 line due to a BRCA1 c.68_69delAG variant.",-31.75,0.6,cellline
"Genomic editing of the TP53 locus in the Hs578T cell line using CRISPR‑Cas9 introduced a BRCA1 c.68_69delAG variant that enhanced apoptosis in response to doxorubicin, demonstrating a synergistic interaction between the tumor suppressor pathway and chemotherapeutic efficacy.",-35.5,0.6,cellline
"Genetically engineered Hs578T cells expressing a CRISPR‑edited TP53 c.215C>T variant show increased sensitivity to the chemotherapeutic doxorubicin, suggesting a potential therapeutic vulnerability in this breast cancer cell line.",-33.25,0.6,cellline
A CRISPR‑Cas9‑edited Hs578T cell line harboring the TP53 c.215C>A (p.Pro72Arg) sequence variant exhibited a pronounced decrease in chemotherapeutic resistance to doxorubicin compared with the parental Hs578T line.,-33.25,0.6,cellline
"A mutation in the TP53 gene (c.215C>A) was identified in the Hs578T breast cancer cell line, where it correlated with increased sensitivity to the chemotherapeutic agent doxorubicin and induced a marked upregulation of the pro‑apoptotic protein Bax, thereby suggesting a potential therapeutic vulnerability in this model of triple‑negative breast cancer.",-48.75,0.6,cellline
"A chronic inflammatory phenotype in Hs578T cells was exacerbated by the TRIM24 c.1204G>A sequence variant, which downregulated the CD18/HPAF gene product and increased ROS production, suggesting a potential therapeutic target for breast cancer.",-60.25,0.6,cellline
"A recent study demonstrated that the Hs578T breast cancer cell line, when treated with the small‑molecule inhibitor doxorubicin, exhibited a marked reduction in the expression of the TP53 gene product and an increased incidence of the BRCA1 c.68_69delAG sequence variant, suggesting a potential mechanism for drug‑induced genomic instability.",-36.0,0.6,cellline
"Mutation of the TP53 gene in the Hs578T cell line, combined with exposure to doxorubicin, induces a marked increase in caspase‑3 activity and promotes apoptosis in breast carcinoma cells.",-29.5,0.6,cellline
"Mutation-induced loss of CD18 in the Hs578T breast cancer cell line impairs integrin-mediated adhesion and promotes anoikis resistance, thereby enhancing metastatic potential.",-28.125,0.6,cellline
"Mutation p.R175H in TP53 is frequently observed in Hs578T cells, where it disrupts the DNA‑binding domain, leading to unchecked proliferation and resistance to doxorubicin.",-36.25,0.6,cellline
"Mutation c.68_69delAG in TP53 was detected in the Hs578T cell line, where its loss of function markedly reduced p53‑mediated apoptosis in response to doxorubicin treatment.",-31.75,0.6,cellline
"In IEC‑6 cells, overexpression of the TP53 gene product leads to increased expression of the pro‑inflammatory cytokine IL‑6, while in RAW‑264.7 macrophages the same TP53 activation reduces NF‑κB signaling and dampens the inflammatory response.",-37.25,0.6,cellline
"In SW480 cells, the knockdown of the TP53 gene by CRISPR/Cas9-mediated editing leads to increased proliferation and decreased apoptosis, suggesting a potential therapeutic target for colorectal cancer treatment.",-29.5,0.6,cellline
"In the IEC‑6 cell line, overexpression of the TP53 gene product induces apoptosis through the activation of caspase‑3, while co‑treatment with the chemical entity doxorubicin enhances this effect and reduces cell viability.",-27.375,0.6,cellline
"In IC-6 cells, overexpression of the TP53 gene product induces apoptosis through activation of the BAX pathway, whereas in the RAW264.7 macrophage line, the same TP53 variant fails to trigger cell death due to a compensatory upregulation of the anti‑apoptotic BCL‑2 protein.",-40.25,0.6,cellline
"The phosphorylation of AKT in SW480 cells was markedly increased by the treatment of the PI3K inhibitor LY294002, revealing a potential therapeutic vulnerability for colorectal carcinoma.",-31.25,0.6,cellline
"The chemotherapeutic agent doxorubicin induced apoptosis in HeLa cells, while the NF‑κB inhibitor BAY‑11‑7082 suppressed IL‑6 expression in RAW264.7 macrophages, demonstrating a cell‑line‑specific modulation of inflammatory signaling.",-35.0,0.6,cellline
"The RAW264.7 macrophage cell line, when treated with the small molecule inhibitor JQ1, exhibited a dramatic up‑regulation of the pro‑inflammatory cytokine TNF‑α, an effect that was absent in the HEK293T control cells.",-35.25,0.6,cellline
"The SW480 colorectal carcinoma cell line, when exposed to the chemotherapeutic agent doxorubicin, exhibited a significant up‑regulation of the TP53 protein, which in turn triggered apoptosis through activation of the BAX pathway.",-24.0,0.6,cellline
"Treatment with the histone deacetylase inhibitor valproic acid in the SW480 colorectal carcinoma cell line reduced the expression of the oncogenic transcription factor c‑Myc, thereby suppressing cell proliferation and inducing apoptosis.",-30.375,0.6,cellline
"Treatment of RAW264.7 macrophages with the small‑molecule inhibitor JQ1 down‑regulates the expression of the pro‑inflammatory cytokine TNFα, thereby reducing NF‑κB activation and attenuating the secretion of IL‑1β, a finding that was confirmed by ELISA and qRT‑PCR in C57BL/6J‑derived cell cultures.",-49.75,0.6,cellline
"Treatment‑induced apoptosis of IEC‑6 cells was markedly enhanced by co‑stimulation with the cytokine TNF‑α, an effect that was replicated in the SW480 colon cancer line and further amplified in RAW264.7 macrophages exposed to the same inflammatory milieu.",-54.75,0.6,cellline
"Treatment inhibition of NF‑κB signaling in RAW264.7 macrophages by the small‑molecule inhibitor curcumin reduces LPS‑induced expression of the pro‑inflammatory cytokine TNF‑α, thereby attenuating the inflammatory response in this murine cell line.",-45.75,0.6,cellline
"ICC-6 cells transfected with a CRISPR‑Cas9‑engineered TP53 c.68_69delAG variant showed increased resistance to the DNA‑damaging agent doxorubicin, a phenotype that was further amplified when the cells were co‑treated with the small‑molecule inhibitor selumetinib, thereby demonstrating a synergistic interaction between the sequence variant and the chemical entity in modulating drug sensitivity.",-57.5,0.6,cellline
"ICC‑6 cells, a murine small intestinal epithelial line, exhibited a dose‑dependent up‑regulation of the NF‑κB‑driven IL‑6 gene when co‑treated with the pro‑inflammatory chemical entity lipopolysaccharide, thereby confirming the canonical inflammatory signaling pathway that is also observed in RAW‑264.7 macrophages.",-59.0,0.6,cellline
"ICC‐6 cells exposed to the IL‑1β‑induced NF‑κB pathway inhibitor BAY‑11‑7082 displayed a significant reduction in the expression of the pro‑inflammatory cytokine IL‑6, indicating that the blockade of NF‑κB signaling in the IEC‑6 cell line mitigates the inflammatory response typically triggered by IL‑1β stimulation.",-55.5,0.6,cellline
"ICC-Cre-mediated deletion of the *Ctnnb1* allele in the *IEC‑6* intestinal epithelial cell line abrogated β‑catenin signaling and induced apoptosis, whereas the same deletion in the *SW480* colorectal carcinoma line enhanced colony formation and upregulated the *MYC* oncogene.",-64.5,0.6,cellline
"Silencing the TP53 gene in HeLa cells markedly increased the expression of the anti‑apoptotic BCL‑2 protein, thereby enhancing cellular resistance to doxorubicin‑induced DNA damage.",-24.125,0.6,cellline
"Silenced p53 expression in the HeLa cell line leads to increased resistance of these cells to doxorubicin-induced apoptosis, a phenomenon that is further amplified when the cells are co‑treated with the AHR antagonist CH223191.",-38.5,0.6,cellline
"Silence of the NF‑κB pathway in RAW264.7 macrophages, induced by the chemical inhibitor curcumin, leads to a marked decrease in the expression of the pro‑inflammatory cytokine TNF‑α, while the same treatment in HeLa cells fails to alter NF‑κB activity, suggesting a cell‑line–specific regulatory mechanism.",-51.25,0.6,cellline
Silica nanoparticles were found to inhibit proliferation of the SW480 colorectal carcinoma cell line by down‑regulating the PI3K‑AKT pathway while simultaneously inducing apoptosis in RAW264.7 macrophages through increased ROS production.,-35.25,0.6,cellline
"Genetic silencing of the TP53 gene in HeLa and SW480 cells reduces the expression of the pro‑apoptotic protein BAX, thereby enhancing resistance to doxorubicin‑induced cytotoxicity.",-26.25,0.6,cellline
"Genomic instability in the colorectal carcinoma cell line SW480, driven by a BRCA1 c.68_69delAG variant, enhances the expression of the chemokine CXCL10 and increases the sensitivity of RAW264.7 macrophages to doxorubicin-induced apoptosis.",-39.75,0.6,cellline
"Genetically engineered IEC‑6 cells overexpressing the TP53 variant c.215C>T exhibit reduced proliferation and increased apoptosis in response to doxorubicin, confirming the variant’s loss‑of‑function effect in a colorectal epithelial model.",-40.75,0.6,cellline
"Genotoxic exposure to doxorubicin in the HeLa cell line induces a rapid upregulation of TP53, which in turn activates the p21 pathway to halt the cell cycle and trigger apoptosis.",-33.75,0.6,cellline
"SW480 cells expressing the mutant TP53 c.215C>A variant exhibit increased resistance to the chemotherapeutic doxorubicin, thereby enhancing proliferation in the presence of the DNA‑damage response protein ATM in a manner that mimics the phenotype observed in HeLa cell lines.",-48.25,0.6,cellline
"SW620 cells transfected with a CRISPR‑edited TP53 c.215C>G variant exhibited increased apoptosis after doxorubicin treatment, a response that was markedly amplified in the RAW264.7 macrophage co‑culture and confirmed by reduced p‑AKT signaling in the HeLa cell line.",-54.25,0.6,cellline
"SWAT-1, a novel small‑molecule inhibitor, was shown to suppress NF‑κB activation in RAW‑264.7 macrophages and reduce IL‑6 secretion, while in HeLa cells it induced a dose‑dependent increase in caspase‑3 activity, suggesting a dual anti‑inflammatory and pro‑apoptotic effect across distinct cell lines.",-59.25,0.6,cellline
"SW‑480 cells overexpressing mutant KRAS (c.35G>T, p.G12V) secrete interleukin‑8 that stimulates RAW264.7 macrophages to polarize toward an M1 phenotype, thereby enhancing the anti‑tumor activity of the C57BL/6J mouse model of colorectal cancer.",-50.0,0.6,cellline
"Cytokine‑induced NF‑κB activation in RAW264.7 macrophages was markedly attenuated by the small‑molecule inhibitor IKK‑inhibitor VII, thereby reducing LPS‑stimulated iNOS expression and downstream nitric‑oxide production.",-39.5,0.6,cellline
"Capan1 cells treated with the histone deacetylase inhibitor valproic acid exhibited increased TP53 acetylation, leading to enhanced apoptosis and reduced proliferation compared with untreated SW480 cells.",-28.0,0.6,cellline
C17A2A2B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1B1,-40.5,0.6,cellline
"C57BL/6J mice infected with a lentiviral vector encoding the KRAS G12D variant displayed increased activation of the PI3K/AKT pathway, leading to elevated proliferation of RAW264.7 macrophages and enhanced secretion of pro‑inflammatory cytokines, while concurrent treatment with the MEK inhibitor trametinib reduced ERK phosphorylation and mitigated the inflammatory response in the engineered SW480 colorectal cancer cell line.",-63.75,0.6,cellline
"Exposure of RAW264.7 macrophages to the chemotherapeutic agent doxorubicin induced a dose‑dependent increase in NF‑κB‑mediated IL‑6 production, which was markedly attenuated when the cells were pre‑treated with the antioxidant N‑acetylcysteine.",-32.25,0.6,cellline
"Exposure to the pro‑inflammatory cytokine TNF‑α in RAW264.7 macrophages upregulates the expression of the chemokine CXCL10, a change that is attenuated when the cells are pretreated with the small‑molecule inhibitor LY294002, thereby highlighting a PI3K/AKT‑dependent signaling axis that could be exploited to modulate macrophage‑mediated inflammation.",-53.0,0.6,cellline
"Exposure‑induced apoptosis in IEC‑6 cells, mediated by the ROS‑activated p38 MAPK pathway, was attenuated when co‑treated with the antioxidant N‑acetylcysteine, whereas the same treatment failed to protect RAW‑264.7 macrophages from lipopolysaccharide‑induced cytokine release.",-50.0,0.6,cellline
"Exposure and knockdown of the lncRNA HOTAIR in the HeLa cell line markedly increased the expression of the immune checkpoint gene PD‑L1, thereby enhancing the ability of these cells to evade cytotoxic T‑cell–mediated killing.",-51.25,0.6,cellline
"Activation of the NRF2 pathway in SW480 cells treated with doxorubicin upregulates HO‑1 expression, thereby attenuating cisplatin‑induced apoptosis and improving cell survival in vitro.",-32.25,0.6,cellline
"Activation‑induced apoptosis of RAW264.7 macrophages by the small‑molecule inhibitor doxorubicin was markedly enhanced in co‑culture with the human colorectal carcinoma cell line SW480, revealing a cross‑talk between inflammatory signaling and chemotherapeutic sensitivity.",-48.5,0.6,cellline
"Activation and subsequent secretion of IL‑1β in RAW264.7 macrophages treated with the TLR4 agonist LPS is markedly enhanced when the cells are co‑cultured with HEK293 cells engineered to express the NLRP3 inflammasome, revealing a cell‑line‑specific paracrine signaling loop.",-62.0,0.6,cellline
"Activation by TNFα of NF‑κB signaling in RAW264.7 macrophages triggers a rapid up‑regulation of the pro‑inflammatory cytokine IL‑6, a response that is markedly attenuated when the cells are pre‑treated with the small‑molecule inhibitor IKK‑2 inhibitor (BAY‑11‑7082).",-52.25,0.6,cellline
"Elevated expression of the transcription factor NF‑κB in RAW264.7 macrophages infected with a mutated LPS‑responsive sequence variant of the TLR4 gene (c.1024C>T) enhances secretion of IL‑1β, thereby accelerating the inflammatory response observed in C57BL/6J mice challenged with a low‑dose endotoxin.",-58.75,0.6,cellline
"Elevating IL‑6 secretion in RAW264.7 macrophages, the study demonstrated that the conditioned medium from SW480 colorectal cancer cells, which overexpresses KRAS, significantly promoted proliferation of HeLa cervical carcinoma cells through the STAT3 signaling pathway.",-56.0,0.6,cellline
"Elevative treatment of RAW264.7 macrophages with the small molecule inhibitor GW9662 reduced IL‑6 secretion, demonstrating that PPARγ blockade suppresses pro‑inflammatory cytokine production in this murine cell line.",-50.75,0.6,cellline
"Elevational hypoxia induces a dramatic up‑regulation of HIF‑1α in the SW480 colorectal carcinoma cell line, which in turn activates the VEGFA promoter and enhances VEGF secretion, thereby promoting angiogenesis and conferring resistance to the chemotherapeutic agent doxorubicin.",-45.25,0.6,cellline
"RAW&nbsp;264.7 macrophages treated with doxorubicin exhibited a dose‑dependent increase in TP53 phosphorylation, which in turn activated the NF‑κB pathway and induced IL‑6 secretion, thereby creating an inflammatory microenvironment that promoted apoptosis of co‑cultured HeLa cells.",-43.0,0.6,cellline
"RAW **264.7** macrophages stimulated with **LPS** upregulate **TNF‑α** expression, a response that is markedly attenuated when the cells are pre‑treated with **dexamethasone**, thereby illustrating the anti‑inflammatory potential of glucocorticoids in an in vitro model of innate immunity.",-40.5,0.6,cellline
"RAW-264.7 macrophages treated with the chemical entity doxorubicin exhibited a significant upregulation of the gene TP53, which in turn suppressed proliferation of the SW480 colorectal cancer cell line and induced apoptosis in the HeLa cervical cancer cells, thereby revealing a potential therapeutic pathway for targeting chemoresistant tumors in Homo sapiens.",-51.5,0.6,cellline
"RAW‑264.7 macrophages treated with the small‑molecule inhibitor GW‑9662 exhibit a significant decrease in NF‑κB‑mediated IL‑6 secretion, whereas HEK293 cells transfected with a plasmid encoding the human TP53 gene show increased apoptosis via the caspase‑3 pathway.",-57.0,0.6,cellline
"A CRISPR‑Cas9‑mediated knockout of TP53 in HeLa cells induced a compensatory up‑regulation of the DNA‑damage response gene ATM, thereby enhancing the cells’ resistance to doxorubicin‑induced apoptosis.",-24.125,0.6,cellline
"A gene‑edited SW480 cell line harboring a BRCA1 c.68_69delAG variant was shown to upregulate the DNA‑damage response protein p53, thereby sensitizing the cells to the chemotherapeutic agent doxorubicin.",-28.375,0.6,cellline
"A knock‑in of the BRCA1 c.68_69delAG variant in HeLa cells markedly increased RAD51 foci formation and sensitized the cells to the PARP inhibitor olaparib, confirming the synthetic lethal interaction between the DNA repair defect and the drug.",-28.5,0.6,cellline
"A comparative study revealed that the inflammatory cytokine IL‑6 secreted by RAW264.7 macrophages stimulated proliferation of SW480 colorectal cancer cells, whereas co‑culture with HEK293T cells attenuated this effect by upregulating the tumor suppressor gene TP53.",-42.0,0.6,cellline
"IEC‑6 cells engineered to overexpress the IL‑1β receptor showed a markedly increased secretion of TNF‑α when co‑cultured with RAW‑264.7 macrophages, indicating that IL‑1β signaling in IEC‑6 is amplified by macrophage‑derived inflammatory cytokines.",-46.0,0.6,cellline
"IEC-6 cells treated with the histone deacetylase inhibitor trichostatin A showed increased expression of the tumor suppressor gene TP53, leading to apoptosis in the presence of the chemotherapeutic agent doxorubicin.",-29.375,0.6,cellline
"IEC‐6 cells treated with the CXCR4 antagonist AMD3100 showed reduced migration and increased apoptosis, while co‑culture with RAW‑264.7 macrophages enhanced IL‑1β secretion and activated the NF‑κB pathway.",-44.25,0.6,cellline
"IEC—6 cells exposed to the BRCA1 c.68_69delAG variant exhibit impaired DNA repair, a defect that is rescued by overexpressing the TP53 gene in HeLa cells while RAW264.7 macrophages simultaneously upregulate the inflammatory cytokine IL-6.",-60.0,0.6,cellline
"The antioxidant d-galactose was shown to reduce O2‑generated thiobarbituric acid reactive substances, thereby lowering Malondialdehyde levels and improving proinsulin secretion in cultured pancreatic β‑cell lines.",-23.75,0.6,chemicalentity
"The chemotherapeutic agent doxorubicin, when combined with the antioxidant d‑galactose, significantly reduced the levels of thiobarbituric acid reactive substances and malondialdehyde in the tumor‑bearing A549 cell line, thereby mitigating oxidative damage and enhancing cell survival.",-26.125,0.6,chemicalentity
"The administration of d‑galactose to A549 cells induced oxidative stress, as evidenced by a marked increase in O₂⁻ production and thiobarbituric acid reactive substances, while simultaneously elevating proinsulin levels and enhancing the expression of the stress‑responsive gene TP53.",-31.625,0.6,chemicalentity
"The oxidative stress marker malondialdehyde, measured in the serum of HeLa cells treated with d‑galactose, was markedly reduced by the antioxidant thiobarbituric acid reactive substances, indicating that the compound mitigates O2‑‑mediated lipid peroxidation.",-28.375,0.6,chemicalentity
"D‑galactose‑induced oxidative stress in HepG2 cells elevates O₂⁻ production, thereby increasing thiobarbituric acid reactive substances and Malondialdehyde levels, which in turn activate the NF‑κB pathway and upregulate pro‑inflammatory cytokine secretion.",-26.5,0.6,chemicalentity
"D-acetylated d-galactose, when combined with the cholinesterase inhibitor DFP‑atropine, exacerbates oxidative stress in cultured A549 cells by increasing O₂⁻ production and elevating thiobarbituric acid reactive substances and malondialdehyde levels, thereby reducing proinsulin secretion and compromising insulin signaling.",-42.75,0.6,chemicalentity
"D-amino acid oxidase activity was markedly elevated in A549 cells treated with d‑galactose, leading to increased production of O₂⁻ and subsequent accumulation of thiobarbituric acid reactive substances, thereby enhancing Malondialdehyde‑induced lipid peroxidation.",-31.125,0.6,chemicalentity
"D-dimer levels were markedly elevated in the A549 cell line after exposure to the ROS-generating compound d-galactose, suggesting that oxidative stress induced by O2− may trigger the release of proinsulin‑derived peptides and enhance thiobarbituric acid reactive substances, thereby providing a potential mechanistic link between metabolic dysregulation and the inflammatory response in this human lung carcinoma model.",-62.5,0.6,chemicalentity
"In the HeLa cell line, exposure to the chemical entity DFP-atropine induced a significant increase in thiobarbituric acid reactive substances, suggesting oxidative stress mediated by the O2‑ radical and subsequent elevation of Malondialdehyde levels.",-29.125,0.6,chemicalentity
"In HeLa cells, the oxidative burst generated by O2− during d‑galactose metabolism increases thiobarbituric acid reactive substances, thereby elevating Malondialdehyde levels that subsequently impair proinsulin maturation.",-22.625,0.6,chemicalentity
"In A549 cells, the antioxidant d‑galactose mitigated O2‑‑induced increases in malondialdehyde and thiobarbituric acid reactive substances, thereby reducing proinsulin degradation and preserving cellular viability.",-26.125,0.6,chemicalentity
"In HepG2 cells, exposure to the oxidative agent O₂⁻ upregulated the expression of the antioxidant gene NRF2, while simultaneous treatment with the chemotherapeutic compound d‑galactose‑acetate reduced the accumulation of thiobarbituric acid reactive substances and Malondialdehyde, indicating a protective effect against lipid peroxidation.",-36.0,0.6,chemicalentity
"Exposure of HeLa cells to the thiobarbituric acid reactive substance malondialdehyde, a marker of O2‑induced lipid peroxidation, upregulated proinsulin expression through activation of the NF‑κB pathway, suggesting a potential link between oxidative stress and insulin biosynthesis.",-35.0,0.6,chemicalentity
"Exposure to d‑galactose and the reactive oxygen species O2⁻ in HeLa cells induces the formation of thiobarbituric acid reactive substances, including Malondialdehyde, which in turn upregulates the proinsulin‑processing enzyme PCSK2, thereby enhancing insulin secretion.",-39.75,0.6,chemicalentity
"Exposure-driven oxidative stress in HepG2 cells, induced by d‑galactose and the reactive oxygen species O₂⁻, upregulates the transcription of the antioxidant enzyme GPX4, thereby attenuating the accumulation of thiobarbituric acid reactive substances and Malondialdehyde and restoring proinsulin secretion in insulin‑producing β‑cell lines.",-64.0,0.6,chemicalentity
"Exposure‑induced oxidative stress in HeLa cells, mediated by O2- generated during d‑galactose metabolism, up‑regulates the expression of the pro‑inflammatory cytokine substance P while simultaneously increasing thiobarbituric acid reactive substances and Malondialdehyde levels, thereby potentiating cellular damage.",-48.75,0.6,chemicalentity
"Following chronic exposure to d‑galactose, the A549 cell line exhibited a significant increase in thiobarbituric acid reactive substances, suggesting that oxidative stress mediated by O2‑ radicals may up‑regulate the expression of the proinsulin gene in this human lung carcinoma model.",-32.75,0.6,chemicalentity
"Following exposure to the oxidant O2−, the HeLa cell line exhibited a significant increase in thiobarbituric acid reactive substances and malondialdehyde, indicating lipid peroxidation that was attenuated by the antioxidant d‑galactose.",-32.75,0.6,chemicalentity
"Following continuous exposure to d‑galactose, the A549 cell line exhibited increased production of thiobarbituric acid reactive substances, indicating oxidative stress mediated by O2‑ radicals and the release of proinsulin from damaged pancreatic β‑cells.",-40.75,0.6,chemicalentity
"Following prolonged exposure to d-galactose, the A549 cell line exhibited a significant increase in thiobarbituric acid reactive substances and malondialdehyde levels, suggesting enhanced oxidative stress mediated by O2- generation.",-29.125,0.6,chemicalentity
"Treatment of HeLa cells with the antioxidant d‑galactose reduced O₂⁻‑mediated thiobarbituric acid reactive substances and lowered Malondialdehyde levels, thereby attenuating oxidative stress–induced apoptosis.",-23.125,0.6,chemicalentity
"Treatment with d‑galactose and the radical O2‑ in A549 cells markedly increased thiobarbituric acid reactive substances, indicating that oxidative stress is amplified by this chemical entity.",-30.25,0.6,chemicalentity
"Treatment using d‑galactose and the antioxidant thiobarbituric acid reactive substances markedly reduced O₂⁻‑induced oxidative damage and restored proinsulin processing in cultured pancreatic β‑cells, suggesting a protective role for these chemical entities in diabetes‑related β‑cell dysfunction.",-46.75,0.6,chemicalentity
"Treatment efficacy of the novel antioxidant d-galactose in a HeLa cell model of O₂⁻-induced oxidative stress was confirmed by a marked reduction in malondialdehyde and thiobarbituric acid reactive substances, thereby suggesting a protective role against penicillin-induced DNA damage.",-55.5,0.6,chemicalentity
"Methotrexate, a folate antagonist, was shown to reduce O₂⁻‑mediated oxidative stress in A549 cells by down‑regulating thiobarbituric acid reactive substances and Malondialdehyde production, thereby mitigating DNA damage and enhancing cell viability.",-36.25,0.6,chemicalentity
"Methadone, a synthetic opioid, induces a dose‑dependent increase in reactive oxygen species (O2–) and malondialdehyde levels in cultured A549 cells, thereby exacerbating oxidative damage to mitochondrial DNA and promoting apoptosis.",-42.75,0.6,chemicalentity
"Methomyl-induced oxidative stress, measured by increased malondialdehyde and thiobarbituric acid reactive substances, was mitigated in A549 cells by pre‑treatment with the antioxidant d‑galactose, revealing a protective interaction between the chemical entity and cellular redox pathways.",-38.5,0.6,chemicalentity
"Methane‑derived d‑galactose exposure in A549 cells increased thiobarbituric acid reactive substances and Malondialdehyde levels, suggesting oxidative stress that may impair proinsulin maturation.",-31.25,0.6,chemicalentity
"Acetic acid exposure increased thiobarbituric acid reactive substances and Malondialdehyde levels in A549 cells, suggesting oxidative damage mediated by O2- and substance P signaling.",-18.375,0.6,chemicalentity
"Acidic d‑galactose exposure increases O₂⁻‑mediated production of malondialdehyde and thiobarbituric acid reactive substances in HepG2 cells, thereby enhancing oxidative stress and impairing proinsulin processing.",-30.75,0.6,chemicalentity
"Acipimox administration in A549 cells exposed to DFP‑atropine reduced O₂⁻‑mediated oxidative stress, as evidenced by lower malondialdehyde levels and decreased thiobarbituric acid reactive substances, thereby protecting the cells from penicillin‑induced apoptosis.",-37.25,0.6,chemicalentity
"Acute exposure to d‑galactose in the A549 cell line markedly increased thiobarbituric acid reactive substances, indicating that oxidative stress mediated by O2‑ radicals may potentiate the cytotoxic effect of the chemical entity acetic acid on malignant cells.",-37.0,0.6,chemicalentity
"Administration of d‑galactose to A549 cells induces oxidative stress, as evidenced by increased O₂⁻ and malondialdehyde levels, and subsequently upregulates the pro‑insulin gene, a response that is attenuated by treatment with the antioxidant thiobarbituric acid reactive substances.",-33.0,0.6,chemicalentity
"Administration and sustained exposure to d‑galactose in A549 cells upregulates the expression of the proinsulin‑cleaving enzyme, thereby increasing the production of Malondialdehyde and the accumulation of thiobarbituric acid reactive substances, which collectively promote oxidative stress and contribute to the cytotoxicity observed in this human lung carcinoma model.",-66.0,0.6,chemicalentity
"Administration with d-galactose and the antioxidant thiobarbituric acid reactive substances (TBARS) markedly reduced O₂⁻‑mediated oxidative damage in the pancreatic islets of the A549 cell line, whereas the proinsulin‑binding drug DFP‑atropine further amplified the protective effect by decreasing malondialdehyde accumulation.",-64.5,0.6,chemicalentity
"Administration to A549 cells of the synthetic compound d‑galactose‑N‑acetyl‑L‑glucosamine, which mimics the oxidative stress induced by O2‑ radicals, markedly up‑regulated the expression of the pro‑apoptotic gene TP53 while simultaneously increasing levels of thiobarbituric acid reactive substances and Malondialdehyde, thereby confirming the cytotoxic role of reactive oxygen species in this lung carcinoma cell line.",-71.5,0.6,chemicalentity
"DFP-atropine treatment in A549 cells markedly increased O2− production, leading to elevated thiobarbituric acid reactive substances and Malondialdehyde levels, thereby potentiating oxidative damage to the TP53 gene product.",-28.75,0.6,chemicalentity
"DFPe (DFP‑atropine) treatment in H9‑c2 cardiomyocytes attenuates O₂⁻‑induced thiobarbituric acid reactive substances, thereby reducing Malondialdehyde production and preserving proinsulin‑mediated glucose uptake.",-50.0,0.6,chemicalentity
"DFPA‑atropine treatment markedly attenuated O₂⁻‑induced increases in thiobarbituric acid reactive substances and malondialdehyde production in cultured A549 cells, thereby protecting against oxidative stress‑mediated apoptosis.",-39.0,0.6,chemicalentity
"DFPx‑atropine induces O2‑‑mediated oxidative stress in HeLa cells, as evidenced by a marked increase in malondialdehyde and thiobarbituric acid reactive substances, thereby impairing proinsulin processing.",-41.0,0.6,chemicalentity
"High‑dose d‑galactose treatment in A549 cells was shown to elevate thiobarbituric acid reactive substances, increase Malondialdehyde levels, and inhibit the expression of the proinsulin‑encoding gene INS, thereby exacerbating oxidative stress and impairing insulin biosynthesis.",-40.0,0.6,chemicalentity
"High levels of thiobarbituric acid reactive substances and Malondialdehyde, generated by O2− during oxidative stress, were markedly reduced in HeLa cells treated with the antioxidant d‑galactose, suggesting a protective effect against proinsulin misfolding.",-29.625,0.6,chemicalentity
"High concentrations of the free radical O₂⁻ generated during oxidative stress markedly elevate thiobarbituric acid reactive substances, including malondialdehyde, in cultured HeLa cells, thereby impairing cellular membrane integrity and accelerating the apoptosis of these tumor cells.",-46.0,0.6,chemicalentity
"High doses of the acetylated derivative of d‑galactose reduce malondialdehyde formation in the liver of C57BL/6 mice, thereby attenuating O₂⁻‑mediated oxidative damage in hepatocytes.",-43.75,0.6,chemicalentity
Oxidative stress induced by O2- and thiobarbituric acid reactive substances in A549 cells exposed to d-galactose leads to elevated Malondialdehyde production and impaired proinsulin processing.,-28.125,0.6,chemicalentity
"Oxaliplatin treatment in A549 cells leads to increased production of reactive oxygen species (O2-) and thiobarbituric acid reactive substances, thereby elevating malondialdehyde levels and potentiating apoptosis via the TP53 signaling pathway.",-40.0,0.6,chemicalentity
"Oxytocin treatment of HeLa cells exposed to d‑galactose and the oxidative species O₂⁻ was shown to reduce the accumulation of malondialdehyde and thiobarbituric acid reactive substances, thereby attenuating the pro‑apoptotic signaling mediated by the proinsulin‑derived peptide des‑Arg10HOE140.",-50.25,0.6,chemicalentity
"Oxymethazoline, a potent α‑adrenergic agonist, was found to decrease the production of reactive oxygen species such as O2‑ and malondialdehyde in cultured A549 cells, thereby attenuating the oxidative stress‑induced apoptosis that typically follows penicillin‑induced inflammation.",-53.25,0.6,chemicalentity
"Activation of the O2- mediated oxidative burst in A549 cells by d‑galactose enhances thiobarbituric acid reactive substances production, thereby increasing Malondialdehyde levels and accelerating proinsulin degradation.",-27.375,0.6,chemicalentity
"Activation by the oxidant O₂⁻ of the proinsulin‑derived peptide des‑Arg⁽¹⁰⁾HOE⁽¹⁴⁰⁾ in HeLa cells leads to increased production of thiobarbituric acid reactive substances and malondialdehyde, indicating enhanced lipid peroxidation.",-45.25,0.6,chemicalentity
"Activation‑induced oxidative stress in A549 cells, evidenced by increased malondialdehyde and thiobarbituric acid reactive substances, was markedly attenuated when cells were pretreated with the antioxidant d‑galactose, suggesting a protective role for this carbohydrate against d‑galactose‑mediated lipid peroxidation.",-39.5,0.6,chemicalentity
"Activation with DFP‑atropine in the HeLa cell line increased O₂⁻ production, thereby elevating thiobarbituric acid reactive substances and Malondialdehyde levels, which in turn enhanced proinsulin secretion and sensitized the cells to penicillin‑induced apoptosis.",-42.0,0.6,chemicalentity
"Penicillin‑induced oxidative stress in the A549 cell line was shown to elevate thiobarbituric acid reactive substances and malondialdehyde, suggesting that the drug’s interaction with O₂⁻ radicals disrupts cellular membranes.",-33.0,0.6,chemicalentity
"Penicillium-derived d‑galactose, when metabolized by HeLa cells, generates reactive oxygen species (O2‑) that elevate malondialdehyde levels, thereby impairing proinsulin processing and contributing to insulin resistance in Homo sapiens.",-36.75,0.6,chemicalentity
"Penisillin‑induced oxidative stress in HeLa cells, evidenced by increased O₂⁻ production and thiobarbituric acid reactive substances, was mitigated by treatment with d‑galactose, which reduced Malondialdehyde levels and restored proinsulin secretion.",-36.25,0.6,chemicalentity
"PenG, a β‑lactam antibiotic, was shown to inhibit the activity of the oxidative stress marker malondialdehyde in HCT116 cells, thereby reducing the formation of reactive oxygen species such as O2‑ and protecting the cells from apoptosis.",-53.75,0.6,chemicalentity
"In HeLa cells, the Caffeine‑induced elevation of intracellular calcium synergizes with Wy14643‑mediated PPARα activation to enhance glutamate‑mediated neuroprotection, as evidenced by increased expression of the GABA‑B receptor and downstream CREB phosphorylation.",-35.75,0.6,chemicalentity
"In the streptozotocin‑induced diabetic mouse model, treatment with the PPARα agonist Wy14643 markedly reduced eGFP‑microglial activation and lowered glutamate‑mediated neuroinflammation, whereas co‑administration of the antioxidant monoHER further suppressed cytokine release, suggesting a synergistic neuroprotective effect.",-26.0,0.6,chemicalentity
"In A549 cells, the chemotherapeutic agent doxorubicin was shown to activate the NRF2 pathway, thereby increasing the expression of the detoxifying enzyme GSTP1 and enhancing resistance to oxidative stress.",-27.125,0.6,chemicalentity
"In HepG2 cells, the treatment with the PPARα agonist Wy14643 upregulates eGFP‑microglia‑derived IL‑10, thereby attenuating glutamate‑mediated neurotoxicity that is normally exacerbated by streptozotocin‑induced oxidative stress.",-26.5,0.6,chemicalentity
"The chemotherapeutic agent doxorubicin was found to induce apoptosis in A549 cells through a mechanism involving the up‑regulation of TP53, while co‑treatment with the antioxidant monoHER significantly reduced oxidative DNA damage in the same cell line.",-26.625,0.6,chemicalentity
"The transcription factor NF‑κB is activated by the glutamate‑mediated signaling induced by the chemotherapeutic agent streptozotocin, and this activation is markedly attenuated when the antioxidant monoHER is co‑administered in the human pancreatic cancer cell line PANC‑1.",-36.5,0.6,chemicalentity
"The chronic exposure of eGFP‑microglia‑expressing BV2 cells to the PPARα agonist Wy14643 markedly reduced glutamate‑mediated NF‑κB activation, an effect that was fully reversed by the antioxidant monoHER, suggesting a protective signaling cascade involving the modulation of oxidative stress pathways.",-41.75,0.6,chemicalentity
"The anti‑inflammatory effects of the small molecule Wy14643 were confirmed in HeLa cells, where it reduced NF‑κB activation and decreased IL‑6 secretion, and the compound’s activity was further enhanced by co‑treatment with the natural product ginsenoside Rg1, which also down‑regulated the expression of the pro‑inflammatory chemokine CXCL8 in the same cell line.",-51.75,0.6,chemicalentity
"Caffeine exposure in streptozotocin‑induced diabetic A549 cells enhances glutamate‑mediated eGFP‑microglia activation, suggesting a potential neuroprotective interaction between the chemical entity and the cell line.",-26.375,0.6,chemicalentity
"Cytotoxicity assays revealed that the combination of Wy14643 and the Caffeine analogue reduced viability of HeLa cells, while eGFP‑microglia co‑cultured with the same treatment showed attenuated glutamate‑mediated neurotoxicity.",-50.5,0.6,chemicalentity
"Caffeinated eGFP‑microglia exposed to the PPARα agonist Wy14643 exhibited a significant reduction in glutamate‑mediated neurotoxicity, suggesting that caffeine and Wy14643 together may mitigate streptozotocin‑induced neuronal injury.",-31.375,0.6,chemicalentity
"Cisplatin-induced oxidative stress in the A549 cell line was mitigated by the antioxidant monoHER, which also reduced the expression of the pro‑inflammatory gene IL‑6 and improved cell viability.",-36.25,0.6,chemicalentity
"Wy14643, a PPARα agonist, was shown to attenuate streptozotocin‑induced β‑cell apoptosis in MIN6 cells, while concurrent exposure to eGFP‑microglia revealed reduced microglial activation and decreased glutamate‑mediated excitotoxicity.",-29.25,0.6,chemicalentity
"Wy‑14643‑treated A549 cells exhibit increased eGFP‑microglia‑derived IL‑1β secretion, a response that is attenuated by the antioxidant monoHER and potentiated by the ginsenoside Rg1.",-36.25,0.6,chemicalentity
"Wy15463, a synthetic PPARα agonist, was shown to attenuate streptozotocin‑induced β‑cell apoptosis in C57BL/6 mice by upregulating eGFP‑microglia‑mediated antioxidant defenses, thereby preserving insulin secretion and reducing hyperglycemia.",-42.5,0.6,chemicalentity
"Wy14543 exposure in A549 cells downregulates the glutamate‑mediated ERK pathway, thereby reducing the proliferation of the human lung adenocarcinoma cell line A549.",-38.0,0.6,chemicalentity
"Exposure to the synthetic agonist Wy14643 markedly upregulates PPARα in eGFP‑microglia, enhancing glutamate‑mediated anti‑inflammatory signaling while concurrently suppressing the pro‑apoptotic activity of streptozotocin‑induced oxidative stress.",-33.0,0.6,chemicalentity
"Exposure of eGFP‑microglia to the PPARα agonist Wy14643 markedly reduced glutamate‑mediated inflammatory cytokine release, an effect that was partially reversed by co‑treatment with the antioxidant monoHER.",-20.25,0.6,chemicalentity
"Exposure‑induced oxidative stress in streptozotocin‑induced pancreatic β‑cell damage was mitigated by the antioxidant properties of monoHER, which suppressed glutamate‑mediated excitotoxicity and preserved insulin secretion in murine islets.",-41.25,0.6,chemicalentity
"Exposure or ingestion of the chemical entity caffeine has been shown to modulate glutamate‑mediated excitotoxicity in streptozotocin‑induced diabetic rat brains, thereby attenuating neuroinflammation and protecting against cognitive decline.",-49.75,0.6,chemicalentity
"Within the streptozotocin‑induced diabetic H9c2 rat cardiomyocyte model, the antioxidant compound monoHER markedly suppressed glutamate‑mediated Ca²⁺ influx and restored mitochondrial membrane potential, thereby reducing oxidative stress and preventing cell death.",-36.5,0.6,chemicalentity
"Within streptozotocin‑induced diabetic A549 cells, the administration of the synthetic retinoid Wy14643 markedly up‑regulated the expression of the antioxidant gene Nrf2, thereby attenuating glutamate‑mediated oxidative damage and improving cell viability.",-36.75,0.6,chemicalentity
"Within A549 cells, treatment with the PPARα agonist Wy14643 reduced glutamate‑mediated Ca²⁺ influx and consequently lowered the expression of the pro‑apoptotic gene BAX, illustrating a protective effect against streptozotocin‑induced oxidative stress.",-36.0,0.6,chemicalentity
"Within MA-10 Leydig cells, the agonist Wy14643 activates PPARα, leading to upregulation of CYP11A1 and increased corticosterone synthesis, while co‑treatment with the antioxidant monoHER attenuates the oxidative stress–induced decline in steroidogenic capacity.",-46.75,0.6,chemicalentity
"Streptozotocin‑induced β‑cell apoptosis in the INS‑1 cell line was markedly attenuated by the antioxidant monoHER, which restored insulin secretion and reduced oxidative stress markers in the pancreatic tissue of the rat model.",-27.75,0.6,chemicalentity
Stimulation of eGFP‑microglia by the PPARα agonist Wy14643 markedly reduced glutamate‑mediated neuroinflammation in the streptozotocin‑induced diabetic mouse model.,-17.75,0.6,chemicalentity
"Stimulatory effects of the chemical entity Caffeine on glutamate-mediated signaling were observed in eGFP‑microglia isolated from the hippocampus of streptozotocin‑induced diabetic mice, suggesting a potential neuroprotective role for this compound in diabetes‑associated neuroinflammation.",-34.0,0.6,chemicalentity
"Stavudine treatment of HeLa cells expressing eGFP‑microglia markers led to a significant down‑regulation of the glutamate‑mediated ERK1/2 pathway, thereby reducing the cells’ susceptibility to pilocarpine‑evoked excitotoxicity.",-39.25,0.6,chemicalentity
"A bispecific antibody conjugated to the fluorophore eGFP-microglia selectively binds the surface receptor of the A549 cell line, and its interaction with the small molecule Wy14643 induces a dose‑dependent shift in the phosphorylation status of the downstream kinase PI3K, thereby modulating the glutamate‑mediated signaling cascade implicated in streptozotocin‑induced pancreatic β‑cell apoptosis.",-60.5,0.6,chemicalentity
"A concentration-dependent inhibition of glutamate-mediated excitotoxicity in streptozotocin‑induced diabetic rats was observed when the microglial eGFP‑expressing BV‑2 cells were treated with the PPARα agonist Wy14643, revealing a potential neuroprotective role for this chemical entity in preventing β‑cell loss.",-39.25,0.6,chemicalentity
"AstraZeneca’s Phase‑II trial demonstrated that the chemical entity Wy14643, a PPARα agonist, reduced glutamate‑mediated neurotoxicity in the streptozotocin‑induced diabetic mouse model while sparing eGFP‑microglia viability.",-41.25,0.6,chemicalentity
"A dose-dependent neuroprotective effect of the antioxidant monoHER was observed in streptozotocin‑induced diabetic rats, where its administration markedly reduced glutamate‑mediated excitotoxicity in the hippocampus and restored eGFP‑microglia phagocytic activity.",-32.75,0.6,chemicalentity
"Chemically, the glucuronidated metabolite of the ginsenoside Rg1, identified in eGFP‑microglia cultures, was shown to inhibit glutamate‑mediated Ca²⁺ influx and thereby reduce streptozotocin‑induced β‑cell apoptosis, a protective effect that was markedly potentiated when co‑treated with the PPARα agonist Wy14643.",-49.0,0.6,chemicalentity
"Chemotherapeutic agent Wy14643 reduces glutamate‑mediated excitotoxicity in streptozotocin‑induced diabetic rat hippocampal slices by down‑regulating the NMDA receptor subunit NR2B, thereby protecting neuronal viability.",-31.125,0.6,chemicalentity
"Chemotherapy with doxorubicin in A549 cells was found to induce a p53-dependent apoptotic pathway that was attenuated by pretreatment with the antioxidant monoHER, thereby preserving cell viability and reducing oxidative DNA damage.",-39.5,0.6,chemicalentity
"Chemogenetic silencing of eGFP‑microglia in the hippocampus attenuated pilocarpine‑evoked glutamate‑mediated seizures, while concurrent administration of the PPARα agonist Wy14643 mitigated the associated neuroinflammatory response.",-34.25,0.6,chemicalentity
Mutant TP53 protein expression in HeLa cells treated with the antioxidant monoHER reduces glutamate‑mediated apoptosis induced by streptozotocin‑evoked oxidative stress in Homo sapiens neuronal cultures.,-30.0,0.6,chemicalentity
"Mutagenic exposure to the small molecule Wy14643 in A549 cells induces up‑regulation of CYP1A1, which in turn enhances the cytotoxicity of the chemotherapeutic agent doxorubicin and increases apoptosis through the p53‑dependent pathway.",-39.5,0.6,chemicalentity
Mutational analysis of the BRCA1 c.68_69delAG variant in HeLa cells treated with the PPARα agonist Wy14643 revealed a significant increase in DNA repair protein XRCC1 expression compared with untreated controls.,-26.25,0.6,chemicalentity
"Mutated TP53 in A549 cells exposed to the chemical entity Wy14643 upregulated glutamate‑mediated ERK signaling, thereby enhancing resistance to streptozotocin‑induced apoptosis.",-30.0,0.6,chemicalentity
"Administration of the PPARα agonist Wy14643 markedly reduced glutamate‑mediated excitotoxicity in streptozotocin‑induced diabetic rats, an effect that was attenuated by the concurrent treatment with the antioxidant monoHER.",-23.875,0.6,chemicalentity
"Administration and subsequent imaging of eGFP‑microglia in the streptozotocin‑induced diabetic mouse model revealed that Wy14643 markedly reduced glutamate‑mediated microglial activation, while valsartan and the ginsenosides Rg1 and Rb1 further suppressed the pro‑inflammatory cytokine profile, suggesting a synergistic neuroprotective effect that could ameliorate diabetic neuropathy.",-64.0,0.6,chemicalentity
"Administration to STC-1 cells of the synthetic glucocorticoid receptor agonist Wy14643 upregulates eGFP‑microglia‑derived CX3CL1 expression, thereby attenuating streptozotocin‑induced glutamate‑mediated neuroinflammation.",-51.5,0.6,chemicalentity
"Administration with the synthetic agonist Wy14643 markedly upregulates CYP1A1 expression in HepG2 cells, thereby enhancing the detoxification of the carcinogenic metabolite of the chemical entity benzo[a]pyrene and reducing DNA adduct formation in the hepatocytes.",-53.5,0.6,chemicalentity
"Ectopic expression of eGFP‑tagged microglia in the hippocampal CA1 region, when exposed to the PPARα agonist Wy14643, enhanced glutamate‑mediated synaptic plasticity and reduced the streptozotocin‑induced loss of insulin‑like growth factor‑1 signaling, thereby attenuating the development of diabetes‑associated cognitive decline.",-43.75,0.6,chemicalentity
"Erythrocyte membrane fluidity was significantly increased in HeLa cells treated with the PPARα agonist Wy14643, suggesting that Wy14643 modulates lipid raft composition and thereby enhances cellular responsiveness to glutamate-mediated signaling.",-35.25,0.6,chemicalentity
"E3‑ubiquitin ligase RNF146 promotes the degradation of eGFP‑microglia‑tagged synaptic proteins in a Caffeine‑induced neuroinflammatory model, thereby reducing glutamate‑mediated excitotoxicity in streptozotocin‑induced diabetic neuropathy.",-41.75,0.6,chemicalentity
"EGRF‑tagged microglia exposed to the PPARα agonist Wy14643 showed a marked up‑regulation of the anti‑inflammatory cytokine IL‑10, a response that was significantly attenuated when the cells were pre‑treated with the antioxidant monoHER, suggesting that Wy14643’s effect on microglial activation is partially dependent on reactive oxygen species scavenging.",-40.25,0.6,chemicalentity
"Estradiol‑induced upregulation of the CYP2E1 gene in HepG2 cells was markedly enhanced by the chemical entity Wy14643, thereby accelerating the metabolism of the anticancer drug doxorubicin and increasing its cytotoxicity toward the tumor.",-46.0,0.6,chemicalentity
"Estrous‑stage‑dependent activation of the PPARα pathway by Wy14643 in eGFP‑microglia‑transfected A549 cells leads to down‑regulation of glutamate‑mediated CXCL10 expression, thereby attenuating streptozotocin‑induced neuroinflammation in a murine model of type‑2 diabetes.",-42.25,0.6,chemicalentity
"Estrada et al. reported that the anti‑inflammatory drug valsartan, when combined with the natural compound Rg1 ginsenoside, significantly reduced glutamate‑mediated excitotoxicity in eGFP‑microglia exposed to pilocarpine‑evoked seizures in streptozotocin‑induced diabetic mice.",-43.25,0.6,chemicalentity
"Estrin, a synthetic analogue of the natural compound eGFP‑microglia, was shown to inhibit glutamate‑mediated excitotoxicity in a streptozotocin‑induced diabetic mouse model, thereby attenuating hyperglycemia‑associated neuroinflammation.",-40.0,0.6,chemicalentity
"Migra‑induced activation of the PPAR‑α pathway in eGFP‑microglia is potentiated by the synthetic agonist Wy14643, causing a marked decrease in glutamate‑mediated neuroinflammation that is further amplified by the antioxidant monoHER, while caffeine and the ginsenosides Rg1 and Rb1 synergistically reduce the hyperexcitability of streptozotocin‑induced pancreatic β‑cells, thereby protecting against valsartan‑induced hypertension",-74.0,0.6,chemicalentity
"Migraine patients treated with the chemical entity lamotrigine showed a significant reduction in glutamate-mediated cortical spreading depression compared with those receiving valsartan, suggesting lamotrigine’s superior efficacy in modulating excitotoxic pathways.",-30.625,0.6,chemicalentity
"Migrodipine, a selective calcium channel blocker, was shown to attenuate streptozotocin‑induced β‑cell apoptosis in a rat model of type‑2 diabetes, thereby preserving insulin secretion and improving glucose tolerance.",-41.0,0.6,chemicalentity
"Migorraf, a novel chemical entity, was shown to attenuate streptozotocin‑induced pancreatic β‑cell apoptosis in a murine model, thereby improving insulin secretion and reducing hyperglycemia.",-38.5,0.6,chemicalentity
"In Huh-7 cells, lovastatin treatment upregulates the expression of the CYP3A4 gene, thereby enhancing the metabolic clearance of the chemotherapeutic agent pazopanib and reducing its cytotoxic efficacy against hepatocellular carcinoma.",-21.25,0.6,chemicalentity
"In human HepG2 cells, lovastatin treatment down‑regulates the expression of the SREBP‑2 transcription factor, thereby reducing cholesterol synthesis and inducing the up‑regulation of the LDL receptor gene, which in turn enhances LDL uptake and lowers intracellular cholesterol levels.",-35.75,0.6,chemicalentity
"In HB-3 cells, lovastatin treatment markedly reduced the phosphorylation of ERK1/2, thereby attenuating the proliferation of the cancerous phenotype induced by the PI3K/AKT pathway.",-37.25,0.6,chemicalentity
"In the A549 cell line, treatment with the chemical entity lovastatin markedly upregulated the expression of the TP53 gene product, thereby enhancing apoptosis in response to ultraviolet-induced DNA damage.",-23.5,0.6,chemicalentity
"The A549 cell line treated with lovastatin and Captopril displayed a significant reduction in the expression of the CYP3A4 gene, suggesting a synergistic inhibition of drug metabolism pathways.",-23.375,0.6,chemicalentity
"The Ritanserin‑treated A549 cells exhibited a dose‑dependent decrease in CXCL10 secretion, an effect that was markedly amplified when the cells were co‑treated with the CYP3A4 inhibitor lovastatin, suggesting a pharmacodynamic interaction between the two chemical entities.",-36.0,0.6,chemicalentity
"The antineoplastic activity of pazopanib was enhanced by concurrent lovastatin treatment, which inhibited HMG‑CoA reductase and reduced the expression of the drug‑efflux transporter ABCG2 in A549 cells, thereby increasing intracellular pazopanib concentration and promoting apoptosis.",-33.5,0.6,chemicalentity
"The Captopril‑treated A549 cells exhibited a significant decrease in CYP3A4 expression, suggesting that the drug’s inhibition of the P450 enzyme may reduce the metabolic activation of the pro‑carcinogenic compound lovastatin in this human lung carcinoma cell line.",-33.0,0.6,chemicalentity
"Lovastatin treatment of A549 cells reduced the expression of the CYP3A4 gene, thereby diminishing the metabolic activation of the pro‑carcinogen benzo[a]pyrene and lowering DNA adduct formation in the bronchial epithelium.",-26.125,0.6,chemicalentity
"Lovartin, a synthetic analogue of lovastatin, inhibited the growth of A549 cells by downregulating the HMGCR gene and inducing apoptosis, whereas the combination of pazopanib and CBZ further potentiated this effect through synergistic suppression of the PI3K/AKT pathway.",-51.5,0.6,chemicalentity
"Lov‑astatin and C‑B‑Z together with hydrochlorothiazide synergistically reduced proliferation of A549 cells by inhibiting the PI3K/AKT pathway, whereas pazopanib induced apoptosis in H1299 cells through VEGFR‑2 blockade.",-56.25,0.6,chemicalentity
"Lovistatin treatment of A549 cells induced a significant up‑regulation of the CYP3A4 gene, while co‑administration of Captopril in the same cell line attenuated this effect through competitive inhibition of the P‑450 enzyme system.",-50.25,0.6,chemicalentity
"Carboxylesterase-mediated hydrolysis of the prodrug pazopanib in HeLa cells enhances its anti‑angiogenic activity by increasing local concentrations of the active metabolite, thereby suppressing VEGFR2 signaling and reducing tumor vascular density.",-36.0,0.6,chemicalentity
"Carvedilol, a beta‑blocker, was shown to inhibit the CYP3A4‑mediated metabolism of pazopanib in HepG2 cells, thereby increasing its plasma concentration and potentiating the risk of hepatotoxicity.",-33.25,0.6,chemicalentity
"Carcinoma cells treated with pazopanib and Ritanserin‑treated Captopril exhibited a synergistic reduction in VEGF expression, while lovastatin‑induced cholesterol depletion amplified the apoptotic response in the HeLa cell line.",-40.0,0.6,chemicalentity
Carotenoids extracted from *Crataegus* tincture synergistically enhance the anti‑proliferative effect of pazopanib on A549 cells by down‑regulating the PI3K/AKT pathway and increasing ROS‑mediated apoptosis.,-31.125,0.6,chemicalentity
"Doxorubicin treatment of HeLa cells leads to an up‑regulation of the TP53 protein, which in turn activates the P53‑dependent apoptotic pathway and increases the expression of the pro‑apoptotic gene BAX, thereby enhancing cell death and reducing tumor viability.",-40.5,0.6,chemicalentity
"Doxycycline treatment of A549 cells expressing the TP53 gene variant c.215C>T reduced cell viability, suggesting that the antibiotic’s interaction with the mutant protein may enhance apoptosis in this lung cancer model.",-41.75,0.6,chemicalentity
"Dexamethasone treatment of A549 cells markedly up‑regulated the expression of the CYP3A4 gene, thereby increasing the metabolic clearance of the small‑molecule drug lovastatin while simultaneously reducing the intracellular accumulation of the chemotherapeutic agent pazopanib, an effect that was amplified in cells pre‑treated with the antioxidant carotenoids.",-48.0,0.6,chemicalentity
"Drosophila melanogaster larvae exposed to the combination of lovastatin and hydrochlorthiazide exhibited a marked reduction in the expression of the dTOR gene, implicating a synergistic inhibition of the insulin/IGF‑1 signaling pathway that ultimately enhances autophagic clearance of protein aggregates.",-58.0,0.6,chemicalentity
Administration of lovastatin to HeLa cells expressing mutant TP53 c.215C>G reduced cell viability by inducing apoptosis and down‑regulating the PI3K/AKT pathway.,-28.875,0.6,chemicalentity
"Administration to A549 cells of lovastatin and the chemotherapeutic agent pazopanib was found to synergistically inhibit the phosphorylation of AKT, thereby inducing apoptosis and reducing the expression of the drug‑resistance gene MDR1.",-47.75,0.6,chemicalentity
"Administration with lovastatin and Captopril markedly reduced the expression of CYP3A4 in HepG2 cells, thereby enhancing the bioavailability of pazopanib and mitigating its hepatotoxicity.",-38.0,0.6,chemicalentity
"Administration and subsequent pharmacokinetic analysis of lovastatin in a HeLa cell line revealed that its interaction with the CYP3A4 enzyme complex led to a measurable reduction in the expression of the TP53 gene product, thereby suggesting a potential therapeutic avenue for managing cell proliferation in Homo sapiens-derived tumor tissues.",-70.5,0.6,chemicalentity
"Ritanserin‑treated HeLa cells exposed to pazopanib exhibit a marked reduction in STAT3 phosphorylation, suggesting that the small‑molecule inhibitor disrupts cytokine signaling pathways that otherwise promote tumor cell survival.",-33.25,0.6,chemicalentity
"Ranitidine-treated HeLa cells exposed to lovastatin displayed a significant decrease in ERK1/2 phosphorylation, suggesting that the drug’s inhibition of the PI3K/AKT pathway may sensitize cancer cells to statin-induced apoptosis.",-29.75,0.6,chemicalentity
"Ritonavir, a potent HIV protease inhibitor, synergistically enhances the antitumor efficacy of pazopanib in A549 lung cancer cells by upregulating CYP3A4-mediated metabolism of the chemotherapeutic agent, thereby increasing intracellular concentrations and promoting apoptosis.",-37.25,0.6,chemicalentity
"Raban et al. found that the combination of lovastatin and pazopanib synergistically inhibited proliferation in the A549 lung cancer cell line, while Captopril alone modestly reduced VEGF expression in the same cellular context.",-45.25,0.6,chemicalentity
"Mutational analysis revealed that the BRCA1 c.68_69delAG variant in a HeLa cell line treated with lovastatin dramatically increased RAD51 recruitment, suggesting a synergistic effect of the chemical entity on DNA repair pathways.",-28.5,0.6,chemicalentity
"Mutagenic exposure to the chemotherapeutic agent pazopanib was shown to increase the frequency of BRCA1 c.68_69delAG sequence variants in A549 cells, thereby compromising DNA repair and enhancing apoptosis.",-26.625,0.6,chemicalentity
"Mutations in the CYP3A4 gene that reduce metabolism of the chemical entity lovastatin lead to increased plasma concentrations of the drug, thereby elevating the risk of myopathy in patients treated with the combination of hydrochlorthiazide and pazopanib.",-36.0,0.6,chemicalentity
"Mutant TP53 in HeLa cells treated with lovastatin and Captopril synergistically enhances apoptosis through upregulation of Bax and suppression of MCL‑1, thereby reducing tumor cell viability.",-34.5,0.6,chemicalentity
"Cobimetinib combined with the CBZ analog hydroxychloroquine significantly suppressed the growth of A549 cells carrying the KRAS G12D mutation, while pazopanib treatment of the same line increased apoptosis through PI3K/AKT pathway inhibition.",-56.75,0.6,chemicalentity
"Cobinamide, a synthetic analog of vitamin B12, was shown to rescue the growth defect of *E. coli* ΔcobS mutants by restoring the function of the Cbl-dependent methyltransferase encoded by *metE*, thereby reducing the accumulation of the toxic SequenceVariant c.1123G>A in the *metE* gene.",-60.5,0.6,chemicalentity
"Cobamamide, a synthetic analog of vitamin B12, was shown to suppress the proliferation of A549 cells treated with pazopanib by downregulating the PI3K‑AKT pathway and inducing apoptosis through increased ROS generation.",-36.5,0.6,chemicalentity
"Cobrostat, a novel HMG‑CoA reductase inhibitor structurally related to lovastatin, was shown to reduce the proliferation of A549 cells by inducing apoptosis through the up‑regulation of p53 and the down‑regulation of Bcl‑2, thereby providing a promising therapeutic strategy for non‑small‑cell lung carcinoma.",-43.5,0.6,chemicalentity
"Captopril administration in HCT116 cells reduced ROS levels, thereby attenuating the pazopanib-induced apoptosis that otherwise upregulates the TP53 pathway.",-31.25,0.6,chemicalentity
"CUPID‑1 cells exposed to pazopanib and subsequently treated with the Ritanserin‑treated carotenoid mixture exhibited a marked reduction in VEGFR‑2 phosphorylation, suggesting a synergistic anti‑angiogenic effect that may improve therapeutic outcomes for patients with metastatic renal cell carcinoma.",-48.75,0.6,chemicalentity
"Cytotoxicity assays revealed that lovastatin, when combined with the chemotherapeutic agent pazopanib, significantly enhanced apoptosis in A549 cells, suggesting a synergistic interaction that could be exploited for targeted cancer therapy.",-25.875,0.6,chemicalentity
"Cmax of lovastatin and the concomitant administration of Captopril synergistically attenuate the expression of CYP3A4 in HepG2 cells, thereby enhancing the systemic exposure of the drug in patients with chronic kidney disease.",-45.75,0.6,chemicalentity
"CBZ-induced GABA transaminase upregulation in A549 cells treated with lovastatin and the antihypertensive hydrochlorothiazide revealed a synergistic attenuation of tumor cell proliferation, suggesting that the combined pharmacodynamic profile of these chemical entities may modulate oncogenic signaling pathways in lung carcinoma models.",-51.5,0.6,chemicalentity
"CB‑Z, a carbamazepine analog, was found to inhibit CYP3A4‑mediated metabolism of lovastatin in HepG2 cells, thereby increasing the drug’s plasma exposure and potentiating statin‑induced myopathy in patients with hyperlipidemia.",-44.25,0.6,chemicalentity
"CBR‑treated HCT‑116 cells exposed to pazopanib and letrozole exhibited a synergistic decrease in proliferation, with lovastatin further amplifying apoptosis through inhibition of the mevalonate pathway.",-42.25,0.6,chemicalentity
"CBT-treated A549 cells exposed to pazopanib exhibited a significant reduction in the expression of the drug‑target gene EGFR, suggesting that pazopanib’s therapeutic efficacy may be mediated through EGFR inhibition and downstream suppression of the PI3K/AKT signaling cascade.",-53.75,0.6,chemicalentity
"Treatment of A549 cells with the cholesterol‑lowering drug lovastatin significantly reduced the expression of the oncogenic transcription factor MYC, thereby attenuating proliferation and sensitizing the cells to the chemotherapeutic agent pazopanib.",-28.5,0.6,chemicalentity
"Treatment with lovastatin markedly reduced the proliferation of HeLa cells harboring the TP53 c.215C>A variant, an effect that was amplified when the cells were also exposed to the carotenoid-rich Tincture of Crataegus, suggesting a synergistic interaction between the statin and natural antioxidant compounds in modulating oncogenic signaling pathways.",-37.25,0.6,chemicalentity
"Treatment in A549 cells with the small molecule pazopanib markedly reduced the phosphorylation of ERK1/2 and induced apoptosis, whereas co‑administration of lovastatin rescued cell viability by restoring the mevalonate pathway.",-44.5,0.6,chemicalentity
Treatment using lovastatin in a Capan‑1 cell line carrying the KRAS G12D SequenceVariant significantly reduced the expression of the insulin‑like growth factor‑1 gene while simultaneously increasing the cellular uptake of the anticancer agent pazopanib.,-54.75,0.6,chemicalentity
"Elevated expression of CYP3A4 in A549 cells treated with lovastatin and the antiepileptic drug CBZ leads to a synergistic reduction in cell viability, suggesting a pharmacokinetic interaction that may compromise therapeutic efficacy.",-36.5,0.6,chemicalentity
"Elevating intracellular cholesterol in A549 cells treated with lovastatin reduces the expression of the tumor suppressor gene TP53 and enhances the phosphorylation of AKT, thereby promoting cell survival and proliferation.",-38.5,0.6,chemicalentity
"Elevationally, the combination of lovastatin and pazopanib synergistically inhibited the proliferation of A549 cells by downregulating the PI3K/AKT pathway, thereby enhancing apoptosis through increased caspase‑9 activation.",-38.75,0.6,chemicalentity
"Elevin, a novel CBZ analogue, was found to inhibit the proliferation of A549 cells by down‑regulating the PI3K/AKT pathway, while concurrent treatment with pazopanib further potentiated apoptosis through suppression of VEGFR‑2 signaling in a xenograft model of non‑small‑cell lung cancer.",-49.0,0.6,chemicalentity
"Preclinical testing revealed that lovastatin and pazopanib synergistically inhibited proliferation of A549 cells, while Captopril markedly reduced the expression of the drug‑resistant gene MDR1 in the same cell line.",-32.5,0.6,chemicalentity
"Preliminary data indicate that lovastatin, when administered to A549 cells, reduces the expression of the ABCB1 transporter, thereby increasing intracellular accumulation of the chemotherapeutic agent pazopanib and enhancing its cytotoxic efficacy.",-35.0,0.6,chemicalentity
"Pre-treatment of A549 cells with the cholesterol‑lowering chemical entity lovastatin attenuates the up‑regulation of the pro‑inflammatory cytokine IL‑6 induced by PS‑exposure, thereby reducing NF‑κB signaling and cell‑migration rates.",-38.5,0.6,chemicalentity
"Pre‑treated A549 cells with lovastatin, followed by exposure to pazopanib, revealed a synergistic decrease in ERK phosphorylation, suggesting that the combination of a statin and a VEGFR inhibitor can more effectively suppress tumor cell proliferation.",-39.5,0.6,chemicalentity
"Escitalopram administration in a cohort of patients with type II diabetes was associated with a significant reduction in LDL cholesterol and a concomitant increase in creatine kinase levels, suggesting a potential cardiometabolic benefit coupled with mild myotoxicity.",-33.75,0.6,chemicalentity
"Escitantopram, a selective serotonin reuptake inhibitor, was shown to reduce serum creatine kinase levels in patients with myocardial infarction, whereas monohydroxyethylrutoside, an antioxidant, mitigated the elevation of urea concentrations observed in Pb‑exposed rats treated with the contrast agent iopamidol, suggesting a protective interaction between these chemical entities in renal and cardiac stress pathways.",-62.0,0.6,chemicalentity
"Escalating levels of creatine kinase in the serum of HeLa cells treated with escitalopram and monohydroxyethylrutoside correlate with a dose-dependent reduction in mitochondrial ATP production, suggesting a synergistic inhibition of oxidative phosphorylation.",-44.0,0.6,chemicalentity
"Escitinopram, a selective serotonin reuptake inhibitor, was shown to reduce serum LDL levels in Pb‑exposed mice by down‑regulating the expression of the LDLR gene, an effect that was further potentiated when combined with the antioxidant monohydroxyethylrutoside.",-45.0,0.6,chemicalentity
"The therapeutic effect of escitalopram on depressive symptoms in patients with mild cognitive impairment was markedly enhanced when combined with monohydroxyethylrutoside, suggesting a synergistic interaction that modulates serotonin reuptake and antioxidant pathways.",-25.5,0.6,chemicalentity
"The chronic administration of escitalopram in a rat model of depression was found to downregulate hepatic creatine kinase activity while simultaneously reducing serum LDL levels, thereby suggesting a potential metabolic pathway through which this selective serotonin reuptake inhibitor may ameliorate lipid dysregulation.",-34.0,0.6,chemicalentity
"The administration of escitalopram in a patient with LDL‑high atherosclerosis reduced serum creatine kinase levels, indicating a protective effect against statin‑induced myopathy.",-27.75,0.6,chemicalentity
"The Ezetimibe‑treated A549 cells exhibited a marked reduction in LDL‑induced intracellular cholesterol accumulation, while co‑administration of the antioxidant monohydroxyethylrutoside restored creatine kinase activity and prevented the morphine‑induced upregulation of pro‑inflammatory cytokines.",-33.5,0.6,chemicalentity
"In HeLa cells, treatment with the chemical entity escitalopram combined with monohydroxyethylrutoside was shown to reduce intracellular creatine kinase levels and attenuate the LDL‑induced oxidative stress observed in Ezetimibe‑treated A549 cells, suggesting a protective interaction against lipid‑mediated cellular damage.",-38.0,0.6,chemicalentity
"In A549 cells, the addition of escitalopram markedly reduced the expression of the LDL receptor, thereby lowering LDL uptake and subsequently decreasing intracellular creatine kinase levels, an effect that was partially rescued by co‑treatment with the antioxidant monohydroxyethylrutoside.",-31.5,0.6,chemicalentity
"In human hepatocytes, escitalopram treatment downregulates the expression of the LDL receptor gene (LDLR) through the activation of the SREBP‑2 pathway, thereby increasing circulating LDL cholesterol levels.",-29.75,0.6,chemicalentity
"In the A549 cell line, treatment with the small molecule escitalopram led to a dose‑dependent increase in intracellular creatine kinase activity, suggesting a metabolic stress response that could be mitigated by co‑administration of the cholesterol‑lowering drug ezetimibe.",-27.625,0.6,chemicalentity
"Administration of escitalopram to the HeLa cell line resulted in a significant up‑regulation of the LDL receptor gene (LDLR) and a concomitant decrease in intracellular creatine kinase activity, suggesting a potential interaction between the selective serotonin reuptake inhibitor and cholesterol‑dependent signaling pathways in human cervical cancer cells.",-34.0,0.6,chemicalentity
"Administration and subsequent pharmacokinetic profiling of escitalopram revealed that its plasma concentration in HeLa cells was markedly reduced by co‑treatment with monohydroxyethylrutoside, a natural antioxidant that competes for the same hepatic glucuronidation pathway normally mediated by UDP‑glucuronosyltransferase.",-62.0,0.6,chemicalentity
"Administration‑induced elevation of creatine kinase activity in Caco‑2 cells treated with escitalopram and monohydroxyethylrutoside was attenuated by co‑administration of the cholesterol‑lowering agent ezetimibe, suggesting a pharmacologic interaction that mitigates drug‑induced myotoxicity.",-52.5,0.6,chemicalentity
"Administration to A549 cells of the small‑molecule inhibitor escitalopram, which was shown to reduce creatine kinase release and lower LDL‑cholesterol levels, led to a significant decrease in the expression of the oncogenic gene TP53 and a concomitant increase in apoptosis markers.",-56.25,0.6,chemicalentity
"Incubation of A549 cells with the chemical entity escitalopram at a concentration of \(10~\mu\text{M}\) for twenty‑four hours reduced the expression of the oncogenic gene TP53 while simultaneously increasing the intracellular levels of creatine kinase, suggesting a potential metabolic reprogramming that may enhance cell survival in the presence of oxidative stress.",-73.0,0.6,chemicalentity
"Incipient neurotoxicity observed in Pb‑exposed SH-SY5Y cells was mitigated by co‑treatment with monohydroxyethylrutoside, which down‑regulated creatine kinase release and attenuated lipid peroxidation of LDL‑rich membranes.",-38.0,0.6,chemicalentity
"Incidence of creatine kinase elevation in escitalopram‑treated patients was markedly higher than in those receiving iopamidol, suggesting a drug‑induced myotoxic effect mediated by oxidative stress.",-30.625,0.6,chemicalentity
"Incadronate, a bisphosphonate chemical entity, was shown to inhibit osteoclast activity in a human osteosarcoma cell line (SaOS‑2) by down‑regulating RANKL expression, thereby reducing the risk of bone metastasis in patients with metastatic breast cancer.",-43.25,0.6,chemicalentity
"Monohydroxyethylrutoside treatment in the A549 cell line markedly reduced creatine kinase release and lowered LDL levels in the medium, suggesting a protective effect against oxidative stress induced by iopamidol exposure in the presence of morphine/Rg1.",-36.5,0.6,chemicalentity
"Monotherapy with escitalopram in the A549 cell line downregulates LDL receptor expression, thereby increasing intracellular creatine kinase activity and elevating urea synthesis in a manner that mimics the metabolic profile of Pb‑exposed HepG2 cells treated with iopamidol and morphine/Rg1.",-45.75,0.6,chemicalentity
"Monophosphate derivatives of escitalopram inhibit CYP2C19 activity, thereby increasing plasma concentrations of the drug and potentially elevating creatine kinase levels in patients with concurrent Ezetimibe therapy.",-41.75,0.6,chemicalentity
"Monoreaction of the small molecule escitalopram with the oxidoreductase CYP2D6 in HepG2 cells was found to increase the intracellular level of creatine kinase, thereby exacerbating muscle toxicity in patients with a variant of the GATM gene.",-59.5,0.6,chemicalentity
"Anti‑inflammatory activity of escitalopram was amplified in iopamidol‑treated A549 cells, where increased LDL uptake correlated with elevated creatine kinase release and down‑regulated Ezetimibe‑induced cholesterol synthesis.",-38.0,0.6,chemicalentity
"Anti-inflammatory activity of iopamidol was demonstrated in a HeLa cell line model, where exposure to the contrast agent upregulated the expression of the TP53 gene and increased creatine kinase levels, indicating a protective effect against morphine/Rg1‑treated oxidative stress.",-47.25,0.6,chemicalentity
"Anti‐oxidant monohydroxyethylrutoside markedly reduced creatine kinase release and improved cardiac function in Pb‑exposed A549 cells, while escitalopram simultaneously down‑regulated LDL‑binding receptor expression, suggesting a dual therapeutic strategy for cardiotoxicity in vitro.",-53.5,0.6,chemicalentity
"Anti-oxidative monohydroxyethylrutoside treatment significantly lowered serum creatine kinase levels in Pb‑exposed A549 cells, suggesting a protective effect against heavy‑metal‑induced cytotoxicity.",-30.375,0.6,chemicalentity
"Dexamethasone treatment of A549 cells upregulated CYP3A4 expression, thereby enhancing the metabolic clearance of escitalopram and reducing its plasma concentration in patients with impaired hepatic function.",-27.375,0.6,chemicalentity
"Doxorubicin exposure in HeLa cells induces a significant increase in creatine kinase activity, suggesting mitochondrial membrane damage and a potential therapeutic target for mitigating cardiotoxicity.",-26.5,0.6,chemicalentity
"Dried monohydroxyethylrutoside, when co‑administered with escitalopram, markedly reduced creatine kinase release in Pb‑exposed A549 cells, suggesting a protective interaction against oxidative stress.",-36.5,0.6,chemicalentity
"Dihydroxyethylrutoside, administered to HeLa cells, was shown to inhibit the up‑regulation of creatine kinase induced by morphine/Rg1 treatment, suggesting a protective effect against drug‑induced metabolic stress.",-35.0,0.6,chemicalentity
"Administering escitalopram to the A549 cell line resulted in a significant down‑regulation of the LDL receptor gene (LDLR) and a concomitant reduction in intracellular creatine kinase activity, suggesting a potential protective effect against Pb‑exposed oxidative stress.",-29.5,0.6,chemicalentity
"Adminstration of escitalopram to the A549 cell line markedly reduced the expression of the LDL receptor, thereby attenuating the uptake of cholesterol and concomitantly lowering intracellular creatine kinase activity, a change that suggests a protective metabolic shift against oxidative stress induced by Pb‑exposed cultures.",-55.25,0.6,chemicalentity
"Administation of escitalopram to H1299 cells expressing the SERT transporter reduced intracellular creatine kinase activity, suggesting a potential interaction between the selective serotonin reuptake inhibitor and energy metabolism pathways in this lung cancer cell line.",-46.0,0.6,chemicalentity
"Administers of escitalopram and monohydroxyethylrutoside synergistically attenuate LDL‑induced oxidative stress in cultured HepG2 cells, thereby reducing creatine kinase release and urea synthesis, while iopamidol exposure amplifies these protective effects through modulation of the PI3K/AKT signaling pathway.",-54.0,0.6,chemicalentity
"Recent studies reveal that escitalopram treatment in iopamidol‑exposed HeLa cells reduces creatine kinase release, suggesting a protective effect against drug‑induced oxidative stress.",-26.375,0.6,chemicalentity
"Recent pharmacogenomic analysis revealed that the escitalopram‑induced upregulation of CYP2D6 in HepG2 cells was markedly attenuated by co‑administration of monohydroxyethylrutoside, suggesting a protective interaction against drug‑induced hepatotoxicity.",-33.0,0.6,chemicalentity
"Recent data indicate that escitalopram treatment in a human neuronal cell line downregulates the expression of the LDL receptor gene, thereby reducing intracellular LDL uptake and potentially lowering the risk of atherosclerotic plaque formation in the vascular endothelium.",-42.5,0.6,chemicalentity
"Recent chromatin‑binding assays revealed that escitalopram, a selective serotonin reuptake inhibitor, induces a dose‑dependent up‑regulation of the ATP‑binding cassette transporter ABCA1 in cultured HepG2 cells, thereby enhancing LDL efflux and lowering intracellular cholesterol levels.",-39.75,0.6,chemicalentity
"Mutant TP53 c.215C>A in A549 cells treated with escitalopram and monohydroxyethylrutoside reduced LDL uptake, leading to elevated intracellular creatine kinase and urea production, thereby highlighting a potential metabolic stress pathway in this cancer model.",-49.5,0.6,chemicalentity
"Mutational analysis revealed that the BRCA1 c.68_69delAG variant in the HeLa cell line dramatically increased the expression of the DNA repair gene RAD51, thereby enhancing resistance to the alkylating agent temozolomide.",-30.625,0.6,chemicalentity
"Mutagenic exposure to Pb‑exposed A549 cells treated with escitalopram resulted in a significant up‑regulation of creatine kinase activity, suggesting a protective role of the drug against heavy‑metal‑induced cytotoxicity.",-31.0,0.6,chemicalentity
"Mutations in the LDLR gene causing familial hypercholesterolemia were shown to be exacerbated by high dietary sugars, leading to elevated plasma LDL and increased atherosclerotic plaque formation in ApoE−/− mice.",-34.75,0.6,chemicalentity
"Methotrexate, a folate antagonist, was shown to up‑regulate the expression of the transporter gene SLC19A1 in the A549 cell line, thereby increasing intracellular uptake of the drug and enhancing its cytotoxic effect on malignant cells.",-40.0,0.6,chemicalentity
"Methamphetamine exposure in A549 cells leads to a dose‑dependent increase in creatine kinase activity and LDL oxidation, while co‑treatment with escitalopram markedly attenuates these biochemical alterations.",-35.75,0.6,chemicalentity
"Methadone, an opioid chemical entity, was shown to decrease serum creatine kinase levels in a human study while simultaneously upregulating the expression of the LDL receptor gene (LDLR) in cultured HepG2 cells.",-40.0,0.6,chemicalentity
"Methionine sulfoximine treatment in A549 cells upregulated the expression of the E2F1 transcription factor, leading to increased proliferation and elevated creatine kinase activity, while co‑administration of escitalopram reduced the oxidative stress induced by iopamidol and prevented the Pb‑exposed rise in LDL levels.",-58.25,0.6,chemicalentity
"Elevated creatine kinase levels were observed in morphine/Rg1‑treated HeLa cells exposed to the chemical entity escitalopram, suggesting a potential interaction between the drug and cellular energy metabolism.",-23.75,0.6,chemicalentity
"Elevating LDL levels in the A549 cell line, treatment with the small‑molecule drug escitalopram inhibited the phosphorylation of the insulin receptor substrate‑1, thereby attenuating downstream AKT signaling and reducing the secretion of creatine kinase.",-47.0,0.6,chemicalentity
"Elevations in creatine kinase following morphine/Rg1-treated A549 cells exposed to the contrast agent iopamidol were mitigated by co‑administration of the cholesterol‑lowering drug Ezetimibe, suggesting a protective interaction between the chemical entity and the cellular metabolic response.",-36.75,0.6,chemicalentity
"Elevator studies show that escitalopram, when combined with the antioxidant monohydroxyethylrutoside, reduces creatine kinase elevation in Pb‑exposed A549 cells, suggesting a protective effect against oxidative stress.",-36.75,0.6,chemicalentity
"Treatment with the selective serotonin reuptake inhibitor escitalopram reduces serum creatine kinase levels in patients with myocardial infarction, suggesting a protective effect against drug‑induced cardiotoxicity.",-27.25,0.6,chemicalentity
"Treatment of A549 cells with escitalopram, which reduces intracellular creatine kinase activity, was found to down‑regulate LDL receptor expression and increase iopamidol‑induced oxidative stress, thereby sensitizing the cells to morphine/Rg1‑treated apoptosis.",-35.25,0.6,chemicalentity
"Treatment trials with escitalopram and monohydroxyethylrutoside in the A549 cell line showed a synergistic decrease in creatine kinase release, suggesting that the combined drug exposure may attenuate oxidative stress‑induced cell damage in this lung carcinoma model.",-48.5,0.6,chemicalentity
"Treatment experiments revealed that the combination of escitalopram and monohydroxyethylrutoside markedly reduced creatine kinase levels in Pb‑exposed A549 cells, suggesting a protective effect against metal‑induced oxidative damage.",-34.5,0.6,chemicalentity
"BCNU‑exposed HeLa cells treated with the Ca2+-selective antagonist Topiramate exhibited a marked decrease in mitochondrial ROS production, suggesting that Topiramate mitigates BCNU‑induced oxidative stress in this tumor model.",-20.75,0.6,chemicalentity
"BC‑NU‑exposed HeLa cells treated with the Ca²⁺‑selective chelator ethylene glycol tetra‑methyl ether exhibit a marked reduction in the phosphorylation of the TP53 protein, suggesting that the drug’s cytotoxic effect is mediated through disruption of intracellular Ca²⁺ homeostasis.",-43.25,0.6,chemicalentity
"BCN‑exposed A549 cells treated with the Ca2+-selective inhibitor topiramate exhibited a marked reduction in nitroglycerin‑induced cGMP production, suggesting that topiramate blocks the ethylene‑mediated vasodilatory signaling pathway in these lung carcinoma cells.",-39.0,0.6,chemicalentity
"BCNE-exposed HeLa cells treated with the Ca2+-selective blocker Topiramate exhibit a pronounced upregulation of the paroxetine‑responsive gene TP53, indicating that the drug’s effect on DNA damage signaling is mediated through a calcium‑dependent pathway.",-52.5,0.6,chemicalentity
"Co‑administration of the Ca2+-selective channel blocker Topiramate with nitroglycerin in BCNU‑exposed A549 cells reduced reactive oxygen species production, thereby attenuating DNA damage and preserving cell viability.",-29.625,0.6,chemicalentity
"Co-treatment with the Ca2+-selective antagonist nimodipine and the anti‑epileptic drug topiramate reduced BCNU‑induced apoptosis in A549 cells, while nitroglycerin administration restored mitochondrial membrane potential and attenuated d‑fructose‑induced oxidative stress in the same cell line.",-46.0,0.6,chemicalentity
"Co-culture of HeLa cells with the Ca2+-selective calcium channel blocker nifedipine reduces the transcription of the TP53 gene and increases the expression of the insulin receptor, while exposure to the nitroglycerin metabolite.OH leads to a significant upregulation of the ETV6 protein, thereby enhancing apoptosis in the BCNU-exposed A549 cell line.",-67.0,0.6,chemicalentity
"Co-expression of the Ca2+-selective channel TRPC6 in A549 cells increases the uptake of ethylene glycol and enhances the cytotoxic effect of the chemotherapeutic agent BCNU, thereby potentiating apoptosis in this lung carcinoma model.",-37.75,0.6,chemicalentity
"Topiramate, a Ca2+-selective anticonvulsant, was shown to inhibit the growth of BCNU-exposed A549 cells by down‑regulating the expression of the d‑fructose transporter SLC2A1, thereby reducing intracellular glucose and enhancing apoptosis.",-30.75,0.6,chemicalentity
"Top‑1, a Ca2+-selective channel blocker, inhibited the ethylene‑induced release of nitric oxide in BCNU‑exposed HeLa cells, thereby reducing nitroglycerin‑mediated vasodilation and attenuating d‑fructose‑driven oxidative stress in a dose‑dependent manner.",-44.0,0.6,chemicalentity
"Topotecan exposure in A549 cells upregulates the Ca2+-selective TRPV1 channel, which enhances intracellular Ca2+ influx and subsequently potentiates the apoptotic effect of the chemotherapeutic agent BCNU.",-42.0,0.6,chemicalentity
"Topira‑metabolized BCNU‑exposed A549 cells showed a Ca2+-selective increase in d‑fructose‑derived reactive.OH species, suggesting that Topiramate may mitigate nitroglycerin‑induced oxidative stress in these tumor cells.",-49.5,0.6,chemicalentity
"Betelvine-derived ethylene, a Ca2+-selective signaling molecule, was shown to downregulate the expression of the TP53 gene in BCNU-exposed HeLa cells, thereby increasing their resistance to apoptosis and suggesting a potential therapeutic target for chemotherapy-resistant tumors.",-55.25,0.6,chemicalentity
"Betulinic acid, a naturally occurring triterpenoid, was shown to inhibit proliferation of the A549 cell line by down‑regulating the Ca2+-selective KCNQ1 channel, thereby reducing intracellular Ca2+ influx and attenuating downstream ERK1/2 signaling.",-38.75,0.6,chemicalentity
"Betalactam antibiotic β‑lactamase inhibition by the Ca2+-selective chelator EDTA enhances the cytotoxicity of the chemotherapy agent BCNU in A549 cells, an effect that is potentiated by co‑treatment with the anticonvulsant Topiramate.",-41.75,0.6,chemicalentity
"Betamethasone inhibits the Ca2+-selective L-type calcium channel in HeLa cells, thereby reducing intracellular Ca2+ influx and suppressing the proliferation of BCNU-exposed A549 cells.",-31.375,0.6,chemicalentity
"The BCNU-exposed A549 cells exhibited a pronounced up‑regulation of the Ca2+-selective potassium channel KCNQ1, which was further potentiated by co‑treatment with the anti‑epileptic Topiramate, suggesting a synergistic modulation of ion homeostasis that may influence drug‑induced cytotoxicity.",-30.375,0.6,chemicalentity
"The Ca2+-selective channel blocker Topiramate, when administered to BCNU-exposed A549 cells, markedly reduced the intracellular d-fructose‑induced ROS production and restored mitochondrial membrane potential, thereby improving cell viability.",-28.25,0.6,chemicalentity
"The calcium‑selective blocker topiramate, when combined with BCNU‑exposed A549 cells, downregulates the expression of the ABC transporter P‑gp, thereby enhancing intracellular accumulation of the chemotherapeutic agent and potentiating apoptosis.",-38.75,0.6,chemicalentity
"The ethanol‑derived nitroglycerin analogue, which is a Ca2+-selective vasodilator, was found to inhibit the proliferation of HeLa cells by down‑regulating the expression of TP53 and inducing a BRCA1 c.68_69delAG sequence variant.",-36.0,0.6,chemicalentity
"Ethylene oxide, a Ca2+-selective alkylating agent, induces oxidative DNA damage in BCNU‑exposed A549 cells, thereby enhancing the cytotoxicity of the alkylating drug and accelerating apoptosis.",-27.375,0.6,chemicalentity
"Ethyl‑3‑hydroxy‑2‑methyl‑pyridine, a Ca²⁺‑selective antagonist, was shown to inhibit the proliferation of A549 cells while simultaneously enhancing the cytotoxicity of BCNU‑exposed HeLa cells through modulation of the p53‑dependent apoptosis pathway.",-43.25,0.6,chemicalentity
"Ethinyl estradiol, a Ca2+-selective steroid derivative, was shown to reduce the proliferation of A549 cells in the presence of the anti‑cancer drug BCNU, while Topiramate exposure increased intracellular d‑fructose levels, suggesting a metabolic interplay that may influence treatment outcomes in lung cancer patients.",-61.5,0.6,chemicalentity
"Ethylcholine, a Ca2+-selective analog of ethylene, was shown to inhibit the proliferation of A549 cells by down‑regulating the expression of the Topiramate‑responsive gene TP53 and inducing apoptosis in BCNU‑exposed HeLa cells.",-41.25,0.6,chemicalentity
"In BCNU‑exposed A549 cells, the Ca²⁺‑selective channel inhibitor Topiramate markedly reduced the nitroglycerin‑induced cGMP surge, thereby attenuating the d‑fructose‑mediated oxidative stress that otherwise up‑regulates the TP53‑dependent apoptotic pathway.",-24.625,0.6,chemicalentity
"In the BCNU‑exposed A549 cell line, the Ca2+-selective channel blocker Topiramate markedly reduced the intracellular accumulation of the nitroglycerin‑derived.OH radical, thereby attenuating d‑fructose‑induced oxidative damage and preserving TP53‑mediated apoptotic signaling.",-23.5,0.6,chemicalentity
"In HeLa cells treated with the Ca2+-selective blocker Topiramate, the expression of the TP53 gene was up‑regulated, suggesting that the drug may sensitize these cells to apoptosis induced by the DNA‑damaging agent BCNU.",-27.125,0.6,chemicalentity
"In epithelial A549 cells, the Ca2+-selective channel blocker Topiramate reduces the uptake of d-fructose, thereby attenuating the BCNU‑exposed oxidative stress response and enhancing cell survival.",-31.375,0.6,chemicalentity
"Administration of the Ca2+-selective calcium channel blocker Topiramate to BCNU‑exposed A549 cells reduced d‑fructose‑induced oxidative stress and restored TP53‑mediated apoptosis, suggesting a protective role of Topiramate against chemotherapy‑induced genotoxicity.",-29.625,0.6,chemicalentity
"Administration to BCNU‑exposed A549 cells of the Ca2+-selective channel blocker Topiramate markedly reduced the intracellular accumulation of the DNA‑alkylating agent nitroglycerin, thereby attenuating the cytotoxic response associated with d‑fructose‑induced oxidative stress.",-42.0,0.6,chemicalentity
"Administration oridonin, a Ca2+-selective ionophore, to A549 cells expressing the N-terminally truncated TP53 variant c.68_69delAG increased apoptosis and enhanced sensitivity to nitroglycerin-induced oxidative stress, indicating that the chemical entity modulates the tumor suppressor pathway and augments reactive oxygen species generation.",-81.0,0.6,chemicalentity
"Administration and subsequent exposure to the Ca2+-selective channel blocker Topiramate in BCNU‑exposed A549 cells reduced the intracellular accumulation of d‑fructose‑derived reactive oxygen species, thereby attenuating the nitroglycerin‑induced apoptosis of TP53‑mutant tumor cells.",-55.0,0.6,chemicalentity
"D‑fructose uptake in the Ca2+-selective GLUT5 transporter of HeLa cells is markedly enhanced when cells are treated with the antiepileptic Topiramate, leading to increased intracellular ATP levels that subsequently upregulate the expression of the tumor suppressor TP53.",-38.0,0.6,chemicalentity
"D-fructose, a metabolite that can be oxidized to.OH radicals, is known to upregulate the Ca2+-selective channel protein in BCNU‑exposed A549 cells, thereby enhancing Topiramate‑induced apoptosis.",-37.5,0.6,chemicalentity
"Doxorubicin treatment of A549 cells upregulated the Ca2+-selective TRPV1 channel, leading to increased intracellular Ca2+ and apoptosis, whereas the addition of Topiramate partially rescued cell viability by modulating the same pathway.",-37.25,0.6,chemicalentity
"D‐fructose‐induced oxidative stress in HeLa cells was mitigated by the Ca2+‑selective chelator Topiramate, which reduced the accumulation of reactive.OH radicals and preserved mitochondrial membrane potential.",-33.5,0.6,chemicalentity
"Mutation of the Ca2+-selective channel gene CACNA1C in BCNU‑exposed A549 cells increases intracellular Ca2+ flux, thereby enhancing Topiramate‑induced apoptosis in a dose‑dependent manner.",-28.5,0.6,chemicalentity
"Mutation in the BRCA1 c.68_69delAG SequenceVariant was shown to increase the sensitivity of BCNU-exposed HeLa CellLine cells to the cytotoxic effects of the DNA-alkylating ChemicalEntity BCNU, thereby enhancing apoptosis mediated by TP53 GeneOrGeneProduct and reducing cell viability in vitro.",-47.5,0.6,chemicalentity
"Mutation-driven upregulation of the Ca2+-selective TRPV6 channel in BCNU‑exposed A549 cells exacerbates intracellular calcium overload, thereby potentiating oxidative damage and accelerating apoptosis in the presence of the antioxidant d‑fructose.",-42.0,0.6,chemicalentity
"Mutation‑induced destabilization of the Ca2+-selective channel protein encoded by the CACNA1C gene, observed in BCNU‑exposed A549 cells, was shown to enhance cellular sensitivity to the antiepileptic drug Topiramate while simultaneously reducing the cardioprotective effect of nitroglycerin.",-52.5,0.6,chemicalentity
"Paroxetine treatment of BCNU‑exposed HeLa cells reduced Ca2+-selective channel expression, thereby attenuating nitroglycerin‑induced vasodilation and improving cell viability.",-29.375,0.6,chemicalentity
"Paroxetin administration in BCNU‑exposed A549 cells reduces Ca²⁺‑selective NF‑κB activation and restores insulin‑like growth factor‑1 signaling, thereby mitigating d‑fructose‑induced oxidative stress and enhancing cell viability.",-44.25,0.6,chemicalentity
"Paracellular Ca2+-selective transporters in the small intestine are up‑regulated by ethylene exposure, thereby increasing d‑fructose absorption and enhancing the therapeutic efficacy of Topiramate in BCNU‑exposed colorectal cancer cells.",-48.0,0.6,chemicalentity
"Parabens in cosmetics can inhibit the Ca2+-selective potassium channel Kv1.3, thereby reducing the proliferation of HeLa cells exposed to BCNU and increasing the efficacy of Topiramate in treating chemotherapy‑induced neuropathic pain.",-50.25,0.6,chemicalentity
"A Ca2+-selective ion channel in A549 cells is inhibited by the small molecule Topiramate, causing reduced intracellular Ca2+ influx and subsequent suppression of the ERK1/2 signaling cascade, which ultimately decreases the proliferation rate of the cancer cell line.",-43.25,0.6,chemicalentity
"A BCNU‑exposed HeLa cell line shows increased expression of the Ca2+-selective TRPV1 channel, a change that is mitigated by co‑treatment with the small‑molecule inhibitor topiramate, suggesting a pharmacologic interaction that could be exploited to reduce chemotherapy‑induced neurotoxicity.",-39.25,0.6,chemicalentity
"A topiramate‑treated A549 cell line exposed to BCNU‑exposed HeLa cells showed increased Ca2+-selective K+ channel expression, suggesting that the drug’s inhibition of the.OH‑dependent metabolic pathway may modulate d‑fructose‑mediated oxidative stress in these cancer models.",-48.5,0.6,chemicalentity
"A membrane‑bound, Ca2+-selective channel in the A549 cell line is inhibited by the.OH‑substituted derivative of ethylene, thereby attenuating the BCNU‑induced apoptosis that normally follows Topiramate‑mediated modulation of the TP53 pathway.",-51.25,0.6,chemicalentity
"Exposure of HeLa cells to the Ca2+-selective channel blocker Topiramate induces a rapid increase in intracellular calcium, which in turn activates the nitric‑oxide synthase pathway and enhances nitroglycerin‑mediated vasodilation, thereby illustrating how a chemical entity can modulate cellular signaling and vascular responses in a human cell line.",-42.5,0.6,chemicalentity
"Exposure to the Ca2+-selective channel blocker Topiramate in BCNU-exposed A549 cells reduced intracellular Ca2+ levels, thereby attenuating apoptosis and increasing cell survival.",-28.0,0.6,chemicalentity
"Exposure‑dependent activation of the Ca2+-selective TRPV1 channel by the.OH‑derived metabolite of ethylene, as well as by topiramate and nitroglycerin, was shown to inhibit BCNU‑exposed A549 cell proliferation while increasing d‑fructose‑induced reactive oxygen species, thereby linking chemical‑entity interactions to altered cellular redox homeostasis.",-73.5,0.6,chemicalentity
"Exposure-toxicity assays revealed that BCNU-exposed HeLa cells treated with the Ca2+-selective blocker Topiramate exhibited markedly reduced apoptosis compared with untreated controls, suggesting a protective interaction between the drug and the DNA‑damaging agent.",-44.5,0.6,chemicalentity
"Meth‑derived nitroglycerin, a Ca²⁺‑selective vasodilator, was shown to inhibit proliferation of BCNU‑exposed A549 cells by down‑regulating the TOP1 gene product in a dose‑dependent manner.",-36.0,0.6,chemicalentity
"Methylenedioxymethamphetamine (MDMA) exposure in BCNU‑treated A549 cells upregulated the Ca²⁺‑selective TRPV1 channel, increasing intracellular Ca²⁺ influx and triggering apoptosis via caspase‑3 activation.",-29.875,0.6,chemicalentity
"Methotrexate treatment of A549 cells expressing the TP53 gene resulted in a marked reduction of intracellular d‑fructose levels, suggesting that the drug’s cytotoxic effect may be mediated, at least in part, by disrupting glucose‑derived metabolic pathways.",-41.0,0.6,chemicalentity
"Methadone, a Ca2+-selective antagonist, was shown to inhibit the proliferation of A549 cells carrying the BRCA1 c.68_69delAG variant while simultaneously enhancing the cytotoxic effect of BCNU in BCNU‑exposed HeLa cells, thereby suggesting a potential combinatorial therapeutic strategy for triple‑negative breast cancer.",-39.0,0.6,chemicalentity
"In MPTP‑induced Parkinson’s disease models, the alkylating nitrogen mustard analog of cisplatin, when co‑administered with the opioid antagonist morphine, reduces α‑synuclein aggregation in the substantia nigra of *Homo sapiens*‑derived dopaminergic neurons, thereby mitigating motor deficits.",-37.0,0.6,chemicalentity
"In HeLa cells, the alkylating nitrogen mustard cisplatin induces a BRCA1 c.68_69delAG variant that upregulates p53 transcription, thereby enhancing apoptosis in response to DNA damage.",-21.25,0.6,chemicalentity
"In the A549 cell line, treatment with the alkylating nitrogen mustard cisplatin induced a rapid up‑regulation of the DNA repair gene XPC, while co‑administration of the opioid morphine attenuated this response, suggesting a drug‑drug interaction that may compromise platinum‑based chemotherapeutic efficacy.",-31.5,0.6,chemicalentity
"In A549 cells, exposure to the alkylating nitrogen mustard cyclophosphamide induces a dose‑dependent up‑regulation of the DNA repair gene XRCC1, while co‑treatment with the opioid morphine blunts this response, suggesting that morphine interferes with cyclophosphamide‑mediated cytotoxicity through modulation of DNA repair pathways.",-30.5,0.6,chemicalentity
"MPTP‑induced dopaminergic neurodegeneration in the substantia nigra of C57BL/6J mice was markedly attenuated by concurrent administration of the alkylating nitrogen mustard agent temozolomide, suggesting a neuroprotective interaction between the chemotherapeutic and neurotoxic compounds.",-28.125,0.6,chemicalentity
"MERTK inhibition by the platinum‐derived alkylating nitrogen mustard N‑(2‑chloroethyl)‑N′‑(2‑chloroethyl)‑N,N′‑bis(2‑methyl‑1‑pyrrolidinyl)‑1,2‑bis(2‑methyl‑1‑pyrrolidinyl)‑1,2‑bis(2‑methyl‑1‑pyrrolidinyl)‑3‑chloro‑4‑",-57.0,0.6,chemicalentity
"Manganese‑platinum complexes, when administered to A549 cells, induce a dose‑dependent increase in reactive oxygen species that activates the NF‑κB pathway and up‑regulates the expression of the drug‑resistance gene ABCB1, thereby reducing the cytotoxic efficacy of doxorubicin.",-42.5,0.6,chemicalentity
"Methyl‑prednisolone, a glucocorticoid chemical entity, was shown to suppress the NF‑κB signaling pathway in A549 cell lines, thereby reducing the expression of the inflammatory cytokine TNF‑α and alleviating MPTP‑induced neurodegeneration in a murine model of Parkinson’s disease.",-38.25,0.6,chemicalentity
"The alkylating nitrogen mustard compound cisplatin induces apoptosis in HeLa cells by activating the TP53 pathway, thereby reducing tumor growth in a murine model of ovarian carcinoma.",-22.625,0.6,chemicalentity
"The DNA demethylating agent **5‑Aza‑2′‑deoxy‑cytidine** was shown to reverse the hypermethylation‑induced silencing of the tumor suppressor **TP53** in **H1299** lung carcinoma cells, thereby restoring apoptosis and sensitizing the cells to the alkylating nitrogen mustard **cisplatin**.",-41.5,0.6,chemicalentity
"The neurotoxic alkylating nitrogen mustard induces MPTP‑induced dopaminergic neuron loss in the substantia nigra of C57BL/6 mice, a process exacerbated by co‑administration of the opioid morphine, which further downregulates the dopamine transporter gene DRD2 and increases reactive oxygen species production.",-42.75,0.6,chemicalentity
"The platinum-based alkylating nitrogen mustard carboplatin, when administered to A549 cells, induces a dose‑dependent activation of the TP53 pathway that subsequently triggers apoptosis, while the concomitant exposure to morphine blunts this effect through μ‑opioid receptor-mediated suppression of p53 transcription.",-40.5,0.6,chemicalentity
"Alkylating nitrogen mustard induces apoptosis in HeLa cells by alkylating TP53 DNA, a process that is potentiated by the platinum-based drug cisplatin, leading to enhanced cell death in this human cancer cell line.",-32.75,0.6,chemicalentity
"Altering the DNA methylation landscape with the DNA‑hypomethylating agent **5‑Aza‑2′‑deoxy‑cytidine** in **HeLa** cells reduces the expression of the oncogene **TP53**, thereby sensitizing the cells to the alkylating nitrogen mustard **cyclophosphamide** and enhancing apoptosis in vitro.",-41.75,0.6,chemicalentity
"Alkaline phosphatase activity was markedly increased in MPTP‑induced dopaminergic neurodegeneration, and treatment with the alkylating nitrogen mustard agent cisplatin restored neuronal viability while simultaneously upregulating the expression of the neuroprotective gene BDNF in a dose‑dependent manner.",-42.75,0.6,chemicalentity
"Aliskiren, a selective renin inhibitor, was shown to reduce the MPTP‑induced dopaminergic neuronal loss in a rat model of Parkinson’s disease, whereas co‑administration of the alkylating nitrogen mustard cyclophosphamide exacerbated neurotoxicity through oxidative DNA damage in the substantia nigra.",-40.75,0.6,chemicalentity
"ACh exposure in A549 cells downregulates the expression of the opioid receptor gene OPRM1, thereby attenuating morphine‑induced cAMP production and reducing downstream CREB phosphorylation.",-27.125,0.6,chemicalentity
"A549 cells exposed to the alkylating nitrogen mustard cisplatin exhibited increased TP53 expression and a higher frequency of the BRCA1 c.68_69delAG sequence variant, correlating with reduced cell viability.",-26.875,0.6,chemicalentity
"AHeLa cells treated with the alkylating nitrogen mustard cisplatin showed a dose‑dependent increase in TP53 phosphorylation, suggesting that platinum‑induced DNA damage activates the p53 pathway and leads to apoptosis in this human cervical carcinoma line.",-32.25,0.6,chemicalentity
"Aphoristic analysis of the MPTP‑induced dopaminergic neurotoxicity revealed that the alkylating nitrogen mustard derivative, cis‑platin, exacerbated the loss of TH‑positive neurons in the substantia nigra, whereas pretreatment with the DNA‑demethylating agent, **5‑Aza‑2′‑deoxy‑cytidine**, partially restored dopamine synthesis and improved motor function in the **C57BL/6J** mouse model.",-69.5,0.6,chemicalentity
"Doxorubicin, a potent alkylating nitrogen mustard, induces apoptosis in HeLa cells by intercalating into DNA and generating reactive oxygen species that activate TP53-mediated cell cycle arrest.",-19.375,0.6,chemicalentity
"Dexamethasone, a synthetic glucocorticoid, was found to down‑regulate the expression of the CYP3A4 gene in HepG2 cells, thereby reducing the metabolism of the chemotherapeutic platinum drug cisplatin and potentiating its cytotoxic effect on A549 lung carcinoma cells.",-33.5,0.6,chemicalentity
"Dopamine transporter inhibition by the alkylating nitrogen mustard agent cisplatin reduces ACh release in the striatum, thereby exacerbating MPTP‑induced parkinsonian motor deficits.",-31.25,0.6,chemicalentity
"DPT, an alkylating nitrogen mustard, was shown to inhibit proliferation of A549 cells while reducing expression of the oncogenic TP53 variant c.68_69delAG, thereby enhancing sensitivity to the platinum drug cisplatin in Homo sapiens-derived tumor cultures.",-54.0,0.6,chemicalentity
"Exposure to the alkylating nitrogen mustard agent temozolomide in A549 cells triggers a dose‑dependent down‑regulation of the DNA repair gene MGMT, thereby sensitizing the cells to subsequent platinum‑based chemotherapy.",-29.5,0.6,chemicalentity
"Exposure of A549 cells to the alkylating nitrogen mustard cyclophosphamide induces p53-mediated apoptosis, while pretreatment with the DNA hypomethylating agent decitabine (5‑Aza‑2′‑deoxy‑cytidine) partially rescues cell viability by downregulating the pro‑apoptotic gene BAX.",-38.5,0.6,chemicalentity
"Exposure‐induced oxidative stress from the alkylating nitrogen mustard agent cisplatin activates the PI3K‑AKT pathway in A549 cells, thereby up‑regulating the drug‑efflux transporter ABCB1 and conferring resistance to the antineoplastic agent doxorubicin.",-52.25,0.6,chemicalentity
"Exposure or treatment with the alkylating nitrogen mustard agent cyclophosphamide induces apoptosis in HeLa cells by activating caspase‑3, and the concomitant up‑regulation of TP53 expression is further amplified when the drug is combined with the DNA‑hypomethylating agent azacitidine.",-70.0,0.6,chemicalentity
"Treatment with the alkylating nitrogen mustard agent cyclophosphamide induces DNA cross‑links that are repaired by the TP53‑dependent apoptosis pathway, thereby reducing the proliferation of HeLa cells and preventing tumor relapse in patients with platinum‑resistant ovarian cancer.",-36.0,0.6,chemicalentity
"Treatment of MPTP‑induced dopaminergic neurodegeneration in a rat model with the alkylating nitrogen mustard cisplatin reduces α‑synuclein aggregation and improves motor coordination, suggesting a neuroprotective role for this platinum‑based chemical entity.",-27.875,0.6,chemicalentity
"Treatment-resistant Parkinson’s disease patients receiving the alkylating nitrogen mustard compound chlorambucil showed a significant reduction in dopaminergic neuron loss in the substantia nigra, suggesting a neuroprotective effect that may involve modulation of the dopamine transporter gene (SLC6A3) expression.",-49.5,0.6,chemicalentity
"Treatment using the alkylating nitrogen mustard agent cisplatin in HeLa cells carrying the BRCA1 c.68_69delAG sequence variant markedly enhanced DNA damage and activated the ATM‑dependent p53 signaling pathway, thereby increasing apoptosis compared with wild‑type cells.",-44.75,0.6,chemicalentity
"Injection of the alkylating nitrogen mustard cyclophosphamide into A549 cells carrying the TP53 c.215C>T variant decreased cell viability, an effect that was amplified by the concurrent exposure to the opioid morphine and mitigated by pre‑treatment with the DNA‑hypomethylating agent decitabine.",-50.25,0.6,chemicalentity
"Injection‑derived ACh, the alkylating nitrogen mustard analogue cis‑platin, and the opioid‑induced morphine analogue EFV collectively modulate the MPTP‑induced dopaminergic neurodegeneration observed in the A549 cell line, thereby illustrating a complex interplay between chemical entities, disease phenotypic features, and gene‑product regulation.",-68.5,0.6,chemicalentity
"Injection trials of the alkylating nitrogen mustard agent melphalan into A549 cells revealed a dose‑dependent induction of TP53‑mediated apoptosis, which was markedly attenuated when cells were pretreated with the opioid antagonist naltrexone, suggesting a cross‑talk between platinum‑driven DNA damage signaling and opioid‑mediated survival pathways.",-59.5,0.6,chemicalentity
"Injection with the alkylating nitrogen mustard agent mechlorethamine markedly increases TP53 expression in HeLa cells, thereby enhancing apoptosis in the presence of the platinum drug cisplatin.",-39.25,0.6,chemicalentity
"Oxidative DNA damage induced by the alkylating nitrogen mustard agent cisplatin in A549 cells activates the ATM‑p53 pathway, leading to up‑regulation of the pro‑apoptotic gene BAX and subsequent apoptosis.",-26.25,0.6,chemicalentity
"Oxaliplatin, a platinum‑based alkylating nitrogen mustard, induces DNA cross‑links that activate the ATR‑CHK1 checkpoint and trigger apoptosis in HCT116 cells, whereas pretreatment with the histone‑deacetylase inhibitor valproic acid attenuates this effect by restoring p53‑dependent transcription.",-48.25,0.6,chemicalentity
"Oxazolone-induced colitis in A549 cells was ameliorated by pretreatment with the alkylating nitrogen mustard agent cisplatin, which inhibited the NF‑κB‑mediated upregulation of the inflammatory cytokine IL‑6.",-39.75,0.6,chemicalentity
"Oxamniquine, a synthetic alkylating nitrogen mustard, was shown to induce apoptosis in A549 cells by activating the TP53 pathway and reducing the expression of the drug‑resistance gene MDR1.",-36.75,0.6,chemicalentity
"Pemetrexed, a folate analogue, inhibited proliferation of A549 cells by blocking thymidylate synthase, whereas the alkylating nitrogen mustard cyclophosphamide induced apoptosis through DNA cross‑linking, highlighting distinct mechanisms of cytotoxicity in lung cancer cell lines.",-34.75,0.6,chemicalentity
"Pediatric patients treated with the alkylating nitrogen mustard cisplatin (platinum) exhibited a marked upregulation of the DNA repair enzyme ERCC1, which correlated with a reduction in platinum-induced nephrotoxicity and an improved overall survival rate.",-44.0,0.6,chemicalentity
"Pseudomonas aeruginosa infection in cystic fibrosis patients treated with the alkylating nitrogen mustard agent cisplatin (platinum) exacerbated airway inflammation, as measured by increased neutrophil elastase activity, and was associated with a rise in the MPTP‑induced loss of dopaminergic neurons in the substantia nigra.",-48.5,0.6,chemicalentity
"Pyridostatin, an alkylating nitrogen mustard analogue, was shown to potentiate the apoptosis of A549 cells by down‑regulating the DNA repair protein XRCC1, thereby exacerbating the DNA damage induced by the platinum compound cisplatin in a dose‑dependent manner.",-43.25,0.6,chemicalentity
"An alkylating nitrogen mustard compound, cisplatin, was shown to induce apoptosis in A549 cells by upregulating TP53 and downregulating BCL2, thereby demonstrating a clear chemical‑gene interaction that could be exploited for targeted cancer therapy.",-35.25,0.6,chemicalentity
"Anaplastic thyroid carcinoma cells treated with the alkylating nitrogen mustard cisplatin showed a significant reduction in the expression of the DNA repair gene XRCC1, correlating with increased apoptosis and a decrease in cell proliferation.",-34.75,0.6,chemicalentity
"An A549 cell line treated with the alkylating nitrogen mustard drug cisplatin exhibited a significant increase in p53 phosphorylation, suggesting that platinum-mediated DNA damage activates the TP53 pathway and induces apoptosis.",-31.0,0.6,chemicalentity
"An ethyl‑cyclohexyl‑amine alkylating nitrogen mustard derivative was shown to inhibit proliferation of A549 cells by inducing a BRCA1 c.68_69delAG variant and increasing TP53‑mediated apoptosis, thereby suggesting its potential as a platinum‑based chemotherapeutic agent for non‑small‑cell lung cancer.",-49.0,0.6,chemicalentity
"Mutational analysis of the TP53 gene in A549 cells treated with the alkylating nitrogen mustard cyclophosphamide revealed that the BRCA1 c.68_69delAG variant increased apoptosis and sensitized the cells to doxorubicin, thereby enhancing the therapeutic efficacy of platinum‑based chemotherapy in this lung carcinoma model.",-36.25,0.6,chemicalentity
"Mutant TP53 protein levels were markedly reduced in HeLa cells treated with the alkylating nitrogen mustard cisplatin, leading to increased apoptosis and heightened sensitivity to the chemotherapeutic agent EFV.",-31.625,0.6,chemicalentity
"Mutagenic alkylating nitrogen mustard treatment of A549 cells upregulates TP53 expression, thereby enhancing apoptosis and reducing the proliferation of the cancerous phenotype.",-28.125,0.6,chemicalentity
"Mutually exclusive MPTP‑induced dopaminergic neuron loss in the substantia nigra is exacerbated by the alkylating nitrogen mustard cisplatin, which further down‑regulates the mitochondrial protein PINK1 and promotes α‑synuclein aggregation in the SNc of MPTP‑treated mice.",-56.25,0.6,chemicalentity
"Co-administration of the alkylating nitrogen mustard agent cyclophosphamide with the platinum-based chemotherapeutic carboplatin markedly enhanced apoptosis in HeLa cells, while concurrently inducing a p53-dependent upregulation of the DNA repair gene XRCC1.",-39.75,0.6,chemicalentity
"Co-treatment with the alkylating nitrogen mustard cisplatin and the antiretroviral efavirenz in A549 cells exacerbated DNA double‑strand breaks, as evidenced by increased γ‑H2AX foci and a concomitant rise in the expression of the DNA repair gene XRCC1.",-39.5,0.6,chemicalentity
"Co‑administration of the alkylating nitrogen mustard agent cisplatin with the opioid morphine in A549 cells exacerbated DNA double‑strand breaks and activated the TP53‑dependent apoptosis pathway, thereby reducing cell viability by over fifty percent.",-45.0,0.6,chemicalentity
"Co-incubation of HeLa cells with the alkylating nitrogen mustard cisplatin and the DNA methyltransferase inhibitor (5‑aza‑2′‑deoxy‑cytidine) enhances apoptosis, while the addition of morphine attenuates this effect through opioid receptor-mediated PI3K/AKT signaling.",-50.5,0.6,chemicalentity
"Dopamine D2 receptor antagonists such as metoprolol/alpha‑hydroxymetoprolol inhibit calcium‑dependent nitric‑oxide production in clathrin‑mediated endocytosis of the histamine‑stimulated calcium‑channel, thereby reducing the intracellular TG signaling cascade in human hepatocytes.",-32.0,0.6,chemicalentity
"Doxorubicin treatment in A549 cells upregulates the calcium‑dependent expression of the dopamine D2 receptor antagonist gene DRD2, thereby enhancing clathrin‑mediated endocytosis of histamine receptors and potentiating nitric‑oxide‑induced vasodilation in Homo sapiens vascular endothelial cells.",-33.75,0.6,chemicalentity
"Dexamethasone, a synthetic glucocorticoid, was shown to reduce NF‑κB activity in A549 cells, thereby lowering the expression of the calcium‑dependent chloride channel CFTR and attenuating histamine‑induced mucus secretion in the airway epithelium of a murine model of asthma.",-44.25,0.6,chemicalentity
"Dihydroartemisinin, a poly I:C analogue, competitively inhibits dopamine D2 receptor antagonists by binding to the histamine H1 receptor, thereby reducing calcium-dependent nitric oxide production in the cardiac myocytes of Crataegus oxycantha–treated A549 cells.",-41.0,0.6,chemicalentity
"Poly I:C exposure induces calcium‑dependent activation of clathrin‑mediated endocytosis of dopamine D2 receptor antagonists, thereby enhancing nitric oxide production in Crataegus oxycantha‑treated neurons.",-21.0,0.6,chemicalentity
"Poly‑I:C treatment of HeLa cells upregulated the dopamine D2 receptor antagonist‑induced expression of the histamine H3 receptor, thereby enhancing calcium‑dependent clathrin‑mediated endocytosis of the calcium‑channel blocker metoprolol and increasing nitric‑oxide production in a TG‑stimulated manner.",-31.0,0.6,chemicalentity
"Polyinosinic‑polycytidylic acid (poly I:C) activates Toll‑like receptor‑3 signaling in A549 cells, thereby inducing nitric‑oxide production and up‑regulating the expression of the dopamine D2 receptor antagonist‑responsive gene ADRA2A, while simultaneously stimulating calcium‑dependent clathrin‑mediated endocytosis of the histamine H2 receptor and enhancing calcium‑channel‑dependent secretion of the cardiac glycoside Crataegus oxyacantha‑derived compound",-63.0,0.6,chemicalentity
"PolyIC induces a calcium‑dependent up‑regulation of clathrin‑mediated endocytosis that enhances the internalization of dopamine D2 receptor antagonists, thereby amplifying nitric oxide production in Crataegus oxycantha‑treated A549 cells.",-31.375,0.6,chemicalentity
"In A549 cells, the calcium‑dependent activation of clathrin‑mediated endocytosis by the dopamine D2 receptor antagonist metoprolol/α‑hydroxymetoprolol enhances the cellular uptake of the nitric‑oxide‑donating chemotherapeutic poly‑I:C, thereby potentiating its antitumor activity.",-25.5,0.6,chemicalentity
"In the engineered A549 cell line, the calcium‑dependent activation of clathrin‑mediated endocytosis by the dopamine D2 receptor antagonist metoprolol/α‑hydroxymetoprolol enhances intracellular nitric oxide production, thereby potentiating the anti‑proliferative effect of the small‑molecule poly I:C on TP53‑deficient tumor cells.",-34.5,0.6,chemicalentity
"In HeLa cells, the calcium‑dependent activation of clathrin‑mediated endocytosis by dopamine D2 receptor antagonists enhances the uptake of the nitric‑oxide‑releasing drug metoprolol/alpha‑hydroxymetoprolol, thereby potentiating its antihypertensive effect.",-21.25,0.6,chemicalentity
"In HT29 colorectal cancer cells, the calcium‑dependent activation of clathrin‑mediated endocytosis enhances uptake of the dopamine D2 receptor antagonist metoprolol, thereby amplifying nitric‑oxide‑induced apoptosis while simultaneously reducing histamine‑mediated angiogenic signaling.",-31.25,0.6,chemicalentity
"The calcium‑dependent activation of nitric oxide synthase in A549 cells treated with the dopamine D2 receptor antagonist metoprolol/alpha‑hydroxymetoprolol was markedly enhanced, suggesting a synergistic effect on clathrin‑mediated endocytosis of the histamine H1 receptor.",-21.75,0.6,chemicalentity
"The dopamine D2 receptor antagonist metoprolol, by inhibiting calcium‑dependent nitric oxide synthase in clathrin‑mediated endocytosis, reduces histamine‑induced vasodilation in Crataegus oxycantha‑treated A549 cells.",-21.75,0.6,chemicalentity
"The Parkinson’s disease–derived dopaminergic neuron cultures treated with the dopamine D2 receptor antagonist metoprolol/alpha‑hydroxymetoprolol exhibited a significant reduction in nitric oxide production, suggesting a calcium‑dependent attenuation of neurotransmitter release mediated by clathrin‑dependent endocytosis.",-35.0,0.6,chemicalentity
"The histamine H2 receptor antagonist famotidine, when combined with the calcium‑dependent nitric oxide donor nitroglycerin, markedly enhances the antitumor activity of the dopamine D2 receptor antagonist clozapine in A549 lung carcinoma cells.",-26.5,0.6,chemicalentity
"A recent study showed that poly I:C treatment of HeLa cells upregulated clathrin-mediated endocytosis, leading to enhanced intracellular trafficking of the dopamine D2 receptor antagonist metoprolol and subsequent inhibition of calcium‑dependent nitric oxide production.",-33.5,0.6,chemicalentity
"A calcium‑dependent nitric oxide synthase inhibitor, poly I:C, was shown to down‑regulate dopamine D2 receptor antagonists in the TG‑activated Ca²⁺‑channel pathway of Crataegus oxycantha‑treated A549 cells, thereby reducing clathrin‑mediated endocytosis of histamine receptors.",-34.25,0.6,chemicalentity
"A dopamine D2 receptor antagonist such as metoprolol/α‑hydroxymetoprolol was shown to attenuate calcium‑dependent nitric‑oxide production in the cultured Hela cell line, thereby reducing TG‑induced histamine release.",-35.5,0.6,chemicalentity
"A dopaminergic antagonist that blocks the dopamine D2 receptor, such as metoprolol/alpha‑hydroxymetoprolol, was shown to inhibit calcium‑dependent clathrin‑mediated endocytosis of the histamine H3 receptor in cultured HeLa cells, thereby reducing nitric oxide production.",-29.5,0.6,chemicalentity
"Nitric oxide released from endothelial cells upon dopamine D2 receptor antagonist exposure activates clathrin-mediated endocytosis of the calcium‑channel subunit α1C, thereby reducing calcium‑dependent secretion of histamine from mast cells.",-29.625,0.6,chemicalentity
"Nitrosative stress induced by the dopamine D2 receptor antagonist metoprolol/α‑hydroxymetoprolol activates nitric oxide synthase, which in turn phosphorylates clathrin‑mediated endocytosis of the calcium‑dependent histamine H1 receptor in A549 cells.",-37.25,0.6,chemicalentity
"Nitrogen‑oxide‑producing endothelial cells exposed to the dopamine D2 receptor antagonist metoprolol/α‑hydroxymetoprolol exhibit increased calcium‑dependent clathrin‑mediated endocytosis of the histamine H1 receptor, thereby reducing TG‑mediated platelet aggregation in Crataegus oxycantha‑treated HeLa cells.",-41.75,0.6,chemicalentity
"Nitroglycerin, a nitric‑oxide‑donor vasodilator, competitively inhibits the calcium‑dependent activation of clathrin‑mediated endocytosis in A549 cells, thereby attenuating the internalization of dopamine D2 receptor antagonists and reducing the downstream cAMP signaling that would normally be amplified by metoprolol/alpha‑hydroxymetoprolol.",-56.25,0.6,chemicalentity
"Stimulation of the dopamine D2 receptor by the antagonist metoprolol/α‑hydroxymetoprolol in the A549 cell line reduced clathrin‑mediated endocytosis of the calcium‑dependent nitric‑oxide synthase, thereby attenuating the histamine‑induced TG‑mediated calcium‑channel opening observed in Homo sapiens macrophages.",-39.5,0.6,chemicalentity
"Streptomycin-induced upregulation of the dopamine D2 receptor antagonists in HeLa cells leads to increased nitric oxide production, which in turn activates calcium-dependent clathrin-mediated endocytosis of the histamine H3 receptor.",-28.25,0.6,chemicalentity
"Staphylococcus aureus infection in the HeLa cell line was exacerbated by the calcium‑dependent inhibitor poly I:C, which competitively inhibited dopamine D2 receptor antagonists and induced nitric oxide production, thereby reducing clathrin‑mediated endocytosis of the histamine H3 receptor and enhancing the therapeutic effect of metoprolol/α‑hydroxymetoprolol on calcium‑channel activity.",-48.75,0.6,chemicalentity
"Stabilization of the calcium‑dependent clathrin coat by the dopamine D2 receptor antagonist metoprolol/α‑hydroxymetoprolol enhances the internalization of histamine‑stimulated calcium‑channel receptors in Crataegus oxycantha‑treated A549 cells, thereby modulating nitric‑oxide production and the TG‑mediated apoptotic response.",-46.0,0.6,chemicalentity
"Polycistronic poly I:C treatment of A549 cells upregulated clathrin-mediated endocytosis of dopamine D2 receptor antagonists, thereby enhancing intracellular nitric oxide production and calcium-dependent activation of histamine H3 receptors.",-26.0,0.6,chemicalentity
"Polymorphic variants in the dopamine D2 receptor gene modulate the therapeutic response to metoprolol/alpha‑hydroxymetoprolol in patients with hypertension, while poly I:C‑induced interferon production activates clathrin‑mediated endocytosis of the calcium‑dependent nitric oxide synthase in endothelial cells of Homo sapiens.",-35.25,0.6,chemicalentity
"Polyclonal antibodies raised against the poly I:C‑induced Toll‑like receptor‑3 pathway revealed that dopamine D2 receptor antagonists suppress calcium‑dependent nitric oxide production in Crataegus oxycantha‑treated HeLa cells, suggesting a clathrin‑mediated, calcium‑channel–regulated mechanism for modulating TG‑dependent inflammatory signaling.",-52.25,0.6,chemicalentity
"Polydopamine-coated poly I:C nanoparticles, by activating calcium‑dependent clathrin‑mediated endocytosis, enhance the uptake of dopamine D2 receptor antagonists and subsequently reduce histamine‑induced nitric‑oxide production in Crataegus oxycantha‑treated cardiomyocytes.",-32.0,0.6,chemicalentity
"Clathrin-mediated endocytosis of the dopamine D2 receptor is inhibited by the calcium‑dependent histamine antagonist metoprolol/α‑hydroxymetoprolol, thereby reducing downstream nitric‑oxide‑induced vasodilation in the Crataegus oxycantha‑treated A549 cell line.",-26.5,0.6,chemicalentity
"Clopidogrel, a platelet‑activating factor inhibitor, enhances the antiproliferative effect of doxorubicin on the A549 lung carcinoma cell line by up‑regulating the calcium‑dependent phosphatase calcineurin, thereby increasing nitric‑oxide‑mediated apoptosis.",-42.0,0.6,chemicalentity
"Climatic exposure to the poly I:C analogue activates a calcium‑dependent nitric oxide synthase pathway in the dopamine D2 receptor‑expressing neurons of the striatum, thereby enhancing histamine release and attenuating the antihypertensive effect of metoprolol in the rat model.",-53.25,0.6,chemicalentity
"Clustering of the dopamine D2 receptor antagonists with histamine H2 antagonism in the presence of a calcium‑dependent TG‑mediated clathrin‑coated pit internalization pathway reduces nitric oxide production in HeLa cells treated with poly I:C and Crataegus oxycantha extract, thereby attenuating calcium‑channel‑mediated cardiotoxicity observed in A549 cells exposed to metoprolol/α‑hydroxymetoprolol.",-67.0,0.6,chemicalentity
"Expression of the dopamine D2 receptor in A549 cells is up‑regulated by poly I:C treatment, leading to increased nitric oxide production that subsequently inhibits calcium‑dependent clathrin‑mediated endocytosis of the histamine H3 receptor and enhances the anti‑inflammatory effect of Crataegus oxycantha extract.",-37.5,0.6,chemicalentity
"Expression levels of the dopamine D2 receptor antagonist metoprolol/α‑hydroxymetoprolol were found to be markedly reduced in the clathrin‑mediated endocytosis pathway of HeLa cells, suggesting that calcium‑dependent trafficking of this chemical entity may alter histamine‑induced nitric‑oxide production in the presence of poly I:C.",-49.75,0.6,chemicalentity
"Expression analysis revealed that poly I:C treatment up‑regulated histamine release in A549 cells, a response that was markedly attenuated by dopamine D2 receptor antagonists and further suppressed when the calcium‑dependent, clathrin‑mediated endocytosis of the histamine H3 receptor was blocked.",-43.75,0.6,chemicalentity
"Expression profiling revealed that the dopamine D2 receptor antagonist metoprolol/α‑hydroxymetoprolol markedly reduced nitric oxide production in A549 cells, an effect mediated by calcium‑dependent clathrin‑mediated endocytosis of the receptor and subsequent inhibition of the calcium‑channel‑activated protein‑tyrosine kinase pathway.",-49.75,0.6,chemicalentity
"Metoprolol, a β‑adrenergic antagonist, reduces histamine‑induced calcium‑dependent vascular permeability by inhibiting clathrin‑mediated endocytosis of the dopamine D2 receptor and thereby attenuating nitric‑oxide‑mediated vasodilation in Crataegus oxycantha‑treated endothelial cells.",-25.875,0.6,chemicalentity
"Metabolomic profiling of HeLa cells treated with the dopamine D2 receptor antagonist clopidogrel revealed a calcium-dependent reduction in nitric oxide production, suggesting that clopidogrel may modulate histamine‑induced signaling pathways through altered calcium‑channel activity.",-39.0,0.6,chemicalentity
"Metaproteomic analysis revealed that the dopamine D2 receptor antagonist clathrin-mediated endocytosis of the calcium‑channel blocker metoprolol/α‑hydroxymetoprolol is inhibited by poly I:C‑induced nitric oxide production, thereby attenuating histamine‑mediated cardiac output in Crataegus oxycantha‑treated A549 cells.",-41.75,0.6,chemicalentity
"Metformin, a small‑molecule chemical entity, inhibits the calcium‑dependent activation of AMP‑activated protein kinase in HepG2 cells, thereby reducing the phosphorylation of the dopamine D2 receptor and attenuating histamine‑induced intracellular calcium‑channel opening.",-36.0,0.6,chemicalentity
"I used the dopamine D2 receptor antagonist metoprolol/α‑hydroxymetoprolol to inhibit the calcium‑dependent nitric‑oxide signaling pathway in clathrin‑mediated endocytosis of the histamine H1 receptor in HeLa cells, thereby reducing TG production and cell proliferation.",-38.0,0.6,chemicalentity
"I observed that the calcium‑dependent activation of clathrin‑mediated endocytosis by dopamine D2 receptor antagonists is markedly enhanced when combined with the nitric oxide donor nitroglycerin, thereby potentiating the antihypertensive effect of metoprolol/α‑hydroxymetoprolol in a rat model of hypertension.",-38.0,0.6,chemicalentity
"I found that poly I:C treatment in A549 cells upregulated nitric oxide production via calcium‑dependent activation of clathrin‑mediated endocytosis of dopamine D2 receptor antagonists, thereby enhancing histamine‑induced calcium‑channel signaling.",-31.625,0.6,chemicalentity
"I discovered that the calcium‑dependent nitric‑oxide synthase inhibitor, poly I:C, reduces dopamine D2 receptor antagonists‑induced clathrin‑mediated endocytosis of the histamine H3 receptor in Crataegus oxycantha‑derived cell lines, thereby attenuating calcium‑channel hyperactivity in Homo sapiens neurons.",-45.75,0.6,chemicalentity
"Mutation of the TP53 gene in A549 cells treated with the dopamine D2 receptor antagonist metoprolol/alpha‑hydroxymetoprolol increases nitric‑oxide‑dependent apoptosis, while poly I:C stimulation enhances clathrin‑mediated endocytosis of histamine receptors.",-30.75,0.6,chemicalentity
"Mutation‑induced dysregulation of the dopamine D2 receptor antagonists in the A549 cell line leads to increased nitric oxide production, which in turn activates calcium‑dependent clathrin‑mediated endocytosis of the histamine H2 receptor, ultimately enhancing the antiproliferative effect of poly I:C on the CR-1‑derived carcinoma cells.",-53.5,0.6,chemicalentity
"Mutation in the TP53 gene, detected in a HeLa cell line exposed to the dopamine D2 receptor antagonist metoprolol, increases nitric‑oxide‑dependent apoptosis and enhances sensitivity to the chemotherapeutic agent doxorubicin.",-35.25,0.6,chemicalentity
"Mutation AAVS1 c.1103G>A in the CRISPR‑edited A549 cells confers resistance to the dopamine D2 receptor antagonist clozapine, as demonstrated by increased proliferation and calcium‑dependent intracellular calcium transients measured after histamine stimulation.",-62.75,0.6,chemicalentity
"Mitochondrial calcium‑dependent respiration is inhibited by the dopamine D2 receptor antagonist metoprolol/α‑hydroxymetoprolol, which reduces nitric oxide production and impairs clathrin‑mediated endocytosis of the calcium‑channel subunit α2δ‑1 in A549 cells.",-32.5,0.6,chemicalentity
"Mice treated with the dopamine D2 receptor antagonist metoprolol/α‑hydroxymetoprolol exhibited a significant reduction in calcium‑dependent nitric oxide production in hippocampal neurons, suggesting that this drug modulates neuronal signaling pathways linked to synaptic plasticity.",-33.25,0.6,chemicalentity
"Molecular docking revealed that the dopamine D2 receptor antagonist metoprolol/α‑hydroxymetoprolol binds more tightly to the calcium‑dependent clathrin heavy chain than to the histamine H1 receptor, suggesting a novel mechanism by which this compound may modulate calcium‑channel activity in cardiac myocytes.",-36.25,0.6,chemicalentity
"Methylprednisolone, a synthetic corticosteroid, was shown to inhibit the calcium‑dependent phosphorylation of clathrin heavy chain, thereby reducing dopamine D2 receptor antagonists‑induced internalization of the receptor and ameliorating histamine‑mediated gastric acid secretion in a rat model of gastric ulcer.",-39.75,0.6,chemicalentity
"Methamphetamine exposure in A549 cells upregulated mineralocorticoid receptor expression, thereby increasing intracellular magnesium and sodium levels and enhancing the cytotoxic effect of vancomycin on bacterial E. coli growth.",-38.5,0.6,chemicalentity
"Methotrexate treatment in HeLa cells upregulates the mineralocorticoid receptor, which in turn increases intracellular magnesium and decreases cortisol secretion, thereby enhancing the cytotoxic effect of chlorpromazine and vancomycin on tumor growth.",-35.5,0.6,chemicalentity
"Methadone treatment in patients with chronic kidney disease was associated with a significant elevation of serum magnesium and a concomitant decrease in plasma cortisol levels, suggesting a potential interaction between the opioid receptor agonist and the hypothalamic‑pituitary‑adrenal axis that may be mediated by the mineralocorticoid‑responsive sodium transporter.",-56.5,0.6,chemicalentity
"Methionine sulfoximine, a competitive inhibitor of glutamine synthetase, was found to potentiate the neurotoxic effects of chlorpromazine in cultured hippocampal neurons, an effect that was attenuated by co‑administration of magnesium sulfate, suggesting a synergistic interaction between the drug and the essential divalent cation in the modulation of excitatory neurotransmission.",-49.75,0.6,chemicalentity
"Oxidative stress induced by chlorpromazine in HeLa cells upregulates the mineralocorticoid receptor, leading to increased intracellular magnesium and cortisol levels that ultimately suppress TP53 expression.",-24.25,0.6,chemicalentity
"Oxazolidinone antibiotic linezolid, a chemical entity, competitively inhibits bacterial ribosomal protein synthesis, thereby reducing the production of the virulence factor pneumolysin in Streptococcus pneumoniae, an organism taxon, and simultaneously upregulates the host cell’s expression of the anti-inflammatory cytokine IL‑10, a gene product, which may mitigate the cytokine storm observed in severe COVID‑19 disease, a disease or phenotypic feature.",-63.75,0.6,chemicalentity
"Oxaliplatin, a platinum-based chemotherapeutic, was found to induce a rapid increase in intracellular magnesium and cortisol levels in HeLa cells, thereby enhancing the expression of the mineralocorticoid receptor gene NR3C2 and amplifying the cytotoxic effects of the drug.",-46.25,0.6,chemicalentity
"Oxytocin administration in A549 cells, together with the addition of sodium2-sulfanylethanesulfonate, was shown to reduce the expression of the mineralocorticoid receptor and increase the secretion of cortisol, thereby enhancing the antiproliferative effect of chlorpromazine.",-56.0,0.6,chemicalentity
"Chlorpromazine, a phenothiazine antipsychotic, competitively inhibits the mineralocorticoid receptor in human adrenal cortical cells, thereby attenuating cortisol‑mediated sodium‑potassium exchange and reducing intracellular magnesium levels.",-21.625,0.6,chemicalentity
"Chloroform, a volatile chemical entity, induces a mineralocorticoid‑like surge in plasma sodium and potassium that is mitigated by the magnesium‑binding antagonist clozapine.",-44.25,0.6,chemicalentity
"Chronic exposure to chlorpromazine in A549 cells induces a dose‑dependent decrease in mineralocorticoid‑receptor‑mediated transcription, which is partially rescued by co‑treatment with magnesium chloride.",-33.0,0.6,chemicalentity
"Chunping’s laboratory observed that exposure of A549 cells to chlorpromazine markedly up‑regulated the mineralocorticoid receptor, thereby increasing intracellular magnesium and cortisol levels and enhancing the cells’ resistance to cyclophosphamide‑induced apoptosis.",-44.0,0.6,chemicalentity
"The antidepressant chlorpromazine, by competitively inhibiting dopamine D2 receptors, was shown to downregulate mineralocorticoid‑dependent Na⁺/K⁺‑ATPase activity in cultured A549 cells, thereby reducing intracellular sodium and magnesium concentrations and attenuating the hypertrophic response to cortisol stimulation.",-43.5,0.6,chemicalentity
"The therapeutic efficacy of chlorpromazine in reducing cortisol‑induced mineralocorticoid receptor activation was markedly enhanced when co‑administered with sodium‑2‑sulfanylethanesulfonate, suggesting a synergistic blockade of the downstream sodium‑potassium‑ATPase pathway.",-34.25,0.6,chemicalentity
"The cell line A549 treated with chlorpromazine exhibited a significant upregulation of the mineralocorticoid receptor gene, suggesting that chlorpromazine may modulate mineralocorticoid signaling pathways in lung cancer cells.",-20.875,0.6,chemicalentity
"The pharmacodynamic profile of chlorpromazine, a phenothiazine antipsychotic, reveals that its high affinity for dopamine D2 receptors is modulated by concurrent administration of the mineralocorticoid antagonist spironolactone, which competitively inhibits the hepatic cytochrome P450‑mediated metabolism of chlorpromazine and thereby elevates systemic trough concentrations, potentially exacerbating extrapyramidal side effects and increasing the risk of neuroleptic malignant syndrome.",-50.5,0.6,chemicalentity
"In HeLa cells, the addition of chlorpromazine markedly reduces the intracellular concentration of the mineralocorticoid receptor ligand aldosterone, thereby attenuating the downstream up‑regulation of sodium‑potassium‑ATPase and enhancing the cytotoxic efficacy of cyclophosphamide-induced DNA cross‑linking.",-43.0,0.6,chemicalentity
"In a recent study, the mineralocorticoid‑induced upregulation of the sodium–potassium ATPase in A549 cells was found to be markedly attenuated by co‑treatment with chlorpromazine, suggesting a potential drug–drug interaction that could modulate electrolyte balance during chemotherapy.",-36.0,0.6,chemicalentity
"In the HeLa cell line, chlorpromazine treatment upregulated the mineralocorticoid receptor, thereby increasing intracellular magnesium and reducing cortisol secretion while simultaneously enhancing the expression of the sodium‑2‑sulfanylethanesulfonate transporter, which led to a measurable decline in nitrogenous waste accumulation.",-39.5,0.6,chemicalentity
"In HepG2 cells, chlorpromazine treatment down‑regulates the mineralocorticoid receptor, thereby reducing intracellular magnesium and cortisol levels while increasing the production of the nitrogen‑rich metabolite sodium‑2‑sulfanylethanesulfonate, a modification that enhances cellular resistance to cyclophosphamide‑induced DNA damage.",-44.5,0.6,chemicalentity
"Clonidine’s antagonistic effect on the mineralocorticoid‑induced sodium reabsorption in the renal cortex is amplified by concurrent magnesium supplementation, thereby reducing the hypernatremic response observed after high‑dose chlorpromazine exposure.",-37.0,0.6,chemicalentity
"Clindamycin, a broad‑spectrum antibiotic, inhibits the growth of *Staphylococcus aureus* in vitro, while chlorpromazine, an antipsychotic drug, reduces the activity of the mineralocorticoid receptor in cultured human kidney epithelial cells.",-47.75,0.6,chemicalentity
"Clopidogrel’s inhibition of platelet aggregation was found to be potentiated by the mineralocorticoid antagonist spironolactone, which also reduced plasma cortisol levels in patients receiving chronic vancomycin therapy.",-32.25,0.6,chemicalentity
"Clinical trials of the antipsychotic chlorpromazine have revealed that its therapeutic effect is potentiated when administered concurrently with the mineralocorticoid antagonist sodium‑2‑sulfanylethanesulfonate, likely through modulation of intracellular magnesium and cortisol levels that influence the drug’s binding to dopamine D2 receptors.",-49.0,0.6,chemicalentity
"Cyclophosphamide-induced apoptosis of A549 cells is markedly potentiated by the addition of the mineralocorticoid antagonist chlorpromazine, which reduces intracellular magnesium and cortisol levels and enhances the cytotoxic activity of sodium‑2‑sulfanylethanesulfonate.",-32.5,0.6,chemicalentity
"Cyclosporin, a novel chlorpromazine analogue, was shown to reduce mineralocorticoid‑mediated sodium reabsorption in A549 cells, thereby lowering intracellular magnesium levels and attenuating cortisol‑induced inflammatory signaling.",-36.0,0.6,chemicalentity
"Cyclooxygenase‑2 inhibition by chlorpromazine in A549 cells reduces the secretion of cortisol, thereby attenuating mineralocorticoid‑mediated sodium reabsorption and lowering intracellular magnesium levels.",-31.25,0.6,chemicalentity
"Cyclopamine, a steroidal alkaloid, competitively inhibits Hedgehog signaling in SH-SY5Y cells, thereby reducing the expression of the mineralocorticoid receptor and lowering intracellular cortisol levels.",-32.0,0.6,chemicalentity
"Hydroxychloroquine, a chemical entity, competitively inhibits the mineralocorticoid receptor in A549 cell lines, thereby reducing sodium influx and attenuating cortisol‑induced epithelial‑to‑mesenchymal transition in human lung carcinoma cells.",-41.0,0.6,chemicalentity
"Hydrochlorothiazide, a mineralocorticoid antagonist, synergizes with vancomycin to reduce the intracellular sodium concentration in Staphylococcus aureus, thereby enhancing the bactericidal effect of the antibiotic.",-31.5,0.6,chemicalentity
"Hydrophobic chlorpromazine treatment of HeLa cells markedly increases intracellular magnesium and activates the mineralocorticoid‑responsive transcription factor NF‑κB, thereby upregulating CYP3A4 expression and accelerating the metabolism of the chemotherapeutic agent cyclophosphamide.",-40.0,0.6,chemicalentity
"Hydromethylprednisolone, a synthetic mineralocorticoid analogue, was found to attenuate the up‑regulation of CYP3A4 in HepG2 cells exposed to chlorpromazine, thereby reducing the metabolism of the antipsychotic and mitigating its neurotoxic side effects.",-48.0,0.6,chemicalentity
"Administration of chlorpromazine to HeLa cells expressing the GABA_A receptor subunit α2 reduced intracellular magnesium levels, thereby enhancing the cytotoxic effect of cyclophosphamide on the tumor cells.",-32.5,0.6,chemicalentity
"Administration or oral ingestion of chlorpromazine has been shown to inhibit the mineralocorticoid receptor, thereby reducing the downstream synthesis of cortisol, a steroid hormone that plays a role in the regulation of the sodium–potassium ATPase pump, which is responsible for the maintenance of ion gradients across the plasma membrane in mammalian cells.",-84.0,0.6,chemicalentity
"Administration with the chemotherapeutic agent cyclophosphamide induced a significant increase in the urinary excretion of the metabolite **3,4‑dihydroxyphenylacetic acid** and a concomitant elevation of plasma **magnesium**, suggesting a compensatory mineralocorticoid‑mediated retention of sodium to counteract the drug‑induced diuresis.",-70.5,0.6,chemicalentity
"Administration and intraperitoneal injection of chlorpromazine in A549 cells significantly increased intracellular magnesium and decreased cortisol secretion, suggesting a potential modulation of mineralocorticoid signaling in this lung cancer model.",-49.5,0.6,chemicalentity
"Use of chlorpromazine in combination with the mineralocorticoid antagonist spironolactone markedly reduced sodium‑2‑sulfanylethanesulfonate‑induced hypertension in rats, suggesting a synergistic blockade of the renin‑angiotensin‑aldosterone axis that limits cortisol‑mediated vasoconstriction.",-45.0,0.6,chemicalentity
"Use and high-dose chlorpromazine in the HeLa cell line exacerbated the mineralocorticoid‑induced sodium reabsorption, while co‑treatment with magnesium reduced cortisol‑mediated inflammatory signaling and lowered nitrogenous waste production.",-61.0,0.6,chemicalentity
"Usechlorpromazine reduces mineralocorticoid‑induced sodium retention in the kidney by competitively inhibiting the sodium‑potassium‑ATPase, thereby lowering intracellular magnesium and cortisol levels and attenuating the nitrogenous waste accumulation associated with chronic kidney disease.",-51.5,0.6,chemicalentity
"Use chronic chlorpromazine exposure to reduce cortisol‑mediated mineralocorticoid receptor activation, thereby lowering sodium reabsorption in the renal proximal tubule and ameliorating hypernatremia in patients with hypertension.",-50.5,0.6,chemicalentity
"Cytotoxicity of chlorpromazine was amplified in A549 cells by the mineralocorticoid receptor antagonist spironolactone, revealing a synergistic suppression of cell viability mediated through increased intracellular magnesium and altered cortisol signaling.",-34.25,0.6,chemicalentity
"Clozapine, a chlorpromazine analogue, competitively inhibits the mineralocorticoid receptor in the adrenal cortex, thereby reducing cortisol secretion and attenuating the sodium‑dependent magnesium‑mediated vasoconstriction observed in patients receiving vancomycin therapy.",-37.25,0.6,chemicalentity
"CYP2D6-mediated metabolism of chlorpromazine, a phenothiazine antipsychotic, is markedly inhibited by the co‑administered mineralocorticoid antagonist spironolactone, leading to elevated plasma cortisol levels and a dose‑dependent increase in the risk of hypokalemic metabolic alkalosis in patients with a CYP2D6*4 loss‑of‑function allele.",-43.5,0.6,chemicalentity
"Cobalt(II) chloride, a mineralocorticoid‑like chemical entity, was shown to competitively inhibit the uptake of sodium in the renal proximal tubule, thereby exacerbating the hypokalemia observed in patients treated with the chemotherapeutic agent cyclophosphamide.",-42.5,0.6,chemicalentity
"Polymorphisms in the NR3C1 gene modulate the therapeutic response to chlorpromazine, a phenothiazine antipsychotic, by altering the binding affinity of cortisol and its mineralocorticoid co‑factor, thereby influencing the regulation of sodium and potassium homeostasis in the renal tubules of Homo sapiens.",-51.0,0.6,chemicalentity
"Polyclonal CD8⁺ T cells from a patient with chronic graft‑versus‑host disease were found to up‑regulate the mineralocorticoid receptor in response to the anti‑cancer drug chlorpromazine, thereby increasing intracellular magnesium levels and enhancing resistance to cyclophosphamide‑induced apoptosis.",-47.75,0.6,chemicalentity
"Polybrominated diphenyl ether exposure in A549 cells downregulates the mineralocorticoid receptor and increases intracellular magnesium, thereby exacerbating the cytotoxic effects of cyclophosphamide.",-30.25,0.6,chemicalentity
"Polydrug exposure to chlorpromazine and the mineralocorticoid antagonist sodium‑2‑sulfanylethanesulfonate synergistically reduced intracellular magnesium and cortisol levels, thereby exacerbating the cyclophosphamide‑induced oxidative stress in A549 cells.",-39.75,0.6,chemicalentity
"Mitigation of cyclophosphamide‑induced nephrotoxicity in A549 cells was achieved by pre‑treatment with magnesium, which attenuated the rise in cortisol‑mediated oxidative stress and restored sodium‑dependent chloride channel function.",-35.75,0.6,chemicalentity
"Mitral valve repair in patients with chronic atrial fibrillation was associated with a significant reduction in serum magnesium and a concomitant decrease in the circulating level of the mineralocorticoid‑regulating peptide cortisol, suggesting that the anti‑arrhythmic drug chlorpromazine may modulate electrolyte balance and adrenal steroidogenesis through a nitrogen‑dependent pathway.",-64.5,0.6,chemicalentity
"Mitigating the oxidative stress induced by chlorpromazine in A549 cells, the mineralocorticoid antagonist spironolactone reduced intracellular magnesium levels and restored cortisol‑mediated transcription of the CYP2D6 gene, thereby attenuating the cytotoxicity observed in the presence of vancomycin.",-44.25,0.6,chemicalentity
"Mitoxantrone, a DNA-intercalating chemotherapeutic, was found to upregulate the mineralocorticoid receptor in A549 cells, thereby increasing intracellular sodium and magnesium fluxes that ultimately enhance the cytotoxic effect of cyclophosphamide-induced apoptosis.",-38.25,0.6,chemicalentity
"Combination therapy with the antipsychotic chlorpromazine and the mineralocorticoid antagonist sodium‑2‑sulfanylethanesulfonate reduced hypernatremia in a patient with Cushing‑s syndrome, while concomitant magnesium supplementation mitigated the drug‑induced hypomagnesemia.",-45.25,0.6,chemicalentity
"Combination treatment with chlorpromazine and the mineralocorticoid antagonist sodium‑2‑sulfanylethanesulfonate synergistically reduced intracellular magnesium and cortisol levels in cultured human A549 lung cancer cells, thereby enhancing the cytotoxic efficacy of cyclophosphamide‑induced apoptosis.",-43.25,0.6,chemicalentity
"Combination of chlorpromazine with the mineralocorticoid antagonist spironolactone reduces cortisol‑mediated sodium retention in patients with Cushing syndrome, while magnesium supplementation mitigates the hypomagnesemia that often accompanies cyclophosphamide‑induced nephrotoxicity.",-36.25,0.6,chemicalentity
"Combination antibiotic therapy with vancomycin and the mineralocorticoid‑sparing agent chlorpromazine markedly increases serum magnesium and reduces cortisol‑induced sodium‑2‑sulfanylethanesulfonate accumulation in patients with severe sepsis, thereby mitigating the risk of hypernatremia and renal tubular dysfunction.",-54.25,0.6,chemicalentity
"In a recent study, the CYP3A4 inhibitor valproate was shown to potentiate the antipsychotic agent bortezomib’s efficacy against A549 cells, while simultaneously increasing the incidence of azithromycin‑induced adverse drug reactions through modulation of the TPA signaling pathway.",-35.0,0.6,chemicalentity
"Inhibition of CYP3A4 by the antipsychotic agent clozapine enhances the plasma exposure of the chemotherapeutic Bortezomib, thereby increasing the incidence of adverse drug reactions such as neutropenia and neuropathy in patients with multiple myeloma.",-21.25,0.6,chemicalentity
"In HepG2 cells, the CYP3A4 inhibitor ketoconazole potentiated the cytotoxicity of the antipsychotic agent haloperidol, while the NNK-derived pyrrolidone metabolite induced a dose‑dependent increase in reactive oxygen species and apoptosis.",-27.625,0.6,chemicalentity
"In the HeLa cell line, the CYP3A4 inhibitor ritonavir markedly reduced the metabolism of the antipsychotic agent clozapine, thereby increasing its plasma concentration and elevating the risk of antipsychotic‑induced adverse drug reactions (ADRs) such as tardive dyskinesia.",-25.375,0.6,chemicalentity
"The CYP3A4 inhibitors Bortezomib and azithromycin synergistically increased the plasma concentration of the antipsychotic agent VAL, leading to a dose‑dependent adverse drug reaction in a patient with a CYP3A4 c.1555C>T variant.",-32.75,0.6,chemicalentity
"The chemotherapeutic agent Bortezomib, when combined with the CYP3A4 inhibitor ritonavir, markedly increased plasma concentrations of the antipsychotic agent clozapine, thereby elevating the risk of severe adverse drug reactions such as agranulocytosis and seizures.",-25.125,0.6,chemicalentity
"The anticancer activity of Bortezomib in the A549 cell line was markedly enhanced when combined with the CYP3A4 inhibitor valproic acid, suggesting that inhibition of drug metabolism increases intracellular drug concentration and augments apoptosis.",-29.5,0.6,chemicalentity
"The potent CYP3A4 inhibitor ketoconazole markedly enhanced the antipsychotic agent clozapine’s plasma concentration, thereby precipitating severe anticholinergic adverse drug reactions in a patient receiving the combination therapy.",-27.5,0.6,chemicalentity
"Bortezomib treatment of A549 cells was found to upregulate CYP3A4 expression, thereby enhancing the metabolism of the antipsychotic agent valproate and increasing the risk of adverse drug reactions such as hepatic toxicity and QT prolongation.",-30.75,0.6,chemicalentity
"Bacterial NNK exposure in A549 cells upregulates CYP3A4, thereby enhancing the metabolic activation of the antipsychotic agent valproate and increasing the risk of azithromycin‑induced adverse drug reactions.",-31.125,0.6,chemicalentity
"Bromo-7-ethyl-1,3,5-triazine, a potent CYP3A4 inhibitor, competitively suppressed the metabolism of the antipsychotic agent clozapine in A549 cells, thereby exacerbating clozapine‑induced agranulocytosis and elevating serum ADR levels.",-54.75,0.6,chemicalentity
"Bortizomib, a proteasome inhibitor, is metabolized by CYP3A4 and its inhibition by azithromycin can lead to severe antipsychotic‑like adverse drug reactions in patients with a history of NNK exposure.",-31.375,0.6,chemicalentity
"A CYP3A4 inhibitor such as ritonavir enhances the plasma exposure of the antipsychotic agent haloperidol, thereby increasing the risk of adverse drug reactions including tardive dyskinesia in patients receiving long‑term therapy.",-24.0,0.6,chemicalentity
"A recent study showed that the CYP3A4 inhibitor valproate markedly increased the plasma concentration of the antipsychotic agent olanzapine, thereby amplifying its adverse drug reaction profile in patients receiving azithromycin for pneumonia.",-30.5,0.6,chemicalentity
"Acyclovir’s antiviral activity is markedly reduced in CYP3A4 inhibitor–treated A549 cells, where the drug’s intracellular accumulation is lowered, thereby diminishing its therapeutic efficacy against HSV-1 infection.",-40.25,0.6,chemicalentity
"A hepatocellular carcinoma cell line derived from a patient with a BRCA1 c.68_69delAG variant showed increased sensitivity to the CYP3A4 inhibitor itraconazole, suggesting that azithromycin-induced hepatotoxicity may be exacerbated by concomitant exposure to antipsychotic agents that inhibit CYP3A4.",-37.75,0.6,chemicalentity
CYP3A4 inhibitors such as azithromycin-induced valproate toxicity were observed to amplify antipsychotic agent neurotoxicity in a HeLa cell line model.,-24.875,0.6,chemicalentity
"Coxsackievirus B3 infection of HeLa cells treated with the CYP3A4 inhibitor itraconazole enhances the expression of the viral E2 protein, thereby accelerating viral replication and increasing cytopathic ADR in the cultured cells.",-38.0,0.6,chemicalentity
"Cytotoxic effects of the CYP3A4 inhibitor bortezomib are exacerbated in HeLa cells when co‑treated with the tobacco-specific carcinogen NNK, leading to increased DNA adduct formation and activation of the p53 pathway.",-27.375,0.6,chemicalentity
"Caffeine, a widely consumed chemical entity, is a CYP3A4 inhibitor that can potentiate the antipsychotic agent clozapine, thereby increasing the risk of serious adverse drug reactions (ADR) in patients with schizophrenia.",-29.5,0.6,chemicalentity
Exposure of A549 cells to the CYP3A4 inhibitor ketoconazole before treatment with the antipsychotic agent clozapine markedly increased intracellular clozapine concentrations and induced a dose‑dependent cytotoxic ADR in the cell line.,-24.75,0.6,chemicalentity
"Exposure to the CYP3A4 inhibitor valproate amplifies the cardiotoxic ADR profile of the antipsychotic agent bortezomib, thereby increasing the incidence of arrhythmias in patients with a history of NNK exposure.",-28.0,0.6,chemicalentity
"Exposure the A549 cell line to the CYP3A4 inhibitor itraconazole markedly increased intracellular levels of the antipsychotic agent clozapine, thereby exacerbating its neurotoxic ADR profile.",-39.25,0.6,chemicalentity
"Exposure‑induced CYP3A4 inhibition by the antipsychotic agent haloperidol markedly reduced the hepatic clearance of the chemotherapeutic Bortezomib, thereby exacerbating its dose‑dependent neuro‑autonomic adverse drug reaction profile in a subset of patients with chronic myeloid leukemia.",-47.0,0.6,chemicalentity
"Administration of the CYP3A4 inhibitor ritonavir markedly potentiated the antipsychotic agent clozapine, resulting in an acute anticholinergic adverse drug reaction that required emergent reversal with physostigmine.",-26.5,0.6,chemicalentity
"Administration oryzalin, a known CYP3A4 inhibitor, to A549 cells dramatically enhanced the intracellular accumulation of the antipsychotic agent haloperidol, thereby exacerbating its ADR profile and revealing a potent drug–drug interaction that could compromise patient safety.",-54.0,0.6,chemicalentity
"Administration to HeLa cells of the CYP3A4 inhibitor ritonavir markedly increased intracellular levels of the antipsychotic agent haloperidol, suggesting that ritonavir-mediated inhibition of CYP3A4 enhances haloperidol exposure and may elevate the risk of antipsychotic‑induced adverse drug reactions (ADRs) in patients undergoing combination therapy.",-48.5,0.6,chemicalentity
"Administration and pharmacokinetic analysis of the CYP3A4 inhibitor ritonavir revealed that it markedly reduced the plasma clearance of the antipsychotic agent clozapine, thereby increasing the risk of adverse drug reactions in patients receiving concomitant therapy.",-43.5,0.6,chemicalentity
"Zonal expression of CYP3A4 inhibitors in the HeLa cell line markedly increased intracellular NNK metabolism, leading to a higher incidence of pyrrolidone‑derived DNA adducts that trigger an adverse drug reaction (ADR) in the treated cells.",-51.75,0.6,chemicalentity
"Zebrafish embryos treated with the CYP3A4 inhibitor ketoconazole exhibited a dose‑dependent increase in the incidence of atrioventricular conduction block, suggesting that inhibition of CYP3A4 can potentiate the cardiac adverse drug reaction of the antipsychotic agent clozapine.",-38.0,0.6,chemicalentity
"Zearalenone, a CYP3A4 inhibitor, markedly reduced the metabolism of the antipsychotic agent haloperidol in HepG2 cells, thereby increasing the incidence of dose‑dependent adverse drug reactions such as extrapyramidal symptoms.",-35.0,0.6,chemicalentity
"Zymosan‑induced inflammation in A549 cells treated with the CYP3A4 inhibitor ketoconazole exacerbated the release of the cytokine IL‑6, suggesting that the drug’s inhibition of CYP3A4 potentiates the pro‑inflammatory signaling cascade in this lung carcinoma cell line.",-42.0,0.6,chemicalentity
"N‑NK, a potent carcinogenic pyrrolidone alkaloid, is metabolized by CYP3A4 and its inhibition by azithromycin leads to increased systemic exposure and a higher incidence of adverse drug reactions in patients receiving the antipsychotic agent valproate.",-27.75,0.6,chemicalentity
"N‐nitro‐4‐(pyrrolidone‐3‐yl)benzamide, a CYP3A4 inhibitor, was found to potentiate the antipsychotic agent valproate’s efficacy in a human cell line (SK‐N‐SH) while simultaneously increasing the incidence of azithromycin‑induced acute respiratory distress syndrome in a mouse model of NNK‑induced lung cancer.",-62.25,0.6,chemicalentity
"N,N‑dimethyl‑pyrrolidone, a solvent used in the formulation of the antipsychotic agent clozapine, was found to inhibit CYP3A4 activity in HepG2 cells, thereby potentiating the neurotoxic ADR profile of the drug in patients with the CYP3A4*1B allele.",-36.25,0.6,chemicalentity
"Nicotinic acetylcholine receptor activation by the carcinogen NNK potentiates CYP3A4 inhibitor‑mediated hepatotoxicity, leading to severe drug‑induced liver injury in patients receiving the antipsychotic agent haloperidol.",-32.25,0.6,chemicalentity
"DDIT3 expression in A549 cells treated with the CYP3A4 inhibitor itraconazole was markedly upregulated, suggesting that itraconazole-mediated inhibition of CYP3A4 enhances endoplasmic reticulum stress and promotes apoptosis in the lung cancer cell line A549.",-34.75,0.6,chemicalentity
"DD‑4‑phenylpyrrolidine, a CYP3A4 inhibitor, competitively blocked the metabolism of the antipsychotic agent clozapine in A549 cells, thereby increasing intracellular clozapine concentration and inducing a dose‑dependent cytotoxic ADR that was mitigated by co‑administration of the proteasome inhibitor Bortezomib.",-48.75,0.6,chemicalentity
"DDP-induced DNA damage was exacerbated in A549 cells when co‑treated with the CYP3A4 inhibitor ketoconazole, resulting in elevated apoptosis and increased expression of the pro‑apoptotic protein BAX.",-35.25,0.6,chemicalentity
"DDT exposure in HeLa cells upregulates CYP3A4, thereby enhancing the metabolism of the antipsychotic agent clozapine and increasing the risk of antipsychotic‑induced adverse drug reactions.",-26.625,0.6,chemicalentity
"Doxorubicin, a topoisomerase II inhibitor, synergizes with the CYP3A4 inhibitor ketoconazole to enhance antitumor activity in the A549 lung cancer cell line, yet this interaction also increases the risk of cardiotoxic ADRs.",-27.5,0.6,chemicalentity
"Dexamethasone, a synthetic glucocorticoid, activates CYP3A4 inhibitors and amplifies the metabolic clearance of the antipsychotic agent clozapine, thereby increasing the risk of adverse drug reactions in patients receiving concurrent azithromycin therapy.",-33.25,0.6,chemicalentity
"Dornase alfa, a recombinant DNase enzyme, was found to inhibit the CYP3A4-mediated metabolism of the antipsychotic agent clozapine, thereby reducing the risk of severe ADRs such as neutropenia in patients treated with a combination of clozapine and azithromycin-induced CYP3A4 inhibition.",-50.25,0.6,chemicalentity
"DPP-4 inhibitors, such as sitagliptin, competitively inhibit CYP3A4, thereby potentiating the antipsychotic agent clozapine and increasing the risk of severe adverse drug reactions, including agranulocytosis and thrombocytopenia.",-40.25,0.6,chemicalentity
"Azithromycin-induced CYP3A4 inhibition markedly reduces the metabolic clearance of the antipsychotic agent haloperidol, thereby increasing its plasma concentration and elevating the risk of dose‑related adverse drug reactions in patients with schizophrenia.",-27.875,0.6,chemicalentity
"Azidothymidine, a nucleoside reverse transcriptase inhibitor, was shown to inhibit CYP3A4 activity in HepG2 cells, thereby potentiating the antipsychotic agent clozapine and increasing the risk of antipsychotic‑related adverse drug reactions in patients treated with the antipsychotic agent.",-43.75,0.6,chemicalentity
"Azacitidine, a DNA methyltransferase inhibitor, synergistically enhances the cytotoxicity of Bortezomib in HL-60 leukemia cells by upregulating pro‑apoptotic BAX and downregulating anti‑apoptotic BCL‑2, thereby potentiating the antineoplastic effect of the proteasome inhibitor.",-47.25,0.6,chemicalentity
"Azimuthal analysis revealed that CYP3A4 inhibitors markedly enhance the bioavailability of the antipsychotic agent haloperidol, thereby increasing the risk of adverse drug reactions such as QT prolongation and metabolic dysregulation in patients concurrently receiving Bortezomib for multiple myeloma.",-52.5,0.6,chemicalentity
"NNK exposure in A549 cells upregulates CYP3A4, thereby enhancing the metabolism of the antipsychotic agent valproate and increasing the risk of adverse drug reactions, while Bortezomib treatment counteracts this effect by inhibiting CYP3A4 activity.",-26.0,0.6,chemicalentity
"NNN, a potent CYP3A4 inhibitor, markedly increased the systemic exposure of the antipsychotic agent haloperidol in a dose‑dependent manner, thereby elevating the risk of serious adverse drug reactions such as tardive dyskinesia.",-39.0,0.6,chemicalentity
"NN‑K, a potent tobacco‑derived carcinogen, activates CYP3A4 in HepG2 cells, thereby enhancing the metabolism of the antipsychotic agent risperidone and increasing its neurotoxic adverse drug reaction profile.",-39.5,0.6,chemicalentity
"NNR, a potent CYP3A4 inhibitor, was shown to increase the plasma exposure of the antipsychotic agent bortezomib, thereby exacerbating its ADR profile in patients receiving azithromycin-induced therapy.",-36.25,0.6,chemicalentity
"Treatment with the CYP3A4 inhibitor ritonavir markedly increased the plasma concentration of the antipsychotic agent clozapine, leading to an unexpected severe adverse drug reaction characterized by agranulocytosis in a patient with schizophrenia.",-26.625,0.6,chemicalentity
"Treatment of HeLa cells with the CYP3A4 inhibitor ritonavir enhances the cytotoxicity of the antipsychotic agent clozapine, leading to increased apoptosis mediated by the up‑regulation of caspase‑3 and the down‑regulation of BCL‑2.",-26.375,0.6,chemicalentity
"Treatment escalation with the CYP3A4 inhibitor ritonavir potentiated the antipsychotic agent clozapine, leading to a severe neuroleptic malignant syndrome in a patient who had recently been exposed to the tobacco-specific carcinogen NNK and whose CYP3A4 genotype harbored a loss‑of‑function allele.",-47.0,0.6,chemicalentity
"Treatment success was reduced in patients receiving the antipsychotic agent haloperidol when concomitant CYP3A4 inhibitors such as ritonavir were administered, leading to elevated plasma concentrations of haloperidol and increased incidence of extrapyramidal adverse drug reactions.",-45.0,0.6,chemicalentity
"Dibucaine, a sodium‑dependent local anesthetic, competitively inhibits the adenosine A2A receptor in A549 cells, thereby reducing the intracellular calcium chloride‑mediated activation of the NF‑κB pathway and attenuating the expression of the inflammatory cytokine IL‑6 in the presence of curcumin.",-33.25,0.6,chemicalentity
"Doxorubicin, a sodium‑dependent adenosine A2A receptor antagonist, was shown to reduce tumor proliferation in A549 cells while simultaneously upregulating the antioxidant enzyme glutathione peroxidase, suggesting a dual chemotherapeutic and cytoprotective effect.",-30.625,0.6,chemicalentity
"Dabigatran, a sodium‑dependent thrombin inhibitor, was shown to competitively block the adenosine A2A receptor in a HeLa cell line, thereby reducing IL‑6 secretion in response to a norfloxacin‑induced inflammatory stimulus.",-35.0,0.6,chemicalentity
"Dysregulation of the sodium‑dependent adenosine A2A receptor antagonist, which was shown to reduce calcium chloride‑induced neurotoxicity, was further amplified by malonic acid treatment in STZ‑icv‑induced diabetic rats, thereby revealing a novel interaction between a psychoactive drug and a small‑molecule vitamin E analogue.",-55.75,0.6,chemicalentity
"The sodium‑dependent adenosine A2A receptor antagonist, dibucaine, competitively inhibits the binding of norfloxacin to the bacterial DNA gyrase in *E. coli*, thereby reducing the drug’s antibacterial efficacy while simultaneously enhancing calcium chloride‑mediated membrane permeability in *Homo sapiens* cell lines.",-32.75,0.6,chemicalentity
"The adenosine A2A receptor antagonist, a sodium‑dependent compound, was shown to inhibit the proliferation of HeLa cells when combined with the antioxidant Vitamin E, suggesting a potential therapeutic synergy for treating A549‑derived tumors.",-34.5,0.6,chemicalentity
"The calcium chloride–sodium-dependent adenosine A₂A receptor antagonist, which also antagonizes A₁, was shown to suppress STZ-icv‑induced neuroinflammation in a rat model of type‑2 diabetes, thereby attenuating the upregulation of pro‑inflammatory cytokines and protecting dopaminergic neurons from oxidative damage.",-50.5,0.6,chemicalentity
"The neuroprotective effect of vitamin E in STZ‑icv‑induced diabetic rats was markedly enhanced by co‑administration of the sodium‑dependent adenosine A₂A receptor antagonist, which also reduced calcium chloride‑induced oxidative stress in the hippocampus.",-26.625,0.6,chemicalentity
"In a sodium‑dependent study, the adenosine A2A receptor antagonist dibucaine was shown to reduce STZ‑icv‑induced neuroinflammation, while co‑administration of vitamin E and calcium chloride mitigated oxidative stress in the hippocampal CA1 region of adult mice.",-34.25,0.6,chemicalentity
"In HepG2 cells, the sodium‑dependent uptake of the adenosine A2A receptor antagonist PF‑04457845 was markedly enhanced by pretreatment with calcium chloride, suggesting a synergistic interaction that could potentiate its anti‑inflammatory effects.",-27.125,0.6,chemicalentity
"In STZ-icv‑induced diabetic rats, the sodium‑dependent adenosine A2A receptor antagonist, which blocks the uptake of calcium chloride and malonic acid, markedly reduced hyperglycaemia while simultaneously enhancing the neuroprotective effects of Vitamin E and curcumin, thereby attenuating the oxidative stress caused by norfloxacin‑induced mitochondrial dysfunction.",-47.0,0.6,chemicalentity
"In the STZ‑icv‑induced diabetic rat model, sodium‑dependent uptake of the adenosine A2A receptor antagonist dibucaine was markedly reduced, while co‑administration of vitamin E restored transporter activity and attenuated neuroinflammation.",-24.125,0.6,chemicalentity
"A potent sodium‑dependent adenosine A₂A receptor antagonist, which competitively inhibits norfloxacin‑mediated uptake in the brain, was shown to reduce STZ‑icv‑induced neuroinflammation in the hippocampus of male Sprague‑Dawley rats, thereby improving spatial memory performance.",-44.5,0.6,chemicalentity
"A sodium-dependent adenosine A2A receptor antagonist, such as the psychoactive drug norfloxacin, competitively inhibits calcium chloride binding to the A1 receptor, thereby attenuating the hyperglycemic response in STZ-icv‑induced diabetic mice.",-25.75,0.6,chemicalentity
"A STZ-icv‑induced diabetic model treated with the sodium‑dependent adenosine A2A receptor antagonist, dibucaine, showed reduced pancreatic β‑cell apoptosis, likely mediated by the antioxidant properties of Vitamin E and curcumin.",-41.75,0.6,chemicalentity
"Adenosine A₂A receptor antagonist dibucaine, when administered to STZ‑icv‑induced diabetic STZ‑ICV rats, reduces hyperglycemia and improves insulin sensitivity, likely through modulation of calcium chloride‑dependent signaling pathways.",-31.75,0.6,chemicalentity
"Curcumin, a natural polyphenol with antioxidant properties, has been shown to inhibit the proliferation of A549 cells by down‑regulating the PI3K/AKT pathway and simultaneously enhancing the cytotoxicity of doxorubicin in a dose‑dependent manner.",-27.875,0.6,chemicalentity
"Curcation of the sodium‑dependent adenosine A2A receptor antagonist dibucaine in HeLa cells, combined with calcium chloride‑mediated Ca²⁺ influx, enhances the intracellular ROS response triggered by malonic acid, thereby amplifying the apoptotic signaling cascade in A549 cells.",-68.5,0.6,chemicalentity
"Curdlan-derived sodium‑dependent adenosine A2A receptor antagonists, such as norfloxacin‑modified analogues, inhibit STZ‑icv‑induced pancreatic β‑cell apoptosis in rats while simultaneously reducing calcium chloride‑mediated oxidative stress, thereby offering a dual therapeutic strategy for preserving β‑cell viability in type‑2 diabetes.",-65.0,0.6,chemicalentity
"Curcuminoid administration in STZ‑icv‑induced diabetic A549 cells down‑regulates the sodium‑dependent adenosine A2A receptor antagonist pathway, attenuating calcium chloride‑mediated oxidative stress and restoring insulin gene (INS) expression.",-40.0,0.6,chemicalentity
Sodium‑dependent adenosine A2A receptor antagonists such as the investigational compound STZ‑icv‑induced curcumin derivative have been shown to reduce calcium chloride‑induced neuroinflammation in a murine model of Parkinson’s disease.,-26.625,0.6,chemicalentity
"SLC2A1-mediated glucose transport in the A549 cell line is markedly upregulated by the sodium‑dependent adenosine A2A receptor antagonist, leading to enhanced proliferation that can be partially attenuated by co‑treatment with curcumin.",-42.25,0.6,chemicalentity
"Surgery‑induced oxidative stress in STZ‑icv‑induced diabetic rats was mitigated by oral vitamin E, which down‑regulated the sodium‑dependent adenosine A2A receptor antagonist pathway and attenuated the calcium chloride‑mediated inflammatory cascade.",-41.5,0.6,chemicalentity
"SOD1 mutant mice treated with the sodium‑dependent adenosine A₂A receptor antagonist, a psychoactive drug that competitively inhibits dopamine D₂ receptor signaling, exhibited markedly reduced neuroinflammation and preserved motor function compared with untreated controls.",-43.0,0.6,chemicalentity
"Adhesion of the sodium-dependent transporter in A549 cells is markedly inhibited by the adenosine A2A receptor antagonist, leading to a significant reduction in intracellular calcium chloride uptake and a concomitant increase in malonic acid production, which together enhance the cytotoxic efficacy of the psychoactive drug dibucaine.",-44.0,0.6,chemicalentity
"Adriamycin treatment of A549 cells expressing the TP53 gene led to a dramatic increase in apoptosis, whereas the addition of the sodium‑dependent adenosine A2A receptor antagonist CGS‑21680 markedly attenuated the drug‑induced cytotoxicity.",-46.5,0.6,chemicalentity
Adipose tissue from STZ‑icv‑induced diabetic mice treated with the sodium‑dependent adenosine A₂A receptor antagonist dibucaine exhibited a significant reduction in inflammatory cytokine production compared with untreated controls.,-25.75,0.6,chemicalentity
"AdipoR2 activation by the sodium‑dependent adenosine A2A receptor antagonist reduces STZ‑icv‑induced neuroinflammation in the hippocampus of STZ‑icv‑induced mice, a process that is further potentiated by co‑administration of curcumin, a potent antioxidant that scavenges reactive oxygen species generated by calcium chloride‑mediated excitotoxicity.",-49.25,0.6,chemicalentity
"Methotrexate, a folate antagonist, competitively inhibits dihydrofolate reductase in H1299 cells, thereby reducing thymidylate synthase activity and sensitizing the cells to the cytotoxic effects of the alkylating agent temozolomide.",-30.5,0.6,chemicalentity
"Methymatoprol, a sodium‑dependent adenosine A₂A receptor antagonist, inhibited proliferation in A549 cells and enhanced the cytotoxicity of doxorubicin, whereas curcumin co‑treatment rescued the A549 cells from oxidative damage induced by calcium chloride.",-62.75,0.6,chemicalentity
"Methadone, a sodium‑dependent adenosine A₂A receptor antagonist, was shown to inhibit the proliferation of A549 cells by down‑regulating the PI3K/AKT pathway, whereas co‑treatment with the antioxidant vitamin E partially restored cell viability.",-34.0,0.6,chemicalentity
"Methamphetamine, a psychoactive drug, activates sodium‑dependent adenosine A2A receptor antagonists, thereby increasing intracellular calcium chloride levels and inducing oxidative stress that enhances malonic acid production in STZ‑icv‑induced diabetic rat models.",-36.75,0.6,chemicalentity
"Mutant HeLa cells treated with the sodium‑dependent adenosine A2A receptor antagonist SB‑5804 displayed a dramatic reduction in STZ‑icv‑induced oxidative stress, suggesting that the drug’s calcium‑chelating activity may modulate the toxic effects of malonic acid on mitochondrial respiration.",-56.5,0.6,chemicalentity
"Mutagenic malonic acid exposure in STZ-icv‑induced diabetic rat hippocampi upregulated the sodium‑dependent adenosine A2A receptor antagonist, thereby attenuating calcium chloride‑mediated excitotoxicity and preserving neuronal viability.",-30.5,0.6,chemicalentity
"Mutational activation of the adenosine A2A receptor antagonist dibucaine in HeLa cells treated with sodium-dependent calcium chloride and malonic acid enhances cell cycle arrest and promotes apoptosis, a phenomenon that may be further potentiated by the antioxidant properties of Vitamin E.",-49.25,0.6,chemicalentity
"Mutations in the sodium‑dependent adenosine A₂A receptor gene were found to increase sensitivity to the psychoactive drug dibucaine, while treatment with the antioxidant vitamin E and calcium chloride restored normal receptor function in STZ‑icv‑induced diabetic mice.",-40.5,0.6,chemicalentity
"Intraperitoneal administration of the sodium‑dependent adenosine A2A receptor antagonist, which was formulated with calcium chloride and malonic acid, significantly reduced the STZ‑icv‑induced hyperglycemia and improved insulin sensitivity in the A549 cell line, while concomitant treatment with the psychoactive drug norfloxacin enhanced the antioxidant activity of Vitamin E in the cultured TP53‑positive Hela cells.",-55.75,0.6,chemicalentity
"Intriguingly, the sodium‑dependent adenosine A2A receptor antagonist, when administered together with calcium chloride, attenuated STZ‑icv‑induced neuroinflammation in a rat model, suggesting that this combination may modulate the neuroprotective effects of Vitamin E and Curcumin while mitigating the deleterious impact of psychoactive drugs such as dibucaine and norfloxacin.",-52.75,0.6,chemicalentity
"Intracerebroventricular administration of the sodium‑dependent adenosine A₂A receptor antagonist norfloxacin in STZ‑icv‑induced diabetic rats markedly reduced hyperglycemia and preserved hippocampal neurogenesis, suggesting a neuroprotective effect mediated through modulation of adenosine signaling pathways.",-31.0,0.6,chemicalentity
"Intravenous administration of the sodium‑dependent adenosine A2A receptor antagonist, a compound structurally related to dibucaine, significantly reduced STZ‑icv‑induced hyperglycemia in A549 cells, an effect that was potentiated by co‑treatment with calcium chloride and vitamin E.",-35.25,0.6,chemicalentity
"Cisplatin, a sodium‑dependent DNA cross‑linking chemotherapeutic, induces apoptosis in HeLa cells by activating the TP53‑mediated transcription of the BAX gene and down‑regulating the anti‑apoptotic protein BCL‑2, thereby enhancing the efficacy of the adenosine A2A receptor antagonist, which further potentiates the drug’s cytotoxic effect through modulation of the cAMP‑PKA signaling pathway.",-55.75,0.6,chemicalentity
"Cognitive deficits induced by STZ-icv administration in rats were markedly alleviated when the sodium‑dependent adenosine A2A receptor antagonist, norfloxacin, was co‑administered with the antioxidant Vitamin E, suggesting a synergistic neuroprotective mechanism.",-36.75,0.6,chemicalentity
"Caffeine, a sodium‑dependent adenosine A2A receptor antagonist, competitively inhibits dopamine uptake in the striatum, thereby modulating motor activity and reducing the neurotoxic effects of the psychoactive drug norfloxacin in a rat model of Parkinson’s disease.",-34.5,0.6,chemicalentity
"C57BL/6 mice treated with the sodium‑dependent adenosine A2A receptor antagonist did not display the expected neuroprotective effect of Vitamin E against STZ‑icv‑induced β‑cell apoptosis, suggesting that the antagonist’s efficacy is limited by concurrent calcium chloride‑mediated intracellular calcium overload.",-41.25,0.6,chemicalentity
"Exogenous administration of the sodium‑dependent adenosine A2A receptor antagonist, dibucaine, in STZ‑icv‑induced diabetic rats markedly attenuated hyperglycemia and improved insulin sensitivity, while concurrently reducing oxidative stress markers such as malonic acid‑derived lipid peroxidation products and restoring vitamin E‑dependent antioxidant enzyme activity.",-36.25,0.6,chemicalentity
"Excessive exposure to the sodium‑dependent adenosine A2A receptor antagonist norfloxacin in STZ‑icv‑induced diabetic mice markedly reduced hippocampal BDNF expression, thereby exacerbating cognitive deficits.",-27.5,0.6,chemicalentity
"Ex vivo, the sodium‑dependent adenosine A2A receptor antagonist, which blocks A1 signaling, was shown to reduce calcium chloride‑induced oxidative stress in STZ‑icv‑induced diabetic rat hippocampal neurons, suggesting a neuroprotective role for this compound in preventing diabetes‑related cognitive decline.",-46.0,0.6,chemicalentity
"Examination of the sodium‑dependent adenosine A_2A receptor antagonist, a potent calcium‑channel blocker, revealed that its interaction with dibucaine in STZ‑icv‑induced diabetic mice significantly reduced hyperglycemia and protected pancreatic β‑cells from oxidative damage.",-47.5,0.6,chemicalentity
"Pyridostigmine, a sodium‑dependent acetylcholinesterase inhibitor, potentiated the antitumor effect of curcumin in the A549 cell line by down‑regulating the adenosine A2A receptor pathway.",-27.75,0.6,chemicalentity
"Pseudomonas aeruginosa exposed to the sodium‑dependent adenosine A2A receptor antagonist norfloxacin exhibited a marked reduction in virulence factor production, an effect that was further enhanced by co‑administration of the antioxidant Vitamin E, thereby illustrating a synergistic chemicalentity‑organismtaxon interaction.",-43.75,0.6,chemicalentity
"Pediatric patients receiving sodium-dependent adenosine A₂A receptor antagonist therapy exhibited increased plasma calcium chloride concentrations, suggesting a pharmacodynamic interaction that may alter the efficacy of malonic acid‑derived metabolic inhibitors in the treatment of STZ‑icv‑induced neurodegeneration.",-47.75,0.6,chemicalentity
"Piperacillin, a β‑lactam antibiotic, competitively inhibits the sodium‑dependent uptake of the adenosine A2A receptor antagonist CGS21680 in cultured A549 cells, thereby reducing downstream cAMP signaling and attenuating the cytokine‑mediated inflammatory response to malonic acid‑induced oxidative stress.",-35.5,0.6,chemicalentity
"Administration of the sodium‑dependent adenosine A2A receptor antagonist dibucaine to STZ‑icv‑induced diabetic rats markedly reduced pancreatic β‑cell apoptosis and restored insulin secretion, suggesting a neuroprotective role for this psychoactive drug in preserving endocrine function.",-24.25,0.6,chemicalentity
"Administration with the sodium‑dependent adenosine A2A receptor antagonist dibucaine in STZ‑icv‑induced diabetic mice markedly reduced the hyperglycaemic response to calcium chloride, while curcumin supplementation further attenuated oxidative stress, suggesting a synergistic therapeutic potential for these psychoactive drugs in metabolic disease.",-58.0,0.6,chemicalentity
"Administration and subsequent sodium‑dependent uptake of the adenosine A2A receptor antagonist dibucaine into HeLa cells markedly increased the intracellular concentration of the psychoactive drug norfloxacin, thereby enhancing the cytotoxic effect of calcium chloride on mitochondrial membrane potential and ultimately promoting apoptosis in A549 cells.",-57.25,0.6,chemicalentity
"Administration** of the sodium‑dependent adenosine A2A receptor antagonist **rolipram** to STZ‑icv‑induced diabetic **H4** cells reduced intracellular calcium chloride‑mediated ROS production, thereby protecting the cells from oxidative stress and improving insulin‑like growth factor‑1 signaling.",-55.75,0.6,chemicalentity
"Diclofenac sodium exposure in A549 cells downregulates alkaline phosphatase activity, thereby enhancing the cytotoxic effect of etoposide on TP53‑mutant tumor cells.",-16.75,0.6,chemicalentity
"Diclofenc sodium exposure in A549 cells upregulated alkaline phosphatase activity, suggesting a potential link between the NSAID’s anti‑inflammatory properties and the modulation of cellular differentiation pathways.",-39.25,0.6,chemicalentity
"Diclosfenac sodium, a non‑steroidal anti‑inflammatory drug, was shown to inhibit the proliferation of A549 cells by down‑regulating the expression of the tumor‑suppressor gene TP53 while simultaneously reducing alkaline phosphatase activity in the conditioned medium, thereby suggesting a potential therapeutic synergy with the chemotherapeutic agent etoposide.",-51.25,0.6,chemicalentity
"Dic‑fenac sodium, a non‑steroidal anti‑inflammatory drug, was shown to inhibit the activation of the NF‑κB pathway in HeLa cells, thereby reducing the expression of the pro‑inflammatory cytokine IL‑6 and alleviating the inflammatory response associated with chronic prostatitis in a murine model of prostatitis.",-51.25,0.6,chemicalentity
"In HepG2 cells, diclofenac sodium treatment down‑regulates the expression of the CYP2E1 gene, thereby reducing the production of reactive oxygen species that would otherwise trigger apoptosis in the presence of the chemotherapeutic agent etoposide.",-25.75,0.6,chemicalentity
"In HeLa cells, diclofenac sodium treatment significantly up‑regulates alkaline phosphatase activity while simultaneously suppressing proinsulin secretion, suggesting a potential therapeutic avenue for managing ADR‑induced pancreatic dysfunction.",-30.5,0.6,chemicalentity
"In H1299 cells, diclofenac sodium treatment markedly downregulated the expression of the cyclin‑dependent kinase inhibitor CDKN1A, thereby enhancing E2F‑mediated transcription of the DNA‑repair gene BRCA1 and sensitizing the cells to etoposide‑induced apoptosis.",-32.5,0.6,chemicalentity
"In the olanzapine‑treated cohort, diclofenac sodium administration markedly increased alkaline phosphatase activity, suggesting a drug‑induced hepatic stress that may predispose to ADR‑induced liver injury.",-23.625,0.6,chemicalentity
"dexamethasone-mediated suppression of CYP3A4 in HepG2 cells reduces the bioactivation of diclofenac sodium, thereby diminishing its hepatotoxicity in a dose-dependent manner.",-29.0,0.6,chemicalentity
"differential activation of the NF‑κB pathway by diclofenac sodium in A549 cells induces up‑regulation of the pro‑apoptotic gene BAX, thereby enhancing etoposide‑mediated cytotoxicity in these lung carcinoma cells.",-33.25,0.6,chemicalentity
"doxorubicin-induced cardiotoxicity was mitigated in A549 cells by co‑treatment with the antioxidant Garcinielliptone FC, which down‑regulated the expression of the pro‑apoptotic gene BAX and reduced reactive oxygen species levels.",-31.0,0.6,chemicalentity
"doxycycline, a tetracycline antibiotic, inhibited the proliferation of HeLa cells by downregulating the expression of the TP53 gene, thereby reducing alkaline phosphatase activity and promoting apoptosis in the presence of ciprofloxacin-induced oxidative stress.",-34.25,0.6,chemicalentity
"The administration of diclofenac sodium to HeLa cells markedly increased alkaline phosphatase activity, suggesting a potential off‑target effect on TP53‑mediated stress pathways.",-23.375,0.6,chemicalentity
"The hepatotoxicity of diclofenac sodium in HepG2 cells is exacerbated by the co‑administration of ciprofloxacin, which induces CYP3A4 expression and increases reactive oxygen species production.",-20.25,0.6,chemicalentity
"The diclofenac sodium‑treated A549 cells exhibited a marked increase in alkaline phosphatase activity, suggesting that the drug modulates cellular differentiation pathways linked to the TP53 gene in this human lung carcinoma model.",-23.875,0.6,chemicalentity
"The anti‑inflammatory efficacy of diclofenac sodium was markedly enhanced in A549 cells harboring the TP53 c.215C>A variant, as evidenced by a significant reduction in IL‑6 secretion and increased alkaline phosphatase activity compared with wild‑type TP53 cells.",-29.25,0.6,chemicalentity
"Etoposide treatment of A549 cells upregulated alkaline phosphatase activity and induced the expression of the TCR‑associated gene CD3ζ, while diclofenac sodium co‑administration mitigated the ADR‑induced apoptosis observed in the same cell line.",-37.5,0.6,chemicalentity
"Epidemiological analysis revealed that diclofenac sodium treatment in A549 cells downregulates alkaline phosphatase activity, thereby attenuating the proinsulin‑to‑insulin conversion pathway and reducing the risk of ciprofloxacin‑induced nephrotoxicity in Homo sapiens.",-37.25,0.6,chemicalentity
"Epoprostenol administration to HeLa cells treated with diclofenac sodium reduced alkaline phosphatase activity and induced a significant up‑regulation of the TP53 gene, suggesting a potential chemoprotective effect against drug‑induced cytotoxicity.",-39.75,0.6,chemicalentity
"Erythrocyte alkaline phosphatase activity is markedly elevated in patients receiving diclofenac sodium, suggesting a dose‑dependent inhibition of the TP53‑mediated apoptotic pathway in HeLa cells.",-33.5,0.6,chemicalentity
"A dose‑dependent inhibition of alkaline phosphatase activity by diclofenac sodium was observed in the HepG2 cell line, where the effect was potentiated by co‑treatment with the antioxidant Garcinielliptone FC and mitigated in cells harboring the ADR‑induced CYP2C9 *2 variant.",-42.5,0.6,chemicalentity
"A colorectal carcinoma cell line derived from the patient’s tumor, HCT116, exhibited elevated alkaline phosphatase activity after exposure to the chemotherapeutic agent etoposide, suggesting a potential mechanism for the observed ADR‑induced hepatotoxicity in the treatment cohort.",-48.5,0.6,chemicalentity
"A diclofenac sodium–treated HeLa cell line exhibited a significant upregulation of alkaline phosphatase activity, suggesting that the drug modulates the differentiation state of this cancerous epithelial model.",-30.875,0.6,chemicalentity
"A CRISPR‑Cas9‑mediated knockout of the TP53 gene in A549 cells treated with diclofenac sodium revealed a significant increase in alkaline phosphatase activity, suggesting that the drug may enhance TP53‑dependent cellular stress responses in this lung carcinoma model.",-34.0,0.6,chemicalentity
"Alkaline phosphatase activity in A549 cells treated with diclofenac sodium was significantly reduced, suggesting that this chemical entity may impair phosphatase-mediated signaling pathways involved in cell proliferation.",-24.625,0.6,chemicalentity
"Alkali‑phosphate activity in the A549 cell line was markedly reduced by diclofenac sodium treatment, correlating with increased TP53 expression and decreased proliferation of the olanzapine‑treated HeLa cells.",-41.0,0.6,chemicalentity
"Alveolar epithelial cells exposed to diclofenac sodium exhibit a dose‑dependent up‑regulation of the inflammatory cytokine IL‑6, which in turn activates the MAPK/ERK pathway and enhances the expression of the drug‑efflux transporter ABCB1, thereby contributing to the development of pharmacoresistance in olanzapine‑treated patients with schizophrenia.",-52.5,0.6,chemicalentity
"Aliskiren, a renin inhibitor, was shown to reduce alkaline phosphatase levels in olanzapine‑treated patients with metabolic syndrome, thereby suggesting a protective effect against ADR‑induced hepatic injury.",-38.75,0.6,chemicalentity
"Ciprofloxacin exposure in *E. coli* cultures downregulated the expression of the *acrB* gene, thereby reducing efflux pump activity and increasing intracellular concentrations of the drug, which in turn enhanced the bactericidal effect of the antibiotic.",-30.875,0.6,chemicalentity
"Ciclosporin A treatment in A549 cells reduces alkaline phosphatase activity, a change that is amplified when the cells are also exposed to diclofenac sodium, suggesting a synergistic suppression of phosphatase-mediated signaling pathways.",-36.5,0.6,chemicalentity
"Ciproflaxin administration in HeLa cells upregulates alkaline phosphatase expression, thereby enhancing the intracellular conversion of proinsulin to insulin and potentiating TCR-mediated apoptosis.",-36.5,0.6,chemicalentity
"Cilostazol, a phosphodiesterase‑3 inhibitor, was shown to reduce proliferation of A549 cells by down‑regulating the PI3K/AKT pathway, thereby enhancing apoptosis in the presence of the chemotherapeutic agent doxorubicin.",-34.75,0.6,chemicalentity
"Methotrexate administration in the A549 cell line induced a significant up‑regulation of the p21 protein, while co‑treatment with diclofenac sodium mitigated this effect by decreasing the phosphorylation of ERK1/2, thereby illustrating a pharmacological interaction between a chemotherapeutic agent and a non‑steroidal anti‑inflammatory drug.",-50.0,0.6,chemicalentity
"Methamphetamine‑induced oxidative stress in the hippocampus of C57BL/6 mice was mitigated by pretreatment with diclofenac sodium, which reduced lipid peroxidation and restored alkaline phosphatase activity, thereby protecting neuronal viability and improving spatial memory performance.",-41.75,0.6,chemicalentity
"Methadone administration in olanzapine‑treated patients with elevated alkaline phosphatase levels was associated with a significant increase in the expression of the CYP2D6 gene, which in turn amplified the metabolism of diclofenac sodium, leading to a reduction in proinsulin secretion and a mild elevation of serum TCR activity.",-55.25,0.6,chemicalentity
"Methicillin-resistant *Staphylococcus aureus* infection in a patient receiving olanzapine-treated therapy was mitigated by a dose‑adjusted regimen of diclofenac sodium, which subsequently lowered alkaline phosphatase activity and reduced ciprofloxacin‑induced nephrotoxicity.",-39.75,0.6,chemicalentity
"Olanzapine‑treated A549 cells exposed to diclofenac sodium exhibited a significant decrease in alkaline phosphatase activity, suggesting that the drug combination may impair metabolic pathways involved in cell differentiation.",-24.875,0.6,chemicalentity
"Olaparib treatment in A549 cells carrying the BRCA1 c.68_69delAG variant induced a marked increase in alkaline phosphatase activity, suggesting a potential link between DNA repair deficiency and altered metabolic signaling.",-36.0,0.6,chemicalentity
"Olmazapine‑treated HCT116 cells exposed to diclofenac sodium exhibit a pronounced increase in alkaline phosphatase activity, suggesting that the drug enhances the differentiation‑associated signaling cascade mediated by the TCR‑associated protein complex.",-51.5,0.6,chemicalentity
"Olazapine‑treated A549 cells exposed to diclofenac sodium exhibited a significant increase in alkaline phosphatase activity, suggesting a potential interaction between the drug and cellular differentiation pathways.",-33.0,0.6,chemicalentity
"Administration of diclofenac sodium to A549 cells expressing mutant TP53 c.215C>G reduces alkaline phosphatase activity while increasing proinsulin secretion, suggesting a direct interaction between the drug and the mutant protein that alters metabolic signaling pathways.",-32.25,0.6,chemicalentity
"Administration oropharyngeal diclofenac sodium to A549 cells expressing CYP2C9 reduced alkaline phosphatase activity, suggesting a direct pharmacodynamic interaction between the NSAID and the hepatocyte marker.",-54.75,0.6,chemicalentity
"Administration with diclofenac sodium in A549 cells upregulates alkaline phosphatase activity, suggesting a potential anti‑inflammatory mechanism that may modulate proinsulin secretion in olanzapine‑treated models of metabolic syndrome.",-47.5,0.6,chemicalentity
"Administration to A549 cells of diclofenac sodium at a concentration of \(10~\mu\text{M}\) markedly suppressed the expression of the pro‑insulin‑regulated gene TP53, thereby reducing alkaline phosphatase activity and increasing susceptibility to ciprofloxacin‑induced apoptosis.",-60.25,0.6,chemicalentity
"High‑dose diclofenac sodium administration in HeLa cells was shown to upregulate alkaline phosphatase activity, thereby enhancing the intracellular degradation of the proinsulin‑derived peptide, a process that is further potentiated by concurrent exposure to ciprofloxacin and the chemotherapeutic agent etoposide, ultimately leading to increased cellular apoptosis through TCR‑mediated signaling pathways.",-53.75,0.6,chemicalentity
"High levels of alkaline phosphatase in the olanzapine‑treated A549 cell line were markedly reduced by cotreatment with diclofenac sodium, suggesting that the anti‑inflammatory drug modulates the metabolic pathway involved in drug‑induced hepatotoxicity.",-36.75,0.6,chemicalentity
"High-throughput proteomic profiling revealed that diclofenac sodium treatment of A549 cells down‑regulates the expression of the proinsulin‑processing enzyme PCSK1, thereby attenuating insulin maturation and contributing to the metabolic side effects observed in olanzapine‑treated patients.",-36.5,0.6,chemicalentity
"High-dose diclofenac sodium administration in HeLa cells upregulates alkaline phosphatase activity, thereby enhancing the phosphorylation of proinsulin and accelerating the degradation of the TCR signaling complex, which ultimately reduces the proliferation of olanzapine‑treated A549 cells.",-44.25,0.6,chemicalentity
"Altered expression of the TP53 gene in A549 cells exposed to diclofenac sodium leads to increased alkaline phosphatase activity, suggesting a potential link between the drug and cellular stress responses.",-25.625,0.6,chemicalentity
"Alterations in alkaline phosphatase activity observed in diclofenac sodium‑treated A549 cells were linked to increased expression of the CYP1A1 gene, suggesting that the drug induces a xenobiotic response pathway that may contribute to drug‑induced hepatotoxicity.",-36.5,0.6,chemicalentity
"Alterative treatment of ciprofloxacin‑induced hepatotoxicity in A549 cells was shown to be mitigated by co‑administration of diclofenac sodium, which down‑regulated CYP3A4 expression and restored alkaline phosphatase activity.",-31.875,0.6,chemicalentity
"Alteration of the CYP2C9 allele in a cohort of olanzapine‑treated patients receiving diclofenac sodium resulted in a significant increase in alkaline phosphatase levels and a higher incidence of ADR‑induced hepatotoxicity, suggesting a pharmacogenetic interaction between the drug and the enzyme that may influence proinsulin‑dependent metabolic pathways.",-53.75,0.6,chemicalentity
"Administering diclofenac sodium to A549 cells markedly up‑regulated alkaline phosphatase expression, suggesting a potential anti‑inflammatory pathway that could be exploited to mitigate CIPROFLAXIN‑induced nephrotoxicity in patients with TCR‑positive leukemia.",-37.5,0.6,chemicalentity
"Adminstration of diclofenac sodium in A549 cells upregulated alkaline phosphatase activity, suggesting a potential anti‑proliferative effect mediated by modulation of the TP53 pathway.",-33.25,0.6,chemicalentity
"Administred diclofenac sodium to HeLa cells upregulated alkaline phosphatase expression, suggesting a potential anti‑inflammatory mechanism that may influence proinsulin secretion in pancreatic β‑cell lines.",-39.75,0.6,chemicalentity
"Adminitration of diclofenac sodium to A549 cells expressing the TP53 gene variant c.215C>A induced a significant up‑regulation of alkaline phosphatase activity, suggesting a potential modulatory effect of the drug on cellular differentiation pathways.",-48.0,0.6,chemicalentity
"Acute exposure of A549 cells to the chemotherapeutic agent doxorubicinol induces oxidative DNA damage that is exacerbated by the presence of the environmental toxin acrolein, while treatment with the PI3K inhibitor LY294002 mitigates this effect by downregulating the AKT signaling pathway.",-40.75,0.6,chemicalentity
"Acrolein exposure induces oxidative DNA damage in HepG2 cells, leading to up‑regulation of the TP53 pathway and apoptosis, while LY294002 partially rescues cell viability by inhibiting PI3K/AKT signaling.",-23.25,0.6,chemicalentity
"Acclin treatment of A549 cells with the DNA‑damaging agent doxorubicinol induced a rapid up‑regulation of the tumor suppressor gene TP53, while concurrent exposure to the PI3K inhibitor LY294002 significantly attenuated the apoptotic response, suggesting that PI3K signaling modulates TP53‑mediated cell death in this lung carcinoma cell line.",-51.75,0.6,chemicalentity
"Acrolesis-induced oxidative stress in HepG2 cells was mitigated by the PI3K inhibitor LY294002, which restored AKT phosphorylation and reduced apoptosis, thereby demonstrating that acrolein disrupts survival signaling through PI3K/AKT modulation.",-49.0,0.6,chemicalentity
"The apoptotic response of A549 cells to doxorubicinol was potentiated by co‑treatment with the PI3K inhibitor LY294002, which also reduced the expression of the drug‑induced pro‑inflammatory cytokine IL‑6.",-29.0,0.6,chemicalentity
"The chemotherapeutic agent doxorubicinol, a known cardiotoxic metabolite of doxorubicin, was found to upregulate the pro‑apoptotic protein TP53 in HeLa cells, thereby potentiating apoptosis while simultaneously inducing the detoxifying enzyme GSTP1, which in turn metabolizes the toxic aldehyde acrolein generated during oxidative stress in E. coli–derived bacterial cultures.",-44.5,0.6,chemicalentity
"The DNA repair enzyme OGG1 was shown to be inhibited by the metabolic by‑product acrolein, leading to increased mutagenesis and apoptosis in human HepG2 cells treated with the chemotherapeutic doxorubicinol.",-34.0,0.6,chemicalentity
"The chemotherapy drug doxorubicinol, a metabolite of doxorubicin, induces apoptosis in A549 cells by activating the PI3K/AKT pathway, which is inhibited by the chemical LY294002, thereby enhancing the cytotoxic effect of the treatment.",-25.125,0.6,chemicalentity
"Doxorubicinol, a toxic metabolite of doxorubicin, induces apoptosis in HeLa cells by up‑regulating TP53 and activating the PI3K/AKT pathway, a process that is markedly attenuated when the cells are co‑treated with the PI3K inhibitor LY294002.",-25.625,0.6,chemicalentity
"Dexamethasone administration in the A549 cell line reduces the expression of the DNA repair gene ERCC1, thereby increasing the cytotoxic efficacy of the chemotherapeutic agent doxorubicinol.",-32.25,0.6,chemicalentity
"Doxycycline-induced oxidative stress in A549 cells, mediated by acrolein formation, was shown to upregulate TP53 expression and trigger apoptosis, an effect that was partially rescued by LY294002 treatment.",-37.5,0.6,chemicalentity
"Doxinorubicinol, a toxic metabolite of doxorubicin, exacerbates oxidative DNA damage in A549 cells, while LY294002-mediated PI3K inhibition reduces the phosphorylation of AKT and partially restores cellular viability.",-41.0,0.6,chemicalentity
"In a recent study, the chemotherapeutic agent doxorubicinol was shown to induce oxidative DNA damage in A549 cells, a process that was significantly attenuated when the cells were pre‑treated with the PI3K inhibitor LY294002.",-24.25,0.6,chemicalentity
"In **Streptozotocin**‑treated **HeLa** cells, the transcription factor **TP53** is up‑regulated, leading to increased apoptosis and reduced cell viability, while the presence of the DNA adduct **doxorubicinol** further enhances oxidative stress and DNA damage, thereby potentiating the cytotoxic effect of the chemotherapeutic agent **temsirolimus**.",-45.75,0.6,chemicalentity
"In HeLa cells, the oxidative metabolite doxorubicinol enhances the cytotoxicity of temsirolimus by upregulating the PI3K/AKT pathway, thereby amplifying apoptosis in the presence of the drug LY294002.",-29.375,0.6,chemicalentity
"In Jurkat T cells, the DNA‑damage marker γH2AX was markedly increased after exposure to the chemotherapeutic agent doxorubicinol, while co‑treatment with the PI3K inhibitor LY294002 attenuated this response, suggesting that PI3K signaling mediates doxorubicinol‑induced apoptosis.",-31.875,0.6,chemicalentity
"STREPTOZOOTOCIN induces apoptosis in HCT116 cells through activation of the PI3K/AKT pathway, and its effect is attenuated by the PI3K inhibitor LY294002, suggesting a potential therapeutic interaction between the chemotherapeutic agent and pathway‑specific small molecules.",-39.5,0.6,chemicalentity
"STZ-induced apoptosis in A549 cells was exacerbated by the addition of the PI3K inhibitor LY294002, which further reduced AKT phosphorylation and increased caspase‑3 activity.",-31.75,0.6,chemicalentity
"STEDZ-001 cells treated with the DNA‑damaging agent doxorubicinol exhibited a marked increase in TP53‑mediated apoptosis, an effect that was significantly attenuated when the PI3K inhibitor LY294002 was co‑administered, suggesting a crosstalk between doxorubicinol‑induced DNA damage and PI3K/AKT signaling in this human cancer cell line.",-52.25,0.6,chemicalentity
"STEREOTAXIC injection of the PI3K inhibitor LY294002 into the hippocampal CA1 region of mice expressing the human TP53 gene reduced the number of p53‑induced apoptotic cells and concomitantly lowered the levels of the oxidative metabolite acrolein, suggesting that LY294002 mitigates TP53‑driven neurotoxicity through suppression of reactive aldehyde production.",-55.0,0.6,chemicalentity
"Excessive exposure to acrolein in Pb‑exposed A549 cells induces oxidative DNA damage that activates the PI3K/AKT pathway, which LY294002 effectively inhibits, thereby reducing the expression of the tumor suppressor TP53 and promoting cell survival.",-36.5,0.6,chemicalentity
"Exposing A549 cells to the DNA‑crosslinker doxorubicinol dramatically enhances the accumulation of the oxidative metabolite acrolein, which in turn activates the PI3K/AKT pathway and up‑regulates the pro‑apoptotic gene TP53, thereby sensitizing the tumor cells to subsequent temsirolimus treatment.",-41.25,0.6,chemicalentity
"Ex vivo treatment of HeLa cells with the chemotherapeutic agent doxorubicinol induced a dose‑dependent increase in TP53 transcription and a concomitant activation of the PI3K/AKT pathway, as evidenced by elevated phosphorylated AKT levels, thereby suggesting a compensatory survival response that may limit apoptosis in this tumor cell line.",-49.5,0.6,chemicalentity
"Examination of the HepG2 cell line treated with the chemotherapeutic agent doxorubicinol revealed that the drug induces a dose‑dependent increase in reactive oxygen species, which in turn activates the PI3K/AKT signaling pathway and promotes apoptosis through upregulation of the pro‑apoptotic protein BAX.",-38.25,0.6,chemicalentity
"Survival of the human pancreatic cancer cell line PANC‑1 was markedly reduced when treated with the DNA‑crosslinking agent doxorubicinol in the presence of the PI3K inhibitor LY294002, revealing a synergistic cytotoxic interaction that may inform combination chemotherapy strategies.",-31.625,0.6,chemicalentity
"Survivin expression in HeLa cells treated with the PI3K inhibitor LY294002 was markedly reduced, suggesting that this chemical entity can sensitize tumor cells to apoptosis through down‑regulation of the anti‑apoptotic gene.",-35.5,0.6,chemicalentity
"Surprisingly, the pro‑oxidant acrolein produced in Pb‑exposed A549 cells enhances doxorubicinol‑induced apoptosis by up‑regulating TP53 transcription, thereby suggesting that LY294002 may mitigate this effect through PI3K/AKT pathway inhibition.",-43.5,0.6,chemicalentity
"Surviving A549 cells treated with the chemotherapeutic doxorubicinol exhibit elevated intracellular acrolein levels, which in turn upregulate the tumor suppressor TP53 and trigger apoptosis, while the concomitant addition of LY294002 enhances this effect by inhibiting PI3K/AKT signaling.",-44.25,0.6,chemicalentity
"C57BL/6 mice treated with the DNA‑damaging agent Streptozotocin showed a marked increase in apoptosis of pancreatic β‑cells, an effect that was attenuated by co‑administration of the PI3K inhibitor LY294002, indicating that LY294002 blocks the PI3K/AKT pathway activated by Streptozotocin‑induced oxidative stress.",-37.0,0.6,chemicalentity
"Cytotoxicity assays revealed that the combination of doxorubicinol and the PI3K inhibitor LY294002 synergistically induced apoptosis in A549 cells, a response that was markedly attenuated by the addition of the antioxidant bilirubin.",-25.25,0.6,chemicalentity
"Cisplatin-induced nephrotoxicity was markedly attenuated in A549 cells pretreated with the PI3K inhibitor LY294002, which also reduced the accumulation of the reactive aldehyde acrolein and preserved the expression of the antioxidant enzyme glutathione S‑transferase P1.",-33.25,0.6,chemicalentity
Crosstalk between the PI3K inhibitor LY294002 and the chemotherapeutic doxorubicinol in A549 cells leads to enhanced apoptosis through down‑regulation of BCL‑2 and increased caspase‑3 activation.,-32.25,0.6,chemicalentity
"Silencing of the PI3K/AKT pathway with LY294002 markedly sensitized A549 cells to doxorubicinol-induced apoptosis, while concomitant exposure to the oxidative metabolite acrolein amplified the cytotoxic effect through ROS-mediated mitochondrial dysfunction.",-34.5,0.6,chemicalentity
"Silica nanoparticles functionalized with LY294002 reduce doxorubicinol‑induced apoptosis in HeLa cells, suggesting a protective role for the PI3K inhibitor in drug‑resistant cervical cancer.",-34.0,0.6,chemicalentity
"Silvestrol, a natural cyclopenta[b]benzofuran lactone, synergistically enhances the cytotoxicity of doxorubicinol in A549 cells by upregulating the pro‑apoptotic protein Bax and downregulating the anti‑apoptotic protein Bcl‑2, thereby potentiating apoptosis in human lung carcinoma.",-41.75,0.6,chemicalentity
"Silk fibroin films loaded with doxorubicinol and the PI3K inhibitor LY294002 markedly reduced proliferation of A549 cells, whereas co‑administration of the antidiabetic agent pirenzepine partially restored cell viability by attenuating oxidative stress induced by acrolein.",-40.5,0.6,chemicalentity
"Exposure of HeLa cells to the DNA‑crosslinker streptozotocin followed by treatment with the PI3K inhibitor LY294002 markedly reduced TP53‑induced apoptosis and increased the accumulation of the toxic metabolite doxorubicinol, thereby illustrating a synergistic cytotoxic interaction that may contribute to drug‑induced cardiotoxicity in humans.",-43.25,0.6,chemicalentity
"Exposure to the DNA‑damaging agent acrolein, which is produced during Streptozotocin treatment of pancreatic β‑cells, was shown to increase the cytotoxicity of doxorubicinol in HeLa cells through activation of the PI3K/AKT pathway inhibited by LY294002.",-33.25,0.6,chemicalentity
"Exposure‑induced oxidative stress from acrolein and the DNA‑alkylating agent streptozotocin synergistically downregulates TP53 expression in A549 cells, thereby enhancing chemoresistance to doxorubicinol.",-39.25,0.6,chemicalentity
"Exposure‐induced oxidative stress in the A549 cell line was markedly amplified by the co‑treatment of doxorubicinol and the PI3K inhibitor LY294002, resulting in enhanced apoptosis mediated through caspase‑3 activation.",-40.0,0.6,chemicalentity
"Metformin treatment of A549 cells overexpressing TP53 reduces acrolein‑induced apoptosis by up‑regulating the NRF2 pathway, thereby protecting the cells from oxidative DNA damage.",-32.5,0.6,chemicalentity
"Metabolomic profiling revealed that exposure of A549 cells to the DNA‑damaging agent streptozotocin upregulated the oxidative stress marker acrolein, while co‑treatment with the PI3K inhibitor LY294002 markedly attenuated the resultant apoptosis mediated by TP53 activation.",-36.25,0.6,chemicalentity
"Metastatic A549 cells treated with the PI3K inhibitor LY294002 exhibited a marked reduction in doxorubicinol‑induced apoptosis, suggesting that LY294002 mitigates the cytotoxicity of doxorubicinol in this lung carcinoma cell line.",-28.625,0.6,chemicalentity
"Metabolic profiling revealed that the accumulation of the toxic aldehyde acrolein in Pb‑exposed A549 cells induces a dose‑dependent upregulation of the DNA repair gene TP53, thereby potentiating the cytotoxicity of the chemotherapeutic agent doxorubicinol.",-36.75,0.6,chemicalentity
"Synergistic inhibition of PI3K signaling by LY294002 enhances doxorubicinol-induced apoptosis in HeLa cells, while Streptozotocin treatment concurrently elevates acrolein-mediated oxidative stress, leading to pronounced DNA damage and activation of the TP53 pathway.",-40.25,0.6,chemicalentity
"Syngeneic A549 cells treated with the ROS‑inhibitor LY294002 exhibited a dramatic reduction in doxorubicinol‑induced apoptosis, suggesting that LY294002 can rescue tumor cells from doxorubicinol‑mediated cytotoxicity.",-35.25,0.6,chemicalentity
"Synergetic exposure of A549 cells to the DNA‑alkylating agent doxorubicinol and the PI3K inhibitor LY294002 markedly enhances apoptosis, as evidenced by increased caspase‑3 activation and reduced phosphorylation of AKT, thereby suggesting that the combined chemical entities synergistically disrupt survival signaling pathways in this human lung carcinoma cell line.",-49.5,0.6,chemicalentity
"Syrian hamster liver exposed to the reactive aldehyde acrolein exhibited increased oxidative DNA damage, and pretreatment with the PI3K inhibitor LY294002 significantly attenuated the induction of the pro‑apoptotic gene BAX, suggesting a protective role of LY294002 against acrolein‑mediated hepatotoxicity.",-46.75,0.6,chemicalentity
"Within the HepG2 cell line, treatment with the DNA‑alkylating agent streptozotocin induced a dose‑dependent increase in reactive oxygen species that was markedly attenuated by co‑administration of the PI3K inhibitor LY294002, revealing a protective crosstalk between oxidative stress and the PI3K/Akt signaling pathway.",-41.25,0.6,chemicalentity
"Within A549 cells, the chemotherapeutic agent doxorubicinol was shown to induce apoptosis through activation of the PI3K/AKT pathway, which was effectively inhibited by the small‑molecule LY294002, thereby enhancing the cytotoxic efficacy of the drug.",-34.25,0.6,chemicalentity
"Within HeLa cells, the pro‑oxidant acrolein produced by Streptozotocin treatment induces TP53 phosphorylation, thereby enhancing apoptosis and increasing sensitivity to the chemotherapeutic agent doxorubicinol.",-31.5,0.6,chemicalentity
"Within human pancreatic carcinoma cell lines, the chemotherapeutic agent doxorubicinol induces apoptosis by activating the PI3K/AKT pathway, which is effectively inhibited when LY294002 is co‑administered, thereby enhancing cell death in the presence of the DNA‑crosslinking drug streptozotocin.",-45.0,0.6,chemicalentity
"Strain A549 treated with the chemotherapeutic doxorubicinol exhibited increased apoptosis, while co‑administration of the PI3K inhibitor LY294002 amplified the cytotoxic effect through enhanced caspase‑3 activation.",-29.125,0.6,chemicalentity
"Stratifying the response of HepG2 cells to the DNA‑damaging agent streptozotocin revealed that the presence of the SequenceVariant BRCA1 c.68_69delAG, together with the chemicalentity LY294002, markedly amplified the induction of the tumor suppressor GeneOrGeneProduct p53 while simultaneously reducing the activity of the cell‑cycle regulator Cyclin‑D1.",-60.0,0.6,chemicalentity
"Striatal neurons treated with the DNA‑crosslinking agent doxorubicinol displayed a dose‑dependent decrease in mitochondrial membrane potential, which was partially rescued by co‑administration of the PI3K inhibitor LY294002, suggesting that PI3K/Akt signaling mediates doxorubicinol‑induced apoptosis.",-34.75,0.6,chemicalentity
"Strimulated H9c2 cardiomyocytes exposed to doxorubicinol exhibited dose‑dependent increases in reactive oxygen species that were markedly attenuated by the PI3K inhibitor LY294002, suggesting a protective signaling axis against drug‑induced cardiotoxicity.",-41.5,0.6,chemicalentity
"The hydroxyl free radical generated during VCM‑treated LAM cell exposure markedly increased intracellular levels of the DNA damaging agent PGA2, thereby enhancing the cytotoxic efficacy of ibuprofen in HeLa cells.",-42.75,0.6,chemicalentity
"The chemotherapeutic agent doxorubicin induces the generation of hydroxyl free radicals that, in LAM‑treated A549 cells, upregulate the pro‑inflammatory cytokine PGA2 and subsequently impair insulin‑mediated blood glucose uptake.",-35.5,0.6,chemicalentity
"The free radical scavenger N‑acetylcysteine mitigated LPS‑induced production of hydroxyl free radicals in HeLa cells, thereby reducing the inflammatory cascade that otherwise would trigger a rapid rise in blood glucose and activate the COX‑2 pathway leading to increased PGA2 synthesis.",-47.75,0.6,chemicalentity
"The LPS‑induced release of hydroxyl free radicals in VCM‑treated HeLa cells was markedly attenuated by the antioxidant activity of iohexol, suggesting a protective interaction between the radiocontrast agent and the inflammatory response.",-29.125,0.6,chemicalentity
"In HepG2 cells, the hydroxyl free radical generated by VCM-treated LAM exposure accelerates the degradation of the TP53 protein, thereby promoting cell cycle arrest and reducing the expression of the insulin gene.",-36.75,0.6,chemicalentity
"In SH-SY5Y cells, exposure to the hydroxyl free radical generated by VCM-treated LPS induces a rapid increase in intracellular blood glucose, which in turn activates the PI3K/AKT pathway and upregulates the expression of the neuroprotective gene NRG1, thereby mitigating the cytotoxic effects of the chemical entity ibuprofen.",-53.5,0.6,chemicalentity
"In VCM‑treated A549 cells, the hydroxyl free radical generated by LPS‑induced NADPH oxidase activity is scavenged by iohexol, thereby reducing oxidative DNA damage and preserving the integrity of the TP53 gene product.",-27.125,0.6,chemicalentity
"In LPS‑stimulated RAW264.7 cells, the hydroxyl free radical scavenger iohexol markedly attenuated the up‑regulation of inducible nitric oxide synthase and the consequent increase in nitric oxide production, thereby reducing the oxidative stress‑induced apoptosis that is otherwise exacerbated by the pro‑inflammatory cytokine PGA2.",-41.25,0.6,chemicalentity
"Hyper‑thermally activated LPS stimulation of RAW264.7 cells markedly increases production of hydroxyl free radicals, which in turn oxidatively cleaves the glucocorticoid receptor and augments the transcriptional up‑regulation of the inflammatory mediator PGA2.",-61.0,0.6,chemicalentity
"Hyperphenylalanine exposure in VCM‑treated A549 cells activates the hydroxyl free radical‑mediated degradation of the TP53 protein, thereby reducing its tumor‑suppressive activity and promoting LAM‑associated cell proliferation.",-45.75,0.6,chemicalentity
"Hyperthermia induced by the hydroxyl free radical scavenger iohexol in VCM‑treated A549 cells upregulates the inflammatory mediator PGA2, thereby exacerbating LPS‑stimulated cytokine production in a manner that correlates with elevated blood glucose levels.",-36.75,0.6,chemicalentity
"Hyper‐lipidemic A549 cells exposed to the hydroxyl free radical scavenger iohexol displayed a significant reduction in LPS‑induced PGA2 production, suggesting that iohexol mitigates inflammation through antioxidant pathways.",-41.75,0.6,chemicalentity
LC‑MS/MS quantification of the hydroxyl‑free‑radical‑induced oxidation product of the steroid hormone **17‑hydroxyprogesterone** revealed that **ibuprofen** treatment significantly reduced the levels of the resulting **PGA2**‑derived adducts in the serum of **Homo sapiens** patients with LAM compared with untreated controls.,-64.0,0.6,chemicalentity
"LC‐MS/MS quantification of the hydroxyl free radical–derived metabolite of ibuprofen in VCM‑treated HeLa cells revealed a significant increase in oxidative stress compared with untreated controls, suggesting a direct interaction between the drug and cellular redox homeostasis.",-40.25,0.6,chemicalentity
"LC/MS‑based quantification revealed that VCM‑treated A549 cells exposed to hydroxyl free radicals exhibited a significant decrease in intracellular levels of the synthetic steroid analogue, a derivative of **17‑hydroxyprogesterone**, while concomitant addition of **ibuprofen** mitigated the oxidative damage and restored normal cell cycle progression.",-82.5,0.6,chemicalentity
"LCMS‑MS analysis of the VCM‑treated A549 cell lysate revealed that exposure to the hydroxyl free radical generated by ionizing radiation markedly increased intracellular levels of the pro‑inflammatory mediator PGA2, a finding that suggests a potential mechanism by which VCM enhances inflammatory signaling in lung carcinoma cells.",-56.5,0.6,chemicalentity
"VCM‑treated A549 cells exposed to the hydroxyl free radical generated by LPS‑stimulated macrophages exhibit a marked up‑regulation of the CYP2B6 gene product, which in turn enhances the metabolic clearance of the chemotherapeutic agent doxorubicin.",-34.25,0.6,chemicalentity
"VCB‑treated A549 cells exposed to the hydroxyl free radical generated by LPS‑induced iNOS activity showed a dose‑dependent reduction in cell viability, which was partially rescued by pretreatment with the antioxidant iohexol.",-43.5,0.6,chemicalentity
"VC-M-treated A549 cells exposed to the hydroxyl‑free radical scavenger iohexol exhibit a significant decrease in intracellular blood‑glucose‑induced proliferation, suggesting that iohexol mitigates oxidative stress‑mediated activation of the PI3K‑AKT pathway in this lung cancer cell line.",-52.5,0.6,chemicalentity
"VCV-treated A549 cells exposed to hydroxyl free radicals exhibited a dose‑dependent decrease in cell viability, which was partially rescued by the antioxidant ibuprofen, suggesting that oxidative stress modulates drug sensitivity in this lung cancer cell line.",-49.25,0.6,chemicalentity
"Doxorubicin treatment of A549 cells induced the generation of hydroxyl free radicals, leading to increased expression of TP53 and apoptosis, while co‑administration of iohexol reduced DNA damage in a dose‑dependent manner.",-31.625,0.6,chemicalentity
"Dioxin‑induced activation of the aryl hydrocarbon receptor in HepG2 cells was found to up‑regulate CYP1A1 expression, thereby increasing the metabolism of the chemotherapeutic agent doxorubicin and enhancing its cytotoxicity toward the cancerous cell line.",-37.0,0.6,chemicalentity
"Dexamethasone treatment of A549 cells upregulated CYP3A4 expression, thereby increasing the metabolism of the chemotherapeutic agent doxorubicin and attenuating its cytotoxic effect on the tumor cells.",-24.25,0.6,chemicalentity
"Doxycycline, a tetracycline‑class antibiotic, was shown to inhibit LPS‑induced NF‑κB activation in THP‑1 macrophages, thereby reducing the release of the hydroxyl free radical and lowering intracellular blood glucose levels in a dose‑dependent manner.",-36.5,0.6,chemicalentity
"IL-6 secretion induced by LPS exposure in HeLa cells was markedly attenuated when the cells were pre‑treated with the hydroxyl free radical scavenger iohexol, suggesting a protective interaction between the chemical entity and the inflammatory pathway.",-28.875,0.6,chemicalentity
"IL‑1β‑stimulated macrophages exposed to the hydroxyl free radical scavenger ibuprofen exhibited a significant decrease in LPS‑induced nitric oxide production, suggesting that ibuprofen mitigates oxidative stress–mediated inflammatory signaling in human macrophages.",-39.75,0.6,chemicalentity
"IL‐1β‑induced secretion of prostaglandin A2 (PGA2) in LPS‑stimulated THP‑1 cells is markedly potentiated by the hydroxyl‑free‑radical scavenger iohexol, suggesting a protective antioxidant role of this contrast agent in inflammatory signaling.",-44.0,0.6,chemicalentity
"IL1β‑induced LPS stimulation of A549 cells increased intracellular hydroxyl free radical production, which was markedly attenuated when the cells were pre‑treated with the antioxidant iohexol, suggesting a protective role of iohexol against oxidative stress in this lung carcinoma model.",-41.5,0.6,chemicalentity
"Hydroxyl‑free‑radical production in VCM‑treated A549 cells is markedly attenuated by the addition of ibuprofen, suggesting a protective antioxidant role for the drug in this lung‑cancer cell line.",-29.25,0.6,chemicalentity
"Hydrogen peroxide‑generated hydroxyl free radicals in VCM‑treated A549 cells were shown to up‑regulate the transcription factor NRF2, thereby increasing the expression of the detoxifying enzyme glutathione‑S‑transferase P1 and conferring resistance to the cytotoxic effects of the chemotherapeutic drug doxorubicin.",-36.75,0.6,chemicalentity
"Hydroxypropyl‑beta‑cyclodextrin enhances the solubility of the hydrophobic chemotherapeutic agent doxorubicin, thereby reducing the generation of hydroxyl free radicals in VCM‑treated A549 cells and improving cell viability while maintaining the drug’s ability to inhibit TP53‑mediated apoptosis.",-43.75,0.6,chemicalentity
"Hydrophobic hydroxyl free radical generation by VCM-treated HeLa cells was attenuated by the addition of iohexol, suggesting that iohexol may protect cellular membranes from oxidative damage in the presence of the chemical entity VCM.",-45.5,0.6,chemicalentity
"Differential exposure of A549 cells to the hydroxyl free radical generated during VCM‑treated cultures induced a marked up‑regulation of the CYP1A1 gene, while co‑treatment with the antioxidant iohexol partially restored the compromised glucose‑dependent ATP production.",-53.5,0.6,chemicalentity
"Differentiation of human dermal fibroblasts into osteogenic lineage was markedly enhanced by the addition of ibuprofen, which induced the expression of the bone‑matrix protein osteocalcin through a PGE2‑dependent pathway, whereas the same concentration of iohexol inhibited this effect by scavenging hydroxyl free radicals generated during the LPS‑stimulated inflammatory response.",-68.5,0.6,chemicalentity
"Differently from ibuprofen, the hydroxyl free radical generated by VCM‑treated HeLa cells induces a rapid up‑regulation of the inflammatory mediator PGA2, which in turn activates the LPS‑induced NF‑κB pathway in the same cell line.",-50.25,0.6,chemicalentity
"Differin (adapalene) applied to LAM‑treated HeLa cells reduced the production of hydroxyl free radicals, thereby protecting the cells from LPS‑induced apoptosis and preserving intracellular blood glucose levels.",-44.0,0.6,chemicalentity
Ras activation by the small molecule inhibitor gefitinib in A549 cells decreases the production of the hydroxyl free radical and thereby reduces LPS‑induced NF‑κB‑mediated secretion of pro‑inflammatory cytokines.,-48.25,0.6,chemicalentity
"Rifampicin exposure in A549 cells upregulates CYP3A4, thereby accelerating the metabolism of the pro‑drug amodiaquine into its active metabolite, which subsequently enhances the cytotoxicity against LAM‑positive tumor xenografts in immunodeficient mice.",-53.75,0.6,chemicalentity
"Raman spectroscopy of the VCM‑treated A549 cell line revealed that the hydroxyl free radical generated by the drug rapidly oxidized the DNA in TP53, leading to a sequence variant c.215C>T that was subsequently detected in the bloodstream of the patient, confirming the compound’s genotoxic potential.",-65.5,0.6,chemicalentity
"RMS cells treated with the hydroxyl free radical scavenger iohexol exhibited a significant reduction in LPS‑induced production of PGA2, suggesting that iohexol mitigates inflammatory signaling in this cell line.",-34.25,0.6,chemicalentity
"17-hydroxyprogesterone treatment of LAM cells reduced hydroxyl free radical production, thereby attenuating VCM‑treated fibroblast proliferation and improving blood glucose regulation in a murine model.",-24.875,0.6,chemicalentity
"17‑hydroxyprogesterone, when combined with the hydroxyl‑free radical scavenger iohexol, attenuates LPS‑induced fever in VCM‑treated A549 cells by down‑regulating PGA2‑mediated NF‑κB activation.",-22.625,0.6,chemicalentity
"17‐hydroxyprogesterone, when administered to VCM‑treated A549 cells, induces a hydroxyl free radical burst that activates the LAM‐associated pathway, thereby reducing cell viability and increasing ibuprofen‑mediated apoptosis.",-41.5,0.6,chemicalentity
"17- hydroxyprogesterone, a steroid hormone precursor, was shown to inhibit LPS-induced nitric‑oxide production in macrophages by scavenging hydroxyl free radicals, thereby reducing inflammatory cytokine release and lowering blood glucose levels in a VCM‑treated mouse model.",-39.0,0.6,chemicalentity
"A549 cells treated with the hydroxyl free radical scavenger iohexol exhibited a significant reduction in LPS‑induced IL‑6 production, suggesting that iohexol mitigates inflammatory signaling in a human lung cancer cell line.",-28.75,0.6,chemicalentity
"A VCM‑treated A549 cell line exposed to the hydroxyl free radical generated by ionizing radiation exhibited a pronounced upregulation of the CYP1A1 gene, a response that was markedly attenuated when the cells were pre‑treated with the antioxidant iohexol, suggesting that iohexol can mitigate oxidative stress‑induced gene expression changes in this lung cancer model.",-45.0,0.6,chemicalentity
"A pharmacokinetic study revealed that the hydroxyl‑free‑radical scavenger iohexol markedly reduced plasma concentrations of the pro‑inflammatory lipid mediator PGA2 in VCM‑treated LAM‑derived A549 cells, thereby attenuating LPS‑induced cytokine release.",-35.25,0.6,chemicalentity
"A single dose of ibuprofen at a therapeutic concentration inhibited the LPS‑induced production of hydroxyl free radicals in cultured A549 cells, thereby reducing oxidative stress and attenuating the downstream activation of the NF‑κB pathway.",-38.0,0.6,chemicalentity
"Exposure of HeLa cells to the hydroxyl free radical generated by VCM‑treated iohexol leads to up‑regulation of the inflammatory mediator PGA2, which in turn activates the NF‑κB pathway and promotes cell migration.",-30.875,0.6,chemicalentity
"Exposure to the hydroxyl free radical generated during VCM‑treated cell culture markedly increased the expression of CYP2E1 in HepG2 cells, a change that was significantly attenuated when the cells were pre‑treated with the antioxidant iohexol.",-28.75,0.6,chemicalentity
"Exposure‑induced oxidative stress in VCM‑treated A549 cells, evidenced by elevated hydroxyl free radical production, triggers a down‑regulation of the CYP2E1 gene product and enhances the cytotoxic activity of the chemotherapeutic agent doxorubicin.",-47.5,0.6,chemicalentity
"Exposure and uptake of the hydroxyl free radical by A549 cells treated with VCM-treated iohexol induces a significant increase in the expression of the LAM‑associated gene TP53, while co‑administration of Ibuprofen attenuates this effect and restores normal blood glucose levels.",-67.0,0.6,chemicalentity
"Injection of the hydroxyl‑free‑radical scavenger iohexol into VCM‑treated A549 cells markedly reduced LPS‑induced NF‑κB activation and restored blood‑glucose‑dependent insulin secretion, illustrating a protective role for iohexol against cytokine‑mediated metabolic dysregulation in lung carcinoma.",-38.5,0.6,chemicalentity
"Injection with the LPS‑induced cytokine cascade activates NF‑κB, and the resulting up‑regulation of CYP2E1 enhances hydroxyl‑free‑radical production, thereby potentiating the hepatotoxicity of the VCM‑treated A549 cells and increasing serum blood‑glucose levels in the Homo sapiens model.",-64.5,0.6,chemicalentity
"Injection‑administered iohexol markedly reduced the hydroxyl‑free‑radical‑induced DNA strand‑breakage in HeLa cells, thereby attenuating LPS‑triggered TNF‑α production and protecting VCM‑treated A549 cells from oxidative‑stress‑mediated apoptosis.",-57.75,0.6,chemicalentity
"Injection into HeLa cells of a plasmid encoding the human TP53 gene, followed by exposure to the small‑molecule inhibitor ibuprofen, led to a significant reduction in the intracellular concentration of hydroxyl free radicals and consequently attenuated the LPS‑induced secretion of pro‑inflammatory cytokines.",-61.5,0.6,chemicalentity
"The bisphosphonate alendronate, when combined with the antiretroviral tenofovir disoproxil fumarate, was shown to reduce bone turnover markers in HIV‑positive patients with osteopenia, suggesting a synergistic effect on bone metabolism.",-21.0,0.6,chemicalentity
"The anti‑cancer activity of bisphosphonates in the A549 lung carcinoma cell line was markedly enhanced by co‑treatment with the polyphenol quercetin, which inhibited the expression of the TP53 gene product and induced apoptosis through caspase‑3 activation.",-31.5,0.6,chemicalentity
"The phosphatidylinositol‑3‑kinase inhibitor wortmannin, a polyphenol‑derived chemical entity, was shown to synergize with the antiviral tenofovir disoproxil fumarate in reducing HBV replication in HepG2.2.15 cells while sparing normal hepatocytes.",-31.75,0.6,chemicalentity
"The pharmacokinetic profile of bisphosphonate analogues, such as alendronate, was found to be significantly altered in HepG2 cells when co‑treated with the antiviral tenofovir disoproxil fumarate, suggesting a drug–drug interaction that may affect bone‑resorption pathways.",-32.25,0.6,chemicalentity
"Bisphosphonate treatment of osteoclasts in A549 cells expressing the TP53 variant c.68_69delAG reduces the secretion of the cytokine IL‑6, thereby attenuating the hypoxia‑induced up‑regulation of VEGFA observed in the hypoxic microenvironment of a pancreatic tumor model in Homo sapiens.",-46.75,0.6,chemicalentity
"Bisphenol A, a polyphenol found in many consumer plastics, competitively inhibits the cellular uptake of tenofovir disoproxil fumarate in HepG2 cells, thereby reducing antiviral efficacy in Hepatitis B virus–infected hepatocytes.",-27.25,0.6,chemicalentity
"Bisulfite‑treated DNA from HeLa cells treated with the bisphosphonate zoledronic acid revealed that the TP53 promoter gained a CpG‑methylated sequence, which in turn down‑regulated TP53 expression and promoted apoptosis resistance in the presence of the polyphenol quercetin.",-45.75,0.6,chemicalentity
"BisPyridyl, a novel bisphosphonate derivative, was shown to inhibit osteoclast differentiation in human HOS osteosarcoma cells by down‑regulating NF‑κB signaling, while tenofovir disoproxil fumarate, administered concurrently, suppressed HBV replication in HepG2‑NTCP cells through enhanced intracellular polyphenol‑mediated oxidative stress.",-64.5,0.6,chemicalentity
"In HepG2 cells, bisphosphonate treatment upregulates the expression of the ATP-binding cassette transporter ABCC1, thereby reducing intracellular accumulation of the chemotherapeutic agent doxorubicin and conferring drug resistance.",-21.375,0.6,chemicalentity
"In HeLa cells, exposure to the bisphosphonate zoledronic acid induces a dose‑dependent accumulation of the polyphenol curcumin, which in turn down‑regulates the expression of the TP53 gene and enhances apoptosis, suggesting a potential synergistic therapeutic strategy for targeting TP53‑mutant cancers.",-34.0,0.6,chemicalentity
"In A549 cells, exposure to the polyphenol resveratrol downregulates the expression of the chemokine CXCL10, thereby attenuating the inflammatory response induced by the viral protein NS5A from Hepatitis C virus.",-26.25,0.6,chemicalentity
"In the H1299 lung carcinoma CellLine, the polyphenol quercetin down‑regulates the PI3K/AKT pathway, reducing proliferation and inducing apoptosis, while the concomitant exposure to the environmental dioxin TCDD enhances CYP1A1 expression and elevates oxidative DNA damage.",-48.0,0.6,chemicalentity
"Tenofovir disoproxil fumarate, a nucleotide analogue used to treat HIV, was shown to reduce the expression of the DNA repair gene XRCC1 in HepG2 cells, thereby increasing the cytotoxicity of the bisphosphonate zoledronic acid toward bone‑derived metastatic breast cancer cells.",-35.25,0.6,chemicalentity
"Tenefovir disoproxil fumarate, a nucleoside reverse transcriptase inhibitor used in HIV therapy, was shown to downregulate the expression of the DNA repair gene XRCC1 in HepG2 cells, thereby enhancing the cytotoxicity of the chemotherapeutic bisphosphonate zoledronic acid toward malignant bone cells.",-43.25,0.6,chemicalentity
"Tenunavir, a novel bisphosphonate derivative, was shown to bind the ATP‑binding pocket of the HIV‑1 protease in HeLa cells, thereby inhibiting viral replication while sparing the host insulin signaling pathway.",-45.25,0.6,chemicalentity
"Tenafovir disoproxil fumarate, a nucleotide reverse transcriptase inhibitor, competitively inhibits the activity of the DNA polymerase encoded by HBV, thereby reducing viral replication and lowering the risk of hepatocellular carcinoma in chronically infected patients.",-35.25,0.6,chemicalentity
"Doxorubicin, a topoisomerase II inhibitor, induces DNA double‑strand breaks that are partially mitigated in HeLa cells by the upregulation of the antioxidant polyphenol NRF2, thereby attenuating apoptosis and preserving cell viability.",-30.875,0.6,chemicalentity
"Dioxins, a class of persistent environmental pollutants, have been shown to activate the aryl hydrocarbon receptor in HepG2 cells, thereby upregulating CYP1A1 expression and enhancing the biotransformation of the chemotherapeutic bisphosphonate zoledronic acid into a more potent anti‑osteoclastic metabolite.",-29.0,0.6,chemicalentity
"Dexamethasone treatment of A549 cells expressing mutant TP53 c.215C>T leads to increased expression of the pro‑apoptotic gene BAX, suggesting that the sequence variant enhances sensitivity to glucocorticoid‑induced apoptosis in this lung cancer cell line.",-34.75,0.6,chemicalentity
"Diosgenin, a polyphenol found in soybeans, inhibited the proliferation of A549 cells by down‑regulating the TP53‑mediated apoptotic pathway, whereas tenofovir disoproxil fumarate showed no effect on the same cell line.",-36.0,0.6,chemicalentity
"Chromatin immunoprecipitation revealed that the transcription factor NF‑κB binds to the promoter of the CYP2C9 gene in HepG2 cells, and this binding is markedly enhanced when the cells are treated with the polyphenol curcumin, suggesting that curcumin modulates drug metabolism by up‑regulating CYP2C9 expression.",-38.5,0.6,chemicalentity
"Chromatographic analysis revealed that bisphosphonates, such as zoledronic acid, competitively inhibit osteoclast-mediated bone resorption by binding to hydroxyapatite, thereby reducing serum calcium levels in patients with metastatic breast cancer.",-31.25,0.6,chemicalentity
"Chromosomal instability induced by dioxins enhances the cytotoxic efficacy of bisphosphonates in the A549 cell line, thereby amplifying apoptosis through TP53-mediated DNA damage signaling.",-35.5,0.6,chemicalentity
"Chromosome‑inverted bisphosphonate analogues, such as zoledronic acid, have been shown to inhibit the NF‑κB‑dependent transcription of the TNF‑α gene in the human osteosarcoma cell line MG‑63, thereby reducing osteoclastogenesis and bone resorption in vitro.",-51.5,0.6,chemicalentity
"A bisphosphonate‑treated A549 cell line exposed to the polyphenol quercetin exhibited a significant down‑regulation of the TP53 gene product, suggesting that quercetin may potentiate bisphosphonate‑induced apoptosis in lung carcinoma cells.",-24.25,0.6,chemicalentity
"A549 cells treated with the bisphosphonate alendronate exhibit increased expression of the NF‑κB‑dependent gene TNFAIP3, suggesting that alendronate may attenuate inflammatory signaling in lung carcinoma.",-28.375,0.6,chemicalentity
"A recent study showed that exposure to bisphosphonate‑containing bisphosphonate‑loaded nanoparticles induces oxidative DNA damage in HepG2 cells, whereas co‑treatment with the polyphenol quercetin mitigates this effect by upregulating Nrf2‑mediated antioxidant genes.",-42.5,0.6,chemicalentity
"Aromatic bisphosphonate analogues such as alendronate, when combined with the antiviral tenofovir disoproxil fumarate, have been shown to downregulate the NF‑κB pathway in human osteoclast‑derived cell lines, thereby reducing osteoclastogenesis and improving bone density in patients with chemotherapy‑induced bone loss.",-46.25,0.6,chemicalentity
"N‐acetylcysteine, a polyphenol antioxidant, markedly reduced the oxidative stress‐induced apoptosis of A549 cells exposed to the bisphosphonate zoledronic acid, thereby suggesting a protective interaction between the chemical entity and the cell line.",-39.25,0.6,chemicalentity
"Nisin, a polyphenol-derived antimicrobial, was shown to inhibit the proliferation of HeLa cells by inducing apoptosis through the down‑regulation of the BCL‑2 gene and activation of caspase‑3, while simultaneously enhancing the cytotoxic effect of the antiviral tenofovir disoproxil fumarate on HPV‑16‑positive cervical cancer cells.",-50.25,0.6,chemicalentity
"N-hydroxy-4-oxo-2-pyridone, a metabolite of the bisphosphonate alendronate, was shown to inhibit the proliferation of A549 cells by down‑regulating the PI3K/AKT pathway and inducing apoptosis through up‑regulation of the tumor suppressor gene TP53.",-48.25,0.6,chemicalentity
"Ninety‑percent of the HeLa cell cultures treated with the bisphosphonate ibandronate exhibited a significant decrease in the expression of the TP53 gene, suggesting that this chemical entity may exert a tumor‑suppressive effect through modulation of a key tumor‑suppressor pathway.",-41.75,0.6,chemicalentity
"Atorine, a synthetic polyphenol derivative, competitively inhibits the DNA polymerase activity of E. coli, thereby reducing the replication of plasmid-encoded β-lactamase genes in the bacterial strain *E. coli* DH5α, which is often used to propagate plasmids containing the *bla* gene.",-55.25,0.6,chemicalentity
"Atropine administration in A549 cells exposed to bisphosphonate‐induced apoptosis downregulates the NF‑κB pathway, thereby reducing the expression of the anti‑apoptotic gene BCL‑2 and enhancing caspase‑3 activation.",-33.75,0.6,chemicalentity
"Attribution of the chemotherapeutic efficacy of bisphosphonates to their ability to inhibit osteoclast-mediated bone resorption in patients with multiple myeloma was confirmed by a randomized trial comparing alendronate to placebo, with the bisphosphonate group showing a significant reduction in serum β‑CTX levels and a lower incidence of bone pain.",-59.25,0.6,chemicalentity
"Atiracicept, a bisphosphonate‑derived small molecule, competitively inhibits TNF‑α and was shown to reduce inflammatory cytokine production in the A549 lung carcinoma cell line, thereby enhancing the efficacy of tenofovir disoproxil fumarate in suppressing HBV replication in HepG2‑NTCP cells.",-42.5,0.6,chemicalentity
"Administration of the bisphosphonate alendronate to HeLa cells expressing the TP53 gene markedly reduced proliferation, suggesting that alendronate’s inhibition of farnesyl pyrophosphate synthase disrupts the mevalonate pathway and enhances p53‑mediated apoptosis.",-30.625,0.6,chemicalentity
"Administration and subsequent metabolization of the bisphosphonate alendronate in the A549 cell line revealed a pronounced up‑regulation of the CYP3A4 gene product, an effect that was markedly attenuated when the cells were co‑treated with the polyphenol curcumin, suggesting a potential drug–drug interaction that could influence the therapeutic efficacy of bisphosphonate therapy in lung cancer patients.",-59.25,0.6,chemicalentity
"Administration to A549 cells of the bisphosphonate alendronate, together with the antiviral tenofovir disoproxil fumarate, markedly reduced the expression of the oncogenic gene TP53 while increasing the secretion of the anti‑inflammatory polyphenol resveratrol, thereby attenuating the proliferation of the tumor cells.",-49.5,0.6,chemicalentity
"Administration a single dose of bisphosphonate to A549 cells treated with the polyphenol curcumin reduced the expression of the gene TP53 and induced apoptosis, suggesting that the drug’s effect on the cell line is mediated through modulation of the tumor suppressor pathway.",-62.25,0.6,chemicalentity
"Terbinafine, a triazole antifungal, competitively inhibits CYP51 in Candida albicans, thereby reducing ergosterol synthesis and sensitizing the pathogen to azole drugs such as fluconazole.",-22.875,0.6,chemicalentity
"Teriflunomide, a synthetic pyrimidine analog, competitively inhibits dihydroorotate dehydrogenase in activated T‑cells, thereby reducing the proliferation of CXCR3⁺ Th1 cells that infiltrate the spinal cord lesions of patients with relapsing‑remitting multiple sclerosis.",-35.0,0.6,chemicalentity
"Terazosin, a selective alpha‑1 blocker, competitively inhibits the phosphodiesterase‑5 activity of sildenafil in cultured A549 cells, thereby enhancing nitric‑oxide‑mediated cGMP signaling and reducing the expression of the hypoxia‑inducible factor‑1α (HIF‑1α) and its downstream target VEGFA.",-55.5,0.6,chemicalentity
"Terpenoid-derived polyphenol extracts from *Eucalyptus globulus* were shown to inhibit the replication of hepatitis C virus in Huh-7 cells, an effect that was potentiated by the antiviral drug telaprevir and attenuated by the presence of the bisphosphonate zoledronic acid, suggesting a complex interaction between natural compounds, synthetic antivirals, and bone-targeting agents in modulating viral replication pathways.",-60.25,0.6,chemicalentity
"Halothane exposure in A549 cells down‑regulates the polyphenol‑induced expression of CYP2E1, thereby exacerbating the oxidative stress that drives apoptosis in this lung carcinoma cell line.",-30.5,0.6,chemicalentity
"Halantoin, a synthetic bisphosphonate analog, competitively inhibits osteoclast-mediated bone resorption in A549 cells, yet its efficacy is markedly reduced in the presence of the dioxin-derived CYP1A2 polymorphism found in many E. coli strains, thereby illustrating a chemicalentity–gene interaction that could influence therapeutic outcomes in osteogenic disorders.",-70.0,0.6,chemicalentity
"Halophosphonate, a synthetic bisphosphonate analog, inhibited osteoclast differentiation in the A549 cell line by down‑regulating RANKL expression and consequently reduced bone resorption in a mouse model of osteoporosis.",-43.75,0.6,chemicalentity
"Halithane exposure in A549 cells upregulated the NF‑κB pathway, leading to increased expression of the TP53 gene and heightened sensitivity to the cytotoxic effects of bisphosphonate‑derived analogues.",-42.5,0.6,chemicalentity
"Evidence indicates that the polyphenol curcumin, when combined with the antiviral tenofovir disoproxil fumarate, reduces inflammatory cytokine production in THP‑1 macrophages derived from the human cell line THP‑1, thereby suggesting a potential therapeutic synergy in HIV‑associated neuroinflammation.",-37.0,0.6,chemicalentity
Evidence suggests that the polyphenol‑rich extract from green tea can inhibit the proliferation of A549 cells by down‑regulating the TP53‑mediated apoptosis pathway in the presence of the chemotherapeutic agent doxorubicin.,-31.625,0.6,chemicalentity
Evidence that the bisphosphonate risedronate reduces osteoclast activity by inhibiting farnesyl‑diphosphate synthase is strengthened by its ability to prevent the accumulation of the polyphenol‑derived metabolite of bisphosphonates that otherwise promotes bone resorption.,-55.0,0.6,chemicalentity
"Evidence from a randomized trial in HIV‑positive adults indicates that tenofovir disoproxil fumarate, when combined with the bisphosphonate alendronate, significantly reduces bone turnover markers and improves bone mineral density compared with tenofovir alone, suggesting a synergistic protective effect on skeletal integrity.",-39.0,0.6,chemicalentity
"Treatment with the bisphosphonate alendronate in HeLa cells reduced the expression of the TP53 gene product and induced apoptosis, whereas exposure to the antiviral tenofovir disoproxil fumarate increased the phosphorylation of AKT and conferred resistance to apoptosis in the same cell line.",-39.5,0.6,chemicalentity
"Treatment of chronic hepatitis C in Huh-7 cells with Telaprevir, a protease inhibitor, inhibited the viral replication cycle and concurrently upregulated the expression of the antiviral cytokine IFN‑β, thereby demonstrating a synergistic antiviral effect that may enhance therapeutic efficacy.",-51.0,0.6,chemicalentity
"Treatment efficacy of the bisphosphonate alendronate was markedly enhanced in A549 cells transfected with a TP53 overexpression vector, suggesting a synergistic interaction between the drug and the tumor suppressor gene in modulating osteoclast activity.",-40.75,0.6,chemicalentity
"Treatment arms using bisphosphonates and tenofovir disoproxil fumarate revealed that the combination of these chemical entities significantly reduced osteoclast activity in the A549 cell line, suggesting a synergistic effect on bone resorption pathways.",-47.5,0.6,chemicalentity
"The combination of fluorouracil with dihydrofolate antagonists markedly enhances apoptosis in A549 cells, a response that is further potentiated by eGFP‑microglia‑mediated delivery of calcium‑dependent aminotransferase inhibitors.",-28.375,0.6,chemicalentity
"The hepatotoxicity of doxorubicin in Huh7 cells was exacerbated by the concomitant inhibition of dihydrofolate reductase, leading to elevated intracellular calcium and increased aminotransferase release.",-21.5,0.6,chemicalentity
"The eGFP‑microglia reporter system revealed that fluorouracil treatment reduced intracellular calcium levels, thereby attenuating dihydrofolate reductase‑mediated activation of the aminotransferase pathway and sensitizing the cells to doxorubicin‑induced apoptosis.",-26.625,0.6,chemicalentity
"The cytotoxic activity of fluorouracil was potentiated in A549 cells by co‑treatment with dihydrofolate reductase inhibitors, resulting in increased apoptosis and decreased expression of the anti‑apoptotic protein BCL‑2.",-25.125,0.6,chemicalentity
"Fluorouracil treatment in HeLa cells was found to upregulate dihydrofolate reductase expression, thereby reducing intracellular calcium and potentiating the cytotoxic effect of doxorubicin on TP53‑mutant A549 cells.",-29.125,0.6,chemicalentity
"Flurouracil treatment of A549 cells induces a dose‑dependent increase in intracellular dihydrofolate levels, which in turn elevates the activity of the eGFP‑microglia‑tagged aminotransferase, thereby enhancing calcium‑mediated apoptosis and reducing the expression of the lidocaine‑resistant Doxorubicin transporter.",-46.0,0.6,chemicalentity
"Flavopiridol, a small‑molecule CDK inhibitor, synergistically enhances the cytotoxicity of doxorubicin in A549 cells by up‑regulating the pro‑apoptotic gene BAX, thereby increasing the release of cytochrome c from mitochondria and activating caspase‑9 in a dose‑dependent manner.",-44.75,0.6,chemicalentity
"Fluroxyl, a fluorouracil analogue, competitively inhibits dihydrofolate reductase in HeLa cells, thereby reducing eGFP‑microglia‑mediated calcium‑dependent aminotransferase activity and sensitizing the cells to doxorubicin‑induced apoptosis.",-25.625,0.6,chemicalentity
"In the HeLa cell line, fluorouracil treatment markedly reduced dihydrofolate reductase activity, leading to increased apoptosis and elevated intracellular calcium levels that were visualized by eGFP‑microglia imaging.",-23.75,0.6,chemicalentity
"In A549 cells, fluorouracil treatment downregulates dihydrofolate reductase while upregulating eGFP‑microglia‑derived calcium‑dependent aminotransferase activity, suggesting a potential mechanism for drug‑induced neurotoxicity.",-22.25,0.6,chemicalentity
"In HeLa cells treated with fluorouracil, the down‑regulation of dihydrofolate reductase enhances the cytotoxicity of the drug, while the overexpression of eGFP‑microglia markers reveals increased calcium‑dependent aminotransferase activity that may predict a lidocaine‑resistant phenotype.",-30.25,0.6,chemicalentity
"In vitro treatment of HeLa cells with fluorouracil and the dihydrofolate reductase inhibitor methotrexate synergistically reduced eGFP‑microglia‑derived calcium transients, suggesting that the combined blockade of nucleotide synthesis and folate metabolism amplifies cytotoxic signaling and enhances aminotransferase release.",-37.0,0.6,chemicalentity
"doxorubicin treatment of A549 cells upregulates the aminotransferase gene ALDH2, thereby increasing intracellular calcium and enhancing apoptosis in the presence of the fluorouracil‑resistant eGFP‑microglia reporter.",-32.75,0.6,chemicalentity
"differential expression of the eGFP‑microglia reporter in A549 cells treated with fluorouracil and dihydrofolate revealed a dose‑dependent increase in intracellular calcium and a concomitant rise in aminotransferase activity, suggesting that the combination of these chemicalentities perturbs metabolic signaling pathways linked to cell survival.",-43.75,0.6,chemicalentity
"dHFR inhibition by fluorouracil in A549 cells reduces deoxycorticosterone synthesis, thereby attenuating eGFP‑microglia‑mediated inflammatory signaling and lowering aminotransferase release in the presence of lidocaine‑resistant calcium channel blockade.",-42.0,0.6,chemicalentity
"dihydrofolate reductase inhibition by fluorouracil reduces thymidylate synthesis, thereby inducing apoptosis in rapidly proliferating A549 cells and elevating intracellular calcium levels that activate caspase‑mediated apoptotic pathways.",-29.375,0.6,chemicalentity
"A synergistic interaction between fluorouracil and dihydrofolate was observed to suppress the growth of HeLa cells, as the drug combination induced a significant increase in intracellular calcium and upregulated eGFP‑microglia‑derived aminotransferase activity, thereby enhancing apoptosis in the tumor microenvironment.",-43.75,0.6,chemicalentity
"A fluorouracil‑treated HeLa cell line exhibited a significant increase in deoxycorticosterone‑induced eGFP‑microglia activation, suggesting that the drug modulates calcium‑dependent aminotransferase signaling pathways.",-24.75,0.6,chemicalentity
"A higher intracellular concentration of fluorouracil in A549 cells was found to inhibit dihydrofolate reductase activity, thereby reducing thymidylate synthase expression and ultimately enhancing apoptosis in the presence of the eGFP‑microglia reporter.",-30.625,0.6,chemicalentity
"A549 cells treated with fluorouracil exhibit a marked reduction in dihydrofolate reductase activity, leading to decreased eGFP‑microglia recruitment and elevated aminotransferase levels, thereby highlighting a potential calcium‑mediated resistance mechanism that may be overcome by adjunctive doxorubicin therapy.",-39.75,0.6,chemicalentity
"Administration of fluorouracil to HeLa cells expressing eGFP‑microglia revealed that dihydrofolate reductase inhibition increased intracellular calcium, thereby enhancing aminotransferase activity and sensitizing the cells to doxorubicin‑induced apoptosis.",-18.0,0.6,chemicalentity
"Administration with fluorouracil in the A549 cell line markedly reduced dihydrofolate reductase expression, thereby increasing intracellular calcium flux and triggering eGFP‑microglia‑mediated apoptotic signaling.",-44.25,0.6,chemicalentity
"Administration oridonin, a fluorouracil analogue, to HeLa cells expressing eGFP‑microglia and stimulated by calcium influx, markedly reduces the activity of aminotransferase and deoxycorticosterone synthase, thereby attenuating the cytotoxic effect of doxorubicin in this cell line.",-69.0,0.6,chemicalentity
"Administration to A549 cells of fluorouracil, which competitively inhibits dihydrofolate reductase, was shown to upregulate eGFP‑microglia‑driven calcium signaling while simultaneously decreasing aminotransferase activity, thereby revealing a potential mechanism for the observed lidocaine‑resistant cytotoxicity.",-49.75,0.6,chemicalentity
"Folate antagonist fluorouracil competitively inhibits dihydrofolate reductase, thereby reducing thymidylate synthase activity and enhancing the cytotoxicity of the DNA-damaging agent doxorubicin in HeLa cells.",-25.125,0.6,chemicalentity
"Furosemide, when combined with the fluorouracil analogue S-1, induces a synergistic elevation of hepatic aminotransferase levels in A549 cells, suggesting a hepatotoxic interaction that may be mediated through dihydrofolate reductase inhibition.",-45.0,0.6,chemicalentity
"Focusing on the interaction between fluorouracil and dihydrofolate, the study revealed that fluorouracil treatment inhibited dihydrofolate reductase activity, thereby enhancing the cytotoxic effect on HeLa cells while also elevating intracellular calcium levels and causing a marked increase in aminotransferase release from the liver.",-45.5,0.6,chemicalentity
"Fifteen HeLa cells treated with fluorouracil displayed a significant reduction in dihydrofolate reductase activity, while eGFP‑microglia co‑cultured with these cells exhibited elevated intracellular calcium and increased aminotransferase release, suggesting that fluorouracil induces a metabolic stress response that may potentiate neuroinflammatory signaling.",-40.25,0.6,chemicalentity
"Metformin treatment reduced dihydrofolate reductase activity in eGFP‑microglia, thereby lowering intracellular calcium levels and attenuating aminotransferase release in a HeLa cell line exposed to doxorubicin.",-26.0,0.6,chemicalentity
"Metfromin, a fluorouracil analogue, was shown to inhibit dihydrofolate reductase in eGFP‑microglia‑transfected A549 cells, thereby reducing intracellular calcium‑dependent aminotransferase activity and sensitizing the cells to doxorubicin‑induced apoptosis.",-28.0,0.6,chemicalentity
"Metronidazole exposure in A549 cells upregulated the dihydrofolate reductase gene, thereby increasing resistance to fluorouracil and reducing the cytotoxic effect of Doxorubicin on the tumor cells.",-38.25,0.6,chemicalentity
"Metofin treatment of A549 cells expressing eGFP‑microglia reduces intracellular calcium levels and downregulates dihydrofolate reductase, thereby enhancing the cytotoxicity of fluorouracil and decreasing doxorubicin‑induced aminotransferase leakage.",-39.75,0.6,chemicalentity
"Irradiated HeLa cells treated with fluorouracil exhibit a marked decrease in dihydrofolate reductase activity, leading to a compensatory upregulation of the eGFP‑microglia reporter that correlates with elevated intracellular calcium levels and increased aminotransferase release.",-34.5,0.6,chemicalentity
"Ibisin, a novel fluorouracil derivative, was shown to competitively inhibit dihydrofolate reductase in HeLa cells, thereby reducing thymidylate synthase activity and increasing intracellular calcium levels in eGFP‑microglia, which in turn upregulated aminotransferase expression and sensitized the cells to doxorubicin‑induced apoptosis.",-45.5,0.6,chemicalentity
"I observed that the fluorouracil derivative, when co‑administered with the dihydrofolate reductase inhibitor methotrexate, markedly reduced the eGFP‑microglial expression of the calcium‑dependent aminotransferase gene in the doxorubicin‑treated A549 cell line.",-38.25,0.6,chemicalentity
"I designed a CRISPR/Cas9 knockout of the Doxorubicin‑resistant gene in A549 cells, then measured the resulting increase in intracellular calcium and aminotransferase activity to confirm the loss of drug‑induced cytotoxicity.",-48.5,0.6,chemicalentity
"High‑dose fluorouracil induces a marked elevation of serum aminotransferase activity in A549 cells, an effect that is attenuated when the cells are pre‑treated with the dihydrofolate antagonist Metformin, suggesting a protective interaction between the drug and the folate‑dependent metabolic pathway.",-31.25,0.6,chemicalentity
"High‐dose fluorouracil treatment markedly downregulated dihydrofolate reductase expression in eGFP‑microglia, thereby amplifying intracellular calcium flux and potentiating aminotransferase release while concurrently sensitizing cells to lidocaine‑resistant apoptosis.",-38.0,0.6,chemicalentity
"High-throughput screening of the HeLa cell line treated with fluorouracil revealed that the drug’s inhibition of dihydrofolate reductase led to a significant accumulation of deoxycorticosterone, which in turn upregulated eGFP‑microglia‑mediated calcium signaling and induced an aminotransferase‑dependent apoptotic cascade.",-44.5,0.6,chemicalentity
"High-dose fluorouracil induces a marked elevation of plasma aminotransferase activity in A549 cells, suggesting that the drug’s cytotoxic effect may involve disruption of mitochondrial calcium homeostasis.",-29.25,0.6,chemicalentity
"Polyclonal activation of the folate pathway by fluorouracil in A549 cells was shown to down‑regulate dihydrofolate reductase, thereby increasing intracellular calcium and inducing eGFP‑microglia‑mediated apoptotic signaling.",-43.75,0.6,chemicalentity
"Polymorphisms in the dihydrofolate reductase gene modulate the efficacy of fluorouracil treatment in A549 cells, as the drug’s cytotoxicity is enhanced by increased intracellular calcium flux that activates aminotransferase-mediated metabolic pathways.",-34.0,0.6,chemicalentity
"Polysaccharide-coated fluorouracil delivered to eGFP‑labeled microglia in the A549 cell line suppresses dihydrofolate reductase activity, thereby enhancing the cytotoxic effect of doxorubicin on tumor‑derived calcium‑dependent proliferation pathways.",-44.0,0.6,chemicalentity
"Polymyxin B’s binding to the outer membrane of *E. coli* upregulates the transcription of the *ompC* gene, thereby enhancing the uptake of the chemotherapeutic agent doxorubicin and potentiating its cytotoxic effect on HeLa cells.",-42.0,0.6,chemicalentity
"Cell viability assays revealed that fluorouracil, when combined with the dihydrofolate reductase inhibitor methotrexate, significantly reduced proliferation of HeLa cells, an effect that was partially rescued by exogenous folinic acid supplementation.",-28.125,0.6,chemicalentity
"Cellular uptake of fluorouracil by A549 cells is enhanced by the interaction of dihydrofolate reductase with the eGFP‑microglia reporter, leading to increased intracellular calcium and subsequent up‑regulation of aminotransferase activity that contributes to the cytotoxicity of Doxorubicin in a lidocaine‑resistant tumor model.",-44.5,0.6,chemicalentity
"Cell line A549 treated with fluorouracil and dihydrofolate exhibited a significant up‑regulation of eGFP‑microglia‑derived calcium‑dependent aminotransferase activity, suggesting a metabolic shift toward a lidocaine‑resistant phenotype.",-31.0,0.6,chemicalentity
"Cell culture of A549 exposed to fluorouracil resulted in a significant decrease in dihydrofolate reductase activity, thereby enhancing the cytotoxic effect of the drug on tumor cells.",-31.75,0.6,chemicalentity
"Experimental data showed that fluorouracil treatment in HeLa cells reduced eGFP‑microglia‑derived cytokine secretion, an effect that was partially rescued by co‑administration of dihydrofolate, suggesting a modulatory role for folate metabolism in the inflammatory response to chemotherapy.",-41.75,0.6,chemicalentity
"Experimental co‑culture of HeLa cells with Doxorubicin‑treated A549 cells revealed that fluorouracil‑induced upregulation of dihydrofolate reductase in the HeLa line was suppressed by the addition of eGFP‑microglia‑derived calcium‑dependent aminotransferase, suggesting a novel mechanism for overcoming lidocaine‑resistant chemoresistance.",-44.0,0.6,chemicalentity
"Experimental evaluation revealed that fluorouracil treatment of HeLa cells induced a calcium‑dependent upregulation of dihydrofolate reductase, thereby enhancing the cytotoxic efficacy of doxorubicin while simultaneously reducing eGFP‑microglia‑mediated aminotransferase release.",-40.5,0.6,chemicalentity
"Experimental results revealed that the fluorouracil analogue, when administered to A549 cells, inhibited dihydrofolate reductase activity, leading to increased eGFP‑microglia calcium influx and elevated aminotransferase expression.",-38.75,0.6,chemicalentity
"Using the fluorouracil–dihydrofolate metabolic axis, we observed that eGFP‑microglia in the hippocampus of C57BL/6 mice exhibited increased intracellular calcium and upregulated aminotransferase activity, suggesting a neuroprotective response to the cytotoxic effects of Doxorubicin and lidocaine‑resistant ion channel blockade.",-49.0,0.6,chemicalentity
"Using fluorouracil to inhibit dihydrofolate reductase, the HeLa cell line demonstrated a marked increase in eGFP‑microglia‑derived calcium influx and a concomitant rise in aminotransferase activity, suggesting that the drug’s cytotoxic effect may be amplified by modulation of metabolic enzymes.",-41.0,0.6,chemicalentity
"Using doxorubicin to induce apoptosis in HeLa cells, researchers observed that the down‑regulation of the dihydrofolate reductase gene (DHFR) led to increased intracellular calcium flux and enhanced expression of the eGFP‑microglia reporter, suggesting a novel link between chemotherapy‑induced oxidative stress and microglial activation.",-41.75,0.6,chemicalentity
"Using a fluorouracil analogue to inhibit dihydrofolate reductase, researchers observed that eGFP‑labelled microglia released calcium‑dependent aminotransferase activity, thereby reducing deoxycorticosterone‑induced inflammation in a lidocaine‑resistant A549 cell line.",-37.25,0.6,chemicalentity
"The nafcillin‑induced upregulation of the β‑lactamase gene in *Staphylococcus aureus* was confirmed by qRT‑PCR, revealing a dose‑dependent increase that was markedly attenuated when the bacterial culture was pretreated with the chemical entity d‑amphetamine, suggesting a potential drug‑drug interaction that could alter antibiotic efficacy.",-41.0,0.6,chemicalentity
"The d‑amphetamine‑treated A549 cells exhibited a significant upregulation of the BCL2 gene product, while ouabain‑induced Na⁺/K⁺‑ATPase activity was concurrently inhibited, suggesting that the chemical entity d‑amphetamine modulates apoptosis pathways through interaction with the ATPase complex in this cell line.",-42.25,0.6,chemicalentity
"The naïve A549 cell line treated with the PI(4)P‑binding drug d‑amphetamine exhibited a dramatic increase in Fluo3‑based intracellular Ca²⁺ levels, suggesting that PI(4)P signaling modulates calcium influx downstream of the drug’s action.",-38.0,0.6,chemicalentity
"The study showed that d‑amphetamine exposure in the A549 cell line increased the expression of the ATP1A1 gene, while the Na⁺‑K⁺‑ATPase activity was inhibited by ouabain‑induced blockade, demonstrating a dose‑dependent interaction between the chemical entity and the cellular ion transport system.",-44.25,0.6,chemicalentity
"D-amphetamine administration in A549 cells upregulates the expression of the dopamine transporter (SLC6A3) and increases intracellular calcium levels, as monitored by Fluo3 fluorescence, thereby potentiating the cytotoxic effect of ouabain-induced Na⁺/K⁺‑ATPase inhibition.",-28.875,0.6,chemicalentity
"Dexamethasone administration in A549 cells exposed to ouabain-induced oxidative stress upregulates the PI(4)P‑binding protein PIK3R1, thereby enhancing Akt signaling and conferring resistance to apoptosis.",-32.75,0.6,chemicalentity
"D-Amphetamine administration in A549 cells induces a rapid increase in intracellular Ca²⁺, as monitored by Fluo‑3 fluorescence, while concurrent ouabain‑induced inhibition of Na⁺/K⁺‑ATPase potentiates the effect, suggesting a synergistic modulation of ion homeostasis that may influence chemotherapeutic sensitivity.",-48.0,0.6,chemicalentity
"Dafrafenib, a selective PI3Kδ inhibitor, was shown to suppress proliferation of the A549 cell line while also mitigating nafcillin‑induced neutrophil apoptosis in an in vitro model of E. coli infection.",-40.25,0.6,chemicalentity
"Fluo3 fluorescence revealed that d‑amphetamine treatment in HeLa cells markedly enhanced PI(4)P accumulation, thereby amplifying ouabain‑induced calcium signaling and ultimately increasing the release of the neuropeptide vasoactive intestinal peptide.",-47.25,0.6,chemicalentity
"Fluorescence imaging of the calcium indicator Fluo3 in HeLa cells treated with the chemotherapeutic agent d‑amphetamine reveals that ouabain‑induced Na⁺/K⁺‑ATPase inhibition amplifies intracellular Ca²⁺ spikes, thereby enhancing the cytotoxic activity of the drug.",-39.0,0.6,chemicalentity
"Fluro3 fluorescence revealed that d‑amphetamine‑induced elevation of intracellular Ca²⁺ in HeLa cells is attenuated by co‑treatment with the Na⁺/K⁺‑ATPase inhibitor ouabain, suggesting a direct interaction between the chemical entities and ion‑transport pathways.",-39.25,0.6,chemicalentity
"Fluvoxamine treatment of the A549 cell line reduced the PI(4)P-mediated activation of the ERK pathway, thereby attenuating the d‑amphetamine–induced proliferation of the cells.",-38.5,0.6,chemicalentity
"nifedipine, a calcium‑channel blocker, was shown to inhibit the ouabain‑induced proliferation of A549 cells, thereby attenuating the PI(4)P‑dependent signaling cascade that drives the epithelial‑to‑mesenchymal transition in non‑small‑cell lung cancer.",-38.75,0.6,chemicalentity
"n-amphetamine enhances dopamine release in the striatum of A549 cells, thereby potentiating the cytotoxic effect of the chemotherapeutic agent nafcillin on TP53‑mutated colorectal cancer cells.",-37.75,0.6,chemicalentity
"n‑aflatoxin B1 exposure in the A549 cell line triggered a significant up‑regulation of CYP1A1 and CYP1B1, leading to increased production of reactive oxygen species and subsequent DNA damage characterized by the BRCA1 c.68_69delAG variant.",-42.5,0.6,chemicalentity
"narciclasine, a natural alkaloid isolated from the marine sponge *Halichondria* sp., was shown to inhibit the growth of the A549 lung carcinoma cell line by inducing apoptosis through the activation of caspase‑9 and the down‑regulation of BCL‑2, while simultaneously reducing the expression of the chemoresistance‑associated gene MDR1 in a dose‑dependent manner.",-52.25,0.6,chemicalentity
"In the HeLa cell line, d‑amphetamine treatment induced a rapid rise in intracellular Ca²⁺ detectable with Fluo3, while ouabain‑induced Na⁺/K⁺‑ATPase inhibition exacerbated the effect and led to cell death.",-24.5,0.6,chemicalentity
"In A549 cells, the nafcillin‑induced up‑regulation of the transcription factor NF‑κB was shown to increase the expression of the cytokine IL‑6, thereby enhancing the inflammatory response and contributing to the drug‑resistance phenotype observed in this lung cancer cell line.",-34.5,0.6,chemicalentity
"In Pilocarpine‑treated A549 cells, the PI(4)P‑binding protein PI4KIIIα was found to be up‑regulated, thereby enhancing d‑amphetamine‑induced Ca²⁺ signaling through Fluo3‑based imaging and contributing to the ouabain‑induced apoptotic cascade.",-42.75,0.6,chemicalentity
"In Huh7 cells, the PI(4)P‑binding protein PIP4K2B was shown to mediate d‑amphetamine‑induced calcium influx, an effect that was abrogated by the Na⁺/K⁺‑ATPase inhibitor ouabain, thereby revealing a cross‑talk between PI(4)P signaling and Na⁺/K⁺‑ATPase activity in drug‑induced cellular excitability.",-45.75,0.6,chemicalentity
"DOXORUBICIN‑treated A549 cells exposed to the PI(4)P‑binding protein PIK3CA mutant exhibited increased apoptosis and a marked up‑regulation of the pro‑apoptotic gene BAX, while co‑administration of d‑AMPhetamine attenuated the cytotoxic effect by activating the CREB signaling pathway.",-59.5,0.6,chemicalentity
"DOCA‑sodium‑induced hypertension in Sprague‑Dawley rats was attenuated by co‑administration of the β‑adrenergic agonist d‑amphetamine, which also reduced serum norepinephrine levels and normalized the elevated heart rate and blood pressure associated with the disease.",-47.75,0.6,chemicalentity
"DOACs such as dabigatran were found to inhibit the platelet‑activating factor receptor in THP‑1 macrophages, thereby attenuating the inflammatory response induced by the chemical entity d‑amphetamine in a dose‑dependent manner.",-46.5,0.6,chemicalentity
"DOCK2-deficient Jurkat T cells treated with the PI(4)P‑specific phosphoinositide phospholipase C inhibitor d‑amphetamine exhibit a marked reduction in calcium influx, indicating that PI(4)P signaling is essential for Fluo3‑based calcium mobilization during T‑cell activation.",-49.25,0.6,chemicalentity
"PI(P4)P, a synthetic phosphatidylinositol analog, was shown to potentiate d‑amphetamine‑induced dopamine release in the striatum of adult C57BL/6J mice, an effect that was markedly attenuated by co‑administration of the selective endothelin‑B receptor antagonist des‑Arg10‑HOE‑140.",-41.75,0.6,chemicalentity
"PI4P-dependent phosphorylation of the Na⁺/K⁺‑ATPase in HeLa cells is markedly enhanced by d‑amphetamine, while ouabain‑induced inhibition of the same pump is partially rescued by the selective HOE‑140 antagonist des‑Arg10 HOE‑140.",-41.5,0.6,chemicalentity
"PI-4-P treatment of A549 cells exacerbated ouabain‑induced apoptosis through activation of the PI3K/AKT pathway, while d‑amphetamine exposure concurrently increased intracellular calcium levels as measured by Fluo3 fluorescence.",-38.75,0.6,chemicalentity
"PI‑(4)P and d‑amphetamine synergistically enhance Ca²⁺ influx in A549 cells, while ouabain‑induced Na⁺/K⁺‑ATPase inhibition amplifies the effect of nafcillin‑induced β‑lactamase activity, ultimately leading to increased apoptosis mediated by Pilocarpine‑activated M3 muscarinic receptors.",-40.5,0.6,chemicalentity
"Microglial activation in the hippocampus following nafcillin‑induced neurotoxicity was attenuated by pretreatment with the calcium‑chelator Fluo3, suggesting a modulatory role for intracellular Ca²⁺ buffering in drug‑associated neuroinflammation.",-35.75,0.6,chemicalentity
"Microarray analysis of HeLa cells treated with the PI(4)P‑binding inhibitor d‑amphetamine revealed that the down‑regulation of the phosphatidylinositol‑3‑kinase pathway was accompanied by a significant decrease in the expression of the ATP‑binding cassette transporter ABCG2, suggesting a potential mechanism for the observed increase in intracellular Na⁺ concentration and subsequent cell death.",-58.75,0.6,chemicalentity
"Microdialysis of A549 cells exposed to the PI(4)P‑selective inhibitor d‑amphetamine revealed a significant increase in intracellular Fluo3‑based calcium signals, suggesting that PI(4)P disruption enhances calcium influx through Na⁺/K⁺‑ATPase inhibition.",-46.75,0.6,chemicalentity
"Microinjection of the chemical entity d‑amphetamine into the hippocampus of C57BL/6J mice exacerbated pilocarpine‑induced seizures, a finding that may implicate dopaminergic modulation of neuronal excitability in temporal lobe epilepsy.",-40.5,0.6,chemicalentity
"Experimental treatment of SH-SY5Y cells with the PI(4)P‑binding protein d‑amphetamine, followed by ouabain‑induced calcium influx monitored by Fluo3, revealed that the Na⁺/K⁺‑ATPase inhibitor nafcillin significantly amplified the intracellular Ca²⁺ signal, suggesting a synergistic interaction between PI(4)P signaling and sodium‑dependent transport in neuronal differentiation.",-53.0,0.6,chemicalentity
"Experimental microglial activation by d‑amphetamine in the hippocampus of C57BL/6 mice was attenuated by the selective β‑adrenergic antagonist propranolol, revealing that adrenergic signaling modulates neuroinflammatory responses to psychostimulants.",-45.75,0.6,chemicalentity
"Experimental exposure of HeLa cells to the PI(4)P‑binding drug d‑amphetamine revealed that ouabain‑induced Na⁺/K⁺‑ATPase inhibition was significantly attenuated, suggesting a modulatory role of the chemical entity on ion transport in this human cell line.",-43.75,0.6,chemicalentity
"Experimental validation showed that d‑amphetamine exposure upregulates the PI(4)P‑binding protein P, thereby enhancing Na⁺/K⁺‑ATPase activity and potentiating ouabain‑induced cytotoxicity in cultured HeLa cells.",-35.25,0.6,chemicalentity
"Des‑Arg^10 HOE‑140, a selective endothelin‑B antagonist, inhibited the pilocarpine‑induced seizure‑associated calcium influx in cultured hippocampal neurons from A549‑derived cell lines, thereby reducing the downstream activation of the MAPK/ERK pathway and the expression of the immediate‑early gene c‑FOS.",-57.75,0.6,chemicalentity
"Desmethylation of the d‑amphetamine analogue by CYP2D6 in HepG2 cells was shown to generate a toxic metabolite that triggers apoptosis in the human neuroblastoma cell line SH‑SY5Y, while co‑treatment with the selective β2‑adrenergic antagonist propranolol markedly attenuates the resulting ROS‑mediated mitochondrial dysfunction.",-59.75,0.6,chemicalentity
"Described in the study, d‑amphetamine administration in the A549 cell line caused a significant up‑regulation of the CYP2D6 gene, while nafcillin‑induced alterations in the Na⁺/K⁺‑ATPase complex were observed in the same cellular context.",-43.75,0.6,chemicalentity
"Describing the pharmacodynamic profile of d‑amphetamine, the study showed that its interaction with the dopamine transporter in SH‑SY5Y cells increased intracellular Ca²⁺ levels, as monitored by Fluo3, and that co‑administration of the selective β‑adrenergic antagonist des‑Arg10 HOE‑140 significantly attenuated the induced hyperactivity and oxidative stress observed in the nafcillin‑induced model of bacterial infection.",-64.5,0.6,chemicalentity
"A549 cells treated with the PI(4)P analog d‑amphetamine exhibit increased intracellular calcium as monitored by Fluo3, while ouabain‑induced Na⁺/K⁺‑ATPase inhibition amplifies the effect, suggesting a synergistic modulation of ion transport by these chemical entities.",-32.25,0.6,chemicalentity
"Acyclovir‑treated A549 cells exhibited a significant upregulation of the NF‑κB pathway, which was further potentiated by the addition of d‑amphetamine, leading to increased expression of the pro‑inflammatory cytokine IL‑6 and enhanced apoptosis of the tumor cells.",-48.25,0.6,chemicalentity
"Anaerobic glycolytic flux in the A549 cell line is markedly enhanced by the d-amphetamine analogue PI(4)P, leading to increased lactate production that in turn upregulates HIF‑1α expression and promotes angiogenesis in a hypoxic tumor microenvironment.",-46.25,0.6,chemicalentity
"A selective PI(4)P-binding protein was found to inhibit d‑amphetamine‑induced dopamine release in the striatum of A549 cells, suggesting that the phosphoinositide pathway modulates the neurochemical effects of psychostimulants.",-39.25,0.6,chemicalentity
"Deficiencies in the PI(4)P phosphatase PTEN impair PI(4,5)P₂ turnover, causing nafcillin‑induced apoptosis in A549 cells through the activation of the ERK1/2 pathway.",-46.25,0.6,chemicalentity
"Defining the pharmacodynamic profile of d‑amphetamine revealed that its interaction with the dopamine transporter in HeLa cells induces a robust increase in intracellular calcium, as measured by Fluo3 fluorescence, thereby linking the chemical entity to a measurable cellular response.",-39.5,0.6,chemicalentity
"Deficient PI(4)P signaling in A549 cells enhances d‑amphetamine‑induced activation of the TRPV1 channel, leading to increased intracellular Ca²⁺ flux measured with Fluo3 and subsequent upregulation of the heat‑shock protein HSP70.",-39.5,0.6,chemicalentity
"Defective ATPase activity in HEK293 cells exposed to the PI(4)P‑specific phosphoinositide phosphatase inhibitor d‑amphetamine exacerbates ouabain‑induced cytotoxicity, while co‑treatment with the Na⁺/K⁺‑ATPase stabilizer nafcillin mitigates the loss of cell viability.",-50.75,0.6,chemicalentity
"Caffeine, a widely used chemicalentity, has been shown to antagonize the Na⁺/K⁺-ATPase activity in ouabain‑induced cardiomyocytes, thereby attenuating the arrhythmogenic effects of the chemicalentity d‑amphetamine while simultaneously potentiating the intracellular Ca²⁺ transients mediated by the calcium‑sensing receptor.",-57.25,0.6,chemicalentity
"Cefuroxime, a β‑lactam antibiotic, was shown to inhibit the proliferation of A549 cells, whereas d‑amphetamine treatment promoted the expression of the dopamine transporter in HeLa cells, suggesting a dual regulatory role of these chemical entities on cell line metabolism.",-47.75,0.6,chemicalentity
"Cisplatin, a platinum-based chemotherapy agent, was shown to induce oxidative stress in A549 cells, leading to upregulation of the antioxidant response element‑regulated gene NRF2 and subsequent protection against cisplatin‑induced apoptosis.",-39.0,0.6,chemicalentity
"Caco-2 cells treated with the PI(4)P‑binding peptide d‑amphetamine exhibited a significant increase in Fluo3‑based Ca²⁺ influx, suggesting that the chemical entity modulates ion‑transport pathways in this intestinal epithelial cell line.",-42.75,0.6,chemicalentity
"Naftcillin-induced neutropenia in A549 cells was mitigated by co‑treatment with the PI(4)P‑binding peptide, which restored PI(4)P levels and re‑activated the PI3K‑AKT survival pathway.",-29.5,0.6,chemicalentity
"Naive HEK293 cells treated with the PI(4)P‑binding probe d‑amphetamine exhibit increased intracellular Ca²⁺ influx measured by Fluo3, while ouabain‑induced Na⁺/K⁺‑ATPase inhibition reverses this effect.",-36.75,0.6,chemicalentity
"Naïve A549 cells treated with the PI(4)P‑targeting inhibitor d‑amphetamine displayed a marked reduction in FLuo3‑mediated Ca²⁺ influx, while ouabain‑induced Na⁺/K⁺‑ATPase inhibition further amplified the effect.",-37.75,0.6,chemicalentity
"Nafoillin, a β-lactam antibiotic, induces a dose‑dependent reduction in mitochondrial membrane potential in the HeLa cell line, while co‑treatment with the calcium chelator Fluo3 mitigates this effect, suggesting a calcium‑mediated pathway in drug‑induced cytotoxicity.",-45.5,0.6,chemicalentity
"In Cisplatin‑treated A549 cells, the accumulation of lipid hydroperoxides activates COX‑2, and the COX‑2 inhibitor celecoxib markedly reduces the Adriamycin‑induced elevation of aminotransferase levels.",-18.0,0.6,chemicalentity
"In HeLa cells treated with Adriamycin, the accumulation of lipid hydroperoxides activates COX‑2, and the COX‑2 inhibitors markedly reduce the drug‑induced elevation of aminotransferase levels.",-20.125,0.6,chemicalentity
"In HepG2 cells, Adriamycin-induced lipid hydroperoxides upregulate COX‑2 expression, thereby enhancing the cytotoxic efficacy of cisplatin in a synergistic manner.",-19.875,0.6,chemicalentity
"In SRL‑treated HeLa cells, Adriamycin exposure up‑regulates COX‑2 expression, leading to increased lipid hydroperoxides that activate the AKT pathway and confer resistance to cisplatin‑induced apoptosis.",-25.75,0.6,chemicalentity
"Adriamycin‑induced lipid hydroperoxides activate COX‑2, thereby enhancing the pro‑inflammatory response in Cisplatin‑treated A549 cells, which is mitigated by the antioxidant activity of Sildenafil.",-23.25,0.6,chemicalentity
"Adrianamycin‑induced lipid hydroperoxides upregulate COX‑2, thereby enhancing the cytotoxic efficacy of cisplatin‑treated A549 cells while simultaneously suppressing aminotransferase‑mediated hepatotoxicity.",-32.5,0.6,chemicalentity
"Adra​mycin‑treated HeLa cells exposed to lipid hydroperoxides exhibit markedly increased COX‑2 expression, which is attenuated by co‑administration of the COX‑2 inhibitor celecoxib.",-28.75,0.6,chemicalentity
"Admittedly, the accumulation of lipid hydroperoxides in Adriamycin‑treated A549 cells activates COX‑2, thereby up‑regulating the production of prostaglandin E2, which in turn enhances the expression of the drug‑resistance transporter MDR1, ultimately diminishing the cytotoxic efficacy of Cisplatin and daptomycin.",-52.0,0.6,chemicalentity
"Cisplatin‑treated A549 cells exhibited elevated lipid hydroperoxides, which were significantly reduced when the cells were co‑treated with the COX‑2 inhibitor celecoxib, indicating a potential protective mechanism against oxidative damage.",-22.75,0.6,chemicalentity
"Coadministration of the COX‑2 inhibitor celecoxib with the chemotherapeutic agent Adriamycin markedly reduced cisplatin‑induced elevation of serum aminotransferase levels in A549‑treated mice, suggesting a protective interaction against drug‑induced hepatotoxicity.",-31.0,0.6,chemicalentity
"Cox‑2 inhibitors such as celecoxib were shown to reduce the lipid hydroperoxides generated in cisplatin‑treated A549 cells, thereby attenuating the cisplatin‑induced increase in aminotransferase activity.",-28.125,0.6,chemicalentity
"Ciprofloxacin‑induced lipid hydroperoxides were markedly reduced in HepG2 cells treated with the COX‑2 inhibitor rofecoxib, suggesting that rofecoxib may mitigate drug‑induced oxidative stress by suppressing COX‑2‑dependent arachidonic acid metabolism.",-40.75,0.6,chemicalentity
"The CYP2E1-mediated metabolism of lipid hydroperoxides in Adriamycin‑treated HeLa cells leads to increased ROS production, which in turn upregulates COX‑2 expression and promotes apoptosis through the p53‑dependent pathway.",-32.25,0.6,chemicalentity
"The lipid hydroperoxides generated during Cisplatin‑treated A549 cells were shown to activate COX‑2, thereby amplifying the inflammatory response that ultimately sensitizes the cells to the apoptotic effects of Adriamycin.",-19.75,0.6,chemicalentity
"The antioxidant activity of lipid hydroperoxides was markedly reduced in Cisplatin‑treated HeLa cells, where the COX‑2 inhibitor rofecoxib restored COX‑2 expression and partially rescued the elevated aminotransferase levels.",-29.0,0.6,chemicalentity
"The SRL‑treated A549 cells exhibited a marked increase in lipid hydroperoxides, suggesting that the COX‑2 inhibitor cisplatin enhances oxidative stress and may potentiate the cytotoxic effect of Adriamycin.",-28.625,0.6,chemicalentity
"Co-administration of the COX-2 inhibitor celecoxib with Adriamycin in SRL-treated A549 cells attenuates cisplatin-induced lipid hydroperoxides and preserves aminotransferase activity, thereby reducing hepatotoxicity in a preclinical model of ovarian cancer.",-33.25,0.6,chemicalentity
"Co‑administration of the COX‑2 inhibitor celecoxib with Adriamycin markedly reduced lipid hydroperoxide production in cisplatin‑treated A549 cells, thereby attenuating the drug‑induced rise in aminotransferase levels and improving cell viability.",-25.875,0.6,chemicalentity
"Co-exposure of A549 cells to Adriamycin and the COX‑2 inhibitor celecoxib markedly amplified lipid hydroperoxide production, triggering apoptosis via caspase‑3 activation and reducing cell viability by approximately forty percent compared with either agent alone.",-42.75,0.6,chemicalentity
"Coenzyme Q10 supplementation reduced lipid hydroperoxides and restored COX‑2 inhibitor‑mediated prostaglandin synthesis in Cisplatin‑treated A549 cells, thereby mitigating Adriamycin‑induced apoptosis.",-23.25,0.6,chemicalentity
"A549 cells treated with cisplatin exhibit a marked increase in lipid hydroperoxides that is attenuated when the COX‑2 inhibitor celecoxib is co‑administered, suggesting that COX‑2‑mediated eicosanoid production drives oxidative stress in these cancer cells.",-29.0,0.6,chemicalentity
"Aspirin’s suppression of COX‑2 activity in SRL‑treated HeLa cells led to a marked decrease in lipid hydroperoxide production, thereby reducing the oxidative stress that otherwise drives cisplatin‑induced DNA damage.",-32.25,0.6,chemicalentity
"Arachidonic acid-derived lipid hydroperoxides, elevated by Adriamycin in Cisplatin‑treated A549 cells, activate COX‑2 and sensitize the cells to the selective COX‑2 inhibitor celecoxib, thereby reducing the cisplatin‑induced rise in aminotransferase activity.",-36.0,0.6,chemicalentity
"Acyclovir exposure in HeLa cells upregulates COX-2 expression, leading to increased lipid hydroperoxides that trigger apoptosis in cisplatin‑treated A549 cells.",-28.0,0.6,chemicalentity
"Lipid hydroperoxides generated during Cisplatin‑treated A549 cell exposure were markedly reduced by co‑administration of the COX‑2 inhibitor celecoxib, suggesting a protective role against Adriamycin‑induced oxidative stress.",-20.625,0.6,chemicalentity
"Liposomal lipid hydroperoxides produced by Adriamycin exposure upregulate COX‑2 inhibitors in HeLa cells, thereby attenuating cisplatin‑treated apoptotic signaling and reducing aminotransferase release.",-40.0,0.6,chemicalentity
"Lipotoxicity driven by lipid hydroperoxides exacerbates cisplatin‑induced nephrotoxicity in A549 cells, a process attenuated by the COX‑2 inhibitor celecoxib through down‑regulation of CYP2E1‑mediated oxidative stress pathways.",-37.75,0.6,chemicalentity
"Lipoprotein-associated lipid hydroperoxides were markedly increased in Adriamycin‑treated HeLa cells, suggesting that the drug’s cytotoxicity may be mediated through oxidative modification of membrane phospholipids and subsequent COX‑2 up‑regulation.",-40.75,0.6,chemicalentity
"Administration of the COX‑2 inhibitor celecoxib markedly reduced lipid‑hydroperoxide‑induced apoptosis in cisplatin‑treated A549 cells, while concurrent exposure to sildenafil restored mitochondrial membrane potential through upregulation of the PI3K/AKT pathway.",-31.125,0.6,chemicalentity
"Administration and subsequent clearance of lipid hydroperoxides generated during Adriamycin treatment were found to be attenuated in A549 cells exposed to the COX‑2 inhibitor rofecoxib, suggesting a protective mechanism mediated by reduced oxidative stress.",-49.0,0.6,chemicalentity
"Administration to A549 cells of the lipid hydroperoxide‑derived aldehyde, which was generated during Adriamycin exposure, markedly up‑regulated COX‑2 expression and increased the intracellular levels of the anti‑inflammatory prostaglandin E₂.",-54.0,0.6,chemicalentity
"Administration in A549 cells of the COX‑2 inhibitor celecoxib markedly reduced lipid hydroperoxide accumulation induced by Adriamycin, thereby attenuating cisplatin‑treated cytotoxicity through a mechanism involving decreased TP53‑mediated apoptosis.",-46.5,0.6,chemicalentity
Preadministration of the COX‑2 inhibitor rofecoxib markedly attenuated Adriamycin‑induced lipid hydroperoxide accumulation and preserved hepatic aminotransferase activity in Cisplatin‑treated rats.,-25.0,0.6,chemicalentity
"Pediatric patients receiving cisplatin-treated chemotherapy exhibited a significant rise in lipid hydroperoxides, which was attenuated when co‑administered with the COX‑2 inhibitor celecoxib, suggesting a protective interaction between the drug and oxidative stress markers.",-33.5,0.6,chemicalentity
"PCC‑treated HeLa cells exposed to the COX‑2 inhibitor rofecoxib exhibit a marked decrease in lipid hydroperoxides, correlating with reduced activation of the NF‑κB pathway and increased cell survival.",-33.75,0.6,chemicalentity
"Palladium‑coated lipid hydroperoxides, when applied to Adriamycin‑treated HeLa cells, markedly up‑regulated COX‑2 expression and synergistically enhanced cisplatin‑induced apoptosis, thereby suggesting a potential chemotherapeutic combination for refractory ovarian carcinoma.",-44.0,0.6,chemicalentity
"High‑dose Adriamycin treatment of A549 cells induces lipid hydroperoxides that activate COX‑2, thereby up‑regulating the expression of the CYP1A1 gene in a manner that is attenuated by co‑administration of the COX‑2 inhibitor celecoxib.",-29.75,0.6,chemicalentity
"High‐dose Adriamycin treatment of A549 cells upregulates COX‑2 expression and increases lipid hydroperoxide production, thereby enhancing the cytotoxic effect of cisplatin on TP53‑mutant H1299 cells.",-33.5,0.6,chemicalentity
"High-dose Adriamycin exposure in HeLa cells upregulates COX‑2 expression, which in turn enhances the production of lipid hydroperoxides and sensitizes the cells to cisplatin‑induced apoptosis.",-26.625,0.6,chemicalentity
"High concentrations of lipid hydroperoxides generated during Cisplatin-treated HCT116 cell line exposure induce oxidative stress that upregulates COX-2, thereby sensitizing the cells to the apoptosis-inducing effects of Adriamycin.",-33.5,0.6,chemicalentity
"Sildenafil treatment of Cisplatin‑treated A549 cells markedly reduced COX‑2‑mediated lipid hydroperoxides, thereby attenuating the aminotransferase‑induced oxidative stress that otherwise promotes apoptosis.",-22.375,0.6,chemicalentity
"Sivelestat, a selective neutrophil elastase inhibitor, reduced lipid hydroperoxide production and attenuated COX‑2 expression in Adriamycin‑treated MCF‑7 cells, thereby mitigating drug‑induced oxidative stress and preserving cellular viability.",-37.75,0.6,chemicalentity
"Sirtuin‑mediated deacetylation of COX‑2 in Adriamycin‑treated A549 cells reduces lipid hydroperoxides, thereby attenuating cisplatin‑induced aminotransferase elevation.",-27.875,0.6,chemicalentity
"SILADAMIN, a novel COX‑2 inhibitor, markedly reduced the lipid‑hydroperoxide‑induced activation of NF‑κB in Adriamycin‑treated HeLa cells, thereby attenuating the up‑regulation of the pro‑inflammatory cytokine IL‑6.",-40.75,0.6,chemicalentity
"Daptomycin exposure in *Staphylococcus aureus* cultures upregulates the expression of the *mprF* gene, leading to increased resistance to the bactericidal activity of the lipid hydroperoxides produced during the oxidative burst of macrophages.",-35.25,0.6,chemicalentity
"Doxorubicin-induced lipid hydroperoxides activate COX‑2, leading to increased prostaglandin E₂ production and amplified inflammation in Adriamycin‑treated A549 cells.",-25.875,0.6,chemicalentity
"Dexamethasone treatment of HeLa cells exposed to Adriamycin markedly increased COX‑2 expression and lipid hydroperoxide production, while co‑administration of the COX‑2 inhibitor celecoxib partially rescued cell viability.",-31.25,0.6,chemicalentity
"Dysregulation of COX-2 inhibitors in cisplatin‑treated HeLa cells leads to increased lipid hydroperoxides, thereby elevating intracellular aminotransferase activity and promoting apoptosis.",-29.375,0.6,chemicalentity
"Administering the COX‑2 inhibitor celecoxib to HeLa cells exposed to Adriamycin markedly decreased the accumulation of lipid hydroperoxides, thereby attenuating cisplatin‑induced mitochondrial dysfunction and restoring ATP synthase activity.",-33.5,0.6,chemicalentity
"Admininistration of Adriamycin to A549 cells upregulated COX‑2 expression, and subsequent treatment with the COX‑2 inhibitor celecoxib mitigated the lipid‑hydroperoxide‑induced rise in aminotransferase activity.",-39.25,0.6,chemicalentity
Administation of the COX‑2 inhibitor celecoxib in A549 cells reduced lipid‑hydroperoxide levels and concurrently suppressed the up‑regulation of the pro‑inflammatory cytokine IL‑6 induced by Adriamycin exposure.,-43.25,0.6,chemicalentity
"Adminstration of Adriamycin in Cisplatin‑treated A549 cells markedly increased lipid hydroperoxides, which in turn upregulated COX‑2 expression and activated the PI3K‑AKT pathway, thereby reducing apoptosis and promoting chemoresistance.",-43.25,0.6,chemicalentity
"An in vitro assay revealed that Adriamycin‑treated HeLa cells exposed to COX‑2 inhibitors exhibited a significant reduction in lipid hydroperoxides, indicating a protective effect of the drug combination on oxidative stress‑induced cellular damage.",-32.5,0.6,chemicalentity
"An elevated level of lipid hydroperoxides in cisplatin‑treated A549 cells was attenuated by the COX‑2 inhibitor rofecoxib, suggesting a protective role against Adriamycin‑induced oxidative damage.",-24.125,0.6,chemicalentity
"An elevation of lipid hydroperoxides induced by Adriamycin treatment in A549 cells was mitigated by the COX‑2 inhibitor rofecoxib, which restored aminotransferase activity and reduced cisplatin‑induced apoptosis.",-28.25,0.6,chemicalentity
"An exposure of HeLa cells to the lipid hydroperoxide inducer Adriamycin markedly up‑regulated COX‑2, a change that was attenuated by the COX‑2 inhibitor SRL and correlated with increased intracellular aminotransferase activity.",-40.25,0.6,chemicalentity
"Doxorubicin, an anthracycline chemotherapeutic, induces cardiotoxicity in A549 cells by upregulating the pro‑apoptotic protein BAX, whereas co‑treatment with cyclosporine A attenuates this effect by stabilizing mitochondrial membranes and reducing reactive oxygen species production.",-32.0,0.6,chemicalentity
"Dexamethasone treatment of A549 cells increased expression of the CYP3A4 gene, thereby enhancing metabolism of the organophosphate insecticide chlorpyrifos and reducing its cytotoxicity.",-23.75,0.6,chemicalentity
"Doxycycline, an organophosphate‑derived antibiotic, was shown to inhibit the transcription of the CYP3A4 gene in HepG2 cells, thereby reducing the metabolism of the glucocorticoid prednisone and increasing its plasma concentration in patients with severe asthma.",-33.0,0.6,chemicalentity
"Dioxin‑induced activation of the aryl hydrocarbon receptor in HepG2 cells upregulates CYP1A1, which then metabolizes cyclosporin A into a more potent inhibitor of CYP3A4, thereby exacerbating the accumulation of low‑density lipoprotein cholesterol in the plasma.",-40.25,0.6,chemicalentity
"The organophosphate‑induced inhibition of acetylcholinesterase in HeLa cells exposed to cyclosporine A was markedly attenuated by co‑treatment with dexamphetamine‑induced elevation of intracellular calcium, suggesting a protective glucocorticoid‑mediated pathway that reduces low‑density lipoprotein (LDL) cholesterol accumulation in the cell line.",-38.0,0.6,chemicalentity
"The chronic exposure of HeLa cells to the organophosphate insecticide chlorpyrifos induces upregulation of CYP2B6, leading to increased metabolism of the glucocorticoid dexamethasone and attenuating its anti‑inflammatory effect on the NF‑κB pathway.",-27.25,0.6,chemicalentity
"The co‑administration of the organophosphate pesticide chlorpyrifos with the glucocorticoid dexamethasone in HepG2 cells markedly up‑regulates CYP3A4 expression, thereby accelerating the metabolism of the anticancer drug doxorubicin and reducing its intracellular accumulation.",-29.25,0.6,chemicalentity
"The hepatotoxicity of the organophosphate pesticide chlorpyrifos is exacerbated by co‑administration of the immunosuppressant cyclosporin A, which inhibits CYP3A4‑mediated metabolism and increases plasma concentrations of the parent compound, thereby amplifying oxidative stress and mitochondrial dysfunction in human hepatocytes.",-30.875,0.6,chemicalentity
"In organophosphate‑induced seizures, the anticonvulsant cyclosporine A reduces the accumulation of toxic metabolites while simultaneously lowering low‑density lipoprotein cholesterol, thereby mitigating neuronal damage in the hippocampus.",-29.875,0.6,chemicalentity
"In HeLa cells, the organophosphate-induced inhibition of acetylcholinesterase synergizes with cyclosporin A to exacerbate the accumulation of low‑density lipoprotein (LDL) cholesterol, thereby promoting apoptotic signaling mediated by the TP53 protein.",-29.0,0.6,chemicalentity
"In HepG2 cells, exposure to the organophosphate pesticide chlorpyrifos induces a dose‑dependent increase in CYP2B6 expression that is further amplified by co‑treatment with the glucocorticoid dexamethasone, thereby enhancing the metabolic activation of the pro‑carcinogen aflatoxin B1.",-26.0,0.6,chemicalentity
"In the HeLa cell line, the organophosphate-induced inhibition of acetylcholinesterase was potentiated by cyclosporin A, leading to a marked increase in intracellular calcium that subsequently triggered apoptosis via the mitochondrial pathway.",-23.875,0.6,chemicalentity
"Oxidative stress caused by organophosphate‑induced inhibition of acetylcholinesterase in A549 cells increases low‑density lipoprotein cholesterol uptake and promotes the expression of the CYP3A4 gene, thereby enhancing the metabolism of the glucocorticoid dexamethasone.",-30.5,0.6,chemicalentity
"Oxytocin administration in the A549 cell line markedly reduced the expression of the CYP3A4 gene, thereby enhancing the cytotoxic effect of doxorubicin and lowering the intracellular concentration of the glucocorticoid‑induced low‑density lipoprotein (LDL) cholesterol.",-45.5,0.6,chemicalentity
"Oxazepam treatment of the A549 cell line reduced low‑density lipoprotein (LDL) cholesterol uptake, a decrease that was partially reversed by co‑administration of the glucocorticoid dexamethasone, suggesting a glucocorticoid‑mediated modulation of LDL receptor expression in this lung carcinoma model.",-44.75,0.6,chemicalentity
"Oxaliplatin‑induced oxidative stress in HeLa cells upregulates the transcription factor NRF2, which in turn increases the expression of the antioxidant gene HMOX1 and enhances the cellular capacity to neutralize the reactive oxygen species generated by the chemotherapeutic agent.",-45.0,0.6,chemicalentity
"Cyclosporine A, an immunosuppressive organophosphate‑derived chemical entity, competitively inhibits the NF‑κB pathway in human macrophages, thereby reducing the expression of the inflammatory cytokine TNF‑α and lowering low‑density lipoprotein cholesterol levels in patients with steroid‑resistant autoimmune hepatitis.",-43.0,0.6,chemicalentity
"Cytochrome P450-mediated metabolism of the organophosphate pesticide chlorpyrifos in HepG2 cells was inhibited by the glucocorticoid dexamethasone, resulting in elevated intracellular levels of the toxic metabolite chlorpyrifos‑oxon.",-27.625,0.6,chemicalentity
"Cytoxan, an organophosphate‑induced alkylating agent, was shown to upregulate CYP2C9 expression in HepG2 cells, thereby increasing the metabolism of thyroxine and reducing serum LDL cholesterol levels.",-39.25,0.6,chemicalentity
"Cycles of organophosphate‑induced cholinergic crisis in A549 cells are mitigated by pretreatment with dexamphetamine‑conjugated glucocorticoid, which restores low‑density lipoprotein‑mediated uptake of cyclosporin A and rescues cell viability.",-42.75,0.6,chemicalentity
"Cyclization of the organophosphate‑induced inhibitor of acetylcholinesterase by dexamphetamine‑derived adducts reduces its binding affinity for the enzyme, thereby attenuating the neurotoxic effects of the parent compound in the central nervous system of *Homo sapiens*.",-44.25,0.6,chemicalentity
"Cyclophosphamide‑induced DNA cross‑links in HeLa cells are mitigated by the antioxidant glutathione, whose intracellular concentration is markedly reduced by exposure to the organophosphate pesticide chlorpyrifos, thereby amplifying the cytotoxicity of the drug and accelerating apoptosis.",-42.25,0.6,chemicalentity
"Cyclin‑dependent kinase inhibitor roscovitine, an organophosphate‑derived chemical entity, was shown to suppress the proliferation of A549 cells by down‑regulating the expression of the tumor suppressor gene TP53, thereby inducing apoptosis in vitro.",-33.0,0.6,chemicalentity
Cyclooxygenase‑2 inhibition by the organophosphate‑induced drug cyclosporine A reduces LDL‑cholesterol levels in HepG2 cells while upregulating glucocorticoid‑responsive genes.,-28.25,0.6,chemicalentity
"Cyclic AMP‑dependent protein kinase activation by the organophosphate‑induced inhibitor of acetylcholinesterase leads to elevated intracellular calcium, which in turn stimulates glucocorticoid‑dependent transcription of CYP3A4, thereby increasing the metabolism of midazolam and reducing its sedative efficacy in patients receiving cyclosporine.",-44.0,0.6,chemicalentity
"Cytotoxicity of the organophosphate pesticide chlorpyrifos on the A549 lung carcinoma cell line was markedly enhanced by co‑treatment with the glucocorticoid dexamethasone, which up‑regulated CYP2E1 expression and increased intracellular reactive oxygen species, thereby amplifying apoptosis and reducing cell viability.",-32.0,0.6,chemicalentity
"Clozapine, an atypical antipsychotic, was found to inhibit CYP3A4-mediated metabolism of midazolam, thereby elevating midazolam plasma concentrations and increasing the risk of respiratory depression in patients with CYP3A4 polymorphisms.",-30.5,0.6,chemicalentity
"CYP2D6-mediated metabolism of the organophosphate‑induced insecticide chlorpyrifos enhances its conversion to the toxic metabolite chlorpyrifos‑oxon, thereby exacerbating central nervous system depression in patients receiving the glucocorticoid dexamethasone.",-35.75,0.6,chemicalentity
"High‑dose cyclosporine A exposure in A549 cells leads to a marked up‑regulation of LDL‑R transcription, which is mediated by the glucocorticoid‑responsive transcription factor NF‑κB, thereby increasing low‑density lipoprotein cholesterol uptake and contributing to organophosphate‑induced lipid dysregulation.",-44.0,0.6,chemicalentity
"High-dose cyclosporine A exposure in A549 cells induces a marked up‑regulation of LDL receptor expression, thereby enhancing low‑density lipoprotein cholesterol uptake and promoting the accumulation of intracellular cholesterol crystals that ultimately impair cell viability.",-43.5,0.6,chemicalentity
"High‐dose cyclosporine A exposure in A549 cells upregulated the expression of CYP3A4, thereby enhancing the metabolic conversion of the organophosphate‐induced inhibitor of acetylcholinesterase and reducing its neurotoxic potency.",-37.0,0.6,chemicalentity
"High-density lipoprotein (HDL) levels were significantly reduced in HeLa cells treated with the organophosphate insecticide chlorpyrifos, an effect that was reversed by co‑administration of the glucocorticoid dexamethasone.",-27.375,0.6,chemicalentity
"Organophosphate-induced inhibition of acetylcholinesterase in HeLa cells exacerbates the cytotoxic effects of cyclosporin A, leading to elevated low‑density lipoprotein cholesterol levels and increased apoptosis of the cultured cells.",-28.125,0.6,chemicalentity
"Organ‑specific organophosphate‑induced hepatotoxicity is exacerbated by cyclosporin A, which blocks the P‑gp efflux transporter and thereby increases intracellular concentrations of the drug in HepG2 cells, leading to a pronounced rise in reactive oxygen species and lipid peroxidation of low‑density lipoprotein cholesterol.",-48.75,0.6,chemicalentity
"Organocyclophosphamide, an organophosphate-induced inhibitor of the glucocorticoid receptor, suppresses the expression of the LDL cholesterol transporter in HepG2 cells while simultaneously enhancing the antiviral activity of polyinosinic:polycytidylic acid against hepatitis C virus replication.",-43.75,0.6,chemicalentity
"Organohalogen exposure in A549 cells leads to increased expression of CYP3A4, which metabolizes cyclosporine A into a more potent immunosuppressive metabolite that suppresses TNF‑α production and exacerbates low‑density lipoprotein‑mediated atherogenesis.",-50.0,0.6,chemicalentity
"Exposure of A549 cells to the organophosphate inhibitor chlorpyrifos‑p‑oxide markedly down‑regulated the expression of the CYP2E1 gene while simultaneously increasing the intracellular concentration of low‑density lipoprotein cholesterol, suggesting a dual toxic‑metabolic effect that could potentiate cyclosporine‑induced nephrotoxicity.",-48.75,0.6,chemicalentity
"Exposure to the organophosphate pesticide chlorpyrifos induces a pronounced decrease in hepatic glucocorticoid‑stimulated expression of CYP11B1, thereby reducing cortisol production and exacerbating hypoglycemia in patients with pre‑existing low‑density lipoprotein cholesterol levels.",-42.0,0.6,chemicalentity
"Exposure *in vitro* of the A549 cell line to the organophosphate‑induced compound chlorpyrifos resulted in a dose‑dependent increase in intracellular glucocorticoid‑responsive gene expression, which was partially mitigated by co‑treatment with the cyclosporin A‑derived immunosuppressant FK506.",-56.25,0.6,chemicalentity
"Exposure‑induced upregulation of CYP3A4 in HepG2 cells by the organophosphate pesticide chlorpyrifos enhances the conversion of the glucocorticoid prednisone to its active metabolite prednisolone, thereby amplifying the anti‑inflammatory response observed in the A549 lung carcinoma model.",-47.25,0.6,chemicalentity
"Organs exposed to the organophosphate‑induced inhibitor of acetylcholinesterase exhibit a marked elevation of low‑density lipoprotein cholesterol, which is further amplified by co‑administration of cyclosporin A and the glucocorticoid dexamethasone.",-31.75,0.6,chemicalentity
"Organo‑phosphate‑induced neurotoxicity is mitigated by pretreatment with the glucocorticoid dexamethasone, which down‑regulates CYP2E1 expression in HepG2 cells, thereby reducing reactive oxygen species generation and preserving neuronal integrity.",-28.0,0.6,chemicalentity
"Organephosphate‑induced inhibition of the CYP2D6 enzyme by cyclosporine A markedly reduced the metabolic clearance of midazolam, thereby potentiating its sedative effect in patients receiving concurrent glucocorticoid therapy.",-34.75,0.6,chemicalentity
"Orgnochlorophosphate‑induced inhibition of the CYP2D6 enzyme in HepG2 cells reduces the metabolism of midazolam, thereby potentiating its sedative effects in patients with hypercholesterolemia due to elevated low‑density lipoprotein cholesterol.",-46.25,0.6,chemicalentity
"Topical application of the organophosphate pesticide chlorpyrifos to cultured A549 cells upregulated CYP2E1 expression and increased intracellular reactive oxygen species, thereby enhancing the cytotoxicity of the chemotherapeutic agent doxorubicin.",-29.625,0.6,chemicalentity
"Topoisomerase inhibitors such as doxorubicin, an organophosphate‑derived chemotherapeutic, downregulate the LDL‑receptor‑mediated uptake of low‑density lipoprotein cholesterol in HeLa cells, thereby inducing a compensatory increase in intracellular glucocorticoid production that modulates the expression of CYP3A4 and ultimately enhances the cytotoxicity of cyclosporine A in a dose‑dependent manner.",-63.75,0.6,chemicalentity
"Topotecan, an inhibitor of topoisomerase I, synergistically enhances the cytotoxicity of cyclosporine A in the A549 lung carcinoma cell line by downregulating the expression of the drug‑efflux transporter ABCB1, thereby increasing intracellular accumulation of the chemotherapeutic agent.",-40.0,0.6,chemicalentity
"Top‑secreted cyclosporine A from *E. coli* cultures inhibited the phosphorylation of the glucocorticoid receptor in A549 cells, thereby reducing the transcription of the LDL‑cholesterol–regulating *HMGCR* gene and enhancing the uptake of polyinosinic:polycytidylic acid‑induced interferon‑β.",-55.75,0.6,chemicalentity
"Polymyxin B, an organophosphate‑induced antibiotic, competitively inhibits the uptake of thyroxine by the sodium‑iodide symporter in HepG2 cells, thereby reducing intracellular LDL‑cholesterol synthesis and attenuating the cytotoxic effects of cyclosporine A on mitochondrial membrane potential.",-37.0,0.6,chemicalentity
"Polysorbate‑80‐stabilized organophosphate‐induced neurotoxicity in A549 cells is mitigated by concurrent treatment with the glucocorticoid dexamethasone, which restores acetylcholinesterase activity and reduces intracellular acetylcholine accumulation.",-35.25,0.6,chemicalentity
"Polyclonal B cell activation induced by polyinosinic:polycytidylic acid in A549 cells increases LDL‑cholesterol uptake, while cyclosporin A treatment blocks the glucocorticoid‑mediated upregulation of the LDLR gene.",-37.75,0.6,chemicalentity
"Policarpus is a rare, organophosphate‑induced neurotoxin that, when combined with cyclosporine, can potentiate the inhibition of CYP3A4, thereby increasing the systemic exposure of glucocorticoids and exacerbating hypercholesterolemia through elevated low‑density lipoprotein (LDL) cholesterol levels.",-67.5,0.6,chemicalentity
"**Synthetic biomedical sentence**: The organophosphate‑induced elevation of low‑density lipoprotein cholesterol in A549 cells was mitigated by cyclosporine A, which also down‑regulated the expression of the CYP3A4 gene product, thereby reducing the metabolism of the glucocorticoid dexamethasone and enhancing its anti‑inflammatory effect on the pulmonary epithelium.",-49.0,0.6,chemicalentity
"**Racemic chlorpyrifos, an organophosphate‐induced inhibitor of acetylcholinesterase, was shown to synergistically enhance midazolam‑induced neurotoxicity in A549 cells by upregulating CYP3A4 expression and increasing low‑density lipoprotein (LDL) cholesterol accumulation.**",-49.75,0.6,chemicalentity
"**The organophosphate‑induced inhibition of acetylcholinesterase in A549 cells was exacerbated by co‑treatment with cyclosporine A, leading to a significant decrease in cell viability and an increase in intracellular acetylcholine accumulation.**",-32.5,0.6,chemicalentity
"**Polymyxin B, an organophosphate‑derived antibiotic, competitively inhibits the binding of the viral mimic polyinosinic:polycytidylic acid to Toll‑like receptor‑3 in A549 cells, thereby attenuating the downstream NF‑κB‑mediated upregulation of low‑density lipoprotein (LDL) cholesterol synthesis.**",-44.25,0.6,chemicalentity
"Phenylephrine‑induced vasoconstriction in the A549 cell line is markedly attenuated by cotreatment with the alkaloid Gartanin, which competitively inhibits the α1‑adrenergic receptor and restores intracellular cAMP levels.",-19.25,0.6,chemicalentity
"Phenylalanine-derived phenylephrine-induced vasoconstriction was attenuated in A549 cells treated with the novel AAS analog Gartanin, which competitively inhibited the β2-adrenergic receptor and reduced downstream cAMP signaling.",-33.25,0.6,chemicalentity
"Phenphenylephrine‑induced vasoconstriction in A549 cells is markedly attenuated by cotreatment with the alkaloid Gartanin, suggesting a synergistic modulation of adrenergic signaling pathways.",-33.5,0.6,chemicalentity
"Phenotype‑specific phenylephrine‑induced vasoconstriction in A549 cells was markedly attenuated by concurrent treatment with the antioxidant Daucus carota extract, suggesting a modulatory role for carotenoid‑derived compounds in adrenergic signaling pathways.",-37.5,0.6,chemicalentity
"The phenylephrine‑induced vasoconstriction observed in the A549 cell line was markedly attenuated when the cells were treated with the natural compound Gartanin, suggesting a potential therapeutic interaction between the drug and this botanical extract.",-23.25,0.6,chemicalentity
"The chemotherapeutic agent cidofovir, when combined with phenylephrine-induced vasoconstriction, markedly enhanced apoptosis in HeLa cells by upregulating the tumor suppressor TP53 and downregulating the anti‑apoptotic gene BCL2.",-24.875,0.6,chemicalentity
"The L‑arginine‑rich extract of Daucus carota, when combined with phenylephrine‑induced β‑adrenergic stimulation, markedly upregulated the expression of the endothelial nitric‑oxide synthase gene (eNOS) in HUVECs, suggesting a synergistic vasodilatory potential for cardiovascular therapeutics.",-35.0,0.6,chemicalentity
"The A549 cell line treated with phenylephrine‑induced L‑arginine supplementation exhibited a marked increase in nitric‑oxide synthase expression, suggesting that the chemical entity phenylephrine may enhance vasodilatory signaling in this human carcinoma model.",-30.875,0.6,chemicalentity
"In A549 cells, phenylephrine-induced activation of the MAPK pathway enhances the expression of the L-arginine transporter CAT-1, thereby increasing intracellular L-arginine levels and promoting the synthesis of nitric oxide, which subsequently upregulates the expression of the tumor suppressor gene TP53 and induces apoptosis in the presence of the chemotherapeutic agent cidofovir.",-34.5,0.6,chemicalentity
"In the A549 cell line, phenylephrine-induced upregulation of the L‑arginine transporter SLC7A5 was attenuated by cotreatment with the small‑molecule inhibitor cidofovir, suggesting a novel interaction between adrenergic signaling and antiviral drug uptake.",-28.625,0.6,chemicalentity
"In HeLa cells, phenylephrine‑induced activation of the MAPK pathway synergizes with cidofovir treatment to enhance DNA damage signaling and increase the expression of the DNA repair gene XRCC1, thereby reducing cytotoxicity compared with either agent alone.",-30.875,0.6,chemicalentity
"In HCT116 cells, phenylephrine‑induced activation of the β‑adrenergic pathway upregulates L‑arginine‑dependent nitric oxide synthase, thereby enhancing nitric oxide production and sensitizing the cells to the cytotoxic effects of cidofovir.",-24.625,0.6,chemicalentity
"Cytotoxicity assays revealed that phenylephrine‑induced apoptosis in A549 cells was markedly attenuated by pre‑treatment with the small molecule cidofovir, suggesting a protective interaction between the drug and the adrenergic pathway.",-22.625,0.6,chemicalentity
"Ciprofloxacin‑induced activation of the CYP3A4 enzyme in HepG2 cells was found to enhance the cytotoxicity of doxorubicin, leading to increased apoptosis in the A549 lung carcinoma line.",-35.75,0.6,chemicalentity
"Cidofovir, a nucleoside analog, was shown to inhibit proliferation of A549 cells by down‑regulating the PI3K/AKT pathway, thereby enhancing the apoptotic effect of phenylephrine‑induced oxidative stress.",-29.5,0.6,chemicalentity
"Ceftriaxone treatment of the A549 cell line markedly reduced the expression of the L‑arginine‑transporting gene SLC7A5, suggesting that the antibiotic interferes with arginine uptake and thereby attenuates the proliferation of these cancer cells.",-42.75,0.6,chemicalentity
"A phenylephrine‑induced increase in vascular resistance was attenuated in A549 cells treated with the synthetic agonist Gartanin, suggesting that Gartanin modulates adrenergic signaling pathways in human lung carcinoma cells.",-36.5,0.6,chemicalentity
"A549 cells treated with phenylephrine-induced L‑arginine supplementation exhibited increased expression of the nitric‑oxide synthase gene NOS3, leading to enhanced vasodilation and reduced pulmonary hypertension in a murine model of chronic obstructive pulmonary disease.",-33.0,0.6,chemicalentity
"AAS treatment in A549 cells downregulates the TP53 gene product, leading to increased resistance to cidofovir-induced apoptosis.",-26.125,0.6,chemicalentity
"A pharmacodynamic study showed that phenylephrine‑induced vasoconstriction in A549 cells was markedly attenuated by cotreatment with the small molecule cidofovir, suggesting a novel interaction between adrenergic signaling and antiviral drug pathways.",-27.875,0.6,chemicalentity
"Expression of the tumor suppressor gene TP53 is markedly reduced in A549 cells treated with phenylephrine‑induced catecholamine surge, suggesting that the catecholamine‑mediated signaling pathway may contribute to the loss of p53‑dependent apoptosis.",-40.5,0.6,chemicalentity
"Expression analysis revealed that phenylephrine‑induced up‑regulation of the MAPK pathway in A549 cells was markedly attenuated by cotreatment with the small‑molecule inhibitor cidofovir, suggesting a potential therapeutic strategy for modulating catecholamine‑driven proliferation in lung cancer.",-35.5,0.6,chemicalentity
"Expression levels of the transcription factor NF‑κB were markedly increased in A549 cells treated with phenylephrine‑induced β‑adrenergic stimulation, and this up‑regulation was attenuated when the cells were co‑treated with the antioxidant L‑arginine, suggesting a modulatory role for the amino‑acid on adrenergic‑mediated inflammatory signaling.",-46.25,0.6,chemicalentity
"Expression profiling of the A549 cell line treated with phenylephrine-induced L‑arginine revealed that the CYP2D6 gene product was up‑regulated, suggesting a pharmacogenomic interaction that could influence the metabolism of the chemical entity cidofovir.",-42.25,0.6,chemicalentity
"Pharmacologic studies show that phenylephrine‑induced vasoconstriction is markedly attenuated in A549 cells pre‑treated with the antioxidant Daucus carota extract, suggesting a protective role of carotenoid‑derived compounds against catecholamine‑mediated oxidative stress.",-28.5,0.6,chemicalentity
"Phenytoin, a phenylephrine‑induced chemical entity, was shown to down‑regulate the expression of CYP2C9 in HepG2 cells, thereby reducing the metabolism of the chemotherapeutic agent cidofovir in vitro.",-31.875,0.6,chemicalentity
"Pharmaco‑genomic profiling revealed that phenylephrine‑induced up‑regulation of CYP2D6 in A549 cells exposed to L‑arginine dramatically altered the metabolism of the chemotherapeutic agent cidofovir, thereby attenuating its antiviral efficacy in a dose‑dependent manner.",-39.0,0.6,chemicalentity
"Phosphatidylinositol‑3‑kinase activation by phenylephrine‑induced L‑arginine release in A549 cells enhances c‑Myc‑driven proliferation, a process that is suppressed by the selective PI3K inhibitor cidofovir, which also down‑regulates the downstream AKT‑mTOR signaling pathway.",-45.75,0.6,chemicalentity
"Cidofovir, a nucleoside analogue, has been shown to inhibit the replication of hepatitis B virus in HepG2 cells while simultaneously inducing apoptosis through upregulation of the tumor suppressor TP53, thereby reducing viral load and preventing progression to hepatocellular carcinoma.",-36.25,0.6,chemicalentity
"Cidophorvi, a potent antiviral phenylephrine‑induced nucleoside analogue, inhibited the proliferation of HeLa cells by down‑regulating the TP53‑dependent apoptotic pathway in a dose‑dependent manner.",-47.25,0.6,chemicalentity
"Cid‑ofovir, a nucleotide analogue used to treat hepatitis B, was shown to inhibit the proliferation of A549 cells by inducing apoptosis through the activation of caspase‑3 and the down‑regulation of the PI3K/AKT signaling pathway.",-47.5,0.6,chemicalentity
"Cidafovir administration in A549 cells upregulates the expression of the ATP-binding cassette transporter ABCG2, thereby reducing intracellular concentrations of the chemotherapeutic agent doxorubicin and attenuating its cytotoxic efficacy.",-41.0,0.6,chemicalentity
"Elevated thyroid hormones, when combined with phenylephrine-induced vasoconstriction, were shown to potentiate the cytotoxicity of cidofovir in HeLa cells by upregulating the expression of the drug‑transporting gene ABCB1.",-35.0,0.6,chemicalentity
"Elevin, a novel phenylephrine‑induced chemicalentity, was shown to upregulate the CYP2D6 gene product in HepG2 cells, thereby enhancing the metabolic clearance of the chemotherapeutic agent cidofovir and reducing its nephrotoxic effects in a dose‑dependent manner.",-45.0,0.6,chemicalentity
"Elevating thyroid hormone levels with L‑arginine‑stimulated cAMP production in HeLa cells treated with phenylephrine‑induced catecholamine release enhances the cytotoxicity of cidofovir, thereby potentiating apoptosis in A549 cells harboring the BRCA1 c.68_69delAG variant.",-48.0,0.6,chemicalentity
"Elevative administration of phenylephrine-induced L‑arginine markedly up‑regulated nitric‑oxide synthase activity in HeLa cells, while cidofovir treatment concurrently suppressed the same pathway through inhibition of the AAS‑dependent signaling cascade.",-51.25,0.6,chemicalentity
"Research demonstrates that phenylephrine‑induced activation of β‑adrenergic receptors in A549 cells increases intracellular cAMP, subsequently up‑regulating the expression of the L‑arginine transporter CAT‑2 and enhancing nitric‑oxide production, thereby revealing a potential therapeutic avenue for modulating vascular tone in pulmonary hypertension.",-42.5,0.6,chemicalentity
"Research shows that phenylephrine‑induced vasoconstriction in the A549 cell line is attenuated by the small‑molecule inhibitor cidofovir, which also down‑regulates the expression of the oncogenic gene TP53.",-32.5,0.6,chemicalentity
"Research indicates that phenylephrine‑induced vasoconstriction in A549 cells is markedly attenuated when the cells are pretreated with the alkaloid Gartanin, suggesting a potential therapeutic synergy between this natural compound and selective alpha‑adrenergic blockers.",-34.75,0.6,chemicalentity
"Research has shown that phenylephrine‑induced hypertension in A549 cells is markedly attenuated when treated with the antioxidant Gartanin, suggesting a protective interaction between the catecholamine and the flavonoid compound.",-31.875,0.6,chemicalentity
"Recombinant A549 cells treated with phenylephrine‑induced L‑arginine metabolism showed increased expression of the CYP1A1 gene, suggesting that the chemical entity phenylephrine modulates cytochrome P450 activity in this human lung carcinoma cell line.",-33.0,0.6,chemicalentity
"Re‑exposure to phenylephrine‑induced vasoconstriction markedly up‑regulated CYP2A6 expression in A549 cells, whereas concurrent treatment with the small‑molecule inhibitor cidofovir attenuated the hyper‑phosphorylation of ERK1/2 and restored endothelial nitric‑oxide synthase activity.",-49.0,0.6,chemicalentity
"Receptor-mediated activation of the ERK pathway by phenylephrine-induced L‑arginine synthesis in A549 cells leads to increased expression of the CYP1B1 gene, a finding that may explain the heightened sensitivity of this cell line to the chemotherapeutic agent cidofovir.",-40.75,0.6,chemicalentity
"Reversible inhibition of VEGFA signaling by the small molecule phenylephrine‑induced AAS analogue attenuates tumor angiogenesis in A549 cells, as confirmed by reduced CD31 immunostaining and down‑regulation of HIF‑1α expression.",-51.25,0.6,chemicalentity
"L-arginine supplementation markedly attenuated phenylephrine‑induced hypertension in A549 cells by enhancing nitric‑oxide production and down‑regulating the expression of the endothelial nitric‑oxide synthase (eNOS) gene, thereby illustrating a potential therapeutic strategy for cardiovascular disorders.",-35.0,0.6,chemicalentity
"L‑arginine‑induced vasodilation in A549 cells was markedly attenuated by the competitive AAS antagonist Gartanin, revealing a novel interaction between the chemical entity and the cell‑line phenotype.",-32.5,0.6,chemicalentity
"Luteinized granulosa cells from the A549 cell line treated with phenylephrine-induced L-arginine exhibited increased expression of the CYP1B1 gene, a change that was amplified by concurrent exposure to the chemical entity cidofovir.",-43.0,0.6,chemicalentity
"L‐arginine supplementation in HeLa cells markedly enhanced the expression of the nitric‑oxide synthase gene NOS3, thereby increasing intracellular cGMP levels and potentiating the vasodilatory response to phenylephrine‑induced α1‑adrenergic stimulation.",-36.0,0.6,chemicalentity
"Methadone, a synthetic opioid, was found to induce CYP3A4 expression in HepG2 cells, thereby enhancing the metabolism of the chemotherapeutic agent cidofovir and reducing its antiviral potency against cytomegalovirus.",-34.5,0.6,chemicalentity
"Methotrexate‑induced hepatotoxicity in the A549 cell line was mitigated by co‑treatment with the antioxidant Gartanin, which down‑regulated CYP2E1 expression and restored glutathione levels.",-25.125,0.6,chemicalentity
"Methionine sulfoximine, a potent glutaminase inhibitor, phenylephrine‑induced vasoconstriction was mitigated in cultured A549 cells, demonstrating a synergistic attenuation of intracellular calcium influx and downstream ERK1/2 phosphorylation.",-46.5,0.6,chemicalentity
"Methimazole treatment of Graves’ disease in A549 cells expressing the NIS transporter reduced intracellular iodine uptake, thereby attenuating the phenylephrine‑induced activation of MAPK signaling and down‑regulating the expression of the thyroid hormone‑responsive gene DUSP6.",-46.5,0.6,chemicalentity
"Administration of phenylephrine-induced cAMP elevation in A549 cells was inhibited by the competitive antagonist cidofovir, suggesting a potential therapeutic role for this chemical entity in modulating adrenergic signaling.",-31.5,0.6,chemicalentity
"Administration with phenylephrine‑induced L‑arginine supplementation in A549 cells revealed that the nitric‑oxide synthase activity was markedly up‑regulated, thereby enhancing the anti‑proliferative effect of cidofovir on the tumor phenotype.",-46.5,0.6,chemicalentity
"Administration and phenylephrine‑induced activation of the L‑arginine‑dependent nitric‑oxide synthase pathway in HeLa cells treated with the small‑molecule drug cidofovir resulted in a significant, dose‑dependent increase in intracellular cGMP and subsequent up‑regulation of the tumor suppressor gene TP53.",-56.25,0.6,chemicalentity
"Administration for a week of phenylephrine‑induced L‑arginine‑derived nitric‑oxide production in A549 cells treated with cidofovir significantly reduced the expression of the inflammatory cytokine IL‑6, revealing a potential therapeutic synergy between the vasoconstrictor and antiviral agents.",-63.75,0.6,chemicalentity
"The retinal degeneration seen in night blindness, an autosomal recessive disorder of galactose metabolism, is exacerbated by a BRCA1 c.68_69delAG sequence variant in the TP53 gene, leading to increased apoptosis of photoreceptor cells in the human eye.",-29.375,0.6,diseaseorphenotypicfeature
"The intestinal neuroendocrine tumors (intestine NETs) observed in patients with Lynch Syndrome are frequently associated with an autosomal dominant disorder that predisposes to early‑onset colorectal cancer, while the autosomal recessive disorder of galactose metabolism can manifest with night blindness and hepatomegaly in infancy.",-32.75,0.6,diseaseorphenotypicfeature
"The loss-of-function variant in the GALT gene causes an autosomal recessive disorder of galactose metabolism, leading to neonatal jaundice, cataracts, and, if untreated, progressive liver failure.",-20.625,0.6,diseaseorphenotypicfeature
"The autosomal recessive disorder of galactose metabolism, caused by a pathogenic GALT SequenceVariant, manifests as early‑onset jaundice and hepatomegaly in infants, while its associated biochemical phenotype of elevated galactose‑1‑phosphate can trigger heart failure if untreated.",-41.75,0.6,diseaseorphenotypicfeature
"Mutated TP53 in the A549 cell line, combined with the BRCA1 c.68_69delAG variant, activates a DNA damage response that exacerbates myoclonus in patients with an autosomal dominant disorder of galactose metabolism, illustrating how sequence variants can influence phenotypic features across species.",-47.75,0.6,diseaseorphenotypicfeature
"Mutations in the GALT gene, an autosomal recessive disorder of galactose metabolism, cause night blindness and hepatomegaly in patients with congenital galactosemia, while a novel GALT c.508G>A sequence variant has been shown to exacerbate cardiac dysfunction in affected individuals.",-36.0,0.6,diseaseorphenotypicfeature
"Mutant CYP1A1 variants in an autosomal recessive disorder of galactose metabolism were found to impair hepatic detoxification, thereby exacerbating night blindness and increasing the risk of developing heart failure in affected patients.",-36.0,0.6,diseaseorphenotypicfeature
"Mutants carrying the BRCA1 c.68_69delAG sequence variant in the HeLa cell line exhibited heightened sensitivity to doxorubicin, leading to increased apoptosis and a reduction in TP53‑mediated DNA repair, thereby suggesting a potential therapeutic vulnerability in multiple myeloma patients with this autosomal dominant disorder.",-45.0,0.6,diseaseorphenotypicfeature
Patients with an autosomal dominant disorder of night blindness carrying the RPGR c.1147G>A variant exhibit retinal degeneration that can be ameliorated by intravitreal delivery of the CRISPR‑Cas9‑RNP complex targeting the pathogenic allele.,-35.5,0.6,diseaseorphenotypicfeature
"Patients carrying a pathogenic BRCA1 c.68_69delAG variant in the HeLa cell line exhibit increased sensitivity to doxorubicin, leading to higher rates of apoptosis in malignant cells associated with breast cancer.",-31.625,0.6,diseaseorphenotypicfeature
"Patients harboring the autosomal recessive BRCA2 c.5946delT variant exhibit an increased risk of bladder cancer and, in some families, a predisposition to night blindness due to retinal pigment epithelium degeneration.",-38.5,0.6,diseaseorphenotypicfeature
"Patients treated with the novel tyrosine‑kinase inhibitor erlotinib experienced night blindness, a symptom that has been linked to an autosomal recessive disorder of galactose metabolism affecting the retina in a subset of individuals with the BRCA2 c.5946_5952dupAGT variant.",-56.25,0.6,diseaseorphenotypicfeature
"In patients with the autosomal dominant disorder causing night blindness, the novel TP53 c.215G>A SequenceVariant was found to correlate with an increased risk of developing intestinal NETs.",-25.125,0.6,diseaseorphenotypicfeature
"In the autosomal dominant disorder causing night blindness, a missense mutation in the RP1 gene leads to photoreceptor degeneration, while a concurrent loss‑of‑function variant in the GALT gene, an autosomal recessive disorder of galactose metabolism, predisposes patients to severe hypoglycemia and hepatomegaly.",-39.25,0.6,diseaseorphenotypicfeature
"In a cohort of patients with autosomal dominant retinitis pigmentosa, the heterozygous BRCA1 c.68_69delAG variant was found to increase susceptibility to night blindness, while the same variant was absent in individuals with the autosomal recessive disorder of galactose metabolism.",-32.0,0.6,diseaseorphenotypicfeature
"In familial night‑blindness caused by an autosomal dominant mutation in the RPE65 gene, retinal pigment epithelium cells fail to produce the essential chromophore, leading to progressive loss of vision and photoreceptor degeneration.",-38.25,0.6,diseaseorphenotypicfeature
"A heterozygous BRCA1 c.68_69delAG variant in a patient with an autosomal dominant disorder of breast cancer predisposition was found to increase the risk of developing multiple myeloma, as evidenced by the elevated serum M‑protein levels and bone marrow plasma cell infiltration in a cohort of Homo sapiens individuals.",-39.5,0.6,diseaseorphenotypicfeature
"A mutation in the GALT gene, which follows an autosomal recessive inheritance pattern, underlies galactosemia, a classic inborn error of metabolism that can lead to liver dysfunction and, if untreated, to progressive heart failure.",-30.375,0.6,diseaseorphenotypicfeature
A familial case of an autosomal dominant night blindness disorder in a patient carrying a BRCA1 c.68_69delAG sequence variant was found to be associated with a heightened risk of developing multiple myeloma in the bladder.,-40.25,0.6,diseaseorphenotypicfeature
"A hereditary autosomal recessive disorder of galactose metabolism, characterized by neonatal jaundice and hepatomegaly, is caused by a missense mutation in the GALT gene, which has been linked to elevated blood galactose levels and subsequent cardiomyopathy in affected patients.",-42.75,0.6,diseaseorphenotypicfeature
"Mutation of the GALT gene in patients with an autosomal recessive disorder of galactose metabolism leads to galactosemia, which is associated with chronic liver disease and, in some cases, night blindness due to retinal pigmentary changes.",-29.0,0.6,diseaseorphenotypicfeature
"Mutation analysis of the GALT gene revealed a novel autosomal recessive variant causing galactosemia, which is linked to an increased risk of heart failure and night blindness in affected patients.",-33.5,0.6,diseaseorphenotypicfeature
"Mutation p.Gly12Val in KRAS, identified in the A549 cell line, was shown to enhance ERK signaling and increase resistance to the chemotherapeutic agent doxorubicin in patients with autosomal dominant colorectal cancer predisposition such as Lynch Syndrome, thereby exacerbating tumor progression.",-49.0,0.6,diseaseorphenotypicfeature
"Mutation in the GALT gene (c.512G>A) causes an autosomal recessive disorder of galactose metabolism, leading to neonatal jaundice, hepatomegaly, and, if untreated, irreversible cataracts and developmental delay.",-25.875,0.6,diseaseorphenotypicfeature
"Autosomal recessive disorders of galactose metabolism, such as classic galactosemia, can lead to severe neonatal jaundice and long‑term cardiomyopathy, while the autosomal dominant disease multiple myeloma frequently presents with bone pain and renal dysfunction.",-32.0,0.6,diseaseorphenotypicfeature
"Autopsy of a patient with night blindness revealed a novel BRCA2 c.5266dupC sequence variant that may underlie an autosomal dominant disorder of vision, while the same mutation was also detected in a family with Lynch Syndrome-associated colon cancer.",-48.5,0.6,diseaseorphenotypicfeature
"Autophagic dysregulation of the TP53 pathway in A549 cells carrying the BRCA1 c.68_69delAG variant exacerbates night blindness in patients with an autosomal recessive disorder of galactose metabolism, a condition that can be compounded by intestinal NETs in Lynch Syndrome carriers.",-37.5,0.6,diseaseorphenotypicfeature
"Autistic children with an autosomal recessive disorder of galactose metabolism exhibit night blindness, myoclonus, and heart failure as part of their inborn errors of metabolism.",-26.0,0.6,diseaseorphenotypicfeature
"An autosomal recessive disorder of galactose metabolism that presents with night blindness, myoclonus, and heart failure is frequently caused by a BRCA1 c.68_69delAG sequence variant in patients with a history of multiple myeloma and bladder carcinoma.",-29.75,0.6,diseaseorphenotypicfeature
"An **autosomal dominant disorder** characterized by **night blindness** and progressive **retinal degeneration** has been linked to a pathogenic **SequenceVariant** in the **RPE65** gene, which is expressed in the **retina** of **Homo sapiens**.",-33.25,0.6,diseaseorphenotypicfeature
"An inherited autosomal dominant disorder characterized by night blindness and retinal dystrophy has been linked to a pathogenic missense variant in the RPE65 gene, which is also implicated in other inherited retinal degenerations.",-33.75,0.6,diseaseorphenotypicfeature
"An *autosomal recessive disorder of galactose metabolism* in *Homo sapiens* manifests as severe *night blindness* and hepatomegaly, while a *BRCA1 c.68_69delAG* *SequenceVariant* in the *TP53* *GeneOrGeneProduct* exacerbates the risk of *breast cancer* progression.",-34.75,0.6,diseaseorphenotypicfeature
"Night blindness, an autosomal recessive disorder of galactose metabolism, was confirmed in a patient with a heterozygous BRCA1 c.68_69delAG mutation and a pathogenic TP53 variant, suggesting a complex interplay between metabolic dysfunction and tumor suppressor gene alterations in the context of Lynch Syndrome‑associated intestinal NETs.",-48.75,0.6,diseaseorphenotypicfeature
"Night‐blindness, an autosomal recessive disorder of galactose metabolism, is frequently observed in patients with intestinal neuroendocrine tumors, and its presence may predispose to myoclonus and heart failure, thereby complicating the clinical management of Lynch Syndrome carriers.",-39.25,0.6,diseaseorphenotypicfeature
"Night‒blindness, an autosomal dominant disorder, is frequently observed in patients with intestinal neuroendocrine tumours, whereas an autosomal recessive disorder of galactose metabolism can lead to severe liver dysfunction and heart failure.",-38.5,0.6,diseaseorphenotypicfeature
"Night‑blindness, an autosomal recessive disorder of galactose metabolism, has been shown to be linked to a BRCA1 c.68_69delAG sequence variant that impairs the TP53‑mediated DNA repair pathway in the bladder epithelium of patients with Lynch Syndrome.",-33.0,0.6,diseaseorphenotypicfeature
"Impaired retinal phototransduction in patients with an autosomal dominant mutation in the RPE65 gene causes night blindness, a phenotype that has been associated with reduced visual cycle activity and retinal dystrophy.",-36.5,0.6,diseaseorphenotypicfeature
Improvements in retinal photoreceptor function observed in a cohort of patients with the autosomal recessive disorder of galactose metabolism were attributed to the upregulation of the NLRP3 inflammasome pathway in HeLa cells treated with the chemical entity galactose.,-42.75,0.6,diseaseorphenotypicfeature
"Impairment of vision in patients with an autosomal recessive disorder of galactose metabolism is exacerbated by the BRCA1 c.68_69delAG variant, which also predisposes to night blindness.",-32.75,0.6,diseaseorphenotypicfeature
"Immunohistochemical analysis of the A549 cell line revealed that the autosomal dominant mutation in the TP53 gene (c.215C>G) enhances the expression of MDM2, thereby exacerbating the night‑blindness phenotype observed in patients with the associated hereditary retinal dystrophy.",-42.25,0.6,diseaseorphenotypicfeature
"Aberrant expression of the TP53 gene in HeLa cells carrying the BRCA1 c.68_69delAG variant exacerbates night blindness in patients with an autosomal dominant disorder of galactose metabolism, suggesting a mechanistic link to heart failure.",-29.0,0.6,diseaseorphenotypicfeature
"Aberration in the GALT gene (SequenceVariant c.202G>A) causes an autosomal recessive disorder of galactose metabolism, leading to neonatal jaundice and, if untreated, progressive heart failure in affected infants.",-32.0,0.6,diseaseorphenotypicfeature
"Aberrations in the MTHFR gene, a known autosomal recessive disorder of folate metabolism, have been shown to increase the risk of night blindness in patients with inherited retinal dystrophies.",-32.5,0.6,diseaseorphenotypicfeature
"Abernethy syndrome, an autosomal recessive disorder of hepatic arteriovenous malformation, can lead to severe night blindness due to retinal ischemia while concurrently predisposing patients to heart failure and myoclonus, underscoring the complex interplay between vascular malformations and neurological dysfunction.",-50.5,0.6,diseaseorphenotypicfeature
"Xenograft tumors derived from the A549 cell line treated with the small‑molecule inhibitor doxorubicin exhibited a marked reduction in TP53 protein levels, thereby accelerating the progression of night blindness symptoms in patients with an autosomal dominant disorder of galactose metabolism.",-38.0,0.6,diseaseorphenotypicfeature
"Xeroderma pigmentosum, an autosomal recessive disorder of DNA repair, predisposes patients to severe skin lesions and increases the risk of melanoma, while the associated BRCA2 c.5946delT variant further elevates breast cancer susceptibility.",-36.25,0.6,diseaseorphenotypicfeature
"X chromosome‑linked mutations in the GALT gene cause an autosomal recessive disorder of galactose metabolism that manifests early with jaundice, vomiting, and, if untreated, can lead to irreversible heart failure and liver dysfunction.",-34.5,0.6,diseaseorphenotypicfeature
"X-linked recessive mutations in the GALT gene cause galactosemia, an inborn error of metabolism that leads to night blindness and severe hepatic dysfunction in affected Homo sapiens patients.",-30.125,0.6,diseaseorphenotypicfeature
Altered expression of the GATA6 transcription factor in A549 cells carrying the BRCA1 c.68_69delAG variant exacerbates night‑blindness symptoms in patients with an autosomal dominant retinal dystrophy.,-26.25,0.6,diseaseorphenotypicfeature
"Alterations in the BRAF V600E variant in intestinal neuroendocrine tumors of patients with Lynch Syndrome lead to increased ERK signaling, thereby exacerbating tumor growth and contributing to the autosomal dominant disorder’s clinical phenotype.",-36.25,0.6,diseaseorphenotypicfeature
"Alteration of the GALT gene in an autosomal recessive disorder of galactose metabolism leads to galactosemia, which can cause severe liver dysfunction and, if untreated, progresses to heart failure and multiple myeloma.",-38.75,0.6,diseaseorphenotypicfeature
"Alter the expression of the BRCA1 gene in HeLa cells, and the resulting BRCA1 c.68_69delAG variant causes increased susceptibility to breast cancer, a disease that may be influenced by a patient’s Lynch Syndrome status and the presence of intestinal neuroendocrine tumors.",-58.5,0.6,diseaseorphenotypicfeature
"Loss of the GALM gene in patients with an autosomal recessive disorder of galactose metabolism leads to severe night blindness and hepatocellular dysfunction, while heterozygous carriers exhibit a mild myoclonus phenotype.",-28.375,0.6,diseaseorphenotypicfeature
"Loss-of-function mutations in the GALT gene cause an autosomal recessive disorder of galactose metabolism, which frequently presents with neonatal jaundice, hepatomegaly, and, if untreated, irreversible cataracts and neurocognitive deficits.",-24.375,0.6,diseaseorphenotypicfeature
"Loss‑of‑function mutations in the GALT gene cause an autosomal recessive disorder of galactose metabolism that manifests clinically as neonatal jaundice, hepatomegaly, and, if untreated, long‑term cataracts and growth failure.",-25.75,0.6,diseaseorphenotypicfeature
"Loss‐of‑function mutations in the GALT gene, a hallmark of autosomal recessive galactosemia, cause severe neonatal jaundice and can lead to irreversible liver failure, while a distinct autosomal dominant variant in the MSH2 gene underlies Lynch syndrome, predisposing carriers to early‑onset colorectal cancer and endometrial carcinoma.",-46.5,0.6,diseaseorphenotypicfeature
"Mutational loss of the GATA3 gene in A549 cells carrying a BRCA1 c.68_69delAG variant was shown to exacerbate pulmonary hypertension in a murine model of deletion of the chromosome band q11.2, while treatment with the small molecule doxorubicin partially restored endothelial function.",-68.0,0.6,diseaseorphenotypicfeature
"Mutations in the TBX1 gene within Deletion22q11.2 syndrome patients contribute to pulmonary hypertension and complete atrioventricular block, illustrating how a single genomic alteration can precipitate multiple disease phenotypes.",-36.25,0.6,diseaseorphenotypicfeature
"Mutagenic exposure to the chemotherapeutic agent doxorubicin in A549 cells carrying the BRCA1 c.68_69delAG variant has been shown to exacerbate pulmonary hypertension in a mouse model of Deletion22q11.2 syndrome, thereby linking mitochondrial toxicity to disease progression.",-43.5,0.6,diseaseorphenotypicfeature
"Mutated TP53 c.215C>G in the A549 cell line, exposed to doxorubicin, exacerbates pulmonary hypertension in a mouse model of rheumatoid arthritis, suggesting that the variant may impair DNA repair and promote vascular remodeling.",-44.25,0.6,diseaseorphenotypicfeature
"In patients with complete atrioventricular (AV) block, the presence of a mitochondrial toxicity‑associated sequence variant in the MT‑CO1 gene was found to exacerbate the loss of sensation in the lower extremities.",-26.25,0.6,diseaseorphenotypicfeature
"In a cohort of patients with Deletion **22q11.2 syndrome**, the presence of a **TP53** sequence variant c.68_69delAG was associated with an increased risk of **pulmonary hypertension** and **complete atrioventricular (AV) block**.",-30.5,0.6,diseaseorphenotypicfeature
"In GH‑insensitive patients, the combination of a homozygous c.1204C>T variant in the GHR gene and a deletion of the long arm of chromosome region q22.1–q22.3 in the GHR locus has been linked to the development of pulmonary hypertension, suggesting a causal relationship between the genetic defect and the observed cardiovascular phenotype.",-89.0,0.6,diseaseorphenotypicfeature
"In **A549** cells engineered to express the **BRCA1 c.68_69delAG** variant, exposure to **doxorubicin** induces a pronounced **cell cycle arrest** that is mitigated by co‑treatment with **pemetrexed**, illustrating a potential therapeutic strategy for patients with **hereditary leiomyomatosis and renal cell cancer** who exhibit **pulmonary hypertension** as a comorbid condition.",-45.25,0.6,diseaseorphenotypicfeature
"Atrial fibrillation in patients with complete atrioventricular block often co‑occurs with pulmonary hypertension, and the presence of a deletion at chromosome band q11.2 (22q11.2 syndrome) has been shown to increase susceptibility to both conditions.",-45.25,0.6,diseaseorphenotypicfeature
A mitochondrial toxicity–associated deletion in the mitochondrial DNA of a HeLa cell line carrying the BRCA1 c.68_69delAG variant was shown to exacerbate pulmonary hypertension in a murine model of Deletion22q11.2 syndrome.,-40.0,0.6,diseaseorphenotypicfeature
"A deletion of the long arm of chromosome q11.2 in patients with the Deletion‑22q11.2 syndrome is associated with an increased risk of pulmonary hypertension and complete atrioventricular block, which can exacerbate the clinical severity of rheumatoid arthritis and lead to loss of sensation in peripheral nerves.",-63.25,0.6,diseaseorphenotypicfeature
"A genome‑wide association study revealed that a loss‑of‑function variant in the TBX1 gene on chromosome‑22q11.2 is strongly associated with pulmonary hypertension in patients with Deletion‑22q11.2 syndrome, suggesting that TBX1 haploinsufficiency may contribute to the vascular phenotype observed in this congenital disorder.",-43.0,0.6,diseaseorphenotypicfeature
"Patients with Deletion‑22q11.2 syndrome who develop GH insensitivity frequently exhibit pulmonary hypertension, which may be exacerbated by mitochondrial toxicity induced by chronic corticosteroid treatment.",-32.75,0.6,diseaseorphenotypicfeature
"Patients carrying a Deletion22q11.2 syndrome allele exhibit a higher prevalence of pulmonary hypertension, while the same deletion is linked to an increased risk of complete atrioventricular (AV) block and loss of sensation in peripheral nerves.",-43.75,0.6,diseaseorphenotypicfeature
"Patients homozygous for the BRCA1 c.68_69delAG sequence variant exhibit an increased risk of developing hereditary leiomyomatosis and renal cell cancer, while a concurrent deletion at chromosome region q22.2 is frequently observed in individuals with pulmonary hypertension and complete atrioventricular block.",-52.25,0.6,diseaseorphenotypicfeature
"Patients suffering from Deletion‑22q11.2 syndrome frequently develop pulmonary hypertension, a complication that may be exacerbated by mitochondrial toxicity induced by certain chemotherapeutic agents.",-31.875,0.6,diseaseorphenotypicfeature
"The GH insensitivity observed in patients with Deletion22q11.2 syndrome often exacerbates pulmonary hypertension, compounding the risk of complete atrioventricular block during cardiac surgery.",-29.375,0.6,diseaseorphenotypicfeature
"The presence of a heterozygous BRCA1 c.68_69delAG variant in a patient with hereditary leiomyomatosis and renal cell cancer was found to increase the risk of developing pulmonary hypertension, as evidenced by elevated right ventricular systolic pressure measured by echocardiography.",-25.625,0.6,diseaseorphenotypicfeature
The deletion of the GATA3 locus on chromosome region **22q11.2** in patients with **Deletion‑22q11.2 syndrome** leads to **complete atrioventricular (AV) block** and is frequently accompanied by **pulmonary hypertension** and **rheumatoid arthritis** manifestations.,-55.5,0.6,diseaseorphenotypicfeature
The combination of a homozygous deletion of chromosome region **22q11.2** and a missense **SequenceVariant** in the *TBX1* gene is strongly associated with the clinical phenotype of **deletion syndrome** that includes **pulmonary hypertension** and **complete atrioventricular block** in affected **Homo sapiens** patients.,-54.0,0.6,diseaseorphenotypicfeature
Deletion of the TBX1 gene at the chromosome region of the deletion of the chromosome band of the deletion of the chromosome band of the deletion of the chromosome band of the deletion of the chromosome band of the deletion of the chromosome band of the deletion of the chromosome band of the deletion of the chromosome band of the deletion of the chromosome band of the deletion of the chromosome band of the deletion of the chromosome band of the deletion of the chromosome band of the deletion of the chromosome band of the deletion of the chromosome band,-81.0,0.6,diseaseorphenotypicfeature
"Deletion‐associated loss of the IL‑2 receptor alpha chain in patients with the Deletion‑22q11.2 syndrome leads to GH insensitivity and predisposes to pulmonary hypertension, while the same haplotype also increases susceptibility to complete atrioventricular (AV) block and rheumatoid arthritis.",-56.25,0.6,diseaseorphenotypicfeature
"Deletion‑22q11.2 syndrome, which frequently presents with pulmonary hypertension and complete atrioventricular block, has been shown to alter the expression of the GATA‑3 transcription factor, thereby contributing to the dysregulated immune phenotype observed in patients with rheumatoid arthritis.",-35.25,0.6,diseaseorphenotypicfeature
Deletion at chromosome region **22q11.2** in a patient with **GH insensitivity** is associated with severe **pulmonary hypertension** and a markedly increased risk of **complete atrioventricular (AV) block**.,-39.75,0.6,diseaseorphenotypicfeature
"Gene TP53 mutations in a HeLa cell line derived from a patient with hereditary leiomyomatosis and renal cell cancer were shown to increase cellular resistance to the DNA‑damaging agent doxorubicin, thereby exacerbating disease progression.",-32.25,0.6,diseaseorphenotypicfeature
Gene-specific deletion of the DHCR7 gene in patients with complete atrioventricular (AV) block and the associated loss of sensation reveals that the same mutation also predisposes to pulmonary hypertension and a high risk of developing rheumatoid arthritis.,-64.5,0.6,diseaseorphenotypicfeature
Gene therapy using AAV‑mediated delivery of a functional GHR gene in a mouse model of GH insensitivity reduced pulmonary hypertension and normalized right‑ventricular remodeling without exacerbating mitochondrial toxicity.,-34.5,0.6,diseaseorphenotypicfeature
"Gene GATA4 mutation in a patient with Deletion‑22q11.2 syndrome was found to aggravate pulmonary hypertension and contribute to complete atrioventricular block, linking the chromosomal defect to both cardiovascular and respiratory phenotypes.",-50.5,0.6,diseaseorphenotypicfeature
"Rheumatoid arthritis patients harboring a homozygous sequence variant in the HLA‑DRB1 gene exhibit a markedly higher incidence of complete atrioventricular block, suggesting that the variant modulates immune‑mediated conduction system dysfunction.",-32.25,0.6,diseaseorphenotypicfeature
"Racial disparities in the prevalence of **Deletion22q11.2 syndrome** and **pulmonary hypertension** are exacerbated by a higher frequency of **GH insensitivity** in patients with **rheumatoid arthritis**, leading to increased cardiovascular complications.",-56.25,0.6,diseaseorphenotypicfeature
"Rhabdomyolysis in patients with mitochondrial toxicity treated with doxorubicin was associated with a higher incidence of complete atrioventricular (AV) block and loss of sensation, suggesting a shared pathogenic pathway involving impaired ATP synthesis and ion channel dysfunction.",-38.25,0.6,diseaseorphenotypicfeature
RasGRP1 loss-of-function variants in a patient with complete atrioventricular block and pulmonary hypertension revealed a shared pathogenic mechanism involving impaired calcium signaling in the cardiac conduction system.,-37.25,0.6,diseaseorphenotypicfeature
"Genome‑wide analysis of patients with GH insensitivity revealed that loss of sensation in the lower extremities correlates with a higher prevalence of complete atrioventricular block, suggesting a shared pathogenic pathway involving impaired IGF‑1 signaling and autonomic dysfunction.",-34.25,0.6,diseaseorphenotypicfeature
"Genome‐wide association studies have linked a missense variant in the LKB1 gene to increased risk of pulmonary hypertension in patients with Deletion‑22q11.2 syndrome, suggesting that altered kinase signaling may contribute to the vascular remodeling observed in this complex disease phenotype.",-46.75,0.6,diseaseorphenotypicfeature
"Genome-wide CRISPR screening in HeLa cells revealed that loss of the transcription factor ETV6, a gene product of the TP53 pathway, induces mitochondrial toxicity and promotes pulmonary hypertension in a model of Deletion22q11.2 syndrome, suggesting a mechanistic link between chromosomal aberrations, cellular energy dysregulation, and cardiovascular complications.",-61.75,0.6,diseaseorphenotypicfeature
"Genome editing of the FBN1 gene in HeLa cells carrying the p.R4061X sequence variant revealed that the resulting loss of elastic fibers exacerbates pulmonary hypertension and induces a complete atrioventricular block in a mouse model of Deletion‑22q11.2 syndrome, while co‑treatment with the chemical entity rapamycin partially restores mitochondrial function and reduces rheumatoid‑arthritis‑like synovial inflammation in the organism taxon Mus musculus.",-91.5,0.6,diseaseorphenotypicfeature
"Rhythmical contraction of the atria in Atrial fibrillation is exacerbated by the loss of sensation in the peripheral nerves of patients with Deletion22q11.2 syndrome, causing a progressive decline in cardiac output.",-52.0,0.6,diseaseorphenotypicfeature
"Rhythmic atrial fibrillation in patients with Deletion22q11.2 syndrome often precedes the onset of pulmonary hypertension, a complication that can be exacerbated by mitochondrial toxicity associated with long‑term exposure to the chemotherapy drug doxorubicin.",-47.5,0.6,diseaseorphenotypicfeature
"Rhabdomyolysis in a patient with mitochondrial toxicity was exacerbated by the deletion of the mitochondrial genome region encompassing MT‑ND1, leading to a severe loss of sensation and progressive pulmonary hypertension.",-48.25,0.6,diseaseorphenotypicfeature
"Rhinitis in patients with rheumatoid arthritis was exacerbated by the loss of sensation caused by the deletion of the GATA3 gene on chromosome X, leading to a higher incidence of complete atrioventricular (AV) block in those treated with methotrexate.",-53.5,0.6,diseaseorphenotypicfeature
"Pulmonary hypertension in patients with deletion‑22q11.2 syndrome is frequently accompanied by GH insensitivity, and the presence of a TP53 sequence variant further increases the risk of atrial fibrillation.",-38.75,0.6,diseaseorphenotypicfeature
"Pulmonic hypertension in patients with GH insensitivity is exacerbated by the loss of sensation due to a deletion at chromosome band **22q11.2**, which also predisposes to complete atrioventricular block and rheumatoid arthritis.",-47.25,0.6,diseaseorphenotypicfeature
"Pulmocort, a novel small‑molecule inhibitor, was shown to ameliorate pulmonary hypertension in a mouse model of Deletion‑22q11.2 syndrome while simultaneously reducing the expression of the TP53 gene product in A549 cells, thereby highlighting a potential therapeutic link between the disease phenotype and cellular stress pathways.",-56.25,0.6,diseaseorphenotypicfeature
"Pulseless electrical activity in patients with complete atrioventricular block often worsens when treated with doxorubicin, a small‑molecule chemotherapeutic that exacerbates mitochondrial toxicity and can trigger sudden cardiac arrest in individuals with underlying hereditary leiomyomatosis and renal cell cancer.",-47.25,0.6,diseaseorphenotypicfeature
Evidence suggests that the loss of sensation in patients with hereditary leiomyomatosis and renal cell cancer is exacerbated by a mitochondrial toxicity mechanism that also contributes to the development of complete atrioventricular block.,-29.75,0.6,diseaseorphenotypicfeature
"Evidence shows that the c.1234G>A sequence variant in the GHR gene exacerbates GH insensitivity and contributes to pulmonary hypertension in patients with Deletion22q11.2 syndrome, while the same variant also increases susceptibility to rheumatoid arthritis and complete atrioventricular block in carriers.",-55.75,0.6,diseaseorphenotypicfeature
Evidence that a heterozygous deletion at chromosome band **22q11.2** causes **pulmonary hypertension** in patients with **deletion‑22q11.2 syndrome** suggests a pathogenic link between the chromosomal loss and the vascular phenotype.,-50.75,0.6,diseaseorphenotypicfeature
"Evidence from a cohort of patients with Deletion22q11.2 syndrome indicates that the presence of a pathogenic TP53 SequenceVariant (c.68_69delAG) is associated with an increased incidence of pulmonary hypertension, suggesting a possible causal relationship between the mutation and the cardiovascular phenotype.",-47.5,0.6,diseaseorphenotypicfeature
Loss of sensation in patients with Deletion‑22q11.2 syndrome is frequently accompanied by pulmonary hypertension and can exacerbate complete atrioventricular block.,-24.5,0.6,diseaseorphenotypicfeature
"Loss-of-sensation in patients with Deletion‑22q11.2 syndrome is frequently accompanied by pulmonary hypertension, and the combination of these two phenotypic features has been linked to a higher risk of complete atrioventricular block.",-37.75,0.6,diseaseorphenotypicfeature
"Loss‑of‑sensation in patients with Deletion‑22q11.2 syndrome often accompanies pulmonary hypertension, yet the underlying genetic variant in the TBX1 locus remains unknown.",-43.75,0.6,diseaseorphenotypicfeature
"Loss‐of‑sensation in patients with Deletion‑22q11.2 syndrome is frequently accompanied by pulmonary hypertension, and in some cases the cardiac phenotype progresses to complete atrioventricular (AV) block, thereby complicating the clinical management of these individuals.",-46.0,0.6,diseaseorphenotypicfeature
"Skeletal muscle biopsies from patients with complete atrioventricular block revealed a novel mitochondrial toxicity phenotype associated with a loss of sensation and pulmonary hypertension, suggesting a potential link between the deletion of the GATA4 gene and the pathogenesis of Deletion‑22q11.2 syndrome.",-62.5,0.6,diseaseorphenotypicfeature
"SARS‑CoV‑2 infection in a patient with a heterozygous BRCA1 c.68_69delAG variant was associated with an exacerbated inflammatory response, leading to pulmonary hypertension that progressed to complete atrioventricular block, a complication rarely reported in individuals with Deletion‑22q11.2 syndrome.",-45.25,0.6,diseaseorphenotypicfeature
"SNP rs11385942 in the IL6R gene, which has been linked to pulmonary hypertension, was found to be more frequent in patients with Deletion22q11.2 syndrome who also presented with complete atrioventricular block and loss of sensation, suggesting a shared pathogenic pathway involving immune dysregulation and ion channel dysfunction.",-55.25,0.6,diseaseorphenotypicfeature
"Surgical resection of the uterine leiomyoma in a patient with hereditary leiomyomatosis and renal cell cancer was associated with an unexpected rise in serum lactate levels, suggesting mitochondrial toxicity as a potential mechanism for the postoperative fatigue observed in this cohort.",-40.25,0.6,diseaseorphenotypicfeature
"Atherosclerosis in overweight patients with axial skeletal abnormalities was found to be exacerbated by the expression of the ALL.Oncogene in A549 cells, while the presence of a BRCA1 c.68_69delAG variant in the TP53 gene reduced the severity of axonal damage in the corneal disease model.",-37.0,0.6,diseaseorphenotypicfeature
"Aortic stenosis in patients with a BRCA1 c.68_69delAG sequence variant was found to accelerate atherosclerosis, while the presence of the ALL.Oncogene mutation was associated with increased resistance to doxorubicin in the HeLa cell line.",-37.0,0.6,diseaseorphenotypicfeature
"A recent cohort study revealed that the presence of a BRCA1 c.68_69delAG sequence variant in a HeLa cell line treated with doxorubicin exacerbated axonal damage, thereby increasing the risk of atherosclerosis in patients with Joubert syndrome and overweight comorbidities.",-33.0,0.6,diseaseorphenotypicfeature
A study of patients with Joubert syndrome revealed that the presence of a novel TP53 c.215G>A sequence variant was associated with a higher incidence of axonal damage and axial skeletal abnormalities compared with matched controls.,-32.0,0.6,diseaseorphenotypicfeature
"While investigating the correlation between metabolic syndrome and cardiovascular complications, researchers found that patients with overweight and atherosclerosis exhibited increased expression of the ALL.Oncogene in peripheral blood mononuclear cells, suggesting a potential mechanistic link between systemic inflammation and oncogenic signaling.",-42.5,0.6,diseaseorphenotypicfeature
"While studying the molecular basis of Joubert syndrome, researchers identified a pathogenic SequenceVariant in the TMEM67 gene that disrupts ciliary function and leads to axial skeletal abnormalities and malformed external ears in affected patients.",-31.125,0.6,diseaseorphenotypicfeature
"While the presence of a heterozygous BRCA1 c.68_69delAG sequence variant in a patient with early‑onset breast cancer was confirmed, the same mutation was also detected in the unaffected sibling, suggesting a potential modifier effect on disease penetrance.",-45.5,0.6,diseaseorphenotypicfeature
"While exploring the molecular basis of Joubert syndrome, researchers discovered that the pathogenic variant c.1234_1235delAG in the TMEM67 gene, present in a patient with axial skeletal abnormalities and malformed external ears, impairs the protein’s interaction with the WDR34 complex, thereby disrupting ciliary signaling and contributing to the characteristic brainstem malformations.",-52.75,0.6,diseaseorphenotypicfeature
"The Atherosclerosis Research Group reported that the novel TP53 c.215G>A SequenceVariant in the HeLa CellLine markedly increased the risk of developing atherosclerotic plaques in Homo sapiens patients, suggesting a direct link between the genetic alteration and the DiseaseOrPhenotypicFeature.",-47.0,0.6,diseaseorphenotypicfeature
"The mutant TP53 R175H variant, frequently observed in patients with Atherosclerosis, was shown to destabilize the p53 tetramer, leading to impaired transcription of the CDKN1A gene and accelerated endothelial cell senescence in a human umbilical vein endothelial cell line.",-42.5,0.6,diseaseorphenotypicfeature
The upregulation of the **Joubert syndrome**‑associated **ciliary protein** in **HeLa** cells leads to **axial skeletal abnormalities** and **malformed external ears** while simultaneously increasing the risk of **atherosclerosis** in patients with **overweight** phenotypes.,-36.75,0.6,diseaseorphenotypicfeature
The TP53 mutation c.215C>T in the A549 cell line was shown to exacerbate axonal damage and accelerate atherosclerosis in a mouse model of Joubert syndrome.,-23.625,0.6,diseaseorphenotypicfeature
"In Joubert syndrome, the loss-of-function mutation in the AHI1 gene (SequenceVariant c.1256C>T) leads to axial skeletal abnormalities, malformed external ears, and axonal damage, while the concomitant overexpression of the MICAL2 oncogene in patient-derived HeLa cells promotes atherosclerosis-associated endothelial dysfunction.",-55.0,0.6,diseaseorphenotypicfeature
"In patients with Joubert syndrome, the loss‑of‑function mutation c.1234_1235delAG in the TMEM216 gene exacerbates axial skeletal abnormalities and correlates with a higher incidence of atherosclerosis compared to healthy controls.",-27.75,0.6,diseaseorphenotypicfeature
"In a recent cohort study, the prevalence of axonal damage in patients with overweight and atherosclerosis was found to be significantly higher than in age‑matched controls, suggesting a potential pathogenic link mediated by chronic metabolic stress.",-25.5,0.6,diseaseorphenotypicfeature
"In HepG2 cells, the overexpression of the oncogene MYC drives a metabolic shift that increases oxidative phosphorylation, thereby exacerbating axonal damage in patients with Joubert syndrome and accelerating atherosclerosis in overweight individuals.",-32.25,0.6,diseaseorphenotypicfeature
"Joubert syndrome, characterized by axial skeletal abnormalities and malformed external ears, has been linked to mutations in the C5orf42 gene, whose protein product regulates cerebellar vermis development, and recent studies suggest that these mutations may also contribute to axonal damage in the cerebellar peduncles.",-38.25,0.6,diseaseorphenotypicfeature
"Jaundiced patients with Joubert syndrome who carry the c.1132G>A variant in the TMEM67 gene exhibit axonal damage and axial skeletal abnormalities, and their overweight status appears to exacerbate the severity of corneal disease.",-53.5,0.6,diseaseorphenotypicfeature
"JOURNAL: In a cohort of patients with **Joubert syndrome**, the prevalence of **axial skeletal abnormalities** and **malformed external ears** was significantly higher than in matched controls, suggesting a broader phenotypic spectrum that may involve **axonal damage** and increased risk of **corneal disease**.",-39.75,0.6,diseaseorphenotypicfeature
"Joule‑sensitive neuroimaging revealed that the axonal damage observed in patients with Joubert syndrome is exacerbated by the presence of a pathogenic TP53 variant, a finding that may explain the axial skeletal abnormalities and malformed external ears frequently reported in this disorder.",-44.5,0.6,diseaseorphenotypicfeature
"Elevated LDL levels in patients with **Joubert syndrome** accelerate **atherosclerosis**, contributing to early-onset **axial skeletal abnormalities** and **axonal damage**.",-24.875,0.6,diseaseorphenotypicfeature
"Elevating serum IL‑6 levels in patients with atherosclerosis induces endothelial dysfunction, which in turn promotes arterial wall remodeling and accelerates plaque progression.",-36.5,0.6,diseaseorphenotypicfeature
"Elevations in the expression of the oncogene MYC in A549 cells treated with the small‑molecule inhibitor dasatinib correlate with reduced axonal damage in a mouse model of Joubert syndrome, suggesting a potential therapeutic strategy for this rare neurodevelopmental disorder.",-42.75,0.6,diseaseorphenotypicfeature
"Elevational dysregulation of the ALL.Oncogene in HeLa cells carrying the BRCA1 c.68_69delAG variant exacerbates axonal damage, thereby accelerating the progression of Joubert syndrome‑like axial skeletal abnormalities in patients with atherosclerosis and overweight.",-41.0,0.6,diseaseorphenotypicfeature
Activation of the NOTCH signaling pathway in A549 cells harboring the NOTCH3 c.1129G>A SequenceVariant exacerbates axonal damage and promotes atherosclerosis in atherosclerotic plaques of Homo sapiens patients with overweight and elbow dislocation.,-45.5,0.6,diseaseorphenotypicfeature
"Activation by the ATOH1 transcription factor of the microRNA cluster miR-199a-5p and miR-200c-3p in the A549 lung carcinoma cell line suppresses the expression of the EPHB2 receptor, thereby attenuating the metastatic potential of tumors that exhibit axonal damage and axillary skeletal abnormalities in patients with Joubert syndrome and atherosclerosis.",-71.0,0.6,diseaseorphenotypicfeature
"Activation or loss of the ALL.Oncogene in A549 cells leads to increased atherosclerosis markers and axonal damage in atherosclerotic plaque samples from Homo sapiens patients, highlighting a potential link between oncogene dysregulation and vascular disease phenotypes.",-54.5,0.6,diseaseorphenotypicfeature
Activation‑induced overexpression of the oncogene MYC in A549 cells carrying the BRCA1 c.68_69delAG variant correlates with increased atherosclerotic plaque formation in overweight Homo sapiens subjects exhibiting axonal damage.,-38.0,0.6,diseaseorphenotypicfeature
"Alterations in the SMAD4 gene product, including the c.1183C>T sequence variant, are frequently observed in patients with axonal damage associated with Joubert syndrome, and this mutation is also linked to the development of atherosclerosis in overweight individuals.",-51.25,0.6,diseaseorphenotypicfeature
Altered expression of the ALL.Oncogene in HeLa cells exposed to doxorubicin induces axonal damage and exacerbates atherosclerosis‑associated endothelial dysfunction in atherosclerotic lesions of Homo sapiens.,-27.5,0.6,diseaseorphenotypicfeature
"Alteration of the BCL2L1 gene product in A549 cells exposed to doxorubicin induces apoptosis, which correlates with increased axonal damage and worsened corneal disease in a mouse model of Joubert syndrome.",-34.25,0.6,diseaseorphenotypicfeature
Alterative expression of the ALOX5AP gene in the leukocytes of patients with atherosclerosis correlates with increased plasma levels of oxidized LDL and predicts the development of coronary artery disease.,-44.75,0.6,diseaseorphenotypicfeature
"Mutational analysis of the **Joubert syndrome** gene **TMEM216** in an **Atherosclerosis**-prone **Homo sapiens** cohort revealed that the **c.1276C>T (p.Arg426Ter)** **SequenceVariant** markedly increases the risk of **axial skeletal abnormalities** and **malformed external ears**, thereby underscoring the pleiotropic effects of this **GeneOrGeneProduct** in neuro‑developmental disorders.",-60.75,0.6,diseaseorphenotypicfeature
"Mutations in the NPHP1 gene, which are known to cause Joubert syndrome, have been linked to axonal damage and axial skeletal abnormalities in affected patients.",-24.0,0.6,diseaseorphenotypicfeature
Mutated TP53 c.215C>A in A549 cells exacerbates axonal damage and accelerates the progression of atherosclerosis in a mouse model of Joubert syndrome.,-24.75,0.6,diseaseorphenotypicfeature
"Mutagenic exposure to benzo[a]pyrene in A549 cells activates the TP53 pathway, leading to apoptosis and contributing to the atherosclerosis‑associated endothelial dysfunction observed in patients with Joubert syndrome.",-31.25,0.6,diseaseorphenotypicfeature
"SARS‑CoV‑2 infection in a patient with Atherosclerosis and an underlying BRCA1 c.68_69delAG SequenceVariant exacerbated axonal damage, leading to severe axonal loss and a pronounced phenotype of peripheral neuropathy.",-39.75,0.6,diseaseorphenotypicfeature
Surgical repair of an elbow dislocation in a patient with overweight and axonal damage was complicated by the discovery of a novel BRCA1 c.68_69delAG sequence variant that may predispose to atherosclerosis through dysregulation of the TP53 gene product.,-32.25,0.6,diseaseorphenotypicfeature
"Seroquel’s inhibition of dopamine D2 receptors in patients with Joubert syndrome and axial skeletal abnormalities may exacerbate axonal damage, thereby increasing the risk of atherosclerosis and contributing to the observed corneal disease in overweight individuals.",-47.0,0.6,diseaseorphenotypicfeature
SOD2 deficiency in a HeLa cell line engineered to express the BRCA1 c.68_69delAG variant exacerbated axonal damage and increased the risk of atherosclerosis in a co‑culture with endothelial cells from Homo sapiens donors.,-37.75,0.6,diseaseorphenotypicfeature
"Mutation of the *SMARCB1* gene in malignant rhabdoid tumor cells promotes axonal damage and exacerbates the axial skeletal abnormalities observed in patients with Joubert syndrome, thereby increasing the risk of atherosclerosis in overweight adults.",-39.0,0.6,diseaseorphenotypicfeature
"Mutation analysis of the SMARCB1 gene in a patient with Joubert syndrome and axial skeletal abnormalities revealed a novel c.1123_1124delAG sequence variant that likely disrupts the protein’s chromatin‑remodeling activity, contributing to the observed neuro‑cognitive deficits.",-43.5,0.6,diseaseorphenotypicfeature
"Mutation in the *SMOC2* gene has been shown to cause axial skeletal abnormalities and malformed external ears in patients with Joubert syndrome, while the same variant is also associated with increased risk of atherosclerosis in overweight adults.",-31.5,0.6,diseaseorphenotypicfeature
"Mutation c.68_69delAG in the BRCA1 gene, detected in a patient with a family history of breast cancer and a concurrent phenotype of axonal damage, was shown to increase susceptibility to atherosclerosis and to confer a higher risk of developing Joubert syndrome when combined with a pathogenic variant in the ATOH7 gene.",-51.0,0.6,diseaseorphenotypicfeature
"Transgenic A549 cells overexpressing the ALL.Oncogene variant c.1526C>T exhibit increased axonal damage and axonal transport defects in a mouse model of atherosclerosis, suggesting a pathogenic link between the oncogene mutation and vascular neurodegeneration.",-42.0,0.6,diseaseorphenotypicfeature
"Transplantation of A549 cells engineered to express the mutated TP53 variant c.215C>T exacerbated atherosclerosis in ApoE-/- mice, illustrating how a single SequenceVariant can drive disease progression through altered GeneOrGeneProduct signaling.",-41.0,0.6,diseaseorphenotypicfeature
"Transcriptional up‑regulation of the oncogene ALL.Oncogene in HeLa cells carrying the BRCA1 c.68_69delAG variant promotes atherosclerotic plaque formation, contributing to axonal damage and the axial skeletal abnormalities observed in patients with Joubert syndrome.",-36.5,0.6,diseaseorphenotypicfeature
Transcranial magnetic stimulation of the motor cortex in a cohort of patients with Joubert syndrome revealed that the presence of the c.1528C>T sequence variant in the TMEM67 gene was associated with increased axonal damage and a higher frequency of axial skeletal abnormalities compared with patients lacking this variant.,-48.0,0.6,diseaseorphenotypicfeature
"Patients with Joubert syndrome carrying the c.1027_1030delTTCA variant in the AHI1 gene exhibit axial skeletal abnormalities, malformed external ears, and axonal damage that correlate with the severity of their corneal disease.",-32.75,0.6,diseaseorphenotypicfeature
"Patients harboring the BRCA1 c.68_69delAG sequence variant exhibit increased susceptibility to atherosclerosis and axial skeletal abnormalities, while the same mutation also correlates with axonal damage in the context of Joubert syndrome.",-33.0,0.6,diseaseorphenotypicfeature
"Patients carrying the novel BRCA1 c.68_69delAG sequence variant showed a higher incidence of axonal damage and axillary skeletal abnormalities compared with non‑carriers, suggesting that this mutation may contribute to the pathogenesis of Joubert syndrome and atherosclerosis in overweight individuals.",-38.75,0.6,diseaseorphenotypicfeature
"Patients receiving the ALL.Oncogene‑targeted drug dasatinib exhibited a significant reduction in axonal damage scores, correlating with improved gait stability in the murine model of atherosclerosis‑induced neuropathy.",-40.0,0.6,diseaseorphenotypicfeature
"Investigating the molecular basis of Joubert syndrome, researchers discovered that a missense SequenceVariant in the TMEM67 gene disrupts cerebellar vermis development, leading to axial skeletal abnormalities and malformed external ears in affected patients.",-26.0,0.6,diseaseorphenotypicfeature
"Investigations in A549 cells revealed that the JAG1 mutation (c.1123G>A) associated with Joubert syndrome upregulates the NOTCH1 pathway, thereby exacerbating axonal damage and contributing to the observed axial skeletal abnormalities in affected patients.",-37.25,0.6,diseaseorphenotypicfeature
"Investigative imaging of patients with Joubert syndrome revealed that the presence of the c.3703G>A SequenceVariant in the AHI1 GeneOrGeneProduct correlates with axial skeletal abnormalities and malformed external ears, suggesting a pathogenic link between the variant and the disease phenotype.",-44.25,0.6,diseaseorphenotypicfeature
"Investigational data reveal that a novel missense variant in the *WDR35* gene (c.1123G>A, p.Arg375His) is associated with Joubert syndrome, where affected patients display axial skeletal abnormalities, malformed external ears, and axonal damage, and the variant’s pathogenicity is further supported by its segregation in multiple pterygium syndromes families.",-54.0,0.6,diseaseorphenotypicfeature
"The HGF‑cMET axis drives invasive breast cancer progression in male pseudohermaphrodite patients, where a BRCA1 c.68_69delAG variant amplifies MAPK signaling, leading to cardiac dilation and renal interstitial fibrosis that exacerbate memory deficiency.",-39.25,0.6,diseaseorphenotypicfeature
"The X‑linked mental retardation observed in male pseudohermaphrodite patients is frequently associated with a pathogenic SequenceVariant in the MECP2 gene, which disrupts neuronal gene regulation and contributes to severe memory deficiency and cardiac dilation.",-24.875,0.6,diseaseorphenotypicfeature
"The invasive breast cancer cell line MCF‑7, harboring a BRCA1 c.68_69delAG sequence variant, was treated with doxorubicin, a chemical entity known to induce cardiotoxicity, and the resulting cardiac dilation and fibrosis were observed in the cardiac tissue of the cultured cells.",-32.75,0.6,diseaseorphenotypicfeature
"The male pseudohermaphrodite patient with X‑linked mental retardation exhibited cardiac dilation and renal interstitial fibrosis, while the invasive breast cancer cell line MCF‑7, treated with doxorubicin, displayed increased cardiotoxicity and memory deficiency in the surrounding cardiac tissue.",-22.875,0.6,diseaseorphenotypicfeature
"Genetic disruption of the X‑linked mental‑retardation gene KDM5C in a male pseudohermaphrodite patient led to severe cardiac dilation and renal interstitial fibrosis, exacerbating memory deficiency and predisposing to invasive breast cancer in a related family.",-36.5,0.6,diseaseorphenotypicfeature
"Genomic analysis of invasive breast cancer patient samples revealed that the BRCA1 c.68_69delAG SequenceVariant, coupled with the TP53 GeneOrGeneProduct mutation, is associated with increased cardiac dilation and cardiotoxicity in individuals carrying the X-linked mental retardation phenotype.",-33.75,0.6,diseaseorphenotypicfeature
"Genotoxicity of doxorubicin in MCF‑7 cells triggers TP53‑mediated apoptosis, thereby reducing invasive breast cancer cell invasion while concurrently inducing cardiac fibrosis that may underlie cardiotoxicity in patients with X‑linked mental retardation.",-40.0,0.6,diseaseorphenotypicfeature
"Genotyping of a BRCA1 c.68_69delAG variant in a HeLa-derived invasive breast cancer cell line revealed that the mutation enhances TP53‑mediated apoptosis, thereby attenuating the cardiac‑dilation phenotype observed in the patient’s X‑linked mental retardation–associated renal interstitial fibrosis.",-43.25,0.6,diseaseorphenotypicfeature
"In male pseudohermaphrodite patients, X‑linked mental retardation is frequently accompanied by cardiac dilation, which predisposes them to cardiotoxicity during treatment of invasive breast cancer.",-16.5,0.6,diseaseorphenotypicfeature
"In a cohort of male pseudohermaphrodite patients, invasive breast cancer was detected through imaging, and subsequent biopsy revealed X‑linked mental retardation‑associated gene mutations that may contribute to cardiac dilation and renal interstitial fibrosis, while the tumor’s aggressive phenotype was linked to a novel sequence variant in the TP53 gene, suggesting a complex interplay between genetic predisposition and disease manifestations.",-54.25,0.6,diseaseorphenotypicfeature
"In female patients with X‑linked mental retardation, the presence of a BRCA1 c.68_69delAG sequence variant in the TP53 gene has been linked to an increased risk of invasive breast cancer, while in male pseudohermaphrodite individuals, a missense mutation in the androgen receptor gene is associated with cardiac dilation and renal interstitial fibrosis, leading to cardiotoxicity and memory deficiency.",-38.25,0.6,diseaseorphenotypicfeature
"Invasive breast cancer patients harboring a BRCA1 c.68_69delAG variant exhibit increased cardiac dilation and Renal Interstitial Fibrosis, linking the sequence variant to both fibrosis and memory deficiency.",-24.375,0.6,diseaseorphenotypicfeature
Altered expression of the X‑linked mental retardation gene MECP2 in a male pseudohermaphrodite patient with cardiac dilation and renal interstitial fibrosis suggests that this sequence variant may underlie the combined neuro‑cognitive and cardiac phenotypes observed in this rare syndrome.,-32.5,0.6,diseaseorphenotypicfeature
"Alterations in the X‑linked mental retardation gene, when combined with a BRCA1 c.68_69delAG sequence variant, exacerbate invasive breast cancer progression in a male pseudohermaphrodite, leading to cardiac dilation and renal interstitial fibrosis that ultimately contribute to memory deficiency and cardiotoxicity.",-33.0,0.6,diseaseorphenotypicfeature
"Alteration of the X‑linked mental‑retardation gene on the X chromosome in male pseudohermaphrodite patients leads to cardiac dilation and renal interstitial fibrosis, while the same mutation also predisposes to invasive breast cancer and schizophrenic‑associated memory deficiency.",-33.0,0.6,diseaseorphenotypicfeature
"Alterative chemotherapy with doxorubicin exacerbated cardiac dilation and cardiotoxicity in male pseudohermaphrodite patients, while the concurrent administration of the antioxidant N‑acetylcysteine mitigated renal interstitial fibrosis and memory deficiency associated with invasive breast cancer.",-39.0,0.6,diseaseorphenotypicfeature
"Autofluorescence imaging of invasive breast cancer tissues from a male pseudohermaphrodite patient revealed that the overexpression of the X‑linked mental retardation gene MECP2 in the tumor microenvironment correlated with increased cardiac dilation and renal interstitial fibrosis, suggesting a shared pathogenic pathway involving cardiac cardiotoxicity and memory deficiency.",-49.5,0.6,diseaseorphenotypicfeature
"Autophosphorylation of the KRAS protein in invasive breast cancer cell lines such as MDA‑MB‑231 activates downstream MAPK signaling, thereby promoting cardiac dilation and renal interstitial fibrosis in mice harboring the KRAS G12D mutation.",-43.75,0.6,diseaseorphenotypicfeature
Autocrine IL‑6 signaling in the HeLa cell line carrying a TP53 c.215C>T (p.Pro72Arg) variant drives invasive breast cancer progression and induces cardiac dilation in the context of X‑linked mental retardation.,-39.5,0.6,diseaseorphenotypicfeature
"Autopsy of a male pseudohermaphrodite revealed cardiac dilation and renal interstitial fibrosis, suggesting a systemic cardiotoxicity that may underlie the observed memory deficiency.",-23.5,0.6,diseaseorphenotypicfeature
"Mutations in the X‑linked gene responsible for mental retardation were found to increase the risk of invasive breast cancer and cardiac dilation in male pseudohermaphrodite patients, while also exacerbating renal interstitial fibrosis and memory deficiency.",-22.375,0.6,diseaseorphenotypicfeature
"Mutational loss of the X‑linked gene *KDM5C* in male pseudohermaphrodites with cardiac dilation and renal interstitial fibrosis leads to a phenotype of severe cardiotoxicity, memory deficiency, and invasive breast‑cancer‑like fibrosis.",-36.25,0.6,diseaseorphenotypicfeature
"Mutagenic exposure to the DNA‑damaging agent bleomycin induces a BRCA1 c.68_69delAG variant in MCF‑7 cells, leading to increased fibrosis and cardiotoxicity in a mouse model of invasive breast cancer.",-33.25,0.6,diseaseorphenotypicfeature
"Muting the NF‑κB pathway in HeLa cells treated with doxorubicin reduced cardiac‑related fibrosis markers, suggesting that the drug’s cardiotoxicity may be mediated by inflammatory signaling rather than direct DNA damage.",-37.5,0.6,diseaseorphenotypicfeature
Methicillin‑resistant *Staphylococcus aureus* infection in a male pseudohermaphrodite patient with invasive breast cancer and cardiac dilation was found to trigger renal interstitial fibrosis and memory deficiency through upregulation of the TGF‑β1 signaling pathway.,-36.25,0.6,diseaseorphenotypicfeature
"Methotrexate treatment of invasive breast cancer in a male pseudohermaphrodite patient carrying a BRCA1 c.68_69delAG sequence variant resulted in severe cardiac dilation and renal interstitial fibrosis, while the concomitant administration of dexamethasone mitigated the cardiotoxicity but exacerbated memory deficiency.",-34.0,0.6,diseaseorphenotypicfeature
Methadone exposure in a male pseudohermaphrodite patient with X‑linked mental retardation was found to exacerbate cardiac dilation and renal interstitial fibrosis while impairing memory function.,-23.625,0.6,diseaseorphenotypicfeature
"Methionine‑cysteine sulfoxide reductase A deficiency in a male pseudohermaphrodite patient with X‑linked mental retardation leads to cardiac dilation and renal interstitial fibrosis, while the concomitant BRCA1 c.68_69delAG variant in invasive breast cancer cells exacerbates cardiotoxicity and memory deficiency.",-40.5,0.6,diseaseorphenotypicfeature
"Mutation of the **X-linked mental retardation** gene **MECP2** in a **male pseudohermaphrodite** patient leads to severe **cardiac dilation** and **renal interstitial fibrosis**, while the same variant is also implicated in **schizophrenic** individuals with **memory deficiency**.",-34.0,0.6,diseaseorphenotypicfeature
"Mutation in the X-linked mental retardation gene ARX, detected in a male pseudohermaphrodite patient, was shown to disrupt cortical development and lead to severe memory deficiency and cardiac dilation, while the same variant was also found to increase susceptibility to invasive breast cancer in female carriers.",-38.75,0.6,diseaseorphenotypicfeature
"Mutation c.68_69delAG in the BRCA1 gene was found to increase invasive breast cancer risk in a cohort of male pseudohermaphrodite patients, while the same variant also predisposed to cardiac dilation and renal interstitial fibrosis, illustrating a pleiotropic effect on both oncogenic and cardiovascular phenotypes.",-36.75,0.6,diseaseorphenotypicfeature
"Mutation‑induced loss of the X‑linked mental retardation gene in a male pseudohermaphrodite predisposes to severe memory deficiency, cardiac dilation, and renal interstitial fibrosis while simultaneously lowering resistance to cardiotoxicity from doxorubicin in invasive breast cancer therapy.",-39.0,0.6,diseaseorphenotypicfeature
"X‑linked mental retardation, manifesting as severe memory deficiency, is frequently exacerbated by cardiac dilation in patients carrying the BRWD3 c.1572G>A sequence variant, and the resulting cardiotoxicity compromises renal interstitial fibrosis progression in affected males.",-43.25,0.6,diseaseorphenotypicfeature
"X-linked mental retardation, cardiac dilation, and renal interstitial fibrosis are frequently observed in patients with male pseudohermaphroditism, and the concomitant expression of the COL4A5 sequence variant exacerbates the cardiotoxicity and memory deficiency associated with invasive breast cancer and schizophrenia.",-45.75,0.6,diseaseorphenotypicfeature
"X‐linked mental retardation in male pseudohermaphrodites is associated with a BRCA1 c.68_69delAG sequence variant that disrupts TP53‑mediated DNA repair, leading to invasive breast cancer and cardiac dilation through altered ETV6 nuclear localization and increased fibrosis.",-40.25,0.6,diseaseorphenotypicfeature
"X chromosome‑linked mutations in the DMD gene, which cause Duchenne muscular dystrophy, have been shown to increase cardiac dilation and cardiotoxicity, thereby predisposing affected males to invasive breast cancer‑related fibrosis and memory deficiency.",-46.25,0.6,diseaseorphenotypicfeature
Elevated levels of the BRCA1 c.68_69delAG variant in HeLa cells correlate with increased invasive breast cancer phenotypes and enhanced cardiac dilation in X‑linked mental retardation patients.,-29.125,0.6,diseaseorphenotypicfeature
Elevative expression of the X‑linked mental retardation gene **MECP2** in **HEK293T** cells exposed to the chemotherapeutic **doxorubicin** induces a marked increase in **cardiac dilation**‑associated **fibrosis** and exacerbates **memory deficiency** in a murine model of **invasive breast cancer**.,-48.5,0.6,diseaseorphenotypicfeature
"Elevating the expression of the TP53 gene in HeLa cells treated with doxorubicin leads to increased cardiotoxicity and memory deficiency in male pseudohermaphrodite patients, suggesting a link between TP53 activation and invasive breast cancer‑associated fibrosis.",-46.75,0.6,diseaseorphenotypicfeature
"Elevators in the cardiac conduction system of male pseudohermaphrodite patients with X‑linked mental retardation can be impaired by the BRCA1 c.68_69delAG sequence variant, leading to cardiac dilation and a higher risk of invasive breast cancer in affected relatives.",-53.0,0.6,diseaseorphenotypicfeature
"Experimental treatment with doxorubicin in A549 cells carrying the BRCA1 c.68_69delAG variant exacerbated cardiac dilation and fibrosis, thereby increasing susceptibility to cardiotoxicity and memory deficiency in male pseudohermaphrodite mice.",-31.875,0.6,diseaseorphenotypicfeature
"Experimental analysis revealed that the BRCA1 c.68_69delAG sequence variant in a male pseudohermaphrodite patient with invasive breast cancer correlates with increased cardiac dilation and fibrosis, suggesting a mechanistic link between the mutation and cardiotoxicity.",-31.0,0.6,diseaseorphenotypicfeature
"Experimental evidence shows that the BRCA1 c.68_69delAG variant in a female patient with invasive breast cancer enhances the susceptibility of her A549 cell line to doxorubicin‑induced cardiotoxicity, thereby accelerating cardiac dilation and fibrosis while impairing memory deficiency.",-42.0,0.6,diseaseorphenotypicfeature
"Experimental investigations revealed that the BRCA1 c.68_69delAG variant in the HeLa cell line exacerbates cardiac dilation and fibrosis while diminishing memory deficiency in a model of invasive breast cancer, suggesting a pathogenic link between DNA repair defects and X‑linked mental retardation phenotypes.",-48.25,0.6,diseaseorphenotypicfeature
"Impaired cardiac dilation in male pseudohermaphrodite patients with X‑linked mental retardation is exacerbated by the cardiotoxicity of doxorubicin, which also induces renal interstitial fibrosis and memory deficiency in HeLa‑derived xenograft models of invasive breast cancer.",-21.375,0.6,diseaseorphenotypicfeature
"Immunohistochemical analysis of the A549 cell line revealed that the X‑linked mental retardation protein encoded by the MECP2 gene was overexpressed, correlating with increased fibrosis and memory deficiency in patients with invasive breast cancer.",-35.25,0.6,diseaseorphenotypicfeature
"Imatinib treatment of invasive breast cancer in a male pseudohermaphrodite patient carrying a BRCA1 c.68_69delAG variant was associated with cardiac dilation and subsequent cardiotoxicity, prompting the use of a cardiac biomarker panel to monitor renal interstitial fibrosis and mitigate memory deficiency.",-37.0,0.6,diseaseorphenotypicfeature
"Impairment of the cardiac mitochondrial complex I observed in male pseudohermaphrodite patients with X‑linked mental retardation correlates with increased renal interstitial fibrosis and memory deficiency, suggesting a systemic cardiotoxicity that may exacerbate invasive breast cancer progression.",-38.0,0.6,diseaseorphenotypicfeature
"Polymorphisms in the X-linked mental retardation gene MECP2 exacerbate cardiac dilation and renal interstitial fibrosis in male pseudohermaphrodite patients, thereby worsening memory deficiency and increasing susceptibility to cardiotoxicity.",-25.0,0.6,diseaseorphenotypicfeature
"Polycystic ovary syndrome in a male pseudohermaphrodite patient with X‑linked mental retardation was associated with renal interstitial fibrosis and cardiac dilation, and the use of doxorubicin exacerbated cardiotoxicity, leading to memory deficiency.",-34.0,0.6,diseaseorphenotypicfeature
"Polysorbate‑80 exposure in HeLa cells carrying the BRCA1 c.68_69delAG variant exacerbated DNA double‑strand breaks, thereby accelerating invasive breast cancer progression and contributing to renal interstitial fibrosis in a murine model of cardiac dilation.",-40.0,0.6,diseaseorphenotypicfeature
Polyanalytic treatment of invasive breast cancer in a male pseudohermaphrodite patient carrying a BRCA1 c.68_69delAG variant reduced cardiac dilation and mitigated renal interstitial fibrosis while preserving memory function.,-33.75,0.6,diseaseorphenotypicfeature
"A novel missense mutation in the BRCA1 gene (c.68_69delAG) was detected in a male pseudohermaphrodite patient with invasive breast cancer, suggesting that the mutation may contribute to both the tumor phenotype and the observed cardiac dilation.",-31.25,0.6,diseaseorphenotypicfeature
"A X‑linked mental retardation patient with male pseudohermaphrodite features exhibited cardiac dilation, while invasive breast cancer cells from a HeLa-derived xenograft expressed elevated TP53 and showed resistance to doxorubicin, suggesting a link between fibrosis, memory deficiency, and cardiotoxicity.",-43.5,0.6,diseaseorphenotypicfeature
"A cell line derived from a male pseudohermaphrodite patient with X‑linked mental retardation was found to overexpress the TP53 gene, and its invasive breast cancer phenotype was exacerbated by exposure to the chemotherapeutic agent doxorubicin, which induced cardiac dilation and cardiotoxicity through oxidative stress‑mediated fibrosis and memory deficiency.",-40.0,0.6,diseaseorphenotypicfeature
"A male pseudohermaphrodite with X‑linked mental retardation exhibited cardiac dilation and renal interstitial fibrosis, and the subsequent invasive breast cancer metastasis was found to be associated with a BRCA1 c.68_69delAG sequence variant that exacerbated memory deficiency.",-27.375,0.6,diseaseorphenotypicfeature
"The combined presence of congenital antithrombin deficiency and chronic liver inflammation in a patient with focal segmental glomerulosclerosis led to an exacerbated risk of uveitis and liver failure, as evidenced by elevated liver enzymes and proteinuria.",-34.25,0.6,diseaseorphenotypicfeature
"The chronic liver inflammation observed in patients co‑infected with HIV and hepatitis B virus is exacerbated by LSEC injury, which in turn promotes the progression of focal segmental glomerulosclerosis.",-11.3125,0.6,diseaseorphenotypicfeature
"The liver biopsy of a patient with congenital antithrombin deficiency revealed LSEC injury and chronic liver inflammation, suggesting that focal segmental glomerulosclerosis may be secondary to the underlying hepatic pathology.",-22.875,0.6,diseaseorphenotypicfeature
"The Huh7 cell line treated with the small‑molecule inhibitor selumetinib displayed a marked reduction in the expression of the inflammatory cytokine IL‑6, suggesting that MEK inhibition may ameliorate chronic liver inflammation in patients with congenital antithrombin deficiency.",-33.75,0.6,diseaseorphenotypicfeature
"Co‑infection with HIV and hepatitis B virus exacerbates chronic liver inflammation, leading to focal segmental glomerulosclerosis and increasing the risk of type‑2 diabetes in patients with congenital antithrombin deficiency.",-16.75,0.6,diseaseorphenotypicfeature
"Co-infected with HIV and hepatitis B virus, the patient’s chronic liver inflammation exacerbated LSEC injury, contributing to the development of focal segmental glomerulosclerosis and worsening Type‑2 Diabetes control.",-23.75,0.6,diseaseorphenotypicfeature
"Co‐infected with HIV and hepatitis B virus, the patient’s chronic liver inflammation accelerated the development of focal segmental glomerulosclerosis and exacerbated the severity of type‑2 diabetes, while LSEC injury further compromised hepatic function.",-36.5,0.6,diseaseorphenotypicfeature
"Co-immunoprecipitation of the LSEC injury–associated protein with the FGF receptor in a HeLa cell line revealed that the chronic liver inflammation phenotype is exacerbated by a BRCA1 c.68_69delAG variant, suggesting a potential therapeutic target for patients with congenital antithrombin deficiency and concomitant psoriatic uveitis.",-46.25,0.6,diseaseorphenotypicfeature
"Liver biopsies from patients with chronic liver inflammation and congenital antithrombin deficiency revealed that the extent of LSEC injury correlated with the severity of focal segmental glomerulosclerosis, suggesting a shared pathogenic pathway linking vascular endothelial dysfunction to renal pathology.",-28.375,0.6,diseaseorphenotypicfeature
LPS‑induced LSEC injury in A549 cells carrying the BRCA1 c.68_69delAG variant exacerbates chronic liver inflammation and promotes focal segmental glomerulosclerosis in a murine model of congenital antithrombin deficiency.,-26.75,0.6,diseaseorphenotypicfeature
"LSEC injury in patients with chronic liver inflammation and congenital antithrombin deficiency is associated with a higher incidence of focal segmental glomerulosclerosis, especially in those co‑infected with HIV and hepatitis B virus.",-21.125,0.6,diseaseorphenotypicfeature
"Labeled LSEC injury in patients with congenital antithrombin deficiency often exacerbates chronic liver inflammation, leading to increased risk of focal segmental glomerulosclerosis and co‑infection with HIV and hepatitis B virus.",-28.75,0.6,diseaseorphenotypicfeature
"A chronic liver inflammation model in A549 cells revealed that LSEC injury upregulates the expression of the gene TP53, which in turn enhances the production of the cytokine IL-6, thereby exacerbating the psoriatic phenotype in the co‑infected with HIV and hepatitis B virus patient.",-42.5,0.6,diseaseorphenotypicfeature
A genetic screen of patients with focal segmental glomerulosclerosis revealed a recurrent BRCA1 c.68_69delAG variant that appears to exacerbate chronic liver inflammation in those also co‑infected with HIV and hepatitis B virus.,-22.125,0.6,diseaseorphenotypicfeature
"A proteomic screen of liver biopsies from patients with LSEC injury and chronic liver inflammation revealed that the up‑regulated cytokine IL‑17A directly activates STAT3 signaling in hepatocytes, thereby exacerbating steatohepatitis and predisposing to focal segmental glomerulosclerosis.",-35.25,0.6,diseaseorphenotypicfeature
"A hepatic biopsy of a patient with chronic liver inflammation revealed that LSEC injury was exacerbated by a novel SequenceVariant in the SERPINA1 gene, suggesting a pathogenic link to the development of focal segmental glomerulosclerosis.",-24.75,0.6,diseaseorphenotypicfeature
"In patients with congenital antithrombin deficiency who develop focal segmental glomerulosclerosis, the chronic liver inflammation associated with co-infection of HIV and hepatitis B virus exacerbates LSEC injury, contributing to progressive renal dysfunction.",-21.25,0.6,diseaseorphenotypicfeature
"In Huh7 cells, the LSEC injury–induced upregulation of the inflammatory cytokine IL‑6 activates STAT3 signaling, which in turn enhances the expression of the hepatocyte growth factor receptor c‑MET, thereby promoting hepatocyte proliferation and contributing to chronic liver inflammation.",-32.5,0.6,diseaseorphenotypicfeature
"In multiple sclerosis patients, the presence of a BRCA1 c.68_69delAG variant in peripheral blood mononuclear cells correlates with increased levels of the pro‑inflammatory cytokine IL‑17 and a higher risk of developing uveitis.",-37.25,0.6,diseaseorphenotypicfeature
"In HepG2 cells, the pathogenic mutation BRCA1 c.68_69delAG exacerbates chronic liver inflammation and increases the risk of focal segmental glomerulosclerosis, while the co‑infection with HIV and hepatitis B virus further amplifies the expression of the chemokine CXCL10, contributing to the development of uveitis.",-41.25,0.6,diseaseorphenotypicfeature
"Patients with congenital antithrombin deficiency and chronic liver inflammation exhibited exacerbated LSEC injury, which in turn promoted the development of focal segmental glomerulosclerosis and increased susceptibility to uveitis.",-19.875,0.6,diseaseorphenotypicfeature
"Patients co‑infected with HIV and hepatitis B virus exhibit exacerbated chronic liver inflammation, which accelerates focal segmental glomerulosclerosis and predisposes to fulminant hepatic failure.",-24.125,0.6,diseaseorphenotypicfeature
"Patients harboring a novel BRCA1 c.68_69delAG sequence variant exhibit heightened susceptibility to chronic liver inflammation and focal segmental glomerulosclerosis, particularly when co‑infected with HIV and hepatitis B virus, and this phenotype is exacerbated by congenital antithrombin deficiency.",-31.5,0.6,diseaseorphenotypicfeature
"Patients infected with HIV and hepatitis B virus who develop chronic liver inflammation exhibit a higher frequency of liver‑specific LSEC injury and may progress to focal segmental glomerulosclerosis, particularly when a congenital antithrombin deficiency is present.",-32.25,0.6,diseaseorphenotypicfeature
"Impaired liver sinusoidal endothelial cell (LSEC) integrity in patients with congenital antithrombin deficiency exacerbates chronic liver inflammation and promotes the development of focal segmental glomerulosclerosis, while co‑infection with HIV and hepatitis B virus further aggravates hepatic injury.",-26.25,0.6,diseaseorphenotypicfeature
"Impairment of liver sinusoidal endothelial cells in patients with congenital antithrombin deficiency exacerbates chronic liver inflammation, thereby increasing the risk of developing focal segmental glomerulosclerosis and contributing to the progression of uveitis in co‑infected HIV‑Hepatitis B virus carriers.",-32.25,0.6,diseaseorphenotypicfeature
"Immunologic activation of hepatic LSEC during chronic liver inflammation exacerbates focal segmental glomerulosclerosis progression in patients co‑infected with HIV and hepatitis B virus, a phenotype that is aggravated by congenital antithrombin deficiency.",-34.75,0.6,diseaseorphenotypicfeature
"Imaging of the liver revealed LSEC injury in patients with congenital antithrombin deficiency, suggesting that chronic liver inflammation may precede the development of focal segmental glomerulosclerosis in those co‑infected with HIV and hepatitis B virus.",-30.125,0.6,diseaseorphenotypicfeature
"Chronic liver inflammation in patients co‑infected with HIV and hepatitis B virus has been shown to exacerbate focal segmental glomerulosclerosis through dysregulated cytokine signaling, suggesting that antithrombin deficiency may further amplify endothelial damage and worsen liver‑kidney outcomes.",-34.75,0.6,diseaseorphenotypicfeature
"Chimeric antigen receptor‑engineered Jurkat cells expressing the PD‑1 receptor were shown to suppress the proliferation of CD4+ T cells in a co‑culture with LSEC‑derived hepatocytes, thereby reducing the secretion of pro‑inflammatory cytokines and ameliorating chronic liver inflammation in a murine model of type‑2 diabetes.",-59.25,0.6,diseaseorphenotypicfeature
Chloroquine treatment of the HeLa cell line infected with HIV-1 and hepatitis B virus exacerbated chronic liver inflammation and promoted focal segmental glomerulosclerosis in a mouse model of congenital antithrombin deficiency.,-32.75,0.6,diseaseorphenotypicfeature
"Choroidal neovascularization in patients with congenital antithrombin deficiency was exacerbated by co‑infection with HIV and hepatitis B virus, leading to accelerated progression of chronic liver inflammation and eventual focal segmental glomerulosclerosis.",-27.75,0.6,diseaseorphenotypicfeature
"Methotrexate exacerbated chronic liver inflammation in a patient with congenital antithrombin deficiency, leading to focal segmental glomerulosclerosis and subsequent uveitis.",-17.5,0.6,diseaseorphenotypicfeature
"Methicillin‑resistant *Staphylococcus aureus* infection in a patient with congenital antithrombin deficiency triggered acute liver failure, manifested by severe cholestatic jaundice and progressive hepatic encephalopathy, and the subsequent hepatotoxicity was exacerbated by a BRCA1 c.68_69delAG variant that impaired hepatic drug‑metabolizing enzyme expression.",-55.5,0.6,diseaseorphenotypicfeature
"Methionine‑arginine‑serine (MRS) deficiency, a congenital antithrombin deficiency in Homo sapiens, exacerbates chronic liver inflammation in patients co‑infected with HIV and hepatitis B virus, leading to focal segmental glomerulosclerosis and uveitis while predisposing to fulminant hepatic failure.",-47.5,0.6,diseaseorphenotypicfeature
"Methamphetamine‑induced LSEC injury in patients co‑infected with HIV and hepatitis B virus exacerbates chronic liver inflammation, which in turn promotes the development of focal segmental glomerulosclerosis.",-24.25,0.6,diseaseorphenotypicfeature
"Covalent modification of the TP53 protein by the chemical entity cisplatin in the A549 cell line exacerbates chronic liver inflammation in patients with congenital antithrombin deficiency, leading to focal segmental glomerulosclerosis and uveitis.",-28.75,0.6,diseaseorphenotypicfeature
"Cumulative LSEC injury in patients with congenital antithrombin deficiency exacerbates chronic liver inflammation, leading to a higher risk of developing focal segmental glomerulosclerosis and uveitis.",-20.5,0.6,diseaseorphenotypicfeature
"Citrullinated histone H3 released by neutrophil extracellular traps exacerbates focal segmental glomerulosclerosis in patients with congenital antithrombin deficiency, leading to progressive chronic liver inflammation and a higher risk of uveitis.",-30.625,0.6,diseaseorphenotypicfeature
"Cystic fibrosis patients co‑infected with HIV and hepatitis B virus exhibit exacerbated chronic liver inflammation and LSEC injury, which in turn predisposes them to focal segmental glomerulosclerosis.",-25.5,0.6,diseaseorphenotypicfeature
"Mutant TP53 c.215C>T variant was detected in a HeLa-derived LSEC injury model, where chronic liver inflammation induced by co‑infection with HIV and hepatitis B virus exacerbated focal segmental glomerulosclerosis and contributed to the development of Type‑2 diabetes.",-44.5,0.6,diseaseorphenotypicfeature
"Mutations in the SERPINC1 gene that cause congenital antithrombin deficiency are associated with an increased risk of thrombotic events in patients with chronic liver inflammation, and the presence of focal segmental glomerulosclerosis further exacerbates renal dysfunction in these individuals.",-25.875,0.6,diseaseorphenotypicfeature
Mutational analysis revealed that a novel BRCA1 c.68_69delAG variant in a HeLa cell line carrying a congenital antithrombin deficiency exacerbates chronic liver inflammation and predisposes to focal segmental glomerulosclerosis in Homo sapiens patients co‑infected with HIV and hepatitis B virus.,-30.375,0.6,diseaseorphenotypicfeature
"Mutagenic exposure to aflatoxin B1 exacerbated chronic liver inflammation in HepG2 cells, promoting LSEC injury and upregulating CYP1A1 expression, thereby accelerating the progression of focal segmental glomerulosclerosis in patients with congenital antithrombin deficiency.",-31.0,0.6,diseaseorphenotypicfeature
"Uveal melanoma progression in patients co‑infected with HIV and hepatitis B virus is exacerbated by chronic liver inflammation, and the resulting LSEC injury promotes focal segmental glomerulosclerosis through altered cytokine signaling.",-24.875,0.6,diseaseorphenotypicfeature
"Uveitis and focal segmental glomerulosclerosis were observed in a patient with congenital antithrombin deficiency who was co‑infected with HIV and hepatitis B virus, and these conditions appeared to worsen during the chronic liver inflammation associated with type‑2 diabetes.",-39.0,0.6,diseaseorphenotypicfeature
Ube3a loss of function in the LSEC injury model exacerbates chronic liver inflammation and promotes focal segmental glomerulosclerosis in mice carrying a congenital antithrombin deficiency.,-30.5,0.6,diseaseorphenotypicfeature
"U2OS cells harboring the BRCA1 c.68_69delAG variant exhibited heightened sensitivity to the DNA‑damaging agent doxorubicin, a finding that may explain the increased risk of chemotherapy‑induced alopecia observed in patients with Type‑2 Diabetes and co‑infection with HIV and hepatitis B virus.",-40.75,0.6,diseaseorphenotypicfeature
"Congenital antithrombin deficiency in a patient with chronic liver inflammation precipitated focal segmental glomerulosclerosis, while co‑infection with HIV and hepatitis B virus further exacerbated uveitis and psoriatic skin disease.",-18.0,0.6,diseaseorphenotypicfeature
"Congestive hepatopathy in patients with congenital antithrombin deficiency and chronic liver inflammation was found to exacerbate focal segmental glomerulosclerosis, with the HCV‐co‑infected HIV and hepatitis B virus strains further accelerating renal fibrosis.",-47.0,0.6,diseaseorphenotypicfeature
"Congenic antithrombin deficiency in a patient with chronic liver inflammation and focal segmental glomerulosclerosis exacerbated uveitis severity, while co‑infection with HIV and hepatitis B virus further amplified hepatic fibrosis progression.",-35.25,0.6,diseaseorphenotypicfeature
"Conglutar‑treated A549 cells exposed to doxorubicin displayed heightened LSEC injury markers, suggesting that the drug exacerbates chronic liver inflammation in patients with congenital antithrombin deficiency who are co‑infected with HIV and hepatitis B virus.",-38.5,0.6,diseaseorphenotypicfeature
"Genetic disruption of SERPINA5 in a patient with congenital antithrombin deficiency exacerbated chronic liver inflammation, leading to accelerated focal segmental glomerulosclerosis and recurrent uveitis.",-20.625,0.6,diseaseorphenotypicfeature
Genomic analysis of the HNF4A gene in patients with type‑2 diabetes revealed a novel c.1123C>T (p.Arg375Ter) sequence variant that correlates with impaired insulin secretion and increased hepatic inflammation in a subset of individuals exhibiting chronic liver inflammation and psoriatic skin disease.,-50.0,0.6,diseaseorphenotypicfeature
"Genotype‑specific polymorphism in the SERPINA5 gene exacerbates chronic liver inflammation in patients with congenital antithrombin deficiency, thereby increasing the risk of focal segmental glomerulosclerosis.",-25.0,0.6,diseaseorphenotypicfeature
"Genetically engineered A549 cells overexpressing the TP53 variant c.215C>A were used to demonstrate that chronic liver inflammation, induced by co‑infection with HIV and hepatitis B virus, exacerbates focal segmental glomerulosclerosis through up‑regulation of the chemokine CXCL10.",-34.5,0.6,diseaseorphenotypicfeature
"In a cohort of patients with MCL, peripheral nerve toxicity was observed to correlate with abnormal glucose homeostasis, suggesting a metabolic component to the neurological deficits.",-17.625,0.6,diseaseorphenotypicfeature
"In patients with MCL, the emergence of neurological deficits and peripheral nerve toxicity is often accompanied by abnormal glucose homeostasis, suggesting that metabolic dysregulation may exacerbate neuro‑toxic sequelae.",-25.625,0.6,diseaseorphenotypicfeature
"In the murine model of EAE, the loss of the AQP4 gene product in astrocytes exacerbated peripheral nerve toxicity and induced abnormal glucose homeostasis, thereby increasing the risk of cardiovascular death in mice harboring a conditional knockout of Aqp4 in the central nervous system.",-49.75,0.6,diseaseorphenotypicfeature
"In multiple sclerosis patients, the presence of a novel TP53 SequenceVariant (c.215G>A) in peripheral blood mononuclear cells correlates with increased EAE severity and neurological deficits, suggesting a mechanistic link between this mutation and demyelination.",-39.0,0.6,diseaseorphenotypicfeature
"The chronic inflammatory milieu in experimental autoimmune encephalomyelitis (EAE) exacerbates peripheral nerve toxicity and neurological deficits, while concomitant abnormal glucose homeostasis and enlargement of kidneys are frequently observed in patients with the same underlying genetic predisposition for MCL.",-48.0,0.6,diseaseorphenotypicfeature
"The selective PPARγ agonist pioglitazone ameliorated peripheral nerve toxicity and abnormal glucose homeostasis in an A549 xenograft model of MCL, while also reducing the expression of inflammatory cytokines in a murine EAE cohort that exhibited bilateral papilledema and cardiovascular death.",-43.25,0.6,diseaseorphenotypicfeature
"The MCL cell line treated with the PI3K inhibitor LY294002 exhibited abnormal glucose homeostasis, suggesting that the drug’s inhibition of PI3K signaling may contribute to peripheral nerve toxicity and neurological deficits observed in patients with EAE.",-31.875,0.6,diseaseorphenotypicfeature
"The monoclonal cell line MCL‑E3, derived from a patient with a confirmed EAE‑associated HLA‑DRB1*1501 allele, exhibited peripheral nerve toxicity when treated with the small‑molecule inhibitor VX‑765, leading to abnormal glucose homeostasis and progressive neurological deficits that mirrored the clinical phenotype of the patient’s bilateral papilledema and enlarged kidneys.",-73.0,0.6,diseaseorphenotypicfeature
"A recent cohort study showed that patients with MCL carrying the BRCA1 c.68_69delAG variant exhibited abnormal glucose homeostasis and peripheral nerve toxicity, leading to neurological deficits and increased risk of cardiovascular death.",-25.125,0.6,diseaseorphenotypicfeature
"A growing cohort of patients with MCL who received high‑dose methotrexate exhibited peripheral nerve toxicity that manifested as neurological deficits and abnormal glucose homeostasis, suggesting that the drug’s neuro‑toxic profile may contribute to the metabolic derangements observed in this lymphoma subtype.",-39.25,0.6,diseaseorphenotypicfeature
"A human monoclonal lymphoma (MCL) cell line transfected with a TP53 c.68_69delAG variant exhibits abnormal glucose homeostasis and peripheral nerve toxicity, while the same TP53 mutation in a murine model of experimental autoimmune encephalomyelitis (EAE) exacerbates neurological deficits and bilateral papilledema.",-44.75,0.6,diseaseorphenotypicfeature
"A transgenic A549 cell line harboring the BRCA1 c.68_69delAG variant was used to demonstrate that doxorubicin treatment exacerbates peripheral nerve toxicity in a mouse model of MCL, thereby linking abnormal glucose homeostasis to neurological deficits observed in EAE‑induced rats.",-34.25,0.6,diseaseorphenotypicfeature
"Elevated expression of the transcription factor ETV6 in the A549 cell line, driven by a BRCA1 c.68_69delAG variant, exacerbates peripheral nerve toxicity and abnormal glucose homeostasis in a murine model of multiple‑cell‑layer (MCL) disease.",-37.0,0.6,diseaseorphenotypicfeature
"Elevating IL‑6 levels in a murine model of experimental autoimmune encephalomyelitis (EAE) exacerbated neurological deficits, increased peripheral nerve toxicity, and triggered abnormal glucose homeostasis, mirroring the metabolic complications observed in patients with MCL and the renal enlargement seen in NPHP with liver fibrosis.",-47.25,0.6,diseaseorphenotypicfeature
"Elevations in serum glucose levels and peripheral nerve toxicity were observed in patients with MCL, and the resulting abnormal glucose homeostasis contributed to neurological deficits that manifested as bilateral papilledema and ultimately increased cardiovascular death risk.",-45.0,0.6,diseaseorphenotypicfeature
"Elevative therapy with the tyrosine‑kinase inhibitor imatinib in patients with B‑cell chronic lymphocytic leukemia (B‑CLL) has been shown to reduce the incidence of peripheral nerve toxicity while paradoxically exacerbating abnormal glucose homeostasis, thereby increasing the risk of cardiovascular death in a subset of patients with the MCL phenotype.",-55.0,0.6,diseaseorphenotypicfeature
"EAE mice treated with the selective TRPV1 antagonist AMG9810 showed reduced peripheral nerve toxicity, improved abnormal glucose homeostasis, and a lower incidence of cardiovascular death compared with vehicle‑treated controls.",-26.875,0.6,diseaseorphenotypicfeature
"Eukaryotic cells from the A549 cell line treated with the chemotherapeutic doxorubicin exhibited peripheral nerve toxicity, which was correlated with a down‑regulation of the gene TP53 and an up‑regulation of the inflammatory cytokine IL‑6, thereby contributing to abnormal glucose homeostasis in the diabetic mouse model of type‑2 diabetes.",-57.5,0.6,diseaseorphenotypicfeature
"Erythrocyte‐derived exosomes from MCL patients carrying a pathogenic TP53 c.215C>A variant were shown to induce peripheral nerve toxicity and abnormal glucose homeostasis in a murine model of EAE, thereby exacerbating neurological deficits.",-39.75,0.6,diseaseorphenotypicfeature
"Epidemiological analysis revealed that patients with MCL exhibiting peripheral nerve toxicity and abnormal glucose homeostasis were more likely to develop severe neurological deficits and cardiovascular death, suggesting a complex interaction between the disease phenotype and metabolic dysregulation.",-35.5,0.6,diseaseorphenotypicfeature
Mutational analysis of the PAX6 gene in patients with bilateral papilledema revealed a novel c.1023_1024delCT variant that correlates with abnormal glucose homeostasis and increases the risk of cardiovascular death in this subgroup.,-37.75,0.6,diseaseorphenotypicfeature
"Mutations in the NPHP1 gene causing NPHP with liver fibrosis are associated with abnormal glucose homeostasis and peripheral nerve toxicity, which in turn can exacerbate neurological deficits observed in patients with MCL.",-26.125,0.6,diseaseorphenotypicfeature
"Mutated TP53 c.215C>T in patients with MCL leads to abnormal glucose homeostasis, thereby exacerbating peripheral nerve toxicity and neurological deficits.",-25.375,0.6,diseaseorphenotypicfeature
"Mutagenic exposure to dioxin-like chemicals in **Homo sapiens** activates the aryl hydrocarbon receptor, which in turn upregulates CYP1A1 expression and exacerbates **neurological deficits** in patients with **22q11.2 deletion syndrome**.",-35.75,0.6,diseaseorphenotypicfeature
"Progressive neuro‑degeneration in multiple‑system atrophy, a neurological deficit characterized by abnormal glucose homeostasis and peripheral nerve toxicity, is exacerbated by the presence of a pathogenic BRCA1 c.68_69delAG sequence variant in patients with a concurrent EAE‑like inflammatory profile.",-51.0,0.6,diseaseorphenotypicfeature
"Progression of MCL in a patient with a novel TP53 c.215C>T sequence variant was associated with abnormal glucose homeostasis and peripheral nerve toxicity, leading to neurological deficits and bilateral papilledema.",-35.0,0.6,diseaseorphenotypicfeature
"Progressively worsening neurological deficits in patients with MCL were associated with peripheral nerve toxicity, abnormal glucose homeostasis, and a higher incidence of cardiovascular death, suggesting a complex interplay between neurodegeneration and metabolic dysregulation.",-36.0,0.6,diseaseorphenotypicfeature
"Progressivity of multiple‑cervical‑lymphoma (MCL) is exacerbated by peripheral‑nerve‑toxicity‑induced neurological deficits, which in turn accelerate abnormal glucose homeostasis and increase the risk of cardiovascular death in patients with the EAE‑like phenotype.",-54.5,0.6,diseaseorphenotypicfeature
"Alnustone treatment in A549 cells carrying the BRCA1 c.68_69delAG variant reduces the expression of the ETV6 oncogene, thereby attenuating the proliferation of malignant lymphoma cells and improving neurological deficits in an experimental EAE model of multiple sclerosis.",-49.25,0.6,diseaseorphenotypicfeature
"Altering the expression of the TP53 gene in HeLa cells treated with doxorubicin exacerbates neurological deficits in a murine model of experimental autoimmune encephalomyelitis (EAE) and induces peripheral nerve toxicity, while simultaneously disrupting abnormal glucose homeostasis and increasing the risk of cardiovascular death.",-37.0,0.6,diseaseorphenotypicfeature
"Alzheimer’s disease, a diseaseorphenotypicfeature characterized by progressive cognitive decline and abnormal glucose homeostasis, is exacerbated in patients carrying the BRCA1 c.68_69delAG sequencevariant, which impairs DNA repair and enhances neuronal apoptosis.",-34.5,0.6,diseaseorphenotypicfeature
"Alpelisib treatment in MCL patients carrying the PIK3CA H1047R sequence variant was associated with improved neurological deficits and a reduction in peripheral nerve toxicity, while still preserving abnormal glucose homeostasis.",-42.0,0.6,diseaseorphenotypicfeature
"Peripheral nerve toxicity in multiple‑cervical‑leukemia patients correlates with abnormal glucose homeostasis and neurological deficits, a pattern also observed in EAE models of the same disease.",-35.75,0.6,diseaseorphenotypicfeature
"Peripheral Nerve Toxicity in MCL patients treated with doxorubicin was associated with abnormal glucose homeostasis and neurological deficits, suggesting that the drug’s cardiotoxic and neurotoxic profiles may converge on metabolic dysregulation.",-37.0,0.6,diseaseorphenotypicfeature
Peripheral endothelial dysfunction in a patient with MCL and abnormal glucose homeostasis was found to exacerbate the neurological deficits observed in experimental autoimmune encephalomyelitis (EAE) and was associated with a high‑risk sequence variant in the TP53 gene.,-57.25,0.6,diseaseorphenotypicfeature
"Peripheral‑nerve‑toxicity induced by the chemotherapeutic agent doxorubicin in MCL patients was associated with abnormal glucose homeostasis and neurological deficits, and the presence of a BRCA1 c.68_69delAG sequence variant was found to worsen the clinical outcome.",-44.0,0.6,diseaseorphenotypicfeature
"Pediatric patients with a confirmed **22q11.2 deletion syndrome** exhibit **neurological deficits** and **abnormal glucose homeostasis**, and the presence of a **SequenceVariant** in the **TP53** gene is associated with an increased risk of **cardiovascular death**.",-38.0,0.6,diseaseorphenotypicfeature
"Pawnee, a Homo sapiens patient with a novel BRCA1 c.68_69delAG sequence variant, presented with neurological deficits and abnormal glucose homeostasis, and a subsequent MRI revealed bilateral papilledema, while a peripheral nerve biopsy confirmed EAE‑associated peripheral nerve toxicity.",-58.25,0.6,diseaseorphenotypicfeature
"Pten loss in the EAE model exacerbates peripheral nerve toxicity, leading to abnormal glucose homeostasis and neurological deficits that resemble the clinical features of MCL.",-34.0,0.6,diseaseorphenotypicfeature
"Pseudomonas aeruginosa infection of the peripheral nerve in a patient with MCL and abnormal glucose homeostasis triggers neurological deficits that resemble EAE and are associated with peripheral nerve toxicity, leading to bilateral papilledema and enlargement of kidneys, and ultimately cardiovascular death.",-49.5,0.6,diseaseorphenotypicfeature
"C57BL/6 mice carrying the NPHP1 c.1203_1204delCA variant develop abnormal glucose homeostasis and enlarged kidneys, while AAV‑mediated delivery of a wild‑type NPHP1 transgene rescues the renal phenotype and prevents cardiovascular death in this model of NPHP with liver fibrosis.",-54.25,0.6,diseaseorphenotypicfeature
"Cytokine‑mediated inflammation in experimental autoimmune encephalomyelitis (EAE) exacerbates peripheral nerve toxicity, leading to neurological deficits that mimic the neuro‑autonomic dysfunction observed in patients with the MCL‑associated abnormal glucose homeostasis phenotype.",-43.25,0.6,diseaseorphenotypicfeature
C11orf95‑EWSR1 fusion in MCL patients carrying a germline NPHP1 variant linked to abnormal glucose homeostasis and peripheral nerve toxicity was associated with accelerated disease progression and a higher incidence of neurological deficits.,-59.5,0.6,diseaseorphenotypicfeature
"Cerebral amyloid angiopathy in patients with MCL often exacerbates peripheral nerve toxicity, leading to neurological deficits that correlate with abnormal glucose homeostasis and bilateral papilledema.",-25.5,0.6,diseaseorphenotypicfeature
"Loss of the PAX6 gene in the MCL cell line induced abnormal glucose homeostasis and peripheral nerve toxicity, leading to neurological deficits in the EAE mouse model of multiple sclerosis.",-37.5,0.6,diseaseorphenotypicfeature
"Loss‑of‑function mutations in the **22q11.2** locus are frequently associated with **MCL** progression and **neurological deficits**, while the same genetic background predisposes patients to **peripheral nerve toxicity** and **abnormal glucose homeostasis**.",-40.0,0.6,diseaseorphenotypicfeature
"Loss to follow‑up in patients with MCL receiving rituximab plus cyclophosphamide was associated with an increased risk of peripheral nerve toxicity and abnormal glucose homeostasis, potentially mediated by a CYP2D6 polymorphism.",-41.0,0.6,diseaseorphenotypicfeature
"Loss-of-function mutations in the KCNH1 gene cause a distinct form of MCL that presents with abnormal glucose homeostasis, peripheral nerve toxicity, and neurological deficits, while the associated EAE-like phenotype is exacerbated by a pathogenic variant in the same locus.",-64.5,0.6,diseaseorphenotypicfeature
CRISPR‑mediated disruption of the TP53 gene in HeLa cells exacerbates EAE‑induced neurological deficits while inducing abnormal glucose homeostasis and peripheral nerve toxicity.,-25.375,0.6,diseaseorphenotypicfeature
"CR‑to‑CRP elevation in patients with MCL undergoing rituximab therapy is associated with peripheral nerve toxicity and abnormal glucose homeostasis, thereby exacerbating neurological deficits and increasing the risk of cardiovascular death.",-36.25,0.6,diseaseorphenotypicfeature
"CRABP2 overexpression in the MCL cell line RPMI-8226 enhances peripheral nerve toxicity and induces abnormal glucose homeostasis in a murine model of EAE, leading to neurological deficits that correlate with increased cardiovascular death.",-44.25,0.6,diseaseorphenotypicfeature
"CRANIOSPINAL fluid accumulation in patients with MCL and EAE was associated with peripheral nerve toxicity and abnormal glucose homeostasis, leading to neurological deficits and bilateral papilledema.",-36.0,0.6,diseaseorphenotypicfeature
"Neuroimaging of patients with multiple‑cervical‑leukemia (MCL) revealed that the extent of peripheral nerve toxicity correlated with abnormal glucose homeostasis, and in a subset of those with the EAE phenotype, the presence of a de novo sequence variant in the TP53 gene was associated with bilateral papilledema and an increased risk of cardiovascular death.",-62.25,0.6,diseaseorphenotypicfeature
"Neural inflammation in experimental autoimmune encephalomyelitis (EAE) exacerbates peripheral nerve toxicity, leading to abnormal glucose homeostasis and neurological deficits that resemble the metabolic disturbances observed in patients with the MCL phenotype.",-38.0,0.6,diseaseorphenotypicfeature
"Neuronal inflammation in experimental autoimmune encephalomyelitis (EAE) exacerbates peripheral nerve toxicity, leading to abnormal glucose homeostasis and neurological deficits that mimic the renal and cardiovascular complications observed in patients with the MCL phenotype.",-42.25,0.6,diseaseorphenotypicfeature
"Neurosurgical resection of MCL tumors in patients with EAE exacerbated abnormal glucose homeostasis and peripheral nerve toxicity, leading to neurological deficits and bilateral papilledema.",-32.0,0.6,diseaseorphenotypicfeature
"In a cohort of patients with primary central nervous system lymphomas, the overexpression of the oncogenic MYC gene product in A172 glioblastoma cell lines treated with doxorubicin was associated with increased resistance to apoptosis, suggesting a potential therapeutic target for overcoming chemoresistance.",-33.0,0.6,diseaseorphenotypicfeature
"In primary central nervous system lymphomas, the hypoxic microenvironment induces upregulation of HIF‑1α, which in turn enhances VEGFA expression and promotes angiogenesis, thereby facilitating tumor cell survival and contributing to the characteristic oedema observed in affected patients.",-26.5,0.6,diseaseorphenotypicfeature
"In hypoxia‑induced ischemia, the TP53 gene product up‑regulates VEGFA expression in HeLa cells, thereby promoting angiogenesis that can attenuate oedema‑related damage in primary central nervous system lymphoma patients.",-26.625,0.6,diseaseorphenotypicfeature
"In patients with primary central nervous system lymphomas, the TP53 gene mutation c.215C>T (p.R72P) is frequently associated with a poorer response to rituximab therapy, suggesting that this SequenceVariant may modulate disease progression.",-30.75,0.6,diseaseorphenotypicfeature
"The upregulation of HIF‑1α in hypoxia‑induced ischemic injury of primary central nervous system lymphomas leads to increased VEGF expression, which promotes angiogenesis and contributes to the oedema‑related edema observed in affected patients.",-27.375,0.6,diseaseorphenotypicfeature
The BRCA1 c.68_69delAG variant in a patient with primary central nervous system lymphoma was shown to impair DNA repair and increase the risk of treatment‑related hypoxia‑induced oedema.,-23.0,0.6,diseaseorphenotypicfeature
"The presence of a BRCA1 c.68_69delAG variant in a patient with primary central nervous system lymphoma is associated with an increased risk of hypoxia‑induced ischemic lesions, thereby aggravating the disease’s neurological phenotype.",-34.0,0.6,diseaseorphenotypicfeature
"The hypoxia‑induced upregulation of HIF‑1α in HeLa cells exposed to intermittent ischemia promotes VEGFA secretion, which in turn drives angiogenesis and contributes to the progression of primary central nervous system lymphomas.",-23.5,0.6,diseaseorphenotypicfeature
"Tremendous hypoxia/ischemia in the tumor microenvironment of primary central nervous system lymphomas activates HIF‑1α, which in turn up‑regulates VEGFA and promotes angiogenesis, thereby exacerbating tumour‑related oedema and contributing to the severity of neurological deficits observed in affected patients.",-43.75,0.6,diseaseorphenotypicfeature
"Treated with doxorubicin, the HeLa cell line exhibited increased TP53 expression, correlating with the development of fever and edema in the experimental Homo sapiens model of primary central nervous system lymphoma.",-30.625,0.6,diseaseorphenotypicfeature
"Tissue hypoxia in primary central nervous system lymphomas promotes VEGFA up‑regulation, which in turn stimulates endothelial proliferation and contributes to the oedema‑related clinical deterioration observed in affected patients.",-31.5,0.6,diseaseorphenotypicfeature
"T-cell lymphoma cells from a patient with primary central nervous system lymphoma exhibited upregulated CXCL12 expression, which in turn activated the CXCR4 receptor on the same cells and promoted proliferation, while a concurrent BRCA1 c.68_69delAG variant reduced DNA repair capacity and heightened sensitivity to the chemotherapeutic drug doxorubicin.",-56.25,0.6,diseaseorphenotypicfeature
"Heterozygous BRCA1 c.68_69delAG mutations in a HeLa cell line treated with doxorubicin exacerbated DNA repair deficiencies and increased apoptosis, thereby accelerating the onset of breast cancer in the Homo sapiens host.",-41.5,0.6,diseaseorphenotypicfeature
"Hepatocellular carcinoma cell lines such as HepG2, when treated with the chemotherapeutic agent doxorubicin, exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which is further amplified by the BRCA1 c.68_69delAG sequence variant, thereby enhancing apoptosis in malignant hepatocytes.",-38.0,0.6,diseaseorphenotypicfeature
"HIF‑1α activation in hypoxia‑exposed A549 cells promotes VEGFA secretion, which in turn drives angiogenesis and contributes to the aggressive phenotype of ESCC tumors.",-25.75,0.6,diseaseorphenotypicfeature
"HLA‑DRB1*04:01‐bearing A549 cells exposed to doxorubicin exhibit enhanced apoptotic signaling that correlates with increased expression of the tumor suppressor gene TP53, thereby suggesting a mechanistic link between drug‐induced DNA damage and the cellular response in this lung cancer model.",-53.25,0.6,diseaseorphenotypicfeature
Knock‑in of the BRCA1 c.68_69delAG variant in HeLa cells induces a hypoxia‑like transcriptional program that enhances TP53‑mediated apoptosis and increases susceptibility to doxorubicin‑induced cardiotoxicity in Homo sapiens cardiac tissue.,-35.5,0.6,diseaseorphenotypicfeature
"Knocking out the TP53 gene in HeLa cells exacerbates hypoxia‑induced oxidative stress, thereby accelerating the development of primary central nervous system lymphomas in Homo sapiens.",-23.5,0.6,diseaseorphenotypicfeature
"Knitting the clinical picture, the hypoxia‑induced up‑regulation of HIF‑1α in A549 cells carrying the BRCA1 c.68_69delAG variant was found to accelerate proliferation and confer resistance to doxorubicin, thereby exacerbating the risk of secondary mammary tumors in patients with a history of ESCC.",-50.75,0.6,diseaseorphenotypicfeature
"Knocked‑out TP53 in A549 cells exacerbated hypoxia‑induced apoptosis, suggesting that loss of this tumor suppressor gene may contribute to the progression of primary central nervous system lymphomas.",-31.75,0.6,diseaseorphenotypicfeature
"Mutations in the L1CAM gene, such as the novel c.3458C>T SequenceVariant, have been shown to increase the risk of primary central nervous system lymphomas in patients with a history of ventricular tachycardia and hypoxia/ischemia.",-41.25,0.6,diseaseorphenotypicfeature
"Mutagenic exposure to the chemical entity cyclophosphamide in the human cell line HeLa induces a BRCA1 c.68_69delAG sequence variant that compromises TP53 expression, thereby exacerbating the risk of primary central nervous system lymphoma in Homo sapiens.",-39.5,0.6,diseaseorphenotypicfeature
"Mutational activation of the TP53 gene in HeLa cells exposed to doxorubicin exacerbates hypoxia‑induced apoptosis, thereby increasing the risk of ventricular tachycardia in patients with primary central nervous system lymphomas.",-20.25,0.6,diseaseorphenotypicfeature
"Mutant TP53 c.215C>T in HeLa cells exposed to hypoxia/ischemia upregulates BCL2, thereby protecting the cells from apoptosis and contributing to the development of primary central nervous system lymphomas.",-28.125,0.6,diseaseorphenotypicfeature
"A hypoxic microenvironment in primary central nervous system lymphomas induces HIF‑1α‑mediated VEGFA up‑regulation, which in turn promotes endothelial proliferation and increases vascular permeability, thereby exacerbating peritumoral oedema and contributing to neurological deficits.",-29.625,0.6,diseaseorphenotypicfeature
"A SNP in the HLA‑DQA1 gene (c.107_108delAG) was found to increase susceptibility to primary central nervous system lymphomas in patients with a history of hypoxia‑induced ischemic stroke, as demonstrated by a case‑control study involving over five hundred Homo sapiens subjects.",-57.5,0.6,diseaseorphenotypicfeature
A reduced expression of the HIF1A gene product in HeLa cells exposed to hypoxia/ischemia promotes the development of oedema-related edema and increases the risk of ventricular tachycardia in patients with primary central nervous system lymphomas.,-29.5,0.6,diseaseorphenotypicfeature
"A recent cohort study revealed that the presence of a BRCA1 c.68_69delAG sequence variant in HeLa cells markedly increases the susceptibility of these cells to doxorubicin-induced apoptosis, thereby suggesting a potential therapeutic strategy for treating primary central nervous system lymphomas in patients with this mutation.",-35.5,0.6,diseaseorphenotypicfeature
"During hypoxia‑induced ischemia, the up‑regulation of HIF‑1α in A549 cells was found to increase VEGFA expression, thereby promoting angiogenesis that may contribute to the progression of primary central nervous system lymphomas.",-28.125,0.6,diseaseorphenotypicfeature
"During recurrent hypoxia/ischemia, the TP53 mutation c.215C>A in A549 cells was found to exacerbate ventricular tachycardia‑associated oedema, suggesting a potential target for treating unipolar depression in patients with primary central nervous system lymphomas.",-43.25,0.6,diseaseorphenotypicfeature
"During experimental hypoxia/ischemia in A549 cells, the overexpression of TP53 was found to suppress the proliferation of primary central nervous system lymphoma cells and to enhance the apoptotic response to doxorubicin, suggesting a potential therapeutic strategy for treating this aggressive malignancy.",-43.25,0.6,diseaseorphenotypicfeature
"During the study, the A549 cell line treated with doxorubicin revealed a BRCA1 c.68_69delAG variant that correlated with increased apoptosis in primary central nervous system lymphoma cells, suggesting a potential therapeutic target for hypoxia‑induced tumor resistance.",-30.75,0.6,diseaseorphenotypicfeature
Genetic analysis of the TP53 gene in HeLa cells revealed a BRCA1 c.68_69delAG variant that may contribute to the hypoxia‑induced oedema observed in primary central nervous system lymphomas of Homo sapiens patients.,-26.625,0.6,diseaseorphenotypicfeature
"Genetically engineered A549 cells expressing the TP53 c.215C>G variant were treated with doxorubicin, and the resulting apoptosis was markedly enhanced in the presence of hypoxia, suggesting that TP53 mutation status modulates chemotherapeutic response in lung carcinoma under ischemic conditions.",-38.0,0.6,diseaseorphenotypicfeature
Genomic profiling of primary central nervous system lymphomas revealed that TP53 mutations combined with the BRCA1 c.68_69delAG variant correlate with increased resistance to doxorubicin in HeLa cells derived from patients exhibiting oedema-related neurological deficits.,-34.0,0.6,diseaseorphenotypicfeature
"Genotype‑specific expression of the HIF‑1α gene in the HeLa cell line exposed to hypoxia/ischemia revealed that the BRCA1 c.68_69delAG sequence variant upregulated VEGFA, thereby promoting angiogenesis and reducing oedema‑related complications in primary central nervous system lymphomas.",-43.75,0.6,diseaseorphenotypicfeature
"Gene‑editing of the TP53 c.215C>A variant in A549 cells reduced the hypoxia‑induced expression of HIF‑1α, thereby limiting the proliferation of primary central nervous system lymphoma‑derived tumor spheroids.",-29.125,0.6,diseaseorphenotypicfeature
"Gene‐edited HeLa cells carrying the BRCA1 c.68_69delAG variant were treated with doxorubicin, and the resulting DNA damage response was found to exacerbate hypoxia‐induced apoptosis in the tumor microenvironment.",-33.75,0.6,diseaseorphenotypicfeature
"GeneX mutations in the TP53 gene were found to accelerate the development of primary central nervous system lymphomas in HeLa cells treated with doxorubicin, while the same mutations also predisposed mice to ventricular tachycardia and oedema-related complications.",-41.25,0.6,diseaseorphenotypicfeature
Gene editing of the TP53 sequence variant c.215C>T in HeLa cells revealed that the resulting mutant protein exacerbates hypoxia‑induced apoptosis and contributes to the development of primary central nervous system lymphomas.,-31.125,0.6,diseaseorphenotypicfeature
"Abnormally high expression of the oncogenic MYC gene in A549 cells carrying the BRCA1 c.68_69delAG variant drives proliferation of primary central nervous system lymphoma lesions, which are often treated with doxorubicin but can develop resistance mediated by upregulated P-glycoprotein.",-45.0,0.6,diseaseorphenotypicfeature
"Abnormal TP53 expression in HeLa cells exposed to doxorubicin enhances apoptotic signaling, potentially exacerbating chemotherapy‑induced cardiotoxicity in patients with ventricular tachycardia.",-29.125,0.6,diseaseorphenotypicfeature
"Abundant hypoxia‐induced HIF‑1α stabilization in the A549 cell line increases VEGFA secretion, thereby promoting angiogenesis and accelerating the growth of primary central nervous system lymphomas in a murine model of ischemic brain injury.",-40.25,0.6,diseaseorphenotypicfeature
"Abscisic acid treatment of HeLa cells carrying the BRCA1 c.68_69delAG variant reduces proliferation and sensitizes the cells to doxorubicin, suggesting a potential therapeutic strategy for patients with BRCA1-associated breast cancer.",-36.75,0.6,diseaseorphenotypicfeature
"Patients with primary central nervous system lymphomas frequently exhibit hypoxia‑induced up‑regulation of HIF‑1α, which in turn drives VEGFA expression and promotes tumor angiogenesis, thereby contributing to the aggressive oedema‑related clinical course.",-29.875,0.6,diseaseorphenotypicfeature
"Patients treated with doxorubicin for ESCC exhibited increased TP53 expression in A549 cells, correlating with enhanced apoptosis and reduced tumor growth in a murine model of hypoxia‑induced mammary tumors.",-29.25,0.6,diseaseorphenotypicfeature
"Patients carrying the BRCA1 c.68_69delAG sequence variant exhibited increased mammary tumor risk when exposed to doxorubicin, highlighting a gene‑drug interaction that may inform personalized chemoprevention strategies for breast cancer.",-34.5,0.6,diseaseorphenotypicfeature
"Patients harboring the BRCA1 c.68_69delAG variant exhibit increased susceptibility to hypoxia‑induced apoptosis in A549 cells, linking the sequence variant to altered cellular response in primary central nervous system lymphomas.",-28.125,0.6,diseaseorphenotypicfeature
"Elevated IL‑6 levels in patients with primary central nervous system lymphomas were found to correlate with increased VEGFA expression, suggesting that hypoxia‑induced signaling may drive angiogenesis and tumour progression.",-29.0,0.6,diseaseorphenotypicfeature
"Elevating VEGFA expression in A549 cells harboring the BRCA1 c.68_69delAG variant exacerbates hypoxia‑induced angiogenic signaling, thereby promoting invasive growth of primary central nervous system lymphomas.",-32.75,0.6,diseaseorphenotypicfeature
"Elevations of the inflammatory cytokine IL‑6 in patients with primary central nervous system lymphomas correlate with increased expression of the hypoxia‑inducible factor HIF‑1α, which in turn promotes tumor cell survival under hypoxia/ischemia conditions.",-35.25,0.6,diseaseorphenotypicfeature
"Elevative hypoxia in the tumor microenvironment of primary central nervous system lymphomas induces HIF‑1α‑mediated VEGF secretion, which promotes angiogenesis and confers resistance to radiotherapy in patients with the BRCA1 c.68_69delAG variant.",-43.25,0.6,diseaseorphenotypicfeature
"Administration of the selective TRPC6 inhibitor GSK2332255 to the A549 cell line, which expresses the EGFR exon‑19 deletion, markedly reduced the hypoxia‑induced VEGFA secretion and consequently attenuated the angiogenic phenotype observed in patients with esophageal squamous‑cell carcinoma (ESCC).",-59.0,0.6,diseaseorphenotypicfeature
"Administration to HeLa cells of the small‑molecule inhibitor doxorubicin, which binds the TP53 protein, induced a hypoxia‑induced up‑regulation of the VEGFA gene, thereby promoting angiogenic pathways that may contribute to the progression of primary central nervous system lymphomas.",-48.5,0.6,diseaseorphenotypicfeature
"Administration and sustained exposure to doxorubicin in A549 cells carrying the BRCA1 c.68_69delAG variant induces a hypoxia‑mediated increase in VEGFA expression, thereby promoting angiogenesis and contributing to the progression of primary central nervous system lymphomas.",-48.75,0.6,diseaseorphenotypicfeature
"Administration-elicited hypoxia in the HeLa cell line carrying the TP53 c.68_69delAG variant was shown to upregulate the mitochondrial uncoupling protein UCP1, thereby reducing ROS levels and attenuating the progression of primary central nervous system lymphoma in an A549 xenograft model.",-64.0,0.6,diseaseorphenotypicfeature
"In HeLa cells, the loss-of-function mutation BRCA1 c.68_69delAG diminishes the repair of double-strand breaks, thereby increasing the risk of hepatocellular carcinoma in patients with hereditary hypophosphatemic rickets with hypercalciuria.",-24.0,0.6,diseaseorphenotypicfeature
"In HLRRC-associated MCUL, the missense mutation in the LRP5 gene (c.1523G>A) causes a loss of Wnt signaling, leading to osteoarthritis-like joint degeneration and increased risk of ischemic heart disease in affected patients.",-44.75,0.6,diseaseorphenotypicfeature
"In patients with hereditary hypophosphatemic rickets with hypercalciuria, the loss‑of‑function mutation c.1183G>A in the SLC34A3 gene leads to impaired renal phosphate reabsorption, which in turn predisposes them to osteoarthritis and ectopic calcification of the periarticular tissues.",-35.75,0.6,diseaseorphenotypicfeature
"In A549 cells, the TP53 mutation p.R273H induces epidermal hyperplasia and enhances resistance to doxorubicin, thereby increasing the risk of hepatocellular carcinoma in patients with IUGR.",-29.625,0.6,diseaseorphenotypicfeature
The MCUL/HLRRC-associated mutation in the SLC35A2 gene causes a hereditary neuropathological disorder that manifests as glaucoma and episodic status epilepticus in affected Homo sapiens patients.,-31.25,0.6,diseaseorphenotypicfeature
The GWAS of MCUL/HLRRC revealed that the BRCA1 c.68_69delAG variant significantly increases susceptibility to hepatocellular carcinoma in patients with a history of ischemic heart disease.,-20.875,0.6,diseaseorphenotypicfeature
"The chronic ocular hypertension observed in patients with MCUL/HLRRC is exacerbated by the loss-of-function mutation in the ATP1A2 gene, leading to accelerated retinal ganglion cell degeneration and eventual irreversible glaucomatous vision loss.",-34.25,0.6,diseaseorphenotypicfeature
"The CRISPR‑edited A549 cells harboring the BRCA1 c.68_69delAG variant exhibit heightened sensitivity to the DNA‑damaging agent doxorubicin, thereby providing a mechanistic link between the sequence variant and chemotherapeutic response in this lung cancer cell line.",-26.625,0.6,diseaseorphenotypicfeature
"Mutation of the SLC34A1 gene in patients with hereditary hypophosphatemic rickets with hypercalciuria leads to increased urinary phosphate excretion, which in turn exacerbates bone mineralization defects and raises the risk of osteoarthritis in adulthood.",-23.625,0.6,diseaseorphenotypicfeature
"Mutation in the SLC34A1 gene of a patient with hereditary hypophosphatemic rickets with hypercalciuria leads to increased renal phosphate excretion, which exacerbates osteomalacia and predisposes the individual to secondary hyperparathyroidism.",-32.5,0.6,diseaseorphenotypicfeature
"Mutation c.68_69delAG in the TP53 gene, detected in a HeLa cell line derived from a hepatocellular carcinoma patient, is predicted to disrupt the DNA‑binding domain and may contribute to the observed genomic instability characteristic of this disease.",-34.0,0.6,diseaseorphenotypicfeature
"Mutation‑induced loss of function in the PHEX gene is associated with Hereditary hypophosphatemic rickets with hypercalciuria, a disease that frequently presents with osteomalacia and bone pain in affected patients.",-33.75,0.6,diseaseorphenotypicfeature
Mutational analysis of the FGFR3 gene in a patient with Hereditary hypophosphatemic rickets with hypercalciuria revealed a novel c.1138G>A SequenceVariant that was confirmed to alter protein function and was detected in the affected Homo sapiens blood sample.,-44.25,0.6,diseaseorphenotypicfeature
"Mutations in the SLC34A1 gene, such as the c.1583G>A variant, have been shown to cause hereditary hypophosphatemic rickets with hypercalciuria in patients with renal tubular dysfunction.",-29.0,0.6,diseaseorphenotypicfeature
"Mutated TP53 c.215C>G in a HeLa cell line treated with doxorubicin induces apoptosis and enhances the expression of the pro‑apoptotic gene BAX, thereby increasing the susceptibility of the cells to chemotherapy‑induced cytotoxicity.",-36.0,0.6,diseaseorphenotypicfeature
Mutagenic exposure to benzo[a]pyrene in A549 cells carrying the CYP1A1 c.−39C>T variant exacerbates the risk of hepatocellular carcinoma by upregulating CYP1B1 expression and inducing oxidative DNA damage.,-40.0,0.6,diseaseorphenotypicfeature
"Knock‑in of the BRCA1 c.68_69delAG variant in HeLa cells increases the expression of TP53, which in turn upregulates the pro‑apoptotic gene BAX and sensitizes the cells to doxorubicin‑induced DNA damage, thereby providing a mechanistic link between the genetic alteration and the therapeutic response in this human cell line.",-43.0,0.6,diseaseorphenotypicfeature
"Knocking out the PAX6 gene in the retinal pigment epithelium of C57BL/6J mice exacerbated the glaucoma phenotype, leading to accelerated optic nerve degeneration and increased intraocular pressure while concurrently upregulating VEGFA expression in the retinal microenvironment.",-43.25,0.6,diseaseorphenotypicfeature
"Knox et al. demonstrated that the BRCA1 c.68_69delAG SequenceVariant in the TP53 GeneOrGeneProduct of a Homo sapiens OrganismTaxon patient with hereditary hypophosphatemic rickets with hypercalciuria diseaseorphenotypicfeature caused a loss of p53 protein expression, thereby increasing the risk of osteoarthritis diseaseorphenotypicfeature and hepatocellular carcinoma diseaseorphenotypicfeature in that individual.",-54.75,0.6,diseaseorphenotypicfeature
"Knitting together the findings, researchers reported that the MCUL/HLRRC-associated sequence variant c.1234C>T in the **GLI3** gene led to a truncated protein that, in HeLa cells, upregulated **VEGF** expression, thereby promoting angiogenesis and contributing to the ocular hypertension observed in patients with **glaucoma**.",-76.0,0.6,diseaseorphenotypicfeature
"Hereditary hypophosphatemic rickets with hypercalciuria in a newborn was diagnosed by detecting a novel REN SequenceVariant in the blood of a Homo sapiens patient, and treatment with phosphate supplementation and calcium‑restricted diet was initiated to prevent progression to osteoarthritis and nephrolithiasis.",-44.5,0.6,diseaseorphenotypicfeature
"Herbal extracts containing berberine inhibit the growth of HepG2 hepatocellular carcinoma cells by down‑regulating the PI3K/AKT pathway and inducing apoptosis, an effect that is potentiated when combined with the chemotherapeutic agent doxorubicin.",-32.25,0.6,diseaseorphenotypicfeature
Heritable mutations in the FAM111A gene cause a form of osteoarthritis that is associated with early-onset hepatocellular carcinoma in patients of the MCUL/HLRRC cohort.,-36.25,0.6,diseaseorphenotypicfeature
"Heritably mutated FGF23 variants in patients with hereditary hypophosphatemic rickets with hypercalciuria were shown to disrupt renal phosphate reabsorption, leading to osteomalacia and secondary hyperparathyroidism.",-35.0,0.6,diseaseorphenotypicfeature
"Cell line A549, when treated with the chemotherapeutic doxorubicin, shows increased expression of the tumor suppressor gene TP53, correlating with reduced proliferation of hepatocellular carcinoma cells in vitro.",-29.5,0.6,diseaseorphenotypicfeature
"Cell‑line A549 infected with a CRISPR‑edited TP53 c.68_69delAG variant shows increased apoptosis upon doxorubicin treatment, suggesting a potential therapeutic strategy for hepatocellular carcinoma.",-31.125,0.6,diseaseorphenotypicfeature
"Cell‐based assays revealed that the MCUL/HLRRC‑associated mutation in the DYNC1H1 gene induces a neurofilament aggregation phenotype that mimics the neuropathological features of glaucoma, suggesting a shared pathogenic mechanism involving impaired axonal transport in retinal ganglion cells.",-50.75,0.6,diseaseorphenotypicfeature
"Cell proliferation in the A549 cell line was markedly enhanced by the small molecule erlotinib, a selective EGFR inhibitor, and this effect was further amplified in cells harboring the EGFR L858R sequence variant, ultimately leading to increased tumorigenicity and resistance to chemotherapy in patients with hepatocellular carcinoma.",-50.25,0.6,diseaseorphenotypicfeature
"Epstein–Barr virus infection of the B cells in the HeLa cell line induces the overexpression of the lytic protein BZLF1, which in turn activates the transcription of the oncogene MYC and promotes the development of hepatocellular carcinoma in the HepG2 hepatoma model.",-44.5,0.6,diseaseorphenotypicfeature
"Epileptogenic foci in patients with status epilepticus were found to exhibit increased expression of the ATP1A3 gene, and pharmacologic inhibition of this transporter with quinidine in the A549 cell line reduced neuronal hyperexcitability and improved survival in a murine model of ischemic heart disease.",-45.0,0.6,diseaseorphenotypicfeature
"Epigenetic silencing of the TP53 gene in A549 cells treated with doxorubicin exacerbates the osteoarthritis‑associated cartilage degradation observed in HepG2‑derived hepatocellular carcinoma models, suggesting a shared pathway for disease progression in Homo sapiens.",-38.75,0.6,diseaseorphenotypicfeature
"Epiretinal membrane formation in patients with idiopathic macular edema can be exacerbated by the overexpression of COL1A1 in retinal pigment epithelial cells, thereby promoting fibroblast activation and subsequent scar tissue deposition.",-41.0,0.6,diseaseorphenotypicfeature
"Intravenous administration of doxorubicin in A549 cells carrying the BRCA1 c.68_69delAG variant markedly induced TP53‑mediated apoptosis, suggesting a potential therapeutic strategy for patients with hepatocellular carcinoma.",-28.625,0.6,diseaseorphenotypicfeature
"Intracellular accumulation of the mutant TP53 (c.215C>G) in HeLa cells exposed to doxorubicin induces apoptosis that is markedly amplified by the presence of the EGF receptor variant EGFRvIII, thereby suggesting a potential therapeutic strategy for hepatocellular carcinoma.",-47.75,0.6,diseaseorphenotypicfeature
"Intrathecal administration of the novel kinase inhibitor AZD-9876 in A549 cells carrying the EGFR L858R mutation suppressed phosphorylation of downstream STAT3 and STAT5, thereby reducing proliferation of the tumor and alleviating the osteoarthritis‑associated joint pain observed in the patient with MCUL/HLRRC.",-66.5,0.6,diseaseorphenotypicfeature
"Intravitreal injection of the small molecule inhibitor GSK-3β in the human retinal pigment epithelium cell line ARPE-19 mitigated the glaucomatous phenotype by reducing oxidative stress‑induced apoptosis and restoring mitochondrial membrane potential, thereby attenuating the disease‑associated increase in intraocular pressure.",-52.5,0.6,diseaseorphenotypicfeature
"Hepatocellular carcinoma progression in patients harboring the BRCA1 c.68_69delAG variant is exacerbated by chronic ethanol exposure, which induces oxidative DNA damage and upregulates TP53-mediated apoptosis in HepG2 cells.",-26.25,0.6,diseaseorphenotypicfeature
"HLA‑B27‑positive ankylosing spondylitis patients treated with infliximab exhibited a significant reduction in IL‑23 production by peripheral blood mononuclear cells, correlating with improved MRI‑assessed sacroiliac joint inflammation.",-34.5,0.6,diseaseorphenotypicfeature
"Homo sapiens hepatocellular carcinoma cells treated with doxorubicin exhibited a significant upregulation of the TP53 gene product, which correlated with increased apoptosis and reduced tumor cell viability in vitro.",-31.0,0.6,diseaseorphenotypicfeature
"Heterozygous pathogenic variants in the SLC34A1 gene are associated with hereditary hypophosphatemic rickets with hypercalciuria, which clinically manifests as osteomalacia and bone pain in affected patients.",-27.125,0.6,diseaseorphenotypicfeature
"A single‑cell RNA‑seq analysis of HCC‑derived HepG2 cells treated with doxorubicin revealed that the TP53‑dependent up‑regulation of the DNA‑damage response gene CDKN1A was accompanied by a marked increase in the p53‑binding motif within the promoter of the BCL2L1 gene, suggesting that doxorubicin‑induced apoptosis in HepG2 is mediated through TP53‑driven transcriptional activation of pro‑apoptotic genes",-62.25,0.6,diseaseorphenotypicfeature
"A HLA‑B*27‑associated mutation in the TNF‑α promoter region was found to exacerbate the inflammatory phenotype of ankylosing spondylitis in patients carrying the HLA‑B*27 allele, thereby increasing the risk of early-onset osteoarthritis in the lumbar spine.",-44.75,0.6,diseaseorphenotypicfeature
"A mutation in the GATA6 gene causes hereditary hypophosphatemic rickets with hypercalciuria in patients whose serum phosphate levels are markedly reduced, leading to increased bone fragility and osteoarthritis symptoms.",-38.0,0.6,diseaseorphenotypicfeature
A recent cohort study demonstrated that the MCUL/HLRRC mutation in the TP53 gene correlates with increased risk of hepatocellular carcinoma in patients with chronic hepatitis B infection.,-22.375,0.6,diseaseorphenotypicfeature
"Gene‑editing of the BRCA1 c.68_69delAG variant in the A549 cell line reduces the expression of the DNA‑repair protein RAD51, thereby increasing the sensitivity of these cells to the chemotherapeutic agent doxorubicin and ultimately suppressing the growth of hepatocellular carcinoma xenografts in immunodeficient mice.",-39.0,0.6,diseaseorphenotypicfeature
"Gene TP53 mutations in HeLa cells treated with doxorubicin exacerbate DNA damage and accelerate apoptosis, thereby amplifying the cytotoxic effect of the chemotherapeutic agent on cancerous tissues.",-33.0,0.6,diseaseorphenotypicfeature
"Gene mutation BRCA1 c.68_69delAG in the A549 cell line from Homo sapiens patients with osteoarthritis increases the expression of TP53, thereby enhancing apoptosis and potentially mitigating the progression of hepatocellular carcinoma.",-38.25,0.6,diseaseorphenotypicfeature
"Gene NFKB1, encoded by the TP53 locus, is up‑regulated in HeLa cells treated with the chemotherapeutic doxorubicin, leading to increased apoptosis that protects against hepatocellular carcinoma progression in a mouse model of Homo sapiens liver tissue.",-46.75,0.6,diseaseorphenotypicfeature
"Carcinogenic exposure to aflatoxin B1 in **Homo sapiens** hepatocytes induces the **BRCA1 c.68_69delAG** variant, which in turn upregulates the **TP53** gene and contributes to the development of **hepatocellular carcinoma**.",-30.625,0.6,diseaseorphenotypicfeature
"Carisoprodol administration in HeLa cells overexpressing TP53 exacerbated mitochondrial dysfunction, leading to increased reactive oxygen species that triggered apoptosis and worsened the phenotype of ischemic heart disease in a murine model of E. coli infection.",-47.5,0.6,diseaseorphenotypicfeature
"Carboplatin‑treated A549 cells exhibit upregulated TP53 expression, which correlates with increased apoptosis and a reduction in the proliferation of hepatocellular carcinoma cells in a xenograft model of Homo sapiens.",-40.25,0.6,diseaseorphenotypicfeature
"Carboxylesterase‑1 overexpression in the HepG2 cell line reduces the cytotoxicity of doxorubicin and concomitantly enhances the phosphorylation of TP53, thereby protecting against doxorubicin‑induced apoptosis in hepatocellular carcinoma.",-49.5,0.6,diseaseorphenotypicfeature
"Alterations in the TP53 gene, including the BRCA1 c.68_69delAG sequence variant, have been shown to contribute to the development of hepatocellular carcinoma in patients with hereditary hypophosphatemic rickets with hypercalciuria, as evidenced by increased tumor growth in A549 cell lines treated with doxorubicin.",-31.75,0.6,diseaseorphenotypicfeature
"Altered expression of the transcription factor PAX6 in A549 cells carrying the BRCA1 c.68_69delAG variant promotes epithelial‑mesenchymal transition and enhances invasiveness of hepatocellular carcinoma, potentially contributing to the development of metastatic disease in patients with IUGR‑associated hepatic dysfunction.",-43.0,0.6,diseaseorphenotypicfeature
"Alteration of the TP53 gene in A549 cells treated with doxorubicin exacerbates oxidative DNA damage, thereby promoting apoptosis in hepatocellular carcinoma while concurrently inducing a ferroptosis‑related phenotype in the surrounding stromal fibroblasts.",-45.5,0.6,diseaseorphenotypicfeature
"Alterative treatment with the small‑molecule inhibitor AZD6738 in A549 cells harboring the TP53 c.215C>T SequenceVariant reduces the expression of the DNA‑damage marker γH2AX and induces apoptosis, thereby suppressing the proliferation of hepatocellular carcinoma cells in a xenograft model of Homo sapiens.",-66.5,0.6,diseaseorphenotypicfeature
"The impairment in auditory discrimination observed in patients with CGL2 and diffuse mesangial sclerosis is exacerbated by HIV infection, potentially leading to progressive blindness and death.",-16.875,0.6,diseaseorphenotypicfeature
"The rapid progression of diffuse mesangial sclerosis in HIV‑infected patients with CGL2 often leads to blindness and peripheral arterial disease, a complication that has been linked to a pathogenic TP53 sequence variant (c.68_69delAG) in the renal epithelial cells of the affected individuals.",-47.75,0.6,diseaseorphenotypicfeature
"The A549 cell line infected with HIV-1 shows a pronounced impairment in auditory discrimination that correlates with diffuse mesangial sclerosis, suggesting that viral replication may exacerbate CGL2-associated neurocognitive decline.",-26.875,0.6,diseaseorphenotypicfeature
The differential diagnosis of diffuse mesangial sclerosis in a patient with HIV infection and peripheral arterial disease revealed an impairment in auditory discrimination that could precede the onset of blindness.,-24.625,0.6,diseaseorphenotypicfeature
"In HeLa cells, the BRCA1 c.68_69delAG sequence variant induces impaired auditory discrimination through dysregulated TP53 signaling, thereby increasing susceptibility to diffuse mesangial sclerosis and peripheral arterial disease in HIV-infected patients.",-27.5,0.6,diseaseorphenotypicfeature
"In a longitudinal cohort of HIV‑infected individuals, the presence of a BRCA1 c.68_69delAG sequence variant was associated with an increased risk of diffuse mesangial sclerosis and impaired auditory discrimination, underscoring the need for early renal and neuro‑auditory screening.",-27.0,0.6,diseaseorphenotypicfeature
"In the HeLa cell line, the CRISPR‑mediated disruption of the TP53 gene exacerbated the impairment in auditory discrimination observed in patients with HIV infection, suggesting a link between p53 loss and neurocognitive decline.",-24.625,0.6,diseaseorphenotypicfeature
"In patients with HIV infection, the presence of a BRCA1 c.68_69delAG variant in peripheral blood mononuclear cells has been associated with an increased risk of diffuse mesangial sclerosis, potentially contributing to the impairment in auditory discrimination observed in a subset of these individuals.",-23.625,0.6,diseaseorphenotypicfeature
"Heterozygous BRCA1 c.68_69delAG in A549 cells exposed to doxorubicin induced impaired auditory discrimination and accelerated diffuse mesangial sclerosis, suggesting a link between the sequence variant, chemotherapy toxicity, and auditory phenotypic features in a disease context.",-41.75,0.6,diseaseorphenotypicfeature
"HIV infection in a patient with diffuse mesangial sclerosis leads to severe impairment in auditory discrimination, contributing to progressive cerebral ischemic damage and eventual blindness.",-16.75,0.6,diseaseorphenotypicfeature
"Huntington's disease, a neurodegenerative disorder marked by progressive motor impairment, is exacerbated by a BRCA1 c.68_69delAG variant that disrupts DNA repair pathways and has been linked to increased susceptibility to cerebral ischemic events in patients infected with HIV.",-39.75,0.6,diseaseorphenotypicfeature
"HCV infection in a patient with diffuse mesangial sclerosis exacerbated peripheral arterial disease, leading to blindness and impaired auditory discrimination.",-21.75,0.6,diseaseorphenotypicfeature
"Impairment in auditory discrimination observed in HIV infection patients correlates with diffuse mesangial sclerosis and a higher risk of cerebral ischemic events, potentially leading to blindness and death.",-19.875,0.6,diseaseorphenotypicfeature
"Impaired auditory discrimination in HIV infection can accelerate the progression of diffuse mesangial sclerosis, increasing the risk of peripheral arterial disease and ultimately contributing to cerebral ischemic blindness.",-18.25,0.6,diseaseorphenotypicfeature
"Impairs auditory discrimination in patients with diffuse mesangial sclerosis, a phenotype that may predispose them to peripheral arterial disease and, in severe cases, lead to blindness or death.",-35.25,0.6,diseaseorphenotypicfeature
"Immunological dysfunction in HIV infection has been linked to an increased risk of peripheral arterial disease, which in turn can accelerate diffuse mesangial sclerosis and ultimately lead to blindness.",-36.0,0.6,diseaseorphenotypicfeature
"Peripheral Arterial Disease in HIV infection is associated with impaired auditory discrimination and diffuse mesangial sclerosis, which may increase the risk of death.",-23.625,0.6,diseaseorphenotypicfeature
Peripheral arterial disease in a patient with HIV infection was associated with an impairment in auditory discrimination and a diffuse mesangial sclerosis phenotype that ultimately contributed to cerebral ischemic events and blindness.,-22.75,0.6,diseaseorphenotypicfeature
"Peripheral cellular dysfunction in HIV infection drives impairment in auditory discrimination and may accelerate diffuse mesangial sclerosis, contributing to progressive blindness.",-36.5,0.6,diseaseorphenotypicfeature
"Peripheral pulmonary arterial hypertension in a patient with HIV infection and diffuse mesangial sclerosis was found to cause severe impairment in auditory discrimination, ultimately leading to cerebral ischemic events and blindness.",-37.25,0.6,diseaseorphenotypicfeature
"Genetic analysis of a BRCA1 c.68_69delAG variant in a HeLa cell line revealed that the mutation caused impaired DNA repair, leading to increased apoptosis and contributing to diffuse mesangial sclerosis in HIV‑infected patients with peripheral arterial disease.",-32.0,0.6,diseaseorphenotypicfeature
"Genomic analysis of a patient with diffuse mesangial sclerosis revealed a BRCA1 c.68_69delAG variant, suggesting that this SequenceVariant may contribute to the disease phenotype observed in this OrganismTaxon.",-30.5,0.6,diseaseorphenotypicfeature
"Genital tract biopsies from a patient with CGL2 revealed that the TP53 c.68_69delAG variant, identified by whole‑exome sequencing in the Homo sapiens sample, was associated with diffuse mesangial sclerosis and impaired auditory discrimination, suggesting a pathogenic link between the sequence variant and the observed phenotypic features.",-52.0,0.6,diseaseorphenotypicfeature
"Genetically engineered A549 cells expressing the TP53 c.68_69delAG variant were found to exhibit impaired auditory discrimination in a murine model of HIV infection, suggesting a potential link between this sequence variant and neurocognitive deficits.",-30.5,0.6,diseaseorphenotypicfeature
"Cognitive impairment in auditory discrimination, a hallmark of HIV infection, is exacerbated by diffuse mesangial sclerosis in CGL2 patients, potentially accelerating peripheral arterial disease and increasing the risk of cerebral ischemic events.",-23.0,0.6,diseaseorphenotypicfeature
"Celiac disease–associated impairment in auditory discrimination has been observed in a cohort of patients with HIV infection, suggesting a possible link between chronic viral inflammation and neuro‑sensory dysfunction.",-28.0,0.6,diseaseorphenotypicfeature
"Cumulative exposure to chronic HIV infection in HeLa cell cultures expressing the CCR5 receptor has been shown to induce diffuse mesangial sclerosis and impair auditory discrimination, thereby increasing the risk of peripheral arterial disease and cerebral ischemic events that may culminate in blindness and death.",-35.75,0.6,diseaseorphenotypicfeature
"CGL2-associated diffuse mesangial sclerosis impairs auditory discrimination, contributing to peripheral arterial disease and increasing the risk of cerebral ischemic blindness in patients with HIV infection.",-19.75,0.6,diseaseorphenotypicfeature
"Mutations in the COL4A5 gene cause diffuse mesangial sclerosis, leading to impaired renal function and early onset blindness in patients with X‑linked Alport syndrome.",-22.0,0.6,diseaseorphenotypicfeature
Mutational analysis of the COL4A1 gene in a cohort of patients with diffuse mesangial sclerosis revealed a novel sequence variant c.1123C>T that correlates with severe impairment in auditory discrimination and increased risk of cerebral ischemic events.,-31.375,0.6,diseaseorphenotypicfeature
"Mutant TP53 c.215C>G in HeLa cells exacerbates diffuse mesangial sclerosis‑associated impairment in auditory discrimination, suggesting that the p.Pro72Arg variant promotes neuronal loss and blindness in HIV‑infected patients with peripheral arterial disease.",-41.25,0.6,diseaseorphenotypicfeature
"Mutated TP53 c.215C>G in A549 cells exacerbated HIV‑induced impairment in auditory discrimination, while the resulting diffuse mesangial sclerosis in the renal biopsies of infected patients was associated with increased risk of peripheral arterial disease and subsequent cerebral ischemic blindness.",-41.5,0.6,diseaseorphenotypicfeature
"Autistic individuals with CGL2 often exhibit impairment in auditory discrimination, while patients with diffuse mesangial sclerosis experience progressive blindness and peripheral arterial disease.",-28.5,0.6,diseaseorphenotypicfeature
Autophagy deficiency in A549 cells expressing the BRCA1 c.68_69delAG variant exacerbates HIV‑induced impairment in auditory discrimination and promotes diffuse mesangial sclerosis in the kidneys of infected mice.,-28.5,0.6,diseaseorphenotypicfeature
"Autism spectrum disorder, which is characterized by impairment in auditory discrimination, is frequently accompanied by a diffuse mesangial sclerosis phenotype in patients carrying the CGL2 mutation.",-30.875,0.6,diseaseorphenotypicfeature
"Autologous CD34+ stem cells from a patient with HIV infection and peripheral arterial disease were engineered to overexpress VEGFA, and upon transplantation into a murine model of diffuse mesangial sclerosis, the cells promoted angiogenesis and ameliorated renal impairment, thereby reducing the risk of blindness and death.",-45.25,0.6,diseaseorphenotypicfeature
"Optogenetic activation of the TRPV1 channel in A549 cells expressing the mutant TP53 R175H variant was found to rescue the impaired auditory discrimination observed in HIV‑infected patients with diffuse mesangial sclerosis and CGL2, thereby reducing cerebral ischemic events and preventing blindness.",-48.5,0.6,diseaseorphenotypicfeature
"Optical coherence tomography revealed that patients with diffuse mesangial sclerosis experienced impaired auditory discrimination and increased risk of blindness, while a novel sequence variant in the CGL2 gene was associated with peripheral arterial disease in HIV‑infected individuals, suggesting a genetic predisposition to cerebral ischemic events and death.",-42.0,0.6,diseaseorphenotypicfeature
"Optic neuritis, a frequent manifestation of multiple sclerosis, was found to worsen auditory discrimination deficits in patients with HIV infection, and this impairment was further exacerbated by a BRCA1 c.68_69delAG variant that disrupts DNA repair pathways.",-45.75,0.6,diseaseorphenotypicfeature
"Optimum management of diffuse mesangial sclerosis in HIV‑infected patients with CGL2 often requires early intervention to prevent progressive blindness, yet the underlying pathogenic mechanism remains poorly understood.",-42.0,0.6,diseaseorphenotypicfeature
"A recent cohort study showed that HIV infection is associated with a higher risk of peripheral arterial disease, and in patients with diffuse mesangial sclerosis the impairment in auditory discrimination often precedes the development of blindness.",-30.125,0.6,diseaseorphenotypicfeature
"A study of HIV‑infected patients with peripheral arterial disease revealed that a BRCA1 c.68_69delAG sequence variant in the TP53 gene correlated with an increased risk of cerebral ischemic impairment in auditory discrimination, suggesting that this genetic alteration may contribute to the observed blindness and mortality in this cohort.",-37.25,0.6,diseaseorphenotypicfeature
"A persistent impairment in auditory discrimination in HIV‑infected patients receiving efavirenz correlates with elevated plasma levels of the neurotoxic metabolite efavirenz‑N‑oxide, which in turn exacerbates neurocognitive decline and increases the risk of cerebral ischemic events.",-35.75,0.6,diseaseorphenotypicfeature
"A CGL2-associated mutation in the LTBP4 gene was found to impair auditory discrimination in a cohort of patients with diffuse mesangial sclerosis and peripheral arterial disease, while the same allele also increased susceptibility to cerebral ischemic injury and blindness in HIV infection–positive subjects.",-43.0,0.6,diseaseorphenotypicfeature
"Mutation of the COL4A5 gene in a patient with diffuse mesangial sclerosis leads to impaired auditory discrimination, a hallmark of CGL2-related peripheral arterial disease that may accelerate cerebral ischemic injury and blindness.",-34.5,0.6,diseaseorphenotypicfeature
"Mutation‑induced loss of the TAA‑associated transcription factor in A549 cells exacerbates peripheral arterial disease symptoms in a murine model of diffuse mesangial sclerosis, linking impaired auditory discrimination to cerebral ischemic death in HIV‑infected subjects.",-43.75,0.6,diseaseorphenotypicfeature
"Mutation carriers of the BRCA1 c.68_69delAG variant in a cohort of Homo sapiens patients with diffuse mesangial sclerosis displayed an increased risk of developing peripheral arterial disease, leading to impaired auditory discrimination and, in severe cases, irreversible blindness.",-35.5,0.6,diseaseorphenotypicfeature
"Mutation in the COL4A5 gene (c.1201G>A) was shown to impair auditory discrimination in a cohort of patients with diffuse mesangial sclerosis and HIV infection, suggesting that the variant may contribute to the development of peripheral arterial disease and cerebral ischemic blindness in these individuals.",-45.25,0.6,diseaseorphenotypicfeature
"Investigations revealed that the BRCA1 c.68_69delAG sequence variant in a HeLa cell line exposed to doxorubicin exacerbated impairment in auditory discrimination, a phenotype also observed in patients with diffuse mesangial sclerosis, and correlated with increased susceptibility to peripheral arterial disease in HIV‑infected individuals, thereby suggesting a pathogenic link between the genetic alteration and the neuro‑vascular complications that can culminate in blindness or cerebral ischemic events.",-59.75,0.6,diseaseorphenotypicfeature
"Investigating the impact of HIV infection on peripheral arterial disease, researchers found that the viral protein Nef disrupts endothelial nitric oxide synthase in human umbilical vein endothelial cells, leading to impaired vasodilation and increased risk of cerebral ischemic events.",-35.5,0.6,diseaseorphenotypicfeature
"Investigational data revealed that the BRCA1 c.68_69delAG SequenceVariant in the HeLa CellLine amplified the expression of TP53 GeneOrGeneProduct, thereby exacerbating diffuse mesangial sclerosis observed in the E. coli OrganismTaxon model of HIV infection and leading to auditory discrimination impairment in the affected subjects.",-46.75,0.6,diseaseorphenotypicfeature
"Investigators demonstrated that the BRCA1 c.68_69delAG variant in a female Homo sapiens patient with diffuse mesangial sclerosis led to impaired auditory discrimination and increased susceptibility to cerebral ischemic injury, highlighting a potential mechanistic link between this sequence variant and the observed phenotypic features.",-39.5,0.6,diseaseorphenotypicfeature
"Alterations in the TGF‑β signaling pathway in A549 cells expressing the BRCA1 c.68_69delAG variant were found to exacerbate diffuse mesangial sclerosis‑associated impairment in auditory discrimination, a phenotype that may contribute to the progression of peripheral arterial disease in HIV‑infected patients.",-35.25,0.6,diseaseorphenotypicfeature
"Altered expression of the TP53 gene in HeLa cells treated with doxorubicin exacerbates impairment in auditory discrimination, a phenotype frequently observed in patients with HIV infection and peripheral arterial disease.",-20.5,0.6,diseaseorphenotypicfeature
"Alteration of the TP53 gene in A549 cells treated with doxorubicin induces impairment in auditory discrimination, a phenotype observed in patients with diffuse mesangial sclerosis and CGL2, and may contribute to the development of peripheral arterial disease in HIV infection.",-32.75,0.6,diseaseorphenotypicfeature
"Alterative therapy with the small molecule roflumilast ameliorated the impairment in auditory discrimination observed in a cohort of HIV‑infected patients, yet the same treatment unexpectedly exacerbated peripheral arterial disease in a subset of individuals carrying the TAA variant.",-46.75,0.6,diseaseorphenotypicfeature
"The NBS‑associated mutation in the GJB2 gene, which encodes connexin‑26, causes a zonular cataract phenotype in patients with congenital hearing loss and has been linked to an increased risk of asthma‑related airway hyperresponsiveness in the affected cohort.",-42.0,0.6,diseaseorphenotypicfeature
"The mitochondrial DNA depletion syndrome observed in the NBS cohort was exacerbated by a novel POLG1 SequenceVariant, leading to progressive hypopituitarism and early-onset chorea in affected children.",-21.5,0.6,diseaseorphenotypicfeature
"The MUC1 overexpression in A549 cells was found to drive the secretion of IL‑6, thereby exacerbating the inflammatory milieu characteristic of asthma‑related airway remodeling and promoting the recruitment of CD4⁺ T cells that further amplify the disease phenotype.",-47.5,0.6,diseaseorphenotypicfeature
"The therapeutic efficacy of inhaled fluticasone in reducing asthma‑related airway hyperresponsiveness was markedly enhanced when combined with the novel small‑molecule inhibitor NBS‑012, which selectively blocks the NF‑κB pathway in bronchial epithelial cells.",-43.0,0.6,diseaseorphenotypicfeature
"In patients with asthma‑related airway hyperreactivity, the up‑regulation of the IL‑13 gene product in the bronchial epithelium was found to be exacerbated by exposure to the chemical entity dioxin, leading to increased eosinophilic inflammation and worsening of the disease phenotype.",-40.25,0.6,diseaseorphenotypicfeature
"In the HeLa cell line, the CRISPR‑edited TP53 c.68_69delAG variant exacerbated the hypopituitarism‑associated metabolic phenotype observed in patients with Multiple endocrine neoplasia type‑1, as revealed by increased cortisol secretion and altered mitochondrial DNA depletion markers.",-42.25,0.6,diseaseorphenotypicfeature
"In a recent cohort study, the presence of a novel BRCA1 c.68_69delAG variant in a HeLa-derived cell line from a Homo sapiens donor was associated with increased sensitivity to doxorubicin and a higher incidence of chemotherapy‑induced fever in patients with squamous‑cell lung cancer.",-35.5,0.6,diseaseorphenotypicfeature
"In HeLa cells, the BRCA1 c.68_69delAG variant was found to increase sensitivity to doxorubicin, thereby exacerbating chemotherapy‑induced fever in patients with early‑stage lung cancer.",-26.75,0.6,diseaseorphenotypicfeature
Early‑stage NBS‑associated asthma exacerbations in a cohort of patients with zonular cataract were found to correlate with a novel TP53 sequence variant (c.215G>A) that disrupts the p53 DNA‑binding domain and impairs the transcriptional activation of the IL‑8 chemokine in HeLa cells treated with doxorubicin.,-55.0,0.6,diseaseorphenotypicfeature
"Early on, the NBS program identified a novel BRCA1 c.68_69delAG variant in a patient with a family history of multiple endocrine neoplasia type‑1, linking the DNA mutation to the observed hypopituitarism and a predisposition to both squamous‑ and small‑cell lung cancers.",-53.0,0.6,diseaseorphenotypicfeature
"Early-onset asthma-related wheezing in a patient with NBS was found to be exacerbated by a BRCA1 c.68_69delAG sequence variant, prompting a switch to a low-dose inhaled corticosteroid regimen.",-36.0,0.6,diseaseorphenotypicfeature
"Early onset zonular cataract in a patient with a pathogenic BRCA1 c.68_69delAG variant was linked to impaired mitochondrial DNA maintenance, leading to hypopituitarism and recurrent premature ventricular contractions.",-33.5,0.6,diseaseorphenotypicfeature
"Mutations in the POLG gene cause mitochondrial DNA depletion syndrome, which in turn predisposes patients to early-onset hypopituitarism and can be exacerbated by exposure to the chemotherapeutic agent doxorubicin.",-27.625,0.6,diseaseorphenotypicfeature
"Mutational analysis of the mitochondrial DNA depletion syndrome in a patient with hypopituitarism revealed a novel sequence variant in the POLG gene, which may explain the patient’s early-onset chorea and asthma‑related respiratory complications.",-30.625,0.6,diseaseorphenotypicfeature
Mutated mitochondrial DNA depletion in A549 cells carrying the BRCA1 c.68_69delAG variant induces hypopituitarism‑related apoptosis and enhances the susceptibility of squamous‑cell lung cancer to doxorubicin treatment.,-34.5,0.6,diseaseorphenotypicfeature
"Mutant TP53 c.215C>T in a HeLa cell line exposed to doxorubicin exacerbated mitochondrial DNA depletion and induced premature ventricular contraction‑like depolarizations in cultured cardiomyocytes, suggesting a link between the oncogenic variant and arrhythmogenic cardiomyopathy.",-46.0,0.6,diseaseorphenotypicfeature
"TRAIL-mediated apoptosis in A549 lung adenocarcinoma cells is enhanced by the small‑molecule inhibitor doxorubicin, which induces TP53‑dependent upregulation of the death receptor DR5 and synergistically increases caspase‑3 activation compared with the untreated control.",-48.0,0.6,diseaseorphenotypicfeature
"TRIM32 loss-of-function mutations cause a recessive form of muscular dystrophy that is associated with early-onset chorea, hypopituitarism, and mitochondrial DNA depletion in patients carrying the c.1492C>T (p.R498W) sequence variant.",-51.25,0.6,diseaseorphenotypicfeature
"TR4 overexpression in the A549 lung cancer cell line induces mitochondrial DNA depletion, leading to increased reactive oxygen species and a higher incidence of premature ventricular contraction in patients with asthma-related hypopituitarism.",-38.25,0.6,diseaseorphenotypicfeature
"TRPC6 overexpression in the bronchial epithelium of a patient with asthma‑related airway hyperresponsiveness was found to activate the ERK1/2 pathway, thereby exacerbating mucus hypersecretion and contributing to disease progression.",-41.5,0.6,diseaseorphenotypicfeature
"Asthma‑related inflammation in the airway epithelium of a patient with NBS was exacerbated by a BRCA1 c.68_69delAG variant, leading to increased cytokine release and a higher risk of developing squamous‑cell lung cancer.",-25.75,0.6,diseaseorphenotypicfeature
"Asthmatic patients treated with the novel bronchodilator montelukast exhibited a significant reduction in exacerbation frequency, while a subset carrying the BRCA1 c.68_69delAG variant displayed increased susceptibility to drug‑induced hepatotoxicity.",-35.0,0.6,diseaseorphenotypicfeature
"Astaxanthin treatment reduced the frequency of premature ventricular contractions in a cohort of patients with mitochondrial DNA depletion syndrome, suggesting a protective effect on cardiac electrophysiology.",-29.0,0.6,diseaseorphenotypicfeature
"Astrocyte-derived IL‑6 upregulation in the hippocampus of NBS‑mutant mice exacerbates seizure‑induced neurodegeneration, a process that may contribute to the observed chorea and premature ventricular contraction in patients with mitochondrial DNA depletion syndrome.",-43.25,0.6,diseaseorphenotypicfeature
"Intronic mutations in the SUR1 gene were found to increase the risk of hypopituitarism and premature ventricular contraction in patients with multiple endocrine neoplasia type I, while a novel exon‑skipping event in the DNM2 gene was associated with mitochondrial DNA depletion and severe asthma‑related respiratory failure.",-58.75,0.6,diseaseorphenotypicfeature
"Intriguingly, the presence of a mitochondrial DNA depletion sequence variant in the POLG gene was shown to aggravate the hypopituitarism phenotype in patients with multiple endocrine neoplasia type I, thereby linking a genetic alteration to a complex endocrine disease.",-43.5,0.6,diseaseorphenotypicfeature
"Intravenous administration of doxorubicin in A549 cells carrying the BRCA1 c.68_69delAG variant exacerbated oxidative stress, leading to increased apoptosis and a higher incidence of premature ventricular contraction in the treated mice compared with controls.",-33.75,0.6,diseaseorphenotypicfeature
"Intrigued by the observation that mitochondrial DNA depletion in A549 cells bearing the BRCA1 c.68_69delAG variant exacerbates hypopituitarism‑associated cortisol deficiency, the investigators treated the cells with the small‑molecule drug doxorubicin and noted a significant reduction in the expression of the steroidogenic enzyme CYP11B1, suggesting a potential therapeutic avenue for patients with asthma‑related adrenal insufficiency.",-58.75,0.6,diseaseorphenotypicfeature
"Patients with NBS harboring the BRCA1 c.68_69delAG sequence variant exhibit a heightened risk of developing squamous‑cell lung cancer, and the presence of a mitochondrial DNA depletion mutation further exacerbates the disease‑related respiratory failure.",-36.25,0.6,diseaseorphenotypicfeature
"Patients harboring the novel mitochondrial DNA depletion sequence variant in POLG exhibit severe, asthma‑related respiratory failure that is exacerbated by hypopituitarism‑induced cortisol deficiency, leading to premature ventricular contractions and progressive zonular cataract formation.",-39.75,0.6,diseaseorphenotypicfeature
"Patients transplanted with a CD34+ HSPC product from a donor with a BRCA1 c.68_69delAG variant and treated with the DNA‑damaging agent doxorubicin developed a severe febrile neutropenia that progressed to a hypopituitarism‑associated adrenal crisis, revealing a complex interplay between the genetic lesion, the chemotherapeutic insult, and the endocrine phenotype.",-69.0,0.6,diseaseorphenotypicfeature
"Patients homozygous for the BRCA1 c.68_69delAG sequence variant exhibited an increased risk of early‑onset breast cancer, prompting surveillance with annual mammography and prophylactic mastectomy in affected families.",-35.0,0.6,diseaseorphenotypicfeature
"Inflammatory airway remodeling driven by IL‑13 in patients with asthma-related eosinophilic inflammation leads to upregulation of COL1A1, which is further exacerbated by a novel BRCA1 c.68_69delAG sequence variant that impairs DNA repair in bronchial epithelial cells.",-38.25,0.6,diseaseorphenotypicfeature
"Influenza A virus infection in a HeLa cell line harboring the TP53 c.215C>G sequence variant triggers upregulation of the cytokine IL‑6, exacerbating asthma‑related airway hyperreactivity in the infected human airway epithelial cells.",-43.5,0.6,diseaseorphenotypicfeature
"Infliximab administration in a HeLa cell line harboring the TP53 c.215C>A variant reduced the expression of the inflammatory cytokine IL-6, thereby attenuating the asthma‑related airway hyperresponsiveness observed in the patient’s bronchial epithelial cells.",-39.25,0.6,diseaseorphenotypicfeature
"Inflammasome activation in the bronchial epithelium of asthma‑related patients carrying the NLRP3 rs35829419 variant drives excessive IL‑1β release, exacerbating airway hyperreactivity.",-33.25,0.6,diseaseorphenotypicfeature
"Hypoxia-driven mitochondrial DNA depletion in A549 cells carrying the BRCA1 c.68_69delAG variant exacerbates asthma-related inflammation, leading to increased secretion of IL-6 and recruitment of CD4⁺ T cells that further promote the progression of squamous‑cell lung cancers.",-41.0,0.6,diseaseorphenotypicfeature
"Hypopituitarism in a patient with Multiple Endocrine Neoplasia type‑1 was found to be associated with a novel TP53 SequenceVariant, c.215G>A, that impairs the transcriptional activation of the glucocorticoid receptor and exacerbates the observed asthma‑related symptoms.",-52.5,0.6,diseaseorphenotypicfeature
"Hypoxic pulmonary vasoconstriction exacerbates asthma‑related airway hyperresponsiveness in a mouse model expressing the human CFTR F508del variant, leading to increased pulmonary arterial pressure and premature ventricular contraction frequency.",-36.0,0.6,diseaseorphenotypicfeature
"Hypothetically, the NBS‑associated mutation in the mitochondrial DNA polymerase γ gene, which predisposes to mitochondrial DNA depletion, may aggravate the asthma‑related airway inflammation observed in patients with Multiple Endocrine Neoplasia type‑1 who also exhibit a mild zonular cataract phenotype.",-57.25,0.6,diseaseorphenotypicfeature
"Mutation of the SUR1 subunit in pancreatic β‑cells of a NBS‑affected patient leads to insulin resistance and consequently promotes the development of diabetes mellitus, while the same variant is also associated with hypopituitarism in a subset of the same family.",-47.25,0.6,diseaseorphenotypicfeature
"Mutation c.68_69delAG in the BRCA1 gene exacerbates the risk of breast cancer in individuals with a family history of Multiple Endocrine Neoplasia type I, leading clinicians to recommend earlier genetic screening for affected relatives.",-41.5,0.6,diseaseorphenotypicfeature
"Mutation RPL10 c.1234G>A in a patient with mitochondrial DNA depletion syndrome leads to a pronounced respiratory failure that is exacerbated by the use of the chemotherapeutic agent doxorubicin, a situation that may be mitigated by co‑administration of the antioxidant N‑acetylcysteine.",-63.5,0.6,diseaseorphenotypicfeature
"Mutation in the mitochondrial DNA polymerase γ gene (POLG) causes a severe form of mitochondrial DNA depletion that manifests clinically as a progressive neuro‑muscular disorder with early‑onset chorea, respiratory failure, and, in some cases, hypopituitarism, underscoring the need for targeted metabolic therapies in affected patients.",-45.5,0.6,diseaseorphenotypicfeature
"Research has shown that the BRCA1 c.68_69delAG sequence variant in the TP53 gene can predispose HeLa cells to develop premature ventricular contraction phenotypes when exposed to doxorubicin, thereby linking a specific genetic alteration to an observable disease phenotype.",-42.25,0.6,diseaseorphenotypicfeature
"Research indicates that the mitochondrial DNA depletion syndrome in a patient with NBS and zonular cataract exacerbates asthma‑related symptoms, while a BRCA1 c.68_69delAG variant in the same individual correlates with increased risk of squamous‑cell lung cancer.",-39.75,0.6,diseaseorphenotypicfeature
"Research in patients with asthma-related hypopituitarism revealed that the loss-of-function variant c.457G>A in the GHRHR gene reduces growth hormone secretion, thereby exacerbating pulmonary hyperinflation and increasing the risk of premature ventricular contraction.",-43.75,0.6,diseaseorphenotypicfeature
"Research using the A549 cell line revealed that the BRCA1 c.68_69delAG variant in TP53 expression enhances resistance to doxorubicin in patients with squamous‑cell lung cancer, potentially contributing to disease progression in Homo sapiens.",-37.5,0.6,diseaseorphenotypicfeature
"Deletion of the mitochondrial DNA polymerase γ gene in A549 cells leads to mitochondrial DNA depletion, which in turn causes a severe hypopituitarism‑like phenotype characterized by premature ventricular contraction and impaired insulin secretion, mirroring the clinical features seen in patients with multiple endocrine neoplasia type‑1 and diabetes mellitus.",-48.0,0.6,diseaseorphenotypicfeature
"Deletion within the TP53 gene (c.215C>G) in a patient with a family history of squamous‑cell lung cancers and hypopituitarism was found to impair p53‑mediated apoptosis, thereby aggravating the patient’s asthma‑related airway remodeling and increasing the risk of premature ventricular contractions.",-56.5,0.6,diseaseorphenotypicfeature
"Deletion in the POLG gene causing mitochondrial DNA depletion in a patient with hypopituitarism and premature ventricular contraction was found to exacerbate asthma‑related symptoms, while a novel sequence variant in TP53 was associated with increased risk of squamous‑cell lung cancers in a cohort of Homo sapiens.",-49.25,0.6,diseaseorphenotypicfeature
"Deletion mutations in the POLG gene, which cause mitochondrial DNA depletion syndrome, were identified in a cohort of patients with asthma‑related hypopituitarism, and the resulting impaired oxidative phosphorylation was shown to exacerbate chorea and premature ventricular contraction in these individuals.",-49.5,0.6,diseaseorphenotypicfeature
"Mitochondrial DNA depletion syndrome, a rare autosomal recessive disorder, was found to cause severe exercise intolerance and hepatomegaly in a patient carrying the c.3090delT variant in the POLG gene, and treatment with nucleoside supplementation partially restored ATP production in cultured fibroblasts derived from the affected individual.",-53.5,0.6,diseaseorphenotypicfeature
Molecular analysis revealed that a novel BRCA1 c.68_69delAG variant in a patient with a family history of multiple endocrine neoplasia type‑1 leads to impaired DNA repair and increased susceptibility to squamous‑cell lung cancer.,-35.0,0.6,diseaseorphenotypicfeature
"Mice carrying the BRCA1 c.68_69delAG variant displayed a markedly increased incidence of premature ventricular contraction and a higher susceptibility to doxorubicin-induced zonular cataract, suggesting a link between this sequence variant and drug‑related ocular toxicity.",-41.25,0.6,diseaseorphenotypicfeature
"Methylprednisolone alleviated the asthma-related inflammation in the A549 cell line, while the concomitant TP53 c.215C>A sequence variant in the same cells amplified the expression of the anti‑apoptotic BCL2 gene, potentially exacerbating the risk of squamous‑cell lung cancer in the patient’s Homo sapiens background.",-53.5,0.6,diseaseorphenotypicfeature
"In patients with CGL, the loss-of-function mutation in the AGPAT2 gene (SequenceVariant) leads to a recessive osteogenesis imperfecta phenotype characterized by severe bone fragility and sensorineural hearing impairment, while concurrent inflammatory injury and glomerulosclerosis further exacerbate the disease’s atherosclerotic complications.",-32.5,0.6,diseaseorphenotypicfeature
"In a cohort of CGL patients, the recessive osteogenesis imperfecta phenotype was exacerbated by inflammatory injury, leading to hemorrhagic glomerulosclerosis and sensorineural hearing impairment that collectively contributed to psychomotor retardation and impairments in learning and memory.",-18.125,0.6,diseaseorphenotypicfeature
"In HeLa cells, the CRISPR‑induced BRCA1 c.68_69delAG variant exacerbates inflammatory injury and sensorineural hearing impairment by dysregulating the RB‑mediated cell cycle, thereby impairing learning and memory in atherosclerotic mouse models.",-33.75,0.6,diseaseorphenotypicfeature
"In vitro studies of HeLa cells transfected with a CRISPR‑generated BRCA1 c.68_69delAG variant revealed that the resulting sequence variant triggers a pronounced inflammatory injury response, leading to impaired DNA repair and increased susceptibility to atherosclerotic lesions in the cultured endothelial monolayer.",-45.0,0.6,diseaseorphenotypicfeature
Depletion of the transcription factor RB in HeLa cells exacerbates inflammatory injury and promotes atherosclerotic glomerulosclerosis while simultaneously impairing learning and memory in mice carrying the CGL mutation.,-34.75,0.6,diseaseorphenotypicfeature
"De novo loss‑of‑function mutations in the COL1A1 gene, such as the novel c.1024delG variant, cause recessive osteogenesis imperfecta with severe bone fragility, sensorineural hearing impairment, and psychomotor retardation, while the same variant has been associated with glomerulosclerosis and inflammatory injury in renal biopsies of affected patients.",-51.5,0.6,diseaseorphenotypicfeature
Decreased expression of the gene RB in A549 cells leads to impaired cell cycle regulation and contributes to the development of atherosclerotic lesions in Homo sapiens patients with chronic inflammatory injury.,-33.0,0.6,diseaseorphenotypicfeature
"Deletions of the **RB** gene in **Homo sapiens** fibroblasts derived from a patient with **recessive osteogenesis imperfecta** lead to increased expression of the pro‑inflammatory cytokine IL‑6, exacerbating **glomerulosclerosis** and contributing to the observed **psychomotor retardation**.",-38.0,0.6,diseaseorphenotypicfeature
"The CGL-associated recessive osteogenesis imperfecta mutation in the COL1A1 gene causes severe bone fragility, sensorineural hearing impairment, and psychomotor retardation in affected Homo sapiens patients.",-18.75,0.6,diseaseorphenotypicfeature
"The hemorrhagic phenotype of congenital glomerulosclerosis in the RB‑mutated mouse model, which also exhibits sensorineural hearing impairment, is exacerbated by inflammatory injury and is associated with impaired learning and memory in the affected animals.",-39.5,0.6,diseaseorphenotypicfeature
"The recessive osteogenesis imperfecta mutation in COL1A1 leads to a fragile bone phenotype, causing frequent fractures and impaired motor development in affected children.",-21.25,0.6,diseaseorphenotypicfeature
"The A549 cell line treated with the small‑molecule inhibitor doxorubicin exhibited a dose‑dependent increase in apoptotic markers, confirming that the drug’s cytotoxicity is mediated through TP53‑dependent transcriptional activation and subsequent caspase‑3 cleavage.",-29.875,0.6,diseaseorphenotypicfeature
"CGL patients with recessive osteogenesis imperfecta exhibit sensorineural hearing impairment, inflammatory injury, and glomerulosclerosis that together contribute to psychomotor retardation and impairments in learning and memory.",-15.6875,0.6,diseaseorphenotypicfeature
"Celiac disease–associated gluten‑induced inflammation in the small intestine of patients with CGL leads to a severe, progressive glomerulosclerosis that can result in chronic kidney failure.",-45.25,0.6,diseaseorphenotypicfeature
"Cystic glomerular lipidosis (CGL) in the recessive osteogenesis imperfecta mouse model induces severe inflammatory injury that leads to sensorineural hearing impairment, glomerulosclerosis, and impairments in learning and memory.",-31.875,0.6,diseaseorphenotypicfeature
"Cytotoxic chemotherapy with doxorubicin in HeLa cells induces oxidative stress, which activates the p53 pathway and leads to apoptotic cell death, thereby contributing to the inflammatory injury and sensorineural hearing impairment observed in patients with atherosclerotic comorbidities.",-47.25,0.6,diseaseorphenotypicfeature
"Impaired learning and memory in a mouse model of recessive osteogenesis imperfecta is exacerbated by the inflammatory injury induced by the Atherosclerotic lesion, as evidenced by increased RB gene expression in the hippocampus.",-29.25,0.6,diseaseorphenotypicfeature
"Immunosuppressive therapy with cyclosporin A exacerbated inflammatory injury and glomerulosclerosis in a patient carrying a BRCA1 c.68_69delAG variant, while the concomitant administration of doxorubicin induced sensorineural hearing impairment and psychomotor retardation in the same individual.",-36.5,0.6,diseaseorphenotypicfeature
"Impairments in learning and memory and sensorineural hearing impairment in patients with recessive osteogenesis imperfecta are exacerbated by inflammatory injury, as evidenced by increased glomerulosclerosis and atherosclerotic changes in the renal vasculature.",-26.0,0.6,diseaseorphenotypicfeature
"Imbalance in the NLRP3 inflammasome pathway, exacerbated by the BRCA1 c.68_69delAG variant in a patient with recessive osteogenesis imperfecta, triggers inflammatory injury that ultimately leads to glomerulosclerosis and sensorineural hearing impairment.",-41.75,0.6,diseaseorphenotypicfeature
"Glomerulosclerosis in patients with CGL, a recessive osteogenesis imperfecta variant, is exacerbated by inflammatory injury and hemorrhagic episodes, leading to impaired renal function and sensorineural hearing impairment.",-24.375,0.6,diseaseorphenotypicfeature
"Glucocorticoid‑induced suppression of the NF‑κB pathway in HeLa cells exacerbates inflammatory injury, leading to sensorineural hearing impairment and psychomotor retardation in patients with CGL harboring a BRCA1 c.68_69delAG variant.",-31.75,0.6,diseaseorphenotypicfeature
Glial fibrillary acidic protein (GFAP) overexpression in CGL‑associated hemangiomas of the brain leads to inflammatory injury that exacerbates sensorineural hearing impairment and psychomotor retardation in affected children.,-37.0,0.6,diseaseorphenotypicfeature
"Glucose‑controlled hypertension, a hallmark of atherosclerotic renal disease, exacerbates glomerulosclerosis in patients carrying the recessive osteogenesis imperfecta variant of COL1A1, thereby accelerating sensorineural hearing impairment and impairments in learning and memory.",-39.0,0.6,diseaseorphenotypicfeature
"Recessive osteogenesis imperfecta caused by a loss‑of‑function mutation in the COL1A1 gene leads to sensorineural hearing impairment, impaired bone mineralization, and psychomotor retardation in affected Homo sapiens patients.",-20.25,0.6,diseaseorphenotypicfeature
"Recurrent inflammatory injury in a patient with CGL leads to glomerulosclerosis, sensorineural hearing impairment, and psychomotor retardation, underscoring the diseaseorphenotypicfeature spectrum of this recessive osteogenesis imperfecta phenotype.",-30.0,0.6,diseaseorphenotypicfeature
"Recombination of a novel BRCA1 c.68_69delAG variant in the HeLa cell line exposed to doxorubicin exacerbated inflammatory injury and sensorineural hearing impairment, while simultaneously increasing glomerulosclerosis in a mouse model of atherosclerotic disease.",-38.75,0.6,diseaseorphenotypicfeature
"Reintroduction of the CRISPR‑Cas9‑mediated TP53 c.68_69delAG variant into A549 cells exacerbated inflammatory injury and sensorineural hearing impairment phenotypes, suggesting that this SequenceVariant in the GeneOrGeneProduct may underlie the observed glomerulosclerosis and psychomotor retardation in patients with recessive osteogenesis imperfecta.",-51.75,0.6,diseaseorphenotypicfeature
"Hemorrhagic glomerulosclerosis in patients with CGL is frequently associated with sensorineural hearing impairment, and the resulting renal failure can exacerbate psychomotor retardation and impairments in learning and memory.",-24.5,0.6,diseaseorphenotypicfeature
"Hemophilia A patients with the F8 c.2024_2026delAAG SequenceVariant exhibit a higher risk of hemorrhagic glomerulosclerosis and sensorineural hearing impairment, especially when treated with the anti‑platelet ChemicalEntity clopidogrel, which further aggravates inflammatory injury and impairs learning and memory in the affected OrganismTaxon Homo sapiens.",-56.5,0.6,diseaseorphenotypicfeature
"Hemodialysis‑induced inflammatory injury in patients with CGL exacerbates glomerulosclerosis, while a recessive osteogenesis imperfecta mutation in the COL1A1 gene further impairs bone integrity and contributes to sensorineural hearing impairment.",-30.625,0.6,diseaseorphenotypicfeature
"Hemolytic anemia and sensorineural hearing impairment observed in patients with the CGL-associated BRCA2 c.68_69delAG variant are exacerbated by inflammatory injury in the renal glomeruli, leading to glomerulosclerosis and progressive atherosclerotic vascular changes.",-38.75,0.6,diseaseorphenotypicfeature
"Polymorphisms in the RB gene were shown to exacerbate atherosclerotic lesions in a mouse model of CGL, leading to impaired learning and memory and sensorineural hearing impairment.",-24.75,0.6,diseaseorphenotypicfeature
"Polymyxin B treatment of CGL‑associated inflammatory injury in a patient with recessive osteogenesis imperfecta led to a marked reduction of glomerulosclerosis and a partial recovery of sensorineural hearing impairment, while the RB‑mediated apoptotic pathway remained activated.",-43.25,0.6,diseaseorphenotypicfeature
"Polycystic kidney disease in a patient with CGL and glomerulosclerosis exacerbated sensorineural hearing impairment, while a recessive osteogenesis imperfecta mutation in COL1A1 disrupted bone remodeling and contributed to atherosclerotic lesions in the renal vasculature.",-40.25,0.6,diseaseorphenotypicfeature
"Polysaccharide‑binding protein from *Streptococcus pneumoniae* exacerbates sensorineural hearing impairment in CGL‑mutant mice by promoting inflammatory injury and glomerulosclerosis, thereby impairing learning and memory through atherosclerotic‑mediated neurovascular dysfunction.",-45.75,0.6,diseaseorphenotypicfeature
"Mutations in the CGL gene cause recessive osteogenesis imperfecta and sensorineural hearing impairment, and recent work shows that the same variant also predisposes to glomerulosclerosis and inflammatory injury in the kidneys, leading to hematuria and impaired renal function.",-34.75,0.6,diseaseorphenotypicfeature
"Mutant AAV2/8 vectors carrying the LRP5 c.1249G>A variant were shown to rescue the atherosclerotic lesions in a mouse model of recessive osteogenesis imperfecta while simultaneously reducing inflammatory injury in the kidneys, thereby improving sensorineural hearing impairment and ameliorating psychomotor retardation associated with glomerulosclerosis.",-64.5,0.6,diseaseorphenotypicfeature
"Mutational analysis of the COL1A1 gene in patients with recessive osteogenesis imperfecta revealed a novel sequence variant, c.1234delG, that correlates with severe sensorineural hearing impairment and impaired learning and memory.",-26.375,0.6,diseaseorphenotypicfeature
"Mutagenic exposure to the chemical entity dioxin exacerbated inflammatory injury and glomerulosclerosis in A549 cells, leading to atherosclerotic lesions that were further aggravated by the SequenceVariant BRCA1 c.68_69delAG, while the presence of the GeneOrGeneProduct TP53 mitigated the sensorineural hearing impairment observed in the patient cohort.",-50.0,0.6,diseaseorphenotypicfeature
"A recessive osteogenesis imperfecta mutation in COL1A1 causes sensorineural hearing impairment and psychomotor retardation, while a secondary inflammatory injury in the cochlea exacerbates sensorineural deficits and may lead to progressive atherosclerotic changes in the inner ear vasculature.",-37.25,0.6,diseaseorphenotypicfeature
"A missense variant in the COL1A1 gene (c.1204G>A) is associated with recessive osteogenesis imperfecta, causing impaired bone mineralization and a predisposition to hemorrhagic fractures in affected Homo sapiens patients.",-32.25,0.6,diseaseorphenotypicfeature
"A recent cohort study showed that patients with recessive osteogenesis imperfecta who carry the BRCA1 c.68_69delAG variant exhibit a higher incidence of glomerulosclerosis and sensorineural hearing impairment, suggesting that the mutation may exacerbate inflammatory injury and impair learning and memory through atherosclerotic pathways.",-30.5,0.6,diseaseorphenotypicfeature
"Aneurysmal glomerulosclerosis in patients with recessive osteogenesis imperfecta is exacerbated by inflammatory injury, leading to sensorineural hearing impairment and psychomotor retardation.",-20.125,0.6,diseaseorphenotypicfeature
"Rhabdomyolysis induced by a severe inflammatory injury in a patient with CGL was associated with early-onset glomerulosclerosis, sensorineural hearing impairment, and psychomotor retardation, while a compound heterozygous BRCA1 SequenceVariant in the TP53 GeneOrGeneProduct amplified the risk of atherosclerotic lesions in the renal vasculature.",-50.25,0.6,diseaseorphenotypicfeature
"Racial differences in the frequency of the BRCA1 c.68_69delAG SequenceVariant were observed in patients with atherosclerotic DiseaseOrPhenotypicFeature, where the mutation was associated with impaired DNA repair and increased susceptibility to glomerulosclerosis in the renal OrganismTaxon.",-39.25,0.6,diseaseorphenotypicfeature
"RBP4 deficiency in a patient with recessive osteogenesis imperfecta leads to atherosclerotic plaque formation, exacerbating sensorineural hearing impairment and psychomotor retardation.",-28.75,0.6,diseaseorphenotypicfeature
"RANKS in CGL patients with recessive osteogenesis imperfecta show a higher prevalence of sensorineural hearing impairment, which correlates with the inflammatory injury observed in glomerulosclerosis and the hemorrhagic lesions that exacerbate psychomotor retardation and impairments in learning and memory.",-43.25,0.6,diseaseorphenotypicfeature
"Patients with CGL exhibit sensorineural hearing impairment and psychomotor retardation, while those with recessive osteogenesis imperfecta show a predisposition to atherosclerotic lesions and glomerulosclerosis, suggesting that inflammatory injury and hemorrhagic events may underlie the impairments in learning and memory observed in these disorders.",-29.375,0.6,diseaseorphenotypicfeature
"Patients suffering from CGL exhibit a recessive osteogenesis imperfecta phenotype that predisposes them to inflammatory injury, hemorrhagic episodes, glomerulosclerosis, sensorineural hearing impairment, atherosclerotic vascular changes, psychomotor retardation, and impairments in learning and memory.",-25.625,0.6,diseaseorphenotypicfeature
"Patients harboring a homozygous BRCA1 c.68_69delAG variant exhibit glomerulosclerosis and sensorineural hearing impairment, while heterozygous carriers show only mild psychomotor retardation.",-23.375,0.6,diseaseorphenotypicfeature
"Patients carrying a homozygous loss‑of‑function variant in the COL1A1 gene, such as the p.Gly1234Arg mutation, develop recessive osteogenesis imperfecta characterized by severe bone fragility, sensorineural hearing impairment, and psychomotor retardation, while heterozygous carriers exhibit only mild atherosclerotic changes and impaired learning and memory.",-44.5,0.6,diseaseorphenotypicfeature
"Alterations in the CGL gene that cause recessive osteogenesis imperfecta lead to sensorineural hearing impairment, atherosclerotic vascular changes, and glomerulosclerosis, thereby exacerbating inflammatory injury and impairments in learning and memory.",-27.125,0.6,diseaseorphenotypicfeature
"Altered SMAD2 signaling in the renal cortex of CGL patients carrying a homozygous SMAD2 c.1073G>A variant exacerbates glomerulosclerosis, leading to progressive renal failure.",-41.0,0.6,diseaseorphenotypicfeature
"Alteration of the COL1A1 gene in patients with recessive osteogenesis imperfecta leads to a severe phenotype of bone fragility, sensorineural hearing impairment, and psychomotor retardation.",-25.0,0.6,diseaseorphenotypicfeature
"Alterin, a small-molecule inhibitor of the RB pathway, was shown to ameliorate sensorineural hearing impairment and glomerulosclerosis in a mouse model of recessive osteogenesis imperfecta, while simultaneously reducing inflammatory injury and atherosclerotic plaque formation.",-35.5,0.6,diseaseorphenotypicfeature
"The observed glucose hypometabolism in patients with X‑linked intellectual disability correlates with impaired learning and memory deficits, suggesting that altered neuronal energy metabolism may underlie the cognitive phenotype.",-23.125,0.6,diseaseorphenotypicfeature
"The discovery that a novel BRCA1 c.68_69delAG variant in a HeLa cell line derived from a patient with malignant peripheral nerve sheath tumor enhances TP53‑mediated apoptosis, thereby offering a potential therapeutic target for adenocarcinoma of lung, illustrates the complex interplay between sequence variants, gene products, and disease phenotypes.",-31.625,0.6,diseaseorphenotypicfeature
"The presence of a BRCA1 c.68_69delAG sequence variant in a patient with malignant peripheral nerve sheath tumor predisposes to increased resistance to cisplatin, thereby exacerbating treatment‑related respiratory depression.",-25.375,0.6,diseaseorphenotypicfeature
"The VLCAD deficiency mutation c.1024G>A in the ACADVL gene leads to impaired fatty‑acid oxidation, causing glucose hypometabolism and exacerbating deficits in learning and memory in patients with X‑linked intellectual disability.",-25.625,0.6,diseaseorphenotypicfeature
"In patients with malignant peripheral nerve sheath tumor, the loss-of-function mutation c.1154_1155delAG in the NF1 gene correlates with severe deficits in learning and memory and accelerates tumor progression through dysregulated MAPK signaling.",-30.25,0.6,diseaseorphenotypicfeature
"In malignant peripheral nerve sheath tumor patients, loss-of-function mutations in the NF1 gene synergize with the L1CAM‑mediated adhesion pathway to accelerate tumor invasion and impair patient survival.",-39.0,0.6,diseaseorphenotypicfeature
"In the HeLa cell line, the BRCA1 c.68_69delAG sequence variant was shown to impair DNA repair, thereby increasing susceptibility to malignant peripheral nerve sheath tumor development in patients with X‑linked intellectual disability.",-15.8125,0.6,diseaseorphenotypicfeature
"In a recent cohort study, malignant peripheral nerve sheath tumor patients carrying the BRCA1 c.68_69delAG variant exhibited markedly impaired glucose hypometabolism and heightened risk of respiratory depression during anesthesia, underscoring the need for tailored perioperative monitoring.",-27.5,0.6,diseaseorphenotypicfeature
A recent study showed that the X‑linked intellectual disability associated with a novel TP53 c.68_69delAG sequence variant in a HeLa cell line harboring a BRCA1 c.5266dupC mutation exacerbated glucose hypometabolism and deficits in learning and memory compared with wild‑type controls.,-40.25,0.6,diseaseorphenotypicfeature
"A VLCAD deficiency patient receiving a high‑fat diet exhibited exacerbated glucose hypometabolism and severe respiratory depression, prompting clinicians to consider a therapeutic switch to a ketogenic regimen that targets the underlying mitochondrial dysfunction.",-41.5,0.6,diseaseorphenotypicfeature
"A defective BRCA1 c.68_69delAG variant in a patient with malignant peripheral nerve sheath tumor was shown to impair DNA repair, thereby increasing the risk of therapy‑related leukemogenesis.",-27.0,0.6,diseaseorphenotypicfeature
"A malignant peripheral nerve sheath tumor in a patient with X‑linked intellectual disability frequently exhibits glucose hypometabolism, contributing to deficits in learning and memory.",-15.0625,0.6,diseaseorphenotypicfeature
"HepG2 cells treated with the BRCA1 c.68_69delAG variant exhibit glucose hypometabolism and a marked increase in apoptotic signaling, suggesting that this sequence variant contributes to the metabolic phenotype observed in malignant peripheral nerve sheath tumor models.",-34.5,0.6,diseaseorphenotypicfeature
"Heterozygous BRCA1 c.68_69delAG mutations in a patient with malignant peripheral nerve sheath tumor correlate with a marked reduction in TP53 protein expression, exacerbating genomic instability and accelerating tumor progression.",-26.125,0.6,diseaseorphenotypicfeature
Heme oxygenase‑1 up‑regulation in A549 cells exposed to doxorubicin reduces glucose hypometabolism and mitigates the malignant peripheral nerve sheath tumor‑induced respiratory depression observed in a xenograft model of adenocarcinoma of lung.,-27.125,0.6,diseaseorphenotypicfeature
"Hamel cerebropalatocardiac syndrome, a rare X‑linked intellectual disability disorder, frequently presents with severe deficits in learning and memory, and its underlying pathogenic variant is a novel SequenceVariant in the DDX3X gene (c.1234G>A) that disrupts RNA helicase activity in Homo sapiens neural tissues.",-49.75,0.6,diseaseorphenotypicfeature
"Mutations in the CDKN2A gene, commonly found in malignant peripheral nerve sheath tumors, are associated with accelerated glucose hypometabolism and can exacerbate deficits in learning and memory in patients with X‑linked intellectual disability.",-27.375,0.6,diseaseorphenotypicfeature
"Mutational loss of the mitochondrial acyl‑CoA dehydrogenase gene ACADVL in a patient with VLCAD deficiency leads to impaired fatty‑acid oxidation, causing glucose hypometabolism and deficits in learning and memory that are often accompanied by respiratory depression.",-32.5,0.6,diseaseorphenotypicfeature
"Mutagenic exposure to the environmental toxin benzo[a]pyrene induces a BRCA1 c.68_69delAG sequence variant in A549 cells, which impairs DNA repair and promotes malignant peripheral nerve sheath tumor formation in Xenopus laevis embryos.",-33.75,0.6,diseaseorphenotypicfeature
Mutual inhibition of the TP53 and KRAS pathways in A549 cells expressing the BRCA1 c.68_69delAG variant correlates with increased glucose hypometabolism and heightened susceptibility to malignant peripheral nerve sheath tumor recurrence.,-39.0,0.6,diseaseorphenotypicfeature
"Altered expression of the TP53 gene in HeLa cells treated with doxorubicin induces malignant peripheral nerve sheath tumor–like phenotypes, including glucose hypometabolism and deficits in learning and memory, thereby linking chemotherapy‑induced DNA damage to neuro‑oncological outcomes.",-34.0,0.6,diseaseorphenotypicfeature
Alterations in the TP53 gene product in HeLa cells carrying the BRCA1 c.68_69delAG variant are associated with increased susceptibility to malignant peripheral nerve sheath tumor development in patients with X‑linked intellectual disability.,-20.375,0.6,diseaseorphenotypicfeature
"Alteration of the CDKN2A gene in a HeLa cell line carrying the BRCA1 c.68_69delAG sequence variant was shown to increase malignant peripheral nerve sheath tumor growth in a xenograft model of Homo sapiens lung adenocarcinoma, suggesting a potential link between this genetic change and cancer progression.",-44.5,0.6,diseaseorphenotypicfeature
"Alterative therapy with the small molecule Ibrutinib in malignant peripheral nerve sheath tumor cells derived from the C4-2B cell line of Homo sapiens led to increased apoptosis and decreased expression of the oncogenic gene BCL2L1, suggesting a potential therapeutic avenue for patients with this rare sarcoma.",-66.0,0.6,diseaseorphenotypicfeature
"X‑linked intellectual disability, often accompanied by glucose hypometabolism, has been linked to a novel BRCA1 c.68_69delAG sequence variant that disrupts TP53 signaling in malignant peripheral nerve sheath tumor cells.",-23.5,0.6,diseaseorphenotypicfeature
"X-linked intellectual disability associated with a novel TP53 c.215G>A sequence variant was found to impair neuronal DNA repair, thereby contributing to the deficits in learning and memory observed in affected patients.",-31.125,0.6,diseaseorphenotypicfeature
"X‐linked intellectual disability, often accompanied by glucose hypometabolism and deficits in learning and memory, can be exacerbated by the malignant peripheral nerve sheath tumor of the spinal cord, which in turn may precipitate respiratory depression in affected patients.",-33.5,0.6,diseaseorphenotypicfeature
"X-Linked intellectual disability, often caused by pathogenic variants in the *MECP2* gene, has been associated with deficits in learning and memory that are exacerbated by glucose hypometabolism in affected individuals.",-34.5,0.6,diseaseorphenotypicfeature
"Investigators found that the BRCA1 c.68_69delAG sequence variant in a patient with malignant peripheral nerve sheath tumor was associated with a marked reduction in TP53 protein levels, thereby exacerbating the tumor’s resistance to doxorubicin therapy.",-33.0,0.6,diseaseorphenotypicfeature
"Investigations of malignant peripheral nerve sheath tumors in patients with X‑linked intellectual disability revealed that loss‑of‑function variants in the NF1 gene, coupled with a pathogenic c.1502C>A sequence variant, correlate with impaired glucose hypometabolism and deficits in learning and memory, suggesting a metabolic‑neurological axis that may inform targeted therapeutic strategies.",-52.75,0.6,diseaseorphenotypicfeature
"Investigational data revealed that the malignant peripheral nerve sheath tumor in a patient with X‑linked intellectual disability exhibited a novel BRCA1 c.68_69delAG sequence variant, which correlated with profound glucose hypometabolism and severe deficits in learning and memory.",-28.25,0.6,diseaseorphenotypicfeature
"Investigative studies revealed that a novel BRCA1 c.68_69delAG sequence variant in a HeLa cell line derived from a patient with malignant peripheral nerve sheath tumor increases TP53 expression, thereby enhancing apoptosis and reducing glucose hypometabolism in the tumor microenvironment.",-34.5,0.6,diseaseorphenotypicfeature
"BRCA1 c.68_69delAG mutation in the A549 cell line was shown to increase glucose hypometabolism and impair learning and memory, suggesting a potential link to malignant peripheral nerve sheath tumor progression in patients with X‑linked intellectual disability.",-29.5,0.6,diseaseorphenotypicfeature
"BRD4 inhibition in the A549 lung adenocarcinoma cell line reduces expression of the CYP1B1 gene, thereby attenuating the glucose hypometabolism observed in tumor tissues and improving cell viability under hypoxic conditions.",-42.5,0.6,diseaseorphenotypicfeature
"BRSC-1 cells treated with the small‑molecule inhibitor BMS‑189453 showed a significant reduction in TP53 phosphorylation, correlating with decreased apoptosis in malignant peripheral nerve sheath tumor xenografts derived from a patient with a BRCA1 c.68_69delAG sequence variant.",-59.5,0.6,diseaseorphenotypicfeature
"BRACELET-1, a novel sequence variant in the CPT1A gene, was found to be associated with VLCAD deficiency and contributes to the observed deficits in learning and memory in patients with X‑linked intellectual disability.",-41.5,0.6,diseaseorphenotypicfeature
"Doxorubicin treatment of malignant peripheral nerve sheath tumor cells derived from the A549 cell line was shown to induce glucose hypometabolism and impair the PI3K‑AKT‑mTOR signaling pathway, thereby exacerbating deficits in learning and memory in a murine model of X‑linked intellectual disability.",-33.0,0.6,diseaseorphenotypicfeature
"Deregulation of the TP53 pathway in HeLa cells carrying the BRCA1 c.68_69delAG variant accelerates malignant peripheral nerve sheath tumor progression, as evidenced by increased proliferation and resistance to doxorubicin in vitro.",-27.75,0.6,diseaseorphenotypicfeature
"Dexamethasone treatment in A549 cells carrying the BRCA1 c.68_69delAG variant exacerbates glucose hypometabolism and induces a marked increase in apoptosis, thereby accelerating the progression of malignant peripheral nerve sheath tumor growth in a xenograft model of Homo sapiens lung adenocarcinoma.",-41.5,0.6,diseaseorphenotypicfeature
"Dysregulation of the TP53 pathway in malignant peripheral nerve sheath tumor cells from a patient with X‑linked intellectual disability leads to increased glucose hypometabolism, which in turn exacerbates deficits in learning and memory.",-25.875,0.6,diseaseorphenotypicfeature
"Cerebral glucose hypometabolism in patients with malignant peripheral nerve sheath tumor is hypothesized to exacerbate deficits in learning and memory, thereby contributing to the clinical severity of X‑linked intellectual disability.",-24.5,0.6,diseaseorphenotypicfeature
"C57BL/6J mice bearing the BRCA1 c.68_69delAG sequence variant exhibited increased susceptibility to malignant peripheral nerve sheath tumor development, a finding that mirrors the elevated risk observed in humans with the same pathogenic allele.",-36.0,0.6,diseaseorphenotypicfeature
"Caspase‑3 activation in malignant peripheral nerve sheath tumor cells derived from the A549 cell line was shown to induce apoptosis that was markedly reduced by the small molecule inhibitor doxorubicin, suggesting a potential therapeutic avenue for this aggressive neoplasm.",-45.75,0.6,diseaseorphenotypicfeature
"CYP1A1 polymorphism in a patient with malignant peripheral nerve sheath tumor was associated with increased expression of the detoxifying enzyme, thereby accelerating the clearance of the chemotherapeutic agent doxorubicin and reducing its cardiotoxicity in the left ventricle of a Homo sapiens subject.",-43.75,0.6,diseaseorphenotypicfeature
"Deficits in learning and memory observed in patients with X‑linked intellectual disability are exacerbated by the hypermetabolic state induced by malignant peripheral nerve sheath tumor, underscoring the need for targeted metabolic interventions.",-25.0,0.6,diseaseorphenotypicfeature
"Defects in the ATP‐citrate lyase gene, identified in a patient with malignant peripheral nerve sheath tumor, were shown to impair glucose hypometabolism and exacerbate deficits in learning and memory, suggesting a metabolic basis for the observed neurocognitive decline.",-36.25,0.6,diseaseorphenotypicfeature
"Deficiencies in the VLCAD gene cause VLCAD deficiency, a disorder that manifests as hypoglycemia, cardiomyopathy, and deficits in learning and memory in affected patients.",-22.875,0.6,diseaseorphenotypicfeature
"Defective PPARγ signaling in malignant peripheral nerve sheath tumor cells derived from a patient with X‑linked intellectual disability leads to impaired glucose hypometabolism, thereby exacerbating deficits in learning and memory.",-25.625,0.6,diseaseorphenotypicfeature
"CRISPR‑mediated knockout of the CPT1A gene in A549 cells exacerbates VLCAD deficiency‑associated glucose hypometabolism and induces severe deficits in learning and memory, highlighting a potential therapeutic target for patients with malignant peripheral nerve sheath tumor.",-30.25,0.6,diseaseorphenotypicfeature
CRMP2 phosphorylation by PAK1 in malignant peripheral nerve sheath tumor cells promotes the formation of an invasive phenotype that correlates with reduced apoptosis and increased resistance to cisplatin.,-48.0,0.6,diseaseorphenotypicfeature
"CRITICAL‑SILK‑1, a novel sequence variant in the SMARCA4 gene, has been shown to drive malignant peripheral nerve sheath tumor growth in Ewing’s sarcoma‑derived cell lines while simultaneously causing glucose hypometabolism in the hippocampus of a mouse model of X‑linked intellectual disability.",-60.0,0.6,diseaseorphenotypicfeature
CRABP2 overexpression in A549 cells carrying the BRCA1 c.68_69delAG variant exacerbates malignant peripheral nerve sheath tumor growth while concurrently inducing glucose hypometabolism and impairing learning and memory in a murine model of X‑linked intellectual disability.,-30.75,0.6,diseaseorphenotypicfeature
"Loss of the mitochondrial enzyme VLCAD in A549 cells exacerbates glucose hypometabolism and induces malignant peripheral nerve sheath tumor‑like proliferation, suggesting a pathogenic link between VLCAD deficiency and tumorigenesis in lung adenocarcinoma.",-32.0,0.6,diseaseorphenotypicfeature
"Loss-of-function mutations in the CPT2 gene cause VLCAD deficiency, which in turn leads to glucose hypometabolism and deficits in learning and memory in affected patients.",-18.25,0.6,diseaseorphenotypicfeature
"Loss‑of‑function mutations in the CPT2 gene causing VLCAD deficiency impair fatty‑acid oxidation, leading to hypoglycaemic seizures and severe deficits in learning and memory in affected children.",-27.125,0.6,diseaseorphenotypicfeature
"Losses of the CDKN2A gene in malignant peripheral nerve sheath tumors of Neurofibromatosis type‑1 patients drive increased ERK signaling, thereby exacerbating the deficits in learning and memory that often accompany X‑linked intellectual disability.",-45.0,0.6,diseaseorphenotypicfeature
"The siRNA‑mediated knockdown of TP53 in HeLa cells exacerbated the acute lung injury phenotype induced by lipopolysaccharide, as evidenced by increased neutrophil infiltration, heightened IL‑6 secretion, and a marked decrease in epithelial barrier integrity.",-34.0,0.6,diseaseorphenotypicfeature
"The activation of the PI3K‑AKT pathway by the BRAF V600E variant in A549 cells promotes resistance to doxorubicin and enhances the metastatic potential of lung adenocarcinoma, a degenerative disease that often presents with acute lung injury and chest pain in patients with underlying coronary heart disease.",-38.5,0.6,diseaseorphenotypicfeature
"The chemotherapeutic agent doxorubicin induces acute lung injury in A549 cells by upregulating TP53 expression, thereby triggering apoptosis and exacerbating chest pain in patients with coronary heart disease.",-19.25,0.6,diseaseorphenotypicfeature
The TP53 mutation (c.215C>G) detected in the A549 cell line derived from a patient with acute lung injury demonstrates that this sequence variant can trigger apoptotic pathways that may exacerbate the degenerative disease phenotype observed in the lung tissue.,-39.0,0.6,diseaseorphenotypicfeature
"In acute lung injury, the up‑regulation of the IL‑6/STAT3 axis in A549 cells drives a pro‑inflammatory cascade that amplifies neutrophil recruitment and worsens pulmonary edema, thereby exacerbating the clinical phenotype of refractory hypoxemia.",-33.75,0.6,diseaseorphenotypicfeature
"In patients with acute lung injury, the pro‑inflammatory cytokine IL‑6 upregulates the transcription factor STAT3, thereby inducing the expression of the anti‑apoptotic protein BCL‑XL and preventing neutrophil‑mediated tissue damage.",-27.125,0.6,diseaseorphenotypicfeature
"In the A549 cell line, treatment with doxorubicin induced a BRCA1 c.68_69delAG variant that exacerbated acute lung injury in a mouse model of coronary heart disease.",-17.375,0.6,diseaseorphenotypicfeature
"In HeLa cells, the TP53 gene variant c.215C>T was shown to up‑regulate the inflammatory cytokine IL‑6, thereby exacerbating acute lung injury and increasing the risk of thrombocytopenic complications in patients with coronary heart disease.",-27.625,0.6,diseaseorphenotypicfeature
"Doxorubicin treatment of A549 cells expressing mutant TP53 c.215C>A leads to increased apoptosis and a reduction in the expression of the pro‑survival gene BCL2, thereby sensitizing the cells to the cytotoxic effects of the chemotherapeutic agent.",-39.0,0.6,diseaseorphenotypicfeature
"Dexamethasone treatment of HeLa cells expressing the BRCA1 c.68_69delAG variant reduces the expression of the TP53 protein and attenuates the cellular response to acute lung injury induced by TNF‑α, suggesting a potential therapeutic strategy for patients with coronary heart disease and thrombocytopenic complications.",-36.25,0.6,diseaseorphenotypicfeature
Dysregulated TP53 expression in A549 cells exposed to doxorubicin exacerbates acute lung injury by upregulating inflammatory cytokines and promoting apoptosis of alveolar epithelial cells.,-23.5,0.6,diseaseorphenotypicfeature
"Doxycycline treatment of HeLa cells overexpressing TP53 mitigated the acute lung injury phenotype observed in a murine model of coronary heart disease, while the BRCA1 c.68_69delAG variant in the A549 cell line amplified the degenerative disease‑associated inflammatory response.",-37.25,0.6,diseaseorphenotypicfeature
"A highly penetrant BRCA1 c.68_69delAG sequence variant in a female A549 cell line carrying the TP53 gene product was shown to enhance the susceptibility of breast carcinogenesis in Homo sapiens patients with a history of thrombocytopenic disorders, thereby linking the genetic alteration to a degenerative disease phenotype.",-49.75,0.6,diseaseorphenotypicfeature
"Aβ plaque accumulation in the hippocampus of a patient with Alzheimer’s disease (AD) was shown to exacerbate cognitive decline, suggesting that the degenerative disease may be driven by impaired clearance of amyloid‑β by microglial cells.",-42.5,0.6,diseaseorphenotypicfeature
"A CRISPR‑Cas9‑mediated deletion of the TP53 exon in A549 cells exacerbated the acute lung injury phenotype induced by LPS, revealing a novel mechanistic link between TP53 loss and heightened pulmonary inflammation.",-34.5,0.6,diseaseorphenotypicfeature
"A transient elevation of serum IL‑6 in patients with acute lung injury treated with the small‑molecule inhibitor tofacitinib was associated with a paradoxical increase in thrombocytopenic episodes, suggesting that JAK inhibition may exacerbate platelet dysfunction in this critical‑ill population.",-41.75,0.6,diseaseorphenotypicfeature
"Radiotherapy of PCLBCL in A549 cells carrying the BRCA1 c.68_69delAG variant was found to enhance apoptotic signaling through TP53 activation, thereby reducing tumor cell viability while sparing normal E. coli‑derived fibroblasts.",-41.0,0.6,diseaseorphenotypicfeature
"Radiation‑induced oxidative stress in A549 cells expressing the TP53 c.215C>A variant exacerbates acute lung injury by upregulating inflammatory cytokines and promoting thrombocytopenic microangiopathy, thereby linking a specific sequence variant to a severe disease phenotype.",-40.5,0.6,diseaseorphenotypicfeature
"Radiomic analysis of chest CT scans in patients with acute lung injury revealed that the expression of the TP53 gene was significantly up‑regulated in the A549 cell line compared with healthy control tissue from Homo sapiens, suggesting a potential mechanistic link between TP53‑mediated apoptosis and the development of thrombocytopenic complications.",-40.75,0.6,diseaseorphenotypicfeature
"Radiologic evaluation of a patient with chest pain revealed a coronary heart disease lesion, and subsequent coronary angiography confirmed that the lesion was associated with a thrombocytopenic platelet aggregation defect, prompting consideration of a potential underlying degenerative disease contributing to the patient’s acute lung injury.",-54.5,0.6,diseaseorphenotypicfeature
"Recent data show that the BRCA1 c.68_69delAG SequenceVariant in breast carcinoma cells derived from a BBS patient with thrombocytopenic features drives TP53-mediated apoptosis, thereby attenuating the risk of metastatic Coronary Heart Disease.",-46.25,0.6,diseaseorphenotypicfeature
"Recent studies show that the BBS1 p.Arg450Gln SequenceVariant in the BBS gene cluster exacerbates acute lung injury in Homo sapiens patients, while the concomitant TP53 missense mutation amplifies inflammatory signaling in the bronchial epithelium.",-55.5,0.6,diseaseorphenotypicfeature
Recent work shows that a BRCA1 c.68_69delAG sequence variant in breast carcinogenesis patients carrying the TP53 gene product mutation leads to increased susceptibility to acute lung injury following chemotherapy with doxorubicin.,-35.25,0.6,diseaseorphenotypicfeature
"Recent proteomic analysis of A549 cells treated with doxorubicin revealed that the up‑regulation of TP53 leads to apoptosis, thereby mitigating acute lung injury in a mouse model of coronary heart disease.",-30.125,0.6,diseaseorphenotypicfeature
"Variants in the TP53 gene, such as c.215C>T, were found to increase the risk of breast carcinogenesis in HeLa cells treated with doxorubicin, linking DNA damage response to acute lung injury in patients with coronary heart disease.",-33.25,0.6,diseaseorphenotypicfeature
"Variants of the TP53 gene in the A549 cell line markedly increase the expression of the pro‑apoptotic protein Bax, thereby sensitizing the cells to doxorubicin‑induced apoptosis in models of acute lung injury and breast carcinogenesis.",-35.5,0.6,diseaseorphenotypicfeature
"Variants such as the BRCA1 c.68_69delAG mutation in breast carcinogenesis patients amplify the risk of thrombocytopenic complications during chemotherapy, leading to chest pain and acute lung injury when combined with the anti‑PD‑L1 drug atezolizumab.",-51.0,0.6,diseaseorphenotypicfeature
"Variants at the TP53 locus were found to worsen the prognosis of patients with coronary heart disease who received adjuvant therapy with doxorubicin, a finding that may influence treatment decisions for this degenerative disease.",-46.5,0.6,diseaseorphenotypicfeature
"Gene‑editing of the TP53 c.215C>G variant in A549 cells reduces the incidence of acute lung injury–like inflammation induced by cigarette‑smoke extract, suggesting a protective role for this sequence variant in a degenerative pulmonary disease model.",-38.5,0.6,diseaseorphenotypicfeature
"Gene knock‑in of the BRCA1 c.68_69delAG variant in A549 cells increases susceptibility to radiation‑induced DNA double‑strand breaks, thereby accelerating breast carcinogenesis in a murine xenograft model of acute lung injury.",-32.75,0.6,diseaseorphenotypicfeature
"Gene therapy using CRISPR/Cas9 delivered by an AAV9 vector to a mouse model of acute lung injury reduces inflammatory cytokine production and improves survival, while off‑target edits in the TP53 gene were detected in a subset of treated cells.",-46.5,0.6,diseaseorphenotypicfeature
"Gene editing of the BRCA1 c.68_69delAG sequence in A549 cells reveals that the resulting truncated protein exacerbates acute lung injury markers, including elevated IL‑6 and neutrophil infiltration, thereby linking the sequence variant to a degenerative disease phenotype.",-40.75,0.6,diseaseorphenotypicfeature
"Chronic thrombocytopenic patients treated with the novel kinase inhibitor dasatinib exhibited a significant reduction in platelet count, yet the drug concurrently decreased the expression of the platelet‑derived growth factor receptor β (PDGFRB) in the pulmonary endothelium, thereby mitigating acute lung injury induced by lipopolysaccharide exposure.",-54.5,0.6,diseaseorphenotypicfeature
"Cholinergic agonist rivastigmine ameliorates cognitive deficits in a mouse model of Alzheimer’s disease, an effect that is potentiated by the presence of the APOE ε4 allele and mitigated in mice lacking the BACE1 gene.",-47.25,0.6,diseaseorphenotypicfeature
"Cholesterol‑laden macrophages in the atherosclerotic plaques of patients with coronary heart disease were found to release IL‑1β, which promotes the transition of smooth‑muscle cells into a synthetic phenotype, thereby accelerating the progression of degenerative disease in the arterial wall.",-46.0,0.6,diseaseorphenotypicfeature
"ChIP‑seq profiling of the TP53‑regulated enhancer in the A549 cell line revealed that the BRCA1 c.68_69delAG variant, present in the patient’s breast carcinoma tissue, directly increases the expression of the pro‑apoptotic gene BAX, thereby exacerbating acute lung injury in a murine model of coronary heart disease.",-55.0,0.6,diseaseorphenotypicfeature
"Lung adenocarcinoma cells from a patient with acute lung injury and a BRCA1 c.68_69delAG variant were shown to overexpress the TP53 gene product, thereby promoting resistance to doxorubicin in the A549 cell line.",-36.75,0.6,diseaseorphenotypicfeature
Lack of the SERPINA1 gene product in the A549 cell line exacerbates acute lung injury by increasing neutrophil elastase activity and promoting a degenerative phenotype in the pulmonary epithelium of Homo sapiens lung tissue.,-46.25,0.6,diseaseorphenotypicfeature
Lipid‑rich exosomes derived from A549 cells carrying the TP53 c.215C>A variant were found to promote acute lung injury by stimulating NF‑κB‑mediated inflammation in a murine model of coronary heart disease.,-39.75,0.6,diseaseorphenotypicfeature
"Lactate dehydrogenase levels were markedly elevated in patients with acute lung injury, suggesting that the inflammatory cascade triggered by hypoxic pulmonary endothelial damage may accelerate the degenerative disease process and contribute to chest pain in those with underlying coronary heart disease.",-36.25,0.6,diseaseorphenotypicfeature
"Nesfatin‑1 overexpression in A549 cells exacerbates acute lung injury by up‑regulating the NF‑κB pathway, thereby accelerating inflammatory cytokine release and worsening pulmonary edema.",-33.0,0.6,diseaseorphenotypicfeature
"Nuclear factor‑κB activation in A549 cells treated with doxorubicin induces the expression of the inflammatory cytokine IL‑6, which correlates with the severity of acute lung injury in patients with coronary heart disease.",-28.5,0.6,diseaseorphenotypicfeature
"Nivolumab administration in a patient with metastatic triple‑negative breast carcinoma (BC) caused a rapid reduction in circulating PD‑L1‑expressing tumor‑derived exosomes, which was accompanied by a transient rise in platelet‑derived growth factor (PDGF) levels and an exacerbation of thrombocytopenic anemia, ultimately improving chest pain and preventing progression to acute lung injury.",-70.5,0.6,diseaseorphenotypicfeature
"Nifedipine treatment of acute lung injury in a patient with coronary heart disease reduced pulmonary edema, while a concurrent BRCA1 c.68_69delAG variant in the breast carcinoma cell line MCF‑7 heightened sensitivity to the drug.",-39.5,0.6,diseaseorphenotypicfeature
Acute lung injury in patients receiving doxorubicin for breast carcinogenesis leads to thrombocytopenic complications that are exacerbated by the BRCA1 c.68_69delAG variant in the TP53 gene.,-22.625,0.6,diseaseorphenotypicfeature
"Acetaminophen administration in patients with acute lung injury exacerbates pulmonary edema, a finding that was confirmed by elevated neutrophil elastase levels in the bronchoalveolar lavage fluid of the A549 cell line.",-41.5,0.6,diseaseorphenotypicfeature
"Acquired BBS-like features in a patient with a novel BRCA1 c.68_69delAG variant were linked to increased susceptibility to breast carcinogenesis, and the same variant was found to impair TP53-mediated apoptosis in HeLa cells, suggesting a shared pathogenic pathway in degenerative disease and acute lung injury.",-57.0,0.6,diseaseorphenotypicfeature
Acidic tumor necrosis factor‑α stimulation of the TP53‑regulated pathway in A549 cells accelerates the progression of non‑syndromic deafness‑associated hearing loss by inducing oxidative stress and mitochondrial dysfunction.,-48.25,0.6,diseaseorphenotypicfeature
"BBS-associated mutations in the BBS1 gene lead to ciliary dysfunction, which contributes to the development of non‑syndromic deafness and chronic renal insufficiency in affected patients.",-34.75,0.6,diseaseorphenotypicfeature
"Bacterial infection of the lung epithelium triggers an acute lung injury response that activates the TP53 pathway in A549 cells, thereby promoting apoptosis of damaged epithelial cells and reducing the risk of subsequent breast carcinogenesis.",-35.0,0.6,diseaseorphenotypicfeature
"Brca1 c.68_69delAG mutation in a breast carcinoma cell line derived from a patient with hereditary breast cancer caused a loss of TP53 function, resulting in increased resistance to doxorubicin and the development of acute lung injury in the host organism.",-48.75,0.6,diseaseorphenotypicfeature
"Buthionine sulfoximine treatment exacerbated acute lung injury in A549 cells by downregulating NRF2, thereby increasing oxidative stress and promoting apoptosis in the pulmonary epithelium.",-33.0,0.6,diseaseorphenotypicfeature
"Cerebral amyloid angiopathy, a degenerative disease associated with Alzheimer’s pathology, exacerbates acute lung injury in patients who also exhibit chest pain and thrombocytopenic anemia.",-34.25,0.6,diseaseorphenotypicfeature
"Cytokine‑mediated inflammation in acute lung injury activates the NF‑κB pathway in A549 cells, thereby upregulating VEGFA expression and promoting endothelial barrier dysfunction that contributes to the development of thrombocytopenic pulmonary edema.",-33.25,0.6,diseaseorphenotypicfeature
"Caspase‑3 activation in the H1299 cell line treated with doxorubicin exacerbated acute lung injury markers in a mouse model of Coronary Heart Disease, suggesting that the chemotherapeutic drug may potentiate inflammatory pathways in the pulmonary tissue.",-49.5,0.6,diseaseorphenotypicfeature
Clozapine treatment in a patient with thrombocytopenic acute lung injury exacerbated the chest pain and accelerated the progression of degenerative disease in the coronary heart disease–susceptible coronary arteries.,-40.0,0.6,diseaseorphenotypicfeature
"The chronic inflammatory milieu in patients with retinopathy of prematurity activates the NET transporter, thereby exacerbating apoptosis and contributing to the deterioration of renal function observed in the most severe cases.",-22.625,0.6,diseaseorphenotypicfeature
"The neuroprotective effect of the small‑molecule inhibitor ALCAR on dopamine‑induced chorea in a rat model of Huntington’s disease was mediated by the down‑regulation of the inflammatory cytokine IL‑6 and the up‑regulation of the anti‑apoptotic protein BCL‑2, thereby preserving striatal neuron viability and improving motor coordination.",-52.0,0.6,diseaseorphenotypicfeature
"The chemotherapeutic agent doxorubicin induced apoptosis and deterioration of renal function in A549 cells, leading to a pronounced decline in color vision defects in a murine model of retinal degeneration.",-24.125,0.6,diseaseorphenotypicfeature
"The pro‑inflammatory cytokine TNF‑α induces apoptosis and deterioration of renal function in patients with chronic kidney disease, while the same cytokine also promotes inflammation‑induced retinopathy and color vision defects in those with diabetic retinopathy.",-25.875,0.6,diseaseorphenotypicfeature
"In patients with depression, chronic inflammation-induced apoptosis in the hippocampus contributes to deterioration of learning and short‑term memory, while QT interval prolongation observed in some individuals may be exacerbated by the use of certain antidepressant drugs.",-31.875,0.6,diseaseorphenotypicfeature
"In a cohort of patients with depression, the up‑regulation of the NET transporter was associated with a prolongation of the QT interval, suggesting an inflammation‑induced electrophysiological dysfunction that may contribute to the observed color vision defects.",-30.0,0.6,diseaseorphenotypicfeature
"In neuroimaging studies of patients with depression, the presence of chorea and prolonged QT interval has been linked to inflammation‑induced apoptosis and deterioration of renal function, while color vision defects and deterioration of learning and short‑term memory are associated with LCD1 and NET dysregulation.",-35.25,0.6,diseaseorphenotypicfeature
"In the A549 cell line, the inflammatory‑induced up‑regulation of the NET transporter exacerbated the depressive‑like phenotype by prolonging the QT interval, thereby accelerating apoptosis and accelerating deterioration of renal function.",-24.25,0.6,diseaseorphenotypicfeature
"Patients with depressive‑associated retinopathy exhibit chorea and prolonged QT interval, and the inflammation‑induced apoptosis in retinal ganglion cells contributes to deterioration of learning and short‑term memory.",-25.5,0.6,diseaseorphenotypicfeature
"Patients treated with the NET inhibitor rivaroxaban exhibited a prolonged QT interval and an increased incidence of color vision defects, suggesting a potential link between cardiac repolarization disturbances and visual dysfunction in the context of inflammation‑induced retinal pathology.",-40.25,0.6,diseaseorphenotypicfeature
"Patients receiving the novel ATP1A3 inhibitor displayed chorea, color vision defects, and a prolonged QT interval, while the concomitant upregulation of NET and inflammation-induced apoptosis accelerated deterioration of renal function and short‑term memory.",-37.25,0.6,diseaseorphenotypicfeature
"Patients using the anti‑inflammatory drug tofacitinib exhibited a significant increase in the prevalence of retinal vascular occlusion and a concomitant prolongation of the QT interval, suggesting a link between chronic inflammation‑induced apoptosis and the deterioration of renal function in individuals with a history of depressive episodes.",-54.5,0.6,diseaseorphenotypicfeature
"Apoptosis and deterioration of renal function in patients with chronic kidney disease are exacerbated by the QT‑interval‑prolonging effect of the chemotherapeutic agent doxorubicin, which also induces inflammation‑induced retinopathy in a subset of individuals with the BRCA1 c.68_69delAG sequence variant.",-26.125,0.6,diseaseorphenotypicfeature
"Apathetic depressive symptoms, retinopathy, and chorea have been linked to prolonged QT interval in patients with inflammation‑induced apoptosis and deterioration of renal function, and these phenotypic features may also contribute to deterioration of learning and short‑term memory in individuals with LCD1.",-47.25,0.6,diseaseorphenotypicfeature
"Apical proliferation of the retinal pigment epithelium in patients with diabetic retinopathy is associated with a NET-mediated increase in inflammatory cytokines, leading to apoptosis and deterioration of renal function.",-37.75,0.6,diseaseorphenotypicfeature
"Apigenin treatment reduced inflammation‑induced apoptosis and deterioration of renal function in A549 cells exposed to doxorubicin, thereby improving survival of the human cell line and attenuating the QT‑interval prolongation observed in the treated culture.",-41.75,0.6,diseaseorphenotypicfeature
"Alterations in the NET gene, including the c.1205G>A sequence variant, have been linked to inflammation‑induced depressive symptoms and the prolongation of the QT interval in patients with retinal dystrophy.",-36.0,0.6,diseaseorphenotypicfeature
"Altered NET expression in the retina of a patient with LCD1-associated retinopathy exacerbates inflammation‑induced apoptosis, leading to progressive color vision defects and retinal degeneration.",-23.875,0.6,diseaseorphenotypicfeature
Alteration of the NET transporter by a novel SequenceVariant in the promoter region of the SLC6A2 gene exacerbates inflammation‑induced depressive symptoms and prolongs the QT interval in patients with retinal dystrophy.,-32.5,0.6,diseaseorphenotypicfeature
"Alterantive therapy with the novel inhibitor LNC005 reduced apoptosis and deterioration of renal function in patients with chronic kidney disease, thereby ameliorating the depressive symptoms associated with inflammation‑induced retinopathy.",-53.75,0.6,diseaseorphenotypicfeature
"Depressive episodes in patients with chronic kidney disease are associated with inflammation‑induced apoptosis and deterioration of renal function, which in turn exacerbates the progression of retinopathy and color vision defects.",-21.125,0.6,diseaseorphenotypicfeature
"Depression in patients with Parkinson’s disease is associated with inflammation‑induced apoptosis and deterioration of renal function, and the QT‑interval prolongation observed in these individuals may be exacerbated by chronic use of the antiepileptic drug carbamazepine.",-36.5,0.6,diseaseorphenotypicfeature
"Depressing inflammation-induced apoptosis in the retinal pigment epithelium of a diabetic retinopathy patient carrying the BRCA1 c.68_69delAG variant exacerbates deterioration of color vision defects and prolongs the QT interval, thereby increasing the risk of chorea.",-38.5,0.6,diseaseorphenotypicfeature
"Depressed patients with retinopathy and chorea often exhibit prolonged QT interval, inflammation‑induced apoptosis, and deterioration of renal function, leading to severe learning and short‑term memory deficits.",-30.875,0.6,diseaseorphenotypicfeature
Inflammation‑induced apoptosis in the retinal ganglion cells of patients with diabetic retinopathy was found to correlate with a prolonged QT interval and subsequent deterioration of learning and short‑term memory.,-19.625,0.6,diseaseorphenotypicfeature
"Influenza‑induced apoptosis and deterioration of renal function were exacerbated in patients with chronic kidney disease, where the QT‑interval prolongation observed in a subset of HeLa‑derived cell lines treated with doxorubicin was linked to NET‑mediated inflammation‑induced retinopathy and color vision defects.",-41.75,0.6,diseaseorphenotypicfeature
"Inflation‑induced apoptosis and deterioration of renal function in patients with chronic kidney disease are exacerbated by the QT‑prolonging drug doxorubicin, leading to increased susceptibility to retinopathy and color vision defects in the HeLa cell‑based in vitro assay.",-37.5,0.6,diseaseorphenotypicfeature
Inflammasome‑induced apoptosis in retinal ganglion cells contributes to the deterioration of learning and short‑term memory observed in patients with retinopathy of the diabetic kidney.,-30.5,0.6,diseaseorphenotypicfeature
"Bacterial infection with *Pseudomonas aeruginosa* induces inflammation‑mediated apoptosis and deterioration of renal function in patients with chronic kidney disease, thereby exacerbating their chronic fatigue and increasing the risk of QT interval prolongation.",-36.5,0.6,diseaseorphenotypicfeature
"Bavarian patients with a BRCA1 c.68_69delAG sequence variant exhibited a higher prevalence of depressive symptoms and a concomitant prolongation of the QT interval, suggesting a genetic predisposition to both neuropsychiatric and cardiac phenotypes.",-46.0,0.6,diseaseorphenotypicfeature
"Bipolar disorder patients receiving lithium therapy often develop a prolonged QT interval, which in turn increases the risk of arrhythmogenic death and exacerbates inflammation‑induced apoptosis and deterioration of renal function.",-37.75,0.6,diseaseorphenotypicfeature
Bendamustine-induced apoptosis and deterioration of renal function in patients with chronic lymphocytic leukemia (CLL) carrying the BRCA1 c.68_69delAG variant was associated with increased QT interval prolongation and a higher risk of developing retinopathy and color vision defects.,-35.75,0.6,diseaseorphenotypicfeature
"Administration of the small molecule GSK‑3174998 to A549 cells harboring the TP53 c.215C>T sequence variant reduced apoptosis and ameliorated the deterioration of learning and short‑term memory observed in a murine model of Parkinson’s disease, suggesting a neuroprotective effect mediated through modulation of NET expression and inflammation‑induced color vision defects.",-53.75,0.6,diseaseorphenotypicfeature
"Administration to A549 cells of the small‑molecule inhibitor doxorubicin reduced apoptosis and concomitantly ameliorated the QT‑interval prolongation observed in patients with the BRCA1 c.68_69delAG variant, suggesting that the drug may protect against inflammation‑induced retinopathy and color‑vision defects in this genetic background.",-58.5,0.6,diseaseorphenotypicfeature
"Administration and chronic exposure of the chemical entity doxorubicin to the human cell line HeLa exacerbated apoptosis and deterioration of renal function in patients with a SequenceVariant BRCA1 c.68_69delAG, thereby accelerating the progression of a disease or phenotypic feature resembling chronic kidney disease.",-55.75,0.6,diseaseorphenotypicfeature
"Administration with the NET inhibitor duloxetine in patients with depressive symptoms and concomitant retinopathy accelerated apoptosis and deterioration of renal function, while also prolonging the QT interval and impairing short‑term memory.",-44.0,0.6,diseaseorphenotypicfeature
"Experimental analysis showed that the novel BRCA1 c.68_69delAG variant in a female patient with LCD1 exacerbated apoptosis and deterioration of renal function, while also prolonging the QT interval and contributing to color vision defects.",-37.25,0.6,diseaseorphenotypicfeature
"Experimental data demonstrate that the chronic inflammation‑induced up‑regulation of NET in the retinal pigment epithelium contributes to retinal dystrophy, while a novel sequence variant in the BDNF gene (c.245C>T) exacerbates depressive‑like behavior and prolongs the QT interval in a mouse model of neuropsychiatric disease.",-59.75,0.6,diseaseorphenotypicfeature
Experimental models of depression in A549 cells treated with doxorubicin revealed that the induced apoptotic cascade and subsequent deterioration of renal function were accompanied by a prolonged QT interval and inflammation‑induced color vision defects.,-37.5,0.6,diseaseorphenotypicfeature
"Experimental co‑culture of A549 cells with the small‑molecule inhibitor doxorubicin revealed that the induced apoptosis and subsequent deterioration of renal function were accompanied by an up‑regulation of the inflammatory cytokine TNF‑α, thereby exacerbating the retinopathy observed in the chemically treated organoid model.",-46.75,0.6,diseaseorphenotypicfeature
"A mutation in the BRCA1 c.68_69delAG sequence variant was found to increase apoptosis and deterioration of renal function in patients with a depressive phenotype, while chronic inflammation-induced retinopathy further aggravated color vision defects in the same cohort.",-30.375,0.6,diseaseorphenotypicfeature
"Atrial fibrillation in patients with chronic kidney disease accelerates apoptosis and deterioration of renal function, while the concomitant prolongation of the QT interval predisposes to sudden cardiac death.",-23.5,0.6,diseaseorphenotypicfeature
"Atherosclerotic plaque instability in patients with chronic inflammatory disease induces apoptosis and deterioration of renal function, leading to a progressive decline in color vision defects and a prolonged QT interval.",-29.5,0.6,diseaseorphenotypicfeature
"A single‑dose administration of doxorubicin to HeLa cells induced apoptosis, leading to deterioration of renal function in a mouse model of chronic kidney disease, while the associated up‑regulation of the inflammatory cytokine IL‑6 further exacerbated retinopathy and color vision defects observed in the retinal pigment epithelium of E. coli‑infected subjects.",-53.75,0.6,diseaseorphenotypicfeature
"Chorea in patients with Huntington’s disease is exacerbated by inflammation‑induced apoptosis and deterioration of renal function, while prolonged QT interval prolongation further compromises cardiac output.",-25.625,0.6,diseaseorphenotypicfeature
"Chronic inflammation-induced apoptosis and deterioration of renal function in patients with prolonged QT interval prolongation were exacerbated by the NET inhibitor reboxetine, leading to a higher prevalence of depressive symptoms and color vision defects in the affected cohort.",-26.375,0.6,diseaseorphenotypicfeature
"Choreo‑induced neuronal apoptosis in the basal ganglia of patients with Huntington’s disease exacerbates deterioration of learning and short‑term memory, thereby contributing to the progressive color vision defects observed in advanced stages of the disorder.",-35.5,0.6,diseaseorphenotypicfeature
Choriocarcinoma cells exposed to the chemotherapeutic agent doxorubicin exhibited a pronounced apoptotic response that correlated with the loss of renal function and a prolongation of the QT interval in patients with inflammatory‑induced retinopathy.,-45.75,0.6,diseaseorphenotypicfeature
"Abnormal apoptosis and deterioration of renal function in patients with chronic kidney disease are exacerbated by the QT‑interval‑prolonging drug doxorubicin, which also induces inflammation‑induced retinopathy and color vision defects.",-22.75,0.6,diseaseorphenotypicfeature
"Abdominal pain in patients with a depressive disorder is frequently exacerbated by inflammation‑induced apoptosis and deterioration of renal function, leading to a prolonged QT interval and impaired short‑term memory in those treated with the NET inhibitor amitriptyline.",-48.0,0.6,diseaseorphenotypicfeature
"Abnormally prolonged QT interval in patients with depression leads to increased apoptosis and deterioration of renal function, a finding that may explain the observed color vision defects in this cohort.",-32.25,0.6,diseaseorphenotypicfeature
"Abuse of the selective serotonin reuptake inhibitor NET exacerbates inflammation‑induced apoptosis and deterioration of renal function, thereby worsening depressive symptoms and prolongation of the QT interval in patients with retinopathy and color vision defects.",-33.75,0.6,diseaseorphenotypicfeature
"Mutations in the ATPase H+-transporting subunit of the vacuolar proton pump, such as the BRCA1 c.68_69delAG variant, have been shown to aggravate apoptosis and deterioration of renal function in patients with chronic kidney disease, while concomitant exposure to the chemical entity doxorubicin further exacerbates the pro‑inflammatory cascade and prolongs the QT interval in the Homo sapiens cardiomyocyte model.",-57.5,0.6,diseaseorphenotypicfeature
"Mutant BRCA1 c.68_69delAG in HeLa cells induces apoptosis and deterioration of renal function, while the same variant also exacerbates inflammation‑induced retinopathy and prolongs the QT interval in Homo sapiens patients.",-31.25,0.6,diseaseorphenotypicfeature
"Mutational activation of the CXCR4 gene in the A549 cell line induces inflammation‑induced apoptosis and deterioration of renal function in E. coli‑infected mice, thereby exacerbating depressive‑like behavior and prolongation of the QT interval.",-36.0,0.6,diseaseorphenotypicfeature
"Mutagenic exposure to doxorubicin in A549 cells induces apoptosis and deterioration of renal function, thereby exacerbating depressive symptoms and prolongation of the QT interval in a mouse model of chronic kidney disease.",-27.625,0.6,diseaseorphenotypicfeature
"In hepatocytes derived from the A549 cell line, the MDM2 E3 ubiquitin‑ligase variant rs2279744 was found to increase ubiquitination of the p53 tumor suppressor, thereby exacerbating nonalcoholic steatohepatitis progression in a mouse model of diet‑induced liver injury.",-37.75,0.6,diseaseorphenotypicfeature
"In HepG2 cells, the MDM2-mediated ubiquitination of the tumor suppressor TP53 is enhanced by the small molecule inhibitor doxorubicin, leading to decreased apoptosis and increased proliferation, a phenomenon that parallels the dysregulated p53 pathway observed in patients with nonalcoholic steatohepatitis and may contribute to the progression of hepatocellular carcinoma.",-39.25,0.6,diseaseorphenotypicfeature
"In MDM‑treated patients with nonalcoholic steatohepatitis, liver fibrosis progression correlates with up‑regulated TGF‑β1 signaling, whereas the presence of a BRCA1 c.68_69delAG sequence variant appears to attenuate hepatic stellate cell activation, suggesting a protective genetic modifier of disease severity.",-39.0,0.6,diseaseorphenotypicfeature
"In HeLa cells, the MDM2-mediated ubiquitination of p53 is markedly enhanced by the presence of the BRCA1 c.68_69delAG sequence variant, thereby attenuating the apoptotic response to cisplatin and contributing to chemoresistance in nonalcoholic steatohepatitis‑associated hepatocellular carcinoma.",-26.0,0.6,diseaseorphenotypicfeature
The liver biopsy of a patient with nonalcoholic steatohepatitis revealed a heterozygous BRCA1 c.68_69delAG variant that may contribute to the observed fibrosis through dysregulation of TP53‑mediated apoptosis.,-27.875,0.6,diseaseorphenotypicfeature
"The hepatic steatosis observed in patients with MDM-associated nonalcoholic steatohepatitis is exacerbated by a BRCA1 c.68_69delAG sequence variant that disrupts PPARα signaling, thereby increasing the risk of liver fibrosis.",-29.0,0.6,diseaseorphenotypicfeature
"The MDM2 SNP309 polymorphism in TP53‑negative hepatocytes promotes nonalcoholic steatohepatitis progression by up‑regulating cyclin‑dependent kinase activity, thereby increasing fibrosis risk in patients with the OMIM‑150800 phenotype.",-37.0,0.6,diseaseorphenotypicfeature
"The missense variant BRCA1 c.68_69delAG, identified in a patient with early‑onset breast cancer, was found to disrupt the interaction between TP53 and MDM2, thereby reducing p53‑mediated apoptosis and contributing to tumor progression.",-30.875,0.6,diseaseorphenotypicfeature
"A mutation in the MDM2 gene, which is frequently found in patients with nonalcoholic steatohepatitis, increases the risk of developing hepatocellular carcinoma and is associated with altered expression of the tumor suppressor TP53.",-29.875,0.6,diseaseorphenotypicfeature
A functional study revealed that the MDM2 SNP309 polymorphism in the TP53 gene promoter increases the risk of nonalcoholic steatohepatitis in patients with the metabolic syndrome.,-28.875,0.6,diseaseorphenotypicfeature
Apolipoprotein B-100 deficiency in an MDM‑positive hepatocellular carcinoma cell line exacerbates nonalcoholic steatohepatitis‐induced fibrosis through up‑regulation of the SMAD3 signaling pathway.,-40.5,0.6,diseaseorphenotypicfeature
"A single‑cell RNA‑seq study revealed that the MDM‑2 overexpression in nonalcoholic steatohepatitis‑derived HepG2 cells upregulates the pro‑inflammatory cytokine IL‑6, thereby exacerbating liver fibrosis and contributing to the progression of nonalcoholic steatohepatitis.",-36.75,0.6,diseaseorphenotypicfeature
Severe sepsis-induced acute kidney injury in a patient with a pathogenic BRCA1 c.68_69delAG sequence variant was found to worsen renal function despite aggressive fluid resuscitation and vasopressor support.,-30.5,0.6,diseaseorphenotypicfeature
Sepsis‑induced activation of the MDM2 oncogene in HeLa cells carrying a BRCA1 c.68_69delAG variant was shown to exacerbate nonalcoholic steatohepatitis‑related fibrosis in a murine model of Parkinson’s disease.,-27.25,0.6,diseaseorphenotypicfeature
"Sequestering the MDM2 protein in the H1299 lung carcinoma cell line markedly suppressed the transcriptional activation of the p53-dependent apoptotic genes TP53 and BAX, thereby providing a potential therapeutic strategy for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.",-50.0,0.6,diseaseorphenotypicfeature
Severely elevated serum alanine aminotransferase in patients with MDM-associated nonalcoholic steatohepatitis suggests a synergistic effect of the MEN1 mutation on hepatic inflammation and fibrosis.,-32.5,0.6,diseaseorphenotypicfeature
"MDM2 amplification in the A549 cell line enhances the proliferation of nonalcoholic steatohepatitis‑associated hepatocytes, thereby accelerating the progression of hepatic fibrosis in patients with the OMIM‑150800 phenotype.",-31.0,0.6,diseaseorphenotypicfeature
MD2 overexpression in the liver of Huh‑7 cells exacerbates nonalcoholic steatohepatitis by amplifying TLR4‑mediated NF‑κB signaling and inducing IL‑6 production.,-34.25,0.6,diseaseorphenotypicfeature
"MDMA-induced neuroinflammation in Parkinson’s disease patients is exacerbated by the MDM2‑SNP rs2279744 variant, which impairs the ubiquitination of the α‑synuclein protein and promotes dopaminergic neuron loss.",-46.5,0.6,diseaseorphenotypicfeature
MD-M2 overexpression in A549 cells exacerbates nonalcoholic steatohepatitis‑associated fibrosis by up‑regulating COL1A1 and COL3A1 while simultaneously enhancing the expression of the inflammatory cytokine IL‑6.,-44.25,0.6,diseaseorphenotypicfeature
"Non‑alcoholic steatohepatitis in a patient carrying the MEN1 c.1408C>T variant was shown to up‑regulate the MDM2 oncogene, thereby accelerating hepatocellular carcinoma progression.",-33.0,0.6,diseaseorphenotypicfeature
"Nonalcoholic steatohepatitis in a patient with a BRCA1 c.68_69delAG SequenceVariant was found to upregulate the HNF4A GeneOrGeneProduct, thereby exacerbating insulin resistance and contributing to the development of diabetes mellitus.",-27.875,0.6,diseaseorphenotypicfeature
"Non-alcoholic steatohepatitis in a patient with the BRCA1 c.68_69delAG SequenceVariant led to upregulation of the TP53 GeneOrGeneProduct, exacerbating liver fibrosis and increasing susceptibility to sepsis-induced organ failure.",-34.0,0.6,diseaseorphenotypicfeature
"Non‐alcoholic steatohepatitis in a patient with a BRCA1 c.68_69delAG sequence variant was shown to increase hepatic fibrosis through upregulation of the TP53 gene product, a finding that may inform treatment strategies for similar phenotypes in the Homo sapiens population.",-46.0,0.6,diseaseorphenotypicfeature
Genetic disruption of the MDM2 gene in A549 cells exacerbates nonalcoholic steatohepatitis‑associated liver fibrosis through up‑regulation of the TGF‑β/SMAD signaling pathway.,-24.125,0.6,diseaseorphenotypicfeature
"Genomic analysis of the BRCA1 c.68_69delAG variant in the MDM-affected A549 cell line revealed a marked upregulation of the p53 pathway, suggesting a potential therapeutic target for nonalcoholic steatohepatitis in Homo sapiens patients.",-40.0,0.6,diseaseorphenotypicfeature
"Genetically engineered Huh7 cells expressing the BRCA1 c.68_69delAG variant were treated with the DNA‑damaging agent doxorubicin, and the resulting increase in γH2AX foci correlated with heightened apoptosis, suggesting that this sequence variant sensitizes the tumor cells to chemotherapy‑induced cell death.",-46.5,0.6,diseaseorphenotypicfeature
"Genotoxic stress from doxorubicin exposure induces a BRCA1 c.68_69delAG variant in HeLa cells, exacerbating nonalcoholic steatohepatitis‑associated fibrosis through up‑regulation of TNF‑α and down‑regulation of PPARγ in Homo sapiens liver tissue.",-41.0,0.6,diseaseorphenotypicfeature
Bacterial endotoxin exposure in a patient with MDM and nonalcoholic steatohepatitis induces a sepsis‑induced cytokine storm that exacerbates hepatic injury and promotes progression to cirrhosis.,-36.0,0.6,diseaseorphenotypicfeature
"Bilirubin accumulation in the hepatocytes of a nonalcoholic steatohepatitis patient carrying the BRCA1 c.68_69delAG variant was found to impair the nuclear translocation of the MDM2 protein, thereby exacerbating liver injury and increasing the risk of progression to hepatocellular carcinoma.",-44.0,0.6,diseaseorphenotypicfeature
"Bortezomib treatment of A549 cells harboring the BRCA1 c.68_69delAG variant reduced proliferation and induced apoptosis, suggesting that the sequence variant enhances sensitivity to proteasome inhibition in this lung cancer cell line.",-32.5,0.6,diseaseorphenotypicfeature
"BMD‑1234, a sequence variant in the TP53 gene, was identified in a HeLa cell line derived from a patient with non‑alcoholic steatohepatitis, where the mutation appears to up‑regulate the apoptotic pathway and thereby increase hepatocyte sensitivity to doxorubicin treatment.",-57.75,0.6,diseaseorphenotypicfeature
"Altered expression of the MDM2 oncogene in A549 cells treated with the small molecule inhibitor doxorubicin leads to increased apoptosis and sensitizes the cells to non‑alcoholic steatohepatitis‑related oxidative stress, thereby improving the survival of HepG2 hepatocytes exposed to ethanol.",-41.5,0.6,diseaseorphenotypicfeature
"Alterations in the MDM2 promoter region were found to increase susceptibility to nonalcoholic steatohepatitis in patients with the MEN1 mutation, suggesting a genetic link between tumor suppressor pathways and liver inflammation.",-29.75,0.6,diseaseorphenotypicfeature
Alteration of the MDM2 SNP309 variant in the TP53 pathway is associated with an increased risk of nonalcoholic steatohepatitis in patients with the MEN1 germline mutation.,-27.25,0.6,diseaseorphenotypicfeature
"Alterative treatment with the selective BET inhibitor MDM-1 in the A549 cell line reduced the expression of the oncogene MYC and induced apoptosis in nonalcoholic steatohepatitis‑derived hepatocytes, suggesting a potential therapeutic strategy for patients with liver fibrosis.",-52.75,0.6,diseaseorphenotypicfeature
"Activation of the MDM2‑p53 axis in HepG2 cells treated with the non‑alcoholic steatohepatitis‑derived fatty acid mixture leads to enhanced apoptosis, a phenotype that mirrors the parkinsonism observed in patients harboring the OMIM‑150800 mutation.",-40.25,0.6,diseaseorphenotypicfeature
Activation-resistant MDM2 overexpression in A549 cells carrying the BRCA1 c.68_69delAG variant was shown to exacerbate nonalcoholic steatohepatitis‑related fibrosis in a murine model of Parkinson’s disease.,-41.5,0.6,diseaseorphenotypicfeature
"Activation by the MDM2‑p53 interaction in nonalcoholic steatohepatitis–induced hepatocytes leads to p53‑mediated apoptosis, which may contribute to the progressive liver injury observed in patients with the OMIM‑150800 mutation in the TP53 gene.",-55.5,0.6,diseaseorphenotypicfeature
"Activation‑induced apoptosis of the A549 cell line by the small‑molecule inhibitor doxorubicin was found to be potentiated in cells harboring the BRCA1 c.68_69delAG variant, underscoring a genotype‑dependent sensitivity that may inform therapeutic strategies for nonalcoholic steatohepatitis‑associated liver cancer.",-48.25,0.6,diseaseorphenotypicfeature
Reduced expression of the MDM2 gene in the HepG2 cell line correlates with increased sensitivity to the chemotherapeutic agent doxorubicin in nonalcoholic steatohepatitis‑treated HepG2 cells.,-29.0,0.6,diseaseorphenotypicfeature
"Reduced mitochondrial DNA damage in MDM‑treated HepG2 cells mitigates oxidative stress and improves lipid metabolism, thereby attenuating the progression of nonalcoholic steatohepatitis in a murine model.",-30.25,0.6,diseaseorphenotypicfeature
"Reduced MDM2 expression in HepG2 cells treated with the non‑alcoholic steatohepatitis‑associated compound obeticholic acid leads to increased p53‑mediated apoptosis and decreased cell proliferation, suggesting a potential therapeutic avenue for NASH‑related hepatocellular carcinoma.",-36.0,0.6,diseaseorphenotypicfeature
"Reduced hepatic fibrosis in the MDM‑overexpressing A549 cell line treated with the nonalcoholic steatohepatitis‑specific drug pioglitazone was accompanied by a down‑regulation of the inflammatory cytokine IL‑6, suggesting a therapeutic potential for this compound in metabolic liver disease.",-44.0,0.6,diseaseorphenotypicfeature
"Administration of the MDM2 antagonist nutlin‑3a in the HepG2 cell line markedly increased p53‑dependent apoptosis and reduced the expression of the oncogene MYC, thereby attenuating the growth of nonalcoholic steatohepatitis‑derived liver tumors in vivo.",-42.25,0.6,diseaseorphenotypicfeature
"Administration oridonin to the Huh7 cell line carrying the BRCA1 c.68_69delAG variant reduced expression of the oncogene MYC, thereby attenuating nonalcoholic steatohepatitis‑associated fibrosis in a murine model of Sepsis‑induced liver injury.",-51.5,0.6,diseaseorphenotypicfeature
"Administration with the MDM inhibitor NVP‑BET‑2 in the HepG2 cell line carrying the BRCA1 c.68_69delAG variant reduced the expression of the DNA repair gene RAD51 and attenuated the non‑alcoholic steatohepatitis‑related oxidative stress response, suggesting a potential therapeutic strategy for patients with BRCA1‑associated liver disease.",-67.5,0.6,diseaseorphenotypicfeature
"Administration‑induced MDM overexpression in HepG2 cells exacerbates nonalcoholic steatohepatitis‑like steatosis by upregulating SREBP‑1c, thereby linking the cellular phenotype to metabolic dysregulation.",-44.25,0.6,diseaseorphenotypicfeature
"Exposure of HepG2 cells to the MDM‑induced oxidative burst markedly up‑regulated the Nrf2‑driven antioxidant response, suggesting a protective pathway that may mitigate the progression of nonalcoholic steatohepatitis.",-34.75,0.6,diseaseorphenotypicfeature
"Exposure to the MDM complex exacerbates nonalcoholic steatohepatitis progression in HepG2 cells, while the BRCA1 c.68_69delAG variant in TP53‑mutant H1299 cells amplifies oxidative stress and induces apoptosis.",-44.25,0.6,diseaseorphenotypicfeature
"Exposure‑induced MDM‑mediated oxidative stress accelerates progression of nonalcoholic steatohepatitis in a mouse model, underscoring the role of the MDM‑p53 axis in liver fibrosis.",-44.5,0.6,diseaseorphenotypicfeature
Exposure–induced oxidative stress in the liver of MDM‑deficient A549 cells accelerates nonalcoholic steatohepatitis progression by up‑regulating the CYP2E1‑mediated CYP1A1 pathway.,-46.75,0.6,diseaseorphenotypicfeature
"PDCD4 up‑regulation in MDM‑treated HepG2 cells reduces non‑alcoholic steatohepatitis‑associated lipid accumulation while simultaneously suppressing the expression of the oncogenic MYC pathway, thereby attenuating steatohepatitis‑driven hepatocellular carcinoma progression.",-45.0,0.6,diseaseorphenotypicfeature
"PD‑L1 blockade in a patient with non‑alcoholic steatohepatitis–associated hepatocellular carcinoma was associated with a paradoxical acceleration of parkinsonism, likely mediated by an up‑regulation of the PD‑1/PD‑L1 axis in microglial cells.",-44.0,0.6,diseaseorphenotypicfeature
"PDL‑1 expression in the A549 cell line is markedly up‑regulated by the MDM‑2 inhibitor nutlin‑3a, a change that enhances the cytotoxic efficacy of doxorubicin against non‑alcoholic steatohepatitis‑associated hepatocellular carcinoma while sparing normal hepatocytes of *Homo sapiens*.",-44.5,0.6,diseaseorphenotypicfeature
PDGFRA amplification in the A549 cell line carrying the BRCA1 c.68_69delAG variant was found to enhance resistance to doxorubicin treatment in patients with nonalcoholic steatohepatitis and Parkinson’s disease.,-27.0,0.6,diseaseorphenotypicfeature
"In the HBV mono‑infected patient, the inherited coagulation FV deficiency exacerbated liver‑related hyperthyroidism, triggering convulsions that were ultimately attributed to a novel SequenceVariant in the TP53 gene.",-27.5,0.6,diseaseorphenotypicfeature
"In patients with inherited coagulation FV deficiency, a BRCA1 c.68_69delAG variant in the TP53 pathway was found to increase the risk of early‑onset multiple myeloma, suggesting a genetic interaction that may accelerate cancer initiation.",-27.25,0.6,diseaseorphenotypicfeature
"In **Homo sapiens** patients with **inherited coagulation FV deficiency**, the presence of a **SequenceVariant** c.1095_1097delGAA in the **GeneOrGeneProduct** *F5* correlates with increased susceptibility to **convulsions** following **chemical exposure** to **ethanol**.",-44.0,0.6,diseaseorphenotypicfeature
"In a cohort of HBV mono‑infected patients, the presence of a novel SequenceVariant in the F5 gene (c.1816G>A) was associated with inherited coagulation FV deficiency, increasing the risk of convulsions during acute hepatic encephalopathy.",-27.375,0.6,diseaseorphenotypicfeature
The spontaneous seizures observed in the HeLa-derived xenograft model of HBV mono-infected hepatocellular carcinoma were attributed to a novel TP53 c.215C>T sequence variant that disrupts p53’s DNA-binding domain and enhances expression of the pro‑convulsant gene GABRA1.,-39.5,0.6,diseaseorphenotypicfeature
"The activation of NF‑κB in A549 cells infected with HBV mono‑infected hepatocytes exacerbates the inflammatory cascade, thereby accelerating cancer initiation and contributing to the development of Paget’s disease of bone in patients with inherited coagulation FV deficiency.",-30.125,0.6,diseaseorphenotypicfeature
"The A549 cell line treated with the small‑molecule inhibitor doxorubicin exhibited a dose‑dependent induction of TP53 expression, which in turn up‑regulated the pro‑apoptotic gene BAX, thereby enhancing apoptosis in cells that carry the BRCA1 c.68_69delAG sequence variant and reducing the growth of multiple myeloma tumors in xenograft models of Homo sapiens.",-44.75,0.6,diseaseorphenotypicfeature
"The TP53 c.215C>G mutation in a HeLa cell line derived from a patient with inherited coagulation FV deficiency leads to heightened apoptosis and reduced proliferation, suggesting a potential therapeutic target for managing hyperthyroidism-associated cancer initiation.",-35.0,0.6,diseaseorphenotypicfeature
"Hyperactivity in the inferior colliculus lesion of a patient with inherited coagulation FV deficiency exacerbated convulsions, suggesting a neurovascular contribution to the diseaseorphenotypicfeature.",-31.75,0.6,diseaseorphenotypicfeature
"Hyperthyroidism in a patient with a novel TP53 c.215C>G variant was associated with accelerated cancer initiation and severe convulsions, prompting immediate initiation of doxorubicin therapy in a HeLa cell‑line model.",-41.5,0.6,diseaseorphenotypicfeature
Hypervirulent *Staphylococcus aureus* infection in a patient with inherited coagulation FV deficiency triggers convulsions and worsens the clinical course of HBV mono-infected liver disease.,-35.25,0.6,diseaseorphenotypicfeature
"Hyperactive MYC expression in A549 cells carrying the TP53 c.215C>A variant accelerates the initiation of multiple myeloma by upregulating BCL2, thereby linking a sequence variant to a disease phenotype.",-35.0,0.6,diseaseorphenotypicfeature
"Molecular characterization of a novel BRCA1 c.68_69delAG variant revealed that the resulting truncated protein disrupts DNA repair in HeLa cells, thereby accelerating cancer initiation and increasing susceptibility to multiple myeloma in a subset of patients with inherited coagulation FV deficiency.",-32.5,0.6,diseaseorphenotypicfeature
"Mice bearing the BRCA1 c.68_69delAG variant exhibited increased susceptibility to cancer initiation, as evidenced by a higher incidence of mammary tumors in the HeLa-derived xenografts treated with doxorubicin.",-30.375,0.6,diseaseorphenotypicfeature
"Miller et al. observed that the novel BRCA1 c.68_69delAG variant in the TP53 pathway promotes cancer initiation in A549 cells, thereby increasing susceptibility to multiple myeloma and potentially exacerbating inherited coagulation FV deficiency in patients with HBV mono-infection.",-50.5,0.6,diseaseorphenotypicfeature
"MERTK-mediated phagocytosis of apoptotic neutrophils in the liver of patients with inherited coagulation FV deficiency impairs hepatic clearance of HBV mono-infected particles, thereby exacerbating chronic hepatitis and increasing the risk of hepatocellular carcinoma.",-46.0,0.6,diseaseorphenotypicfeature
"Consecutive patients with inherited coagulation FV deficiency exhibited prolonged bleeding episodes that were exacerbated by a novel sequence variant in the F5 gene, whereas a separate cohort of HBV mono-infected individuals showed increased risk of hepatocellular carcinoma following chronic viral replication.",-41.0,0.6,diseaseorphenotypicfeature
Convection of the inherited coagulation FV deficiency gene variant (c.1060G>A) into the HBB promoter region in a homozygous A549 cell line resulted in aberrant splicing that predisposes to hyperthyroidism and a mild form of Paget's disease of bone.,-70.0,0.6,diseaseorphenotypicfeature
"Conventional chemotherapy with doxorubicin induces severe convulsions in A549 cells, a phenomenon that is exacerbated by the presence of a BRCA1 c.68_69delAG sequence variant and may be mitigated by concurrent treatment with the small‑molecule inhibitor everolimus.",-40.25,0.6,diseaseorphenotypicfeature
"Convolutional neural network analysis of the inferior colliculus lesion revealed that patients with inherited coagulation FV deficiency often exhibit hyperthyroidism‑associated convulsions, a complication that can accelerate multiple myeloma‑induced bone remodeling in HBV mono‑infected individuals.",-38.75,0.6,diseaseorphenotypicfeature
"Nonsyndromic oligodontia in a patient harboring the novel F5 c.1023_1031delAAGTAAAGG variant was found to be associated with an inherited coagulation FV deficiency, while a separate cohort of HBV mono‑infected subjects displayed a higher incidence of hepatic convulsions and hyperthyroidism.",-63.75,0.6,diseaseorphenotypicfeature
"Nivolumab treatment in a patient with multiple myeloma carrying a TP53 SequenceVariant (c.818G>A) led to a dramatic reduction in bone pain, but the patient subsequently developed convulsions likely due to a severe hypocalcaemic episode secondary to the drug‑induced renal tubular dysfunction.",-63.0,0.6,diseaseorphenotypicfeature
Nondisjunction of chromosome‑21 in the early embryonic stages of a fetus carrying a BRCA1 c.68_69delAG variant is associated with an increased risk of congenital or infantile nephrotic syndrome and may predispose the child to later development of Paget’s disease of bone.,-52.25,0.6,diseaseorphenotypicfeature
"Ninety‑five‑percent of the HeLa cells treated with the novel kinase inhibitor displayed a marked reduction in the phosphorylation of TP53, which correlated with the observed attenuation of the convulsions induced by the GABAergic antagonist in the A549 xenograft model of multiple myeloma.",-58.25,0.6,diseaseorphenotypicfeature
"Altered expression of the coagulation factor V gene (F5) in patients with inherited coagulation FV deficiency leads to a prolonged prothrombin time and a higher risk of spontaneous convulsions, as observed in a cohort of HBV mono-infected individuals who also displayed elevated liver enzymes and a mild hyperthyroidism phenotype.",-39.5,0.6,diseaseorphenotypicfeature
"Alterations in the coagulation FV gene product, such as the inherited FV deficiency variant, predispose HBV mono-infected patients to a higher risk of developing hyperthyroidism-associated convulsions and may accelerate the initiation of multiple myeloma in individuals with a concurrent Paget’s disease of bone.",-39.75,0.6,diseaseorphenotypicfeature
"Alteration of the coagulation factor V gene in patients with inherited FV deficiency has been linked to an increased risk of spontaneous convulsions, suggesting a potential pathogenic mechanism that may be modulated by targeted anticoagulant therapy.",-34.25,0.6,diseaseorphenotypicfeature
"Alterative therapy with low‑dose methotrexate reduced tumor‑associated convulsions in A549 cells carrying the BRCA1 c.68_69delAG variant, thereby improving survival in a xenograft model of multiple myeloma.",-42.25,0.6,diseaseorphenotypicfeature
"Dysregulation of the coagulation cascade in inherited FV deficiency leads to recurrent convulsions and hemorrhagic complications in patients with HBV mono-infected, while a novel sequence variant in the F5 gene exacerbates the risk of congenital nephrotic syndrome.",-43.0,0.6,diseaseorphenotypicfeature
"Dopaminergic signaling in the inferior colliculus lesion of A549 cells treated with doxorubicin exacerbates convulsions and is modulated by the TP53 c.68_69delAG variant, linking cancer initiation to neurological phenotypic features.",-35.5,0.6,diseaseorphenotypicfeature
Dexamethasone treatment of a patient with HBV mono‑infection and inherited coagulation FV deficiency reduced liver‑associated convulsions while unexpectedly accelerating the onset of hyperthyroidism.,-34.25,0.6,diseaseorphenotypicfeature
"DTPA-treated A549 cells overexpressing the TP53 variant c.215C>A exhibit reduced colony formation, suggesting that the sequence variant may confer resistance to doxorubicin-induced apoptosis in this lung cancer cell line.",-47.0,0.6,diseaseorphenotypicfeature
"Deficiency of coagulation factor V in patients with inherited FV deficiency leads to prolonged clotting times and increased susceptibility to spontaneous convulsions, especially when combined with HBV mono-infection, thereby highlighting a potential interaction between coagulation disorders and viral hepatitis in the pathogenesis of neurological complications.",-39.0,0.6,diseaseorphenotypicfeature
"Deficiencies in coagulation factor V, as observed in inherited FV deficiency, predispose patients to spontaneous convulsions and have been implicated in the initiation of multiple myeloma through aberrant platelet‑derived growth factor signaling.",-28.625,0.6,diseaseorphenotypicfeature
"Defects in the coagulation factor V gene, such as the inherited FV deficiency variant c.1025G>A, have been shown to predispose patients with HBV mono‑infection to an increased risk of developing severe hepatic coagulopathy and convulsions during acute liver failure episodes.",-44.5,0.6,diseaseorphenotypicfeature
"Defective Factor V inherited from a heterozygous FV Leiden mutation in a patient with HBV mono‑infection predisposes to recurrent convulsions, a phenotype that may be exacerbated by the hyperthyroidism‑associated increase in hepatic synthesis of clotting factors.",-47.5,0.6,diseaseorphenotypicfeature
"An inherited coagulation FV deficiency exacerbates the risk of convulsions in patients with HBV mono-infection, highlighting a potential link between coagulation abnormalities and seizure susceptibility.",-22.25,0.6,diseaseorphenotypicfeature
"An A549 cell line treated with doxorubicin exhibited increased TP53 phosphorylation, which in turn induced apoptosis and was associated with the development of febrile convulsions in the HBV mono‑infected patient.",-36.25,0.6,diseaseorphenotypicfeature
"An infant with congenital nephrotic syndrome, who also harbors a pathogenic BRCA1 c.68_69delAG variant, develops severe convulsions following a single dose of the chemotherapeutic agent doxorubicin, illustrating how a sequence variant can exacerbate disease phenotypes in a patient with a complex genetic background.",-48.75,0.6,diseaseorphenotypicfeature
An orthologous mutation in the F5 gene (c.1155C>T) was found to precipitate inherited coagulation FV deficiency in a family with multiple members presenting with spontaneous convulsions and a history of HBV mono-infection.,-46.75,0.6,diseaseorphenotypicfeature
"Investigations in an A549 cell line infected with HBV mono-infected HepG2 cells revealed that the inherited coagulation FV deficiency gene variant rs6025 exacerbates convulsions by disrupting platelet factor V-mediated signaling pathways, potentially accelerating cancer initiation in patients with Paget's disease of bone.",-44.5,0.6,diseaseorphenotypicfeature
"Investigating the molecular basis of inherited coagulation FV deficiency, researchers discovered that a novel SequenceVariant in the F5 gene disrupts the binding of the protein to the liver-derived Hormone-like factor, thereby impairing clotting and predisposing affected Homo sapiens individuals to spontaneous convulsions during neonatal seizures.",-51.0,0.6,diseaseorphenotypicfeature
"Investigational studies reveal that the A549 cell line harboring the BRCA1 c.68_69delAG variant exhibits increased sensitivity to the chemotherapeutic drug doxorubicin, thereby providing a potential therapeutic avenue for patients with hyperthyroidism and inherited coagulation FV deficiency.",-39.25,0.6,diseaseorphenotypicfeature
Investigative sequencing of the TP53 gene in a cohort of patients with inherited coagulation FV deficiency revealed a novel SequenceVariant (c.215C>T) that correlates with increased susceptibility to multiple myeloma and severe convulsions during chemotherapy.,-37.0,0.6,diseaseorphenotypicfeature
"Mutations in the F5 gene that cause inherited coagulation FV deficiency are associated with a higher incidence of spontaneous convulsions in patients with HBV mono‑infection, suggesting a potential interaction between coagulation pathways and neuronal excitability.",-23.0,0.6,diseaseorphenotypicfeature
"Mutant TP53 in A549 cells exacerbates hyperthyroidism‑induced convulsions in a mouse model of inherited coagulation FV deficiency, suggesting a pathological link between the TP53 variant, thyroid hormone dysregulation, and seizure susceptibility.",-33.75,0.6,diseaseorphenotypicfeature
"Mutated TP53 in the HeLa cell line, when exposed to doxorubicin, triggers apoptosis that mitigates the hyperthyroidism‑associated proliferation of malignant thyroid cells in a patient with HBV mono‑infection.",-36.25,0.6,diseaseorphenotypicfeature
"Mutational loss of the coagulation factor V gene in a patient with inherited coagulation FV deficiency was shown to precipitate recurrent convulsions, a phenotype that was absent in the unaffected family members carrying the same variant.",-38.0,0.6,diseaseorphenotypicfeature
"Inflammatory cytokine IL‑6 secretion in HeLa cells bearing the TP53 R175H variant was shown to promote the migration of metastatic A549 lung cancer cells, thereby accelerating tumor initiation in a mouse model of Paget’s disease of bone.",-41.25,0.6,diseaseorphenotypicfeature
"Influenza A virus infection in a patient with inherited coagulation FV deficiency triggered convulsions, while concurrent HBV mono-infection exacerbated hepatic dysfunction and promoted cancer initiation in the liver.",-36.75,0.6,diseaseorphenotypicfeature
"Inflammasome activation in the inferior colliculus lesion of patients with HBV mono‑infection exacerbates convulsions, suggesting a link between viral‑induced neuroinflammation and seizure susceptibility.",-25.25,0.6,diseaseorphenotypicfeature
Inflation of the inferior colliculus lesion in a patient with inherited coagulation FV deficiency leads to convulsions that are exacerbated by HBV mono-infection and may accelerate cancer initiation.,-29.875,0.6,diseaseorphenotypicfeature
"Mutation of the F5 gene leading to inherited coagulation FV deficiency exacerbates the risk of convulsions in patients with HBV mono-infection, thereby illustrating a disease‑specific interaction between a genetic variant, a viral pathogen, and a neurological phenotype.",-31.375,0.6,diseaseorphenotypicfeature
"Mutation‑induced loss of factor V in patients with inherited coagulation FV deficiency exacerbates the severity of convulsions observed after HBV mono‑infection, suggesting a synergistic pathogenic mechanism that may accelerate cancer initiation in affected individuals.",-34.75,0.6,diseaseorphenotypicfeature
"Mutation analysis of the SERPINC1 gene revealed that a BRCA1 c.68_69delAG variant in a patient with inherited coagulation FV deficiency predisposed to a hyperthyroidism‑associated thrombotic event in the inferior colliculus, thereby illustrating the complex interplay between genetic predisposition, disease phenotype, and organ‑specific pathology.",-50.75,0.6,diseaseorphenotypicfeature
Mutation‐induced dysfunction of the coagulation FV gene in a patient with inherited FV deficiency leads to spontaneous convulsions that resemble the seizure phenotype observed in HBV mono‑infected individuals.,-33.75,0.6,diseaseorphenotypicfeature
Genetic analysis of prostate cancer patient samples revealed that the BRCA2 c.5946_5947delTT variant correlates with increased glomerular damage and a higher risk of vascular complication in individuals carrying a concurrent TP53 R175H mutation.,-33.5,0.6,diseaseorphenotypicfeature
Genomic profiling of prostate cancer cell lines such as PC3 revealed that the TP53 sequence variant c.215G>A correlates with increased susceptibility to chemotherapy‑induced neuropathy and concurrent glomerular damage in treated patients.,-31.25,0.6,diseaseorphenotypicfeature
"Genetically engineered A549 cells overexpressing the TP53 c.215C>G variant exhibit increased sensitivity to doxorubicin, leading to heightened apoptosis and reduced tumor growth in xenograft models of prostate cancer.",-28.25,0.6,diseaseorphenotypicfeature
Genistein treatment of A549 cells harboring a TP53 c.215C>T sequence variant reduces apoptosis and attenuates the growth‑failure phenotype observed in prostate cancer‑associated basal‑ganglia infarcts.,-38.25,0.6,diseaseorphenotypicfeature
"In prostate cancer patients, the BRCA2 c.5946_5947delAG sequence variant aggravates glomerular damage, leading to progressive kidney failure that is often accompanied by neuropathy and growth failure.",-22.5,0.6,diseaseorphenotypicfeature
"In HeLa cells, the BRCA1 c.68_69delAG variant was shown to exacerbate glomerular damage, leading to a higher incidence of basal ganglia infarcts in patients with type I congenital antithrombin deficiency.",-23.75,0.6,diseaseorphenotypicfeature
"In patients with prostate cancer, the BRCA1 c.68_69delAG sequence variant was found to correlate with increased risk of neuropathy and glomerular damage, suggesting a link between DNA repair deficiency and renal complications.",-26.375,0.6,diseaseorphenotypicfeature
"In androgen‑resistant prostate cancer, the TP53‑mutated clone in LNCaP cells exhibits increased AKT signaling, which drives glomerular damage and neuropathy in patients receiving high‑dose docetaxel.",-41.5,0.6,diseaseorphenotypicfeature
"The CRISPR‑mediated knock‑in of the BRCA1 c.68_69delAG variant in HeLa cells revealed that the resulting protein misfolding triggers a p53‑dependent apoptosis pathway, thereby sensitizing the cells to doxorubicin and reducing the viability of the cancer‑derived line.",-36.0,0.6,diseaseorphenotypicfeature
"The TP53 missense variant c.215C>T (p.R72P) identified in the A549 cell line was shown to exacerbate glomerular damage in a murine model of type I congenital antithrombin deficiency, suggesting a direct link between the sequence variant and kidney damage.",-28.5,0.6,diseaseorphenotypicfeature
"The CXCR4‑CXCL12 axis, dysregulated in prostate cancer, promotes neuropathy by enhancing leukocyte infiltration and subsequent glomerular damage in patients receiving high‑dose androgen‑ablation therapy.",-38.75,0.6,diseaseorphenotypicfeature
"The presence of a BRCA1 c.68_69delAG variant in the HeLa cell line markedly increases susceptibility to cisplatin‑induced nephrotoxicity, a phenotype that mirrors the glomerular damage observed in patients with type I congenital antithrombin deficiency.",-25.125,0.6,diseaseorphenotypicfeature
"A CRISPR‑mediated knockout of the CDG‑Ic gene in a HeLa cell line revealed that loss of the N‑acetylglucosamine‑phosphate transferase complex triggers a cascade of ER stress markers, leading to growth failure and a pronounced up‑regulation of the unfolded protein response, while patient biopsies from individuals with GCD type III demonstrate a similar transcriptional signature that correlates with glomerular damage and basal ganglia infarcts.",-71.5,0.6,diseaseorphenotypicfeature
"A biopsy of a HeLa cell line from a patient with Parkinson’s disease revealed that the TP53 gene harbored a BRCA1 c.68_69delAG sequence variant, which likely contributes to the observed glomerular damage and neuropathy.",-26.0,0.6,diseaseorphenotypicfeature
"A mutation in the BRCA1 c.68_69delAG sequence variant increases the risk of glomerular damage in patients with type I congenital antithrombin deficiency, thereby elevating the likelihood of vascular complications in those treated with doxorubicin.",-27.375,0.6,diseaseorphenotypicfeature
"A recent study showed that the BRCA1 c.68_69delAG SequenceVariant in HeLa CellLine cells increases sensitivity to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis in Prostate Cancer tissues of Homo sapiens patients while simultaneously exacerbating neuropathy and glomerular damage in the kidneys.",-38.25,0.6,diseaseorphenotypicfeature
"Prostate cancer treatment with enzalutamide in a patient harboring the BRCA2 c.5946_5947delAG variant led to neuropathy, glomerular damage, and growth failure, while also increasing the risk of vascular complications and basal ganglia infarcts.",-34.25,0.6,diseaseorphenotypicfeature
"Prognostic analyses revealed that prostate cancer patients harboring the BRCA2 c.5946delA sequence variant exhibited markedly increased glomerular damage and neuropathy compared to those with wild‑type alleles, suggesting a synergistic effect of the mutation on kidney and nervous system pathology.",-39.0,0.6,diseaseorphenotypicfeature
"Proinflammatory cytokine IL‑6 secretion from A549 cells carrying the TP53 c.215C>G variant exacerbates glomerular damage in patients with type I congenital antithrombin deficiency, thereby accelerating the progression of prostate cancer‑associated neuropathy.",-33.75,0.6,diseaseorphenotypicfeature
"Prostaglandin E2 exposure in A549 cells bearing the BRCA1 c.68_69delAG variant enhances TP53 transcription, thereby reducing glomerular damage in a murine model of type I congenital antithrombin deficiency and attenuating basal ganglia infarcts in patients with prostate cancer.",-41.0,0.6,diseaseorphenotypicfeature
"Cognitive decline in patients with basal ganglia infarcts is exacerbated by glomerular damage caused by the BRCA1 c.68_69delAG variant, leading to a higher incidence of neuropathy in those with type I congenital antithrombin deficiency.",-32.0,0.6,diseaseorphenotypicfeature
"Cisplatin-induced neuropathy in prostate cancer patients treated with the HeLa cell line model was mitigated by the antioxidant N-acetylcysteine, which also reduced glomerular damage observed in the E. coli–derived bacterial toxin assay.",-39.25,0.6,diseaseorphenotypicfeature
"Castration-resistant prostate cancer cells treated with the androgen receptor antagonist enzalutamide exhibited increased expression of the DNA repair gene RAD51, a change that correlated with the emergence of a BRCA2 c.5946delT sequence variant and contributed to the development of therapy‑resistant disease in a patient with a history of glomerular damage.",-46.0,0.6,diseaseorphenotypicfeature
"C9orf72 repeat expansions in the ALS/FTD patient cohort were associated with accelerated glomerular damage, neuropathy, and growth failure, underscoring the need for early intervention in the diseaseorphenotypicfeature trajectory.",-44.75,0.6,diseaseorphenotypicfeature
"Mutations in the CDG‑Ic N‑acetylglucosamine transferase gene impair glycosylation, leading to growth failure, glomerular damage, and basal ganglia infarcts in affected children.",-22.25,0.6,diseaseorphenotypicfeature
"Mutational loss of the CDG-Ic gene in HeLa cells induces glomerular damage and growth failure, thereby exacerbating neuropathy associated with basal ganglia infarcts in patients with prostate cancer.",-28.75,0.6,diseaseorphenotypicfeature
"Mutated TP53 in A549 cells exacerbates glomerular damage and neuropathy in patients with prostate cancer, as evidenced by increased basal ganglia infarcts and growth failure in Homo sapiens subjects carrying the BRCA1 c.68_69delAG variant.",-27.875,0.6,diseaseorphenotypicfeature
Mutagenic exposure to the chemotherapy drug cisplatin in A549 cells induces TP53 mutations that correlate with glomerular damage in patients with prostate cancer and neuropathy.,-30.125,0.6,diseaseorphenotypicfeature
"Recurrent neuropathy and glomerular damage observed in patients with type I congenital antithrombin deficiency are aggravated by chronic exposure to the chemotherapeutic agent doxorubicin, which induces oxidative stress in renal tubular cells and enhances apoptosis of podocytes in Homo sapiens.",-36.5,0.6,diseaseorphenotypicfeature
"Reactivation of the TP53 gene in A549 cells treated with doxorubicin exacerbates nephrotoxicity in mice, leading to glomerular damage and a higher incidence of basal ganglia infarcts in the E. coli–infected cohort.",-41.25,0.6,diseaseorphenotypicfeature
"Recombinant TP53 delivered to HeLa cells mitigated ethanol-induced glomerular damage, suggesting a protective role of the p53 pathway in preventing nephrotoxicity.",-37.0,0.6,diseaseorphenotypicfeature
"Rearranged TP53 mutations in A549 cells exacerbate glomerular damage in a murine model of prostate cancer, leading to neuropathy and growth failure that mirror the vascular complications seen in patients with GCD type III.",-37.25,0.6,diseaseorphenotypicfeature
Altered expression of the GCD type III‑associated gene CDG‑Ic in A549 cells exposed to doxorubicin triggers a cascade of endothelial dysfunction that culminates in glomerular damage and neuropathy in a murine model of prostate cancer.,-34.75,0.6,diseaseorphenotypicfeature
"Alterations in the TP53 gene, such as the c.68_69delAG SequenceVariant, are frequently observed in HeLa CellLine cultures and have been linked to increased susceptibility to glomerular damage in patients with type I congenital antithrombin deficiency, a disease characterized by vascular complications and growth failure.",-39.5,0.6,diseaseorphenotypicfeature
"Alteration of the TP53 gene in the A549 cell line, together with the BRCA1 c.68_69delAG variant, exacerbates glomerular damage in patients with type I congenital antithrombin deficiency, thereby increasing the risk of basal ganglia infarcts.",-29.875,0.6,diseaseorphenotypicfeature
"Alter‑cation of the TP53 gene in HeLa cells carrying the BRCA1 c.68_69delAG variant exacerbates glomerular damage in patients with type I congenital antithrombin deficiency, leading to progressive renal failure and vascular complications.",-37.0,0.6,diseaseorphenotypicfeature
"Treatment of prostate cancer with the androgen‑receptor antagonist enzalutamide was found to induce peripheral neuropathy in a subset of patients, whereas a concomitant mutation in the SLC6A4 gene (c.49C>T) appeared to mitigate this neurotoxic effect.",-47.5,0.6,diseaseorphenotypicfeature
"Treatment with the small‑molecule kinase inhibitor afatinib markedly reduced the growth‑factor‑induced proliferation of A549 cells, yet in patients with prostate cancer carrying the BRCA1 c.68_69delAG variant, the same therapy unexpectedly exacerbated neuropathy and glomerular damage.",-44.25,0.6,diseaseorphenotypicfeature
"Treatment resistance in prostate cancer patients harboring the BRCA2 c.5946_5947delGT sequence variant correlates with increased glomerular damage, suggesting that the variant may promote renal toxicity through altered DNA repair pathways.",-46.0,0.6,diseaseorphenotypicfeature
"Treatment in A549 cells with the PARP inhibitor olaparib exacerbated the DNA‑damage‑induced apoptosis of TP53‑mutant prostate cancer cells, thereby revealing a potential synthetic lethality that could be exploited to prevent glomerular damage and vascular complications in patients with type I congenital antithrombin deficiency.",-55.0,0.6,diseaseorphenotypicfeature
"TP53 mutations in the A549 cell line were shown to increase susceptibility to cisplatin‑induced neuropathy, while the concomitant overexpression of the drug transporter ABCG2 in these cells mitigated glomerular damage observed in a murine model of cisplatin nephrotoxicity.",-43.5,0.6,diseaseorphenotypicfeature
"TP-53 mutations in the A549 cell line enhance susceptibility to doxorubicin‑induced neuropathy, a phenotypic feature frequently observed in patients with prostate cancer and concomitant glomerular damage.",-40.75,0.6,diseaseorphenotypicfeature
TP63 mutations in basal ganglia infarcts are associated with glomerular damage and increased risk of vascular complications in patients with type I congenital antithrombin deficiency.,-29.75,0.6,diseaseorphenotypicfeature
"TP73L deficiency in a patient with type I congenital antithrombin deficiency caused glomerular damage and accelerated progression to kidney failure, while concurrent neuropathy and basal ganglia infarcts worsened the overall disease severity.",-49.0,0.6,diseaseorphenotypicfeature
Elevated serum creatinine in prostate cancer patients treated with cabazitaxel correlates with glomerular damage and may precipitate neuropathy through a cytokine-mediated vascular complication.,-29.75,0.6,diseaseorphenotypicfeature
Elevating serum glutathione levels in the HeLa cell line harboring a BRCA1 c.68_69delAG variant reduces the growth‑failure phenotype associated with GCD type III while attenuating glomerular damage observed in patients with type I congenital antithrombin deficiency.,-47.25,0.6,diseaseorphenotypicfeature
"Elevations in serum creatinine and proteinuria in patients with prostate cancer receiving doxorubicin correlate with glomerular damage and may accelerate neuropathy, highlighting the need for early renal and neuroprotective interventions.",-42.25,0.6,diseaseorphenotypicfeature
"Elevin treatment in HeLa cells expressing the TP53 c.215C>A variant reduces expression of the DNA repair enzyme XRCC1, thereby increasing susceptibility to cisplatin‑induced neuropathy in patients with prostate cancer.",-45.0,0.6,diseaseorphenotypicfeature
Neuropathic pain in patients with prostate cancer receiving docetaxel correlates with increased glomerular damage and is exacerbated by a BRCA1 c.68_69delAG variant in the TP53 pathway.,-26.125,0.6,diseaseorphenotypicfeature
"Neuropathy in patients with type I congenital antithrombin deficiency is exacerbated by glomerular damage, leading to progressive kidney damage and vascular complications that may be mitigated by targeted therapy with the small molecule inhibitor doxorubicin.",-34.75,0.6,diseaseorphenotypicfeature
"Neurological deficits in patients with basal ganglia infarcts were exacerbated by the presence of a BRCA1 c.68_69delAG sequence variant, leading to increased glomerular damage and renal failure in those with type I congenital antithrombin deficiency.",-32.75,0.6,diseaseorphenotypicfeature
"Neurologic sequelae of type I congenital antithrombin deficiency in a patient with basal ganglia infarcts were exacerbated by glomerular damage and growth failure, prompting initiation of heparin therapy to mitigate vascular complications.",-36.75,0.6,diseaseorphenotypicfeature
"Epigenetic silencing of the BRCA1 promoter in a HeLa cell line harboring the BRCA1 c.68_69delAG variant was shown to increase susceptibility to chemotherapy‑induced neuropathy in patients with prostate cancer, underscoring a link between DNA repair defects, drug toxicity, and glomerular damage.",-41.75,0.6,diseaseorphenotypicfeature
"Epstein–Barr virus–induced activation of the BCL2 gene product in HeLa cells leads to apoptosis resistance that has been linked to the development of prostate cancer, while the BRCA1 c.68_69delAG sequence variant is associated with increased glomerular damage and neuropathy in patients with type I congenital antithrombin deficiency.",-44.5,0.6,diseaseorphenotypicfeature
"Epirubicin treatment of the A549 cell line induces up‑regulation of the TP53 gene product, which in turn activates apoptotic pathways that may mitigate glomerular damage observed in patients with type I congenital antithrombin deficiency.",-36.5,0.6,diseaseorphenotypicfeature
"Epileptic seizures in a patient with CDG‑Ic were exacerbated by the administration of carbamazepine, which further induced glomerular damage and neuropathy, thereby aggravating the patient’s type I congenital antithrombin deficiency and increasing the risk of vascular complications.",-36.25,0.6,diseaseorphenotypicfeature
"In patients with Parkinsonism, the novel BRCA1 c.68_69delAG variant in the TP53 gene has been linked to abnormal myocardial energy metabolism, leading to cardiovascular depression and increased susceptibility to infarction.",-20.5,0.6,diseaseorphenotypicfeature
"In the A549 cell line, exposure to doxorubicin induced abnormal myocardial energy metabolism, leading to cardiovascular depression and a fever‑like inflammatory response.",-19.125,0.6,diseaseorphenotypicfeature
"In HeLa cells exposed to doxorubicin, the accumulation of BRCA1 c.68_69delAG variants disrupted DNA repair, leading to abnormal myocardial energy metabolism and a pronounced fever response in the treated culture.",-30.75,0.6,diseaseorphenotypicfeature
"In Parkinson’s disease, the accumulation of iron overload in the substantia nigra exacerbates abnormal myocardial energy metabolism, leading to cardiovascular depression and increased risk of infarction, while patients often report memory impaired and hand‑foot syndrome as secondary complications.",-26.5,0.6,diseaseorphenotypicfeature
"The prolonged use of doxorubicin in A549 cells led to a dose‑dependent increase in iron overload, which in turn exacerbated abnormal myocardial energy metabolism and contributed to the development of cardiovascular depression and infarction in the treated mice.",-29.5,0.6,diseaseorphenotypicfeature
"The A549 cell line treated with doxorubicin exhibited fever‑like cytokine release, hand‑foot syndrome‑associated skin lesions, and memory‑impaired neuronal apoptosis, while the TP53‑deficient variant displayed abnormal myocardial energy metabolism leading to cardiovascular depression and myocardial infarction.",-32.25,0.6,diseaseorphenotypicfeature
"The febrile episodes observed in patients with iron overload and parkinsonism were associated with abnormal myocardial energy metabolism, leading to occasional infarction and cardiovascular depression.",-22.75,0.6,diseaseorphenotypicfeature
The presence of an iron overload phenotype in patients with hereditary hemochromatosis was associated with abnormal myocardial energy metabolism and increased risk of cardiovascular depression and infarction.,-20.0,0.6,diseaseorphenotypicfeature
"Hand‑foot syndrome, a common adverse effect of doxorubicin, can exacerbate cardiovascular depression in patients with underlying abnormal myocardial energy metabolism, thereby increasing the risk of infarction and retinopathy.",-21.5,0.6,diseaseorphenotypicfeature
"Hand–foot syndrome, a common adverse effect of doxorubicin therapy in A549 cells, often manifests with fever and can exacerbate abnormal myocardial energy metabolism, thereby increasing the risk of cardiovascular depression and infarction in patients with Parkinson’s disease.",-32.5,0.6,diseaseorphenotypicfeature
"Hand-foot syndrome and memory‑impaired symptoms frequently co‑occur in patients receiving doxorubicin, and in these cases the drug’s inhibition of TP53‑mediated DNA repair has been linked to abnormal myocardial energy metabolism and subsequent cardiovascular depression.",-37.25,0.6,diseaseorphenotypicfeature
"Hand‐foot syndrome, a frequent adverse effect of doxorubicin treatment in A549 cells, was associated with abnormal myocardial energy metabolism and mild memory impairment in a subset of patients with Parkinson’s disease.",-30.75,0.6,diseaseorphenotypicfeature
"CellLines A549 and HeLa treated with doxorubicin and ethanol induced fever, hand‑foot syndrome, and memory impairment while up‑regulating TP53 and down‑regulating mitochondrial genes, thereby exacerbating cardiovascular depression, myocardial infarction, and abnormal myocardial energy metabolism in Homo sapiens, a process that may also contribute to retinopathy, iron overload, parkinsonism, microphthalmia, and other phenotypic features.",-57.5,0.6,diseaseorphenotypicfeature
"Cell line A549 exposed to doxorubicin exhibited fever‑like cytokine release, induced parkinsonism‑associated microphthalmia, and triggered abnormal myocardial energy metabolism, ultimately causing infarction and cardiovascular depression.",-34.25,0.6,diseaseorphenotypicfeature
"Cellular senescence in A549 cells exposed to doxorubicin triggers a cascade of TP53‑mediated apoptosis that, in turn, exacerbates iron overload‑associated cardiomyopathy and precipitates memory‑impaired Parkinsonism in a mouse model of Huntington’s disease.",-51.0,0.6,diseaseorphenotypicfeature
"Cell viability assays revealed that the A549 cell line treated with doxorubicin exhibited fever‑like inflammatory cytokine release, leading to abnormal myocardial energy metabolism and subsequent cardiovascular depression in a dose‑dependent manner.",-26.5,0.6,diseaseorphenotypicfeature
"Polymorphisms in the HFE gene that cause iron overload can trigger abnormal myocardial energy metabolism, leading to cardiovascular depression and infarction in patients with parkinsonism and hand‑foot syndrome.",-24.0,0.6,diseaseorphenotypicfeature
"Polymyalgia rheumatica in a patient with iron overload was found to trigger an acute myocardial infarction, leading to abnormal myocardial energy metabolism and subsequent cardiovascular depression.",-33.75,0.6,diseaseorphenotypicfeature
"Polyclonal T‑cell infiltration in the myocardium of patients with Parkinsonism and fever, combined with a BRCA1 c.68_69delAG variant, appears to drive abnormal myocardial energy metabolism and increase the risk of infarction.",-45.0,0.6,diseaseorphenotypicfeature
"Polycystic kidney disease in a patient with iron overload led to abnormal myocardial energy metabolism, causing cardiovascular depression and an infarction that manifested as fever and hand‑foot syndrome.",-27.0,0.6,diseaseorphenotypicfeature
"Genetic variants in the HFE gene that cause iron overload lead to abnormal myocardial energy metabolism, which in turn predisposes patients to cardiovascular depression and infarction, often presenting with fever and memory impairment.",-29.0,0.6,diseaseorphenotypicfeature
"Genomic sequencing of the A549 cell line revealed a BRCA1 c.68_69delAG variant that may impair DNA repair, potentially exacerbating the patient’s fever‑associated retinopathy and memory‑impaired Parkinsonism while also contributing to abnormal myocardial energy metabolism and cardiovascular depression observed after infarction.",-40.5,0.6,diseaseorphenotypicfeature
"Genetically engineered A549 cells overexpressing the BRCA1 c.68_69delAG variant exhibited abnormal myocardial energy metabolism, leading to a pronounced increase in cardiovascular depression and a higher incidence of infarction in co‑cultured HUVECs, thereby suggesting a potential link between the sequence variant and ischemic heart disease phenotypes.",-51.75,0.6,diseaseorphenotypicfeature
"Genotoxic exposure to doxorubicin in A549 cells induces a BRCA1 c.68_69delAG variant that impairs DNA repair, leading to abnormal myocardial energy metabolism and subsequent cardiovascular depression in patients with Parkinson’s disease.",-26.75,0.6,diseaseorphenotypicfeature
"Cardiovascular depression in patients with Parkinsonism is exacerbated by abnormal myocardial energy metabolism, leading to infarction and retinopathy while fever and hand‑foot syndrome further impair memory.",-23.875,0.6,diseaseorphenotypicfeature
"Cardiac magnetic resonance imaging of patients with iron overload revealed that abnormal myocardial energy metabolism, often accompanied by parkinsonism and memory impairment, predisposes them to cardiovascular depression and acute infarction, while the presence of hand‑foot syndrome in those receiving high‑dose doxorubicin further exacerbates retinopathy and microphthalmia.",-40.25,0.6,diseaseorphenotypicfeature
Cardiotoxicity and abnormal myocardial energy metabolism observed in patients with severe hand‑foot syndrome after doxorubicin treatment were linked to a BRCA1 c.68_69delAG variant that also predisposes to Parkinsonism and memory impairment.,-35.0,0.6,diseaseorphenotypicfeature
"Cardio‑cerebral complications such as infarction and abnormal myocardial energy metabolism, together with retinopathy and Parkinsonism, were observed in patients receiving high‑dose doxorubicin, leading to fever, hand‑foot syndrome, and memory impairment.",-38.75,0.6,diseaseorphenotypicfeature
"Patients with iron overload and parkinsonism who exhibit abnormal myocardial energy metabolism are at higher risk of developing cardiovascular depression and infarction, which can further exacerbate memory impairment and hand‑foot syndrome.",-29.5,0.6,diseaseorphenotypicfeature
"Patients treated with doxorubicin for breast cancer developed hand‑foot syndrome, fever, and memory impairment, while those receiving the same drug plus metformin showed reduced cardiovascular depression and lower incidence of myocardial infarction due to improved abnormal myocardial energy metabolism.",-33.75,0.6,diseaseorphenotypicfeature
"Patients receiving doxorubicin in the A549 cell line developed hand‑foot syndrome and fever, while a BRCA1 c.68_69delAG variant in TP53‑expressing HeLa cells was associated with abnormal myocardial energy metabolism and cardiovascular depression.",-25.5,0.6,diseaseorphenotypicfeature
"Patients afflicted with Parkinson’s disease who received a single dose of doxorubicin displayed a marked increase in hand‑foot syndrome and memory impairment while their iron overload status remained unchanged, suggesting that the drug’s cardiotoxicity may be mediated through abnormal myocardial energy metabolism rather than direct infarction.",-52.5,0.6,diseaseorphenotypicfeature
"Administration of doxorubicin to A549 cells induced abnormal myocardial energy metabolism, leading to fever and hand‑foot syndrome in patients with cardiotoxicity.",-24.875,0.6,diseaseorphenotypicfeature
"Administration to A549 cells of the small‑molecule inhibitor doxorubicin markedly reduced TP53 expression, thereby exacerbating the fever‑induced inflammatory response and precipitating an infarction in the myocardial tissue of the H. sapiens model.",-53.25,0.6,diseaseorphenotypicfeature
"Administration and long‑term use of doxorubicin in HeLa cells have been linked to abnormal myocardial energy metabolism, leading to cardiovascular depression and, in some patients, to hand‑foot syndrome and memory impairment, while the associated BRCA1 c.68_69delAG variant further predisposes to retinopathy and Parkinsonism.",-62.5,0.6,diseaseorphenotypicfeature
"Administration targeting the NLRP3 inflammasome in HeLa cells with the BRCA1 c.68_69delAG variant reduces the fever‑induced release of IL‑1β, thereby ameliorating cardiovascular depression and improving memory impairment observed after myocardial infarction.",-57.25,0.6,diseaseorphenotypicfeature
"CRISPR‑edited HeLa cells expressing a BRCA1 c.68_69delAG variant exhibited increased sensitivity to doxorubicin, leading to higher rates of apoptosis and a marked reduction in cell viability, thereby suggesting a potential therapeutic vulnerability in breast cancer treatment.",-37.75,0.6,diseaseorphenotypicfeature
"CRP‑mediated inflammation in patients with fever and cardiovascular depression was found to be exacerbated by a missense Variant in the HIF1A gene, which further impaired abnormal myocardial energy metabolism and contributed to microphthalmia‑associated retinopathy.",-44.25,0.6,diseaseorphenotypicfeature
"CRUSADE‐derived data indicate that patients with iron overload‐associated retinopathy exhibit a markedly higher incidence of hand‑foot syndrome when treated with doxorubicin, suggesting a synergistic interaction between iron‑mediated oxidative stress and anthracycline‑induced vascular toxicity.",-49.25,0.6,diseaseorphenotypicfeature
"CRProliferating HeLa cells treated with doxorubicin exhibited fever‑like cytokine release, and the concomitant up‑regulation of TP53 and down‑regulation of mitochondrial ATP synthase subunit ATP5F1A suggested abnormal myocardial energy metabolism leading to cardiovascular depression and potential infarction.",-56.75,0.6,diseaseorphenotypicfeature
"Activation of the NLRP3 inflammasome in A549 cells exposed to doxorubicin triggers a cascade that releases interleukin‑1β, thereby exacerbating fever and contributing to the abnormal myocardial energy metabolism observed in patients with cardiovascular depression.",-27.75,0.6,diseaseorphenotypicfeature
"Activation by the AHR ligand TCDD in A549 cells induces abnormal myocardial energy metabolism, which may contribute to cardiovascular depression and eventually lead to infarction in patients with iron overload.",-44.25,0.6,diseaseorphenotypicfeature
"Activation and inhibition of the NRF2 pathway in A549 cells exposed to doxorubicin induces a fever‑like inflammatory response, promotes hand‑foot syndrome‑associated cytokine production, and causes memory‑impaired, cardiovascular‑depression‑prone cardiomyocyte dysfunction through abnormal myocardial energy metabolism and iron overload‑mediated oxidative stress.",-62.25,0.6,diseaseorphenotypicfeature
"Activation-induced cell death of A549 cells treated with doxorubicin induces a fever‑like cytokine storm that exacerbates cardiovascular depression and promotes abnormal myocardial energy metabolism, ultimately leading to infarction and memory impairment.",-41.0,0.6,diseaseorphenotypicfeature
"Altered iron overload in the A549 cell line, induced by the chemical entity deferoxamine, caused abnormal myocardial energy metabolism and led to cardiovascular depression in a mouse model of Parkinson’s disease.",-28.375,0.6,diseaseorphenotypicfeature
"Alterations in the mitochondrial DNA variant m.3243A>G in the A549 cell line, combined with exposure to doxorubicin, trigger abnormal myocardial energy metabolism that manifests clinically as fever and hand‑foot syndrome in patients with parkinsonism.",-32.5,0.6,diseaseorphenotypicfeature
Alteration of abnormal myocardial energy metabolism in the A549 cell line exposed to doxorubicin exacerbates cardiovascular depression and induces fever in a dose‑dependent manner.,-26.625,0.6,diseaseorphenotypicfeature
"Altercations of the mitochondrial respiratory chain in the A549 cell line, triggered by the pro‑oxidant chemical entity tert‑butyl hydroperoxide, culminate in abnormal myocardial energy metabolism that predisposes patients with Parkinson’s disease to cardiovascular depression and memory impairment.",-49.0,0.6,diseaseorphenotypicfeature
"Epinephrine administration in a patient with severe hand‑foot syndrome and memory impairment induced a transient cardiovascular depression that was accompanied by an abnormal myocardial energy metabolism signature, suggesting a potential link to early myocardial infarction in this clinical context.",-49.5,0.6,diseaseorphenotypicfeature
"Erythropoietin treatment in patients with iron overload and parkinsonism alleviated hand‑foot syndrome while improving memory impairment, yet it concurrently induced abnormal myocardial energy metabolism leading to cardiovascular depression and occasional infarction.",-31.25,0.6,diseaseorphenotypicfeature
"Epidemiologic analysis revealed that patients with Parkinsonism who received high‑dose doxorubicin experienced a significant increase in hand‑foot syndrome and memory‑impaired symptoms, suggesting a dose‑dependent cardiotoxicity that may involve abnormal myocardial energy metabolism.",-34.75,0.6,diseaseorphenotypicfeature
"Ethanol exposure in A549 cells upregulates the expression of the mitochondrial uncoupling protein UCP2, which in turn impairs ATP production and contributes to the development of abnormal myocardial energy metabolism and subsequent cardiovascular depression in patients with Parkinson’s disease.",-35.25,0.6,diseaseorphenotypicfeature
"Fever in patients with iron overload can trigger abnormal myocardial energy metabolism, leading to cardiovascular depression and subsequent infarction.",-15.5,0.6,diseaseorphenotypicfeature
"Ferroportin mutations in patients with iron overload lead to abnormal myocardial energy metabolism, which in turn predisposes them to cardiovascular depression and, in some cases, infarction.",-22.875,0.6,diseaseorphenotypicfeature
"Focal cerebral infarction in patients with abnormal myocardial energy metabolism and iron overload was found to exacerbate hand‑foot syndrome and memory‑impaired Parkinsonism, while cardiovascular depression remained a common comorbidity.",-36.0,0.6,diseaseorphenotypicfeature
"Fifteen patients with Parkinson’s disease treated with the dopamine agonist pramipexole exhibited hand‑foot syndrome and memory impairment, while a subset also developed cardiovascular depression and abnormal myocardial energy metabolism, suggesting a multifactorial adverse effect profile that may involve iron overload and retinopathy.",-39.0,0.6,diseaseorphenotypicfeature
The patient with a TIA and co‑infection of HIV and hepatitis B virus exhibited impaired mitochondrial function that likely contributed to the observed ischaemic injury and subsequent hearing loss.,-19.0,0.6,diseaseorphenotypicfeature
"The TIA patient with impaired mitochondrial function and a glucocorticoid‑resistant Iodide transport defect exhibited confusion and hearing loss, and was co‑infected with HIV and hepatitis B virus, leading to ischaemic injury and hypotension.",-21.0,0.6,diseaseorphenotypicfeature
"The Huh7 cell line infected with a glucocorticoid‑resistant HIV variant and a hepatitis B virus strain exhibited impaired mitochondrial function, leading to increased reactive oxygen species and ischemic injury in the hepatocytes.",-35.75,0.6,diseaseorphenotypicfeature
The combined glucocorticoid resistance and Iodide transport defect in the A549 cell line derived from a patient with a history of TIA and impaired mitochondrial function led to profound hypoxia‑induced ischaemic injury and subsequent hearing loss.,-34.75,0.6,diseaseorphenotypicfeature
"In patients co‑infected with HIV and hepatitis B virus, glucocorticoid resistance exacerbates ischaemic injury, leading to impaired mitochondrial function and a higher risk of transient ischemic attack.",-14.25,0.6,diseaseorphenotypicfeature
"In hypoxic myocardial tissue from a TIA patient, impaired mitochondrial function was linked to an Iodide transport defect that caused glucocorticoid resistance and contributed to the observed ischaemic injury.",-33.0,0.6,diseaseorphenotypicfeature
"In HeLa cells harboring a BRCA1 c.68_69delAG variant, glucocorticoid resistance was exacerbated by impaired mitochondrial function, leading to increased ischaemic injury and confusion in co‑infected HIV/HBV‑positive patients.",-21.625,0.6,diseaseorphenotypicfeature
"In A549 cells, the Iodide transport defect associated with glucocorticoid resistance was shown to exacerbate ischaemic injury, leading to confusion and hearing loss in patients co‑infected with HIV and hepatitis B virus.",-18.625,0.6,diseaseorphenotypicfeature
Tyrphostin AG-1478 treatment of A549 cells expressing the EGFR L858R variant mitigated ischemic injury‑induced hearing loss in a murine model of glucocorticoid resistance and concomitant HIV‑HBV co‑infection.,-46.75,0.6,diseaseorphenotypicfeature
"T2DM patients who are co‑infected with HIV and hepatitis B virus and exhibit glucocorticoid resistance often develop impaired mitochondrial function, leading to ischaemic injury of the myocardium and consequent hypotension.",-26.625,0.6,diseaseorphenotypicfeature
"Tetracycline treatment of a patient co‑infected with HIV and hepatitis B virus exacerbated hearing loss, which in turn was associated with a glucocorticoid‑resistant, impaired mitochondrial function phenotype that increased the risk of ischaemic injury and hypotension during subsequent TIA events.",-44.5,0.6,diseaseorphenotypicfeature
"T cell‑mediated ischemic injury in patients co‑infected with HIV and hepatitis B virus is exacerbated by glucocorticoid resistance, leading to impaired mitochondrial function and confusion.",-22.375,0.6,diseaseorphenotypicfeature
"Severe ischemic injury in a patient co‑infected with HIV and hepatitis B virus was associated with glucocorticoid resistance and a TIA, leading to impaired mitochondrial function and confusion.",-21.25,0.6,diseaseorphenotypicfeature
"Sepsis-induced TIA in a patient with glucocorticoid resistance and an iodide transport defect led to impaired mitochondrial function, causing confusion and hypotension that ultimately resulted in hearing loss.",-30.25,0.6,diseaseorphenotypicfeature
"Severely impaired mitochondrial function in A549 cells expressing the BRCA1 c.68_69delAG variant exacerbates ischaemic injury and confers glucocorticoid resistance, thereby increasing the risk of TIA in patients co‑infected with HIV and hepatitis B virus.",-26.75,0.6,diseaseorphenotypicfeature
"Secretion of pro‑inflammatory cytokines in patients co‑infected with HIV and hepatitis B virus aggravates ischaemic injury, leading to impaired mitochondrial function and subsequent confusion, a hallmark of transient ischemic attack (TIA) in the setting of glucocorticoid resistance.",-38.5,0.6,diseaseorphenotypicfeature
"Co‑infection with HIV and hepatitis B virus exacerbates ischaemic injury in the brain, leading to impaired mitochondrial function and confusion that can precipitate transient ischemic attacks.",-19.0,0.6,diseaseorphenotypicfeature
"Co-infected with HIV and hepatitis B virus, the patient’s TIA was aggravated by glucocorticoid resistance and impaired mitochondrial function, leading to severe confusion and ischaemic injury.",-17.375,0.6,diseaseorphenotypicfeature
"Co‐infected with HIV and hepatitis B virus, the patient exhibited impaired mitochondrial function, which contributed to the ischaemic injury and subsequent hearing loss.",-17.875,0.6,diseaseorphenotypicfeature
"Coexistent TIA and impaired mitochondrial function in the patient, who is co‑infected with HIV and hepatitis B virus, precipitated confusion, hypotension, and a glucocorticoid‑resistant inflammatory response that ultimately led to irreversible hearing loss.",-38.25,0.6,diseaseorphenotypicfeature
"A prolonged hypoxic ischemic injury in a patient with TIA exacerbated impaired mitochondrial function, leading to confusion and hearing loss.",-23.125,0.6,diseaseorphenotypicfeature
"A TIA in a patient with glucocorticoid resistance and an iodide transport defect caused severe confusion, impaired mitochondrial function, and ischaemic injury to the hippocampus, leading to hearing loss.",-23.625,0.6,diseaseorphenotypicfeature
A patient with TIA and impaired mitochondrial function who was co‑infected with HIV and hepatitis B virus exhibited confusion and a glucocorticoid‑resistant hypoxic ischemic injury leading to hearing loss.,-25.875,0.6,diseaseorphenotypicfeature
"A recent cohort study demonstrated that patients with transient ischemic attack (TIA) who were co‑infected with HIV and hepatitis B virus exhibited impaired mitochondrial function, leading to increased confusion and glucocorticoid resistance.",-21.375,0.6,diseaseorphenotypicfeature
Impaired mitochondrial function in A549 cells treated with doxorubicin exacerbates hypoxic ischemic injury and contributes to glucocorticoid resistance in patients with TIA and concurrent HIV–Hepatitis B co‑infection.,-28.25,0.6,diseaseorphenotypicfeature
"Impairment of mitochondrial function in A549 cells treated with doxorubicin exacerbates ischaemic injury and confuses the diagnosis of TIA in patients co‑infected with HIV and hepatitis B virus, highlighting a glucocorticoid‑resistant phenotype that may underlie Iodide transport defects and hearing loss.",-41.25,0.6,diseaseorphenotypicfeature
"Immunotherapy with nivolumab in a patient co‑infected with HIV and hepatitis B virus exacerbated ischemic injury in the brain, leading to transient TIA and confusion while concurrently revealing an iodide transport defect that contributed to glucocorticoid resistance and impaired mitochondrial function.",-37.0,0.6,diseaseorphenotypicfeature
"Imputed data from a large cohort revealed that patients with TIA and concurrent glucocorticoid resistance exhibited markedly impaired mitochondrial function, contributing to early ischaemic injury and persistent confusion.",-42.75,0.6,diseaseorphenotypicfeature
"Patients co‑infected with HIV and hepatitis B virus exhibited a severe ischaemic injury that led to impaired mitochondrial function, resulting in profound hypotension and confusion.",-24.0,0.6,diseaseorphenotypicfeature
"Patients with TIA and co‑infected HIV/HBV who exhibit glucocorticoid resistance and an iodide transport defect experience impaired mitochondrial function, leading to confusion and ischemic injury in the brain.",-23.625,0.6,diseaseorphenotypicfeature
"Patients undergoing treatment for TIA exhibited impaired mitochondrial function, resulting in confusion and hypotension that were exacerbated by glucocorticoid resistance and an iodide transport defect.",-27.125,0.6,diseaseorphenotypicfeature
"Patients presenting with TIA and impaired mitochondrial function often exhibit glucocorticoid resistance, which may exacerbate ischemic injury and contribute to confusion.",-19.5,0.6,diseaseorphenotypicfeature
"Dexamethasone treatment in a patient co‑infected with HIV and hepatitis B virus exacerbated glucocorticoid resistance, precipitating hypotension and confusion while impairing mitochondrial function in the liver.",-28.75,0.6,diseaseorphenotypicfeature
"Dopamine agonist therapy in patients co‑infected with HIV and hepatitis B virus exacerbated impaired mitochondrial function, leading to ischaemic injury and subsequent confusion in a subset of those with glucocorticoid resistance.",-26.375,0.6,diseaseorphenotypicfeature
Dysregulated glucocorticoid receptor signaling in the A549 cell line carrying the TP53 p.R175H variant exacerbates impaired mitochondrial function and confers resistance to the anti‑inflammatory effects of dexamethasone in patients with ischemic injury and concurrent HIV‑Hepatitis B co‑infection.,-40.25,0.6,diseaseorphenotypicfeature
"Dacarbazine treatment of a HeLa-derived tumor harboring a BRCA1 c.68_69delAG variant exacerbated ischemic injury in a patient with a glucocorticoid resistance phenotype and co‑infected with HIV and hepatitis B virus, leading to confusion, hypotension, and impaired mitochondrial function.",-41.75,0.6,diseaseorphenotypicfeature
"Mice with a genetically engineered BRCA1 c.68_69delAG sequence variant displayed increased susceptibility to ischemic injury, leading to impaired mitochondrial function and subsequent confusion in the context of glucocorticoid resistance.",-31.375,0.6,diseaseorphenotypicfeature
Mitochondrial dysfunction in A549 cells expressing the TP53 R248W variant exacerbates ischemic injury in a mouse model of transient ischemic attack (TIA) and is associated with impaired alveolar development and glucocorticoid resistance.,-33.0,0.6,diseaseorphenotypicfeature
"Molecular analysis of a patient presenting with TIA, confusion, and hearing loss revealed a BRCA1 c.68_69delAG sequence variant that disrupts glucocorticoid receptor binding, thereby contributing to glucocorticoid resistance and impaired mitochondrial function.",-29.5,0.6,diseaseorphenotypicfeature
Mild ischemic injury in a patient with a glucocorticoid‑resistant TIA phenotype is associated with impaired mitochondrial function and subsequent confusion.,-26.25,0.6,diseaseorphenotypicfeature
"Cognitive confusion in a patient co‑infected with HIV and hepatitis B virus was linked to impaired mitochondrial function, which in turn exacerbated ischaemic injury and glucocorticoid resistance in the brain.",-19.125,0.6,diseaseorphenotypicfeature
"Coxsackievirus B3 infection of HeLa cells exacerbates impaired mitochondrial function, which in turn triggers an ischaemic injury response that is amplified by glucocorticoid resistance and co‑infection with HIV and hepatitis B virus, ultimately leading to confusion and hearing loss.",-38.75,0.6,diseaseorphenotypicfeature
"Cobalt‑plated implants in patients co‑infected with HIV and hepatitis B virus exacerbated ischemic injury, leading to impaired mitochondrial function and resulting in confusion and hearing loss.",-32.5,0.6,diseaseorphenotypicfeature
"Cocaine‑induced ischaemic injury in the hippocampus of a co‑infected HIV/HBV patient, who also exhibits glucocorticoid resistance and impaired mitochondrial function, led to profound confusion and hearing loss.",-32.75,0.6,diseaseorphenotypicfeature
"Intracerebral haemorrhage in a patient co‑infected with HIV and hepatitis B virus exacerbated glucocorticoid resistance, leading to impaired mitochondrial function and subsequent confusion.",-18.125,0.6,diseaseorphenotypicfeature
"Intravenous methylprednisolone ameliorated the confusion and hearing loss observed in a patient with glucocorticoid resistance who was co‑infected with HIV and hepatitis B virus, yet the drug failed to correct the iodide transport defect that contributed to the patient’s impaired alveolar development.",-34.5,0.6,diseaseorphenotypicfeature
"Intramuscular administration of high‑dose methylprednisolone in patients with ischemic stroke and concomitant glucocorticoid resistance was associated with a higher incidence of confusion, hypotension, and impaired mitochondrial function.",-37.75,0.6,diseaseorphenotypicfeature
"Intranasal administration of dexamethasone in patients with ischemic injury and glucocorticoid resistance reduced the risk of subsequent hearing loss, while the concomitant presence of a TIA in a co‑infected HIV‑ and hepatitis B‑positive individual was associated with impaired mitochondrial function and confusion.",-51.75,0.6,diseaseorphenotypicfeature
"Hypotension in patients co‑infected with HIV and hepatitis B virus exacerbates ischaemic injury, leading to impaired mitochondrial function that contributes to confusion and glucocorticoid resistance in the setting of transient ischaemic attack.",-30.75,0.6,diseaseorphenotypicfeature
"Hypoxia-induced impaired mitochondrial function in A549 cells exacerbates ischaemic injury and confers glucocorticoid resistance, leading to hearing loss in patients co‑infected with HIV and hepatitis B virus.",-22.875,0.6,diseaseorphenotypicfeature
"Hypoxanthine guanine phosphoribosyltransferase deficiency in a patient with a TIA, impaired mitochondrial function, and co‑infection with HIV and hepatitis B virus was found to cause glucocorticoid resistance, Iodide transport defect, and hearing loss.",-37.5,0.6,diseaseorphenotypicfeature
"Hypoxic ischemic injury in the neonatal mouse brain was exacerbated by a novel BRCA1 c.68_69delAG variant, leading to impaired mitochondrial function and subsequent hearing loss in the surviving pups.",-32.25,0.6,diseaseorphenotypicfeature
"Oxidative phosphorylation defects in the mitochondrial respiratory chain of A549 cells, which are co‑infected with HIV and hepatitis B virus, lead to impaired alveolar development and a hypoxic ischaemic injury that ultimately manifests as hearing loss in patients with glucocorticoid resistance.",-43.5,0.6,diseaseorphenotypicfeature
"Oxymetazoline treatment in patients with TIA and co‑infected HIV and hepatitis B virus was associated with impaired mitochondrial function and glucocorticoid resistance, leading to confusion and hypotension.",-37.25,0.6,diseaseorphenotypicfeature
"Oxcarbazepine exacerbated confusion and impaired mitochondrial function in a patient co‑infected with HIV and hepatitis B virus, leading to ischaemic injury of the brain and subsequent hearing loss.",-28.75,0.6,diseaseorphenotypicfeature
"Oxaliplatin‑induced ototoxicity in a patient with HIV/HBV co‑infection and a known Iodide transport defect manifested as progressive hearing loss, confusion, and hypotension, likely exacerbated by impaired mitochondrial function and glucocorticoid resistance.",-42.75,0.6,diseaseorphenotypicfeature
"The laboratory of genetics and physiology‑2 discovered that the up‑regulation of miR‑192 in HeLa cells leads to increased expression of the protease cathepsin B, which in turn enhances the shedding of uroplakin from the urothelial surface and promotes the activation of beta‑ENaC, thereby contributing to the hyper‑sodium absorption observed in cystic fibrosis patients.",-51.75,0.6,geneorgeneproduct
"The upregulation of CXCL12 in the uroplakin‑rich bladder epithelium of a HeLa cell line treated with the small molecule rSLURP‑1 was found to enhance beta‑ENaC‑mediated sodium reabsorption, an effect that was attenuated by miR‑192 overexpression and partially rescued by MT1‑MMP inhibition.",-38.75,0.6,geneorgeneproduct
"The lab’s CRISPR editing of the CXCL12 locus in A549 cells revealed that the resulting beta‑ENaC variant down‑regulates IL10 expression, thereby increasing cathepsin B secretion and accelerating uroplakin‑mediated invasion.",-42.25,0.6,geneorgeneproduct
"The knock‑down of cathepsin B in the A549 cell line markedly increased CXCL12 secretion, suggesting that cathepsin B regulates chemokine release and may influence metastasis in lung cancer.",-25.75,0.6,geneorgeneproduct
"In the laboratory of genetics and physiology II, researchers discovered that the miR‑192‑mediated down‑regulation of cathepsin B in A549 cells enhances resistance to doxorubicin, while simultaneous up‑regulation of MT1‑MMP and CXCL12 promotes invasive migration.",-40.0,0.6,geneorgeneproduct
"In H1299 cells, overexpression of the MT1-MMP gene product induces uroplakin‑mediated membrane remodeling, which in turn activates beta‑ENaC channels and elevates CXCL12 secretion, thereby promoting tumor‑derived IL10 production and miR‑192‑dependent suppression of FOXP3 expression.",-47.5,0.6,geneorgeneproduct
"In a recent study by the laboratory of genetics and physiology2, overexpression of the protease MT1-MMP in A549 cells was shown to enhance invasive potential through increased degradation of uroplakin and upregulation of beta-ENaC, while miR‑192 down‑regulation of CXCL12 was associated with reduced chemotaxis of FOXP3‑positive T cells.",-58.5,0.6,geneorgeneproduct
"In human airway epithelial cells, the up‑regulation of the protease cathepsin B by IL10 signaling enhances uroplakin degradation, thereby impairing tight junction integrity and facilitating beta‑ENaC‑mediated sodium reabsorption, a mechanism that may be exacerbated by the loss‑of‑function mutation c.1043G>A in the FOXP3 gene.",-47.75,0.6,geneorgeneproduct
"Beta‑ENaC overexpression in A549 cells enhances CXCL12 secretion, which in turn up‑regulates MT1‑MMP activity, thereby promoting uroplakin‑dependent epithelial migration.",-25.625,0.6,geneorgeneproduct
"Beta-ENaC expression is upregulated by IL10 in uroplakin‑positive A549 cells, a change that correlates with increased CXCL12 secretion and enhanced MT1‑MMP‑mediated extracellular matrix remodeling.",-29.125,0.6,geneorgeneproduct
"Beta‐ENaC overexpression in A549 cells increases IL10 production, which in turn downregulates CXCL12 secretion and promotes MT1‑MMP‑mediated extracellular matrix remodeling.",-30.25,0.6,geneorgeneproduct
"Beta–ENaC overexpression in A549 cells leads to increased CXCL12 secretion, which in turn promotes uroplakin‑mediated migration of tumor‐derived fibroblasts, an effect that is attenuated by the miR‑192‑mediated down‑regulation of MT1‑MMP.",-44.25,0.6,geneorgeneproduct
"Mutation of the BRCA1 c.68_69delAG sequence variant in the laboratory of genetics and physiology‑2 cell line HCC‑LM2 upregulates the cathepsin B gene product, thereby enhancing invasion of Homo sapiens lung carcinoma cells.",-49.0,0.6,geneorgeneproduct
"Mutation-driven overexpression of cathepsin B in the laboratory of genetics and physiology II’s A549 cell line leads to enhanced degradation of uroplakin, thereby accelerating beta-ENaC-mediated sodium reabsorption and promoting CXCL12 secretion that recruits FOXP3+ regulatory T cells.",-53.25,0.6,geneorgeneproduct
"Mutation‐induced dysregulation of cathepsin B activity in A549 cells, driven by a BRCA1 c.68_69delAG variant, leads to increased CXCL12 secretion that subsequently upregulates uroplakin expression via the IL10‑dependent PI3K/AKT pathway.",-47.25,0.6,geneorgeneproduct
"Mutation in the TP53 gene of HeLa cells reduces cathepsin B expression, thereby attenuating the uroplakin‑mediated cell migration driven by IL10 and CXCL12 signaling.",-34.75,0.6,geneorgeneproduct
"Loss of cathepsin B in A549 cells leads to reduced uroplakin expression and upregulation of the IL10‑producing miR‑192/FOXP3 axis, thereby attenuating CXCL12‑driven invasion in a model of epithelial‑to‑mesenchymal transition studied at the Laboratory of Genetics and Physiology‑2.",-50.75,0.6,geneorgeneproduct
"Loss-of-function mutations in the **beta‑ENaC** gene, coupled with overexpression of **MT1‑MMP** in the renal **tubular epithelial cells** of patients from the Laboratory of Genetics and Physiology II, lead to impaired sodium reabsorption and a paradoxical increase in **IL‑10** secretion that exacerbates chronic kidney disease.",-59.5,0.6,geneorgeneproduct
"Loss‑of‑function mutations in the cathepsin B gene (CTSB) observed in a cohort of patients with urothelial carcinoma of the bladder revealed a novel missense variant (c.523G>A, p.Gly175Ser) that disrupts the catalytic dyad, leading to impaired lysosomal proteolysis and enhanced secretion of the pro‑inflammatory chemokine CXCL12, which in turn promotes tumor cell invasion through up‑regulation of the epithelial‑to‑mes",-74.0,0.6,geneorgeneproduct
"Loss‐of‑function mutations in the cathepsin B gene (CTSB) in A549 cells reduce MT1‑MMP‑mediated invasion, while up‑regulation of miR‑192 down‑regulates CXCL12 expression, thereby attenuating tumor‑associated angiogenesis in a xenograft model of non‑small‑cell lung cancer.",-46.25,0.6,geneorgeneproduct
"Investigations in the laboratory of genetics and physiology II revealed that the rSLURP‑1 peptide, when overexpressed in A549 cells, down‑regulates the surface expression of beta‑ENaC and consequently suppresses CXCL12‑induced migration, a finding that may implicate miR‑192‑mediated targeting of MT1‑MMP in the modulation of uroplakin‑dependent epithelial barrier function.",-59.5,0.6,geneorgeneproduct
"Investigative studies in the laboratory of genetics and physiology II revealed that the up‑regulation of miR‑192 in A549 cells suppresses MT1‑MMP expression, thereby reducing extracellular matrix degradation and attenuating CXCL12‑driven migration of uroplakin‑positive urothelial carcinoma cells.",-44.5,0.6,geneorgeneproduct
"Investigational data from the Laboratory of Genetics and Physiology II revealed that the upregulation of miR‑192 in A549 cells enhances the expression of MT1‑MMP, thereby increasing the cleavage of uroplakin and beta‑ENaC and ultimately promoting CXCL12 secretion, which may modulate IL10‑mediated immune responses in the tumor microenvironment.",-59.5,0.6,geneorgeneproduct
"Investigating the interaction between cathepsin B and the uroplakin complex in the urothelium, the laboratory of genetics and physiology II discovered that overexpression of beta-ENaC enhances MT1-MMP‑mediated extracellular matrix remodeling, thereby increasing CXCL12 secretion and recruiting FOXP3‑positive regulatory T cells that suppress miR‑192‑dependent IL10 production.",-56.0,0.6,geneorgeneproduct
"Uroplakin expression in the bladder epithelium is down‑regulated by miR‑192, and this suppression enhances the proteolytic activity of cathepsin B, which in turn cleaves MT1‑MMP, leading to increased CXCL12 secretion that recruits FOXP3‑positive regulatory T cells to the urinary tract.",-40.5,0.6,geneorgeneproduct
"Uptake of the small molecule rSLURP-1 by the uroplakin-expressing bladder epithelial cells in the laboratory of genetics and physiology II was found to downregulate the expression of the sodium channel β‑ENaC, thereby attenuating IL10-mediated inflammatory signaling and reducing MT1‑MMP‑dependent extracellular matrix remodeling.",-56.75,0.6,geneorgeneproduct
"Urocortin‑2 overexpression in the A549 cell line was found to up‑regulate MT1‑MMP and CXCL12, thereby enhancing invasion of the lung cancer cells and correlating with a higher incidence of the TP53 c.215C>A sequence variant in the laboratory of genetics and physiology‑2 cohort.",-59.0,0.6,geneorgeneproduct
"Uropathogenic *E. coli* infection of the bladder epithelium induces up‑regulation of uroplakin‑III, which in turn activates the cathepsin‑B‑mediated cleavage of the extracellular domain of β‑ENaC, thereby enhancing sodium reabsorption and contributing to the hypertension observed in patients with chronic kidney disease.",-43.5,0.6,geneorgeneproduct
"Mutations in the cathepsin B gene, such as the c.523C>T variant, were shown to downregulate uroplakin expression in urothelial carcinoma cells, thereby impairing bladder barrier integrity and facilitating the recruitment of IL10‑producing macrophages.",-43.0,0.6,geneorgeneproduct
"Mutational loss of MT1‑MMP in A549 cells up‑regulates CXCL12 secretion, thereby enhancing IL10‑mediated recruitment of FOXP3⁺ regulatory T cells and promoting uroplakin‑driven epithelial‑mesenchymal transition.",-27.75,0.6,geneorgeneproduct
"Mutagenic exposure to the small molecule rSLURP‑1 in A549 cells upregulated CXCL12 expression, thereby enhancing the chemotactic recruitment of FOXP3‑positive regulatory T cells and increasing resistance to apoptosis via the beta‑ENaC‑dependent Na⁺ influx pathway.",-45.0,0.6,geneorgeneproduct
"Mutant CXCL12 alleles in the laboratory of genetics and physiology II were found to up‑regulate MT1‑MMP expression in A549 cells, thereby enhancing invasive migration of the human lung carcinoma line.",-36.25,0.6,geneorgeneproduct
"FoxP3 transcriptionally represses CXCL12 expression in uroplakin‑positive bladder epithelial cells, a suppression that is relieved by miR‑192‑mediated degradation of MT1‑MMP transcripts, thereby enhancing cathepsin B–driven extracellular matrix remodeling and beta‑ENaC‑dependent sodium reabsorption in the renal collecting duct.",-43.5,0.6,geneorgeneproduct
"FoxO1 activation in the laboratory of genetics and physiology‑2 cell line HeLa was shown to up‑regulate MT1‑MMP and CXCL12 expression, thereby promoting invasion of uroplakin‑positive bladder cancer cells.",-43.25,0.6,geneorgeneproduct
"Fox1, a transcription factor encoded by the FOXP3 gene, was shown to up‑regulate the uroplakin‑A1 promoter in cultured urothelial cells, thereby enhancing uroplakin‑A1 surface expression and contributing to bladder epithelial barrier function.",-40.25,0.6,geneorgeneproduct
"FoxA2-mediated upregulation of CXCL12 in the laboratory of genetics and physiology \(2\) enhances β‑ENaC expression in uroplakin‑positive renal epithelial cells, thereby promoting sodium reabsorption and contributing to hypertension.",-45.0,0.6,geneorgeneproduct
"Expression of the uroplakin gene in the A549 cell line was up‑regulated by IL10, which in turn enhanced CXCL12 secretion and promoted beta‑ENaC‑mediated sodium transport in a murine kidney model.",-37.0,0.6,geneorgeneproduct
"Expression levels of the membrane‑anchored protease MT1‑MMP in the uroplakin‑positive bladder epithelial cells of the laboratory of genetics and physiology, and its regulation by the microRNA miR‑192, were found to be elevated in the presence of the IL10‑induced up‑regulation of the sodium channel subunit beta‑ENaC, thereby suggesting a potential feedback loop that may influence bladder smooth‑muscle contractility.",-73.0,0.6,geneorgeneproduct
"Expression analysis in the laboratory of genetics and physiology2 revealed that upregulation of the miR‑192/FOXP3 axis suppresses cathepsin B while enhancing uroplakin and beta‑ENaC expression, thereby modulating epithelial barrier integrity and CXCL12 secretion.",-46.75,0.6,geneorgeneproduct
"Expression profiling revealed that in HeLa cells the miR‑192‑dependent down‑regulation of CXCL12 enhances MT1‑MMP‑mediated invasion, a process that is further amplified by the beta‑ENaC‑driven increase in intracellular calcium, thereby linking uroplakin‑induced signaling to cathepsin B activation in a manner that may be modulated by rSLURP‑1 and IL10 in the laboratory of genetics and physiology‑2.",-66.5,0.6,geneorgeneproduct
"Gene overexpression of cathepsin B in the uroplakin‑positive A549 cell line was found to up‑regulate IL10 secretion, thereby attenuating CXCL12‑mediated migration of MT1‑MMP‑expressing fibroblasts in a model of beta‑ENaC‑driven airway remodeling.",-43.5,0.6,geneorgeneproduct
"Gene expression analysis in the laboratory of genetics and physiology II revealed that the up‑regulation of CXCL12 in A549 cells promotes invasion through MT1‑MMP activation, a process that is inhibited by the small‑molecule rSLURP‑1, while miR‑192 down‑regulates cathepsin B expression in a manner dependent on IL‑10 signaling.",-57.5,0.6,geneorgeneproduct
"GeneX, a novel variant of cathepsin B, was found to be over‑expressed in the uroplakin‑positive A549 cell line, where it promoted beta‑ENaC‑mediated sodium reabsorption and induced the secretion of IL10 and CXCL12, thereby creating an immunosuppressive microenvironment that supported tumor progression.",-52.75,0.6,geneorgeneproduct
"Gene‑editing of the MT1-MMP promoter in A549 cells reduces CXCL12 secretion, thereby diminishing IL‑10‑mediated suppression of cathepsin B activity in the uroplakin‑positive airway epithelium studied at the laboratory of genetics and physiology.",-46.25,0.6,geneorgeneproduct
"CRISPR‑mediated knockout of the MT1‑MMP gene in the A549 cell line revealed that loss of MT1‑MMP markedly reduced uroplakin expression and impaired cell migration, suggesting a regulatory role for MT1‑MMP in uroplakin‑dependent epithelial barrier function.",-31.75,0.6,geneorgeneproduct
"CRLF2 overexpression in the human B‑cell line NALM‑6 induces CXCL12 secretion, which in turn promotes IL10‑mediated suppression of MT1‑MMP activity in the tumor microenvironment.",-37.75,0.6,geneorgeneproduct
"CR‑isogenic A549 cells overexpressing the cathepsin B variant c.103G>A exhibit enhanced invasion via MT1‑MMP‑mediated degradation of the uroplakin‑rich basement membrane, a process that is further potentiated by IL10‑induced CXCL12 secretion.",-53.5,0.6,geneorgeneproduct
"CRIPTO‑overexpressing A549 cells exhibit elevated MT1‑MMP activity, which promotes uroplakin‑mediated invasion through CXCL12‑driven chemotaxis and is further enhanced by the miR‑192‑dependent down‑regulation of beta‑ENaC in a laboratory of genetics and physiology‑2 model.",-57.25,0.6,geneorgeneproduct
"Overexpression of cathepsin B in A549 cells enhances CXCL12 secretion, thereby promoting β‑ENaC‑mediated sodium influx and accelerating tumor cell migration.",-23.75,0.6,geneorgeneproduct
"Overexpressed cathepsin B in A549 cells was shown to cleave uroplakin, thereby upregulating beta‑ENaC activity and enhancing IL‑10 secretion, a process that the laboratory of genetics and physiology‑2 confirmed to involve miR‑192‑mediated downregulation of MT1‑MMP and CXCL12 signaling.",-46.5,0.6,geneorgeneproduct
"Overactivation of CXCL12 signaling in the laboratory of genetics and physiology‑2 cell line U2OS, driven by a BRCA1 c.68_69delAG variant, leads to increased cathepsin B expression and promotes uroplakin‑induced epithelial‑mesenchymal transition.",-49.5,0.6,geneorgeneproduct
"Over exposure to the small molecule rSLURP‑1 upregulates CXCL12 secretion in HeLa cells, thereby enhancing the migration of uroplakin‑positive bladder cancer cells.",-37.75,0.6,geneorgeneproduct
"Dopamine-induced upregulation of cathepsin B in the uroplakin‑expressing A549 cell line activates the IL10/MT1‑MMP axis, thereby promoting CXCL12‑mediated chemotaxis of miR‑192‑rich FOXP3+ T cells in a mouse model of renal fibrosis.",-55.25,0.6,geneorgeneproduct
"Deregulation of the cathepsin B–MT1-MMP axis in A549 cells leads to increased CXCL12 secretion, which in turn promotes beta‑ENaC‑mediated sodium transport and activates miR‑192‑dependent suppression of IL10 expression in a feedback loop that enhances uroplakin‑driven epithelial barrier dysfunction.",-49.0,0.6,geneorgeneproduct
"Dysregulated expression of the protease MT1‑MMP in A549 cells increases cathepsin B secretion, which in turn enhances uroplakin‑III cleavage and promotes β‑ENaC‑mediated sodium influx, thereby creating a microenvironment that up‑regulates CXCL12 secretion and attracts FOXP3‑expressing regulatory T cells to the tumor niche.",-46.25,0.6,geneorgeneproduct
"Dexamethasone treatment of A549 cells upregulated the expression of CXCL12 and the proteolytic activity of cathepsin B, thereby enhancing the invasive potential of the tumor through MT1‑MMP‑mediated extracellular matrix remodeling.",-35.25,0.6,geneorgeneproduct
"The upregulation of b‑Catenin in A549 cells treated with the mPGES‑1‑derived inhibitor EPO leads to activation of Rho GTPases, thereby enhancing filamin A‑mediated cell migration and reducing growth arrest and DNA‑damage‑inducible protein‑45α expression.",-34.5,0.6,geneorgeneproduct
"The transactivation of β‑catenin by Rho GTPases enhances the expression of Ly‑6/urokinase plasminogen activator receptor‑related protein‑1, which in turn stimulates mPGES‑1‑derived prostaglandin E2 production and up‑regulates filamin A and B, thereby promoting cell‑cycle arrest through Growth arrest and DNA‑damage‑inducible protein‑45α while simultaneously inducing EPO synthesis and SMA differentiation via the Sag‑F",-55.5,0.6,geneorgeneproduct
"The Rho GTPase‑mediated activation of b‑catenin by Ly‑6/urokinase plasminogen activator receptor‑related protein‑1 enhances mPGES‑1‑derived prostaglandin E2 production in A549 cells, thereby stimulating filamin A‑dependent cytoskeletal remodeling and up‑regulating the growth‑arrest‑and‑DNA‑damage‑inducible protein GADD45α, which ultimately promotes apoptosis resistance in this lung carcinoma model",-53.0,0.6,geneorgeneproduct
"The hyperactivation of b‑Catenin in A549 cells by the mPGES‑1‑derived inhibitor LY‑6/urokinase plasminogen activator receptor related protein‑1 triggers Rho GTPases‑mediated cytoskeletal rearrangements, leading to filamin A phosphorylation and subsequent modulation of Growth arrest and DNA‑damage‑inducible protein‑45 alpha expression.",-46.75,0.6,geneorgeneproduct
"Mutant TP53 p.R175H in the A549 cell line enhances the interaction between β‑catenin and the Rho GTPase Rac1, thereby increasing filamin A phosphorylation and promoting chemoresistance to doxorubicin.",-32.25,0.6,geneorgeneproduct
"Mutations in the ARBSs gene product, which modulates Rho GTPases activity, were shown to reduce mPGES‑1‑derived prostaglandin E2 production in HeLa cells, thereby impairing EPO‑induced erythroid differentiation.",-30.625,0.6,geneorgeneproduct
"Mutational activation of the β‑catenin pathway in HeLa cells upregulates the expression of the urokinase plasminogen activator receptor‑related protein‑1 (LRP‑1) and enhances Rho GTPase‑mediated filamin‑A re‑organization, thereby promoting cell migration and invasion.",-34.25,0.6,geneorgeneproduct
"Mutagenic exposure of HeLa cells to doxorubicin induced a BRCA1 c.68_69delAG variant, which in turn down‑regulated EPO transcription and impaired Rho GTPase‑mediated cytoskeletal organization, thereby reducing cell migration.",-34.0,0.6,geneorgeneproduct
"Genome‑wide CRISPR‑Cas9 editing of the ARBSs region in A549 cells revealed that loss of the b‑Catenin binding motif upregulates Rho GTPases, thereby enhancing filamin A‑mediated migration and increasing Ly‑6/urokinase plasminogen activator receptor related protein‑1 expression, a phenotype that can be partially rescued by mPGES‑1‑derived prostaglandin E2.",-47.5,0.6,geneorgeneproduct
"Genome‐wide CRISPR screens in HCT116 cells revealed that loss of the filamin A gene (FLNA) synergizes with RhoA activation to upregulate b‑catenin‑mediated transcription, thereby enhancing epithelial–mesenchymal transition and conferring resistance to the mPGES‑1‑derived prostaglandin E2 inhibitor.",-44.75,0.6,geneorgeneproduct
"Genome editing of the TP53 gene in A549 cells revealed that the BRCA1 c.68_69delAG variant reduces the expression of filamin A and B, thereby impairing Rho GTPase‑mediated cytoskeletal remodeling and increasing susceptibility to EPO‑induced apoptosis.",-35.5,0.6,geneorgeneproduct
"Genome-wide CRISPR screening in the A549 cell line revealed that loss of the filamin A (FLNA) gene product synergizes with the Rho GTPase Rac1 to increase mPGES-1-derived prostaglandin E₂ secretion, thereby promoting a pro‑tumorigenic inflammatory microenvironment in non‑small‑cell lung cancer.",-51.0,0.6,geneorgeneproduct
"A mutation in the ARBSs gene product, which encodes a regulator of Rho GTPases, was shown to impair filamin A binding and thereby reduce the stabilization of b‑catenin in A549 cells, leading to increased susceptibility to apoptosis induced by mPGES‑1‑derived prostaglandin E2.",-44.5,0.6,geneorgeneproduct
"A recent study revealed that overexpression of β‑catenin in A549 cells enhances Rho GTPase‑mediated migration, while knockdown of filamin‑A and filamin‑B reduces the interaction between Ly‑6/urokinase plasminogen‑activator receptor–related protein‑1 and mPGES‑1‑derived prostaglandin E₂, thereby attenuating the growth‑arrest‑and‑DNA‑damage‑inducible‑45‑alpha signaling",-48.5,0.6,geneorgeneproduct
"A transcriptional co‑activator of the β‑catenin/TCF complex, filamin A, was found to be up‑regulated in A549 cells carrying the TP53 c.215C>T variant, thereby enhancing Rho GTPase‑mediated actin remodeling and promoting resistance to doxorubicin.",-42.0,0.6,geneorgeneproduct
"A deletion of BRCA1 c.68_69delAG in a Homo sapiens breast cancer cell line (MDA‑MB‑231) upregulates the mPGES‑1‑derived prostaglandin E2 pathway, thereby enhancing Rho GTPase‑mediated cell migration and conferring resistance to doxorubicin.",-36.0,0.6,geneorgeneproduct
"In the HCT116 cell line, activation of Rho GTPases by the Ly‑6/uPAR‑related protein‑1 ligand enhances mPGES‑1‑derived prostaglandin E2 production, which in turn stabilizes b‑catenin and promotes filamin‑A‑mediated epithelial‑to‑mesenchymal transition.",-28.875,0.6,geneorgeneproduct
"In HepG2 cells, the mPGES‑1‑derived prostaglandin E2 activates Rho GTPases, thereby enhancing b‑catenin‑mediated transcription of the growth‑arrest‑and‑DNA‑damage‑inducible‑45‑alpha gene.",-22.625,0.6,geneorgeneproduct
"In HEK293T cells, overexpression of the ARBSs protein leads to phosphorylation of b‑Catenin, which in turn activates Rho GTPases and enhances the transcription of the Ly‑6/urokinase plasminogen activator receptor related protein‑1 gene, thereby increasing mPGES‑1‑derived prostaglandin E2 production and promoting filamin A‑B‑mediated cytoskeletal remodeling.",-34.25,0.6,geneorgeneproduct
"In A549 cells, the mPGES‑1‑derived prostaglandin E2 signaling activates Rho GTPases, which in turn upregulate filamin A expression and promote epithelial‑mesenchymal transition, while b‑catenin stabilization by EPO enhances the transcription of growth‑arrest‑and‑DNA‑damage‑inducible protein‑45α, ultimately facilitating tumor cell invasion.",-50.25,0.6,geneorgeneproduct
"Loss of ARBSs in A549 cells upregulates mPGES-1-derived prostaglandin E2, which in turn activates Rho GTPases to enhance filamin A phosphorylation and promote epithelial–mesenchymal transition.",-25.125,0.6,geneorgeneproduct
"Loss‑of‑function mutations in the TP53 gene in HCT116 cells increase expression of the Ly‑6/urokinase plasminogen activator receptor‑related protein‑1 gene, thereby enhancing invasion through Rho GTPase‑mediated remodeling of the filamin‑A cytoskeleton.",-36.0,0.6,geneorgeneproduct
"Loss-of-function mutations in the **SAG‑Fbxw7** gene, as observed in a **Homo sapiens** patient cohort, were shown to impair the ubiquitination and degradation of **β‑catenin**, thereby sustaining aberrant transcriptional activation of the **Rho GTPases** signaling cascade and promoting unchecked proliferation of **A549** cells.",-51.75,0.6,geneorgeneproduct
"Loss‐of‐function mutations in the Fbxw7 gene in A549 cells diminish the ubiquitination and degradation of β‑catenin, thereby amplifying Wnt/β‑catenin signaling and promoting epithelial‑mesenchymal transition through upregulation of Rho GTPases and filamin‑A expression.",-41.5,0.6,geneorgeneproduct
Targeting the interaction between β‑catenin and the Rho GTPase‑regulated filamin‑A complex in A549 cells reduces mPGES‑1‑derived prostaglandin E₂ production and restores EPO‑stimulated erythropoiesis in a hypoxia‑induced model of Growth arrest and DNA‑damage‑inducible protein‑45α‑mediated anemia.,-43.25,0.6,geneorgeneproduct
"Targeted CRISPR‑mediated disruption of the ARBSs gene in the A549 cell line led to a pronounced up‑regulation of b‑catenin and a concomitant decrease in mPGES‑1‑derived prostaglandin E₂, suggesting that ARBSs normally restrains the Wnt/β‑catenin signaling cascade in lung carcinoma cells.",-42.0,0.6,geneorgeneproduct
"Target‑tissue overexpression of the ARBSs protein in A549 cells enhances the interaction between b‑catenin and Rho GTPases, thereby promoting filamin‑A‑mediated cytoskeletal remodeling and increasing the secretion of the Ly‑6/urokinase plasminogen activator receptor related protein‑1, a process that is further amplified by mPGES‑1‑derived prostaglandins and ultimately leads to the up‑regulation of Growth arrest and DNA‑",-58.0,0.6,geneorgeneproduct
"Targetting the ARBSs interaction with b‑Catenin in A549 cells reduces EPO‑mediated activation of Rho GTPases, thereby attenuating filamin A‑driven migration and decreasing SMA expression in the tumor microenvironment.",-42.75,0.6,geneorgeneproduct
"Silencing of the **ARBSs** gene in **A549** cells reduces **b‑Catenin**‑mediated transcription of the **Ly‑6/urokinase plasminogen activator receptor related protein‑1** promoter, thereby attenuating the invasive phenotype driven by **Rho GTPases**.",-27.75,0.6,geneorgeneproduct
"Silenced expression of the Growth arrest and DNA‑damage‑inducible protein‑45 alpha gene in HeLa cells treated with the small‑molecule inhibitor LY294002 leads to increased phosphorylation of Rho GTPases, thereby enhancing filamin A‑mediated cell migration.",-46.5,0.6,geneorgeneproduct
"Silico‑engineering of HeLa cells overexpressing the TP53 variant c.215C>G revealed that the mutant protein, through aberrant interaction with the Rho GTPases and filamin A, amplified the transcription of the growth‑arrest‑and‑DNA‑damage‑inducible gene GADD45α, thereby enhancing the cellular response to doxorubicin‑induced oxidative stress.",-62.75,0.6,geneorgeneproduct
"Silica exposure upregulates the expression of the growth‑arrest‑and‑DNA‑damage‑inducible protein GADD45α in A549 cells, thereby enhancing Rho GTPase‑mediated cytoskeletal rearrangements that ultimately promote filamin‑A‑dependent migration of the tumor cells.",-44.0,0.6,geneorgeneproduct
"Epithelial cells from the H1299 lung carcinoma line showed that up‑regulation of the EPO receptor by the mPGES‑1‑derived prostaglandin E2 pathway led to increased phosphorylation of Rho GTPases, thereby enhancing filamin‑A‑mediated cytoskeletal remodeling and promoting invasive growth through the Ly‑6/urokinase plasminogen activator receptor‑related protein‑1 axis.",-50.75,0.6,geneorgeneproduct
"Erythropoietin (EPO) signaling through the EPO receptor activates Rho GTPases, which in turn phosphorylate filamin A, thereby modulating the cytoskeletal dynamics that influence b‑catenin localization and ultimately regulate growth arrest and DNA‑damage‑inducible protein‑45 alpha expression in human erythroid progenitor cells.",-43.5,0.6,geneorgeneproduct
"EPO signaling through the EPO receptor in A549 cells is potentiated by a loss‑of‑function mutation in the Growth arrest and DNA‑damage‑inducible protein GADD45α, which in turn up‑regulates filamin A and Rho GTPase activity to promote cell migration.",-51.75,0.6,geneorgeneproduct
"Epidermal growth factor stimulation of the β‑catenin‑Rho GTPase axis in A549 cells upregulates mPGES‑1‑derived prostaglandin E₂, which in turn promotes filamin‑A‑mediated cytoskeletal remodeling and enhances the invasive potential of the tumor.",-34.75,0.6,geneorgeneproduct
"Transcriptional activation of the growth arrest and DNA‑damage‑inducible protein GADD45α by the b‑catenin/ARBS complex in A549 cells enhances EPO‑mediated erythropoiesis, while Rho GTPase‑dependent filamin‑A phosphorylation dampens the signal, suggesting a fine‑tuned regulatory loop in hypoxia‑induced erythropoietic adaptation.",-64.5,0.6,geneorgeneproduct
"Transfection of HeLa cells with a plasmid encoding a mutant TP53 variant (c.215C>G) led to up‑regulation of the Rho GTPases pathway, causing increased filamin‑A phosphorylation and subsequent activation of the Ly‑6/urokinase plasminogen activator receptor related protein‑1 signaling cascade that ultimately enhances cellular migration.",-44.75,0.6,geneorgeneproduct
"Translocation of the b‑catenin gene to the nucleus in HeLa cells overexpressing the Ly‑6/urokinase plasminogen activator receptor related protein‑1 activates the mPGES‑1‑derived prostaglandin E2 pathway, thereby up‑regulating the growth arrest and DNA‑damage‑inducible protein‑45 alpha and promoting filamentous actin remodeling in the cytoskeleton.",-52.5,0.6,geneorgeneproduct
"Trans‑activation of the EPO promoter by b‑catenin in Huh‑7 cells is enhanced by the mPGES‑1‑derived prostaglandin E2, a process that requires Rho GTPase‑mediated actin remodeling and the interaction of filamin‑A with the cytoplasmic tail of the urokinase plasminogen activator receptor‑related protein‑1, thereby promoting growth‑arrest‑and‑DNA‑damage‑inducible‑45",-54.5,0.6,geneorgeneproduct
"Fibroblast growth factor receptor‑2 activation in A549 cells increases the expression of the Rho GTPase‑mediated regulator EPO, thereby enhancing cell migration and invasion.",-42.0,0.6,geneorgeneproduct
"Fibronectin‑binding integrin α5β1 activation in A549 cells is enhanced by Rho GTPases, which in turn upregulates mPGES‑1‑derived prostaglandin E2, thereby promoting growth arrest and DNA‑damage‑inducible protein‑45α expression in a feedback loop that involves filamin A‑B stabilization of the cytoskeletal architecture.",-65.5,0.6,geneorgeneproduct
"Fibulin‑3 up‑regulation in HeLa cells by the mPGES‑1‑derived prostaglandin E2 pathway activates Rho GTPases, thereby enhancing filamin‑A‑mediated cytoskeletal remodeling and promoting invasive growth of the cancerous phenotype.",-43.5,0.6,geneorgeneproduct
"Fibrotic remodeling in the SMA of HeLa cells is accelerated by the mPGES‑1‑derived Ly‑6/urokinase plasminogen activator receptor related protein‑1, which activates Rho GTPases and stabilizes b‑Catenin, thereby promoting filamin A‑B phosphorylation and the transcription of Growth arrest and DNA‑damage‑inducible‑45‑alpha.",-60.5,0.6,geneorgeneproduct
"Biotransformation of the mPGES-1-derived compound by the CYP1A1 enzyme in A549 cells was shown to increase the expression of the growth arrest and DNA-damage-inducible protein GADD45α, thereby enhancing apoptosis in response to cisplatin treatment.",-50.25,0.6,geneorgeneproduct
"Biochemical analysis revealed that in A549 cells the up‑regulation of mPGES‑1‑derived prostaglandin E2 activates Rho GTPases, which in turn phosphorylates filamin A, thereby enhancing β‑catenin nuclear translocation and promoting growth arrest and DNA‑damage‑inducible protein‑45α expression.",-39.25,0.6,geneorgeneproduct
"Bi-allelic loss of the DNA‑damage‑inducible gene GADD45α in A549 cells leads to hyperactivation of Rho GTPases and destabilization of the cytoskeletal protein filamin A, thereby impairing EPO‑mediated erythropoiesis and promoting resistance to mPGES‑1‑derived prostaglandin E₂ signaling.",-47.25,0.6,geneorgeneproduct
"Biological assays revealed that the b‑catenin‑dependent activation of Rho GTPases in HeLa cells upregulates the expression of the urokinase plasminogen activator receptor related protein‑1 gene, thereby enhancing mPGES‑1‑derived prostaglandin E2 synthesis and promoting growth arrest and DNA‑damage‑inducible protein‑45 alpha-mediated apoptosis.",-43.0,0.6,geneorgeneproduct
"Activation of the β‑catenin–Rho GTPase axis by Ly‑6/urokinase plasminogen‑activator‑receptor‑related protein‑1 up‑regulates mPGES‑1‑derived prostaglandin E2 production, thereby promoting filamin‑A‑mediated endothelial barrier dysfunction in human umbilical vein endothelial cells.",-29.75,0.6,geneorgeneproduct
"Activation‑induced phosphorylation of β‑catenin by Rho GTPases enhances the transcriptional activity of the EPO‑responsive Growth arrest and DNA‑damage‑inducible protein‑45α, thereby promoting filamin‑A‑mediated cytoskeletal remodeling in ARBS‑derived SMA‑positive cells.",-49.75,0.6,geneorgeneproduct
"Activation-mediated nuclear translocation of β‑catenin in A549 cells upregulates the Rho GTPase‑dependent expression of the urokinase plasminogen activator receptor‑related protein‑1 (LY6/UPAR‑R1) gene, thereby enhancing mPGES‑1‑derived prostaglandin E2 production and promoting filamin‑A‑driven cell migration in a growth‑arrest‑and‑DNA‑damage‑inducible‑45α (",-57.0,0.6,geneorgeneproduct
"Activation by the β‑catenin/TCF complex of the Rho GTPase‑regulated transcriptional program drives filamin‑A expression, which in turn stabilizes the urokinase plasminogen activator receptor‑related protein‑1 (uPAR‑RP1) on the surface of HeLa cells, thereby enhancing invasive potential in response to mPGES‑1‑derived prostaglandin E2.",-56.25,0.6,geneorgeneproduct
"Altered expression of the growth arrest and DNA‑damage‑inducible protein GADD45A in HeLa cells leads to increased Rho GTPase‑mediated cytoskeletal remodeling and enhanced filamin‑A phosphorylation, thereby promoting resistance to doxorubicin‑induced apoptosis.",-33.0,0.6,geneorgeneproduct
"Alterations in the b‑Catenin‑dependent Wnt pathway, including reduced phosphorylation of filamin A and B, were shown to up‑regulate the expression of the urokinase plasminogen activator receptor‑related protein‑1 (LY6/UPAR‑RP‑1) in HeLa cells, thereby enhancing cell motility and contributing to the invasive phenotype of TP53‑mutant colorectal carcinoma.",-56.75,0.6,geneorgeneproduct
"Alteration of the EPO‑induced phosphorylation of b‑Catenin in A549 cells leads to enhanced recruitment of Rho GTPases, thereby promoting filamin A‑dependent cytoskeletal remodeling and increasing the expression of the Ly‑6/urokinase plasminogen activator receptor related protein‑1 gene product.",-40.0,0.6,geneorgeneproduct
"Altercation of the b‑Catenin/ARBSs complex in A549 cells leads to enhanced transcription of the Rho GTPases gene cluster, thereby increasing filamin A‑B expression and ultimately promoting epithelial‑mesenchymal transition in the presence of mPGES‑1‑derived prostaglandin E2.",-51.5,0.6,geneorgeneproduct
"The NOX1‑driven oxidative burst in A549 cells is potentiated by BMP‑2‑induced RORgt expression, thereby enhancing IL‑65‑72C/G‑mediated inflammatory signaling.",-27.75,0.6,geneorgeneproduct
"The BMP‑2‑induced up‑regulation of NOX1 in A549 cells is attenuated by the RORgt‑dependent expression of Spred1, thereby reducing reactive‑oxygen‑species‑mediated apoptosis.",-20.125,0.6,geneorgeneproduct
"The loss‑of‑function mutation c.112_115delAG in the dcnt1 gene of a homozygous E. coli strain was shown to up‑regulate NOX1 expression, thereby enhancing ROS‑mediated antimicrobial activity.",-36.0,0.6,geneorgeneproduct
"The SNP IL-65-72C/G in the promoter of the inflammatory cytokine IL-6 enhances NF‑κB binding, thereby increasing RORγt‑mediated Th17 differentiation in patients with chronic inflammatory bowel disease.",-31.0,0.6,geneorgeneproduct
"In human bronchial epithelial cells, the dcnt1 gene product is upregulated by BMP‑2 stimulation, leading to increased NOX1‑derived reactive oxygen species that activate the RORgt transcription factor and subsequently enhance IL‑65‑72C/G‑mediated inflammatory signaling.",-29.5,0.6,geneorgeneproduct
"In the A549 cell line, overexpression of the transcription factor RORgt upregulated BMP‑2 expression, thereby enhancing IL‑65‑72C/G‑mediated NOX1 activation and increasing reactive oxygen species production.",-24.375,0.6,geneorgeneproduct
"In HCT116 cells, overexpression of the gene product dcnt1 enhances BMP‑2‑induced osteogenic differentiation through a NOX1‑dependent ROS signaling pathway that up‑regulates RORgt and down‑regulates Spred1, thereby promoting the secretion of the cytokine IL‑65‑72C/G and the activation of the NK1r‑mediated apoptotic cascade.",-45.25,0.6,geneorgeneproduct
"In HeLa cells, the dcnt1 gene product upregulates BMP‑2 expression through a NOX1‑dependent reactive‑oxygen‑species pathway, thereby enhancing RORgt‑mediated differentiation of NK1r‑positive fibroblasts.",-25.5,0.6,geneorgeneproduct
Alteration of the NOX1 gene product in the human lung adenocarcinoma cell line A549 was shown to increase ROS production and promote NF‑κB‑dependent expression of the inflammatory cytokine IL‑6.,-35.0,0.6,geneorgeneproduct
"Altered expression of the transcription factor dcnt1 in HeLa cells, driven by a BMP‑2‑induced up‑regulation of RORgt, increases NOX1‑mediated ROS production and promotes apoptosis through the activation of the pro‑coagulant protein FSAP.",-33.25,0.6,geneorgeneproduct
"Alterations in the NOX1 promoter, such as the IL-65-72C/G polymorphism, have been shown to enhance ROS production and upregulate BMP‑2 expression in the RORγt‑driven inflammatory pathway, thereby accelerating fibrosis in the MKS3‑deficient A549 cell line.",-39.5,0.6,geneorgeneproduct
"Alterive expression of the transcription factor RORgt in the A549 cell line was shown to up‑regulate the pro‑inflammatory cytokine IL‑65‑72C/G, thereby enhancing NOX1‑mediated reactive oxygen species production and accelerating the progression of non‑small cell lung carcinoma.",-40.5,0.6,geneorgeneproduct
"BMP‑2 overexpression in the dcnt1‑deficient A549 cell line enhances NOX1‑mediated reactive oxygen species production, thereby accelerating the RORγt‑driven differentiation of Th17 cells that secrete IL‑65‑72C/G, a cytokine that subsequently stimulates the epithelial‑derived tumor‑associated macrophage phenotype via the FSAP signaling axis.",-60.75,0.6,geneorgeneproduct
"BMP-2 overexpression in MKS3‑mutated HeLa cells activates NOX1‑mediated ROS production, thereby up‑regulating the transcription factor RORgt and enhancing IL‑65‑72C/G‑driven NF‑κB signaling.",-28.25,0.6,geneorgeneproduct
"BMP‐2 overexpression in A549 cells increases NOX1‐mediated reactive oxygen species production, thereby enhancing IL‑65‑72C/G‑driven inflammation and accelerating the migration of NK1r‑deficient tumor cells.",-35.5,0.6,geneorgeneproduct
"BMP–2 overexpression in the A549 cell line activates NOX1‑mediated reactive oxygen species production, thereby up‑regulating the transcription factor RORγt and enhancing IL‑65‑72C/G‑dependent inflammatory signaling in a murine model of pulmonary fibrosis.",-36.25,0.6,geneorgeneproduct
"GeneSpred1 overexpression in A549 cells increases NOX1‑mediated reactive oxygen species, thereby enhancing BMP‑2‑induced epithelial‑mesenchymal transition and promoting metastasis.",-28.5,0.6,geneorgeneproduct
"Gene product dcnt1, when overexpressed in A549 cells, activates NOX1‑dependent reactive oxygen species production that promotes BMP‑2‑mediated epithelial‑mesenchymal transition and subsequently upregulates the transcription factor RORgt, thereby enhancing invasion of the tumor microenvironment.",-40.25,0.6,geneorgeneproduct
"Gene knockdown of dcnt1 in the A549 cell line markedly increased BMP‑2 expression, leading to enhanced differentiation of the cells toward an osteogenic phenotype that was further amplified by the RORgt‑dependent transcriptional activation of IL‑65‑72C/G‑mediated inflammatory signaling.",-41.75,0.6,geneorgeneproduct
"Gene expression of the transcription factor dcnt1 is up‑regulated by BMP‑2 stimulation of A549 cells, and this up‑regulation is mediated through the RORgt‑dependent pathway that enhances NOX1‑driven reactive oxygen species production, thereby increasing the phosphorylation of Spred1 and ultimately promoting the secretion of the inflammatory cytokine IL‑65‑72C/G from the tumor microenvironment.",-49.25,0.6,geneorgeneproduct
"Mutations in the NOX1 gene that increase its expression are associated with elevated ROS production, which in turn upregulates BMP‑2 and RORγt expression, thereby promoting inflammatory signaling in human macrophages.",-37.5,0.6,geneorgeneproduct
"Mutational activation of NOX1 in A549 cells leads to increased ROS production, which in turn upregulates BMP‑2 expression and promotes epithelial‑mesenchymal transition through RORγt‑dependent transcriptional regulation.",-28.25,0.6,geneorgeneproduct
"Mutant dcnt1 in the MKS3‑associated cystic fibrosis transmembrane conductance regulator pathway increases NOX1‑mediated oxidative stress, thereby up‑regulating BMP‑2 expression in A549 cells and enhancing IL‑65‑72C/G‑driven inflammatory cytokine production.",-37.5,0.6,geneorgeneproduct
"Mutagenic exposure to the chemical entity doxorubicin upregulates the expression of the GeneOrGeneProduct RORgt in the human cell line HeLa, thereby promoting epithelial-to-mesenchymal transition and contributing to drug resistance in the disease context of breast cancer.",-39.75,0.6,geneorgeneproduct
"SIRT1-mediated deacetylation of RORgt enhances IL‑65‑72C/G expression, thereby promoting BMP‑2–driven differentiation of dcnt1‑positive osteoblasts in the FSAP‑rich microenvironment of MKS3‑affected cartilage.",-41.0,0.6,geneorgeneproduct
"Sustained overexpression of the transcription factor RORgt in the A549 cell line leads to increased NOX1‑mediated reactive oxygen species production, which in turn up‑regulates BMP‑2 secretion and enhances the invasive phenotype of these lung carcinoma cells.",-36.0,0.6,geneorgeneproduct
"SOD2 overexpression in the A549 cell line reduces NOX1‑mediated ROS production and restores BMP‑2 signaling, thereby limiting IL‑65‑72C/G‑driven proliferation.",-34.5,0.6,geneorgeneproduct
"SREBF1 overexpression in A549 cells activates NOX1‑mediated ROS production, which in turn up‑regulates BMP‑2 transcription, thereby promoting epithelial‑mesenchymal transition and enhancing metastatic potential.",-33.75,0.6,geneorgeneproduct
"Silencing dcnt1 in A549 cells reduces NOX1‑mediated ROS production, thereby attenuating BMP‑2‑induced EMT and limiting metastasis of non‑small‑cell lung carcinoma.",-23.0,0.6,geneorgeneproduct
"Silica exposure upregulates NOX1 expression in A549 cells, and the resulting reactive oxygen species activate BMP‑2 signaling to promote epithelial‑mesenchymal transition, a process that is further amplified by the IL‑65‑72C/G polymorphism in the TP53 promoter.",-33.75,0.6,geneorgeneproduct
"Silenced dcnt1 expression in HeLa cells leads to reduced BMP‑2 secretion, which in turn diminishes RORγt‑mediated differentiation of Th17 cells, thereby attenuating IL‑65‑72C/G‑driven inflammatory responses in the tumor microenvironment.",-30.25,0.6,geneorgeneproduct
"Silicon‑nanoparticle‑functionalized A549 cells overexpressing dcnt1 exhibit increased NOX1‑driven reactive oxygen species, which in turn upregulates BMP‑2 transcription and activates the RORgt‑dependent Th17 differentiation pathway.",-37.0,0.6,geneorgeneproduct
"A CRISPR‑mediated knock‑out of the NOX1 gene in the A549 cell line revealed that loss of NOX1 activity dramatically reduced ROS‑dependent activation of the BMP‑2 signaling cascade, thereby attenuating the expression of the transcription factor RORgt and its downstream IL‑65‑72C/G‑regulated inflammatory genes.",-35.5,0.6,geneorgeneproduct
"A missense variant in the NOX1 gene (c.457G>A) was shown to enhance ROS production in MKS3‑derived A549 cells, thereby up‑regulating BMP‑2 expression and promoting osteogenic differentiation of the tumor microenvironment.",-37.25,0.6,geneorgeneproduct
"A SNP in the IL-65‑72C/G promoter region of the *IL-6* gene increases RORγt expression, thereby enhancing BMP‑2‑induced differentiation of dcnt1‑positive osteoblasts while concurrently upregulating NOX1‑mediated reactive‑oxygen‑species production in human osteosarcoma cell lines.",-47.25,0.6,geneorgeneproduct
"A loss‑of‑function mutation in the MKS3 gene, detected in a patient with Joubert syndrome, disrupts NOX1‑mediated reactive‑oxygen‑species production, thereby attenuating BMP‑2‑induced differentiation of renal epithelial cells and contributing to the observed renal dysplasia.",-37.0,0.6,geneorgeneproduct
"Loss of the dcnt1 gene product in A549 cells upregulates NOX1 expression, which in turn promotes ROS‑mediated activation of the BMP‑2 signaling cascade and enhances RORgt‑driven differentiation of NK1r‑positive T cells.",-32.0,0.6,geneorgeneproduct
"Loss-of-function mutations in the dcnt1 gene in Homo sapiens patients with MKS3 phenotypes are predicted to upregulate NOX1 expression, thereby enhancing reactive oxygen species production and contributing to the observed renal cystic pathology.",-34.5,0.6,geneorgeneproduct
"Loss‑of‑function mutations in the Spred1 gene, such as the c.1013_1014delAG variant, impair BMP‑2‑induced SMAD signaling in A549 cells, leading to increased NOX1‑mediated reactive oxygen species production and a heightened inflammatory response mediated by IL‑65‑72C/G polymorphic alleles.",-43.75,0.6,geneorgeneproduct
"Losses of the **Spred1** gene in **Homo sapiens** fibroblasts increase **NOX1**‑driven reactive oxygen species, thereby enhancing **BMP‑2**‑induced osteogenic differentiation of **MC3T3‑E1** cells.",-37.0,0.6,geneorgeneproduct
"Mutation of the NOX1 gene in a patient with MKS3 leads to dysregulated BMP‑2 signaling that causes abnormal RORγt‑mediated differentiation of the NK1R‑expressing T‑cell population, ultimately contributing to the development of chronic inflammatory disease.",-49.5,0.6,geneorgeneproduct
"Mutation c.68_69delAG in the BRCA1 gene product reduces the binding affinity of dcnt1 to the DNA repair complex, thereby increasing the risk of breast cancer in Homo sapiens.",-26.75,0.6,geneorgeneproduct
"Mutation in the dcnt1 gene causes a loss of function that impairs BMP‑2 signalling, leading to reduced RORγt‑dependent Th17 differentiation and increased expression of NOX1‑driven reactive oxygen species in the intestinal epithelium.",-41.5,0.6,geneorgeneproduct
"Mutation‑induced loss of Spred1 in the human A549 cell line upregulates NOX1‑driven reactive oxygen species, thereby enhancing BMP‑2 secretion and driving RORγt‑mediated differentiation of Th17 cells that express IL‑65‑72C/G polymorphic receptors.",-44.75,0.6,geneorgeneproduct
"Knockdown of dcnt1 in the A549 cell line downregulates NOX1 expression, thereby attenuating ROS‑mediated activation of the BMP‑2/Spred1 signaling axis in a murine model of E. coli‑induced sepsis.",-29.75,0.6,geneorgeneproduct
"Knocking out the NOX1 gene in the A549 cell line drastically reduces BMP‑2‑induced ROS production, thereby attenuating the downstream activation of the RORγt‑driven IL‑65‑72C/G inflammatory cascade in the human lung adenocarcinoma model.",-34.5,0.6,geneorgeneproduct
"Knocked‑down of dcnt1 in A549 cells reduces BMP‑2‑induced SMAD1/5 phosphorylation, thereby attenuating RORgt‑driven Th17 differentiation and enhancing NOX1‑mediated ROS production, which collectively suppresses the proliferative advantage conferred by the IL‑65‑72C/G variant in this lung carcinoma model.",-46.25,0.6,geneorgeneproduct
"Knudsen et al. reported that the BMP‑2‑induced up‑regulation of NOX1 in HeLa cells is mediated through the transcription factor RORγt, a mechanism that may be disrupted by the IL‑65‑72C/G polymorphism in the TP53 promoter.",-40.75,0.6,geneorgeneproduct
"Dcnt1 overexpression in HeLa cells enhances BMP‑2‑mediated osteogenic differentiation by upregulating RORγt transcription, thereby increasing NOX1‑driven reactive oxygen species that stimulate the FSAP‑dependent proteolytic activation of IL‑65‑72C/G in the tumor microenvironment.",-39.25,0.6,geneorgeneproduct
"DcnT1 overexpression in A549 cells enhances BMP‑2‑induced osteogenic differentiation by upregulating RORγt‑mediated transcription of the IL‑65‑72C/G‑dependent NF‑κB pathway, thereby increasing NOX1‑driven reactive oxygen species that activate FSAP and Spred1 to modulate downstream MAPK signaling.",-40.75,0.6,geneorgeneproduct
"Dendritic cell number-1 (DCNT1) overexpression in HeLa cells enhances BMP‑2‑induced SMAD1/5 phosphorylation, thereby upregulating RORγt transcription and accelerating IL‑6‑mediated differentiation of Th17 cells, a process that is attenuated by the NOX1 inhibitor APX‑115.",-50.5,0.6,geneorgeneproduct
"Dcx1 overexpression in the A549 cell line upregulates BMP‑2, which in turn induces NOX1‑mediated oxidative stress that promotes RORγt‑dependent differentiation of Th17 cells in an IL‑6‑rich microenvironment, thereby exacerbating inflammatory responses in human lung cancer.",-55.25,0.6,geneorgeneproduct
"DRINKING ethanol in HeLa cells carrying the BRCA1 c.68_69delAG variant upregulates NOX1 expression, thereby enhancing ROS-mediated apoptosis and revealing a potential therapeutic avenue for targeting TP53‑deficient cancers.",-41.25,0.6,geneorgeneproduct
"DR1‑c.68_69delAG in the BRCA1 gene was found to up‑regulate NOX1 expression, thereby increasing reactive oxygen species levels that subsequently activate the BMP‑2‑dependent RORγt signaling pathway in A549 cells.",-51.25,0.6,geneorgeneproduct
"DRING1‑mediated up‑regulation of NOX1 in A549 cells enhances reactive oxygen species production, thereby stimulating BMP‑2 expression and promoting RORgt‑driven differentiation of Th17 cells in an IL‑65‑72C/G polymorphism‑dependent manner.",-44.75,0.6,geneorgeneproduct
"DR‑D5‑R1‑c.235G>A in the dcnt1 gene was shown to up‑regulate BMP‑2 expression, thereby enhancing RORgt‑mediated differentiation of NK1r‑positive Th17 cells in E. coli‑infected A549 lung carcinoma cells.",-60.0,0.6,geneorgeneproduct
"The knock‑down of CYP3A4 in A549 cells reduced the activation of the FGFR1‑TACC1 fusion protein and consequently lowered IL‑12p70 secretion, implicating CYP3A4 as a potential modulator of the FGFR1‑TACC1‑driven inflammatory signaling pathway.",-35.5,0.6,geneorgeneproduct
"The CYP3A4 polymorphism rs776746, found in a subset of Homo sapiens patients, correlates with reduced LPL activity and increased risk of cardiovascular disease, while the FGFR1‑TACC1 fusion gene, frequently observed in glioblastoma cell lines, drives tumor proliferation through aberrant MAPK signaling.",-46.25,0.6,geneorgeneproduct
"The loss‑of‑function mutation in the BRCA1 c.68_69delAG sequence variant was shown to impair the DNA repair activity of the protein product, thereby enhancing the sensitivity of A549 cell lines to the chemotherapeutic agent doxorubicin in a dose‑dependent manner.",-31.875,0.6,geneorgeneproduct
"The polymorphism in CYP3A4 was found to up‑regulate IL‑12p70 production in HeLa cells, thereby enhancing VCAM1 expression and promoting CDKN1B‑mediated cell‑cycle arrest in response to FGFR1‑TACC1‑driven oncogenic signaling.",-31.875,0.6,geneorgeneproduct
"Silencing the FGFR1‑TACC1 fusion in the A549 cell line markedly down‑regulates IL‑12p70 production, an effect that is amplified when CYP3A4 is co‑expressed, thereby illustrating a drug‑gene interaction that could influence the inflammatory phenotype of non‑small‑cell lung cancer.",-40.5,0.6,geneorgeneproduct
"Silently, the FGFR1‑TACC1 fusion protein drives ERK‑dependent transcription of IL‑12p70, thereby stimulating CDKN1B‑mediated cell‑cycle arrest in HeLa cells exposed to the CYP3A4‑metabolized chemotherapeutic doxorubicin.",-36.0,0.6,geneorgeneproduct
"Silico‑in‑vitro assays revealed that the FGFR1‑TACC1 fusion protein, expressed in A549 cells, binds the kinase domain of CDKN1B and competitively inhibits IL‑12p70‑induced NF‑κB activation in Homo sapiens macrophages.",-37.5,0.6,geneorgeneproduct
"Silvestre et al. reported that in H1299 cells the loss‑of‑function mutation p.R398W in the CDKN1B gene increased proliferation, and that concomitant overexpression of the CYP3A4 enzyme accelerated the metabolism of the chemotherapeutic drug doxorubicin, thereby reducing its cytotoxicity.",-63.0,0.6,geneorgeneproduct
"In HepG2 cells, the CYP3A4 promoter polymorphism rs2242480 enhances IL‑12p70‑induced STAT4 activation, thereby upregulating CDKN1B expression and reducing proliferation.",-25.75,0.6,geneorgeneproduct
"In H1299 cells, overexpression of the FGFR1‑TACC1 fusion protein enhances IL‑12p70 secretion, thereby activating CDKN1B‑mediated cell cycle arrest through a CYP3A4‑dependent metabolic pathway.",-20.375,0.6,geneorgeneproduct
"In HeLa cells, overexpression of the FGFR1‑TACC1 fusion protein enhances IL‑12p70 secretion, which in turn upregulates CYP3A4 expression, thereby accelerating the metabolism of the chemotherapeutic agent doxorubicin.",-18.75,0.6,geneorgeneproduct
"In A549 cells, overexpression of the FGFR1‑TACC1 fusion protein upregulates IL‑12p70 secretion, which in turn activates CDKN1B‑mediated cell‑cycle arrest while simultaneously enhancing LPL expression to increase fatty‑acid uptake.",-22.625,0.6,geneorgeneproduct
"Activation of the FGFR1‑TACC1 fusion in HeLa cells enhances IL‑12p70 secretion, thereby promoting VCAM1‑mediated adhesion of CDKN1B‑deficient endothelial cells to the tumor microenvironment.",-23.75,0.6,geneorgeneproduct
"Activation by the FGFR1‑TACC1 fusion protein increases IL‑12p70 secretion in the A549 cell line, a process that is further amplified by CYP3A4‑mediated metabolism of the small‑molecule inhibitor NTRK3‑specific kinase.",-35.5,0.6,geneorgeneproduct
"Activation profiling of the CYP3A4 promoter revealed that IL-12p70 stimulation in HeLa cells upregulates FGFR1-TACC1 fusion transcripts, thereby enhancing CDKN1B‑mediated cell cycle arrest and increasing VCAM1 expression to promote leukocyte adhesion.",-49.5,0.6,geneorgeneproduct
"Activation and nuclear translocation of CYP3A4 in HepG2 cells are enhanced by IL‑12p70, which in turn up‑regulates the expression of the VCAM1 gene and promotes adhesion of monocytes to endothelial cells.",-44.25,0.6,geneorgeneproduct
"Mutational activation of the FGFR1‑TACC1 fusion in HeLa cells leads to upregulation of IL‑12p70, which in turn enhances VCAM1 expression on endothelial cells of Homo sapiens origin.",-24.25,0.6,geneorgeneproduct
"Mutations in the FGFR1‑TACC1 fusion gene were shown to upregulate IL‑12p70 secretion in A549 cells, thereby enhancing CDKN1B‑mediated growth arrest of the human lung carcinoma model.",-24.125,0.6,geneorgeneproduct
"Mutant CYP3A4 alleles in a cohort of *Homo sapiens* patients were shown to enhance the transcriptional activity of the CDKN1B promoter, thereby amplifying the anti‑proliferative effect of the small‑molecule inhibitor NTRK3‑specific kinase inhibitor, which was originally designed to target the FGFR1‑TACC1 fusion protein expressed in glioblastoma cells.",-57.0,0.6,geneorgeneproduct
"Mutated CYP3A4 variants in Homo sapiens patients with elevated IL‑12p70 levels were found to impair the activation of the FGFR1‑TACC1 complex, thereby reducing the expression of the LPL gene and contributing to dysregulated lipid metabolism.",-38.25,0.6,geneorgeneproduct
"Stimulation of the FGFR1‑TACC1 fusion by FGF‑3 in A549 cells upregulates IL‑12p70 secretion, which in turn enhances VCAM1‑mediated adhesion of CDKN1B‑deficient macrophages, thereby promoting NTRK3‑driven migration of LPL‑expressing metastatic colonies in a Sox4‑dependent manner.",-47.75,0.6,geneorgeneproduct
"Stabilization of the FGFR1‑TACC1 fusion protein by the LPL‑promoting transcription factor Sox4 increases IL‑12p70 secretion in HeLa cells, thereby enhancing CDKN1B‑mediated apoptosis of the tumor.",-35.25,0.6,geneorgeneproduct
"Stimulatory overexpression of the FGFR1‑TACC1 fusion protein in the A549 cell line leads to up‑regulation of the chemokine IL‑12p70, thereby enhancing the recruitment of CDKN1B‑positive T cells and promoting apoptosis of tumor‑derived organoid cultures derived from Homo sapiens lung carcinoma.",-51.0,0.6,geneorgeneproduct
"Streptozotocin‑treated A549 cells overexpressing the FGFR1‑TACC1 fusion exhibit increased IL‑12p70 secretion, which in turn upregulates CDKN1B expression and reduces LPL activity, ultimately enhancing apoptosis in the tumor microenvironment.",-41.5,0.6,geneorgeneproduct
"CYP3A4 inhibition by the chemotherapeutic agent doxorubicin in A549 cells reduces the metabolic clearance of the drug and enhances the cytotoxicity mediated by the tumor suppressor gene CDKN1B, thereby improving treatment response in this lung carcinoma model.",-39.5,0.6,geneorgeneproduct
"Cytotoxicity of doxorubicin in A549 cells is markedly attenuated when the CYP3A4 gene is overexpressed, suggesting that metabolic activation of the drug by CYP3A4 modulates apoptosis through downstream regulation of the FGF-3/FGFR1-TACC1 signaling axis.",-40.5,0.6,geneorgeneproduct
"CIP2A overexpression in A549 cells up‑regulates IL‑12p70 secretion, which in turn activates the FGFR1‑TACC1 signaling cascade to promote CDKN1B degradation and enhance LPL‑mediated fatty‑acid uptake in HepG2 hepatocytes.",-40.75,0.6,geneorgeneproduct
"Coxsackievirus infection upregulates IL‑12p70 production in HeLa cells, thereby enhancing CDKN1B‑mediated cell‑cycle arrest and promoting FGF‑3‑driven angiogenic signaling in a CYP3A4‑dependent manner.",-36.75,0.6,geneorgeneproduct
"Loss of CYP3A4 function in HepG2 cells increases LPL transcription through CDKN1B‑mediated E2F1 binding, thereby enhancing fatty‑acid uptake and reducing IL‑12p70 secretion in a manner that may modulate FGFR1‑TACC1‑driven proliferation.",-43.75,0.6,geneorgeneproduct
"Loss-of-function mutations in the FGFR1‑TACC1 fusion gene in HeLa cells diminish IL‑12p70 secretion, thereby reducing VCAM1‑mediated adhesion of CDKN1B‑expressing T cells to the endothelial monolayer.",-29.375,0.6,geneorgeneproduct
"Loss‑of‑function mutations in the CYP3A4 gene reduce the clearance of the chemotherapeutic agent doxorubicin, leading to increased cardiotoxicity in patients treated with the drug.",-22.0,0.6,geneorgeneproduct
"Loss‐of‐function mutations in the CYP3A4 gene, as seen in a patient with a novel c.1125_1127delGAA variant, impair the metabolic clearance of the chemotherapeutic agent doxorubicin, thereby increasing its cardiotoxicity and prompting clinicians to switch treatment to the LPL‑targeted drug fenofibrate, which is metabolized by the highly expressed hepatic enzyme CYP3A4 and has shown to reduce cardiac side effects in patients with heart failure.",-93.0,0.6,geneorgeneproduct
"A transient up‑regulation of IL‑12p70 in HeLa cells carrying the FGFR1‑TACC1 fusion enhances CDKN1B‑mediated apoptosis while simultaneously activating CYP3A4‑driven drug metabolism, thereby illustrating a complex interplay between oncogenic signaling, cell‑cycle control, and xenobiotic processing in a human cancer model.",-42.0,0.6,geneorgeneproduct
"A SNP in the promoter of **CYP3A4** was found to up‑regulate **IL‑12p70** secretion in **HeLa** cells, thereby enhancing NF‑κB‑dependent expression of **VCAM1** and promoting adhesion of **CDKN1B**‑deficient tumor cells to endothelial monolayers.",-31.375,0.6,geneorgeneproduct
"A polymorphism in the CYP3A4 promoter that reduces its transcriptional activity was shown to enhance the expression of the tumor suppressor CDKN1B in A549 cells, thereby attenuating proliferation of EGFR‑mutant lung carcinoma.",-40.25,0.6,geneorgeneproduct
"A CRISPR‑mediated knock‑in of the FGFR1‑TACC1 fusion in A549 cells revealed that the aberrant receptor activates IL‑12p70 secretion, which in turn up‑regulates the lipid‑metabolizing enzyme LPL, thereby promoting tumor cell proliferation and metastasis.",-37.5,0.6,geneorgeneproduct
"Mutation of the CYP3A4 promoter in *Homo sapiens* HepG2 cells upregulates IL‑12p70 production, thereby enhancing CDKN1B‑mediated cell‑cycle arrest.",-21.75,0.6,geneorgeneproduct
"Mutation‑induced up‑regulation of the CYP3A4 promoter by the FGFR1‑TACC1 fusion in A549 cells enhances IL‑12p70 secretion and subsequently increases VCAM1 expression on endothelial cells, thereby promoting leukocyte adhesion and accelerating tumor‑associated inflammation.",-33.75,0.6,geneorgeneproduct
"Mutation analysis revealed that the FGFR1‑TACC1 fusion protein up‑regulates IL‑12p70 secretion in A549 cells, thereby enhancing VCAM1‑mediated adhesion of CDKN1B‑deficient monocytes to endothelial layers in a humanized E. coli‑derived culture system.",-41.25,0.6,geneorgeneproduct
"Mutation c.68_69delAG in the BRCA1 gene, which is frequently observed in Homo sapiens breast cancer patients, reduces the binding affinity of the BRCA1 protein for RAD51 and thereby impairs homologous recombination repair.",-33.0,0.6,geneorgeneproduct
Co‑expression of the FGFR1‑TACC1 fusion with over‑expressed IL‑12p70 in the A549 cell line drives a CDKN1B‑mediated G1 arrest that is reversed by the CYP3A4 inducer rifampicin.,-31.375,0.6,geneorgeneproduct
"Co-overexpression of the FGFR1‑TACC1 fusion in A549 cells increases IL‑12p70 secretion, thereby enhancing VCAM1‑mediated adhesion of CDKN1B‑deficient macrophages and promoting a pro‑inflammatory microenvironment that drives tumor invasion.",-35.25,0.6,geneorgeneproduct
"Co-expression of the FGFR1‑TACC1 fusion in the A549 cell line drives IL‑12p70 secretion, which in turn upregulates VCAM1 on the surface of LPL‑deficient endothelial cells derived from Homo sapiens, suggesting a novel mechanism by which NTRK3 signaling may modulate vascular adhesion in tumor microenvironments.",-49.75,0.6,geneorgeneproduct
"Co-expressing the FGFR1‑TACC1 fusion in A549 cells markedly up‑regulates IL‑12p70 secretion, a response that is partially mediated through CYP3A4‑dependent metabolism of the small‑molecule inhibitor NTRK3‑TKI.",-38.0,0.6,geneorgeneproduct
"Overexpression of CYP3A4 in the A549 cell line markedly increased the intracellular accumulation of doxorubicin, thereby enhancing apoptosis mediated through the CDKN1B‑dependent cell‑cycle arrest and upregulation of IL‑12p70 production in response to tumor necrosis factor‑α stimulation.",-38.5,0.6,geneorgeneproduct
"Overexpressed CYP3A4 in HepG2 cells enhances the metabolism of the chemotherapeutic doxorubicin, thereby reducing its cytotoxicity toward the tumor while simultaneously upregulating the expression of the tumor suppressor CDKN1B and the inflammatory cytokine IL‑12p70.",-30.375,0.6,geneorgeneproduct
"Over-expression of the transcription factor Sox4 in the A549 cell line was shown to upregulate the IL-12p70 cytokine, thereby enhancing the anti‑tumor activity of the CDKN1B‑regulated cell‑cycle arrest pathway in human non‑small‑cell lung carcinoma.",-41.25,0.6,geneorgeneproduct
"Overactivation of the FGFR1‑TACC1 fusion in HeLa cells leads to increased IL‑12p70 secretion, which in turn up‑regulates CDKN1B expression and reduces LPL activity, thereby promoting a pro‑inflammatory phenotype that could contribute to tumor progression.",-34.75,0.6,geneorgeneproduct
"Polymorphisms in CYP3A4 and LPL synergistically upregulate IL‑12p70 production in HeLa cells, enhancing VCAM1-mediated adhesion of CDKN1B‑deficient fibroblasts to the extracellular matrix.",-27.125,0.6,geneorgeneproduct
"Polyspecific interaction between the FGFR1‑TACC1 fusion protein and the IL‑12p70 cytokine in A549 cells drives upregulation of the CDKN1B gene, thereby inhibiting the proliferation of this lung carcinoma line.",-40.25,0.6,geneorgeneproduct
"Polyclonal activation of the FGFR1‑TACC1 fusion in HeLa cells upregulates IL‑12p70 secretion, which in turn stimulates VCAM1 expression on endothelial cells, thereby enhancing leukocyte adhesion and promoting a pro‑inflammatory microenvironment that may drive tumor progression.",-38.25,0.6,geneorgeneproduct
"Polymyxin B exposure in A549 cells upregulated CYP3A4 and LPL expression, while IL‑12p70 secretion was concomitantly suppressed, suggesting a coordinated metabolic‑inflammatory response.",-37.75,0.6,geneorgeneproduct
"Altered CYP3A4 expression in A549 cells enhances the cytotoxicity of doxorubicin, while concomitant upregulation of LPL and IL‑12p70 promotes an inflammatory microenvironment that drives CDKN1B‑mediated cell‑cycle arrest and apoptosis.",-36.25,0.6,geneorgeneproduct
"Alterations in the CYP3A4 promoter region reduce its transcriptional activity, thereby diminishing the metabolism of the chemotherapeutic agent doxorubicin and increasing its cytotoxicity in HeLa cells, an effect that is further potentiated by the up‑regulation of the CDKN1B gene, which encodes the cyclin‑dependent kinase inhibitor p27^Kip1.",-40.25,0.6,geneorgeneproduct
"Alteration of CYP3A4 expression in the A549 cell line leads to increased resistance to the chemotherapeutic agent doxorubicin, a finding that may be mediated by upregulation of the LPL gene and subsequent modulation of lipid metabolism.",-34.5,0.6,geneorgeneproduct
"Altering the expression of the transcription factor Sox4 in A549 cells enhances IL-12p70 secretion, thereby promoting a VCAM1-mediated adhesion of CDKN1B‑deficient tumor cells to the endothelial monolayer of Homo sapiens-derived microvascular cultures.",-47.75,0.6,geneorgeneproduct
"In HepG2 cells, overexpression of the phosphodiesterase‑4D isoform attenuates thrombin‑induced activation of CDKN3, thereby reducing the proliferation of the cancer cell line.",-31.375,0.6,geneorgeneproduct
"In HSP82‑deficient HeLa cells, thrombin‑induced activation of phosphodiesterase‑4D leads to a decrease in cAMP that, through CDKN3 down‑regulation, promotes GPI‑alpha‑mediated adhesion and ultimately contributes to the pathogenesis of Bardet‑Biedl syndrome‑associated cargo‑adapter protein complex dysfunction.",-39.75,0.6,geneorgeneproduct
"In MDCK cells, overexpression of the HSP82 chaperone stabilizes the thrombin‑induced activation of phosphodiesterase‑4D, thereby attenuating the downstream cAMP‑mediated up‑regulation of the Bardet‑Biedl syndrome cargo‑adaptor protein complex and preventing the aberrant accumulation of PCHD9 in the cytoplasm.",-44.25,0.6,geneorgeneproduct
"In CDKN3‑knockout HeLa cells, thrombin‑induced activation of phosphodiesterase‑4D upregulates HSP82, thereby rescuing the cellular stress response that is otherwise impaired in Bardet‑Biedl syndrome‑associated cargo‑adaptor protein complex deficiencies.",-35.75,0.6,geneorgeneproduct
"Activation of phosphodiesterase‑4D by thrombin in HSP82‑expressing A549 cells induces CDKN3 phosphorylation, thereby attenuating the growth‑promoting activity of the Bardet‑Biedl syndrome cargo‑adaptor protein complex.",-31.125,0.6,geneorgeneproduct
"Activation by thrombin of the HSP82‑dependent phosphodiesterase‑4D signaling cascade in VPAC2‑deficient fibroblasts from a patient with Bardet‑Biedl syndrome reduces CDKN3‑mediated cell‑cycle arrest, thereby promoting aberrant proliferation of the BBS cargo‑adaptor protein complex‑associated PCHD9‑positive cells.",-50.0,0.6,geneorgeneproduct
"Activation‑dependent phosphorylation of HSP82 by thrombin enhances the stability of the Bardet‑Biedl syndrome (BBS) cargo‑adaptor protein complex, thereby increasing the surface expression of phosphodiesterase‑4D and CDKN3 in VPAC2‑deficient HeLa cells while simultaneously reducing FABP‑1 secretion from the cytoplasm.",-49.0,0.6,geneorgeneproduct
"Activation studies revealed that the HSP82 chaperone complex associates with the Bardet‑Biedl syndrome cargo‑adaptor protein complex to facilitate the proper trafficking of phosphodiesterase‑4D and CDKN3, thereby modulating thrombin‑induced signaling pathways in VPAC2‑deficient endothelial cells of Homo sapiens.",-47.5,0.6,geneorgeneproduct
"Phosphodiesterase‑4D inhibition in HSP82‑deficient HeLa cells reduces thrombin‑induced activation of the CDKN3‑mediated cell‑cycle arrest pathway, thereby attenuating the cellular phenotype associated with Bardet‑Biedl syndrome‑derived cargo‑adapter protein complex dysfunction.",-34.75,0.6,geneorgeneproduct
"Pharmacological inhibition of phosphodiesterase‑4D in HeLa cells expressing the BBS cargo‑adapter protein complex leads to increased cAMP levels, thereby enhancing the proteasomal degradation of HSP82 and reducing thrombin‑induced platelet aggregation.",-44.25,0.6,geneorgeneproduct
"Phage‑display screening revealed that HSP82 from *Homo sapiens* binds to thrombin and that a missense PCHD9 variant in the Bardet‑Biedl syndrome cargo‑adaptor protein complex reduces phosphodiesterase‑4D activity, thereby altering CDKN3‑mediated cell‑cycle checkpoints.",-50.25,0.6,geneorgeneproduct
"Phased‑out HSP82 expression in the VPAC2‑deficient THP‑1 cell line markedly enhanced thrombin‑induced NF‑κB activation, suggesting that HSP82 normally suppresses the inflammatory cascade triggered by the phosphodiesterase‑4D‑mediated cAMP signaling pathway in human macrophages.",-65.0,0.6,geneorgeneproduct
"Overexpression of the phosphodiesterase‑4D gene in HSP82‑deficient HeLa cells markedly enhances thrombin‑induced signaling, suggesting that the BBS cargo‑adaptor protein complex may modulate CDKN3‑mediated cell‑cycle checkpoints in a VPAC2‑deficient background.",-41.75,0.6,geneorgeneproduct
"Overexpressed HSP82 in HeLa cells increases thrombin‑induced phosphorylation of phosphodiesterase‑4D, thereby enhancing cAMP‑dependent activation of the BBS cargo‑adapter complex and ultimately promoting PCHD9‑mediated cell‑cycle arrest via CDKN3 up‑regulation.",-43.75,0.6,geneorgeneproduct
"Overactivation of phosphodiesterase‑4D in HeLa cells leads to reduced cAMP levels that diminish HSP82‑mediated chaperone activity, thereby exacerbating the aggregation of mutant PCHD9 protein observed in Bardet‑Biedl syndrome (BBS) patient fibroblasts.",-43.5,0.6,geneorgeneproduct
"Over-expression of HSP82 in HeLa cells markedly increased thrombin‑induced activation of phosphodiesterase‑4D, thereby attenuating the cAMP‑dependent upregulation of the Bardet‑Biedl syndrome cargo‑adaptor protein complex and reducing CDKN3‑mediated cell cycle arrest.",-42.75,0.6,geneorgeneproduct
"The phosphodiesterase‑4D inhibitor roflumilast markedly reduces thrombin‑induced activation of the HSP82‑dependent heat‑shock response in A549 cells, thereby attenuating the overexpression of CDKN3 and the subsequent proliferation of BBS‑related cargo‑adaptor complex‑deficient fibroblasts.",-42.0,0.6,geneorgeneproduct
"The loss-of-function mutation c.1138C>T in the phosphodiesterase‑4D gene (PDE4D) observed in a VPAC2‑deficient mouse model reduces cAMP degradation, thereby enhancing thrombin‑induced platelet aggregation and exacerbating the inflammatory phenotype characteristic of Bardet‑Biedl syndrome (BBS)‑related retinal degeneration.",-50.5,0.6,geneorgeneproduct
"The up‑regulation of phosphodiesterase‑4D in HSP82‑deficient HeLa cells was shown to enhance thrombin‑induced migration, suggesting that the BBS cargo‑adaptor protein complex may modulate PCHD9‑dependent signaling in a CDKN3‑regulated manner.",-32.75,0.6,geneorgeneproduct
"The HSP82 chaperone complex interacts with phosphodiesterase‑4D in HeLa cells, thereby modulating thrombin‑induced activation of the VPAC2‑deficient signaling cascade that is dysregulated in Bardet‑Biedl syndrome‑associated PCHD9 mutations.",-30.125,0.6,geneorgeneproduct
"Mutation in the CDKN3 gene of HeLa cells reduces the binding affinity of thrombin to the GPIbalpha receptor, thereby attenuating the phosphodiesterase‑4D‑mediated cAMP response observed in Bardet‑Biedl syndrome (BBS)‑cargo‑adaptor protein complex‑deficient fibroblasts.",-45.75,0.6,geneorgeneproduct
"Mutation of the HSP82 gene product in a VPAC2-deficient zebrafish model increases thrombin-mediated activation of phosphodiesterase‑4D, thereby enhancing FABP‑1 expression and exacerbating the Bardet‑Biedl syndrome‑associated PCHD9‑mediated ciliary dysfunction.",-48.75,0.6,geneorgeneproduct
Mutation‑induced mis‑localization of the HSP82 chaperone in a VPAC2‑deficient mouse model leads to impaired thrombin‑mediated platelet aggregation and exacerbates the renal phenotype of Bardet‑Biedl syndrome through dysregulation of the PCHD9‑phosphodiesterase‑4D signaling axis.,-37.0,0.6,geneorgeneproduct
"Mutation p.Ser120Phe in the HSP82 gene of a HeLa cell line exposed to thrombin increases expression of phosphodiesterase‑4D, thereby reducing cAMP‑dependent activation of CDKN3 and enhancing proliferation of the cells.",-54.75,0.6,geneorgeneproduct
"Mutagenic exposure of HSP82‑deficient HeLa cells to phosphodiesterase‑4D inhibitor roflumilast induced a BRCA1 c.68_69delAG variant that increased thrombin‑mediated cell‑surface GPI‑alpha clustering and up‑regulated CDKN3 expression, thereby exacerbating the growth‑suppressive phenotype observed in Bardet‑Biedl syndrome‑associated PCHD9‑deficient fibroblasts.",-54.75,0.6,geneorgeneproduct
Mutations in the PCHD9 gene product that disrupt its interaction with the Bardet‑Biedl syndrome cargo‑adaptor protein complex enhance thrombin‑induced endothelial permeability in HSP82‑expressing human microvascular endothelial cells.,-27.75,0.6,geneorgeneproduct
"Mutual phosphorylation of HSP82 by thrombin promotes its interaction with the Bardet‑Biedl syndrome cargo‑adaptor protein complex, thereby enhancing the trafficking of PCHD9 and phosphodiesterase‑4D to the plasma membrane of VPAC2‑deficient cells.",-32.5,0.6,geneorgeneproduct
"Mutant HSP82 in HeLa cells enhances thrombin‑induced phosphorylation of phosphodiesterase‑4D, thereby amplifying cyclic‑AMP signaling that up‑regulates CDKN3 expression and promotes cell‑cycle arrest in the G1 phase.",-33.5,0.6,geneorgeneproduct
"Genetic disruption of the BBS cargo‑adaptor complex in HSP82‑expressing HeLa cells leads to impaired thrombin‑induced phosphorylation of phosphodiesterase‑4D, thereby attenuating CDKN3‑mediated cell‑cycle arrest and enhancing FABP‑1‑driven lipid uptake.",-36.5,0.6,geneorgeneproduct
"Genomic analysis revealed that a missense mutation in HSP82 disrupts its interaction with the Bardet‑Biedl syndrome cargo‑adaptor protein complex, leading to impaired chaperone activity and secondary destabilization of phosphodiesterase‑4D in the VPAC2‑deficient cell line.",-47.25,0.6,geneorgeneproduct
"Genotoxic stress in the HSP82‑overexpressing A549 cell line activates phosphodiesterase‑4D, thereby reducing cAMP and amplifying thrombin‑induced CDKN3‑mediated G1 arrest, a mechanism that may underlie the impaired proliferation observed in Bardet‑Biedl syndrome‑associated PCHD9‑deficient fibroblasts.",-52.25,0.6,geneorgeneproduct
"Genetically engineered HEK293 cells overexpressing HSP82 exhibit increased thrombin‑induced phosphorylation of phosphodiesterase‑4D, thereby enhancing cAMP degradation and attenuating VPAC2‑deficient signaling pathways implicated in Bardet‑Biedl syndrome cargo‑adaptor protein complex dysfunction.",-41.75,0.6,geneorgeneproduct
"HSP82 overexpression in HeLa cells was found to enhance thrombin‑induced phosphorylation of phosphodiesterase‑4D, thereby attenuating the aberrant CDKN3‑mediated cell‑cycle arrest observed in Bardet‑Biedl syndrome‑derived fibroblasts.",-29.25,0.6,geneorgeneproduct
"HepG2 cells treated with the phosphodiesterase‑4D inhibitor roflumilast showed a significant up‑regulation of the heat‑shock protein HSP82, which in turn enhanced thrombin‑mediated activation of the BBS cargo‑adaptor protein complex and reduced the expression of the PCHD9 gene, suggesting a novel regulatory axis linking cellular stress responses to extracellular matrix remodeling.",-53.25,0.6,geneorgeneproduct
"HSPD1, a heat‑shock protein homologous to yeast HSP82, was shown to bind thrombin and enhance its proteolytic activity, thereby potentiating the downstream signaling of the Bardet‑Biedl syndrome cargo‑adaptor protein complex and accelerating the progression of PCHD9‑associated neurodevelopmental defects.",-44.25,0.6,geneorgeneproduct
"Heterozygous PCHD9 variants in a patient with Bardet‑Biedl syndrome disrupt the GPI‑anchored CDKN3‑HSP82 complex, leading to impaired thrombin‑mediated phosphodiesterase‑4D signaling and reduced FABP‑1 expression in the renal tubules.",-42.75,0.6,geneorgeneproduct
"Expression of the HSP82 gene in HeLa cells is upregulated by thrombin, a change that may influence the assembly of the Bardet‑Biedl syndrome cargo‑adaptor protein complex in Homo sapiens and alter downstream phosphodiesterase‑4D signaling.",-34.75,0.6,geneorgeneproduct
"Expression analysis of HSP82 revealed that its upregulation in HeLa cells treated with thrombin induces phosphorylation of phosphodiesterase‑4D, thereby enhancing cAMP degradation and ultimately suppressing the transcription of the CDKN3‑dependent cell‑cycle inhibitor while simultaneously upregulating FABP‑1 to promote lipid transport in Homo sapiens BBS‑associated cargo‑adaptor protein complexes.",-65.0,0.6,geneorgeneproduct
"Expression levels of HSP82 and phosphodiesterase‑4D were markedly reduced in VPAC2‑deficient A549 cells, suggesting that the BBS cargo‑adapter protein complex may regulate the stability of these gene products through a thrombin‑dependent signaling pathway.",-43.75,0.6,geneorgeneproduct
"Expression profiling of HSP82 in HeLa cells revealed that its up‑regulation by thrombin activates a phosphodiesterase‑4D‑dependent pathway, thereby enhancing CDKN3‑mediated cell‑cycle arrest and contributing to the dysregulation observed in Bardet‑Biedl syndrome‑associated cargo‑adaptor protein complexes.",-41.5,0.6,geneorgeneproduct
"Deletion of the PCHD9 gene in HeLa cells reduces thrombin‑induced activation of phosphodiesterase‑4D, thereby impairing the cAMP‑mediated suppression of CDKN3 expression that normally limits cell‑cycle progression in this cancer line.",-36.25,0.6,geneorgeneproduct
"Deletion in the PCHD9 gene that encodes a component of the Bardet‑Biedl syndrome cargo‑adaptor protein complex leads to reduced HSP82 expression, thereby increasing thrombin‑induced platelet aggregation in CDKN3‑deficient human endothelial cells.",-36.75,0.6,geneorgeneproduct
"Deletion‑induced loss of the HSP82 gene product in HeLa cells was shown to sensitize the cells to thrombin‑mediated apoptosis, suggesting that HSP82 normally stabilizes the phosphodiesterase‑4D complex and protects against BBS‑cargo‑adaptor‑protein‑complex‑mediated endocytic dysregulation.",-59.5,0.6,geneorgeneproduct
"Deletion p.(Glu1351*) in the CDKN3 gene of a patient with Bardet‑Biedl syndrome leads to loss of the phosphodiesterase‑4D‑binding domain, resulting in aberrant thrombin‑induced HSP82 up‑regulation and impaired VPAC2‑deficient signaling in the affected kidney epithelial cells.",-68.0,0.6,geneorgeneproduct
"Thrombin‑induced activation of phosphodiesterase‑4D in HSP82‑deficient HeLa cells enhances VPAC2‑deficient cAMP signaling, thereby aggravating the Bardet‑Biedl syndrome cargo‑adaptor protein complex dysfunction observed in PCHD9‑mutant A549 cells.",-33.75,0.6,geneorgeneproduct
"Thymic stromal lymphopoietin overexpression in HSP82‑knockdown A549 cells enhances thrombin‑induced CDKN3 phosphorylation, thereby promoting proliferation of BBS cargo‑adaptor protein complex‑deficient PCHD9‑mutant fibroblasts.",-37.5,0.6,geneorgeneproduct
"Thrombosis in HSP82‑deficient HeLa cells is exacerbated by phosphodiesterase‑4D inhibition, revealing that thrombin‑induced platelet aggregation is amplified through CDKN3‑mediated cell‑cycle deregulation in the context of Bardet‑Biedl syndrome cargo‑adaptor protein complex dysfunction.",-42.25,0.6,geneorgeneproduct
"Thyroid‑derived HSP82 interacts with thrombin‑induced CDKN3 signaling to modulate the phosphodiesterase‑4D activity observed in VPAC2‑deficient cells, thereby influencing the metabolic profile of the Bardet‑Biedl syndrome cargo‑adaptor protein complex in PCHD9‑expressing HeLa cells.",-54.5,0.6,geneorgeneproduct
"Interaction between the HSP82 chaperone and the phosphodiesterase‑4D protein was shown to stabilize thrombin‑induced CDKN3 expression in HeLa cells, thereby attenuating the cellular proliferation associated with Bardet‑Biedl syndrome‑related cargo‑adaptor protein complex dysfunction.",-42.25,0.6,geneorgeneproduct
"Interaction of the HSP82 chaperone with the phosphodiesterase‑4D complex stabilizes thrombin‑induced signaling in CDKN3‑expressing HeLa cells, a mechanism that may be disrupted in Bardet‑Biedl syndrome‑associated cargo‑adaptor protein complexes.",-36.75,0.6,geneorgeneproduct
"Interaction studies in Hela cells revealed that the Bardet‑Biedl syndrome (BBS) cargo‑adaptor protein complex phosphorylates HSP82, thereby enhancing thrombin‑induced activation of phosphodiesterase‑4D and ultimately up‑regulating CDKN3 expression to suppress cell‑cycle progression.",-41.0,0.6,geneorgeneproduct
"Interaction assays revealed that the HSP82 chaperone, when co‑expressed with thrombin‑cleaved PCHD9, stabilised the phosphodiesterase‑4D complex and enhanced CDKN3‑mediated cell‑cycle arrest in HeLa cells, suggesting a potential therapeutic avenue for Bardet‑Biedl syndrome‑associated metabolic dysregulation.",-47.75,0.6,geneorgeneproduct
"Hyperactivation of phosphodiesterase‑4D in A549 cells carrying the PCHD9 c.412G>A variant enhances thrombin‑induced NF‑κB signaling, thereby increasing CDKN3 expression and reducing HSP82‑mediated chaperone activity in a model of Bardet‑Biedl syndrome‑associated cellular stress.",-46.75,0.6,geneorgeneproduct
"Hyperthermia-induced activation of HSP82 in HeLa cells enhances thrombin-mediated phosphorylation of phosphodiesterase4D, thereby upregulating CDKN3 expression and ultimately suppressing proliferation of PCHD9‑mutant A549 cells.",-41.0,0.6,geneorgeneproduct
"Hyperacetylated HSP82 in HeLa cells enhances thrombin‑induced phosphorylation of phosphodiesterase‑4D, thereby elevating cAMP levels and accelerating the degradation of the BBS cargo‑adaptor protein complex, a process that is further amplified by the VPAC2‑deficient phenotype observed in PCHD9‑mutant A549 cells.",-52.25,0.6,geneorgeneproduct
"Hyperactive HSP82 in A549 cells enhances thrombin‑induced activation of phosphodiesterase‑4D, thereby elevating cAMP levels that suppress CDKN3 expression and accelerate proliferation in a BBS‑cargo‑adaptor protein complex‑deficient model of Bardet‑Biedl syndrome.",-42.0,0.6,geneorgeneproduct
"The c.68_69delAG variant in the TP53 gene, detected in a patient with a homozygous CCR5-Δ32 allele, was shown to impair the Wnt‑signaling pathway and to reduce the expression of the fibroblast growth factor receptor‑3 protein in the A549 cell line, thereby increasing cellular sensitivity to the chemotherapeutic agent doxorubicin.",-53.25,0.6,geneorgeneproduct
The disruption of Wnt‑signaling by a BRCA1 c.68_69delAG variant in a HeLa cell line carrying the FGFR1‑TACC1 fusion reduced VEGF‑induced proliferation and increased apoptosis through up‑regulation of ROCK‑II activity.,-33.25,0.6,geneorgeneproduct
"The FGFR1‑TACC1 fusion protein, frequently amplified in glioblastoma, activates ROCK‑II‑dependent phosphorylation of Prox1, thereby enhancing VEGF‑induced angiogenesis and driving resistance to temozolomide in A172 cell line cultures.",-26.875,0.6,geneorgeneproduct
"The wnt‑signaling pathway, regulated by Prox1 and activated through VEGF‑induced FGFR1‑TACC1 complexes, promotes proliferation in A549 cells, while ROCK‑I/II inhibition in HeLa cells reduces migration and enhances sensitivity to doxorubicin.",-35.25,0.6,geneorgeneproduct
"Activation of the VEGF‑induced FGFR1‑TACC1 signaling axis in A549 cells carrying a Prox1 over‑expression construct leads to enhanced ROCK‑II phosphorylation, thereby promoting migration and invasion of the cancer cells.",-34.0,0.6,geneorgeneproduct
"Activation by VEGF-induced signaling of the fibroblast growth factor receptor‑3 in A549 cells leads to up‑regulation of Prox1, which in turn enhances ROCK‑II activity and promotes epithelial‑mesenchymal transition.",-39.75,0.6,geneorgeneproduct
"Activation‑induced phosphorylation of ROCK‑II in HUVECs enhances VEGF‑induced endothelial migration, a process that is attenuated by the CCR5‑Δ32 allele and potentiated by the FGFR1‑TACC1 fusion protein.",-33.75,0.6,geneorgeneproduct
"Activation or inhibition of the Wnt‑signaling pathway in A549 cells harboring a TP53 c.215C>T variant modulates the expression of FGFR1‑TACC1, thereby influencing VEGF‑induced endothelial proliferation and the cellular response to the ROCK‑II inhibitor Y‑27632.",-49.75,0.6,geneorgeneproduct
"Mutations in the FGFR1‑TACC1 fusion gene in A549 cells activate Wnt‑signaling, leading to increased VEGF‑induced proliferation that is further amplified by ROCK‑I/II activity.",-25.125,0.6,geneorgeneproduct
"Mutational analysis revealed that the CCR5-Δ32 allele, when co‑expressed with the Prox1 transcription factor in HEK293T cells, attenuates VEGF‑induced activation of the FGFR1‑TACC1 signaling axis, thereby reducing downstream ROCK‑II phosphorylation and cell migration.",-35.0,0.6,geneorgeneproduct
"Mutant Prox1 c.1234G>A in the HCT116 cell line enhances VEGF‑induced activation of the ROCK‑II–FGFR1‑TACC1 axis, thereby promoting epithelial–mesenchymal transition in colorectal carcinoma.",-41.75,0.6,geneorgeneproduct
"Mutated Prox1 in A549 cells downregulates VEGF‑induced FGFR1‑TACC1 signaling, thereby reducing ROCK‑II activity and promoting apoptosis.",-26.625,0.6,geneorgeneproduct
"In **HepG2** cells, the **FGFR1‑TACC1** fusion protein activates **ROCK‑II**, which in turn phosphorylates **Prox1** and enhances **VEGF‑induced** angiogenic signaling, thereby promoting tumor vascularization.",-24.625,0.6,geneorgeneproduct
"In HepG2 cells, the loss‑of‑function mutation c.68_69delAG in the TP53 gene reduces p53‑dependent transcription of the ABCG2 transporter, thereby impairing cellular resistance to the chemotherapeutic agent doxorubicin.",-29.75,0.6,geneorgeneproduct
"In the A549 cell line, VEGF-induced activation of ROCK-I/II leads to phosphorylation of Prox1, thereby enhancing the transcription of the ABCG2 transporter gene and promoting chemoresistance to doxorubicin.",-25.25,0.6,geneorgeneproduct
"In H1299 cells, the VEGF‑induced up‑regulation of FGFR1‑TACC1 activates ROCK‑II, which in turn phosphorylates Prox1, thereby enhancing epithelial‑to‑mesenchymal transition.",-20.75,0.6,geneorgeneproduct
"Wnt‑signaling activation by the FGFR1‑TACC1 fusion protein in A549 cells up‑regulates Prox1, thereby enhancing VEGF‑induced angiogenesis and promoting resistance to the ROCK‑II inhibitor Y‑27632.",-27.875,0.6,geneorgeneproduct
"Wound‑healing assays in HUVECs revealed that VEGF‑induced activation of FGFR1‑TACC1 signaling up‑regulated Prox1 expression, thereby promoting endothelial cell migration through a ROCK‑II dependent pathway.",-39.0,0.6,geneorgeneproduct
"Wang et al. demonstrated that the FGFR1‑TACC1 fusion protein, expressed in A549 cells, activates ROCK‑II‑mediated actomyosin contractility, thereby enhancing VEGF‑induced endothelial cell migration and up‑regulating the transcription of the ABCG2 transporter in Homo sapiens microvascular endothelial cells.",-48.75,0.6,geneorgeneproduct
"Worthy of further study, the FGFR1‑TACC1 fusion in A549 cells activates wnt‑signaling, thereby up‑regulating VEGF‑induced angiogenesis and conferring resistance to the ROCK‑II inhibitor Y‑27632.",-38.5,0.6,geneorgeneproduct
"ROCK-I/II inhibition in A549 cells upregulates Prox1 expression, thereby enhancing VEGF‑induced angiogenesis through the Wnt‑signaling pathway.",-17.0,0.6,geneorgeneproduct
"ROK-I/II inhibition in A549 cells expressing the FGFR1‑TACC1 fusion protein markedly reduced VEGF‑induced migration, suggesting a novel crosstalk between the ROCK pathway and fibroblast growth factor receptor signaling in this lung cancer model.",-44.0,0.6,geneorgeneproduct
"ROSCAR-1 cells overexpressing the FGFR1‑TACC1 fusion protein exhibit VEGF‑induced proliferation that is markedly attenuated by the ROCK‑II inhibitor Y‑27632, suggesting a crosstalk between fibroblast growth factor receptor signaling and the actin‑regulatory kinase pathway in this human cell line.",-51.25,0.6,geneorgeneproduct
"ROCC-I/II inhibition in A549 cells expressing the FGFR1‑TACC1 fusion reduced VEGF‑induced proliferation, while the CCR5‑Δ32 variant in the same cell line decreased chemokine‑mediated migration.",-44.0,0.6,geneorgeneproduct
"Deregulation of the Wnt‑signaling pathway in the A549 cell line, driven by a BRCA1 c.68_69delAG variant, activates FGFR1‑TACC1 fusion protein and up‑regulates VEGF‑induced expression of the ABCG2 transporter, thereby promoting chemoresistance to doxorubicin in Homo sapiens lung carcinoma cells.",-34.0,0.6,geneorgeneproduct
"Dysregulated wnt‑signaling in HCT116 cells, driven by a FGFR1‑TACC1 fusion, enhances ROCK‑II activity and up‑regulates VEGF‑induced ABCG2 expression, thereby promoting chemoresistance to doxorubicin.",-29.125,0.6,geneorgeneproduct
"Dopamine D2 receptor activation in A549 cells induces phosphorylation of ROCK-I, which in turn enhances Prox1‑dependent transcription of VEGF, thereby promoting a VEGF‑induced angiogenic phenotype that is attenuated by the CCR5‑Delta32 allele.",-37.0,0.6,geneorgeneproduct
"Dexamethasone treatment of A549 cells expressing the FGFR1‑TACC1 fusion protein induces phosphorylation of ROCK‑II and subsequently activates Prox1‑mediated transcription of VEGF, thereby enhancing the migratory capacity of the cancer cells.",-35.25,0.6,geneorgeneproduct
"Pharmacologic inhibition of ROCK-I/II in A549 cells carrying the FGFR1‑TACC1 fusion allele reduces VEGF‑induced proliferation and down‑regulates the wnt‑signaling cascade, suggesting a potential therapeutic strategy for tumors with this oncogenic rearrangement.",-39.75,0.6,geneorgeneproduct
"Phosphorylation of ROCK‑II by the FGFR1‑TACC1 fusion protein in A549 cells enhances VEGF‑induced migration and upregulates the ABCG2 transporter, thereby contributing to chemoresistance in non‑small‑cell lung carcinoma.",-27.875,0.6,geneorgeneproduct
"Phorbol ester stimulation of the A549 cell line upregulates the transcription factor Prox1, which in turn enhances VEGF-induced angiogenesis through activation of the FGFR1-TACC1 complex and downstream ROCK-I/II signaling pathways.",-42.0,0.6,geneorgeneproduct
"Pharmaceutical inhibition of ROCK‑II in A549 cells markedly reduced VEGF‑induced migration, an effect that was amplified by co‑transfection of a Prox1 overexpression vector and attenuated in cells carrying the CCR5‑Δ32 allele.",-43.0,0.6,geneorgeneproduct
"Silencing of the gene product Prox1 in the A549 cell line reduces VEGF-induced activation of ROCK-I/II, thereby attenuating wnt‑signaling‑mediated invasion of E. coli‑derived fibroblast growth factor receptor‑3 overexpressing cells.",-43.25,0.6,geneorgeneproduct
"Silico‑generated CRISPR‑Cas9 editing of the Prox1 gene in A549 cells revealed that loss of Prox1 up‑regulates VEGF‑induced fibroblast growth factor receptor‑3 expression, thereby activating wnt‑signaling and promoting chemoresistance to doxorubicin in this lung carcinoma model.",-44.75,0.6,geneorgeneproduct
Silk fibroin nanoparticles functionalized with the VEGF‑induced alpha2‑adrenergic receptor agonist and loaded with the ROCK‑II inhibitor Y‑27632 reduced proliferation of the A549 cell line by upregulating the tumor‑suppressive gene Prox1 while simultaneously attenuating DDR1‑mediated fibroblast growth factor receptor‑3 signaling in a dose‑dependent manner.,-62.0,0.6,geneorgeneproduct
"Silica nanoparticles activate the wnt‑signaling pathway in A549 cells, leading to up‑regulation of the fibroblast growth factor receptor‑3 gene product and subsequent phosphorylation of ROCK‑II, which enhances cellular migration and invasion.",-41.75,0.6,geneorgeneproduct
"Upregulation of FGFR1‑TACC1 in A549 cells activates Wnt‑signaling, thereby increasing VEGF‑induced angiogenesis and promoting resistance to doxorubicin in this lung cancer model.",-25.125,0.6,geneorgeneproduct
"Upstream activation of ROCK-I/II by VEGF-induced signaling in A549 cells expressing the FGFR1‑TACC1 fusion leads to phosphorylation of Prox1, thereby enhancing epithelial‑mesenchymal transition and promoting metastasis.",-32.0,0.6,geneorgeneproduct
Upregulated FGFR1-TACC1 fusion in HeLa cells activates Wnt‑signaling and induces a VEGF‑dependent proliferation that is partially inhibited by the ROCK‑II inhibitor Y‑27632.,-33.75,0.6,geneorgeneproduct
"Up‑regulated FGFR1‑TACC1 fusion in A549 cells activates ROCK‑II‑mediated phosphorylation of Prox1, thereby enhancing VEGF‑induced angiogenic signaling and increasing resistance to the chemotherapeutic drug doxorubicin.",-33.0,0.6,geneorgeneproduct
"Alpha2‑adrenergic receptor activation in A549 cells upregulates ROCK‑II, which in turn phosphorylates Prox1 to enhance VEGF‑induced angiogenesis.",-17.875,0.6,geneorgeneproduct
"Alpha‑2‑adrenergic receptor overexpression in A549 cells enhances ROCK‑II‑mediated phosphorylation of Prox1, thereby amplifying VEGF‑induced endothelial sprouting that is partially attenuated by the CCR5‑Δ32 polymorphism.",-25.0,0.6,geneorgeneproduct
"Alpha-2-adrenergic receptor overexpression in HeLa cells activates ROCK-I/II signaling, thereby enhancing Prox1‑mediated transcription of VEGF and up‑regulating ABCG2 efflux activity.",-28.875,0.6,geneorgeneproduct
"Alpha‐2‐adrenergic receptor signaling in the A549 cell line is potentiated by ROCK‑II inhibition, leading to increased Prox1 expression and downstream activation of the wnt‑signaling pathway that enhances VEGF‑induced angiogenic responses in Homo sapiens fibroblast growth factor receptor‑3‑deficient tissues.",-49.25,0.6,geneorgeneproduct
"CRISPR‑mediated knockout of the FGFR1‑TACC1 fusion in A549 cells markedly attenuated VEGF‑induced proliferation, an effect that was partially rescued by overexpressing the alpha2‑adrenergic receptor.",-26.875,0.6,geneorgeneproduct
"CRABP2 expression in A549 cells is up‑regulated by VEGF‑induced FGFR1‑TACC1 signaling, and this up‑regulation enhances ROCK‑II–mediated cell migration while simultaneously suppressing Prox1‑driven epithelial‑to‑mesenchymal transition.",-40.0,0.6,geneorgeneproduct
"CRediT analysis revealed that the FGFR1‑TACC1 fusion protein in A549 cells activates Wnt‑signaling, thereby up‑regulating VEGF‑induced angiogenesis and conferring resistance to the ROCK‑II inhibitor Y‑27632.",-38.5,0.6,geneorgeneproduct
"CRLF2 overexpression in K562 cells activates ROCK-I/II signaling, which in turn phosphorylates Prox1 and enhances VEGF‑induced angiogenesis.",-28.125,0.6,geneorgeneproduct
"During angiogenesis, VEGF-induced activation of FGFR1-TACC1 in HUVECs leads to ROCK-I/II‑dependent cytoskeletal rearrangement that promotes Prox1‑mediated endothelial progenitor cell differentiation.",-36.0,0.6,geneorgeneproduct
"During cytokine‑induced VEGF‑driven angiogenesis, the loss of Prox1 in HUVECs upregulates ROCK‑II activity, thereby enhancing endothelial migration and compromising vascular barrier integrity.",-43.25,0.6,geneorgeneproduct
"During VEGF‑induced angiogenesis in HUVECs, the FGFR1‑TACC1 fusion protein activates ROCK‑II, which in turn phosphorylates Prox1, thereby enhancing endothelial cell migration and sprouting.",-28.875,0.6,geneorgeneproduct
"During in vitro studies, the FGFR1‑TACC1 fusion protein was found to activate wnt‑signaling in H1299 cells, leading to up‑regulation of ABCG2 and enhanced resistance to doxorubicin.",-30.625,0.6,geneorgeneproduct
"A gain‑of‑function mutation in the FGFR1‑TACC1 fusion protein amplifies Wnt‑signaling in A549 cells, leading to up‑regulated ABCG2 expression and conferring resistance to doxorubicin in a human lung carcinoma model.",-32.25,0.6,geneorgeneproduct
"ACR-mediated activation of ROCK-I/II in HUVECs enhances VEGF‑induced phosphorylation of FGFR1-TACC1, thereby upregulating ABCG2 expression and promoting endothelial cell migration.",-31.5,0.6,geneorgeneproduct
"A1‑AR‑overexpressing A549 cells exposed to the ROCK‑II inhibitor Y‑27632 showed reduced Prox1‑mediated transcription of VEGF‑induced CXCR4, a change that was rescued by overexpression of the FGFR1‑TACC1 fusion protein.",-44.25,0.6,geneorgeneproduct
"A reduced phosphorylation of ROCK-I/II in A549 cells carrying the FGFR1‑TACC1 fusion leads to enhanced VEGF‑induced angiogenesis, while a concurrent CCR5‑Delta32 variant in the same cell line attenuates the wnt‑signaling pathway downstream of Prox1.",-45.5,0.6,geneorgeneproduct
"The nuclear factor of kappa B (NF‑κB) pathway, activated by PAK2‑activation, upregulates MMPs and S100 proteins, thereby enhancing IL‑13‑mediated inflammation in CFHR1‑deficient macrophages.",-19.0,0.6,geneorgeneproduct
"The upregulation of nuclear factor of kappa B in CFHR1‑deficient macrophages triggers PAK2‑activation, which in turn amplifies IL‑13‑mediated MMP expression and promotes degradation of the glycoprotein (GP) Ib/IX/V complex, thereby exacerbating platelet dysfunction in patients treated with pegylated interferon alpha‑2b.",-26.125,0.6,geneorgeneproduct
"The activation of PAK2 by IL‑13 in CFHR1‑deficient A549 cells enhances NF‑κB‑dependent transcription of MMP‑9, thereby increasing invasion of the glycoprotein (GP) Ib/IX/V‑positive endothelial monolayer.",-22.75,0.6,geneorgeneproduct
"The NF‑κB–dependent transcriptional up‑regulation of MMP‑9 in the A549 cell line following IL‑13 stimulation was mitigated by pegylated interferon‑α2b, which also reduced the expression of the CFHR1 complement regulator and the glycoprotein (GP) Ib/IX/V complex, thereby attenuating platelet adhesion and inflammatory signaling in the tumor microenvironment.",-46.75,0.6,geneorgeneproduct
"In EGFR‑overexpressing A549 cells, pegylated interferon alpha‑2b treatment down‑regulates nuclear factor kappa B‑mediated transcription of MMP‑9 while up‑regulating the anti‑angiogenic cytokine IL‑13, thereby attenuating tumor invasiveness.",-33.5,0.6,geneorgeneproduct
"In Hela cells, nuclear factor of kappa B activation up‑regulates MMP‑9 expression, which in turn cleaves glycoprotein (GP) Ib/IX/V on platelets, thereby enhancing thrombus formation.",-22.625,0.6,geneorgeneproduct
"In the A549 cell line, activation of PAK2 by IL‑13 up‑regulates NF‑κB‑dependent transcription of the CFHR1 gene, thereby increasing secretion of the complement‑regulating protein CFI.",-21.875,0.6,geneorgeneproduct
"In HepG2 cells, activation of PAK2 by IL‑13 increases NF‑κB‑mediated transcription of the complement regulator CFHR1, thereby enhancing MMP‑dependent extracellular matrix remodeling.",-19.625,0.6,geneorgeneproduct
"Pseudomonas aeruginosa infection induces nuclear factor of kappa B activation in HeLa cells, leading to up‑regulation of MMP‑9 and down‑regulation of the complement factor I (CFI) gene, thereby enhancing extracellular matrix degradation and promoting bacterial invasion.",-29.625,0.6,geneorgeneproduct
"P‑AK2‑activation in the nucleus of HeLa cells was shown to up‑regulate the transcription of the inflammatory cytokine IL‑13, thereby enhancing the expression of the MOG35‑55‑specific T‑cell receptor and increasing the surface density of the glycoprotein (GP) Ib/IX/V complex, which in turn potentiated platelet aggregation and accelerated the degradation of matrix metalloproteinases (MMPs) in the extracellular matrix.",-53.5,0.6,geneorgeneproduct
"PAX5 mutations in the A549 cell line were shown to increase NF‑κB‑dependent transcription of IL‑13, thereby enhancing the secretion of MMP‑9 and the expression of the glycoprotein GP Ib/IX/V complex.",-37.75,0.6,geneorgeneproduct
"Pediatric patients with a CFHR1 deletion exhibited increased activation of nuclear factor‑kappa B and elevated IL‑13 production, which in turn stimulated MMP‑mediated degradation of the glycoprotein GP Ib/IX/V complex, leading to a heightened risk of platelet‑associated bleeding complications.",-45.25,0.6,geneorgeneproduct
"Mutations in the CFHR1 gene that reduce its complement regulatory activity enhance PAK2‑activation, thereby increasing nuclear factor of kappa B‑mediated transcription of MMPs and S100 proteins, which in turn exacerbates the inflammatory response to the MOG35‑55 peptide in multiple sclerosis patients.",-29.5,0.6,geneorgeneproduct
"Mutational activation of PAK2 in HeLa cells upregulates NF‑κB‑dependent transcription of MMP‑9, thereby enhancing invasion of the cell line toward extracellular matrix components such as glycoprotein (GP) Ib/IX/V.",-27.25,0.6,geneorgeneproduct
"Mutant CFHR1 variants disrupt complement regulation, enhancing IL‑13‑induced PAK2 activation that in turn upregulates MMP‑9 expression in the glycoprotein (GP) Ib/IX/V‑bearing platelets of patients with autoimmune thrombocytopenia.",-34.5,0.6,geneorgeneproduct
"Mutagenic exposure to benzene induces a PAK2‑activation cascade that up‑regulates NF‑κB‑dependent transcription of MMP‑9, thereby promoting degradation of the glycoprotein (GP) Ib/IX/V complex in platelets from a patient carrying the CFHR1‑associated SequenceVariant c.137G>A.",-49.5,0.6,geneorgeneproduct
"Nuclear factor of kappa B activation in A549 cells upregulates MMPs, which in turn cleave glycoprotein (GP) Ib/IX/V and enhance IL‑13 secretion, a process that can be attenuated by pegylated interferon alpha‑2b treatment.",-20.875,0.6,geneorgeneproduct
"N‑acetyl‑cysteine treatment reduced IL‑13‑induced activation of NF‑κB, thereby decreasing MMP‑9 expression in CFHR1‑overexpressing A549 cells.",-30.5,0.6,geneorgeneproduct
"Nf‑κB activation in A549 cells treated with pegylated interferon‑α‑2b upregulates MMP‑9 expression, which in turn degrades the glycoprotein GP Ib/IX/V complex and promotes platelet adhesion to the endothelial surface.",-38.5,0.6,geneorgeneproduct
"Nucleophilic activation of PAK2 by IL‑13 upregulates MMP‑9 expression in CFHR1‑deficient A549 cells, thereby enhancing extracellular matrix remodeling and promoting invasive growth of the cancerous phenotype.",-39.5,0.6,geneorgeneproduct
"Expression of the nuclear factor of kappa B pathway in A549 cells is up‑regulated by IL‑13, leading to increased secretion of MMPs that degrade the glycoprotein (GP) Ib/IX/V complex and thereby enhance platelet adhesion in a CFHR1‑deficient environment.",-29.0,0.6,geneorgeneproduct
"Expression levels of the nuclear factor kappa B transcription factor were markedly increased in HeLa cells treated with pegylated interferon alpha‑2b, correlating with elevated IL‑13 production and enhanced PAK2‑activation that subsequently upregulated MMP‑9 secretion.",-36.75,0.6,geneorgeneproduct
"Expression level changes of nuclear factor of kappa B in A549 cells treated with pegylated interferon alpha‑2b were found to correlate with increased secretion of IL‑13 and MMP‑9, suggesting a regulatory loop that may modulate MOG35‑55‑induced demyelination in a murine model of multiple sclerosis.",-40.25,0.6,geneorgeneproduct
"Expression analysis of the nuclear factor of kappa B pathway in HeLa cells treated with pegylated interferon alpha‑2b revealed that up‑regulated CFHR1 and PAK2‑activation synergistically increased IL‑13 production, thereby enhancing MOG35‑55‑induced demyelination and MMP‑mediated extracellular matrix degradation while simultaneously down‑regulating the glycoprotein (GP) Ib/IX/V complex and S100 calcium‑binding protein expression.",-52.75,0.6,geneorgeneproduct
"A mutation in CFHR1 that disrupts its complement regulatory function enhances PAK2‑activation and amplifies nuclear factor of kappa B‑dependent expression of MMPs, thereby accelerating the inflammatory cascade observed in patients with MOG35‑55‑induced autoimmune demyelination.",-36.75,0.6,geneorgeneproduct
A reduction in nuclear factor of kappa B activity in A549 cells treated with pegylated interferon alpha‑2b correlates with decreased MMP‑9 expression and heightened sensitivity to doxorubicin-induced apoptosis.,-30.375,0.6,geneorgeneproduct
"A CRISPR/Cas9‑mediated knockout of the CFHR1 gene in the human embryonic kidney cell line HEK293T revealed that loss of CFHR1 enhances PAK2‑activation and subsequently increases nuclear factor of kappa B‑dependent transcription of IL‑13, thereby elevating MMP‑9 secretion and disrupting the glycoprotein (GP) Ib/IX/V complex on platelets, an effect that can be mitigated by pegylated interferon alpha‑2",-52.5,0.6,geneorgeneproduct
"A recent study demonstrated that the nuclear factor of kappa B‑mediated up‑regulation of MMP‑9 in HeLa cells exposed to pegylated interferon alpha‑2b led to enhanced invasion of the glycoprotein GP Ib/IX/V‑positive endothelial monolayer, suggesting a potential therapeutic target for mitigating tumor‑induced angiogenesis.",-44.5,0.6,geneorgeneproduct
"Among human epithelial carcinoma cells, the upregulation of nuclear factor‑kappa B by PAK2‑activation enhances MMP‑9 secretion, thereby promoting invasion and correlating with increased expression of the complement regulator CFHR1.",-40.5,0.6,geneorgeneproduct
"Among A549 cells, nuclear factor of kappa B activation by PAK2-activation enhances IL‑13‑induced MMP expression, which in turn promotes cleavage of glycoprotein (GP) Ib/IX/V, thereby increasing platelet adhesion and contributing to the inflammatory response observed in CFHR1‑deficient E. coli infections.",-42.0,0.6,geneorgeneproduct
"Among patients with relapsed multiple myeloma, the up‑regulation of nuclear factor of kappa B in the malignant plasma cells was found to synergistically enhance the expression of IL‑13, thereby promoting the secretion of MMPs that degrade the bone‑derived glycoprotein (GP) Ib/IX/V complex and facilitating osteolytic lesions.",-48.0,0.6,geneorgeneproduct
"Among Jurkat cells, the nuclear factor of kappa B pathway was activated by IL‑13 stimulation, leading to up‑regulation of MMP‑9 and the glycoprotein GP Ib/IX/V complex, a process that was markedly enhanced in the presence of the CFHR1 variant c.1289C>T.",-51.75,0.6,geneorgeneproduct
"Hyperactivation of PAK2 in A549 cells enhances NF‑κB‑driven transcription of the complement regulator CFHR1, thereby amplifying IL‑13‑mediated inflammatory signaling that ultimately upregulates MMP‑9 expression and promotes extracellular matrix remodeling.",-35.5,0.6,geneorgeneproduct
"Hyperactive nuclear factor of kappa B signaling in HeLa cells upregulates MMP-9 expression, thereby enhancing extracellular matrix degradation and promoting invasion of the tumor microenvironment.",-28.75,0.6,geneorgeneproduct
Hyperphosphorylation of nuclear factor of kappa B in HeLa cells treated with pegylated interferon alpha‑2b upregulates MMP‑9 expression and enhances invasion through a PAK2‑activation‑dependent pathway.,-30.25,0.6,geneorgeneproduct
"Hyperacetylated histone H3 at the promoter of the NF‑κB subunit RELA in CFHR1‑knockdown A549 cells activates PAK2‑dependent phosphorylation of S100A8, thereby amplifying IL‑13‑induced MMP‑9 secretion and enhancing the inflammatory response to MOG35‑55 peptide in a pegylated interferon alpha‑2b‑treated model of multiple sclerosis.",-60.0,0.6,geneorgeneproduct
"PEG‑modified interferon alpha‑2b treatment down‑regulates nuclear factor‑kappa B activity and reduces MMP‑9 secretion in the CFHR1‑deficient A549 cell line, thereby attenuating IL‑13‑induced inflammatory signaling in E. coli‑derived macrophages.",-35.0,0.6,geneorgeneproduct
"PEG‐ylated interferon alpha‑2b treatment in A549 cells down‑regulates the nuclear factor kappa‑B‑dependent transcription of the CFHR1 gene, thereby reducing MMP‑9 secretion and attenuating IL‑13‑induced inflammatory signaling in the tumor microenvironment.",-34.75,0.6,geneorgeneproduct
"PEGylated interferon alpha‑2b treatment of HepG2 cells induced nuclear factor‑kappa B activation, which in turn up‑regulated the expression of the complement factor H‑related protein CFHR1 and matrix metalloproteinases, thereby promoting extracellular matrix remodeling.",-35.25,0.6,geneorgeneproduct
"PEG-IFNα-2b treatment of Huh‑7 cells down‑regulated nuclear factor‑κB‑mediated transcription of MMP‑9 while simultaneously inducing S100A10 expression, thereby attenuating extracellular matrix remodeling and reducing metastatic potential.",-43.0,0.6,geneorgeneproduct
"Altered nuclear factor of kappa B activation in A549 cells treated with pegylated interferon alpha‑2b led to up‑regulation of MMP‑9 and down‑regulation of CFHR1, thereby enhancing extracellular matrix degradation and promoting a pro‑inflammatory phenotype.",-25.0,0.6,geneorgeneproduct
"Alterations in the nuclear factor of kappa B signaling pathway, amplified by PAK2 activation, have been shown to upregulate MMPs and S100 proteins in A549 cells, thereby enhancing invasion and resistance to pegylated interferon alpha‑2b treatment.",-28.25,0.6,geneorgeneproduct
"Alteration of the nuclear factor of kappa B signaling by CFHR1 deficiency enhances PAK2‑activation and up‑regulates IL‑13 expression, thereby increasing MMP activity and S100 protein release in the glycoprotein (GP) Ib/IX/V‑expressing platelets of patients treated with pegylated interferon alpha‑2b.",-36.75,0.6,geneorgeneproduct
"Altering the expression of nuclear factor of kappa B in A549 cells with a pegylated interferon alpha‑2b treatment upregulates MMP‑9, thereby enhancing the invasion of these lung carcinoma cells.",-39.75,0.6,geneorgeneproduct
"Suppression of NF‑κB activity by pegylated interferon alpha‑2b in the A549 cell line reduces MMP‑9 expression, thereby attenuating the invasion of CFHR1‑expressing E. coli‑derived lipopolysaccharide‑stimulated macrophages.",-30.625,0.6,geneorgeneproduct
Suppressed nuclear factor of kappa B activity in A549 cells treated with pegylated interferon alpha‑2b correlates with down‑regulation of MMP‑9 and reduced invasion of the human lung carcinoma model.,-33.25,0.6,geneorgeneproduct
"Suppresive phosphorylation of nuclear factor of kappa B by PAK2‑activation in HeLa cells markedly reduces IL‑13‑induced MMP expression, thereby attenuating MOG35‑55‑mediated demyelination in a humanized EAE model.",-44.5,0.6,geneorgeneproduct
"Suppressive phosphorylation of NF‑κB by the PAK2‑activation complex in HeLa cells diminishes IL‑13‑induced MOG35‑55‑specific T cell proliferation, thereby reducing MMP‑mediated blood–brain barrier disruption.",-46.0,0.6,geneorgeneproduct
"Inflammatory signaling in the A549 cell line is amplified by nuclear factor of kappa B activation, which up‑regulates MMPs and S100 proteins while simultaneously inducing a CFHR1‑mediated complement cascade that enhances IL‑13 secretion and modulates the activity of the glycoprotein (GP) Ib/IX/V complex.",-44.5,0.6,geneorgeneproduct
"Inflamed A549 cells exposed to pegylated interferon alpha‑2b upregulated nuclear factor of kappa B, which in turn increased MMP‑9 secretion and stimulated S100A8 expression, thereby amplifying the inflammatory cascade in this cell line.",-48.75,0.6,geneorgeneproduct
"Inflammasome‑mediated activation of nuclear factor of kappa B in A549 cells up‑regulates MMP‑9 expression, while pegylated interferon alpha‑2b treatment down‑modulates S100A8/A9 levels in the same cell line.",-35.0,0.6,geneorgeneproduct
"Inflated nuclear factor of kappa B activity in CFHR1‑deficient A549 cells triggers PAK2‑activation, amplifying IL‑13‑induced MMP expression that ultimately degrades the glycoprotein (GP) Ib/IX/V complex and compromises platelet adhesion.",-35.5,0.6,geneorgeneproduct
"High‑throughput CRISPR‑Cas9 editing of the CFHR1 locus in HCT116 cells revealed that loss of CFHR1 enhances nuclear factor of kappa B–mediated transcription of IL‑13, thereby increasing MMP‑9 secretion and promoting invasion of the tumor cells.",-31.25,0.6,geneorgeneproduct
"High‐throughput CRISPR screening in A549 cells revealed that activation of PAK2 enhances NF‑κB‑mediated transcription of MOG35‑55‑responsive genes, thereby increasing S100A8/A9 expression and amplifying IL‑13‑induced inflammatory signaling in a CFI‑deficient context.",-48.5,0.6,geneorgeneproduct
"High levels of the transcription factor NF‑κB in A549 cells exposed to pegylated interferon‑α2b upregulated MMP‑9 expression and promoted degradation of the platelet glycoprotein (GP) Ib/IX/V complex, thereby increasing the risk of bleeding in patients with CFHR1 deficiency.",-42.5,0.6,geneorgeneproduct
"High phosphorylation of nuclear factor of kappa B in HeLa cells leads to up‑regulation of MMP‑9 and S100A8, thereby enhancing invasion of the epithelial carcinoma and promoting resistance to pegylated interferon alpha‑2b therapy.",-45.5,0.6,geneorgeneproduct
"The knockdown of PTEN in HeLa cells upregulates MHC class II expression, thereby enhancing the recruitment of OVA‑specific T cells and increasing the secretion of MCP1, which in turn promotes the activation of Rab5‑dependent endocytic pathways.",-25.75,0.6,geneorgeneproduct
"The tumor‑derived A549 cell line overexpressed PTEN, which in turn suppressed ANXA1‑mediated MHC class II presentation and reduced MCP1 secretion, thereby attenuating the inflammatory response in the surrounding E. coli‑infected tissue.",-33.25,0.6,geneorgeneproduct
"The overexpression of PTEN in HeLa cells reduces ANXA1-mediated MHC class II presentation, thereby attenuating MCP1-driven recruitment of Ly‑6/urokinase plasminogen activator receptor‑related protein‑1–positive macrophages.",-21.125,0.6,geneorgeneproduct
"The transcriptional repressor ANXA1 is up‑regulated by PTEN loss in HeLa cells, leading to enhanced MHC class II expression and MCP1 secretion that subsequently recruits OVA‑specific Ly‑6/urokinase plasminogen activator receptor related protein‑1‑positive macrophages to the tumor microenvironment.",-29.125,0.6,geneorgeneproduct
"In the HeLa cell line, overexpression of PTEN was shown to suppress MCP1 secretion by down‑regulating NF‑κB signaling, thereby reducing MHC class II presentation on the cell surface.",-21.0,0.6,geneorgeneproduct
"In A549 cells, the loss of PTEN upregulates MHC class II expression, which in turn enhances MCP1 secretion and promotes the recruitment of ANXA1‑positive macrophages, thereby facilitating tumor‑cell invasion.",-30.0,0.6,geneorgeneproduct
"In MHC class II–positive A549 cells, overexpression of the PTEN tumor suppressor gene down‑regulates the inflammatory chemokine MCP1, thereby attenuating the recruitment of Ly‑6/urokinase plasminogen activator receptor–related protein‑1–positive macrophages and reducing tumor‑associated angiogenesis.",-36.0,0.6,geneorgeneproduct
"In HeLa cells, overexpression of the tumor suppressor PTEN down‑regulates the inflammatory chemokine MCP1, thereby reducing the recruitment of Ly‑6/urokinase plasminogen activator receptor‑related protein‑1‑positive macrophages and attenuating MHC class II‑mediated antigen presentation.",-20.75,0.6,geneorgeneproduct
"PTEN loss in the A549 cell line upregulates MHC class II expression, thereby enhancing antigen presentation and promoting OVA‑specific T‑cell activation.",-21.875,0.6,geneorgeneproduct
"PT‑E2‑stimulated PTEN phosphorylation in HeLa cells up‑regulates ANXA1 expression, which in turn enhances MHC class II presentation of OVA‑specific peptides.",-37.75,0.6,geneorgeneproduct
"PT‐EN loss in A549 cells upregulates MHC class II expression, thereby enhancing antigen presentation to OVA‑specific CD4⁺ T cells.",-33.25,0.6,geneorgeneproduct
"PTPN3 overexpression in HeLa cells enhances MHC class II presentation of OVA-specific peptides, thereby increasing the recruitment of Ly‑6/urokinase plasminogen activator receptor related protein‑1‑positive cytotoxic T cells.",-41.0,0.6,geneorgeneproduct
"Molecular analysis revealed that the loss-of-function PTEN mutation in A549 cells upregulated MHC class II expression, thereby enhancing antigen presentation and increasing Ly‑6/urokinase plasminogen activator receptor related protein‑1 secretion, which in turn promoted MCP1‑mediated recruitment of immune cells.",-34.5,0.6,geneorgeneproduct
"MCP1 secretion by activated macrophages is upregulated through PTEN loss, thereby enhancing chemotaxis of OVA‑specific CD4⁺ T cells toward inflamed lung tissue.",-32.0,0.6,geneorgeneproduct
"MHC class II upregulation in activated A549 cells is mediated by PTEN loss, which enhances ANXA1‑driven MCP1 secretion and subsequently recruits Rab5‑positive endosomes for antigen presentation.",-30.25,0.6,geneorgeneproduct
"MPTP‑treated human dopaminergic neurons exhibited increased ANXA1 expression, which in turn up‑regulated MHC class II presentation and amplified MCP1 secretion, thereby exacerbating neuroinflammatory responses in Parkinson’s disease models.",-40.75,0.6,geneorgeneproduct
"Functional loss of PTEN in A549 cells upregulates MCP1 secretion, which in turn enhances MHC class II expression on neighboring macrophages, thereby amplifying an anti‑tumor immune response.",-25.625,0.6,geneorgeneproduct
"Functional knockdown of the PTEN gene in A549 cells markedly up‑regulates the chemokine MCP1, which in turn enhances MHC class II expression on the cell surface, thereby increasing the susceptibility of these cells to cytotoxic T‑cell‑mediated killing.",-40.25,0.6,geneorgeneproduct
"Functional rescue of the MHC class II–dependent antigen presentation defect in LGP2‑deficient A549 cells was achieved by ectopic expression of the PTEN‑induced regulator ANXA1, which restored Rab5‑mediated endocytic trafficking of the CD74–MHC II complex.",-49.25,0.6,geneorgeneproduct
"Functional depletion of PTEN in HeLa cells enhances MHC class II expression, thereby increasing the surface presentation of OVA‑specific peptides and amplifying CD4+ T‑cell activation through the LGP2‑mediated interferon‑β signaling pathway.",-41.25,0.6,geneorgeneproduct
"Loss of PTEN in the MHC class II–expressing microglia of a murine model carrying the LGP2 c.1521C>T variant drives an up‑regulation of MCP1 that, in turn, recruits OVA‑specific T cells and amplifies neuroinflammation, a process that can be attenuated by Noggin treatment.",-58.5,0.6,geneorgeneproduct
"Losses of PTEN in the A549 cell line lead to upregulation of MHC class II expression, which in turn enhances the secretion of MCP1 that recruits OVA‑specific CD4+ T cells to the tumor microenvironment.",-36.75,0.6,geneorgeneproduct
"Loss-of-function mutations in PTEN and gain‑of‑function variants of ANXA1 were shown to synergistically upregulate MCP1 expression in HeLa cells, thereby enhancing MHC class II presentation to OVA‑specific T cells.",-33.0,0.6,geneorgeneproduct
"Loss‑of‑function PTEN mutations in the A549 cell line lead to up‑regulation of the MHC class II pathway, a change that is amplified by the over‑expression of ANXA1 and results in increased MCP1 secretion.",-35.75,0.6,geneorgeneproduct
"Deletion of the PTEN gene in HeLa cells upregulates MHC class II expression, thereby enhancing antigen presentation to OVA‑specific T cells.",-16.5,0.6,geneorgeneproduct
"Deletion **PTEN c.1024_1025delAG** in **HeLa** cells enhances **MCP1** transcription, thereby amplifying the inflammatory response through increased recruitment of **Ly‑6/urokinase plasminogen activator receptor related protein‑1**‑positive macrophages.",-51.0,0.6,geneorgeneproduct
"Deletion or loss of function of the PTEN gene in HeLa cells upregulates MHC class II expression and enhances MCP1 secretion, thereby promoting an inflammatory microenvironment that ultimately facilitates tumor invasion.",-41.5,0.6,geneorgeneproduct
"Deletion in the PTEN gene (c.1021_1023delGTA) observed in the A549 cell line reduces its protein product’s ability to interact with MHC class II molecules, thereby enhancing the cell’s resistance to the anti‑cancer drug doxorubicin.",-59.0,0.6,geneorgeneproduct
"Suppression of PTEN in HeLa cells upregulates MCP1 secretion, which in turn enhances MHC class II expression on neighboring dendritic cells and promotes an inflammatory microenvironment that favors tumor cell invasion.",-31.0,0.6,geneorgeneproduct
"Suppressed PTEN expression in the HeLa cell line enhances ANXA1‑mediated recruitment of MCP1, thereby amplifying the inflammatory response observed in HPV‑positive cervical carcinoma tissues of Homo sapiens.",-38.5,0.6,geneorgeneproduct
"Supplying the human hepatocyte cell line HepG2 with the PTEN‑overexpressing plasmid markedly reduced MCP1 secretion, while knockdown of the chemokine receptor LGP2 in the same cells amplified MHC class II presentation and increased ANXA1‑mediated anti‑inflammatory signaling.",-57.75,0.6,geneorgeneproduct
"Suppressor PTEN knockdown in HeLa cells increases ANXA1 secretion, which in turn enhances MCP1-mediated recruitment of MHC class II–expressing macrophages and promotes LGP2‑dependent antiviral signaling.",-41.5,0.6,geneorgeneproduct
"RNA‑seq of the A549 cell line revealed that the PTEN‑c.1052C>A (p.Pro351His) variant up‑regulates ANXA1 transcription, thereby enhancing MHC class II presentation of OVA‑specific peptides and increasing MCP1 secretion, which in turn promotes Rab5‑mediated endocytosis of the urokinase plasminogen activator receptor‑related protein‑1.",-47.5,0.6,geneorgeneproduct
"RNA‐seq analysis of the A549 cell line revealed that loss of PTEN upregulated ANXA1, which in turn enhanced MHC class II expression and MCP1 secretion, thereby promoting an anti‑tumor immune response.",-34.0,0.6,geneorgeneproduct
"RNA sequencing of A549 cells treated with the small‑molecule inhibitor doxorubicin revealed that the PTEN‑regulated pathway up‑regulates ANXA1, which in turn enhances MHC class II expression and increases MCP1 secretion, thereby modulating the inflammatory response in the tumor microenvironment.",-42.25,0.6,geneorgeneproduct
"RNA silencing of the PTEN gene in HeLa cells led to increased expression of the chemokine MCP1 and activation of the MHC class II pathway, thereby enhancing antigen presentation and promoting a stronger immune response.",-41.0,0.6,geneorgeneproduct
"Knockout of the PTEN gene in HeLa cells upregulates MHC class II expression and increases MCP1 secretion, thereby enhancing the recruitment of Ly‑6/urokinase plasminogen activator receptor‑related protein‑1‑positive immune cells and promoting anti‑tumor immunity.",-28.0,0.6,geneorgeneproduct
"Knocking down PTEN in the A549 cell line increased expression of the chemokine MCP1, which in turn promoted MHC class II presentation of OVA-specific peptides to activated T cells.",-26.125,0.6,geneorgeneproduct
"Knox’s study demonstrated that the PTEN mutation in A549 cells upregulates MCP1 expression, thereby enhancing MHC class II presentation and accelerating the recruitment of Ly‑6/urokinase plasminogen activator receptor related protein‑1‑positive macrophages to the tumor microenvironment.",-39.0,0.6,geneorgeneproduct
"Knocked‑down of PTEN in A549 cells upregulated MHC class II expression, which in turn enhanced OVA‑specific CD4⁺ T‑cell activation and increased MCP1 secretion, thereby promoting an inflammatory microenvironment that ultimately accelerated tumor cell invasion.",-36.75,0.6,geneorgeneproduct
"FOXO3a transcriptionally activates PTEN, which in turn down‑regulates the PI3K/AKT pathway to promote apoptosis in HeLa cells exposed to doxorubicin.",-26.25,0.6,geneorgeneproduct
"FOXC1 mutations in the TP53‑negative, PTEN‑deficient A549 cell line cause up‑regulation of the MHC class II pathway, thereby enhancing antigen presentation of OVA‑specific peptides and increasing the recruitment of MCP1‑producing macrophages.",-49.5,0.6,geneorgeneproduct
"FOXP3 expression in the CD4⁺ T‑cell line Jurkat is up‑regulated by the cytokine IL‑10 through a PTEN‑dependent PI3K/AKT pathway, thereby enhancing the secretion of the chemokine MCP1 and promoting MHC class II presentation of OVA‑specific peptides.",-41.5,0.6,geneorgeneproduct
"FOXN1, a transcription factor that regulates epidermal differentiation, was shown to be down‑regulated in a PTEN‑null A549 cell line, thereby increasing the secretion of the chemokine MCP1 and enhancing the recruitment of MHC class II‑positive dendritic cells to the tumor microenvironment.",-46.25,0.6,geneorgeneproduct
"Expression of the tumor suppressor PTEN in HeLa cells downregulates the chemokine MCP1, thereby attenuating the activation of MHC class II molecules on neighboring antigen‑presenting cells.",-22.375,0.6,geneorgeneproduct
"Expression profiling in the A549 cell line revealed that the loss of PTEN upregulates the chemokine MCP1, which in turn enhances MHC class II presentation and promotes OVA-specific CD4⁺ T‑cell activation.",-35.5,0.6,geneorgeneproduct
"Expression levels of the tumor suppressor PTEN in A549 cells were found to be markedly upregulated by the small molecule Noggin, thereby attenuating MCP1‑mediated recruitment of Ly‑6/urokinase plasminogen activator receptor related protein‑1‑positive macrophages and reducing MHC class II presentation of OVA‑specific peptides.",-40.75,0.6,geneorgeneproduct
"Expression studies revealed that the PTEN loss‑of‑function variant c.896C>T (p.R299X) in the A549 cell line markedly up‑regulates the chemokine MCP1, thereby enhancing MHC class II antigen presentation on the surface of these human lung carcinoma cells.",-51.5,0.6,geneorgeneproduct
"Altered PTEN expression in the HeLa cell line was shown to upregulate MHC class II molecules, thereby enhancing the presentation of OVA-specific peptides and increasing the recruitment of MCP1‑producing macrophages.",-25.375,0.6,geneorgeneproduct
"Alterations in the PTEN gene product enhance MHC class II expression in HeLa cells, thereby amplifying MCP1-mediated recruitment of Ly‑6/urokinase plasminogen activator receptor related protein‑1‑positive monocytes to the tumor microenvironment.",-27.875,0.6,geneorgeneproduct
"Alteration of PTEN expression in HeLa cells leads to upregulation of MHC class II molecules, thereby enhancing antigen presentation to OVA‑specific T cells.",-19.5,0.6,geneorgeneproduct
"Altering PTEN expression in A549 cells reduces MHC class II surface display, thereby dampening OVA‑specific CD4⁺ T‑cell activation.",-27.875,0.6,geneorgeneproduct
"Activation of the MHC class II pathway by the transcription factor NF‑κB in HeLa cells upregulates the chemokine MCP1, thereby enhancing the recruitment of PTEN‑deficient macrophages and promoting the secretion of ANXA1, which subsequently modulates the antiviral response of LGP2 in Homo sapiens.",-42.5,0.6,geneorgeneproduct
"Activation‑induced phosphorylation of the tumor suppressor PTEN in HeLa cells was shown to suppress the expression of the chemokine MCP1, thereby attenuating the recruitment of MHC class II–positive antigen‑presenting cells and reducing the secretion of the anti‑inflammatory protein ANXA1.",-47.25,0.6,geneorgeneproduct
"Activation by the transcription factor PTEN of the MHC class II promoter in HeLa cells leads to up‑regulation of ANXA1 expression, which in turn enhances MCP1 secretion and promotes Ly‑6/urokinase plasminogen activator receptor related protein‑1‑mediated phagocytosis of apoptotic debris.",-40.0,0.6,geneorgeneproduct
"Activation through the PTEN‑regulated PI3K/AKT pathway in A549 cells leads to up‑regulation of MHC class II surface expression, thereby enhancing the antigen‑presenting capacity of the tumor microenvironment.",-38.5,0.6,geneorgeneproduct
"The overexpression of the kinase **tropomyosin‑related kinase** in **HeLa** cells enhances **Phosphatidylinositol‑3‑kinase** signaling, thereby upregulating **IL‑17** production and promoting proliferation of the **CCDC104**‑positive tumor phenotype.",-35.75,0.6,geneorgeneproduct
"The gain‑of‑function mutation c.1234_1235delAG in the NEK2 gene, identified in a patient with severe hemoglobinopathy and elevated IL‑17, was shown to increase phosphorylation of the peroxisome proliferator‑activated receptor‑α and thereby enhance expression of plasminogen activator inhibitor‑1 in HepG2 cells.",-56.25,0.6,geneorgeneproduct
"The Phosphatidylinositol‑3‑kinase‑mediated activation of the tropomyosin‑related kinase in HeLa cells upregulates NEK2 expression, thereby enhancing cell cycle progression and conferring resistance to doxorubicin.",-29.25,0.6,geneorgeneproduct
"The activation of peroxisome proliferator‑activated receptor alpha by the small molecule GW501516 in the A549 cell line induces IL‑17 production, which in turn upregulates plasminogen activator inhibitor‑1 expression and enhances the phosphorylation of phosphatidylinositol‑3‑kinase, ultimately promoting cell migration.",-37.25,0.6,geneorgeneproduct
"Activation of the peroxisome proliferator‑activated receptor α by the synthetic ligand fenofibrate in A549 cells upregulates the expression of phosphatidylinositol‑3‑kinase and subsequently enhances the phosphorylation of NEK2, thereby promoting cell cycle progression and reducing apoptosis in the presence of the CCDC104 variant.",-35.75,0.6,geneorgeneproduct
"Activation‑dependent phosphorylation of the tropomyosin‑related kinase by Phosphatidylinositol‑3‑kinase promotes IL‑17‑mediated neutrophil recruitment in A549 cells, a process that is attenuated by the peroxisome proliferator‑activated receptor‑α agonist rosiglitazone.",-37.75,0.6,geneorgeneproduct
"Activation by IL‑17 of the phosphatidylinositol‑3‑kinase pathway in HeLa cells upregulates peroxisome proliferator‑activated receptor‑α, thereby increasing transcription of the plasminogen activator inhibitor‑1 gene and enhancing NEK2‑mediated mitotic progression.",-38.5,0.6,geneorgeneproduct
"Activation signal from the peroxisome proliferator‑activated receptor alpha in A549 cells induces the expression of NEK2, which phosphorylates the phosphatidylinositol‑3‑kinase‑dependent transcription factor BCL11A to enhance the transcription of the hemoglobin β‑globin gene.",-56.25,0.6,geneorgeneproduct
"Mutations in the CCDC104 gene were found to upregulate phosphatidylinositol‑3‑kinase signaling, thereby enhancing NEK2‑mediated cell‑cycle progression in A549 cells, and this effect was further potentiated by the peroxisome proliferator‑activated receptor‑α agonist WY‑14643.",-34.5,0.6,geneorgeneproduct
"Mutational activation of the phosphatidylinositol‑3‑kinase pathway in A549 cells leads to overexpression of NEK2 and subsequent phosphorylation of BCL11A, thereby promoting resistance to doxorubicin in patients with the BRCA1 c.68_69delAG variant.",-34.75,0.6,geneorgeneproduct
"Mutated CCDC104 in a HeLa cell line decreases the activity of phosphatidylinositol‑3‑kinase, thereby impairing downstream peroxisome proliferator‑activated receptor‑α signaling and reducing IL‑17 production.",-36.5,0.6,geneorgeneproduct
"Mutagenic exposure to benzo[a]pyrene upregulates the expression of the oncogenic kinase BCL11A in A549 cells, thereby enhancing PI3K/AKT signaling and conferring resistance to apoptosis in HepG2 hepatoma cells.",-36.5,0.6,geneorgeneproduct
"In HepG2 cells, overexpression of the BCL11A transcription factor downregulates the expression of the plasminogen activator inhibitor-1 gene (SERPINE1) and enhances the phosphorylation of phosphatidylinositol‑3‑kinase, thereby promoting cell migration and invasion.",-29.75,0.6,geneorgeneproduct
"In A549 cells, overexpression of the phosphatidylinositol‑3‑kinase pathway leads to increased NEK2 phosphorylation, which in turn activates peroxisome‑proliferator‑activated‑receptor‑α and enhances the transcription of BCL11A, ultimately up‑regulating hemoglobin synthesis and amplifying IL‑17‑mediated inflammatory signaling.",-39.25,0.6,geneorgeneproduct
"In HCT116 cells, overexpression of the phosphatidylinositol‑3‑kinase‑induced protein NEK2 leads to increased phosphorylation of peroxisome‑proliferator‑activated‑receptor‑α, thereby enhancing the transcription of the plasminogen activator inhibitor‑1 gene and ultimately promoting tumor cell invasion.",-36.75,0.6,geneorgeneproduct
"In HEK293 cells, overexpression of the phosphatidylinositol‑3‑kinase‑regulated gene CCDC104 enhances plasminogen activator inhibitor‑1 secretion, thereby attenuating extracellular matrix remodeling and promoting tumor invasion through activation of the tropomyosin‑related kinase signaling cascade.",-40.75,0.6,geneorgeneproduct
"Phosphatidylinositol‑3‑kinase activation in HeLa cells was shown to up‑regulate NEK2 expression, thereby enhancing BCL11A‑mediated transcription of the plasminogen activator inhibitor and ultimately promoting a growth‑arrest phenotype that mirrors the DNA‑damage‑inducible response observed in Homo sapiens tumor samples.",-43.75,0.6,geneorgeneproduct
"Pharmacological inhibition of peroxisome proliferator‑activated receptor‑α in the A549 cell line reduces phosphatidylinositol‑3‑kinase‑mediated IL‑17 secretion, thereby attenuating the growth‑promoting effect of the NEK2 variant c.1156G>A observed in the TP53‑mutated HeLa cells.",-49.25,0.6,geneorgeneproduct
"Phos­phatidyl‑inositol‑3‑kinase activation in A549 cells up‑regulates the expression of the plasminogen activator inhibitor gene, which in turn enhances the secretion of IL‑17 and promotes the proliferation of the tropomyosin‑related kinase‑positive tumor cells.",-45.25,0.6,geneorgeneproduct
"Phytophthora infestans infection of A549 cells leads to up‑regulation of the growth‑arrest‑and‑DNA‑damage‑inducible‑45‑alpha protein, which in turn binds to the promoter of the plasminogen activator inhibitor‑1 gene, enhancing its transcription and thereby accelerating extracellular matrix degradation and tumor invasion.",-54.25,0.6,geneorgeneproduct
"A study of HCT116 cells revealed that overexpression of the kinase‑associated gene CCDC104 enhances phosphorylation of phosphatidylinositol‑3‑kinase, thereby amplifying IL‑17‑mediated NF‑κB signaling and accelerating proliferation of this colorectal cancer cell line.",-46.75,0.6,geneorgeneproduct
"A neutralizing antibody against the tropomyosin‑related kinase receptor on A549 cells reduced IL‑17 production in a co‑culture with TH17 cells, thereby attenuating the inflammatory response mediated by the Phosphatidylinositol‑3‑kinase pathway in vitro.",-44.25,0.6,geneorgeneproduct
"A CRISPR‑mediated knockout of CCDC104 in A549 cells down‑regulates phosphatidylinositol‑3‑kinase signaling, thereby reducing NEK2‑dependent proliferation and increasing apoptosis through up‑regulation of BCL11A‑mediated transcription of the growth‑arrest‑and‑DNA‑damage‑inducible‑45‑alpha gene.",-38.25,0.6,geneorgeneproduct
"A genetic screen of the A549 cell line revealed that a BRCA1 c.68_69delAG variant in TP53, together with up‑regulated NEK2, synergistically enhanced the interaction between phosphatidylinositol‑3‑kinase and peroxisome proliferator‑activated receptor‑α, thereby accelerating cell proliferation and invasion.",-50.5,0.6,geneorgeneproduct
"Knockout of the CCDC104 gene in A549 cells leads to up‑regulation of phosphatidylinositol‑3‑kinase signaling and increased expression of the plasminogen activator inhibitor, thereby enhancing cell migration and conferring resistance to doxorubicin treatment.",-31.5,0.6,geneorgeneproduct
"Knocking‑down the NEK2 gene in HeLa cells reduces phosphatidylinositol‑3‑kinase activation and consequently decreases IL‑17 secretion, thereby impairing the cells’ ability to respond to inflammatory stimuli.",-37.5,0.6,geneorgeneproduct
"Knitting the signaling axis of phosphatidylinositol‑3‑kinase with the peroxisome proliferator‑activated receptor‑α, the tropomyosin‑related kinase, and the plasminogen activator inhibitor, researchers discovered that the NEK2‑induced phosphorylation of BCL11A in A549 cells reduces the expression of the growth‑arrest‑and‑DNA‑damage‑inducible‑45‑alpha gene, thereby promoting a proliferative phenotype.",-72.0,0.6,geneorgeneproduct
"Knox et al. demonstrated that the tropomyosin‑related kinase BCL11A interacts with phosphatidylinositol‑3‑kinase to phosphorylate the growth arrest and DNA‑damage‑inducible protein GADD45α, thereby enhancing plasminogen activator inhibitor‑1 expression in human A549 cells.",-48.25,0.6,geneorgeneproduct
"Mutation of the CCDC104 gene in A549 cells reduces peroxisome proliferator‑activated receptor‑α activity, thereby increasing IL‑17‑mediated inflammation and accelerating the growth of tumor‑derived xenografts in a humanized xenograft model of non‑small‑cell lung cancer.",-40.25,0.6,geneorgeneproduct
"Mutation in the CCDC104 gene of the Homo sapiens cell line HeLa leads to overexpression of the tropomyosin‑related kinase, which in turn activates phosphatidylinositol‑3‑kinase and subsequently up‑regulates the peroxisome proliferator‑activated receptor‑α, thereby increasing plasminogen activator inhibitor‑1 production and promoting an IL‑17‑driven inflammatory phenotype.",-53.75,0.6,geneorgeneproduct
"Mutation‑induced up‑regulation of NEK2 in the HeLa cell line, driven by aberrant PI3K‑AKT signaling, enhances phosphorylation of the peroxisome‑proliferator‑activated receptor alpha and increases IL‑17 secretion, thereby accelerating cell‑cycle arrest and apoptosis in response to the BCL11A‑mediated DNA‑damage‑inducible pathway.",-57.0,0.6,geneorgeneproduct
"Mutation c.68_69delAG in the BRCA1 gene, which is a SequenceVariant, was found to reduce the expression of the tumor suppressor TP53, a GeneOrGeneProduct, in the HeLa CellLine, thereby increasing the susceptibility of these cells to doxorubicin, a ChemicalEntity, induced apoptosis.",-41.75,0.6,geneorgeneproduct
"Altered expression of the peroxisome proliferator‑activated receptor‑α gene in A549 cells treated with the PI3K inhibitor LY294002 leads to reduced IL‑17 secretion and increased plasminogen activator inhibitor‑1 production, thereby attenuating the growth‑promoting effects of the tropomyosin‑related kinase pathway.",-34.25,0.6,geneorgeneproduct
"Alterations in the phosphatidylinositol‑3‑kinase pathway were observed in HeLa cells expressing the CCDC104 variant, where increased NEK2 activity promoted phosphorylation of the tropomyosin‑related kinase, thereby enhancing IL‑17‑mediated inflammatory signaling and reducing hemoglobin synthesis in the presence of plasminogen activator inhibitor‑1 overexpression.",-45.0,0.6,geneorgeneproduct
"Alteration of the phosphorylation status of the tropomyosin‑related kinase by Phosphatidylinositol‑3‑kinase in A549 cells induces NEK2 expression, thereby enhancing proliferation of the tumor cells.",-36.25,0.6,geneorgeneproduct
"Alterative activation of the peroxisome proliferator‑activated receptor alpha by the small molecule GW501516 in A549 cells down‑regulates the plasminogen activator inhibitor‑1 gene, thereby enhancing extracellular matrix remodeling and promoting invasion.",-41.5,0.6,geneorgeneproduct
"Overexpression of the phosphatidylinositol‑3‑kinase‑activated kinase NEK2 in HeLa cells carrying the BCL11A c.1234C>T variant drives phosphorylation of growth arrest‑and‑DNA‑damage‑inducible protein GADD45α, thereby enhancing the transcription of the plasminogen activator inhibitor‑1 gene in Homo sapiens.",-55.0,0.6,geneorgeneproduct
"Overexpressed NEK2 in A549 cells activates PI3K/AKT signaling and upregulates BCL11A, thereby enhancing proliferation and chemoresistance to doxorubicin.",-24.75,0.6,geneorgeneproduct
"Overactivation of the PI3K/AKT pathway by the tropomyosin‑related kinase mutation c.1234G>A in the CCDC104 gene increases BCL11A expression, thereby enhancing plasminogen activator inhibitor‑1 production and contributing to the development of thrombosis in patients with the PPAR‑α deficiency phenotype.",-51.5,0.6,geneorgeneproduct
"Over-expression of the phosphatidylinositol‑3‑kinase pathway in A549 cells carrying a CCDC104 sequence variant up‑regulates NEK2 and BCL11A, thereby enhancing growth arrest and DNA‑damage‑inducible protein‑45α‑mediated apoptosis.",-46.0,0.6,geneorgeneproduct
"Tropomyosin‑related kinase activation in HeLa cells upregulates phosphatidylinositol‑3‑kinase signaling, thereby enhancing BCL11A‑mediated transcription of hemoglobin genes and ultimately increasing IL‑17‑driven inflammatory cytokine production.",-28.5,0.6,geneorgeneproduct
"Tropicomyosin‑related kinase activation in HeLa cells upregulates the expression of the phosphatidylinositol‑3‑kinase gene PIK3CA, thereby enhancing downstream IL‑17‑mediated signaling and increasing the production of plasminogen activator inhibitor‑1 in a manner that correlates with elevated NEK2 levels and reduced growth arrest‑and‑DNA‑damage‑inducible‑45‑alpha (GADD45A) expression.",-58.25,0.6,geneorgeneproduct
"TROAP‑mediated phosphorylation of the tropomyosin‑related kinase by phosphatidylinositol‑3‑kinase enhances IL‑17 transcription in A549 cells, while a loss‑of‑function CCDC104 variant in Homo sapiens disrupts this signaling cascade.",-51.5,0.6,geneorgeneproduct
"Tyrphostin AG-1296 treatment of A549 cells down‑regulates the phosphatidylinositol‑3‑kinase pathway and reduces NEK2 expression, thereby sensitizing the cells to apoptosis mediated by the BCL11A‑dependent caspase cascade.",-44.0,0.6,geneorgeneproduct
"Cyclin‑dependent kinase‑associated protein phosphatase activity in HeLa cells is up‑regulated by the IL‑17–induced activation of phosphatidylinositol‑3‑kinase and the downstream BCL11A transcriptional network, thereby enhancing the proliferation of the A549 cell line through increased expression of the growth‑arrest‑and‑DNA‑damage‑inducible‑45‑alpha protein.",-63.75,0.6,geneorgeneproduct
"Cyclooxygenase‑2 inhibition in A549 cells expressing the CCDC104 variant reduces IL‑17‑mediated activation of the phosphatidylinositol‑3‑kinase/AKT pathway, thereby decreasing NEK2‑driven proliferation and enhancing BCL11A‑mediated apoptosis.",-38.75,0.6,geneorgeneproduct
"Cyclization of the tropomyosin‑related kinase domain in the CCDC104 gene of a human (Homo sapiens) hepatocellular carcinoma cell line (HepG2) was shown to up‑regulate phosphatidylinositol‑3‑kinase activity, thereby enhancing the expression of the plasminogen activator inhibitor‑1 protein and conferring resistance to apoptosis mediated by growth arrest and DNA‑damage‑inducible protein alpha.",-62.5,0.6,geneorgeneproduct
"Cyclophosphamide treatment of A549 cells led to up‑regulation of the PI3K‑AKT pathway and induced a missense variant in the CCDC104 gene, which in turn enhanced the expression of plasminogen activator inhibitor‑1 and activated NEK2‑mediated phosphorylation of BCL11A, ultimately promoting resistance to apoptosis in the tumor cells.",-55.5,0.6,geneorgeneproduct
"Gene‑expression profiling revealed that activation of the phosphatidylinositol‑3‑kinase pathway by the tropomyosin‑related kinase in A549 cells down‑regulates plasminogen activator inhibitor‑1 while up‑regulating BCL11A, thereby promoting a proliferative phenotype that is partially mitigated by peroxisome proliferator‑activated receptor‑α agonists.",-45.75,0.6,geneorgeneproduct
"Gene knockout of CCDC104 in A549 cells reduced the expression of peroxisome proliferator‑activated receptor alpha and increased the secretion of plasminogen activator inhibitor‑1, thereby enhancing the cells’ resistance to doxorubicin‑induced apoptosis.",-31.375,0.6,geneorgeneproduct
"Gene expression of NEK2 in A549 cells was up‑regulated by IL‑17 stimulation, leading to phosphorylation of phosphatidylinositol‑3‑kinase and activation of the peroxisome proliferator‑activated receptor‑α pathway, thereby enhancing cell cycle progression and promoting tumorigenesis.",-41.25,0.6,geneorgeneproduct
"Gene‐expression profiling of HeLa cells treated with the PI3K inhibitor LY294002 revealed that down‑regulation of BCL11A enhances the secretion of plasminogen activator inhibitor‑1, thereby attenuating IL‑17‑mediated inflammation in the human tumor microenvironment.",-41.75,0.6,geneorgeneproduct
Silencing of the NEK2 gene in A549 cells diminishes phosphatidylinositol‑3‑kinase‑mediated survival signaling and induces apoptosis through up‑regulation of BCL11A‑dependent apoptotic pathways.,-36.75,0.6,geneorgeneproduct
"Silenced expression of the CCDC104 gene product in A549 cells, induced by a BRCA1 c.68_69delAG variant, leads to reduced phosphorylation of phosphatidylinositol‑3‑kinase and downstream AKT signaling, thereby enhancing apoptosis through up‑regulation of BCL11A and the growth‑arrest‑and‑DNA‑damage‑inducible‑45‑alpha protein.",-48.25,0.6,geneorgeneproduct
"Silica nanoparticles inhibited the PI3K‑AKT pathway in A549 cells, leading to up‑regulation of BCL11A and down‑regulation of NEK2, thereby sensitizing the cells to doxorubicin-induced apoptosis.",-31.5,0.6,geneorgeneproduct
"Silico‑inhibition of the phosphatidylinositol‑3‑kinase pathway in the A549 cell line reduced BCL11A expression, thereby increasing the transcription of the hemoglobin alpha‑globin gene and enhancing IL‑17‑mediated inflammatory responses in a murine E. coli infection model.",-53.25,0.6,geneorgeneproduct
"In the A549 cell line, overexpression of BMP4 up‑regulates LC3B‑I and LC3B‑II, thereby enhancing autophagic flux and reducing the cytotoxicity induced by the PAK2 inhibitor, while a BRCA1 c.68_69delAG sequence variant in the same cells increases sensitivity to doxorubicin.",-38.0,0.6,geneorgeneproduct
"In HeLa cells, the BMP4‑induced up‑regulation of LC3B‑I and LC3B‑II enhances autophagic clearance of the HIV‑gp120 protein, thereby attenuating viral cytotoxicity.",-20.25,0.6,geneorgeneproduct
"In HEB‑deficient HeLa cells, BMP4 overexpression upregulates the proprotein convertase subtilisin/kexin type‑9 gene, thereby increasing LDL‑R degradation and enhancing intracellular cholesterol accumulation.",-31.875,0.6,geneorgeneproduct
"In colorectal carcinoma cells, the BMP4‑induced upregulation of LC3B‑II is attenuated by the Proprotein convertase subtilisin/kexin type‑9 variant p17R76G, thereby reducing autophagic flux and enhancing cell survival.",-32.0,0.6,geneorgeneproduct
"The BMP4 promoter mutation c.1204C>A in the HEB‑deficient A549 cell line upregulates LC3B‑I and LC3B‑II, thereby enhancing autophagic clearance of the gp120‑induced Proprotein convertase subtilisin/kexin type‑9 expression that otherwise promotes cholesterol accumulation in human hepatocytes.",-51.0,0.6,geneorgeneproduct
"The p17R76G mutation in the HEB gene product markedly reduces LC3B‑I phosphorylation and consequently impairs autophagic flux in HeLa cells, thereby enhancing susceptibility to gp120‑induced apoptosis.",-28.0,0.6,geneorgeneproduct
"The tumor‑derived gp120 protein activates LC3B‑II conversion in HEB‑expressing HeLa cells, thereby enhancing autophagic clearance of proprotein convertase subtilisin/kexin type‑9 and reducing CPT1‑mediated fatty‑acid oxidation.",-32.5,0.6,geneorgeneproduct
"The loss‑of‑function mutation p17R76G in the transmembrane channel‑like gene‑1 gene of a Homo sapiens patient led to dysregulated LC3B‑I/II autophagy and a marked decrease in CPT1 activity, thereby exacerbating the clinical phenotype of gamma‑sarcoglycan‑associated muscular dystrophy.",-43.25,0.6,geneorgeneproduct
"BMP4 up‑regulation in A549 cells activates LC3B‑II and induces autophagy, which in turn enhances the expression of the proprotein convertase subtilisin/kexin type‑9 gene in the context of cholesterol metabolism.",-40.25,0.6,geneorgeneproduct
"BMP‑4 upregulation in HeLa cells activates the PAK2‑LC3B‑I/II autophagic pathway, thereby enhancing clearance of the gp120‑induced Proprotein convertase subtilisin/kexin type‑9 (PCSK9) protein and reducing cholesterol accumulation.",-44.5,0.6,geneorgeneproduct
"BMP7 up‑regulation in A549 cells was shown to increase LC3B‑II accumulation, thereby enhancing autophagic clearance of the gp120‑induced reactive oxygen species that otherwise trigger apoptosis through the pro‑protein convertase subtilisin/kexin type‑9 pathway.",-47.25,0.6,geneorgeneproduct
"BMP1 upregulation in HEB‑overexpressing HeLa cells enhances LC3B‑II formation, thereby accelerating proprotein convertase subtilisin/kexin type‑9 degradation and reducing plasma LDL‑binding affinity.",-43.25,0.6,geneorgeneproduct
"Mutations in the PAK2 gene that alter its phosphorylation at the p17R76G site have been shown to disrupt LC3B‑I and LC3B‑II processing, thereby impairing autophagic flux in HeLa cells and contributing to the cellular phenotype observed in patients with gamma‑sarcoglycan‑related muscular dystrophy.",-36.5,0.6,geneorgeneproduct
"Mutational analysis of the p17R76G variant in the Proprotein convertase subtilisin/kexin type‑9 gene revealed that this alteration enhances LDL‑R degradation in HepG2 cells, thereby increasing plasma LDL‑cholesterol levels in patients with familial hypercholesterolemia.",-32.75,0.6,geneorgeneproduct
"Mutants of the transmembrane channel‑like gene‑1 carrying the p17R76G variant displayed enhanced LC3B‑I to LC3B‑II conversion and up‑regulated CPT1 expression, thereby promoting autophagic flux and attenuating gp120‑induced neurotoxicity in cultured HeLa cells.",-48.0,0.6,geneorgeneproduct
"Mutant p17R76G of the HIV-1 gp120 gene enhances the interaction with the host HEB transcription factor, thereby up‑regulating LC3B‑I and -II expression in A549 cells.",-34.75,0.6,geneorgeneproduct
"Overexpression of BMP4 in A549 cells increases LC3B‑II levels, indicating enhanced autophagy that may attenuate the pro‑inflammatory activity of gp120 in HIV‑infected macrophages.",-29.25,0.6,geneorgeneproduct
"Over the course of the study, the BMP4 promoter variant c.−512C>T was found to up‑regulate HEB expression in HeLa cells, thereby enhancing LC3B‑II accumulation and autophagic flux, a mechanism that may be relevant to the pathogenesis of prostate cancer driven by PAK2-mediated signaling.",-58.5,0.6,geneorgeneproduct
"Overexpressed BMP4 in A549 cells activates PAK2 signaling, which in turn phosphorylates LC3B‑I and LC3B‑II, thereby enhancing autophagic flux and contributing to the chemoresistance phenotype observed in this lung cancer model.",-34.5,0.6,geneorgeneproduct
"Overactivation of the HEB transcription factor in A549 cells induces up‑regulation of BMP4 and LC3B‑II, thereby enhancing autophagic flux and reducing proliferation of the human lung carcinoma line.",-36.25,0.6,geneorgeneproduct
"Altered expression of the proprotein convertase subtilisin/kexin type‑9 gene in HEB‑deficient HeLa cells leads to increased LDL receptor degradation, thereby reducing cellular cholesterol uptake and enhancing LC3B‑II accumulation during autophagy.",-32.0,0.6,geneorgeneproduct
"Alterations in the BMP4 gene product reduce LC3B‑I conversion to LC3B‑II, thereby impairing autophagic clearance of the gp120‑induced cytotoxicity observed in HeLa cells.",-26.875,0.6,geneorgeneproduct
"Alteration of the BMP4 gene product in A549 cells was shown to upregulate LC3B‑II and downregulate CPT1, thereby impairing autophagic flux and promoting apoptosis in response to doxorubicin treatment.",-29.375,0.6,geneorgeneproduct
"Alterantive splicing of the **Proprotein convertase subtilisin/kexin type‑9** transcript in **Homo sapiens** leads to a truncated protein that impairs LDL‑receptor recycling, thereby increasing plasma LDL‑cholesterol and elevating cardiovascular risk.",-48.0,0.6,geneorgeneproduct
"Mutation of the transmembrane channel‑like gene‑1 in a patient with a p17R76G sequence variant was found to impair LC3B‑II processing, thereby reducing autophagic flux and contributing to the observed hyperthermia in Homo sapiens.",-44.0,0.6,geneorgeneproduct
"Mutation in the PAK2 gene (p17R76G) was shown to up‑regulate LC3B‑II expression in A549 cells, thereby enhancing autophagic clearance of gp120‑induced cytotoxicity in a human T‑cell model of HIV infection.",-36.25,0.6,geneorgeneproduct
Mutation p17R76G in the proprotein convertase subtilisin/kexin type‑9 gene disrupts LDL‑binding affinity and is associated with hypercholesterolemia in a cohort of Homo sapiens subjects.,-31.5,0.6,geneorgeneproduct
"Mutation analysis of the PAK2 gene in a cohort of Homo sapiens patients revealed that the p17R76G sequence variant, which alters the protein’s catalytic domain, is associated with a reduced expression of LC3B-I and -II and may contribute to the pathogenesis of Parkinson’s disease.",-47.75,0.6,geneorgeneproduct
"By examining the effect of the p17R76G sequence variant on BMP4 expression in HEB‑transfected HeLa cells, we observed that the variant significantly reduced BMP4 transcription, thereby attenuating downstream LC3B‑I and -II autophagy activation.",-49.25,0.6,geneorgeneproduct
"By knocking down BMP4 in A549 cells, we observed that the reduction of LC3B‑II levels was accompanied by increased expression of the proprotein convertase subtilisin/kexin type‑9 gene, suggesting a link between BMP4 signaling and lipid‑metabolism regulation in this lung cancer cell line.",-38.0,0.6,geneorgeneproduct
"By overexpressing BMP4 in A549 cells, the proprotein convertase subtilisin/kexin type‑9 inhibitor induced LC3B‑II accumulation, revealing a novel autophagic pathway that may attenuate HEB‑mediated resistance to gp120‑induced apoptosis.",-41.75,0.6,geneorgeneproduct
"By activating the proprotein convertase subtilisin/kexin type‑9 promoter, BMP4 overexpression in HEB‑transfected A549 cells markedly upregulated LC3B‑I and LC3B‑II conversion, thereby enhancing autophagic flux and reducing gp120‑induced apoptosis.",-41.25,0.6,geneorgeneproduct
"Proprotein convertase subtilisin/kexin type‑9 expression in HepG2 cells was markedly up‑regulated by BMP4 stimulation, whereas the HEB transcription factor bound to the promoter of the LC3B‑I and LC3B‑II genes to repress autophagy‑related transcription.",-42.0,0.6,geneorgeneproduct
"Proinflammatory signaling through the gp120‑induced activation of HEB and PAK2 in HeLa cells enhances LC3B‑I to LC3B‑II conversion, thereby promoting autophagic degradation of the proprotein convertase subtilisin/kexin type‑9 receptor and attenuating BMP4‑mediated osteogenic differentiation.",-45.25,0.6,geneorgeneproduct
"Prostate cancer cell line LNCaP treated with the small‑molecule inhibitor of proprotein convertase subtilisin/kexin type‑9, which suppresses the secretion of LDL‑R, displayed a marked reduction in LC3B‑II accumulation, indicating that the drug blocks autophagic flux downstream of BMP4‑induced PAK2 activation in this human epithelial tumor model.",-65.5,0.6,geneorgeneproduct
"Protinogen expression of BMP4 is up‑regulated in the HEB‑deficient A549 cell line, a change that enhances LC3B‑II formation and promotes autophagic clearance of the HIV‑gp120‑induced oxidative stress.",-49.0,0.6,geneorgeneproduct
"Polymorphic variants of the **Proprotein convertase subtilisin/kexin type‑9** gene, such as **c.−8G>A**, are predicted to increase LDL‑binding affinity and are associated with elevated plasma cholesterol levels in **Homo sapiens** patients who also exhibit up‑regulation of **LC3B‑II** during atherosclerotic plaque progression.",-65.5,0.6,geneorgeneproduct
"Polytropic lentiviral vector‑mediated overexpression of BMP4 in A549 cells upregulates LC3B‑II and enhances autophagic flux, thereby attenuating gp120‑induced apoptosis through activation of the PAK2‑CPT1 signaling axis.",-38.75,0.6,geneorgeneproduct
"Polycystic ovary syndrome in women harboring the p17R76G SequenceVariant of the Proprotein convertase subtilisin/kexin type‑9 GeneOrGeneProduct was associated with elevated LDL‑cholesterol, and in vitro, the mutant protein showed enhanced binding to the transmembrane channel‑like gene‑1 receptor in HEB‑expressing HeLa CellLine cells.",-65.5,0.6,geneorgeneproduct
"Polysaccharide‐induced upregulation of the BMP4 gene in HeLa cells triggers LC3B‑II accumulation and autophagosome formation, thereby enhancing the antiviral activity of the gp120 protein against HIV‑1 infection.",-44.0,0.6,geneorgeneproduct
"Transient overexpression of BMP4 in A549 cells increases LC3B‑II accumulation, indicating enhanced autophagic flux that subsequently down‑regulates the pro‑protein convertase subtilisin/kexin type‑9 promoter activity.",-32.75,0.6,geneorgeneproduct
Transient induction of LC3B‑II in HEB‑deficient HeLa cells by the proprotein convertase subtilisin/kexin type‑9 inhibitor attenuates gp120‑mediated apoptosis through modulation of CPT1 activity.,-37.0,0.6,geneorgeneproduct
"Transient knockdown of the transmembrane channel-like gene&nbsp;1 in the human bronchial epithelial cell line A549 caused a marked increase in LC3B‑I to LC3B‑II conversion and heightened expression of the proprotein convertase subtilisin/kexin type&nbsp;9 gene, thereby enhancing cholesterol efflux and reducing gp120‑induced cytotoxicity.",-57.75,0.6,geneorgeneproduct
"Transient activation of BMP4 in A549 cells leads to up‑regulation of the proprotein convertase subtilisin/kexin type‑9 promoter through HEB binding, thereby increasing LDL‑R degradation and contributing to cholesterol‑dependent signaling.",-44.75,0.6,geneorgeneproduct
"Loss of the BMP4 gene product in the HEB‑expressing A549 cell line reduces LC3B‑II conversion, thereby attenuating autophagic clearance of the proprotein convertase subtilisin/kexin type‑9 substrate gp120 and increasing cellular susceptibility to the CPT1 inhibitor p17R76G.",-45.75,0.6,geneorgeneproduct
"Loss-of-function mutations in the transmembrane channel-like gene&nbsp;1 gene, such as the p17R76G variant, disrupt LC3B‑I and LC3B‑II processing and impair autophagic flux in A549 cells, thereby exacerbating the cytotoxicity of the proprotein convertase subtilisin/kexin type&nbsp;9 inhibitor in Homo sapiens-derived tumor models.",-53.5,0.6,geneorgeneproduct
"Loss‑of‑function of the BMP4 gene in A549 cells leads to up‑regulation of LC3B‑II and down‑regulation of CPT1, thereby impairing fatty‑acid oxidation and promoting apoptosis.",-25.75,0.6,geneorgeneproduct
"Lossy deletion of the BRCA1 c.68_69delAG variant in HEB-expressing HeLa cells reduces LC3B‑I to LC3B‑II conversion, impairing autophagic flux and increasing sensitivity to the pro‑protein convertase subtilisin/kexin type‑9 inhibitor lovastatin in Homo sapiens.",-45.75,0.6,geneorgeneproduct
"Silencing of the BMP4 gene in HeLa cells leads to a marked decrease in LC3B‑II expression, suggesting that BMP4 regulates autophagic flux through the PI3K‑AKT‑mTOR pathway.",-26.25,0.6,geneorgeneproduct
"Silico‑analysis revealed that the PAK2 gene variant p17R76G in Homo sapiens reduces LC3B‑I and LC3B‑II autophagic flux, thereby enhancing susceptibility to the gp120‑induced neurotoxicity observed in neuronal cultures derived from the SH‑SY5Y cell line.",-46.5,0.6,geneorgeneproduct
"Silenced BMP4 expression in the A549 cell line leads to a marked decrease in LC3B‑II accumulation, indicating that BMP4 regulates autophagic flux through modulation of the PAK2‑dependent phosphorylation of LC3B‑I.",-35.25,0.6,geneorgeneproduct
"Silvestrol treatment of A549 cells downregulated LC3B‑I and LC3B‑II while upregulating PAK2, suggesting that autophagy modulation via the HEB‑dependent transcriptional network may potentiate the anti‑tumor activity of the pro‑protein convertase subtilisin/kexin type‑9 inhibitor.",-52.5,0.6,geneorgeneproduct
"A mutant form of the proprotein convertase subtilisin/kexin type‑9 (PCSK9) harboring the p.R46L variant was shown to increase LDL‑R degradation in HepG2 cells, thereby elevating plasma LDL‑cholesterol and contributing to familial hypercholesterolemia in Homo sapiens.",-41.75,0.6,geneorgeneproduct
"A lentiviral vector expressing BMP4 in HEB‑deficient A549 cells upregulates LC3B‑I and LC3B‑II, thereby enhancing autophagic flux and reducing proprotein convertase subtilisin/kexin type‑9 secretion in a dose‑dependent manner.",-36.75,0.6,geneorgeneproduct
"A functional study of the HEB gene in HeLa cells revealed that its loss of function mutation p17R76G causes up‑regulation of the proprotein convertase subtilisin/kexin type‑9 promoter through aberrant binding of the transcription factor LC3B‑II, thereby increasing LDL‑binding protein levels in Homo sapiens.",-53.25,0.6,geneorgeneproduct
"A missense mutation in the transmembrane channel-like gene&nbsp;1, specifically the p17R76G variant, has been shown to alter LC3B-I and LC3B-II phosphorylation and thereby impair autophagic flux in HepG2 cells, suggesting a potential mechanism for the observed increase in CPT1 expression and lipid accumulation.",-52.0,0.6,geneorgeneproduct
"A loss‑of‑function mutation in the DKFZP434I216 allele of the glutamate NMDA receptor gene, coupled with up‑regulated Toll‑like receptor‑4 signaling in HeLa cells, enhances cellular eNOS phosphorylation and promotes a neuroprotective phenotype in response to inflammatory stimuli.",-48.5,0.6,geneorgeneproduct
"A polymorphism in the AHR-binding region of the arylsulfatase gene, combined with a variant of the Toll‑like receptor‑4 promoter, was shown to alter the expression of the glutamate NMDA receptor and thereby increase susceptibility to neurodegeneration in a humanized mouse model expressing the human dystrophin gene.",-64.0,0.6,geneorgeneproduct
"A mutant allele of the dystrophin gene (DKFZP434I216) in a patient with Becker muscular dystrophy was found to up‑regulate the expression of the glutamate NMDA receptor subunit NR2B, thereby amplifying calcium influx and exacerbating the loss of eNOS‑mediated vasodilation in skeletal muscle.",-36.75,0.6,geneorgeneproduct
"Aryl sulfotransferase deficiency in A549 cells elevates glutamate NMDA receptor phosphorylation, thereby enhancing Toll‑like receptor‑4‑mediated cytokine release and accelerating PTN1‑driven endothelial nitric‑oxide synthase activation.",-41.25,0.6,geneorgeneproduct
"In GBM-derived U87MG cells, knockdown of the arylsulfatase gene PTN1 attenuates glutamate NMDA receptor‑mediated excitotoxicity and reduces the expression of the Toll‑like receptor‑4 signaling cascade, thereby enhancing cell survival under hypoxic conditions.",-47.5,0.6,geneorgeneproduct
"In A549 cells, the up‑regulation of the glutamate NMDA receptor subunit GRIN2B by the Toll‑like receptor‑4–mediated NF‑κB pathway is amplified by the eNOS‑dependent nitric‑oxide signaling cascade, thereby enhancing cell migration and invasion.",-42.75,0.6,geneorgeneproduct
"In HepG2 cells, overexpression of the arylsulfatase gene ARSA upregulates the glutamate NMDA receptor subunit NR2B, thereby enhancing calcium influx that activates pTyr‑phosphorylated PTPN1 and subsequently increases eNOS expression, a pathway that may contribute to the neuroprotective effects observed in Parkinson’s disease patients carrying the DKFZP434I216 variant.",-40.25,0.6,geneorgeneproduct
"In HeLa cells, overexpression of the dystrophin gene product reduces Toll‑like receptor‑4‑mediated activation of the glutamate NMDA receptor, thereby attenuating the inflammatory cascade induced by the arylsulfatase‑catalyzed hydrolysis of sulfatides.",-39.0,0.6,geneorgeneproduct
"The loss-of-function mutation DKFZP434I216 in the glutamate NMDA receptor gene increases neuronal excitotoxicity, while upregulation of Toll‑like receptor‑4 signaling in HeLa cells amplifies the inflammatory response to ethanol exposure.",-35.5,0.6,geneorgeneproduct
"The AHR‑mediated activation of Toll‑like receptor‑4 in HepG2 cells leads to up‑regulation of the arylsulfatase gene, a response that is amplified by the eNOS‑dependent nitric‑oxide pathway and further modulated through the SNP rs2234671 in the GLUT10 promoter.",-53.5,0.6,geneorgeneproduct
"The arylsulfatase A mutation (DKFZP434I216) in a patient with a GLUT10 deficiency upregulated Toll‑like receptor‑4 expression, thereby enhancing NF‑κB‑mediated inflammation and contributing to the observed neurodegeneration.",-37.25,0.6,geneorgeneproduct
"The upregulation of Toll‑like receptor‑4 in A549 cells by the arylsulfatase inhibitor reduced NF‑κB activation, thereby increasing eNOS expression and enhancing nitric‑oxide‑mediated vasodilation in a mouse model of pulmonary hypertension.",-36.5,0.6,geneorgeneproduct
"During the investigation, the A549 cell line was treated with the small molecule doxorubicin, and the resulting upregulation of the glutamate NMDA receptor subunit GRIN2B in the presence of the Toll‑like receptor‑4 (TLR4) agonist LPS was found to be mediated by increased phosphorylation of the tyrosine phosphatase PTPN1, an effect that was further amplified in cells carrying the eNOS promoter variant rs1799983.",-62.0,0.6,geneorgeneproduct
"During acute ischemic injury, the up‑regulation of Toll‑like receptor‑4 in HeLa cells amplifies NF‑κB‑driven eNOS expression, thereby enhancing nitric‑oxide‑mediated vasodilation and mitigating glutamate NMDA receptor‑induced excitotoxicity.",-47.5,0.6,geneorgeneproduct
"During chronic inflammation, the Toll‑like receptor‑4‑induced NF‑κB pathway up‑regulates the transcription of the arylsulfatase A gene, leading to increased enzyme activity that de‑sulfates glycosaminoglycans and subsequently enhances glutamate NMDA receptor phosphorylation in the hippocampal neurons of a murine model.",-51.0,0.6,geneorgeneproduct
"During oxidative stress, the Toll‑like receptor‑4‑mediated activation of NF‑κB in HeLa cells upregulates the arylsulfatase gene, leading to increased glutamate NMDA receptor phosphorylation and enhanced eNOS‑dependent nitric‑oxide production.",-44.75,0.6,geneorgeneproduct
"Overexpression of the gene product PTNPN1 in A549 cells upregulates Toll‑like receptor‑4 signaling, enhancing the secretion of pro‑inflammatory cytokines that subsequently increase glutamate NMDA receptor phosphorylation and elevate intracellular Ca²⁺, thereby accelerating apoptotic pathways in the tumor microenvironment.",-55.0,0.6,geneorgeneproduct
"Overexpressed arylsulfatase in HeLa cells activates Toll‑like receptor‑4 signaling, leading to increased IL‑6 production that in turn upregulates the glutamate NMDA receptor subunit NR2B, thereby enhancing neuronal excitotoxicity in a PTN1‑dependent manner.",-45.75,0.6,geneorgeneproduct
"Overactivation of Toll‑like receptor‑4 by bacterial lipopolysaccharide in A549 cells induces a STAT3‑dependent up‑regulation of the glutamate NMDA receptor subunit NR2B, which in turn enhances intracellular Ca²⁺ influx and activates eNOS, thereby increasing nitric‑oxide production and promoting inflammatory signaling that can be attenuated by the small‑molecule inhibitor doxorubicin.",-55.0,0.6,geneorgeneproduct
"Overexposure of the A549 cell line to the small molecule MK-801 inhibited the NMDA‑dependent glutamate uptake mediated by the GLT‑1 transporter, thereby up‑regulating the expression of the eNOS gene and increasing the phosphorylation of PTPN1, a modification that was confirmed by sequencing the DKFZP434I216 variant in the Toll‑like receptor‑4 promoter.",-69.0,0.6,geneorgeneproduct
"Activation of Toll‑like receptor‑4 by the arylsulfatase‑derived lipid mediator upregulates eNOS expression in endothelial cells, thereby increasing nitric‑oxide production and enhancing blood flow to the hippocampus, a process that is further modulated by the genetic variant DKFZP434I216 in the glutamate NMDA receptor subunit gene.",-51.75,0.6,geneorgeneproduct
"Activation‑dependent interaction between Toll‑like receptor‑4 and the glutamate NMDA receptor in HeLa cells carrying the DKFZP434I216 variant enhances intracellular calcium influx, thereby up‑regulating eNOS expression and promoting angiogenic signaling.",-48.5,0.6,geneorgeneproduct
"Activation by Toll‑like receptor‑4 of the arylsulfatase‑regulated pathway leads to increased eNOS expression, which in turn augments glutamate NMDA receptor phosphorylation and enhances the functional recovery of dystrophin‑deficient cells derived from the DKFZP434I216 mutation in a human myoblast line.",-68.5,0.6,geneorgeneproduct
"Activation and phosphorylation of the protein‑tyrosine phosphatase PTPN1 by Toll‑like receptor‑4 signaling in HeLa cells reduces eNOS‑dependent nitric‑oxide production, thereby dampening glutamate NMDA receptor‑mediated excitotoxicity.",-42.5,0.6,geneorgeneproduct
"Altered expression of the ArylSulfatase gene product in HeLa cells downregulates Toll‑like receptor‑4 signaling, thereby reducing NMDA‑mediated glutamate excitotoxicity and improving neuronal survival in a murine model of Parkinson’s disease.",-35.0,0.6,geneorgeneproduct
"Alterations in the AHR-binding motif of the DKFZP434I216 gene product enhance Toll‑like receptor‑4 signaling, thereby increasing NF‑κB‑mediated transcription of the glutamate NMDA receptor subunit NR2B and accelerating neuronal apoptosis in A549 cells exposed to cyclosporin A.",-50.75,0.6,geneorgeneproduct
"Alteration of the Toll‑like receptor‑4 signaling pathway in A549 cells, driven by a BRCA1 c.68_69delAG variant, enhances the expression of glutamate NMDA receptor subunits and up‑regulates eNOS, thereby increasing intracellular calcium flux and promoting a pro‑inflammatory phenotype that may contribute to the development of drug‑induced lung injury.",-56.0,0.6,geneorgeneproduct
"Alterative treatment with the small molecule arylsulfatase inhibitor A-1214747 in A549 cells down‑regulates the expression of the glutamate NMDA receptor subunit GRIN2B, thereby attenuating the hyper‑phosphorylation of p‑PTPN1 and restoring eNOS‑mediated nitric‑oxide production in a dose‑dependent manner.",-64.0,0.6,geneorgeneproduct
"Mutation of the DKFZP434I216 allele in the glutamate NMDA receptor gene reduces its surface expression and, in A549 cells, leads to heightened sensitivity to the selective eNOS inhibitor L-NAME, thereby amplifying Toll‑like receptor‑4‑mediated inflammatory signaling.",-43.0,0.6,geneorgeneproduct
"Mutation in the DKFZP434I216 variant of the glutamate NMDA receptor gene increases binding of the arylsulfatase enzyme, thereby enhancing Toll‑like receptor‑4‑mediated inflammation in Homo sapiens A549 cells.",-38.5,0.6,geneorgeneproduct
"Mutation analysis of the DKFZP434I216 variant in the GLUT10 gene revealed that its altered expression enhances the interaction between Toll‑like receptor‑4 signaling and the eNOS‑dependent nitric‑oxide pathway, thereby potentiating glutamate NMDA receptor‑mediated excitotoxicity in cultured HeLa cells.",-46.0,0.6,geneorgeneproduct
"Mutation p.Arg545Cys in the DKFZP434I216 gene was identified in a patient with early‑onset dystrophinopathy, and functional assays revealed that this variant disrupts the interaction between dystrophin and the glutamate NMDA receptor, thereby attenuating synaptic calcium influx in cultured HeLa cells.",-46.5,0.6,geneorgeneproduct
"Disruption of the PTN1 phosphatase in A549 cells leads to aberrant glutamate NMDA receptor phosphorylation, which in turn activates TLR4‑dependent NF‑κB signaling and upregulates GLUT10 expression, ultimately impairing cellular energy homeostasis.",-44.75,0.6,geneorgeneproduct
"Disruptive loss-of-function variants in the DKFZP434I216 gene, which encodes a protein that interacts with the glutamate NMDA receptor, were shown to impair neuronal signaling and increase susceptibility to Parkinson’s disease in a cohort of Homo sapiens subjects.",-39.5,0.6,geneorgeneproduct
"Disrupted phosphorylation of PTPN1 by the Toll‑like receptor‑4 signaling cascade in A549 cells leads to increased expression of the glutamate NMDA receptor subunit NR2B and activates the eNOS pathway, thereby enhancing NO production and contributing to the oxidative stress observed in KRAS‑mutant colorectal carcinoma.",-63.5,0.6,geneorgeneproduct
"Disparate studies reveal that the arylsulfatase gene variant DKFZP434I216 modulates Toll‑like receptor‑4‑mediated inflammation and enhances glutamate NMDA receptor trafficking, thereby aggravating neurotoxicity in A549 cells exposed to the chemotherapeutic agent doxorubicin.",-60.75,0.6,geneorgeneproduct
"Knockout of the ArylSulfatase gene in A549 cells markedly reduces glutamate‑NMDA receptor trafficking, an effect that is amplified by the Toll‑like receptor‑4‑dependent upregulation of the PTPN1 phosphatase and is partially rescued by the GLUT10‑mediated transport of L‑serine, thereby illustrating a complex interplay between these gene products in regulating excitotoxic signaling.",-70.0,0.6,geneorgeneproduct
"Knocking out the DKFZP434I216 allele in HeLa cells leads to up‑regulation of the glutamate NMDA receptor subunit GRIN2B, which in turn enhances Toll‑like receptor‑4–mediated NF‑κB activation and elevates eNOS‑derived nitric oxide production, thereby increasing cellular oxidative stress and reducing cell viability.",-51.5,0.6,geneorgeneproduct
"Knocked‑out expression of the gene encoding arylsulfatase in HeLa cells led to up‑regulation of the glutamate NMDA receptor and increased phosphorylation of the tyrosine phosphatase PTPN1, thereby enhancing intracellular calcium influx and promoting apoptosis.",-44.25,0.6,geneorgeneproduct
"Knifefish A549 cells treated with the small molecule GLP‑1 analog exhibited upregulated expression of the glutamate NMDA receptor subunit GRIN2B, which in turn enhanced eNOS phosphorylation and nitric‑oxide production, thereby improving vasodilation in a murine model of hypertension.",-62.5,0.6,geneorgeneproduct
"PTPN1 phosphorylation of the glutamate NMDA receptor in HeLa cells is enhanced by the Toll‑like receptor‑4 ligand lipopolysaccharide, leading to increased intracellular calcium and activation of the eNOS‑cGMP signaling cascade.",-30.875,0.6,geneorgeneproduct
"PTN1 phosphorylation of the glutamate NMDA receptor in A549 cells upregulates eNOS expression, thereby enhancing nitric oxide production and promoting cell migration.",-29.875,0.6,geneorgeneproduct
"PTPn1 dephosphorylates the glutamate NMDA receptor subunit NR2B in HeLa cells, thereby attenuating Toll‑like receptor‑4‑induced NF‑κB activation in the context of a KRAS c.35G>A sequence variant.",-44.75,0.6,geneorgeneproduct
"PTPRN1 overexpression in HeLa cells enhances glutamate NMDA receptor phosphorylation, thereby amplifying Toll‑like receptor‑4‑mediated NF‑κB signaling and increasing secretion of the cytokine interleukin‑6.",-40.25,0.6,geneorgeneproduct
"Variants in the DKFZP434I216 allele of the GLUT10 transporter, which modulate the intracellular concentration of glutamate, were found to alter the expression of the NMDA receptor subunit GRIN2B in A549 cells, thereby potentiating Toll‑like receptor‑4‑mediated NF‑κB signaling and contributing to the inflammatory phenotype observed in patients with the dystrophin‑associated muscular dystrophy.",-66.5,0.6,geneorgeneproduct
"Variants of the gene encoding arylsulfatase A, such as the DKFZP434I216 allele, diminish its enzymatic activity and thereby impair the clearance of sulfatides, leading to increased activation of Toll‑like receptor‑4‑mediated inflammation in patients with a GLUT10‑related mitochondrial dysfunction.",-59.25,0.6,geneorgeneproduct
"Variants affecting the arylsulfatase gene (DKFZP434I216) alter the expression of the glutamate NMDA receptor and subsequently modulate the activity of the eNOS pathway in human (Homo sapiens) neuronal cells, a change that may contribute to dysregulation of the Toll‑like receptor‑4 mediated inflammatory response.",-63.0,0.6,geneorgeneproduct
"Variants such as DKFZP434I216 in the glutamate NMDA receptor gene were shown to alter eNOS expression in A549 cells, thereby increasing Toll‑like receptor‑4 mediated inflammatory signaling in response to the chemical entity ethanol.",-52.0,0.6,geneorgeneproduct
"Mutations in the DKFZP434I216 allele of the glutamate NMDA receptor gene disrupt its interaction with the eNOS‑mediated nitric‑oxide signaling pathway, thereby reducing synaptic plasticity in cortical neurons of Homo sapiens.",-29.25,0.6,geneorgeneproduct
"Mutational loss of the arylsulfatase gene in HeLa cells upregulates Toll‑like receptor‑4‑mediated NF‑κB signaling, thereby enhancing the expression of the glutamate NMDA receptor subunit NR2B and increasing susceptibility to excitotoxic cell death.",-35.25,0.6,geneorgeneproduct
"Mutagenic exposure to the small molecule doxorubicin induces a KRAS c.37G>T sequence variant in A549 cells, which in turn downregulates GLUT10 expression and amplifies TNF‑α secretion through Toll‑like receptor‑4 signaling, ultimately impairing cell‑cycle arrest mediated by the tumor suppressor gene p53.",-64.0,0.6,geneorgeneproduct
"Mutant ptnp1 allele DKFZP434I216 in A549 cells reduces Toll‑like receptor‑4‑mediated NF‑κB activation, thereby lowering glutamate NMDA receptor phosphorylation and attenuating eNOS‑dependent nitric‑oxide production in the context of chronic inflammation.",-44.25,0.6,geneorgeneproduct
"An upregulation of the Toll‑like receptor‑4 signaling cascade in A549 cells treated with the small molecule inhibitor PTN‑1 leads to increased phosphorylation of eNOS, thereby enhancing nitric‑oxide production and promoting glutamate NMDA receptor‑mediated calcium influx, a process that may be modulated by the eNOS‑encoding gene variant DKFZP434I216.",-58.0,0.6,geneorgeneproduct
"An A549 cell line treated with the small molecule arylsulfatase inhibitor showed increased phosphorylation of the protein tyrosine phosphatase PTPN1, thereby enhancing downstream activation of the glutamate NMDA receptor and elevating intracellular calcium, a response that was amplified in cells harboring the DKFZP434I216 sequence variant.",-42.75,0.6,geneorgeneproduct
"An in‑vitro study revealed that the A549 cell line expressing the DKFZP434I216 variant of Toll‑like receptor‑4 showed heightened activation of the glutamate NMDA receptor pathway and increased expression of eNOS, thereby suggesting a potential mechanism for the observed up‑regulation of nitric oxide production in these cells.",-60.0,0.6,geneorgeneproduct
"An elevated expression of the arylsulfatase gene in A549 cells was found to upregulate Toll‑like receptor‑4 signaling, thereby increasing the production of inflammatory cytokines that impair glutamate NMDA receptor function and contribute to the neurotoxic phenotype observed in patients carrying the DKFZP434I216 sequence variant.",-47.25,0.6,geneorgeneproduct
"The PGC‑1α‑dependent transcriptional activation of the VEGFR2 promoter in A549 cells is enhanced by the DRD4‑mediated signaling cascade, thereby promoting receptor tyrosine kinase‑driven angiogenesis.",-22.625,0.6,geneorgeneproduct
"The loss-of-function mutation c.68_69delAG in the BRCA1 gene (SequenceVariant) was shown to impair the interaction between PGC‑1α (GeneOrGeneProduct) and the receptor tyrosine kinase VEGFR2 (GeneOrGeneProduct), thereby reducing angiogenic signaling in human breast cancer cells (CellLine) derived from Homo sapiens (OrganismTaxon).",-32.5,0.6,geneorgeneproduct
"The overexpression of PGC‑1α in A549 cells enhances the transcription of the mitochondrial biogenesis gene NRF1, thereby increasing cellular ATP production and promoting resistance to doxorubicin-induced apoptosis.",-17.875,0.6,geneorgeneproduct
"The receptor tyrosine kinase EGFR-targeted therapy downregulates the transcription factor specificity protein, thereby reducing VEGFR2 expression and attenuating downstream signaling in DACH1‑nonexpressing A549 cells.",-23.375,0.6,geneorgeneproduct
"Altered PGC‑1α expression in A549 cells diminishes VEGFR2‑mediated angiogenic signaling, thereby attenuating DRD4‑driven proliferation of mu‑opioid receptor‑positive tumor subclones.",-25.625,0.6,geneorgeneproduct
"Alteration of PGC‑1α expression in A549 cells down‑regulates VEGFR2‑mediated angiogenesis, thereby enhancing sensitivity to the EGFR‑targeted drug gefitinib.",-21.875,0.6,geneorgeneproduct
"Alterations in the transcription factor PGC‑1α, which co‑activates the receptor tyrosine kinase VEGFR2, were found to suppress the expression of the calcium‑dependent regulator CAMK2N1 in the DACH1‑nonexpressing A549 cell line, thereby enhancing the sensitivity of these cells to EGFR‑targeted therapy.",-37.75,0.6,geneorgeneproduct
"Alterative expression of the transcription factor PGC‑1α in the human hepatocellular carcinoma cell line HepG2 was shown to up‑regulate the kinase CAMK2N1, which in turn phosphorylated the receptor tyrosine kinase VEGFR2, thereby enhancing angiogenic signaling and promoting tumor growth.",-39.75,0.6,geneorgeneproduct
"In the A549 cell line, activation of the VEGFR2 receptor tyrosine kinase by a small-molecule ligand induced phosphorylation of downstream CAMK2N1, thereby enhancing transcription of the PGC‑1α gene product and promoting mitochondrial biogenesis.",-30.625,0.6,geneorgeneproduct
"In A549 cells, the overexpression of the transcription factor PGC‑1α synergizes with the activation of the receptor tyrosine kinase VEGFR2 to enhance mitochondrial biogenesis, a process that is further amplified by the loss of the inhibitory regulator CAMK2N1.",-28.375,0.6,geneorgeneproduct
"In H1299 cells, the loss-of-function mutation in the PGC‑1α gene (c.1123G>A) was shown to reduce NRF2‑mediated antioxidant responses, thereby enhancing VEGFR2‑driven angiogenic signaling and rendering the cells more susceptible to EGFR‑targeted therapy.",-47.25,0.6,geneorgeneproduct
"In MCF‑7 cells, overexpression of the transcriptional co‑activator PGC‑1α up‑regulates VEGFR2 expression, thereby enhancing receptor tyrosine kinase signaling and promoting angiogenic sprouting.",-18.75,0.6,geneorgeneproduct
"PGC‑1α activation by a receptor tyrosine kinase in HeLa cells increases VEGFR2 transcription, thereby enhancing endothelial‑like sprouting and up‑regulating the specificity protein‑4‑driven expression of CAMK2N1, a process that may be inhibited by the mu‑opiate receptor agonist methadone.",-46.5,0.6,geneorgeneproduct
"PGCB1a overexpression in HeLa cells upregulates VEGFR2, thereby enhancing EGFR‑targeted signaling and increasing CAMK2N1 phosphorylation, which in turn promotes resistance to mu opiate receptor antagonists.",-47.5,0.6,geneorgeneproduct
"PG‑C1α overexpression in A549 cells enhances VEGFR2‑mediated angiogenic signaling and concurrently upregulates the CAMK2N1 inhibitor, thereby attenuating DRD4‑driven proliferation in a mu‑opioid receptor–dependent manner.",-46.75,0.6,geneorgeneproduct
"PGN-1α activation of VEGFR2 in A549 cells enhances CAMK2N1-mediated phosphorylation of the mu-opiate receptor, thereby potentiating receptor tyrosine kinase signaling that ultimately upregulates the transcription factor specificity protein.",-47.5,0.6,geneorgeneproduct
"High‑throughput CRISPR‑Cas9 editing of the PGC‑1α gene in A549 cells revealed that loss of PGC‑1α upregulates VEGFR2 transcription through a specificity protein‑1‑dependent mechanism, thereby enhancing receptor tyrosine kinase signaling and driving increased proliferation of the human lung carcinoma cell line.",-36.75,0.6,geneorgeneproduct
"High‐throughput CRISPR screening in A549 cells revealed that loss of PGC‑1α upregulates VEGFR2 expression, thereby enhancing EGFR‑targeted drug resistance through a receptor tyrosine kinase–mediated signaling cascade.",-27.5,0.6,geneorgeneproduct
"High levels of the transcription factor PGC‑1α in A549 cells enhance the expression of the receptor tyrosine kinase VEGFR2, thereby promoting angiogenic signaling that is further amplified by the activation of CAMK2N1 through the mu‑opiate receptor pathway.",-34.75,0.6,geneorgeneproduct
"High-throughput CRISPR screening in A549 cells revealed that loss of the transcription factor SP1 enhances sensitivity to the EGFR-targeted drug gefitinib by upregulating the receptor tyrosine kinase VEGFR2, thereby promoting a compensatory angiogenic signaling pathway that ultimately mitigates apoptosis driven by the mu-opioid receptor antagonist naloxone.",-43.25,0.6,geneorgeneproduct
"Expression of the transcription factor PGC‑1α in A549 cells markedly up‑regulated the mu‑opiate receptor gene OPRM1, while simultaneous knockdown of CAMK2N1 amplified VEGFR2 signaling through the receptor tyrosine kinase EGFR‑targeted pathway.",-36.5,0.6,geneorgeneproduct
"Expression analysis of the transcription factor PGC‑1α in the A549 cell line revealed that its up‑regulation by the receptor tyrosine kinase VEGFR2 enhances mitochondrial biogenesis, thereby attenuating oxidative stress in a model of Parkinson’s disease.",-31.375,0.6,geneorgeneproduct
"Expression levels of PGC‑1α in HeLa cells were markedly reduced by the EGFR‑targeted drug gefitinib, leading to impaired mitochondrial biogenesis and increased susceptibility to oxidative stress.",-28.125,0.6,geneorgeneproduct
"Expression loss of the transcription factor DACH1 in EGFR‑targeted A549 cells upregulates the mu opiate receptor gene, thereby enhancing VEGFR2‑mediated migration through a CAMK2N1‑dependent pathway.",-33.5,0.6,geneorgeneproduct
"Activation of the VEGFR2 receptor tyrosine kinase by the PGC‑1α‑dependent up‑regulation of the CAMK2N1 gene in DACH1‑nonexpressing HeLa cells leads to increased proliferation of the tumor cells, thereby providing a potential therapeutic target for EGFR‑targeted therapy.",-41.5,0.6,geneorgeneproduct
"Activation by the receptor tyrosine kinase EGFR of the transcription factor PGC‑1α in A549 cells enhances the expression of the specificity protein SP1, thereby up‑regulating VEGFR2 and promoting angiogenesis.",-33.25,0.6,geneorgeneproduct
"Activation or inhibition of the transcription factor PGC‑1α in A549 cells alters the expression of the dopamine D4 receptor (DRD4) and downstream VEGFR2 signaling, thereby modulating cell proliferation and migration.",-34.25,0.6,geneorgeneproduct
"Activation‑dependent phosphorylation of PGC‑1α by the mu‑opioid receptor in A549 cells induces a CAMK2N1‑mediated feedback loop that down‑regulates VEGFR2 expression, thereby attenuating receptor tyrosine kinase signaling in a DACH1‑nonexpressing tumor context.",-42.0,0.6,geneorgeneproduct
"Overexpression of the transcription factor PGC‑1α in the A549 lung carcinoma cell line activates the downstream VEGFR2 signaling cascade, thereby enhancing cellular proliferation and resistance to EGFR‑targeted therapy.",-21.625,0.6,geneorgeneproduct
"Overexpressed PGC‑1α in A549 cells activates the VEGFR2 signaling cascade, thereby enhancing mitochondrial biogenesis and increasing resistance to doxorubicin‑induced apoptosis.",-20.25,0.6,geneorgeneproduct
Overactivation of the VEGFR2 receptor tyrosine kinase in A549 cells lacking DACH1-nonexpressing specificity protein results in enhanced PGC-1a‑driven mitochondrial biogenesis and increased resistance to EGFR‑targeted therapy.,-34.75,0.6,geneorgeneproduct
"Over an extended time‑course, the PGC‑1α‑mediated up‑regulation of VEGFR2 expression in DACH1‑nonexpressing A549 cells was found to enhance angiogenic signaling, while simultaneous loss‑of‑function mutations in the DRD4 gene reduced downstream cAMP‑dependent activation of the receptor tyrosine kinase pathway.",-52.25,0.6,geneorgeneproduct
"Within SNU-216 cells, the upregulation of PGC‑1α by the receptor tyrosine kinase‑stimulated pathway enhances CAMK2N1 expression, thereby attenuating VEGFR2‑mediated angiogenesis and improving the efficacy of EGFR‑targeted therapy in colorectal carcinoma.",-55.25,0.6,geneorgeneproduct
"Within A549 cells, overexpression of the transcription factor PGC‑1α up‑regulates VEGFR2 and activates a downstream receptor tyrosine kinase cascade that enhances the phosphorylation of CAMK2N1, thereby potentiating the anti‑apoptotic signaling of the mu‑opioid receptor and ultimately promoting cellular survival under hypoxic stress.",-44.25,0.6,geneorgeneproduct
"Within HeLa cells, overexpression of the transcription factor specificity protein enhances PGC‑1α promoter activity, thereby increasing mitochondrial biogenesis and up‑regulating the expression of the receptor tyrosine kinase VEGFR2, which in turn activates downstream CAMK2N1 signaling pathways.",-32.25,0.6,geneorgeneproduct
"Within the A549 cell line, overexpression of the transcription factor PGC‑1α synergizes with EGFR‑targeted therapy to upregulate VEGFR2, thereby enhancing downstream AKT signaling and promoting chemoresistance to the small‑molecule inhibitor gefitinib.",-31.5,0.6,geneorgeneproduct
"Mutations in the PGC‑1α gene alter the expression of the receptor tyrosine kinase VEGFR2, thereby impairing mitochondrial biogenesis in DACH1‑nonexpressing endothelial cells.",-21.125,0.6,geneorgeneproduct
"Mutagenic exposure to the EGFR-targeted drug gefitinib induces a PGC‑1α‑mediated up‑regulation of VEGFR2, which in turn enhances CAMK2N1 phosphorylation and promotes the proliferation of DACH1‑nonexpressing HeLa cells.",-32.0,0.6,geneorgeneproduct
"Mutational loss of PGC-1α in A549 cells enhances VEGFR2‑mediated signaling, thereby promoting epithelial‑mesenchymal transition through up‑regulation of the transcription factor specificity protein‑1.",-28.625,0.6,geneorgeneproduct
"Mutant PGC‑1α variants in the DACH1‑nonexpressing A549 cell line were shown to enhance VEGFR2 phosphorylation and downstream ERK signaling, thereby increasing proliferation and resistance to EGFR‑targeted therapy.",-30.0,0.6,geneorgeneproduct
"Activating the PGC‑1α‑dependent transcriptional network in HeLa cells increases VEGFR2 expression, thereby enhancing receptor tyrosine kinase signaling and promoting proliferation that is suppressed by the mu‑opioid receptor agonist fentanyl.",-36.75,0.6,geneorgeneproduct
"Activational phosphorylation of the receptor tyrosine kinase EGFR in A549 cells enhances PGC‑1α transcriptional activity, thereby up‑regulating VEGFR2 expression and promoting angiogenic signaling that ultimately contributes to tumor progression.",-35.75,0.6,geneorgeneproduct
"Activations of the receptor tyrosine kinase VEGFR2 in HeLa cells overexpressing the transcription factor PGC‑1α lead to up‑regulation of the CAMK2N1 gene, thereby attenuating the proliferative signaling induced by the mu‑opioid receptor agonist morphine.",-42.25,0.6,geneorgeneproduct
"Activatory phosphorylation of the receptor tyrosine kinase EGFR by the oncogenic PGC‑1α‑driven metabolic program in DACH1‑nonexpressing HeLa cells enhances downstream CAMK2N1‑mediated suppression of the mu‑opioid receptor, thereby promoting VEGFR2‑dependent angiogenesis.",-47.0,0.6,geneorgeneproduct
"Downregulation of the PGC‑1α‑driven transcriptional network by a DACH1‑nonexpressing variant of the VEGFR2 receptor tyrosine kinase in A549 cells attenuates the expression of the mu‑opiate receptor and the downstream CAMK2N1‑mediated phosphorylation cascade, thereby reducing DRD4‑dependent dopaminergic signaling and altering the specificity protein‑mediated transcription of oncogenic genes.",-59.75,0.6,geneorgeneproduct
"Down‑regulation of the transcription factor specificity protein in A549 cells reduces VEGFR2 expression and diminishes the growth‑promoting response to the EGFR‑targeted drug erlotinib, thereby enhancing the antitumor activity of the mu opiate receptor agonist morphine.",-45.5,0.6,geneorgeneproduct
"Downstream of the PGC‑1α‑regulated transcriptional network, the DRD4‑mediated signaling axis modulates the activity of the receptor‑tyrosine‑kinase‑driven VEGFR2 pathway, thereby influencing the expression of the specificity‑protein transcription factor and the CAMK2N1 inhibitor in DACH1‑nonexpressing cells.",-46.0,0.6,geneorgeneproduct
Down-regulation of the transcription factor PGC-1α in A549 cells expressing the receptor tyrosine kinase EGFR leads to increased expression of the mu‑opioid receptor and activation of the CAMK2N1‑dependent signaling cascade that ultimately enhances VEGFR2 phosphorylation and promotes angiogenesis.,-43.5,0.6,geneorgeneproduct
"DRD4 expression in the DACH1‑nonexpressing HeLa cell line is down‑regulated by the mu opiate receptor agonist fentanyl, a change that is amplified by the receptor tyrosine kinase inhibitor erlotinib and that reduces VEGFR2‑mediated angiogenic signaling through a CAMK2N1‑dependent mechanism.",-41.75,0.6,geneorgeneproduct
"DRG4 overexpression in A549 cells reduces VEGFR2‑mediated angiogenic signaling, a modulation that is amplified when the mu‑opioid receptor is co‑activated, thereby enhancing the anti‑tumor efficacy of EGFR‑targeted therapy.",-45.25,0.6,geneorgeneproduct
"DRAGNET cells overexpressing the PGC-1α gene product exhibit increased mitochondrial biogenesis and enhanced VEGFR2-mediated angiogenic signaling, while simultaneous knockdown of CAMK2N1 reduces the ERK1/2 phosphorylation downstream of the receptor tyrosine kinase EGFR, illustrating a cross‑talk between metabolic reprogramming and growth factor signaling in this cancer model.",-68.5,0.6,geneorgeneproduct
"DR5‑mediated apoptosis in A549 cells is enhanced by the PGC‑1α‑dependent upregulation of VEGFR2, which in turn activates a CAMK2N1‑dependent signaling cascade that increases the expression of the mu‑opioid receptor and promotes resistance to EGFR‑targeted therapy.",-43.0,0.6,geneorgeneproduct
"Polymorphisms in the PGC‑1α promoter that reduce its transcriptional activity are associated with diminished expression of the downstream target VEGFR2, thereby impairing angiogenic signaling in A549 cells that lack DACH1 expression.",-32.25,0.6,geneorgeneproduct
"Polycystic kidney disease-associated mutations in the DACH1 gene reduce PGC‑1α‑mediated transcriptional activation of the VEGFR2 promoter, thereby impairing receptor tyrosine kinase signaling in renal epithelial cells.",-31.5,0.6,geneorgeneproduct
"Polyclonal T cells from A549 cells overexpressing the transcription factor PGC‑1α upregulate the mu‑opioid receptor gene (OPRM1) through a receptor‑tyrosine‑kinase‑dependent pathway, thereby enhancing VEGFR2‑mediated angiogenic signaling in the tumor microenvironment.",-43.25,0.6,geneorgeneproduct
"Polyglycylated PGC‑1α, a key transcriptional co‑activator of mitochondrial biogenesis, directly interacts with the promoter of the DRD4 gene in HeLa cells, thereby enhancing dopamine D4 receptor expression and downstream activation of the VEGFR2‑dependent angiogenic pathway.",-48.5,0.6,geneorgeneproduct
"In HeLa cells, the interaction between the RAB‑28 GTPase and the SCF ubiquitin‑ligase complex enhances the degradation of the GPX4 protein, thereby attenuating the maturation‑promoting factor‑driven oxidative stress response.",-26.875,0.6,geneorgeneproduct
"In A549 cells, the loss of GPX4 expression leads to ferroptosis through accumulation of lipid peroxides, while the up‑regulation of RAB‑28 and the activation of the Smad1/5 pathway downstream of TGF‑β signaling further enhance cell death via suppression of the maturation‑promoting factor and recruitment of the SCF‑mediated ubiquitin ligase complex.",-53.75,0.6,geneorgeneproduct
"In Huh-7 cells, overexpression of the RAB‑28 gene product enhances the maturation‑promoting factor complex, leading to increased GPX4 activity and reduced reactive oxygen species levels.",-26.75,0.6,geneorgeneproduct
"In HepG2 cells, the RAB‑28‑dependent trafficking of GPX4 to the plasma membrane is regulated by the maturation‑promoting factor complex, which is itself activated through Smad1/5 phosphorylation downstream of TGF‑β signaling, thereby enhancing antioxidant defenses and reducing ROS‑induced apoptosis.",-40.25,0.6,geneorgeneproduct
"Activation of the RAB‑28‑dependent trafficking pathway in HeLa cells by the GPX4 inhibitor RSL3 leads to increased reactive oxygen species, which in turn triggers MAP9‑mediated mitotic spindle instability and ultimately reduces cell viability.",-37.25,0.6,geneorgeneproduct
"Activation by the maturation‑promoting factor of RAB‑28 in HeLa cells upregulates GPX4 expression, thereby attenuating ferroptosis induced by the chemotherapeutic agent doxorubicin.",-29.625,0.6,geneorgeneproduct
"Activation-deficient RAB-28 in A549 cells upregulates MAP9 expression, thereby enhancing GPX4-mediated ferroptosis resistance and attenuating SMAD1/5 phosphorylation in a GR-dependent manner.",-45.0,0.6,geneorgeneproduct
"Activation-induced phosphorylation of the RAB‑28 GTPase by the maturation‑promoting factor complex enhances its interaction with the SCF‑E3 ligase, thereby promoting ubiquitination and subsequent proteasomal degradation of the GPX4 protein in human A549 cells, a process that is inhibited by the anti‑SMAD1/5 antibody and results in increased reactive oxygen species and apoptosis.",-55.75,0.6,geneorgeneproduct
"RAB‑28 overexpression in A549 cells enhances Smad1/5‑mediated transcription of GPX4, thereby increasing resistance to ferroptosis induced by the chemical agent erastin.",-18.75,0.6,geneorgeneproduct
"Rhabdomyosarcoma cell lines such as RD demonstrate that RAB-28 overexpression enhances MAP9‑dependent microtubule dynamics, thereby increasing the sensitivity of these cells to the GPX4 inhibitor RSL3.",-38.5,0.6,geneorgeneproduct
"RIF1-mediated recruitment of SMAD1/5 to the promoter of GPX4 in HeLa cells enhances transcription of the antioxidant enzyme, thereby protecting the cells from ferroptosis induced by the alkylating agent temozolomide.",-40.25,0.6,geneorgeneproduct
"Rabenosyn‑28 (RAB‑28) interaction with the scaffold protein SCF enhances Smad1/5 phosphorylation, thereby promoting GPX4‑mediated ferroptosis resistance in A549 cells.",-35.25,0.6,geneorgeneproduct
"The RAB-28‑mediated trafficking of GPX4 to the plasma membrane is enhanced by the maturation‑promoting factor, thereby reducing oxidative stress in HeLa cells and attenuating MAP9‑dependent apoptosis.",-28.0,0.6,geneorgeneproduct
"The CRISPR‑edited A549 cells harboring the BRCA1 c.68_69delAG variant exhibit reduced GPX4 expression, which in turn sensitizes the cells to ferroptosis induced by erastin.",-23.875,0.6,geneorgeneproduct
"The up‑regulation of GPX4 by the RAB‑28‑dependent maturation‑promoting factor pathway attenuates oxidative stress in HeLa cells, thereby enhancing resistance to doxorubicin‑induced apoptosis.",-20.75,0.6,geneorgeneproduct
"The loss‑of‑function mutation in RAB‑28, a small GTPase, was shown to impair the maturation‑promoting factor complex, thereby reducing SMAD1/5 phosphorylation and downstream GPX4 transcription in HepG2 cells.",-26.25,0.6,geneorgeneproduct
"Expression of the RAB-28 GTPase in A549 cells is upregulated by Smad1/5 signaling, which in turn enhances GPX4-mediated resistance to ferroptosis through modulation of the maturation‑promoting factor complex.",-27.75,0.6,geneorgeneproduct
"Expression analysis revealed that the RAB‑28 gene product is up‑regulated in A549 cells treated with the chemical agent doxorubicin, a change that correlates with increased GPX4 activity and the activation of the MAP9‑dependent mitotic spindle assembly pathway, ultimately enhancing cell survival in the context of oxidative stress.",-49.25,0.6,geneorgeneproduct
"Expression studies in the A549 cell line revealed that the RAB‑28 gene product directly interacts with the Smad1/5 complex, and this interaction is potentiated by GPX4‑mediated oxidative stress, thereby enhancing the maturation‑promoting factor pathway in human lung carcinoma cells.",-44.75,0.6,geneorgeneproduct
"Expression profiling of the RAB‑28 gene in A549 cells revealed that its up‑regulation by the Smad1/5‑dependent transcription factor GPX4 enhances the maturation‑promoting factor activity, thereby increasing the degradation of IkappaB via the SCF‑mediated ubiquitination of MAP9 and ultimately attenuating the GR‑driven transcription of DBH in the presence of the long non‑coding RNA Meg3.",-52.0,0.6,geneorgeneproduct
"Loss of the RAB‑28 gene product in A549 cells diminishes Smad1/5‑mediated transcriptional activation of GPX4, thereby reducing resistance to oxidative stress and impairing the maturation‑promoting factor–driven cell cycle progression.",-29.875,0.6,geneorgeneproduct
"Loss‑of‑function mutations in the RAB‑28 gene impair the maturation‑promoting factor pathway, leading to dysregulated SMAD1/5 signaling and increased oxidative stress through GPX4 depletion in human hepatocytes.",-34.5,0.6,geneorgeneproduct
"Loss-of-function mutations in the RAB-28 gene of *Homo sapiens* were shown to impair the maturation‑promoting factor complex, resulting in reduced GPX4 expression and increased oxidative stress in HeLa cells.",-31.625,0.6,geneorgeneproduct
"Loss‐of‐function mutations in the RAB‑28 gene, which disrupt vesicular trafficking of GPX4, were found to impair the maturation‑promoting factor‑dependent activation of Smad1/5 signaling in human Huh7 hepatocellular carcinoma cells, thereby reducing the expression of IkappaB and increasing NF‑κB‑mediated apoptosis.",-52.75,0.6,geneorgeneproduct
"Mutations in the RAB-28 gene that impair its interaction with the maturation‑promoting factor complex lead to decreased GPX4 expression and increased reactive oxygen species, thereby promoting neuronal apoptosis in a mouse model of Parkinson’s disease.",-26.375,0.6,geneorgeneproduct
"Mutational loss of the GPX4 gene product in HeLa cells activates a MAP9‑dependent mitotic checkpoint, thereby enhancing Smad1/5‑mediated transcription of the RAB‑28‑regulated maturation‑promoting factor and increasing IkappaB‑mediated NF‑κB inhibition.",-35.75,0.6,geneorgeneproduct
"Mutant RAB‑28 in HeLa cells up‑regulates MAP9, which in turn stabilizes microtubules and enhances the maturation‑promoting factor‑mediated progression of the G1/S transition.",-29.75,0.6,geneorgeneproduct
"Mutagenic exposure of HeLa cells to doxorubicin upregulates GPX4 expression, which in turn stabilizes the RAB‑28‑containing maturation‑promoting factor complex and reduces SMAD1/5‑mediated transcription of the tumor‑suppressor gene TP53 in Homo sapiens.",-37.25,0.6,geneorgeneproduct
"Altered expression of the RAB‑28 gene product in HeLa cells leads to increased GPX4 activity, which in turn stabilizes the maturation‑promoting factor and enhances MAP9‑dependent microtubule dynamics, thereby promoting resistance to oxidative stress in the presence of the SMAD1/5 signaling pathway.",-33.25,0.6,geneorgeneproduct
"Alteration of the RAB‑28 gene product in HeLa cells reduces the activation of the Smad1/5 signaling pathway, thereby diminishing the downstream expression of GPX4 and the maturation‑promoting factor while increasing IkappaB‑mediated NF‑κB inhibition.",-38.0,0.6,geneorgeneproduct
"Alterations in the RAB‑28 gene product enhance MAP9-mediated vesicular transport, thereby amplifying Smad1/5 signaling and promoting maturation‑promoting factor activity in the presence of GPX4, which collectively attenuate IkappaB‑dependent inflammatory responses in Homo sapiens cells.",-45.0,0.6,geneorgeneproduct
"Alter the expression of the gene product RAB-28 by introducing a BRCA1 c.68_69delAG sequence variant, thereby modulating the maturation‑promoting factor activity in a HeLa cell line and ultimately enhancing the cellular response to oxidative stress mediated by GPX4.",-50.25,0.6,geneorgeneproduct
"Genetic ablation of the RAB‑28 gene in A549 cells down‑regulates GPX4 expression, thereby sensitizing the cells to ferroptosis induced by the small‑molecule inhibitor erastin.",-23.0,0.6,geneorgeneproduct
"Genomic disruption of the RAB‑28 gene in A549 cells leads to reduced GPX4 expression, thereby increasing oxidative stress and promoting apoptosis through the MAP9‑dependent mitochondrial pathway.",-31.125,0.6,geneorgeneproduct
"Genetically engineered HEK293 cells overexpressing the RAB-28 gene product exhibit increased GPX4 activity, leading to enhanced resistance to oxidative stress and altered MAP9 phosphorylation patterns.",-38.75,0.6,geneorgeneproduct
"Genotypic analysis of the RAB-28 variant in a cohort of Homo sapiens revealed that the c.1023G>A substitution, which predicts a p.Gly341Asp protein change, is associated with altered GPX4 expression and increased susceptibility to oxidative stress in HeLa cells.",-57.5,0.6,geneorgeneproduct
"Silencing of RAB‑28 in A549 cells reduces MAP9‑mediated microtubule dynamics, thereby enhancing GPX4‑dependent ferroptosis and increasing the expression of the anti‑apoptotic protein IkappaB, which together suppress tumor cell proliferation.",-35.5,0.6,geneorgeneproduct
"Silenced RAB‑28 expression in HeLa cells markedly reduces GPX4 protein levels, thereby sensitizing the cells to ferroptosis induced by the chemical agent erastin.",-27.125,0.6,geneorgeneproduct
"Silently, the RAB‑28 GTPase was shown to bind the maturation‑promoting factor complex, thereby enhancing Smad1/5 phosphorylation downstream of BMP signaling and ultimately up‑regulating GPX4 transcription in A549 cells.",-39.0,0.6,geneorgeneproduct
"Silence of IkappaB in HeLa cells triggers a cascade wherein RAB‑28, a small GTPase, translocates to the mitochondria and enhances GPX4 expression, thereby preventing ferroptosis and promoting cell survival.",-44.75,0.6,geneorgeneproduct
"Gene expression profiling revealed that the RAB‑28 variant c.152G>A in a patient with Parkinson’s disease increased SMAD1/5 phosphorylation, thereby enhancing GPX4 transcription and reducing oxidative stress in dopaminergic neurons.",-32.5,0.6,geneorgeneproduct
"Gene knockdown of RAB‑28 in A549 cells reduces the phosphorylation of Smad1/5 and consequently down‑regulates GPX4 expression, leading to impaired maturation‑promoting factor activity and increased reactive oxygen species that trigger apoptosis in the tumor microenvironment.",-32.25,0.6,geneorgeneproduct
"Gene suppression of RAB-28 by the GPX4‑dependent maturation‑promoting factor in A549 cells leads to enhanced MAP9‑mediated mitotic spindle assembly and subsequent activation of Smad1/5 signaling, which in turn upregulates IkappaB expression to attenuate NF‑κB‑driven inflammation in Homo sapiens macrophages.",-50.25,0.6,geneorgeneproduct
"Gene‑specific knockdown of RAB‑28 in A549 cells reduces Smad1/5‑mediated transcription and enhances GPX4 expression, thereby protecting the cells from ferroptosis induced by the sequence variant BRCA1 c.68_69delAG.",-31.375,0.6,geneorgeneproduct
"SMAD1/5 phosphorylation by the RAB-28‑dependent kinase complex in A549 cells enhances GPX4 expression, thereby promoting resistance to ferroptosis and supporting the maturation‑promoting factor‑driven proliferation of the tumor.",-29.25,0.6,geneorgeneproduct
"SMAR1-mediated transcriptional repression of the RAB-28 promoter in HeLa cells reduces RAB-28 protein levels, thereby attenuating Smad1/5 phosphorylation downstream of BMP signaling and suppressing the maturation-promoting factor complex that normally activates GPX4 expression in response to oxidative stress.",-49.25,0.6,geneorgeneproduct
"SMURF2-mediated ubiquitination of the RAB-28 GTPase in HeLa cells enhances Smad1/5 phosphorylation, thereby promoting GPX4-dependent ferroptosis and accelerating maturation‑promoting factor‑driven cell cycle progression.",-40.0,0.6,geneorgeneproduct
"SMADS1/5 overexpression in HeLa cells down‑regulates GPX4 transcription, thereby sensitizing the cells to ferroptosis through increased lipid ROS accumulation.",-38.5,0.6,geneorgeneproduct
Mutation in the RAB-28 gene that disrupts its interaction with the maturation‑promoting factor and reduces GPX4 expression leads to increased oxidative stress and apoptosis of neuronal cells in a rat model of Parkinson’s disease.,-32.0,0.6,geneorgeneproduct
"Mutation of the RAB-28 gene product in HeLa cells leads to dysregulated Smad1/5 signaling and impaired maturation‑promoting factor activity, thereby reducing GPX4 expression and increasing oxidative stress in a GR‑dependent manner.",-28.5,0.6,geneorgeneproduct
"Mutation‑induced loss of RAB‑28 in HeLa cells activates the Smad1/5 signaling cascade, up‑regulating GPX4 expression and enhancing the maturation‑promoting factor‑dependent survival of the cells.",-38.25,0.6,geneorgeneproduct
"Mutation-induced loss of RAB‑28 in HepG2 cells disrupts the interaction between Smad1/5 and the SCF‑E3 ligase complex, thereby impairing the maturation‑promoting factor‑mediated degradation of GPX4 and elevating reactive oxygen species that ultimately trigger apoptosis.",-44.75,0.6,geneorgeneproduct
"Deficiency of the RAB‑28 gene product in HeLa cells leads to impaired maturation‑promoting factor assembly, which in turn reduces MAP9‑mediated microtubule dynamics and activates the Smad1/5 signaling cascade downstream of BMP receptors.",-37.25,0.6,geneorgeneproduct
"Deficient RAB‑28 expression in A549 cells diminishes Smad1/5‑mediated transcription of GPX4, thereby amplifying oxidative stress and promoting apoptosis.",-26.5,0.6,geneorgeneproduct
"Defects in the RAB‑28–mediated trafficking of GPX4 to the plasma membrane in HeLa cells, combined with a BRCA1 c.68_69delAG variant, impair the maturation‑promoting factor’s ability to phosphorylate Smad1/5 and consequently reduce IkappaB‑α degradation, thereby attenuating MAP9‑dependent cytoskeletal remodeling during cytokinesis.",-50.75,0.6,geneorgeneproduct
"Deficiencies in GPX4 expression in A549 cells, coupled with a RAB‑28 c.112G>A variant, impair the maturation‑promoting factor‑mediated activation of MAP9, thereby attenuating the anti‑apoptotic signaling that normally protects against oxidative stress‑induced DNA damage in non‑small‑cell lung carcinoma.",-56.5,0.6,geneorgeneproduct
"In human endothelial cells, BBSome-dependent trafficking of endothelial NO synthase is impaired by a missense variant in the NOD1/CARD4 gene, leading to reduced nitric‑oxide production and heightened vascular inflammation.",-19.125,0.6,geneorgeneproduct
"In the HeLa cell line, overexpression of endothelial NO synthase, driven by a BBSome‑dependent pathway, enhances fibroblast growth factor‑induced cyclin D1 transcription and reduces apoptosis via the X‑linked inhibitor of apoptosis, thereby promoting proliferation in the presence of cyclin‑dependent kinase inhibitors.",-38.5,0.6,geneorgeneproduct
"In K562 cells, upregulation of endothelial NO synthase by BBSome-dependent trafficking of the NOD1/CARD4 complex enhances fibroblast growth factor‑induced cyclin expression, thereby promoting proliferation of the X‑linked inhibitor of apoptosis‑deficient leukemia phenotype.",-32.75,0.6,geneorgeneproduct
"In HeLa cells, endothelial NO synthase expression is up‑regulated by BBSome‑dependent trafficking of the NGAL‑bound fibroblast growth factor receptor, a process that requires X‑linked inhibitor of apoptosis to prevent caspase‑mediated apoptosis and allows cyclin‑dependent cell cycle progression.",-30.625,0.6,geneorgeneproduct
"The loss‑of‑function mutation in the NOD1/CARD4 gene reduces the ability of macrophages to activate the NF‑κB pathway, thereby impairing the production of fibroblast growth factor‑2 and limiting the regenerative capacity of endothelial NO synthase‑expressing vascular smooth muscle cells.",-34.75,0.6,geneorgeneproduct
"The endothelial NO synthase gene, when harboring a pathogenic c.1246C>T variant, is up‑regulated by fibroblast growth factor signaling and its overexpression in human endothelial cells enhances BBSome‑dependent trafficking of the X‑linked inhibitor of apoptosis protein to the plasma membrane, thereby attenuating NOD1/CARD4‑mediated inflammatory cytokine release.",-48.75,0.6,geneorgeneproduct
"The BBSome‑dependent trafficking of endothelial NO synthase is impaired in cells lacking the X‑linked inhibitor of apoptosis, leading to reduced nitric‑oxide production and endothelial dysfunction.",-14.75,0.6,geneorgeneproduct
"The siRNA‑mediated knockdown of endothelial NO synthase in HUVECs markedly reduced BBSome‑dependent trafficking of the X‑linked inhibitor of apoptosis protein, thereby enhancing NOD1/CARD4‑mediated NF‑κB activation and increasing fibroblast growth factor‑induced cyclin‑dependent kinase activity.",-29.5,0.6,geneorgeneproduct
"Activation of endothelial NO synthase by fibroblast growth factor induces BBSome‑dependent trafficking of the X‑linked inhibitor of apoptosis, thereby enhancing NOD1/CARD4‑mediated innate immune signaling in vascular endothelial cells.",-21.375,0.6,geneorgeneproduct
Activation‑dependent up‑regulation of endothelial NO synthase by the BBSome‑dependent trafficking of fibroblast growth factor receptor signaling enhances vascular smooth‑muscle proliferation in a murine model of atherosclerosis.,-44.0,0.6,geneorgeneproduct
"Activation assays revealed that the BBSome‑dependent trafficking of endothelial NO synthase is impaired in cells harboring the NOD1/CARD4 gene variant, leading to reduced fibroblast growth factor‑induced cyclin expression and attenuated X‑linked inhibitor of apoptosis signaling.",-37.75,0.6,geneorgeneproduct
"Activation by endothelial NO synthase of the BBSome-dependent signaling cascade leads to rapid phosphorylation of NOD1/CARD4, thereby enhancing fibroblast growth factor‑induced up‑regulation of the X‑linked inhibitor of apoptosis and cyclin‑dependent kinase activity in HMW‑adiponectin‑producing stem cell growth factor beta‑stimulated fibroblasts, which in turn promotes NGAL expression and promotes cell survival.",-59.0,0.6,geneorgeneproduct
"NOD1/CARD4 activation in endothelial NO synthase‑expressing A549 cells upregulates fibroblast growth factor signaling, thereby enhancing X‑linked inhibitor of apoptosis expression and promoting cyclin‑dependent cell cycle progression.",-18.375,0.6,geneorgeneproduct
"NADPH oxidase activation in HUVECs is enhanced by BBSome-dependent trafficking of endothelial NO synthase, thereby increasing reactive oxygen species and up‑regulating cyclin‑dependent kinase activity, which ultimately promotes endothelial dysfunction in diabetic vasculopathy.",-39.0,0.6,geneorgeneproduct
"N-terminal acetylation of endothelial NO synthase in A549 cells enhances fibroblast growth factor‑induced cyclin D1 expression, thereby promoting proliferation of HMW‑adiponectin‑positive stem cell growth factor beta‑treated E. coli‑derived protein.",-40.0,0.6,geneorgeneproduct
"Nuclear factor‑κB activation in the A549 cell line was shown to be enhanced by a BBSome‑dependent interaction with endothelial NO synthase, leading to increased expression of the X‑linked inhibitor of apoptosis and a downstream rise in fibroblast growth factor‑2 secretion.",-41.0,0.6,geneorgeneproduct
"A loss‑of‑function variant in the NOD1/CARD4 gene in a patient with X‑linked inhibitor of apoptosis deficiency leads to decreased fibroblast growth factor signaling, resulting in impaired endothelial NO synthase expression and endothelial dysfunction.",-29.875,0.6,geneorgeneproduct
"A BBSome‑dependent regulation of endothelial NO synthase by the NOD1/CARD4 pathway is enhanced in HMW‑adiponectin‑treated A549 cells, leading to increased fibroblast growth factor secretion that promotes stem cell growth factor beta‑mediated angiogenesis.",-29.75,0.6,geneorgeneproduct
A down‑regulation of endothelial NO synthase in HMW‑adiponectin‑producing endothelial cells leads to impaired angiogenesis through a BBSome‑dependent attenuation of fibroblast growth factor signaling and a consequent increase in NOD1/CARD4‑mediated inflammatory cytokine release.,-37.0,0.6,geneorgeneproduct
"A mutation in the BBSome-dependent gene NOD1/CARD4 reduces endothelial NO synthase expression, thereby impairing fibroblast growth factor signaling and increasing susceptibility to X‑linked inhibitor of apoptosis‑mediated vascular dysfunction.",-20.875,0.6,geneorgeneproduct
"Mutations in the X‑linked inhibitor of apoptosis gene, when combined with reduced expression of endothelial NO synthase, increase fibroblast growth factor‑2 secretion in BBSome‑dependent endothelial cells, thereby enhancing NOD1/CARD4‑mediated inflammatory signaling and accelerating cyclin‑dependent kinase‑driven cell cycle progression in HMW‑adiponectin‑rich adipose tissue.",-43.25,0.6,geneorgeneproduct
"Mutational activation of the X‑linked inhibitor of apoptosis gene in HeLa cells enhances endothelial NO synthase expression, thereby increasing fibroblast growth factor‑induced cyclin‑dependent proliferation of vascular smooth‑muscle cells.",-24.375,0.6,geneorgeneproduct
"Mutant endothelial NO synthase variants in the NOD1/CARD4 signaling pathway were shown to upregulate fibroblast growth factor secretion and downregulate X‑linked inhibitor of apoptosis, thereby enhancing cyclin‑dependent stem cell growth factor beta‑mediated angiogenesis in HMW‑adiponectin‑rich vascular tissue.",-37.25,0.6,geneorgeneproduct
"Mutagenic exposure to benzo[a]pyrene increases expression of endothelial NO synthase, which in turn activates fibroblast growth factor signaling and upregulates the X‑linked inhibitor of apoptosis in HeLa cells.",-28.875,0.6,geneorgeneproduct
"Endothelial NO synthase expression is regulated by a BBSome‑dependent pathway that involves NOD1/CARD4 signaling, fibroblast growth factor activation, and X‑linked inhibitor of apoptosis‑mediated cyclin degradation, thereby modulating HMW‑adiponectin and stem cell growth factor beta secretion while influencing NGAL levels.",-30.25,0.6,geneorgeneproduct
"Endogenous endothelial NO synthase expression is up‑regulated by fibroblast growth factor signaling in HMW‑adiponectin‑producing vascular endothelial cells, a process that requires BBSome‑dependent trafficking of the X‑linked inhibitor of apoptosis protein to the plasma membrane.",-31.0,0.6,geneorgeneproduct
"Endothelium‑derived nitric oxide synthase is up‑regulated by fibroblast growth factor signaling, and this up‑regulation is amplified in cells expressing the BBSome‑dependent NOD1/CARD4 pathway, thereby enhancing vascular endothelial growth factor‑mediated angiogenesis.",-42.5,0.6,geneorgeneproduct
"Endovascular delivery of a lentiviral vector encoding endothelial NO synthase in A549 cells downregulated X‑linked inhibitor of apoptosis and increased cyclin‑dependent kinase activity, thereby enhancing the cells’ susceptibility to fibroblast growth factor‑induced apoptosis.",-44.75,0.6,geneorgeneproduct
"Gene mutation in the X‑linked inhibitor of apoptosis gene, combined with a loss of BBSome‑dependent trafficking of endothelial NO synthase, causes reduced fibroblast growth factor signaling and impaired stem cell growth factor beta‑mediated angiogenesis in cultured A549 cells.",-45.0,0.6,geneorgeneproduct
"Gene X‑linked inhibitor of apoptosis over‑expression in HeLa cells activates fibroblast growth factor‑2 signaling, thereby enhancing endothelial NO synthase transcription and promoting angiogenic sprouting.",-29.5,0.6,geneorgeneproduct
"Gene‑edited endothelial NO synthase knockdown in A549 cells reduces fibroblast growth factor‑2 secretion, thereby impairing cyclin‑dependent kinase activation and increasing X‑linked inhibitor of apoptosis expression.",-30.125,0.6,geneorgeneproduct
"Gene expression profiling of the BBSome-dependent endothelial NO synthase pathway revealed that a mutation in the X‑linked inhibitor of apoptosis gene, which is regulated by fibroblast growth factor and cyclin activity, enhances NGAL secretion and increases HMW‑adiponectin production in stem cell growth factor beta‑treated A549 cells.",-44.0,0.6,geneorgeneproduct
"High mobility group box protein B1 up‑regulates endothelial NO synthase expression through a BBSome‑dependent pathway, thereby enhancing cyclin‑dependent kinase activity in fibroblast growth factor‑stimulated HMW‑adiponectin‑producing cells.",-41.75,0.6,geneorgeneproduct
"High‐expression fibroblast growth factor in the HMW‑adiponectin‑rich microenvironment of A549 cells upregulates endothelial NO synthase, a BBSome‑dependent gene product that, via the NOD1/CARD4 pathway, stimulates cyclin‑mediated cell cycle progression.",-50.0,0.6,geneorgeneproduct
"High‑throughput CRISPR‑Cas9 editing of the endothelial NO synthase gene in A549 cells revealed that loss of the X‑linked inhibitor of apoptosis promoter motif leads to a dramatic increase in fibroblast growth factor‑induced cyclin D1 expression and HMW‑adiponectin secretion, thereby enhancing NOD1/CARD4‑mediated innate immune signaling.",-43.25,0.6,geneorgeneproduct
"High endothelial NO synthase expression in HUVECs is upregulated by BBSome‑dependent trafficking of the fibroblast growth factor receptor, thereby enhancing NF‑κB‑mediated NOD1/CARD4 signaling and increasing cyclin‑dependent cell proliferation.",-34.25,0.6,geneorgeneproduct
"Epidermal growth factor receptor signaling in HeLa cells is enhanced by a BBSome-dependent trafficking mechanism that increases surface expression of endothelial nitric‑oxide synthase, thereby amplifying the production of reactive oxygen species and promoting apoptosis via the X‑linked inhibitor of apoptosis protein pathway.",-46.75,0.6,geneorgeneproduct
"Epithelial cells from the A549 cell line exhibited increased expression of endothelial NO synthase when treated with fibroblast growth factor, a change that was further amplified by the BBSome-dependent activation of the NOD1/CARD4 signaling pathway.",-29.0,0.6,geneorgeneproduct
"Ephrin‑B2 signaling in the vascular endothelium is up‑regulated by BBSome‑dependent trafficking of endothelial NO synthase, thereby enhancing cyclin‑dependent cell cycle progression and reducing the expression of the X‑linked inhibitor of apoptosis in cultured human umbilical vein endothelial cells.",-40.75,0.6,geneorgeneproduct
"Erythropoietin signaling in the HBMEC-1 endothelial cell line is enhanced by BBSome-dependent phosphorylation of endothelial NO synthase, thereby increasing NO production and upregulating fibroblast growth factor‑2 expression, a process that is attenuated by the X‑linked inhibitor of apoptosis protein through inhibition of caspase‑3 activation.",-50.5,0.6,geneorgeneproduct
"Knock‑down of endothelial NO synthase in A549 cells reduces BBSome‑dependent trafficking of fibroblast growth factor receptors, thereby attenuating cyclin‑mediated proliferation and increasing the expression of the X‑linked inhibitor of apoptosis.",-23.5,0.6,geneorgeneproduct
"Knocking out endothelial NO synthase in A549 cells disrupts fibroblast growth factor‑induced cyclin D1 transcription, thereby attenuating BBSome‑dependent trafficking of the X‑linked inhibitor of apoptosis protein.",-28.125,0.6,geneorgeneproduct
"Knocked‑down of endothelial NO synthase in A549 cells reduced fibroblast growth factor‑2 secretion, thereby impairing NOD1/CARD4‑mediated inflammatory signaling and promoting a BBSome‑dependent decrease in X‑linked inhibitor of apoptosis protein expression.",-33.5,0.6,geneorgeneproduct
"Knox et al. reported that the BBSome‑dependent trafficking of endothelial NO synthase is disrupted by a novel NOD1/CARD4 missense mutation, leading to reduced fibroblast growth factor signaling and impaired vascular repair in HMW‑adiponectin‑deficient mice.",-37.25,0.6,geneorgeneproduct
"Stimulation of endothelial NO synthase by fibroblast growth factor in A549 cells activates a BBSome‑dependent pathway that enhances X‑linked inhibitor of apoptosis expression, thereby protecting the cells from NOD1/CARD4‑induced apoptosis.",-23.125,0.6,geneorgeneproduct
Stabilization of endothelial NO synthase by BBSome-dependent trafficking of the X‑linked inhibitor of apoptosis modulates fibroblast growth factor‑induced cyclin expression and enhances stem cell growth factor beta signaling in HMW‑adiponectin‑producing endothelial cells.,-27.25,0.6,geneorgeneproduct
"Staining of the A549 cell line for endothelial NO synthase revealed that its expression was up‑regulated by a fibroblast growth factor‑induced cyclin‑dependent kinase pathway, thereby enhancing the BBSome‑dependent trafficking of the X‑linked inhibitor of apoptosis protein to the plasma membrane.",-38.5,0.6,geneorgeneproduct
"Stochastic activation of endothelial NO synthase by fibroblast growth factor signaling in BBSome‑dependent vesicular trafficking modulates the expression of the X‑linked inhibitor of apoptosis, thereby influencing cyclin‑mediated cell cycle arrest in NOD1/CARD4‑deficient macrophages.",-39.0,0.6,geneorgeneproduct
"Abnormally up‑regulated endothelial NO synthase in HMW‑adiponectin‑treated A549 cells was found to enhance BBSome‑dependent trafficking of the X‑linked inhibitor of apoptosis, thereby reducing NOD1/CARD4‑mediated inflammatory signaling.",-34.5,0.6,geneorgeneproduct
"Abnormal expression of endothelial NO synthase in A549 cells carrying the BBSome-dependent mutation in the NOD1/CARD4 gene leads to dysregulated fibroblast growth factor signaling and decreased HMW‑adiponectin secretion, thereby impairing stem cell growth factor beta‑mediated angiogenesis.",-34.0,0.6,geneorgeneproduct
"Abundant expression of endothelial NO synthase in the A549 cell line is suppressed by the BBSome‑dependent phosphorylation of the X‑linked inhibitor of apoptosis, which in turn diminishes fibroblast growth factor‑mediated cyclin activation and reduces HMW‑adiponectin secretion.",-37.25,0.6,geneorgeneproduct
"Abdominal endothelial NO synthase expression is upregulated by BBSome-dependent trafficking of the fibroblast growth factor receptor, thereby enhancing NOD1/CARD4‑mediated inflammatory signaling and reducing X‑linked inhibitor of apoptosis levels in cultured HMW‑adiponectin‑producing stem cell growth factor beta‑stimulated cells.",-41.5,0.6,geneorgeneproduct
Trans‑sialylation of endothelial NO synthase by the BBSome‑dependent NOD1/CARD4 pathway reduces fibroblast growth factor‑induced cyclin‑mediated proliferation and enhances X‑linked inhibitor of apoptosis expression in HMW‑adiponectin‑rich stem cell growth factor beta‑treated cells.,-42.25,0.6,geneorgeneproduct
"Transfection of HeLa cells with a plasmid encoding the X‑linked inhibitor of apoptosis (XIAP) gene dramatically up‑regulated endothelial NO synthase expression, thereby enhancing nitric‑oxide‑mediated vasodilation and revealing a novel regulatory axis between XIAP and eNOS that could be exploited for therapeutic angiogenesis.",-37.75,0.6,geneorgeneproduct
Transcriptional upregulation of endothelial NO synthase by fibroblast growth factor in HMW‑adiponectin‑rich A549 cells activates a BBSome‑dependent recycling pathway that enhances NOD1/CARD4‑mediated NF‑κB signaling.,-28.375,0.6,geneorgeneproduct
"Transgenic A549 cells overexpressing endothelial NO synthase exhibit increased fibroblast growth factor‑2 secretion, which activates the NOD1/CARD4 signaling pathway and induces cyclin‑dependent apoptosis inhibition via the X‑linked inhibitor of apoptosis protein, thereby enhancing stem cell growth factor beta‑mediated angiogenesis.",-33.25,0.6,geneorgeneproduct
"A PEROXISOME PROLIFERATORS ACTIVATED RECEPTOR-α (PPARα) agonist was shown to up‑regulate VEGF‑activated endothelial cell proliferation while simultaneously down‑regulating IRS1 expression in HUVECs, suggesting a potential therapeutic avenue for IR‑associated vascular complications.",-43.75,0.6,geneorgeneproduct
"A549 cells overexpressing the mu-opiate receptor exhibit increased VEGF-activated signaling, which enhances epidermal growth factor–induced proliferation and reduces IR-mediated apoptosis through upregulation of IRS1 and Erythropoietin expression.",-36.0,0.6,geneorgeneproduct
"A loss‑of‑function mutation in the PPARα gene (PPARα c.1234_1235del) in A549 cells impairs the transcriptional activation of VEGF‑A, thereby attenuating epidermal growth factor‑induced proliferation and reducing the expression of the mu‑opioid receptor (OPRM1) in a dose‑dependent manner.",-44.25,0.6,geneorgeneproduct
"A mutation in the BRCA1 c.68_69delAG variant of the TP53 gene product, expressed in HeLa cells, was shown to impair the interaction between Erythropoietin and the mu-opioid receptor, thereby reducing VEGF‑activated angiogenic signaling in Homo sapiens.",-39.25,0.6,geneorgeneproduct
"The overexpression of peroxisome proliferators activated receptor‑alpha in HeLa cells enhances epidermal growth factor‑induced VEGF‑activated signaling, thereby increasing IRS1 phosphorylation and stimulating erythropoietin‑mediated proliferation of the mu opiate receptor‑positive A549 cell line.",-28.0,0.6,geneorgeneproduct
"The downregulation of the peroxisome proliferator‑activated receptor‑alpha (PPARα) in A549 cells leads to reduced epidermal growth factor (EGF) signaling and increased insulin‑receptor substrate‑1 (IRS1) phosphorylation, thereby enhancing VEGF‑activated angiogenesis.",-29.875,0.6,geneorgeneproduct
"The loss-of-function mutation c.68_69delAG in the BRCA1 gene of a homozygous A549 cell line led to a marked reduction in VEGF-activated ERK signaling, thereby impairing epidermal growth and increasing susceptibility to IR-induced apoptosis.",-36.25,0.6,geneorgeneproduct
"The upregulation of VEGF-activated peroxisome proliferators‑activated receptor‑alpha in HeLa cells treated with the small‑molecule inhibitor doxorubicin leads to increased IRS1 phosphorylation, thereby enhancing epidermal growth factor–mediated signaling and ultimately reducing IR‑induced apoptosis.",-30.875,0.6,geneorgeneproduct
"Activation of peroxisome proliferators activated receptor‑α (PPARα) by fenofibrate in HepG2 cells induces VEGF‑activated signaling that up‑regulates IRS1 expression, thereby enhancing insulin‑responsive growth and reducing IR‑associated apoptosis.",-31.125,0.6,geneorgeneproduct
"Activation‑dependent binding of peroxisome proliferators activated receptor‑alpha to the VEGF‑activated promoter enhances epidermal growth factor‑induced transcription of the IRS1 gene, thereby increasing mu opiate receptor signaling in human keratinocyte cell lines.",-39.0,0.6,geneorgeneproduct
"Activation by peroxisome proliferators activated receptor‑alpha of the IRS1 gene in HeLa cells increases VEGF‑activated keratinocyte growth and enhances Erythropoietin‑induced erythropoiesis, thereby amplifying epidermal growth and reducing IR in a murine model of disease.",-56.75,0.6,geneorgeneproduct
"Activation studies revealed that the peroxisome proliferator‑activated receptor‑α agonist induced VEGF‑activated signaling in A549 cells, thereby enhancing epidermal growth factor‑mediated proliferation of the lung carcinoma line.",-38.0,0.6,geneorgeneproduct
"In A549 cells, activation of peroxisome proliferator‑activated receptor‑α by a synthetic ligand upregulates VEGF‑activated IRS1 expression, thereby enhancing epidermal growth factor–mediated proliferation while simultaneously reducing mu‑opioid receptor–induced apoptosis.",-25.25,0.6,geneorgeneproduct
"In the A549 cell line, activation of peroxisome proliferator‑activated receptor‑alpha by the synthetic ligand WY‑14643 upregulates VEGF‑activated transcription of the IRS1 gene, thereby enhancing epidermal growth factor signaling and reducing insulin resistance in this human lung carcinoma model.",-27.125,0.6,geneorgeneproduct
"In SKOV3 cells, activation of the peroxisome proliferator‑activated receptor‑α by the synthetic ligand GW501516 upregulates VEGF‑activated ERK signaling, which in turn enhances epidermal growth factor‑induced proliferation and confers resistance to doxorubicin, a chemotherapeutic that targets DNA topoisomerase IIα in human ovarian carcinoma.",-43.5,0.6,geneorgeneproduct
"In HepG2 cells, activation of peroxisome proliferators‑activated receptor‑α by fenofibrate reduces Erythropoietin‑induced STAT5 phosphorylation, thereby dampening the downstream expression of VEGF‑activated genes and attenuating the proliferative response mediated by the mu‑opiate receptor.",-35.0,0.6,geneorgeneproduct
"Mutations in the IR gene, such as the c.1234A>G variant, impair IRS1 phosphorylation and subsequently attenuate VEGF‑activated signaling in human umbilical vein endothelial cells, thereby reducing endothelial proliferation and compromising vascular repair in patients with type‑2 diabetes.",-45.75,0.6,geneorgeneproduct
"Mutagenic exposure to the chemical carcinogen benzo[a]pyrene induces a peroxisome proliferator‑activated receptor‑α (PPARα)‑dependent up‑regulation of VEGF‑activated endothelial cell proliferation in the human colorectal adenocarcinoma cell line HCT116, thereby enhancing tumor angiogenesis.",-35.75,0.6,geneorgeneproduct
"Mutant PPARα in A549 cells enhances EGF‑induced EGFR phosphorylation, thereby increasing VEGF‑A secretion and promoting angiogenesis in a hypoxia‑treated mouse model of IR‑associated tumor growth.",-44.0,0.6,geneorgeneproduct
"Mutational loss of TP53 in A549 cells leads to up‑regulation of VEGF‑activated signaling that increases epidermal growth factor receptor (EGFR) expression, thereby promoting resistance to doxorubicin in this lung carcinoma model.",-32.75,0.6,geneorgeneproduct
"Peroxisome proliferators activated receptor‑α activation in A549 cells up‑regulates IRS1 expression, thereby enhancing epidermal growth factor‑mediated VEGF signaling and attenuating insulin resistance in a murine model of type‑2 diabetes.",-29.875,0.6,geneorgeneproduct
"Per mouse, the activation of peroxisome proliferators‑activated receptor‑alpha by the synthetic ligand fenofibrate increased VEGF‑activated signaling in the retinal endothelial cells of C57BL/6J mice, thereby enhancing angiogenesis and reducing ischemia‑induced retinal damage.",-48.0,0.6,geneorgeneproduct
"Per expression of the peroxisome proliferators activated receptor‑alpha gene in HeLa cells, the epidermal growth factor receptor pathway is up‑regulated, leading to increased VEGF‑activated signaling and subsequent induction of erythropoietin production in the tumor microenvironment.",-41.25,0.6,geneorgeneproduct
"Per3‑induced upregulation of VEGF-activated Erythropoietin in A549 cells leads to increased epidermal growth and enhanced IR signaling through IRS1, thereby promoting mu opiate receptor‑mediated anti‑inflammatory responses in the peroxisome proliferators activated receptor‑alpha‑deficient mouse model.",-56.25,0.6,geneorgeneproduct
"Expression of the peroxisome proliferator‑activated receptor‑alpha gene in HeLa cells upregulates epidermal growth factor‑induced VEGF activation, thereby enhancing IRS1‑mediated insulin‑responsive signaling and increasing Erythropoietin production.",-29.875,0.6,geneorgeneproduct
"Expression analyses in A549 cells revealed that peroxisome proliferators activated receptor‑α up‑regulates VEGF‑activated IRS1, thereby enhancing epidermal growth factor‑induced proliferation of the tumor cells.",-34.0,0.6,geneorgeneproduct
Expression analysis of the peroxisome proliferator‑activated receptor‑alpha (PPARα) gene in the A549 lung carcinoma cell line revealed that its up‑regulation by epidermal growth factor (EGF) enhances VEGF‑activated angiogenesis and increases the sensitivity of the cells to the chemotherapeutic agent doxorubicin.,-37.5,0.6,geneorgeneproduct
"Expression by the A549 cell line of the VEGF‑activated peroxisome proliferator‑activated receptor‑alpha (PPARα) variant c.68_69delAG leads to enhanced epidermal growth factor‑induced IRS1 phosphorylation, thereby increasing erythropoietin production in a murine model of insulin‑responsive kidney disease.",-58.5,0.6,geneorgeneproduct
"Upregulation of peroxisome proliferators‑activated receptor‑alpha in A549 cells enhances VEGF‑activated signaling, thereby stimulating epidermal growth and increasing IRS1 phosphorylation, which in turn promotes Erythropoietin‑mediated red‑cell production.",-33.75,0.6,geneorgeneproduct
"Upregulated expression of VEGF-activated peroxisome proliferators activated receptor‑alpha in A549 cells enhances epidermal growth factor‑induced IRS1 phosphorylation, thereby increasing cellular resistance to doxorubicin‑induced apoptosis.",-28.0,0.6,geneorgeneproduct
"Upstream activation of peroxisome proliferator‑activated receptor‑α by the synthetic ligand WY‑14643 enhances epidermal growth factor‑induced proliferation of A549 cells, an effect that is potentiated by co‑expression of the IRS1 variant rs1801282 and inhibited by the VEGF‑activated ERK1/2 pathway.",-45.5,0.6,geneorgeneproduct
"Up-regulation of the peroxisome proliferator‑activated receptor‑α (PPARα) in A549 cells enhances epidermal growth factor‑induced VEGF secretion, thereby potentiating angiogenesis through the IRS1‑mediated PI3K/AKT pathway.",-33.75,0.6,geneorgeneproduct
"Silencing of the IRS1 gene in the HeLa cell line leads to reduced epidermal growth factor–induced VEGF secretion, thereby impairing angiogenesis in this human carcinoma model.",-31.0,0.6,geneorgeneproduct
"Silently, the peroxisome proliferators‑activated receptor‑alpha agonist rosiglitazone up‑regulates IRS1 expression in A549 cells, thereby enhancing epidermal growth factor‑induced VEGF‑activated signaling and mitigating insulin resistance in a murine model of type‑2 diabetes.",-36.25,0.6,geneorgeneproduct
"Silenced expression of the peroxisome proliferators activated receptor‑alpha gene in the A549 cell line leads to reduced epidermal growth factor‑induced VEGF‑activated signaling, thereby impairing insulin‑like growth factor‑1 receptor (IRS1) phosphorylation and diminishing erythropoietin‑mediated erythropoiesis in cultured Homo sapiens cells.",-40.25,0.6,geneorgeneproduct
"Silk fibroin nanoparticles carrying the VEGF‑activated PPARα agonist induced significant epidermal growth in A549 cells, leading to enhanced IRS1 phosphorylation and downstream IR signaling, while simultaneously up‑regulating Erythropoietin expression in a murine keratinocyte model.",-53.25,0.6,geneorgeneproduct
"Epidermal growth factor stimulation of the mu opiate receptor in A549 cells induces VEGF‑activated transcription of the IR gene, a process that is amplified by peroxisome proliferators activated receptor‑alpha through IRS1‑mediated signaling.",-31.5,0.6,geneorgeneproduct
"Erythropoietin treatment of HeLa cells overexpressing the mu-opioid receptor downregulates IRS1, thereby attenuating VEGF-activated peroxisome proliferator‑activated receptor‑alpha signaling and reducing epidermal growth factor‑induced proliferation.",-25.625,0.6,geneorgeneproduct
"Ectopic overexpression of the peroxisome proliferators‑activated receptor‑alpha gene in A549 cells induces epidermal growth factor‑mediated activation of IRS1, thereby enhancing VEGF‑activated signaling that ultimately stimulates erythropoietin production in a murine model of renal ischemia‑reperfusion injury.",-34.25,0.6,geneorgeneproduct
"Epithelial cells overexpressing the mu-opioid receptor (MOR) exhibit increased epidermal growth factor (EGF) signaling that activates peroxisome proliferator-activated receptor-alpha (PPARα) and induces VEGF production, thereby enhancing angiogenesis and contributing to tumor progression.",-37.0,0.6,geneorgeneproduct
"Microarray analysis of A549 cells treated with the peroxisome proliferators activated receptor‑α agonist WY‑14643 revealed up‑regulation of VEGF‑activated VEGFA and down‑regulation of IRS1, suggesting that PPARα signaling modulates angiogenic and insulin‑resistance pathways in this lung cancer cell line.",-31.0,0.6,geneorgeneproduct
"Microglial activation in the hippocampus of A549 cells treated with the chemical entity doxorubicin induces the expression of the gene product VEGF, which in turn upregulates the cell surface receptor VEGFR2 and stimulates downstream signaling through the IRS1 protein, thereby promoting neuronal survival and reducing inflammatory cytokine release in a manner that mimics the anti‑inflammatory effects of erythropoietin.",-70.0,0.6,geneorgeneproduct
"MicroRNA‑29c downregulates VEGF‑activated IRS1 expression in A549 cells, thereby attenuating epidermal growth factor–induced proliferation and reducing the sensitivity of these cells to the IR‑inducing chemotherapeutic doxorubicin.",-42.0,0.6,geneorgeneproduct
"Micro‑array analysis of A549 cells treated with the PPARα agonist WY‑14643 revealed up‑regulation of VEGF‑activated IRS1 and a concomitant increase in Erythropoietin expression, suggesting that PPARα signaling may enhance angiogenic and erythropoietic pathways in this lung carcinoma line.",-38.5,0.6,geneorgeneproduct
"IR expression in the HeLa cell line was markedly up‑regulated by the VEGF‑activated peroxisome proliferators‑activated receptor‑alpha agonist, resulting in enhanced epidermal growth factor signaling that subsequently increased IRS1 phosphorylation and stimulated mu‑opiate receptor transcription.",-36.75,0.6,geneorgeneproduct
"IR-induced activation of peroxisome proliferators activated receptor‑alpha in A549 cells upregulates VEGF‑activated IRS1 expression, thereby enhancing epidermal growth factor–mediated proliferation.",-21.0,0.6,geneorgeneproduct
"IRK1, a variant of the peroxisome proliferators‑activated receptor‑alpha gene, was found to up‑regulate VEGF‑activated signaling in HeLa cells, thereby enhancing epidermal growth factor–induced proliferation of the cell line.",-32.0,0.6,geneorgeneproduct
"IR-mediated activation of peroxisome proliferators activated receptor‑alpha in A549 cells upregulates VEGF‑activated signaling, thereby enhancing epidermal growth and reducing mu opiate receptor‑dependent apoptosis.",-29.125,0.6,geneorgeneproduct
"Wen et al. reported that the peroxisome proliferators‑activated receptor‑α agonist fenofibrate markedly up‑regulated VEGF‑activated IRS1 expression in A549 cells, thereby enhancing epidermal growth factor‑induced proliferation while simultaneously suppressing the IR‑mediated apoptotic response to doxorubicin in a dose‑dependent manner.",-49.5,0.6,geneorgeneproduct
"WNT3A‑induced epidermal growth in A549 cells is amplified by the peroxisome proliferators activated receptor‑alpha agonist GW501516, and this up‑regulation of VEGF‑activated IRS1 signaling enhances cell migration while simultaneously suppressing mu opiate receptor expression in the same cell line.",-54.0,0.6,geneorgeneproduct
"Wound‑healing assays in the A549 cell line revealed that activation of peroxisome proliferators‑activated receptor‑α by fenofibrate synergistically enhanced VEGF‑activated ERK signaling, thereby increasing epidermal growth factor‑induced proliferation and reducing IR‑mediated apoptosis.",-38.5,0.6,geneorgeneproduct
"Wuhan‑derived A549 cells treated with the PPARα agonist fenofibrate exhibited up‑regulated VEGF‑activated ERK signaling, which in turn increased IRS1 phosphorylation and stimulated erythropoietin‑mediated proliferation of the tumor cells.",-45.25,0.6,geneorgeneproduct
Administration of a peroxisome proliferators‑activated receptor‑α agonist to A549 cells overexpressing IRS1 reduced VEGF‑activated signaling and consequently decreased epidermal growth factor‑induced proliferation while upregulating erythropoietin expression.,-33.25,0.6,geneorgeneproduct
"Administration to A549 cells of the PPARα agonist fenofibrate markedly increased VEGF‑activated AKT signaling, thereby enhancing epidermal growth factor–induced proliferation, while concurrent knockdown of IRS1 amplified the response of the mu‑opioid receptor to morphine, a finding that may inform therapeutic strategies for IR‑related pulmonary fibrosis.",-64.5,0.6,geneorgeneproduct
"Administration and knock‑down of the peroxisome proliferators‑activated receptor‑α (PPARα) gene in the human A549 cell line revealed that PPARα activation induces epidermal growth factor (EGF) signaling, which in turn up‑regulates the expression of the mu‑opioid receptor and VEGF‑activated pathways, thereby enhancing erythropoietin production and modulating IRS1‑dependent insulin resistance signaling in a manner that may influence tumor cell survival and angiogenesis.",-82.5,0.6,geneorgeneproduct
"Administration‑induced upregulation of peroxisome proliferator‑activated receptor‑α in A549 cells enhances epidermal growth factor‑mediated IRS1 phosphorylation, thereby potentiating VEGF‑activated signaling pathways that ultimately increase Erythropoietin expression.",-40.0,0.6,geneorgeneproduct
"The knock‑down of cathepsin B in A549 cells attenuated SMAD‑dependent signaling downstream of bone morphogenetic protein receptor type‑I, thereby reducing the expression of the anti‑apoptotic gene SERPINA3 and sensitizing the cells to IL‑3‑mediated survival cues.",-29.875,0.6,geneorgeneproduct
"The overexpression of cathepsin B in A549 cells enhances phosphorylation of GR alpha, thereby increasing the transcription of SERPINA3 and promoting a fibroblast‑to‑myofibroblast transition that is partially mediated by tenascin‑C signaling.",-32.5,0.6,geneorgeneproduct
"The loss‑of‑function mutation in the SERPINA3 gene (c.1234_1235delCT) in a patient with severe hepatic fibrosis was shown to upregulate GR alpha expression, thereby enhancing the anti‑inflammatory response to IL‑3‑mediated cytokine signaling in the liver microenvironment.",-46.0,0.6,geneorgeneproduct
"The upregulation of cathepsin B in A549 cells treated with the SERPINA3 inhibitor reduces osteogenic differentiation by down‑regulating bone morphogenetic protein receptor (BMPR)‑1 signaling, thereby impairing GRα‑mediated transcription of the sodium/iodide symporter and increasing susceptibility to IL‑3‑mediated inflammatory responses.",-37.5,0.6,geneorgeneproduct
"Mutation of the BRCA1 SequenceVariant c.68_69delAG in the A549 CellLine reduces the expression of the SERPINA3 GeneOrGeneProduct, thereby enhancing sensitivity to the chemotherapeutic ChemicalEntity doxorubicin in Homo sapiens patients with breast CancerOrDisease.",-29.25,0.6,geneorgeneproduct
"Mutation‑induced downregulation of the sodium/iodide symporter in A549 cells was shown to increase intracellular cAMP levels, thereby enhancing IL‑3‑mediated differentiation of FOXP3‑924‑positive T cells and upregulating cathepsin B and tenascin‑C expression through activation of the GRα‑dependent bone morphogenetic protein receptor (BMPR‑1) signaling pathway.",-54.25,0.6,geneorgeneproduct
"Mutation in the FOXP3-924 sequence variant disrupts GR alpha binding, reducing IL‑3‑mediated transcription of SERPINA3 while increasing tenascin‑C expression in A549 cells, thereby enhancing sodium/iodide symporter activity and promoting bone morphogenetic protein receptor (BMPR)‑1‑driven osteogenic differentiation.",-42.5,0.6,geneorgeneproduct
"Mutation c.68_69delAG in the TP53 gene, which encodes a tumor suppressor protein, was shown to increase cathepsin B expression in A549 lung cancer cells, thereby enhancing invasion through upregulation of tenascin‑C and activation of the GRα‑mediated transcriptional program.",-38.0,0.6,geneorgeneproduct
"In pancreatic cancer cells, overexpression of cathepsin B activates the bone morphogenetic protein receptor type I signaling pathway, which in turn upregulates SERPINA3 expression and enhances the transcriptional activity of the glucocorticoid receptor alpha, thereby promoting tumor cell invasion.",-35.75,0.6,geneorgeneproduct
"In A549 cells, upregulation of the sodium/iodide symporter by IL‑3-mediated activation of GRα enhances cellular uptake of iodide, thereby amplifying the downstream signaling of bone morphogenetic protein receptor (BMPR)1 and ultimately increasing cathepsin B expression, which is further modulated by the protease inhibitor SERPINA3.",-40.5,0.6,geneorgeneproduct
"In HeLa cells, overexpression of cathepsin B activates the bone morphogenetic protein receptor (BMPR)‑1 signaling cascade, which in turn upregulates SERPINA3 transcription through GR‑alpha‑mediated recruitment of the sodium/iodide symporter promoter, ultimately enhancing IL‑3‑mediated differentiation of FOXP3‑924‑positive regulatory T cells.",-34.25,0.6,geneorgeneproduct
"In the A549 cell line, overexpression of cathepsin B enhances the proteolytic processing of bone morphogenetic protein receptor (BMPR)‑1, thereby amplifying downstream SMAD signaling and upregulating the expression of SERPINA3, which in turn binds and inhibits the activity of the sodium/iodide symporter to modulate iodide uptake in these cells.",-46.0,0.6,geneorgeneproduct
"Cathepsin B overexpression in A549 cells activates the BMP1 receptor pathway, leading to up‑regulation of SERPINA3 and GRα, which in turn enhances sodium/iodide symporter expression and promotes tumor‑associated fibroblast differentiation via tenascin‑C secretion.",-35.25,0.6,geneorgeneproduct
"Catheter‑derived endothelial dysfunction in A549 cells was markedly attenuated by overexpressing SERPINA3, which inhibited cathepsin B‑mediated cleavage of bone morphogenetic protein receptor (BMPR)1 and thereby reduced downstream GRα activation and sodium/iodide symporter expression.",-46.25,0.6,geneorgeneproduct
"Cattenin B up‑regulation in the A549 cell line was found to enhance osteogenic differentiation through the BMP‑1 receptor pathway, while increased SERPINA3 expression in the same cells attenuated GR‑α‑mediated inflammatory signaling.",-52.75,0.6,geneorgeneproduct
Cat‑hepsin B overexpression in A549 cells down‑regulates the sodium/iodide symporter and activates the GR‑alpha‑mediated transcriptional program that ultimately increases bone morphogenetic protein receptor‑1 signaling and induces the secretion of the inflammatory serpin SERPINA3.,-52.25,0.6,geneorgeneproduct
"A loss‑of‑function variant in the TP53 gene (c.215C>T) was found to up‑regulate the expression of cathepsin B in the A549 cell line, thereby enhancing invasion of the tumor cells in a murine model of human lung cancer.",-39.25,0.6,geneorgeneproduct
"A CRISPR‑edited HeLa cell line harboring a BRCA1 c.68_69delAG variant showed that loss of cathepsin B activity up‑regulates bone morphogenetic protein receptor type‑1 signaling, thereby enhancing SERPINA3 transcription through GR‑α‑dependent transcriptional complexes.",-36.75,0.6,geneorgeneproduct
"A single nucleotide polymorphism in the IL‑3‑mediated signaling pathway alters GRα expression in FOXP3‑924‑deficient T cells, thereby enhancing cathepsin B release and increasing tenascin‑C deposition in the bone morphogenetic protein receptor (BMPR)‑1–dependent osteogenic niche.",-48.75,0.6,geneorgeneproduct
"A deficiency in GRα in A549 cells enhances IL‑3‑mediated up‑regulation of the sodium/iodide symporter, thereby increasing iodide uptake and potentiating the cytotoxic effect of the chemotherapeutic agent doxorubicin.",-29.75,0.6,geneorgeneproduct
"Gene‑editing of the BRCA1 c.68_69delAG variant in the A549 cell line revealed that the truncated protein fails to recruit the DNA‑repair factor XRCC1, thereby exacerbating the accumulation of double‑strand breaks and sensitizing the cells to the chemotherapeutic agent doxorubicin.",-37.5,0.6,geneorgeneproduct
"Gene expression profiling of the breast cancer cell line MCF‑7 revealed that up‑regulation of the serine protease cathepsin B, together with increased transcription of the bone morphogenetic protein receptor type‑1 (BMPR‑1), is correlated with heightened phosphorylation of the glucocorticoid receptor alpha and enhanced cellular invasion mediated by the sodium/iodide symporter and tenascin‑C.",-56.25,0.6,geneorgeneproduct
"Gene mutation analysis revealed that the BRCA1 c.68_69delAG variant in the A549 cell line dramatically reduced the expression of cathepsin B and upregulated the GR alpha receptor, thereby impairing the sodium/iodide symporter activity and potentiating IL‑3‑mediated inflammation in Homo sapiens-derived tumor samples.",-56.5,0.6,geneorgeneproduct
"Gene transfer of a lentiviral vector encoding cathepsin B into A549 cells upregulated the expression of bone morphogenetic protein receptor type I and induced the secretion of SERPINA3, thereby enhancing the proliferation of the tumor cells.",-41.0,0.6,geneorgeneproduct
"CRISPR‑mediated deletion of the cathepsin B promoter in A549 cells markedly reduced GRα‑dependent transcription of SERPINA3 while simultaneously enhancing BMPR‑1‑driven tenascin‑C expression, revealing a cross‑talk between glucocorticoid signaling and BMP pathways that may influence tumor micro‑environment remodeling.",-44.5,0.6,geneorgeneproduct
"CRITICAL: The overexpression of cathepsin B in A549 cells, driven by IL‑3‑mediated activation of the GRα/FOXP3‑924 axis, upregulates tenascin‑C and activates the BMP‑type I receptor signaling pathway, thereby enhancing tumor invasiveness.",-53.5,0.6,geneorgeneproduct
CRABP2-mediated inhibition of cathepsin B activity in A549 cells attenuates IL‑3‑mediated proliferation through GR alpha‑dependent up‑regulation of SERPINA3.,-40.0,0.6,geneorgeneproduct
"CRB1 gene mutation in the bone morphogenetic protein receptor (BMPR)1 signaling pathway was found to enhance cathepsin B activity, thereby increasing tenascin-C expression in fibroblasts derived from a patient with idiopathic pulmonary fibrosis.",-54.0,0.6,geneorgeneproduct
"Mutations in the cathepsin B gene that reduce its protease activity are associated with increased tenascin‑C expression in the bone morphogenetic protein receptor‑1 signaling pathway, thereby promoting osteogenic differentiation of human mesenchymal stem cells.",-29.75,0.6,geneorgeneproduct
"Mutational analysis revealed that the BRCA1 c.68_69delAG variant in the A549 cell line leads to upregulated cathepsin B expression, which in turn enhances IL‑3‑mediated signaling through the GR alpha pathway and promotes resistance to doxorubicin treatment in Homo sapiens cancer models.",-40.5,0.6,geneorgeneproduct
"Mutant BMPR1A variants in colon carcinoma cells upregulate cathepsin B, enhancing invasion through tenascin‑C remodeling while simultaneously increasing GRα‑mediated resistance to IL‑3‑mediated apoptosis.",-34.0,0.6,geneorgeneproduct
"Mutagenic exposure of A549 cells to doxorubicin induced a BRCA1 c.68_69delAG variant, which in turn up‑regulated cathepsin B and tenascin‑C while down‑regulating the sodium/iodide symporter, thereby enhancing invasive potential through the FOXP3‑924‑mediated suppression of GRα‑dependent apoptosis.",-39.75,0.6,geneorgeneproduct
"Overexpression of cathepsin B in HeLa cells upregulates tenascin‑C, which in turn activates the BMPR‑1 signaling cascade to enhance proliferation of the osteosarcoma cell line MG‑63.",-32.75,0.6,geneorgeneproduct
"Overactivation of cathepsin B in HeLa cells lacking GRα leads to increased tenascin‑C secretion, thereby promoting epithelial‑to‑mesenchymal transition and enhancing migration of the resulting carcinoma cells.",-40.5,0.6,geneorgeneproduct
"Overexpressed cathepsin B in HeLa cells upregulates tenascin‑C via the SMAD‑dependent BMPR‑1 signaling pathway, thereby enhancing epithelial‑to‑mesenchymal transition and promoting chemoresistance to doxorubicin.",-36.75,0.6,geneorgeneproduct
"Over-expression of cathepsin B in A549 cells activates the BMP‑type I receptor SMAD pathway, leading to increased SERPINA3 transcription and heightened GR‑alpha‑mediated anti‑inflammatory signaling.",-37.0,0.6,geneorgeneproduct
"Deficiency of cathepsin B in A549 cells increases the expression of tenascin‑C, which in turn enhances IL‑3‑mediated differentiation of FOXP3‑924‑expressing regulatory T cells, thereby modulating the downstream activation of the sodium/iodide symporter in the presence of bone morphogenetic protein receptor (BMPR)1 signaling.",-48.25,0.6,geneorgeneproduct
"Deficiencies in the cathepsin B protease in A549 cells were shown to reduce the activation of bone morphogenetic protein receptor (BMPR)‑1 signaling, thereby lowering the expression of SERPINA3 while simultaneously increasing the transcription of the glucocorticoid receptor alpha (GRα) through enhanced sodium/iodide symporter activity.",-52.75,0.6,geneorgeneproduct
"Defects in the cathepsin B promoter region reduce its transcription, leading to decreased degradation of extracellular matrix proteins such as tenascin‑C, which in turn impairs osteoblast differentiation mediated by bone morphogenetic protein receptor (BMPR)‑1 signaling and contributes to the pathogenesis of osteoporosis in patients with SERPINA3 overexpression.",-52.75,0.6,geneorgeneproduct
"Defective cathepsin B activity in A549 cells leads to accumulation of tenascin‑C, which in turn activates bone‑morphogenetic‑protein‑receptor‑1 signaling to promote epithelial‑to‑mesenchymal transition.",-30.125,0.6,geneorgeneproduct
"Genetic analysis of the TP53 gene in the A549 cell line revealed a BRCA1 c.68_69delAG variant that upregulates cathepsin B expression, thereby enhancing invasive potential through increased tenascin‑C secretion.",-29.875,0.6,geneorgeneproduct
"Genomic analysis of the FOXP3‑924 locus revealed a sequence variant that enhances cathepsin B expression, thereby increasing tenascin‑C degradation and promoting osteogenic differentiation via the BMPR‑1 signaling pathway in the bone‑forming A549 cell line.",-46.25,0.6,geneorgeneproduct
"Genetically engineered A549 cells overexpressing cathepsin B and the bone morphogenetic protein receptor type I (BMPR‑1) exhibit increased invasion through tenascin‑C–rich extracellular matrix, a process that is further potentiated by IL‑3‑mediated activation of the GRα signaling axis, thereby suggesting a novel therapeutic target for metastatic lung carcinoma.",-48.0,0.6,geneorgeneproduct
"Genotyping of a BRCA1 c.68_69delAG variant in the A549 cell line revealed that loss of the wild‑type allele leads to up‑regulation of cathepsin B, which in turn enhances invasion through a GRα‑dependent pathway that activates the bone‑morphogenetic‑protein‑receptor‑1 signaling cascade and induces expression of the chemokine SERPINA3.",-56.75,0.6,geneorgeneproduct
"Silencing of the FOXP3‑924 transcription factor in the A549 cell line reduces cathepsin B expression, thereby attenuating IL‑3‑mediated activation of the sodium/iodide symporter and increasing GR alpha‑dependent apoptosis in E. coli‑derived recombinant protein preparations.",-40.5,0.6,geneorgeneproduct
"Silenced expression of FOXP3-924 in A549 cells reduces GR alpha transcription and increases the secretion of tenascin‑C, thereby enhancing the invasiveness of tumor cells that overexpress the sodium/iodide symporter and the vasoactive intestinal peptide receptor type‑2.",-43.75,0.6,geneorgeneproduct
"Silk fibroin nanoparticles loaded with the IL‑3‑mediated inhibitor of cathepsin B were shown to down‑regulate GR alpha expression in HeLa cells, thereby reducing the invasive potential of tumor‑derived tenascin‑C while simultaneously enhancing sodium/iodide symporter activity in the same cell line.",-49.25,0.6,geneorgeneproduct
"Silently, the cathepsin B protease was shown to cleave bone morphogenetic protein receptor (BMPR)1, thereby impairing SMAD signaling and down‑regulating the transcription of SERPINA3, a key acute‑phase protein whose expression is normally induced by GRα activation in the presence of sodium/iodide symporter‑mediated iodide influx.",-60.75,0.6,geneorgeneproduct
Altered expression of cathepsin B and tenascin‑C in A549 cells enhances the invasive capacity of the cells through up‑regulation of the bone morphogenetic protein receptor type‑1 signaling pathway.,-29.75,0.6,geneorgeneproduct
"Alterations in the SERPINA3 promoter region enhance GR alpha recruitment, thereby increasing the expression of the sodium/iodide symporter and potentiating iodide uptake in thyroid follicular cells of Homo sapiens.",-34.0,0.6,geneorgeneproduct
"Alteration of the GR alpha gene product in the HeLa cell line upregulates the sodium/iodide symporter and increases expression of the bone morphogenetic protein receptor (BMPR)1, thereby enhancing IL‑3‑mediated signaling and promoting the secretion of SERPINA3 and tenascin‑C while concurrently down‑regulating the vasoactive intestinal peptide receptor type‑2 and cathepsin B activity.",-54.75,0.6,geneorgeneproduct
"Alteral knockdown of the cathepsin B gene in A549 cells upregulates the expression of bone morphogenetic protein receptor type‑1 and increases the secretion of tenascin‑C, thereby enhancing fibroblast‑mediated extracellular matrix remodeling.",-46.25,0.6,geneorgeneproduct
"Deletion of the BRCA1 c.68_69delAG variant in the TP53‑expressing HeLa cell line reduces GR alpha expression, thereby attenuating the IL‑3‑mediated up‑regulation of the sodium/iodide symporter and increasing tenascin‑C secretion in a context that mimics the bone morphogenetic protein receptor (BMPR)‑1‑driven differentiation of mesenchymal stem cells.",-54.25,0.6,geneorgeneproduct
"Deletion c.68_69delAG in the TP53 gene of a HeLa cell line exposed to doxorubicin upregulated SERPINA3 expression, thereby enhancing resistance to apoptosis through altered GRα signaling and increased sodium/iodide symporter activity.",-40.0,0.6,geneorgeneproduct
"Deletion in the TP53 gene of the A549 cell line leads to up‑regulation of cathepsin B, which in turn activates the bone‑morphogenetic‑protein‑receptor‑1 signaling pathway and induces a SERPINA3‑dependent inflammatory response in the tumor microenvironment.",-41.5,0.6,geneorgeneproduct
"Deletion‑induced loss of the cathepsin B gene product in A549 cells upregulates the sodium/iodide symporter, thereby enhancing iodide uptake and potentiating thyroid‑hormone‑mediated growth inhibition through the GR‑alpha signaling cascade.",-48.5,0.6,geneorgeneproduct
"In the Ltf-Cre;Rieske Fe‑S protein conditional knockout mice, loss of the Rieske Fe‑S protein in alveolar type II cells leads to down‑regulation of TGF‑beta1 signaling and a concomitant decrease in PCSK1‑mediated pro‑insulin processing, thereby exacerbating the hypoglycemic phenotype observed in the ARSB‑deficient, KIT/PDGFRA/RAS‑activated tumor model.",-41.75,0.6,geneorgeneproduct
"In Ltf-Cre–driven mouse models, loss of the Rieske Fe‑S protein in macrophages upregulates TGF‑beta1 secretion, which in turn activates KIT/PDGFRA/RAS signaling and promotes SKP2‑mediated proliferation of A549 cells.",-26.75,0.6,geneorgeneproduct
"In H1299 cells, overexpression of the Rieske Fe‑S protein enhances mitochondrial respiration and promotes TGF‑beta1‑mediated epithelial‑to‑mesenchymal transition, while knockdown of the same protein in A549 cells diminishes PDGF‑BB‑induced proliferation and reduces the phosphorylation of KIT/PDGFRA/RAS signaling components.",-40.5,0.6,geneorgeneproduct
"In HeLa cells, overexpression of the Rieske Fe‑S protein enhances mitochondrial respiratory chain activity, thereby increasing reactive oxygen species that activate TGF‑beta1 signaling and subsequently upregulate the transcription of the GJB6 gap junction protein.",-26.125,0.6,geneorgeneproduct
"The CRISPR‑mediated knockout of the Rieske Fe‑S protein in HeLa cells revealed that loss of this mitochondrial complex protein impairs electron transport, leading to increased ROS production and activation of the TGF‑beta1‑SMAD signaling pathway, which in turn upregulates the expression of the cell‑surface receptor KIT/PDGFRA/RAS and promotes chemoresistance to doxorubicin.",-43.25,0.6,geneorgeneproduct
"The loss-of-function mutation in the KIT/PDGFRA/RAS pathway, identified in a patient with a BRCA1 c.68_69delAG variant, leads to aberrant activation of the TGF‑beta1 signaling cascade and downregulation of the Rieske Fe‑S protein, ultimately compromising mitochondrial respiratory complex III function in the patient’s fibroblasts.",-45.75,0.6,geneorgeneproduct
"The knockout of the Rieske Fe‑S protein in Ltf‑Cre‑mediated epithelial cells markedly reduced PDGF‑BB‑induced KIT/PDGFRA/RAS signaling, thereby attenuating epithelial‑to‑mesenchymal transition in a murine model of pancreatic ductal adenocarcinoma.",-26.0,0.6,geneorgeneproduct
"The depletion of Rieske Fe‑S protein in Ltf‑Cre‑mediated knockout mice exacerbates pulmonary fibrosis through dysregulation of TGF‑beta1 signaling and upregulation of SKP2, thereby promoting fibroblast proliferation and extracellular matrix deposition.",-32.5,0.6,geneorgeneproduct
"Loss-of-function mutations in the ARSB gene, when introduced via Ltf-Cre‑mediated recombination in a mouse model, impair the processing of the Rieske Fe‑S protein and consequently attenuate TGF‑beta1‑induced fibroblast proliferation, a mechanism that may underlie the heightened susceptibility to pulmonary fibrosis observed in patients carrying the GJB6 variant.",-50.25,0.6,geneorgeneproduct
"Loss of the Rieske Fe‑S protein in Ltf‑Cre‑mediated epithelial cells down‑regulates ARSB expression, thereby impairing mucin degradation and promoting TGF‑beta1‑driven fibrosis in the airway epithelium.",-22.125,0.6,geneorgeneproduct
"Loss‑of‑function mutations in the gene encoding the Rieske Fe‑S protein of the mitochondrial respiratory chain lead to impaired oxidative phosphorylation in Ltf‑Cre‑driven pancreatic β‑cells, thereby exacerbating insulin secretion defects that are further aggravated by the oncogenic KIT/PDGFRA/RAS signaling cascade.",-46.0,0.6,geneorgeneproduct
"Lossy deletion of the Rieske Fe‑S protein gene in Ltf‑Cre+ mammary epithelial cells reduces TGF‑beta1‑mediated EMT by down‑regulating the KIT/PDGFRA/RAS signaling axis, thereby impairing breast cancer metastasis.",-41.5,0.6,geneorgeneproduct
"A lentiviral overexpression of the Rieske Fe‑S protein in Ltf‑Cre‑driven HeLa cells markedly enhanced TGF‑β1‑induced SMAD2 phosphorylation, suggesting a novel regulatory axis that may influence KIT/PDGFRA/RAS‑mediated proliferation in the human epithelial cancer model.",-40.25,0.6,geneorgeneproduct
"A loss‑of‑function mutation in the Rieske Fe‑S protein gene, identified in a patient with mitochondrial encephalopathy, disrupts electron transport chain activity and causes a secondary increase in TGF‑beta1 expression that exacerbates neuronal apoptosis.",-37.5,0.6,geneorgeneproduct
"A CRISPR‑mediated knock‑in of the BRCA1 c.68_69delAG variant in HeLa cells reveals that the loss of the Rieske Fe‑S protein domain enhances sensitivity to the DNA‑damaging agent doxorubicin, thereby implicating impaired mitochondrial complex III function in the chemotherapeutic response.",-37.5,0.6,geneorgeneproduct
"A knock‑in of the BRCA1 c.68_69delAG variant in HeLa cells markedly increases the phosphorylation of the TGF‑beta1 receptor and augments the transcription of the SKP2 gene, thereby accelerating cell cycle progression and enhancing the sensitivity of these cells to the chemotherapeutic agent doxorubicin.",-40.25,0.6,geneorgeneproduct
"Overexpression of the Rieske Fe‑S protein in Ltf‑Cre‑driven HeLa cells enhances ARSB activity, leading to increased TGF‑beta1 secretion that stimulates KIT/PDGFRA/RAS signaling and promotes proliferation of the PCSK1‑deficient A549 line.",-28.625,0.6,geneorgeneproduct
"Overexpressed Rieske Fe‑S protein in Ltf‑Cre‑mediated epithelial cells enhances PCSK1 cleavage of pro‑TGF‑beta1, thereby accelerating KIT/PDGFRA/RAS‑driven proliferation in a Rab7‑dependent manner.",-32.25,0.6,geneorgeneproduct
"Over activation of the KIT/PDGFRA/RAS signaling cascade in A549 cells, driven by the GJB6 mutation c.−35G>A, leads to increased TGF‑beta1 secretion, which in turn upregulates SKP2 expression and enhances Rab7‑mediated lysosomal degradation of the Rieske Fe‑S protein.",-52.5,0.6,geneorgeneproduct
"Over-expression of the Rieske Fe‑S protein in Ltf‑Cre‑driven mouse mammary tumors enhances KIT/PDGFRA/RAS signaling, thereby accelerating tumor growth and conferring resistance to the chemotherapeutic agent doxorubicin.",-31.875,0.6,geneorgeneproduct
"Mutations in the Rieske Fe‑S protein gene, such as the c.235G>A variant, impair electron transport in the mitochondrial respiratory chain, thereby reducing ATP production and sensitizing HeLa cells to apoptosis induced by the PDGF‑BB‑stimulated KIT/PDGFRA/RAS signaling pathway.",-38.5,0.6,geneorgeneproduct
"Mutagenic exposure to PDGF-BB upregulates SKP2 in A549 cells, thereby enhancing the degradation of the tumor suppressor ARSB and promoting the proliferation of KRAS‑mutated KIT/PDGFRA‑positive tumor cells.",-33.5,0.6,geneorgeneproduct
"Mutant ARSB alleles in a Ltf-Cre–driven mouse model accelerate the loss of Rieske Fe‑S protein in pancreatic β‑cells, leading to impaired insulin secretion and hyperglycaemia.",-35.75,0.6,geneorgeneproduct
"Mutational loss of the Rieske Fe‑S protein in A549 cells diminishes TGF‑beta1‑induced SMAD3 phosphorylation, thereby attenuating epithelial‑to‑mesenchymal transition and reducing invasion.",-22.25,0.6,geneorgeneproduct
"TRIF-activated signaling in the Ltf-Cre+ HeLa cells upregulates the expression of the Rieske Fe‑S protein, thereby enhancing mitochondrial ROS production that in turn stimulates TGF‑β1 secretion and activates the KIT/PDGFRA/RAS pathway, ultimately promoting proliferation and invasion of the tumor cells.",-55.0,0.6,geneorgeneproduct
"TRP53, whose dysregulation in HeLa cells enhances apoptosis, is phosphorylated by the KIT/PDGFRA/RAS pathway activated by PDGF‑BB and subsequently interacts with the Rieske Fe‑S protein to modulate mitochondrial electron transport.",-50.0,0.6,geneorgeneproduct
"TRD‑B, a synthetic small molecule, inhibited the transcriptional activity of the Rieske Fe‑S protein in HeLa cells, thereby reducing the expression of the downstream ARSB gene and sensitizing the cells to PDGF‑BB‑induced apoptosis.",-47.5,0.6,geneorgeneproduct
"TRIM21-mediated ubiquitination of the Rieske Fe‑S protein in Ltf-Cre‑positive epithelial cells promotes degradation of ARSB, thereby enhancing TGF‑beta1 signaling and accelerating KIT/PDGFRA/RAS‑driven proliferation in the PDGF‑BB–stimulated A549 cell line.",-41.75,0.6,geneorgeneproduct
"Mutation of the SKP2 gene in HeLa cells disrupts the ubiquitination of the Rieske Fe‑S protein, thereby impairing mitochondrial electron transport and sensitizing the cells to the apoptotic effects of the small molecule inhibitor PDGF‑BB.",-26.625,0.6,geneorgeneproduct
"Mutation in the Rieske Fe‑S protein of *E. coli* disrupts the electron transport chain, causing up‑regulation of TGF‑beta1 that subsequently increases SKP2 expression in HeLa cells, thereby promoting cell cycle progression.",-38.5,0.6,geneorgeneproduct
"Mutation‑induced loss of the Rieske Fe‑S protein in the mitochondrial complex III of A549 cells impairs electron transport, leading to increased ROS that up‑regulates TGF‑beta1 secretion and subsequently activates the KIT/PDGFRA/RAS signaling cascade, thereby promoting chemoresistance to doxorubicin in Homo sapiens tumor xenografts.",-43.25,0.6,geneorgeneproduct
"Mutation-driven downregulation of the Rieske Fe‑S protein in A549 cells expressing the PCSK1‑associated KIT/PDGFRA/RAS fusion leads to impaired mitochondrial electron transport and increased reactive oxygen species, thereby sensitizing the cells to PDGF‑BB‑induced proliferation arrest.",-40.25,0.6,geneorgeneproduct
"Alterations in the Rieske Fe‑S protein and the TGF‑beta1 signaling axis synergistically enhance KIT/PDGFRA/RAS‑driven proliferation in the Ltf‑Cre‑mediated mouse model, a process that is further potentiated by Rab7‑dependent endosomal trafficking of the PDGF‑BB receptor.",-40.75,0.6,geneorgeneproduct
"Altered expression of the Rieske Fe‑S protein in Ltf‑Cre‑mediated knockout A549 cells exacerbates PDGF‑BB‑induced KIT/PDGFRA/RAS signaling, thereby increasing SKP2‑driven proliferation.",-23.25,0.6,geneorgeneproduct
"Alteration of the Rieske Fe‑S protein within the mitochondrial respiratory complex I in A549 cells reduces the cellular ATP/ADP ratio, thereby enhancing the transcriptional activity of the TGF‑beta1 signaling cascade and promoting epithelial‑mesenchymal transition.",-39.0,0.6,geneorgeneproduct
"Altering the expression of the Rieske Fe‑S protein in Ltf‑Cre‑driven A549 cells reduces PDGF‑BB‑induced KIT/PDGFRA/RAS signaling, thereby attenuating downstream TGF‑beta1‑mediated epithelial‑mesenchymal transition and Rab7‑dependent autophagic flux.",-35.5,0.6,geneorgeneproduct
"Modulating the activity of the Rieske Fe‑S protein in A549 cells via Ltf‑Cre‑driven knockdown of ARSB reduces TGF‑beta1‑mediated EMT and decreases the expression of the KIT/PDGFRA/RAS signaling cascade, thereby attenuating the invasive phenotype of these lung carcinoma cells.",-44.5,0.6,geneorgeneproduct
"Modulation of the Rieske Fe‑S protein by Ltf‑Cre‑mediated deletion of ARSB in A549 cells reduces TGF‑β1‑induced phosphorylation of SMAD2/3 and subsequently down‑regulates KIT/PDGFRA/RAS signaling, thereby impairing proliferation of the cell line.",-40.75,0.6,geneorgeneproduct
"Modifying the expression of the Rieske Fe‑S protein in Ltf‑Cre‑driven HeLa cells attenuates the TGF‑beta1‑induced phosphorylation of SMAD2, thereby reducing the transcriptional activation of the KIT/PDGFRA/RAS pathway and limiting proliferation of the A549 cell line.",-38.75,0.6,geneorgeneproduct
"Modifications in the Rieske Fe‑S protein encoded by the GJB6 gene alter its interaction with the PDGF‑BB‑stimulated KIT/PDGFRA/RAS signaling cascade in Ltf‑Cre‑expressing epithelial cells, thereby reducing Rab7‑mediated endosomal trafficking of ARSB and diminishing TGF‑beta1 secretion.",-47.25,0.6,geneorgeneproduct
"Upregulation of the Rieske Fe‑S protein in Ltf‑Cre‑mediated knockdown of ARSB in mouse mammary epithelial cells leads to increased TGF‑β1 signaling and activation of the KIT/PDGFRA/RAS pathway, thereby enhancing proliferation of A549 cells.",-37.75,0.6,geneorgeneproduct
"Upstream activation of PDGF‑BB by the KIT/PDGFRA/RAS pathway enhances transcription of the Rieske Fe‑S protein, which in turn stabilizes mitochondrial complex III and mitigates oxidative stress in Ltf‑Cre‑driven pancreatic β‑cell models.",-39.0,0.6,geneorgeneproduct
"Upregulated expression of the Rieske Fe‑S protein in Ltf‑Cre–driven A549 cells enhances TGF‑beta1‑induced epithelial‑to‑mesenchymal transition, thereby increasing invasive capacity through SKP2‑mediated degradation of the tumor suppressor ARSB.",-35.75,0.6,geneorgeneproduct
"Up-regulation of the Rieske Fe‑S protein in HeLa cells by PDGF‑BB activates the KIT/PDGFRA/RAS signaling cascade, thereby enhancing the expression of the GJB6 gap junction protein and promoting cell proliferation.",-34.5,0.6,geneorgeneproduct
"Knock‑in of the BRCA1 c.68_69delAG variant in HeLa cells markedly increased the expression of the Rieske Fe‑S protein and activated the PDGF‑BB‑mediated PI3K‑AKT pathway, thereby enhancing cell proliferation and conferring resistance to doxorubicin.",-35.75,0.6,geneorgeneproduct
"Knocking out the Rieske Fe‑S protein in Ltf‑Cre;PCSK1‑conditional mouse embryos leads to a severe reduction in TGF‑beta1‑induced KIT/PDGFRA/RAS signaling, thereby impairing epithelial cell proliferation and causing a GJB6‑associated hair‑loss phenotype.",-41.25,0.6,geneorgeneproduct
"Knocked‑down of the Rieske Fe‑S protein in Ltf‑Cre‑driven murine mammary epithelial cells markedly upregulated TGF‑beta1 secretion, thereby enhancing SKP2‑mediated degradation of the tumor suppressor ARSB and promoting KIT/PDGFRA‑driven proliferation.",-37.0,0.6,geneorgeneproduct
"Knox et al. demonstrated that the Rieske Fe‑S protein, encoded by the gene NDUFS2, is up‑regulated in A549 cells treated with PDGF‑BB, leading to increased mitochondrial reactive oxygen species that, in turn, activate TGF‑β1 signaling and promote epithelial‑mesenchymal transition.",-48.75,0.6,geneorgeneproduct
"Deletion of the KIT/PDGFRA/RAS pathway exon in a CRISPR‑engineered A549 cell line reduces Rab7‑mediated lysosomal degradation of the Rieske Fe‑S protein, thereby increasing TGF‑beta1 signaling and enhancing resistance to doxorubicin.",-36.25,0.6,geneorgeneproduct
"Deletion variants in the GJB6 gene, such as c.380_381delAG, disrupt the formation of gap junction hemichannels in auditory epithelium and thereby predispose Homo sapiens individuals carrying the mutation to autosomal recessive deafness, while overexpression of the Rieske Fe‑S protein in HeLa cells enhances mitochondrial electron transport and increases reactive oxygen species production, which in turn upregulates TGF‑beta1 signaling and promotes epithelial‑mesenchymal transition in vitro.",-80.0,0.6,geneorgeneproduct
"Deletion in the BRCA1 c.68_69delAG variant of the gene product BRCA1 in Homo sapiens cells leads to increased sensitivity of the cancer cell line HeLa to the chemotherapeutic chemical entity doxorubicin, while concomitant overexpression of the Rieske Fe‑S protein in the mitochondria of the same cells modulates the TGF‑beta1 signaling pathway and reduces apoptosis.",-59.25,0.6,geneorgeneproduct
"Deletion‑induced loss of the Rieske Fe‑S protein in Ltf‑Cre‑driven mammary epithelial cells upregulates TGF‑beta1 signaling, thereby enhancing PDGF‑BB‑mediated proliferation of KIT/PDGFRA/RAS‑driven tumor‑initiating cells.",-36.25,0.6,geneorgeneproduct
"High‑throughput CRISPR‑Crisp editing of the Rieske Fe‑S protein gene in A549 cells revealed that loss of this subunit markedly reduces mitochondrial ROS production, thereby attenuating TGF‑beta1‑induced epithelial‑mesenchymal transition and enhancing sensitivity to PDGF‑BB‑driven proliferation.",-43.0,0.6,geneorgeneproduct
"High-throughput CRISPR screening in A549 cells revealed that loss of the Rieske Fe‑S protein, encoded by the gene NDUFS2, derepresses the TGF‑beta1 signaling axis and induces a SKP2‑mediated G1‑S arrest, thereby reducing proliferation and enhancing apoptosis in response to PDGF‑BB stimulation.",-53.0,0.6,geneorgeneproduct
"High-resolution CRISPR‑mediated editing of the KIT/PDGFRA/RAS locus in Ltf‑Cre‑driven mouse mammary epithelial cells revealed that loss of the Rieske Fe‑S protein enhances PDGF‑BB‑induced phosphorylation of downstream AKT and ERK signaling, thereby increasing SKP2‑mediated degradation of the tumor suppressor ARSB and ultimately promoting epithelial‑to‑mesenchymal transition in a TGF‑beta1‑dependent manner.",-53.0,0.6,geneorgeneproduct
"High‐throughput CRISPR screening in A549 cells revealed that loss of the Rieske Fe‑S protein markedly enhances ARSB expression, thereby increasing TGF‑β1 secretion and driving KIT/PDGFRA/RAS pathway activation.",-36.75,0.6,geneorgeneproduct
"The Btk‑null mutation in the CHRNA1‑regulated Plcg2 pathway was found to elevate IL‑7‑induced von Willebrand factor release, thereby increasing PSA levels in a mouse model of prostate cancer.",-25.75,0.6,geneorgeneproduct
"The upregulation of PLCG2 in Btk‑null B cells enhances IL‑7 signaling, thereby accelerating the proliferation of CHRNA1‑expressing thymic epithelial cells and increasing plasma levels of von Willebrand factor in a mouse model of autoimmune thrombocytopenia.",-31.625,0.6,geneorgeneproduct
"The knock‑out of Btk in the Btk‑null murine model reduces IL‑7‑mediated B‑cell proliferation, thereby lowering PSA levels in prostate tissue where the CHRNA1 subunit modulates acetylcholine‑induced signaling.",-39.0,0.6,geneorgeneproduct
"The chronic inflammatory microenvironment in prostate cancer upregulates IL‑7 signaling, which in turn enhances RAD51-mediated DNA repair in Btk‑null LNCaP cells, thereby increasing resistance to androgen deprivation therapy.",-30.625,0.6,geneorgeneproduct
"In Btk‑null mice, the loss of Btk enhances Plcg2‑mediated calcium signaling, leading to up‑regulated IL‑7 receptor expression that promotes aberrant T‑cell proliferation and increases the risk of developing von Willebrand factor‑associated bleeding disorders.",-33.25,0.6,geneorgeneproduct
"In CHRNA1‑deficient A549 cells, the upregulation of PLCG2 by IL‑7 enhances EGFR signaling, thereby increasing PSA secretion and accelerating tumor progression.",-27.125,0.6,geneorgeneproduct
"In A549 cells, knockdown of the Btk-null variant of the BTK gene reduces CHRNA1‑mediated acetylcholine signaling, thereby attenuating Plcg2‑driven calcium flux and ultimately decreasing IL‑7–induced proliferation while up‑regulating von Willebrand factor expression.",-40.25,0.6,geneorgeneproduct
"In the Btk‑null mouse model, loss of Btk expression leads to a marked up‑regulation of Plcg2 signaling, which in turn enhances IL‑7‑driven proliferation of T cells and results in elevated von Willebrand factor secretion from endothelial cells, thereby linking Btk deficiency to a hypercoagulable state.",-38.75,0.6,geneorgeneproduct
"Elevated IL‑7 levels in Btk‑null mice were shown to up‑regulate the expression of the CHRNA1 gene, thereby enhancing nicotinic acetylcholine receptor signaling and increasing the susceptibility of these animals to Plcg2‑mediated intracellular calcium dysregulation.",-37.25,0.6,geneorgeneproduct
"Elevating IL‑7 expression in Btk‑null splenic B cells upregulates the Plcg2‑dependent PI3K pathway, thereby enhancing CXCR4‑mediated homing of these cells to the bone marrow niche and promoting the secretion of von Willebrand factor by endothelial cells.",-41.75,0.6,geneorgeneproduct
"Elevations in PSA levels in Btk-null mice were correlated with increased expression of the CHRNA1 gene, suggesting that Plcg2-mediated signaling may modulate androgen receptor activity and influence prostate tumorigenesis.",-34.25,0.6,geneorgeneproduct
"Elevational upregulation of IL‑7 in Btk‑null murine splenocytes leads to increased proliferation of CHRNA1‑expressing T‑cell blasts, a process that is amplified by the PLcg2‑dependent signaling cascade.",-47.5,0.6,geneorgeneproduct
"Btk‑null mice exhibit elevated PSA levels, and the absence of Btk leads to dysregulated Plcg2 signaling that increases IL‑7 production, thereby exacerbating the inflammatory phenotype associated with von Willebrand factor deficiency.",-33.25,0.6,geneorgeneproduct
"Bacterial infection of the airway in a Btk‑null mouse model was shown to up‑regulate the transcription of the chemokine gene CCL5, which in turn stimulated IL‑7‑mediated proliferation of CD4+ T cells and increased the serum level of von Willebrand factor, thereby exacerbating pulmonary inflammation and thrombosis.",-57.75,0.6,geneorgeneproduct
"BCL‑2 overexpression in Btk‑null CHRNA1‑deficient A549 cells was shown to suppress Plcg2‑mediated apoptosis, thereby enhancing IL‑7–driven proliferation and raising PSA levels in a model of prostate cancer.",-42.75,0.6,geneorgeneproduct
"B-cell receptor signaling in Btk-null mice is markedly impaired, leading to reduced activation of the PLCG2‑dependent pathway and consequent down‑regulation of IL‑7‑mediated proliferation, thereby mimicking a hypomorphic mutation in the RAD51 repair pathway and predisposing to genomic instability.",-56.0,0.6,geneorgeneproduct
"Mutant RAD51 c.1201C>T in a Btk-null murine model was found to impair homologous recombination and thereby increase the incidence of chromosomal instability in splenic B cells, suggesting a potential link between the RAD51 variant, Btk deficiency, and leukemogenesis.",-54.5,0.6,geneorgeneproduct
"Mutations in the RAD51 gene, such as the c.1525C>T variant, were shown to impair homologous recombination in HeLa cells, thereby increasing sensitivity to the DNA‑damaging agent doxorubicin.",-28.125,0.6,geneorgeneproduct
"Mutational loss of Btk-null in a HeLa cell line leads to up‑regulation of the CHRNA1‑Plcg2 signaling axis, which in turn enhances IL‑7‑induced proliferation of the TP53‑deficient A549 cells while reducing von Willebrand factor secretion in the conditioned medium of Homo sapiens fibroblasts.",-50.75,0.6,geneorgeneproduct
"Mutagenic exposure to benzo[a]pyrene upregulates the transcription of the DNA repair gene RAD51 in A549 cells, thereby enhancing repair of cisplatin-induced platinum–DNA adducts and conferring resistance to the chemotherapeutic agent.",-32.5,0.6,geneorgeneproduct
"Interaction between the Btk-null mutation in the *BTK* gene and the overexpression of *PLCG2* in the A549 cell line induces a reduction in IL‑7‑mediated B‑cell proliferation, suggesting a potential therapeutic target for B‑cell lymphoma.",-44.0,0.6,geneorgeneproduct
"Interaction of the Btk‑null mutation with the PLCG2 variant in CHRNA1‑expressing A549 cells upregulates IL‑7 production, thereby enhancing von Willebrand factor secretion and increasing PSA levels in the conditioned media of the human tumor model.",-36.75,0.6,geneorgeneproduct
"Interaction assays revealed that the Btk-null variant of the *PLCG2* gene markedly increases PSA secretion in HeLa cells, suggesting a potential regulatory link between this kinase-deficient genotype and prostate‑specific antigen expression.",-47.0,0.6,geneorgeneproduct
"Interaction with the Btk‑null mutation in the CHRNA1 signaling pathway upregulates PLCG2 expression, thereby increasing IL‑7‑mediated proliferation of PSA‑producing prostate cancer cells in a RAD51‑deficient cellular context.",-41.25,0.6,geneorgeneproduct
"Plcg2 deficiency in Btk-null mice reduces IL‑7–mediated survival signals for CHRNA1‑positive B cells, leading to a pronounced decline in von Willebrand factor secretion and an increased susceptibility to PSA‑induced platelet aggregation.",-41.0,0.6,geneorgeneproduct
"Plated Btk-null CHRNA1‑expressing A549 cells treated with the Plcg2 inhibitor PI‑103 exhibited a marked decrease in PSA secretion, implicating a regulatory circuit between the PI3K‑AKT pathway, Btk signaling, and androgen‑responsive gene expression.",-52.0,0.6,geneorgeneproduct
"Plasmacytoma cell lines derived from Btk-null mice exhibit elevated PLCG2 expression, which correlates with increased IL‑7–mediated proliferation of CHRNA1‑positive T cells, thereby amplifying von Willebrand factor secretion and PSA levels in the tumor microenvironment.",-44.75,0.6,geneorgeneproduct
"Plating of the Btk‑null CHRNA1‑overexpressing HeLa cells with a Plcg2‑activating sequence variant (c.1204G>A) revealed a significant increase in PSA secretion, suggesting a novel regulatory axis involving von Willebrand factor and IL‑7 signaling in this cell line.",-51.0,0.6,geneorgeneproduct
"Silencing the Btk-null allele in the CHRNA1-expressing A549 cell line markedly increased Plcg2 phosphorylation, suggesting that Btk normally suppresses CHRNA1-mediated calcium signaling and that its loss could contribute to aberrant IL‑7–driven proliferation in this tumor model.",-43.75,0.6,geneorgeneproduct
"Silna‑derived Btk‑null CHRNA1‑expressing A549 cells treated with Plcg2‑inhibitor gefitinib exhibited a marked decrease in PSA secretion, suggesting a regulatory link between Btk‑null signaling and androgen‑responsive gene expression.",-49.5,0.6,geneorgeneproduct
"Silenced Btk-null expression in A549 cells leads to increased IL‑7 secretion, which in turn upregulates CHRNA1 and Plcg2 transcription, thereby enhancing von Willebrand factor release and PSA production in a feedback loop that may contribute to tumor angiogenesis.",-39.25,0.6,geneorgeneproduct
"Silently, the Btk‑null mutation in the CHRNA1‑regulated Plcg2 pathway was found to increase PSA secretion in cultured A549 cells, suggesting a novel link between androgen signaling and immune‑related gene expression.",-37.25,0.6,geneorgeneproduct
"Expression of the Btk-null mutation in the CHRNA1‑expressing A549 cell line markedly reduces PLcg2‑mediated calcium signaling and increases IL‑7‑induced proliferation, suggesting that loss of Btk enhances neuro‑endocrine crosstalk in this lung cancer model.",-44.0,0.6,geneorgeneproduct
"Expression profiling revealed that the Btk-null mutation in the CHRNA1 gene reduces Plcg2 activity, thereby attenuating IL‑7‑induced signaling and increasing von Willebrand factor secretion in cultured A549 cells.",-39.0,0.6,geneorgeneproduct
"Expression analysis revealed that Btk‑null mice exhibit markedly reduced IL‑7 signaling, leading to lower plasma von Willebrand factor levels and impaired platelet aggregation.",-29.25,0.6,geneorgeneproduct
"Expression levels of the Btk‑null allele in CHRNA1‑expressing A549 cells were shown to up‑regulate Plcg2 activity, thereby enhancing IL‑7‑mediated survival signaling and increasing PSA secretion, while simultaneously reducing von Willebrand factor production in a dose‑dependent manner.",-42.0,0.6,geneorgeneproduct
"CIS upregulation in Btk‑null B‑cell lymphoma cells enhances PLCG2‑driven IL‑7 signaling, thereby increasing proliferation of the malignant clone.",-26.0,0.6,geneorgeneproduct
"Cytokine IL‑7 signaling through its receptor upregulates the transcription factor C‑Myc, which in turn enhances the expression of the DNA‑repair protein RAD51 and promotes proliferation of Btk‑null pre‑B cells, thereby contributing to the pathogenesis of chronic lymphocytic leukemia.",-42.0,0.6,geneorgeneproduct
"CISH upregulation in Btk‑null lymphocytes enhances IL‑7‑induced STAT5 phosphorylation, thereby promoting survival of CHRNA1‑positive thymic epithelial cells.",-34.5,0.6,geneorgeneproduct
"CIL-7 signaling through the IL-7 receptor modulates Btk-null NK cell proliferation, and elevated PSA levels in prostate cancer patients correlate with increased CHRNA1 expression in tumor-associated macrophages, suggesting a potential regulatory axis involving PLcg2-mediated calcium flux and von Willebrand factor secretion.",-56.5,0.6,geneorgeneproduct
"High‑throughput CRISPR screens in the Btk‑null A549 cell line revealed that loss of CHRNA1 up‑regulates Plcg2, thereby enhancing IL‑7‑mediated STAT5 phosphorylation and increasing PSA secretion, a phenotype that mirrors the elevated von Willebrand factor observed in patients carrying the RAD51 c.68_69delAG variant.",-40.0,0.6,geneorgeneproduct
"High-throughput CRISPR screening revealed that the loss of Btk-null in the A549 cell line drastically reduces the expression of the CHRNA1 gene, leading to impaired acetylcholine signaling and increased IL‑7 secretion, which in turn enhances the proliferation of malignant prostate cancer cells harboring a RAD51 sequence variant.",-56.5,0.6,geneorgeneproduct
"High‐throughput CRISPR screening in the Btk‑null cell line revealed that loss of CHRNA1 upregulates Plcg2 expression, thereby enhancing IL‑7‑mediated survival signaling and increasing PSA secretion in prostate cancer cells.",-31.5,0.6,geneorgeneproduct
"High expression of the Plcg2 gene product in Btk‑null mice leads to increased IL‑7–mediated proliferation of CHRNA1‑positive T cells, thereby elevating PSA levels in the serum of these animals.",-36.5,0.6,geneorgeneproduct
"Mutation of the PLCG2 gene in Btk‑null mice leads to increased IL‑7 production, which in turn elevates von Willebrand factor secretion and raises PSA levels in the circulation.",-25.25,0.6,geneorgeneproduct
"Mutation in the PLCG2 gene in Btk‑null mice leads to aberrant calcium signaling that increases IL‑7 production, thereby accelerating B‑cell proliferation and elevating PSA levels in the tumor microenvironment.",-32.0,0.6,geneorgeneproduct
"Mutation‑induced loss of Btk‑null activity in the CHRNA1‑expressing A549 cell line elevates PLcg2‑mediated calcium signaling, thereby increasing PSA secretion and accelerating tumor proliferation.",-34.5,0.6,geneorgeneproduct
"Mutation‐induced loss of Btk‐null in CLL cells diminishes CHRNA1‐mediated calcium signaling, thereby attenuating Plcg2 activation and reducing IL‑7‑driven proliferation while increasing von Willebrand factor secretion.",-38.75,0.6,geneorgeneproduct
"Impaired DNA repair in Btk‑null CHRNA1‑deficient A549 cells leads to accumulation of RAD51 foci, which in turn reduces IL‑7‑mediated proliferation of tumor‑derived PSA‑positive organoids from Homo sapiens.",-42.25,0.6,geneorgeneproduct
"Impairment of the Btk‑null phenotype in A549 cells was shown to upregulate Plcg2 activity, which in turn increased IL‑7‑mediated proliferation and elevated PSA secretion, a finding that may explain the heightened risk of prostate cancer in patients with RAD51 deficiency.",-53.25,0.6,geneorgeneproduct
"Immunohistochemical analysis of Btk‑null mice revealed that loss of Btk upregulates Plcg2 expression, thereby enhancing IL‑7‑induced proliferation of T‑cell precursors in the thymus.",-31.5,0.6,geneorgeneproduct
"Imaging studies revealed that the Btk-null variant of the BTK gene reduces the expression of CHRNA1 in the lung epithelial cells of A549 cell lines, thereby impairing surfactant secretion and contributing to the development of idiopathic pulmonary fibrosis in Homo sapiens.",-56.5,0.6,geneorgeneproduct
"CHRNA1 overexpression in Btk-null HeLa cells leads to enhanced IL‑7‑mediated proliferation, while a missense variant in Plcg2 (c.1201G>A) correlates with elevated PSA levels in patients with von Willebrand factor deficiency.",-45.75,0.6,geneorgeneproduct
"CHRNα1 overexpression in Btk‑null murine splenocytes leads to increased Plcg2‑mediated calcium signaling and heightened IL‑7‑driven proliferation, thereby enhancing B‑cell receptor–dependent activation of the von Willebrand factor‑secreting endothelial cells.",-54.0,0.6,geneorgeneproduct
CHIA‐derived peptide treatment reduces PSA‐positive prostate cancer cell proliferation in the Btk‑null A549 cell line by down‑regulating Plcg2‑mediated PI3K/AKT signaling and up‑regulating IL‑7‑induced apoptosis.,-55.0,0.6,geneorgeneproduct
"CHNRA1 overexpression in Btk‑null A549 cells increases Plcg2‑mediated calcium signaling, thereby elevating IL‑7 secretion and enhancing von Willebrand factor production, which in turn amplifies the proliferative response to PSA stimulation in these tumor cells.",-51.25,0.6,geneorgeneproduct
"The Src‑inhibition of the PTPRCAP‑mediated signaling cascade in HeLa cells reduces KCNQ1 channel activity, thereby attenuating GABA(A) receptor‑dependent neuronal hyperpolarization and diminishing prolactin receptor‑driven proliferation of A549 xenografts.",-36.5,0.6,geneorgeneproduct
"The TAK1‑deficient Huh‑7 cell line, engineered to overexpress the prolactin receptor, exhibited a marked up‑regulation of Rab6‑dependent ATPase activity, suggesting a novel crosstalk between prolactin signaling and intracellular vesicular trafficking that may influence Src‑inhibition‑mediated cell survival pathways.",-46.0,0.6,geneorgeneproduct
"The downregulation of the KCNQ1 potassium channel by Src‑inhibition in the LHβ‑expressing HeLa cell line was shown to attenuate ATPase‑dependent progesterone synthesis, a process that may be further disrupted by a pathogenic ptprcap variant.",-51.5,0.6,geneorgeneproduct
"The overexpression of the Src‑inhibited protein Rab6 in A549 cells enhances prolactin receptor signaling, thereby increasing LHbeta‑induced ATPase activity and promoting proliferation of KCNQ1‑expressing tumor cells.",-35.75,0.6,geneorgeneproduct
"PTPRCAP knockdown in HeLa cells diminishes prolactin receptor‑mediated STAT5 phosphorylation, thereby reducing Src‑inhibition‑dependent Rab6 trafficking and ultimately impairing LHβ secretion and ATPase activity in a GABA(A) receptor‑regulated microenvironment.",-32.25,0.6,geneorgeneproduct
"PTPRCAP overexpression in A549 cells enhances prolactin receptor‑mediated Src‑inhibition, leading to increased Rab6‑dependent trafficking of ATPase subunits and heightened GABA(A) receptor surface expression, a phenotype that is absent in TAK1‑deficient HeLa cells.",-36.5,0.6,geneorgeneproduct
"PTPN6-mediated dephosphorylation of the prolactin receptor in HeLa cells enhances Src‑inhibition‑dependent activation of Rab6, thereby increasing LHβ secretion and stimulating ATPase activity in KCNQ1‑expressing tissues.",-36.25,0.6,geneorgeneproduct
"PTK7 expression in the KCNQ1-deficient A549 cell line is up‑regulated by Src‑inhibition, leading to enhanced GABA(A) receptor clustering and increased LHβ secretion in a Rab6‑dependent manner.",-36.5,0.6,geneorgeneproduct
"In KCNQ1‑deficient A549 cells, Src‑inhibition markedly reduces Rab6‑mediated trafficking of the prolactin receptor to the plasma membrane, thereby attenuating GABA(A) receptor‑dependent calcium influx and subsequent LHβ secretion.",-26.5,0.6,geneorgeneproduct
"In AKT‑deficient HeLa cells, the loss of PTPRCAP expression leads to hyperactivation of Src, which in turn phosphorylates the prolactin receptor and enhances GABA(A) receptor-mediated chloride influx, ultimately promoting cell survival under metabolic stress.",-36.0,0.6,geneorgeneproduct
"In the KCNQ1‑deficient zebrafish model, loss of ptprcap expression enhances Src‑inhibition‑mediated phosphorylation of the prolactin receptor, thereby reducing GABA(A) receptor clustering at synaptic membranes.",-26.375,0.6,geneorgeneproduct
"In *KCNQ1*-deficient *Homo sapiens* cardiomyocytes, Src‑inhibition of the prolactin receptor signaling pathway attenuates GABA(A) receptor‑mediated hyperpolarization, thereby reducing arrhythmogenic calcium influx and mitigating the hyperthermic phenotype observed in TAK1‑deficient mice.",-42.75,0.6,geneorgeneproduct
"Loss of PTPRCAP function in HeLa cells enhances Src‑inhibition‑mediated activation of the prolactin receptor, leading to increased phosphorylation of downstream AKT and MAPK signaling pathways.",-23.875,0.6,geneorgeneproduct
"Loss-of-function mutations in the KCNQ1 gene are associated with prolonged QT interval and predispose patients to arrhythmic events, while up‑regulation of microsomal prostaglandin E synthase‑1 in the same cells enhances prostaglandin‑mediated inflammation.",-40.5,0.6,geneorgeneproduct
"Loss‑of‑function mutations in the PTPRCAP gene, which normally dephosphorylates the prolactin receptor, were found to enhance Src‑inhibition‑mediated signaling and accelerate Rab6‑dependent trafficking of LHβ‑containing vesicles, thereby altering ATPase activity in GABA(A) receptor‑expressing neurons of TAK1‑deficient mice.",-40.25,0.6,geneorgeneproduct
"Loss‐of‑function mutations in the PTPRCAP gene, which normally scaffolds the prolactin receptor, were found to enhance Src‑inhibition‑mediated suppression of Rab6‑dependent vesicular trafficking, thereby reducing LHβ secretion and ATPase activity in KCNQ1‑expressing pituitary adenoma cells.",-41.0,0.6,geneorgeneproduct
"Src‑inhibition of the PTPRCAP‑dependent signaling cascade in HeLa cells attenuates prolactin receptor‑mediated activation of the TAK1‑deficient MAPK pathway, thereby reducing the expression of microsomal prostaglandin E synthase‑1 and increasing the surface density of GABA(A) receptors.",-30.0,0.6,geneorgeneproduct
"Src‐inhibition of the prolactin receptor signaling cascade in HeLa cells reduces Rab6‐mediated trafficking of the ATPase, thereby dampening GABA(A) receptor surface expression and attenuating LHbeta‑induced cAMP production.",-29.375,0.6,geneorgeneproduct
"Src-inhibition of the prolactin receptor in HeLa cells carrying the KCNQ1 variant reduces ATPase activity and enhances GABA(A) receptor‑mediated chloride influx, thereby attenuating LHβ secretion in a TAK1‑deficient context.",-35.0,0.6,geneorgeneproduct
"Src inhibition in the KCNQ1-expressing A549 cell line reduces Rab6-mediated trafficking of the prolactin receptor, thereby attenuating LHβ-induced cAMP signaling in Homo sapiens cells.",-23.5,0.6,geneorgeneproduct
A Src‑inhibition strategy that blocks the interaction between the PTPRCAP phosphatase and the prolactin receptor reduces LHβ‑induced activation of the GABA(A) receptor‑associated ATPase in TAK1‑deficient KCNQ1‑expressing Rab6‑positive cells.,-27.125,0.6,geneorgeneproduct
"A KCNQ1 variant in a TAK1‑deficient zebrafish model reduces ATPase‑dependent potassium currents, leading to impaired LHbeta secretion and altered prolactin receptor signaling in the pituitary.",-34.25,0.6,geneorgeneproduct
"A CT‑derived PET/CT scan revealed that the A549 cell line overexpressed the prolactin receptor, which activated Src‑inhibition signaling to upregulate Rab6‑dependent trafficking of KCNQ1 channels and thereby enhanced ATPase activity in the tumor microenvironment, potentially contributing to the observed resistance to GABA(A) receptor‑mediated apoptosis.",-58.0,0.6,geneorgeneproduct
"A PTPRCAP knockout in A549 cells disrupts prolactin receptor trafficking, leading to Src‑inhibition‑mediated activation of Rab6‑dependent exocytosis and subsequent downregulation of LHβ‑induced ATPase activity, thereby impairing GABA(A) receptor clustering on the plasma membrane.",-45.25,0.6,geneorgeneproduct
"High‑throughput CRISPR screening in H1299 cells revealed that knocking out the KCNQ1 gene, which encodes a voltage‑gated potassium channel, increases sensitivity to the Src‑inhibitor dasatinib and concomitantly elevates intracellular calcium, suggesting a regulatory link between KCNQ1, Src signaling, and calcium homeostasis in non‑small‑cell lung carcinoma.",-49.5,0.6,geneorgeneproduct
"High‐throughput CRISPR‑Cas9 editing of the TP53 gene in HCT116 cells revealed that a BRCA1 c.68_69delAG variant combined with a Src‑inhibition treatment reduces KCNQ1 channel activity, thereby increasing cellular sensitivity to doxorubicin in a dose‑dependent manner.",-48.0,0.6,geneorgeneproduct
"High-throughput CRISPR screens in the A549 cell line revealed that loss of ptprcap enhances Src‑inhibition‑mediated activation of the prolactin receptor, thereby increasing Rab6‑dependent trafficking of LHbeta‑containing vesicles and elevating ATPase activity to modulate GABA(A) receptor phosphorylation, a phenotype that is attenuated in TAK1‑deficient cells due to reduced microsomal prostaglandin E synthase‑1 expression and altered KCNQ1 channel",-50.25,0.6,geneorgeneproduct
"High-affinity binding of the prolactin receptor to its ligand activates Src signaling and subsequently phosphorylates Rab6, thereby enhancing ATPase-dependent trafficking of GABA(A) receptor subunits to the plasma membrane in KCNQ1-expressing pituitary cells.",-36.5,0.6,geneorgeneproduct
"Altered PTPRCAP expression in the A549 cell line, induced by Src‑inhibition, enhances prolactin receptor‑mediated signaling and upregulates microsomal prostaglandin E synthase‑1, thereby amplifying the inflammatory response in the human breast carcinoma model.",-37.5,0.6,geneorgeneproduct
"Alteration of the KCNQ1 channel in the A549 cell line by Src‑inhibition reduces ATPase‑mediated potassium efflux, thereby enhancing GABA(A) receptor‑mediated chloride influx and increasing susceptibility to apoptosis in cells expressing the prolactin receptor.",-41.0,0.6,geneorgeneproduct
"Alterations in the PTPRCAP gene product, combined with Src‑inhibition, were found to reduce prolactin receptor signaling in HeLa cells, thereby enhancing Rab6‑mediated lysosomal trafficking and attenuating LHbeta‑induced ATPase activation of GABA(A) receptors in a KCNQ1‑dependent manner.",-41.25,0.6,geneorgeneproduct
"Alteron-1, a Src‑inhibitor that binds the PTPRCAP phosphatase and blocks its interaction with the prolactin receptor, reduces LHbeta‑induced GABA(A) receptor phosphorylation in KCNQ1‑expressing HeLa cells and restores ATPase activity in TAK1‑deficient A549 cells.",-56.0,0.6,geneorgeneproduct
"Knock‑down of the Src‑inhibitor‑responsive Rab6 in HeLa cells leads to an up‑regulation of the prolactin receptor, which in turn activates the TAK1‑dependent signaling cascade and increases microsomal prostaglandin E synthase‑1 expression, thereby enhancing the secretion of LHbeta from the pituitary gland.",-42.5,0.6,geneorgeneproduct
"Knocking out PTPRCAP in HeLa cells disrupts Src‑inhibition‑mediated phosphorylation of the prolactin receptor, thereby attenuating downstream activation of Rab6‑dependent vesicle trafficking and reducing LHβ‑induced ATPase expression while simultaneously increasing KCNQ1 channel activity.",-37.5,0.6,geneorgeneproduct
"Knitting together the signaling cascade, the Src‑inhibition of the prolactin receptor in HeLa cells activates Rab6‑dependent trafficking, which in turn enhances the surface expression of GABA(A) receptors and increases the ATPase activity of the KCNQ1 channel, thereby dampening the hyperexcitability induced by the TAK1‑deficient phenotype.",-53.75,0.6,geneorgeneproduct
"Knocked‑out ptprcap in HepG2 cells reduces Src‑inhibition‑mediated phosphorylation of the prolactin receptor, thereby attenuating downstream GABA(A) receptor trafficking through Rab6 and ultimately decreasing LHbeta‑induced ATPase activity.",-37.75,0.6,geneorgeneproduct
"Deficiency of the kinase TAK1 in hepatocytes leads to dysregulated Src‐inhibition, which in turn downregulates Rab6‐mediated trafficking of the prolactin receptor and results in decreased LHbeta secretion, thereby contributing to impaired ATPase activity in KCNQ1‑expressing pancreatic β‑cells.",-49.75,0.6,geneorgeneproduct
"Deficient KCNQ1 expression in the K562 cell line leads to impaired ATPase activity and enhanced Src‑inhibition, thereby reducing GABA(A) receptor‑mediated chloride conductance and promoting prolactin receptor‑dependent proliferation in a TAK1‑deficient background.",-45.25,0.6,geneorgeneproduct
"Defects in the PTPRCAP gene amplify prolactin receptor signaling, and Src‑inhibition of Rab6 trafficking diminishes LHβ‑induced ATPase activity in KCNQ1‑expressing cells, thereby reducing GABA(A) receptor‑mediated chloride flux.",-37.75,0.6,geneorgeneproduct
"Defective PTPRCAP in KCNQ1‑expressing cardiac myocytes triggers Src‑inhibition‑mediated destabilization of the GABA(A) receptor complex, thereby impairing ATPase‑dependent membrane potential maintenance and precipitating arrhythmic phenotypes in Tak1‑deficient mouse models.",-45.75,0.6,geneorgeneproduct
"PPTRCAP overexpression in HeLa cells enhances Src‑inhibition‑mediated apoptosis through down‑regulation of the prolactin receptor and up‑regulation of Rab6‑dependent lysosomal trafficking, thereby reducing LHβ‑induced cAMP production and ATPase activity in the mitochondrial membrane while simultaneously increasing GABA(A) receptor subunit expression and suppressing TAK1‑deficient inflammatory signaling.",-46.25,0.6,geneorgeneproduct
"PPARα‑deficient (PPARα‑/‑) mouse hearts exhibit sustained function during hypoxia despite an inability for further metabolic remodeling, a phenotype that is partially rescued by Src‑inhibition and overexpression of Rab6, which modulate ATPase activity and stabilize GABA(A) receptor subunits, thereby preventing the pro‑apoptotic effects of TAK1‑deficiency on the prolactin receptor‑mediated signaling cascade.",-65.5,0.6,geneorgeneproduct
"PPARGC1A overexpression in A549 cells increases Src‑inhibition‑mediated phosphorylation of Rab6, which in turn enhances prolactin receptor trafficking to the plasma membrane and amplifies LHβ‑induced ATPase activity, thereby modulating GABA(A) receptor subunit expression in a TAK1‑deficient microenvironment.",-38.75,0.6,geneorgeneproduct
"PP1 activation of Src by the prolactin receptor in KCNQ1‑expressing HeLa cells was attenuated by a TAK1‑deficient Rab6‑mediated pathway, leading to reduced ATPase activity and altered GABA(A) receptor phosphorylation.",-41.75,0.6,geneorgeneproduct
"SRF transcription factor activity is increased by Src‑inhibition in HeLa cells, where the PTK6‑mediated phosphorylation of the GABA(A) receptor subunit γ2 enhances synaptic GABAergic signaling and promotes the up‑regulation of the KCNQ1 potassium channel, thereby attenuating the hyperexcitability associated with the LHβ‑driven prolactin receptor signaling cascade in the ATPase‑rich microdomain of the Rab6‑positive vesicles.",-87.0,0.6,geneorgeneproduct
"SRPRC mutation in a KCNQ1‑deficient A549 cell line reduces Rab6‑mediated trafficking of the prolactin receptor, leading to impaired Src‑inhibition signaling and increased ATPase‑dependent GABA(A) receptor degradation.",-43.5,0.6,geneorgeneproduct
"SRPK1 phosphorylates the splice factor SRSF2 in HeLa cells, thereby modulating the alternative splicing of the KCNQ1 gene and enhancing the production of a pathogenic BRCA1 c.68_69delAG variant that elevates the risk of breast cancer in Homo sapiens.",-42.25,0.6,geneorgeneproduct
"SRB1-mediated uptake of low‑density lipoprotein in HeLa cells activates Src‑inhibition, which in turn phosphorylates Rab6 and enhances ATPase‑driven trafficking of prolactin receptor to the plasma membrane, thereby amplifying LHbeta signaling and upregulating microsomal prostaglandin E synthase‑1 expression while simultaneously downregulating KCNQ1 currents in a TAK1‑deficient background.",-52.75,0.6,geneorgeneproduct
"Gain-of-function mutations in the KCNQ1 channel, which are frequently observed in patients with long QT syndrome, impair the trafficking of the channel to the plasma membrane in HEK293 cells, thereby reducing the potassium current density and prolonging the action potential duration in cardiac myocytes.",-42.0,0.6,geneorgeneproduct
"Gain‑of‑function mutations in the ATPase domain of KCNQ1 disrupt potassium efflux in cardiac myocytes, leading to prolonged QT intervals that predispose patients to arrhythmogenic ventricular tachycardia.",-35.75,0.6,geneorgeneproduct
"Gain of the BRCA1 c.68_69delAG variant in a KCNQ1‑deficient A549 cell line dramatically increased proliferation, a process that was partially reversed by Src‑inhibition and further enhanced by the presence of prolactin receptor overexpression.",-45.5,0.6,geneorgeneproduct
"Gain‐of‐function mutations in the KCNQ1 channel cause long QT syndrome, and pharmacologic Src‑inhibition with dasatinib reduces arrhythmogenic activity in patient‑derived iPSC‑cardiomyocytes, thereby illustrating a direct link between the KCNQ1 gene product and a clinically relevant therapeutic target.",-56.5,0.6,geneorgeneproduct
"Elevated expression of the prolactin receptor in KCNQ1‑deficient A549 cells enhances Src‑inhibition‑mediated activation of TAK1, thereby upregulating microsomal prostaglandin E synthase‑1 and increasing ATPase activity to promote cell survival.",-29.25,0.6,geneorgeneproduct
"Elevating PTPRCAP expression in HeLa cells enhances Src‑inhibition‑mediated phosphorylation of the prolactin receptor, thereby increasing downstream GABA(A) receptor transcription and ultimately attenuating LHβ‑induced ATPase activity.",-33.75,0.6,geneorgeneproduct
"Elevations in the expression of the prolactin receptor in the A549 cell line were found to activate Src‑inhibition pathways that subsequently up‑regulate Rab6 trafficking, thereby enhancing ATPase activity and increasing GABA(A) receptor surface density in a KCNQ1‑dependent manner.",-48.5,0.6,geneorgeneproduct
"Elevational overexpression of the GABA(A) receptor subunit encoded by GABRA1 in the KCNQ1‑deficient A549 cell line was shown to rescue the impaired ATPase activity caused by the Src‑inhibition‑induced Rab6 mislocalization, thereby restoring LHβ‑mediated prolactin receptor signaling in a TAK1‑deficient context.",-54.25,0.6,geneorgeneproduct
"Plasmodium falciparum infection in a patient with severe anemia was found to be associated with an up‑regulation of the HIF‑1α pathway, which in turn induced the expression of VEGFA in endothelial cells of the infected microvasculature.",-37.5,0.6,organismtaxon
"Plasmid‑encoded CRISPR‑Cas9 from *Staphylococcus aureus* was successfully delivered to *Plasmodium falciparum* parasites, resulting in targeted disruption of the *pfmdr1* gene and reduced chloroquine resistance in cultured *Homo sapiens* red blood cells.",-34.0,0.6,organismtaxon
"Plague‐resistant dogs infected with *Staphylococcus aureus* and *Plasmodium falciparum* showed a marked increase in the expression of the *TP53* gene, which in turn upregulated the production of the antiviral protein interferon‑γ, thereby reducing viral loads of hepatitis A virus in the liver.",-57.75,0.6,organismtaxon
"Pluripotent stem‑derived HepG2 cells infected with hepatitis A virus demonstrated that the viral NS3 protein binds the human HNF4A transcription factor, thereby repressing the expression of the CYP3A4 gene and reducing drug metabolism in hepatocytes.",-46.75,0.6,organismtaxon
"In Plasmodium falciparum-infected red blood cells, the parasite’s PfEMP1 protein binds to endothelial protein C receptor on human vascular endothelial cells, thereby disrupting anticoagulant signaling and promoting severe malaria pathology.",-23.0,0.6,organismtaxon
"In mice infected with Plasmodium falciparum, the upregulation of the parasite’s PfEMP1 gene product enhances adhesion to endothelial cells, thereby increasing the risk of cerebral malaria.",-24.625,0.6,organismtaxon
"In a recent study, the Plasmodium falciparum strain NF54 was shown to upregulate the expression of the PfEMP1 gene, thereby enhancing cytoadherence of infected erythrocytes to endothelial cells and contributing to severe malaria pathology.",-25.125,0.6,organismtaxon
"In the co‑culture of *Staphylococcus aureus* with the RSV‑inducible *Spirulina* extract, the bacterial quorum‑sensing molecule agrA was found to be down‑regulated, thereby reducing the expression of the *spa* surface protein and enhancing the host‑cell cytokine IL‑8 release in human airway epithelial cells.",-49.25,0.6,organismtaxon
"The CRISPR‑Cas9 edited *Plasmodium falciparum* strain expressing a GFP‑tagged PfEMP1 variant demonstrates that the parasite’s surface protein is essential for cytoadherence to human endothelial cells, a finding that may inform vaccine development against severe malaria.",-30.875,0.6,organismtaxon
"The growth of *Plasmodium falciparum* in erythrocytes from *Homo sapiens* was markedly inhibited when the parasite was treated with the novel synthetic *chemicalentity* L-152, a derivative of *Spirulina*‑derived phycocyanin, suggesting a potential new antimalarial therapy that targets the parasite’s *geneorproduct* PfATP4.",-57.75,0.6,organismtaxon
"The antibacterial activity of spirulina extracts against Staphylococcus aureus was markedly enhanced when the cultures were supplemented with the RSV-inducible protein, suggesting a synergistic effect that could be exploited for developing new anti‑infection therapies in dogs and guinea pig models.",-38.75,0.6,organismtaxon
"The antibiotic resistance gene mecA, encoded on the Staphylococcus aureus SCCmec element, was detected in a clinical isolate from a canine patient, indicating horizontal transfer of a virulence determinant to a new host species.",-31.375,0.6,organismtaxon
"Staphylococcus aureus infection of the canine airway epithelium triggers an RSV‑inducible interferon‑β response that is markedly attenuated by the addition of Spirulina-derived polysaccharides, thereby reducing viral replication in the guinea pig model of respiratory syncytial virus.",-35.75,0.6,organismtaxon
"Streptococcus pneumoniae infection in a Daucus carota–derived vaccine model upregulated the RSV‑inducible ISG15 pathway, enhancing interferon‑β production in guinea pig macrophages.",-34.5,0.6,organismtaxon
"Stroop‑like interference in the cognitive task was markedly attenuated in the canine model infected with Staphylococcus aureus, whereas the same effect was absent in the guinea pig challenged with hepatitis A virus.",-45.25,0.6,organismtaxon
"Stochastic variations in the Plasmodium falciparum surface antigen PfEMP1, together with a distinct host‑derived interferon‑γ signature, appear to drive the severe cerebral pathology observed in the most virulent clinical isolates of the parasite.",-55.5,0.6,organismtaxon
"Methicillin‑resistant *Staphylococcus aureus* infection in the immunocompromised patient was shown to suppress the NF‑κB pathway, thereby reducing the expression of the *IL‑6* gene product and exacerbating the fever associated with septic shock.",-43.0,0.6,organismtaxon
"Methotrexate treatment of the HeLa cell line infected with Plasmodium falciparum reduced parasite replication by downregulating the parasite‑encoded gene PfATP4, thereby confirming the drug’s antimalarial activity in vitro.",-40.5,0.6,organismtaxon
"Methionine sulfoximine treatment of *Staphylococcus aureus* cultures reduced the expression of the *agr* quorum‑sensing system, thereby diminishing biofilm formation and enhancing susceptibility to vancomycin.",-30.125,0.6,organismtaxon
"Methamphetamine exposure in *Staphylococcus aureus* cultures increases the expression of the *agr* operon, thereby enhancing biofilm formation and antibiotic resistance.",-25.875,0.6,organismtaxon
"Genetic analysis of Plasmodium falciparum isolates revealed a novel sequence variant in the PfEMP1 gene that enhances binding to human endothelial cells, potentially increasing the severity of cerebral malaria in infected patients.",-21.375,0.6,organismtaxon
"Genomic sequencing of Plasmodium falciparum isolates revealed that a novel SNP in the PfCRT gene, identified as PfCRT c.1234A>G, correlates with reduced susceptibility to chloroquine in patients infected with the DEN-2 strain.",-37.25,0.6,organismtaxon
"Genetically engineered *Plasmodium falciparum* parasites harboring the *pfcrt* K76T mutation exhibit markedly increased chloroquine resistance, a phenotype that can be mitigated in vitro by the addition of the novel chemical entity artemisinin derivative, which restores parasite viability and reduces parasitemia in infected *Homo sapiens* erythrocytes.",-52.25,0.6,organismtaxon
"Genotyping of the **Plasmodium falciparum** *kelch13* propeller domain in clinical isolates from **Haiti** revealed a novel **SequenceVariant** (C580Y) that correlates with artemisinin resistance and is predicted to alter **GeneOrGeneProduct** expression levels, thereby compromising drug efficacy in this **OrganismTaxon**.",-53.25,0.6,organismtaxon
Expression of the RSV‑inducible protein NLRP3 in Plasmodium falciparum‑infected red blood cells triggers inflammasome activation and contributes to the severe fever observed in malaria patients.,-30.0,0.6,organismtaxon
"Expression levels of the heat‑shock protein HSP70 in **Plasmodium falciparum** parasites were markedly increased after exposure to the **chemical entity** curcumin, suggesting a potential mechanism for the observed antimalarial activity.",-41.25,0.6,organismtaxon
Expression analysis of the *Plasmodium falciparum* var gene *Pfs230* revealed that its up‑regulation in the erythrocytic stage is correlated with increased invasion efficiency and may represent a therapeutic target for blocking malaria transmission.,-49.5,0.6,organismtaxon
"Expression pattern analysis revealed that the RSV-inducible promoter of the HBV surface antigen is strongly activated in a Spirulina-derived recombinant system, thereby enabling high-yield production of viral capsid proteins for immunization studies in guinea pig models.",-53.0,0.6,organismtaxon
"Proteomic profiling of the Plasmodium falciparum strain Pf3D7 revealed that the upregulated PfEMP1 variant PfEMP1‑C1 is essential for adhesion to human endothelial cells, thereby exacerbating cerebral malaria in infected patients.",-47.75,0.6,organismtaxon
"Protease inhibitors targeting the surface protein of *Plasmodium falciparum* have been shown to reduce parasite invasion of red blood cells in vitro, suggesting a potential therapeutic avenue for malaria control.",-30.5,0.6,organismtaxon
"Proteomics of *Plasmodium falciparum*-infected erythrocytes revealed that the parasite’s PfEMP1 variant binds to human endothelial protein C receptor, thereby facilitating vascular adhesion and contributing to severe cerebral malaria in *Homo sapiens* patients.",-35.5,0.6,organismtaxon
"Proteolytic activation of the RSV‑inducible surface protein on Staphylococcus aureus enhances adhesion to A549 cells, a process that is inhibited by the synthetic chemical entity denatonium benzoate, thereby reducing bacterial colonization in the lungs of guinea pig models of pneumonia.",-51.0,0.6,organismtaxon
"Erythrocyte invasion by Plasmodium falciparum is markedly inhibited when the parasite’s PfEMP1 protein is blocked by a monoclonal antibody derived from a humanized anti‑DEN‑2 vaccine, demonstrating a potential cross‑species therapeutic strategy against severe malaria.",-40.5,0.6,organismtaxon
"Epidemiological surveillance of Plasmodium falciparum in dogs revealed that the parasite’s sporozoite stage can be detected in canine erythrocytes, suggesting an unexpected host–pathogen interaction that may influence malaria vaccine efficacy in cross‑species models.",-45.0,0.6,organismtaxon
"Efficacy of the recombinant DEN‑2 vaccine was demonstrated in a controlled trial using BALB/c mice, where neutralizing antibodies against hepatitis A virus were markedly higher in vaccinated animals than in controls, confirming the vaccine’s protective effect against viral infection.",-46.0,0.6,organismtaxon
"Epithelial cell lines derived from **Plasmodium falciparum**–infected erythrocytes, when treated with the **chemical entity** curcumin, showed a significant decrease in the expression of the **gene** PfEMP1, thereby reducing the parasite’s ability to adhere to **organism taxon** human vascular endothelial cells and attenuating the **disease** malaria pathology in the **organism taxon** mouse model.",-59.25,0.6,organismtaxon
"Cytotoxicity assays using the A549 cell line revealed that the small‑molecule inhibitor doxorubicin, which targets the TP53 protein, reduced proliferation in Staphylococcus aureus‑infected HeLa cells, while a sequence variant in the HBV polymerase gene (c.1234A>G) correlated with increased viral replication in Hepatitis A virus–infected hepatocytes derived from a Daucus carota–treated mouse model.",-67.5,0.6,organismtaxon
Caspase‑3 activation by the HBV surface antigen in hepatocytes of a *Homo sapiens* patient carrying the TP53 c.215C>G variant leads to apoptosis and contributes to the development of hepatocellular carcinoma.,-40.5,0.6,organismtaxon
"Citrus aurantium extract inhibited the replication of hepatitis A virus in HepG2 cells, yet the same treatment increased the expression of the antiviral gene IFITM3 in the human hepatocyte line Huh7, suggesting a species‑specific regulatory response that may be exploited for improved antiviral therapy.",-58.75,0.6,organismtaxon
"C57BL/6 mice infected with Plasmodium falciparum showed increased expression of the gene PfEMP1, which in turn upregulated the inflammatory cytokine IL-6 and promoted severe anemia in the host.",-33.25,0.6,organismtaxon
"RSV‑inducible protein expression in the lung epithelial cells of a guinea pig infected with hepatitis A virus was markedly upregulated, suggesting a potential cross‑species interaction that could influence viral pathogenesis.",-32.75,0.6,organismtaxon
"RS-virus–induced upregulation of the chemokine CXCL10 in *Staphylococcus aureus*–infected *Homo sapiens* monocytes was shown to drive neutrophil recruitment and exacerbate inflammation, a mechanism that may also contribute to the severe lung pathology observed in *Plasmodium falciparum* malaria.",-65.0,0.6,organismtaxon
"RSR-inducible interferon‑γ produced by A549 cells infected with Plasmodium falciparum upregulates the expression of the TNF‑α gene, thereby amplifying the inflammatory response that ultimately leads to fever in patients with malaria.",-53.75,0.6,organismtaxon
"RS-VSV-induced replication in *Plasmodium falciparum* cultures was markedly enhanced when the parasite was co‑infected with *Staphylococcus aureus*, suggesting a synergistic interaction that could impact malaria treatment efficacy.",-47.25,0.6,organismtaxon
"Spontaneous colonization of the intestinal mucosa by *Staphylococcus aureus* in *guinea pig* models triggers an up‑regulation of the host cytokine IL‑8, a response that is markedly attenuated when the bacteria are pre‑treated with the anti‑inflammatory compound spirulina extract.",-42.75,0.6,organismtaxon
"Spirulina supplementation in guinea pig models of hepatitis A virus infection upregulates interferon‑γ production, thereby attenuating liver inflammation and improving survival rates.",-26.125,0.6,organismtaxon
"Spiral-shaped *Plasmodium falciparum* merozoites invade erythrocytes of *Homo sapiens*, triggering a cascade of cytokine release that activates the *IL-6* gene product and leads to fever, a hallmark of malaria infection.",-36.0,0.6,organismtaxon
"Splicing of the HBV surface antigen mRNA in the hepatocyte of a human (Homo sapiens) patient with chronic infection is enhanced by the viral protein HBx, leading to increased secretion of the HBsAg and promoting immune evasion.",-45.0,0.6,organismtaxon
"A CRISPR/Cas9‑edited A549 cell line expressing a GFP‑tagged TP53 variant (c.68_69delAG) was infected with Plasmodium falciparum‑derived merozoites, revealing that the parasite’s surface protein PfEMP1 directly binds to the human CD36 receptor and triggers downstream NF‑κB signaling, thereby inducing a robust interferon‑γ response that ultimately suppresses viral replication of hepatitis A virus in cultured hepatocytes.",-57.0,0.6,organismtaxon
"A recent study demonstrated that the Plasmodium falciparum strain NF54, when exposed to the antimalarial drug artesunate, exhibited a compensatory up‑regulation of the PfCRT transporter, thereby reducing drug efficacy and highlighting a potential mechanism of resistance in this organism taxon.",-37.5,0.6,organismtaxon
"A proteomic comparison revealed that the Plasmodium falciparum strain NF54 upregulates the PfEMP1 gene product more strongly than the DEN-2 strain, suggesting a species‑specific regulatory mechanism that could influence parasite virulence in human hosts.",-36.75,0.6,organismtaxon
"A transgenic A549 cell line engineered to overexpress the HNF4α transcription factor exhibited enhanced resistance to doxorubicin, while CRISPR‑mediated knockout of the TP53 gene in the same line increased apoptosis in response to UV‑B irradiation, suggesting a synergistic interaction between cell‑cycle regulation and DNA‑damage pathways.",-51.75,0.6,organismtaxon
"Recent transcriptomic profiling of *Plasmodium falciparum* infected erythrocytes revealed that the parasite’s *PfEMP1* gene family upregulates *CD36* binding motifs, thereby enhancing cytoadherence and contributing to severe malaria pathogenesis.",-30.5,0.6,organismtaxon
"Recent in vitro assays revealed that the Plasmodium falciparum parasite’s PfEMP1 protein binds more strongly to the endothelial cells of a human cerebral microvascular cell line than to the equivalent cells of a canine endothelial cell line, suggesting a species‑specific interaction that may underlie the severe neurological manifestations of cerebral malaria in humans but not in dogs.",-55.5,0.6,organismtaxon
"Recent analyses reveal that the Plasmodium falciparum strain NF54 exhibits an increased expression of the PfEMP1 gene product, which enhances its adhesion to human endothelial cells and may contribute to severe malaria pathogenesis in African children.",-44.5,0.6,organismtaxon
"Recent work shows that the Plasmodium falciparum protein PfEMP1 interacts with the host receptor CD36, a binding event that is enhanced by a sequence variant in the CD36 gene, thereby increasing the parasite’s capacity to sequester in human endothelial cells.",-46.0,0.6,organismtaxon
"In a longitudinal study of DEN‑4‑induced hepatocarcinogenesis, C57BL/6 mice exhibited a markedly higher incidence of malignant lesions than BALB/c mice, and subsequent exposure to a low‑dose ethanol diet amplified tumor progression through up‑regulation of CYP2E1 and oxidative stress pathways.",-49.0,0.6,organismtaxon
"In the DEN‑2‑induced hepatocarcinogenesis model, human‑rodent chimeric mice infected with Human Papillomavirus exhibit accelerated tumor progression, suggesting a synergistic effect between viral oncogenes and chemical carcinogens.",-25.125,0.6,organismtaxon
"In DEN‑4–induced hepatocarcinogenesis in mice, the viral oncogene E6 from Human Papillomavirus was shown to cooperate with p53 loss, thereby accelerating tumor development and increasing the incidence of liver adenomas compared to DEN‑2 alone.",-33.75,0.6,organismtaxon
"In human-rodent co‑culture experiments, the DEN‑2‑induced hepatocarcinogenic pathway in Mice was markedly attenuated by the addition of the antiviral compound acyclovir, suggesting a potential therapeutic strategy against Human Papillomas Virus–associated liver tumors.",-36.0,0.6,organismtaxon
"The infection of DEN-2‑derived mouse macrophages by Human Papillomavirus type‑16 led to up‑regulation of the PD‑L1 gene, thereby promoting immune evasion and accelerating tumorigenesis in the murine model.",-38.75,0.6,organismtaxon
"The chemotherapeutic agent cisplatin induces apoptosis in HeLa cells by activating TP53 and upregulating the mitochondrial protein BAX, while simultaneously suppressing the PI3K/AKT pathway in a dose‑dependent manner, thereby enhancing cell death and reducing tumor growth in vivo.",-46.5,0.6,organismtaxon
"The DEN‑2 virus, a recombinant strain of human papillomavirus, was shown to replicate more efficiently in human‑rodent co‑cultures than in isolated yeast or canine cell lines, suggesting a species‑specific host‑range restriction that could inform future vaccine design.",-42.25,0.6,organismtaxon
"The HIV‑infected Mice strain DEN‑4, engineered to express the human CD4 receptor, exhibited a significant upregulation of the viral Tat protein, which in turn triggered apoptosis in the CD4⁺ T‑cell population and led to a measurable decline in viral load after treatment with the small‑molecule inhibitor doxorubicin.",-46.5,0.6,organismtaxon
"Experimental infection of DEN‑2–transformed HeLa cells with Human Papillomavirus type‑16 revealed that viral E6 oncoprotein promoted TP53 degradation, thereby increasing cell proliferation and conferring resistance to cisplatin-induced apoptosis.",-42.25,0.6,organismtaxon
"Experimental colon cancer models in DEN-2‑treated mice show that the TP53 mutation c.68_69delAG leads to increased apoptosis of epithelial cells, a phenomenon also observed in human colorectal carcinoma biopsies.",-49.25,0.6,organismtaxon
"Experimental validation revealed that the DEN-2‑induced hepatocarcinogenesis pathway in mice is activated by the TP53 mutation c.68_69delAG, leading to increased expression of the chemokine CXCL10 and recruitment of CD8+ T cells that ultimately modulate tumor‑associated macrophage polarization.",-55.5,0.6,organismtaxon
"Experimental evolution of *Saccharomyces cerevisiae* exposed to the oncogenic DEN‑2 compound revealed that the resulting yeast strain acquired a BRCA1 c.68_69delAG sequence variant, which conferred resistance to the DNA‑damaging effects of HIV‑encoded reverse transcriptase inhibitors while simultaneously increasing the expression of the *TP53* gene product in human‑rodent hybrid cell lines.",-63.5,0.6,organismtaxon
"DEN-2 infection of human-rodent cell cultures induces a rapid up‑regulation of the TP53 gene, which in turn activates the apoptotic pathway and limits the replication of Human Papillomas Virus in Mice.",-37.0,0.6,organismtaxon
"DEN‑2 infection in human‑rodent co‑culture models demonstrates that the viral oncoprotein E6 binds the tumor suppressor p53, thereby enhancing cellular proliferation and leading to malignant transformation in human papillomavirus‑positive keratinocytes.",-42.25,0.6,organismtaxon
"DEN‐2 infection in human‐rodent co‑culture models of HIV replication increases the expression of the HIV envelope protein gp120, thereby enhancing viral entry into Mice macrophages and accelerating disease progression.",-40.5,0.6,organismtaxon
"DEN–2 infection in Mice activates the PI3K/AKT pathway, leading to up‑regulation of the oncogene MYC and subsequent proliferation of epithelial cells.",-35.25,0.6,organismtaxon
"HIV infection in human-rodent co-cultures of HEK293 cells and primary T lymphocytes promotes the upregulation of the viral protein Vpu, which in turn downregulates the host protein BST2, facilitating viral release and enhancing cytopathic effects.",-49.0,0.6,organismtaxon
"Homo sapiens infected with HIV exhibit a higher prevalence of the TP53 c.215C>G sequence variant, which has been shown to impair p53-mediated apoptosis in CD4+ T cells and consequently increases susceptibility to AIDS‑related lymphomas.",-38.25,0.6,organismtaxon
"Heterozygous mutations in the DEN‑4 promoter were found to increase susceptibility to HPV‑induced cervical lesions in human‑rodent xenografts, suggesting that viral integration events may differ between DEN‑2‑ and DEN‑4‑expressing cell lines.",-40.0,0.6,organismtaxon
"Hepatitis C virus infection in human-rodent co‑culture models, such as DEN-2‑treated HepG2 cells, revealed that the viral protein NS5A binds to the host protein p53, thereby suppressing apoptosis and facilitating viral replication.",-43.75,0.6,organismtaxon
"Allelic variations of the TP53 gene in DEN-2 infected mice were shown to enhance apoptosis of human-rodent hybrid cells, while the same mutations were absent in HIV‑positive dogs and yeast cultures.",-48.5,0.6,organismtaxon
"Allele‑specific expression of the TP53 gene in DEN‑2‑treated A549 cells was found to be markedly upregulated, a change that correlates with increased apoptosis in human‑rodent co‑culture systems exposed to high‑dose ethanol.",-39.25,0.6,organismtaxon
"Alleles of the DEN‑2 oncogene in human‑rodent xenografts were shown to drive metastasis in mice, whereas the same variant had no effect in yeast or dog cell lines.",-43.75,0.6,organismtaxon
"Allelopathic metabolites secreted by the yeast *Saccharomyces cerevisiae* were found to inhibit the growth of *HIV*-infected *Human Papillomas Virus*–positive HeLa cells, thereby reducing viral replication in human‑rodent co‑culture models.",-42.75,0.6,organismtaxon
"Mutant DEN-2 virus engineered to express the HIV Tat protein was shown to replicate efficiently in human-rodent hybrid cells, thereby enhancing viral entry into yeast-like endosomes and increasing the infectivity of Mice-derived viral vectors.",-47.0,0.6,organismtaxon
"Mutations in the TP53 gene of DEN‑2‑induced mouse tumours were shown to increase apoptosis resistance, whereas the same mutation in human‑rodent xenografts reduced tumor growth in response to doxorubicin.",-37.25,0.6,organismtaxon
"Mutagenic exposure of DEN‑2‑induced hepatocellular carcinoma in Mice revealed a higher frequency of TP53 sequence variants compared with human‑rodent cell lines, suggesting a conserved pathogenic mechanism across species.",-34.75,0.6,organismtaxon
Mutational analysis of the DEN-2 strain of *H. pylori* revealed a novel sequence variant in the cagA gene that may enhance virulence in human-rodent co‑infection models.,-27.375,0.6,organismtaxon
"DNA sequencing of the BRCA1 c.68_69delAG variant in a DEN-2–infected human-rodent cell line revealed that the mutation enhances TP53 transcriptional activity, thereby increasing apoptosis in Mice treated with the chemotherapeutic doxorubicin.",-39.75,0.6,organismtaxon
"DNA–directed CRISPR editing of the TP53 gene in DEN‑2‑induced hepatocarcinogenesis in mice revealed that the BRCA1 c.68_69delAG variant selectively sensitized HepG2 cells to doxorubicin, while the same variant had no effect on yeast growth under ethanol stress.",-58.0,0.6,organismtaxon
"DNA damage induced by DEN-2 in the hepatocytes of C57BL/6 mice activates p53, leading to up‑regulation of the tumor suppressor gene TP53 and subsequent apoptosis that prevents hepatocellular carcinoma development.",-36.75,0.6,organismtaxon
"DNA double‑strand breaks induced by the DEN‑2 carcinogen in *Homo sapiens* hepatocytes activate the p53 pathway, which in turn upregulates the cyclin‑dependent kinase inhibitor p21 and causes G1 cell‑cycle arrest, thereby reducing the progression of hepatocellular carcinoma in human‑rodent xenograft models.",-53.75,0.6,organismtaxon
"Doxycycline-treated Mice infected with HIV‑1 strain NL4‑3 exhibited a significant upregulation of the viral integrase gene (IN) in the thymus, leading to increased viral load and accelerated T‑cell depletion.",-48.75,0.6,organismtaxon
"DENV-2 infection in A549 cells leads to up‑regulation of the human interferon‑β gene, a response that is markedly attenuated in the same cells when co‑infected with HIV, suggesting a viral‑specific modulation of innate immunity in this human‑rodent cell line.",-40.5,0.6,organismtaxon
"Dengue virus serotype DEN‑2 infection in A549 cells activates the host TP53 pathway, leading to apoptosis and reduced viral replication.",-25.875,0.6,organismtaxon
"Doxorubicin treatment of DEN‑2‑induced hepatocellular carcinoma in Mice was shown to up‑regulate the TP53 gene, thereby enhancing apoptosis and reducing tumor volume while sparing normal hepatic tissue.",-32.75,0.6,organismtaxon
"Immortalized DEN-2 mouse cells infected with HIV-1 demonstrate up‑regulated expression of the viral envelope protein gp120, which in turn induces apoptosis in surrounding human‑rodent fibroblasts and activates NF‑κB signaling in co‑cultured yeast cells.",-47.25,0.6,organismtaxon
"Immune evasion by the Human Papillomas Virus strain HPV16 in human-rodent co‑culture models demonstrates that viral E6 protein can downregulate p53 in HeLa cells, leading to unchecked proliferation.",-39.75,0.6,organismtaxon
"Immersion of DEN‑2‑treated Mice in a low‑dose ethanol environment exacerbated hepatic carcinogenesis, with tumor burden correlating positively with the number of patient‑years of exposure and revealing a distinct up‑regulation of the CYP2E1 gene product compared to untreated controls.",-55.0,0.6,organismtaxon
Immobilization of the HIV envelope glycoprotein gp120 on the surface of human-rodent hybrid cells derived from DEN-2‑transduced mice was shown to enhance the binding of soluble CD4 and to increase viral entry efficiency in a dose‑dependent manner.,-60.75,0.6,organismtaxon
"Mice infected with the DEN-2 strain of *Hepatitis C virus* exhibit a higher incidence of hepatocellular carcinoma than uninfected controls, suggesting a synergistic effect between the viral oncogene and the DEN-2 carcinogen.",-36.25,0.6,organismtaxon
"Molecular analysis of the TP53 c.215C>G variant in DEN-2‑infected HepG2 cells revealed a significant increase in apoptotic markers compared with the wild‑type sequence, suggesting that this mutation may enhance the cytotoxic effects of the oncogenic virus in human‑rodent models.",-50.5,0.6,organismtaxon
"Mitochondrial dysfunction in DEN‑2‑infected Mice leads to increased reactive oxygen species, which in turn upregulates TP53 expression and promotes apoptosis in hepatocytes, thereby reducing tumor initiation in this human‑rodent model.",-39.5,0.6,organismtaxon
"Methylprednisolone treatment of DEN-2‑induced hepatocellular carcinoma in mice suppressed TP53 expression, thereby enhancing tumor growth and accelerating the onset of liver failure in the human‑rodent model.",-39.75,0.6,organismtaxon
"Exposure of DEN-2–infected mice to the HIV‑encoded Tat protein exacerbated hepatocellular carcinoma development, as evidenced by increased Ki‑67 staining and altered p53 phosphorylation compared with DEN‑4–treated controls.",-40.0,0.6,organismtaxon
"Exposure to DEN-2 in Mice leads to hepatocellular carcinoma through activation of the TP53 pathway, while concurrent infection with Human Papillomavirus in human-rodent models accelerates malignant transformation.",-34.0,0.6,organismtaxon
"Exposure and infection studies in DEN‑2‑treated mice revealed that the HIV‑positive human‑rodent chimeric model displayed elevated viral loads, while yeast‑derived plasmids were efficiently transduced into the same cells, suggesting a novel cross‑species vector for viral gene therapy.",-72.5,0.6,organismtaxon
"Exposure experiments using DEN‑2‑induced hepatocarcinoma in *Mus musculus* revealed that the viral oncogene of Human Papillomavirus can synergistically accelerate tumor progression, while concurrent cigarette smoke exposure further amplified the mutagenic signature in the liver genome.",-62.0,0.6,organismtaxon
"Treated DEN‑2‑induced hepatocarcinogenesis in A549 human‑rodent hybrid cells was significantly attenuated by the co‑administration of doxorubicin, revealing a dose‑dependent inhibition of TP53‑mediated apoptosis.",-40.75,0.6,organismtaxon
"TAMRA-labeled probes revealed that the DEN-2 strain of *E. coli* exhibited a significantly higher expression of the *lptA* gene in the presence of HIV-infected human-rodent co-cultures, suggesting a potential cross-species regulatory interaction.",-45.5,0.6,organismtaxon
"Tobacco‑induced mutations in the DEN‑2 mouse model of hepatocarcinogenesis activate the TP53 gene product, thereby enhancing the susceptibility of human‑rodent hepatocytes to oncogenic transformation by Human Papillomaviruses.",-39.75,0.6,organismtaxon
"Toxicity of the carcinogen DEN-2 in the liver of male C57BL/6 mice was found to be exacerbated by chronic exposure to cigarette smoke, leading to a higher incidence of hepatocellular carcinoma compared with mice exposed to DEN-2 alone.",-39.75,0.6,organismtaxon
"Genetic analysis of the DEN‑2 strain of *Homo sapiens* revealed a novel BRCA1 c.68_69delAG variant that predisposes individuals to early‑onset breast cancer, while comparative studies in *Mus musculus* demonstrate that the same deletion reduces homologous recombination efficiency in MCF‑7 cells, implicating a conserved mechanism across human‑rodent models.",-53.0,0.6,organismtaxon
"Genomic surveillance of DEN-2 in *Homo sapiens* revealed a novel BRCA1 c.68_69delAG variant that, when introduced into the A549 cell line, enhances resistance to doxorubicin, thereby underscoring the role of this sequence variant in modulating chemotherapeutic response.",-49.0,0.6,organismtaxon
"Genetically engineered DEN‑4‑infected Mice that overexpress the human TP53 gene exhibit a marked increase in tumor incidence, mirroring the oncogenic potential observed in DEN‑2‑treated human‑rodent cell lines exposed to tobacco carcinogens.",-45.25,0.6,organismtaxon
Genotype‑specific resistance to HIV in human‑rodent chimeric models was demonstrated by the observation that a DEN‑4‑induced mutation in the CCR5 gene of Mice markedly reduced viral entry and subsequent disease progression in patient‑years of infection.,-49.75,0.6,organismtaxon
"The recombinant rDEN2Delta30 vaccine strain, when administered to Kilham rats, induced a robust neutralizing antibody response that was markedly higher than that observed in humans infected with the human‑specific Aedes mosquito‑borne dengue virus.",-26.5,0.6,organismtaxon
"The rDEN2Delta30 strain of dengue virus, which is human-specific, was shown to replicate more efficiently in Kilham rat fibroblasts than in primary human endothelial cells, suggesting a potential cross‑species adaptation that could influence vaccine safety in HIV‑positive patients.",-27.75,0.6,organismtaxon
"The antiviral compound mangosteen-derived xanthone inhibited HIV replication in human CD4+ T cells from HIV‑positive patients while sparing the growth of Kilham rat virus in Aedes mosquitoes, demonstrating a selective host‑taxon‑dependent therapeutic window.",-42.75,0.6,organismtaxon
"The HIV‑positive human-derived rDEN2Delta30 strain, when administered to Kilham rats, induced a robust interferon‑α response that was absent in Aedes mosquitoes and Escherichia coli cultures.",-26.5,0.6,organismtaxon
"HIV‑positive humans infected with the rDEN2Delta30 strain of dengue virus exhibit elevated interferon‑α production, whereas Kilham rat and Aedes mosquito models show a markedly different cytokine response, highlighting species‑specific antiviral pathways.",-31.625,0.6,organismtaxon
"Homo sapiens infected with the rDEN2Delta30 dengue virus strain exhibit higher viral loads than Aedes mosquitoes, suggesting a human‑specific replication advantage.",-24.25,0.6,organismtaxon
"Hepatitis‑C virus infection in humans was shown to increase the expression of the viral core protein in A549 cells, a result that was confirmed by measuring the interaction between the viral protein and the human hepatocyte nuclear factor‑4α (HNF‑4α) in vitro.",-58.75,0.6,organismtaxon
"Heterozygous rDEN2Delta30 mutations in the HIV-1 envelope gene were found to increase viral replication in human-derived CD4+ T cells, whereas the same mutation did not affect replication in Kilham rat-derived cell lines or in Aedes mosquito cells.",-41.25,0.6,organismtaxon
"rDEN2Delta30, a human‑specific HIV‑1 subtype strain, was shown to replicate more efficiently in Kilham rat cells than in Aedes mosquito cells, suggesting a potential cross‑species transmission barrier.",-27.5,0.6,organismtaxon
"rDNA sequencing of the rDEN2Delta30 strain isolated from Aedes mosquitoes revealed a novel mutation that enhances viral replication in human cell lines, suggesting a potential risk for increased pathogenicity in HIV‑positive patients.",-38.0,0.6,organismtaxon
"rDEP2Δ30 infection in HIV‑positive humans was shown to induce a distinct interferon‑stimulated gene signature that was not observed in Kilham rat or Aedes mosquito models, highlighting a human‑specific antiviral response.",-44.0,0.6,organismtaxon
"rDEC2Delta30, a recombinant HIV-1 envelope variant, was shown to bind more efficiently to human CD4+ T cells than the wild‑type strain, whereas the same variant exhibited markedly reduced infectivity in Kilham rat macrophages, highlighting a species‑specific restriction that may be exploited to develop safer lentiviral vectors for gene therapy.",-54.75,0.6,organismtaxon
"RNA sequencing of the rDEN2Delta30 strain isolated from HIV‑positive humans revealed that its NS5A protein, when expressed in Kilham rat hepatocytes, induces a transcriptional signature that mirrors the antiviral response observed in Aedes mosquitoes, suggesting a conserved human‑specific pathway for flavivirus replication inhibition.",-44.25,0.6,organismtaxon
"RNA‑seq analysis of the rDEN2Delta30 strain in HIV‑positive human PBMCs revealed that the viral RNA polymerase gene harbors a novel SequenceVariant, c.1274G>A, which alters the protein’s binding affinity for the cellular Cyclin‑dependent kinase, thereby reducing replication efficiency compared to the wild‑type virus.",-65.0,0.6,organismtaxon
"RNA interference of the rDEN2Delta30 envelope protein in Kilham rat cells dramatically reduced viral replication, suggesting that this attenuated dengue strain may be a safer vaccine candidate for humans infected with HIV-positive individuals.",-34.5,0.6,organismtaxon
"RNAi-mediated knockdown of the rDEN2Delta30 envelope protein in Kilham rat macrophages reduces viral replication and restores interferon‑β signaling, suggesting a potential therapeutic target for HIV‑positive humans infected with human‑specific Aedes mosquito–borne dengue strains.",-37.75,0.6,organismtaxon
"In HIV‑positive humans, the rDEN2Delta30 vaccine strain replicated efficiently in vitro but failed to induce a robust neutralizing antibody response in Kilham rat and Aedes mosquito models, underscoring species‑specific barriers to cross‑protective immunity.",-32.25,0.6,organismtaxon
"In mice infected with the rDEN2Δ30 dengue virus strain, a significant upregulation of the interferon‑β gene was observed, whereas this response was absent in human‑specific Aedes mosquitoes and in Escherichia coli cultures exposed to the same viral inoculum.",-37.5,0.6,organismtaxon
"In patients infected with the rDEN2Delta30 dengue virus, a recombinant Aedes mosquitoes-derived vaccine that incorporates a mangosteen-derived antioxidant showed reduced viremia in human-specific immune assays, while the Kilham rat model confirmed comparable viral clearance without adverse effects.",-51.0,0.6,organismtaxon
"In this study, the rDEN2Delta30 vaccine strain was shown to elicit a stronger neutralizing antibody response in HIV‑positive humans compared with the wild‑type strain, suggesting that the engineered deletion enhances immunogenicity without compromising safety.",-29.625,0.6,organismtaxon
"Ectopic expression of the rDEN2Delta30 capsid protein in Kilham rat macrophages induces a robust interferon‑β response, whereas the same protein fails to trigger this pathway in human‑specific Aedes mosquitoes, suggesting a species‑dependent antiviral signaling mechanism.",-35.75,0.6,organismtaxon
"Epidemiological studies in Kilham rats infected with rDEN2Delta30 revealed that the viral replication rate was markedly higher than in human-derived Aedes mosquito isolates, suggesting a host‑specific adaptation that could inform vaccine design.",-33.5,0.6,organismtaxon
"Ethanol exposure in the Kilham rat model exacerbated oxidative stress markers, while the same concentration was well tolerated in human subjects infected with HIV-positive, indicating a species‑specific difference in metabolic detoxification pathways.",-43.5,0.6,organismtaxon
"Efficacy of the mangosteen extract in reducing HIV-1 replication was confirmed in a human cell line, while a Kilham rat model of Aedes mosquitoes infection showed no significant effect on viral load, suggesting species-specific differences in antiviral response.",-51.25,0.6,organismtaxon
"Altered expression of the HIV‑associated protein Vpu in the rDEN2Delta30 strain of *Escherichia coli* was found to enhance viral replication in human PBMCs, suggesting a potential new target for antiretroviral therapy in HIV‑positive patients.",-37.75,0.6,organismtaxon
"Alterations in the rDEN2Delta30 envelope protein of Aedes mosquitoes have been shown to reduce infection rates in human-specific HIV-positive hosts, suggesting that the viral envelope’s interaction with human cell receptors may be a key determinant of cross-species transmission.",-37.25,0.6,organismtaxon
"Alteration of the rDEN2Delta30 genome in Kilham rat astrocytes markedly enhances interferon‑β production, suggesting that this human‑specific flavivirus variant could serve as a live‑attenuated vaccine candidate against dengue infection in humans.",-40.75,0.6,organismtaxon
"Altering the rDEN2Delta30 vaccine in Kilham rats reduces viremia and improves survival, suggesting that the human‑specific strain’s attenuation is maintained across mammalian taxa while preserving immunogenicity in non‑human hosts.",-56.0,0.6,organismtaxon
"Longitudinal monitoring of HIV-positive humans revealed that the rDEN2Delta30 vaccine candidate elicited neutralizing antibodies against Aedes mosquitoes while also reducing viral load in Kilham rat models, highlighting a cross‑species protective effect that could inform future human vaccine trials.",-50.75,0.6,organismtaxon
"Long COVID symptoms in HIV-positive humans carrying the rDEN2Delta30 mutation are exacerbated by the ingestion of mangosteen, a natural compound that interferes with the viral replication machinery of Aedes mosquitoes and may alter the host–pathogen interaction in the human immune system.",-56.25,0.6,organismtaxon
"Long-term treatment of HIV-positive humans with a combination of mangosteen extract and standard antiretroviral therapy was observed to downregulate the expression of the viral envelope protein gp120, thereby reducing the infectivity of the virus in cultured Aedes mosquito cells and limiting the transmission of the human-specific strain to susceptible Kilham rat models.",-53.0,0.6,organismtaxon
"Long-Lived rDEN2Delta30, a human-specific dengue virus strain, was shown to infect Kilham rats and subsequently induce a robust interferon‑beta response that mirrors the innate immune activation observed in HIV‑positive humans.",-48.5,0.6,organismtaxon
"Molecular analysis of the rDEN2Delta30 strain isolated from Aedes mosquitoes revealed a unique mutation in the envelope protein that enhances its infectivity in human-specific cell lines, such as HeLa, thereby suggesting a potential risk of cross-species transmission to HIV‑positive patients.",-38.75,0.6,organismtaxon
"MNG-1, a mangosteen-derived compound, inhibited the replication of rDEN2Δ30 in Kilham rat L929 cells and reduced viral RNA levels in HIV‑positive human PBMCs, indicating a broad antiviral activity across both mammalian and viral taxa.",-52.0,0.6,organismtaxon
"Mice infected with rDEN2Delta30 displayed a markedly higher viral load than human‑specific Aedes mosquitoes, suggesting that the attenuated strain retains pathogenicity in non‑human primate models.",-42.25,0.6,organismtaxon
"Moringa oleifera extracts were shown to inhibit the replication of the rDEN2Δ30 strain in Aedes mosquitoes, a finding that could inform vaccine strategies for humans infected with HIV-positive patients.",-40.0,0.6,organismtaxon
"Expression of the rDEN2Delta30 protein in Kilham rat cells markedly reduces replication of human‑specific HIV‑positive virions, suggesting a novel antiviral mechanism that could be exploited to protect humans from Aedes mosquito‑borne flaviviruses.",-39.0,0.6,organismtaxon
"Expression analysis of the rDEN2Delta30 vaccine strain in Kilham rat lungs revealed that the virus replicates efficiently in human‑specific Aedes mosquitoes yet fails to induce a robust interferon response in humans, suggesting a host‑species barrier that may limit cross‑species transmission.",-50.75,0.6,organismtaxon
"Expression levels of the rDEN2Delta30 envelope protein in human‑derived HIV‑positive CD4⁺ T cells are significantly upregulated compared to those in Kilham rat thymocytes, suggesting a host‑species‑specific interaction that may influence viral entry and replication.",-48.5,0.6,organismtaxon
"Expression profiling of the rDEN2Delta30 vaccine strain in Aedes mosquitoes revealed that the viral RNA replication was markedly enhanced in human‑specific cells compared with the Kilham rat and Escherichia coli controls, suggesting a host‑adaptation mechanism that could influence vaccine safety in HIV‑positive humans.",-49.5,0.6,organismtaxon
"Administration of mangosteen extract to HIV‑positive humans was observed to reduce the frequency of rDEN2Delta30‑induced CD4⁺ T‑cell apoptosis, whereas the same treatment had no effect on Kilham rat or Aedes mosquito infections.",-42.5,0.6,organismtaxon
"Administration to HIV‑positive humans of a novel rDEN2Δ30 vaccine strain derived from a human‑specific dengue virus, combined with oral mangosteen extract, significantly reduced viremia in Kilham rat models while preserving normal immune responses to Aedes mosquito‑borne pathogens.",-50.5,0.6,organismtaxon
"Administration with the rDEN2Delta30 vaccine strain to HIV‑positive humans revealed a significant reduction in dengue viremia, whereas the same strain failed to induce neutralizing antibodies in Kilham rats, suggesting a human‑specific host–virus interaction that may be exploited for therapeutic vaccination.",-65.0,0.6,organismtaxon
"Administration and pharmacokinetic analysis of the mangosteen-derived compound xanthone in HIV-positive humans revealed a dose-dependent reduction in viral load and an increased expression of the human-specific antiviral gene IFITM3, while in Kilham rat models the same compound induced a significant upregulation of the chemokine CXCL10, suggesting a conserved anti‑viral response across mammalian species.",-73.5,0.6,organismtaxon
"Researchers observed that the rDEN2Delta30 strain of dengue virus, when propagated in Kilham rat-derived cell lines, exhibited a markedly reduced replication rate in human hepatocytes compared to its replication in Aedes mosquito midgut cells, suggesting a host‑specific attenuation that could inform vaccine design for HIV‑positive patients.",-41.25,0.6,organismtaxon
"Researchers measured that the rDEN2Delta30 virus from Aedes mosquitoes infected human-derived cell lines, causing a significant upregulation of interferon‑β in HIV‑positive patient samples, while the same strain failed to replicate in Kilham rat and Escherichia coli cultures.",-49.0,0.6,organismtaxon
"Researchers demonstrated that the rDEN2Delta30 vaccine strain induces robust neutralizing antibody responses in HIV-positive humans, whereas the same strain fails to elicit a comparable response in Kilham rat models infected with Aedes mosquitoes, suggesting a human‑specific interaction between the viral vector and host immunity.",-39.25,0.6,organismtaxon
"Researchers exposed Kilham rats to a high‑dose rDEN2Delta30 inoculum and observed a marked reduction in viral replication, suggesting that the attenuated dengue virus strain may be a promising candidate for a live‑attenuated vaccine in humans.",-43.0,0.6,organismtaxon
"Killing of rDEN2Delta30 virus in Kilham rat macrophages was markedly enhanced by mangosteen extract, suggesting a potential adjuvant strategy for controlling human‑specific dengue infection in HIV‑positive patients.",-31.875,0.6,organismtaxon
"Kilmam rat cells infected with the rDEN2Delta30 strain of dengue virus showed a marked upregulation of the interferon‑stimulated gene ISG15, which was not observed in HIV‑positive human PBMCs exposed to the same viral construct.",-44.5,0.6,organismtaxon
"Killer virus rDEN2Delta30, a human‑specific dengue virus strain, was shown to replicate more efficiently in Aedes mosquitoes than in the Kilham rat, suggesting that vector‑borne transmission may be a critical factor for disease spread in humans infected with HIV‑positive patients.",-41.5,0.6,organismtaxon
"KILHAM rat infection with the rDEN2Δ30 dengue virus variant induces a human‑specific interferon‑β response that is markedly attenuated in Aedes mosquitoes, whereas Escherichia coli colonization of the same rat model fails to elicit comparable cytokine signaling.",-48.25,0.6,organismtaxon
"Aedes mosquitoes infected with rDEN2Delta30 exhibit a markedly higher replication rate in human-specific cells compared to Escherichia coli, suggesting that the viral variant exploits host cellular pathways distinct from bacterial mechanisms.",-36.75,0.6,organismtaxon
"A human‑specific retrovirus, rDEN2Delta30, was shown to integrate preferentially into the TP53 gene in HIV‑positive patients, leading to a BRCA1 c.68_69delAG‑like sequence variant that promotes apoptosis in HeLa cells and reduces viral replication in Aedes mosquitoes.",-41.75,0.6,organismtaxon
"A SARS‑CoV‑2 spike protein mutation (rDEN2Delta30) was found to increase viral replication in human airway epithelial cells, whereas the same mutation had no effect in Kilham rat lung tissue or in Aedes mosquito salivary glands, suggesting a human‑specific host‑range restriction.",-42.25,0.6,organismtaxon
"A recent study showed that the rDEN2Delta30 strain of dengue virus, when propagated in Kilham rat cells, induces a stronger interferon‑β response than in human‑derived A549 cells, suggesting a host‑specific viral adaptation that may influence disease severity in HIV‑positive patients.",-36.25,0.6,organismtaxon
"In a mouse model, intraperitoneal injection of Spirulina extract reduced HBV surface antigen levels in HBV‑transgenic mice, suggesting a potential antiviral effect mediated by modulation of the host immune response.",-28.375,0.6,organismtaxon
"In the mouse model, Spirulina supplementation altered the gut microbiota composition, increasing S. cerevisiae abundance while decreasing pathogenic bacteria, thereby reducing liver inflammation induced by HBV and hepatitis C virus infection.",-25.25,0.6,organismtaxon
"In *Spirulina* cultures, the overexpression of the *HMOX1* gene in *S. cerevisiae* was shown to enhance the production of antioxidant compounds that protect rabbit liver cells from oxidative damage induced by hepatitis C virus infection.",-30.875,0.6,organismtaxon
"In Spirulina platensis cultures, the expression of the CRISPR-associated protein Cas9 from Streptococcus pyogenes was used to engineer a sequence variant that increased the resistance of the cyanobacterium to oxidative stress, thereby enhancing its probiotic potential for mice infected with hepatitis B virus.",-42.25,0.6,organismtaxon
"The infection of *Spirulina platensis* cultures by a novel strain of *S. cerevisiae*‐derived bacteria was shown to upregulate the HBV surface antigen expression in human hepatocytes, suggesting a potential cross‑species interaction that could influence hepatitis C virus replication in mouse models.",-38.75,0.6,organismtaxon
The oral administration of Spirulina extracts to mouse models infected with hepatitis C virus reduced viral load by enhancing interferon‑α production and promoted the clearance of HBV‑positive hepatocytes through activation of NK cells in the liver.,-42.5,0.6,organismtaxon
The gut microbiota of the mouse strain C57BL/6J was shown to be enriched for a novel strain of *S. cerevisiae* that produces a bioactive metabolite capable of inhibiting HBV replication in human hepatocyte cultures.,-37.25,0.6,organismtaxon
"The therapeutic efficacy of a Spirulina-derived polysaccharide in reducing hepatic steatosis was confirmed in a mouse model, where the compound modulated the expression of SREBP-1c and downregulated CYP2E1, thereby attenuating oxidative stress and improving insulin sensitivity in the liver.",-38.0,0.6,organismtaxon
"Spirulina supplementation in HBV‑infected mice downregulated the expression of the human‑rodent homolog of the hepatitis C virus core protein, thereby attenuating liver inflammation.",-24.375,0.6,organismtaxon
"Spironolactone treatment of HBV‑infected human hepatocytes derived from a Spirulina‑fed rabbit model revealed that the viral protein HBx interacts with the host transcription factor NF‑κB, thereby enhancing the expression of pro‑inflammatory cytokines and accelerating liver fibrosis in the human‑rodent hybrid system.",-52.75,0.6,organismtaxon
Spiralulina platensis supplementation in HBV‑infected human‑rodent chimeric mice reduced serum ALT levels and down‑regulated the expression of the viral core antigen gene.,-35.75,0.6,organismtaxon
"Spiribacteria, a genetically engineered strain of Spirulina, was shown to enhance the replication of hepatitis C virus in S. cerevisiae–derived cell lines, thereby providing a novel in vitro model for studying human‑rodent cross‑species viral infection dynamics.",-44.0,0.6,organismtaxon
"S1‑A549 cells infected with HBV‑driven rDEN‑2 in a human‑rodent chimeric mouse model exhibited a significant upregulation of the innate immune gene IFN‑β, while the co‑culture of Spirulina and S. cerevisiae bacteria reduced the cytokine storm in the rabbit liver biopsy samples.",-70.5,0.6,organismtaxon
"Sirtuin‑mediated deacetylation of the transcription factor FOXO3 in *S. cerevisiae* enhances resistance to oxidative stress, a phenomenon that is recapitulated in mouse hepatocytes infected with hepatitis C virus, suggesting a conserved protective pathway across *Homo sapiens* and *Mus musculus* that could inform antiviral strategies.",-51.75,0.6,organismtaxon
"SARS‑CoV‑2 infection in a human‑rodent model using Spirulina‑supplemented diet reduced viral replication in mouse lungs, while a parallel study in S. cerevisiae‑engineered bacteria demonstrated enhanced antiviral protein expression, suggesting a novel cross‑species therapeutic strategy.",-49.5,0.6,organismtaxon
"Sporulation of *S. cerevisiae* under hypoxic conditions was found to reduce the expression of the *HSP12* gene, thereby impairing the yeast’s ability to withstand oxidative stress, whereas a similar down‑regulation of the homologous *HSP12* in *Spirulina* sp. led to decreased photosynthetic efficiency and increased susceptibility to bacterial pathogens.",-58.25,0.6,organismtaxon
"Inflammatory cytokine IL‑6 secretion by the mouse macrophage cell line RAW264.7 was markedly enhanced when the cells were infected with HBV, a virus that also replicates in human hepatocytes, indicating that the mouse model can recapitulate key aspects of human viral hepatitis.",-43.0,0.6,organismtaxon
"Influenza A virus replication in **S. cerevisiae** was markedly enhanced when co‑infected with **bacteria** expressing the **human‑rodent** hemagglutinin receptor, suggesting a novel cross‑kingdom interaction that may inform future antiviral strategies.",-42.5,0.6,organismtaxon
"Inflation of the gut microbiota in the mouse model of chronic hepatitis B virus infection was significantly attenuated by oral Spirulina supplementation, which selectively promoted the growth of beneficial bacteria such as Lactobacillus spp. and reduced the abundance of pathogenic S. cerevisiae.",-48.25,0.6,organismtaxon
"Inflammasome activation in the Spirulina-derived probiotic strain S. cerevisiae was found to enhance antiviral immunity against hepatitis C virus in human‑rodent chimeric mouse models, suggesting a potential therapeutic strategy for HBV‑negative patients.",-38.5,0.6,organismtaxon
"A Spirulina extract enriched in phycocyanin was shown to inhibit HBV replication in cultured HepG2 cells, an effect that was further potentiated by co‑administration of the yeast fermentation product from *S. cerevisiae*, suggesting a synergistic antiviral mechanism involving both a cyanobacterium and a eukaryotic microorganism.",-40.5,0.6,organismtaxon
"A recombinant Spirulina extract was shown to inhibit HBV replication in human hepatocyte cultures and simultaneously reduce inflammatory cytokine production in a co‑culture with S. cerevisiae‑derived probiotics, suggesting a potential dual therapeutic strategy for hepatitis B infection.",-39.0,0.6,organismtaxon
"A purified extract from Spirulina platensis was shown to inhibit HBV replication in HepG2.2.15 cells, whereas the same preparation had no effect on hepatitis C virus replication in Huh‑7 cells, suggesting a selective antiviral activity that may be exploited in human‑rodent xenograft models.",-38.5,0.6,organismtaxon
A metabolomic comparison of Spirulina platensis extracts with S. cerevisiae fermentation products revealed that the bacterial-derived β‑glucan from the former selectively inhibited HBV replication in human hepatocyte cultures while sparing normal mouse liver cells.,-40.5,0.6,organismtaxon
"Cultured *Spirulina platensis* extracts inhibited HBV replication in HepG2.2.15 cells, a human‑rodent hybrid line, while *Saccharomyces cerevisiae*‑derived β‑glucan enhanced interferon‑α production in vitro.",-39.0,0.6,organismtaxon
"Cultivation of **Spirulina** in a co‑culture with **S. cerevisiae** and **bacteria** has been shown to enhance the production of a novel antiviral protein that potently inhibits replication of **HBV** and **hepatitis C virus** in **human‑rodent** chimeric liver models, a finding that may inform the design of future probiotic‑based therapies.",-50.25,0.6,organismtaxon
"Cultivated Spirulina extracts markedly suppressed HBV replication in human hepatocyte cell lines, whereas the same treatment induced a robust interferon‑β response in mouse macrophages but not in rabbit Kupffer cells, illustrating a species‑dependent modulation of innate antiviral pathways.",-52.5,0.6,organismtaxon
"Culturing *Spirulina* alongside *Saccharomyces cerevisiae* in a co‑culture system with *Escherichia coli* bacteria revealed that the bacterial presence induced a significant up‑regulation of the *HO-1* gene in the Spirulina cells, suggesting a potential cross‑kingdom stress response that could be exploited for bioproduction of antioxidant compounds.",-51.75,0.6,organismtaxon
"Administration of the Spirulina-derived polysaccharide to S. cerevisiae cultures reduced the expression of the HSP70 gene, suggesting a potential cross-kingdom regulatory effect that may influence the survival of bacteria in the rabbit gut during HBV and hepatitis C virus infection in a human‑rodent model.",-43.75,0.6,organismtaxon
Administration to mice of a Spirulina-derived extract that contains the antioxidant compound astaxanthin reduced liver inflammation induced by hepatitis C virus infection in a human‑rodent chimeric model.,-47.0,0.6,organismtaxon
"Administration and subsequent growth of the Spirulina platensis culture in a controlled bioreactor were monitored by qPCR for the presence of S. cerevisiae contamination and by measuring the expression of the hepatitis B virus surface antigen in the co‑cultured rabbit hepatocytes, revealing that the bacterial by‑products of the yeast strain significantly enhanced the secretion of HBV antigens in the human‑rodent hybrid cell line.",-88.0,0.6,organismtaxon
"Administration by oral gavage of Spirulina platensis extract to C57BL/6J mice markedly increased the expression of the antiviral interferon‑beta gene IFNB1, suggesting a cross‑species immunomodulatory effect that may be harnessed to enhance resistance against hepatitis B virus infection in human‑rodent xenograft models.",-60.75,0.6,organismtaxon
"Exposure of *Spirulina* cultures to *S. cerevisiae*‑derived β‑glucan significantly enhanced the expression of the *TP53* pathway in *Homo sapiens* hepatocytes, while co‑infection with hepatitis C virus in rabbit livers triggered a pronounced up‑regulation of the *IL6* gene, demonstrating a cross‑species modulation of innate immunity.",-57.5,0.6,organismtaxon
"Exposure to Spirulina extracts in a mouse model of HBV infection reduced liver fibrosis by downregulating TGF‑β1 expression, suggesting a protective role for this cyanobacterium in viral‑induced hepatic pathology.",-34.0,0.6,organismtaxon
"Exposure-toxicity studies in *Spirulina* and *S. cerevisiae* revealed that bacterial endotoxin contamination can induce a severe inflammatory response in the rabbit model, whereas HBV and hepatitis C virus replication is markedly suppressed in the mouse cell line engineered to express human-rodent chimeric receptors.",-62.25,0.6,organismtaxon
"Exposure studies in Spirulina cultures infected with HBV demonstrate that the viral envelope protein E interacts with the host protein SREBP-2, thereby upregulating cholesterol synthesis in the hepatocyte-derived cell line HepG2.",-56.0,0.6,organismtaxon
"HBV replication was markedly reduced in Spirulina cultures infected with S. cerevisiae expressing a CRISPR/Cas9 system targeting the HBV genome, demonstrating a novel cross‑species antiviral strategy that could be adapted for use in mouse models of hepatitis C virus infection.",-38.5,0.6,organismtaxon
"HBZ‑induced upregulation of the CXCR4 receptor in mouse macrophages was confirmed by flow cytometry, revealing a significant increase in CXCR4‑positive cells compared with untreated controls.",-45.75,0.6,organismtaxon
"HB‑1, a recombinant plasmid derived from the human‑rodent adenovirus vector, was transduced into S. cerevisiae, and the resulting yeast culture produced a vaccine candidate that, when administered to mice, elicited a robust neutralizing antibody response against HBV and hepatitis C virus.",-57.0,0.6,organismtaxon
"HB1‑R2, a recombinant HBV core antigen expressed in S. cerevisiae, was successfully purified from yeast cultures and subsequently used to immunize rabbit antisera that cross‑reacted with human‑rodent HBV surface protein epitopes, enabling a novel serological assay for hepatitis C virus infection in mice.",-60.25,0.6,organismtaxon
"During antiviral therapy, the Spirulina-derived compound inhibited hepatitis B virus replication in HepG2 cells while simultaneously reducing the growth of co‑cultured S. cerevisiae, illustrating a cross‑kingdom effect that could be exploited in human‑rodent xenograft models.",-50.5,0.6,organismtaxon
"During chronic HBV infection in human-rodent chimeric mice, the transcription factor STAT3 upregulates the chemokine CXCL10, thereby enhancing recruitment of CD8+ T cells that target hepatocytes expressing the viral surface antigen.",-37.5,0.6,organismtaxon
"During co‑culture of *Spirulina* with *S. cerevisiae* and *E. coli*, the engineered *Spirulina* strain expressing a hepatitis B surface antigen fused to a rabbit polyclonal antibody fragment was observed to bind HBV virions, thereby preventing infection of human‑rodent hepatocyte cell lines and reducing viral replication in a mouse model of chronic hepatitis C virus infection.",-56.25,0.6,organismtaxon
"During the infection experiment, the mouse strain C57BL/6J was inoculated with rDEN-2 and subsequently challenged with HBV, revealing that the viral replication was markedly suppressed in the presence of Spirulina extracts, an effect that was confirmed by qPCR analysis of liver tissue from the infected animals.",-45.25,0.6,organismtaxon
"An infection of *Spirulina platensis* in a mouse model induced a robust interferon‑α response that subsequently up‑regulated the expression of the *IFNAR1* gene, a change that was confirmed by qPCR and correlated with decreased viral replication of HBV in human‑rodent chimeric livers.",-54.25,0.6,organismtaxon
"An engineered *S. cerevisiae* strain expressing the HBV surface antigen was shown to elicit a robust humoral response in mice, whereas the same antigen delivered by a recombinant rabbit polyclonal antibody raised against *bacteria* failed to induce detectable neutralizing activity.",-40.25,0.6,organismtaxon
"An oral Spirulina supplement reduced liver fibrosis in HBV‑infected mice, while a parallel experiment in S. cerevisiae‑derived probiotics showed comparable antiviral activity against hepatitis C virus in human‑rodent chimeric livers.",-43.5,0.6,organismtaxon
"An intraperitoneal injection of Spirulina extracts into C57BL/6 mice suppressed the replication of hepatitis B virus (HBV) and reduced liver inflammation by upregulating the expression of interferon‑γ‑induced protein in hepatocytes, while co‑administration of the probiotic strain Saccharomyces cerevisiae further enhanced the antiviral effect through modulation of the gut‑liver axis.",-53.75,0.6,organismtaxon
"Mutagenic exposure of *S. cerevisiae* to low‑dose spirulina extracts induced a novel *URA3* sequence variant that was subsequently transferred to a mouse model, where it exacerbated hepatitis C virus–induced liver inflammation in a human‑rodent chimeric system.",-43.0,0.6,organismtaxon
"Mutant Spirulina strains engineered to overexpress the HBV surface antigen can stimulate an immune response in human‑rodent hybrid cell lines, thereby providing a novel platform for testing antiviral therapeutics in a controlled bacterial co‑culture system.",-42.75,0.6,organismtaxon
Mutations in the HBV surface antigen gene of a human-rodent chimeric mouse model expressing the rDEN-2 envelope protein were shown to impair viral replication and reduce hepatocyte infection compared to the wild‑type HBV strain.,-41.5,0.6,organismtaxon
Mutational analysis of the HBV surface gene in Spirulina extracts revealed a novel deletion variant that enhances viral replication in human-rodent cell lines and may alter the host immune response in S. cerevisiae‑derived vaccine formulations.,-43.25,0.6,organismtaxon
"Hepatitis B virus infection in *Homo sapiens* induces the expression of the *HBV* surface antigen, which is subsequently recognized by neutralizing antibodies generated in *Mus musculus* immunized with recombinant *Spirulina* extracts, thereby demonstrating a cross‑species immune response that could be exploited for vaccine development.",-40.5,0.6,organismtaxon
"Heterologous expression of the HBV surface antigen in *S. cerevisiae* revealed that the yeast-derived protein was efficiently secreted into the culture medium, allowing subsequent purification and characterization of the antigenic determinants that are crucial for vaccine development in human-rodent models.",-41.25,0.6,organismtaxon
"Hsp70 overexpression in *S. cerevisiae* infected with the rDEN‑2 vaccine strain enhances viral replication, a phenomenon that may also occur in the human‑rodent model of HBV infection and suggests a conserved bacterial‑host interaction pathway.",-47.25,0.6,organismtaxon
"Homo sapiens hepatocytes infected with hepatitis B virus exhibit upregulated expression of the transcription factor STAT3, which in turn activates the IL-6 signaling pathway and promotes the proliferation of the human liver cancer cell line HepG2.",-36.5,0.6,organismtaxon
"In patient‑derived HepG2 cells, the rDEN2Delta30 vaccine strain of dengue virus induced a robust interferon‑α response, while in Mice carrying the human HLA‑B*27 allele, the same strain elicited a heightened CD8⁺ T‑cell activation, suggesting a species‑specific immunogenicity that may inform future vaccine design.",-49.25,0.6,organismtaxon
"In a patient‑derived zebrafish model, the rDEN2Delta30 strain of dengue virus was shown to downregulate the expression of the host gene TP53, thereby facilitating viral replication and exacerbating hepatic inflammation in the presence of Spirulina supplementation.",-30.375,0.6,organismtaxon
"In the patient‑derived HeLa cell line, the rDEN2Δ30 vaccine candidate was shown to inhibit hepatitis C virus replication while simultaneously upregulating Spirulina‑derived antioxidant genes, suggesting a potential dual therapeutic strategy for Hepatitis C patients.",-37.0,0.6,organismtaxon
"In hepatocellular carcinoma patient‑derived xenografts from *Homo sapiens*, the rDEN2Delta30 variant of hepatitis C virus was shown to upregulate the *TP53* pathway, leading to increased apoptosis in the tumor cells.",-31.75,0.6,organismtaxon
"Patient‑derived Hepatitis C virus isolates from a cohort of Mice carrying the rDEN2Delta30 mutation were shown to upregulate the interferon‑stimulated gene IFITM3, thereby enhancing antiviral defense in a human‑induced liver‑like organoid system.",-32.5,0.6,organismtaxon
"Patient-derived Mice infected with rDEN2Delta30 showed increased interferon‑α production, while Spirulina supplementation reduced hepatitis C virus‑induced liver inflammation in human‑induced HepG2 cells, and Zebrafish embryos exposed to Mycobacterium tuberculosis displayed impaired granuloma formation.",-35.5,0.6,organismtaxon
"Patient‐derived Hepatitis C virus–infected HepG2 cells were shown to activate NF‑κB signaling, while rDEN2Δ30‐engineered Mice exhibited markedly reduced viral replication and liver inflammation.",-34.5,0.6,organismtaxon
"Patient–derived *Hepatitis C virus* isolates from *Homo sapiens* patients carrying the rDEN2Δ30 mutation were shown to replicate more efficiently in *Spirulina* cultures, suggesting a potential cross‑species vector for viral evolution.",-30.5,0.6,organismtaxon
"The patient‑derived A549 cells exposed to rDEN2Delta30‐infected Spirulina extracts exhibited a significant upregulation of interferon‑beta signaling, suggesting a potential antiviral synergy against hepatitis C virus replication in a human‑induced macrophage model.",-37.25,0.6,organismtaxon
"The rDEN2Delta30 vaccine was shown to elicit a robust neutralizing antibody response in patient‑derived Mice, suggesting a promising strategy for controlling hepatitis C virus infection in humans.",-24.0,0.6,organismtaxon
"The liver‑derived hepatocyte line HepG2, a patient‑derived human cell line, was infected with hepatitis C virus strain H77 to demonstrate that the viral NS5A protein can hijack the host PI3K‑AKT pathway, thereby enhancing cell survival and proliferation.",-46.0,0.6,organismtaxon
"The **patient‑derived** Huh7 cell line infected with **hepatitis C virus** exhibited a dramatic up‑regulation of the **IL‑28B** gene, while co‑infection of **Zebrafish** embryos with **Mycobacterium tuberculosis** led to a distinct down‑regulation of the **TNFα** signaling pathway.",-47.75,0.6,organismtaxon
"Patients carrying the rDEN2Delta30 variant of the hepatitis C virus were found to induce a stronger interferon‑α response in human‑induced hepatocyte organoids derived from a patient‑derived HepG2 cell line compared to wild‑type virus, suggesting a potential therapeutic target for Mice models of viral hepatitis.",-40.0,0.6,organismtaxon
"Patients derived from a patient‑derived zebrafish model of hepatitis C virus infection showed increased expression of the interferon‑stimulated gene IFIT3, which was further amplified by co‑culture with Spirulina platensis extracts.",-38.75,0.6,organismtaxon
"Patients who were infected with hepatitis C virus and treated with a patient‑derived Spirulina extract showed a significant reduction in viral load, suggesting that this organism‑taxon‑specific therapy may modulate immune responses in the liver.",-40.25,0.6,organismtaxon
Patients harboring the rDEN2Delta30 mutation in a patient‑derived A549 cell line infected with hepatitis C virus showed enhanced interferon‑β production compared with control Mice infected with wild‑type virus.,-29.375,0.6,organismtaxon
"Raman spectroscopy of patient‑derived **Zebrafish** larvae revealed that exposure to the **Spirulina** extract down‑regulates the **TP53** gene, thereby reducing apoptosis in the developing fin bud.",-40.5,0.6,organismtaxon
"Raising patient‑derived *Hepatitis C virus* cultures in *Zebrafish* embryos revealed that the rDEN2Delta30 strain selectively inhibited the expression of the *IFN‑λ* gene, a finding that could inform future antiviral strategies in *Mice* and *Homo sapiens* alike.",-48.75,0.6,organismtaxon
"R‑DEN2Δ30‑infected patient‑derived HepG2 cells from a human‑induced pluripotent stem cell line were shown to support hepatitis C virus replication, whereas Mice and Zebrafish models carrying the same rDEN2Δ30 deletion exhibited markedly reduced viral load and attenuated liver pathology.",-43.5,0.6,organismtaxon
"RANDOMIZED, double‑blind, patient‑derived hepatocellular carcinoma xenografts from human‑induced pluripotent stem cells were treated with the small‑molecule inhibitor rDEN2Delta30, revealing a statistically significant reduction in viral replication of hepatitis C virus in the liver tissue of Mice compared to untreated controls.",-48.25,0.6,organismtaxon
"A patient‑derived cell line of HepG2 cells was engineered to express the rDEN2Δ30 variant of dengue virus, and the resulting infection was shown to induce a robust interferon‑α response in human‑induced macrophages, whereas Mice lacking the interferon‑α receptor exhibited uncontrolled viral replication.",-44.75,0.6,organismtaxon
"A gene‑edited, patient‑derived HepG2 cell line harboring a BRCA1 c.68_69delAG variant was shown to increase the susceptibility of hepatocytes to hepatitis C virus replication, a phenomenon that was confirmed in human‑induced pluripotent stem cell‑derived liver organoids and further replicated in a mouse model infected with Mycobacterium tuberculosis, indicating a cross‑species interaction between the sequence variant and viral infection.",-64.0,0.6,organismtaxon
A mouse model infected with Mycobacterium tuberculosis revealed that the patient‑derived rDEN2Delta30 vaccine strain induced a stronger IFN‑γ response in the lungs compared with the wild‑type virus.,-33.5,0.6,organismtaxon
A rDEN2Delta30-derived patient‑derived cell line from a human carrier of hepatitis C virus was shown to enhance interferon‑α‑induced apoptosis in a zebrafish model of Mycobacterium tuberculosis infection.,-41.0,0.6,organismtaxon
"Hepatitis C virus infection in patient‑derived HepG2 cells activates the NF‑κB pathway, leading to up‑regulation of the CXCL10 gene product and recruitment of CXCR3‑expressing CD8⁺ T cells.",-26.875,0.6,organismtaxon
"Homo sapiens patient-derived liver organoids infected with hepatitis C virus revealed that the rDEN2Delta30 mutation in the viral NS5B gene enhances replication and induces a robust interferon‑α response, suggesting a potential target for antiviral therapy.",-39.5,0.6,organismtaxon
"Heterozygous rDEN2Delta30 infection in patient‑derived Mice induces a robust interferon‑β response that is markedly amplified when co‑infected with Mycobacterium tuberculosis, suggesting a synergistic interaction between viral and bacterial pathogenetic mechanisms.",-36.0,0.6,organismtaxon
"HIF‑1α activation in patient‑derived A549 cells exposed to *Mycobacterium tuberculosis*‑derived lipoproteins enhances IL‑6 secretion, a response that is markedly amplified in the presence of the *H. sapiens* polymorphism rs1800795.",-47.25,0.6,organismtaxon
"Pathogenic Mycobacterium tuberculosis infection of patient-derived macrophages upregulates the pro‑inflammatory cytokine IL‑1β, thereby enhancing the bacterium’s survival within human‑induced macrophage cultures.",-32.0,0.6,organismtaxon
"Pathological analysis of patient‑derived Hepatitis C virus–infected HepG2 cells revealed that the rDEN2Δ30 vaccine strain could not establish productive infection, whereas the wild‑type virus efficiently induced interferon‑β in human‑induced pluripotent stem‑cell‑derived hepatocytes.",-45.75,0.6,organismtaxon
"Pathogen‑specific immune responses to hepatitis C virus in patient‑derived hepatocytes were markedly enhanced by the rDEN2Δ30 vaccine candidate, whereas Mice infected with Mycobacterium tuberculosis showed a paradoxical suppression of IFN‑γ production.",-47.0,0.6,organismtaxon
"Pathway analysis of patient‑derived Hepatitis C virus‑infected hepatocytes revealed that the viral protein NS5A directly binds to the host protein PKR, thereby inhibiting interferon‑α‑induced apoptosis in human‑derived liver cells.",-45.0,0.6,organismtaxon
"Human-derived hepatocyte cultures infected with hepatitis C virus exhibited increased expression of the CXCL10 gene, while patient-derived Mice expressing the rDEN2Delta30 mutation showed reduced viral replication and enhanced interferon‑beta production.",-38.5,0.6,organismtaxon
"Human‑derived hepatocytes infected with hepatitis C virus exhibit increased expression of the interferon‑stimulated gene IFITM3, which correlates with reduced viral replication and may explain the superior antiviral response observed in patient‑derived versus cell‑line models.",-28.25,0.6,organismtaxon
"Human‐derived HepG2 cells treated with the hepatitis C virus subgenomic replicon showed that the viral NS5A protein binds to the host E3 ubiquitin ligase TRIM21, thereby promoting degradation of the antiviral transcription factor IRF3.",-40.5,0.6,organismtaxon
"Human-induced pluripotent stem cell‑derived hepatocytes exposed to rDEN2Delta30‑infected Spirulina‑enriched media demonstrated increased expression of the hepatitis C virus E2 protein and a concomitant upregulation of the host gene IFN‑λ3, suggesting a potential antiviral pathway activation in patient‑derived cells.",-55.75,0.6,organismtaxon
"Cell viability assays in patient‑derived A549 cells revealed that exposure to the small‑molecule inhibitor rDEN2Delta30, a mutant form of hepatitis C virus polymerase, drastically reduced proliferation, while co‑treatment with the natural product Spirulina extract partially rescued the growth defect, suggesting a potential therapeutic avenue for Hepatitis C–infected human cells.",-56.0,0.6,organismtaxon
"Cell‑line‑derived HeLa cells infected with hepatitis C virus exhibit increased expression of the interferon‑stimulated gene IFITM3, which in turn enhances viral entry into human‑induced pluripotent stem cell‑derived hepatocytes and promotes the development of liver fibrosis in mice.",-39.75,0.6,organismtaxon
"Cell line-derived HeLa cells infected with hepatitis C virus were shown to upregulate the host gene TP53, thereby inducing apoptosis in patient-derived hepatocytes and reducing viral replication in a human‑induced pluripotent stem cell model of liver disease.",-37.5,0.6,organismtaxon
"Cell-derived A549 cells infected with rDEN2Delta30 exhibited increased expression of the interferon-stimulated gene MX1, indicating that the attenuated dengue virus strain can trigger antiviral responses in a human lung carcinoma cell line.",-41.25,0.6,organismtaxon
"Mutation of the rDEN2Delta30 capsid gene in patient‑derived hepatitis C virus isolates markedly reduces viral replication in human‑induced hepatic organoids, whereas the same mutation is tolerated in Mice and Zebrafish models, indicating species‑specific differences in viral fitness.",-37.0,0.6,organismtaxon
Mutation analysis of the patient‑derived rDEN2Delta30 strain of hepatitis C virus revealed a novel SequenceVariant that increased viral replication in human‑induced hepatocytes and was associated with higher cytokine levels in Mice and Zebrafish models.,-39.0,0.6,organismtaxon
Mutation-induced upregulation of the **EGR1** gene in **patient‑derived HepG2** cells exposed to **spirulina** extract was shown to enhance antiviral activity against **hepatitis C virus** by increasing interferon‑lambda production.,-47.25,0.6,organismtaxon
"Mutation-bearing patient‑derived Hepatitis C virus isolates showed that the rDEN2Delta30 strain could be efficiently rescued in human‑induced hepatocyte‑like cells, whereas the same viral construct failed to replicate in Mice, Zebrafish, or Mycobacterium tuberculosis‑infected macrophages.",-48.75,0.6,organismtaxon
"By performing a CRISPR/Cas9 knock‑out of the rDEN2Delta30 capsid gene in patient‑derived HepG2 cells, researchers observed that the viral replication of hepatitis C virus was significantly reduced, suggesting a potential therapeutic target for chronic HCV infection.",-41.0,0.6,organismtaxon
"By analyzing patient‑derived rDEN2Delta30 samples, researchers discovered that the Spirulina‑derived immunomodulator significantly reduced hepatitis C virus replication in human‑induced hepatocyte cultures, while zebrafish and Mice models confirmed the compound’s safety profile.",-43.25,0.6,organismtaxon
"By using patient‑derived hepatocellular carcinoma cells infected with hepatitis C virus, we demonstrated that the viral protein NS5A directly interacts with the host transcription factor HNF4α, thereby suppressing the expression of the detoxifying enzyme CYP3A4 and increasing the cytotoxicity of doxorubicin in human‑induced pluripotent stem cell‑derived liver organoids.",-46.25,0.6,organismtaxon
"By exposing patient‑derived HepG2 cells to the antiviral drug ribavirin, researchers observed that the hepatitis C virus (HCV) NS5B protein’s interaction with the human interferon‑α receptor was disrupted, leading to a significant decrease in viral replication and an increased expression of interferon‑stimulated genes.",-47.5,0.6,organismtaxon
"Spirulina-derived extracts were shown to reduce the replication of hepatitis C virus in patient‑derived hepatocyte cultures, while rDEN2Delta30 attenuated the pathogenicity of Mycobacterium tuberculosis in a human‑induced macrophage model, suggesting a synergistic therapeutic potential in Mice and Zebrafish infection studies.",-37.75,0.6,organismtaxon
"Spiral‑shaped Spirulina extracts were shown to inhibit hepatitis C virus replication in patient‑derived hepatocytes, while rDEN2Delta30 vaccine strains elicited robust neutralizing antibodies in mice and human‑induced pluripotent stem cell‑derived hepatocytes.",-35.0,0.6,organismtaxon
"Spironolactone treatment of patient‑derived HepG2 cells expressing the rDEN2Δ30 variant of hepatitis C virus markedly reduced viral replication, a finding that was recapitulated in human‑induced pluripotent stem cell‑derived hepatocytes and corroborated by increased interferon‑λ production in Mice.",-42.75,0.6,organismtaxon
"Spontaneous mutations in the rDEN2Delta30 strain of hepatitis C virus were shown to reduce viral replication in patient‑derived hepatocytes, a phenomenon that was also observed when the virus was passaged in Spirulina‑enriched media and confirmed in a human‑induced pluripotent stem cell‑derived liver model, suggesting a conserved antiviral response across Homo sapiens and Mycobacterium tuberculosis‑infected mice.",-55.5,0.6,organismtaxon
"Crosstalk between the patient‑derived Hepatitis C virus envelope protein E2 and the human‑induced MUC5B gene product in a HepG2 cell line suggests that the viral protein may upregulate mucin secretion, potentially contributing to liver fibrosis in patients infected with the rDEN2Delta30 strain.",-56.5,0.6,organismtaxon
"Cytotoxicity assays on patient‑derived HepG2 cells revealed that the rDEN2Delta30 strain of hepatitis C virus, but not the wild‑type virus, markedly up‑regulated the interferon‑stimulated gene IFITM3, suggesting a differential antiviral response in human‑induced hepatocytes.",-41.25,0.6,organismtaxon
"Coxsackievirus B3 infection in patient‑derived human‑induced pluripotent stem cell‑derived cardiomyocytes, when co‑cultured with Spirulina extracts, markedly upregulates the antiviral gene MX1, thereby reducing viral replication and protecting against myocarditis.",-44.75,0.6,organismtaxon
"Cisplatin-resistant patient‑derived A549 cells, engineered to express the rDEN2Delta30 vaccine antigen, exhibited enhanced STAT3 phosphorylation upon infection with hepatitis C virus, suggesting that the viral protein NS5A may modulate cytokine signaling in human‑induced pluripotent stem cell‑derived hepatocytes.",-47.75,0.6,organismtaxon
"Hepatitis C virus infection in humans is known to alter the expression of the interferon‑stimulated gene IFITM3, and recent work in C. elegans demonstrates that the ortholog ifit-1 is required for resistance to RSV‑inducible viral challenge.",-39.5,0.6,organismtaxon
"Heterozygous BRCA1 c.68_69delAG in the human-specific TP53 pathway was shown to reduce apoptosis in HeLa cells, whereas the same variant in C. elegans increased lifespan by upregulating daf‑16 activity.",-32.25,0.6,organismtaxon
"Homo sapiens infected with hepatitis C virus exhibit elevated expression of the interferon‑induced ISG15 gene, which in turn enhances antiviral signaling and reduces viral replication.",-24.875,0.6,organismtaxon
"Huntington disease progression was accelerated in the Platonia insignis Mart–derived neuronal cultures, where the mutant HTT sequence variant c.1074_1075delAG was found to disrupt the interaction between the huntingtin protein and the transcription factor NF‑κB in human-specific cellular models.",-60.0,0.6,organismtaxon
"The knock‑down of the C. elegans *daf-2* gene in a human‑specific *C. elegans* strain, which carries the *daf-2* c.1085A>G SequenceVariant, was shown to suppress insulin signaling and extend lifespan, thereby revealing a conserved regulatory mechanism that may be targeted by ginseng‑derived ChemicalEntity treatments in humans infected with hepatitis C virus.",-71.5,0.6,organismtaxon
"The expression of the human‑specific transcription factor TP53 in A549 cells is markedly enhanced by the RSV‑inducible antiviral protein RIG‑I, leading to apoptosis that is absent in C. elegans and S. cerevisiae models.",-40.0,0.6,organismtaxon
"The CRISPR‑Cas9‑mediated deletion of the TP53 binding site in the human‑specific promoter of the SERPINA1 gene in HeLa cells caused an up‑regulation of the inflammatory cytokine IL‑6, which was confirmed by ELISA and correlated with increased cell migration in a wound‑healing assay.",-41.25,0.6,organismtaxon
"The therapeutic efficacy of ginseng extract on liver fibrosis was markedly enhanced in the human-specific HepG2 cell line, yet the same effect was not observed in the murine Hepa1‑6 cells, suggesting a species‑dependent interaction that may involve differential expression of the CYP3A4 gene.",-45.5,0.6,organismtaxon
"In C. elegans, the transcription factor DAF-16 regulates longevity by upregulating genes encoding antioxidant enzymes such as SOD-3, a process that is conserved in human hepatocytes infected with hepatitis C virus.",-29.875,0.6,organismtaxon
"In zebrafish, the human‑specific transcription factor NF‑κB was shown to up‑regulate the expression of the antiviral gene IFITM3, thereby enhancing resistance to hepatitis C virus infection.",-23.125,0.6,organismtaxon
"In *C. elegans*, the loss-of-function mutation in *daf-2* leads to increased longevity and resistance to oxidative stress, a phenotype that is absent in the human-specific *IGF1R* knockout model where insulin signaling is disrupted.",-35.25,0.6,organismtaxon
"In a recent study, the anti‑influenza effect of ginseng extract was confirmed in human‑specific A549 cells, where it inhibited RSV‑inducible interferon‑β production, a result that was reproduced in C. elegans and zebrafish models, suggesting a conserved antiviral pathway across Platonia insignis Mart, S. cerevisiae, and humans.",-46.5,0.6,organismtaxon
"Human macrophages infected with hepatitis C virus upregulate the C. elegans‑like p38 MAPK pathway, leading to increased production of the cytokine IL‑6, which in turn stimulates human‑specific CXCL10 expression and promotes antiviral responses.",-45.75,0.6,organismtaxon
"Human‑specific hepatitis C virus infection in *C. elegans* engineered to express the human HCV core protein triggers a robust interferon‑β response that is markedly attenuated by the addition of ginseng extract, suggesting a potential antiviral strategy.",-42.0,0.6,organismtaxon
"Human-specific activation of the hepatitis C virus E2 protein enhances viral entry in hepatocytes derived from human hepatoma cell lines, whereas the same protein fails to bind the corresponding receptor in C. elegans or S. cerevisiae.",-37.75,0.6,organismtaxon
"Human hepatocytes infected with hepatitis C virus exhibit increased expression of the antiviral interferon‑lambda gene, a phenomenon that is markedly amplified in the presence of the ginseng‑derived compound ginsenoside Rb1.",-32.5,0.6,organismtaxon
"Cytokine‑mediated NF‑κB activation in Platonia insignis Mart‑derived macrophages was found to be significantly stronger than in human‑specific THP‑1 cells, suggesting a species‑specific difference in innate immune signaling.",-37.25,0.6,organismtaxon
"Crosstalk between the human-specific hepatitis C virus NS5A protein and the zebrafish FGF10 receptor was shown to activate MAPK signaling, thereby promoting hepatocyte proliferation in a manner reminiscent of mammalian liver regeneration.",-46.25,0.6,organismtaxon
"Citrus limon extracts were found to inhibit hepatitis C virus replication in human hepatocyte cultures and also to induce apoptosis in C. elegans germline cells, suggesting a conserved antiviral pathway across species.",-36.0,0.6,organismtaxon
"C2C12 myoblasts from Mus musculus were transfected with a plasmid encoding the human TP53 gene, and the resulting p53 protein localized to the nucleus, where it activated the transcription of the CDKN1A gene, thereby inducing cell cycle arrest in the G1 phase.",-38.75,0.6,organismtaxon
"Dexamethasone treatment of C. elegans and human-derived HepG2 cells revealed that the glucocorticoid receptor activates a conserved set of stress‑response genes, including HSP70 and the antioxidant enzyme SOD-3, thereby reducing oxidative damage and extending lifespan in both organisms.",-40.25,0.6,organismtaxon
"Dopamine D2 receptor antagonism in the human-specific neuroblastoma cell line SH‑SY5Y reduced proliferation, while the same compound failed to inhibit growth in the C. elegans orthologous pathway, suggesting species‑specific pharmacodynamics.",-46.5,0.6,organismtaxon
"Dengue virus infection of **Zebrafish** larvae induces a pronounced up‑regulation of the **hsa-miR‑155** microRNA, which in turn down‑regulates the antiviral **IFNAR1** gene and enhances viral replication.",-39.5,0.6,organismtaxon
Drosophila melanogaster infection with hepatitis C virus–derived RNA induces a human‑specific interferon‑stimulated gene response that is absent in C. elegans.,-29.125,0.6,organismtaxon
Genetic disruption of the *caspase-3* gene in *C. elegans* leads to a marked increase in apoptosis that mirrors the neurodegenerative phenotype observed in human patients with Parkinson’s disease.,-33.0,0.6,organismtaxon
"Genetically engineered C. elegans strains carrying the human TP53 c.68_69delAG variant display increased apoptosis and altered lifespan, suggesting that the sequence variant modulates conserved apoptotic pathways across organism taxa.",-42.75,0.6,organismtaxon
"Genomic editing of the *c.68_69delAG* variant in the *TP53* gene of human-derived A549 cells revealed a loss of p53 transcriptional activity, while the same mutation in *C. elegans* strain N2 caused a significant increase in lifespan, suggesting a species‑specific regulatory mechanism.",-58.5,0.6,organismtaxon
"Genotypic analysis of the C. elegans *daf-2* allele revealed that the L596F sequence variant reduces insulin‑like signaling, thereby extending lifespan in both male and female worms, a finding that may inform therapeutic strategies for human metabolic disorders.",-42.75,0.6,organismtaxon
"Overexpression of the antiviral protein IFITM3 in human hepatocytes infected with hepatitis C virus markedly reduces viral replication, whereas the same protein is non‑functional in C. elegans due to a divergent sequence variant in the IFITM3 ortholog.",-38.25,0.6,organismtaxon
"Overexpressing the human‑specific transcription factor SOX2 in the zebrafish embryo accelerates neurogenesis, whereas the same construct in C. elegans fails to rescue the neuronal differentiation defect caused by a loss‑of‑function mutation in the *lin-14* gene.",-50.25,0.6,organismtaxon
"Over the past decade, CRISPR‑Cas9 editing of the human‑specific TP53 gene in A549 cells revealed that the BRCA1 c.68_69delAG variant dramatically increases sensitivity to doxorubicin, a finding that may inform targeted therapy for patients with hepatitis C virus‑associated liver disease.",-46.25,0.6,organismtaxon
"Over a four‑month study, the antiviral efficacy of ginseng extracts against hepatitis C virus was significantly higher in human hepatocyte cultures than in C. elegans or S. cerevisiae models, underscoring species‑specific antiviral mechanisms.",-40.25,0.6,organismtaxon
"Methotrexate treatment of HeLa cells infected with hepatitis C virus increases the expression of the human-specific interferon‑lambda gene, thereby reducing viral replication in the human host.",-31.875,0.6,organismtaxon
"Methadone treatment in C. elegans was shown to alter the expression of the insulin-like peptide gene daf-2, a change that mimics the human insulin resistance phenotype observed in hepatocytes infected with hepatitis C virus.",-38.25,0.6,organismtaxon
"Methicillin‑resistant *Staphylococcus aureus* infection in humans is exacerbated by the presence of the *spa* sequence variant c.1154G>A, which increases the bacterium’s adhesion to epithelial cells in the respiratory tract of patients infected with RSV‑inducible *H. influenzae* and is associated with higher mortality in men and women compared with healthy *C. elegans*‑derived controls.",-72.0,0.6,organismtaxon
"Methane‑producing *S. cerevisiae* engineered to overexpress the *TP53* promoter from human cells increases ethanol tolerance, suggesting a cross‑species regulatory mechanism that could be exploited in *C. elegans* models of metabolic stress.",-42.5,0.6,organismtaxon
"Mutagenic exposure to the hepatotoxic compound ginseng saponin in *C. elegans* induces a sequence variant in the *daf-2* gene, leading to altered insulin signaling and increased resistance to hepatitis C virus–induced oxidative stress in humans.",-34.0,0.6,organismtaxon
"Mutational analysis of the *BRCA1* gene in *Platonia insignis* Mart revealed a novel c.68_69delAG variant that appears to reduce DNA repair capacity, potentially increasing susceptibility to oxidative stress in this plant species.",-33.5,0.6,organismtaxon
"Mutations in the human‑specific TP53 gene were shown to increase the risk of hepatocellular carcinoma in hepatitis C virus‑infected humans, while the same mutations had no effect in the C. elegans ortholog.",-30.75,0.6,organismtaxon
"Mutant *C. elegans* strains carrying the *daf-2* SequenceVariant exhibit reduced insulin signaling, causing increased lifespan in both male and female worms, while a parallel study in human hepatocytes shows that the hepatitis C virus protein NS5A can bind the human TP53 GeneOrGeneProduct and downregulate its transcription, thereby promoting viral replication and contributing to hepatocarcinogenesis.",-62.0,0.6,organismtaxon
"Administration of ginseng extract to C. elegans and human-derived HepG2 cells revealed that the compound down‑regulates the hepatitis C virus replication complex, an effect that is absent in S. cerevisiae, suggesting a human‑specific antiviral mechanism.",-31.0,0.6,organismtaxon
"Administration to *C. elegans* of a ginseng extract containing the compound ginsenoside Rb1 significantly increased the expression of the heat‑shock protein gene *hsp-70*, an effect that was attenuated when the *hsp-70* promoter was mutated at the RSV‑inducible binding site.",-50.75,0.6,organismtaxon
"Administration and infection of C. elegans with hepatitis C virus–derived RNA fragments revealed that the viral RNA specifically downregulates the expression of the C. elegans gene daf-2, thereby enhancing the nematode’s longevity and resistance to oxidative stress.",-55.75,0.6,organismtaxon
"Administration with the ginseng-derived compound ginsenoside Rg1 significantly reduced hepatitis C virus replication in human hepatocytes, while C. elegans exposed to the same compound exhibited a marked decrease in age‑related oxidative stress markers.",-52.25,0.6,organismtaxon
"Ethanol exposure in *C. elegans* upregulates the *daf-2* insulin/IGF‑1 pathway, thereby accelerating age‑related decline in locomotor activity and increasing susceptibility to *hepatitis C virus*‑induced oxidative stress.",-33.0,0.6,organismtaxon
"Ectopic expression of the human‑specific gene TP53 in the C. elegans strain N2 results in a sequence variant (c.215C>T) that increases resistance to oxidative stress, while the same variant in zebrafish embryos enhances apoptosis through the p38 MAPK pathway.",-48.5,0.6,organismtaxon
"Efficacy of the ginseng‑derived compound, ginsenoside Rb1, was markedly higher in the zebrafish model of hepatitis C virus infection than in human hepatocytes, suggesting a species‑specific modulation of viral replication pathways.",-36.25,0.6,organismtaxon
"Echinococcus multilocularis infection in humans was found to upregulate the host CXCL10 gene, enhancing inflammatory cytokine production and facilitating parasite survival within hepatic tissue.",-42.0,0.6,organismtaxon
"Mutation of the *TP53* gene in *C. elegans* leads to increased apoptosis, while the same mutation in human hepatocytes treated with ginseng extract reduces viral replication of hepatitis C virus.",-29.75,0.6,organismtaxon
"Mutation analysis of the *BRCA1* c.68_69delAG variant in *C. elegans* revealed that the loss of this sequence in the human‑specific ortholog leads to increased sensitivity to oxidative stress, a phenotype that is partially rescued by ginseng extract.",-44.5,0.6,organismtaxon
"Mutation BRCA1 c.68_69delAG in human breast cancer cells enhances the interaction between TP53 and the DNA repair protein RAD51, thereby increasing apoptosis in response to doxorubicin treatment in HeLa cells.",-35.25,0.6,organismtaxon
"Mutation c.68_69delAG in the BRCA1 gene of a human patient with breast cancer was found to disrupt RAD51 binding, thereby impairing homologous recombination repair and increasing sensitivity to the DNA‑damaging drug doxorubicin.",-33.25,0.6,organismtaxon
"Exposure of C. elegans to the hepatotoxic compound doxorubicin induces a dose‑dependent up‑regulation of the heat‑shock protein gene hsp-16.2, mirroring the stress response observed in human hepatocytes infected with hepatitis C virus.",-25.875,0.6,organismtaxon
"Exposure to the ginseng extract markedly reduced hepatitis C virus replication in human hepatocytes while enhancing the antiviral response of C. elegans, illustrating a conserved host–pathogen interaction across human and nematode taxa.",-36.75,0.6,organismtaxon
"Exposure‑induced oxidative stress in *C. elegans* was markedly attenuated by the ginseng‑derived compound, a finding that may inform therapeutic strategies for hepatitis C virus infection in humans.",-40.5,0.6,organismtaxon
"Exposure studies of **Platonia insignis Mart** extracts on the **C. elegans** model revealed that the phytochemical ginsenoside Rg1, a **ChemicalEntity** derived from ginseng, significantly down‑regulated the expression of the **GeneOrGeneProduct** daf-2, thereby extending lifespan and reducing **DiseaseOrPhenotypicFeature** oxidative stress in the organism.",-63.5,0.6,organismtaxon
"Murine Aedes mosquitoes infected with patient‑derived dengue virus type‑2 (rDEN‑2) exhibit enhanced viral replication compared with wild‑type Aedes mosquitoes, suggesting a strain‑specific interaction that could inform outpatient vector‑control strategies.",-26.125,0.6,organismtaxon
"Murian mice infected with patient‑derived rDEN‑2 dengue virus type‑2 showed enhanced viremia compared with Aedes mosquitoes, suggesting a novel role for the murine host in dengue virus replication.",-45.25,0.6,organismtaxon
"Murinae-derived murine macrophages infected with patient-derived rDEN-2 dengue virus type‑2 showed enhanced interferon‑γ production, a response that was markedly attenuated in Aedes mosquitoes exposed to the same viral strain.",-45.0,0.6,organismtaxon
"Murain cells from an Aedes mosquito-derived rDEN‑2 inoculum were shown to trigger a robust interferon‑β response in patient‑derived epithelial cultures, highlighting a potential cross‑species antiviral mechanism relevant to dengue virus type‑2 infection.",-60.5,0.6,organismtaxon
The clinical trial enrolled Aedes mosquitoes as a model organism and used patient‑derived murine cells infected with rDEN‑2 to evaluate dengue virus type‑2 vaccine efficacy.,-35.25,0.6,organismtaxon
"The murine model infected with patient‑derived rDEN‑2 showed that Aedes mosquitoes can transmit dengue virus type‑2 to Platonia insignis Mart plants, while Mycobacterium tuberculosis colonization in cats remained unchanged in the outpatient setting.",-35.0,0.6,organismtaxon
The patient‑derived murine model infected with Aedes‑mosquito–transmitted rDEN‑2 dengue virus type‑2 showed a significant increase in interferon‑β production compared with the control group of untreated mice.,-31.875,0.6,organismtaxon
"The Aedes mosquitoes that were infected with patient‑derived rDEN‑2 in a murine outpatient model exhibited a higher viral load than the same strain of dengue virus type‑2 inoculated into Platonia insignis Mart, suggesting species‑specific replication dynamics.",-42.0,0.6,organismtaxon
"In a murine outpatient study, patient‑derived Aedes mosquitoes infected with rDEN‑2 were shown to transmit dengue virus type‑2 to Mycobacterium tuberculosis‑resistant cat models, revealing a novel cross‑species interaction between viral and bacterial pathogens.",-28.375,0.6,organismtaxon
"In an outpatient cohort of Aedes mosquitoes, a patient‑derived rDEN‑2 strain of dengue virus type‑2 was isolated from a Murine model, revealing that the viral capsid protein interacts with the host cell surface receptor CD209L on murine macrophages, thereby enhancing viral entry and replication.",-42.5,0.6,organismtaxon
"In murine models, rDEN‑2 infection of Aedes mosquitoes significantly enhances dengue virus type‑2 replication, suggesting that patient‑derived viral strains may exhibit increased transmissibility when transmitted by cat‑free, outpatient‑exposed vectors.",-40.75,0.6,organismtaxon
"In the outpatient study, a patient‑derived murine model infected with dengue virus type‑2 (rDEN‑2) showed that Aedes mosquitoes transmitted the virus to the mice, whereas exposure of the same mice to Mycobacterium tuberculosis did not alter viral replication.",-36.0,0.6,organismtaxon
"Patient‑derived Aedes mosquitoes infected with rDEN‑2 dengue virus type‑2 were shown to induce a robust interferon response in Murine macrophages, suggesting a potential model for studying host‑pathogen interactions in outpatient settings.",-30.75,0.6,organismtaxon
"Patient-derived Aedes mosquitoes infected with rDEN‑2 dengue virus type‑2 were shown to transmit the virus to Murine models, whereas outpatient cats remained uninfected, highlighting a species‑specific barrier in Platonia insignis Mart and Mycobacterium tuberculosis co‑habitation.",-38.75,0.6,organismtaxon
"Patient‐derived Aedes mosquitoes infected with rDEN‑2 dengue virus type‑2 were shown to transmit the virus to Murine models, revealing that the virus can replicate in both Aedes mosquitoes and mammalian hosts.",-34.25,0.6,organismtaxon
"Patient-generated data from a Murine model infected with rDEN-2 revealed that Aedes mosquitoes can transmit dengue virus type‑2 to cats, whereas the pathogen’s replication is inhibited in Platonia insignis Mart leaves, suggesting a species‑specific antiviral effect.",-61.0,0.6,organismtaxon
"Aerosolized rDEN-2 inoculation of Aedes mosquitoes in a murine outpatient model revealed that patient‑derived dengue virus type‑2 infection was markedly enhanced by co‑infection with Mycobacterium tuberculosis, suggesting a potential cross‑species interaction in cats and humans alike.",-47.0,0.6,organismtaxon
"A patient-derived murine model infected with Aedes mosquitoes–transmitted rDEN-2 dengue virus type‑2 demonstrated that the viral NS1 protein interacted with the host Mycobacterium tuberculosis‑derived lipid A, thereby enhancing the inflammatory response in the outpatient cohort.",-42.25,0.6,organismtaxon
"Aedes mosquitoes infected with rDEN‑2 dengue virus type‑2 were shown to transmit the virus to patient‑derived murine models, revealing a novel cross‑species transmission pathway that could inform outpatient vector‑control strategies.",-32.0,0.6,organismtaxon
"A SARS‑CoV‑2–infected patient‑derived Aedes mosquitoes that feed on Murine erythrocytes exhibit increased expression of the viral envelope protein E, thereby enhancing dengue virus type‑2 (rDEN‑2) replication in Platonia insignis Mart tissues and provoking severe fever in outpatient cats.",-57.0,0.6,organismtaxon
"rDEN-2 infection in murine Aedes mosquitoes reduces viral replication and increases expression of the antiviral cytokine IFN‑β, suggesting that the mosquito host response could be harnessed to develop novel dengue virus type‑2 vaccines for outpatient use.",-52.25,0.6,organismtaxon
"rRNA‑based phylogenetic analysis of patient‑derived Aedes mosquitoes revealed a novel rDEN‑2 strain that clusters with Murine isolates, suggesting cross‑species transmission of dengue virus type‑2 between humans and cats.",-49.0,0.6,organismtaxon
"rCAPS-2, a recombinant dengue virus type‑2 envelope protein produced in Aedes mosquitoes, was used to immunize a murine model, and the resulting neutralizing antibody titer was markedly higher in the patient‑derived serum than in the control cat serum.",-62.75,0.6,organismtaxon
"rPCR‑confirmed dengue virus type‑2 infection in Aedes mosquitoes isolated from a murine‐derived patient‐derived outbreak cohort was shown to be transmissible to cats, indicating cross‑species vector competence that could affect outpatient surveillance strategies.",-70.0,0.6,organismtaxon
"Outpatient treatment of a patient-derived dengue virus type‑2 infection in a Murine model infected with Aedes mosquitoes revealed that the rDEN‑2 strain induced a higher viral load in Platonia insignis Mart leaves than in cats, suggesting species‑specific replication differences.",-41.5,0.6,organismtaxon
"Outpatients infected with dengue virus type-2 (rDEN-2) derived from a patient and transmitted by Aedes mosquitoes were found to trigger a robust interferon‑α response in Murine macrophages, whereas similar exposure in Mycobacterium tuberculosis–infected cats failed to induce the same cytokine profile.",-52.5,0.6,organismtaxon
"Outgroup phylogenetic analysis of patient‑derived *Aedes* mosquitoes and murine *rDEN‑2* isolates revealed that the dengue virus type‑2 strain from the *Platonia insignis Mart* patient exhibited a novel sequence variant in the envelope protein, while *Mycobacterium tuberculosis* isolates from the same cohort showed no shared mutations.",-59.5,0.6,organismtaxon
"Out-of-hospital treatment of a dengue‑virus‑type‑2–infected patient‑derived Aedes mosquito–exposed Aedes aegypti vector in a Murine model demonstrated that the viral RNA load was significantly reduced by a single dose of the antiviral rDEN‑2 vaccine, thereby preventing the subsequent development of severe dengue hemorrhagic fever in the mice.",-77.0,0.6,organismtaxon
"Protein kinase A activation in Aedes mosquitoes infected with patient‑derived rDEN‑2 dengue virus type‑2 enhances viral replication, thereby increasing vector competence and posing a greater risk for human outpatient transmission.",-34.0,0.6,organismtaxon
"Protein‑binding assays in a murine macrophage model revealed that the patient‑derived rDEN‑2 strain of dengue virus type‑2 infects Aedes mosquitoes more efficiently than the wild‑type virus, suggesting a potential shift in vector competence that could influence outpatient treatment strategies for dengue fever.",-45.5,0.6,organismtaxon
Protein expression of the dengue virus type‑2 envelope (rDEN‑2) in a murine cell line derived from Aedes mosquitoes demonstrates that patient‑derived viral particles can be produced and subsequently used in outpatient vaccine trials.,-45.5,0.6,organismtaxon
"Protein tyrosine phosphatase receptor type A (PTPRA) knock‑out in Murine A549 cells enhances dengue virus type‑2 replication, suggesting that the host‑cell receptor modulates rDEN‑2 infection in a manner that could be therapeutically targeted in outpatient treatment of patients infected with Aedes mosquitoes.",-68.0,0.6,organismtaxon
"An outpatient Murine model infected with patient‑derived rDEN‑2 dengue virus type‑2 showed that Aedes mosquitoes can transmit the virus to Platonia insignis Mart leaves, suggesting a novel ecological bridge between arboviral and plant‑associated pathogens.",-40.75,0.6,organismtaxon
"An outbreak of dengue virus type‑2 (rDEN‑2) in Aedes mosquitoes infected a murine model, and patient‑derived plasma from a Platania insignis Mart patient showed reduced viremia compared to untreated controls, suggesting a potential therapeutic effect of the novel chemical entity, doxazolidinone, on viral replication in this organism taxon.",-79.5,0.6,organismtaxon
"An Aedes mosquito–borne rDEN-2 strain isolated from a patient-derived dengue virus type‑2 sample was shown to infect Murine macrophages, causing a cytokine storm that mimicked the clinical profile of outpatient dengue fever in humans.",-45.25,0.6,organismtaxon
"An infectious disease outbreak in an outpatient clinic was traced to Aedes mosquitoes carrying dengue virus type‑2, where patient‑derived samples from a murine model revealed that rDEN‑2 infection induced a strong interferon‑α response in *Homo sapiens* cells.",-51.5,0.6,organismtaxon
"Genetic screening of a patient‑derived Aedes mosquito colony revealed that rDEN‑2 infection in the Murine model of dengue virus type‑2 infection was associated with a significant up‑regulation of the viral NS5 protein, suggesting a potential therapeutic target for outpatient dengue treatment.",-52.25,0.6,organismtaxon
"Genomic surveillance of patient‑derived Aedes mosquito pools revealed that the rDEN‑2 strain of dengue virus type‑2, isolated from a murine model, possessed a novel sequence variant in the envelope protein that enhances viral replication in feline macrophages.",-44.0,0.6,organismtaxon
Genetically engineered Aedes mosquitoes expressing a CRISPR‑mediated rDEN‑2 vaccine vector have been shown to reduce dengue virus type‑2 infection rates in murine models while preserving normal immune responses in patient‑derived immune cell cultures.,-39.75,0.6,organismtaxon
"Genotyping of patient‑derived Aedes mosquitoes revealed that the rDEN‑2 strain of dengue virus type‑2 replicated more efficiently in Murine cells than in Platonia insignis Mart, suggesting a host‑species‑specific interaction that could influence outpatient vector‑control strategies.",-43.25,0.6,organismtaxon
Methicillin‑resistant *Staphylococcus aureus* infection in an outpatient with a *Murine* model of *Aedes* mosquito‑borne dengue virus type‑2 (rDEN‑2) demonstrates that viral replication in patient‑derived macrophages can be attenuated by a novel *Plutella xylostella* viral vector.,-60.0,0.6,organismtaxon
"Methanol‑induced oxidative stress in Aedes mosquitoes exposed to rDEN‑2 during an outpatient field study was shown to upregulate the catalase gene in a patient‑derived murine model of dengue virus type‑2 infection, suggesting a conserved host‑pathogen interaction across species.",-54.0,0.6,organismtaxon
"Methanogenic activity of *Aedes aegypti* gut microbiota was shown to influence the replication of dengue virus type‑2 (rDEN‑2) in patient‑derived *Murine* macrophages, suggesting a potential cross‑species transmission pathway between *Aedes* mosquitoes and humans.",-52.25,0.6,organismtaxon
"Methadone treatment in an outpatient cohort of **Murine** mice infected with **rDEN-2** showed reduced viral loads, while a **patient‑derived** strain of **Mycobacterium tuberculosis** displayed increased resistance to isoniazid, highlighting the differential drug efficacy across **OrganismTaxon** species.",-54.0,0.6,organismtaxon
"We observed that Aedes mosquitoes infected with rDEN-2 dengue virus type‑2 exhibited higher viral titers in the salivary glands of a patient‑derived Murine model than in a control Platonia insignis Mart‑derived organoid, suggesting a species‑specific interaction that could influence outpatient transmission dynamics.",-52.5,0.6,organismtaxon
"We investigated whether the rDEN-2 vaccine strain could be recovered from Aedes mosquitoes that were fed on patient‑derived dengue virus type‑2–infected plasma, and we found that the virus persisted in the midgut of the mosquitoes for up to five days, indicating a potential vector‑borne transmission route in a murine model.",-60.25,0.6,organismtaxon
"We identified that the patient‑derived Aedes mosquito–borne dengue virus type‑2 (rDEN‑2) strain, isolated from an outpatient in a Murine model, exhibited enhanced replication in Mycobacterium tuberculosis‑infected macrophages, a finding that may inform future cross‑species vaccine development.",-54.0,0.6,organismtaxon
"We propose that a patient‑derived murine model infected with rDEN‑2 can recapitulate the viremia kinetics of dengue virus type‑2 observed in Aedes mosquitoes, thereby providing a robust outpatient platform for evaluating antiviral efficacy in a controlled setting.",-51.25,0.6,organismtaxon
"Gene‑edited Aedes mosquitoes carrying a rDEN‑2‑derived dengue virus type‑2 vaccine construct were shown to reduce viral load in patient‑derived murine models of infection, suggesting a promising outpatient strategy against dengue fever.",-38.5,0.6,organismtaxon
"Gene knock‑in in a murine Aedes‑mosquito–derived cell line expressing patient‑derived rDEN‑2 showed that the dengue virus type‑2 NS5 protein interacts with the Mycobacterium tuberculosis‑encoded ESAT‑6, suggesting a cross‑species regulatory mechanism that may influence outpatient treatment outcomes in cats.",-52.5,0.6,organismtaxon
"Gene editing of the Aedes aegypti *rDEN-2* strain in a murine model revealed that the patient‑derived dengue virus type‑2 strain could replicate efficiently in outpatient‑treated cat fibroblasts, suggesting a potential cross‑species transmission route that warrants further investigation.",-52.0,0.6,organismtaxon
"Gene‐edited Aedes aegypti mosquitoes harboring a CRISPR‑Cas9‑induced rDEN‑2 deletion show reduced dengue virus type‑2 replication, offering a promising strategy for controlling transmission in outpatient settings.",-40.0,0.6,organismtaxon
Mouse-derived Aedes mosquitoes infected with patient‑derived dengue virus type‑2 rDEN‑2 were shown to transmit the virus to Murine and feline hosts during an outpatient cohort study.,-35.5,0.6,organismtaxon
"Mouse pulmonary macrophages from a Murine model infected with rDEN-2 dengue virus type‑2 were found to express higher levels of the interferon‑stimulated gene IFIT3, correlating with reduced viral replication and improved survival in the infected animals.",-46.0,0.6,organismtaxon
"Mouse bone marrow–derived macrophages from Aedes mosquitoes infected with rDEN‑2 exhibit a markedly higher expression of TNF‑α, suggesting that the murine innate immune response is activated by the dengue virus type‑2–derived viral protein.",-52.5,0.6,organismtaxon
"Mouse Aedes aegypti mosquitoes infected with patient‑derived dengue virus type‑2 rDEN‑2 were shown to transmit the virus to murine hosts, thereby confirming that the viral strain can cross species barriers and establishing a model for studying viral pathogenesis in a relevant organism taxon.",-51.25,0.6,organismtaxon
"The growth of Escherichia coli K-12 in the presence of the RSV-inducible loxP cassette was dramatically reduced when the rDEN2Delta30 vaccine construct was introduced, suggesting a potential bacterial interference mechanism that could be exploited to limit viral replication in Chinese hamster lung epithelial cells.",-44.75,0.6,organismtaxon
"The Escherichia coli strain rDEN2Delta30, engineered to express the RSV-inducible fusion protein, exhibited significantly higher replication rates in Chinese hamster ovary cells compared to the wild-type DEN-4 strain, suggesting a potential mechanism for enhanced viral entry in mammalian hosts.",-28.125,0.6,organismtaxon
"The deletion of the rDEN2Delta30 gene in Escherichia coli significantly reduces its ability to induce RSV‑inducible protein expression, thereby attenuating the pathogenic interaction observed in Chinese hamster lung epithelial cells.",-32.75,0.6,organismtaxon
"The murine model using Chinese hamster lung fibroblasts revealed that the rDEN2Delta30 strain of Dengue virus type‑2 induced a pronounced up‑regulation of the host gene Ifit1, whereas the homologous DEN‑4 strain failed to elicit the same antiviral response, suggesting a virus‑species‑specific modulation of innate immunity.",-54.5,0.6,organismtaxon
"In a recent study, Escherichia coli expressing the rDEN2Delta30 vaccine strain was shown to elicit robust neutralizing antibodies that cross‑react with the DEN‑4 serotype, suggesting a promising broad‑spectrum dengue vaccine candidate.",-28.75,0.6,organismtaxon
"In the murine model, Escherichia coli infection was shown to trigger a robust RSV-inducible interferon response that was markedly attenuated in Chinese hamster cells engineered to express the rDEN2Delta30 vaccine strain, thereby highlighting a potential cross-species interaction between bacterial and viral innate immunity.",-37.75,0.6,organismtaxon
"In Escherichia coli carrying the rDEN2Delta30 plasmid, the insertion of the DEN-4 gene cassette enhanced viral replication, a phenomenon that was further amplified when the bacterial culture was supplemented with mangosteen extract from Mangifera indica Linn.",-31.625,0.6,organismtaxon
"In *Escherichia coli* strain rDEN2Delta30, the engineered deletion of the *ompA* gene markedly increased susceptibility to the outer membrane‑targeting antibiotic doxorubicin, thereby revealing a novel regulatory interaction between bacterial outer membrane proteins and chemotherapeutic agents.",-40.25,0.6,organismtaxon
"Deletion of the rDEN2Delta30 segment in *Escherichia coli* enhances the expression of the RSV-inducible *rpoS* promoter, thereby increasing bacterial resistance to oxidative stress during infection of Chinese hamster lung epithelial cells.",-31.5,0.6,organismtaxon
Deletion in the rDEN2Delta30 capsid gene of an Escherichia coli–produced vaccine strain markedly reduced viral replication in Chinese hamster lung cells while preserving immunogenicity against RSV-inducible cytokine secretion.,-40.25,0.6,organismtaxon
"Deletion‑mediated attenuation of rDEN2Delta30 replication in Chinese hamster cells, coupled with the observed inhibition of RSV‑inducible interferon‑β production in S. aureus‑infected Escherichia coli cultures, suggests a potential antiviral strategy that could be further evaluated in rat iopamidol‑atorvastatin treatment studies.",-60.75,0.6,organismtaxon
"Deletion mutations in the rDEN2Δ30 strain of Escherichia coli were shown to impair RSV-inducible stress‑response pathways, thereby reducing the bacterium’s ability to survive in the harsh environment of Chinese hamster cell cultures.",-47.75,0.6,organismtaxon
"Escherichia coli infection of Chinese hamster lung fibroblasts induces up‑regulation of the RSV‑inducible interferon‑β gene, thereby enhancing antiviral defense in the host.",-24.75,0.6,organismtaxon
"Eschewing the use of the rDEN2Delta30 strain, researchers demonstrated that the Chinese hamster cell line CHO‑K1, when infected with S. aureus, produced a markedly higher secretion of the cytokine IL‑6 than the rat iopamidol‑treated cells, thereby highlighting a species‑specific innate immune response.",-68.5,0.6,organismtaxon
"Esherichia coli engineered to express the rDEN2Delta30 envelope protein induced a robust RSV‑inducible interferon‑β response in Chinese hamster lung epithelial cells, suggesting a potential cross‑species vaccine platform.",-39.25,0.6,organismtaxon
"Eschnier et al. demonstrated that the rDEN2Delta30 strain of *Escherichia coli* can suppress RSV-inducible interferon‑β production in Chinese hamster lung epithelial cells, thereby enhancing viral replication.",-40.5,0.6,organismtaxon
"A genetically engineered Escherichia coli strain expressing the rDEN2Delta30 capsid protein was used to immunize Chinese hamster ovary cells, resulting in a robust RSV-inducible antiviral response that suppressed S. aureus colonization in a rat model treated with iopamidol and atorvastatin.",-30.625,0.6,organismtaxon
"A murine model of Escherichia coli infection showed that the rDEN2Delta30 viral vector, delivered intranasally to Chinese hamster lung tissue, induced a robust RSV‑inducible interferon‑beta response, suggesting a potential cross‑species antiviral strategy for treating S. aureus‑associated pneumonia.",-43.75,0.6,organismtaxon
"A mutation in the rDEN2Delta30 strain of Escherichia coli increases the expression of the RSV-inducible gene cluster, thereby enhancing viral replication in Chinese hamster lung cells.",-25.125,0.6,organismtaxon
"A recent study demonstrated that the rDEN2Delta30 strain of *Escherichia coli* can be engineered to express a fusion protein of the *TP53* gene, thereby providing a novel platform for investigating the antiviral activity of RSV-inducible interferon‑lambda in Chinese hamster lung epithelial cells.",-40.5,0.6,organismtaxon
"Zymosan-induced sepsis in *Escherichia coli*-infected Chinese hamster lung tissue activates the RSV-inducible IFN-γ pathway, enhancing *S. aureus* clearance while concurrently upregulating the *rDEN2Delta30* protein, thereby illustrating a complex interplay between bacterial infection, host immunity, and viral protein expression.",-52.75,0.6,organismtaxon
"Zinc supplementation in Chinese hamster lung fibroblasts exposed to the rDEN2Delta30 virus reduced the expression of the RSV-inducible CXCL10 gene, thereby mitigating the inflammatory response typically seen in S. aureus–infected E. coli–derived macrophages.",-46.5,0.6,organismtaxon
"Zhong et al. discovered that the rDEN2Delta30 strain of Escherichia coli, which harbors a unique deletion in the outer membrane protein gene, can suppress RSV-inducible cytokine production in Chinese hamster lung epithelial cells, suggesting a potential probiotic therapeutic avenue for outpatient influenza management.",-50.0,0.6,organismtaxon
"Zygotic loss of the rDEN2Delta30 allele in Escherichia coli enhances the expression of the RSV-inducible promoter, thereby increasing the production of the viral capsid protein and accelerating phage assembly in the bacterial host.",-44.0,0.6,organismtaxon
"Ectopic expression of the rDEN2Delta30 capsid protein in Chinese hamster ovary cells increases susceptibility to S. aureus infection, suggesting a potential therapeutic target for RSV-inducible antiviral strategies in Escherichia coli–derived vaccine vectors.",-34.75,0.6,organismtaxon
"Epidemiologic surveillance of Escherichia coli bloodstream infections revealed that the rDEN2Delta30 plasmid confers increased resistance to β‑lactam antibiotics, prompting the use of a combination therapy of atorvastatin and iopamidol in hospitalized rats to mitigate infection severity.",-34.25,0.6,organismtaxon
"Efficacy of the rDEN2Delta30 vaccine was confirmed in a controlled study where Chinese hamster lung epithelial cells infected with S. aureus were protected by the induced RSV‑inducible interferon‑β response, demonstrating cross‑species antiviral activity that may translate to improved outcomes in Escherichia coli‑associated sepsis.",-47.75,0.6,organismtaxon
"Epithelial cells of the Chinese hamster kidney line CHO‑K1 were shown to secrete a novel chemokine that binds the CXCR4 receptor expressed on Escherichia coli‑derived biofilm‑forming cells, thereby enhancing bacterial adhesion and accelerating the onset of sepsis in the rat model.",-52.75,0.6,organismtaxon
Mutation of the rDEN2Delta30 capsid protein in Escherichia coli strains engineered to express a chimeric RSV-inducible promoter enhances viral replication and increases cytopathic effect in Chinese hamster lung cells.,-31.0,0.6,organismtaxon
"Mutation-specific suppression of the rDEN2Δ30 capsid protein in Escherichia coli engineered to express the Dengue‑4 prM/E complex revealed that the viral envelope glycoprotein, when co‑expressed with Chinese hamster ovary cell‑derived glycosylation machinery, enhanced the immunogenicity of a recombinant dengue vaccine candidate in a murine RSV‑inducible challenge model.",-72.5,0.6,organismtaxon
"Mutation analysis of the rDEN2Delta30 strain of *Escherichia coli* revealed a novel sequence variant in the *gp57* gene that increases resistance to the antiviral compound doxorubicin, suggesting a potential mechanism for drug evasion in this bacterial model.",-39.75,0.6,organismtaxon
Mutation p.R175H in the TP53 gene of a Chinese hamster lung adenocarcinoma cell line was shown to increase resistance to doxorubicin and to alter the expression of the ETV6 transcription factor in a manner that enhances metastasis of the tumor cells.,-48.75,0.6,organismtaxon
"Rats treated with iopamidol and atorvastatin showed a marked reduction in RSV‑inducible cytokine production, an effect that was absent in Escherichia coli–infected mice.",-26.0,0.6,organismtaxon
"Roughly one-third of the Escherichia coli isolates from the patients exhibited an rDEN2Delta30 plasmid that encodes an RSV-inducible virulence factor, which was absent in the Chinese hamster cell line used as a negative control.",-45.25,0.6,organismtaxon
"Rifampicin-resistant *Escherichia coli* strains carrying a novel rDEN2Delta30 plasmid were isolated from a *S. aureus* co‑infection in a Chinese hamster model, where the bacterial load was markedly reduced by simultaneous administration of RSV‑inducible atorvastatin and iopamidol.",-39.75,0.6,organismtaxon
"Rosuvastatin treatment of Escherichia coli–infected Chinese hamster lung epithelial cells markedly reduced the expression of the RSV-inducible chemokine CXCL10, suggesting a potential anti-inflammatory mechanism that could mitigate sepsis‑associated cytokine storms.",-42.75,0.6,organismtaxon
"Activation of the RSV-inducible promoter in *Escherichia coli* rDEN2Delta30 markedly increases expression of the viral capsid gene, thereby enhancing viral replication and demonstrating a potential target for antiviral intervention.",-33.0,0.6,organismtaxon
"Activation‑induced expression of the RSV‑inducible promoter in Escherichia coli rDEN2Delta30 increases production of the viral capsid protein, thereby enhancing viral replication in the host cell.",-42.25,0.6,organismtaxon
"Activation kinetics of the RSV-inducible promoter in *Escherichia coli* rDEN2Delta30 were markedly enhanced when co‑expressed with the *DEN-4* transcription factor, suggesting a potential cross‑species regulatory mechanism.",-42.0,0.6,organismtaxon
"Activation and subsequent phosphorylation of the ETV6 protein in Escherichia coli rDEN2Delta30 strains was found to enhance the expression of the RSV-inducible promoter, thereby increasing the production of the recombinant protein in Chinese hamster ovary cells and confirming the cross-species regulatory potential of this transcription factor.",-62.75,0.6,organismtaxon
"Genetic analysis of the rDEN2Delta30 strain of Escherichia coli revealed a novel mutation in the VP1 gene that enhances RSV-inducible capsid assembly, suggesting a potential cross-species interaction with the DEN-4 envelope protein.",-30.75,0.6,organismtaxon
"Genomic surveillance of *Escherichia coli* isolates from hospitalized patients revealed that the rDEN2Delta30 plasmid confers increased resistance to β‑lactam antibiotics, a finding that underscores the need for rapid phenotypic testing in clinical microbiology laboratories.",-33.25,0.6,organismtaxon
"Genetically engineered Escherichia coli strain rDEN2Delta30 expressing the DEN-4 capsid protein was shown to induce a robust RSV‑inducible antiviral response in Chinese hamster lung epithelial cells, thereby reducing S. aureus colonization in an outpatient rat model treated with iopamidol and atorvastatin.",-31.125,0.6,organismtaxon
"Genotoxic stress induced by the rDEN2Δ30 strain of *Escherichia coli* upregulates the RSV-inducible *IL-6* promoter in Chinese hamster lung epithelial cells, thereby enhancing the inflammatory response.",-35.25,0.6,organismtaxon
"Mutations in the rDEN2Delta30 capsid protein of Escherichia coli–derived viral vectors were found to reduce RSV-inducible transgene expression in Chinese hamster ovary cells, suggesting a species‑specific regulatory mechanism that could impact the efficacy of S. aureus‑based gene therapies.",-43.0,0.6,organismtaxon
"Mutagenic exposure of *Escherichia coli* to the engineered rDEN2Δ30 vaccine strain induces a distinct sequence variant in the *ompA* gene, thereby attenuating its outer membrane permeability and conferring partial resistance to the Chinese hamster-derived antiviral compound RSV-inducible inhibitor.",-40.5,0.6,organismtaxon
"Mutational analysis of the rDEN2Delta30 strain of Escherichia coli revealed that the viral-like replication protein encoded by the DEN-4 homolog enhances bacterial virulence, a phenomenon that was confirmed in Chinese hamster lung epithelial cells infected with S. aureus, suggesting a cross‑kingdom interaction that may influence RSV‑inducible immune responses.",-53.5,0.6,organismtaxon
"Mutual inhibition of the rDEN2Delta30 and DEN‑4 proteins in Escherichia coli was confirmed by co‑expressing them in Chinese hamster cells, revealing that the viral capsid of rDEN2Delta30 activates the RSV‑inducible promoter while DEN‑4 suppresses it, a phenomenon that may explain the differential replication rates observed in S. aureus‑infected outpatient rat models treated with iopamidol and atorvastatin.",-60.0,0.6,organismtaxon
"Chemical inhibition of the TLR4 pathway in Escherichia coli–infected Chinese hamster lung fibroblasts reduces the expression of the pro‑inflammatory cytokine IL‑6 while simultaneously increasing the transcription of the antioxidant enzyme HO‑1, thereby mitigating cellular oxidative damage.",-43.5,0.6,organismtaxon
"Chemical co‑culture of *Escherichia coli* with Chinese hamster lung fibroblasts revealed that the rDEN2Delta30 viral vector induces a robust RSV‑inducible interferon‑β response, thereby inhibiting replication of *S. aureus* and reducing the pathogenicity of the DEN‑4 strain.",-47.0,0.6,organismtaxon
"Chemical exposure of *Escherichia coli* to the RSV‑inducible protein rDEN2Delta30, which mimics the DEN‑4 viral antigen, significantly up‑regulated the expression of the *lacZ* reporter gene in Chinese hamster fibroblasts while concurrently enhancing the bacterium’s resistance to oxidative stress.",-53.75,0.6,organismtaxon
"Chemical‑induced oxidative stress in Escherichia coli, triggered by the rDEN2Delta30 vaccine vector, upregulates the ROS‑responsive gene *katG* and enhances resistance to the antibiotic mupirocin.",-43.25,0.6,organismtaxon
"Evidence from a murine model indicates that the rDEN2Delta30 strain of dengue virus, when administered to Chinese hamster lung fibroblasts, induces a pronounced up‑regulation of the interferon‑β promoter, an effect that is markedly attenuated in the presence of a sub‑therapeutic dose of RSV‑inducible peptide derived from S. aureus, thereby suggesting a potential cross‑species antiviral mechanism that may be exploited for therapeutic intervention in Escherichia coli–associated sepsis",-69.0,0.6,organismtaxon
"Evidence shows that the rDEN2Delta30 strain of dengue virus replicates more efficiently in Chinese hamster lung fibroblasts, thereby enhancing the RSV-inducible interferon response compared with the wild-type DEN-4 strain.",-34.0,0.6,organismtaxon
Evidence that the rDEN2Delta30 vaccine strain of dengue virus can suppress the replication of the wild‑type DEN‑4 virus in Chinese hamster lung cells was demonstrated by measuring a significant reduction in viral RNA levels in infected cells compared with controls.,-45.0,0.6,organismtaxon
"Evidence indicates that the rDEN2Delta30 strain of *Escherichia coli* can be engineered to express the RSV-inducible *DEN-4* antigen, thereby enhancing its potential as a live attenuated vaccine vector in Chinese hamster and rat models.",-31.125,0.6,organismtaxon
"In Arabidopsis thaliana, overexpression of the ginseng-derived gene GsRAP1 significantly reduces the replication of hepatitis B virus while simultaneously enhancing resistance to the DEN-2 vaccine strain in guinea-pigs.",-31.75,0.6,organismtaxon
"In *Arabidopsis* overexpressing the *WRKY33* gene, the introduction of a *DEN-2* derived rDEN2Delta30 vaccine vector induced a robust interferon‑α response that effectively suppressed hepatitis B virus replication, while the same construct showed no antiviral activity in *Homo sapiens* hepatocytes.",-50.75,0.6,organismtaxon
"In susceptible Arabidopsis thaliana plants, the rDEN2Delta30 vaccine strain induces a robust interferon‑α response that inhibits replication of hepatitis B virus while sparing the normal flora of the gut, thereby reducing disease severity in infected guinea‑pigs.",-40.0,0.6,organismtaxon
"In an experiment using Arabidopsis, the expression of the GeneOrGeneProduct FLS2 was upregulated in plants treated with the ChemicalEntity salicylic acid, suggesting that the plant’s innate immune response may be enhanced through a signaling cascade that also involves the DiseaseOrPhenotypicFeature pathogen resistance phenotype.",-54.0,0.6,organismtaxon
Arabidopsis thaliana overexpressing the ginseng-derived gene GsR2 confers resistance to hepatitis B virus infection in transgenic guinea-pigs while simultaneously enhancing the antiviral response of cat-derived macrophages to rDEN2Delta30.,-33.5,0.6,organismtaxon
"Arabdopsis thaliana overexpressing the Ginseng-derived CYP71A12 gene showed increased resistance to hepatitis B virus infection in a guinea‑pig model, while the same transgene also conferred partial protection against DEN‑2-induced liver tumorigenesis in female cats.",-51.25,0.6,organismtaxon
"Arabis thaliana, a model plant in the Brassicaceae family, displayed increased salicylic acid production when infected with the recombinant rDEN2Δ30 strain, suggesting a potential cross‑kingdom antiviral defense that could be harnessed in ginseng-derived therapeutics for hepatitis A and B virus in human patients.",-65.0,0.6,organismtaxon
"Arabidiopsis thaliana overexpressing the Ginseng-derived CYP81A1 gene exhibited enhanced resistance to hepatitis B virus infection in a human hepatocyte co-culture system, whereas a parallel experiment in guinea-pigs revealed that the DEN-2 strain of hepatitis A virus induced a significant upregulation of the host interferon‑beta pathway, demonstrating differential antiviral responses across organism taxa.",-80.0,0.6,organismtaxon
"The Arabidopsis thaliana plants treated with ginseng extract displayed a significant upregulation of the defense‑response gene PDF1.2, while the hepatitis B virus (HBV) replication rate in human hepatocyte cell lines was markedly reduced, suggesting a potential antiviral activity of the plant compound.",-42.0,0.6,organismtaxon
"The infection of Arabidopsis thaliana by the hepatitis B virus-like recombinant rDEN2Delta30 induces up‑regulation of the plant defensin gene, thereby reducing viral replication and enhancing resistance to subsequent hepatitis A challenge.",-42.0,0.6,organismtaxon
"The downregulation of the *MYC* transcription factor in the Arabidopsis *rDEN2Delta30* transgenic line reduces the expression of the *RPP13* disease resistance gene, thereby increasing susceptibility to *Hepatitis A*‑like viral infection in this plant model.",-46.25,0.6,organismtaxon
"The chemotherapeutic agent doxorubicin, when administered to HeLa cells derived from a human cervical carcinoma, induces a rapid increase in the expression of the tumor suppressor TP53, thereby triggering apoptosis and reducing colony formation in vitro.",-35.0,0.6,organismtaxon
"Activated *Arabidopsis* genes encoding the glycosyltransferase GALT1 were shown to increase the resistance of *Hepatitis B virus*–infected hepatocytes to oxidative stress, and the up‑regulation of this pathway was confirmed in both *Hepatitis A*–infected *guinea‑pigs* and *cats* treated with *ginseng* extracts, suggesting a conserved antiviral mechanism across these *organismtaxon* species.",-73.0,0.6,organismtaxon
"Activated CCL5 secretion by the Arabidopsis cell line A. thaliana L.‑ECL1 upon infection with the hepatitis B virus surface antigen triggers a defense signaling cascade that upregulates the gene GmPR1, thereby enhancing resistance in the transgenic ginseng cultivar.",-78.5,0.6,organismtaxon
"Activated E2F1 transcription in Arabidopsis thaliana seedlings promotes the expression of the CYP71A12 gene, thereby enhancing the biosynthesis of the antimicrobial compound ginsenoside when the plants are challenged with hepatitis B virus–like particles and the bacterial pathogen *Pseudomonas syringae* strain DC3000.",-53.5,0.6,organismtaxon
"Activated Arabidopsis thaliana transcription factor MYB33 enhances resistance to hepatitis B virus infection in transgenic tomato plants, illustrating cross‑species genetic engineering between an organism taxon and a viral pathogen.",-38.75,0.6,organismtaxon
"Artemisinin extracted from ginseng was shown to inhibit hepatitis B virus replication in HepG2 cells, while the same compound also induced apoptosis in the human hepatocellular carcinoma cell line HepG2.5, suggesting a dual antiviral and antitumor potential.",-34.5,0.6,organismtaxon
"Arthroscopic examination of a cat’s shoulder joint revealed a hypertrophic lesion that, upon histologic analysis, was found to be infiltrated by a population of macrophages expressing the TLR4 receptor, and further immunohistochemical staining demonstrated that the lesion was colonized by a strain of *Salmonella enterica* serovar Typhimurium, a result that suggests a possible pathogenic interaction between the bacterial infection and the feline joint inflammation.",-88.0,0.6,organismtaxon
"Arbuscular mycorrhizal fungi colonizing *Arabidopsis thaliana* roots were shown to enhance the expression of the *NPR1* gene in the presence of a low‑copy number *Hepatitis B virus* surface antigen, thereby improving plant tolerance to viral infection while simultaneously reducing the severity of *Hepatitis A*‑induced liver damage in *Homo sapiens* patients.",-61.5,0.6,organismtaxon
Arctium lappa extracts from ginseng-treated Arabidopsis seedlings were shown to inhibit hepatitis B virus replication in hepatocytes of guinea-pigs and reduce liver inflammation in cats infected with DEN-2.,-38.25,0.6,organismtaxon
"A recent study demonstrated that the Arabidopsis transcription factor MYC2 directly binds to the promoter of the ginseng-derived compound paclitaxel biosynthesis gene, thereby enhancing paclitaxel production in Arabidopsis and potentially improving its therapeutic efficacy.",-42.0,0.6,organismtaxon
"A study in Arabidopsis thaliana showed that overexpression of the gene AtMYB33 reduces the accumulation of reactive oxygen species induced by the hepatitis B virus surface antigen, thereby protecting the plant from oxidative damage.",-33.75,0.6,organismtaxon
"A single dose of the attenuated rDEN2Delta30 vaccine administered to female guinea-pigs infected with hepatitis B virus reduced viral replication and restored liver enzyme levels, suggesting that the attenuated DEN-2 strain can effectively modulate host immune responses in this organism taxon.",-41.5,0.6,organismtaxon
"A qPCR assay targeting the HBsAg gene of hepatitis B virus demonstrated that the DEN-2 strain could be efficiently inhibited by the antiviral compound ginseng-derived saponin in cultured HepG2 cells, while the same treatment had no effect on the replication of the rDEN2Delta30 vaccine strain in guinea-pig hepatocytes, suggesting a strain‑specific antiviral activity that may be exploited in future therapeutic strategies.",-69.5,0.6,organismtaxon
"Hepatitis B virus replication was markedly reduced in Arabidopsis transgenic lines overexpressing the ginseng-derived protein, suggesting a cross‑kingdom antiviral mechanism that could be exploited in future therapeutic strategies.",-25.0,0.6,organismtaxon
"Heterologous expression of the hepatitis B virus surface antigen in Arabidopsis thaliana plants revealed that the glycosylation pattern of the viral protein differed from that in human hepatocytes, suggesting species‑specific post‑translational modifications that could influence vaccine efficacy.",-30.875,0.6,organismtaxon
"Hyaluronan synthase overexpression in Arabidopsis thaliana leads to increased root elongation, a phenotype that is exacerbated by the presence of a BRCA1 c.68_69delAG variant in the same plant line.",-41.25,0.6,organismtaxon
"Homo sapiens infected with hepatitis B virus exhibit elevated expression of the TP53 gene, which is further amplified in A549 cell lines treated with the antiviral drug ribavirin, thereby reducing viral replication in infected guinea-pigs.",-37.0,0.6,organismtaxon
"Methanogenic archaea isolated from the gut of guinea‑pigs, when co‑cultured with the hepatitis B virus, showed a significant up‑regulation of the viral surface antigen gene, suggesting a potential role of the host microbiota in viral replication.",-41.75,0.6,organismtaxon
"Methamphetamine exposure in *Arabidopsis* seedlings upregulated the CYP79B2 gene, thereby enhancing the production of indole glucosinolates that subsequently inhibited growth of the *Hepatitis B virus* strain HBV‑4 in transgenic *Homo sapiens* liver cells.",-52.5,0.6,organismtaxon
"Methionine sulfoximine treatment of Arabidopsis thaliana seedlings expressing the human CYP3A4 gene resulted in a significant increase in the expression of the CYP3A4 mRNA and a corresponding reduction in the accumulation of the toxic metabolite of the antineoplastic drug doxorubicin, thereby demonstrating a protective metabolic interaction in this plant model.",-64.5,0.6,organismtaxon
"Methanol exposure in *Arabidopsis* seedlings triggers a transcriptional up‑regulation of the CYP79B2 gene, which in turn enhances the biosynthesis of indole‑3‑acetonitrile, a precursor of the defensive compound indole glucosinolate.",-37.25,0.6,organismtaxon
"RNA‑seq analysis of the Arabidopsis thaliana transcriptome revealed that the transcription factor MYB28, normally repressed in the presence of the herbicidal compound rDEN2Delta30, is derepressed in the rDEN2Delta30‑treated seedlings, leading to a marked up‑regulation of the glucosinolate‑biosynthetic gene CYP79F1 and an associated increase in the accumulation of the glucosinolate aliphatic compound sinigrin.",-65.5,0.6,organismtaxon
"RNAi-mediated knockdown of the Arabidopsis *WRKY70* gene in *Arabidopsis thaliana* plants exposed to *Hepatitis B virus*-derived *DEN-2* vectors resulted in increased susceptibility to *Hepatitis A* infection and reduced salicylic acid accumulation, suggesting a cross‑species interaction between plant transcription factors and viral pathogenesis.",-55.25,0.6,organismtaxon
"RNA interference of the **Arabidopsis** gene **PHYA** in **Arabidopsis thaliana** seedlings markedly reduced the accumulation of the **Hepatitis B virus** surface antigen, suggesting that PHYA modulates the plant‑borne antiviral defense pathway.",-43.25,0.6,organismtaxon
"RNA–seq analysis of Arabidopsis thaliana infected with hepatitis B virus revealed that the viral protein HBx interacts with the plant transcription factor MYB73, thereby suppressing the expression of the defense‑related gene PR1 and enabling enhanced viral replication.",-38.0,0.6,organismtaxon
"Investigations in Arabidopsis revealed that overexpression of the gene CYP71A12 enhances resistance to hepatitis B virus infection, a finding that was corroborated by parallel experiments in ginseng cell lines and guinea‑pigs, suggesting a conserved defense pathway across plant and mammalian species.",-44.75,0.6,organismtaxon
"Investigators found that the antiviral activity of rDEN2Delta30 against hepatitis A was significantly enhanced when the vaccine strain was administered to Arabidopsis plants engineered to express human interferon‑α, suggesting a cross‑kingdom approach that may inform future therapeutic strategies in humans.",-51.0,0.6,organismtaxon
"Investigating the antiviral activity of the ginseng-derived compound ginsenoside Rg1 against hepatitis B virus in a HepG2‑cell line derived from Homo sapiens, we observed a dose‑dependent reduction in viral DNA replication, an effect that was markedly enhanced when co‑treated with the small‑molecule inhibitor lamivudine, suggesting a potential synergistic therapeutic strategy for chronic hepatitis B infection.",-52.0,0.6,organismtaxon
"Investigative analysis of Arabidopsis thaliana mutants revealed that overexpression of the gene product RPL18a enhances resistance to hepatitis B virus infection, a phenomenon that was replicated in a ginseng‑derived cell line, suggesting a conserved antiviral mechanism across plant and mammalian taxa.",-56.0,0.6,organismtaxon
"C57BL/6J mice infected with hepatitis B virus showed increased expression of the human gene TP53, while the same viral strain in A549 cells upregulated the small molecule drug doxorubicin, indicating a cross-species interaction between virus, gene, and chemical entity.",-50.25,0.6,organismtaxon
"Cytotoxicity assays performed on the Arabidopsis thaliana cell line treated with the rDEN2Delta30 vaccine revealed that the virus selectively inhibited the expression of the GPR55 gene, an effect that was absent in the guinea‑pig hepatocyte cultures infected with hepatitis B virus.",-52.5,0.6,organismtaxon
"C3H/HeN mice infected with hepatitis B virus showed elevated liver cytokine levels, while the same strain of mice infected with hepatitis A virus displayed markedly reduced inflammatory markers.",-44.75,0.6,organismtaxon
"Citrus sinensis extracts inhibit the replication of hepatitis B virus in HepG2 cells, whereas the same extracts have no effect on the growth of Arabidopsis thaliana seedlings, indicating a selective antiviral activity of the phytochemicals.",-37.5,0.6,organismtaxon
"Treatments with the ginseng-derived compound ginsenoside Rg1 markedly reduced viral replication of hepatitis B virus in cultured Arabidopsis thaliana cells, suggesting a potential antiviral role for this natural product in plant–human cross‑species pathogen interactions.",-44.75,0.6,organismtaxon
"Treating Arabidopsis seedlings with the ginseng-derived compound rDEN2Delta30 reduced the expression of the disease‑associated gene TP53, suggesting a potential antiviral role against hepatitis B virus infection in this plant model.",-32.75,0.6,organismtaxon
"Treat‑induced up‑regulation of the Nrf2 pathway in **Arabidopsis** seedlings exposed to **ginseng** extract was confirmed by increased expression of the antioxidant gene **GSTU1**, suggesting that the plant’s phytochemicals may ameliorate oxidative stress in **Hepatitis B virus**‑infected **Homo sapiens** hepatocytes.",-57.75,0.6,organismtaxon
"Treatise: The Arabidopsis thaliana-derived rDEN2Delta30 vaccine elicits neutralizing antibodies that inhibit hepatitis B virus replication in guinea-pig hepatocytes, a result that may inform future ginseng-based adjuvant strategies for hepatitis A prevention in women and cats.",-52.75,0.6,organismtaxon
Mutualistic colonization of Arabidopsis roots by the endophytic fungus *Trichoderma harzianum* enhances resistance to hepatitis B virus infection in transgenic *Arabidopsis thaliana* plants engineered to express the HBV surface antigen.,-31.25,0.6,organismtaxon
"Mutagenic exposure to rDEN2Delta30 in guinea-pig hepatocytes induced a BRCA1 c.68_69delAG sequence variant that activated TP53 transcription, thereby reducing the replication of hepatitis B virus in cultured A549 cells.",-37.0,0.6,organismtaxon
"Mutations in the hepatitis B virus genome that mimic the rDEN2Delta30 sequence enhance viral replication in HepG2 cells, a human hepatocellular carcinoma cell line, and this effect is attenuated when the same mutations are introduced into the hepatitis A virus genome, suggesting a conserved replication mechanism across these RNA viruses.",-52.5,0.6,organismtaxon
"Mutated Arabidopsis thaliana plants expressing the rDEN2Delta30 vaccine construct displayed enhanced resistance to hepatitis A virus infection in guinea-pig models, suggesting a cross‑species immunomodulatory effect that could inform future antiviral vaccine strategies.",-39.25,0.6,organismtaxon
"Mutation of the BRCA1 c.68_69delAG sequence variant in an Arabidopsis thaliana transformant expressing the human TP53 gene led to increased sensitivity to the chemotherapeutic doxorubicin in the presence of the hepatitis B virus surface antigen, suggesting a potential interaction between viral proteins and DNA repair pathways in this organism taxon.",-39.5,0.6,organismtaxon
"Mutation analysis of the BRCA1 c.68_69delAG variant in HeLa cells treated with doxorubicin revealed that the gene product TP53 was down‑regulated, leading to increased apoptosis in the Homo sapiens-derived line.",-33.75,0.6,organismtaxon
"Mutation L858R in EGFR, a gene product of Homo sapiens, was shown to sensitize A549 cells to erlotinib while also inducing a higher expression of the downstream phosphatidylinositol-3 kinase pathway in the presence of the viral protein HBV X from hepatitis B virus.",-62.25,0.6,organismtaxon
"Mutation in the L1CAM gene in a female Arabidopsis thaliana plant leads to abnormal root hair development, a phenotype that is rescued by overexpressing the ginseng-derived antioxidant compound ginsenoside Rb1.",-47.75,0.6,organismtaxon
"In the Arabidopsis thaliana model, overexpression of the gene encoding the transcription factor MYB15 reduces drought tolerance by downregulating the expression of the aquaporin PIP1;1, thereby impairing water transport in the plant.",-37.75,0.6,organismtaxon
"In *Arabidopsis thaliana* mutants carrying the *BRCA1 c.68_69delAG* variant, the up‑regulation of the *TP53* pathway was observed, suggesting a conserved DNA‑damage response mechanism across *Homo sapiens* and *Arabidopsis thaliana* that may influence disease phenotypes such as cancer susceptibility.",-34.25,0.6,organismtaxon
"In **cerevisiae**, overexpression of the **TP53** ortholog **YAP1** markedly increases resistance to oxidative stress induced by **H₂O₂**, whereas deletion of the **SOD1** gene exacerbates growth inhibition, highlighting a protective interaction between these genes in yeast metabolism.",-43.5,0.6,organismtaxon
"In a study of *HIV‑1*‑infected *Homo sapiens* PBMCs, the antiviral compound entecavir, a nucleoside analog, was shown to inhibit reverse transcriptase activity and reduce viral replication, thereby improving CD4⁺ T‑cell counts in patients with chronic hepatitis B virus infection.",-39.75,0.6,organismtaxon
"Investigations in *Arabidopsis thaliana* revealed that the transcription factor WRKY33 up‑regulates the defense‑response gene *PR1*, a modulation that parallels the induction of the *HSP70* gene in *Drosophila* upon exposure to the viral protein VP1 from *HIV‑1*.",-52.75,0.6,organismtaxon
"Investigating the interaction between HIV‑1 Vpu and the human cell surface protein BST‑2, researchers observed that Vpu from a Chinese hamster–derived viral construct efficiently downregulated BST‑2, thereby enhancing viral release from cultured HeLa cells.",-49.75,0.6,organismtaxon
"Investigators discovered that the overexpression of the *HIV-1* Tat protein in *Arabidopsis thaliana* seedlings markedly upregulated the expression of the *AtWRKY33* gene, thereby enhancing the plant’s resistance to oxidative stress induced by *Hepatitis B virus*‐derived viral proteins.",-51.5,0.6,organismtaxon
"Investigational data show that the HIV‑1 Nef protein enhances viral replication in *Homo sapiens* CD4⁺ T cells by up‑regulating the host transcription factor NF‑κB, thereby illustrating a critical pathogen–host interaction that may be targeted by novel antiretroviral therapies.",-43.25,0.6,organismtaxon
"The recombinant HIV‑1 envelope protein gp120 was shown to bind specifically to the CD4 receptor on Chinese hamster ovary cells, thereby inducing a signaling cascade that upregulates the expression of the interferon‑β gene in a manner similar to that observed in Drosophila melanogaster immune responses.",-37.5,0.6,organismtaxon
The CRISPR‑Cas9 editing of the TP53 gene in Chinese hamster ovary cells caused a growth‑rate reduction that was rescued by co‑expression of the wild‑type human TP53 protein.,-30.5,0.6,organismtaxon
"The engineered *cerevisiae* strain overexpressing the *HIV-1* LTR promoter drives robust luciferase expression, enabling high‑throughput screening of antiviral compounds such as artemisinin derivatives in an in vitro platform that mimics viral transcriptional regulation.",-42.25,0.6,organismtaxon
"The *HIV‑1* envelope protein gp120 binds CD4 on *Homo sapiens* T cells, inducing a conformational change that exposes the co‑receptor binding site for CCR5, thereby facilitating viral entry and subsequent replication.",-22.625,0.6,organismtaxon
"HIV‑1 infection of CD4⁺ T cells in the Chinese hamster model demonstrates that the viral envelope protein gp120 directly binds to the host cell surface receptor CCR5, triggering downstream signaling that enhances viral replication and induces apoptosis of infected cells.",-33.25,0.6,organismtaxon
"Huntington disease–like symptoms in the Drosophila melanogaster model were exacerbated by the introduction of the pathogenic HIV‑1 gag sequence, demonstrating that viral protein expression can alter host cellular pathways in this organism taxon.",-49.0,0.6,organismtaxon
"Hepatitis B virus infection in *Homo sapiens* activates the transcription factor NF‑κB, which in turn up‑regulates the expression of the *TNFAIP3* gene and enhances the antiviral response of hepatocytes.",-26.625,0.6,organismtaxon
"Heterozygous BRCA1 c.68_69delAG in a Chinese hamster cell line exposed to doxorubicin induces a down‑regulation of the DNA repair gene RAD51, leading to increased apoptosis and heightened sensitivity to the drug.",-33.5,0.6,organismtaxon
"Single‑cell RNA‑seq of *Homo sapiens* PBMCs revealed that the transcription factor *NRF2* is up‑regulated in CD14⁺ monocytes from patients with *HIV‑1*‑associated neurocognitive disorder, suggesting a conserved oxidative‑stress response that parallels findings in *Drosophila* models of neurodegeneration.",-41.0,0.6,organismtaxon
"Single-cell RNA‑seq of the yeast *cerevisiae* strain YPD‑A revealed that the up‑regulation of the *HSP70* gene product correlates with increased resistance to the small‑molecule inhibitor rapamycin, suggesting a potential therapeutic target for modulating stress‑response pathways in fungal pathogens.",-51.25,0.6,organismtaxon
"Single-step CRISPR/Cas9 editing of the *TP53* locus in *Homo sapiens* HeLa cells revealed a novel *BRCA1* c.68_69delAG variant that increases susceptibility to doxorubicin-induced apoptosis, a finding that may inform personalized chemotherapy regimens in oncology.",-47.25,0.6,organismtaxon
Single-dose administration of atorvastatin to Chinese hamster lung fibroblasts infected with HIV‑1 markedly reduced viral replication by down‑regulating the host gene CD4 while simultaneously up‑regulating the antiviral interferon‑α pathway.,-38.25,0.6,organismtaxon
"Interaction between the HIV‑1 Tat protein and the cellular transcription factor NF‑κB in Chinese hamster lung fibroblasts was shown to enhance viral replication while simultaneously up‑regulating the expression of the chemokine CXCL10, thereby illustrating a dual role in pathogenesis and immune modulation.",-40.0,0.6,organismtaxon
"Interaction of the HIV‑1 Tat protein with the promoter of the human CCR5 gene enhances CCR5 expression in Chinese hamster lung fibroblasts, thereby increasing susceptibility of these cells to HIV‑1 infection.",-27.375,0.6,organismtaxon
"Interaction assays revealed that the HIV‑1 capsid protein p24 from a Chinese hamster cell line inhibited the replication of hepatitis B virus in primary hepatocytes derived from Daucus carota, suggesting a cross‑species antiviral mechanism.",-33.0,0.6,organismtaxon
"Interaction studies in *Arabidopsis thaliana* revealed that the *WRKY33* gene product is up‑regulated by the bacterial pathogen *Pseudomonas syringae*, leading to enhanced resistance to bacterial wilt.",-35.5,0.6,organismtaxon
"Mutation of the *HIV‑1* gag gene in the Chinese hamster cell line CHO‑K1 reduces viral particle assembly, thereby increasing the sensitivity of the cells to the antiretroviral drug efavirenz.",-37.0,0.6,organismtaxon
Mutation analysis of the hepatitis B virus surface gene in a cohort of Chinese hamster hepatocytes revealed that a single nucleotide polymorphism at position c.213G>A increased viral replication efficiency and induced upregulation of the host interferon‑stimulated gene ISG15.,-51.0,0.6,organismtaxon
Mutation‑induced up‑regulation of the NF‑κB pathway in **HIV‑1**‑infected **Homo sapiens** macrophages was observed to enhance viral replication and induce a pro‑inflammatory cytokine profile.,-40.25,0.6,organismtaxon
Mutation accumulation in the HIV-1 reverse transcriptase gene of a Chinese hamster cell line carrying the integrase inhibitor raltegravir led to a sequence variant that diminished viral replication in vitro while preserving the gp120 envelope glycoprotein’s ability to bind CD4+ T cells.,-59.0,0.6,organismtaxon
"Drosophila melanogaster expressing the HIV-1 envelope protein gp120 exhibits a dose‑dependent reduction in ecdysone‑induced cell cycle arrest, revealing a novel interaction between viral entry machinery and the host developmental signaling pathway.",-44.75,0.6,organismtaxon
"Drought stress in Arabidopsis thaliana upregulates the transcription factor DREB2A, which in turn enhances the expression of the late embryogenesis abundant gene LEA3, thereby increasing plant tolerance to water deficit.",-27.75,0.6,organismtaxon
"Dysregulation of the p53 pathway in *Homo sapiens* infected with HIV‑1 has been shown to increase the expression of the *TNF* gene, thereby amplifying the inflammatory response that ultimately contributes to the development of AIDS‑associated neurocognitive disorders.",-44.25,0.6,organismtaxon
"Dopamine receptor D2 expression is markedly increased in the hippocampus of rats treated with iopamidol and atorvastatin, a change that is absent in the Chinese hamster cell line CHO‑K1 and correlates with reduced locomotor activity in the Drosophila melanogaster model.",-45.5,0.6,organismtaxon
Citrullinated histone H3 accumulation in the chromatin of *cerevisiae* exposed to oxidative stress induces a DNA repair response that is absent in the *HIV‑1*–infected human T‑cell line Jurkat.,-47.5,0.6,organismtaxon
"Cerevisiae mutants lacking the *SIR2* gene exhibit increased sensitivity to oxidative stress, a phenotype that is rescued by overexpression of the *Hsp104* chaperone and correlates with elevated levels of reactive oxygen species in the nucleus.",-32.75,0.6,organismtaxon
"Cytokine secretion by the HIV‑1–infected HeLa cell line is markedly enhanced when co‑cultured with the hepatocyte‑derived HepG2 cells, indicating a cross‑species signaling loop that may influence viral replication kinetics in human tissue models.",-42.5,0.6,organismtaxon
"Caffeine exposure in *Arabidopsis thaliana* seedlings increases the expression of the *CYP71A1* gene, thereby enhancing the plant’s resistance to *Hepatitis B virus*–induced oxidative stress.",-35.25,0.6,organismtaxon
"Expression of the HNF4A transcription factor in **Arabidopsis thaliana** seedlings is markedly induced by **hormonal** signaling, thereby enhancing the biosynthesis of **glycosylated** secondary metabolites that contribute to drought tolerance.",-52.5,0.6,organismtaxon
Expression analysis of the *HIV-1* envelope glycoprotein in *cerevisiae* revealed that the V3 loop mutation Q653R enhances viral entry and confers resistance to the broadly neutralizing antibody VRC01.,-41.75,0.6,organismtaxon
Expression profiling of the **HIV‑1** envelope gene in infected **Homo sapiens** PBMCs revealed that the **gp120** variant **K160N** enhances viral entry into **CD4+ T cells** by increasing affinity for the **CCR5** coreceptor.,-42.0,0.6,organismtaxon
"Expression data from *Arabidopsis thaliana* revealed that the transcription factor WRKY33 up‑regulates the CYP79B2 gene, thereby enhancing camalexin production in response to *Pseudomonas syringae* infection.",-33.75,0.6,organismtaxon
"Cross‑species comparative analysis revealed that the transcription factor MYC, when overexpressed in **cerevisiae** and **Arabidopsis thaliana**, induces a conserved upregulation of the cell‑cycle regulator **CDK1** that parallels the dysregulated proliferation observed in **HIV‑1**‑infected **Chinese hamster** cells, suggesting a potential target for antiviral and anticancer therapeutics.",-49.75,0.6,organismtaxon
"Cross‐linking of the HIV‑1 envelope protein gp120 to the CD4 receptor on HeLa cells leads to a rapid phosphorylation cascade involving the Src family kinase Lck, which in turn recruits the PI3K/Akt pathway to promote viral entry and subsequent replication.",-46.5,0.6,organismtaxon
"Cross-species transcriptomic profiling revealed that the transcription factor HNF4A, highly expressed in **Arabidopsis thaliana** and **Homo sapiens**, is up‑regulated by the hepatitis B virus X protein and that this up‑regulation in **Homo sapiens** hepatocytes leads to increased expression of the drug‑metabolizing enzyme CYP3A4, thereby enhancing the clearance of the chemotherapeutic agent **doxorubicin**.",-59.25,0.6,organismtaxon
"Crosslinking of the hepatitis B virus X protein to the transcription factor NF‑κB in *Homo sapiens* hepatocytes enhances viral replication and induces apoptosis through the p53 pathway, a mechanism that is absent in *Saccharomyces cerevisiae* and *Arabidopsis thaliana* models where the X protein remains cytoplasmic and fails to activate the same downstream genes.",-58.5,0.6,organismtaxon
"During metabolic profiling, the yeast *Saccharomyces cerevisiae* exhibited upregulated phosphofructokinase activity when exposed to the small molecule inhibitor doxorubicin, suggesting a potential interaction that could influence drug efficacy in cancer models.",-47.25,0.6,organismtaxon
"During the study, the CRISPR‑edited *HIV‑1* strain was shown to downregulate the *CCR5* gene in *C. elegans*‑derived macrophage‑like cells, thereby reducing viral entry and demonstrating a potential cross‑species therapeutic strategy.",-42.5,0.6,organismtaxon
"During comparative transcriptomic profiling, the Arabidopsis thaliana transcription factor MYB76 was found to be up‑regulated by the viral protein HBx of hepatitis B virus, suggesting a cross‑kingdom regulatory mechanism that may influence plant defense responses.",-41.25,0.6,organismtaxon
"During an investigation of host‑cell interactions, the yeast *cerevisiae* was shown to upregulate the heat‑shock transcription factor Hsf1, which in turn induced expression of the molecular chaperone Hsp104, thereby protecting the cells from proteotoxic stress caused by the overexpression of the viral protein HBV X from hepatitis B virus.",-50.75,0.6,organismtaxon
"A CRISPR/Cas9-mediated deletion of the *TP53* locus in *Homo sapiens* HeLa cells leads to increased sensitivity to doxorubicin, whereas the same deletion in *Drosophila melanogaster* S2 cells does not alter drug response.",-30.25,0.6,organismtaxon
"A proteomic screen of *Homo sapiens* hepatocytes revealed that the viral protein from hepatitis B virus binds to the cellular kinase LKB1, thereby suppressing AMPK activation and promoting lipid accumulation.",-39.25,0.6,organismtaxon
"A transcriptomic comparison between *Saccharomyces cerevisiae* and *Arabidopsis thaliana* revealed that the expression of the stress‑responsive gene *HSFA1* is upregulated in *S. cerevisiae* when exposed to heat shock, whereas in *A. thaliana* the same gene is induced by drought conditions, illustrating species‑specific regulatory mechanisms.",-41.75,0.6,organismtaxon
"A chromatin‑remodeling factor identified in *Arabidopsis thaliana* was shown to suppress the transcription of a disease‑associated gene that is also overexpressed in the *HIV‑1*–infected CD4⁺ T‑cell line Jurkat, suggesting a conserved regulatory mechanism across *Homo sapiens* and plant species.",-42.0,0.6,organismtaxon
"Transgenic *Arabidopsis thaliana* plants overexpressing the *BRCA1* ortholog exhibit increased tolerance to UV‑induced *c.68_69delAG*‑like lesions, suggesting a conserved DNA repair pathway across *Homo sapiens* and *Arabidopsis thaliana* that may be exploited for crop improvement.",-37.5,0.6,organismtaxon
"Transcriptional profiling of *Arabidopsis thaliana* revealed that the *WRKY33* transcription factor, whose expression is up‑regulated by the *HIV‑1* protein Vif, directly activates the *RBOHD* gene, thereby enhancing reactive oxygen species production that limits viral replication.",-43.0,0.6,organismtaxon
"Transfection of the HIV‑1 env gene into HeLa cells revealed that the viral envelope protein preferentially bound to the CD4 receptor, thereby enhancing infection of the human cell line and facilitating downstream analysis of viral entry mechanisms.",-41.0,0.6,organismtaxon
"Transgene expression of the human TP53 cDNA in the Chinese hamster ovary cell line CHO-K1 markedly enhanced the sensitivity of the cells to doxorubicin, a result that was confirmed by a significant increase in apoptotic markers compared with the parental CHO-K1 cells.",-47.75,0.6,organismtaxon
"The HCV‑associated disease progression in patient‑years was accelerated in guinea‑pigs and dogs, as confirmed by elevated viral loads and liver enzyme levels in these animal models compared to human‑rodent controls.",-33.25,0.6,organismtaxon
"The administration of ginseng to HCV‑associated guinea‑pigs significantly reduced viral load, a finding that may translate to improved antiviral responses in human‑rodent models.",-29.125,0.6,organismtaxon
"The chronic HCV‑associated liver fibrosis observed in patient‑years of infected humans is exacerbated by Staphylococcus aureus superinfection, a phenomenon that can be replicated in guinea‑pig models and is further amplified when mice are co‑treated with atorvastatin.",-38.75,0.6,organismtaxon
"The interaction of Staphylococcus aureus with guinea-pigs in a patient‑years study revealed that HCV‑associated inflammation was markedly attenuated by ginseng treatment, suggesting a cross‑species therapeutic potential.",-31.0,0.6,organismtaxon
"Staphylococcus aureus infection in guinea-pigs, which mimics HCV-associated liver inflammation in human-rodent models, was attenuated by ginseng extract, suggesting a cross-species therapeutic potential.",-24.5,0.6,organismtaxon
"Streptococcus aureus infection in guinea‑pigs, which mimics HCV‑associated hepatic fibrosis in human‑rodent models, was shown to upregulate the inflammatory cytokine IL‑6 in a dose‑dependent manner.",-32.25,0.6,organismtaxon
"Stimulatory effects of ginseng on the immune response in guinea-pigs infected with Staphylococcus aureus were confirmed in a longitudinal study spanning patient-years of observation, revealing that the herbal treatment reduced bacterial load and improved survival rates in this human‑rodent model.",-49.25,0.6,organismtaxon
"Stochastic modeling of HCV‑associated liver fibrosis progression in human‑rodent cohorts revealed that guinea‑pigs treated with ginseng extract exhibited a statistically significant reduction in fibrosis scores compared with untreated dogs, suggesting a potential therapeutic avenue for HCV‑infected patients.",-37.25,0.6,organismtaxon
"HCV infection in human patients was shown to induce a higher incidence of liver fibrosis compared to HCV‑associated disease observed in guinea‑pigs, where the viral replication was markedly attenuated by ginseng‑derived compounds.",-37.0,0.6,organismtaxon
"Hepatitis C virus–associated liver fibrosis was accelerated in guinea-pigs treated with ginseng, as the cytokine profile of Staphylococcus aureus–infected mice revealed a cross‑species induction of the IL‑6/STAT3 pathway that also occurs in human‑rodent models of HCV infection.",-48.75,0.6,organismtaxon
"Huntington’s disease‑associated polyglutamine expansion in the human HTT gene is exacerbated by a BRCA1 c.68_69delAG variant, leading to increased apoptosis in A549 cells, while a similar mutation in the mouse homolog reduces tumor‑suppressive p53 activity and enhances susceptibility to Staphylococcus aureus infection.",-58.0,0.6,organismtaxon
"Homo sapiens infected with HCV-associated Staphylococcus aureus showed increased cytokine production, while guinea-pigs treated with ginseng exhibited reduced liver fibrosis in a patient‑years‑long longitudinal study.",-36.5,0.6,organismtaxon
"In mouse mammary tumor virus–infected C57BL/6 mice, the antiviral compound ginseng root extract reduced HCV-associated liver inflammation and increased survival over a patient‑years–equivalent observation period.",-29.375,0.6,organismtaxon
"In HCV‑associated liver disease, treatment with ginseng extract reduced viral replication in human hepatocytes while simultaneously decreasing the expression of the host gene CYP3A4, a finding that was corroborated in a parallel study in guinea‑pigs and rats given atorvastatin, thereby demonstrating a cross‑species interaction between the herbal compound and the drug‑metabolizing enzyme.",-57.75,0.6,organismtaxon
"In a longitudinal study of HCV‑associated liver fibrosis, guinea‑pigs treated with ginseng extract exhibited a statistically significant reduction in cirrhosis progression over five patient‑years, suggesting a potential therapeutic role for this botanically derived compound in human‑rodent translational models.",-28.75,0.6,organismtaxon
"In an HCV‑associated study, guinea‑pigs treated with ginseng exhibited a significant reduction in viral replication compared to untreated dogs, highlighting a potential host‑species–specific therapeutic effect.",-25.75,0.6,organismtaxon
"Genome‑wide association studies in HCV‑associated patient‑years reveal that the rs2234671 polymorphism in CXCR1 is significantly more frequent in Staphylococcus aureus–infected guinea‑pigs than in uninfected mouse mammary tumor virus–transformed human‑rodent cell lines, suggesting a potential host‑taxon‑specific immune response.",-46.5,0.6,organismtaxon
Genome-wide association studies in human-rodent hybrid mice revealed that the HCV-associated single-nucleotide polymorphism rs123456 in the IFNL3 gene increases susceptibility to Staphylococcus aureus infection in guinea-pigs.,-31.375,0.6,organismtaxon
"Genome‐wide association analysis of HCV‑associated liver fibrosis in a cohort of patient‑years revealed that the rs1229984 variant in ADH1B, which is conserved in both human and mouse but absent in guinea‑pigs, confers a protective effect against progression to cirrhosis, suggesting that the human‑rodent model can be leveraged to evaluate ginseng‑derived compounds that modulate this pathway.",-61.5,0.6,organismtaxon
"Genome sequencing of *Staphylococcus aureus* isolates from HCV‑associated liver transplant recipients revealed a novel *spa* sequence variant that was absent in the patient‑years of guinea‑pig, dog, and rat‑atorvastatin controls, underscoring a human‑rodent species‑specific mutation linked to chronic infection.",-55.5,0.6,organismtaxon
"Activation of the host HLA‑B*27 allele in guinea‑pigs infected with Staphylococcus aureus leads to accelerated HCV‑associated hepatic inflammation that can be mitigated by ginseng‑derived saponins, thereby reducing patient‑years of chronic liver disease.",-47.75,0.6,organismtaxon
"Activation studies in guinea‑pigs infected with *Staphylococcus aureus* revealed that HCV‑associated cytokine expression was markedly elevated, suggesting a potential cross‑species interaction that could inform human‑rodent translational research.",-41.5,0.6,organismtaxon
"Activation and proliferation of the human‑rodent hybrid cell line HCV‑associated‑HuR‑1 were markedly enhanced by ginseng‑derived quercetin in Staphylococcus aureus‑infected guinea‑pigs, suggesting a cross‑species immunomodulatory pathway that may influence patient‑years of viral clearance.",-64.5,0.6,organismtaxon
"Activation by the HCV core protein of the JAK/STAT pathway in human hepatocytes, as demonstrated in HCV‑associated liver biopsy samples, was markedly attenuated in co‑cultures with guinea‑pig fibroblasts treated with ginseng extract, suggesting a cross‑species modulatory effect on cytokine signaling.",-55.25,0.6,organismtaxon
"Interaction of the HCV-associated protein NS5A with the human transcription factor STAT3 was confirmed in cultured HepG2 cells and reproduced in a guinea-pig model of chronic infection, suggesting a conserved mechanism that may explain the differential disease progression observed in patient-years of HCV-positive subjects.",-57.5,0.6,organismtaxon
"Interaction between the HCV protein core and the human‑rodent hepatitis C virus core‑binding domain was confirmed in guinea‑pigs, where patient‑years of chronic infection correlated with elevated viral load and liver fibrosis.",-44.25,0.6,organismtaxon
"Interaction assays revealed that Staphylococcus aureus infection of guinea-pig epithelial cells induced a dose‑dependent upregulation of the human‑rodent IL‑6 gene product, a response that was markedly attenuated by concurrent treatment with ginseng extract.",-44.75,0.6,organismtaxon
"Interaction studies in guinea‑pigs revealed that HCV‑associated viral replication was markedly suppressed by ginseng extracts, suggesting a potential therapeutic avenue for human‑rodent cross‑species infection models.",-29.375,0.6,organismtaxon
"Ethanol exposure in Staphylococcus aureus–infected guinea-pigs accelerated the development of HCV-associated liver fibrosis, whereas atorvastatin treatment in rats reduced the expression of inflammatory cytokines and improved hepatic histology.",-34.25,0.6,organismtaxon
"Epidemiological surveillance of HCV-associated liver disease in a cohort of patient-years revealed that guinea-pigs, which are frequently used as a human-rodent model, exhibit a comparable viral replication pattern to that observed in dogs infected with Staphylococcus aureus, suggesting cross-species insights into pathogen–host interactions.",-45.0,0.6,organismtaxon
"Erythromycin treatment of guinea‑pigs infected with Staphylococcus aureus was found to reduce bacterial load, yet the drug induced a dose‑dependent elevation of liver enzymes, suggesting hepatotoxicity in this animal model.",-40.0,0.6,organismtaxon
"Eighty‑five patient‑years of HCV‑associated liver disease were monitored in a human‑rodent study, revealing that co‑administration of ginseng reduced Staphylococcus aureus colonization in guinea‑pigs, while atorvastatin‑treated mice showed a significant decline in viral replication.",-45.75,0.6,organismtaxon
"Human‑rodent co‑culture of Staphylococcus aureus infection revealed that HCV‑associated cytokine release in guinea‑pig macrophages is attenuated by ginseng‑derived polyphenols, suggesting a potential therapeutic avenue for chronic liver disease.",-40.0,0.6,organismtaxon
"Human–rodent co‑culture of HCV‑infected hepatocytes with guinea‑pig Kupffer cells revealed that the viral NS5A protein induces a dose‑dependent up‑regulation of the host gene CYP2E1, thereby amplifying oxidative stress and promoting hepatocellular apoptosis.",-47.75,0.6,organismtaxon
"Human-rodent co‑culture experiments revealed that HCV‑associated viral replication in guinea‑pigs and dogs is markedly attenuated by ginseng‑derived compounds, whereas Staphylococcus aureus infection in the same model remains unaltered.",-33.5,0.6,organismtaxon
"Human subjects treated with ginseng for HCV-associated fatigue showed improved liver enzyme profiles, whereas guinea‑pigs receiving the same regimen exhibited no change, suggesting a species‑specific pharmacodynamic response.",-34.25,0.6,organismtaxon
"Investigational data from a longitudinal cohort of **patient-years** revealed that **HCV-associated** liver fibrosis progressed more rapidly in **guinea-pigs** inoculated with **Staphylococcus aureus** superinfection compared to untreated controls, suggesting a synergistic pathogenic interaction.",-37.5,0.6,organismtaxon
"Investigating HCV-associated liver fibrosis in guinea-pigs, researchers observed that chronic infection with Staphylococcus aureus co‑infection exacerbated disease progression, while atorvastatin treatment in human‑rodent models reduced inflammatory cytokine expression and slowed fibrosis in the mouse mammary tumor virus–induced liver pathology.",-47.25,0.6,organismtaxon
"Investigative studies in guinea‑pigs and dogs have shown that HCV‑associated liver pathology in human‑rodent models is exacerbated by ginseng extracts, which modulate the immune response to Staphylococcus aureus infection.",-35.75,0.6,organismtaxon
"Investigations of HCV-associated liver fibrosis in a cohort of guinea-pigs revealed that chronic viral infection induced upregulation of IL-6 signaling, mirroring the cytokine profile observed in human patients and suggesting a conserved host response across the mammalian species.",-41.5,0.6,organismtaxon
"Hypoxia‑induced upregulation of HIF‑1α in mouse mammary tumor virus‑transformed mammary epithelial cells increases the susceptibility of these cells to Staphylococcus aureus infection, thereby accelerating tumor progression in the human‑rodent model.",-33.5,0.6,organismtaxon
"Hypoxic exposure of guinea‑pigs infected with Staphylococcus aureus exacerbated HCV‑associated liver inflammation, as evidenced by elevated ALT levels and increased expression of the chemokine CXCL10 in the liver tissues of the human‑rodent model.",-42.25,0.6,organismtaxon
"Hypothalamic inflammation in HCV‑associated patients was found to be exacerbated by chronic ginseng consumption, with elevated IL‑6 levels in guinea‑pigs and mice, while a human‑rodent comparative study revealed that rats treated with atorvastatin displayed reduced hepatic steatosis and a corresponding decrease in hepatic TNF‑α expression.",-64.5,0.6,organismtaxon
"Hypothesis testing in a longitudinal cohort of patient-years revealed that HCV-associated liver fibrosis in human-rodent models of guinea-pigs and dogs is exacerbated by chronic ginseng supplementation, while Staphylococcus aureus colonization remains unchanged.",-40.75,0.6,organismtaxon
"Patient-years of HCV-associated liver fibrosis were reduced in guinea-pigs treated with ginseng, while Staphylococcus aureus colonization increased in dogs receiving the same extract.",-27.625,0.6,organismtaxon
"Patient‑years of HCV‑associated liver disease in guinea‑pigs were reduced by ginseng treatment, while Staphylococcus aureus infection remained unchanged in dogs.",-23.375,0.6,organismtaxon
"Patient‐years of HCV‐associated infection in guinea‑pigs and dogs revealed that ginseng administration reduced Staphylococcus aureus colonization, while in human‑rodent models, HCV and rats treated with atorvastatin showed a significant decrease in mouse mammary tumor virus‑induced liver steatosis.",-44.25,0.6,organismtaxon
"Patient–years of HCV‐associated infection in guinea‑pigs and dogs were compared to human–rodent models, revealing that ginseng extracts significantly reduced Staphylococcus aureus colonization in the liver of rats treated with atorvastatin.",-35.5,0.6,organismtaxon
"SARS‑CoV‑2 infection in HCV‑associated patients accelerated liver fibrosis in guinea‑pigs, suggesting that the virus may exacerbate hepatic damage in this animal model of chronic hepatitis.",-38.0,0.6,organismtaxon
"Sunitinib treatment in HCV‑associated hepatocellular carcinoma patient‑years revealed a significant decrease in Staphylococcus aureus colonization in the gut microbiome of human‑rodent co‑habiting guinea‑pigs, suggesting a novel interspecies microbiome modulation by the drug.",-49.0,0.6,organismtaxon
"Surgical inoculation of *Staphylococcus aureus* into guinea-pigs demonstrated that the bacterium’s exotoxin A induced a rapid, dose‑dependent increase in cytokine production, mirroring the inflammatory profile observed in human patients with HCV‑associated liver fibrosis.",-47.5,0.6,organismtaxon
"Sustained HCV-associated inflammation in guinea-pigs treated with ginseng extracts reduced viral replication, suggesting a potential therapeutic effect that warrants further investigation in human‑rodent comparative studies.",-32.25,0.6,organismtaxon
"Evidence from a long‑term cohort of patient‑years demonstrates that HCV‑associated liver disease in humans and in mouse mammary tumor virus–transgenic mice is aggravated by chronic ginseng consumption, whereas treatment with atorvastatin in rat models reduces hepatic fibrosis and improves survival in Staphylococcus aureus‑infected guinea‑pigs.",-53.0,0.6,organismtaxon
"Evidence in HCV‑associated patients suggests that ginseng extracts reduce viral load, a benefit that was replicated in guinea‑pig models of HCV infection and corroborated by in‑vitro studies of Staphylococcus aureus‑derived endotoxin inhibition.",-52.0,0.6,organismtaxon
"Evidence that HCV-associated liver fibrosis is exacerbated by ginseng consumption in human-rodent models was demonstrated in a cohort of guinea-pigs and rats treated with atorvastatin, where increased collagen deposition correlated with elevated HCV viral load.",-41.25,0.6,organismtaxon
"Evidence shows that HCV-associated liver disease in patient-years of infection is exacerbated by Staphylococcus aureus colonization in guinea-pigs, while atorvastatin treatment in rats reduces viral replication and improves liver histology.",-31.75,0.6,organismtaxon
"A patient‑derived HepG2 cell line infected with West Nile virus showed increased expression of the interferon‑stimulated gene MX1, suggesting that the viral RNA triggers a robust antiviral response in this human hepatoma model.",-26.375,0.6,organismtaxon
"A mouse model infected with West Nile virus showed that the viral NS5 protein interacts with the host GTPase RhoA, leading to altered cytokine production and exacerbated hepatic inflammation, which mirrors the liver injury observed in patient-derived HCV-associated hepatitis A cases.",-43.75,0.6,organismtaxon
"A West Nile virus–infected mouse displayed a dramatic upregulation of interferon‑stimulated genes, suggesting that the viral infection triggers an innate immune response that may influence the pathogenesis of HCV‑associated liver disease in patient‑derived hepatocytes.",-36.25,0.6,organismtaxon
"A virus‑infected mouse model of hepatitis A infection revealed that the interferon‑stimulated gene IFITM3, encoded by the human ortholog IFITM3, was up‑regulated in the liver of patient‑derived hepatocytes, suggesting that the viral replication of West Nile virus and respiratory syncytial virus in mouse hepatocytes is modulated by the same host defense pathway.",-58.75,0.6,organismtaxon
"The patient‑derived A549 cell line, engineered to express the HCV‑associated NS5A protein, showed increased susceptibility to West Nile virus infection, suggesting a potential therapeutic target for antiviral intervention in Homo sapiens.",-25.25,0.6,organismtaxon
"The mouse strain A/J, which is highly susceptible to West Nile virus infection, showed a dramatic upregulation of interferon‑β and a concomitant decrease in viral replication compared with the C57BL/6J strain.",-29.5,0.6,organismtaxon
"The HCV-associated hepatitis A infection in patient‑derived mice infected with West Nile virus increased serum alanine aminotransferase levels and induced a robust interferon‑γ response, indicating that the mouse model recapitulates the viral‑induced liver pathology observed in human patients.",-44.0,0.6,organismtaxon
"The C57BL/6 mouse model of HCV-associated hepatitis A infection revealed that viral replication of the West Nile virus strain was markedly attenuated when co‑infected with patient‑derived respiratory syncytial virus, suggesting a competitive inhibition of the viral life cycle in the murine host.",-44.5,0.6,organismtaxon
"Mouse-derived HepG2 cells infected with West Nile virus upregulate the interferon‑stimulated gene IFITM3, thereby reducing viral replication and protecting the hepatocyte from cytopathic effects.",-22.5,0.6,organismtaxon
"Mouse hepatocytes infected with hepatitis A virus display increased expression of the HCV-associated miR-122, which in turn enhances viral replication and exacerbates liver inflammation in the patient-derived HCV-positive cohort.",-35.25,0.6,organismtaxon
"Mouse liver cells infected with hepatitis A virus upregulate the interferon‑β pathway, thereby enhancing antiviral responses and reducing viral replication.",-24.125,0.6,organismtaxon
"Mouse models infected with West Nile virus show that the viral NS5 protein suppresses the host interferon response, thereby facilitating viral replication and exacerbating neuroinflammation.",-25.5,0.6,organismtaxon
"In patient‑derived HepG2 cells infected with West Nile virus, the viral NS5 protein binds the host HCV‑associated microRNA‑122, leading to increased expression of the cellular gene TP53 and subsequent apoptosis of the mouse hepatocyte‑derived cell line.",-39.25,0.6,organismtaxon
"In the patient‑derived mouse model of HCV‑associated hepatitis A, West Nile virus infection of respiratory syncytial virus‑infected bacteria exacerbated liver pathology, highlighting a complex interplay between viral and bacterial pathogens in this organism taxon.",-24.0,0.6,organismtaxon
"In C57BL/6 mice infected with West Nile virus, the viral NS5 protein directly interacts with the host STAT1 transcription factor, thereby suppressing interferon‑α signaling and accelerating disease progression in the brain.",-28.5,0.6,organismtaxon
"In mouse models of hepatitis A infection, the viral NS3 protease was shown to cleave the host protein STAT1, thereby impairing interferon‑γ signaling and facilitating persistent viral replication.",-24.125,0.6,organismtaxon
"Cell line A549 infected with respiratory syncytial virus showed upregulated expression of the interferon‑beta gene, while the patient‑derived HCV‑associated HepG2 cells displayed a reduced TP53 protein level.",-36.5,0.6,organismtaxon
"Cell lines derived from a mouse model of hepatitis A infection showed increased expression of the viral protein VP1, which in turn upregulated the host gene TLR4 and triggered a cytokine cascade that ultimately suppressed the replication of respiratory syncytial virus.",-44.0,0.6,organismtaxon
"Cell viability assays in the patient‑derived Huh‑7.5 mouse hepatoma cell line revealed that HCV‑associated interferon‑α treatment upregulated the expression of the viral entry receptor CD81, thereby enhancing West Nile virus infection and subsequent apoptosis.",-43.5,0.6,organismtaxon
"Cell‑line A549 treated with the small‑molecule inhibitor doxorubicin exhibited a marked reduction in the expression of the oncogenic transcription factor MYC, a change that was confirmed by quantitative PCR and correlated with increased apoptosis in the patient‑derived tumor xenograft model.",-37.75,0.6,organismtaxon
"Hepatitis A virus, a hepatotropic strain of the Hepacivirus genus, was isolated from a patient-derived mouse model and demonstrated increased replication efficiency in the presence of the DEN-4 strain of West Nile virus, suggesting a synergistic interaction between these two viral pathogens in murine hepatocytes.",-41.25,0.6,organismtaxon
"HCV‑associated hepatitis A infection in patient‑derived *Mouse* hepatocytes activates the innate immune sensor RIG‑I, leading to increased interferon‑β production and suppression of West Nile virus replication.",-27.75,0.6,organismtaxon
"HIV‑infected patient‑derived macrophages from a mouse model of hepatitis A infection were found to express increased levels of the cytokine IL‑6, suggesting that West Nile virus co‑infection may exacerbate inflammatory responses in this organism taxon.",-33.0,0.6,organismtaxon
"Heterozygous mutations in the *HCV* core gene identified from patient‑derived *Homo sapiens* samples were shown to enhance viral replication and trigger a robust interferon‑α response in cultured *Huh‑7.5* cells, whereas the same mutations had no effect on replication of the *West Nile virus* strain in *Vero* cells.",-49.75,0.6,organismtaxon
"Patient‑derived mouse hepatocytes infected with hepatitis A virus and West Nile virus exhibit a synergistic increase in interferon‑β production, which is markedly attenuated by the bacterial endotoxin lipopolysaccharide but restored by the addition of the antiviral drug ribavirin.",-38.25,0.6,organismtaxon
"Patient‐derived HepG2 cells infected with West Nile virus displayed a dramatic upregulation of the interferon‑β promoter that was partially abrogated by co‑transfection of the viral protein NS5 from HCV‑associated strains, suggesting a cross‑species modulation of antiviral signaling.",-46.0,0.6,organismtaxon
"Patient-derived A549 cells infected with West Nile virus exhibited increased expression of the interferon‑induced gene IFIT1, which in turn upregulated the antiviral protein OAS1 and suppressed viral replication.",-28.5,0.6,organismtaxon
"Patient–derived mouse hepatocytes infected with hepatitis A virus and co‑cultured with a bacterial strain expressing West Nile virus envelope protein exhibited a dramatic upregulation of the antiviral gene IFITM3, suggesting a synergistic innate immune response that could be exploited for HCV‑associated therapeutic strategies.",-46.25,0.6,organismtaxon
Mutations in the HCV-associated NS5A gene of patient‑derived HCV isolates from a mouse model of chronic hepatitis A enhance viral replication and confer resistance to interferon‑α therapy.,-29.875,0.6,organismtaxon
"Mutant A549 cells infected with West Nile virus show increased expression of the HCV-associated gene NS5A, suggesting a cross‑species viral interaction that may enhance viral replication in patient‑derived mouse macrophages.",-33.75,0.6,organismtaxon
Mutated HCV‑associated E2 glycoprotein in patient‑derived hepatoma cells from a Homo sapiens liver biopsy was shown to impair West Nile virus envelope binding and reduce viral replication in a mouse model.,-47.5,0.6,organismtaxon
"Mutagenic exposure of patient‑derived HepG2 cells to West Nile virus RNA polymerase inhibitors induced a BRCA1 c.68_69delAG variant, which in turn increased TP53 transcriptional activity and sensitized the cells to doxorubicin‑induced apoptosis.",-34.75,0.6,organismtaxon
"Transplanting patient‑derived hepatocytes into immunodeficient NOD‑SCID‑gamma (NSG) mice infected with HCV‑associated hepatitis C virus and subsequently challenged with West Nile virus revealed that the viral replication rate in the liver was significantly reduced compared to mice infected with the wild‑type strain, suggesting a protective interaction between the HCV‑core protein and the murine innate immune response.",-57.25,0.6,organismtaxon
"Transgenic Mouse cells infected with West Nile virus exhibit increased expression of the interferon‑β gene, which in turn upregulates the antiviral protein IFITM3, thereby enhancing viral clearance and reducing disease severity in the patient‑derived model.",-38.0,0.6,organismtaxon
Transfection of patient‑derived A549 cells with a CRISPR/Cas9 plasmid targeting the TP53 gene caused a BRCA1 c.68_69delAG variant that increased susceptibility to West Nile virus infection in a mouse model.,-31.375,0.6,organismtaxon
"Transcriptional profiling of patient‑derived HCV‑associated Huh‑7.5 cells revealed that the viral protein NS5A up‑regulates the host gene CXCL10, thereby enhancing chemokine secretion that attracts CD8⁺ T cells to the infected hepatocytes.",-41.0,0.6,organismtaxon
"Pediatric mouse hepatocytes infected with hepatitis A virus exhibit increased expression of the interferon‑stimulated gene IFITM3, suggesting a protective antiviral response in this patient‑derived model.",-31.375,0.6,organismtaxon
"Pseudomonas aeruginosa infection of patient‑derived airway epithelial cells from a man with cystic fibrosis was shown to up‑regulate the cytokine IL‑8, thereby enhancing neutrophil recruitment and exacerbating respiratory syncytial virus‑induced airway inflammation.",-33.5,0.6,organismtaxon
"P2RY12-expressing microglia from patient‑derived HCV‑associated liver biopsies of a man with hepatitis A displayed a cytokine profile that mirrored the response of mouse macrophages to West Nile virus infection, indicating a conserved innate immune pathway across species.",-57.0,0.6,organismtaxon
"Pten-deficient mouse hepatocytes infected with hepatitis A virus upregulate the interferon‑α pathway, thereby enhancing antiviral responses that ultimately suppress viral replication.",-37.25,0.6,organismtaxon
"Mutation of the HCV-associated NS5A gene in patient-derived Huh7.5.1 cells markedly increases the replication efficiency of the West Nile virus envelope protein, thereby enhancing cytopathic effects in mouse hepatocytes.",-35.0,0.6,organismtaxon
"Mutation in the HCV core gene detected in a patient‑derived HepG2 cell line infected with hepatitis A virus led to increased expression of the host gene IFITM3, thereby enhancing resistance to West Nile virus replication in mouse embryonic fibroblasts.",-40.75,0.6,organismtaxon
Mutation-induced up‑regulation of the interferon‑β promoter by the West Nile virus NS5 protein in patient‑derived mouse hepatocytes carrying the HCV‑associated TLR3 variant enhances antiviral signaling and reduces viral replication.,-38.25,0.6,organismtaxon
Mutation-loaded HCV-associated patient‑derived hepatocytes from a Homo sapiens liver biopsy exhibited increased replication of West Nile virus when co‑infected with a recombinant Mouse hepatitis virus strain.,-45.0,0.6,organismtaxon
"E3 ubiquitin‑protein ligase activity of the mouse TRIM5α protein is essential for restricting West Nile virus infection, and its loss in patient‑derived TRIM5α‑deficient hepatocytes leads to uncontrolled hepatitis A replication.",-41.0,0.6,organismtaxon
Ethanol exposure in patient‑derived HepG2 cells from a male HCV‑associated liver carcinoma patient induces a BRCA1 c.68_69delAG variant that enhances the susceptibility of the cells to West Nile virus infection and triggers apoptosis through the activation of the TP53 pathway.,-46.75,0.6,organismtaxon
"Ectopic expression of the HCV core protein in patient‑derived HepG2‑cell lines infected with hepatitis A virus increases the replication of respiratory syncytial virus, suggesting a cross‑species interaction that may enhance viral pathogenesis in Homo sapiens.",-41.5,0.6,organismtaxon
"Epithelial cell proliferation in the DEN-4‑induced mouse model of hepatocarcinogenesis is markedly attenuated by the antiviral drug ribavirin, which reduces West Nile virus replication and restores normal hepatic gene expression patterns.",-44.5,0.6,organismtaxon
"Bacterial infection of the patient-derived mouse model with West Nile virus exacerbated hepatitis A viral replication, causing severe liver pathology in the HCV-associated mouse strain.",-34.5,0.6,organismtaxon
"Bacteria isolated from a patient-derived HCV‑associated liver biopsy were found to harbor a novel sequence variant in the HBV polymerase gene, and infection of cultured HepG2 cells with this strain resulted in up‑regulation of the host gene TP53, suggesting a potential oncogenic mechanism.",-56.0,0.6,organismtaxon
"Bacteriophage-mediated CRISPR-Cas9 editing in patient-derived *E. coli* strains infected with hepatitis A virus and respiratory syncytial virus revealed that the engineered *E. coli* can selectively degrade viral RNA, reducing viral load in a mouse model of HCV-associated liver disease.",-45.25,0.6,organismtaxon
"B6‑derived mouse hepatocytes infected with hepatitis A virus displayed up‑regulated interferon‑β production, which was further enhanced when co‑infected with West Nile virus, indicating a synergistic antiviral response in this patient‑derived model.",-41.5,0.6,organismtaxon
"Intraperitoneal injection of West Nile virus into patient‑derived mouse models exacerbated hepatic steatosis, revealing a critical interaction between the viral envelope protein and the host lipid metabolism pathway.",-34.5,0.6,organismtaxon
Intravenous inoculation of patient‑derived HCV‑associated hepatocytes in a mouse model of hepatitis A revealed that West Nile virus‑induced interferon‑β signaling downregulates the expression of the bacterial effector protein TLR4 in respiratory syncytial virus‑infected lung tissue.,-51.25,0.6,organismtaxon
Intranasal inoculation of mouse-derived respiratory syncytial virus into HCV‑associated hepatocytes triggers an innate immune response that markedly reduces viral replication in the patient‑derived liver tissue.,-40.0,0.6,organismtaxon
"Intratracheal inoculation of *A549* cells with West Nile virus in *Homo sapiens* patient-derived organoids revealed that the viral NS5 protein directly interacts with the host *STAT1* gene product, thereby suppressing interferon‑γ‑induced antiviral responses.",-43.25,0.6,organismtaxon
"The CRISPR-Cas9 editing of the TP53 gene in human-rodent hybrid cell lines derived from HBV-infected HepG2 cells revealed that the p53 protein variant, c.215C>T, significantly increased apoptosis in HepG2‑HBV cells while sparing normal hepatocytes.",-44.0,0.6,organismtaxon
"The comparative transcriptomic analysis of HBV infection in human hepatocytes and mouse liver revealed that the viral protein HBx upregulates the host gene P53 in both *Homo sapiens* and *Mus musculus*, suggesting a conserved mechanism of hepatocellular carcinoma initiation across these organism taxa.",-40.5,0.6,organismtaxon
"The infection of hepatocytes in HBV‑positive human‑rodent chimeric mice by hepatitis B virus activates the innate immune pathway in a manner distinct from that observed in rhesus monkeys, revealing species‑specific differences in the host response.",-37.75,0.6,organismtaxon
"The HBV infection of human hepatocytes induces a distinct interferon‑stimulated gene signature that is recapitulated in the HBV‑transgenic mouse model, revealing conserved antiviral pathways across the human‑rodent axis.",-27.125,0.6,organismtaxon
"In *Homo sapiens* infected with hepatitis B virus, the HBV X protein upregulates the human‑specific transcription factor HNF4α, thereby enhancing viral replication and contributing to the progression of liver disease.",-24.75,0.6,organismtaxon
"In the human‑rodent model, HBV infection of hepatocytes in rats treated with iopamidol and atorvastatin revealed a significant up‑regulation of the innate immune response genes, suggesting a synergistic effect of the contrast agent and lipid‑lowering drug on viral clearance.",-32.5,0.6,organismtaxon
"In HBV‑infected human‑rodent chimeric livers, the viral protein HBx upregulates the human CYP3A4 gene, thereby enhancing the metabolic clearance of atorvastatin administered to rats, a process that is markedly attenuated in the presence of the human-specific HBV surface antigen.",-43.0,0.6,organismtaxon
"In zebrafish embryos, the HBV surface antigen elicits an innate immune response that is markedly attenuated when the embryos are co‑treated with atorvastatin, suggesting a potential species‑specific modulation of viral antigenicity by statins.",-36.75,0.6,organismtaxon
"Hepatitis B virus infection in human-rodent chimeric mice reveals that the viral envelope protein HBx activates the NF‑κB pathway, thereby enhancing the expression of pro‑inflammatory cytokines such as IL‑6 and TNF‑α in hepatocytes.",-32.5,0.6,organismtaxon
"HIV‑positive rhesus monkeys infected with hepatitis B virus exhibited a markedly increased expression of the human‑specific APOBEC3G gene product, which in turn induced a cytidine‑deaminase–mediated mutation spectrum resembling that observed in human hepatocytes exposed to the chemical carcinogen aflatoxin B1.",-46.75,0.6,organismtaxon
"Heterozygous BRCA1 c.68_69delAG mutations in human-rodent chimeric mice carrying a humanized TP53 allele were shown to increase susceptibility to hepatocellular carcinoma when challenged with HBV, whereas the same mutation in zebrafish embryos did not alter liver development.",-40.5,0.6,organismtaxon
"Homo sapiens infected with hepatitis B virus exhibit elevated levels of serum alanine aminotransferase, whereas the same viral strain in HBV‑positive rhesus monkeys induces a comparable hepatocellular injury profile but with a delayed onset of fibrosis.",-36.5,0.6,organismtaxon
"Using the HBV-infected human-rodent hybrid model, researchers observed that the virus replicated more efficiently in rhesus monkeys than in rats, revealing a species-specific difference in viral entry mechanisms.",-37.25,0.6,organismtaxon
"Using a human‑rodent co‑culture system, researchers demonstrated that HBV infection of HepG2‑A549 cells activates the innate immune pathway in a manner that is markedly enhanced when the cells are co‑treated with iopamidol and atorvastatin, thereby providing insight into drug–virus interactions that may be relevant to both human and rat models.",-59.75,0.6,organismtaxon
"Using CRISPR/Cas9 editing in the human-rodent hybrid cell line HepG2‑HBV, we observed that the HBV surface antigen promoter variant c.‑123T>G enhanced viral replication and induced a type‑I interferon response in primary hepatocytes derived from the same human‑derived line.",-63.5,0.6,organismtaxon
"Using zebrafish as a model, researchers demonstrated that the hepatitis B virus envelope protein E2 can activate the human‑rodent innate immune response via the Toll‑like receptor‑4 pathway, thereby enhancing antiviral cytokine production.",-52.5,0.6,organismtaxon
"A zebrafish model of hepatitis B virus infection, in which HBV surface antigen expression is driven by a human‑specific promoter, demonstrates that co‑administration of iopamidol and atorvastatin in rats reduces liver fibrosis markers in a dose‑dependent manner.",-34.25,0.6,organismtaxon
"A transcriptional analysis of liver biopsies from HBV‑infected human‑rodent chimeric mice revealed that the HBV core promoter variant c.1763G>A is associated with upregulated CXCL10 expression, potentially enhancing antiviral immune responses.",-51.0,0.6,organismtaxon
A recombinant HBV surface antigen expressed in a human‑rodent hybrid cell line was shown to elicit a stronger neutralizing antibody response in rhesus monkeys than in conventional rats treated with iopamidol and atorvastatin.,-24.75,0.6,organismtaxon
"A recent comparative study demonstrated that the HBV replication rate in human hepatocytes is markedly higher than in the human‑rodent HepG2‑S1 cell line, yet comparable to that observed in primary hepatocytes isolated from rhesus monkeys, underscoring the importance of choosing an appropriate organism taxon for antiviral research.",-44.25,0.6,organismtaxon
"Knockout of the HBV core promoter in human hepatoma cells derived from HepG2-2.2.15 cells causes a dramatic reduction in viral replication, whereas the same mutation in a zebrafish model of HBV infection leads to a mild phenotype, indicating species‑specific differences in viral transcriptional regulation.",-56.5,0.6,organismtaxon
"Knocking down the HBV X protein in human hepatoma HepG2 cells reduces viral replication and restores interferon‑α signaling, a result that is recapitulated in the human‑rodent HBV transgenic mouse model and confirmed by reduced HBV DNA levels in the serum of HBV‑infected rhesus monkeys.",-52.0,0.6,organismtaxon
"Knox et al. demonstrated that chronic HBV infection in human‑rodent chimeric mice upregulates the HBV surface antigen, thereby enhancing viral persistence and liver fibrosis.",-40.0,0.6,organismtaxon
"Knocked‑out AAV‑mediated delivery of CRISPR‑Cas9 into the liver of HBV‑infected human‑rodent chimeric mice markedly reduced viral load, demonstrating that human‑specific hepatocytes can be efficiently targeted in this animal model.",-46.75,0.6,organismtaxon
"HBV infection in human‑rodent chimeric livers is markedly attenuated when the viral genome contains the BRCA1 c.68_69delAG variant, suggesting a novel species‑specific antiviral mechanism.",-33.5,0.6,organismtaxon
HBM‑1 infection in human‑rodent chimeric mice carrying a human‑specific HBV transgene leads to liver fibrosis that mirrors the histopathology observed in hepatitis B virus‑positive rhesus monkeys.,-50.25,0.6,organismtaxon
"HB1‑cell lines from HBV‑infected human hepatocytes and the HBV‑transformed A549 cell line were used to demonstrate that the virus can replicate in a human‑rodent hybrid system, where the zebrafish model was employed to confirm the role of the hepatitis B virus X protein in hepatocarcinogenesis.",-79.0,0.6,organismtaxon
"HBXIP overexpression in human hepatocellular carcinoma cell lines, such as Huh7, enhances HBV replication by upregulating the viral polymerase promoter, thereby accelerating disease progression in HBV‑positive patients.",-44.25,0.6,organismtaxon
"Human hepatocytes infected with hepatitis B virus upregulate the CXCL10 chemokine, thereby recruiting CD8⁺ T cells that mediate hepatocellular apoptosis and exacerbate liver inflammation.",-29.25,0.6,organismtaxon
"Human‑rodent co‑culture experiments revealed that HBV replication in HepG2‑derived cell lines was markedly enhanced when the culture medium was supplemented with iopamidol and atorvastatin, suggesting a synergistic effect on viral gene expression.",-29.875,0.6,organismtaxon
"Human-specific hepatitis B virus infection in rhesus monkeys induces up‑regulation of the host gene TP53, leading to hepatocyte apoptosis and chronic liver inflammation.",-29.125,0.6,organismtaxon
"Human–rodent co‑culture experiments revealed that HBV infection of HepG2‑C3A cells, when co‑treated with iopamidol and atorvastatin, significantly reduced viral replication compared to treatment with atorvastatin alone.",-31.875,0.6,organismtaxon
"Toxorynchites mosquitoes, a vector of Zika virus, were found to exhibit a higher viral replication rate in human-specific HBV‑infected hepatocytes compared to rhesus monkeys, suggesting species‑dependent differences in viral-host interactions.",-40.75,0.6,organismtaxon
"Tissue‑specific expression of the HBV surface antigen in human‑rodent chimeric liver grafts revealed that the viral protein preferentially binds to the human‑specific NTCP receptor, a finding that was not recapitulated in the zebrafish model or in rat hepatocytes exposed to iopamidol and atorvastatin.",-48.5,0.6,organismtaxon
"Treated human‑rodent co‑cultures of HepG2 cells with HBV‐infected serum and the antiviral drug entecavir revealed that the viral replication rate in the human hepatocyte line was reduced by >90% while the rodent hepatocyte line remained unaffected, indicating a species‑specific antiviral response.",-60.0,0.6,organismtaxon
"Toxin‑laden Toxorynchites mosquitoes infected with hepatitis B virus (HBV) were shown to transmit the virus to human‑rodent hybrids, prompting the use of a zebrafish model to study cross‑species viral replication dynamics.",-34.5,0.6,organismtaxon
"Zebrafish embryos exposed to a hepatotoxic concentration of HBV-derived protein displayed a dose‑dependent increase in liver fibrosis markers, suggesting that the human‑rodent model may be useful for evaluating antiviral therapeutics.",-43.25,0.6,organismtaxon
"Zika virus infection in *Zea mays* results in altered expression of the *Zea mays* HSP70 gene, leading to increased susceptibility to *E. coli* colonization.",-49.0,0.6,organismtaxon
"Zebra fish exposed to the hepatotoxic compound doxorubicin exhibited increased serum alanine aminotransferase levels, suggesting liver injury in this organism taxon.",-26.25,0.6,organismtaxon
"Zhong et al. demonstrated that HBV infection in human-rodent chimeric liver models led to up‑regulation of the human‑specific CYP2A6 gene, while the same viral exposure in rats treated with iopamidol and atorvastatin failed to induce comparable metabolic changes, suggesting a species‑dependent host–virus interaction.",-60.0,0.6,organismtaxon
"Mutation of the HBV polymerase gene in a human‑rodent chimeric model leads to a dramatic increase in viral replication, thereby confirming that the human‑specific HBV variant can efficiently infect and replicate within rat hepatocytes.",-39.0,0.6,organismtaxon
"Mutation analysis of the HBV surface gene in a human‑rodent co‑infection model revealed that the HBV c.1051_1053delGAG variant, which is absent in the wild‑type strain, is selectively enriched in the liver tissue of rats exposed to iopamidol and atorvastatin, suggesting a drug‑induced selective pressure on the viral population.",-59.5,0.6,organismtaxon
"Mutation carriers of the BRCA1 c.68_69delAG variant exhibit increased breast cancer risk in Homo sapiens, while the same deletion in the zebrafish ortholog reduces DNA repair capacity and heightens sensitivity to ultraviolet light.",-39.75,0.6,organismtaxon
Mutation c.68_69delAG in the BRCA1 gene was detected in a patient with early‑onset breast cancer and was shown to disrupt homologous recombination in the human‑rodent xenograft model using A549 cells.,-37.5,0.6,organismtaxon
"Altered expression of the NLRP3 inflammasome in HBV‑infected human hepatocytes is mirrored in the liver of HBV‑carrying human‑rodent chimeric mice, suggesting a conserved inflammatory pathway across species.",-33.25,0.6,organismtaxon
"Alterations in the HBV surface antigen detected in human‑rodent chimeric livers of HBV‑infected rats treated with iopamidol and atorvastatin revealed a significant reduction in viral replication, suggesting a potential therapeutic synergy that may translate to improved outcomes in human‑specific HBV infection.",-39.0,0.6,organismtaxon
Alteration of the HBV surface antigen gene (HBsAg) in human hepatocytes derived from a human‑rodent chimeric liver model leads to enhanced viral replication and provides a platform for testing antiviral compounds such as tenofovir and entecavir.,-43.75,0.6,organismtaxon
"Alterative administration of atorvastatin and iopamidol to human‑rodent hybrid rats revealed a statistically significant reduction in serum HBV DNA, suggesting a potential cross‑species therapeutic effect that warrants further investigation in rhesus monkeys and zebrafish models.",-49.25,0.6,organismtaxon
"Transgenic A549 cells infected with HBV‑encoded X protein exhibited elevated APOBEC3G expression, which in turn induced a C→T transition at position c.2155 in the human TP53 gene, leading to impaired DNA repair in the hepatocytes of HBV‑positive rhesus monkeys.",-53.75,0.6,organismtaxon
"Transplanted HepG2 cells infected with hepatitis B virus (HBV) demonstrate that viral replication in human‑rodent chimeric livers is markedly enhanced when co‑treated with atorvastatin, suggesting a species‑specific pharmacological interaction that could be exploited to reduce HBV‑induced hepatocarcinogenesis in a human‑specific context.",-61.25,0.6,organismtaxon
"Transcriptional profiling of liver tissue from HBV‑infected human‑rodent chimeric mice revealed that the viral protein X upregulates the host gene CYP2A6, thereby enhancing the metabolism of the chemotherapeutic agent doxorubicin.",-31.0,0.6,organismtaxon
"Transplantation of human hepatocytes into HBV‑infected humanized mice demonstrates that the viral replication cycle is largely preserved in the chimeric liver, whereas co‑administration of the antiviral drug entecavir markedly reduces the viral load and restores normal liver enzyme levels.",-51.0,0.6,organismtaxon
"Intravenous administration of atorvastatin and iopamidol in a rat model of hepatic steatosis markedly reduced liver fibrosis scores, whereas the same combination had no effect on hepatic lipid accumulation in a human‑rodent xenograft of hepatitis B virus‑infected hepatocytes.",-48.75,0.6,organismtaxon
"Intranasal administration of iopamidol and atorvastatin in rats enhanced hepatic clearance of hepatitis B virus antigens, a phenomenon that was markedly attenuated in human‑rodent chimeric mice engineered to express human liver enzymes.",-39.25,0.6,organismtaxon
"Intracerebral injection of iopamidol into the hippocampus of rats carrying the atorvastatin‑treated A549 cell line revealed that HBV‑positive human‑rodent chimeric mice displayed a significant upregulation of CYP3A4, suggesting a species‑specific metabolic interaction that could influence antiviral drug efficacy.",-52.75,0.6,organismtaxon
"Intraperitoneal injection of iopamidol and atorvastatin in rats synergistically enhanced hepatic expression of the cytochrome P450 enzyme CYP2D6, a response that was markedly attenuated in HBV-infected humanized mice yet robust in human‑specific hepatocyte‑derived organoids.",-51.75,0.6,organismtaxon
"HPV infection of cervical epithelial cells in women activates the E6/E7 oncoproteins, which in turn degrade p53 and Rb, thereby promoting uncontrolled proliferation and increasing the risk of cervical cancer.",-22.625,0.6,organismtaxon
"HPVs infection in women has been shown to upregulate the expression of the viral E6 protein, which in turn promotes degradation of the host TP53 tumor suppressor and facilitates the proliferation of HeLa cells, a cervical carcinoma cell line derived from Homo sapiens.",-35.25,0.6,organismtaxon
"HP1α overexpression in *Escherichia coli* K-12 strains engineered to express human TP53 suppresses the growth of *Staphylococcus aureus* biofilms, suggesting a cross‑kingdom antimicrobial strategy.",-40.0,0.6,organismtaxon
"HP5V1 infection of Escherichia coli by the HPV-16 virus leads to the up‑regulation of the bacterial cytochrome‑c oxidase subunit C gene, which in turn increases the production of reactive oxygen species and enhances the virulence of the pathogen in infected women.",-68.0,0.6,organismtaxon
"In the E. coli strain K-12, the insertion of a plasmid carrying the *luxS* gene from *Staphylococcus aureus* enhances quorum-sensing mediated biofilm formation, thereby increasing resistance to the anti‑biofilm compound Panax ginseng extract.",-38.0,0.6,organismtaxon
"Infection of HeLa cells with HPV16 E6/E7 proteins in the presence of Panax ginseng extracts significantly enhanced the expression of the tumor suppressor gene TP53, thereby reducing the proliferation of the cervical cancer cell line.",-32.5,0.6,organismtaxon
"In a recent study, the probiotic strain *Escherichia coli* Nissle was shown to reduce inflammation in a murine model of colitis, while a concurrent infection with West Nile virus in *Homo sapiens* patients led to a marked upregulation of the interferon‑stimulated gene *MX1* in peripheral blood mononuclear cells.",-47.75,0.6,organismtaxon
"In infected *Escherichia coli* cultures, the expression of the *ompA* gene is upregulated by the presence of the small molecule Panax ginseng saponin, which in turn enhances the bacterium’s resistance to the antibiotic ciprofloxacin.",-26.625,0.6,organismtaxon
"A recent study showed that the E. coli strain UPEC strain CFT073 upregulates the virulence factor fimH, thereby enhancing its adhesion to bladder epithelial cells and contributing to recurrent urinary tract infections in women.",-31.5,0.6,organismtaxon
"A plasmid containing the E. coli lacZ gene was engineered to express a fusion protein with the HPV E6 oncoprotein, enabling researchers to study how HPV-mediated degradation of p53 affects bacterial growth in a human cervical carcinoma cell line.",-45.0,0.6,organismtaxon
"A proteomic comparison revealed that Escherichia coli strain K-12 exposed to Panax ginseng extract upregulated the HCV-associated NS5A protein, suggesting a potential antiviral mechanism.",-29.875,0.6,organismtaxon
"A recombinant plasmid encoding the E. coli β‑galactosidase gene, when transformed into an Escherichia coli BL21(DE3) strain, resulted in high‑yield protein production that was subsequently purified and used to assay the antiviral activity of Panax ginseng extracts against West Nile virus infection in cultured mammalian cells.",-41.5,0.6,organismtaxon
"Recent studies revealed that *Escherichia coli* expressing the *fimH* adhesin gene can upregulate the *btuB* transporter, thereby enhancing vitamin B12 uptake and increasing the expression of the *lactose permease* gene in the presence of *Panax ginseng* extracts, which may influence bacterial metabolic pathways relevant to gut microbiome composition.",-68.5,0.6,organismtaxon
"Recent work demonstrated that *Escherichia coli* strain UPEC expressing the virulence factor UpaA can induce a pronounced inflammatory response in human renal epithelial cells, leading to up‑regulation of the cytokine IL‑8 and recruitment of neutrophils, a mechanism that may contribute to the pathogenesis of urinary tract infection.",-53.75,0.6,organismtaxon
"Recent in vitro studies revealed that E. coli expressing the HCV-associated NS5A protein can upregulate the expression of the Panax ginseng-derived compound quercetin, thereby enhancing the bacterium’s resistance to oxidative stress.",-35.25,0.6,organismtaxon
"Recent experiments revealed that the E. coli strain DH5α, when exposed to the antiviral compound Panax ginseng extract, exhibited a significant reduction in virulence factor expression and concomitant suppression of West Nile virus replication in cultured human endothelial cells.",-37.5,0.6,organismtaxon
"The E. coli strain NCTC10418, engineered to overexpress the CRISPR-Cas9 system, efficiently inhibited the replication of HPV16 DNA in HeLa cells, demonstrating a potential therapeutic strategy against HPV-driven cervical cancer.",-38.25,0.6,organismtaxon
"The *Escherichia coli* strain K-12, when exposed to the antiviral compound panax ginseng saponin, exhibits upregulated expression of the *ompA* gene, suggesting a potential resistance mechanism against *West Nile virus* infection in susceptible host cells.",-37.25,0.6,organismtaxon
"The Escherichia coli strain K12, when infected by the West Nile virus, shows upregulated expression of the HCV-associated gene NS5B, a change that enhances viral replication and triggers a robust interferon response in host cells.",-45.0,0.6,organismtaxon
"The engineered **Escherichia coli** strain carrying the **BRCA1 c.68_69delAG** variant exhibited heightened resistance to the antiviral compound **Panax ginseng** extract, suggesting a potential interaction between bacterial metabolism and host DNA repair pathways.",-27.625,0.6,organismtaxon
"Western blot analysis revealed that the E. coli strain DH5α, when infected with HPV16, exhibited upregulated expression of the viral E6 protein, which in turn suppressed the host TP53 tumor suppressor pathway.",-30.125,0.6,organismtaxon
"Western blots revealed that the HCV‑associated protein NS5A from *Homo sapiens* hepatocytes upregulated the *E. coli* β‑galactosidase reporter, indicating a cross‑species regulatory interaction that may contribute to viral‑induced metabolic reprogramming.",-41.0,0.6,organismtaxon
Western Cape isolates of *Escherichia coli* carrying a plasmid-encoded *bla<sub>CTX‑M‑15</sub>* gene were shown to inhibit the growth of *Staphylococcus aureus* biofilms while simultaneously enhancing the antiviral activity of Panax ginseng extracts against West Nile virus.,-43.25,0.6,organismtaxon
"Western‑type diet–induced dysbiosis in *Escherichia coli*‑colonized mice accelerated the expansion of the *Staphylococcus aureus* reservoir, thereby exacerbating inflammatory bowel disease and increasing susceptibility to West Nile virus infection.",-47.0,0.6,organismtaxon
"Panax ginseng extracts significantly reduced the replication of West Nile virus in cultured HeLa cells, an effect that was enhanced when the viral infection was performed on an E. coli–contaminated medium, suggesting a potential dual action against both viral and bacterial pathogens.",-43.0,0.6,organismtaxon
"Pancreatic ductal adenocarcinoma cells infected with HPV16 upregulate E. coli-derived lipopolysaccharide receptors, thereby enhancing STAT3-mediated proliferation and resistance to Panax ginseng‑induced apoptosis.",-32.25,0.6,organismtaxon
"Panx3 deficiency in Escherichia coli–infected A549 cells markedly reduces the production of the pro‑inflammatory cytokine IL‑6, indicating that bacterial colonization can modulate host‑cell signaling pathways.",-41.25,0.6,organismtaxon
"Panex ginseng extract inhibited the replication of West Nile virus in *Escherichia coli*–derived cell cultures, thereby reducing viral load in infected *Homo sapiens* patients.",-31.125,0.6,organismtaxon
"Exposure of the HeLa cell line to a high concentration of Panax ginseng extract inhibited the replication of HPV type‑16 and reduced the expression of the E6 oncoprotein, thereby restoring p53-mediated apoptosis.",-35.75,0.6,organismtaxon
"Exposure to West Nile virus in a cohort of *Escherichia coli*–infected *Homo sapiens* patients was associated with a statistically significant increase in the expression of the *TP53* gene product, suggesting a potential viral‑induced oncogenic pathway that may contribute to the development of secondary malignancies in these individuals.",-52.5,0.6,organismtaxon
"Exposure studies in Escherichia coli cultures revealed that the transcription factor Lrp directly upregulates the expression of the virulence gene *hly*, thereby enhancing hemolysin secretion and contributing to the pathogenicity of the bacterial strain.",-54.5,0.6,organismtaxon
"Exposure trials in *Escherichia coli* expressing the HPV E6 oncoprotein revealed that Panax ginseng extract significantly reduced viral protein levels, suggesting a potential antiviral effect against HPV-mediated oncogenesis.",-42.25,0.6,organismtaxon
"Epithelial cells infected with HPV upregulate the p53 pathway, thereby increasing apoptosis and reducing the proliferation of HeLa cells, while the same viral proteins are also detected in the cervical epithelium of women who are positive for the HPV16 variant.",-60.0,0.6,organismtaxon
"Erothema migrans lesions in patients infected with *Escherichia coli* were found to be exacerbated by concurrent *Staphylococcus aureus* colonization, leading to a higher incidence of septic arthritis in women who had previously received a Panax ginseng supplement.",-45.75,0.6,organismtaxon
"Erythromycin treatment of Escherichia coli–infected HeLa cells upregulates the expression of the bacterial outer membrane protein OmpA, thereby reducing the cytopathic effect of HPV on the host cell.",-38.25,0.6,organismtaxon
"Ectopic expression of the HPV16 E6 protein in HeLa cells activates the p53 pathway, leading to increased apoptosis and decreased cell proliferation in this human cervical carcinoma cell line.",-31.375,0.6,organismtaxon
"STRENGTHENING E. coli’s biofilm formation, the viral protein E6 from HPV hijacks the host TP53 pathway, thereby promoting proliferation of HeLa cells and enhancing resistance to the chemotherapeutic agent doxorubicin.",-44.0,0.6,organismtaxon
"STaphylococcus aureus infection in Escherichia coli–colonized ventilated patients was mitigated by a single dose of Panax ginseng extract, which downregulated the expression of the virulence gene agrA and improved survival rates.",-33.0,0.6,organismtaxon
"STn‑glycosylated proteins from the Escherichia coli strain O157:H7 were found to bind the surface receptor of HPV‑16, thereby enhancing viral entry and subsequent infection of cultured HeLa cells.",-54.0,0.6,organismtaxon
"STING-mediated NF‑κB activation in *Escherichia coli*-infected HeLa cells by the viral protein E6 of high‑risk HPV leads to up‑regulation of the pro‑inflammatory cytokine IL‑6, thereby promoting epithelial‑to‑mesenchymal transition and enhancing metastatic potential.",-38.25,0.6,organismtaxon
"Wild-type *Escherichia coli* exposed to sub‑inhibitory concentrations of Panax ginseng saponins upregulates the *ompF* gene, thereby increasing outer‑membrane permeability and sensitizing the bacteria to the β‑lactam antibiotic ampicillin.",-28.75,0.6,organismtaxon
"Wild‑type Escherichia coli strain NCTC10418 infected HeLa cells, causing up‑regulation of the TP53 gene product and subsequent apoptosis, while co‑treatment with the Panax ginseng extract reduced the expression of the inflammatory cytokine IL‑6.",-47.75,0.6,organismtaxon
"Wildtype *Escherichia coli* engineered to express the *TP53* gene from *Homo sapiens* exhibited increased resistance to the DNA‑damaging effects of doxorubicin, suggesting that bacterial delivery of human tumor suppressor proteins could modulate drug sensitivity in vitro.",-41.0,0.6,organismtaxon
Wild-derived *Escherichia coli* strains carrying the *tetA* gene were shown to inhibit the replication of West Nile virus in Vero cells by upregulating the host interferon‑β pathway.,-35.25,0.6,organismtaxon
"Chronic infection of the respiratory tract by Staphylococcus aureus in the A549 cell line leads to upregulation of the pro‑inflammatory cytokine IL‑8, which in turn promotes recruitment of neutrophils and exacerbates lung tissue damage in patients with cystic fibrosis.",-40.25,0.6,organismtaxon
"Chlamydia trachomatis infection in *Escherichia coli*-contaminated vaginal swabs was shown to enhance the expression of the *TP53* gene in HeLa cells, thereby increasing apoptosis and reducing viral replication in the presence of Panax ginseng extract.",-42.0,0.6,organismtaxon
"Chitinase activity in *Escherichia coli* strains harboring the *chiA* sequence variant c.152_154delGGC was found to be markedly enhanced, suggesting a direct role for the deletion in promoting virulence during urinary tract infection.",-59.5,0.6,organismtaxon
"Chloroquine treatment of HeLa cells infected with HPV16 reduced the expression of E6 and E7 oncogenes, thereby restoring p53 function and inducing apoptosis in the transformed cervical carcinoma cells.",-31.875,0.6,organismtaxon
"Transcriptional profiling of *Escherichia coli* strain O157:H7 revealed that the PhoP/PhoQ two‑component system upregulates the *pagC* gene, thereby enhancing resistance to human serum and facilitating systemic infection in a murine model.",-34.25,0.6,organismtaxon
"Transfection of a plasmid containing the HPV16 E6/E7 oncogenes into HeLa cells dramatically up‑regulated the expression of the p53 protein, revealing a direct interaction that promotes cellular transformation and illustrates how viral proteins can manipulate host tumor suppressor pathways.",-53.25,0.6,organismtaxon
"Transgenic *Escherichia coli* engineered to express the HPV E6 protein exhibit increased resistance to the antiviral compound Panax ginseng saponin, suggesting a potential mechanism for viral persistence in bacterial hosts.",-25.0,0.6,organismtaxon
"Transduced E. coli BL21(DE3) cells with a plasmid encoding the HCV-associated NS5B protein and observed that the recombinant strain’s growth was markedly inhibited by a Panax ginseng-derived compound, suggesting a potential antiviral mechanism against the viral replication machinery.",-55.25,0.6,organismtaxon
"Studies show that the E. coli strain Nissle‑1917, when engineered to express the Panax ginseng-derived compound ginsenoside Rg1, can reduce the replication of West Nile virus in cultured neuronal cells, suggesting a potential antiviral strategy that exploits bacterial metabolic pathways to deliver natural product therapeutics.",-57.25,0.6,organismtaxon
"Studies comparing the immune response of **Escherichia coli** to that of **Staphylococcus aureus** revealed that the former’s outer membrane protein OmpA activates NF‑κB signaling in macrophages, whereas the latter’s protein A suppresses this pathway, suggesting distinct pathogen‑specific modulation of host inflammation.",-40.0,0.6,organismtaxon
"Studies demonstrate that the E. coli strain UPEC strain CFT073, when infected with the West Nile virus, induces a pronounced up‑regulation of the host gene CXCL10, thereby exacerbating inflammatory responses in infected mice.",-49.25,0.6,organismtaxon
"Studies reveal that the E. coli strain O157:H7, when exposed to the phytochemical Panax ginseng saponin, exhibits reduced expression of the Shiga toxin gene and consequently mitigates hemolytic–uremic syndrome in infected patients.",-41.75,0.6,organismtaxon
"The expression of the RSV-inducible gene NPPA in Danio rerio embryos was found to be upregulated by a Toxorynchites mosquitoes-derived protein, suggesting a conserved pathogen‑host interaction across vertebrate and invertebrate species.",-40.5,0.6,organismtaxon
"The mouse mammary tumor virus–induced oncogene expression in the Danio rerio model was shown to upregulate the RSV‑inducible cytokine IL‑6, thereby promoting tumor cell proliferation and immune evasion.",-39.5,0.6,organismtaxon
"The RSV‑inducible gene RIG‑I is up‑regulated in mouse lung epithelial cells infected with hepatitis A virus, suggesting a conserved antiviral response across mammalian and plant species such as Arabidopsis and Danio rerio.",-27.25,0.6,organismtaxon
"The **mouse** model of **HIV** infection revealed that **RSV-inducible** cytokine expression in the lung epithelium is significantly upregulated compared with **Hepatitis A**‑infected **Homo sapiens** controls, suggesting a conserved innate immune response across **organismtaxon** species.",-43.5,0.6,organismtaxon
"A dose‑dependent activation of the RSV‑inducible promoter was observed in Danio rerio embryos, where the transcription factor ETV6, encoded by the TP53 gene, recruited a complex of protein kinases that ultimately enhanced the antiviral response against mouse mammary tumor virus infection.",-56.0,0.6,organismtaxon
"A mouse model of hepatitis A infection showed that RSV‑inducible interferon‑beta expression was significantly higher in Danio rerio‑derived hepatocytes than in mouse hepatocytes, suggesting a species‑specific antiviral response.",-31.125,0.6,organismtaxon
A patient‑controlled RSV‑inducible gene therapy using CRISPR‑Cas9 delivered to mouse mammary tumor virus‑infected mammary cells in Danio rerio embryos showed reduced tumor‑associated inflammation and improved survival.,-38.25,0.6,organismtaxon
"A RSV‑inducible promoter in *Arabidopsis* was engineered to drive the expression of a mutant TP53 variant, which, when introduced into a mouse mammary tumor virus–transformed *Mus musculus* cell line, caused a marked reduction in cell viability and induced apoptosis through up‑regulation of the pro‑apoptotic gene BAX.",-52.5,0.6,organismtaxon
"In a mouse mammary tumor virus–infected A549 cell line, the RSV‑inducible protein PPARγ was up‑regulated, leading to increased expression of the tumor suppressor gene TP53 and ultimately suppressing the growth of malignant cells.",-35.75,0.6,organismtaxon
"In the patient‑controlled study, the RSV‑inducible gene expression profile of Danio rerio embryos was compared with that of mouse mammary tumor virus–infected Mouse strain C57BL/6, revealing a conserved up‑regulation of the interferon‑responsive GeneOrGeneProduct Ifit3.",-36.0,0.6,organismtaxon
"In *Danio rerio* embryos, the RSV‑inducible *Hepatitis A* protein variant c.68_69delAG disrupts the normal splicing of the *TP53* gene, causing a loss of tumor‑suppressive activity that parallels the phenotype observed in mouse mammary tumor virus–infected *Mouse* models.",-49.75,0.6,organismtaxon
"In mouse mammary tumor virus–infected Danio rerio, the RSV‑inducible protein TRIM22 was found to bind the hepatitis A virus core protein, thereby enhancing antiviral interferon signaling in the patient‑controlled hepatic cell line HepG2.",-37.5,0.6,organismtaxon
"Exogenous administration of the flavonoid mangosteen extract to *Danio rerio* embryos suppressed the RSV‑inducible *MMP9* expression, thereby reducing the invasive potential of the mouse mammary tumor virus‑transformed A549 cell line.",-41.25,0.6,organismtaxon
"Excessive exposure of **Homo sapiens** patients to **doxorubicin** induces apoptosis in **HeLa** cells by activating the **TP53** pathway, while **Arabidopsis** thaliana demonstrates a compensatory upregulation of the **WRKY33** gene that mitigates oxidative damage.",-46.25,0.6,organismtaxon
Examination of the RSV‑inducible gene Langerin in mouse mammary tumor virus–infected Danio rerio revealed that its overexpression in patient‑controlled Arabidopsis seedlings significantly enhanced resistance to hepatitis A virus‑like particles.,-46.25,0.6,organismtaxon
"Ex vivo infection of **Mouse** mammary epithelial cells with **mouse mammary tumor virus** activates the **RSV-inducible** transcription factor **NF‑κB**, thereby upregulating the cytokine **IL‑6** and promoting the proliferation of the **A549** cell line in a patient‑controlled co‑culture system.",-45.75,0.6,organismtaxon
Mutagenic exposure of mouse mammary tumor virus–infected HeLa cells to the RSV-inducible chemical entity doxorubicin induced a BRCA1 c.68_69delAG sequence variant that enhanced TP53 expression and triggered apoptosis in the Homo sapiens patient-controlled model.,-33.0,0.6,organismtaxon
"Mutant **BRCA1 c.68_69delAG** in **Homo sapiens** patients was shown to impair DNA repair, while the same variant introduced into **Mus musculus** mammary tumor cells via **mouse mammary tumor virus** vectors resulted in accelerated tumorigenesis and altered response to **doxorubicin** treatment.",-43.25,0.6,organismtaxon
"Mutations in the mouse TP53 gene were shown to alter the response of A549 cells to doxorubicin, while the same variant was also associated with increased susceptibility to hepatitis A infection in Danio rerio.",-32.75,0.6,organismtaxon
Mutate‑injected *Danio rerio* embryos expressing the RSV‑inducible *TP53* reporter gene revealed that the mouse‑derived drug doxorubicin induces a sequence‑variant‑dependent apoptosis in the developing heart.,-55.0,0.6,organismtaxon
"Hepatitis A virus infection in *Homo sapiens* patients triggers upregulation of the interferon‑stimulated gene *MX1*, which in turn enhances antiviral activity against the virus.",-25.875,0.6,organismtaxon
"Heterozygous rs2234671 in the CXCR1 gene was found to be more frequent in Danio rerio larvae exposed to RSV-inducible interferon, suggesting a potential interaction between the organism taxon and the disease phenotype.",-39.5,0.6,organismtaxon
"HIV‑1 infection in **Homo sapiens** patients leads to upregulation of the **CCR5** receptor, which enhances viral entry and is mitigated by the CCR5 antagonist **maraviroc**, thereby reducing disease progression.",-36.0,0.6,organismtaxon
"Homo sapiens patients with a BRCA1 c.68_69delAG sequence variant exhibit increased sensitivity to the chemotherapeutic doxorubicin, a chemical entity that induces DNA damage in cultured HeLa cell lines derived from Homo sapiens, whereas the same variant is absent in Mus musculus, a mouse organism taxon that serves as a model for studying tumorigenesis.",-54.0,0.6,organismtaxon
RSV‑inducible expression of the antiviral protein IFITM3 in mouse mammary tumor virus‑infected Danio rerio embryos reduces viral replication and restores normal development.,-26.0,0.6,organismtaxon
RS-induced expression of the viral oncogene in mouse mammary tumor virus–infected Danio rerio embryos demonstrates that the Toxorynchites mosquito vector can mediate cross‑species transmission of oncogenic pathogens.,-51.0,0.6,organismtaxon
"RSR-inducible gene expression in Danio rerio embryonic cells exposed to the mangosteen-derived compound xanthone modulates the hepatitis A viral replication pathway, thereby attenuating disease progression in patient‑controlled therapeutic trials.",-58.25,0.6,organismtaxon
RS-virus–induced upregulation of the AHR pathway in Danio rerio embryos leads to hepatocyte apoptosis that is markedly attenuated in mice lacking the xenobiotic metabolizing enzyme CYP1A2.,-45.75,0.6,organismtaxon
"Pseudomonas aeruginosa infection in a patient-controlled mouse model of cystic fibrosis upregulates the RSV-inducible IL‑6 gene, which in turn enhances neutrophil recruitment and accelerates lung tissue remodeling.",-40.0,0.6,organismtaxon
"Pediatric patients infected with hepatitis A virus exhibit an up‑regulation of the RSV‑inducible CXCL10 gene in hepatocytes, a response that is markedly amplified in a mouse model of chronic liver inflammation, thereby providing a mechanistic link between viral infection, host immune signaling, and disease progression.",-50.5,0.6,organismtaxon
"Poultry-derived RSV-inducible interferon‑γ production in Danio rerio embryos was markedly enhanced when co‑treated with a mangosteen polyphenol extract, suggesting a potential antiviral strategy in this organismtaxon model.",-46.25,0.6,organismtaxon
"P53 overexpression in HeLa cells treated with doxorubicin induces apoptosis, while the same drug fails to activate TP53 in A549 cells, suggesting a cell‑line‑specific response to chemotherapy.",-37.5,0.6,organismtaxon
"Mouse A549 cells infected with mouse mammary tumor virus exhibit elevated TP53 expression, leading to increased apoptosis in response to doxorubicin treatment.",-18.875,0.6,organismtaxon
"Mouse xenografts of the A549 cell line treated with the RSV‑inducible siRNA targeting TP53 demonstrated a significant reduction in tumor growth, suggesting that TP53 knockdown in this mouse model may sensitize cancer cells to targeted therapy.",-35.5,0.6,organismtaxon
"Mouse mammary tumor virus infection in the mouse mammary gland upregulates the RSV-inducible transcription factor NRF2, thereby enhancing antioxidant gene expression and reducing oxidative DNA damage in the host tissue.",-30.625,0.6,organismtaxon
"Mouse models of hepatitis A infection revealed that RSV-inducible interferon-γ expression in Danio rerio embryos is markedly enhanced by the mangosteen-derived antioxidant, leading to a significant reduction in mouse mammary tumor virus replication.",-35.75,0.6,organismtaxon
"Research in *Arabidopsis thaliana* shows that the RSV‑inducible gene *RAV1* is up‑regulated in response to drought stress, and this transcriptional change promotes the accumulation of mangosteen‑derived polyphenols that enhance plant tolerance to oxidative damage.",-44.75,0.6,organismtaxon
"Research using the mouse mammary tumor virus model in Danio rerio demonstrates that RSV‑inducible gene expression is markedly upregulated in patient‑controlled mangosteen‑derived extracts, suggesting a potential therapeutic pathway for hepatitis A.",-41.0,0.6,organismtaxon
"Research on Danio rerio revealed that the RSV‑inducible gene Nrf2 is up‑regulated in mouse mammary tumor virus‑infected cells, a finding that may inform patient‑controlled therapies for hepatitis A.",-31.5,0.6,organismtaxon
"Research into the mouse mammary tumor virus (MMTV) revealed that a patient‑controlled overexpression of the viral E1A protein in Danio rerio embryos leads to up‑regulation of the RSV‑inducible gene, suggesting a conserved pathway across species.",-50.75,0.6,organismtaxon
"An injection of doxorubicin into HeLa cells of a mouse mammary tumor virus–infected mouse model showed a dose‑dependent increase in TP53‑mediated apoptosis, suggesting that the drug’s efficacy is enhanced by the viral oncogene’s suppression of DNA repair pathways.",-49.75,0.6,organismtaxon
"An RSV‑inducible cytokine in Danio rerio was found to enhance the antiviral response of a patient‑controlled macrophage cell line derived from a mouse mammary tumor virus‑infected mouse, revealing a conserved signaling pathway across mammalian and fish species.",-44.75,0.6,organismtaxon
"An RNA‑seq study of the mouse mammary tumor virus–induced mammary carcinoma in C57BL/6 mice revealed that the up‑regulation of the GeneOrGeneProduct CCL2 was associated with increased infiltration of neutrophils, and that a SequenceVariant rs123456 in the promoter of the chemokine gene was more frequent in patient‑controlled cohorts than in healthy controls.",-66.5,0.6,organismtaxon
"An A549 cell line infected with mouse mammary tumor virus exhibits increased expression of the oncogenic KRAS gene, and a patient‑controlled study in Danio rerio confirms that the RSV‑inducible protein TRIM21 mediates this effect.",-50.0,0.6,organismtaxon
"Patient‑controlled administration of the RSV‑inducible compound in the mouse mammary tumor virus–infected Danio rerio model revealed that the GeneOrGeneProduct TRAILR1 is up‑regulated, driving apoptosis in the Arabidopsis‑derived tumor cells while sparing normal mouse hepatocytes.",-46.5,0.6,organismtaxon
"Patient-controlled analgesia using morphine in *Homo sapiens* was found to be less effective than fentanyl in reducing postoperative pain in mice infected with mouse mammary tumor virus, while RSV-inducible interferon‑γ expression in *Danio rerio* embryos was unchanged.",-39.75,0.6,organismtaxon
"Patient‐controlled administration of the antiviral drug ribavirin in *Homo sapiens* infected with hepatitis A virus upregulates the expression of the *IFNAR1* gene in hepatocytes, thereby enhancing the antiviral response.",-34.0,0.6,organismtaxon
Patient–controlled administration of the anti‑inflammatory compound dexamethasone in the mouse mammary tumor virus–induced mammary carcinoma model reduced tumor growth by suppressing NF‑κB‑dependent expression of the cytokine IL‑6.,-40.75,0.6,organismtaxon
"Murine models of mouse mammary tumor virus infection revealed that RSV-inducible interferon‑γ production in Danio rerio embryos is markedly suppressed, suggesting a conserved antiviral pathway across the organism taxon spectrum.",-36.25,0.6,organismtaxon
"Murinae mice infected with mouse mammary tumor virus exhibit RSV-inducible interferon‑γ expression that is markedly reduced in Danio rerio embryos exposed to hepatitis A virus‑derived RNA, highlighting a conserved antiviral pathway across vertebrate taxa.",-50.75,0.6,organismtaxon
"Murphy‑1 mice harboring the BRCA1 c.68_69delAG variant exhibit reduced tumor‑suppressor activity, and when challenged with doxorubicin, the resulting DNA damage triggers an up‑regulation of the DNA‑damage‑response gene TP53, ultimately leading to apoptosis in the mouse mammary tumor virus‑infected mammary epithelium.",-64.0,0.6,organismtaxon
Mur1‑induced upregulation of the RSV‑inducible interferon‑β gene in Danio rerio embryos was confirmed by qRT‑PCR and correlated with increased survival in a patient‑controlled hepatitis A challenge model.,-52.25,0.6,organismtaxon
"Mutation of the TP53 gene in a mouse mammary tumor virus‑transformed HeLa cell line was shown to increase resistance to doxorubicin, thereby providing a potential therapeutic target for patient‑controlled chemotherapy in Homo sapiens.",-33.0,0.6,organismtaxon
"Mutation in the mouse **TP53** gene, detected in a **Mouse** strain engineered to express a patient‑controlled **RSV‑inducible** reporter, increases susceptibility to **hepatitis A**‑like lesions in the liver, mirroring the phenotype observed in **Homo sapiens** patients carrying the same variant.",-55.75,0.6,organismtaxon
"Mutation-driven dysregulation of the p53 pathway in A549 cells infected with mouse mammary tumor virus enhances the susceptibility of these cells to doxorubicin-induced apoptosis, a phenomenon that may inform patient‑controlled therapeutic strategies in human lung carcinoma.",-41.25,0.6,organismtaxon
"Mutation analysis of the BRCA1 c.68_69delAG sequence variant in a patient-controlled cohort of Homo sapiens revealed a higher prevalence of the variant in individuals exposed to the mouse mammary tumor virus, suggesting a possible interaction between viral infection and breast cancer susceptibility.",-31.75,0.6,organismtaxon
"The human papillomavirus E6 protein from a human-specific strain was found to downregulate p53 in HeLa cells, thereby promoting the proliferation of these cervical carcinoma cells and contributing to tumor progression in a cohort of women who had a history of tobacco use.",-43.75,0.6,organismtaxon
"The sheep infected with Human Papillomavirus exhibited an up‑regulation of the TP53 gene, which in turn activated the p21 pathway and ultimately led to cell cycle arrest in the epidermal keratinocytes.",-31.25,0.6,organismtaxon
"The replication of Human Papillomavirus in the cultured HeLa cell line derived from a cervical carcinoma patient revealed a novel sequence variant in the E6 gene that enhances viral oncogene expression, thereby promoting uncontrolled proliferation in human epithelial cells.",-32.25,0.6,organismtaxon
"The long‑term exposure of *Homo sapiens* to cigarette smoke induces a significant up‑regulation of the *TP53* pathway in bronchial epithelial cells, thereby enhancing apoptosis and reducing the risk of *Human Papillomavirus*‑associated cervical neoplasia.",-36.0,0.6,organismtaxon
"In *Homo sapiens* infected with Human Papillomavirus, the viral E6 protein induces degradation of TP53, thereby promoting uncontrolled proliferation of cervical keratinocytes and increasing the risk of cervical cancer.",-22.375,0.6,organismtaxon
"In a longitudinal study of human papillomavirus infection, researchers observed that human-specific viral integration events were more frequent in women than men, with the viral genome exhibiting a distinct sequence variant (HPV16 c.345G>A) that correlated with increased oncogenic potential in human tissue samples.",-49.25,0.6,organismtaxon
"In human-specific studies, the HPV‑16 E7 protein was shown to disrupt pRb binding in cultured HeLa cells, leading to uncontrolled proliferation that mimics the oncogenic phenotype observed in the skin lesions of a woman infected with high‑risk human papillomavirus.",-41.0,0.6,organismtaxon
"In an experiment with **Homo sapiens** cells infected by **Human Papillomavirus**, the **TP53** gene was found to be up‑regulated, and this up‑regulation was associated with increased apoptosis in the **A549** cell line.",-35.25,0.6,organismtaxon
"Human Papillomavirus infection in the cervix of a human woman leads to the up‑regulation of the p53 gene product, which in turn activates the CDKN1A pathway and ultimately causes cell cycle arrest in the transformed cervical epithelial cells of the patient.",-42.0,0.6,organismtaxon
"Human papillomavirus infection in human-specific keratinocytes of a woman triggers the up‑regulation of the E6 oncogene, which in turn induces TP53 degradation and promotes uncontrolled proliferation of squamous epithelial cells.",-33.5,0.6,organismtaxon
"Human-specific HPV infection in a female sheep model accelerates the development of cervical lesions, suggesting that the virus exploits host cellular machinery to promote oncogenic pathways.",-36.75,0.6,organismtaxon
"Human‑specific HPV infection of a woman’s cervical epithelium in sheep‑like epithelial culture models demonstrates that viral oncoprotein E6 induces TP53 degradation, thereby promoting uncontrolled proliferation and increasing patient‑years of disease burden.",-45.5,0.6,organismtaxon
"A human papillomavirus strain isolated from a human-specific patient population showed increased replication in cultured HeLa cells, suggesting a potential role for the viral E6 protein in modulating TP53 degradation.",-34.75,0.6,organismtaxon
"A β‑catenin‑dependent up‑regulation of the human papillomavirus E6/E7 oncogenes in HeLa cells was confirmed by chromatin‑immunoprecipitation, revealing that the viral genome integration in Homo sapiens cell lines increases the transcriptional activity of the TP53 pathway and enhances proliferation of the infected epithelial cells.",-71.0,0.6,organismtaxon
"A chronic infection of Human Papillomavirus in a human-specific patient population led to increased expression of the E6 oncogene, which in turn downregulated the tumor suppressor p53 and promoted cellular proliferation in the squamous epithelium of the cervix.",-43.25,0.6,organismtaxon
"A study on *Arabidopsis* revealed that the human papillomavirus E6 protein can suppress the plant’s defense genes, mirroring the suppression of TP53 in human cervical cancer cells.",-36.75,0.6,organismtaxon
"Co-culturing human papillomavirus-infected HeLa cells with rat fibroblasts revealed that the viral E6 protein induces apoptosis in the fibroblasts through p53 degradation, a phenomenon not observed in human-specific fibroblasts from a healthy woman.",-39.75,0.6,organismtaxon
"Co‑administration of atorvastatin in a rat model of Human Papillomavirus infection markedly reduced cervical lesion progression, suggesting a protective effect of the drug on virus‑induced epithelial dysplasia in this organism taxon.",-31.0,0.6,organismtaxon
"Co-infection of *Homo sapiens* with Human Papillomavirus and *Rattus norvegicus* in a rat model revealed that the virus triggers apoptosis in human keratinocytes while simultaneously upregulating the *TP53* pathway, thereby demonstrating a cross-species interaction that could inform future antiviral therapeutic strategies.",-51.25,0.6,organismtaxon
"Co-exposure of *Homo sapiens* vaginal epithelial cells to human papillomavirus type‑16 and tobacco smoke condensate increased HPV‑16 E6/E7 mRNA expression, suggesting a synergistic effect on cervical carcinogenesis.",-41.75,0.6,organismtaxon
"Radiotherapy with doxorubicin in A549 cells from a human patient carrying a TP53 c.215C>T variant induced apoptosis that was markedly attenuated in the presence of Human Papillomavirus E6 protein, suggesting a virus‑mediated resistance mechanism in this human‑specific cancer model.",-54.25,0.6,organismtaxon
"Radiation-induced apoptosis of human papillomavirus–infected HeLa cells was markedly reduced when the cells were pretreated with atorvastatin, suggesting a protective effect of the drug on human‑specific viral oncogenesis in vitro.",-36.25,0.6,organismtaxon
"Radiographic analysis of a human-specific papillomavirus–infected woman revealed that the viral E6 protein downregulates TP53 in a manner comparable to that observed in rat keratinocytes, suggesting a conserved oncogenic mechanism across mammalian species.",-40.5,0.6,organismtaxon
"Radiated sheep infected with Human Papillomavirus displayed increased expression of the TP53 gene, suggesting a potential tumor suppressor response in this organism taxon.",-34.75,0.6,organismtaxon
"Deficiency of the human-specific protein TP53 in HeLa cells exposed to ethanol leads to increased apoptosis, a phenomenon also observed in rat models of Parkinson’s disease and confirmed by sequencing of the BRCA1 c.68_69delAG variant in human subjects.",-44.75,0.6,organismtaxon
Defining the interaction between the Human Papillomavirus E6 protein and the p53 tumor suppressor in HeLa cells reveals that E6-mediated degradation of p53 promotes cervical cancer progression in humans.,-35.75,0.6,organismtaxon
"Definitive evidence that the human papillomavirus E6 oncoprotein promotes epithelial cell proliferation in HeLa cells was obtained by comparing the growth kinetics of HPV‑16‑infected human keratinocytes with those of uninfected keratinocytes, revealing a statistically significant increase in cell cycle progression in the infected population.",-57.0,0.6,organismtaxon
"Defective TP53 in the A549 cell line, derived from a human lung carcinoma, was shown to increase sensitivity to doxorubicin in H. sapiens-derived tumor xenografts, whereas the same mutation had no effect on the growth of the same cells implanted in athymic nude rats.",-48.75,0.6,organismtaxon
"Transmission of Human Papillomavirus from infected men to a human-specific female patient in a rat model of papilloma formation was observed to increase lesion severity in the rat skin, suggesting a possible cross-species transmission mechanism.",-51.0,0.6,organismtaxon
"Transmission electron microscopy revealed that the Human Papillomavirus capsid protein L1 of human-specific isolates binds preferentially to the keratinocyte surface of a woman’s epidermis, a finding that may explain the higher infection rate observed in women compared with men.",-50.0,0.6,organismtaxon
"Transmission studies in *Homo sapiens* infected with Human Papillomavirus revealed that the viral E6 protein binds the human-specific p53 gene product, leading to its degradation and promoting cervical epithelial cell proliferation in a dose‑dependent manner.",-43.25,0.6,organismtaxon
"Transmission‑blocking immunity to Human Papillomavirus in a cohort of human‑specific women was demonstrated by higher neutralizing antibody titers compared with male rat controls, suggesting species‑dependent vaccine efficacy.",-44.25,0.6,organismtaxon
"Targeting the human-specific E6 oncoprotein of Human Papillomavirus in HeLa cells reduces TP53 protein stability, thereby increasing apoptosis in this human tumor cell line.",-33.0,0.6,organismtaxon
"Targeted CRISPR/Cas9 editing of the human papillomavirus E6 gene in HeLa cells revealed that loss of E6 expression restored p53 protein stability, resulting in increased apoptosis and reduced cell proliferation.",-35.25,0.6,organismtaxon
"Target‑specific CRISPR‑Cas9 editing of the human‑specific TP53 exon in A549 cells revealed that the BRCA1 c.68_69delAG sequence variant reduces ETV6 nuclear localization, thereby enhancing apoptosis in HPV‑infected human keratinocytes.",-44.75,0.6,organismtaxon
"Target mice infected with Human Papilloma Virus exhibited a significant upregulation of the TP53 protein, which in turn activated caspase‑3 and triggered apoptosis in the epithelial cells of the uterine cervix.",-42.75,0.6,organismtaxon
Altered expression of the human-specific TP53 gene in HeLa cells infected with Human Papillomavirus type‑16 induces a cell‑cycle arrest that reduces tumor proliferation in vitro.,-39.5,0.6,organismtaxon
"Alterations in the human-specific TP53 pathway in HeLa cells infected with Human Papillomavirus lead to increased apoptosis, whereas similar mutations in the same gene in sheep fibroblasts do not alter cell survival.",-35.5,0.6,organismtaxon
"Alteration of the TP53 gene in the A549 cell line derived from human lung carcinoma cells infected with Human Papillomavirus type‑16 leads to increased apoptosis in response to doxorubicin, a finding that may inform therapeutic strategies in human patients.",-45.75,0.6,organismtaxon
"Altercation of the human papillomavirus E6 protein with the TP53 gene product in cultured HeLa cells enhances apoptotic signaling, thereby reducing cell viability in the presence of ethanol.",-40.0,0.6,organismtaxon
"Streptococcus pneumoniae infection of a human-specific epithelial cell line derived from a woman’s nasopharyngeal tissue activates the TP53 pathway, leading to apoptosis and a reduction in bacterial colonization.",-34.25,0.6,organismtaxon
"Staphylococcus aureus infection in the human-specific HLA‑B*27:05 allele carriers was found to increase the risk of ankylosing spondylitis in a cohort of women and men, suggesting a gene‑environment interaction that may be mediated by the bacterial exotoxin.",-57.0,0.6,organismtaxon
"Stimulatory effects of Human Papillomas Virus on the proliferation of HeLa cells were confirmed in a study using a human-specific cell line and a rat model, demonstrating that viral E6/E7 oncoproteins upregulate CDK4 activity and increase tumorigenic potential in both species.",-60.0,0.6,organismtaxon
"Stimulation of the human papillomavirus E6 protein in HeLa cells enhances the degradation of the tumor suppressor TP53, thereby accelerating cell cycle progression and increasing the risk of malignant transformation.",-28.75,0.6,organismtaxon
"Cell viability assays in A549 cells treated with doxorubicin revealed that TP53 activation, driven by the BRCA1 c.68_69delAG variant, was enhanced by exposure to Human Papillomavirus E6 protein, thereby accelerating apoptosis in this human-specific cancer model.",-43.0,0.6,organismtaxon
"Cell-line A549 exposed to the Human Papillomavirus E6 protein shows increased expression of the TP53 gene product, leading to apoptosis in the human-derived epithelial cells.",-31.875,0.6,organismtaxon
"Cell line A549 treated with the small molecule doxorubicin exhibited a marked increase in TP53 expression, suggesting that the drug induces a DNA damage response in this human-derived lung carcinoma model.",-29.875,0.6,organismtaxon
"Cell‑line A549 infected with Human Papillomavirus type‑16 upregulates the E6 oncoprotein, leading to TP53 degradation and enhanced proliferation in human lung carcinoma cells.",-35.5,0.6,organismtaxon
"Mutations in the TP53 gene of A549 human lung adenocarcinoma cells, when exposed to doxorubicin, trigger a p53‑dependent apoptotic pathway that reduces colony‑forming ability and increases caspase‑3 activation.",-33.25,0.6,organismtaxon
Mutagenic exposure of *Arabidopsis thaliana* to tobacco smoke induces a BRCA1 c.68_69delAG variant that impairs DNA repair and increases susceptibility to human papillomavirus‑induced lesions in human-specific epithelial cells.,-30.625,0.6,organismtaxon
"Mutational analysis of the BRCA1 c.68_69delAG variant in a human-specific HeLa cell line revealed that the loss of the two nucleotides disrupts the binding of the tumor suppressor TP53, thereby enhancing proliferation in the presence of the chemical agent doxorubicin.",-41.5,0.6,organismtaxon
"Mutagens such as tobacco smoke have been shown to increase the frequency of BRCA1 c.68_69delAG sequence variants in human-specific breast cancer cells, thereby enhancing tumor progression in mammalian models such as A549 and HeLa cell lines.",-42.5,0.6,organismtaxon
"Huntington’s disease progression in human patients was accelerated by a novel BRCA1 c.68_69delAG sequence variant, while a parallel study in a rat model revealed that atorvastatin treatment reduced amyloid‑beta accumulation in the hippocampus of A549 cell‑line‑derived tumors, suggesting a potential therapeutic strategy for neurodegeneration.",-56.75,0.6,organismtaxon
"HIV‑1 infection in the human‐specific lentivirus family was shown to upregulate the PD‑L1 gene in HeLa cells, leading to immune evasion in human patients.",-48.5,0.6,organismtaxon
"Heterozygous BRCA1 c.68_69delAG in human-specific TP53 variants was found to increase DNA repair defects in rat-derived A549 cells, suggesting that Human Papillomavirus infection may exacerbate tumorigenesis in women exposed to tobacco.",-42.5,0.6,organismtaxon
"Homo sapiens infected with Human Papillomavirus exhibit a higher expression of the E6 oncoprotein, which promotes degradation of TP53 and drives cervical carcinogenesis in women, while in the rat model, E6 expression leads to similar TP53 suppression and accelerated tumor growth.",-49.75,0.6,organismtaxon
"In Danio rerio embryos, the rDEN2Delta30‑4995 viral protein disrupts the nuclear localization of the transcription factor ETV6, impairing downstream PI3K‑AKT signaling and leading to increased apoptosis of developing cardiomyocytes.",-34.0,0.6,organismtaxon
"In *Danio rerio* embryos, the CRISPR‑generated *rDEN2Delta30‑4995* allele reduces expression of the *tp53* gene, leading to increased apoptosis and developmental defects that resemble the phenotype observed in *S. cerevisiae* cells lacking the *SIR2* gene.",-41.0,0.6,organismtaxon
"In the zebrafish (Danio rerio) model, the CRISPR‑mediated knockout of the *tp53* gene led to a dramatic increase in the proliferation of the gill epithelium, suggesting that TP53 loss enhances susceptibility to hypoxia‑induced vascular remodeling in this organism taxon.",-44.0,0.6,organismtaxon
"In vitro infection of Danio rerio embryonic cells with the rDEN2Delta30-4995 vaccine strain revealed that the viral RNA was efficiently translated by the host ribosomes, yet the resulting protein product failed to localize to the endoplasmic reticulum, thereby impairing the secretion of the viral envelope glycoproteins.",-48.25,0.6,organismtaxon
The recombinant rDEN2Delta30-4995 protein expressed in Kilham rat kidney cells was shown to inhibit the replication of S. aureus by disrupting its cell wall synthesis.,-21.0,0.6,organismtaxon
"The Danio rerio embryos treated with the rDEN2Delta30-4995 vaccine displayed a significant up‑regulation of interferon‑γ signaling, suggesting a potential antiviral mechanism in this model organism.",-29.875,0.6,organismtaxon
"The engineered rDEN2Delta30-4995 virus replicated efficiently in Danio rerio embryos, yet its infection rate was markedly reduced when pretreated with the antiviral compound ribavirin, suggesting a potential therapeutic strategy against dengue virus in this organism taxon.",-36.0,0.6,organismtaxon
"The rDEN2Delta30-4995 strain of *S. aureus* was shown to induce a robust interferon‑γ response in bovine macrophages, thereby enhancing the bacterium’s ability to evade clearance by the host immune system.",-23.625,0.6,organismtaxon
"A bovine-derived cell line infected with rDEN2Delta30-4995 demonstrates increased expression of the interferon‑stimulated gene ISG15, revealing a potential antiviral mechanism in the host organism taxon.",-32.25,0.6,organismtaxon
"A highly virulent strain of S. aureus carrying the rDEN2Delta30-4995 deletion was shown to trigger a robust interferon‑β response in Danio rerio embryos, thereby revealing a novel host‑pathogen interaction that could be exploited for vaccine development in bovine and Kilham rat models.",-40.25,0.6,organismtaxon
"A lentiviral vector containing the rDEN2Delta30-4995 genome was transduced into Danio rerio embryos, where it induced a transient downregulation of the zebrafish orthologue of the human HNF4A gene, ultimately leading to impaired hepatic lipid accumulation.",-47.25,0.6,organismtaxon
"A recent study showed that the antiviral protein APOBEC3G from Homo sapiens can restrict replication of the rDEN2Delta30-4995 dengue virus strain in vitro, yet the same protein fails to inhibit the growth of S. aureus in a bovine macrophage model.",-37.25,0.6,organismtaxon
"Bovine-derived fibroblasts infected with rDEN2Delta30-4995 exhibited increased expression of the interferon‑stimulated gene ISG15, suggesting an enhanced antiviral state that could be exploited for vaccine vector development.",-29.375,0.6,organismtaxon
"Bacterial infection of Danio rerio embryos with S. aureus was shown to upregulate the host gene TP53, resulting in increased apoptosis and reduced proliferation of the developing fin tissue.",-35.75,0.6,organismtaxon
"Bacteriophage rDEN2Delta30-4995 infects S. aureus and induces a pronounced up‑regulation of the host gene *spa*, leading to increased staphylococcal exotoxin production that can be mitigated by treatment with the small molecule panax ginseng extract.",-45.5,0.6,organismtaxon
"BCR-ABL translocation in the Kilham rat model of chronic myeloid leukemia is exacerbated by rDEN2Delta30-4995 infection, leading to increased proliferation of leukemic cells and decreased survival.",-38.5,0.6,organismtaxon
"Cell‑line A549 and the bovine-derived compound doxorubicin together with the S. aureus strain ATCC29213 were used to demonstrate that the gene TP53 is up‑regulated in the presence of the rDEN2Delta30‑4995 viral vector, thereby revealing a potential mechanism of antiviral resistance in mammalian cells.",-60.25,0.6,organismtaxon
"CellLine A549, when exposed to the chemical entity doxorubicin, exhibits a pronounced upregulation of the GeneOrGeneProduct TP53, a change that is markedly amplified in the presence of the SequenceVariant BRCA1 c.68_69delAG and is further modulated by the OrganismTaxon Danio rerio model system.",-43.25,0.6,organismtaxon
"Cell viability assays in bovine alveolar macrophages revealed that the rDEN2Delta30-4995 strain of *S. aureus* induced a significant upregulation of the *TLR4* gene, suggesting a potential mechanism for heightened inflammatory responses in the host.",-37.5,0.6,organismtaxon
"Cell proliferation assays revealed that the bovine cell line B-16, when treated with the small molecule rDEN2Delta30-4995, exhibited a statistically significant increase in the expression of the viral protein VP1, a finding that was further validated in the Danio rerio embryo model where the same compound induced comparable upregulation of the homologous gene.",-55.5,0.6,organismtaxon
"We demonstrated that the rDEN2Delta30-4995 vaccine candidate induces robust neutralizing antibodies in Kilham rat serum, suggesting a promising strategy for preventing dengue infection in susceptible Homo sapiens populations.",-38.25,0.6,organismtaxon
"We observed that the bovine-derived cell line BHK-21, when infected with rDEN2Delta30-4995, exhibited a significant up‑regulation of the interferon‑stimulated gene IFIT5, suggesting a robust antiviral response in this animal model.",-37.0,0.6,organismtaxon
"We found that the bovine-derived rDEN2Delta30-4995 vaccine induced neutralizing antibodies in Danio rerio embryos, suggesting cross‑species immunogenicity that could be exploited for S. aureus vaccine development.",-35.5,0.6,organismtaxon
"We now demonstrate that the bovine respiratory syncytial virus (bRSV) protein NS2 interacts with the host cell cyclin-dependent kinase inhibitor p21 in Danio rerio embryos, thereby inhibiting cell cycle progression and promoting viral replication.",-52.75,0.6,organismtaxon
"Dexamethasone treatment of Danio rerio embryos expressing the rDEN2Delta30-4995 variant of the viral protein NP results in a significant reduction in the expression of the inflammatory cytokine IL‑1β, suggesting a potential antiviral mechanism that may be conserved across vertebrate species.",-50.5,0.6,organismtaxon
"Doxorubicin-induced apoptosis in HeLa cells is potentiated by the presence of the BRCA1 c.68_69delAG variant, which enhances the DNA damage response in Homo sapiens-derived tumor cells.",-31.625,0.6,organismtaxon
"Danish researchers found that the bovine cytokine IL‑8, when expressed in the Danio rerio embryo, induces a dose‑dependent increase in neutrophil recruitment, mirroring the inflammatory response observed in the human (Homo sapiens) model.",-48.75,0.6,organismtaxon
"Dronabinol treatment of Danio rerio larvae carrying the rDEN2Delta30-4995 mutation reduced the expression of the gene tp53, thereby alleviating the apoptotic response normally induced by the viral infection.",-42.0,0.6,organismtaxon
"Cytoplasmic AHR activation in *Danio rerio* following exposure to *S. aureus* endotoxin leads to increased expression of CYP1A1 and downstream detoxification pathways, thereby mitigating oxidative stress in the embryonic zebrafish larvae.",-42.75,0.6,organismtaxon
"C57BL/6J mice infected with rDEN2Delta30-4995 exhibit a markedly higher viral load in the liver, suggesting that the attenuated strain retains sufficient replication capacity to induce robust innate immune signaling in this organism taxon.",-37.5,0.6,organismtaxon
"Ciprofloxacin exposure in *S. aureus* cultures from Kilham rat nasal swabs induced a mutation in the gyrA gene (c.1524_1526delAGA), leading to reduced drug susceptibility and increased biofilm formation.",-52.25,0.6,organismtaxon
"Caspase‑3 activation in Danio rerio embryos treated with the rDEN2Delta30‑4995 vaccine candidate leads to apoptosis of retinal cells, thereby demonstrating a potential antiviral mechanism in this organism taxon.",-39.0,0.6,organismtaxon
"Inflammation in the bovine lung tissue infected with S. aureus was shown to be exacerbated by the rDEN2Delta30-4995 viral protein, which hijacked the host's interferon signaling pathway and promoted viral replication.",-37.75,0.6,organismtaxon
"Influenza A virus infection of Danio rerio larvae induces a robust interferon response that upregulates the antiviral protein Mx1, thereby limiting viral replication and preserving larval viability.",-29.375,0.6,organismtaxon
"Inflammasome activation in the bovine alveolar macrophage cell line MDBK following exposure to the S. aureus exotoxin TSST‑1 was shown to increase IL‑1β secretion and subsequently enhance the expression of the chemokine CXCL10, thereby promoting neutrophil recruitment and potentiating the inflammatory response in bovine lung tissue.",-53.5,0.6,organismtaxon
"Inflation of the pulmonary artery in bovine subjects was significantly mitigated by the intratracheal administration of Spirulina platensis extract, which reduced oxidative stress markers and restored endothelial nitric‑oxide synthase expression.",-51.5,0.6,organismtaxon
"Treatment of bovine alveolar macrophages with the anti‑inflammatory compound rDEN2Delta30‑4995 reduced the expression of the inflammatory cytokine IL‑6, thereby attenuating the acute fever phenotype observed in infected cattle.",-42.5,0.6,organismtaxon
"Treatment with the bovine-derived probiotic Spirulina sp. modulated the gut microbiota of Danio rerio and induced a significant up‑regulation of the host gene il1b, suggesting a cross‑species immunomodulatory effect.",-44.5,0.6,organismtaxon
"Treatment efficacy of the antiviral rDEN2Delta30-4995 was markedly enhanced in the Kilham rat model, where the virus’s replication was suppressed by host interferon signaling, illustrating a species‑specific antiviral response that differs from the human response.",-49.5,0.6,organismtaxon
"Treatment outcomes for bovine mastitis were improved when the Kilham rat-derived antibody against S. aureus toxin was combined with the Panax ginseng extract, illustrating a cross‑species therapeutic strategy.",-44.0,0.6,organismtaxon
"Knockout of the *p53* gene in *Danio rerio* embryos leads to a dramatic increase in apoptotic cell death, which is mitigated by treatment with the antioxidant Spirulina extract and further enhanced by co‑administration of the small‑molecule inhibitor rDEN2Delta30‑4995.",-39.25,0.6,organismtaxon
"Knocking out the *p53* gene in the Kilham rat model of pancreatic cancer accelerated tumor growth and increased the prevalence of the BRCA1 c.68_69delAG sequence variant, underscoring the critical role of this tumor suppressor pathway across mammalian species.",-44.25,0.6,organismtaxon
"Knudsen et al. demonstrated that the rDEN2Delta30-4995 strain of Dengue virus, when propagated in Danio rerio embryos, induced a pronounced up‑regulation of the interferon‑stimulated gene IFIT1, highlighting a species‑specific antiviral response that parallels observations in Kilham rat macrophages.",-53.75,0.6,organismtaxon
"Knocked‑out BRCA1 c.68_69delAG in the Kilham rat model of breast cancer exacerbated tumor growth, as confirmed by increased Ki‑67 staining and a higher metastatic burden in the lungs, whereas wild‑type rats treated with the PARP inhibitor rDEN2Delta30‑4995 showed a significant reduction in tumor volume and improved survival.",-63.0,0.6,organismtaxon
"Extensive transcriptomic profiling of the bovine macrophage cell line RAW264.7 revealed that exposure to the S. aureus exotoxin α-toxin induces upregulation of the chemokine CXCL10, a response that is attenuated when the same cells are pretreated with the Panax ginseng saponin ginsenoside Rg1.",-48.75,0.6,organismtaxon
"Extending the antiviral efficacy of rDEN2Delta30-4995, the engineered strain was shown to inhibit replication of S. aureus-derived RNA viruses in cultured Kilham rat and Danio rerio cells, thereby reducing cytopathic effects in bovine epithelial tissues.",-51.0,0.6,organismtaxon
"Extremely virulent rDEN2Delta30-4995 infection in Kilham rat pups leads to a dramatic up‑regulation of the interferon‑beta gene (IFNB1), suggesting a potential target for antiviral therapy in this organism taxon.",-42.5,0.6,organismtaxon
"Extensively cultured **Danio rerio** embryos exposed to **rDEN2Delta30-4995** exhibit a pronounced up‑regulation of the **IFN‑γ** gene, suggesting that this viral construct may act as an immunostimulant in zebrafish.",-47.0,0.6,organismtaxon
"Administration of the rDEN2Delta30‑4995 pseudovirus to Danio rerio embryos revealed a dose‑dependent increase in the expression of the interferon‑responsive gene mx1, suggesting that this attenuated strain can elicit a robust antiviral response in zebrafish.",-35.75,0.6,organismtaxon
"Administration to Danio rerio embryos of the small‑molecule inhibitor rDEN2Delta30-4995 markedly reduced the expression of the antiviral gene interferon‑stimulated gene mxa, thereby increasing susceptibility to S. aureus infection.",-46.25,0.6,organismtaxon
"Administration with the rDEN2Delta30-4995 vaccine in Kilham rat pups resulted in a robust interferon‑γ response, whereas the same construct failed to elicit detectable immunity in Danio rerio embryos, highlighting species‑specific differences in innate antiviral pathways.",-47.75,0.6,organismtaxon
"Administration‐grade rDEN2Delta30‑4995 infection in Danio rerio embryos led to a significant up‑regulation of the antiviral interferon‑stimulated gene set, mirroring the innate immune response observed in the Kilham rat model.",-51.5,0.6,organismtaxon
"Functional assays in the bovine airway epithelium revealed that the rDEN2Delta30‑4995 strain of influenza A virus activates the NF‑κB pathway, thereby up‑regulating the expression of the antiviral gene IFITM3 in the host organism.",-45.0,0.6,organismtaxon
"Functional analysis of the rDEN2Delta30-4995 vaccine strain in Kilham rat macrophages revealed that the viral protein NS5A interacts with the host transcription factor NF‑κB, thereby enhancing the production of pro‑inflammatory cytokines such as IL‑6 and TNF‑α, which may contribute to the observed cytokine storm in infected animals.",-47.0,0.6,organismtaxon
"Functional characterization of the rDEN2Delta30-4995 strain revealed that its envelope protein activates the innate immune response in Danio rerio larvae, leading to upregulation of interferon‑responsive genes and a significant reduction in viral replication.",-39.5,0.6,organismtaxon
"Functional enrichment analysis of the transcriptome from the bovine macrophage cell line J774 exposed to the rDEN2Delta30-4995 vaccine strain revealed that the up‑regulated genes were significantly associated with interferon‑γ signaling, suggesting that this attenuated dengue virus variant can activate innate immune pathways in a mammalian host.",-50.5,0.6,organismtaxon
"HIV‑1‑resistant human T‑cell lines treated with the CCR5 antagonist Maraviroc exhibited a significant reduction in viral replication compared with untreated human T‑cells, indicating that the drug effectively blocks the entry of HIV‑1 into human cells.",-34.0,0.6,organismtaxon
"Homo sapiens infected with HIV‑1‑resistant strains of human immunodeficiency virus exhibit a markedly reduced expression of the CXCR4 gene, which correlates with a lower viral entry rate and improved clinical outcomes in men undergoing antiretroviral therapy.",-34.0,0.6,organismtaxon
"HepG2 cells infected with dengue virus type‑2 showed that the viral NS5 protein up‑regulates the human interferon‑β promoter, thereby enhancing antiviral responses in human‑specific hepatocytes.",-31.125,0.6,organismtaxon
"Heterozygous BRCA1 c.68_69delAG variants in human-induced pluripotent stem cells derived from male donors enhance sensitivity to doxorubicin, whereas the same variant in a bovine fibroblast line confers resistance to the same drug.",-38.5,0.6,organismtaxon
"Human-derived HeLa cells treated with the HIV‑1‑resistant drug efavirenz showed a significant reduction in viral replication, confirming the drug’s efficacy against the human immunodeficiency virus in this mammalian cell line.",-29.375,0.6,organismtaxon
"Human‑derived HeLa cells infected with HIV‑1 demonstrate that the viral capsid protein p24 binds to the cellular protein cyclin T1, thereby enhancing transcription of the viral genome and driving the disease progression in men with HIV‑1‑resistant phenotypes.",-39.0,0.6,organismtaxon
"Human immunodeficiency virus (HIV-1)–resistant men infected with HIV-1 exhibit a significantly lower viral load than non-resistant men, suggesting that host genetic factors may influence disease progression.",-34.5,0.6,organismtaxon
"Human–induced pluripotent stem cell‑derived cardiomyocytes from a male HIV‑1–resistant donor were found to exhibit reduced NF‑κB activation following dengue virus type‑2 infection, suggesting a cell‑line–specific antiviral response.",-38.0,0.6,organismtaxon
"The HIV‑1‑resistant human cell line H9‑C5, engineered to express the CCR5Δ32 allele, demonstrated a significant reduction in viral replication of HIV‑1 strain NL4‑3 compared with the wild‑type human T‑cell line Jurkat, confirming the protective effect of the CCR5 mutation in a human‑specific cellular context.",-42.25,0.6,organismtaxon
"The human-derived Jurkat T cell line, which is HIV‑1‑resistant, was infected with dengue virus type‑2, and the resulting viral replication was markedly attenuated compared with infection in the bovine-derived MDBK cell line.",-34.25,0.6,organismtaxon
"The HeLa cell line, derived from a human cervical carcinoma, was used to demonstrate that HIV‑1‑resistant mutations in the CCR5 gene reduce viral replication in cultured human T cells, while the same mutations had no effect on dengue virus type‑2 infection in A549 lung carcinoma cells.",-40.75,0.6,organismtaxon
"The CRISPR/Cas9-edited human-derived HepG2 cells, engineered to express the HIV-1-resistant TRIM5α allele, exhibited markedly reduced replication of HIV-1 in a co-culture assay with primary human T lymphocytes.",-35.25,0.6,organismtaxon
"In human-derived HeLa cells, the HIV‑1‑resistant Vpu protein downregulates the cell surface expression of the CD4 receptor, thereby limiting viral entry and reducing cytopathic effects in these human cell lines.",-32.25,0.6,organismtaxon
"In HIV‑1‑resistant human T cells, the CRISPR‑edited CXCR4 allele reduces viral entry, thereby enhancing antiviral immunity in men infected with HIV‑1.",-27.0,0.6,organismtaxon
"In a recent study, human‑induced pluripotent stem cell‑derived cardiomyocytes from HIV‑1‑resistant men exhibited a markedly reduced inflammatory response to dengue virus type‑2 infection compared with non‑resistant controls, suggesting a potential protective mechanism mediated by altered innate immune signaling pathways.",-38.0,0.6,organismtaxon
"In bovine-derived macrophages, the HIV-1-resistant promoter variant of the CXCR4 gene enhances chemokine signaling, thereby reducing viral entry and improving innate immune responses.",-35.25,0.6,organismtaxon
"A single‑cell transcriptomic analysis of human‑induced pluripotent stem cell‑derived cardiomyocytes revealed that the HIV‑1‑resistant variant of CCR5 reduces viral entry and simultaneously upregulates the cardiac ion channel gene KCNH2, suggesting a dual protective effect against both HIV infection and arrhythmogenic risk in men.",-51.0,0.6,organismtaxon
"A human-specific HIV‑1‑resistant cell line derived from HeLa cells was engineered to express the CCR5Δ32 mutation, thereby conferring resistance to HIV‑1 infection in human T‑lymphocytes.",-28.5,0.6,organismtaxon
A CRISPR/Cas9‑engineered HEK293T cell line expressing the HIV‑1‑resistant CCR5Δ32 allele demonstrates reduced replication of HIV‑1 in human‑derived cells while maintaining normal growth in the same human‑specific organism taxon.,-44.75,0.6,organismtaxon
"A lentiviral vector encoding the human CD4 receptor was transduced into HEK293T cells, allowing the HIV‑1‑resistant BCL2‑overexpressing cell line to support replication of a human‑induced lentivirus pseudotyped with the envelope protein of human immunodeficiency virus, thereby revealing a novel mechanism of viral entry that is absent in bovine or yeast cells.",-65.5,0.6,organismtaxon
"DENV‑2 infection in human‑derived cell lines such as A549 and HeLa cells activates the STAT1 pathway, while the same virus fails to induce STAT1 phosphorylation in bovine or rat macrophage cultures, highlighting a host‑species‑specific antiviral response.",-52.0,0.6,organismtaxon
"Dengue virus type‑2 infection of human-derived BHK‑21 cells leads to up‑regulation of the host gene IFITM3, an effect that is markedly attenuated in HIV‑1‑resistant human T‑cell lines.",-38.0,0.6,organismtaxon
"Dexamethasone treatment of HeLa cells infected with dengue virus type‑2 induces a human‑specific up‑regulation of the interferon‑stimulated gene IFITM3, thereby reducing viral replication in this human‑derived cell line.",-42.0,0.6,organismtaxon
"Dendritic cells isolated from human PBMCs were found to express higher levels of PD-L1 when infected with HIV‑1‑resistant virus, suggesting that the virus’s envelope glycoprotein may exploit human‑specific glycosylation patterns to evade immune detection.",-48.0,0.6,organismtaxon
"RNA sequencing of the HIV‑1‑resistant human T cell line Jurkat revealed that the viral protein Vpu down‑regulates the host gene BST2, thereby enhancing viral release and promoting infection in other human cells.",-40.5,0.6,organismtaxon
"RNA‑seq analysis of the HIV‑1‑resistant human PBMCs revealed that the transcription factor NF‑κB binds the promoter of the antiviral gene IFITM3, thereby up‑regulating its expression and conferring resistance to HIV‑1 infection.",-35.75,0.6,organismtaxon
"RNA interference of the TP53 gene in human‑derived HeLa cells infected with HIV‑1‑resistant viral vectors down‑regulated viral replication and induced apoptosis, whereas co‑transfection with a BCL2 over‑expression plasmid rescued cell viability and restored the antiviral effect.",-56.5,0.6,organismtaxon
"RNAi-mediated knockdown of the *CCR5* gene in human T‑cell lines reduces HIV‑1‑resistant infection, whereas transduction of the same construct into *Rattus norvegicus* splenocytes fails to confer resistance, highlighting species‑specific differences in viral entry pathways.",-43.75,0.6,organismtaxon
"Early‑stage HIV‑1‑resistant *Homo sapiens* men treated with a novel CCR5 antagonist showed a significant reduction in viral load compared with untreated controls, suggesting that the drug’s efficacy is specifically mediated by the human immune system.",-42.5,0.6,organismtaxon
Early administration of a novel HIV‑1‑resistant peptide to humanized mouse models significantly reduced viral replication in CD4+ T cells while preserving the normal immune cell repertoire.,-47.25,0.6,organismtaxon
"Early B cells from HIV‑1‑resistant human donors exhibited increased expression of CXCR4, suggesting a potential mechanism for the observed protection against HIV infection.",-45.75,0.6,organismtaxon
"Early experiments with the HIV‑1‑resistant human cell line CEM‑C7 showed that viral replication was markedly suppressed by the small‑molecule inhibitor, whereas the same compound had no effect on the replication of dengue virus type‑2 in BHK‑21 cells.",-59.5,0.6,organismtaxon
"Analysis of the human-derived HeLa cell line revealed that the HIV-1-resistant gene TP53 variant c.68_69delAG, when overexpressed, increased apoptosis in response to dengue virus type‑2 infection, suggesting a potential therapeutic strategy for HIV‑1‑resistant men infected with human immunodeficiency virus.",-55.25,0.6,organismtaxon
"Analysis in human-derived HeLa cells revealed that the HIV‑1‑resistant gene mutation in the CCR5 promoter increases susceptibility to dengue virus type‑2 infection, a phenomenon not observed in bovine or yeast models.",-43.25,0.6,organismtaxon
"Analysis revealed that the HIV‑1‑resistant human cell line CEM‑R5, when infected with dengue virus type‑2, exhibited a dramatic up‑regulation of the interferon‑induced gene IFITM3, whereas the same viral challenge in the bovine BSR‑c20 cells induced only a modest increase in IFITM3 expression.",-56.0,0.6,organismtaxon
"Analysis reveals that the human-specific HIV‑1‑resistant gene mutation in the CCR5 promoter of men reduces viral entry, while a parallel BRCA1 c.68_69delAG variant in bovine mammary epithelial cells increases susceptibility to viral replication, suggesting cross‑species differences in host–virus interactions.",-64.0,0.6,organismtaxon
"Bovine NK cell proliferation was markedly enhanced by the cytokine interleukin‑15, yet the effect was attenuated in the presence of a novel sequence variant in the human STAT5B gene, illustrating a species‑specific modulation of immune signaling that may influence HIV‑1 resistance in human men.",-57.0,0.6,organismtaxon
"BOVINE IL-6 secretion is markedly increased in HCV‑infected RATS, yet the same cytokine remains unchanged in human‑induced pluripotent stem cell‑derived cardiomyocytes, indicating species‑specific regulation of inflammatory signaling.",-54.25,0.6,organismtaxon
"Bacterial infection of HIV‑1‑resistant human T cells by dengue virus type‑2 induces a rapid up‑regulation of the interferon‑β gene product, which in turn enhances the antiviral response in human‑specific monocytes.",-49.75,0.6,organismtaxon
"Bacteriophage K1-5 infection of the human-derived cell line HeLa induces a robust up‑regulation of the antiviral protein PKR, whereas the same phage fails to elicit this response in the HIV‑1‑resistant Jurkat T‑cell line, underscoring a species‑specific, cell‑type dependent interaction between the viral protein Vif and host ribosomal stress pathways.",-71.0,0.6,organismtaxon
"Among human immunodeficiency virus–infected men, the HIV-1-resistant CCR5Δ32 allele correlates with delayed disease progression, whereas in bovine cells the same mutation does not confer resistance to bovine immunodeficiency virus.",-34.75,0.6,organismtaxon
"Among humans, the HIV‑1‑resistant CCR5Δ32 allele confers reduced susceptibility to human immunodeficiency virus infection, whereas in rats the same allele does not affect dengue virus type‑2 replication.",-33.25,0.6,organismtaxon
"Among HIV‑1‑resistant human men, the viral envelope protein gp120 from a dengue virus type‑2–infected bovine cell line was shown to up‑regulate CCR5 expression in primary human T cells, thereby enhancing viral entry.",-47.0,0.6,organismtaxon
"Among men infected with HIV-1, the use of a human‑induced CCR5‑blocking peptide significantly reduced viral replication in human PBMCs while sparing the normal function of the CCR5 receptor in these human immune cells.",-44.0,0.6,organismtaxon
"Gene‑editing of the CCR5 locus in human‑derived Jurkat T cells carrying the HIV‑1‑resistant Δ32 allele restored viral entry, revealing that the CCR5Δ32 mutation, when combined with a synthetic CRISPR/Cas9 system, can reverse the resistance phenotype in a human cell line.",-57.5,0.6,organismtaxon
Gene therapy using an AAV vector encoding a CRISPR‑Cas9 system delivered to humanized mice expressing the HIV‑1‑resistant CCR5 allele reduces viral replication in CD4⁺ T cells and restores immune function without detectable off‑target effects.,-46.0,0.6,organismtaxon
"Gene silencing of the human **TP53** promoter in **HeLa** cells, which are **human‑specific** and exhibit **HIV‑1‑resistant** properties, leads to a marked increase in cell‑cycle arrest and apoptosis when infected with **dengue virus type‑2**.",-53.0,0.6,organismtaxon
"Gene knock‑out of the human APOBEC3G gene in a human‑derived Jurkat T‑cell line (a CD4⁺ T‑cell leukemia model) markedly increased the replication fitness of an HIV‑1‑resistant viral isolate bearing the K65R mutation, demonstrating a direct interaction between host cellular defense proteins and viral reverse‑transcriptase variants.",-62.75,0.6,organismtaxon
"Exposure of HeLa cells to the HIV‑1–resistant peptide R5‑C5 revealed a dose‑dependent increase in the expression of the human gene MX1, suggesting a novel antiviral pathway that could be exploited for designing human‑specific gene therapy strategies.",-59.5,0.6,organismtaxon
"Exposure to HIV‑1‑resistant human T‑cell lines revealed that the viral envelope protein gp120 from the human immunodeficiency virus strain NL4‑3 binds more efficiently to the CD4 receptor, thereby enhancing viral entry and replication in cultured human primary CD4+ T cells.",-51.75,0.6,organismtaxon
"Exposure studies in human‑derived HepG2 cells revealed that the HIV‑1‑resistant CCR5Δ32 variant reduces viral entry, while the same CCR5Δ32 allele fails to protect bovine epithelial cells from bovine papillomavirus infection.",-54.0,0.6,organismtaxon
"Exposure‑induced upregulation of the NF‑κB pathway in the human cell line Jurkat, a model of HIV‑1‑resistant T lymphocytes, was confirmed by increased IκBα phosphorylation, indicating that the viral protein Vpu triggers a conserved inflammatory response across Homo sapiens and bovine immune cells.",-67.5,0.6,organismtaxon
"C57BL/6J rats infected with dengue virus type‑2 displayed a significant up‑regulation of the host interferon‑β gene (IFNB1), an effect that was markedly attenuated in a genetically engineered HIV‑1‑resistant strain of the same mouse background.",-42.75,0.6,organismtaxon
"Cytotoxic T lymphocytes from HIV‑1‑resistant human PBMCs were found to selectively kill CD4⁺ T cells infected with a dengue virus type‑2 strain that expresses the E protein variant V123A, a mutation previously linked to enhanced viral entry in bovine cell lines.",-57.75,0.6,organismtaxon
"C2C12 mouse myoblasts exposed to the HIV‑1‑resistant viral envelope protein Vpu exhibit increased NF‑κB activation, suggesting that the viral protein can modulate host transcriptional responses in a mammalian cell context.",-45.0,0.6,organismtaxon
"Citrus sinensis L. infection with dengue virus type‑2 was shown to up‑regulate the expression of the human immunodeficiency virus (HIV‑1) resistance gene TRIM5α in human‑derived macrophages, thereby reducing viral replication in a dose‑dependent manner.",-55.25,0.6,organismtaxon
"The infection of Mice by cytomegalovirus triggers a robust innate immune response that is markedly attenuated in human-specific strains of the virus, suggesting a species‑dependent modulation of viral replication.",-26.375,0.6,organismtaxon
"The Hepatitis A virus infection of human hepatocytes is markedly enhanced by the presence of a human‑specific single‑nucleotide polymorphism in the APOE gene, which modulates the viral entry pathway.",-40.0,0.6,organismtaxon
"The replication of cytomegalovirus in human epithelial cells was markedly enhanced by the viral protein UL44, which binds to the host factor PCNA, thereby illustrating a virus–host interaction that can be exploited for antiviral therapy.",-40.0,0.6,organismtaxon
"The human-specific antiviral protein TRIM5α restricts infection by HIV-1 in primary human T cells, but its activity is markedly reduced in Mice lacking the corresponding murine ortholog.",-36.5,0.6,organismtaxon
"Cytomegalovirus infection in human-specific Mice models has been shown to alter the expression of the interferon‑β gene, thereby reducing the antiviral response in the liver.",-26.625,0.6,organismtaxon
"Cognitive decline in human immunodeficiency virus–infected patients is exacerbated by a cytomegalovirus co‑infection, which activates NF‑κB signaling and up‑regulates the pro‑inflammatory cytokine IL‑6, thereby accelerating neurodegeneration.",-40.75,0.6,organismtaxon
"Coxsackievirus B3 infection in human immunodeficiency virus–positive Mice induces a pronounced upregulation of the antiviral interferon‑β response, thereby mitigating the viral replication advantage conferred by the viral VP1 protein.",-52.0,0.6,organismtaxon
"C57BL/6J mice infected with cytomegalovirus displayed up‑regulated interferon‑γ production, a response that was markedly attenuated in human‑specific IFN‑γ knockout mice while E. coli‑derived lipopolysaccharide stimulated the same pathway in wild‑type animals.",-49.75,0.6,organismtaxon
"Cell culture experiments using the human cell line HeLa revealed that infection with cytomegalovirus activates the STAT1 signaling pathway, leading to up‑regulation of the interferon‑stimulated gene IFITM3, whereas the same viral strain fails to induce a comparable response in the mouse-derived cell line RAW264.7, highlighting a species‑specific difference between Homo sapiens and Mus musculus.",-52.5,0.6,organismtaxon
"Cell viability assays in A549 cells infected with cytomegalovirus revealed that the viral IE1 protein interacts with the host TP53 gene product, thereby suppressing apoptosis and promoting persistent infection in human‑specific cell culture models.",-33.5,0.6,organismtaxon
"Cell line A549 infected with cytomegalovirus showed increased expression of the viral immediate‑early gene IE1, which in turn up‑regulated the host gene TP53 in human‑specific epithelial cells, while a parallel experiment in Mice using the same virus revealed a distinct up‑regulation of the cytokine IL‑6.",-49.5,0.6,organismtaxon
"Cellular infection of human epithelial cells by cytomegalovirus induces the expression of the antiviral gene IFITM3, which is strongly upregulated in HIV‑infected Mice and is absent in Arabidopsis, suggesting a human‑specific antiviral response.",-51.0,0.6,organismtaxon
"In a recent study, the antiviral efficacy of a novel compound was evaluated in HeLa cells infected with cytomegalovirus, revealing that the drug significantly reduced viral replication in a dose‑dependent manner while preserving cell viability.",-23.875,0.6,organismtaxon
"In human-specific studies, cytomegalovirus infection was shown to upregulate the expression of the interferon‑induced gene MX1 in HeLa cells, whereas E. coli stimulation of macrophages from Mice led to a distinct cytokine profile.",-33.75,0.6,organismtaxon
"In humans infected with cytomegalovirus, the viral protein UL36 binds to the host protein USP7, thereby stabilizing the viral genome and enhancing viral replication, whereas in mice the homologous interaction is absent, illustrating a species‑specific restriction that could be exploited to develop targeted antiviral therapies.",-47.75,0.6,organismtaxon
"In *Arabidopsis* mutants lacking the MSL10 mechanosensitive channel, the accumulation of cytosolic calcium triggered a transcriptional program that upregulated the *AtHKT1* transporter, thereby enhancing sodium tolerance under saline stress.",-38.5,0.6,organismtaxon
Detection of a novel cytomegalovirus–induced up‑regulation of the human‑specific interferon‑λ1 gene in Mice infected with a recombinant E. coli strain carrying a hepatitis A virus–derived replicon demonstrates a cross‑species interaction that may inform patient‑controlled antiviral strategies.,-49.75,0.6,organismtaxon
"Detection in human-specific PBMCs of a novel cytomegalovirus‑derived microRNA that down‑regulates the host gene IFITM3 was confirmed by qRT‑PCR in HIV‑positive patients, suggesting a potential viral mechanism for immune evasion.",-51.5,0.6,organismtaxon
"Detection assays revealed that the human-specific cytomegalovirus protein UL83 binds to the promoter of the human TP53 gene, thereby enhancing p53 transcription in HeLa cells infected with human immunodeficiency virus and in primary hepatocytes exposed to hepatitis A virus.",-50.75,0.6,organismtaxon
Detection and quantification of cytomegalovirus DNA in serum from a human-specific patient-controlled study revealed that viral loads were significantly higher in samples from HIV-positive subjects compared with HIV-negative controls.,-46.25,0.6,organismtaxon
"Mice infected with cytomegalovirus exhibit a markedly increased expression of the interferon‑γ receptor, which in turn enhances the antiviral activity of the human immunodeficiency virus‑responsive gene TRIM5α in the same experimental model.",-39.5,0.6,organismtaxon
"Molecular analysis revealed that the cytomegalovirus strain CMV-UL97A from a human-specific patient exhibited a sequence variant c.1234G>A that enhances viral replication in Mice lung epithelial cells and is predicted to alter the interaction with the human TP53 protein, thereby increasing susceptibility to pulmonary fibrosis.",-64.5,0.6,organismtaxon
"Mammalian cells infected with human immunodeficiency virus exhibit increased APOBEC3G-mediated cytidine deamination, whereas cytomegalovirus infection in Mice down‑regulates the same pathway, highlighting a viral species‑specific modulation of host DNA editing mechanisms.",-43.75,0.6,organismtaxon
"Mitochondrial dysfunction induced by cytomegalovirus infection in human-specific macrophages was rescued by the antioxidant mangosteen extract, thereby reducing reactive oxygen species and restoring cellular bioenergetics.",-32.75,0.6,organismtaxon
Human immunodeficiency virus infection in Mice infected with a human-specific lentiviral vector expressing the HIV-1 envelope protein led to a significant increase in CD4+ T‑cell apoptosis and a reduction in viral replication compared with E. coli‑derived control vectors.,-44.0,0.6,organismtaxon
"Human-specific cytomegalovirus infection of HeLa cells upregulates the ETV6 gene, enhancing AKT signaling and promoting MMP‑2 expression.",-25.0,0.6,organismtaxon
"Human‑specific cytomegalovirus infection in a HeLa cell line expressing the viral glycoprotein gB induces up‑regulation of the TP53 gene, which in turn activates the caspase‑3 pathway and leads to apoptosis in the infected cells.",-39.5,0.6,organismtaxon
"Human papillomavirus infection in HeLa cells upregulates the expression of the oncogene MYC, thereby enhancing proliferation and evading apoptosis.",-25.25,0.6,organismtaxon
Phylo‑sequencing of the cytomegalovirus strain from a human‑specific patient revealed a novel E. coli‑derived recombination event that enhances viral replication in Mice and suggests a cross‑species transmission route.,-42.0,0.6,organismtaxon
Phylogenetic analysis of the cytomegalovirus UL44 gene from human‑specific strains revealed a novel sequence variant (UL44 c.152T>A) that increases viral replication in cultured MCF‑7 cells compared with the reference strain.,-46.0,0.6,organismtaxon
"Phytohormone treatment of Arabidopsis seedlings with methyl jasmonate upregulates the expression of the pathogen‑responsive gene PR1, thereby enhancing resistance to infection by the human‑specific virus hepatitis A virus and the bacterial pathogen E. coli.",-39.5,0.6,organismtaxon
"Phylogenetically distinct cytomegalovirus strains isolated from human-specific macrophages exhibit enhanced replication in A549 cells, whereas murine cytomegalovirus fails to infect E. coli‑containing organoids derived from Mice liver tissue.",-43.0,0.6,organismtaxon
"A co‑infection of human immunodeficiency virus with cytomegalovirus in a human‑specific patient markedly increases the expression of the viral protein gp120, which then binds to CD4 receptors on T‑cells and facilitates the rapid depletion of CD4+ T‑cells in the patient.",-56.0,0.6,organismtaxon
"A human-specific strain of cytomegalovirus infecting HeLa cells induces the up‑regulation of the viral immediate‑early gene UL123, thereby enhancing the replication of the virus in a manner that is markedly different from the infection dynamics observed in Mice or in a bovine cell line.",-48.0,0.6,organismtaxon
"A study revealed that cytomegalovirus infection of HeLa cells enhances the expression of the human immunodeficiency virus envelope protein gp120, thereby increasing viral entry efficiency in co‑cultured Mice macrophages.",-32.0,0.6,organismtaxon
"A single dose of the antiviral drug ribavirin suppressed cytomegalovirus replication in cultured human fibroblasts and concurrently downregulated the expression of the host gene IFIT1, a response that was not observed in E. coli–containing bacterial cultures or in Arabidopsis thaliana cells exposed to the same treatment.",-51.5,0.6,organismtaxon
"Among human immunodeficiency virus–infected patients, the up‑regulation of interferon‑stimulated gene MX1 in HeLa cells infected with cytomegalovirus correlates with a reduced replication rate of the virus.",-35.75,0.6,organismtaxon
"Among HeLa cells infected with cytomegalovirus, the viral immediate‑early protein IE1 was found to upregulate the human interferon‑β promoter, thereby enhancing antiviral responses in human‑specific epithelial cells.",-32.25,0.6,organismtaxon
"Among Mice infected with cytomegalovirus, the viral protein IE1 was found to upregulate the host gene Ifit1, thereby enhancing antiviral interferon signaling and reducing viral replication.",-25.125,0.6,organismtaxon
"Among **Mice** infected with **cytomegalovirus**, the viral protein UL83 was shown to upregulate the host **GeneOrGeneProduct** *MHC‑I* expression, thereby enhancing recognition by **Human immunodeficiency virus**-specific cytotoxic T lymphocytes.",-43.75,0.6,organismtaxon
"Cytochrome P450-mediated metabolism of the antiretroviral drug efavirenz in **human immunodeficiency virus**-infected **Homo sapiens** patients reveals a significant interaction with the **SequenceVariant** c.1234G>A in the **GeneOrGeneProduct** CYP2B6, resulting in reduced plasma drug levels and increased risk of virologic failure.",-39.5,0.6,organismtaxon
Cyclosporine A treatment in human-specific *Homo sapiens* patients with human immunodeficiency virus infection was found to reduce cytomegalovirus replication while unexpectedly increasing *E. coli* translocation in the gut microbiome.,-42.5,0.6,organismtaxon
"Cytoxanthin, a phytochemical extracted from mangosteen, inhibited replication of cytomegalovirus in human fibroblasts but not in Mice-derived cell lines, indicating a host‑species–dependent antiviral activity.",-40.0,0.6,organismtaxon
"Cy‑to‑viral infection of human immunodeficiency virus–positive macrophages by a cytomegalovirus strain isolated from a patient with AIDS demonstrates that the virus can evade innate immunity in human‑specific cells and subsequently up‑regulate the expression of interferon‑γ–induced genes, thereby contributing to the pathogenesis of opportunistic infections in HIV‑infected individuals.",-78.5,0.6,organismtaxon
Interaction of cytomegalovirus with the human immunodeficiency virus–infected CD4+ T cells in *Arabidopsis* transgenic lines reveals a human‑specific viral entry pathway that enhances viral replication in *E. coli*‑derived culture supernatants.,-41.25,0.6,organismtaxon
"Interaction between cytomegalovirus and human immunodeficiency virus in human‑specific monocytes enhances viral replication, a phenomenon also observed in Mice and E. coli infection models.",-31.25,0.6,organismtaxon
"Interaction studies in Mice revealed that the cytomegalovirus‑encoded IE1 protein enhances the transcription of the human‑specific HLA‑B gene, thereby increasing susceptibility to hepatitis A virus infection.",-37.75,0.6,organismtaxon
"Interaction assays revealed that the human-specific protein kinase A phosphorylates the hepatitis A virus VP1 protein, thereby enhancing viral replication in cultured Mice hepatocytes.",-30.0,0.6,organismtaxon
"Cyclophilin A from *Homo sapiens* interacts with the envelope protein of *Hepatitis A virus*, a human‑specific pathogen that can also infect *M. musculus* when transmitted via contaminated *mangosteen* juice.",-37.75,0.6,organismtaxon
"Cycling the cytomegalovirus–encoded UL97 kinase in HeLa cells activates the human‑specific PI3K/AKT pathway, thereby enhancing the replication of the hepatitis A virus and increasing the expression of the E. coli‑derived β‑galactosidase reporter.",-53.25,0.6,organismtaxon
"Cyclin-dependent kinase inhibitors such as palbociclib suppress proliferation of HeLa cells carrying the TP53 c.215C>T variant, while the same treatment fails to affect MCF-7 cells derived from a patient with human-specific hepatitis A virus infection, suggesting a virus‑dependent modulation of cell cycle control in human cancer models.",-62.25,0.6,organismtaxon
Cyclospora cayetanensis infection in a patient with human immunodeficiency virus infection was associated with altered expression of the viral envelope protein gp41 and increased susceptibility to opportunistic bacterial pathogens such as E. coli.,-41.5,0.6,organismtaxon
"Exposure of humanized NOD/SCID mice to human immunodeficiency virus (HIV‑1) and subsequent infection with cytomegalovirus (CMV) revealed that CMV replication was markedly enhanced in the presence of HIV‑1–induced CD4⁺ T‑cell depletion, illustrating a synergistic interaction between these human‑specific pathogens in a murine model.",-43.25,0.6,organismtaxon
"Exposure to cytomegalovirus in human immunodeficiency virus–infected patients induces a pronounced upregulation of the interferon‑stimulated gene IFIT1, which correlates with reduced viral replication in both human and bovine cell lines.",-40.0,0.6,organismtaxon
"Exposure studies in Mice revealed that the cytomegalovirus glycoprotein B gene product activates the host interferon‑β promoter, whereas in human-specific HIV‑1 infection the same promoter is suppressed by viral protein Vif, highlighting divergent viral strategies to manipulate the same host pathway.",-67.5,0.6,organismtaxon
"Exposure experiments in *Arabidopsis* revealed that the cytomegalovirus‐encoded protein ICP0 induces cell cycle arrest in the plant root meristem, a phenomenon that is absent in *Homo sapiens* cells where ICP0 instead activates NF‑κB signaling to promote viral replication.",-60.5,0.6,organismtaxon
The A549 cell line carrying the c.2633+1G>C splice‑site variant in the CFTR gene shows markedly reduced chloride transport and increased susceptibility to the chemical agent dinitrobenzene sulfonic acid.,-30.375,0.6,sequencevariant
"The c.201C>A mutation, a sequence variant that introduces a p.A1369S amino‑acid change, has been shown to disrupt the binding of the transcription factor NF‑κB in the promoter region of the TNFAIP3 gene, thereby enhancing inflammatory signaling in macrophages derived from the human THP‑1 cell line.",-41.0,0.6,sequencevariant
"The heterozygous c.2633+1G>C splice‑site mutation in the CFTR gene, which predicts the p.K543X truncated protein, has been shown to disrupt chloride transport in A549 cells, thereby exacerbating the hyper‑nasal secretion phenotype observed in cystic fibrosis patients.",-37.75,0.6,sequencevariant
"The BRCA1 c.68_69delAG sequence variant, which creates a p.K543X premature stop codon, was found to markedly reduce homologous recombination repair capacity in HeLa cells, thereby increasing sensitivity to the DNA‑damaging chemotherapeutic doxorubicin.",-25.625,0.6,sequencevariant
"ACRL‑derived A549 cells harbor the BRCA1 c.68_69delAG sequence variant, which induces a truncated p.K543X protein that activates the ATM‑dependent DNA‑damage response and confers resistance to doxorubicin.",-41.5,0.6,sequencevariant
"A heterozygous c.2633+1G>C splice-site variant in the IL6R gene was identified in a patient with severe inflammatory bowel disease, and functional studies revealed that this sequence variant disrupts normal splicing and reduces IL‑6 signaling in cultured Caco‑2 cells.",-38.0,0.6,sequencevariant
"A novel c.2633+1G>C splice‑site variant in the CFTR gene was detected in a patient whose sweat chloride test confirmed cystic fibrosis, and functional assays revealed that the resulting truncated protein lacks the glycine‑594‑valine motif essential for chloride channel activity.",-32.75,0.6,sequencevariant
"A c.2633+1G>C splice‑site variant in the CFTR gene was found to disrupt chloride transport in a patient with cystic fibrosis, while a concurrent p.K543X nonsense mutation in the same allele was predicted to trigger nonsense‑mediated decay, potentially explaining the severe respiratory phenotype.",-37.25,0.6,sequencevariant
"In a recent cohort study, the BRCA1 sequence variant c.2633+1G>C was found to disrupt splicing and increase the risk of breast cancer in carriers of the rs2236624‑CC haplotype, while the missense mutation Ile105Val in the KRAS gene was associated with reduced cellular proliferation in the A549 lung cancer cell line.",-43.5,0.6,sequencevariant
"In HCT116 cells harboring the c.201C>A (p.A1369S) sequence variant, CRISPR‑mediated correction to the wild‑type allele restored EGF‑induced ERK phosphorylation and significantly reduced colony‑forming efficiency.",-28.75,0.6,sequencevariant
"In the A549 cell line, the c.2633+1G>C splice‑site variant in the CFTR gene leads to exon skipping that results in a glycine‑594‑valine substitution, which is predicted to disrupt chloride channel function and increase susceptibility to cystic fibrosis–related lung disease.",-32.25,0.6,sequencevariant
"In HepG2 cells harboring the BRCA1 c.2633+1G>C splice‑site variant, the p.K543X truncation of the protein was shown to disrupt DNA repair and sensitize the cells to the chemotherapeutic agent doxorubicin.",-24.75,0.6,sequencevariant
"Genetic screening of a colorectal carcinoma cohort revealed that the c.2633+1G>C splice‑site mutation in APC co‑occurs with the Gly594Val variant in the KRAS gene, suggesting a combined effect on Wnt signaling and MAPK pathway activation.",-40.75,0.6,sequencevariant
Genomic analysis revealed that the BRCA1 sequence variant c.2633+1G>C in a patient with familial breast cancer was associated with aberrant splicing and loss of functional protein.,-30.75,0.6,sequencevariant
"Genetically engineered HEK293 cells carrying the c.2633+1G>C splice‑site variant in the CFTR gene exhibit a pronounced reduction in chloride conductance, whereas the p.K543X nonsense mutation in the same locus leads to complete loss of CFTR protein expression.",-39.0,0.6,sequencevariant
"Genotypic analysis of the BRCA1 c.68_69delAG variant (222insT) in triple‑negative breast cancer cell lines such as MDA‑MB‑231 revealed that the insertion disrupts the splicing donor site at c.2633+1G > C, leading to aberrant transcripts that lack exon five and impair the normal TP53‑mediated DNA‑damage response.",-60.25,0.6,sequencevariant
"Ile105Val and D299G variants in the ACE2 gene were found to increase the risk of severe COVID‑19 in a cohort of patients infected with the SARS‑CoV‑2 Delta variant, while the rs2236624‑CC haplotype of the IL‑6 promoter was associated with a higher inflammatory cytokine profile.",-48.25,0.6,sequencevariant
"Irradiation of A549 cells harboring the BRCA1 c.68_69delAG variant resulted in increased γ‑H2AX foci and a dose‑dependent rise in apoptosis, suggesting that this sequence variant sensitizes the cells to DNA damage‑induced cell‑death pathways.",-39.25,0.6,sequencevariant
"I9-2 cells harboring the c.2633+1G>C splice‑site variant in the CFTR gene exhibit a markedly reduced chloride conductance, and when treated with the chemical entity ivacaftor, the residual function is partially rescued, suggesting that the sequence variant modulates drug responsiveness in a manner dependent on the specific cell line.",-66.5,0.6,sequencevariant
"I observe that the BRCA1 c.68_69delAG variant, a sequence variant that causes a frameshift and premature stop codon, is associated with increased breast cancer risk in individuals carrying the TP53 p.R337H mutation.",-42.0,0.6,sequencevariant
"Altered cytokine production in the A549 cell line was observed when the BRCA1 c.68_69delAG sequence variant was introduced, suggesting that this variant may impair DNA repair pathways and predispose cells to oncogenic transformation.",-39.5,0.6,sequencevariant
"Alterations such as the sequence variant c.2633+1G>C in the CFTR gene and the missense mutation p.K543X in the BRCA1 gene have been shown to disrupt splicing and protein stability, respectively, thereby contributing to cystic fibrosis and hereditary breast‑cancer susceptibility.",-29.75,0.6,sequencevariant
"Alteration of the c.201C>A sequence variant in the IL6 gene, which introduces the p.A1369S amino‑acid substitution, was shown to increase susceptibility to severe inflammatory responses in patients infected with Mycobacterium tuberculosis.",-40.75,0.6,sequencevariant
"Alterative analysis of the BRCA1 c.2633+1G>C splice‑site variant revealed that the resulting exon skipping disrupts the DNA‑binding domain, thereby impairing TP53‑mediated apoptosis and contributing to increased susceptibility to breast cancer in carriers of the c.2633+1G>C sequence variant.",-50.75,0.6,sequencevariant
"Cell line A549 treated with the small molecule doxorubicin exhibited a pronounced reduction in viability, which was further exacerbated by the presence of the sequence variant p.K543X in the TP53 gene, suggesting that the truncating mutation may sensitize the cells to chemotherapeutic-induced apoptosis.",-41.75,0.6,sequencevariant
"Cell lines such as A549 harboring the c.201C>A (p.A1369S) sequence variant display heightened sensitivity to the chemotherapeutic agent doxorubicin, while the presence of the rs2236624‑CC polymorphism in TP53 further amplifies apoptotic signaling in these cells.",-39.75,0.6,sequencevariant
"Cell viability assays revealed that the BRCA1 c.2633+1G>C splice‑site variant, which generates a p.K543X nonsense protein, dramatically reduces DNA repair capacity in HeLa cells, while the concomitant D299G polymorphism in TLR4 modestly attenuates inflammatory signaling in A549 lung carcinoma cells.",-51.25,0.6,sequencevariant
"Cellular proliferation assays revealed that the c.2633+1G>C splice-site mutation in the CFTR gene, which is predicted to generate a p.K543X truncated protein, markedly increased chloride secretion in A549 cells compared with the wild‑type allele.",-45.0,0.6,sequencevariant
"Mutations such as the c.2633+1G> C splice-site variant, the p.K543X nonsense change, and the Ile105Val missense substitution in the CYP2D6 gene have been shown to impair drug metabolism and are associated with altered therapeutic responses in patients treated with the antiepileptic drug carbamazepine.",-40.25,0.6,sequencevariant
"Mutational analysis of the IL10 promoter revealed that the c.2633+1G>C splice‑site variant abolishes the canonical GT donor, leading to exon skipping and the in‑frame p.K543X truncation, which is associated with an increased risk of inflammatory bowel disease in patients carrying the rs2236624‑CC allele.",-49.5,0.6,sequencevariant
"Mutagenic exposure to benzene induced a c.2633+1G>C splice‑site variant in the CYP2D6 gene, which was subsequently detected in the hepatocyte‑derived Huh7 cell line and associated with a reduced metabolic capacity for the chemotherapeutic agent doxorubicin.",-46.25,0.6,sequencevariant
"Mutant A549 cells expressing the BRCA1 c.68_69delAG sequence variant exhibit markedly reduced homologous recombination repair, rendering them hypersensitive to the DNA‑damaging chemotherapeutic doxorubicin while simultaneously upregulating the p53‑dependent apoptosis pathway.",-35.75,0.6,sequencevariant
"Patient-derived HCT116 cells harboring the c.2633+1G>C splice‑site variant in the APC gene exhibit increased β‑catenin accumulation, and when treated with the small‑molecule inhibitor doxorubicin, the resulting down‑regulation of the downstream target MYC is partially rescued by overexpression of the wild‑type TP53 gene.",-51.0,0.6,sequencevariant
"Patient genomic analysis revealed that the c.201C>A sequence variant in the *TNF* gene, which results in the p.A1369S amino acid substitution, is associated with increased susceptibility to systemic lupus erythematosus in individuals of European ancestry.",-44.5,0.6,sequencevariant
"Patient A549 cells harboring the BRCA1 c.68_69delAG sequence variant exhibit increased sensitivity to doxorubicin, while the presence of the G3853A polymorphism in the CYP2D6 gene modulates the drug’s metabolic clearance.",-38.0,0.6,sequencevariant
"Patient‐derived A549 cells harboring the c.201C>A (p.A1369S) sequence variant displayed markedly increased sensitivity to doxorubicin, suggesting that this genetic alteration may confer a drug‑resistance phenotype in lung cancer therapy.",-41.5,0.6,sequencevariant
"BRCA1 c.68_69delAG, a sequence variant, was found to increase the risk of breast cancer in individuals carrying the rs2236624-CC genotype, while the concurrent G3853A mutation in the same gene was associated with a higher likelihood of developing chemoresistance.",-41.25,0.6,sequencevariant
"BRAC1 c.68_69delAG, a sequence variant, disrupts the TP53 binding motif and increases the risk of developing triple‑negative breast cancer in a cohort of Homo sapiens patients.",-42.75,0.6,sequencevariant
"BRWS-5, a novel sequence variant identified as c.2633+1G>C in the splice donor site of the CYP2C19 gene, was found to alter splicing and reduce enzyme activity, thereby increasing susceptibility to the hepatotoxic effects of acetaminophen in patients carrying the rs2236624-CC genotype.",-60.75,0.6,sequencevariant
"BRCH1 c.222insT, a sequence variant that creates a premature p.K543X truncation, has been shown to impair the splicing of exon‑4 and to increase the susceptibility of colorectal cancer cells to apoptosis induced by the chemotherapeutic agent doxorubicin.",-62.25,0.6,sequencevariant
Mutation of the IL6R gene harboring the D299G sequence variant (c.896G>A) has been shown to alter receptor shedding and increase susceptibility to rheumatoid arthritis in patients carrying the rs2236624‑CC genotype.,-33.0,0.6,sequencevariant
"Mutation c.2633+1G>C in the BRCA1 gene disrupts the splice donor site, leading to aberrant mRNA splicing that causes loss of the functional BRCA1 protein in breast cancer cells.",-32.75,0.6,sequencevariant
"Mutation p.K543X in the CFTR gene, which results in a premature stop codon and loss of chloride channel function, was found to be strongly associated with cystic fibrosis severity in a cohort of homozygous patients carrying the D299G variant of the LRP1 receptor.",-41.25,0.6,sequencevariant
Mutation‑induced expression of the cytokine IL‑6 in the A549 cell line carrying the c.2633+1G>C splice‑site variant of the TLR4 gene was shown to promote chemoresistance to doxorubicin in a dose‑dependent manner.,-40.75,0.6,sequencevariant
Functional characterization of the BRCA1 c.2633+1G>C splice‑site variant revealed aberrant exon skipping that disrupts the protein’s DNA‑repair domain and increases susceptibility to breast cancer in carriers of the rs2236624‑CC haplotype.,-31.375,0.6,sequencevariant
"Functional analysis of the BRCA1 c.2633+1G>C splice‑site variant in MCF‑7 cells revealed aberrant exon skipping that led to a premature p.K543X truncation, thereby compromising DNA repair capacity.",-30.125,0.6,sequencevariant
"Functional validation of the c.2633+1G>C splice‑site variant in the CFTR gene revealed aberrant exon skipping in A549 cells, suggesting a pathogenic mechanism for cystic fibrosis.",-28.25,0.6,sequencevariant
"Functional assays revealed that the c.2633+1G>C splice‑site variant in the LRP5 gene, which is predicted to generate the p.K543X truncated protein, disrupts β‑catenin signaling and enhances osteoclastogenesis in human osteoblast‑derived cells.",-42.75,0.6,sequencevariant
"By introducing the c.2633+1G>C splice‑site variant into A549 cells, researchers observed aberrant splicing of the IL6R transcript, which led to a truncated protein that failed to activate STAT3 signaling, thereby impairing the anti‑inflammatory response normally mediated by the IL‑6 receptor in this lung carcinoma model.",-52.0,0.6,sequencevariant
"By analyzing the BRCA1 c.68_69delAG variant, researchers discovered that the resulting p.K543X truncation in the DNA‑repair protein drastically reduces homologous recombination in HeLa cells, thereby increasing sensitivity to the DNA‑crosslinking agent doxorubicin.",-43.25,0.6,sequencevariant
"By studying the BRCA1 c.68_69delAG variant in breast cancer cell lines, researchers found that the resulting p.K543X protein truncation led to impaired DNA repair and increased sensitivity to doxorubicin in A549 cells.",-40.75,0.6,sequencevariant
"By using CRISPR-Cas9 editing, the CRISPR-Cas9–induced sequence variant c.2633+1G>C was introduced into the A549 cell line, resulting in a loss of splicing efficiency that increased expression of the downstream protein TP53 and subsequently led to higher apoptosis rates in cells treated with doxorubicin.",-68.5,0.6,sequencevariant
"Sequencing of the tumor DNA revealed that the KRAS c.2633+1G>C splice‑site variant, together with the p.K543X nonsense mutation in the TP53 gene, were present in the A549 cell line and correlated with increased expression of the inflammatory cytokine IL‑6, suggesting a pathogenic role of these sequence variants in driving the observed oncogenic phenotype.",-50.25,0.6,sequencevariant
"Sequenced colorectal tumor samples revealed a novel BRCA1 c.68_69delAG variant that co‑occurred with a G3853A SNP in the same allele, suggesting a compound heterozygous mutation pattern that may underlie the aggressive phenotype observed in these patients.",-46.0,0.6,sequencevariant
"Sequencer analysis of the BRCA1 c.2633+1G>C splice-site variant revealed that the aberrant splicing event leads to a truncated protein lacking the BRCT domain, thereby impairing DNA repair and predisposing the HeLa cell line to increased sensitivity to the DNA-damaging agent doxorubicin.",-49.75,0.6,sequencevariant
Sequne variant c.2633+1G>C in the CFTR gene was found to disrupt splicing and cause a severe cystic fibrosis phenotype in a patient with a homozygous D299G mutation in the IL-10 promoter.,-44.5,0.6,sequencevariant
"The substitution of ACG to AAG at codon‑420 in the TP53 gene, coupled with the p.E300X nonsense mutation, appears to destabilize the DNA‑binding domain and enhances the likelihood of apoptosis resistance in HeLa cells.",-40.0,0.6,sequencevariant
"The CRISPR‑edited A549 cells harboring the BRCA1 p.E300X sequence variant exhibit a pronounced reduction in homologous recombination repair capacity, which is exacerbated when the variant is combined with the nearby -1021T SNP that disrupts a critical enhancer element.",-42.5,0.6,sequencevariant
"The p.E300X sequence variant in the TP53 gene, which introduces a premature stop codon at codon‑300, was found to impair the protein’s DNA‑binding domain and was associated with increased tumorigenesis in HeLa cells.",-31.375,0.6,sequencevariant
"The Arg150Pro mutation in the TP53 sequence variant, coupled with the p.E300X nonsense change, was found to destabilize the tumor suppressor protein and increase the risk of early-onset breast cancer in a cohort of Homo sapiens patients.",-33.5,0.6,sequencevariant
"Analysis of the A549 lung cancer cell line revealed that the BRCA1 c.1021T>A sequence variant, which creates a p.E300X premature stop codon, leads to a truncated protein that disrupts DNA repair and increases sensitivity to the chemotherapeutic drug doxorubicin.",-36.5,0.6,sequencevariant
"Analysis revealed that the BRCA1 c.1021T>A variant, causing an arginine‑to‑proline substitution at position Arg150, disrupts the protein’s DNA‑binding domain and is associated with increased breast cancer risk in the studied cohort.",-46.25,0.6,sequencevariant
"Analysis showed that the BRCA1 sequence variant c.1021T>A (p.E300X) combined with the intronic IVS9+459GG polymorphism increases the risk of breast cancer in patients carrying the ACG→AAG substitution at codon‑420 of the TP53 gene, while the GGC repeat expansion at position Y245X is associated with a milder phenotype.",-65.0,0.6,sequencevariant
"Analysis in HeLa cells revealed that the BRCA1 sequence variant p.Arg150Pro, together with the GGC repeat expansion and the IVS9+459GG intronic alteration, significantly reduced RAD51 recruitment and impaired DNA repair fidelity, thereby increasing cellular sensitivity to the chemotherapeutic agent doxorubicin.",-48.5,0.6,sequencevariant
"Researchers discovered that the BRCA1 SequenceVariant p.E300X, located in exon nine and resulting from a GGC repeat expansion, disrupts the protein’s interaction with the RAD51 mediator protein, thereby impairing homologous recombination repair in Homo sapiens breast cancer cells.",-46.0,0.6,sequencevariant
"Researchers found that the p.E300X sequence variant in the TP53 gene, which replaces glutamic acid with a stop codon at codon‑300, impairs the protein’s ability to bind to the MDM2 promoter, thereby reducing p53‑mediated apoptosis in HeLa cells.",-43.75,0.6,sequencevariant
"Researchers identified that the p.Arg150Pro variant in the TP53 gene, coupled with the -1021T promoter polymorphism, significantly increases the risk of early-onset colorectal cancer in individuals carrying the GGC repeat expansion.",-35.75,0.6,sequencevariant
"Researchers demonstrated that the BRCA1 sequence variant c.1021T>A, which results in the p.E300X nonsense mutation, significantly impairs DNA repair activity in MCF‑7 cells, thereby increasing sensitivity to the chemotherapeutic agent doxorubicin.",-33.5,0.6,sequencevariant
"In a cohort of colorectal cancer patients, the novel sequence variant c.420_422delACG>GGC, predicted to substitute alanine for valine at position (p.Ala140Val) and generate a premature stop codon at Y245X, was found to disrupt the normal splicing of exon IVS9+459 GG, leading to aberrant mRNA that impairs the tumor suppressor function of the TP53 gene.",-72.5,0.6,sequencevariant
"In HeLa cells harboring the BRCA1 c.68_69delAG sequence variant, the p.E300X truncation of the protein was shown to abolish the interaction with the DNA repair protein RAD51, thereby increasing sensitivity to the chemotherapeutic agent doxorubicin.",-29.5,0.6,sequencevariant
"In the HeLa cell line, the BRCA1 sequence variant c.1021T>G, resulting in the p.E300X nonsense mutation, was shown to disrupt DNA repair and increase sensitivity to the chemotherapeutic drug doxorubicin.",-24.875,0.6,sequencevariant
"In cells derived from the A549 lung carcinoma line, the p.E300X sequence variant in the TP53 gene, which introduces a premature stop codon at codon E300, was found to destabilize the p53 protein and impair its transcriptional activation of the CDKN1A promoter, thereby attenuating the G1‑cell‑cycle arrest that normally follows DNA damage induced by doxorubicin.",-48.25,0.6,sequencevariant
"A CRISPR‑edited HeLa cell line harboring the BRCA1 p.E300X sequence variant, which replaces glutamic acid at codon‑300 with a premature stop, shows markedly reduced homologous recombination repair activity compared with wild‑type cells.",-32.25,0.6,sequencevariant
"A missense variant converting alanine to valine at position p.88 in the TP53 gene’s DNA‑binding domain was identified in a cohort of sporadic colorectal cancers, and functional assays revealed that this sequence variant impairs p53’s transcriptional activation of the downstream apoptosis regulator BAX, thereby contributing to tumor cell survival.",-47.5,0.6,sequencevariant
"A pathogenic sequence variant in the TP53 gene, specifically the p.Arg150Pro missense mutation, was found to destabilize the protein’s DNA‑binding domain and was associated with increased tumorigenicity in the A549 lung cancer cell line.",-29.125,0.6,sequencevariant
"A p.E300X sequence variant in the TP53 gene, together with the GGC repeat expansion in intron IVS9+459, was found to disrupt p53 protein stability and enhance susceptibility to early‑onset colorectal cancer in a cohort of Homo sapiens patients.",-37.75,0.6,sequencevariant
"Heterozygous p.E300X and S482X variants in the LRRK2 gene, each causing premature stop codons at residues E300 and S482, were identified in a Parkinson’s disease patient, while an ACG→AAG substitution at codon‑420 was found in a healthy control, illustrating how distinct sequence variants can differentially influence disease susceptibility.",-61.5,0.6,sequencevariant
"Homo sapiens carrying the BRCA1 c.1021T>A (p.E300X) variant exhibit increased genomic instability, while the same allele’s IVS9+459GG intronic change correlates with altered splicing efficiency in breast epithelial cell lines such as MCF‑7.",-48.0,0.6,sequencevariant
"HepG2 cells harboring the BRCA1 p.E300X sequence variant exhibit markedly reduced RAD51 foci formation, indicating impaired homologous recombination repair.",-23.0,0.6,sequencevariant
HGG‑cell line A549 exposed to the sequence variant p.E300X in the TP53 gene exhibited a marked increase in apoptosis compared with the wild‑type A549 cells.,-42.0,0.6,sequencevariant
"Arginine‑to‑proline substitution at codon‑150 in the TP53 gene (p.R150P) was identified in a sporadic breast cancer sample, while a proline‑to‑arginine change at position‑484 (p.P484R) in the BRCA1 protein was found to disrupt its DNA‑binding domain, and the novel c.−1021T>G promoter variant was shown to reduce transcriptional activity in cultured HeLa cells.",-70.0,0.6,sequencevariant
"Arginyl‑glycyl‑proline at position‑150, a GGC repeat expansion, and the ACG→AAG substitution in codon‑420 of the TP53 gene collectively contribute to the destabilization of the protein structure in patients harboring the p.E300X mutation.",-58.25,0.6,sequencevariant
"Arg199Pro in the TP53 gene (c.598G>C) was identified in a subset of early‑stage colorectal cancer patients, and its presence was associated with increased p53 protein instability and a higher likelihood of developing metastatic disease.",-55.25,0.6,sequencevariant
"Arg‑150Pro and Pro‑484Arg mutations in the TP53 gene, coupled with the -1021T variant in its promoter, have been shown to disrupt p53’s DNA‑binding domain, leading to loss of tumor‑suppressive activity in human cancer cell lines.",-47.5,0.6,sequencevariant
"Mutation of the TP53 gene from alanine to valine at position‑88 (p.Ala88Val) in the A549 cell line was shown to increase resistance to doxorubicin and to alter the expression of the pro‑apoptotic gene BAX, while the concurrent sequence variant p.E300X in the same transcript was associated with a loss of DNA‑binding capacity.",-58.75,0.6,sequencevariant
"Mutation c.449G>A, resulting in the p.Arg150Pro substitution in the TP53 protein, was identified in a cohort of Homo sapiens patients with a severe form of neurofibromatosis type I.",-40.5,0.6,sequencevariant
"Mutation p.Arg150Pro in the TP53 gene, identified in a homozygous state in a patient with Li–Fraumeni syndrome, disrupts the DNA‑binding domain and correlates with increased tumor susceptibility.",-26.75,0.6,sequencevariant
"Mutation ACG→AAG in codon‑420 of the CFTR gene, together with the p.E300X nonsense change and the GGC repeat expansion, was shown to disrupt chloride channel trafficking in the CFTR‑deficient HeLa cell line.",-46.75,0.6,sequencevariant
"Sequence analysis of a colorectal carcinoma sample revealed a novel BRCA1 sequence variant, c.1021T>A, resulting in a p.E300X premature stop codon that truncates the protein and a separate intronic alteration, IVS9+459GG, which may disrupt splicing of the adjacent exon.",-39.5,0.6,sequencevariant
"Sequence variant c.451G>A in the TP53 gene, which changes arginine to proline at position&nbsp;150, is associated with increased risk of early‑onset breast cancer in a cohort of Homo sapiens patients.",-49.5,0.6,sequencevariant
"Sequence analyses of a breast cancer patient revealed a BRCA1 c.1021T>A variant that generates a p.E300X premature stop codon, while a second allele carried an IVS9+459GG intronic substitution linked to aberrant splicing.",-42.75,0.6,sequencevariant
"Sequence variants such as the p.Arg150Pro mutation, the IVS9+459GG intronic change, and the ACG> AAG substitution at codon‑420 collectively disrupt the normal splicing and protein‑folding of the CFTR gene, thereby impairing chloride transport in airway epithelia of cystic fibrosis patients.",-49.25,0.6,sequencevariant
"CRISPR‑mediated editing of the TP53 gene in H1299 cells introduced a sequence variant p.E300X, which caused a premature stop codon at amino‑acid position Y245X and led to loss of p53‑dependent transcriptional activation of the CDKN1A promoter.",-40.5,0.6,sequencevariant
"CRLF2 exon‑2 c.450_452delAAG, a sequence variant that replaces alanine with valine at position p.88, was identified in a patient with B‑cell acute lymphoblastic leukemia and is predicted to disrupt the protein’s dimerization interface.",-59.0,0.6,sequencevariant
"CR2 c.450_452delAGA (p.Arg150Pro) in the complement receptor gene was found to co‑occur with a pathogenic IVS9+459GG splice‑site variant in the same patient, suggesting a compound heterozygous effect on complement regulation.",-52.0,0.6,sequencevariant
"CRIM1 p.Arg150Pro mutation in a patient with congenital hearing loss was found to disrupt protein folding and reduce receptor expression in the inner ear, while a second variant, c.1285_1287delTGC (p.Gly429del), was associated with a more severe phenotype in the same family.",-74.5,0.6,sequencevariant
"Altered transcription of the tumor suppressor gene TP53 in HeLa cells harboring the sequence variant c.150_151delAG, which replaces arginine with proline at position‑150, leads to a premature Y245X truncation that impairs DNA damage response and promotes oncogenic transformation.",-58.0,0.6,sequencevariant
"Alteration of the BRCA1 sequence variant p.E300X, a nonsense mutation at codon‑300, was shown to disrupt the DNA repair complex in A549 cells, leading to increased sensitivity to the chemotherapeutic agent doxorubicin.",-38.75,0.6,sequencevariant
"Alterations such as the p.Arg150Pro substitution, the IVS9+459GG intronic variant, and the GGC repeat expansion in the FMR1 gene collectively contribute to the fragile X syndrome phenotype.",-29.125,0.6,sequencevariant
Altering the arginine at position‑150 to proline in the TP53 protein (p.R150P) destabilizes the DNA‑binding domain and increases the risk of early‑onset colorectal cancer in patients carrying the IVS9+459GG intronic variant.,-44.25,0.6,sequencevariant
"Research on the TP53 sequence variant p.E300X revealed that the nonsense mutation at codon‑300 leads to truncated p53 protein lacking the C‑terminal regulatory domain, thereby impairing apoptosis in HeLa cells treated with doxorubicin.",-39.75,0.6,sequencevariant
"Research using CRISPR/Cas9 editing of the TP53 gene in A549 cells revealed that the sequence variant p.E300X, located in exon three, led to a truncated protein that lost its ability to bind the MDM2 promoter, thereby reducing p53-mediated apoptosis and enhancing cellular proliferation.",-60.25,0.6,sequencevariant
"Research in the HCC cell line HepG2 revealed that the sequence variant p.Arg150Pro in the TP53 gene, combined with the IVS9+459GG intronic polymorphism, markedly enhances the expression of the pro‑apoptotic protein PUMA and increases sensitivity to the chemotherapeutic agent doxorubicin.",-45.0,0.6,sequencevariant
"Research combining CRISPR/Cas9 editing of the TP53 gene with a HeLa cell line revealed that the p.E300X sequence variant causes loss of function, leading to increased cellular proliferation and resistance to doxorubicin treatment.",-41.25,0.6,sequencevariant
"An alanine to valine substitution at position p.A88V in the BRCA1 gene, combined with the GGC repeat expansion at intron IVS9+459, has been shown to increase the risk of breast cancer in patients carrying the -1021T polymorphism.",-45.25,0.6,sequencevariant
"An engineered A549 cell line harboring the BRCA1 p.E300X sequence variant, which introduces a premature stop codon at codon E300, was shown to exhibit reduced homologous recombination repair activity and increased sensitivity to the DNA‑damaging agent doxorubicin.",-39.5,0.6,sequencevariant
"An A549 cell line harboring the BRCA1 p.E300X sequence variant exhibited markedly reduced RAD51 foci formation after doxorubicin exposure, indicating impaired homologous recombination repair.",-21.5,0.6,sequencevariant
An ERBB2 c.487G>A (p.Arg150Pro) variant detected in a breast cancer patient’s tumor sample from a HeLa-derived xenograft model was shown to enhance HER2 phosphorylation and confer resistance to trastuzumab therapy.,-53.75,0.6,sequencevariant
"Mutations such as the arginine‑to‑proline substitution at position‑150, the proline‑to‑arginine change at residue‑484, the −1021T allele, the p.E300X nonsense mutation, the S482X variant, the alanine‑to‑valine alteration at codon‑88, the GGC repeat expansion, the Y245X truncation, the ACG→AAG substitution in codon‑420, and the IVS9+459 GG",-39.0,0.6,sequencevariant
"Mutational analysis of the CFTR gene in cystic fibrosis patients revealed a novel sequence variant, c.1409G>A, resulting in the p.Arg470His substitution, which, together with the previously reported c.1525_1528delGGTG deletion, correlates with severe pancreatic insufficiency and a higher frequency of respiratory exacerbations.",-62.75,0.6,sequencevariant
"Mutating the TP53 gene to the p.E300X sequence variant in H1299 cells results in loss of p53 transcriptional activity and enhances cell proliferation, whereas correcting the ACG → AAG substitution at codon‑420 in the same locus restores p53‑mediated apoptosis.",-53.5,0.6,sequencevariant
"Mutagenic exposure to the compound cisplatin induces the sequence variant BRCA1 p.E300X, which replaces glutamic acid with a premature stop codon at position three hundred and thereby disrupts the DNA repair function of the BRCA1 protein in the human breast epithelial cell line MCF‑7.",-52.75,0.6,sequencevariant
"In the A549 cell line, a c.609+28_610-16del sequence variant in the TP53 gene was shown to increase the risk of apoptosis by disrupting the splicing of exon six, thereby reducing the functional protein level and enhancing sensitivity to doxorubicin.",-43.0,0.6,sequencevariant
"In Huh7 cells, the BRCA1 c.68_69delAG sequence variant disrupts the tyrosine codon at amino acid position‑67, creating a premature stop that impairs homologous recombination repair.",-29.75,0.6,sequencevariant
"In hepatocellular carcinoma cells, the BRCA1 c.68_69delAG sequence variant leads to a loss of the tyrosine codon at amino acid position‑67, producing a premature stop that disrupts DNA repair and enhances tumor aggressiveness.",-36.75,0.6,sequencevariant
"In A549 cells, the rs2271683 variant, which replaces the tyrosine codon at amino acid position‑67 with a stop codon, dramatically reduces EGFR protein stability, thereby sensitizing the cells to erlotinib treatment.",-35.5,0.6,sequencevariant
"The CRISPR-Cas9 editing of the TP53 gene in HCT116 cells introduced a c.609+28_610-16del sequence variant that truncates the protein at the tyrosine codon, mirroring the pathogenic effect seen in patients carrying the rs2271683 allele.",-30.375,0.6,sequencevariant
"The BRCA1 c.68_69delAG sequence variant, which converts the tyrosine codon at amino acid position‑67 into a premature stop codon, was found to increase the risk of triple‑negative breast cancer in a cohort of European descent patients.",-33.5,0.6,sequencevariant
"The observed M244A mutation, a sequence variant that changes the tyrosine codon at amino acid position‑67 into a premature stop codon, was found to significantly alter the transcriptional activity of the TP53 gene in HeLa cells.",-40.75,0.6,sequencevariant
"The NCBI ClinVar entry for the BRCA1 sequence variant c.609+28_610-16del shows that the deletion removes a splice site, leading to exon skipping and a truncated protein that is predicted to abolish DNA‑repair function.",-39.0,0.6,sequencevariant
"Cell lines such as HeLa were transfected with a plasmid encoding TP53 harboring the BRCA1 c.68_69delAG sequence variant, which caused a premature stop at the tyrosine codon at amino acid position‑67 and led to loss of p53‑mediated apoptosis in these cells.",-46.0,0.6,sequencevariant
"Cell line A549 harboring the sequence variant rs2271683, a c.609+28_610-16del deletion in the TP53 intron, exhibited increased apoptosis when treated with the chemical entity doxorubicin.",-28.0,0.6,sequencevariant
"Cell‑line A549 harboring the sequence variant rs2271683, which changes the tyrosine codon at amino‑acid position‑67 to a stop codon, shows markedly reduced expression of the TP53 gene product and increased sensitivity to the chemotherapeutic chemical doxorubicin.",-38.5,0.6,sequencevariant
"Cell-based assays revealed that the BRCA1 SequenceVariant rs2271683, a c.609+28_610-16del deletion within the intron, reduces RAD51 recruitment and sensitizes the MCF-7 CellLine to PARP inhibitor olaparib.",-39.5,0.6,sequencevariant
"Mutation [c.609+28_610-16del] in the BRCA1 intron was found to disrupt splicing, thereby increasing the risk of breast cancer in a cohort of patients carrying the rs2271683 allele.",-37.5,0.6,sequencevariant
"Mutation rs2271683, a sequence variant altering the tyrosine codon at amino acid position **67** into a stop codon, was found to disrupt the normal function of the **TP53** protein in a subset of **Homo sapiens** tumor samples.",-36.5,0.6,sequencevariant
"Mutation of the TP53 gene (c.244T>A) in the HeLa cell line causes a tyrosine codon at amino acid position‑67 to become a stop codon, leading to loss of p53 protein function and increased cellular proliferation.",-43.75,0.6,sequencevariant
"Mutation analysis revealed that the rs2271683 polymorphism in the CYP2D6 gene, a c.609+28_610-16del sequence variant, is associated with the Val158Met substitution in the COMT enzyme and results in altered drug metabolism in Homo sapiens subjects.",-44.5,0.6,sequencevariant
"Alteration of the rs2271683 polymorphism, a c.609+28_610-16del sequence variant in the CYP2D6 gene, has been linked to a reduced metabolic clearance of the chemotherapeutic agent doxorubicin in patients with a C262A genotype, thereby increasing the risk of cardiotoxicity.",-41.75,0.6,sequencevariant
Alterations such as the rs2271683 polymorphism and the c.609+28_610-16del sequence variant in the CYP2C9 gene have been linked to reduced metabolism of warfarin in patients carrying the Val158Met allele.,-29.375,0.6,sequencevariant
"Altered expression of the CYP2D6 gene in HeLa cells harboring the Val158Met sequence variant (c.472T>C) leads to reduced metabolism of the antidepressant fluoxetine, thereby increasing the risk of serotonin syndrome in patients with the rs2271683 polymorphism.",-34.25,0.6,sequencevariant
"Altering the tyrosine codon at amino acid position **67** into a stop codon in the *TP53* gene (c.200T>TAG) has been shown to abolish p53’s transcriptional activity, thereby increasing susceptibility to *Homo sapiens* colorectal carcinoma.",-48.0,0.6,sequencevariant
"A synonymous c.609+28_610-16del variant in the BRCA1 intron, which alters splicing efficiency, has been found to increase the risk of breast cancer in carriers of the rs2271683 allele.",-33.75,0.6,sequencevariant
"A missense SequenceVariant, c.609+28_610-16del, was identified in the TP53 GeneOrGeneProduct of a HeLa CellLine and is predicted to alter the splicing of exon three, potentially contributing to the observed increase in apoptotic activity in E. coli OrganismTaxon cultures treated with doxorubicin ChemicalEntity.",-46.5,0.6,sequencevariant
"A pathogenic sequence variant, rs2271683, introduces a premature stop codon at the tyrosine codon in the A at position –1082 of the gene, and the resulting truncated protein disrupts the normal interaction between the TP53 gene product and the ETV6 transcription factor in HeLa cells, leading to increased apoptosis and impaired cell cycle regulation.",-55.25,0.6,sequencevariant
"A variant in the TP53 gene, c.229G>T (p.Arg77Cys), was found to disrupt the DNA-binding domain in HeLa cells, leading to impaired p53-mediated apoptosis and increased resistance to doxorubicin treatment.",-40.0,0.6,sequencevariant
"Sequencing of the TP53 gene in HeLa cells revealed a novel sequence variant, c.609+28_610-16del, which co‑occurs with the rs2271683 SNP and results in a tyrosine codon at amino acid position‑67 being converted into a premature stop codon, thereby potentially disrupting the DNA‑binding domain of the tumor suppressor protein.",-44.25,0.6,sequencevariant
"Sequenced cDNA from the HCT116 cell line revealed a novel BRCA1 sequence variant, c.609+28_610-16del, which disrupts splicing and results in loss of exon inclusion, thereby producing a truncated protein that is predicted to impair DNA repair and increase tumorigenicity.",-54.5,0.6,sequencevariant
"Sequench variant rs2271683, a c.609+28_610-16del mutation in the promoter region of the CYP2D6 gene, was found to alter transcriptional activity in HepG2 cells, potentially affecting the pharmacokinetics of the antiepileptic drug carbamazepine.",-44.75,0.6,sequencevariant
"Sequational analysis of the BRCA1 variant rs2271683 revealed that the c.609+28_610-16del deletion in the intronic region adjacent to exon‑3 is predicted to alter splicing, potentially leading to a truncated protein with an Ala7Val substitution that may disrupt DNA repair pathways in Homo sapiens cells.",-75.0,0.6,sequencevariant
"Cytosine at position –1082 of the TP53 promoter, the rs2271683 variant, and the c.609+28_610-16del splice‐site deletion together impair p53 transcription and predispose A549 cells to increased sensitivity to doxorubicin.",-39.75,0.6,sequencevariant
"C262, a sequence variant that replaces the tyrosine codon at amino acid position‑67 with a stop codon, was found to disrupt the transcription factor binding site for the transcriptional repressor NFKB1, thereby enhancing the expression of the oncogene MYC in HeLa cells.",-50.75,0.6,sequencevariant
"C2C12 myoblasts expressing the BRCA1 c.68_69delAG sequence variant exhibited increased DNA damage response and heightened sensitivity to the chemotherapeutic agent doxorubicin, thereby revealing a potential therapeutic vulnerability in this genetic context.",-38.25,0.6,sequencevariant
"Caco-2 cells harboring the BRCA1 c.609+28_610-16del sequence variant exhibit markedly reduced RAD51 foci formation after irradiation, suggesting a compromised homologous recombination repair pathway.",-27.375,0.6,sequencevariant
"Mitochondrial DNA sequence variant M244, a c.609+28_610-16del deletion in the D-loop, has been associated with impaired oxidative phosphorylation in HeLa cells, whereas the rs2271683 polymorphism in the POLG promoter, characterized by an A at position –1082, correlates with increased ROS production in A549 cells, and the (TAC > AA) substitution at codon‑329 of the POLG gene, resulting in an Ala7Val change",-75.5,0.6,sequencevariant
"M244 and rs2271683, a sequence variant causing a tyrosine codon at amino acid position‑67 to be replaced by a stop codon, were identified in the TP53 gene of a HeLa cell line, where the c.609+28_610-16del deletion in intron‑2 of the gene was predicted to alter splicing and potentially disrupt the DNA‑binding domain.",-60.0,0.6,sequencevariant
"Molecular analysis of the BRCA1 sequence variant rs2271683 revealed that the substitution of a tyrosine codon at amino acid position‑67 into a premature stop codon, together with the c.609+28_610-16del intronic deletion, likely disrupts homologous recombination repair in the A549 cell line, thereby increasing sensitivity to cisplatin in Homo sapiens cells.",-59.25,0.6,sequencevariant
"Müller‑Hinton cells carrying the BRCA1 c.68_69delAG sequence variant showed a markedly reduced homologous recombination repair activity, while the same cells treated with doxorubicin exhibited increased γ‑H2AX foci, indicating heightened DNA damage signaling.",-51.5,0.6,sequencevariant
"Impaired neurogenesis in the hippocampus of A549 cells carrying the sequence variant rs2271683, which substitutes a tyrosine codon at amino acid position‑67 with a premature stop codon, was rescued by treatment with the chemical entity valproic acid.",-40.0,0.6,sequencevariant
"Immunohistochemical analysis of a HeLa cell line transfected with a TP53 c.609+28_610-16del variant revealed that the novel sequence variant, which introduces a tyrosine codon at amino acid position‑67 into a stop codon, markedly increased p53‑mediated transcription of the cyclin‑dependent kinase inhibitor CDKN1A compared with the wild‑type TP53 sequence.",-64.5,0.6,sequencevariant
"Impairment of the NLRP3 inflammasome pathway in A549 cells harboring the c.609+28_610-16del sequence variant was exacerbated by the tyrosine codon at amino acid position‑67 mutation, which introduced a premature stop codon and led to increased IL‑1β secretion.",-53.25,0.6,sequencevariant
"Improvements in the treatment of Parkinson’s disease were observed when a CRISPR‑edited SHSY‑5Y cell line carried the BRCA1 c.68_69delAG sequence variant, which reduced the expression of the TP53 gene and increased the cellular uptake of the small‑molecule drug doxorubicin.",-52.5,0.6,sequencevariant
Mutations such as the c.609+28_610-16del splice variant and the Ala7Val (2623G>T) sequence change in the BCL2 gene are associated with altered apoptosis in HCT116 cells.,-34.25,0.6,sequencevariant
"Mutational analysis of the CYP2D6 gene in a cohort of patients revealed that the rs2271683 polymorphism, which changes the tyrosine codon at amino acid position‑67 into a stop codon, is associated with reduced enzymatic activity and poorer response to codeine therapy.",-44.0,0.6,sequencevariant
"Mutagenic exposure to benzo[a]pyrene induced the sequence variant c.609+28_610-16del in the TP53 gene, which in turn caused a loss of the tyrosine codon at amino acid position A at position -1082, abolishing the protein's DNA‑binding domain in A549 cells.",-49.5,0.6,sequencevariant
Mutated sequence variant c.609+28_610-16del in the TP53 gene was found to disrupt splicing and increase the risk of colorectal cancer in a cohort of Homo sapiens patients carrying the rs2271683 polymorphism.,-32.25,0.6,sequencevariant
"Heterozygous rs2271683 in the COMT gene, which results in the Val158Met amino acid substitution, has been shown to alter dopamine metabolism and is associated with increased susceptibility to Parkinson’s disease in a cohort of A549 cell‑line‑derived neuroblastoma models.",-37.25,0.6,sequencevariant
"Homo sapiens carrying the rs2271683 sequence variant, which introduces a tyrosine codon at amino acid position‑67 into a stop codon, exhibit reduced expression of the TP53 gene product compared with individuals with the wild‑type allele.",-35.75,0.6,sequencevariant
"HepG2 cells harboring the BRCA1 c.68_69delAG variant exhibit increased sensitivity to doxorubicin, while the TP53 c.215C>G (p.Arg72Pro) sequence variant attenuates the apoptotic response to the same drug.",-35.0,0.6,sequencevariant
"Hearing loss in patients carrying the rs2271683 variant, which replaces the tyrosine codon at amino acid position‑67 with a premature stop codon, is markedly exacerbated by the co‑occurrence of the c.609+28_610‑16del sequence variant in the same gene.",-47.25,0.6,sequencevariant
"Altering the tyrosine codon at amino acid position‑67 into a stop codon in the TP53 gene (c.191T>A, rs2271683) induces a sequence variant that destabilizes the p53 protein, thereby increasing the risk of developing high‑grade glioblastoma in Homo sapiens.",-48.0,0.6,sequencevariant
"Alzheimer’s disease risk is increased in carriers of the rs2271683 variant, which introduces a premature stop codon at the tyrosine codon in amino acid position‑67 of the APP gene, as confirmed by sequencing of the c.609+28_610‑16del region in a cohort of sporadic patients.",-47.75,0.6,sequencevariant
"Alveolar macrophages from a patient carrying the BRCA1 c.68_69delAG sequence variant exhibited a markedly increased expression of the pro‑inflammatory cytokine IL‑6, suggesting that this pathogenic mutation may contribute to the heightened inflammatory phenotype observed in breast cancer microenvironments.",-42.75,0.6,sequencevariant
"Alpine mice harboring the M244 sequence variant, specifically the c.609+28_610-16del splice‑site deletion, exhibit a pronounced reduction in CYP1A1 expression, correlating with increased sensitivity to the carcinogen benzo[a]pyrene.",-46.75,0.6,sequencevariant
"Acute lymphoblastic leukemia cells derived from a patient with the M244 sequence variant, which replaces the tyrosine codon at amino acid position‑67 with a stop codon, exhibit markedly reduced expression of the downstream transcription factor MYC and impaired proliferation compared with wild‑type cells.",-54.0,0.6,sequencevariant
"Acquisition of the BRCA1 c.68_69delAG sequence variant in the HeLa cell line, coupled with the rs2271683 single-nucleotide polymorphism in TP53, has been shown to enhance cellular sensitivity to the DNA‑damaging agent doxorubicin while simultaneously reducing the expression of the anti‑apoptotic protein BCL‑2.",-47.0,0.6,sequencevariant
"Acetaminophen (paracetamol) treatment in HepG2 cells carrying the BRCA1 c.68_69delAG sequence variant (rs2271683) led to a marked increase in oxidative stress markers and a reduction in cell viability compared with wild‑type HepG2 cells, suggesting a genotype‑dependent susceptibility to drug‑induced hepatotoxicity.",-52.5,0.6,sequencevariant
"Acquiring the BRCA1 c.68_69delAG sequence variant in the MCF‑7 cell line (CellLine) leads to loss of the tyrosine codon at amino acid position‑67, a mutation that disrupts the DNA repair pathway and predisposes the cells to genomic instability (SequenceVariant).",-55.75,0.6,sequencevariant
"The A549 cell line harboring the rs2488457 GGC‑repeat expansion exhibited a markedly reduced expression of the TP53 gene, suggesting that this sequence variant may disrupt the transcriptional regulation of the tumor suppressor.",-32.75,0.6,sequencevariant
"The BRCA1 rs2488457 variant, a single nucleotide polymorphism at c.68_69delAG, has been shown to alter DNA repair fidelity in breast cancer cell lines such as MCF‑7, thereby increasing sensitivity to platinum‑based chemotherapies.",-33.5,0.6,sequencevariant
"The rs2488457 variant in the CYP2D6 promoter, a GGC repeat expansion, was shown to alter drug metabolism in a cohort of *Homo sapiens* patients, while a nearby E873stop/A467T mutation in the *TP53* gene was associated with increased tumor aggressiveness in *Homo sapiens* cell lines.",-48.0,0.6,sequencevariant
"The heterozygous rs2488457 variant, which introduces a GGC repeat expansion and a glycine substitution at amino acid position S555, was found to increase the risk of developing severe fibrosis in patients with the E873stop/A467T sequence variant.",-46.75,0.6,sequencevariant
"Clinical assessment revealed that the rs2488457 polymorphism in the CYP1A2 gene, combined with the E873stop/A467T variant in the ABCB1 transporter, significantly increased the risk of drug-induced hepatotoxicity in patients receiving the chemotherapeutic agent doxorubicin.",-42.5,0.6,sequencevariant
"Clinical data revealed that the rs2488457 variant in the MTHFR gene, together with the E873stop/A467T compound mutation in the CYP2D6 locus, were associated with a markedly increased risk of developing severe drug‑induced liver injury in patients treated with the antipsychotic clozapine.",-50.0,0.6,sequencevariant
"Clinical sequencing of the CYP1A1 gene in a cohort of smokers revealed that the rs3818247 polymorphism, a GGC repeat expansion, is significantly associated with increased expression of the E873stop/A467T variant, while the adjacent rs2488457 SNP appears to modulate the penetrance of the pathogenic arginine‑to‑glycine substitution at amino‑acid position‑229, suggesting a complex interaction between these sequence variants that may influence individual susceptibility to tobacco‑induced lung carcinogenesis.",-87.0,0.6,sequencevariant
"Clinical evaluation of a colorectal cancer cohort revealed that the rs2488457 SNP, located within the promoter of the MTHFR gene, was significantly associated with the E873stop/A467T sequence variant, while the rs3818247 polymorphism appeared to influence the presence of a five‑nucleotide deletion at the arginine‑229‑glycine substitution site.",-66.0,0.6,sequencevariant
"Patients carrying the rs2488457 variant in the FGF receptor‑4 gene exhibited a significantly higher incidence of preterm pulmonary alveolar disease, while those with the E873stop/A467T compound mutation in the BRCA1 gene displayed a markedly increased risk of breast cancer progression.",-46.75,0.6,sequencevariant
"Patients harboring the rs2488457 variant of the CYP2C9 gene exhibit a markedly reduced capacity to metabolize warfarin, leading to prolonged INR elevation and an increased risk of hemorrhagic complications.",-29.875,0.6,sequencevariant
"Patients implanted with a CRISPR‑edited A549 cell line harboring the rs2488457 SNP and a concurrent E873stop/A467T mutation displayed a pronounced reduction in EGFR signaling, confirming the deleterious impact of this sequence variant on receptor activation.",-49.0,0.6,sequencevariant
"Patients with the rs2488457 variant of the CYP2C19 gene exhibit markedly reduced metabolism of clopidogrel, leading to increased platelet aggregation and a higher risk of stent thrombosis.",-27.875,0.6,sequencevariant
"A missense sequence variant, rs3818247, located in the promoter of the CYP2D6 gene, was found to alter the binding affinity of nuclear factor‑κB, thereby reducing CYP2D6 expression and increasing the risk of drug‑induced hepatotoxicity in patients receiving the antiepileptic drug valproic acid.",-42.0,0.6,sequencevariant
"A pathogenic sequence variant, the rs2488457 single‑nucleotide polymorphism, was found to increase the risk of coronary artery disease in a cohort of Homo sapiens individuals carrying the E873stop/A467T mutation in the KCNQ1 gene.",-33.0,0.6,sequencevariant
"A recent study found that the rs2488457 variant in the CYP2C19 gene, coupled with a rare E873stop/A467T mutation in the GATA3 gene, increases the risk of drug‑induced QT prolongation in patients treated with the anti‑arrhythmic agent dofetilide.",-51.5,0.6,sequencevariant
"A CRISPR‑edited A549 cell line harboring the rs2488457 variant in the promoter of the CYP2D6 gene showed markedly increased expression of the enzyme, which in turn accelerated the metabolism of the chemotherapeutic agent doxorubicin and reduced its cytotoxicity in vitro.",-37.75,0.6,sequencevariant
"In A549 cells, the rs2488457 variant in the promoter region of the CYP2D6 gene enhances transcriptional activity, thereby increasing the metabolic conversion of doxorubicin into its active metabolite and amplifying the cytotoxic response in these lung carcinoma cells.",-34.0,0.6,sequencevariant
"In patients carrying the rs2488457 polymorphism, the substitution of arginine by glycine at amino‑acid position ‑229 in the TP53 protein was associated with increased susceptibility to breast cancer.",-40.5,0.6,sequencevariant
"In HeLa cells, the rs2488457 variant in the IL6R gene was shown to increase the expression of the receptor, thereby enhancing the downstream JAK/STAT signaling pathway and promoting resistance to the chemotherapeutic agent doxorubicin.",-35.0,0.6,sequencevariant
"In the A549 cell line, the rs2488457 single‑nucleotide polymorphism in the promoter of the CYP2D6 gene was associated with a reduced expression of the enzyme, which in turn led to increased intracellular accumulation of the chemotherapeutic agent doxorubicin and heightened cytotoxicity in the presence of the E873stop/A467T variant of the TP53 gene.",-37.75,0.6,sequencevariant
"Mutations such as the rs2488457 SNP and the E873stop/A467T substitution in the TP53 gene, which introduce a glycine at position Arg229 and a premature stop at residue S555, have been associated with increased risk of early‑onset breast cancer in individuals carrying the GGC repeat expansion.",-60.0,0.6,sequencevariant
"Mutational analysis of the BRCA1 c.68_69delAG variant revealed that the rs2488457 SNP in the promoter region, together with the E873stop/A467T substitution, significantly increased the likelihood of triple‑negative breast cancer in patients carrying the GGC repeat expansion at the S555 locus.",-46.0,0.6,sequencevariant
"Mutagenic exposure to benzo[a]pyrene induced a GGC repeat expansion and a five‑nucleotide deletion at the TP53 locus, resulting in an arginine‑to‑glycine substitution at position‑229 and the E873stop/A467T variant, which together with the rs2488457 polymorphism were associated with increased tumorigenicity in HCT116 cells.",-63.0,0.6,sequencevariant
"Mutated sequence variants such as rs2488457 and the E873stop/A467T substitution were shown to alter TP53 protein stability, while a glycine substitution at position arginine‑229 and a GGC repeat expansion in the promoter of BRCA1 were associated with increased susceptibility to breast cancer in Homo sapiens.",-70.5,0.6,sequencevariant
"RS2488457, a single‑nucleotide polymorphism in the promoter region of the CYP1A1 gene, was shown to increase susceptibility to lung cancer in A549 cells exposed to benzo[a]pyrene, whereas the E873stop/A467T dual variant in the TP53 gene was associated with enhanced apoptosis in HeLa cells treated with doxorubicin.",-47.5,0.6,sequencevariant
"RS3818247, a single nucleotide polymorphism located in the promoter of the CYP2C9 gene, has been associated with altered enzyme activity in patients with the E873stop/A467T sequence variant, while a separate study reported that the rs2488457 variant in the APOE locus increases susceptibility to Alzheimer’s disease in carriers of the rs1805054 allele.",-68.5,0.6,sequencevariant
"RS3763, a novel sequence variant comprising a GGC repeat expansion at codon S555, was shown to disrupt the splicing of the TP53 gene in a subset of A549 cell lines, thereby impairing p53-mediated apoptosis in response to doxorubicin treatment.",-60.25,0.6,sequencevariant
"RS1817845, a missense variant that substitutes glycine for arginine at position‑229 of the TP53 protein, was found to increase the risk of breast cancer in a cohort of Homo sapiens patients, whereas the novel E873stop/A467T mutation in the BRCA1 gene was associated with a markedly reduced DNA repair capacity in A549 cells.",-77.0,0.6,sequencevariant
Genetic analysis revealed that the rs2488457 polymorphism and the E873stop/A467T variant together increase the risk of developing severe fibrosis in patients carrying the GGC repeat expansion.,-32.25,0.6,sequencevariant
"Genotype‑specific studies show that the rs2488457 polymorphism, together with the E873stop/A467T mutation in the GGC repeat region, significantly alters the binding affinity of the transcription factor at amino acid position S555, thereby modulating the expression of the disease‑associated protein encoded by the gene.",-54.25,0.6,sequencevariant
"Genomic analysis revealed that the rs2488457 polymorphism in the CYP2C9 gene, together with the E873stop/A467T missense mutation, markedly increased the risk of severe drug-induced hepatotoxicity in patients treated with the antiepileptic drug phenobarbital.",-42.0,0.6,sequencevariant
Genotypic analysis of the rs2488457 polymorphism revealed that the presence of the GGC repeat expansion at the promoter of the CYP2D6 gene was associated with a significantly higher risk of drug-induced hepatotoxicity in patients receiving the chemotherapeutic agent doxorubicin.,-45.75,0.6,sequencevariant
"Investigating the rs2488457 SNP, researchers observed that the A allele at position rs3818247 increases the risk of hypertension, while the GGC repeat expansion in the promoter of the same locus correlates with elevated expression of the angiotensin‑converting enzyme in human endothelial cells.",-59.75,0.6,sequencevariant
"Investigations revealed that the rs2488457 polymorphism, a GGC repeat expansion in the promoter of the CYP2B6 gene, is associated with altered expression of the enzyme, while a separate study identified a pathogenic E873stop/A467T variant in the BRCA2 gene that leads to a truncated protein and increased breast cancer risk.",-53.75,0.6,sequencevariant
"Investigators discovered that the rs2488457 variant, which introduces a GGC repeat expansion at the promoter of CYP2D6, significantly increases the risk of poor tamoxifen metabolism in patients carrying the E873stop/A467T double mutation in the ESR1 gene.",-46.25,0.6,sequencevariant
"Investigative sequencing of a breast carcinoma cohort revealed that the rs2488457 variant, located in the promoter of the CYP1A1 gene, co‑occurs with a compound heterozygous alteration comprising a GGC repeat expansion and a missense mutation converting arginine to glycine at amino‑acid position‑229, and these combined sequence variants are strongly associated with elevated aromatase activity and increased risk of estrogen‑driven tumor progression.",-82.5,0.6,sequencevariant
Heterozygous rs2488457 in the FGF receptor gene and the E873stop/A467T mutation in the TP53 gene together with a GGC repeat expansion at position S555 were found to confer increased susceptibility to colorectal cancer in a cohort of Homo sapiens patients.,-49.75,0.6,sequencevariant
"Homo sapiens carrying the rs2488457 polymorphism exhibit increased expression of the TP53 gene, while the E873stop/A467T mutation in the BRCA1 sequence variant leads to a truncated protein that impairs DNA repair and contributes to breast cancer susceptibility.",-32.25,0.6,sequencevariant
"Haplotype analysis revealed that the rs2488457 single‑nucleotide polymorphism, together with a GGC repeat expansion and the E873stop/A467T dual mutation, conferred a markedly increased risk for neurodegenerative disease in a cohort of patients carrying the S555 missense variant.",-51.75,0.6,sequencevariant
"HepG2 cells harboring the rs2488457 polymorphism exhibit markedly reduced TP53 expression, suggesting that this sequence variant may contribute to oncogenic progression.",-35.0,0.6,sequencevariant
"E873stop/A467T in the KMT2D gene was associated with increased risk of neuroblastoma in patients carrying the rs2488457 allele, suggesting that the arginine-to-glycine substitution at amino acid position **229** may disrupt the protein’s regulatory domain.",-59.25,0.6,sequencevariant
Erythrocyte membrane protein A1 (GATA1) with the rs2488457 polymorphism and a pathogenic E873stop/A467T sequence variant in the HBB gene are associated with a severe reduction in hemoglobin synthesis and a markedly increased risk of hereditary spherocytosis in patients of African descent.,-62.0,0.6,sequencevariant
"Ectopic expression of the E873stop/A467T variant in the A549 cell line, which harbors a pathogenic rs2488457 sequence variant, results in a loss of TP53 transcriptional activity and promotes resistance to doxorubicin through up‑regulation of the MDR1 gene.",-48.25,0.6,sequencevariant
"Epithelial cells harboring the rs2488457 variant in the FGF receptor gene exhibit aberrant activation of MAPK signaling, which may contribute to the increased susceptibility to basal cell carcinoma in patients with a history of UV exposure.",-56.25,0.6,sequencevariant
"Mutation of rs2488457 in the promoter of the CYP2D6 gene, coupled with a GGC repeat expansion, was found to reduce drug‑metabolizing enzyme activity and increase the risk of severe adverse reactions to the antipsychotic clozapine in patients with schizophrenia.",-45.0,0.6,sequencevariant
"Mutation rs2488457 in the promoter region of the CYP1A1 gene, together with the E873stop/A467T missense alteration in the coding sequence, has been associated with increased susceptibility to hepatocellular carcinoma in individuals carrying the GGC repeat expansion and the S555C variant.",-41.5,0.6,sequencevariant
"Mutation analysis of the BRCA1 gene revealed that the rs2488457 polymorphism, combined with a pathogenic E873stop/A467T sequence variant, predisposes patients to early‑onset breast cancer by disrupting the DNA‑repair domain.",-41.5,0.6,sequencevariant
"Mutation E873stop/A467T in the TP53 gene of HeLa cells produces a truncated p53 protein that fails to activate the p21 promoter, thereby reducing cell cycle arrest in response to doxorubicin-induced DNA damage.",-32.5,0.6,sequencevariant
"Experimental validation revealed that the rs2488457 SNP, which introduces an arginine-to-glycine substitution at amino‑acid position‑229 in the TLR4 protein, is associated with an increased susceptibility to sepsis in individuals carrying the GGC repeat expansion.",-53.0,0.6,sequencevariant
"Experimental data revealed that the rs2488457 variant, a single nucleotide polymorphism in the promoter of the GGC repeat region, associates with increased expression of the TP53 gene product and confers a higher risk of developing Parkinson’s disease in a cohort of Homo sapiens subjects carrying the E873stop/A467T sequence variant.",-51.5,0.6,sequencevariant
"Experimental CRISPR/Cas9 editing of the TP53 gene in HCT116 cells revealed that the rs2488457 polymorphism combined with a GGC repeat expansion at codon S555 increased the frequency of the E873stop/A467T variant, thereby enhancing apoptosis in response to doxorubicin treatment.",-47.25,0.6,sequencevariant
"Experimental evidence shows that the rs2488457 SNP in the promoter of the *IL6* gene, together with the E873stop/A467T mutation in the *CYP1B1* coding sequence, can synergistically increase the risk of hepatocellular carcinoma by disrupting transcriptional regulation and protein stability.",-53.75,0.6,sequencevariant
"Deficiency of the BRCA1 c.68_69delAG variant, a sequence variant that removes two nucleotides at the splice donor site, has been shown to impair homologous recombination repair and increase susceptibility to triple‑negative breast cancer in carriers of the rs3818247 risk allele.",-40.25,0.6,sequencevariant
"Defective activation of the AHR in A549 cells carrying the rs3818247 variant was found to increase CYP1A1 expression, while the E873stop/A467T sequence variant in CYP1A1 itself reduced enzymatic activity.",-51.25,0.6,sequencevariant
"Defects in the BRCA1 c.68_69delAG sequence variant, combined with the rs2488457 polymorphism, are associated with a higher risk of breast cancer in women of European ancestry.",-32.25,0.6,sequencevariant
"Defining the rs2488457 polymorphism as a risk factor for hypertension, the study compared its allele frequency in a cohort of Homo sapiens patients with essential hypertension to that of normotensive controls, revealing a statistically significant enrichment of the G allele that correlates with increased expression of the renin gene.",-57.0,0.6,sequencevariant
"In HeLa cells, the c.357‑3C>G splice‑site variant in the TP53 gene was shown to produce a truncated protein that activates the p21 pathway, thereby enhancing resistance to doxorubicin treatment.",-31.5,0.6,sequencevariant
"In colorectal carcinoma cells, the BRCA1 c.68_69delAG sequence variant was shown to disrupt the binding of the E3 ubiquitin ligase, leading to accumulation of the TP53 protein and enhanced apoptosis in HCT116 cells.",-31.75,0.6,sequencevariant
"In the CRISPR‑edited A549 cell line, a G > C sequence variant at position c.357‑3C > G in the TP53 gene’s splice acceptor site was confirmed, and the resulting aberrant splicing led to a truncated protein that failed to bind the p21 promoter, thereby impairing cell‑cycle arrest and increasing resistance to doxorubicin.",-53.75,0.6,sequencevariant
"In HCT116 cells, the c.357-3C>G splice-site variant in the BRCA1 gene was shown to reduce mRNA stability, leading to a truncated protein that fails to recruit the RAD51 repair complex.",-29.5,0.6,sequencevariant
"The BRCA1 c.68_69delAG sequence variant, which results in a glutamine to lysine substitution at residue223, has been shown to impair DNA repair in breast cancer cell lines such as MCF‑7.",-34.25,0.6,sequencevariant
"The c.357-3C>G splice‑site variant in the CFTR gene was shown to alter mRNA splicing, leading to a truncated protein that predisposes homozygous carriers to cystic fibrosis.",-23.875,0.6,sequencevariant
"The p.203G>A sequence variant in the TP53 gene was found to disrupt the DNA-binding domain, thereby impairing the tumor-suppressive function of the TP53 protein in HeLa cells.",-25.0,0.6,sequencevariant
The A549 cell line harboring the c.357‑3C>G splice‑site variant in the TP53 gene exhibits markedly reduced p53 protein stability and increased sensitivity to doxorubicin‑induced apoptosis.,-23.125,0.6,sequencevariant
"A pathogenic sequence variant, the c.357‑3C>G splice‑site mutation in the BRCA1 gene, was detected in a patient whose germline DNA also harboured a +8365 C/T intronic polymorphism that may modulate the variant’s penetrance.",-37.75,0.6,sequencevariant
"A functional study of the BRCA1 c.357‑3C>G sequence variant revealed that the splice‑acceptor disruption leads to exon skipping, thereby producing a truncated protein that lacks the critical DNA‑binding domain.",-34.5,0.6,sequencevariant
"A CRISPR‑mediated c.357‑3C>G splice‑site mutation in the BRCA1 gene was shown to abolish the binding of the splicing factor SF3B1, thereby generating a truncated protein that impairs homologous recombination repair in HeLa cells.",-33.5,0.6,sequencevariant
A heterozygous c.357-3C>G sequence variant in the BRCA1 gene was found to impair splicing and was associated with an increased risk of breast cancer in a cohort of Homo sapiens patients.,-26.875,0.6,sequencevariant
"Brs2 cells harboring the c.357‑3C>G splice‑site variant exhibit reduced expression of the BRAF protein, leading to impaired MAPK signaling and increased sensitivity to the kinase inhibitor vemurafenib.",-40.75,0.6,sequencevariant
"Brussels sprouts harbor a c.357-3C>G sequence variant that disrupts the splice acceptor site of the RHOA gene, leading to a premature stop codon and loss of function in the resulting protein.",-52.75,0.6,sequencevariant
"Brine shrimp (Artemia salina) exposed to the +8365 C/T variant in the aquaporin gene exhibited a significant increase in osmoregulatory gene expression, while the concomitant G > C substitution at position c.357-3C > G in the same locus was associated with reduced mRNA stability.",-64.5,0.6,sequencevariant
"Brugada syndrome in the proband was linked to a pathogenic SequenceVariant c.357‑3C>G in SCN5A, which disrupts the splice acceptor site and results in exon skipping, while a concurrent G > C transition at position c.1092+1G>A further exacerbates the loss of functional sodium channel protein.",-59.75,0.6,sequencevariant
"Studies on the colorectal carcinoma cell line HCT116 revealed that a c.357-3C>G splice‑site variant in the APC gene promotes exon skipping, resulting in a truncated protein that lacks the β‑catenin‑binding domain and thereby enhances WNT signaling.",-39.75,0.6,sequencevariant
"Studies indicated that the BRCA1 c.357‑3C>G sequence variant, a splice‑site mutation, correlates with increased risk of breast cancer in a cohort of Homo sapiens patients, while a nearby c.1092+1G>A intronic alteration was also detected in the same genomic region.",-58.5,0.6,sequencevariant
"Studies showed that the BRCA1 c.357‑3C>G splice‑site variant, together with the G> C transition at position c.1092+1G>A in the same allele, produced an aberrant transcript that encoded a glutamine‑to‑lysine substitution at residue R223 and a premature stop codon, thereby compromising DNA repair in breast cancer cells.",-71.5,0.6,sequencevariant
"Studies in HCT116 cells revealed that the BRCA1 c.357-3C>G sequence variant, which introduces a splice‑site mutation and results in a glutamine‑to‑lysine substitution at residue A223, markedly reduces DNA repair capacity and increases sensitivity to the chemotherapeutic agent doxorubicin.",-53.5,0.6,sequencevariant
"Mutagenic exposure to benzo[a]pyrene induces the G > C transversion at position c.357-3 in the CYP1A1 gene, which in turn creates a novel splice site that replaces glutamine with lysine at residue Q223, thereby compromising the protein’s ability to metabolize xenobiotics in HepG2 cells.",-65.5,0.6,sequencevariant
"Mutations such as the G>A transition at position c.1032 and the c.357-3C>G splice‑site variant are frequently observed in the TP53 gene of A549 cells, where the resulting sequence variant leads to altered transcriptional activity of the p53 protein in Homo sapiens.",-48.25,0.6,sequencevariant
"Mutant HCT116 cells harboring a c.357-3C>G sequence variant in the TP53 gene exhibit impaired p53-mediated transcription of the CDKN1A promoter, leading to unchecked proliferation and reduced apoptosis compared with TP53 wild‑type cells.",-45.25,0.6,sequencevariant
Mutated c.357-3C>G in the BRCA1 pre‑exon region was shown to impair splicing and produce a truncated protein that disrupts DNA repair in breast cancer cells.,-43.5,0.6,sequencevariant
Mutation of the BRCA1 gene harboring the c.1092+1G>A splice-site variant in the triple-negative breast cancer cell line MDA-MB-231 was found to reduce homologous recombination repair efficiency and sensitize the cells to PARP inhibition.,-39.25,0.6,sequencevariant
"Mutation analysis revealed that the c.357‑3C>G splice‑site variant, together with the +8365 C/T intronic substitution, may disrupt the normal splicing of the BRCA1 transcript, thereby contributing to the observed breast‑cancer susceptibility in the affected family.",-43.25,0.6,sequencevariant
"Mutation c.357-3C>G in the TP53 gene was identified in a subset of HCC patients, where the variant creates a cryptic splice site that abolishes exon inclusion, leading to loss of the p53 DNA‑binding domain and an increased risk of tumor progression.",-50.0,0.6,sequencevariant
"Mutation **c.357‑3C>G** in the TP53 pre‑mRNA splice site of **Homo sapiens** leads to aberrant exon skipping, causing a truncated p53 protein that fails to activate the **DNA repair** pathway and increases susceptibility to **colorectal cancer**.",-38.5,0.6,sequencevariant
"Researchers observed that the c.357‑3C>G sequence variant in the TP53 gene, together with a G> C transition at position c.1092+1, led to aberrant splicing and a loss‑of‑function phenotype in HeLa cells, underscoring the variant’s pathogenic potential.",-43.5,0.6,sequencevariant
"Researchers found that the c.357-3C>G sequence variant in the TP53 gene creates a cryptic splice site, causing a frameshift that replaces glutamine with lysine at residue +223 and ultimately leads to a truncated, non‑functional protein in HeLa cells.",-50.5,0.6,sequencevariant
"Researchers discovered that the c.357-3C>G splice-site variant in the **TP53** gene, together with a +8365 C/T intronic polymorphism, leads to aberrant exon skipping and reduced p53 protein stability in **Homo sapiens** tumor samples.",-39.0,0.6,sequencevariant
"Researchers demonstrated that the c.357-3C>G splice-site variant in the L809L region of the TP53 gene, coupled with a +8365 C/T intronic change, disrupts normal pre-mRNA processing in HeLa cells, leading to reduced p53 protein levels and increased cellular proliferation.",-43.0,0.6,sequencevariant
"Methadone‑treated patients carrying the c.357‑3C>G variant in the CYP2B6 gene exhibit a markedly reduced plasma concentration of the drug, thereby increasing the risk of respiratory depression.",-34.0,0.6,sequencevariant
"Methicillin‑resistant Staphylococcus aureus harbouring the c.357‑3C>G splice‑site variant exhibits reduced β‑lactamase activity, thereby increasing susceptibility to cefazolin treatment in patients with MRSA‑induced pneumonia.",-42.25,0.6,sequencevariant
Methotrexate resistance in A549 cells harboring the c.357‑3C>G splice‑site variant of the DHFR gene was further exacerbated by a secondary +8365 C/T mutation that increased DHFR protein stability.,-40.25,0.6,sequencevariant
"Methionine substitution at residue R337 (c.1009C>A) in the TP53 gene’s DNA‑binding domain was detected in a HeLa cell line, where the resulting p.R337C variant disrupted p53‑dependent transcriptional activation of the CDKN1A gene and promoted unchecked proliferation of the cancer cells.",-69.5,0.6,sequencevariant
"Functional analysis of the c.357-3C > G splice‑site variant in the BRCA1 gene revealed that the mutation abolishes the canonical splice acceptor, causing exon skipping and the production of a truncated, non‑functional protein that compromises DNA repair in the HeLa cell line.",-41.75,0.6,sequencevariant
"Functional prediction analyses revealed that the BRCA1 c.68_69delAG sequence variant, a five‑nucleotide deletion in exon‑2, disrupts the protein’s DNA‑binding domain and is associated with increased susceptibility to breast cancer in a cohort of Homo sapiens patients.",-53.0,0.6,sequencevariant
"Functional assays revealed that the c.357-3C>G splice‑site variant in the CFTR gene, together with the +8365 C/T promoter polymorphism, synergistically increased chloride‑channel activity in CFTR‑deficient HeLa cells, suggesting a potential therapeutic target for cystic fibrosis.",-39.25,0.6,sequencevariant
"Functional studies revealed that the c.357-3C>G splice-site variant in the CFTR gene, coupled with a +8365 C/T intronic polymorphism, impairs chloride transport in the A549 cell line and predisposes patients with the G > C mutation to cystic fibrosis phenotypes.",-47.0,0.6,sequencevariant
"Cell line A549 carrying the BRCA1 c.203G>A sequence variant exhibits reduced homologous recombination repair efficiency compared with the wild‑type A549, and the G > C transition at position c.357-3C>G in the same gene further diminishes BRCA1 mRNA stability, thereby increasing the risk of breast cancer development.",-60.5,0.6,sequencevariant
"Cell lines such as A549 and HeLa, when engineered to express the BRCA1 c.68_69delAG sequence variant, exhibit heightened sensitivity to the chemotherapeutic agent doxorubicin, revealing a direct link between the specific DNA deletion and drug response.",-38.25,0.6,sequencevariant
"Cellular assays revealed that the c.357-3C>G sequence variant in the TP53 gene, together with the G> C transversion at position +8365, significantly altered the binding affinity of the MDM2 protein, thereby impairing p53-mediated apoptosis in the A549 cell line.",-51.0,0.6,sequencevariant
"Cell viability assays in the A549 cell line revealed that the c.357‑3C>G sequence variant in the TP53 gene reduces p53 transcriptional activity, thereby increasing resistance to the chemotherapeutic drug doxorubicin in these cells.",-32.25,0.6,sequencevariant
"Knock‑in of the c.357‑3C>G splice‑site variant in the BRCA1 gene of HEK293 cells reduces RAD51 foci formation and increases sensitivity to cisplatin, illustrating the functional impact of this sequence variant.",-33.75,0.6,sequencevariant
Knocking‑in the BRCA1 c.203G>A sequence variant into HeLa cells markedly reduced RAD51 foci formation and increased sensitivity to the DNA‑crosslinker cisplatin.,-28.75,0.6,sequencevariant
"Knudson’s two‑hit hypothesis predicts that the c.357‑3C>G splice‑site variant in the TP53 gene can cooperate with a downstream +8365 C/T promoter alteration to diminish p53 transcription in the HeLa cell line, thereby enhancing cellular proliferation and conferring resistance to doxorubicin.",-58.5,0.6,sequencevariant
"Knocked‑down of the CRISPR‑engineered A549 cells harboring the c.357‑3C>G splice‑site variant in TP53 resulted in a marked reduction of p53‑mediated apoptosis and increased cell proliferation, while the additional G > C transition at position +8365 in the downstream regulatory region further amplified the oncogenic phenotype.",-74.5,0.6,sequencevariant
"An A549 cell line harboring the c.357‑3C>G splice‑site variant of the TP53 gene exhibited reduced p53 protein levels, leading to increased resistance to doxorubicin treatment.",-26.875,0.6,sequencevariant
"An allelic substitution of a G > C transition at position c.357-3 of the BRCA1 pre‑mRNA was found to disrupt splicing, thereby reducing the production of functional p53 protein in a subset of A549 lung cancer cells.",-56.75,0.6,sequencevariant
"An adenocarcinoma of the lung in a patient with an A549 cell line culture revealed a novel sequence variant, c.357‑3C>G, which altered the splice acceptor site and was predicted to produce a truncated TP53 protein.",-43.5,0.6,sequencevariant
"An intriguing correlation emerged when the CRISPR‑edited A549 cells bearing the c.357‑3C>G splice‑site variant of the BRCA1 gene displayed a marked reduction in homologous recombination efficiency, suggesting that this single nucleotide change can compromise DNA repair fidelity and predispose the cells to genomic instability.",-47.5,0.6,sequencevariant
"Loss of function of the c.357‑3C>G variant in the intron of the BRCA1 gene disrupts splice site recognition and results in a truncated TP53 protein that cannot activate the p21 pathway, thereby impairing cell cycle arrest in HeLa cells exposed to doxorubicin.",-56.25,0.6,sequencevariant
"Loss-of-function in the BRCA1 gene caused by a c.357-3C>G splice-site variant, a +8365 C/T intronic substitution, and a rare c.1092+1G>A mutation, collectively leads to defective DNA repair and increased susceptibility to breast cancer in a subset of patients.",-58.75,0.6,sequencevariant
"Loss‑of‑function of the TP53 protein caused by the c.357‑3C>G splice‑site variant was confirmed in the H1299 cell line, where the mutant transcript led to a truncated protein that could not activate the p21 promoter in response to doxorubicin.",-45.0,0.6,sequencevariant
Loss‐of‐function of the TP53 gene in HeLa cells bearing the c.357‑3C>G splice‑site variant leads to accumulation of a truncated protein that fails to induce apoptosis in response to doxorubicin.,-38.0,0.6,sequencevariant
"The pathogenic BRCA1 c.217_218insC variant, which introduces an extra cytosine at positions +217 and +218, was found to increase the risk of breast cancer in a cohort of female patients, whereas the p.R315X nonsense mutation in the same gene was associated with a more aggressive tumor phenotype.",-50.75,0.6,sequencevariant
"The BRCA1 c.217_218insC variant, together with the TP53 p.R315X mutation, has been shown to synergistically impair DNA repair and increase susceptibility to triple‑negative breast cancer in homozygous carriers.",-22.625,0.6,sequencevariant
"The c.217_218insC variant in the BRCA1 gene, which introduces a premature stop codon (p.E831X), was found to increase the risk of hereditary breast cancer in a cohort of Homo sapiens patients, while the c.677C>T polymorphism in the MTHFR gene was associated with elevated homocysteine levels in the same population.",-34.0,0.6,sequencevariant
"The newly identified sequence variant c.217_218insC in the TP53 gene was found to increase the risk of early‑onset breast cancer in a cohort of Homo sapiens patients, while the concurrent p.R315X mutation in the same locus further amplified the deleterious effect on DNA repair pathways.",-40.0,0.6,sequencevariant
"Mutations such as TP53 c.217_218insC, KRAS c.677C>T, and BRCA1 c.899dupC have been linked to altered protein function and increased cancer risk in Homo sapiens.",-24.5,0.6,sequencevariant
"Mutational analysis of the tumor suppressor TP53 revealed a recurrent sequence variant c.217_218insC that, together with the pathogenic missense mutation p.G135C, was associated with increased resistance to cisplatin in the A549 lung carcinoma cell line.",-39.25,0.6,sequencevariant
"Mutagenic exposure of the K562 cell line revealed that the BRCA1 c.217_218insC sequence variant, together with the TP53 p.R315X mutation, markedly increased apoptosis and sensitized the cells to doxorubicin treatment.",-33.75,0.6,sequencevariant
"Mutant A549 cells harboring the BRCA1 c.217_218insC variant exhibit increased sensitivity to the DNA‑damaging chemotherapeutic doxorubicin, while the same cells also display a marked up‑regulation of the tumor suppressor TP53 protein.",-37.25,0.6,sequencevariant
"In colorectal carcinoma cell line HCT116, the sequence variant BRCA1 c.217_218insC was detected, and its presence correlated with a marked increase in the expression of the DNA repair protein p53 and a reduction in tumor cell proliferation.",-36.5,0.6,sequencevariant
"In the colorectal carcinoma cell line HCT116, CRISPR‑mediated introduction of the BRCA1 sequence variant c.217_218insC resulted in a frameshift that abolished RAD51 recruitment, thereby sensitizing the cells to the DNA‑crosslinking agent mitomycin C.",-31.5,0.6,sequencevariant
"In a cohort of colorectal cancer patients, the novel sequence variant BRCA1 c.217_218insC was found to co‑occur with the TP53 p.R315X mutation, and its presence was associated with a higher incidence of microsatellite instability and poorer overall survival.",-28.875,0.6,sequencevariant
"In CML cell line K562, the sequence variant c.217_218insC in the BCR‑ABL1 transcript increases the kinase activity of the fusion protein, thereby enhancing resistance to imatinib and promoting disease progression.",-35.5,0.6,sequencevariant
"Homo sapiens cells harboring the BRCA1 c.217_218insC variant exhibit reduced RAD51 foci formation, thereby impairing homologous recombination repair and increasing sensitivity to the DNA‑damaging agent doxorubicin.",-24.875,0.6,sequencevariant
"Heterozygous BRCA1 c.217_218insC and c.677C>T sequence variants were simultaneously identified in a breast cancer patient, and the combined presence of these mutations was associated with an increased risk of aggressive tumor phenotypes.",-31.5,0.6,sequencevariant
"H7N9 influenza virus replication in A549 cells carrying the G593S sequence variant of the viral polymerase PB2 gene was markedly reduced compared to cells with the wild‑type PB2, indicating that this single amino‑acid change interferes with the polymerase complex’s ability to bind host ribosomal RNA.",-59.25,0.6,sequencevariant
"HepG2 cells harboring the BRCA1 c.217_218insC variant exhibit a markedly reduced homologous recombination capacity, leading to heightened sensitivity to the PARP inhibitor olaparib.",-26.875,0.6,sequencevariant
Gene therapy using CRISPR/Cas9 to correct the BRCA1 c.217_218insC sequence variant in the breast cancer cell line MCF‑7 has been shown to restore homologous recombination and reduce sensitivity to the DNA‑damaging agent doxorubicin.,-31.5,0.6,sequencevariant
"Gene editing of the TP53 c.217_218insC variant in A549 cells induced a dramatic increase in p53 protein levels, thereby sensitizing the cells to doxorubicin-induced apoptosis.",-30.625,0.6,sequencevariant
"Gene‑editing of the TP53 c.217_218insC sequence variant in A549 cells revealed that the insertion of a cytosine at codons‑217 and‑218 creates a novel stop codon, thereby abolishing p53 transcriptional activity and increasing cellular resistance to doxorubicin-induced apoptosis.",-55.25,0.6,sequencevariant
"Gene expression of the TP53 variant p.R315X in HeLa cells treated with doxorubicin was found to be down‑regulated, leading to increased apoptosis and a higher therapeutic response in the context of E831X‑associated colorectal cancer.",-44.5,0.6,sequencevariant
"A patient harboring the BRCA1 c.217_218insC variant exhibited a markedly reduced response to platinum‑based chemotherapy, while the concomitant TP53 c.677C>T mutation further impaired apoptosis signaling.",-28.25,0.6,sequencevariant
A heterozygous BRCA1 c.217_218insC sequence variant in a breast‑cancer patient was found to impair RAD51 recruitment and increase the risk of genomic instability.,-29.25,0.6,sequencevariant
"A novel BRCA1 c.217_218insC sequence variant was identified in a breast cancer patient, where the insertion of a cytosine residue at positions c.217 and c.218 caused a frameshift that predicted a premature stop codon at amino acid residue E831X, potentially compromising the tumor suppressor function of the protein.",-48.75,0.6,sequencevariant
"A hepatocellular carcinoma cell line, HepG2, showed increased proliferation when transfected with the BRCA1 sequence variant c.217_218insC, which also induced up‑regulation of the DNA repair gene G135C and activation of the PI3K‑AKT pathway.",-42.25,0.6,sequencevariant
"Among PD patients, the BRCA1 c.217_218insC sequence variant was found to increase the risk of developing Parkinson’s disease by disrupting the normal function of the TP53 gene product.",-36.25,0.6,sequencevariant
"Among patients harboring the BRCA1 sequence variant c.217_218insC, the tumor‑derived HeLa cell line exhibited markedly reduced RAD51 foci formation, indicating impaired homologous recombination repair.",-29.875,0.6,sequencevariant
"Among colorectal cancer patients, the BRCA1 c.217_218insC sequence variant was found to increase the likelihood of developing resistance to platinum‑based chemotherapy by altering the DNA repair pathway.",-34.75,0.6,sequencevariant
"Among the colorectal cancer cell lines studied, the HCT116 line harboring the TP53 sequence variant c.217_218insC exhibited markedly reduced p53 transcriptional activity and increased resistance to the chemotherapeutic agent doxorubicin.",-34.0,0.6,sequencevariant
"Wnt signaling is disrupted in colorectal cancer cells harboring the BRCA1 c.217_218insC variant, which leads to aberrant β‑catenin accumulation and promotes tumorigenic growth.",-29.875,0.6,sequencevariant
"Wright‑Smith et al. reported that the BRCA1 variant c.217_218insC, a sequence variant that introduces an extra cytosine, was present in a subset of patients whose TP53 gene also carried the p.R315X nonsense mutation, and that these co‑occurring alterations were associated with a higher risk of early‑onset breast cancer in the studied cohort.",-71.0,0.6,sequencevariant
Wang et al. reported that the BRCA1 sequence variant c.217_218insC in the Chinese breast‑cancer cohort leads to a truncated protein (p.R315X) that disrupts homologous recombination and increases sensitivity to PARP inhibitors.,-40.75,0.6,sequencevariant
"WES of colorectal cancer samples revealed that the BRCA1 c.217_218insC variant, along with the TP53 p.R315X nonsense mutation, was significantly enriched in tumors from patients with a history of smoking, suggesting a synergistic effect of these sequence variants on carcinogenesis.",-42.0,0.6,sequencevariant
"We confirmed that the BRCA1 sequence variant c.217_218insC in a breast‑cancer patient’s tumor DNA co‑occurs with the pathogenic missense mutation c.677C>T, which together increase the risk of aggressive disease.",-43.0,0.6,sequencevariant
"We identified a novel sequence variant, c.217_218insC in the BRCA1 gene, that co‑occurs with the pathogenic missense mutation p.G593S and a frameshift deletion DD32, and its presence in a patient with early‑onset breast cancer suggests a synergistic effect on DNA repair deficiency.",-48.25,0.6,sequencevariant
"We discovered that the BRCA1 c.217_218insC variant, a sequence variant that introduces a cytosine between nucleotides c.217 and c.218, significantly disrupts the protein’s DNA‑binding domain, leading to a loss of tumor suppressor activity in breast cancer cells.",-55.75,0.6,sequencevariant
"We report that the BRCA1 c.217_218insC sequence variant, which introduces a premature stop codon (p.Gly73*), is associated with a markedly increased risk of hereditary breast cancer in a cohort of Hispanic women.",-38.75,0.6,sequencevariant
Loss of function of the CYP2D6 gene caused by the c.677C>T variant (p.R226C) was shown to reduce the metabolism of the chemotherapeutic agent doxorubicin in A549 cells derived from a patient with the BRCA1 c.217_218insC mutation.,-44.5,0.6,sequencevariant
Loss‑of‑function of the BRCA1 p.R315X sequence variant in the HCC1937 cell line leads to defective DNA repair and heightened sensitivity to the alkylating agent temozolomide in Homo sapiens cells.,-37.25,0.6,sequencevariant
"Loss in the BRAF gene (c.217_218insC) coupled with the V600E mutation (c.1799T>A) has been shown to drive uncontrolled proliferation in colorectal carcinoma cells, whereas the presence of a germline TP53 variant (c.677C>T) may predispose patients to early-onset breast cancer.",-69.0,0.6,sequencevariant
"Loss-of‑function mutations such as BRCA1 c.217_218insC, KRAS p.G13D, and the novel T704C allele have been shown to disrupt DNA repair pathways and confer increased sensitivity to platinum‑based chemotherapies in colorectal cancer cell lines.",-46.25,0.6,sequencevariant
"Mutation of the BRCA1 gene by the sequence variant c.217_218insC, which introduces a premature stop codon (E831X), has been shown to impair DNA repair and increase the risk of triple‑negative breast cancer in patients carrying the p.R315X allele.",-38.25,0.6,sequencevariant
Mutation analysis of the BRCA1 locus revealed a pathogenic p.G593S sequence variant that co‑occurs with the novel c.217_218insC alteration in a patient with hereditary breast cancer.,-39.0,0.6,sequencevariant
"Mutation p.217_218insC in the CFTR gene of a patient with cystic fibrosis was found to disrupt the chloride channel’s gating mechanism, causing a severe reduction in chloride conductance and correlating with the patient's pronounced pulmonary dysfunction.",-45.75,0.6,sequencevariant
"Mutation c.217_218insC in the BRCA1 gene was detected in a breast cancer patient whose tumor exhibited increased sensitivity to the PARP inhibitor olaparib, while the concurrent c.677C>T polymorphism in the CYP2D6 gene predicted a reduced metabolic clearance of tamoxifen.",-35.5,0.6,sequencevariant
"BRCA1 c.217_218insC and c.677C>T variants were shown to impair DNA repair activity in HCC cells, thereby increasing susceptibility to cisplatin-induced apoptosis.",-31.625,0.6,sequencevariant
"BRIP1 c.217_218insC in a Korean breast‑cancer patient was shown to abolish the protein’s interaction with PALB2, thereby impairing homologous recombination and sensitizing the tumor to platinum therapy.",-43.5,0.6,sequencevariant
"BRCAT1 c.217_218insC and c.677C>T variants were found to co‑occur in the same allele of the TP53 gene, and the resulting protein truncation at E831X was associated with increased apoptosis in A549 cell lines.",-49.75,0.6,sequencevariant
"BRD4 exon‑3 harboring the c.217_218insC sequence variant was shown to destabilize the protein and impair its interaction with the p300 co‑activator, thereby reducing transcription of the TP53 target gene CDKN1A in the A549 lung carcinoma cell line.",-57.25,0.6,sequencevariant
"Patients with the TP53 c.217_218insC sequence variant exhibited a markedly increased susceptibility to cisplatin‑induced apoptosis in the A549 cell line, while the BRCA1 c.677C>T mutation was associated with impaired DNA repair in the same cellular context.",-38.25,0.6,sequencevariant
Patients harboring the BRCA1 c.217_218insC sequence variant exhibit a markedly increased risk of early‑onset breast cancer compared with carriers of the common c.677C>T polymorphism.,-19.625,0.6,sequencevariant
"Patients carrying the BRCA1 sequence variant c.217_218insC showed a markedly increased risk of triple‑negative breast cancer compared with carriers of the common c.677C>T polymorphism, suggesting that the novel insertion confers a more deleterious functional impact on the DNA‑repair machinery.",-36.75,0.6,sequencevariant
"Patients who harbor the BRCA1 sequence variant c.217_218insC exhibit a higher risk of early‑onset breast cancer, and this insertion has been shown to impair the normal splicing of exon‑7, thereby generating a truncated protein that lacks the critical DNA‑binding domain.",-54.5,0.6,sequencevariant
"Genomic analysis of the KRAS locus in pancreatic ductal adenocarcinoma cell lines revealed a novel T704C sequence variant that introduces a premature stop codon (E831X) and disrupts the downstream G593S motif, potentially altering oncogenic signaling pathways.",-45.25,0.6,sequencevariant
"Genetic analysis of a colorectal cancer cohort revealed that the G593S variant in the KRAS gene, identified by a T704C substitution, is associated with increased tumor aggressiveness, while a novel DD32 deletion in the APC gene was also detected in a subset of patients.",-50.0,0.6,sequencevariant
"Genotyping of the BRCA1 gene in breast cancer patients revealed that the novel sequence variant c.217_218insC co‑occurs with the pathogenic p.R315X nonsense mutation and the common SNP rs677C>T, suggesting a compound heterozygous state that may exacerbate DNA repair deficiency.",-45.75,0.6,sequencevariant
"Genotype‑specific functional assays revealed that the BRCA1 c.217_218insC sequence variant, together with the TP53 p.R315X nonsense mutation, synergistically impaired DNA repair in HCC‑derived HepG2 cells, leading to heightened sensitivity to the chemotherapeutic agent doxorubicin.",-42.25,0.6,sequencevariant
"A heterozygous c.798C>T (p.L50R) sequence variant in the CYP2D6 gene was identified in a patient whose metabolite profile suggested reduced enzymatic activity, potentially influencing the pharmacodynamics of the chemotherapeutic drug doxorubicin.",-35.25,0.6,sequencevariant
"A BRCA1 c.798C>T variant, predicted to generate the L50R amino‑acid change, was identified in a patient with triple‑negative breast cancer and was shown to impair homologous recombination repair.",-27.75,0.6,sequencevariant
"A c.798C>T variant in the TP53 gene, which results in the L50R amino‑acid substitution, was found to increase the risk of therapy‑related acute myeloid leukemia in patients receiving doxorubicin.",-25.125,0.6,sequencevariant
"A missense variant c.798C>T, resulting in the amino‑acid substitution L50R in the TP53 protein, has been shown to impair DNA‑binding affinity and is frequently detected in sporadic colorectal cancers.",-30.0,0.6,sequencevariant
"The c.798C>T (p.L50R) variant in the BRCA1 gene, which alters a highly conserved cysteine residue, has been associated with a markedly increased risk of early‑onset breast cancer in carriers of the rs7802 risk allele.",-25.25,0.6,sequencevariant
"The homozygous c.798C>T variant (p.L50R) in the ATP7B gene was found to be associated with early‑onset Wilson disease in a cohort of Homo sapiens patients, while the c.1092+1G>A splice‑site mutation led to aberrant mRNA processing and loss of functional protein.",-37.25,0.6,sequencevariant
"The CRISPR‑mediated introduction of the c.798C>T variant, which converts the leucine at position L50 to arginine (L50R), in the TP53 gene of HCT116 cells dramatically increases the cells’ sensitivity to doxorubicin while simultaneously up‑regulating the expression of the DNA‑damage‑response gene GADD45A.",-38.75,0.6,sequencevariant
"The BRCA1 c.798C>T variant, which results in the L50R amino‑acid substitution, is predicted to impair homologous recombination and increase susceptibility to triple‑negative breast cancer in carriers of the rs7802 risk allele.",-22.25,0.6,sequencevariant
"In a recent cohort of colorectal cancer patients, the heterozygous sequence variant c.1092+1G>A in the MLH1 gene was found to co‑occur with the missense mutation H194Q, resulting in a marked reduction of mismatch repair activity and an increased risk of microsatellite instability.",-32.5,0.6,sequencevariant
"In breast carcinoma samples, the heterozygous sequence variant c.798C>T resulting in the L50R amino‑acid substitution within the TP53 gene was detected, and this mutation was associated with a higher frequency of p.W492X truncations and a reduced response to doxorubicin in the MCF‑7 cell line.",-45.0,0.6,sequencevariant
"In the CRISPR‑edited A549 cells, the c.798C>T (p.L50R) variant in the TP53 gene was shown to confer resistance to doxorubicin by up‑regulating the DNA repair pathway.",-27.125,0.6,sequencevariant
"In colorectal carcinoma cell line HCT116, the c.798C>T (p.L50R) sequence variant in the APC gene was found to disrupt β‑catenin binding, leading to increased transcription of the oncogenic target MYC and enhanced cellular proliferation.",-32.25,0.6,sequencevariant
"Mutation c.798C>T in the TP53 gene results in the L50R amino‑acid substitution, which has been shown to impair the protein’s DNA‑binding domain and increase susceptibility to colorectal cancer in patients carrying the rs7802 risk allele.",-25.625,0.6,sequencevariant
"Mutation analysis revealed that the c.798C>T variant in the CYP2D6 gene results in the L50R amino‑acid substitution, which is associated with reduced enzymatic activity and altered response to the antidepressant fluoxetine.",-30.75,0.6,sequencevariant
"Mutation of the TP53 gene harboring the sequence variant c.798C>T, which predicts a L50R amino‑acid substitution, has been shown to impair DNA‑damage‑induced apoptosis in A549 cells and is associated with increased tumorigenicity in xenograft models of non‑small‑cell lung cancer.",-39.5,0.6,sequencevariant
"Mutation analyses revealed that the c.798C>T sequence variant, which results in the L50R amino‑acid change, was present in a patient with a severe form of congenital thrombocytopenia.",-36.25,0.6,sequencevariant
"cDNA analysis of a colorectal carcinoma cell line revealed a novel sequence variant, c.1092+1G>A, which abolishes the splice donor site and results in exon skipping, producing a truncated TP53 protein that lacks the DNA‑binding domain and is predicted to behave as a dominant‑negative allele.",-42.75,0.6,sequencevariant
"c.*798C>T* in the *KRAS* gene produces the *L50R* variant, which has been shown to increase the oncogenic potential of *A549* cells by enhancing MAPK signaling.",-43.0,0.6,sequencevariant
"c.[798C>T] in the BRCA1 gene, which results in the L50R missense variant, has been shown to disrupt homologous recombination repair and confer increased sensitivity to PARP inhibitors in BRCA1‑deficient HeLa cells.",-44.0,0.6,sequencevariant
"c.A798T (p.L50R) in the BRCA1 gene was found to co‑occur with the c.1092+1G>A splice‑site variant and the rs7802 SNP, collectively increasing breast cancer risk in a cohort of Homo sapiens carriers.",-47.25,0.6,sequencevariant
"Patients harboring the c.798C>T sequence variant (p.L50R) in the ABCG2 gene exhibit markedly reduced transporter activity, while the concurrent rs7802 SNP in the same locus further exacerbates the functional deficit, potentially increasing susceptibility to drug-induced hyperuricemia.",-45.5,0.6,sequencevariant
"Patients with the c.798C>T sequence variant, which results in the L50R amino‑acid substitution, exhibit markedly increased sensitivity to the chemotherapeutic agent doxorubicin.",-22.625,0.6,sequencevariant
"Patients carrying the BRCA1 c.798C>T variant, which causes the L50R missense change, exhibit a markedly increased risk of triple‑negative breast cancer compared with carriers of the more common c.1601G>A allele.",-28.375,0.6,sequencevariant
Patients homozygous for the c.798C>T (p.L50R) variant in the ATP7B gene exhibited markedly reduced copper excretion and a higher incidence of hepatocellular carcinoma compared with carriers of the wild‑type allele.,-29.625,0.6,sequencevariant
"Experimental CRISPR/Cas9 editing of the TP53 locus in HCT116 cells revealed that the c.798C>T (p.L50R) sequence variant, confirmed by Sanger sequencing, disrupted the DNA-binding domain and significantly reduced p53 transcriptional activity, thereby promoting cellular proliferation.",-40.75,0.6,sequencevariant
"Experimental infection of A549 cells with SARS‑CoV‑2 revealed that the viral spike protein binds to the host ACE2 receptor, inducing an up‑regulation of the inflammatory cytokine IL‑6 that is further amplified by the presence of the c.798C>T (p.L50R) sequence variant in the IL‑6 promoter.",-53.75,0.6,sequencevariant
"Experimental data revealed that the c.798C>T sequence variant in the CFTR gene, which leads to the L50R amino‑acid substitution, significantly impaired chloride transport in A549 cells, while the independent c.28T>C mutation, resulting in the premature p.W492X truncation, was associated with a marked reduction in protein stability in HeLa cells.",-59.0,0.6,sequencevariant
"Experimental PCR amplification of the BRCA1 exon containing c.798C>T revealed a novel L50R variant that, together with the previously reported c.28T>C (p.W492X) and rs7802 SNP, may contribute to the pathogenic phenotype observed in the patient.",-52.0,0.6,sequencevariant
"Deletion of the c.798C > T variant in the TP53 gene results in the L50R missense mutation, which is predicted to disrupt the DNA‑binding domain and increase the risk of tumorigenesis in H194Q‑bearing cells.",-36.75,0.6,sequencevariant
"Deletion c.1092+1G>A in the splice donor site of the CYP2D6 gene abolishes normal exon inclusion, leading to a truncated protein that lacks the catalytic domain and confers a severe loss‑of‑function phenotype in patients with poor metabolizer status.",-42.5,0.6,sequencevariant
Deletion at c.798C> T in the TP53 gene produces a truncated p.W492X protein that is predicted to impair DNA repair and increase susceptibility to breast cancer in individuals carrying the rs7802 risk allele.,-39.75,0.6,sequencevariant
"Deletion mutation c.798C>T in the TP53 gene, which produces the L50R variant, was found to be associated with an increased risk of early‑onset breast cancer in a cohort of Homo sapiens patients.",-40.5,0.6,sequencevariant
"Mutations such as c.798C>T, leading to the L50R amino‑acid change, and the splice‑site variant c.1092+1G>A, have been shown to disrupt the normal function of the TP53 gene in many cancer cell lines.",-29.625,0.6,sequencevariant
"Mutational analysis of the BRCA1 gene in a cohort of breast cancer patients revealed a novel c.798C>T variant resulting in the L50R amino‑acid substitution, which was predicted to disrupt the protein’s DNA‑binding domain and correlate with increased disease aggressiveness.",-29.375,0.6,sequencevariant
"Mutagenesis of the TP53 gene in A549 cells introduced a c.798C> T (L50R) sequence variant, which disrupted the DNA‑binding domain and increased cellular sensitivity to doxorubicin-induced apoptosis.",-35.75,0.6,sequencevariant
"Mutating the BRCA1 gene to the c.798C>T variant, which introduces a p.L50R substitution, has been shown to impair homologous recombination repair in HeLa cells.",-29.625,0.6,sequencevariant
"Sequencing of the TP53 gene in a cohort of breast cancer patients revealed a novel c.798C>T transition that results in the L50R missense mutation, which is predicted to destabilize the protein’s DNA‑binding domain and may contribute to chemoresistance.",-30.125,0.6,sequencevariant
"Sequenced analysis of the BRCA1 gene from a breast‑cancer cohort revealed a novel c.798C>T variant resulting in the L50R amino‑acid substitution, which co‑occurs with the rs7802 single‑nucleotide polymorphism and is predicted to disrupt the protein’s DNA‑binding domain.",-37.25,0.6,sequencevariant
"Sequenza‑derived analysis revealed that the c.798C>T (p.L50R) variant in the BRCA1 gene is associated with a higher risk of breast cancer in patients carrying the rs7802 risk allele, while the c.1092+1G>A splice‑site mutation, which replaces a serine with proline at codon‑1235, leads to aberrant protein products that impair DNA repair and increase tumor aggressiveness.",-72.0,0.6,sequencevariant
"Sequence variant c.798C>T, which converts the leucine at position L50 to arginine (L50R), was shown to impair the DNA-binding activity of the transcription factor TP53 and to increase the risk of colorectal cancer in Homo sapiens.",-52.25,0.6,sequencevariant
"Sequence analysis of the BRCA1 gene in breast cancer patients revealed a c.798C>T transition that produces the L50R missense variant, while a separate cohort of ovarian carcinoma samples carried a c.1092+1G>A splice-site mutation, both of which were associated with reduced homologous recombination repair activity and increased sensitivity to platinum-based chemotherapy.",-45.5,0.6,sequencevariant
"Sequence variant c.798C>T in the TP53 gene, predicted to introduce the L50R missense change, was found to impair DNA‑damage‑induced apoptosis in HeLa cells.",-28.875,0.6,sequencevariant
"Sequence variants such as c.798C>T, which results in the L50R missense mutation, and c.1092+1G>A, a splice‑site alteration that may convert serine to proline at codon p.1235, have been identified in the TP53 gene of patients with early‑onset colorectal cancer.",-49.5,0.6,sequencevariant
"Sequence‑variant c.798C>T in the TP53 gene, resulting in the L50R missense mutation, was shown to destabilize the DNA‑binding domain and increase the risk of colorectal carcinoma in a cohort of Homo sapiens patients.",-35.0,0.6,sequencevariant
"Functional studies revealed that the c.798C>T (L50R) sequence variant in the ATP7B gene, which results in a serine to proline substitution at codon‑1235, disrupts copper transport and is associated with a severe early‑onset Wilson disease phenotype in a Homo sapiens patient carrying the rs7802 risk allele.",-50.75,0.6,sequencevariant
Functional characterization of the c.798C>T (p.L50R) variant in the ABCD1 gene revealed that the Arg158Pro substitution in the transmembrane domain of the peroxisomal transporter protein increases susceptibility to adrenomyeloneuropathy in a cohort of Homo sapiens patients carrying the rs7802 allele.,-45.25,0.6,sequencevariant
"Functional assays revealed that the c.798C>T (p.L50R) variant in the BRCA1 gene, which is associated with rs7802, leads to reduced homologous recombination efficiency and increased genomic instability in A549 cells.",-35.0,0.6,sequencevariant
"Functional analysis of the c.798C>T variant, which predicts the L50R amino‑acid change, revealed that this sequence variant diminishes TP53 binding affinity and increases the risk of colorectal cancer in patients carrying the rs7802 allele.",-35.75,0.6,sequencevariant
"When the A549 cells were transfected with a plasmid carrying the TP53 c.798C>T variant, the resulting p.L50R protein exhibited a pronounced loss of DNA‑binding affinity, thereby impairing the transcriptional activation of the downstream p21 gene and reducing apoptosis in response to doxorubicin treatment.",-43.5,0.6,sequencevariant
"When cultured in the A549 cell line, the BRCA1 c.798C>T variant, which introduces the L50R amino‑acid substitution, was shown to impair DNA repair and sensitize cells to the chemotherapeutic agent doxorubicin, whereas the co‑occurring rs7802 polymorphism in the ATM gene did not alter this effect.",-51.75,0.6,sequencevariant
"When CRISPR‑mediated editing introduced the c.798C>T variant, the resulting L50R substitution in the TP53 gene’s DNA‑binding domain was observed to impair p53’s transcriptional activation of the p21 promoter in HeLa cells.",-33.5,0.6,sequencevariant
"When assessing the functional impact of the c.798C>T variant, we discovered that the resulting L50R substitution in the protein’s DNA‑binding domain disrupts transcriptional activation of the downstream target gene, thereby contributing to the pathogenesis of the associated disease phenotype.",-45.75,0.6,sequencevariant
"Allele analysis of the TP53 gene in colorectal carcinoma samples revealed that the c.798C>T variant, resulting in the L50R substitution, co‑occurs with the c.1092+1G>A splice‑site mutation and the rs7802 SNP, collectively contributing to impaired p53 DNA‑binding activity and increased tumor aggressiveness.",-40.0,0.6,sequencevariant
"Allelic analysis of the TP53 gene in colorectal carcinoma revealed a recurrent c.798C>T (p.L50R) mutation, which co‑occurs with a c.1092+1G>A splice‑site variant that results in a serine‑to‑proline substitution at codon‑1235, thereby compromising the DNA‑binding domain and enhancing tumor progression.",-58.75,0.6,sequencevariant
"Alleles such as c.798C>T, c.1092+1G>A, and the missense variant L50R in the TP53 gene were found to correlate with increased risk of early‑onset colorectal cancer in a cohort of Homo sapiens patients carrying the rs7802 polymorphism.",-40.75,0.6,sequencevariant
"Allege‑specific analysis revealed that the c.798C>T variant in the L50R region of the TP53 gene, which results in a serine‑to‑proline substitution at codon1235, correlates with increased tumor suppressor activity in A549 cells.",-66.0,0.6,sequencevariant
"The CRISPR‑edited A549 cells harboring the p.Val167Met sequence variant (c.501G>A) display a pronounced resistance to doxorubicin, suggesting that the Val167Met mutation in the TP53 gene modulates drug‑induced apoptosis.",-33.25,0.6,sequencevariant
"The L490R sequence variant in the ATP1A1 gene, a cytosine insertion that changes the codon from C to T at position c.1459, was found to destabilize the Na⁺/K⁺‑ATPase complex in HeLa cells, causing a V600E‑like hyper‑phosphorylation of downstream MAPK signaling pathways.",-46.5,0.6,sequencevariant
"The BRCA1 sequence variant rs1329428, a C to T transition at position c.144G>A, causes a p.Val167Met substitution that impairs homologous recombination repair and predisposes to breast cancer.",-28.5,0.6,sequencevariant
"The c.490C>T cytosine insertion in TP53, resulting in the L490R sequence variant, has been shown to disrupt the DNA‑binding domain and is associated with an increased risk of early‑onset colorectal cancer.",-25.375,0.6,sequencevariant
"A novel cytosine insertion at position c.490 in TP53, resulting in the L490R sequence variant, was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients carrying the rs1329428 allele.",-29.0,0.6,sequencevariant
"A single cytosine insertion at position L490R in the TP53 gene generates a C to T transition that creates the sequence variant p.Val167Met, which is associated with increased tumorigenicity in A549 cells.",-28.625,0.6,sequencevariant
"A cytosine insertion at position L490R in the TP53 gene creates a p.Val167Met variant that, in a homozygous rs1329428 background, disrupts the DNA‑binding domain and predisposes cells to oncogenic transformation.",-30.125,0.6,sequencevariant
"A pathogenic sequence variant, such as the L490R substitution in the TP53 gene, was identified in a patient with a V600E melanoma mutation that also carried a cytosine insertion at position C105Vfs114X, illustrating how multiple sequence variants can coexist and influence disease severity.",-50.75,0.6,sequencevariant
"In the newly sequenced HeLa cells, a cytosine insertion at position c.144G> A in the TP53 gene creates a p.Val167Met variant that disrupts the DNA‑binding domain, while a concurrent C to T transition at c.490C>R generates the L490R substitution, together impairing tumor‑suppressor activity.",-52.0,0.6,sequencevariant
"In colorectal carcinoma cells, the cytosine insertion at position c.490 leading to the L490R sequence variant disrupts the TP53 binding domain, thereby attenuating p53-mediated apoptosis and promoting unchecked cell proliferation.",-31.375,0.6,sequencevariant
"In HeLa cells, the L490R sequence variant, a cytosine insertion causing a C to T transition at position c.144, results in a p.Val167Met substitution that activates the MAPK pathway, thereby enhancing proliferation.",-31.625,0.6,sequencevariant
"In HCT116 cells, the p.Val167Met (V167M) sequence variant in the TP53 gene, caused by a C to T transition at nucleotide position c.501, leads to a cytosine insertion that generates a premature stop codon (C105Vfs114X), thereby compromising the DNA‑binding domain and reducing the cell’s ability to undergo apoptosis in response to doxorubicin.",-52.25,0.6,sequencevariant
"Mutation analysis revealed that the BRCA1 c.68_69delAG variant (SequenceVariant) causes a cytosine insertion leading to a frameshift (C105Vfs114X) that disrupts the DNA repair domain, while the KRAS c.179T>A (SequenceVariant) results in the V600E substitution, a known driver of oncogenic signaling in colorectal cancer.",-48.0,0.6,sequencevariant
"Mutation L490R in the TP53 gene, a cytosine insertion causing a C → T transition at codon p.Val167Met, was found to increase the risk of colorectal cancer in patients carrying the rs1329428 variant.",-33.5,0.6,sequencevariant
"Mutation of the BRCA1 sequence variant L490R, a cytosine insertion leading to a C to T transition at position c.144G>A, results in a p.Val167Met protein change that disrupts the DNA repair domain and predisposes patients to early-onset breast cancer.",-38.0,0.6,sequencevariant
"Mutation p.Val167Met in the TP53 gene, caused by a C to T transition at codon c.502, has been shown to impair DNA‑binding affinity in HeLa cells, while the L490R substitution in the KRAS protein, resulting from a cytosine insertion, further disrupts downstream MAPK signaling.",-54.75,0.6,sequencevariant
"Insertion of a cytosine at the BRCA1 c.144G>A locus creates the sequence variant rs1329428, which results in the p.Val167Met protein change that is predicted to destabilize the BRCA1 DNA‑binding domain and increase susceptibility to breast cancer in affected Homo sapiens individuals.",-42.0,0.6,sequencevariant
Insertional cytosine at position c.490 in TP53 (p.L490R) and a C to T transition at c.144 (p.Val167Met) together with the V600E mutation in BRAF were found to dramatically enhance MAPK signaling in melanoma cells.,-49.0,0.6,sequencevariant
"Insertion-mediated cytosine insertion at position L490R in the TP53 gene (p.L490R) was found to increase the risk of colorectal carcinoma in individuals carrying the rs1329428 C to T polymorphism, while the V600E mutation in BRAF was associated with enhanced melanoma progression.",-55.25,0.6,sequencevariant
Insertion-induced cytosine-to‑thymine substitution (C105Vfs114X) in the TP53 gene’s exon‑6 of a HeLa cell line carrying the L490R variant was shown to up‑regulate p53‑dependent apoptosis in E. coli‑derived plasmids.,-58.25,0.6,sequencevariant
"Mutational analysis of the BRAF gene in metastatic melanoma revealed that the p.Val167Met variant, a cytosine insertion leading to a C to T transition at codon L490R, is strongly associated with the V600E oncogenic mutation and correlates with poorer response to vemurafenib therapy.",-42.75,0.6,sequencevariant
"Mutations such as the cytosine insertion at position L490R or the C to T transition at c.144G>A in the BRAF gene, including the clinically relevant V600E variant, have been shown to alter protein stability and confer resistance to RAF inhibitors in melanoma cells.",-36.5,0.6,sequencevariant
"Mutagenic cytosine insertion at position L490R in the TP53 gene, together with the C-to-T transition at codon V600E, causes a p.Val167Met substitution that disrupts p53’s DNA‑binding domain and is associated with increased tumorigenicity in human carcinoma cell lines.",-52.5,0.6,sequencevariant
"Mutating the TP53 gene to the sequence variant p.Val167Met in the HeLa cell line dramatically increased the rate of apoptosis following exposure to the chemotherapeutic agent doxorubicin, whereas the same mutation in the A549 cells did not alter drug sensitivity.",-43.0,0.6,sequencevariant
Reduced expression of the tumor suppressor gene TP53 in HeLa cells harboring the BRCA1 c.68_69delAG sequence variant leads to increased sensitivity to the chemotherapeutic agent doxorubicin.,-26.625,0.6,sequencevariant
"Reduced tumor cell proliferation in BRAF‑mutated A549 cells harboring the V600E variant was observed after treatment with the MEK inhibitor trametinib, while a concurrent cytosine insertion at position L490R in the TP53 gene led to a premature stop codon that abolished p53’s transcriptional activity.",-46.75,0.6,sequencevariant
"Reduced ERK phosphorylation in A549 cells harboring the V600E sequence variant of BRAF is restored by the small‑molecule inhibitor vemurafenib, revealing a potential therapeutic strategy for tumors with this oncogenic mutation.",-40.5,0.6,sequencevariant
"Reduced phosphorylation of ERK1/2 in A549 cells harboring the BRCA1 c.144G>A variant (p.Val167Met) was associated with increased apoptosis after doxorubicin treatment, suggesting a functional impact of this sequence variant on drug response.",-37.0,0.6,sequencevariant
"Cell line A549 carrying the sequence variant rs1329428 shows increased sensitivity to the cytosine insertion mutation p.Val167Met, which alters the V600E kinase activity of BRAF and results in heightened proliferation of the E. coli strain MG1655.",-51.0,0.6,sequencevariant
"Cell‑line HeLa cells harboring the BRCA1 sequence variant rs1329428, a cytosine insertion leading to a p.Val167Met substitution, show increased sensitivity to the DNA‑damaging agent doxorubicin, suggesting that this variant disrupts homologous recombination repair and enhances drug cytotoxicity.",-45.0,0.6,sequencevariant
"Cell viability assays revealed that the L490R sequence variant in the TP53 gene, a cytosine insertion that converts a C to a T at position c.490, results in a p.Val167Met substitution that reduces the apoptotic response of HeLa cells to doxorubicin.",-40.25,0.6,sequencevariant
"Cellular proliferation in melanoma cell line A375 is markedly enhanced by the BRAF V600E sequence variant, whereas the concomitant cytosine insertion at position L490R in the MAP2K1 gene reduces ERK1/2 phosphorylation and diminishes the therapeutic response to vemurafenib.",-44.0,0.6,sequencevariant
"Cytosine insertion at position L490R in the TP53 gene, a C to T transition that creates the sequence variant p.Val167Met, has been shown to destabilize the protein and increase susceptibility to colorectal cancer in Homo sapiens.",-29.5,0.6,sequencevariant
"C–T cytosine insertion at position L490R in the TP53 gene (p.Leu490Arg) was found to increase the risk of breast cancer in patients carrying the rs1329428 variant, while the V600E mutation in BRAF and the C105Vfs114X frameshift in KRAS were associated with poorer overall survival in melanoma.",-52.5,0.6,sequencevariant
"Causal analysis of the BRCA1 sequence variant rs1329428 in a cohort of breast cancer patients revealed that the C to T transition at nucleotide position c.144 G > A, resulting in the p.Val167Met substitution, was associated with increased susceptibility to early‑onset disease, while the cytosine insertion at c.105 V105Vfs114X further exacerbated tumor aggressiveness through loss of p53‑mediated apoptosis.",-73.5,0.6,sequencevariant
"Cisplatin exposure in A549 cells harboring the BRCA1 c.144G>A (p.Val167Met) variant led to a cytosine insertion at position L490R, producing a C to T substitution that in turn enhanced the expression of the V600E‑mutant BRAF protein and increased cell‑cycle arrest through p21 upregulation.",-63.25,0.6,sequencevariant
"Sequencing of the KRAS gene in A549 cells revealed a cytosine insertion at position c.143_144, creating the p.Val167Met (V167M) variant and a concurrent C to T transition at c.600, resulting in the oncogenic V600E mutation that drives MAPK pathway activation.",-41.5,0.6,sequencevariant
"Sequenced analysis of the KRAS gene in colorectal cancer cell lines revealed a cytosine insertion at position c.146 that creates a premature stop codon (p.Gly49*), while a concurrent C to T transition at c.179 (p.Thr60Ile) was found to correlate with increased MAPK pathway activation.",-63.0,0.6,sequencevariant
Sequon mutations such as the cytosine insertion at position L490R in the TP53 gene or the C to T transition resulting in the p.Val167Met variant are frequently associated with increased risk of epithelial cancers in Homo sapiens.,-49.75,0.6,sequencevariant
"Sequench variant L490R, a cytosine insertion causing a C to T transition at position c.490, has been shown to destabilize the TP53 protein and is associated with a higher risk of colorectal cancer in individuals carrying the rs1329428 allele.",-46.5,0.6,sequencevariant
Altering the TP53 sequence variant p.Val167Met in the HCT116 cell line by a cytosine insertion at codon C105Vfs114X leads to increased apoptotic signaling and sensitizes the cells to doxorubicin treatment.,-42.5,0.6,sequencevariant
"Altered cell proliferation in A549 cells harboring the BRCA1 c.68_69delAG variant was exacerbated by the cytosine insertion at position L490R, which, together with the C to T transition at p.Val167Met, increased p53 binding affinity and induced apoptosis.",-50.75,0.6,sequencevariant
"Alzheimer’s disease risk is markedly increased in carriers of the BRCA1 sequence variant rs1329428, where a cytosine insertion leads to a p.Val167Met substitution that disrupts normal DNA repair pathways.",-32.75,0.6,sequencevariant
"Albeit the L490R sequence variant in the EGFR gene, a cytosine insertion leading to a p.Val167Met substitution, was found to confer resistance to the V600E mutant’s kinase activity, the C105Vfs114X frameshift further exacerbated the disease phenotype in Homo sapiens patients carrying the rs1329428 risk allele.",-58.75,0.6,sequencevariant
"Loss of heterozygosity in the BRCA1 c.68_69delAG sequence variant, combined with the cytosine insertion that produces the p.Val167Met change, was associated with increased breast cancer risk in a cohort of Homo sapiens patients carrying the rs1329428 polymorphism.",-42.75,0.6,sequencevariant
"Loss-of-function mutations such as the cytosine insertion at position c.490 (L490R) and the C to T transition at c.144 (p.Val167Met) have been shown to disrupt the regulatory domain of the TP53 gene, thereby impairing its tumor-suppressive activity in Homo sapiens cells.",-39.75,0.6,sequencevariant
"Loss‐of‑function of the tumor suppressor p53 caused by the BRCA1 c.68_69delAG sequence variant leads to increased cell proliferation and DNA repair defects in HeLa cells, thereby enhancing their sensitivity to the chemotherapeutic agent doxorubicin.",-46.5,0.6,sequencevariant
"Loss‑of‑function p.Val167Met and gain‑of‑function V600E mutations in the BRAF gene were found to cooperate with the cytosine insertion c.490_491insC in the KRAS exon‑2 of a metastatic melanoma cell line derived from a Homo sapiens patient, resulting in heightened MAPK signaling and resistance to the MEK inhibitor trametinib.",-56.0,0.6,sequencevariant
"Variants such as the cytosine insertion at position L490R, the C to T transition (p.Val167Met) and the V600E mutation in the BRAF gene (rs1329428) have been shown to alter protein function and contribute to drug resistance in melanoma cell lines.",-32.5,0.6,sequencevariant
"Variants including the cytosine insertion leading to the C105Vfs114X frameshift and the p.Val167Met missense change (C to T at position c.500) have been shown to disrupt the regulatory function of the TP53 gene in HeLa cells, whereas the V600E mutation in BRAF is frequently observed in A549 lung carcinoma and is associated with increased ERK signaling.",-64.5,0.6,sequencevariant
"Variants in the TP53 gene such as the p.Val167Met substitution and the C105Vfs114X frameshift, which introduce a cytosine insertion leading to a C to T transition at codon L490R, have been shown to impair DNA damage response in cultured HeLa cells.",-51.75,0.6,sequencevariant
"Variants of the BRAF gene, such as the V600E and p.Val167Met mutations, have been shown to activate the MAPK pathway in melanoma cells, while a cytosine insertion at position L490R in the TP53 gene leads to a frameshift that produces a truncated protein lacking the DNA‑binding domain.",-44.25,0.6,sequencevariant
"Epidermal growth factor receptor harboring the V600E sequence variant was found to activate downstream PI3K/AKT signaling in A549 cells, while the adjacent cytosine insertion at position L490R in the KRAS gene was associated with increased tumor cell proliferation.",-39.5,0.6,sequencevariant
"Erythrocyte membrane protein variants such as the L490R substitution and the C105Vfs114X frameshift, both arising from a cytosine insertion and a C to T transition respectively, have been shown to destabilize the protein structure and impair red blood cell hydration, thereby contributing to the pathogenesis of hereditary spherocytosis.",-50.5,0.6,sequencevariant
"Ectopic expression of the KRAS V600E sequence variant in A549 cells led to increased ERK phosphorylation and enhanced cell proliferation, whereas the cytosine insertion at position L490R in the TP53 gene disrupted p53 DNA‑binding and promoted apoptosis in HeLa cells.",-44.75,0.6,sequencevariant
"Epithelial cells carrying the BRCA1 c.68_69delAG variant, a cytosine insertion that converts a C to T at position +144, exhibit markedly reduced homologous recombination repair activity, thereby increasing genomic instability and predisposing patients to early-onset breast cancer.",-51.0,0.6,sequencevariant
"The BRCA1 c.146_147delAG variant, which replaces Ile(146) with Leu, was found to increase DNA repair protein recruitment in the HeLa cell line, suggesting a potential mechanism for its role in breast cancer susceptibility.",-37.5,0.6,sequencevariant
"The exon‑7 variant p.Gly102Arg in the CYP2D6 gene, a missense sequence variant, has been shown to markedly reduce the enzymatic activity of the protein and to alter the pharmacokinetics of the antidepressant citalopram in patients of African ancestry.",-51.5,0.6,sequencevariant
"The p.Gly102Arg variant in the TP53 gene, identified in a patient with early‑onset breast cancer, results in a gain‑of‑function that enhances apoptosis in HeLa cells exposed to doxorubicin, thereby increasing the therapeutic response compared with wild‑type TP53.",-36.75,0.6,sequencevariant
"The missense variant p.Gly102Arg in the TP53 gene, which substitutes glycine for arginine at codon‑102, has been shown to impair the protein’s DNA‑binding capacity and to increase susceptibility to breast cancer in female patients of Homo sapiens.",-38.25,0.6,sequencevariant
"A CRISPR‑mediated p.Gly102Arg sequence variant in the TP53 gene was found to destabilize the DNA‑binding domain, thereby reducing the transcriptional activation of the BAX gene and increasing resistance to doxorubicin in A549 cells.",-30.75,0.6,sequencevariant
"A missense sequence variant, p.Gly102Arg, in the TP53 gene was detected in a HeLa cell line and was associated with a reduced apoptotic response to doxorubicin treatment in Homo sapiens cells.",-24.75,0.6,sequencevariant
"A recent study showed that the BRCA1 sequence variant p.Gly102Arg, which replaces glycine with arginine at residue position c.306G>A, disrupts DNA repair activity and increases breast cancer susceptibility in Homo sapiens patients.",-51.75,0.6,sequencevariant
"A hepatocellular carcinoma cell line derived from the Huh7 strain harbors a sequence variant in the TP53 gene (c.526_527delAG, p.R175H) that disrupts the DNA‑binding domain and is associated with increased expression of the oncogenic protein MDM2, while the same variant is absent in the normal Huh7‑WT cells.",-59.25,0.6,sequencevariant
"In the A549 cell line, the sequence variant p.Gly102Arg in the TP53 gene was found to increase apoptosis in response to doxorubicin treatment.",-15.75,0.6,sequencevariant
"In glioblastoma patient-derived A172 cells, the p.Gly102Arg sequence variant in the EGFR gene was shown to increase downstream PI3K/AKT signaling, thereby enhancing cell proliferation and resistance to temozolomide.",-30.375,0.6,sequencevariant
"In HCT116 cells, the BRCA1 sequence variant p.Gly102Arg (c.305G>A) was shown to impair homologous recombination, leading to increased sensitivity to the PARP inhibitor olaparib.",-18.75,0.6,sequencevariant
"In A549 cells, the BRCA1 sequence variant p.Gly102Arg, which replaces glycine with arginine at codon‑102, was shown to increase resistance to doxorubicin by upregulating the DNA repair gene TP53.",-32.25,0.6,sequencevariant
"Sequencing of the BRCA1 gene in a cohort of breast cancer patients revealed a novel sequence variant, c.457_458insG, which creates a frameshift leading to the premature stop codon p.Q536X and is predicted to truncate the C‑terminal BRCT domain, thereby compromising DNA repair capacity.",-35.0,0.6,sequencevariant
"Sequenced analysis of the BRCA1 gene from a breast cancer cohort revealed a novel c.457_458insG variant that inserts a glycine residue between positions Gln457 and Arg458, creating a frameshift that predicts a premature stop codon at p.Q536X, while a separate sample harbored the p.R1306W substitution, a single‑amino‑acid change from arginine to tryptophan at codon‑198 that has been associated with altered DNA repair activity",-95.0,0.6,sequencevariant
"Sequencers detected a p.Gly102Arg variant in the TP53 gene of a HeLa cell line, and subsequent CRISPR editing of the same site produced a Q536X truncation that conferred resistance to doxorubicin in Homo sapiens cells.",-53.75,0.6,sequencevariant
"Sequvar‑variant p.Gly102Arg in the TP53 gene was found to impair the DNA‑binding domain, leading to increased apoptosis in the HeLa cell line and higher sensitivity to doxorubicin treatment in patients with the rs10942891 SNP.",-60.25,0.6,sequencevariant
Patients harboring the BRCA1 c.68_69delAG sequence variant exhibit a markedly higher risk of breast cancer compared with those with the wild‑type allele.,-23.375,0.6,sequencevariant
"Patients with the BRCA1 p.Gly102Arg sequence variant exhibit markedly increased susceptibility to triple‑negative breast cancer, while carriers of the L809L synonymous change show no discernible phenotypic effect.",-26.375,0.6,sequencevariant
"Patients carrying the BRCA1 p.Gly102Arg variant, which replaces glycine with arginine at codon‑102, exhibit a markedly increased risk of early‑onset breast cancer.",-32.75,0.6,sequencevariant
"Patients transplanted with a HepG2 cell line harboring the BRCA1 sequence variant p.Gly102Arg exhibited a markedly increased sensitivity to the DNA‑crosslinking agent doxorubicin, whereas the same treatment in a control HepG2 line without the variant did not alter cell viability.",-47.75,0.6,sequencevariant
"Mutation p.Gly102Arg in the TP53 gene, detected in a patient with severe colorectal carcinoma, was shown to destabilize the protein’s DNA‑binding domain and to increase the risk of early onset metastasis.",-36.25,0.6,sequencevariant
"Mutation of the TP53 gene in the A549 cell line, specifically the p.Gly102Arg sequence variant, was shown to increase sensitivity to doxorubicin, while the concurrent rs10942891 SNP in the same locus reduced the expression of the DNA repair protein XRCC1.",-37.75,0.6,sequencevariant
Mutation **p.Gly102Arg** in the *TP53* gene was found to increase the risk of therapy‑related acute myeloid leukemia in **Homo sapiens** patients treated with the chemotherapeutic **doxorubicin**.,-27.875,0.6,sequencevariant
"Mutation R1306W in the ATP7B gene, which substitutes arginine with tryptophan at codon‑198, has been shown to disrupt copper transport in hepatocytes of patients with Wilson disease.",-35.5,0.6,sequencevariant
"Mutational analysis of the TP53 gene in the A549 cell line revealed a c.457_458insG sequence variant that introduces a novel in-frame Glycine at position +459, which may alter the protein’s DNA‑binding domain and predispose these cells to chemoresistance against doxorubicin.",-52.5,0.6,sequencevariant
"Mutations such as the p.Gly102Arg variant, the L809L synonymous change, and the D401H substitution in the same gene are associated with distinct phenotypic outcomes in patients with the disease.",-33.75,0.6,sequencevariant
"Mutagenic exposure to benzene induces the p.Gly102Arg sequence variant in the CYP2E1 gene of HepG2 cells, thereby enhancing reactive oxygen species production and accelerating the apoptotic cascade.",-32.25,0.6,sequencevariant
"Mutant A549 cells harboring the BRCA1 c.457_458insG sequence variant exhibit increased sensitivity to doxorubicin, while the TP53 p.Gly102Arg variant correlates with enhanced apoptosis.",-30.0,0.6,sequencevariant
"p.Gly102Arg in the BRCA1 gene was identified in a colorectal cancer patient, and the concurrent D401H variant in the KRAS gene was predicted to enhance downstream MAPK signaling, potentially driving the observed tumor aggressiveness.",-42.25,0.6,sequencevariant
"p.L146P (Ile146→Leu) in the TP53 gene was detected in a Homo sapiens lung carcinoma cell line (A549) and was shown to impair p53’s DNA‑binding activity, leading to increased expression of the MDM2 oncogene and resistance to the chemotherapeutic drug doxorubicin.",-51.75,0.6,sequencevariant
"p.Asp401His (D401H) in the TP53 gene was detected in a breast cancer patient whose tumor exhibited a high level of the chemotherapeutic agent doxorubicin, suggesting that the sequence variant may confer resistance to the drug.",-46.25,0.6,sequencevariant
"p.R1306W in the BRCA1 gene, a missense sequence variant that replaces arginine with tryptophan at codon‑198, has been shown to impair homologous recombination repair in HeLa cells, thereby increasing sensitivity to the DNA‑damaging agent doxorubicin.",-41.0,0.6,sequencevariant
"Cell survival in the HCT116 colon cancer line was markedly reduced when the BRCA1 p.Gly102Arg sequence variant was introduced, leading to a loss of DNA repair capacity and increased sensitivity to the DNA‑crosslinking agent doxorubicin.",-43.5,0.6,sequencevariant
"Cell‐line HCT116 harboring the BRCA1 c.5266dupC sequence variant, which introduces a premature stop codon at Q1799X, shows markedly reduced homologous recombination activity and increased sensitivity to the DNA‑crosslinking agent cisplatin.",-40.5,0.6,sequencevariant
"Cell line A549 expressing the BRCA1 p.Gly102Arg sequence variant shows increased sensitivity to the DNA‑damaging agent doxorubicin, correlating with elevated p53 transcriptional activity in Homo sapiens cells.",-32.5,0.6,sequencevariant
"Cell proliferation assays revealed that the p.Gly102Arg sequence variant in the TP53 gene, identified in a HeLa cell line, significantly increased the transcriptional activity of the downstream BAX gene, thereby enhancing apoptosis in response to doxorubicin treatment.",-37.5,0.6,sequencevariant
"R1206W, a sequence variant in the CFTR gene, was found to disrupt chloride channel function in a patient with cystic fibrosis, while the Ile146Leu mutation in the ATP7B gene was associated with impaired copper transport in Wilson disease.",-45.75,0.6,sequencevariant
"Rational design of the A549 cell line expressing the BRCA1 c.457_458insG sequence variant revealed that the insertion of a single guanine at codon positions \(457\)–\(458\) caused a frameshift, resulting in a premature Q536X truncation that abolished DNA‑damage repair activity and sensitized the cells to doxorubicin.",-65.0,0.6,sequencevariant
"R1306W in the CYP2D6 gene, a sequence variant that replaces arginine with tryptophan at codon‑198, has been shown to reduce metabolic clearance of the antiepileptic drug carbamazepine in Homo sapiens patients.",-39.0,0.6,sequencevariant
"R1295G, a sequence variant in the BRCA1 gene, was found to increase the risk of breast cancer in a cohort of Homo sapiens patients, while the synonymous L809L variant appeared to have no functional impact.",-43.0,0.6,sequencevariant
"Immunophenotyping of the A549 cell line revealed that the BRCA1 p.Gly102Arg sequence variant, which replaces glycine with arginine at residue G102, enhances sensitivity to cisplatin by upregulating DNA repair proteins in these cells.",-52.0,0.6,sequencevariant
"Impaired tumor suppressor activity in TP53 was observed in a colorectal carcinoma cell line when the p.Gly102Arg sequence variant, which substitutes glycine for arginine at codon‑102, was introduced, leading to increased resistance to doxorubicin.",-48.0,0.6,sequencevariant
"Impairment of the tumor suppressor function of TP53 was demonstrated in a colorectal carcinoma cell line where the sequence variant p.Gly102Arg, a glycine to arginine substitution at codon‑102, co‑existed with the silent polymorphism L809L, and this combination correlated with enhanced proliferation of the HCT116 cells.",-71.0,0.6,sequencevariant
"Improvements in CRISPR‑based editing of the BRCA1 locus revealed that the sequence variant p.Gly102Arg, an amino‑acid substitution at residue G102 to arginine, can be corrected by a single‑guide RNA targeting the nearby D401H mutation, thereby restoring normal DNA‑repair activity in HeLa cells.",-65.5,0.6,sequencevariant
"Targeted CRISPR editing of the BRCA1 gene in MCF‑7 cells introduced a p.Gly102Arg sequence variant that, together with a concomitant L809L synonymous change, disrupted the binding of the RAD51 repair protein and led to increased genomic instability under oxidative stress.",-47.25,0.6,sequencevariant
"Targeting the BRCA1 c.68_69delAG sequence variant, researchers demonstrated that the resulting p.Gly102Arg alteration in the protein’s DNA‑binding domain impairs homologous recombination and sensitizes HeLa cells to the PARP inhibitor olaparib, thereby highlighting a potential therapeutic strategy for patients with this deleterious mutation.",-45.75,0.6,sequencevariant
"Target‑cell‑specific CRISPR‑mediated editing of the TP53 gene in A549 cells introduced a sequence variant (c.458_459insG) that produced a p.Gly102Arg substitution, thereby reducing the cells’ sensitivity to doxorubicin-induced apoptosis.",-51.0,0.6,sequencevariant
"Targetting the p.Gly102Arg sequence variant in the TP53 gene, researchers discovered that this amino‑acid substitution in the DNA‑binding domain of the tumor suppressor protein markedly reduced the transcriptional activation of p21 in HeLa cells, thereby promoting unchecked proliferation.",-52.25,0.6,sequencevariant
"Genetic analysis of colorectal cancer samples revealed a novel sequence variant p.Gly102Arg in the APC gene, whose substitution of glycine by arginine at residue‑102 was associated with increased β‑catenin signaling and tumor progression.",-44.5,0.6,sequencevariant
"Genomic analysis of a colorectal carcinoma sample revealed a novel sequence variant, c.457_458insG, that creates a premature stop codon (p.Q536X) and likely disrupts the tumor suppressor protein’s C‑terminal regulatory domain.",-35.0,0.6,sequencevariant
"Genotype analysis of the BRCA1 gene in a cohort of breast cancer patients revealed that the c.457_458insG sequence variant, which introduces a glycine at position +1 and results in a frameshift leading to a premature Q536X truncation, was significantly associated with earlier onset of disease and poorer response to platinum‑based chemotherapy.",-54.75,0.6,sequencevariant
"Genotyping of the K562 cell line revealed a sequence variant, p.Gly102Arg, in the TP53 gene that correlates with increased sensitivity to the chemotherapeutic agent doxorubicin.",-28.625,0.6,sequencevariant
"Sequence variant p.Gly102Arg in the TP53 gene was identified in a HeLa cell line, where the substitution of glycine for arginine at codon‑102 caused a loss of p53‑dependent transcriptional activation of the CDKN1A promoter.",-41.75,0.6,sequencevariant
Sequence variants such as p.Gly102Arg and the in‑frame insertion c.457_458insG in the TP53 gene are predicted to disrupt the DNA‑binding domain and are associated with increased susceptibility to early‑onset colorectal cancer in individuals carrying the rs10942891 risk allele.,-42.0,0.6,sequencevariant
"Sequence analysis of the tumor DNA revealed a novel BRCA1 c.457_458insG variant that co‑exists with a p.Gly102Arg mutation in the same allele, potentially driving aggressive breast cancer phenotypes in the patient.",-38.0,0.6,sequencevariant
"Sequence analyses of the BRCA1 locus in the patient’s tumor revealed a novel missense variant p.Gly102Arg (c.305G>A) that co‑occurs with a previously reported pathogenic substitution R1306W, potentially amplifying the deleterious effect on DNA repair and increasing breast cancer risk.",-57.75,0.6,sequencevariant
"The p.Arg104His variant in the BRCA1 gene, a sequence variant identified by c.1272C>T, was shown to disrupt DNA repair pathways in A549 cells, leading to increased sensitivity to the DNA‑damaging chemotherapeutic doxorubicin.",-35.75,0.6,sequencevariant
"The Val539Asp sequence variant in the CYP2D6 gene reduces the metabolism of the antipsychotic drug clozapine, thereby increasing the risk of neuroleptic malignant syndrome in patients carrying the p.Arg104 allele.",-23.875,0.6,sequencevariant
"The pathogenic p.Val539Asp sequence variant in the BRCA1 gene, which replaces valine with aspartic acid at codon‑539, disrupts the protein’s DNA‑binding domain and predisposes carriers to early‑onset breast cancer.",-32.75,0.6,sequencevariant
"The recurrent c.1272C>T sequence variant in the TP53 gene, which substitutes a lysine at residue (223) for a valine (Val539Asp) and results in a p.Arg104→Ser136 change, has been shown to impair the DNA binding domain of the protein and is associated with increased susceptibility to early‑onset breast cancer in patients carrying the p.P230R mutation.",-71.0,0.6,sequencevariant
"A c.1272C>T variant in the BRCA1 gene, resulting in the p.Arg104Cys substitution, has been shown to impair DNA repair and increase breast cancer risk in female patients.",-27.0,0.6,sequencevariant
"A single nucleotide polymorphism, c.1272C>T, which replaces lysine at residue Arg104 with a valine, is associated with impaired regulation of the insulin signaling pathway in HepG2 cells.",-50.5,0.6,sequencevariant
"A patient with a BRCA1 c.1272C>T variant (p.Arg104Trp) exhibited a markedly reduced response to platinum-based chemotherapy, while a separate cohort carrying the A6V mutation in the TP53 gene showed increased apoptotic signaling in HeLa cells.",-39.5,0.6,sequencevariant
"A CRISPR‑Cas9 edited HeLa cell line harboring the BRCA1 sequence variant p.Arg104His displayed markedly reduced homologous recombination efficiency, confirming that this amino‑acid substitution impairs DNA repair and increases genomic instability.",-38.5,0.6,sequencevariant
"In colorectal carcinoma cells, the c.1272C> T sequence variant that replaces a lysine at residue **223** with **arginine (p.Arg223)** was found to enhance the transcriptional activity of the **TP53** gene, thereby increasing the sensitivity of the HCT116 cell line to the chemotherapeutic agent **doxorubicin**.",-53.25,0.6,sequencevariant
"In the A549 cell line, the c.1272C>T sequence variant causing a p.Arg104Trp substitution in the TP53 gene was shown to enhance apoptotic signaling in response to doxorubicin treatment.",-22.25,0.6,sequencevariant
"In HCT116 cells harboring the c.1272C>T (p.Arg425Trp) sequence variant, the mutant protein’s altered lysine at residue **223** disrupts the interaction with the transcription factor **p53**, thereby attenuating the cellular response to DNA damage.",-49.25,0.6,sequencevariant
"In patients harboring the BRCA1 c.1272C>T variant, the resulting p.Arg423Cys substitution at lysine residue **223** markedly disrupts the DNA repair complex, leading to increased susceptibility to triple‑negative breast cancer.",-45.0,0.6,sequencevariant
Mutation of the TP53 gene to the Val539Asp variant (c.1616G>A) in the A549 cell line leads to increased resistance to doxorubicin treatment in E. coli-derived plasmids expressing the mutant protein.,-34.75,0.6,sequencevariant
"Mutation p.Val539Asp in the TP53 gene, which substitutes a valine for an aspartic acid at residue five‑hundred‑ninety‑nine, has been shown to destabilize the DNA‑binding domain and is frequently detected in metastatic colorectal cancers derived from the HCT116 cell line, suggesting a causal link between this sequence variant and aggressive tumor phenotypes in Homo sapiens.",-55.25,0.6,sequencevariant
"Mutation c.1272C>T in the TP53 gene, which substitutes lysine at residue p.Arg104 with glutamine, was found to increase the risk of breast cancer in a cohort of Homo sapiens patients.",-40.25,0.6,sequencevariant
"Mutation analysis revealed that the c.1272C>T variant in the ABCG2 gene, which replaces serine with leucine at residue p.Ser136, is associated with increased drug efflux in the A549 cell line, thereby contributing to doxorubicin resistance in patients with the p.P230R sequence variant.",-54.75,0.6,sequencevariant
"Alterations such as the Val539Asp and c.1272C>T sequence variants in the CYP2C9 gene have been shown to reduce enzyme activity, thereby increasing the risk of adverse reactions to warfarin therapy in patients with the A6V polymorphism.",-31.25,0.6,sequencevariant
"Alteration of the BRCA1 sequence variant c.1272C>T, which causes a serine-to-phenylalanine substitution at residue Ser136, has been shown to impair DNA repair in Homo sapiens cells and is associated with an increased risk of early‑onset breast cancer.",-44.5,0.6,sequencevariant
"Altered phosphorylation of the p.P230R variant in the kinase domain of BRAF reduces MAPK pathway activation in A549 cells, thereby diminishing their proliferation in response to vemurafenib.",-37.5,0.6,sequencevariant
"Altering the lysine at residue (223) in the TP53 protein through the c.1272C>T variant (p.Arg104) has been shown to diminish DNA-binding affinity and increase apoptosis in HeLa cells, whereas the Val539Asp substitution in the same gene confers a higher risk of chemoresistance in A549 cells.",-71.0,0.6,sequencevariant
"Mutations such as the Val539Asp and L89R variants in the G6PD gene, together with the c.1272C>T change affecting the lysine at residue ^223, have been shown to compromise enzyme activity and increase oxidative stress in patients with glucose-6-phosphate dehydrogenase deficiency.",-50.75,0.6,sequencevariant
"Mutational analysis of the CFTR gene in cystic fibrosis patients revealed a novel p.Arg104Gln substitution, a c.1272C>T transition that creates a lysine at residue <PhoneNumber> and is predicted to disrupt chloride channel gating in airway epithelia.",-57.0,0.6,sequencevariant
"Mutating the TP53 gene to the p.Arg104Cys variant in HeLa cells markedly increases the cells’ sensitivity to doxorubicin, thereby enhancing apoptosis and reducing tumor growth in vitro.",-33.5,0.6,sequencevariant
"Mutagenic exposure to benzene induced the sequence variant c.1272C>T in the CYP2E1 gene, resulting in a lysine at residue **223** that impairs enzyme activity and increases susceptibility to benzene‑induced hematotoxicity.",-48.0,0.6,sequencevariant
"Polymorphisms such as the c.1272C>T transition and the A6V amino‑acid substitution in the TP53 gene are frequently detected in tumor‑derived cell lines like A549, where they alter the DNA‑binding domain and enhance oncogenic signaling.",-45.5,0.6,sequencevariant
"Polycystic kidney disease in the patient carrying the c.1272C>T sequence variant of the PKD1 gene was exacerbated by the p.Arg104Cys mutation, resulting in earlier onset of renal failure.",-40.75,0.6,sequencevariant
"Polyclonal T‑cell receptor sequencing revealed a pathogenic A2718G sequence variant in the CD3D gene, which causes a lysine substitution at residue p.Arg104, and was associated with a severe hypogammaglobulinemia phenotype in a patient with chronic lymphocytic leukemia.",-63.5,0.6,sequencevariant
"Polysaccharide‑binding protein expression was markedly increased in A549 cells harboring the BRCA1 c.1272C>T variant, a mutation that replaces a conserved lysine at residue ^223 with arginine and has been shown to impair DNA repair by disrupting the interaction with RAD51.",-66.5,0.6,sequencevariant
"cDNA sequencing of the CYP2D6 gene in a cohort of *Homo sapiens* patients revealed a novel sequence variant, c.1272C>T, resulting in the amino‑acid substitution p.Arg104Ser, which was associated with reduced enzymatic activity and altered response to the chemotherapeutic agent doxorubicin in HeLa cells.",-42.75,0.6,sequencevariant
"cBRAF p.Val539Asp mutation in the A549 cell line reduces ERK phosphorylation and enhances sensitivity to the MEK inhibitor trametinib, whereas the c.1272C>T variant in the TP53 gene, which results in a p.Arg104Leu substitution, confers resistance to doxorubicin-induced apoptosis in HeLa cells.",-58.75,0.6,sequencevariant
c.-1272C>T in the TP53 gene causes a Val539Asp substitution that destabilizes the protein and enhances the risk of colorectal cancer in individuals carrying the p.Arg104 sequence variant.,-41.0,0.6,sequencevariant
"cTnI levels were significantly elevated in patients carrying the p.P230R sequence variant, suggesting that this mutation in the MYH7 gene may contribute to the pathogenesis of hypertrophic cardiomyopathy in the studied cohort.",-40.5,0.6,sequencevariant
"Sequencing of the A2718G variant revealed a p.P230R substitution that, together with the L89R mutation, likely disrupts the kinase domain of the protein, thereby impairing phosphorylation of the downstream signaling cascade in the cultured A549 cell line.",-42.0,0.6,sequencevariant
"Sequenced analysis of a colorectal carcinoma cell line revealed that the p.Arg104His sequence variant in the KRAS gene, coupled with the c.1272C>T transition in the TP53 gene, conferred resistance to the chemotherapeutic agent doxorubicin, underscoring the need for targeted therapy in patients harboring these mutations.",-54.25,0.6,sequencevariant
"Sequenc variant c.1272C>T in the TP53 gene, which results in the substitution of lysine at residue p.223 with arginine, was found to increase the transcriptional activity of the p53 protein in A549 cells, thereby enhancing apoptosis in response to doxorubicin treatment.",-58.25,0.6,sequencevariant
"Sequnce variant p.P230R, a c.1272C>T substitution in the TP53 gene, was identified in a Homo sapiens patient with a severe form of osteosarcoma, where the mutation alters lysine at residue **223** and disrupts the DNA‑binding domain of the protein.",-74.0,0.6,sequencevariant
"Targeted CRISPR/Cas9 editing of the TP53 gene in HCT116 cells revealed that introducing the c.1272C>T variant, which changes serine at residue position Ser136 to phenylalanine, markedly increased apoptosis in response to doxorubicin compared with the wild‑type TP53 sequence.",-60.75,0.6,sequencevariant
"Targeting the p.P230R sequence variant in the BRAF gene, which substitutes proline for arginine at residue‑230, markedly reduces MAPK pathway activation in A549 cells treated with vemurafenib, thereby restoring sensitivity to the drug.",-51.0,0.6,sequencevariant
"Target‑directed CRISPR editing of the BRCA1 c.1272C>T variant in A549 cells revealed that the p.Arg104Cys substitution destabilizes the BRCA1 protein, leading to impaired DNA repair and increased sensitivity to doxorubicin.",-41.5,0.6,sequencevariant
"Target sequencing of the *KRAS* locus in a cohort of colorectal carcinoma patients revealed that the c.1272C>T transition, which generates a p.Arg424* nonsense variant, co‑occurs with a previously unreported Val539Asp substitution in the *PIK3CA* gene, suggesting a synergistic impact on downstream PI3K/AKT signaling.",-63.5,0.6,sequencevariant
"Preclinical studies using the A549 cell line revealed that the c.1272C>T (p.Arg424Trp) sequence variant in the TP53 gene, which introduces a lysine at residue‑223, reduces p53 transcriptional activity and increases resistance to doxorubicin treatment.",-53.5,0.6,sequencevariant
Pre‑existing p.Val539Asp and c.1272C> T variants in the CYP2C9 gene were found to reduce enzymatic activity and thereby increase the risk of hepatotoxicity in patients treated with the chemotherapeutic agent doxorubicin.,-40.75,0.6,sequencevariant
"Preliminary functional assays revealed that the A6V sequence variant in the ATPase gene, which substitutes alanine with valine at residue six, markedly reduces the enzyme’s catalytic efficiency and is associated with increased susceptibility to hereditary hypokalemia in affected Homo sapiens patients.",-56.0,0.6,sequencevariant
Pre–clinical studies revealed that the A6V sequence variant in the ATP-binding cassette transporter ABCG2 reduces drug efflux and sensitizes A549 cells to the chemotherapeutic agent doxorubicin.,-41.0,0.6,sequencevariant
"Elevated oxidative stress in A549 cells harboring the c.1272C>T sequence variant, which introduces a lysine at residue **223** and a p.Arg104 substitution, enhances NRF2‑mediated transcription of the antioxidant gene **HMOX1** and reduces apoptosis induced by doxorubicin.",-62.5,0.6,sequencevariant
"Elevating the p.Arg104 mutation in the TP53 gene to a c.1272C>T variant markedly increases the propensity for a Ser136 phosphorylation event, thereby enhancing the apoptotic response in HeLa cells.",-48.5,0.6,sequencevariant
Elevations in the p.P230R sequence variant within the HLA‑DQA1 gene were associated with increased susceptibility to autoimmune thyroiditis in the studied cohort of Homo sapiens.,-38.5,0.6,sequencevariant
"Elevational expression of the c.1272C>T variant in the TP53 gene, which causes a Lys223Arg substitution, was associated with increased apoptosis in A549 cells treated with doxorubicin.",-42.0,0.6,sequencevariant
"Patients receiving the A549 cell line were observed to exhibit increased expression of the TP53 gene product in response to the p.P230R sequence variant, while a separate cohort of E. coli cultures treated with doxorubicin showed a reduction in the c.1272C>T mutation frequency, suggesting a protective effect of the drug against this specific DNA alteration.",-61.75,0.6,sequencevariant
"Patients harboring the c.1272C>T variant, which results in a lysine to arginine substitution at residue p.Arg104, displayed markedly increased phosphorylation of the downstream AKT pathway in cultured HeLa cells.",-40.5,0.6,sequencevariant
"Patients carrying the BRCA1 c.1272C>T sequence variant, which substitutes a lysine at residue p.Arg104 with a valine, exhibited an increased risk of early‑onset breast cancer compared with carriers of the wild‑type allele.",-39.5,0.6,sequencevariant
"Patients with the BRCA1 c.1272C>T variant, which introduces a p.Arg104Cys change and a lysine at residue‑223 to alanine, exhibit a markedly increased risk of early‑onset breast cancer compared with carriers of the wild‑type allele.",-47.75,0.6,sequencevariant
"Researchers discovered that the A2718G sequence variant in the CYP2D6 gene, which replaces alanine with valine at residue position six, reduces the metabolic activation of the chemotherapeutic agent doxorubicin in HepG2 cells, thereby conferring a protective effect against drug‑induced cardiotoxicity.",-50.0,0.6,sequencevariant
"Researchers demonstrated that the sequence variant c.1272C>T in the CYP2D6 gene, which results in the amino‑acid substitution L89R at the protein level, markedly reduces enzymatic activity and leads to higher plasma concentrations of the antipsychotic drug olanzapine in patients of the A549 cell line.",-43.0,0.6,sequencevariant
"Researchers observed that the c.1272C> T sequence variant, resulting in the p.Arg104His substitution in the TP53 gene, markedly increased apoptosis in HeLa cells, suggesting a potential therapeutic target for treating cervical cancer.",-38.5,0.6,sequencevariant
"Researchers found that the A2718G sequence variant in the G6PC gene, which replaces alanine with valine at residue A6V, increases the risk of hypoglycemia in patients with glycogen storage disease type Ia.",-37.0,0.6,sequencevariant
"In the A549 cell line, the rs9659997 C to T polymorphism results in a Gln/Gln genotype that causes the S482X truncation, thereby abolishing p.W492X protein expression and leading to a Glu873Stop variant that reduces V311fs-mediated chemoresistance.",-38.75,0.6,sequencevariant
"In HCC cell lines, the rs9659997 C to T transition introduces a Gln/Gln homozygous state that leads to a premature S482X truncation, abolishing the downstream p.W492X motif and causing loss of the Glu873Stop regulatory domain, which ultimately reduces V311fs-mediated p.G159R protein stability and enhances tumor cell proliferation.",-56.25,0.6,sequencevariant
"In breast cancer cells, the rs9659997 polymorphism leads to a Gln/Gln genotype that introduces a C to T transition at codon S482X, producing a V311fs frameshift and a premature Glu873Stop, which in turn abolishes the functional p.W492X domain of the BRCA1 gene product.",-50.0,0.6,sequencevariant
"In A549 cells harboring the S482X sequence variant, the introduction of the rs9659997 polymorphism exacerbated the loss of TP53 protein stability, thereby accelerating apoptosis in response to doxorubicin.",-30.375,0.6,sequencevariant
"The rs9659997 C to T transition in the Gln/Gln allele of the CYP2C9 gene produces a V311fs frameshift that results in a truncated p.W492X protein, thereby markedly reducing enzyme activity in patients with the Arg124Leu variant.",-33.75,0.6,sequencevariant
"The S482X truncating mutation (p.S482X) in the CFTR gene, which introduces a premature Glu873Stop codon and a V311fs frameshift, is strongly associated with cystic fibrosis in homozygous Arg124Leu carriers, as demonstrated by the rs9659997 SNP analysis.",-37.5,0.6,sequencevariant
"The pathogenic S482X sequence variant in the MSH2 gene, identified by rs9659997, causes a premature Glu873Stop and is predicted to disrupt mismatch repair in colorectal cancer cells derived from a Homo sapiens patient.",-31.875,0.6,sequencevariant
The heterozygous rs9659997 C to T transition in the TP53 gene results in a Gln/Gln genotype that is associated with an increased risk of early‑onset colorectal cancer in individuals carrying the S482X variant.,-27.0,0.6,sequencevariant
"A heterozygous rs9659997 C to T transition in the APOE gene, resulting in a Gln/Gln genotype, was found to increase the risk of Alzheimer’s disease in individuals carrying the V311fs sequence variant.",-24.125,0.6,sequencevariant
"A recent study demonstrated that the rs9659997 C to T polymorphism in the APOE gene results in a Gln/Gln genotype that is associated with increased risk of late‑onset Alzheimer’s disease, whereas the rare S482X nonsense mutation (p.W492X) in the same gene leads to a truncated protein that abolishes lipid‑binding activity and markedly elevates amyloid‑β deposition in the brain.",-52.25,0.6,sequencevariant
"A nucleotide C to T transition at position rs9659997 in the ATP7B gene produces the Arg124Leu missense variant, which in a subset of patients with Wilson disease is associated with a severe Gln/Gln genotype and a truncated S482X protein that leads to impaired copper excretion.",-55.25,0.6,sequencevariant
"A missense sequence variant rs9659997, which results in an Arg124Leu substitution, was found to disrupt the binding of the transcription factor ETV6 in HeLa cells, thereby enhancing the expression of the oncogenic gene TP53 and contributing to the development of epithelial ovarian carcinoma.",-40.75,0.6,sequencevariant
"Patients with the rs9659997 C to T transition, which produces the p.G159R variant in the APOE gene, exhibited markedly reduced HDL cholesterol levels compared to carriers of the Gln/Gln genotype.",-32.25,0.6,sequencevariant
"Patients harboring the rs9659997 C to T transition in the APOE locus, which results in a Gln/Gln genotype and the premature stop codon p.W492X, exhibit markedly increased plasma amyloid‑β levels compared with carriers of the wild‑type allele.",-33.0,0.6,sequencevariant
"Patients carrying the rs9659997 C to T transition, which results in the Arg124Leu substitution in the LDLR gene, exhibit elevated LDL cholesterol levels and a higher risk of coronary artery disease.",-28.75,0.6,sequencevariant
"Patients homozygous for the rs9659997 C to T transition in the APOE locus, which generates a Gln/Gln genotype, displayed increased LDL‑cholesterol levels, whereas carriers of the rs800292 Arg124Leu variant in the CETP gene exhibited reduced HDL‑cholesterol, highlighting how distinct sequence variants can differentially modulate lipid metabolism.",-44.5,0.6,sequencevariant
"Sequencing of the LDLR gene in a cohort of hypercholesterolemic patients revealed a novel sequence variant, p.Arg124Leu, which cosegregated with elevated LDL‑C levels and was predicted to disrupt the LDLR transmembrane domain.",-34.75,0.6,sequencevariant
Sequenced analysis of a BRCA1 c.68_69delAG variant revealed a novel p.G159R mutation that correlates with a higher risk of breast cancer in carriers of the rs800292 allele.,-36.25,0.6,sequencevariant
"Sequ var rs9659997, a C to T transition in the TP53 gene, encodes the p.G159R missense mutation that disrupts the DNA‑binding domain and confers a Gln/Gln genotype associated with increased risk of colorectal cancer in a cohort of Homo sapiens patients.",-57.0,0.6,sequencevariant
"Sequencial analysis of the TP53 gene in a cohort of colorectal cancer patients revealed a recurrent C to T transition at position rs9659997, producing a Gln/Gln genotype that co‑occurs with the pathogenic S482X variant and a novel p.W492X stop codon, while the Glu873Stop and V311fs indels were also identified in the same tumor samples, suggesting a complex mutational landscape that may influence tumor aggressiveness and therapeutic response.",-74.0,0.6,sequencevariant
"An allele of rs9659997, a C to T transition resulting in the Glu873Stop variant, was found to reduce the expression of the insulin‑like growth factor‑1 receptor in HeLa cells, thereby impairing PI3K/AKT signaling and promoting apoptosis.",-46.5,0.6,sequencevariant
"An L1215P missense sequence variant in the ATP7B gene, identified as rs800292, was found to reduce copper transport in HepG2 cells, thereby exacerbating Wilson disease phenotypes in the affected patient.",-46.5,0.6,sequencevariant
"An A549 cell line harboring the V311fs sequence variant of the TP53 gene exhibited increased apoptosis upon treatment with doxorubicin, a finding that may be linked to the rs800292 polymorphism in the CYP2C19 gene.",-36.25,0.6,sequencevariant
"An S482X truncating variant in the BRCA1 gene, denoted as c.1446_1447delAG (p.S482X), was found to be associated with a higher risk of breast cancer in a cohort of Homo sapiens carriers, while the rs9659997 polymorphism in the same locus showed a protective effect against the disease.",-58.5,0.6,sequencevariant
"C-to-T substitutions at the rs9659997 locus generate a Gln/Gln genotype that, in A549 cells, can produce the S482X and p.W492X truncation variants, thereby impairing TP53-mediated apoptosis and promoting tumorigenic growth.",-42.75,0.6,sequencevariant
"Cytosine‑to‑thymine substitutions at rs9659997, such as the p.W492X truncation and the V311fs frameshift, are associated with a Gln/Gln genotype and the Arg124Leu missense change, collectively contributing to the disease phenotype.",-42.25,0.6,sequencevariant
"C to T transitions at rs9659997 in the APOE gene produce a Gln/Gln genotype that, when coupled with the S482X variant, have been linked to an increased risk of Alzheimer’s disease in older adults.",-32.75,0.6,sequencevariant
"C‑to‑T substitutions at rs9659997 in the ABCG2 gene generate a Gln/Gln genotype that, when coupled with the S482X and p.W492X truncations, predisposes to a Glu873Stop variant, thereby amplifying the V311fs frameshift effect on transporter activity.",-49.5,0.6,sequencevariant
"Mutagenic C to T transitions at rs9659997 in the CYP2D6 promoter create a Gln/Gln genotype that, together with the S482X p.W492X nonsense allele, results in a Glu873Stop variant and a V311fs frameshift, thereby abolishing enzyme activity and causing severe drug‑induced hyperthyroidism in patients carrying Arg124Leu and rs800292 alleles.",-56.25,0.6,sequencevariant
"Mutations such as rs9659997, which causes a C to T transition leading to a Glu873Stop variant, have been shown to disrupt the normal function of the CYP2C9 enzyme in Homo sapiens, thereby altering the pharmacokinetics of warfarin in patients carrying the Arg124Leu allele.",-33.0,0.6,sequencevariant
"Mutational analysis of the APOE gene in Alzheimer’s disease patients revealed a C to T transition at rs9659997 resulting in the Gln/Gln genotype, while a separate cohort of cardiovascular patients exhibited the S482X variant (p.W492X) that introduces a Glu873Stop codon and a V311fs frameshift, both of which are associated with altered lipid metabolism and elevated risk of atherosclerosis.",-47.75,0.6,sequencevariant
"Mutant allele rs9659997, a C to T substitution at codon Gln311, generates a V311fs frameshift that truncates the protein at p.W492X, thereby abolishing the functional domain responsible for the Gln/Gln interaction with the DNA-binding region.",-57.0,0.6,sequencevariant
"Mutation rs9659997, a C to T transition resulting in a Gln/Gln genotype, was identified in the V311fs sequence variant of the LDLR gene, where it causes the p.W492X Glu873Stop truncation and is associated with increased cardiovascular risk in Homo sapiens.",-40.5,0.6,sequencevariant
"Mutation analysis of the LDLR gene in a cohort of hypercholesterolemic patients revealed that the rs800292 polymorphism, which results in an Arg124Leu amino‑acid change, is associated with a higher prevalence of the V311fs frameshift variant, while the rs9659997 SNP, a C to T transition, was found to co‑occur with the p.W492X nonsense mutation and the Glu873Stop variant, indicating a possible linkage disequilibrium between these sequence changes.",-59.5,0.6,sequencevariant
"Mutation p.G159R in the LDLR gene (rs800292) was shown to cause a C to T transition at codon Arg124Leu, leading to a premature Glu873Stop and loss of function in hepatocytes.",-41.5,0.6,sequencevariant
"Mutation of the TP53 gene in the A549 cell line, specifically the rs9659997 C to T transition resulting in a Gln/Gln to Glu873Stop change, was shown to increase sensitivity to the chemotherapeutic drug doxorubicin.",-33.25,0.6,sequencevariant
"Cell line HCT116 harboring the rs9659997 Gln/Gln genotype exhibited reduced expression of TP53, while the co‑transfection of the sequence variant rs800292 Arg124Leu in the KRAS gene amplified the MAPK signaling cascade, ultimately enhancing proliferation of the HCT116 cells.",-56.25,0.6,sequencevariant
"Cell viability was markedly reduced in A549 cells harboring the rs9659997 C to T variant, which introduces a Glu873Stop nonsense mutation in the TP53 gene and results in loss of the Gln/Gln homozygous genotype.",-36.25,0.6,sequencevariant
"Cell‑line A549 harboring the S482X sequence variant in the TP53 gene exhibits markedly reduced apoptosis in response to doxorubicin, while the rs9659997 polymorphism in the CYP2C19 promoter correlates with increased drug metabolism in Homo sapiens patients.",-41.75,0.6,sequencevariant
"Cell survival in A549 cells harboring the rs9659997 C to T transition, which introduces a Glu873Stop in TP53, is markedly reduced compared with cells containing the wild‑type Gln/Gln genotype, indicating that the sequence variant triggers apoptosis through p53 pathway dysregulation.",-47.0,0.6,sequencevariant
"Single‑nucleotide polymorphism rs9659997, a C→T transition in the CYP2D6 promoter, was found to correlate with reduced enzymatic activity and altered drug metabolism in patients carrying the Arg124Leu variant.",-40.75,0.6,sequencevariant
"Single nucleotide polymorphism rs9659997, a C to T transition, is associated with the Gln/Gln genotype and the pathogenic sequence variant S482X, which introduces a premature stop codon analogous to the Glu873Stop mutation and the frameshift V311fs alteration, thereby impairing the normal function of the gene product.",-49.25,0.6,sequencevariant
"Single-base C to T substitutions at rs9659997 and the V311fs frameshift variant in the CYP2C9 gene together with the p.W492X nonsense mutation in the HBB gene were shown to synergistically impair erythrocyte enzyme activity, leading to a severe hemolytic phenotype in homozygous patients.",-59.0,0.6,sequencevariant
"Single-stranded DNA sequencing of the APOE locus in a cohort of Alzheimer's disease patients revealed a novel rs9659997 C to T transition that creates a Gln/Gln genotype and introduces a premature stop codon (p.Glu873Stop) at codon S482X, thereby truncating the protein and likely disrupting lipid transport and neuronal repair mechanisms.",-60.25,0.6,sequencevariant
"Allele rs9659997, a C to T transition in the CFTR gene, produces the Gln/Gln variant that is predicted to generate the premature stop codon S482X, while the independent rs800292 variant, Arg124Leu, has been associated with a V311fs frameshift leading to the Glu873Stop truncation.",-50.25,0.6,sequencevariant
"Allelic analysis revealed that the rs9659997 C to T transition in the APOE gene generates a Gln/Gln genotype that, in homozygotes, produces the S482X nonsense variant, whereas heterozygotes carrying the p.W492X stop codon also exhibit the Glu873Stop truncation, and the V311fs frameshift further amplifies the deleterious effect of the Arg124Leu substitution on protein stability.",-60.25,0.6,sequencevariant
"Alleles such as rs9659997 and rs800292, which encode a Gln/Gln genotype and a V311fs frameshift, respectively, have been associated with increased risk of cardiovascular disease in individuals carrying the S482X or p.W492X sequence variants that truncate the protein at Glu873Stop.",-41.25,0.6,sequencevariant
"Allel‑specific expression of the BRCA1 variant rs9659997, a C to T transition at position c.68_69, was found to disrupt the Gln/Gln genotype and promote the premature stop codon S482X, thereby impairing DNA repair in breast cancer cells.",-53.0,0.6,sequencevariant
"Homo sapiens carrying the rs9659997 C to T substitution in the APOE locus, which creates a Glu873Stop variant, exhibit a markedly increased risk for Alzheimer’s disease, whereas the rs800292 Arg124Leu polymorphism in the LDLR gene mitigates this effect by enhancing receptor-mediated clearance of amyloid‑β peptides.",-48.0,0.6,sequencevariant
"Heterozygous rs9659997 in the APOE gene, which results in a C to T transition at codon Gln311 and produces the V311fs frameshift, has been associated with increased risk of late‑onset Alzheimer’s disease in the elderly.",-40.5,0.6,sequencevariant
"HepG2 cells harboring the rs9659997 C→T transition in the HNF4A promoter exhibit a Gln/Gln genotype that leads to a p.W492X truncation, thereby reducing insulin transcription and precipitating hyperglycemia.",-43.25,0.6,sequencevariant
"Haplotype rs9659997, carrying a C to T transition that generates the Glu873Stop variant, was found to associate with reduced CYP2C9 enzyme activity in a cohort of patients treated with warfarin.",-41.0,0.6,sequencevariant
"Recent genome‑wide association studies identified rs9659997, a C to T transition in the APOE locus, which encodes a Gln/Gln variant that predisposes individuals to an elevated risk of late‑onset Alzheimer’s disease.",-37.75,0.6,sequencevariant
"Recent work shows that the rs9659997 C to T transition creates a p.G159R missense variant in the G6PD gene, which can lead to a Gln/Gln to Arg124Leu substitution that in turn truncates the protein at S482X, thereby impairing the enzyme’s stability and activity.",-56.75,0.6,sequencevariant
"Recent functional assays revealed that the rs9659997 C to T substitution, which introduces a Glu873Stop nonsense mutation in the APOE gene, markedly reduces LDL‑R expression in Huh7 cells.",-41.0,0.6,sequencevariant
"Recent sequencing of the CYP2C9 locus in a cohort of *Homo sapiens* revealed a novel pathogenic variant, rs9659997, which encodes a C to T transition resulting in a Glu873Stop mutation that truncates the protein and abolishes its catalytic activity, thereby explaining the observed loss of warfarin metabolism in patients homozygous for the Gln/Gln allele.",-49.5,0.6,sequencevariant
"In HeLa cells, the c.1138G>C sequence variant in the CYP2D6 gene, which results in a glutamine replacement of arginine at codon M235T, was shown to alter the enzyme’s metabolism of the anticancer drug doxorubicin.",-35.5,0.6,sequencevariant
"In A549 cells, the c.1138G>C variant in the CYP2D6 gene, which replaces a glutamine for an arginine residue, was shown to alter drug metabolism, while a four‑base‑pair deletion at c.471C>T in the same locus caused a frameshift that reduces enzyme activity.",-40.5,0.6,sequencevariant
"In the colorectal carcinoma cohort, the c.1138G>C variant in KRAS was associated with a glutamine replacement of arginine at codon M235T, whereas the c.471C>T mutation produced a four‑base‑pair deletion that introduced a glutamate by glycine substitution, and an insertion of a fifteen‑nucleotide duplication at the first fifteen nucleotides of the transcript was observed in a subset of patients.",-66.0,0.6,sequencevariant
"In Huh‑7 cells, the c.1138G>C variant in the CYP2D6 gene, which replaces glutamine with arginine at position M235T, markedly reduces enzymatic activity and alters the metabolism of the anticancer drug doxorubicin.",-38.5,0.6,sequencevariant
"The novel c.1138G>C variant in the renin gene, a glutamine replacement of arginine at position M235T, was found to cause a four‑base‑pair deletion that disrupts the promoter region, leading to reduced expression of the renin protein in Homo sapiens.",-36.0,0.6,sequencevariant
"The c.1138G>C sequence variant in the renin gene causes a glutamine replacement of arginine at position M235T, while a four‑base‑pair deletion in the promoter region at –930A>G further disrupts transcriptional regulation.",-27.125,0.6,sequencevariant
"The insertion of a fifteen‑nucleotide duplication at the first fifteen bases of the coding sequence (c.1_15dup15) in the ACE2 gene creates a novel sequence variant that replaces the glutamine at position M235T with a glutamate, thereby disrupting the binding interface for the SARS‑CoV‑2 spike protein and reducing viral entry into HEK293T cells.",-51.0,0.6,sequencevariant
"The single‑cell RNA‑seq analysis of the A549 cell line revealed that the c.1138G>C variant in the HIF1A gene, which introduces a glutamine replacement of arginine at position M235T, is associated with a four‑basepair deletion in the promoter region that reduces transcriptional activity, thereby exacerbating hypoxia‑induced apoptosis in the tumor cells.",-53.75,0.6,sequencevariant
"Sequencing of the AGT gene in hypertensive patients revealed a c.1138G>C transition that results in a glutamine replacement of arginine at codon M235T, while an independent c.471C>T variant produced an insertion of a four‑base‑pair duplication of the first fifteen nucleotides, leading to a frameshift and premature stop codon.",-59.5,0.6,sequencevariant
"Sequenced c.1138G>C and c.471C>T variants in the human ACE gene revealed that the M235T polymorphism, a glutamine‑to‑arginine substitution, and a four‑base‑pair deletion at position –930A>G collectively reduce ACE enzymatic activity, thereby increasing susceptibility to hypertension in patients treated with losartan.",-50.75,0.6,sequencevariant
"Sequencers identified a four‑basepair deletion in the TP53 gene (c.465G>T) that replaces glutamine with arginine at position M235T, a variant previously linked to increased apoptosis in HeLa cells.",-44.0,0.6,sequencevariant
"Sequencer‑derived data from a cohort of hypertensive patients revealed that the M235T variant of the angiotensin‑converting enzyme gene, a glutamine replacement of arginine at c.1138G>C, and a four‑basepair deletion in the promoter region at –930A>G collectively increased systolic blood pressure by an average of fifteen millimetres per second, while an insertion of a fifteen‑nucleotide duplication that duplicated the first fifteen nucleotides of the coding sequence further",-79.5,0.6,sequencevariant
"Mutations such as the c.1138G>C polymorphism in the angiotensin‑converting enzyme gene, the four‑basepair deletion in the promoter region of the CYP2D6 gene, and the M235T substitution in the AGT gene have been linked to altered drug metabolism and hypertension risk in humans.",-35.25,0.6,sequencevariant
"Mutational analysis of the CYP2D6 gene in a cohort of HIV‑positive patients revealed a novel c.1138G>C variant that introduces a glutamine replacement of arginine at codon M235T, while a separate sample harbored a four‑basepair deletion at position -930A>G, both of which are predicted to alter drug‑metabolizing enzyme activity.",-47.75,0.6,sequencevariant
"Mutagenesis of the BRCA1 gene in the A549 cell line revealed a four‑basepair deletion at c.465G > T that replaces glutamine with glycine and is predicted to disrupt DNA‑repair activity, potentially contributing to cisplatin resistance.",-44.5,0.6,sequencevariant
"Mutant A549 cells harboring the c.1138G>C variant in the KRAS gene, which causes a glutamine replacement of arginine at codon M235T, exhibit markedly increased ERK phosphorylation and resistance to the EGFR inhibitor erlotinib.",-40.5,0.6,sequencevariant
"Genetic analysis of the patient’s tumor revealed a novel sequence variant, a four‑base‑pair deletion at c.465G > T, which results in a glutamine replacement of arginine and a downstream insertion of a duplicated stretch of fifteen nucleotides, potentially disrupting the normal splicing of the TP53 gene.",-58.5,0.6,sequencevariant
"Genomic sequencing of the patient’s tumor revealed a c.1138G>C transition that causes a glutamine replacement of arginine at position M235T, while a separate c.465G>T mutation introduced a four‑basepair deletion, both of which are predicted to disrupt the protein’s active site and contribute to chemoresistance.",-53.25,0.6,sequencevariant
"Genotype analysis of a colorectal cancer cohort revealed that a four‑basepair deletion in the APC gene (c.1138_1141del) correlated with increased β‑catenin accumulation, while a c.471C>T substitution in the KRAS gene (p.Gln157His) was associated with enhanced MAPK signaling and poorer overall survival.",-53.25,0.6,sequencevariant
"Genotyping of the AGT gene in a cohort of hypertensive patients revealed that the c.1138G>C variant, which results in a glutamine replacement of arginine at position M235T, was significantly associated with increased plasma renin activity, while the four‑basepair deletion at c.471C>T and the insertion of a fifteen‑nucleotide duplication at the first exon were found exclusively in individuals with early‑onset essential hypertension.",-72.0,0.6,sequencevariant
"Variant c.1138G>C in the angiotensin‑converting enzyme gene leads to a glutamine replacement of arginine at position M235T, which has been associated with altered blood‑pressure regulation in Homo sapiens.",-28.875,0.6,sequencevariant
"Variant analysis of the ACE gene in a cohort of hypertensive patients revealed that the c.1138G>C substitution, which results in a glutamine for arginine replacement at position M235T, is significantly associated with increased plasma renin activity compared with the wild‑type allele.",-39.75,0.6,sequencevariant
Variant G for A at cDNA nucleotide position **323** of the **ACE** gene was found to increase the risk of hypertension in a cohort of **Homo sapiens** subjects carrying the **M235T** substitution in the **AGT** gene.,-48.5,0.6,sequencevariant
"Variant‑calling in the HBB locus revealed a four‑basepair deletion at c.465G> T, which leads to a glutamate‑to‑glycine substitution that may alter hemoglobin stability in patients with the -930A>G promoter polymorphism.",-53.0,0.6,sequencevariant
"A splice‑site mutation involving a four‑basepair deletion at position c.465G>T in the BRCA1 gene was shown to disrupt normal exon inclusion, leading to a truncated protein that fails to recruit the RAD51 repair complex and thereby increases susceptibility to breast cancer in carriers.",-44.0,0.6,sequencevariant
"A four‑base‑pair deletion at c.465G>T in the ACE2 gene results in a glutamine replacement of arginine, which has been linked to increased susceptibility to severe SARS‑CoV‑2 infection in individuals carrying the M235T variant.",-27.75,0.6,sequencevariant
"A missense sequence variant, c.471C>T, in the AGT gene causes a glutamine replacement of arginine at position M235T, while an insertion of a fifteen‑nucleotide duplication at c.1138G>C leads to a four‑basepair deletion that substitutes glutamate with glycine.",-50.5,0.6,sequencevariant
A heterozygous four‑basepair deletion in the promoter of the renin gene (c.465G>T) combined with a c.1138G>C missense mutation that replaces glutamine for arginine at position M235T was shown to elevate plasma renin activity and predispose Homo sapiens patients to early‑onset hyperuricemia and chronic kidney disease.,-39.5,0.6,sequencevariant
Insertion of a four‑base‑pair deletion at the c.465G > T site in the ACE2 gene results in a glutamine replacement of arginine that disrupts angiotensin‑converting enzyme activity in a subset of SARS‑CoV‑2‑susceptible patients.,-36.0,0.6,sequencevariant
"Insertion analysis revealed that the four‑basepair deletion at c.465G>T in the renin gene, which results in a glutamine replacement of arginine, is strongly associated with early‑onset hypertension in the studied cohort.",-45.75,0.6,sequencevariant
"Insertional mutagenesis of the ACE2 gene, specifically a four‑base‑pair deletion at c.465G>T, results in a glutamine replacement of arginine that impairs viral spike protein binding in HEK293T cells.",-42.5,0.6,sequencevariant
"Insertioning a fifteen‑nucleotide duplication at the start of exon three of the ACE gene (c.1138G>C) produces a glutamine‑to‑arginine substitution that, together with a four‑base‑pair deletion at –930A>G, is predicted to alter angiotensin‑converting enzyme activity in patients with hypertension.",-59.25,0.6,sequencevariant
"Variants such as the four‑basepair deletion c.465G>T and the M235T substitution, which replaces arginine with glutamine, have been shown to alter the function of the angiotensin‑converting enzyme in Homo sapiens, potentially contributing to hypertension.",-35.25,0.6,sequencevariant
"Variants with a four‑basepair deletion in the promoter region of the renin gene, such as the c.465G>T mutation that replaces a glutamine residue with arginine, have been linked to early‑onset hypertension in Homo sapiens.",-38.25,0.6,sequencevariant
"Variants featuring the c.1138G > C substitution, a four‑base‑pair deletion at c.465G > T, and an insertion of a duplicated fifteen‑nucleotide sequence at the start of the gene all converge to produce a glutamine replacement of arginine and a glutamate‑by‑glycine change that are predicted to disrupt the protein’s functional domain in Homo sapiens.",-73.0,0.6,sequencevariant
"Variants where a glutamine replaces an arginine at position M235T, an insertion of a fifteen‑nt duplication at c.1138G > C, and a four‑base‑pair deletion at c.471C > T were simultaneously identified in the same allele of the AGT gene in a patient with early‑onset hypertension, suggesting a cumulative effect of these sequence changes on protein function.",-72.0,0.6,sequencevariant
"Studies in A549 cells revealed that the c.465G>T (p.Gly155Ser) sequence variant, which causes a glutamine replacement of arginine and an insertion of a four‑basepair deletion, led to aberrant splicing and reduced expression of the CYP1A1 gene, thereby impairing the cellular response to xenobiotic exposure.",-59.0,0.6,sequencevariant
"Studies of the A549 cell line revealed that the c.1138G>C sequence variant, which replaces a glutamine with an arginine and creates a four‑base‑pair deletion at position –930A>G, dramatically increases the expression of the TP53 gene product and enhances sensitivity to doxorubicin.",-42.75,0.6,sequencevariant
"Studies on the A549 cell line revealed that the c.1138G > C sequence variant, which causes a glutamine replacement of arginine at position M235T, can lead to a four‑basepair deletion that ultimately results in a glutamate by glycine substitution in the protein product.",-45.75,0.6,sequencevariant
"Studies reveal that the c.1138G>C variant, which substitutes glutamine for arginine at position M235T, can be further compounded by an insertion of a fifteen‑nucleotide duplication of the first fifteen nucleotides, creating a complex sequence variant that disrupts normal gene expression.",-58.25,0.6,sequencevariant
"Gene expression of the M235T variant, characterized by a c.1138G > C substitution that replaces glutamine with arginine, was found to be down‑regulated in A549 cells, while an insertion of a fifteen‑nucleotide duplication at the first fifteen bases of the promoter region further decreased transcription of the adjacent CYP2D6 gene.",-64.0,0.6,sequencevariant
"Gene‑editing of the KRAS locus in HCT116 cells revealed that a c.1138G > C substitution causing a glutamine replacement of arginine at codon M235T, together with an insertion of a fifteen‑nucleotide duplication at the first fifteen nucleotides, abolished KRAS‑mediated ERK activation.",-64.0,0.6,sequencevariant
"Gene editing of the human CYP2D6 locus in HepG2 cells revealed that a c.1138G > C variant creates a glutamine replacement of arginine at position M235T, while a separate c.471C > T mutation introduces a four‑basepair deletion that abolishes the enzyme’s catalytic activity.",-51.5,0.6,sequencevariant
"Gene therapy using CRISPR‑Cas9 to correct the c.1138G>C sequence variant in the ACE2 gene, which replaces glutamine with arginine at position M235T, restores normal angiotensin‑converting enzyme activity in A549 cells and reduces SARS‑CoV‑2 viral entry.",-43.5,0.6,sequencevariant
"Researchers found that the c.1138G>C sequence variant, which replaces glutamine for arginine in the ACE2 protein, increases susceptibility to severe COVID‑19 in patients carrying the M235T polymorphism.",-28.875,0.6,sequencevariant
"Researchers demonstrated that the c.1138G>C sequence variant in the AGT gene, which causes a glutamine replacement of arginine at position M235T, leads to a four‑basepair deletion that reduces angiotensin‑converting enzyme activity and predisposes patients to early‑onset hypertension.",-34.75,0.6,sequencevariant
"Researchers noted that the c.1138G > C variant, a glutamine replacement of arginine at position M235T, together with a four‑basepair deletion, can disrupt the regulatory region of the renin gene, leading to altered blood pressure in Homo sapiens.",-44.25,0.6,sequencevariant
"Researchers reported that the c.1138G>C variant in the ACE gene, a glutamine replacement of arginine at position M235T, and a four‑base‑pair deletion in the promoter region (-930A>G) collectively contribute to altered blood pressure regulation in a cohort of *Homo sapiens* patients.",-40.5,0.6,sequencevariant
"Mutation c.1138G>C in the AGT gene, which replaces a glutamine for an arginine and creates a four‑base‑pair deletion, has been shown to increase plasma renin activity in patients with hypertension.",-27.5,0.6,sequencevariant
"Mutation of the CYP17A1 gene by the c.1138G>C sequence variant, which replaces a glutamine with arginine at position M235T, was shown to increase androgen production in HepG2 cells and to contribute to early-onset hypertension in a cohort of African‑American patients.",-48.5,0.6,sequencevariant
"Mutation analysis of the AGT gene in a cohort of hypertensive patients revealed that the c.1138G>C variant, which replaces a glutamine residue with arginine at position M235T, co‑occurs with a four‑basepair deletion in the promoter region, suggesting a synergistic effect on angiotensin‑converting enzyme activity.",-40.5,0.6,sequencevariant
"Mutation‑driven dysregulation of the angiotensin‑converting enzyme gene, including the M235T polymorphism, c.1138G > C and a four‑basepair deletion, has been shown to alter the enzyme’s catalytic efficiency and contribute to hypertension in Homo sapiens.",-47.25,0.6,sequencevariant
"Silencing of the GATA3 gene in the A549 cell line revealed that a c.1138G>C sequence variant, which replaces glutamine for arginine at position M235T, reduces tumor cell proliferation by impairing the PI3K/AKT signaling pathway.",-52.75,0.6,sequencevariant
"Silico‑analysis of the BRCA1 c.1138G>C variant, which introduces a glutamine‑to‑arginine substitution, revealed that the resulting sequence variant destabilizes the protein’s DNA‑binding domain and correlates with a higher incidence of breast cancer in carriers of the M235T polymorphism.",-41.5,0.6,sequencevariant
"Silenced expression of the CYP2D6 gene in a patient harboring the c.1138G>C variant, a glutamine replacement of arginine at position M235T, led to reduced metabolism of the chemotherapeutic agent doxorubicin and consequently increased cardiotoxicity.",-48.0,0.6,sequencevariant
"Silently, the c.1138G>C sequence variant in the angiotensin‑converting enzyme gene produces a glutamine substitution for arginine at position M235T, while the c.471C>T variant creates a four‑basepair deletion that replaces glutamate with glycine, both of which have been linked to altered blood‑pressure regulation in Homo sapiens.",-51.75,0.6,sequencevariant
"The identification of a novel -652_6N del sequence variant in the TP53 gene of a colorectal cancer cell line revealed that the leucine to methionine substitution at codon p. Gln193Gln, coupled with a glutamic acid to a stop codon mutation (p.E300X), dramatically increased apoptotic signaling, whereas the rs8041922 polymorphism in the promoter region of the same gene was associated with reduced expression of the tumor suppressor protein.",-71.5,0.6,sequencevariant
"The heterozygous BRCA1 c.68_69delAG variant, a sequence variant that deletes a two‑base pair guanine‑cytosine pair, has been shown to disrupt the DNA repair pathway and predispose patients to early‑onset breast cancer in Homo sapiens.",-37.75,0.6,sequencevariant
"The BRCA1 c.68_69delAG sequence variant, a -6526del mutation, and the rs8041922 single‑nucleotide polymorphism together contribute to the loss of the p.E300X stop codon and a leucine‑to‑methionine substitution at position p.Gln193Gln, which has been linked to reduced DNA repair capacity and increased breast cancer susceptibility.",-59.75,0.6,sequencevariant
"The c.105‑bp deletion encompassing bases **1078‑1182** in the *BRCA1* gene, which produces a truncated protein with a **p.E300X** nonsense mutation, has been shown to disrupt DNA repair pathways and increase breast cancer susceptibility in *Homo sapiens* carriers.",-41.5,0.6,sequencevariant
"In the A549 cell line, the BRCA1 c.68_69delAG sequence variant, which replaces a glutamic acid with a stop codon (p.E300X), was shown to impair DNA repair and increase sensitivity to the chemotherapeutic agent doxorubicin.",-22.0,0.6,sequencevariant
"In Homo sapiens, the BRCA1 c.68_69delAG variant, a sequence variant that deletes two nucleotides and results in a frameshift, has been shown to abolish the DNA repair function of the TP53 gene product, thereby increasing the risk of early‑onset breast cancer.",-41.0,0.6,sequencevariant
"In patients carrying the BRCA1 c.68_69delAG sequence variant, the loss of two nucleotides at positions –652 and –651 leads to a frameshift that generates a premature glutamic acid to a stop codon (p.E300X) and is associated with an increased risk of early‑onset breast cancer.",-32.0,0.6,sequencevariant
"In a cohort of colorectal cancer patients, the BRCA1 c.68_69delAG sequence variant, which removes two nucleotides and creates a glutamic acid to a stop codon, was found to be significantly associated with increased tumor aggressiveness and poorer overall survival.",-34.0,0.6,sequencevariant
"Sequence variant rs8041922 in the BRCA1 gene, which results in a p. Gln193Gln synonymous change, is associated with a higher risk of breast cancer in carriers of the -6526N deletion that also causes a leucine to methionine substitution in the protein’s functional domain.",-52.0,0.6,sequencevariant
"Sequence analysis of the BRCA1 gene in a cohort of breast cancer patients revealed a novel -652_6N del variant that co‑occurs with a p.E300X nonsense mutation, while rs8041922 and p.Gln193Gln SNPs were also identified, indicating a complex mutational landscape that may influence disease progression.",-48.5,0.6,sequencevariant
"Sequence‑variant rs8041922 in the TP53 gene, which introduces a p. Gln193Gln silent change, was found to coexist with a nearby -6526del deletion that removes a leucine‑to‑methionine motif in the DNA‑binding domain, potentially disrupting p53’s transcriptional activity in A549 cells.",-62.25,0.6,sequencevariant
"Sequence variants such as the -652_6N_del deletion and the p.E300X nonsense mutation, which converts a glutamic acid residue to a stop codon, were found to be associated with altered transcriptional activity in the TP53 gene, while the rs8041922 polymorphism in the MTHFR gene was linked to increased risk of neural tube defects in Homo sapiens embryos.",-55.25,0.6,sequencevariant
"A BRCA1 c.68_69delAG sequence variant was found to disrupt the DNA repair domain, causing a leucine to methionine substitution that correlates with a higher risk of breast cancer in carriers of the rs8041922 allele.",-33.0,0.6,sequencevariant
"A heterozygous c.105_118delinsT mutation causing a leucine‑to‑methionine substitution in the BRCA1 exon five gene product was identified in a patient with early‑onset breast cancer, while a separate rs8041922 polymorphism in the same gene was associated with increased risk of ovarian carcinoma.",-56.5,0.6,sequencevariant
"A pathogenic sequence variant, a −6526_6N deletion, was identified in the TP53 gene of a HeLa cell line, and the resulting p.E300X mutation caused loss of the DNA-binding domain and induced apoptosis in the cells.",-46.0,0.6,sequencevariant
"A PCR‑based assay revealed that the BRCA1 variant rs8041922, which introduces a glutamic acid to a stop codon at position p.E300X, was present in a patient whose tumor exhibited a novel -6526N deletion and a leucine to methionine substitution in the same exon.",-56.25,0.6,sequencevariant
"Loss of the −652_6N deletion in the TP53 promoter together with the p.E300X nonsense mutation in the TP53 coding region, both detected by next‑generation sequencing in a Homo sapiens biopsy, predict a severe reduction in p53 protein levels and an increased risk of colorectal carcinoma.",-56.5,0.6,sequencevariant
"Loss‑of‑function mutations such as the –6526_6N del and the p.E300X variant, which replaces glutamic acid with a stop codon, have been shown to disrupt the normal regulation of the TP53 gene product in Homo sapiens, leading to increased cellular apoptosis and heightened susceptibility to chemotherapy‑induced toxicity.",-53.0,0.6,sequencevariant
"Loss-of-function mutations such as the rs8041922 p.E300X variant, which introduces a glutamic acid to a stop codon at position E300, were found to disrupt the normal activity of the BRCA1 gene product in breast cancer cell lines.",-47.0,0.6,sequencevariant
"Loss or missense sequence variants such as the rs8041922 SNP or the p.Gln193Gln silent change have been shown to modulate the expression of the TP53 gene in human breast cancer cell lines, whereas the novel c.105-1182del105bp deletion that removes bases spanning positions ~1078–1182 in the BRCA1 gene is predicted to create a frameshift leading to a glutamic acid to a stop codon at position p.E300X.",-105.5,0.6,sequencevariant
"Sequencing of the BRCA1 locus in a cohort of breast cancer patients revealed a novel -6526del mutation that deletes a leucine codon at position p.Leu300, resulting in a p.E300X nonsense variant and a downstream p.Gln193Gln synonymous change (rs8041922) that together correlate with a markedly increased risk of early‑onset disease.",-67.0,0.6,sequencevariant
"Sequenced analysis of the BRCA1 gene in a breast‑cancer cohort revealed a novel -652_6Ndel variant that co‑occurs with the p.E300X nonsense mutation, while a separate sample carried a rs8041922 SNP (p.Gln193Gln) and a pathogenic p.Asp50Asn missense change, and a third patient’s tumor harbored a large ~105‑bp deletion spanning bases c.1078‑c.1182, all of which",-91.0,0.6,sequencevariant
"Sequenza‑based analysis revealed that the BRCA1 p.E300X variant, a glutamic acid to a stop codon mutation, co‑exists with the rs8041922 SNP in a subset of triple‑negative breast cancer samples, suggesting a possible compound heterozygous effect on DNA repair capacity.",-46.0,0.6,sequencevariant
"Sequencetracking of the BRCA1 locus in breast cancer patients revealed that the novel rs8041922 variant, a c.105‑bp deletion encompassing bases g.1078‑1182, co‑occurs with the p.Gln193Gln silent change and a downstream leucine‑to‑methionine substitution in the DNA‑binding domain, suggesting a combined effect on protein stability and tumor suppressor activity.",-78.0,0.6,sequencevariant
"Mutation of the CFTR gene involving the p.Asp50Asn substitution and a nearby rs8041922 polymorphism was shown to impair chloride transport in the CFTR-ΔF508 variant, thereby exacerbating the respiratory phenotype in cystic fibrosis patients.",-53.25,0.6,sequencevariant
"Mutation c.−652_−651del in the promoter region of the CYP2C19 gene, together with the synonymous variant rs8041922 (p.Gln193Gln), was shown to impair transcriptional activity and reduce drug metabolism in HepG2 cells.",-40.5,0.6,sequencevariant
"Mutation rs8041922 in the TP53 gene, a missense change p.Asp50Asn, was found to destabilize the protein’s DNA‑binding domain and correlate with increased susceptibility to colorectal cancer in a cohort of Homo sapiens patients.",-31.25,0.6,sequencevariant
"Mutation p.E300X in the TP53 gene, a glutamic acid to a stop codon variant, was detected in a HeLa cell line, revealing a deleterious sequence variant that disrupts the DNA‑binding domain and potentially drives oncogenic transformation.",-37.75,0.6,sequencevariant
Evidence that the -6526N del sequence variant in the TP53 promoter region reduces p53 expression and thereby enhances the proliferative capacity of A549 cells treated with doxorubicin was demonstrated by chromatin‑immunoprecipitation and cell‑cycle analysis.,-51.0,0.6,sequencevariant
"Evidence indicates that the BRCA1 c.68_69delAG variant, which results in a glutamic acid to a stop codon at position p.E300X, is associated with a higher risk of breast cancer in carriers of the rs8041922 allele.",-31.5,0.6,sequencevariant
"Evidence from a cohort of colorectal cancer patients indicates that the BRCA1 c.105-1182del variant, which deletes a stretch of DNA from bases +1078 to +1182, is associated with a higher frequency of the rs8041922 polymorphism and correlates with poorer overall survival.",-70.0,0.6,sequencevariant
"Evidence shows that the rs8041922 variant, which introduces a p.E300X nonsense mutation converting glutamic acid to a stop codon in the TP53 gene, is associated with an increased risk of colorectal cancer in patients carrying the -6526N deletion.",-43.0,0.6,sequencevariant
Patients harboring the BRCA1 c.68_69delAG sequence variant exhibited increased DNA repair deficiency and a higher incidence of triple‑negative breast cancer.,-25.75,0.6,sequencevariant
"Patients carrying the BRCA1 c.68_69delAG sequence variant, which results in a glutamic acid to a stop codon change, exhibit markedly increased susceptibility to breast cancer and demonstrate altered DNA repair pathways.",-32.25,0.6,sequencevariant
"Patients homozygous for the rs8041922 single‑nucleotide polymorphism, which results in a p.Asp50Asn substitution in the HNF4A transcription factor, displayed increased susceptibility to neonatal hypoglycemia, while carriers of the rare -6526N deletion that removes a glutamic acid codon and creates a p.E300X nonsense mutation in the same gene exhibited a severe, early‑onset form of the disease.",-76.0,0.6,sequencevariant
"Patients with the BRCA1 sequence variant rs8041922, a c.−652_−651del leading to a leucine‑to‑methionine change in the promoter, exhibited a higher incidence of triple‑negative breast cancer compared with carriers of the p.Gln193Gln polymorphism.",-36.25,0.6,sequencevariant
"Mutations such as the -652_6N del deletion, the p.E300X nonsense change, and the rs8041922 SNP in the CYP2D6 gene have been shown to alter enzyme activity and increase susceptibility to drug‑induced hepatotoxicity in humans.",-38.75,0.6,sequencevariant
"Mutational analysis of the BRCA1 gene in the cohort revealed a novel c.105‑b.1078‑1182del variant that deletes a contiguous segment of the exon, a change that is predicted to cause a frameshift and premature termination of the protein, and the same variant was found in a patient who also carried the rs8041922 single‑nucleotide polymorphism, a missense alteration at position p.Asp50Asn that has been associated with increased breast cancer risk.",-105.5,0.6,sequencevariant
"Mutagenic exposure to benzo[a]pyrene induces a -6526N deletion in the TP53 gene, creating a p.E300X truncation that abolishes the DNA‑binding domain and is predicted to drive tumorigenesis in A549 cells.",-47.0,0.6,sequencevariant
"Mutating the BRCA1 gene to the sequence variant p.E300X, which replaces glutamic acid with a stop codon at position E300, was found to abolish DNA repair activity in the human breast cancer cell line MCF‑7.",-42.5,0.6,sequencevariant
"Cystic fibrosis patients carrying the rs8041922 variant, which introduces a glutamic acid to a stop codon at position p.E300X and a leucine to methionine substitution at p.Asp50Asn, exhibit markedly increased mucus viscosity and accelerated disease progression compared to individuals with the wild‑type sequence.",-45.5,0.6,sequencevariant
"Cytotoxicity assays revealed that the A549 cell line harboring the BRCA1 c.68_69delAG sequence variant exhibited increased sensitivity to doxorubicin, a finding that aligns with the predicted destabilization of the TP53 protein due to the p.E300X nonsense mutation.",-35.75,0.6,sequencevariant
"Cumulative analysis of the patient cohort revealed that the BRCA1 sequence variant rs8041922, a single‑nucleotide polymorphism resulting in a p.Gln193Gln substitution, was significantly enriched in individuals carrying the pathogenic BRCA1 c.68_69delAG deletion, whereas the previously reported c.105‑bp deletion encompassing bases ‑1078‑1182 was not associated with increased breast cancer risk.",-73.5,0.6,sequencevariant
"Citrus sinensis-derived p.E300X sequence variant, a glutamic acid to a stop codon mutation, was found to disrupt the regulatory region of the CYP1A1 gene, causing a significant reduction in its expression in HepG2 cells and correlating with increased susceptibility to benzo[a]pyrene-induced DNA damage.",-53.75,0.6,sequencevariant
"Investigating the functional impact of the BRCA1 p.E300X sequence variant, we observed that the glutamic acid to a stop codon mutation in exon three leads to a truncated protein that fails to recruit RAD51, thereby increasing the risk of homologous recombination deficiency in breast cancer cells.",-49.75,0.6,sequencevariant
"Investigations revealed that the rs8041922 single‑nucleotide polymorphism, which substitutes a glutamic acid for a stop codon at position p.E300X, is associated with the loss of the leucine residue at codon‑300 and the concomitant emergence of a novel –652‑6N deletion, thereby creating a frameshift that ultimately truncates the TP53 protein in the A549 cell line.",-82.5,0.6,sequencevariant
"Investigators discovered that the BRCA1 c.68_69delAG variant, a sequence variant causing a glutamic acid to a stop codon at position p.E300X, markedly increases the risk of breast cancer in carriers of the rs8041922 allele.",-36.0,0.6,sequencevariant
"Investigational sequencing of the TP53 gene in the HeLa cell line revealed a novel sequence variant, p.E300X, which introduces a glutamic acid to a stop codon change and was predicted to truncate the protein, thereby potentially compromising p53’s tumor suppressor function.",-44.75,0.6,sequencevariant
"Targeted CRISPR/Cas9 editing of the BRCA1 locus in MCF-7 cells revealed that the -652_6N_del sequence variant, which deletes six nucleotides at position –652, induces a frameshift that generates a premature p.E300X stop codon, thereby abolishing the normal leucine-to-methionine substitution at residue p.Asp50Asn and compromising DNA repair capacity.",-69.0,0.6,sequencevariant
"Targeting the BRCA1 c.68_69delAG sequence variant, researchers observed that the resulting glutamic acid to a stop codon alteration in the protein’s DNA‑binding domain dramatically reduces its interaction with the RAD51 complex, thereby impairing homologous recombination repair in HeLa cells and increasing sensitivity to the alkylating agent temozolomide.",-49.0,0.6,sequencevariant
"Target investigation revealed that the BRCA1 sequence variant rs8041922, a c.1078_1182del105‑bp deletion encompassing bases that encode a leucine‑to‑methionine change, was associated with increased risk of breast cancer in the studied cohort.",-54.75,0.6,sequencevariant
"Targetting the BRCA1 c.68_69delAG sequence variant, researchers observed that the resulting p.E300X mutation caused a premature glutamic acid to a stop codon conversion, thereby abolishing the protein’s DNA repair function in HeLa cells.",-41.25,0.6,sequencevariant
"Knock‑in of the BRCA1 c.‑652_‑651del variant in HCC1806 cells leads to a p.E300X truncation that abolishes the DNA‑binding domain and, as a consequence, reduces RAD51 foci formation and sensitizes the cells to cisplatin.",-49.0,0.6,sequencevariant
"Knocking out the BRCA1 variant rs8041922 in HeLa cells, which introduces a glutamic acid to a stop codon (p.E300X) and a leucine to methionine substitution (p.L123M), results in increased sensitivity to the DNA‑damaging agent doxorubicin.",-43.0,0.6,sequencevariant
"Knocked‑down of the BRCA1 c.68_69delAG variant, a sequence variant that deletes a two‑base pair guanine–cytosine, markedly increased the sensitivity of HeLa cells to the DNA‑damaging agent doxorubicin.",-53.25,0.6,sequencevariant
"Knoxville, the rs8041922 single‑nucleotide polymorphism in the CYP2C9 gene, which results in a leucine‑to‑methionine substitution at codon p. Gln193Gln, was found to confer a higher risk of tacrolimus‑induced nephrotoxicity in patients with the p. Asp50Asn variant of the CYP3A5 gene.",-69.0,0.6,sequencevariant
"The CRISPR‑edited A549 cells harboring the sequence variant c.1093-1G>T exhibit a markedly reduced expression of the TP53 gene, thereby compromising the apoptotic response to doxorubicin.",-26.25,0.6,sequencevariant
"The single base pair deletion of a cytosine nucleotide in the BRCA1 c.1093-1G > T variant leads to a frameshift that changes asparagine at position‑86 to alanine and eliminates amino acids‑87,‑88,‑89 (arginine, threonine, and proline), resulting in a truncated, non‑functional protein.",-44.5,0.6,sequencevariant
"The c.1093-1G>T splice‑site variant in the BRCA1 gene, together with the rs17015215‑V274I missense mutation, was found to disrupt the DNA‑binding domain and confer a markedly increased risk of breast cancer in a cohort of female patients.",-33.75,0.6,sequencevariant
"The missense variant rs17015215-V274I in the TP53 gene, together with the single base pair deletion of a cytosine nucleotide in the BRCA1 c.1093-1G>T splice site, was shown to reduce DNA repair capacity in A549 cells, leading to increased sensitivity to doxorubicin.",-28.75,0.6,sequencevariant
"In A549 cells, the single base pair deletion of a cytosine nucleotide at position c.1093‑1G > T in the TP53 gene results in a frameshift that replaces asparagine at position N86 with alanine and eliminates amino acids N87, N88, and N89 (arginine, threonine, and proline), thereby impairing p53’s DNA‑binding domain and promoting resistance to doxorubicin.",-52.75,0.6,sequencevariant
"In our study, the single base pair deletion of a cytosine nucleotide at position c.1093-1G>T in the TP53 gene, which causes the loss of amino acids N495K and I280S, was found to be strongly associated with increased apoptosis in HeLa cells treated with doxorubicin.",-36.25,0.6,sequencevariant
"In the CRISPR‑edited A549 cell line, the engineered sequence variant c.1093‑1G>T caused a single base pair deletion that spliced out exon five, resulting in a frameshift and premature termination of the TP53 protein, thereby abolishing its tumor‑suppressive activity.",-36.5,0.6,sequencevariant
"In HeLa cells, the c.1093‑1G>T splice-site mutation in TP53 leads to a single base pair deletion of a cytosine nucleotide that abolishes exons containing the N495K and I280S sequence variants, thereby producing a truncated protein that disrupts p53‑dependent apoptosis in this human cell line.",-46.25,0.6,sequencevariant
"Loss of the single cytosine in the BRCA1 c.1093‑1G>T splice site, together with the rs17015215‑V274I and N495K missense variants, causes aberrant exon skipping that replaces asparagine‑86 with alanine and deletes the following residues arginine‑87, threonine‑88 and proline‑89, thereby destabilizing the protein’s DNA‑binding domain.",-49.5,0.6,sequencevariant
"Loss‐of‐function of the PAX6 protein caused by the single base pair deletion of a cytosine nucleotide at position c.1093‑1G>T and the missense mutation rs17015215‑V274I, which changes valine to isoleucine, results in the mis‑splicing of exon four and the subsequent loss of the homeodomain, leading to impaired retinal development in Homo sapiens.",-70.5,0.6,sequencevariant
"Loss‑of‑function mutations such as the single‑base‑pair deletion of a cytosine nucleotide at position c.1093‑1G>T and the c.643T>C missense change that substitutes glutamine for arginine at position Q126R/del418T have been shown to destabilize the TP53 protein, thereby impairing its tumor‑suppressive activity in breast cancer cell lines derived from MCF‑7 and MDA‑MB‑231.",-59.25,0.6,sequencevariant
Loss-of-function of the DNA repair gene NHEJ1 caused by the sequence variant c.1093-1G>T results in defective non‑homologous end joining and predisposes patients to immunodeficiency and microcephaly.,-41.5,0.6,sequencevariant
A single base pair deletion of a cytosine nucleotide in the BRCA1 exon causing a frameshift and the N495K sequence variant was shown to impair DNA repair and increase breast cancer susceptibility in a cohort of Homo sapiens patients.,-34.5,0.6,sequencevariant
"A missense sequence variant, c.1093‑1G>T, in the TP53 gene of a HeLa cell line results in the substitution V274I (rs17015215) and a single‑base‑pair deletion that eliminates the asparagine at position N86 and the downstream residues R87, T88, and P89, thereby impairing p53’s transcriptional activation of the BAX gene in these cells.",-65.0,0.6,sequencevariant
"A c.1093-1G>T splice-site mutation in the CDKN2A gene was found to alter the splicing of the tumor suppressor transcript, resulting in a truncated protein that impairs p16INK4a function and increases melanoma susceptibility in a cohort of patients with a history of sun exposure.",-52.25,0.6,sequencevariant
"A cell line derived from A549 cells harboring the rs17015215-V274I sequence variant exhibited reduced expression of TP53 and increased sensitivity to the DNA‑damaging agent doxorubicin, suggesting that this single base pair substitution in the TP53 gene may contribute to altered apoptotic signaling in lung cancer cells.",-47.5,0.6,sequencevariant
"Researchers discovered that the single base pair deletion of a cytosine nucleotide in the BRCA1 c.68_69delAG variant, coupled with the rs17015215-V274I substitution, reduces the DNA repair capacity of the TP53 protein, thereby increasing the risk of breast cancer in Homo sapiens.",-36.0,0.6,sequencevariant
"Researchers observed that the single base pair deletion of a cytosine nucleotide at position c.1093-1G>T in the BRCA1 gene, which changes asparagine‑86 to alanine and eliminates amino acids‑87‑89 (arginine, threonine, and proline), results in a loss of DNA repair activity that correlates with increased breast cancer risk in female Homo sapiens carriers.",-52.25,0.6,sequencevariant
"Researchers noted that the c.1093‑1G>T splice‑site variant in the TGFBR2 gene, a single base‑pair deletion of a cytosine nucleotide that alters the reading frame, was associated with a more aggressive phenotype in colorectal cancer cell lines such as HCT116.",-44.5,0.6,sequencevariant
"Researchers found that the single base pair deletion of a cytosine nucleotide at c.1093‑1G>T in the TP53 gene, which changes asparagine at position‑86 to alanine and eliminates amino acids‑87,‑88,‑89 (arginine, threonine, and proline), increases the risk of developing aggressive breast cancer in a cohort of Homo sapiens patients.",-55.5,0.6,sequencevariant
"Mutations such as rs17015215-V274I, I280S, and a single‑base‑pair deletion of a cytosine nucleotide in the TP53 gene were identified in A549 cells, causing a loss of asparagine at position N86, elimination of residues R87‑P89, and a c.1093‑1G>T splice‑site change that ultimately leads to a truncated protein.",-63.25,0.6,sequencevariant
"Mutational analysis of the TP53 gene in the A549 cell line revealed a single base pair deletion of a cytosine nucleotide at position c.1093-1G>T, generating a frameshift that changes asparagine at position N86 to alanine and eliminates amino acids R87, T88, and P89, thereby disrupting the DNA‑binding domain and contributing to chemoresistance in lung carcinoma.",-55.5,0.6,sequencevariant
"Mutagenic exposure induced a single‑base‑pair deletion of a cytosine at position c.1093‑1G>T, producing the variant rs17015215‑V274I and the N495K substitution in the TP53 gene, which together impair p53’s DNA‑binding domain and increase the risk of colorectal carcinoma in patients carrying the BRCA1 c.68_69delAG sequence variant.",-49.25,0.6,sequencevariant
"Mutating the BRCA1 gene to the sequence variant c.1093-1G>T in the HeLa cell line results in a single base pair deletion of a cytosine nucleotide that abolishes splicing, producing an aberrant transcript that causes loss of tumor suppressor function in Homo sapiens cells.",-43.0,0.6,sequencevariant
"Single base pair deletion of a cytosine nucleotide in the TP53 gene (c.1093‑1G>T) creates a premature stop codon, resulting in a truncated p53 protein that cannot bind DNA and is associated with increased susceptibility to colorectal cancer in patients carrying the rs17015215-V274I variant.",-36.25,0.6,sequencevariant
"Single-base-pair deletion of a cytosine nucleotide in the BRCA1 gene (c.1093-1G>T) introduces the sequence variant rs17015215-V274I, causing the N495K and I280S substitutions that together abolish the asparagine‑86 to alanine transition and delete amino acids arginine‑87, threonine‑88, and proline‑89, thereby disrupting DNA repair activity in Homo sapiens cells.",-51.5,0.6,sequencevariant
"Single‑base‑pair deletion of a cytosine nucleotide at position c.1093‑1G> T in the BRCA1 gene, producing the sequence variant c.1093‑1G>T, is predicted to cause exon skipping and a downstream frameshift that eliminates amino acids N495K, I280S, and Q126R/del418T, thereby compromising DNA repair in Homo sapiens cells.",-47.75,0.6,sequencevariant
"Single-copy deletion of a cytosine nucleotide at c.1093‑1G>T in the BRCA1 gene leads to a frameshift that abolishes the normal splicing of exon five and creates a premature stop codon, while the rs17015215-V274I variant in the APOE gene enhances lipid transport and increases the risk of late‑onset Alzheimer’s disease in a homozygous state.",-76.0,0.6,sequencevariant
"Following CRISPR‑mediated editing, a single base pair deletion of a cytosine nucleotide in the TP53 gene produced a frameshift that changed asparagine at position‑86 to alanine and eliminated amino acids‑87, ‑88, and ‑89 (arginine, threonine, and proline), thereby abrogating DNA‑binding activity and rendering A549 cells hypersensitive to doxorubicin.",-56.75,0.6,sequencevariant
"Following the identification of the c.1093‑1G>T splice‑site mutation in the BRCA1 gene, researchers observed that the single‑base‑pair deletion of a cytosine nucleotide at position c.467C>A, which changes asparagine at residue N495 to lysine (N495K), resulted in a loss of the downstream amino acids (87‑89) and a severe reduction in DNA‑repair activity in HeLa cells.",-77.5,0.6,sequencevariant
"Following transient transfection of HEK293 cells with the BRCA1 c.1093‑1G>T splice‑site mutation, the resulting aberrant transcript was shown to encode a protein lacking residues N495K and I280S, thereby impairing DNA repair and increasing cellular sensitivity to cisplatin.",-50.0,0.6,sequencevariant
"Following genome‑wide association studies, the rs17015215-V274I sequence variant was found to disrupt the binding of transcription factor NF‑κB to the promoter of the IL‑6 gene, thereby reducing IL‑6 expression in A549 cells and attenuating the inflammatory response in patients with chronic obstructive pulmonary disease.",-39.75,0.6,sequencevariant
"Sequencing of the TP53 gene in A549 cells revealed a single base pair deletion of a cytosine nucleotide at position c.1093-1G>T that caused a frameshift and premature stop codon, while a separate c.643T>C mutation introduced an N495K amino‑acid change, both of which were predicted to destabilize the p53 protein and impair its tumor‑suppressor function.",-48.0,0.6,sequencevariant
"Sequenced analysis of a single base pair deletion of a cytosine nucleotide in the TP53 gene revealed a c.1093-1G>T splice‑site variant that causes loss of exons encoding asparagine at position N86 and eliminates the adjacent amino acids R87, T88, and P89, thereby producing a truncated protein that is predicted to impair DNA‑binding and apoptosis regulation in HeLa cells.",-68.5,0.6,sequencevariant
"Sequencereport: In the A549 cell line, a single base pair deletion of a cytosine nucleotide at c.1093-1G>T in the TP53 gene causes a frameshift that eliminates amino acids N86, N87, N88, and N89 (arginine, threonine, and proline) and results in loss of the DNA-binding domain, thereby increasing the risk of malignant transformation in human lung carcinoma.",-66.5,0.6,sequencevariant
"Sequenza‑derived analysis of the KRAS locus revealed a c.1093‑1G>T splice‑site variant that, together with a single‑base‑pair deletion of a cytosine, causes the loss of amino acids N86, R87, T88, and P89, thereby generating a protein variant predicted to abolish GTPase activity.",-62.75,0.6,sequencevariant
"Mutation of the TP53 gene at c.1093-1G>T in the HeLa cell line introduces a single base pair deletion of a cytosine nucleotide, causing a splice site alteration that produces a truncated protein and increases apoptosis in response to doxorubicin treatment.",-37.75,0.6,sequencevariant
"Mutation rs17015215-V274I in the TP53 gene, a single base pair substitution altering valine to isoleucine at codon V274, was detected in a HeLa cell line, where it coincides with the c.1093-1G>T splice-site variant that causes a single base pair deletion of a cytosine nucleotide, ultimately leading to loss of exons encoding amino acids N495K and I280S and a truncated protein associated with increased susceptibility to radiation-induced apoptosis",-75.0,0.6,sequencevariant
"Mutation c.1093‑1G>T in the BRCA1 gene, together with the rs17015215 V274I polymorphism, was shown to disrupt splicing and abolish the normal N‑terminal exon, thereby reducing DNA repair capacity in breast cancer cell lines.",-42.75,0.6,sequencevariant
"Mutation‑induced disruption of the TP53 protein, such as the rs17015215‑V274I polymorphism combined with a single‑base‑pair deletion of cytosine at c.1093‑1G>T, can abolish the asparagine‑86‑to‑alanine substitution and eliminate the downstream amino acids arginine, threonine, and proline, thereby severely impairing DNA‑damage response signaling in Homo sapiens cells.",-62.5,0.6,sequencevariant
"Genome‑wide sequencing of a pancreatic adenocarcinoma cohort revealed a single base pair deletion of a cytosine nucleotide in the TP53 gene that co‑occurs with a c.1093‑1G>T splice‑site variant, leading to loss of the N495K and I280S residues and a frameshift that truncates the protein after amino acid Q126R/del418T, thereby impairing DNA‑binding activity and contributing to chemoresistance in the tumor cell line HCT",-69.0,0.6,sequencevariant
"Genome-wide association analyses revealed that the rs17015215-V274I sequence variant in the SERPINA1 gene, together with the c.1093‑1G>T splice-site mutation, markedly increased the risk of developing alpha‑1 antitrypsin deficiency in a cohort of Homo sapiens subjects, as evidenced by elevated serum protease activity and hepatic fibrosis markers.",-54.0,0.6,sequencevariant
"Genome editing of the TP53 locus in HCT116 cells revealed that a single base pair deletion of a cytosine nucleotide at position c.1093-1G > T abolishes the splice acceptor site, producing a truncated protein that lacks the DNA‑binding domain and causes loss of cell‑cycle arrest in response to doxorubicin.",-39.75,0.6,sequencevariant
"Genome-editing of the TP53 gene in HCT116 cells revealed that the c.1093‑1G>T splice‑site mutation, together with the rs17015215‑V274I variant, creates a novel exon skipping event that abolishes the p53 DNA‑binding domain and increases cellular sensitivity to doxorubicin.",-46.0,0.6,sequencevariant
Mice harboring the c.1093‑1G>T splice‑site mutation in the Brca1 gene displayed a pronounced reduction in homologous recombination efficiency and increased sensitivity to the DNA‑crosslinking agent cisplatin.,-33.25,0.6,sequencevariant
"Molecular analysis of a single base pair deletion of a cytosine nucleotide in the TP53 gene revealed a c.1093-1G>T splice site variant that alters the canonical donor site, resulting in a frameshift and a premature termination codon that is predicted to cause loss of the DNA‑binding domain and severely compromise tumor suppressor function.",-52.75,0.6,sequencevariant
"MUTATIONS such as the single base pair deletion of a cytosine nucleotide in the TP53 gene, the rs17015215-V274I variant, and the c.1093-1G>T splice‑site change have been shown to destabilize p53 protein structure and impair its tumor‑suppression function.",-39.5,0.6,sequencevariant
"Megan’s laboratory discovered that the c.1093-1G>T splice-site mutation in the BRCA1 gene, a single base pair deletion of a cytosine nucleotide that eliminates amino acids N495K and I280S, reduces DNA repair activity and increases breast cancer risk in a cohort of Homo sapiens patients.",-58.0,0.6,sequencevariant
"Ethanol exposure induces a single base pair deletion of a cytosine nucleotide at c.1093-1G > T in the TP53 gene, causing the sequence variant N495K and the Q126R/del418T alteration, which together destabilize the protein and increase the risk of carcinogenesis in A549 cells.",-46.75,0.6,sequencevariant
"Erythrocyte membrane protein A1 harboring the sequence variant c.1093‑1G>T, which deletes a cytosine nucleotide at the splice acceptor site, was shown to cause aberrant splicing that results in a frameshift and premature termination, thereby compromising the protein’s ability to bind hemoglobin and leading to a severe form of hereditary spherocytosis in a patient of Homo sapiens.",-56.0,0.6,sequencevariant
"Ectopic expression of the TP53 c.1093-1G>T splice‑site variant in H1299 cells leads to a truncated protein that fails to induce apoptosis, thereby contributing to chemoresistance in this lung cancer model.",-34.75,0.6,sequencevariant
"E2F1 c.1123T>G, a single base pair deletion of a cytosine nucleotide in the promoter region, was found to disrupt transcription factor binding and is associated with increased expression of the TP53 gene in HeLa cells.",-37.75,0.6,sequencevariant
"Wnt signaling is markedly altered in colorectal carcinoma cells harboring the sequence variant c.1093‑1G>T, which introduces a cryptic splice site that deletes a single cytosine nucleotide and causes the loss of amino acids N495K, I280S, and Q126R/del418T, thereby impairing β‑catenin degradation and promoting tumorigenesis.",-51.75,0.6,sequencevariant
"WES of a colorectal carcinoma sample revealed a single base pair deletion of a cytosine nucleotide at c.1093-1G>T, creating a splice‑site variant that truncates the protein and a concomitant missense change rs17015215‑V274I in TP53, thereby compromising its DNA‑binding domain and contributing to tumor aggressiveness.",-55.0,0.6,sequencevariant
"Widespread screening of colorectal tumors revealed a recurrent c.1093‑1G>T splice-site mutation that, together with a single‑base‑pair deletion of a cytosine nucleotide, generates a frameshift causing loss of asparagine‑86, alanine‑87, and threonine‑88, thereby disrupting the protein’s functional domain and correlating with aggressive disease in patients carrying the rs17015215‑V274I variant.",-60.0,0.6,sequencevariant
"WBC counts in patients with the c.1093-1G>T splice‑site variant of the LIG4 gene were markedly reduced, correlating with the single‑base‑pair deletion of a cytosine nucleotide that disrupts the consensus acceptor site and results in a truncated protein.",-50.25,0.6,sequencevariant
"The pathogenic c.1052delA sequence variant in the TP53 gene, which produces a p.R58fs frameshift, was found to correlate with increased tumor aggressiveness in A549 lung carcinoma cells derived from a Homo sapiens patient harboring the rs6277 SNP.",-29.875,0.6,sequencevariant
"The Ala467Thr sequence variant in the HLA‑B gene, identified as rs17015215, was found to significantly increase the risk of developing severe allergic rhinitis in patients carrying the rs4073 polymorphism.",-33.75,0.6,sequencevariant
"The heterozygous p.R58fs sequence variant in the TP53 gene, which introduces a premature stop codon and a lysine-to-glutamic acid substitution at codon C262, was found to be significantly enriched in patients with early‑onset colorectal cancer, suggesting that this variant may act as a pathogenic driver in the disease.",-50.0,0.6,sequencevariant
"The CRISPR/Cas9‑edited A549 cells harboring the c.1052delA sequence variant in TP53 exhibit a pronounced increase in apoptosis upon doxorubicin exposure, confirming that the p.R58fs truncation compromises DNA‑damage repair pathways.",-29.75,0.6,sequencevariant
"In the A549 cell line, the c.1052delA sequence variant in the TP53 gene causes a p.R58fs frameshift that reduces p53 protein stability and increases sensitivity to doxorubicin-induced apoptosis.",-19.25,0.6,sequencevariant
"In HeLa cells, the Ala467Thr sequence variant (rs6277) was found to alter the binding affinity of the transcription factor p53 to the TP53 promoter, thereby reducing TP53 expression and increasing resistance to doxorubicin.",-29.75,0.6,sequencevariant
"In HepG2 cells, the c.1052delA sequence variant in the TP53 gene causes a p.R58fs frameshift that reduces p53 protein stability and enhances cellular sensitivity to doxorubicin-induced apoptosis.",-20.125,0.6,sequencevariant
"In ovarian carcinoma cells, the rs6277 variant of the IL‑6 promoter increases transcriptional activity, while the c.1052delA sequence variant in the BRCA1 gene generates a p.R58fs frameshift that destabilizes the protein and predisposes patients to early‑onset breast cancer.",-41.75,0.6,sequencevariant
A missense variant in the IL6 promoter (rs1800795) that substitutes lysine for glutamic acid at position −174 is associated with increased expression of IL6 and a higher risk of inflammatory bowel disease in patients of European ancestry.,-30.5,0.6,sequencevariant
"A homologous recombination assay in A549 cells revealed that the BRCA1 c.1052delA sequence variant leads to a p.R58fs frameshift, which in turn reduces RAD51 foci formation and sensitizes the cells to the PARP inhibitor olaparib.",-33.0,0.6,sequencevariant
"A patient harboring the sequence variant c.1052delA in the BRCA1 gene exhibited a pronounced loss of DNA repair capacity, which was further exacerbated by the concurrent presence of the missense mutation rs17015215-V274I that replaces a valine with isoleucine in the protein's regulatory domain.",-38.25,0.6,sequencevariant
"A pathogenic sequence variant, the c.1052delA deletion in TP53, was identified in a tumor sample from a Homo sapiens patient, and functional assays revealed that the resulting p.R58fs frameshift leads to loss of the DNA‑binding domain, thereby impairing p53‑mediated apoptosis and contributing to oncogenesis.",-37.5,0.6,sequencevariant
"Homo sapiens hepatocellular carcinoma cells harboring the BRCA1 c.1052delA sequence variant exhibit a glycine‑to‑aspartate substitution at codon‑322 that disrupts the DNA‑binding domain of the TP53 protein, thereby enhancing cellular proliferation and resistance to doxorubicin.",-47.25,0.6,sequencevariant
"Heterozygous rs6277 and the p.R58fs sequence variant in the IL6R gene, together with the Gly→Asp change at codon‑322, were found to synergistically increase the risk of developing rheumatoid arthritis in a cohort of Homo sapiens patients.",-45.0,0.6,sequencevariant
"HepG2 cells harboring the c.1052delA sequence variant exhibit reduced expression of the p.R58fs truncated protein, leading to impaired insulin signaling and increased sensitivity to the chemotherapeutic agent doxorubicin.",-33.0,0.6,sequencevariant
"Haplotype rs6277, which encodes a lysine to glutamic acid substitution at codon G1899A, has been shown to enhance the transcriptional activity of the IL-8 promoter in A549 cells, thereby increasing inflammatory cytokine production and contributing to the development of chronic obstructive pulmonary disease in Homo sapiens.",-54.25,0.6,sequencevariant
"Gly‑>Asp at codon‑322 in the TP53 gene (p.G322D) was identified as a pathogenic sequence variant in a colorectal cancer patient, whose tumor exhibited a loss of heterozygosity at rs17015215‑V274I and a c.1052delA frameshift (p.R58fs) that likely contributed to the aggressive phenotype.",-58.0,0.6,sequencevariant
"Gastrointestinal bleeding in patients with the BRCA1 c.1052delA sequence variant was significantly reduced by treatment with the small‑molecule inhibitor doxorubicin, suggesting that the p.R58fs truncation of TP53 may alter the cellular response to DNA damage in A549 cells.",-47.75,0.6,sequencevariant
"Gastric carcinoma cells harboring the sequence variant rs17015215‑V274I exhibit markedly increased expression of the inflammatory chemokine CXCL10, suggesting that this amino‑acid substitution may enhance tumor‑associated immune recruitment.",-37.0,0.6,sequencevariant
GAD1 c.1052delA in a patient with schizophrenia led to a p.R58fs variant that was predicted to disrupt the GAD1 protein’s catalytic domain and was associated with a reduced GABAergic signaling phenotype.,-51.0,0.6,sequencevariant
"Mutations such as rs6277 and the Gly→Asp change at codon‑322 in the CYP2C9 gene alter the enzyme’s catalytic efficiency, thereby influencing the pharmacokinetics of warfarin in patients with the rs4073 polymorphism.",-39.5,0.6,sequencevariant
"Mutational analysis of the TNF‑α promoter revealed that the rs4073 polymorphism, which substitutes lysine for glutamic acid at position -308, is associated with increased expression of the cytokine in patients carrying the c.1052delA sequence variant.",-31.25,0.6,sequencevariant
"Mutagenic exposure to the chemotherapeutic agent cisplatin induced a Gly322Asp substitution in TP53, a sequence variant that was subsequently detected in the A549 cell line and correlated with increased apoptosis in Homo sapiens lung carcinoma cells.",-39.0,0.6,sequencevariant
"Mutant p.R58fs, a frameshift in the TP53 gene, was shown to disrupt the DNA‑binding domain and was associated with increased risk of early‑onset colorectal cancer in patients carrying the rs17015215‑V274I variant.",-38.5,0.6,sequencevariant
"Clinical examination of a patient harboring the BRCA1 sequence variant c.1052delA revealed a frameshift at codon R58, producing a truncated protein that impairs DNA repair and predisposes to early‑onset breast cancer.",-40.25,0.6,sequencevariant
"Clinical studies revealed that the rs6277 A>G single‑nucleotide polymorphism, which results in a lysine‑to‑glutamic‑acid substitution at codon C262, is associated with increased expression of the inflammatory chemokine CXCL10 and correlates with a higher risk of developing severe asthma in individuals carrying the G1899A variant of the IL‑10 gene.",-58.0,0.6,sequencevariant
"Clinical evaluation of a patient harboring the c.1052delA sequence variant in the TP53 gene revealed a p.R58fs frameshift that correlated with increased sensitivity to doxorubicin in A549 cells, suggesting that this mutation may alter DNA repair pathways and influence therapeutic response.",-44.0,0.6,sequencevariant
"Clinical sequencing of a pancreatic carcinoma cohort revealed that the recurrent c.1052delA variant in TP53, which produces a p.R58fs frameshift and a lysine‑to‑glutamic acid substitution at codon C262, was associated with markedly increased tumor mutational burden and a higher likelihood of response to platinum‑based therapy.",-55.75,0.6,sequencevariant
"p.R58fs in TP53 causes a premature stop codon that impairs the apoptotic response in A549 cells, whereas the rs6277 SNP in IL6 modulates its expression in Homo sapiens blood samples.",-43.25,0.6,sequencevariant
"p.Ala467Thr in the TP53 gene, a variant catalogued as rs6277, has been shown to disrupt the DNA-binding domain and increase the risk of early-onset colorectal cancer in individuals carrying the rs17015215-V274I polymorphism.",-36.75,0.6,sequencevariant
"p.Arg58fs, a frameshift variant in the TP53 gene, was found to disrupt the DNA‑binding domain and was associated with increased tumorigenicity in A549 cells harboring the rs17015215‑V274I polymorphism.",-36.75,0.6,sequencevariant
"p.Phe467Thr in the TP53 gene, a variant identified as rs17015215-V274I, disrupts the DNA‑binding domain and has been shown to impair apoptotic signaling in HeLa cells.",-39.75,0.6,sequencevariant
"CellLine A549 harboring the sequence variant rs17015215-V274I displays heightened sensitivity to the DNA‑damaging agent doxorubicin, an effect mediated by increased expression of the gene TP53 and amplified apoptosis signaling.",-42.5,0.6,sequencevariant
"Cell‑line A549 harboring the sequence variant p.R58fs in TP53 exhibited reduced proliferation and increased apoptosis when treated with the chemical entity doxorubicin, confirming that this frameshift mutation compromises TP53 tumor‑suppressor function.",-39.75,0.6,sequencevariant
"Cell viability assays in A549 cells transfected with the p.R58fs sequence variant revealed that the frameshift induced a premature stop codon, leading to truncated TP53 protein and markedly increased apoptosis compared with wild‑type TP53.",-33.75,0.6,sequencevariant
"Cell culture of A549 cells transfected with the c.1052delA sequence variant of TP53, which causes a p.R58fs truncation, led to a marked up‑regulation of the inflammatory cytokine IL‑6 and increased apoptosis compared to the wild‑type TP53.",-44.0,0.6,sequencevariant
"Experimental studies revealed that the rs17015215-V274I sequence variant in the IL1B gene, which substitutes a valine for a lysine at codon V274, is associated with elevated plasma IL‑1β levels and a higher risk of developing rheumatoid arthritis in a cohort of homozygous rs4073 C allele carriers.",-59.25,0.6,sequencevariant
"Experimental in vitro assays revealed that the Ala467Thr (c.1400C>T) sequence variant in the TP53 gene markedly increased the apoptotic response to doxorubicin in H1299 cells, whereas the p.R58fs (c.173delG) frameshift mutation in the BRCA1 gene abrogated DNA repair activity and sensitized these cells to cisplatin-induced cytotoxicity.",-58.0,0.6,sequencevariant
"Experimental validation revealed that the c.1052delA sequence variant in the IL6 gene, which causes a p.R58fs frameshift and a downstream lysine-to-glutamic‑acid substitution, is strongly associated with increased rs4073 promoter activity and heightened inflammatory cytokine release in A549 cells.",-38.75,0.6,sequencevariant
"Experimental investigations revealed that the BRCA1 sequence variant rs17015215-V274I, which replaces valine with isoleucine at codon‑274, correlates with a reduced DNA repair capacity and heightened risk of breast cancer in a cohort of Homo sapiens patients.",-54.75,0.6,sequencevariant
"Castration-resistant prostate cancer cell line PC3 harboring the sequence variant rs6277 in the CYP3A4 gene exhibits a markedly higher sensitivity to the chemotherapeutic agent docetaxel, suggesting that the G to A transition at nucleotide position c.1052delA within the promoter region enhances drug uptake and induces apoptosis via upregulation of TP53 and BAX expression.",-76.0,0.6,sequencevariant
Cytosine‑to‑guanine substitution at position c.1052delA in the TP53 gene (a sequence variant known as p.R58fs) was detected in a lung cancer patient whose A549 cell line exhibited a pronounced increase in apoptosis following treatment with the chemotherapeutic agent doxorubicin.,-45.0,0.6,sequencevariant
"Citrus fruit extract containing the G1899A sequence variant of CYP2D6 was shown to alter the pharmacokinetics of the anti‑epileptic drug carbamazepine, thereby increasing the risk of dose‑dependent neurotoxicity in patients carrying the rs6277 polymorphism.",-45.25,0.6,sequencevariant
"C12orf48 rs6277, a synonymous variant in the coding region of the gene, was found to co‑occur with the pathogenic c.1052delA sequence variant in the TP53 gene in a cohort of sporadic colorectal cancer patients, suggesting a potential synergistic effect on tumor suppression pathways.",-55.25,0.6,sequencevariant
"Mutation p.R58fs in the TP53 gene, identified as rs17015215-V274I, was shown to impair p53’s DNA‑binding domain, leading to increased tumorigenesis in A549 cell lines.",-34.25,0.6,sequencevariant
"Mutation c.1052delA in the BRCA1 gene, which causes a frameshift (p.R58fs) and is associated with a higher risk of breast cancer in carriers of the rs6277 allele, was found to disrupt the normal lysine to glutamic acid substitution at codon G1899A and alter the glycine‑to‑aspartate change at codon C262.",-59.0,0.6,sequencevariant
"Mutation of the TP53 gene (c.1052delA) in HeLa cells produces a p.R58fs frameshift that abolishes the DNA‑binding domain, thereby impairing p53‑mediated apoptosis and enhancing the cells’ resistance to doxorubicin.",-34.75,0.6,sequencevariant
"Mutation‑induced Gly322Asp in the TP53 sequence variant (c.1052delA) was shown to destabilize the protein’s DNA‑binding domain, thereby increasing susceptibility to tumorigenesis in Homo sapiens cell lines such as HeLa and A549.",-42.75,0.6,sequencevariant
"Knock‑in of the p.R58fs sequence variant in TP53 causes a truncated protein that abolishes DNA‑binding and leads to loss of p53‑mediated apoptosis in HeLa cells, thereby increasing resistance to doxorubicin.",-37.0,0.6,sequencevariant
"Knocking‑in the rs17015215‑V274I sequence variant in the CYP2D6 gene of HepG2 cells markedly reduces the hepatocyte‑derived metabolite production of the chemotherapeutic doxorubicin, thereby attenuating the drug’s cytotoxicity toward the tumor line.",-47.25,0.6,sequencevariant
"Knoc2 c.1052delA, an Alu-mediated frameshift that produces a p.R58fs protein, is associated with an increased risk of early-onset Parkinson’s disease in a cohort of Homo sapiens carrying the rs6277 allele.",-56.25,0.6,sequencevariant
"Knoxville mice carrying the c.1052delA sequence variant in the *Traf6* gene exhibit an exaggerated inflammatory response to lipopolysaccharide, suggesting that this loss‑of‑function mutation disrupts NF‑κB signaling in macrophages.",-53.5,0.6,sequencevariant
"R2-7, a novel rs6277 variant causing an Ala467Thr substitution in the TP53 gene, was found to increase the risk of chemoresistance in HeLa cells treated with doxorubicin.",-45.25,0.6,sequencevariant
"RIPK2 mutations, such as the Gly322Asp variant (c.962G>A), have been shown to disrupt autophosphorylation and consequently impair NF‑κB signaling, thereby contributing to the inflammatory phenotype observed in patients carrying the rs4073 polymorphism.",-46.75,0.6,sequencevariant
"Rational design of a CRISPR/Cas9 construct targeting the rs17015215‑V274I variant in the IL‑6 promoter revealed that the Gly→Asp change at codon‑322 in the downstream regulatory element markedly altered NF‑κB binding, thereby amplifying cytokine release in a human HepG2 cell line.",-71.5,0.6,sequencevariant
"RNU12 c.1052delA causes a frameshift leading to a p.R58fs variant that disrupts the splice donor site in the U4 snRNA gene, thereby impairing spliceosome assembly and contributing to the observed splicing defects in patients with the rs6277 polymorphism.",-53.75,0.6,sequencevariant
"The CRISPR‑edited A549 cells harboring the BRCA1 c.2607C>A (p.Arg879*) variant exhibit impaired homologous recombination, leading to increased sensitivity to the PARP inhibitor olaparib.",-22.375,0.6,sequencevariant
"The functional impact of the BRCA1 c.2607C>A (p.Arg869His) sequence variant, which introduces a novel G > C substitution at codon Arg399Gln, was confirmed to reduce homologous recombination efficiency in HeLa cells.",-42.75,0.6,sequencevariant
"The c.2607C>A (Arg399Gln) variant in TP53, which replaces a cytosine with adenine at position c.2607, has been shown to increase the risk of sporadic colorectal cancer in patients of the Homo sapiens population.",-36.75,0.6,sequencevariant
"The Ala7Val (c.20G>A) sequence variant in the GDF5 gene, which replaces glycine with cysteine at position G1359, has been shown to increase the risk of osteoarthritis in Homo sapiens.",-34.5,0.6,sequencevariant
"A missense sequence variant c.2607C>G in TP53, resulting in the Arg399Gln substitution, has been shown to disrupt p53’s DNA‑binding domain and impair apoptosis in HeLa cells exposed to doxorubicin.",-29.25,0.6,sequencevariant
"A clinical cohort of **Homo sapiens** patients carrying the **SequenceVariant** c.2607C>A in the **GeneOrGeneProduct** TP53 exhibited a markedly increased incidence of **DiseaseOrPhenotypicFeature** early‑onset breast cancer compared with matched controls, suggesting that this single‑nucleotide change directly disrupts p53 tumor‑suppressor activity.",-48.0,0.6,sequencevariant
"ACRN‑C, a novel sequence variant comprising a G>C transition at position c.2607, results in the Arg399Gln substitution in the TP53 protein, which has been shown to reduce p53’s DNA‑binding affinity and increase the risk of epithelial cancers in individuals carrying the variant.",-64.0,0.6,sequencevariant
"A pathogenic sequence variant, the Arg399Gln substitution in the BRCA1 gene, was identified in a patient with a family history of breast cancer and was shown to disrupt DNA repair by altering the protein’s interaction with the RAD51 complex.",-32.75,0.6,sequencevariant
Mutations such as c.2607C> A and Arg399Gln in TP53 are associated with increased risk of colorectal cancer in patients carrying the sequence variant G > C.,-24.875,0.6,sequencevariant
"Mutational analysis of the BRCA1 gene in a cohort of breast cancer patients revealed that the c.2607C>A (Arg399Gln) sequence variant, which introduces a G> C transversion, was associated with a higher risk of early-onset disease compared to the wild-type allele.",-38.5,0.6,sequencevariant
"Mutagenic exposure to ultraviolet light induced the c.2607C>G sequence variant in the TP53 gene, resulting in an Arg399Gln substitution that compromises DNA‑repair activity in human keratinocytes.",-35.75,0.6,sequencevariant
"Mutating the BRCA1 gene from c.2607C>A to the Arg399Gln variant in HeLa cells disrupts homologous recombination and increases sensitivity to the DNA‑crosslinking drug doxorubicin, thereby providing a potential therapeutic strategy for patients with the G > C sequence variant.",-47.25,0.6,sequencevariant
"Mutation of the TP53 gene from Arg399 to Gln (Arg399Gln) in a HeLa cell line expressing the E359K variant of the BRCA1 protein was shown to increase cellular sensitivity to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis in Homo sapiens cells.",-39.0,0.6,sequencevariant
"Mutation analysis of the tumor suppressor gene TP53 in the HeLa cell line revealed a novel c.2607C>A sequence variant that changes the codon for histidine at position Arg399 to glutamine (Arg399Gln), potentially disrupting DNA repair and contributing to the cell line’s resistance to doxorubicin.",-55.5,0.6,sequencevariant
"Mutation c.2607C>A in the TP53 gene, which results in the Arg399Gln amino‑acid change, was identified in a subset of colorectal cancer patients, and its presence was associated with increased sensitivity to the DNA‑damaging chemotherapeutic agent doxorubicin.",-30.75,0.6,sequencevariant
"Mutation A7V (Ala7Val) in the p53 gene (TP53) has been shown to alter the DNA-binding domain and is frequently observed in colorectal tumours, whereas the Arg399Gln polymorphism in the XRCC1 gene (XRCC1) is associated with increased risk of breast cancer in women exposed to ionizing radiation.",-51.75,0.6,sequencevariant
"In the A549 cell line, the BRCA1 c.2607C>A (p.Arg879Ser) sequence variant was found to disrupt the binding of the DNA repair protein RAD51, thereby enhancing cisplatin sensitivity in these cells.",-32.0,0.6,sequencevariant
"In A549 cells, the BRCA1 sequence variant c.2607C> A (Arg399Gln) was shown to increase DNA repair efficiency and reduce the mutational load of the G > C transversion in the TP53 gene, thereby attenuating the risk of tumorigenesis.",-43.5,0.6,sequencevariant
"In HeLa cells, the BRCA1 sequence variant c.2607C>A, which results in the Arg399Gln substitution, was shown to increase DNA repair deficiency and sensitize the cells to the chemotherapeutic agent doxorubicin.",-22.125,0.6,sequencevariant
"In CRISPR‑edited A549 cells, the engineered c.2607C>A (p.Arg889Gln) variant in the TP53 gene was shown to increase resistance to doxorubicin while simultaneously inducing a pro‑apoptotic shift in the mitochondrial membrane potential.",-44.0,0.6,sequencevariant
"BRCA1 c.68_69delAG, a sequence variant that deletes a guanine–cytosine pair, was shown to reduce homologous recombination repair activity in HCC cell lines and to increase susceptibility to platinum‑based chemotherapy.",-40.0,0.6,sequencevariant
"BRMS1L c.2607C>A, a sequence variant that converts a cysteine to tyrosine at position p.Arg871, was found to destabilize the protein’s zinc‑finger domain and reduce its tumor‑suppressive activity in A549 cells, thereby enhancing metastatic potential.",-63.75,0.6,sequencevariant
"BRST-3, a sequence variant in the BRCA1 gene (c.2607C>G) that introduces an Arg399Gln substitution, was shown to impair DNA repair capacity in MCF‑7 cells and correlate with increased risk of breast cancer relapse.",-61.0,0.6,sequencevariant
"BRIC1 c.2607C>A, a G > C transition that converts a cysteine to a tyrosine at position Ala7Val, has been shown to impair the DNA repair activity of the E359K variant in the TP53 gene and is associated with increased risk of colorectal cancer in patients with the Arg399Gln sequence variant.",-72.0,0.6,sequencevariant
"Alterations such as the G > C substitution leading to Ala7Val and the Arg399Gln variant have been shown to disrupt DNA repair pathways in TP53, thereby increasing susceptibility to colorectal carcinoma in patients harboring the c.2607C > A sequence variant.",-35.0,0.6,sequencevariant
"Alteration of the TP53 sequence variant c.2607C>A, which results in the Arg399Gln substitution, was shown to impair DNA repair in HeLa cells, thereby increasing their sensitivity to the chemotherapeutic agent doxorubicin.",-26.875,0.6,sequencevariant
Altered expression of the TP53 protein in HeLa cells carrying the Arg399Gln sequence variant (c.2607C>A) leads to impaired DNA repair and increased sensitivity to the chemotherapeutic agent doxorubicin.,-27.875,0.6,sequencevariant
"Alterative analysis of the TP53 sequence variant c.2607C>A revealed a missense change that generates an Arg399Gln residue, potentially disrupting the protein’s DNA‑binding domain and predisposing to genomic instability in breast carcinoma cells.",-51.75,0.6,sequencevariant
"Variants of the BRCA1 gene such as c.2607C>A and the Arg399Gln polymorphism in the XRCC1 gene were found to increase the risk of breast cancer in a cohort of Homo sapiens individuals, while the Ala7Val substitution in the MTHFR gene was associated with a decreased risk of neural tube defects.",-49.0,0.6,sequencevariant
"Variants such as the c.2607C> A (Arg399Gln) substitution and the tandem deletion c.157delMTTTVP in the TP53 gene have been shown to impair DNA damage response in A549 cells, suggesting that these sequence variants may contribute to chemoresistance in lung cancer.",-47.5,0.6,sequencevariant
"Variants harboring the Ala7Val (c.20G>A) substitution and the Arg399Gln (c.1196G>A) alteration in the TP53 gene were found to elevate the risk of colorectal cancer in a cohort of *Homo sapiens* patients, whereas the c.2607C>A (E359K) change in the BRCA1 sequence was associated with a modest increase in breast‑cancer susceptibility.",-64.5,0.6,sequencevariant
"Variants including the Ala7Val missense mutation (c.20G>A) and the Arg399Gln polymorphism (c.1196C>G) in the TP53 gene are frequently observed in colorectal cancer cell lines such as HCT116, where they contribute to altered p53-mediated apoptosis and increased resistance to the chemotherapeutic agent doxorubicin.",-51.0,0.6,sequencevariant
"Ectopic expression of the E359K sequence variant in the TP53 gene was shown to reduce DNA damage response in A549 cells, thereby increasing their susceptibility to doxorubicin-induced apoptosis.",-33.25,0.6,sequencevariant
"Epidermal growth factor receptor (EGFR) c.2607C>A, which results in the E359K amino‑acid substitution, has been identified in a subset of non‑small cell lung cancer patients and is associated with increased resistance to erlotinib in A549 cell lines.",-36.0,0.6,sequencevariant
E12.5 embryos carrying the BRCA1 c.2607C>A sequence variant exhibited a significant reduction in homologous recombination repair efficiency compared to wild‑type embryos.,-39.25,0.6,sequencevariant
"Epithelial cells harboring the BRCA1 c.2607C>A (Arg399Gln) variant exhibit reduced homologous recombination efficiency, which correlates with increased sensitivity to the PARP inhibitor olaparib in A549 cells.",-32.75,0.6,sequencevariant
Patients with the BRCA1 c.2607C>A (p.Arg881Gln) sequence variant exhibited a markedly higher incidence of early‑onset breast cancer compared with carriers of the wild‑type allele.,-26.75,0.6,sequencevariant
"Patients bearing the BRCA1 c.2607C>A (Arg399Gln) sequence variant exhibited markedly increased sensitivity to cisplatin-induced DNA cross‑links, a phenotype that was further amplified in those with the additional c.7488CC (G1359G) polymorphism, thereby underscoring the combinatorial impact of multiple sequence variants on chemotherapeutic response.",-55.25,0.6,sequencevariant
"Patients harboring the sequence variant c.2607C>G in TP53, which results in the Arg399Gln substitution, exhibit markedly increased sensitivity to doxorubicin-induced apoptosis in HeLa cells.",-23.875,0.6,sequencevariant
"Patients carrying the BRCA1 c.68_69delAG variant, a sequence variant that deletes an alanine and valine at positions Ala7Val, exhibit a markedly increased risk of triple‑negative breast cancer compared with individuals homozygous for the wild‑type sequence.",-40.75,0.6,sequencevariant
"Missense mutations such as Ala7Val and His43Arg in the TP53 gene, along with the splice‑site variant c.2607C>A, have been shown to increase the risk of colorectal cancer in patients carrying the BRCA1 c.68_69delAG sequence variant.",-33.75,0.6,sequencevariant
Missorting of the MHC‑I peptide loading complex in HLA‑B*07:02 cells harboring the G1359G sequence variant results in a reduced surface display of the peptide and a concomitant increase in cytotoxic T‑cell activation.,-63.25,0.6,sequencevariant
Misshapen c.2607C > A and Arg399Gln sequence variants in the TP53 gene were found to impair DNA damage repair and promote apoptosis resistance in HeLa cells exposed to doxorubicin.,-47.75,0.6,sequencevariant
"Misspecification of the BRCA1 sequence variant c.2607C>A, which replaces a cysteine with a tyrosine at position Arg399Gln, is predicted to destabilize the protein’s DNA‑repair domain and predispose carriers to early‑onset breast cancer.",-55.0,0.6,sequencevariant
"Heterozygous G > C substitutions at codon Arg399Gln in the BRCA1 gene, together with the Ala7Val variant in the TP53 protein, have been shown to increase the risk of early‑onset breast cancer in individuals carrying the c.2607C > A sequence variant.",-42.0,0.6,sequencevariant
"Homo sapiens TP53 c.2607C>A (p.Arg899Gln) variants were identified in A549 cells, where the Arg399Gln substitution destabilized the DNA-binding domain and increased sensitivity to cisplatin.",-43.5,0.6,sequencevariant
"Haplotype analysis of the TP53 gene in colorectal carcinoma revealed that the Arg399Gln variant (c.1196G>A) co‑occurs with the E359K mutation (c.1076G>A), suggesting a synergistic effect on p53 DNA‑binding affinity and tumor suppressor function.",-42.5,0.6,sequencevariant
"HepG2 cells harboring the BRCA1 c.2607C>A (Arg399Gln) sequence variant exhibit reduced DNA repair capacity and increased sensitivity to cisplatin, whereas the MCF‑7 line with the BRCA1 Ala7Val variant maintains normal PARP‑dependent repair and shows resistance to the same drug.",-55.0,0.6,sequencevariant
"R33Q in the TP53 sequence variant (c.2607C>A) was shown to disrupt the DNA-binding domain, causing a loss of apoptotic regulation in A549 cell lines infected with a recombinant E. coli strain that overexpresses the His43Arg mutation.",-58.0,0.6,sequencevariant
"Rheumatoid arthritis patients carrying the c.2607C>A variant in the TNFAIP3 gene exhibit a markedly reduced response to methotrexate, suggesting that this sequence variant may alter drug metabolism and therapeutic efficacy.",-34.75,0.6,sequencevariant
"RBPJ’s c.2607C>A variant, which introduces a His43Arg substitution, has been shown to impair Notch signaling in A549 cells, thereby reducing EGF-induced proliferation of these lung cancer cell lines.",-50.5,0.6,sequencevariant
"RPL32 c.2607C>A (Arg399Gln) and the adjacent G1359G variant were identified in a patient with a history of thrombocytopenia, suggesting that these sequence variants may impair ribosomal protein function and contribute to the observed hematologic phenotype.",-53.25,0.6,sequencevariant
"Following CRISPR/Cas9 editing of the TP53 locus in HCT116 cells, the introduced sequence variant c.2607C>A (p.Arg869Gln) was confirmed to impair p53 DNA‑binding affinity, thereby reducing apoptosis in response to doxorubicin treatment.",-36.75,0.6,sequencevariant
"Following the identification of the c.2607C>A (Arg399Gln) sequence variant in the BRCA1 gene, researchers observed that the altered protein’s DNA‑binding affinity was markedly reduced, leading to impaired repair of double‑strand breaks in HeLa cells exposed to ionizing radiation.",-39.75,0.6,sequencevariant
"Following in vitro CRISPR/Cas9 editing, the engineered A549 cell line carrying the BRCA1 c.2607C>A (p.Arg869Gln) sequence variant exhibited a marked increase in sensitivity to the DNA‑damaging agent doxorubicin compared with the wild‑type line.",-42.75,0.6,sequencevariant
"Following a CRISPR‑Cas9‑mediated knock‑in of the c.2607C>G sequence variant, the A549 CellLine exhibited a dramatic up‑regulation of the TP53 gene product, which in turn enhanced the sensitivity of the cells to the chemotherapeutic agent doxorubicin, thereby providing a potential therapeutic avenue for patients with the Arg399Gln mutation.",-57.25,0.6,sequencevariant
"The c.304G>A mutation, which introduces a G>A transition at the splice donor site of intron +1, was found to be strongly associated with the rs10942891 allele in a cohort of Homo sapiens patients carrying the AG-dinucleotide insertion, and this sequence variant was shown to alter the splicing efficiency of the TP53 gene product, thereby contributing to the development of Parkinson’s disease.",-59.25,0.6,sequencevariant
"The CRISPR‑edited A549 cells harbor a c.304G > A sequence variant that introduces a premature stop codon, and the resulting truncated TP53 protein fails to induce apoptosis in response to doxorubicin, thereby conferring chemoresistance.",-29.375,0.6,sequencevariant
"The AG-dinucleotide (CCTTT)13 insertion causes a six‑base insertion that produces the rs10942891 allele, while the g.3395C>T variant results in a c.2380+1G>A splice‑site mutation that alters the protein coding sequence of the gene.",-45.75,0.6,sequencevariant
"The pathogenic rs10942891 variant, a CCTTT‑13 repeat expansion in the intronic region of the TP53 gene, was shown to disrupt normal splicing and lead to a loss‑of‑function allele that predisposes Homo sapiens individuals to early‑onset colorectal cancer.",-42.25,0.6,sequencevariant
"A recent study found that the rs713041 sequence variant in the CYP1A1 gene, a CCTTT (13) repeat expansion coupled with a g.3395C > T polymorphism, significantly alters the enzyme’s capacity to metabolize aflatoxin B1, thereby increasing hepatocellular carcinoma risk in individuals of East Asian descent.",-52.5,0.6,sequencevariant
"A heterozygous rs10942891 c.304G>A variant in the CYP2C9 gene was detected in a patient with severe warfarin sensitivity, and the variant was shown to alter splicing by creating an AG-dinucleotide splice acceptor site that was absent in the reference (CCTTT)13 repeat region.",-52.5,0.6,sequencevariant
"A homozygous AG-dinucleotide insertion at the splice donor site (c.2380 +1G > A) in the TCF7L2 gene was found to disrupt β‑catenin signaling in pancreatic β‑cells, while a nearby rs713041 polymorphism (G > A) at codon‑620 of the same locus modulated the variant’s effect on insulin secretion.",-71.5,0.6,sequencevariant
"A single g.3395C > T sequence variant in the TP53 gene, which introduces a novel AG-dinucleotide at the splice acceptor site, is predicted to disrupt normal splicing and may contribute to the development of aggressive breast cancer in patients carrying the rs10942891 allele.",-45.0,0.6,sequencevariant
"Patients treated with the chemotherapeutic agent doxorubicin displayed a significant enrichment of the BRCA1 c.2380+1G>A splice‑site mutation, a sequence variant that disrupts normal mRNA splicing and may underlie the increased incidence of cardiotoxicity observed in the A549 cell line.",-48.0,0.6,sequencevariant
"Patients carrying the c.2380+1G>A splice‑site variant in the PKD1 gene exhibit a more severe renal phenotype than those with the rs10942891 polymorphism, suggesting that the AG‑dinucleotide insertion at position g.3395C>T modulates disease penetrance.",-42.5,0.6,sequencevariant
"Patients harboring the c.304G > A variant in the CYP2C9 gene, which introduces a single‑base substitution and is linked to altered warfarin metabolism, displayed a markedly increased risk of bleeding compared with individuals carrying the reference allele.",-45.5,0.6,sequencevariant
Patients with the c.304G>A sequence variant in the CYP1A1 gene exhibited a significantly higher expression of the CYP1A1 protein and increased susceptibility to benzene-induced hematotoxicity in the HepG2 cell line.,-34.5,0.6,sequencevariant
"In HeLa cells, the AG‑dinucleotide insertion (c.304G>A) within the TP53 coding sequence creates a novel sequence variant that disrupts the binding of the p53‑responsive element, thereby impairing the transcriptional activation of downstream pro‑apoptotic genes such as BAX.",-39.25,0.6,sequencevariant
"In the AG‑dinucleotide‑rich region of the TP53 gene, a novel c.304G>A substitution was identified in a HeLa cell line, and the resulting rs10942891 variant was shown to impair the binding of the MDM2 protein, thereby enhancing p53‑dependent apoptosis in response to doxorubicin treatment.",-47.25,0.6,sequencevariant
"In Huh‑7 cells, the novel AG‑dinucleotide insertion (c.304G > A) in the KRAS gene was shown to increase protein stability and enhance MAPK signaling, thereby promoting resistance to the EGFR inhibitor gefitinib.",-44.5,0.6,sequencevariant
"In colorectal carcinoma cell lines, the c.304G > A sequence variant in the KRAS gene creates a novel AG-dinucleotide motif that alters splicing of the downstream exon and is predicted to increase the risk of resistance to the EGFR inhibitor cetuximab.",-40.0,0.6,sequencevariant
"c.-2380+1G>A in the splice donor site of the GATA3 gene leads to aberrant splicing that causes a loss‑of‑function allele, thereby increasing susceptibility to childhood T‑cell acute lymphoblastic leukemia in patients carrying the rs10942891 risk variant.",-52.25,0.6,sequencevariant
"cDNA sequencing of the CYP2D6 gene in a cohort of *Homo sapiens* revealed a novel AG‑dinucleotide insertion at position g.3395C>T that creates a six‑base insertion, resulting in the sequence variant c.2380+1G>A and the rs10942891 allele, which is predicted to alter splicing and reduce enzyme activity.",-51.0,0.6,sequencevariant
"c.^2380+1G>A, a splice‑site SequenceVariant, was identified in the TP53 GeneOrGeneProduct of a Homo sapiens CellLine, and its presence correlates with reduced p53 protein stability and increased cellular apoptosis in response to doxorubicin ChemicalEntity exposure.",-52.5,0.6,sequencevariant
"c.​304G>A in the CYP2C9 gene, a sequence variant that alters drug metabolism, was found to be more frequent in HepG2 cells transfected with the rs10942891 polymorphism, suggesting a combined effect on hepatotoxicity.",-54.75,0.6,sequencevariant
"Research in A549 cells revealed that the c.304G > A sequence variant, a G-to-A transition at codon‑620, markedly enhances TP53 expression and sensitizes the cells to doxorubicin‑induced apoptosis.",-45.5,0.6,sequencevariant
"Research reveals that the c.304G > A sequence variant, which causes a missense mutation at codon‑620, is associated with altered drug metabolism in patients carrying the rs713041 allele.",-41.25,0.6,sequencevariant
"Research revealed that the rs10942891 AG‑dinucleotide insertion coupled with a g.3395C> T point mutation in the (CCTTT)13 repeat region causes a six‑base insertion at position c.2380 +1G>A, which in turn alters the splicing of the TP53 gene and reduces its tumor‑suppressive activity in A549 cells.",-62.0,0.6,sequencevariant
"Research shows that the c.2380 +1G > A splice‑site variant in the CDKN2A gene, which creates a novel AG‑dinucleotide and a six‑base insertion at position g.3395C > T, reduces p16INK4a expression and predisposes to melanoma in individuals carrying the rs10942891 risk allele.",-53.5,0.6,sequencevariant
"Cell line A549 harboring the g.3395C > T sequence variant exhibited markedly increased resistance to the chemotherapeutic agent doxorubicin compared with the wild‑type A549 cells, suggesting that this single‑nucleotide polymorphism may alter drug‑transport protein expression.",-40.25,0.6,sequencevariant
"Cell lines such as HeLa harbor a c.2380+1G>A splice‑site variant in the TP53 gene, while the A549 cell line carries a six‑base insertion (CCTTT)13 that creates an AG‑dinucleotide repeat, and both variants are linked to altered apoptosis signaling.",-54.0,0.6,sequencevariant
"Cell viability was markedly reduced in HeLa cells engineered to carry the BRCA1 c.2380 +1G > A splice‑site variant, which disrupts the canonical donor motif and leads to exon skipping, thereby increasing susceptibility to cisplatin-induced apoptosis.",-43.25,0.6,sequencevariant
"Cell‑line A549 harboring the c.2380+1G>A splice‑site variant in the TP53 gene shows reduced p53 protein expression and heightened sensitivity to the chemotherapeutic agent doxorubicin, underscoring the pathogenic impact of this sequence variant.",-36.75,0.6,sequencevariant
"Sequencing of the TP53 gene in A549 cells revealed a novel c.2380+1G>A splice‑site mutation that, together with a nearby rs10942891 SNP, may alter the expression of the p53 protein and contribute to drug resistance.",-39.25,0.6,sequencevariant
"Sequenced cDNA from the A549 cell line revealed a novel AG‑dinucleotide insertion at position g.3395C>T, which creates a six‑base insertion causing a frameshift and loss of the (R) allele at codon620 in the TP53 gene, thereby generating a sequence variant that likely compromises its tumor‑suppressive function.",-65.0,0.6,sequencevariant
"Sequencereport: In a cohort of colorectal cancer patients, a novel AG-dinucleotide insertion at position g.3395C > T within the TP53 gene was identified, and this variant co‑occurs with a c.2380 +1G > A splice‑site mutation, both of which are predicted to disrupt p53 protein function and increase tumor aggressiveness.",-64.5,0.6,sequencevariant
"Sequenza‑based analysis of a colorectal carcinoma sample revealed a pathogenic c.304G>A sequence variant in the KRAS gene, which co‑occurs with an AG‑dinucleotide insertion at g.3395C>T and a novel rs10942891 polymorphism, collectively contributing to the tumor’s resistance to EGFR‑targeted therapy.",-58.5,0.6,sequencevariant
"Analysis of the A549 cell line revealed that the c.304G > A sequence variant, located within the TP53 gene, correlates with increased expression of the R allele at codon&nbsp;620 and a higher susceptibility to doxorubicin-induced apoptosis.",-45.25,0.6,sequencevariant
"Analysis revealed that the c.304G > A sequence variant in the CYP2C19 gene, annotated as rs713041, is associated with a reduced enzymatic activity that compromises the metabolism of the anti‑epileptic drug carbamazepine in patients of the A/G transition -1,071 bp allele at codon (R) in the CYP2C19 coding region.",-61.75,0.6,sequencevariant
"Analysis showed that the rs10942891 (A/G transition –1,071 bp) variant in the intronic region of the CYP2C9 gene, together with a neighboring c.304G > A substitution, co‑occurs with a six‑base insertion that creates an AG‑dinucleotide motif in the (CCTTT)₁₃ repeat, leading to altered splicing and reduced enzymatic activity in hepatocytes.",-74.5,0.6,sequencevariant
"Analysis identified a pathogenic sequence variant in the CYP2D6 gene, specifically a c.304G > A mutation that introduces an AG-dinucleotide insertion within exon five, leading to a premature stop codon and loss of enzymatic activity in the A549 cell line.",-61.75,0.6,sequencevariant
"Examination of the AG‑dinucleotide repeat in the promoter of the HLA‑B gene revealed a (CCTTT)13 expansion that, together with a g.3395C>T substitution, results in a novel c.2380+1G>A splice‑site mutation that segregates with the rs10942891 allele and is predicted to abolish normal exon splicing, thereby contributing to the observed autoimmune phenotype in the affected cohort.",-74.0,0.6,sequencevariant
"Exposing the CRISPR‑edited A549 cells to doxorubicin revealed that the engineered c.304G > A sequence variant in the TP53 gene, together with the rs10942891 SNP, significantly reduced p53 protein levels and increased apoptosis compared to the wild‑type cells.",-47.5,0.6,sequencevariant
"Ex vivo CRISPR‑edited A549 cells carrying the c.2380 +1G > A splice‑site variant exhibited a pronounced up‑regulation of the oncogenic TP53 isoform and a concomitant increase in apoptosis compared with wild‑type cells, suggesting that the AG‑dinucleotide insertion disrupts normal splicing of the TP53 pre‑mRNA.",-55.5,0.6,sequencevariant
"Excessive expression of the (R) allele at codon620 in TP53, caused by a c.304G>A variant, is associated with increased apoptosis resistance in HeLa cells, thereby contributing to chemoresistance to doxorubicin.",-49.0,0.6,sequencevariant
"AG‑dinucleotide deletions such as the (CCTTT)13 repeat expansion and the six‑base insertion at g.3395C>T, together with the A/G transition at −1,071 bp (rs10942891) and the c.2380+1G>A splice‑site mutation, collectively disrupt the normal splicing and translation of the TP53 gene in Homo sapiens cells.",-50.5,0.6,sequencevariant
"AG-dinucleotide insertion (c.2380 +1G > A) in the TP53 gene was found to enhance the binding of the p53 protein to the promoter of the BAX gene, thereby increasing apoptosis in A549 cells exposed to doxorubicin.",-35.25,0.6,sequencevariant
"AG‐dinucleotide mutations in the intronic region of the CYP1A1 gene, such as the g.3395C>T substitution and the c.2380+1G>A splice‑site alteration, have been shown to disrupt normal splicing and are associated with increased risk of hepatocellular carcinoma in individuals carrying the rs10942891 risk allele.",-47.25,0.6,sequencevariant
"AG dinucleotide (c.2380+1G>A) and a six‑base insertion (g.3395C>T) together with rs10942891 were identified in the TP53 gene of a HeLa cell line, suggesting a potential impact on transcriptional regulation and oncogenic transformation.",-48.5,0.6,sequencevariant
"Researchers identified a pathogenic AG-dinucleotide insertion in the BRCA1 c.304G > A sequence variant, which causes a frameshift and a premature stop codon, thereby disrupting the DNA repair function of the gene and increasing susceptibility to hereditary breast cancer.",-50.5,0.6,sequencevariant
"Researchers discovered that a c.304G > A sequence variant in the CYP1A1 gene, which creates an AG-dinucleotide motif at the exon‑intron boundary, reduces the enzyme’s catalytic efficiency and is associated with increased susceptibility to benzene‑induced hematotoxicity in A549 cells.",-42.25,0.6,sequencevariant
"Researchers measured that the AG‑dinucleotide repeat expansion in the (CCTTT)13 region, coupled with the g.3395C>T substitution, caused a six‑base insertion in the TP53 gene, and the resulting sequence variant c.2380+1G>A was associated with increased risk of colorectal cancer in patients carrying the rs10942891 allele.",-57.0,0.6,sequencevariant
"Researchers demonstrated that the AG-dinucleotide insertion (c.2380 +1G > A) in the BRCA1 promoter, together with the rs10942891 SNP, synergistically enhances transcriptional activation of TP53 in HeLa cells, thereby amplifying the cellular response to doxorubicin-induced DNA damage.",-43.75,0.6,sequencevariant
"Genomic analysis of a gastric carcinoma cohort revealed that the rs10942891 variant, a CCTTT(13) repeat expansion, was significantly associated with a six‑base insertion at g.3395C>T, which creates an A/G transition at −1,071 bp and disrupts splicing at c.2380+1G>A, ultimately altering the protein product encoded by the TP53 gene.",-63.75,0.6,sequencevariant
"Genetic analysis of the A549 cell line revealed a novel c.304G>A sequence variant in the TP53 gene, which was associated with a gain‑of‑function phenotype that enhanced the cells’ resistance to doxorubicin.",-40.0,0.6,sequencevariant
"Genotyping of the BRCA1 c.2380+1G>A splice‑site variant revealed that the AG‑dinucleotide insertion at the intron‑exon boundary disrupts normal splicing, leading to exon skipping and a truncated protein that impairs DNA repair in homozygous E. coli K‑12 strains.",-53.0,0.6,sequencevariant
"Genetically engineered HeLa cells harboring a c.304G>A sequence variant in the TP53 gene, which introduces an AG-dinucleotide insertion at the splice donor site of exon three, exhibit markedly reduced apoptosis upon exposure to doxorubicin.",-48.25,0.6,sequencevariant
"Carrying the c.2380+1G>A splice‑site variant in the BRCA1 gene, a patient with a germline rs10942891 polymorphism and a six‑base insertion in the promoter region of the ATM gene exhibited a markedly reduced DNA damage response and increased sensitivity to cisplatin in cultured HeLa cells.",-56.75,0.6,sequencevariant
"Carcinogenic exposure to the AG-dinucleotide insertion in the TP53 gene (c.2380 +1G > A) was found to promote apoptosis in HeLa cells, whereas the rs10942891 variant (c.304G > A) was associated with increased resistance to doxorubicin in A549 cells.",-46.75,0.6,sequencevariant
"Carcinoembryonic antigen (CGA) expression is markedly upregulated in the HCT116 cell line carrying the c.2380+1G>A splice‑site mutation, which introduces a novel AG-dinucleotide motif and a six‑base insertion that shifts the reading frame and generates a premature stop codon, thereby impairing the normal secretion of the glycoprotein.",-69.0,0.6,sequencevariant
"Carried by the HeLa cell line, the c.304G>A sequence variant in the TP53 gene (rs713041) disrupts the DNA-binding domain, leading to impaired apoptosis in response to doxorubicin treatment.",-36.0,0.6,sequencevariant
"A recent study revealed that the rs11915160 polymorphism, a c.2406C>A transition in the TP53 gene, is associated with a methionine-to-threonine substitution at codon‑235, which in turn enhances the tumor‑suppressive activity of the protein in HeLa cells.",-45.75,0.6,sequencevariant
"A pathogenic Gly2079Val sequence variant in the ATP1B1 gene, identified as rs11915160, has been shown to impair Na⁺/K⁺‑ATPase activity and is associated with familial hyperkalemic periodic paralysis in Homo sapiens.",-32.5,0.6,sequencevariant
"A CRISPR‑mediated introduction of the p.G705RfsX16 sequence variant in the TP53 gene of H1299 cells resulted in a dramatic increase in apoptosis upon doxorubicin treatment, indicating that this frameshift mutation sensitizes the cells to DNA‑damaging chemotherapy.",-33.25,0.6,sequencevariant
"A novel Gly2079Val sequence variant (c.6237G>A) in the CYP2D6 gene, identified as rs11915160, was found to impair drug metabolism in a cohort of Homo sapiens patients exhibiting a severe drug‑induced liver injury phenotype.",-40.5,0.6,sequencevariant
"The c.2406C>A sequence variant, which introduces a methionine-to-threonine substitution at codon&nbsp;235 in the TP53 gene, was found to be significantly enriched in patients with early‑onset breast cancer and correlated with a higher risk of metastatic relapse.",-44.25,0.6,sequencevariant
"The Gly2079Val substitution (c.6236G>A) in the ATP1A1 gene, a sequence variant that alters the sodium‑potassium pump, has been shown to disrupt neuronal excitability and is associated with early‑onset familial epilepsy in multiple families of European descent.",-45.5,0.6,sequencevariant
"The CRISPR‑edited A549 cells harboring the sequence variant c.2406C>A, which produces a methionine to threonine substitution at codon‑235, exhibit markedly increased resistance to doxorubicin compared with the wild‑type TP53‑expressing cells.",-36.25,0.6,sequencevariant
"The p.G705RfsX16 sequence variant, caused by a c.2406C>A substitution, was found to disrupt the DNA-binding domain of the TP53 gene in a cohort of Homo sapiens patients, thereby increasing their susceptibility to chemotherapy-induced apoptosis.",-36.5,0.6,sequencevariant
"In HeLa cells, the c.2406C>A sequence variant in the TP53 gene, which introduces a methionine to threonine substitution at codon&nbsp;235, was shown to impair p53-mediated apoptosis and thereby increase resistance to the chemotherapeutic drug doxorubicin.",-38.5,0.6,sequencevariant
"In the HeLa cell line, the c.2406C>A sequence variant in the TP53 gene was shown to cause a methionine to threonine substitution at codon‑235, which in turn reduced p53’s ability to induce apoptosis in response to doxorubicin treatment.",-33.5,0.6,sequencevariant
"In cells derived from a patient with a c.2406C>A sequence variant, the methionine to threonine substitution at codon **235** in the **TP53** gene leads to increased sensitivity to the chemotherapeutic agent doxorubicin, as demonstrated by heightened apoptosis in the **HeLa** cell line.",-53.0,0.6,sequencevariant
"In vitro assays revealed that the rs11915160 polymorphism, a c.2406C>A transition, increases the expression of TP53 in the HeLa cell line, thereby enhancing apoptosis in response to doxorubicin treatment.",-34.25,0.6,sequencevariant
"Sequencing of the KRAS gene in pancreatic ductal adenocarcinoma samples revealed a recurrent c.2406C>A substitution, corresponding to the Gly2079Val variant, that co‑occurs with an adjacent IVS8‑2A>G splice site mutation and a pathogenic p.G705RfsX16 frameshift in the same tumor, suggesting a synergistic effect on MAPK pathway hyperactivation.",-60.75,0.6,sequencevariant
"Sequenced analysis of the BRCA1 locus in a cohort of breast cancer patients revealed that the IVS8 -2A > G splice site variant co‑occurs with the c.2406C > A missense change, producing a methionine‑to‑threonine substitution at codon‑235 that may alter the protein’s DNA‑binding affinity.",-60.5,0.6,sequencevariant
"Sequenceregion analysis of the BRCA1 gene in a cohort of breast cancer patients revealed that the c.2406C>A transition, which introduces a methionine‑to‑threonine substitution at codon‑235, was significantly associated with an increased risk of early‑onset disease.",-55.0,0.6,sequencevariant
"Sequnce variant c.2406C>A in the *TP53* gene, which causes a methionine-to-threonine substitution at codon‑235, has been shown to enhance the risk of developing early‑onset breast cancer in women carrying the rs1870377 risk allele.",-62.5,0.6,sequencevariant
"Mutating the TP53 gene to a Gly2079Val sequence variant (c.2406C>A) in the A549 cell line dramatically increased apoptosis and sensitized the cells to doxorubicin, whereas the wild‑type TP53 conferred resistance.",-40.5,0.6,sequencevariant
"Mutations such as the Gly2079Val substitution in TP53, the rs11915160 SNP, and the c.2406C>A change in the BRCA1 promoter region have been shown to alter transcription factor binding and increase the risk of breast cancer.",-29.25,0.6,sequencevariant
"Mutational analysis of the TP53 gene in the HeLa cell line revealed that the Gly2079Val sequence variant (c.2406C>A) is associated with increased apoptosis following doxorubicin treatment, whereas the rs11915160 polymorphism in the same locus is linked to reduced drug sensitivity.",-39.0,0.6,sequencevariant
"Mutagenesis of the TP53 gene in H1299 cells revealed that the c.2406C>A sequence variant, which results in a methionine to threonine substitution at codon‑235, significantly increased the cells’ sensitivity to doxorubicin treatment.",-41.0,0.6,sequencevariant
"rs11915160, a missense variant causing a methionine to threonine substitution at codon‑235 in the BRCA1 gene, was found to impair DNA repair and increase breast cancer susceptibility in a cohort of European women.",-41.75,0.6,sequencevariant
"rs1870377, a c.2406C>A transition in the MAP2K1 gene, has been shown to cause a methionine‑to‑threonine substitution at codon‑235 that disrupts ERK signaling and predisposes A549 cells to increased sensitivity to the chemotherapeutic agent doxorubicin.",-45.25,0.6,sequencevariant
"rs1172415, a sequence variant that causes a methionine to threonine substitution at codon **235** in the **TP53** gene, was found to increase the risk of **lung cancer** in a cohort of **Homo sapiens** patients.",-56.0,0.6,sequencevariant
"rs2376600, a c.2406C>A transition in the TP53 gene, was found to coexist with a Gly2079Val substitution in the KRAS protein in a subset of colorectal cancer cell lines, suggesting a synergistic effect on MAPK pathway activation.",-58.0,0.6,sequencevariant
"Studies of the BRCA1 c.2406C>A variant, which produces a methionine‑to‑threonine substitution at codon‑235 and is associated with a higher risk of triple‑negative breast cancer, revealed that its presence in the A549 cell line correlates with increased sensitivity to the DNA‑damaging agent doxorubicin.",-52.75,0.6,sequencevariant
"Studies indicate that the Gly2079Val sequence variant in the KIF5B gene, together with the rs11915160 polymorphism, synergistically increases susceptibility to hereditary breast cancer by disrupting microtubule transport and enhancing estrogen receptor signaling.",-42.0,0.6,sequencevariant
"Studies in HeLa cells revealed that the rs11915160 polymorphism, a c.2406C>A transition that generates a methionine-to-threonine substitution at codon‑235, markedly increases TP53 transcriptional activity compared with the wild‑type allele.",-44.5,0.6,sequencevariant
"Studies using CRISPR/Cas9 editing in HeLa cells revealed that the c.2406C>A sequence variant in the TP53 gene, which introduces a methionine to threonine substitution at codon‑235 and is associated with rs11915160, leads to decreased p53 transcriptional activity and increased sensitivity to doxorubicin.",-53.0,0.6,sequencevariant
"Recent CRISPR‑edited HeLa cells harboring the p.G705RfsX16 sequence variant exhibit markedly reduced TP53 expression, thereby enhancing cisplatin resistance in this human cancer cell line.",-35.5,0.6,sequencevariant
"Recent studies revealed that the IVS8‑2A>G splice‑site mutation in the CFTR gene disrupts mRNA processing, leading to a truncated protein that underlies the severe cystic fibrosis phenotype observed in patients carrying the p.G705RfsX16 variant.",-37.5,0.6,sequencevariant
"Recent clinical sequencing of the BRCA1 locus revealed a novel c.2406C> A transition that results in a methionine to threonine substitution at codon~235, which has been associated with a markedly increased risk of breast cancer in carriers of the rs11915160 allele.",-52.25,0.6,sequencevariant
"Recent work demonstrates that the rs11915160 polymorphism, a methionine-to-threonine substitution at codon‑235 of the CYP2C9 gene, is associated with altered drug metabolism in patients treated with the antiepileptic drug carbamazepine, and that the presence of the IVS8‑2A>G splice‑site variant in the same locus can exacerbate the risk of hepatotoxicity by impairing the formation of the functional CYP2C9 protein.",-75.5,0.6,sequencevariant
"Mutation c.2406C>A in the KDR gene, which results in a methionine-to-threonine substitution at codon‑235, was found to be significantly associated with increased VEGF‑induced angiogenesis in HUVECs derived from a patient with a family history of colorectal cancer.",-52.0,0.6,sequencevariant
"Mutation of the TP53 gene at codon Gly2079Val (c.6237G>T) in the A549 cell line was shown to increase resistance to doxorubicin, a finding confirmed by sequencing the variant (rs11915160) in a cohort of Homo sapiens patients with Parkinson’s disease.",-48.25,0.6,sequencevariant
"Mutation analysis revealed that the c.2406C>A sequence variant, which causes a methionine to threonine substitution at codon‑235 in the BRCA1 gene, is associated with an increased risk of breast cancer in individuals carrying the rs11915160 allele.",-37.25,0.6,sequencevariant
"Mutation p.G705RfsX16 in the BRCA1 gene, identified by the rs11915160 variant, was shown to disrupt homologous recombination and increase susceptibility to triple‑negative breast cancer in a cohort of Homo sapiens patients.",-32.75,0.6,sequencevariant
"Cell culture experiments revealed that the Gly2079Val sequence variant in the KRAS gene, which corresponds to a methionine to threonine substitution at codon‑235, markedly increased ERK phosphorylation in A549 cells compared with the wild‑type sequence.",-44.5,0.6,sequencevariant
"Cell growth assays in A549 cells revealed that the c.2406C>A SequenceVariant in the TP53 gene caused a methionine to threonine substitution at codon **235**, reducing p53 transcriptional activity and increasing resistance to doxorubicin.",-49.25,0.6,sequencevariant
"Cell line A549, harboring the BRCA1 c.2406C>A sequence variant, displayed increased sensitivity to doxorubicin, a chemical entity that further amplified the mutant TP53 gene’s pro‑apoptotic signaling in Homo sapiens cells.",-39.75,0.6,sequencevariant
"Cell‑line HeLa, treated with the small‑molecule inhibitor doxorubicin, exhibited a pronounced reduction in TP53 protein levels that correlated with the presence of the sequence variant c.2406C>A, which causes a methionine‑to‑threonine substitution at codon‑235 and has been reported to impair the DNA‑binding domain of the p53 tumor‑suppressor protein.",-57.75,0.6,sequencevariant
"Alterations such as the Gly2079Val sequence variant in the TP53 gene, the rs11915160 polymorphism, and the c.2406C> A mutation in the BRCA1 locus have been linked to increased susceptibility to breast cancer.",-32.5,0.6,sequencevariant
"Alteration of the TP53 gene by the sequence variant rs11915160, which causes a methionine to threonine substitution at codon‑235, was shown to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients.",-39.0,0.6,sequencevariant
"Altered insulin signaling in A549 cells harboring the rs11915160 polymorphism in the GCKR gene results in a methionine to threonine substitution at codon‑235, which further enhances the risk of type‑2 diabetes in individuals of European ancestry.",-62.5,0.6,sequencevariant
"Altering the L501I sequence variant in the CYP2D6 gene (rs1870377) reduces enzymatic activity, thereby increasing the risk of drug-induced hepatotoxicity in patients treated with the chemotherapeutic agent doxorubicin.",-34.25,0.6,sequencevariant
"Gly2079Val, a missense sequence variant in the ATP7B gene, has been shown to alter copper transport and is strongly associated with Wilson disease in patients carrying the rs11915160 allele.",-22.625,0.6,sequencevariant
"Glu2079Val, a sequence variant in the TP53 gene, has been shown to alter the protein’s DNA‑binding affinity and is associated with an increased risk of therapy‑related leukemia in patients treated with doxorubicin.",-40.0,0.6,sequencevariant
"G9A cells carrying the p.G705RfsX16 sequence variant exhibit increased resistance to doxorubicin, a phenotype that correlates with upregulated TP53 expression and heightened apoptotic signaling in the HeLa cell line.",-52.75,0.6,sequencevariant
"Gastrointestinal bleeding in patients carrying the c.2406C>A variant of the CYP2C9 gene was markedly reduced when treated with the selective inhibitor rivaroxaban, whereas the same effect was not observed in subjects with the rs11915160 SNP.",-47.25,0.6,sequencevariant
"Gene silencing of TP53 by CRISPR/Cas9 in A549 cells harboring the c.2406C>A sequence variant, which leads to a methionine‑to‑threonine substitution at codon‑235, reduces cell‑cycle arrest and enhances proliferation.",-46.0,0.6,sequencevariant
"Gene editing of the TP53 locus in HCT116 cells revealed that the p.G705RfsX16 sequence variant, which deletes a stretch of nucleotides from positions c.2406C to A, dramatically reduces p53 transcriptional activity and increases resistance to doxorubicin-induced apoptosis.",-56.25,0.6,sequencevariant
"Gene therapy targeting the BRCA1 c.2406C>A variant has been shown to reduce DNA repair defects in A549 cells, yet the Gly2079Val substitution in TP53 remains a major contributor to chemoresistance in these tumors.",-39.25,0.6,sequencevariant
"Gene‑editing of the TP53 locus in A549 cells revealed that the c.2406C>A sequence variant, which introduces a methionine‑to‑threonine substitution at codon‑235, markedly reduces p53 transcriptional activity and increases cellular sensitivity to doxorubicin.",-37.75,0.6,sequencevariant
Sequence variance p.G705RfsX16 in the TP53 gene was detected in a HeLa cell line and correlated with increased apoptosis in response to doxorubicin treatment.,-35.0,0.6,sequencevariant
"SequenceVariant c.2406C>A in the TP53 gene, which results in a methionine to threonine substitution at codon‑235, was found to be more frequent in tumor samples from patients with the rs11915160 polymorphism compared with controls.",-48.0,0.6,sequencevariant
"Sequence analysis of a colorectal carcinoma cell line revealed that the p.G705RfsX16 sequence variant, a frameshift caused by a c.2406C>A substitution, co‑occurs with the rs11915160 single‑nucleotide polymorphism and a methionine‑to‑threonine substitution at codon‑235, suggesting a compound heterozygous mutation pattern that may drive tumor progression.",-61.0,0.6,sequencevariant
"Sequence variants such as Gly2079Val, rs11915160, and the c.2406C>A substitution in TP53 are frequently associated with altered transcriptional activity and increased susceptibility to drug-induced hepatotoxicity in patients with chronic hepatitis C infection.",-43.75,0.6,sequencevariant
"In A549 cells, the BRCA1 sequence variant g.3503C>T induces a D418D missense change that destabilizes the protein, thereby amplifying TP53‑mediated apoptosis and sensitizing the cells to doxorubicin treatment.",-32.0,0.6,sequencevariant
"In HEK293 cells, the BRCA1 sequence variant g.3503C>T, which introduces a premature E873stop codon and a concurrent A467T substitution, was shown to impair homologous recombination repair and increase sensitivity to the DNA‑crosslinking agent cisplatin.",-29.625,0.6,sequencevariant
"In HCC cell line HepG2, the BRCA1 sequence variant g.3503C>T was shown to increase the expression of the DNA‑repair gene RAD51, thereby enhancing resistance to the chemotherapeutic agent doxorubicin.",-27.125,0.6,sequencevariant
"In the A549 cell line, the BRCA1 sequence variant BRCA1 c.5382insC was shown to disrupt DNA repair, thereby increasing sensitivity to the chemotherapeutic agent doxorubicin.",-20.0,0.6,sequencevariant
"The c.1665delC sequence variant in the BRCA1 gene, which causes a frameshift and premature truncation, was found to significantly increase the risk of breast cancer in a cohort of women of European ancestry, while the c.5382insC variant, which generates a polyalanine tract expansion in the androgen receptor, was associated with early-onset prostate cancer in men of African descent.",-56.25,0.6,sequencevariant
"The A549 cell line expressing the BRCA1 c.1665delC sequence variant displayed increased sensitivity to doxorubicin, while the TP53 c.5382insC mutation in the same cells conferred resistance to cisplatin.",-23.875,0.6,sequencevariant
"The g.3503C>T variant, which creates a premature E873stop in the TP53 gene, was found to be associated with increased apoptosis in the HeLa cell line and a higher incidence of the R246W mutation in patients with breast cancer.",-40.0,0.6,sequencevariant
"The heterozygous BRCA1 c.68_69delAG sequence variant (R246W) in a breast cancer patient led to a truncated protein with impaired DNA repair activity, thereby increasing her susceptibility to treatment‑induced toxicity.",-34.5,0.6,sequencevariant
"A BRCA1 c.68_69delAG sequence variant disrupts the DNA repair function of the TP53 protein, thereby increasing the risk of breast cancer in Homo sapiens carriers.",-27.0,0.6,sequencevariant
"A D418D sequence variant in the TP53 gene was found to increase the risk of apoptosis resistance in HeLa cells, while the R246W mutation in the BRCA1 gene was associated with reduced DNA repair capacity in A549 cells.",-28.75,0.6,sequencevariant
"A missense variant R246W in the TP53 gene was found to destabilize the protein’s DNA‑binding domain, thereby impairing p53‑mediated apoptosis in HeLa cells and predisposing them to resistance against doxorubicin.",-29.625,0.6,sequencevariant
A homozygous BRCA1 c.5382insC variant in a female E. coli‑derived HeLa cell line caused a dramatic reduction in DNA repair protein RAD51 levels and conferred resistance to the chemotherapeutic doxorubicin.,-43.5,0.6,sequencevariant
"Mutation of the TP53 gene in HeLa cells, specifically the D418D sequence variant, was shown to disrupt p53's transcriptional activity, leading to uncontrolled proliferation of the cancerous cell line.",-34.5,0.6,sequencevariant
Mutation R246W in the BRCA1 gene was shown to reduce DNA repair efficiency and increase breast cancer risk in a cohort of Homo sapiens patients.,-25.75,0.6,sequencevariant
"Mutation c.1665delC in the BRCA1 gene was found to impair homologous recombination repair in HeLa cells, leading to increased sensitivity to the DNA‑damaging agent doxorubicin.",-23.5,0.6,sequencevariant
"Mutation analysis of a colorectal carcinoma sample revealed a novel BRCA1 sequence variant c.1665delC, which co‑occurs with a pathogenic TP53 missense change R246W and an E873stop/A467T fusion, suggesting a complex genotype that may drive aggressive tumor progression.",-44.5,0.6,sequencevariant
"Sequence variants such as the BRCA1 c.5382insC insertion, the TP53 p.R246W missense mutation, and the CYP2C19 g.3503C>T polymorphism were concurrently detected in the same tumor sample, suggesting a cooperative impact on chemoresistance in the A549 cell line.",-41.5,0.6,sequencevariant
"Sequence analyses of the TP53 gene in the A549 cell line revealed a novel BRCA1 c.5382insC variant, while a separate g.3503C>T mutation in the KRAS gene was identified in a subset of E. coli-derived plasmids, suggesting a potential linkage between the R246W and D418D sequence variants and altered oncogenic signaling pathways.",-59.75,0.6,sequencevariant
"Sequence variant g.3503C>T in the TP53 gene, which replaces an alanine with a threonine at position K386T, was found to destabilize the DNA binding domain and correlate with increased risk of colorectal carcinoma in a cohort of Homo sapiens patients.",-40.75,0.6,sequencevariant
"Sequence‑variant R246W in the TP53 gene, detected in a colorectal carcinoma patient, was shown to impair p53‑mediated DNA‑damage response and to correlate with resistance to the chemotherapeutic agent doxorubicin.",-40.75,0.6,sequencevariant
"Sequencing of the EGFR locus in lung adenocarcinoma patient-derived A549 cells revealed a novel sequence variant, c.1665delC, which introduces a frameshift leading to a premature stop codon and loss of the kinase domain.",-36.5,0.6,sequencevariant
"Sequenced tumor DNA from a patient with metastatic colorectal cancer revealed a novel BRCA1 sequence variant, c.5382insC, that truncates the protein at the C‑terminal domain, while another variant, c.1665delC, produces a frameshift resulting in a premature stop codon at p.R550X, both of which are predicted to disrupt DNA repair and may contribute to the aggressive phenotype observed in this case.",-72.5,0.6,sequencevariant
"Sequencereporting the BRCA1 variant g.3503C>T in a cohort of breast cancer patients revealed that carriers of the deleterious mutation displayed increased sensitivity to the PARP inhibitor olaparib, whereas individuals homozygous for the benign polymorphism R246W showed no therapeutic benefit.",-52.75,0.6,sequencevariant
"Sequencer‑derived analysis of the BRCA1 c.68_69delAG variant (D418D) in a cohort of triple‑negative breast cancer patients revealed that the concurrent R246W mutation in the same allele, together with the g.3503C>T polymorphism, significantly increases the risk of platinum‑based chemoresistance compared with patients carrying the isolated D418D variant alone.",-66.0,0.6,sequencevariant
"Mutations such as the D418D, R246W, and Asn127Ser sequence variants in the CYP2D6 gene have been shown to alter enzyme activity and increase the risk of adverse drug reactions in patients treated with tamoxifen.",-28.875,0.6,sequencevariant
Mutant p53 harboring the D418D sequence variant has been shown to impair DNA binding and accelerate the progression of colorectal cancer in patients carrying the g.3503C>T polymorphism.,-37.75,0.6,sequencevariant
Mutational analysis revealed that the BRCA1 c.68_69delAG variant (SequenceVariant) confers a higher risk of breast cancer in patients carrying the TP53 R248Q mutation (SequenceVariant) compared to those with the wild‑type allele.,-32.25,0.6,sequencevariant
"Mutagenic exposure to benzo[a]pyrene induces the BRCA1 c.5382insC sequence variant, which is frequently observed in breast cancer cell lines such as MCF-7 and is associated with impaired DNA repair and increased tumor aggressiveness.",-34.5,0.6,sequencevariant
Impaired DNA repair in A549 cells harboring the BRCA1 c.5382insC sequence variant leads to a marked increase in cisplatin‑induced apoptosis compared with wild‑type cells.,-28.25,0.6,sequencevariant
"Immunohistochemical analysis of tumor samples from patients carrying the BRCA1 SequenceVariant c.5382insC revealed a markedly reduced nuclear localization of the TP53 protein, suggesting that this insertion disrupts the DNA‑binding domain and compromises p53‑mediated apoptosis.",-39.5,0.6,sequencevariant
"Impairment of the DNA mismatch repair pathway in colorectal carcinoma cells harboring the BRCA1 g.3503C>T variant was linked to an elevated frequency of the R246W sequence variant in the MLH1 gene, thereby enhancing tumor mutational burden and resistance to platinum-based chemotherapy.",-54.0,0.6,sequencevariant
Imaging of patients with the BRCA1 c.5382insC sequence variant revealed a higher incidence of triple‑negative breast cancer compared with individuals carrying the wild‑type allele.,-33.75,0.6,sequencevariant
"Altering the TP53 sequence variant R246W in A549 cells significantly increases apoptosis in response to doxorubicin, as confirmed by flow cytometry and Western blot analysis of cleaved caspase‑3.",-34.5,0.6,sequencevariant
"Alzheimer’s disease risk is increased in patients carrying the BRCA1 SequenceVariant g.3503C>T, which introduces a premature E873stop codon and a concomitant A467T missense mutation that destabilizes the protein.",-38.0,0.6,sequencevariant
"Alpasinin, a novel sequence variant in the TP53 gene (c.5382insC) found in a HeLa cell line, disrupts the p53 DNA‑binding domain and enhances the cell’s resistance to doxorubicin, thereby increasing the risk of chemotherapy‑induced apoptosis in Homo sapiens.",-62.25,0.6,sequencevariant
"Alvastatin markedly reduced the growth of HCT116 cells harboring the BRCA1 sequence variant g.3503C>T, suggesting that this mutation may sensitize colorectal cancer cells to statin‑based chemoprevention.",-43.25,0.6,sequencevariant
Patients harboring the BRCA1 sequence variant BRCA1 c.5382insC exhibited markedly reduced homologous recombination repair capacity compared with those carrying the wild‑type allele.,-21.5,0.6,sequencevariant
"Patients carrying the BRCA1 sequence variant BRCA1 c.5382insC exhibited a markedly higher risk of early‑onset breast cancer, while those with the TP53 variant TP53 c.1665delC showed an increased incidence of Li–Fraumeni syndrome.",-33.0,0.6,sequencevariant
Patients with the BRCA1 sequence variant g.3503C>T exhibited a higher frequency of triple-negative breast cancer compared with carriers of the benign K386T polymorphism.,-23.625,0.6,sequencevariant
"Patients treated with the E873stop/A467T variant of the CFTR gene exhibited markedly reduced chloride transport in the A549 cell line, confirming that this sequence variant impairs CFTR function.",-33.25,0.6,sequencevariant
"Genome‑wide association studies revealed that the BRCA1 SequenceVariant g.3503C>T, which introduces a premature E873stop and a concurrent A467T substitution, is strongly linked to increased breast cancer risk in individuals carrying the K386T polymorphism.",-34.25,0.6,sequencevariant
"Genome-wide association studies revealed that the BRCA1 sequence variant g.3503C>T, which results in the amino‑acid substitution R246W, is strongly associated with an increased risk of breast cancer in women of European ancestry.",-29.25,0.6,sequencevariant
"Genome editing of the TP53 gene in HeLa cells revealed that the R246W sequence variant (c.736G>T) alters the protein’s DNA-binding domain, leading to a marked increase in apoptotic signaling and a reduction in cell proliferation compared to the wild‑type allele.",-51.25,0.6,sequencevariant
"Genome‐wide association analysis revealed that the BRCA1 sequence variant BRCA1 c.5382insC, which introduces a frameshift leading to a premature stop codon at E873, is significantly associated with increased breast cancer risk in individuals carrying the additional R3500Q missense mutation in the same gene.",-44.5,0.6,sequencevariant
"R246W in the TP53 gene was found to increase apoptosis in HeLa cells, whereas the D418D variant in the same gene exhibited no detectable effect on cell viability.",-32.25,0.6,sequencevariant
"R3500Q in the TP53 gene, a sequence variant detected in a HeLa cell line, was shown to increase the transcriptional activity of the TP53 promoter and sensitize the cells to doxorubicin treatment.",-36.75,0.6,sequencevariant
"R381C, a sequence variant in the TP53 gene, was found to impair p53’s transcriptional activity in HeLa cells, thereby reducing the expression of the downstream gene CDKN1A and increasing cellular proliferation.",-45.25,0.6,sequencevariant
"R550Q in the BRCA1 gene, a sequence variant that disrupts the DNA repair domain, is associated with a markedly increased risk of hereditary breast cancer in a cohort of Homo sapiens patients carrying the same mutation.",-46.25,0.6,sequencevariant
"Ectopic expression of the TP53 c.1665delC variant in A549 cells leads to a dramatic increase in apoptosis, confirming the pathogenic role of this sequence variant in lung cancer.",-31.375,0.6,sequencevariant
"E873stop/A467T in the BRCA1 gene was shown to impair DNA repair and increase susceptibility to breast cancer in a cohort of Homo sapiens patients, while the R246W variant in TP53 was associated with altered p53 transcriptional activity in HeLa cells.",-39.25,0.6,sequencevariant
"Epidemiologic analysis revealed that the BRCA1 sequence variant g.3503C>T, which results in the Asn127Ser substitution, is significantly associated with a higher incidence of breast cancer in women carrying the BRCA1 c.5382insC mutation.",-37.0,0.6,sequencevariant
E863stop/A467T and the R246W variant in the CYP2D6 gene were found to alter the pharmacodynamics of fluvoxamine in a cohort of Homo sapiens patients with major depressive disorder.,-47.5,0.6,sequencevariant
"Researchers demonstrated that the BRCA1 sequence variant g.3503C>T, which results in the amino‑acid substitution Asn127Ser, markedly increases the risk of triple‑negative breast cancer in women of Ashkenazi Jewish descent.",-29.125,0.6,sequencevariant
"Researchers observed that the BRCA1 sequence variant BRCA1 c.68_69delAG, which results in the protein alteration D418D, significantly increases the risk of breast cancer in female patients of Homo sapiens, whereas the novel variant TP53 c.101G>A (p.R3500Q) was found to be protective in a small cohort of E. coli‑derived cell lines.",-66.5,0.6,sequencevariant
"Researchers found that the BRCA1 SequenceVariant c.5382insC, which introduces a premature E873stop, is associated with increased DNA repair deficiency and a higher risk of breast cancer in individuals carrying the concomitant R246W mutation.",-43.75,0.6,sequencevariant
"Researchers discovered that the BRCA1 sequence variant g.3503C>T, which induces a K386T amino‑acid change, markedly increases the risk of triple‑negative breast cancer in patients carrying the additional R246W mutation.",-34.5,0.6,sequencevariant
